PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Garcia-Perez, J; Rueda, P; Staropoli, I; Kellenberger, E; Alcami, J; Arenzana-Seisdedos, F; Lagane, B				Garcia-Perez, Javier; Rueda, Patricia; Staropoli, Isabelle; Kellenberger, Esther; Alcami, Jose; Arenzana-Seisdedos, Fernando; Lagane, Bernard			New Insights into the Mechanisms whereby Low Molecular Weight CCR5 Ligands Inhibit HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR CCR5; MACROPHAGE-TROPIC HIV-1; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; BINDING-PROPERTIES; RESISTANT HIV-1; POTENT ACTIVITY; GP120 BINDING; IN-VITRO	CC chemokine receptor 5 (CCR5) is a G-protein-coupled receptor for the chemokines CCL3, -4, and -5 and a coreceptor for entry of R5-tropic strains of human immunodeficiency virus type 1 (HIV-1) into CD4(+) T-cells. We investigated the mechanisms whereby nonpeptidic, low molecular weight CCR5 ligands block HIV-1 entry and infection. Displacement binding assays and dissociation kinetics demonstrated that two of these molecules, i.e. TAK779 and maraviroc (MVC), inhibit CCL3 and the HIV-1 envelope glycoprotein gp120 binding to CCR5 by a noncompetitive and allosteric mechanism, supporting the view that they bind to regions of CCR5 distinct from the gp120- and CCL3-binding sites. We observed that TAK779 and MVC are full and weak inverse agonists for CCR5, respectively, indicating that they stabilize distinct CCR5 conformations with impaired abilities to activate G-proteins. Dissociation of [I-125] CCL3 from CCR5 was accelerated by TAK779, to a lesser extent by MVC, and by GTP analogs, suggesting that inverse agonism contributes to allosteric inhibition of the chemokine binding to CCR5. TAK779 and MVC also promote dissociation of [S-35] gp120 from CCR5 with an efficiency that correlates with their ability to act as inverse agonists. Displacement experiments revealed that affinities of MVC and TAK779 for the [S-35]gp120-binding receptors are in the same range (IC50 similar to 6.4 versus 22 nM), although we found that MVC is 100-fold more potent than TAK779 for inhibiting HIV infection. This suggests that allosteric CCR5 inhibitors not only act by blocking gp120 binding but also alter distinct steps of CCR5 usage in the course of HIV infection.	[Garcia-Perez, Javier; Rueda, Patricia; Staropoli, Isabelle; Arenzana-Seisdedos, Fernando; Lagane, Bernard] Inst Pasteur, Unite Pathogenie Virale, F-75724 Paris 15, France; [Garcia-Perez, Javier; Rueda, Patricia; Staropoli, Isabelle; Arenzana-Seisdedos, Fernando; Lagane, Bernard] INSERM, U819, F-75724 Paris 15, France; [Garcia-Perez, Javier; Alcami, Jose] Inst Salud Carlos III, Majadahonda Madrid 28220, Spain; [Kellenberger, Esther] Univ Strasbourg, Lab Therapeut Innovat, F-67400 Illkirch Graffenstaden, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Instituto de Salud Carlos III; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lagane, B (corresponding author), Inst Pasteur, Unite Pathogenie Virale, 28 Rue Docteur Roux, F-75724 Paris 15, France.	bernard.lagane@pasteur.fr	Lagane, Bernard/K-8446-2016; Lagane, Bernard/AAA-2205-2019; García-Pérez, Javier/F-9248-2019; Kellenberger, Esther/AFN-2081-2022; Arenzana-Seisdedos, Fernando/E-5835-2016; Alcami, Pepe/T-2242-2018	Lagane, Bernard/0000-0002-3459-7867; García-Pérez, Javier/0000-0001-7551-7803; Kellenberger, Esther/0000-0002-9320-4840; Alcami, Pepe/0000-0003-0023-7377; Rueda, Patricia/0000-0003-1553-0840	Agence Nationale de Recherche sur le SIDA; INSERM; Instituto de Salud Carlos III [ISCIII-RETIC RD06/0006, PI08075]; Fundacion para la Investigacion y la Prevencion del SIDA en Espana [36630/07]	Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion para la Investigacion y la Prevencion del SIDA en Espana	This work was supported in part by the Agence Nationale de Recherche sur le SIDA, INSERM, the Instituto de Salud Carlos III Projects ISCIII-RETIC RD06/0006 and PI08075, and the Fundacion para la Investigacion y la Prevencion del SIDA en Espana Project 36630/07.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Amara A, 2003, J VIROL, V77, P2550, DOI 10.1128/JVI.77.4.2550-2558.2003; Anand AR, 2009, BLOOD, V114, P3588, DOI 10.1182/blood-2009-02-206342; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719; Brower ET, 2009, BIOCHEMISTRY-US, V48, P779, DOI 10.1021/bi8021476; Buontempo PJ, 2009, VIROLOGY, V395, P268, DOI 10.1016/j.virol.2009.09.029; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Chen G, 2000, MOL PHARMACOL, V57, P125; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christopoulos A, 1997, BIOCHEM PHARMACOL, V53, P795, DOI 10.1016/S0006-2952(96)00814-3; Cicala C, 1999, J IMMUNOL, V163, P420; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Del Corno M, 2001, BLOOD, V98, P2909, DOI 10.1182/blood.V98.10.2909; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Doranz BJ, 1999, J VIROL, V73, P10346, DOI 10.1128/JVI.73.12.10346-10358.1999; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Gaibelet G, 2006, J BIOL CHEM, V281, P37921, DOI 10.1074/jbc.M607103200; Garcia-Perez J, 2007, J MED VIROL, V79, P127, DOI 10.1002/jmv.20770; Gonzalez N, 2010, J VIROL, V84, P4341, DOI 10.1128/JVI.02449-09; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Haworth B, 2007, BIOCHEM PHARMACOL, V74, P891, DOI 10.1016/j.bcp.2007.06.032; Heredia A, 2008, P NATL ACAD SCI USA, V105, P20476, DOI 10.1073/pnas.0810843106; Hu QX, 2010, J GEN VIROL, V91, P2965, DOI 10.1099/vir.0.025270-0; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Lee S, 2000, J VIROL, V74, P5016, DOI 10.1128/JVI.74.11.5016-5023.2000; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; McNicholas P, 2010, J INFECT DIS, V201, P1470, DOI 10.1086/652189; Meanger J, 1997, BIOTECHNIQUES, V23, P432, DOI 10.2144/97233bm18; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Muniz-Medina VM, 2009, MOL PHARMACOL, V75, P490, DOI 10.1124/mol.108.052555; Napier C, 2005, BIOCHEM PHARMACOL, V71, P163, DOI 10.1016/j.bcp.2005.10.024; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Pugach P, 2007, VIROLOGY, V361, P212, DOI 10.1016/j.virol.2006.11.004; Pugach P, 2009, VIROLOGY, V387, P296, DOI 10.1016/j.virol.2009.02.044; Ray Neelanjana, 2009, Drug Des Devel Ther, V2, P151; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Safarian D, 2006, VIROLOGY, V352, P477, DOI 10.1016/j.virol.2006.05.016; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Stantchev TS, 2001, CYTOKINE GROWTH F R, V12, P219, DOI 10.1016/S1359-6101(00)00033-2; Staropoli I, 2000, J BIOL CHEM, V275, P35137, DOI 10.1074/jbc.M003868200; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Vandekerckhove L, 2009, J ANTIMICROB CHEMOTH, V63, P1087, DOI 10.1093/jac/dkp113; Verrier FC, 1997, P NATL ACAD SCI USA, V94, P9326, DOI 10.1073/pnas.94.17.9326; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	68	63	65	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4978	4990		10.1074/jbc.M110.168955	http://dx.doi.org/10.1074/jbc.M110.168955			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21118814	Green Published, hybrid			2022-12-25	WOS:000287230600006
J	Harris, SR; Zhang, GF; Sadhukhan, S; Murphy, AM; Tomcik, KA; Vazquez, EJ; Anderson, VE; Tochtrop, GP; Brunengraber, H				Harris, Stephanie R.; Zhang, Guo-Fang; Sadhukhan, Sushabhan; Murphy, Anne M.; Tomcik, Kristyen A.; Vazquez, Edwin J.; Anderson, Vernon E.; Tochtrop, Gregory P.; Brunengraber, Henri			Metabolism of Levulinate in Perfused Rat Livers and Live Rats CONVERSION TO THE DRUG OF ABUSE 4-HYDROXYPENTANOATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; NADP+-DEPENDENT OXIDOREDUCTASE; GAMMA-HYDROXYBUTYRATE; CALCIUM LEVULINATE; ISOTOPIC ENRICHMENT; ETHANOL-METABOLISM; DEHYDROGENASE; KINETICS; GHB; COA	Calcium levulinate (4-ketopentanoate) is used as an oral and parenteral source of calcium. We hypothesized that levulinate is converted in the liver to 4-hydroxypentanoate, a new drug of abuse, and that this conversion is accelerated by ethanol oxidation. We confirmed these hypotheses in live rats, perfused rat livers, and liver subcellular preparations. Levulinate is reduced to (R)-4-hydroxypentanoate by a cytosolic and a mitochondrial dehydrogenase, which are NADPH-and NADH-dependent, respectively. A mitochondrial dehydrogenase or racemase system also forms (S)-4-hydroxypentanoate. In livers perfused with [C-13(5)] levulinate, there was substantial CoA trapping in levulinyl-CoA, 4-hydroxypentanoyl-CoA, and 4-phosphopentanoyl-CoA. This CoA trapping was increased by ethanol, with a 6-fold increase in the concentration of 4-phosphopentanoyl-CoA. Levulinate is catabolized by 3 parallel pathways to propionyl-CoA, acetyl-CoA, and lactate. Most intermediates of the 3 pathways were identified by mass isotopomer analysis and metabolomics. The production of 4-hydroxypentanoate from levulinate and its stimulation by ethanol is a potential public health concern.	[Harris, Stephanie R.; Zhang, Guo-Fang; Murphy, Anne M.; Tomcik, Kristyen A.; Vazquez, Edwin J.; Brunengraber, Henri] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Sadhukhan, Sushabhan; Tochtrop, Gregory P.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Anderson, Vernon E.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Brunengraber, H (corresponding author), 10900 Euclid Ave,WG-48, Cleveland, OH 44106 USA.	hxb8@case.edu	Sadhukhan, Sushabhan/AAS-7136-2020	Sadhukhan, Sushabhan/0000-0002-3302-5875; Harris, Stephanie/0000-0003-2239-0575; Anderson, Vernon Emmett/0000-0002-1699-7621	National Institutes of Health [R33DK070291, R01ES013925, RO1HL053315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R33DK070291 (Roadmap grant) and R01ES013925 (to H.B.) and Grant RO1HL053315 (to G. P.T.).	Anderson IB, 2006, ANN EMERG MED, V47, P177, DOI 10.1016/j.annemergmed.2005.10.012; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; Carter LP, 2005, DRUG ALCOHOL DEPEN, V78, P91, DOI 10.1016/j.drugalcdep.2004.10.002; Croes K, 1997, FEBS LETT, V407, P197, DOI 10.1016/S0014-5793(97)00343-8; Deng S, 2009, J BIOL CHEM, V284, P27799, DOI 10.1074/jbc.M109.048744; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fiehn O, 2003, EUR J BIOCHEM, V270, P579, DOI 10.1046/j.1432-1033.2003.03427.x; Gibson KM, 2005, IUBMB LIFE, V57, P639, DOI 10.1080/15216540500264588; Gordon B, 1933, J LAB CLIN MED, V18, P507; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; HUTH W, 1973, H-S Z PHYSIOL CHEM, V354, P635, DOI 10.1515/bchm2.1973.354.1.635; JOUBERT C, 1995, J LABELLED COMPD RAD, V36, P745, DOI 10.1002/jlcr.2580360806; KASHIWAGI T, 1982, MOL PHARMACOL, V21, P438; Kasumov T, 2002, ANAL BIOCHEM, V305, P90, DOI 10.1006/abio.2002.5639; KAUFMAN EE, 1981, J BIOL CHEM, V256, P6890; KAUFMAN EE, 1987, J NEUROCHEM, V48, P1935, DOI 10.1111/j.1471-4159.1987.tb05758.x; KAUFMAN EE, 1991, NEUROCHEM RES, V16, P965, DOI 10.1007/BF00965839; KOEPPE RE, 1959, J BIOL CHEM, V234, P2219; KOLVRAA S, 1977, CLIN CHIM ACTA, V77, P197, DOI 10.1016/0009-8981(77)90027-4; LEHNINGER AL, 1960, J BIOL CHEM, V235, P2450; Marinetti L. J., 2003, THESIS WAYNE STATE U; Marinetti LJ, 2005, J ANAL TOXICOL, V29, P41, DOI 10.1093/jat/29.1.41; Mercer J, 2006, J ANAL TOXICOL, V30, P539, DOI 10.1093/jat/30.8.539; Mitchell GA, 2008, MOL GENET METAB, V94, P4, DOI 10.1016/j.ymgme.2007.12.005; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; POWERS L, 1994, ANAL BIOCHEM, V221, P323, DOI 10.1006/abio.1994.1420; PREUVENEERS MJ, 1973, BIOCHEM J, V133, P133, DOI 10.1042/bj1330133; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; Sadhukhan S, 2010, J AM CHEM SOC, V132, P6309, DOI 10.1021/ja100399m; Siler SQ, 1999, AM J CLIN NUTR, V70, P928; Struys EA, 2004, FEBS LETT, V557, P115, DOI 10.1016/S0014-5793(03)01459-5; Takayasu T, 1995, FORENSIC SCI INT, V76, P129, DOI 10.1016/0379-0738(95)01807-7; Tischer R., 1942, J AM PHARM ASSOC, V31, P217; Tomcik K, 2011, ANAL BIOCHEM, V410, P110, DOI 10.1016/j.ab.2010.11.030; Veech R L, 1981, Curr Top Cell Regul, V18, P151; Williams M, 2007, Ned Tijdschr Geneeskd, V151, P1191; Zhang G. F., 2011, J BIOL CHEM IN PRESS, P286; Zhang GF, 2009, J BIOL CHEM, V284, P33521, DOI 10.1074/jbc.M109.055665	38	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5895	5904		10.1074/jbc.M110.196808	http://dx.doi.org/10.1074/jbc.M110.196808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21126961	Green Published, hybrid			2022-12-25	WOS:000287230600098
J	Micheli, L; Leonardi, L; Conti, F; Maresca, G; Colazingari, S; Mattei, E; Lira, SA; Farioli-Vecchioli, S; Caruso, M; Tirone, F				Micheli, Laura; Leonardi, Luca; Conti, Filippo; Maresca, Giovanna; Colazingari, Sandra; Mattei, Elisabetta; Lira, Sergio A.; Farioli-Vecchioli, Stefano; Caruso, Maurizia; Tirone, Felice			PC4/Tis7/IFRD1 Stimulates Skeletal Muscle Regeneration and Is Involved in Myoblast Differentiation as a Regulator of MyoD and NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GENE-EXPRESSION; CELL-CYCLE; MYOGENIC DIFFERENTIATION; NUCLEAR-FACTOR; TRANSCRIPTION FACTOR; MOLECULAR REGULATION; MAMMALIAN-CELLS; SATELLITE CELLS; ACTIVATION	In skeletal muscle cells, the PC4 (Tis7/Ifrd1) protein is known to function as a coactivator of MyoD by promoting the transcriptional activity of myocyte enhancer factor 2C (MEF2C). In this study, we show that up-regulation of PC4 in vivo in adult muscle significantly potentiates injury-induced regeneration by enhancing myogenesis. Conversely, we observe that PC4 silencing in myoblasts causes delayed exit from the cell cycle, accompanied by delayed differentiation, and we show that such an effect is MyoD-dependent. We provide evidence revealing a novel mechanism underlying the promyo-genic actions of PC4, by which PC4 functions as a negative regulator of NF-kappa B, known to inhibit MyoD expression post-transcriptionally. In fact, up-regulation of PC4 in primary myoblasts induces the deacetylation, and hence the inactivation and nuclear export of NF-kappa B p65, in concomitance with induction of MyoD expression. On the contrary, PC4 silencing in myoblasts induces the acetylation and nuclear import of p65, in parallel with a decrease of MyoD levels. We also observe that PC4 potentiates the inhibition of NF-kappa B transcriptional activity mediated by histone deacetylases and that PC4 is able to form trimolecular complexes with p65 and HDAC3. This suggests that PC4 stimulates deacetylation of p65 by favoring the recruitment of HDAC3 to p65. As a whole, these results indicate that PC4 plays a role in muscle differentiation by controlling the MyoD pathway through multiple mechanisms, and as such, it positively regulates regenerative myogenesis.	[Micheli, Laura; Leonardi, Luca; Conti, Filippo; Maresca, Giovanna; Colazingari, Sandra; Mattei, Elisabetta; Farioli-Vecchioli, Stefano; Caruso, Maurizia; Tirone, Felice] Fdn S Lucia, CNR, Ist Neurobiol & Med Mol, I-00143 Rome, Italy; [Lira, Sergio A.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA	Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; Icahn School of Medicine at Mount Sinai	Tirone, F (corresponding author), Fdn S Lucia, CNR, Ist Neurobiol & Med Mol, Via Fosso di Fiorano 64, I-00143 Rome, Italy.	tirone@inmm.cnr.it	Caruso, Maurizia/G-8895-2013; Micheli, Laura/AAY-1641-2020; vecchioli, stefano farioli/ABE-2288-2020; Tirone, Felice/P-6745-2014	Caruso, Maurizia/0000-0001-5445-6343; MICHELI, LAURA/0000-0001-8647-7261; farioli vecchioli, stefano/0000-0001-7059-7779; Tirone, Felice/0000-0002-0980-4377	Telethon [GGP00582]; Fondo Investimenti Ricerca di Base [RBIN04P4ET]; Progetti di Ricerca Interesse Nazionale [20074Z3H3N_003]; Finanziaria Laziale di Sviluppo Regione Lazio	Telethon(Fondazione Telethon); Fondo Investimenti Ricerca di Base; Progetti di Ricerca Interesse Nazionale; Finanziaria Laziale di Sviluppo Regione Lazio	This work was supported in part by Telethon Grant GGP00582, Fondo Investimenti Ricerca di Base Project RBIN04P4ET, and Progetti di Ricerca Interesse Nazionale Project 20074Z3H3N_003.; Supported by Finanziaria Laziale di Sviluppo Regione Lazio.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buanne P, 1998, GENOMICS, V51, P233, DOI 10.1006/geno.1998.5260; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Fimia GM, 1998, MOL BIOL CELL, V9, P1449, DOI 10.1091/mbc.9.6.1449; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; GUARDAVACCARO D, 1995, CELL GROWTH DIFFER, V6, P159; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; HOGAN BL, 1995, MANIPULATING MOUSE E; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Jacquemin V, 2007, J CELL SCI, V120, P670, DOI 10.1242/jcs.03371; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; L'honore A, 2007, MOL BIOL CELL, V18, P1992, DOI 10.1091/mbc.E06-09-0867; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; MARTELLI F, 1994, ONCOGENE, V9, P3579; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Micheli L, 2005, MOL CELL BIOL, V25, P2242, DOI 10.1128/MCB.25.6.2242-2259.2005; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; SARTORELLI V, 2004, SCI STKE, pRE11, DOI DOI 10.1126/STKE.2442004RE11; Seale P, 2004, DEV BIOL, V275, P287, DOI 10.1016/j.ydbio.2004.07.034; Soddu S, 1996, J CELL BIOL, V134, P193, DOI 10.1083/jcb.134.1.193; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; TIRONE F, 1989, P NATL ACAD SCI USA, V86, P2088, DOI 10.1073/pnas.86.6.2088; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Vadivelu SK, 2004, MOL CELL BIOL, V24, P3514, DOI 10.1128/MCB.24.8.3514-3525.2004; Vietor I, 2002, EMBO J, V21, P4621, DOI 10.1093/emboj/cdf461; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Welcker M, 2005, CURR BIOL, V15, pR810, DOI 10.1016/j.cub.2005.09.018; Wiekowski MT, 2001, J IMMUNOL, V167, P7102, DOI 10.4049/jimmunol.167.12.7102; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhang JM, 1999, EMBO J, V18, P6983, DOI 10.1093/emboj/18.24.6983	74	51	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5691	5707		10.1074/jbc.M110.162842	http://dx.doi.org/10.1074/jbc.M110.162842			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127072	hybrid, Green Published			2022-12-25	WOS:000287230600078
J	Tran, JR; Tomsic, LR; Brodsky, JL				Tran, Joseph R.; Tomsic, Lauren R.; Brodsky, Jeffrey L.			A Cdc48p-associated Factor Modulates Endoplasmic Reticulum-associated Degradation, Cell Stress, and Ubiquitinated Protein Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; AAA-ATPASE CDC48/P97; TRANSMEMBRANE CONDUCTANCE REGULATOR; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; QUALITY-CONTROL; TRANSCRIPTIONAL REGULATOR; MISFOLDED GLYCOPROTEINS; SHUTTLE VECTORS; UBX DOMAIN	The hexameric AAA-ATPase, Cdc48p, catalyzes an array of cellular activities, including endoplasmic reticulum (ER)-associated degradation (ERAD), ER/Golgi membrane dynamics, and DNA replication. Accumulating data suggest that unique Cdc48p partners, such as Npl4p-Ufd1p and Ubx1p/Shp1p (p47 in vertebrates), target Cdc48p for these diverse functions. Other Cdc48p-associated proteins have been identified, but the interplay among these factors and their activities is largely cryptic. We now report on a previously uncharacterized Cdc48p-associated protein, Ydr049p, also known as Vms1p, which binds Cdc48p at both the ER membrane and in the cytosol under non-stressed conditions. Loss of YDR049 modestly slows the degradation of the cystic fibrosis transmembrane conductance regulator but does not impede substrate ubiquitination, suggesting that Ydr049p acts at a postubiquitination step in the ERAD pathway. Consistent with Ydr049p playing a role in Cdc48p substrate release, ydr049 mutant cells accumulate Cdc48p-bound ubiquitinated proteins at the ER membrane. Moreover, YDR049 interacts with genes encoding select UBX (ubiquitin regulatory X) and UFD (ubiquitin fusion degradation) proteins, which are Cdc48p partners. Exacerbated growth defects are apparent in some of the mutant combinations, and synergistic effects on the degradation of cystic fibrosis transmembrane conductance regulator and CPY*, which is a soluble ERAD substrate, are evident in specific ydr049-ufd and -ubx mutants. These data suggest that Ydr049p acts in parallel with Cdc48p partners to modulate ERAD and other cellular activities.	[Tran, Joseph R.; Tomsic, Lauren R.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Tran, Joseph R.] Univ Pittsburgh, Sch Med, Grad Program Biochem & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall,4942 5th Ave, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu			National Institutes of Health [GM75061, DK 79307]; Cystic Fibrosis Foundation [BRODSK08XXO, TRAN07HO]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM75061. This work was also supported by Cystic Fibrosis Foundation Therapeutics Grant BRODSK08XXO (to J.L.B.).; Supported by Cystic Fibrosis Foundation Grant TRAN07HO.; Supported by an undergraduate research fellowship from the Howard Hughes Medical Institute.; We thank Karen Arndt and Margaret Shirra for help with genetic analysis; Bob Duda and Roger Hendrix for reagents; Alexander Buchberger, Stefan Jentsch, Mark Rose, and Rasmus Hartmann-Petersen for generous gifts of antibodies; the Pittsburgh Center for Kidney Research for use of core microscopy facilities (supported by National Institutes of Health Grant DK 79307); and Ora Weisz and Christopher J. Guerriero for help with microscopy.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams A., 1998, METHODS YEAST GENETI, P19; Ahner A, 2007, MOL BIOL CELL, V18; Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; DeHoratius C, 1996, MOL BIOL CELL, V7, P1835, DOI 10.1091/mbc.7.11.1835; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DESHAIES RJ, 1989, J CELL BIOL, V109, P2653, DOI 10.1083/jcb.109.6.2653; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; Kanehara K, 2010, J CELL BIOL, V188, P707, DOI 10.1083/jcb.200907055; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; MOIR D, 1982, GENETICS, V100, P547; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; SIKORSKI RS, 1989, GENETICS, V122, P19; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Wright R, 2003, YEAST, V20, P881, DOI 10.1002/yea.994; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; ZHANG SR, 1995, MOL CELL BIOL, V15, P2037; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	85	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5744	5755		10.1074/jbc.M110.179259	http://dx.doi.org/10.1074/jbc.M110.179259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148305	Green Published, hybrid			2022-12-25	WOS:000287230600083
J	Thuringer, D; Hammann, A; Benikhlef, N; Fourmaux, E; Bouchot, A; Wettstein, G; Solary, E; Garrido, C				Thuringer, Dominique; Hammann, Arlette; Benikhlef, Naima; Fourmaux, Eric; Bouchot, Andre; Wettstein, Guillaume; Solary, Eric; Garrido, Carmen			Transactivation of the Epidermal Growth Factor Receptor by Heat Shock Protein 90 via Toll-like Receptor 4 Contributes to the Migration of Glioblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; SIGNAL-TRANSDUCTION; CALCIUM OSCILLATIONS; MALIGNANT GLIOMAS; TYROSINE KINASES; EPITHELIAL-CELLS; BRAIN-TUMORS; ASTROCYTES; CANCER; PATHWAY	Extracellular heat shock protein HSP90 alpha was reported to participate in tumor cell growth, invasion, and metastasis formation through poorly understood signaling pathways. Herein, we show that extracellular HSP90 alpha favors cell migration of glioblastoma U87 cells. More specifically, externally applied HSP90 alpha rapidly induced endocytosis of EGFR. This response was accompanied by a transient increase in cytosolic Ca2+ appearing after 1-3 min of treatment. In the presence of EGF, U87 cells showed HSP90 alpha-induced Ca2+ oscillations, which were reduced by the ATP/ADPase, apyrase, and inhibited by the purinergic P-2 inhibitor, suramin, suggesting that ATP release is requested. Disruption of lipid rafts with methyl beta-cyclodextrin impaired the Ca2+ rise induced by extracellular HSP90 alpha combined with EGF. Specific inhibition of TLR4 expression by blocking antibodies suppressed extracellular HSP90 alpha-induced Ca2+ signaling and the associated cell migration. HSPs are known to bind lipopolysaccharides (LPSs). Preincubating cells with Polymyxin B, a potent LPS inhibitor, partially abrogated the effects of HSP90 alpha without affecting Ca2+ oscillations observed with EGF. Extracellular HSP90 alpha induced EGFR phosphorylation at Tyr-1068, and this event was prevented by both the protein kinase C delta inhibitor, rottlerin, and the c-Src inhibitor, PP2. Altogether, our results suggest that extracellular HSP90 alpha transactivates EGFR/ErbB1 through TLR4 and a PKC delta/c-Src pathway, which induces ATP release and cytosolic Ca2+ increase and finally favors cell migration. This mechanism could account for the deleterious effects of HSPs on high grade glioma when released into the tumor cell microenvironment.	[Thuringer, Dominique; Hammann, Arlette; Benikhlef, Naima; Fourmaux, Eric; Wettstein, Guillaume; Solary, Eric; Garrido, Carmen] INSERM, U866, F-21000 Dijon, France; [Bouchot, Andre] Fac Med, Cell Imaging Platform IFR100, F-21000 Dijon, France; [Solary, Eric] Inst Gustave Roussy, INSERM, U1009, F-95008 Villejuif, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Thuringer, D (corresponding author), INSERM, U866, 7 Blvd Jeanne dArc, F-21000 Dijon, France.	dominique.thuringer@u-bourgogne.fr	Garrido, carmen/G-1633-2018; Thuringer, Dominique/AAA-7448-2020; Garrido, Carolina/GWM-5557-2022	Garrido, carmen/0000-0003-1368-1493; Solary, Eric/0000-0002-8629-1341	CNRS; INSERM; Conseil Regional de Bourgogne (CRB); Ligue Nationale Contre le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Conseil Regional de Bourgogne (CRB)(Region Bourgogne-Franche-Comte); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the CNRS, INSERM, and by Conseil Regional de Bourgogne (CRB, Faber Program) and by grants from are supported by the Ligue Nationale Contre le Cancer (to E.S. and C.G.).	Amos S, 2005, J BIOL CHEM, V280, P7729, DOI 10.1074/jbc.M409056200; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Baltuch GH, 1996, BRAIN RES, V710, P143, DOI 10.1016/0006-8993(95)01395-4; Barabe F, 2002, J BIOL CHEM, V277, P13473, DOI 10.1074/jbc.M112149200; Basu S, 2008, J BIOL CHEM, V283, P32369, DOI 10.1074/jbc.M805053200; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Bian XW, 2004, INT IMMUNOPHARMACOL, V4, P1537, DOI 10.1016/j.intimp.2004.07.017; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Blum AE, 2008, AM J PHYSIOL-CELL PH, V295, pC231, DOI 10.1152/ajpcell.00175.2008; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Bredel M, 1997, ACTA NEUROCHIR, V139, P1000, DOI 10.1007/BF01411552; Bryant JA, 2004, CANCER BIOL THER, V3, P1243, DOI 10.4161/cbt.3.12.1233; Climent E, 2000, NEUROSCI LETT, V288, P53, DOI 10.1016/S0304-3940(00)01207-6; COULDWELL WT, 1992, NEUROSURGERY, V31, P717; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Hsieh HL, 2009, ARTERIOSCL THROM VAS, V29, P1594, DOI 10.1161/ATVBAHA.109.185801; Hur EM, 2004, J BIOL CHEM, V279, P5852, DOI 10.1074/jbc.M311687200; Hussaini IM, 2000, J BIOL CHEM, V275, P22348, DOI 10.1074/jbc.M003203200; Jia ZJ, 2005, J BIOL CHEM, V280, P30564, DOI 10.1074/jbc.M501754200; Kleihues P, 2000, TOXICOL PATHOL, V28, P164, DOI 10.1177/019262330002800121; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Morita M, 2005, J NEUROCHEM, V95, P871, DOI 10.1111/j.1471-4159.2005.03430.x; Morita M, 2003, J NEUROSCI, V23, P10944; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Ronde P, 2000, BBA-MOL CELL RES, V1498, P273, DOI 10.1016/S0167-4889(00)00102-6; Schwartzbaum J, 2005, CANCER RES, V65, P6459, DOI 10.1158/0008-5472.CAN-04-3728; Scott JN, 1998, CAN J NEUROL SCI, V25, P197, DOI 10.1017/S0317167100034016; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; SWANN K, 1991, FEBS LETT, V278, P175, DOI 10.1016/0014-5793(91)80110-O; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Tu MT, 2000, BRIT J PHARMACOL, V129, P1481, DOI 10.1038/sj.bjp.0703182; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	44	67	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3418	3428		10.1074/jbc.M110.154823	http://dx.doi.org/10.1074/jbc.M110.154823			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127066	Green Published, hybrid			2022-12-25	WOS:000286653200028
J	Basu, I; Locker, J; Cassera, MB; Belbin, TJ; Merino, EF; Dong, XY; Hemeon, I; Evans, GB; Guha, C; Schramm, VL				Basu, Indranil; Locker, Joseph; Cassera, Maria B.; Belbin, Thomas J.; Merino, Emilio F.; Dong, Xinyuan; Hemeon, Ivan; Evans, Gary B.; Guha, Chandan; Schramm, Vern L.			Growth and Metastases of Human Lung Cancer Are Inhibited in Mouse Xenografts by a Transition State Analogue of 5 '-Methylthioadenosine Phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLTHIOADENOSINE PHOSPHORYLASE; ALPHA-DIFLUOROMETHYLORNITHINE; POLYAMINE BIOSYNTHESIS; S-ADENOSYLMETHIONINE; TUMOR PROGRESSION; POTENT INHIBITOR; CELL-LINE; KINASE 1; GENE; 5-METHYLTHIOADENOSINE	The S-adenosylmethionine (AdoMet) salvage enzyme 5'-methylthioadenosine phosphorylase (MTAP) has been implicated as both a cancer target and a tumor suppressor. We tested these hypotheses in mouse xenografts of human lung cancers. AdoMet recycling from 5'-methylthioadenosine (MTA) was blocked by inhibition of MTAP with methylthio-DADMe-Immucillin-A (MTDIA), an orally available, nontoxic, picomolar transition state analogue. Blood, urine, and tumor levels of MTA increased in response to MTDIA treatment. MTDIA treatment inhibited A549 (human non-small cell lung carcinoma) and H358 (human bronchioloalveolar non-small cell lung carcinoma cells) xenograft tumor growth in immunodeficient Rag2(-/-) gamma C-/- and NCr-nu mice. Systemic MTA accumulation is implicated as the tumor-suppressive metabolite because MTDIA is effective for in vivo treatment of A549 MTAP(-/-) and H358 MTAP(+/+)umors. Tumors from treated mice showed increased MTA and decreased polyamines but little alteration in AdoMet, methionine, or adenine levels. Gene expression profiles of A549 tumors from treated and untreated mice revealed only modest alterations with 62 up-regulated and 63 down-regulated mRNAs (>= 3-fold). MTDIA antitumor activity in xenografts supports MTAP as a target for lung cancer therapy.	[Basu, Indranil; Cassera, Maria B.; Merino, Emilio F.; Hemeon, Ivan; Schramm, Vern L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Locker, Joseph; Belbin, Thomas J.] Yeshiva Univ, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Dong, Xinyuan; Guha, Chandan] Yeshiva Univ, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10461 USA; [Evans, Gary B.] Ind Res Ltd, Carbohydrate Chem Team, Lower Hutt 5040, New Zealand	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Callaghan Innovation	Schramm, VL (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave,Rm 308, Bronx, NY 10461 USA.	vern.schramm@einstein.yu.edu	Evans, Gary/B-8343-2011; Cassera, Maria/L-1572-2013; Evans, Gary/I-4123-2019	Evans, Gary/0000-0002-6973-2002; Evans, Gary/0000-0002-6973-2002	National Institutes of Health [CA135405, CA85953];  [P30 CA013330]; NATIONAL CANCER INSTITUTE [R01CA085953, P30CA013330, R01CA135405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135405 and CA85953 and Pilot Project Award P30 CA013330. Conflict of interest: C. G., G. B. E., and V. L. S. are advisors to Pico Pharmaceuticals, Inc.	ABELOFF MD, 1986, CANCER TREAT REP, V70, P843; ABELOFF MD, 1984, J CLIN ONCOL, V2, P124, DOI 10.1200/JCO.1984.2.2.124; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; Belbin TJ, 2005, ARCH OTOLARYNGOL, V131, P10, DOI 10.1001/archotol.131.1.10; Bistulfi G, 2009, FASEB J, V23, P2888, DOI 10.1096/fj.09-130708; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Christopher SA, 2002, CANCER RES, V62, P6639; Crino L, 2002, SEMIN ONCOL, V29, P9, DOI 10.1053/sonc.2002.34266; ENOUF J, 1979, CANCER RES, V39, P4497; Evans GB, 2005, J MED CHEM, V48, P4679, DOI 10.1021/jm050269z; Garcia-Castellano JM, 2002, CLIN CANCER RES, V8, P782; Gerner EW, 2010, CANCER PREV RES, V3, P125, DOI 10.1158/1940-6207.CAPR-09-0252; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Gu J, 2004, ONCOGENE, V23, P1300, DOI 10.1038/sj.onc.1207239; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kadariya Y, 2009, CANCER RES, V69, P5961, DOI 10.1158/0008-5472.CAN-09-0145; Keppner S, 2009, CHEMMEDCHEM, V4, P1806, DOI 10.1002/cmdc.200900338; Kindler H, 2009, INVEST NEW DRUG, V27, P75, DOI 10.1007/s10637-008-9160-1; Kirsch SH, 2009, J CHROMATOGR B, V877, P3865, DOI 10.1016/j.jchromb.2009.09.039; Klastersky J, 2001, LUNG CANCER-J IASLC, V34, pS95; Kurdistani SK, 2007, BRIT J CANCER, V97, P1, DOI 10.1038/sj.bjc.6603844; Lee SH, 1997, J BIOCHEM MOL BIOL, V30, P403; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; MIYAJI K, 1995, J NEUROSURG, V83, P690, DOI 10.3171/jns.1995.83.4.0690; OLOPADE OI, 1995, P NATL ACAD SCI USA, V92, P6489, DOI 10.1073/pnas.92.14.6489; PAJULA RL, 1979, FEBS LETT, V99, P343, DOI 10.1016/0014-5793(79)80988-6; PEGG AE, 1983, METHOD ENZYMOL, V94, P294; SAHOTA A, 2001, ADENINE PHOSPHORIBOS, P2571; Sajiki H, 2005, SYNLETT, P1385, DOI 10.1055/s-2005-868489; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Stevens AP, 2009, J CELL BIOCHEM, V106, P210, DOI 10.1002/jcb.21984; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Szyf M, 2004, CANCER LETT, V211, P133, DOI 10.1016/j.canlet.2004.04.009; TANOUE LT, 2009, EXPERT REV ANTICANCE; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; WOODCOCK DM, 1983, NUCLEIC ACIDS RES, V11, P489, DOI 10.1093/nar/11.2.489; Yoon YK, 2010, MOL CARCINOGEN, V49, P353, DOI 10.1002/mc.20607	41	50	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4902	4911		10.1074/jbc.M110.198374	http://dx.doi.org/10.1074/jbc.M110.198374			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21135097	Green Published, hybrid			2022-12-25	WOS:000286975700086
J	de Wet, B; Zech, T; Salek, M; Acuto, O; Harder, T				de Wet, Ben; Zech, Tobias; Salek, Mogjiborahman; Acuto, Oreste; Harder, Thomas			Proteomic Characterization of Plasma Membrane-proximal T Cell Activation Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SYNAPSE; SIGNALING COMPLEXES; RECEPTOR; PROTEINS; DOMAINS; FAMILY; LAT; ANTIGEN; MICROCLUSTERS; ACCUMULATION	Early downstream responses of T lymphocytes following T cell antigen receptor (TCR) activation are mediated by protein complexes that assemble in domains of the plasma membrane. Using stable isotope labeling with amino acids in cell culture and mass spectrometry, we quantitatively related the proteome of alpha CD3 immunoisolated native TCR signaling plasma membrane domains to that of control plasma membrane fragments not engaged in TCR signaling. Proteins were sorted according to their relative enrichment in isolated TCR signaling plasma membrane domains, identifying a complex protein network that is anchored in the vicinity of activated TCR. These networks harbor widespread mediators of plasma membrane-proximal T cell activities, including propagation, balancing, and attenuation of TCR signaling, immune synapse formation, as well as cytoskeletal arrangements relative to TCR activation clusters. These results highlight the unique potential of systematic characterizations of plasma membrane-proximal T cell activation proteome in the context of its native lipid bilayer platform.	[de Wet, Ben; Salek, Mogjiborahman; Acuto, Oreste; Harder, Thomas] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Zech, Tobias] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of Oxford; Beatson Institute	Harder, T (corresponding author), S Parks Rd, Oxford OX1 3RE, England.	thomas.harder@path.ox.ac.uk		Zech, Tobias/0000-0001-8394-088X; Salek, Mogjiborahman/0000-0002-6664-4752	Wellcome Trust [082782/2/07/2]; Edward Penley Abraham Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Edward Penley Abraham Trust	This work was supported by Wellcome Trust Project Grant 082782/2/07/2.; Recipient of support from the Edward Penley Abraham Trust.	Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; HARDER T, 2001, SCI SIGNAL TRANSDUCT; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Hawadle MA, 2002, BIOL RES, V35, P247, DOI 10.4067/S0716-97602002000200017; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Ike H, 2003, CHEMPHYSCHEM, V4, P620, DOI 10.1002/cphc.200300670; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sangani D, 2009, MOL MEMBR BIOL, V26, P159, DOI 10.1080/09687680802637660; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	39	18	18	4	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4072	4080		10.1074/jbc.M110.165415	http://dx.doi.org/10.1074/jbc.M110.165415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127068	hybrid, Green Published			2022-12-25	WOS:000286975700005
J	Kumari, D; Biacsi, RE; Usdin, K				Kumari, Daman; Biacsi, Rea Erika; Usdin, Karen			Repeat Expansion Affects Both Transcription Initiation and Elongation in Friedreich Ataxia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; EPIGENETIC CHANGES; METHYLTRANSFERASE COMPLEX; CHROMATIN-STRUCTURE; HISTONE H3; GENE; DNA; METHYLATION; SEQUENCES; IDENTIFICATION	Expansion of a GAA.TTC repeat in the first intron of the frataxin (FXN) gene causes an mRNA deficit that results in Friedreich ataxia (FRDA). The region flanking the repeat on FRDA alleles is associated with more extensive DNA methylation than is seen on normal alleles and histone modifications typical of repressed genes. However, whether these changes are responsible for the mRNA deficit is controversial. Using chromatin immunoprecipitation and cell lines from affected and unaffected individuals, we show that certain marks of active chromatin are also reduced in the promoter region of the FXN gene in patient cells. Thus, the promoter chromatin may be less permissive for transcription initiation than it is on normal alleles. Furthermore, we show that the initiating form of RNA polymerase II and histone H3 trimethylated on lysine 4, a chromatin mark tightly linked to transcription initiation, are both present at lower levels on FRDA alleles. In addition, a mark of transcription elongation, trimethylated H3K36, shows a reduced rate of accumulation downstream of the repeat. Our data thus suggest that repeat expansion reduces both transcription initiation and elongation in FRDA cells. Our findings may have implications for understanding the mechanism responsible for FRDA as well as for therapeutic approaches to reverse the transcription deficit.	[Kumari, Daman; Biacsi, Rea Erika; Usdin, Karen] NIDDK, Sect Gene Struct & Dis, Lab Mol & Cellular Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Usdin, K (corresponding author), NIDDK, Sect Gene Struct & Dis, Lab Mol & Cellular Biol, NIH, Bldg 8,Rm 2A19,8 Ctr Dr, Bethesda, MD 20892 USA.	ku@helix.nih.gov	Kumari, Daman/AAN-6704-2020		NIDDK, National Institutes of Health [DK057810]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057810, Z01DK057810, R01DK057810] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK057810 from the Intramural Program of the NIDDK (to K. U.).	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Biacsi R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000017; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Greene E, 2005, GENOMICS, V85, P221, DOI 10.1016/j.ygeno.2004.10.013; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; HIRAKATA M, 1993, J CLIN INVEST, V91, P2665, DOI 10.1172/JCI116505; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krasilnikova MM, 2007, NUCLEIC ACIDS RES, V35, P1075, DOI 10.1093/nar/gkl1140; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; MISHINA M, 1982, EMBO J, V1, P1533, DOI 10.1002/j.1460-2075.1982.tb01351.x; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Pandolfo M, 2002, ADV EXP MED BIOL, V516, P99; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Rybtsova N, 2007, NUCLEIC ACIDS RES, V35, P3431, DOI 10.1093/nar/gkm214; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SASSONECORSI P, 1981, NUCLEIC ACIDS RES, V9, P3941, DOI 10.1093/nar/9.16.3941; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Soragni E, 2008, NUCLEIC ACIDS RES, V36, P6056, DOI 10.1093/nar/gkn604; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010	39	69	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4209	4215		10.1074/jbc.M110.194035	http://dx.doi.org/10.1074/jbc.M110.194035			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127046	Green Published, hybrid			2022-12-25	WOS:000286975700019
J	Nishimura, K; Sano, M; Ohtaka, M; Furuta, B; Umemura, Y; Nakajima, Y; Ikehara, Y; Kobayashi, T; Segawa, H; Takayasu, S; Sato, H; Motomura, K; Uchida, E; Kanayasu-Toyoda, T; Asashima, M; Nakauchi, H; Yamaguchi, T; Nakanishia, M				Nishimura, Ken; Sano, Masayuki; Ohtaka, Manami; Furuta, Birei; Umemura, Yoko; Nakajima, Yoshiro; Ikehara, Yuzuru; Kobayashi, Toshihiro; Segawa, Hiroaki; Takayasu, Satoko; Sato, Hideyuki; Motomura, Kaori; Uchida, Eriko; Kanayasu-Toyoda, Toshie; Asashima, Makoto; Nakauchi, Hiromitsu; Yamaguchi, Teruhide; Nakanishia, Mahito			Development of Defective and Persistent Sendai Virus Vector A UNIQUE GENE DELIVERY/EXPRESSION SYSTEM IDEAL FOR CELL REPROGRAMMING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; RNA INTERFERENCE; PARTICLE FORMATION; M-PROTEIN; EXPRESSION; GENERATION; EFFICIENT; INDUCTION; DIFFERENTIATION; FIBROBLASTS	The ectopic expression of transcription factors can reprogram differentiated tissue cells into induced pluripotent stem cells. However, this is a slow and inefficient process, depending on the simultaneous delivery of multiple genes encoding essential reprogramming factors and on their sustained expression in target cells. Moreover, once cell reprogramming is accomplished, these exogenous reprogramming factors should be replaced with their endogenous counterparts for establishing autoregulated pluripotency. Complete and designed removal of the exogenous genes from the reprogrammed cells would be an ideal option for satisfying this latter requisite as well as for minimizing the risk of malignant cell transformation. However, no single gene delivery/expression system has ever been equipped with these contradictory characteristics. Here we report the development of a novel replication-defective and persistent Sendai virus (SeVdp) vector based on a non-cytopathic variant virus, which fulfills all of these requirements for cell reprogramming. The SeVdp vector could accommodate up to four exogenous genes, deliver them efficiently into various mammalian cells (including primary tissue cells and human hematopoietic stem cells) and express them stably in the cytoplasm at a prefixed balance. Furthermore, interfering with viral transcription/replication using siRNA could erase the genomic RNA of SeVdp vector from the target cells quickly and thoroughly. A SeVdp vector installed with Oct4/Sox2/Klf4/c-Myc could reprogram mouse primary fibroblasts quite efficiently; similar to 1% of the cells were reprogrammed to Nanog-positive induced pluripotent stem cells without chromosomal gene integration. Thus, this SeVdp vector has potential as a tool for advanced cell reprogramming and for stem cell research.	[Nishimura, Ken; Sano, Masayuki; Ohtaka, Manami; Umemura, Yoko; Nakajima, Yoshiro; Takayasu, Satoko; Motomura, Kaori; Asashima, Makoto; Nakanishia, Mahito] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Ikehara, Yuzuru] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058562, Japan; [Segawa, Hiroaki] Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Tsukuba, Ibaraki 3058562, Japan; [Nishimura, Ken] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ohtaka, Manami; Takayasu, Satoko; Motomura, Kaori] Japan Biol Informat Consortium, Koto Ku, Tokyo 1358073, Japan; [Furuta, Birei; Kanayasu-Toyoda, Toshie; Yamaguchi, Teruhide] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan; [Uchida, Eriko] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan; [Kobayashi, Toshihiro; Sato, Hideyuki; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo 1088639, Japan; [Kobayashi, Toshihiro; Sato, Hideyuki; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Minato Ku, Tokyo 1088639, Japan; [Uchida, Eriko; Asashima, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Nakanishia, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, 1-1-1 Higashi,Cent 4, Tsukuba, Ibaraki 3058562, Japan.	mahito-nakanishi@aist.go.jp	Nishimura, KEN/HGC-6147-2022; Asashima, Makoto/O-8389-2018; Sano, Masayuki/M-1685-2018; Ikehara, yuzuru/R-2239-2019; Ikehara, yuzuru/L-7696-2018; Nakanishi, Mahito/I-9888-2018	Asashima, Makoto/0000-0002-0012-026X; Sano, Masayuki/0000-0001-7117-0515; Ikehara, yuzuru/0000-0002-1915-9172; Ikehara, yuzuru/0000-0002-1915-9172; Nakanishi, Mahito/0000-0002-7068-7587; Nishimura, Ken/0000-0002-0716-4142; Kobayashi, Toshihiro/0000-0001-8019-0008	New Energy and Industrial Technology Development Organization of Japan; National Institute of Biomedical Innovation; JST PRESTO Program	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); JST PRESTO Program	This work was supported in part by a grant from the New Energy and Industrial Technology Development Organization of Japan, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and by JST PRESTO Program.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; CROISILLE L, 1994, BLOOD, V84, P4116, DOI 10.1182/blood.V84.12.4116.bloodjournal84124116; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; Eguchi A, 2000, J BIOL CHEM, V275, P17549, DOI 10.1074/jbc.M910004199; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Griesenbach U, 2005, CURR OPIN MOL THER, V7, P346; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; HOMANN HE, 1990, VIROLOGY, V177, P131, DOI 10.1016/0042-6822(90)90467-6; Horikami SM, 1996, VIROLOGY, V222, P383, DOI 10.1006/viro.1996.0435; Hua J, 1996, J LEUKOCYTE BIOL, V60, P125, DOI 10.1002/jlb.60.1.125; Inoue M, 2003, J VIROL, V77, P3238, DOI 10.1128/JVI.77.5.3238-3246.2003; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Lamb R. A., 2001, Fundamental virology, P689; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Muller LUW, 2009, MOL THER, V17, P947, DOI 10.1038/mt.2009.72; Murakami Y, 2008, J GENE MED, V10, P165, DOI 10.1002/jgm.1142; Nakanishi M, 1998, J CONTROL RELEASE, V54, P61, DOI 10.1016/S0168-3659(97)00220-4; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nishimura K, 2007, J BIOL CHEM, V282, P27383, DOI 10.1074/jbc.M702028200; O'Malley J, 2009, CURR OPIN BIOTECH, V20, P516, DOI 10.1016/j.copbio.2009.09.005; Ogino T, 2005, J BIOL CHEM, V280, P4429, DOI 10.1074/jbc.M411167200; Ogino T, 2003, BIOCHEM BIOPH RES CO, V311, P283, DOI 10.1016/j.bbrc.2003.09.205; Okabe J, 2004, HUM MOL GENET, V13, P285, DOI 10.1093/hmg/ddh032; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Plattet P, 2007, VIROLOGY, V362, P411, DOI 10.1016/j.virol.2006.12.033; Sano M, 2008, NUCLEIC ACIDS RES, V36, P5812, DOI 10.1093/nar/gkn584; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Shimazu Y, 2008, VIROLOGY, V372, P64, DOI 10.1016/j.virol.2007.10.026; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Sutou S., 2008, NUCLEIC ACIDS RES, V36, P5812; TAIRA H, 1995, ARCH VIROL, V140, P187, DOI 10.1007/BF01309734; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YOSHIDA T, 1979, VIROLOGY, V92, P139, DOI 10.1016/0042-6822(79)90220-4; Yoshizaki M, 2006, J GENE MED, V8, P1151, DOI 10.1002/jgm.938; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zidovec S, 1999, CYTOKINE, V11, P140, DOI 10.1006/cyto.1998.0411	50	247	265	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4760	4771		10.1074/jbc.M110.183780	http://dx.doi.org/10.1074/jbc.M110.183780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21138846	hybrid, Green Published			2022-12-25	WOS:000286975700074
J	Toyoda, T; An, D; Witczak, CA; Koh, HJ; Hirshman, MF; Fujii, N; Goodyear, LJ				Toyoda, Taro; An, Ding; Witczak, Carol A.; Koh, Ho-Jin; Hirshman, Michael F.; Fujii, Nobuharu; Goodyear, Laurie J.			Myo1c Regulates Glucose Uptake in Mouse Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN I-BETA; GLUT4 TRANSLOCATION; INSULIN-RECEPTOR; CORTICAL ACTIN; GLYCOGEN-SYNTHASE; TRANSPORT; CONTRACTION; EXERCISE; DISRUPTION; MEMBRANE	Contraction and insulin promote glucose uptake in skeletal muscle through GLUT4 translocation to cell surface membranes. Although the signaling mechanisms leading to GLUT4 translocation have been extensively studied in muscle, the cellular transport machinery is poorly understood. Myo1c is an actin-based motor protein implicated in GLUT4 translocation in adipocytes; however, the expression profile and role of Myo1c in skeletal muscle have not been investigated. Myo1c protein abundance was higher in more oxidative skeletal muscles and heart. Voluntary wheel exercise (4 weeks, 8.2 +/- 0.8 km/day), which increased the oxidative profile of the triceps muscle, significantly increased Myo1c protein levels by similar to 2-fold versus sedentary controls. In contrast, high fat feeding (9 weeks, 60% fat) significantly reduced Myo1c by 17% in tibialis anterior muscle. To study Myo1c regulation of glucose uptake, we expressed wild-type Myo1c or Myo1c mutated at the ATPase catalytic site (K111A-Myo1c) in mouse tibialis anterior muscles in vivo and assessed glucose uptake in vivo in the basal state, in response to 15 min of in situ contraction, and 15 min following maximal insulin injection (16.6 units/kg of body weight). Expression of wild-type Myo1c or K111A-Myo1c had no effect on basal glucose uptake. However, expression of wild-type Myo1c significantly increased contraction- and insulin-stimulated glucose uptake, whereas expression of K111A-Myo1c decreased both contraction-stimulated and insulin-stimulated glucose uptake. Neither wild-type nor K111A-Myo1c expression altered GLUT4 expression, and neither affected contraction- or insulin-stimulated signaling proteins. Myo1c is a novel mediator of both insulin-stimulated and contraction- stimulated glucose uptake in skeletal muscle.	[Toyoda, Taro; An, Ding; Witczak, Carol A.; Koh, Ho-Jin; Hirshman, Michael F.; Fujii, Nobuharu; Goodyear, Laurie J.] Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Goodyear, Laurie J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Goodyear, Laurie J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Goodyear, LJ (corresponding author), 1 Joslin Pl, Boston, MA 02215 USA.	goodyear@joslin.harvard.edu	Fujii, Nobuharu/J-2724-2014	Fujii, Nobuharu/0000-0002-0974-3033	National Institutes of Health [R01 AR45670, R01 AR42238, F32AR051663, K99AR056298]; Diabetes and Endocrinology Research Center [P30 DK36836]; Joslin Diabetes Center; Japan Society for the Promotion of Science Kakenhi [21240063]; Nakatomi Foundation; Naito Foundation; Uehara Memorial Foundation; American Diabetes Association; Canadian Institute for Health Research [MFE-83802]; Canadian Diabetes Association [PF-3-07-2255-DA]; American Physiological Society (APS); Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045670, K99AR056298, F32AR051663, R01AR042238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center; Joslin Diabetes Center; Japan Society for the Promotion of Science Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakatomi Foundation; Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); American Diabetes Association(American Diabetes Association); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; American Physiological Society (APS); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR45670 and R01 AR42238 (to L. J. G.), F32AR051663 and K99AR056298 (to C. A. W.), and the Diabetes and Endocrinology Research Center grant P30 DK36836 (to the Joslin Diabetes Center). This work was also supported by funding from the Graetz Challenge Grant Program of the Joslin Diabetes Center (to L. J. G.); the Japan Society for the Promotion of Science Kakenhi 21240063 (to N. F.); grants from the Nakatomi Foundation, the Naito Foundation, the Uehara Memorial Foundation, and the Japan Society for the Promotion of Science (to T. T.); an American Diabetes Association Mentor-based Award (to L. J. G.); a fellowship from the Canadian Institute for Health Research (MFE-83802) and a Canadian Diabetes Association Incentive Award PF-3-07-2255-DA (to D. A.); and the American Physiological Society (APS) Fellowship in Physiological Genomics (to H.-J. K.).	Ai H, 2003, AM J PHYSIOL-ENDOC M, V285, pE836, DOI 10.1152/ajpendo.00238.2002; An D, 2010, DIABETES, V59, P1358, DOI 10.2337/db09-1266; BERGSTROM J, 1966, NATURE, V210, P309, DOI 10.1038/210309a0; BONDAR RJL, 1974, CLIN CHEM, V20, P586; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; Brozinick JT, 2004, J BIOL CHEM, V279, P40699, DOI 10.1074/jbc.M402697200; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Cartee GD, 2009, EXERC SPORT SCI REV, V37, P188, DOI 10.1097/JES.0b013e3181b7b7c5; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Derave W, 2000, AM J PHYSIOL-ENDOC M, V279, pE947, DOI 10.1152/ajpendo.2000.279.5.E947; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2004, AM J PHYSIOL-CELL PH, V287, pC200, DOI 10.1152/ajpcell.00415.2003; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; GOODYEAR LJ, 1992, DIABETES, V41, P1091, DOI 10.2337/diabetes.41.9.1091; Hayasaki H, 2001, ACTA HISTOCHEM, V103, P355, DOI 10.1078/0065-1281-00605; HENRIKSEN EJ, 1990, AM J PHYSIOL, V259, pE593, DOI 10.1152/ajpendo.1990.259.4.E593; Ho RC, 2004, AM J PHYSIOL-REG I, V286, pR342, DOI 10.1152/ajpregu.00563.2003; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Huang J, 2005, J BIOL CHEM, V280, P42300, DOI 10.1074/jbc.M510920200; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jessen N, 2005, J APPL PHYSIOL, V99, P330, DOI 10.1152/japplphysiol.00175.2005; Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65; Kawanaka K, 2000, AM J PHYSIOL-ENDOC M, V279, pE1311, DOI 10.1152/ajpendo.2000.279.6.E1311; Kido Y, 2001, J CLIN ENDOCR METAB, V86, P972, DOI 10.1210/jc.86.3.972; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai YC, 2010, J APPL PHYSIOL, V108, P1106, DOI 10.1152/japplphysiol.00401.2009; Lauritzen HPMM, 2010, AM J PHYSIOL-ENDOC M, V299, pE169, DOI 10.1152/ajpendo.00066.2010; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MARETTE A, 1992, DIABETES, V41, P1562, DOI 10.2337/diabetes.41.12.1562; Mason S, 2007, ADV EXP MED BIOL, V618, P229; McCarthy AM, 2006, AM J PHYSIOL-CELL PH, V291, pC860, DOI 10.1152/ajpcell.00107.2006; Patti ME, 2004, CURR OPIN CLIN NUTR, V7, P383, DOI 10.1097/01.mco.0000134359.23288.72; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; REIZES O, 1994, P NATL ACAD SCI USA, V91, P6349, DOI 10.1073/pnas.91.14.6349; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; RODNICK KJ, 1992, AM J PHYSIOL, V262, pC9, DOI 10.1152/ajpcell.1992.262.1.C9; RODNICK KJ, 1990, DIABETES, V39, P1425, DOI 10.2337/diabetes.39.11.1425; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; SEXTON WL, 1995, J APPL PHYSIOL, V79, P287, DOI 10.1152/jappl.1995.79.1.287; Tanaka S, 2007, METABOLISM, V56, P1719, DOI 10.1016/j.metabol.2007.07.017; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; TERJUNG RL, 1976, AM J PHYSIOL, V230, P946, DOI 10.1152/ajplegacy.1976.230.4.946; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; VICARIO P, 1987, LIFE SCI, V41, P1233, DOI 10.1016/0024-3205(87)90201-3; VIHKO V, 1979, J APPL PHYSIOL, V47, P43, DOI 10.1152/jappl.1979.47.1.43; WILSON CM, 1994, BIOCHEM J, V299, P755, DOI 10.1042/bj2990755; Witczak CA, 2010, AM J PHYSIOL-ENDOC M, V298, pE1150, DOI 10.1152/ajpendo.00659.2009; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011; Zhu T, 1998, J BIOL CHEM, V273, P20481, DOI 10.1074/jbc.273.32.20481; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	58	36	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4133	4140		10.1074/jbc.M110.174938	http://dx.doi.org/10.1074/jbc.M110.174938			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127070	Green Published, hybrid			2022-12-25	WOS:000286975700012
J	Xu, QS; Akama, R; Isaji, T; Lu, YY; Hashimoto, H; Kariya, Y; Fukuda, T; Du, YG; Gu, JG				Xu, Qingsong; Akama, Ryota; Isaji, Tomoya; Lu, Yingying; Hashimoto, Hirokazu; Kariya, Yoshinobu; Fukuda, Tomohiko; Du, Yuguang; Gu, Jianguo			Wnt/beta-Catenin Signaling Down-regulates N-Acetylglucosaminyltransferase III Expression THE IMPLICATIONS OF TWO MUTUALLY EXCLUSIVE PATHWAYS FOR REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROPELLER DOMAIN; E-CADHERIN; ALPHA-CATENIN; ENDOPLASMIC-RETICULUM; PROTEIN GLYCOSYLATION; CELL-ADHESION; COMPLEX; SUPPRESSION; METASTASIS; STABILITY	In previous studies, we reported that N-acetylglucosaminyl-transferase III (GnT-III) activity and the enzyme product, bisected N-glycans, both were induced in cells cultured under dense conditions in an E-cadherin-dependent manner (Iijima, J., Zhao, Y., Isaji, T., Kameyama, A., Nakaya, S., Wang, X., Ihara, H., Cheng, X., Nakagawa, T., Miyoshi, E., Kondo, A., Narimatsu, H., Taniguchi, N., and Gu, J. (2006) J. Biol. Chem. 281, 13038-13046). Furthermore, we found that alpha-catenin, a component of the E-cadherin-catenin complex, was also required for this induction (Akama, R., Sato, Y., Kariya, Y., Isaji, T., Fukuda, T., Lu, L., Taniguchi, N., Ozawa, M., and Gu, J. (2008) Proteomics 8, 3221-3228). To further explore the molecular mechanism of this regulation, the roles of beta-catenin, an essential molecule in both cadherin-mediated cell adhesion and canonical Wnt signaling, were investigated. Unexpectedly, shRNA knockdown of beta-catenin resulted in a dramatic increase in GnT-III expression and its product, the bisected N-glycans, which was confirmed by RT-PCR and GnT-III activity and by E4-PHA lectin blot analysis. The induction of GnT-III expression increased bisecting GlcNAc residues on beta 1 integrin, which led to down-regulation of integrin-mediated cell adhesion and cell migration. Immunostaining showed that nuclear localization of beta-catenin was greatly suppressed; intriguingly, the knockdown of beta-catenin in the nuclei was more effective than that in cell-cell contacts in the knockdown cells, which was also confirmed by Western blot analysis. Stimulation of the Wnt signaling pathway by the addition of exogenous Wnt3a or BIO, a GSK-3 beta inhibitor, consistently and significantly inhibited GnT-III expression and its products. Conversely, the inhibition of beta-catenin translocation into the nuclei increased GnT-III activation. Taken together, the results of the present study are the first to clearly demonstrate that GnT-III expression may be precisely regulated by the interplay of E-cadherin-catenin complex-mediated cell-cell adhesion and Wnt/beta-catenin signaling, which are both crucial in the process of epithelial-mesenchymal transitions in physiological and pathological conditions.	[Xu, Qingsong; Du, Yuguang] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian 116023, Peoples R China; [Xu, Qingsong; Akama, Ryota; Isaji, Tomoya; Lu, Yingying; Hashimoto, Hirokazu; Kariya, Yoshinobu; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Tohoku Medical & Pharmaceutical University	Du, YG (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, 457 Zhongshan Rd, Dalian 116023, Peoples R China.	duyg@dicp.ac.cn; jgu@tohoku-pharm.ac.jp	Isaji, Tomoya/ABC-9285-2021; Gu, Jianguo/ABC-9257-2020		Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [21370059]	Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency; the Academic Frontier Project for Private Universities of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and Grant-in-Aid for Scientific Research 21370059 from the Japan Society for the Promotion of Science.	ABERLE H, 1994, J CELL SCI, V107, P3655; Akama R, 2008, PROTEOMICS, V8, P3221, DOI 10.1002/pmic.200800038; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Asada M, 1997, CANCER RES, V57, P1073; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Granovsky M, 2000, NAT MED, V6, P306; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Gu JG, 2008, CELL ADHES MIGR, V2, P243, DOI 10.4161/cam.2.4.6748; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; IHARA Y, 1993, J BIOCHEM-TOKYO, V113, P692, DOI 10.1093/oxfordjournals.jbchem.a124105; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kobata A, 2000, GLYCOCONJUGATE J, V17, P443, DOI 10.1023/A:1011006122704; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Matsubara S, 2001, J CELL BIOL, V154, P573, DOI 10.1083/jcb.200103097; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nakopoulou L, 2002, HISTOPATHOLOGY, V40, P536, DOI 10.1046/j.1365-2559.2002.01392.x; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; Ozawa M, 1998, J BIOL CHEM, V273, P29524, DOI 10.1074/jbc.273.45.29524; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; SCHACHTER H, 1983, CAN J BIOCHEM CELL B, V61, P1049, DOI 10.1139/o83-134; Schachter H, 1986, Adv Exp Med Biol, V205, P53; Stanley P, 2002, BBA-GEN SUBJECTS, V1573, P363, DOI 10.1016/S0304-4165(02)00404-X; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; TANIGUCHI N, 2001, HDB GLYCOSYLTRANSFER; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Uozumi N, 1996, J BIOCHEM, V120, P385; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhou F, 2008, GLYCOCONJUGATE J, V25, P727, DOI 10.1007/s10719-008-9133-9	44	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4310	4318		10.1074/jbc.M110.182576	http://dx.doi.org/10.1074/jbc.M110.182576			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115490	hybrid, Green Published			2022-12-25	WOS:000286975700030
J	Ashraf, M; Yadav, B; Perinthottathil, S; Kumar, KS; Vats, D; Muthuswami, R; Komath, SS				Ashraf, Mohammad; Yadav, Bhawna; Perinthottathil, Sreejith; Kumar, Kokila Sree; Vats, Divya; Muthuswami, Rohini; Komath, Sneha Sudha			N-Acetyl-D-glucosaminylphosphatidylinositol De-N-acetylase from Entamoeba histolytica METAL ALTERS CATALYTIC RATES BUT NOT SUBSTRATE AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHETIC-PATHWAY; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; PIG-L; ANCHOR; EXPRESSION; YEAST; GLYCOPROTEIN; PURIFICATION; SPECIFICITY	PIG-L/GPI12 proteins are endoplasmic reticulum-resident membrane proteins involved in the second step of glycosylphosphatidylinositol anchor biosynthesis in eukaryotes. We show that the Entamoeba histolytica PIG-L protein is optimally active in the acidic pH range. The enzyme has an intrinsic low level of de-N-acetylase activity in the absence of metal and is significantly stimulated by divalent cations. Metal binding induces a large conformational change in the protein that appears to improve catalytic rates while not altering the affinity of the enzyme for its substrate.	[Ashraf, Mohammad; Yadav, Bhawna; Perinthottathil, Sreejith; Kumar, Kokila Sree; Vats, Divya; Muthuswami, Rohini; Komath, Sneha Sudha] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Komath, SS (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sskomath@mail.jnu.ac.in	KOMATH, SNEHA SUDHA/AAE-6359-2020; Muthuswami, Rohini/Q-9841-2019; Peri, Sreejith/AAY-9076-2021	KOMATH, SNEHA SUDHA/0000-0002-0491-7102; Muthuswami, Rohini/0000-0002-0559-9484; Peri, Sreejith/0000-0001-5445-3265	Council of Scientific and Industrial Research (CSIR), India; CSIR	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from Council of Scientific and Industrial Research (CSIR), India (to S.S.K. and R.M.) and CSIR junior and senior research fellowships (to M.A. and B.Y.)	Bate C, 2010, J BIOL CHEM, V285, P22017, DOI 10.1074/jbc.M110.108548; DOERING TL, 1989, J BIOL CHEM, V264, P11168; DOERING TL, 1990, J BIOL CHEM, V265, P611; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Figler RA, 2000, ARCH BIOCHEM BIOPHYS, V376, P34, DOI 10.1006/abbi.2000.1712; Handa N, 2003, PROTEIN SCI, V12, P1621, DOI 10.1110/gad.03104003; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; MILNE KG, 1994, J BIOL CHEM, V269, P16403; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; ORLEAN P, 1987, J BIOL CHEM, V262, P5732; Pottekat A, 2004, J BIOL CHEM, V279, P15743, DOI 10.1074/jbc.M313537200; Ramakrishnan G, 2000, EXP PARASITOL, V96, P57, DOI 10.1006/expr.2000.4543; Smith TK, 2002, BIOCHEMISTRY-US, V41, P12395, DOI 10.1021/bi020351l; Smith TK, 2001, EMBO J, V20, P3322, DOI 10.1093/emboj/20.13.3322; STEVENS VL, 1993, J BIOL CHEM, V268, P9718; Sutterlin C, 1997, J CELL SCI, V110, P2703; Urbaniak MD, 2005, J BIOL CHEM, V280, P22831, DOI 10.1074/jbc.M502402200; Vats D, 2005, INFECT IMMUN, V73, P8381, DOI 10.1128/IAI.73.12.8381-8392.2005; Victoria GS, 2010, MICROBIOL-SGM, V156, P3041, DOI 10.1099/mic.0.039628-0; Watanabe R, 1999, BIOCHEM J, V339, P185, DOI 10.1042/0264-6021:3390185	21	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2543	2549		10.1074/jbc.C110.178343	http://dx.doi.org/10.1074/jbc.C110.178343			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21118807	hybrid, Green Published			2022-12-25	WOS:000286464300019
J	Dasgupta, J; Bienkowska-Haba, M; Ortega, ME; Patel, HD; Bodevin, S; Spillmann, D; Bishop, B; Sapp, M; Chen, XS				Dasgupta, Jhimli; Bienkowska-Haba, Malgorzata; Ortega, Marcos E.; Patel, Hetalkumar D.; Bodevin, Sabrina; Spillmann, Dorothe; Bishop, Brooke; Sapp, Martin; Chen, Xiaojiang S.			Structural Basis of Oligosaccharide Receptor Recognition by Human Papillomavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE HEPARAN-SULFATE; VIRUS-LIKE PARTICLES; L1 PROTEIN; TYPE-16 L1; INFECTION; CAPSIDS; BINDING; L2; SITE	High risk human papillomavirus types 16 (HPV16) and 18 (HPV18) can cause cervical cancer. Efficient infection by HPV16 and HPV18 pseudovirions requires interactions of particles with cell-surface receptor heparan sulfate oligosaccharide. To understand the virus-receptor interactions for HPV infection, we determined the crystal structures of HPV16 and HPV18 capsids bound to the oligosaccharide receptor fragment using oligomeric heparin. The HPV-heparin structures revealed multiple binding sites for the highly negatively charged oligosaccharide fragment on the capsid surface, which is different from previously reported virus-receptor interactions in which a single type of binding pocket is present for a particular receptor. We performed structure-guided mutagenesis to generate mutant viruses, and cell binding and infectivity assays demonstrated the functional role of viral residues involved in heparin binding. These results provide a basis for understanding virus-heparan sulfate receptor interactions critical for HPV infection and for the potential development of inhibitors against HPV infection.	[Bishop, Brooke; Chen, Xiaojiang S.] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; [Bienkowska-Haba, Malgorzata; Patel, Hetalkumar D.; Sapp, Martin] Louisiana State Univ, Dept Microbiol & Immunol, Hlth Sci Ctr, Shreveport, LA 71130 USA; [Bienkowska-Haba, Malgorzata; Patel, Hetalkumar D.; Sapp, Martin] Louisiana State Univ, Feist Weiller Canc Ctr, Hlth Sci Ctr, Shreveport, LA 71130 USA; [Bodevin, Sabrina; Spillmann, Dorothe] Uppsala Univ, Inst Med Biochem & Microbiol, Biomed Ctr, SE-75123 Uppsala, Sweden	University of Southern California; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Uppsala University	Chen, XS (corresponding author), Univ So Calif, Dept Mol & Computat Biol, 1050 Childs Way,MCB201, Los Angeles, CA 90089 USA.	xiaojiang.chen@usc.edu		Dasgupta, Jhimli/0000-0002-8030-1262	National Institutes of Health [AI081809]; USC Norris cancer center; Swedish Research Council [15023]; Swedish Cancer Society; Polysackaridforskning AB (Uppsala, Sweden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC Norris cancer center; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Polysackaridforskning AB (Uppsala, Sweden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant AI081809 (to M. S.), USC Norris cancer center postdoctoral fellowship (to M. E. O.), and Swedish Research Council Grant 15023, the Swedish Cancer Society, and Polysackaridforskning AB (Uppsala, Sweden) (to S. B. and D. S.).	BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Bishop B, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-3; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Buck Christopher B., 2006, PLoS Pathogens, V2, DOI 10.1372/journal.ppat.0020069; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Christensen ND, 2001, ANTIMICROB AGENTS CH, V45, P3427, DOI 10.1128/AAC.45.12.3427-3432.2001; Conway MJ, 2009, J DENT RES, V88, P307, DOI 10.1177/0022034509333446; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; HAGENSEE ME, 1993, J VIROL, V67, P315, DOI 10.1128/JVI.67.1.315-322.1993; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Rommel O, 2005, J MED VIROL, V75, P114, DOI 10.1002/jmv.20245; Schadlich L, 2009, J VIROL, V83, P7690, DOI 10.1128/JVI.02588-08; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	32	70	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2617	2624		10.1074/jbc.M110.160184	http://dx.doi.org/10.1074/jbc.M110.160184			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21115492	hybrid, Green Published			2022-12-25	WOS:000286464300027
J	Tavoulari, S; Rizwan, AN; Forrest, LR; Rudnick, G				Tavoulari, Sotiria; Rizwan, Ahsan N.; Forrest, Lucy R.; Rudnick, Gary			Reconstructing a Chloride-binding Site in a Bacterial Neurotransmitter Transporter Homologue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; SUBSTRATE PERMEATION PATHWAY; SEROTONIN TRANSPORTER; LEUCINE TRANSPORTER; MEMBRANE-TRANSPORT; ALTERNATING ACCESS; CRYSTAL-STRUCTURE; SODIUM SYMPORTER; ION-BINDING; MECHANISM	In ion-coupled transport proteins, occupation of selective ion-binding sites is required to trigger conformational changes that lead to substrate translocation. Neurotransmitter transporters, targets of abused and therapeutic drugs, require Na+ and Cl- for function. We recently proposed a chloride-binding site in these proteins not present in Cl- -independent prokaryotic homologues. Here we describe conversion of the Cl- -independent prokaryotic tryptophan transporter TnaT to a fully functional Cl- -dependent form by a single point mutation, D268S. Mutations in TnaT-D268S, in wild type TnaT and in serotonin transporter provide direct evidence for the involvement of each of the proposed residues in Cl- coordination. In both SERT and TnaT-D268S, Cl- and Na+ mutually increased each other's potency, consistent with electrostatic interaction through adjacent binding sites. These studies establish the site where Cl- binds to trigger conformational change during neurotransmitter transport.	[Forrest, Lucy R.] Max Planck Inst Biophys, Computat Struct Biol Grp, D-60438 Frankfurt, Germany; Yale Univ, Dept Pharmacol, Sch Med, New Haven, CT 06520 USA; [Rizwan, Ahsan N.] Quintiles Corp, Overland Pk, KS 66211 USA	Max Planck Society; Yale University; IQVIA	Forrest, LR (corresponding author), Max Planck Inst Biophys, Computat Struct Biol Grp, Max Von Laue Str 3, D-60438 Frankfurt, Germany.	lucy.forrest@biophys.mpg.de; gary.rudnick@yale.edu	Tavoulari, Sotiria/G-3285-2012; Forrest, Lucy/E-8113-2016	Forrest, Lucy/0000-0003-1855-7985	National Institutes of Health [GM075347, DA007259]; Autism Speaks postdoctoral fellowship; Deutsche Forschungsgemeinschaft Collaborative Research Center [807]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007259, R01DA008213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks postdoctoral fellowship; Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM075347 and DA007259 (to G. R.). This work was also supported by an Autism Speaks postdoctoral fellowship (to S. T.) and by the Deutsche Forschungsgemeinschaft Collaborative Research Center 807 "Transport and Communication across Biological Membranes" (to L. R. F.).	Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; BENYONA A, 2010, J BIOL CHEM     1123, DOI DOI 10.1074/JBC.M110149732; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Chen NH, 2003, EUR J PHARMACOL, V479, P213, DOI 10.1016/j.ejphar.2003.08.070; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Howell LL, 2008, BIOCHEM PHARMACOL, V75, P196, DOI 10.1016/j.bcp.2007.08.003; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Kamdar G, 2001, J BIOL CHEM, V276, P4038, DOI 10.1074/jbc.M008483200; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Mager S, 1996, J NEUROSCI, V16, P5405; Mari SA, 2006, CELL MOL LIFE SCI, V63, P100, DOI 10.1007/s00018-005-5512-6; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Rudnick G, 1998, J BIOENERG BIOMEMBR, V30, P173, DOI 10.1023/A:1020573325823; Rudnick Gary, 2002, P25; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	44	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2834	2842		10.1074/jbc.M110.186064	http://dx.doi.org/10.1074/jbc.M110.186064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21115480	Green Published, hybrid			2022-12-25	WOS:000286464300049
J	Ploski, R; Brand, OJ; Jurecka-Lubieniecka, B; Franaszczyk, M; Kula, D; Krajewski, P; Karamat, MA; Simmonds, MJ; Franklyn, JA; Gough, SCL; Jarzab, B; Bednarczuk, T				Ploski, Rafal; Brand, Oliver J.; Jurecka-Lubieniecka, Beata; Franaszczyk, Maria; Kula, Dorota; Krajewski, Pawel; Karamat, Muhammad A.; Simmonds, Matthew J.; Franklyn, Jayne A.; Gough, Stephen C. L.; Jarzab, Barbara; Bednarczuk, Tomasz			Thyroid Stimulating Hormone Receptor (TSHR) Intron 1 Variants Are Major Risk Factors for Graves' Disease in Three European Caucasian Cohorts	PLOS ONE			English	Article							HUMAN THYROTROPIN RECEPTOR; AUTOIMMUNE-DISEASE; ASSOCIATION; GENE; POLYMORPHISM; SUSCEPTIBILITY; GENOME; CTLA-4; POPULATION; ALLELES	Background: The thyroid stimulating hormone receptor (TSHR) gene is an established susceptibility locus for Graves' disease (GD), with recent studies refining association to two single nucleotide polymorphisms (SNPs), rs179247 and rs12101255, within TSHR intron 1. Methodology and Principal Findings: We aimed to validate association of rs179247 and rs12101255 in Polish and UK Caucasian GD case-control subjects, determine the mode of inheritance and to see if association correlates with specific GD clinical manifestations. We investigated three case-control populations; 558 GD patients and 520 controls from Warsaw, Poland, 196 GD patients and 198 controls from Gliwice, Poland and 2504 GD patients from the UK National collection and 2784 controls from the 1958 British Birth cohort. Both rs179247 (P = 1.2x10(-2) -6.2x10(-15), OR = 1.38-1.45) and rs12101255 (P = 1.0x10(-4)-3.68x10(-21), OR = 1.47-1.87) exhibited strong association with GD in all three cohorts. Logistic regression suggested association of rs179247 is secondary to rs12101255 in all cohorts. Inheritance modeling suggested a co-dominant mode of inheritance in all cohorts. Genotype-phenotype correlations provided no clear evidence of association with any specific clinical characteristics. Conclusions: We have validated association of TSHR intron 1 SNPs with GD in three independent European cohorts and have demonstrated that the aetiological variant within the TSHR is likely to be in strong linkage disequilibrium with rs12101255. Fine mapping is now required to determine the exact location of the aetiological DNA variants within the TSHR.	[Ploski, Rafal; Franaszczyk, Maria] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Ploski, Rafal; Krajewski, Pawel] Med Univ Warsaw, Dept Forens Med, Warsaw, Poland; [Brand, Oliver J.; Karamat, Muhammad A.; Simmonds, Matthew J.; Franklyn, Jayne A.] Univ Birmingham, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Brand, Oliver J.; Simmonds, Matthew J.; Gough, Stephen C. L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Jurecka-Lubieniecka, Beata; Kula, Dorota; Jarzab, Barbara] Maria Sklodowska Curie Mem Canc Ctr, Dept Nucl Med & Endocrine Oncol, Gliwice, Poland; [Jurecka-Lubieniecka, Beata; Kula, Dorota; Jarzab, Barbara] Inst Oncol, Gliwice, Poland; [Bednarczuk, Tomasz] Med Univ Warsaw, Dept Endocrinol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; University of Birmingham; University of Oxford; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Warsaw	Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	oliver.brand@ocdem.ox.ac.uk	Jarząb, Barbara/AAI-7942-2020; Barbara, Jarzab/I-4654-2019; Bednarczuk, Tomasz/AFQ-8418-2022	Jarząb, Barbara/0000-0001-9811-9584; Kula, Dorota/0000-0002-0986-1929; Ploski, Rafal/0000-0001-6286-5526; Jurecka-Lubieniecka, Beata/0000-0001-6333-0451; Simmonds, Matt/0000-0003-3154-3510	Warsaw Medical University [1WN/NK1W, 1WY/N/09]; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; MRC [G0000934] Funding Source: UKRI	Warsaw Medical University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by Warsaw Medical University grants 1WN/NK1W and 1WY/N/09. The authors acknowledge use of DNA from the 1958 British Birth Cohort Collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamizu T, 2000, THYROID, V10, P851, DOI 10.1089/thy.2000.10.851; Allahabadia A, 1998, THYROID, V8, P777, DOI 10.1089/thy.1998.8.777; Ban Y, 2002, THYROID, V12, P1079, DOI 10.1089/105072502321085171; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bednarczuk T, 2004, HUM IMMUNOL, V65, P632, DOI 10.1016/j.humimm.2004.02.033; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; CUDDIHY RM, 1995, THYROID, V5, P89, DOI 10.1089/thy.1995.5.89; Dechairo BM, 2005, EUR J HUM GENET, V13, P1223, DOI 10.1038/sj.ejhg.5201485; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gough SCL, 2007, CURR GENOMICS, V8, P453, DOI 10.2174/138920207783591690; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Kaczur V, 2000, EUR J IMMUNOGENET, V27, P17, DOI 10.1046/j.1365-2370.2000.00187.x; Kisiel B, 2008, CLIN ENDOCRINOL, V68, P429, DOI 10.1111/j.1365-2265.2007.03060.x; Kula D, 2006, THYROID, V16, P447, DOI 10.1089/thy.2006.16.447; Manji N, 2006, J CLIN ENDOCR METAB, V91, P4873, DOI 10.1210/jc.2006-1402; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sale MM, 1997, P ASSOC AM PHYSICIAN, V109, P453; Simanainen J, 1999, THYROID, V9, P7, DOI 10.1089/thy.1999.9.7; Smith BR, 2007, THYROID, V17, P923, DOI 10.1089/thy.2007.0239; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621	24	28	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2010	5	11							e15512	10.1371/journal.pone.0015512	http://dx.doi.org/10.1371/journal.pone.0015512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686GM	21124799	Green Submitted, Green Published, gold			2022-12-25	WOS:000284684800002
J	Kuchenreuther, JM; Grady-Smith, CS; Bingham, AS; George, SJ; Cramer, SP; Swartz, JR				Kuchenreuther, Jon M.; Grady-Smith, Celestine S.; Bingham, Alyssa S.; George, Simon J.; Cramer, Stephen P.; Swartz, James R.			High-Yield Expression of Heterologous [FeFe] Hydrogenases in Escherichia coli	PLOS ONE			English	Article							CLOSTRIDIUM-PASTEURIANUM; ONLY HYDROGENASE; ACTIVE-SITE; DESULFOVIBRIO-DESULFURICANS; THERMOTOGA-MARITIMA; LIGHT SENSITIVITY; IRON-HYDROGENASE; MATURATION; PROTEIN; FERREDOXIN	Background: The realization of hydrogenase-based technologies for renewable H-2 production is presently limited by the need for scalable and high-yielding methods to supply active hydrogenases and their required maturases. Principal Findings: In this report, we describe an improved Escherichia coli-based expression system capable of producing 8-30 mg of purified, active [FeFe] hydrogenase per liter of culture, volumetric yields at least 10-fold greater than previously reported. Specifically, we overcame two problems associated with other in vivo production methods: low protein yields and ineffective hydrogenase maturation. The addition of glucose to the growth medium enhances anaerobic metabolism and growth during hydrogenase expression, which substantially increases total yields. Also, we combine iron and cysteine supplementation with the use of an E. coli strain upregulated for iron-sulfur cluster protein accumulation. These measures dramatically improve in vivo hydrogenase activation. Two hydrogenases, HydA1 from Chlamydomonas reinhardtii and HydA (CpI) from Clostridium pasteurianum, were produced with this improved system and subsequently purified. Biophysical characterization and FTIR spectroscopic analysis of these enzymes indicate that they harbor the H-cluster and catalyze H-2 evolution with rates comparable to those of enzymes isolated from their respective native organisms. Significance: The production system we describe will facilitate basic hydrogenase investigations as well as the development of new technologies that utilize these prolific H-2-producing enzymes. These methods can also be extended for producing and studying a variety of oxygen-sensitive iron-sulfur proteins as well as other proteins requiring anoxic environments.	[Kuchenreuther, Jon M.; Bingham, Alyssa S.; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Grady-Smith, Celestine S.; George, Simon J.; Cramer, Stephen P.] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA; [Grady-Smith, Celestine S.; George, Simon J.; Cramer, Stephen P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University	Kuchenreuther, JM (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu		George, Simon/0000-0002-4864-5479	United States Department of Energy BioEnergy Science	United States Department of Energy BioEnergy Science(United States Department of Energy (DOE))	This work was funded by the United States Department of Energy BioEnergy Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1984, J BIOL CHEM, V259, P7045; ADAMS MWW, 1989, P NATL ACAD SCI USA, V86, P4932, DOI 10.1073/pnas.86.13.4932; ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Akhtar MK, 2008, APPL MICROBIOL BIOT, V78, P853, DOI 10.1007/s00253-008-1377-6; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Boyer ME, 2006, BIOTECHNOL BIOENG, V94, P128, DOI 10.1002/bit.20830; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Chen ZJ, 2002, BIOCHEMISTRY-US, V41, P2036, DOI 10.1021/bi011510o; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005; Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; Laffly E, 2010, INT J HYDROGEN ENERG, V35, P10761, DOI 10.1016/j.ijhydene.2010.02.070; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; Moulis JM, 1995, BIOCHEMISTRY-US, V34, P16781, DOI 10.1021/bi00051a028; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Nicolet Y, 2002, J INORG BIOCHEM, V91, P1, DOI 10.1016/S0162-0134(02)00392-6; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2010, INT J HYDROGEN ENERG, V35, P10750, DOI 10.1016/j.ijhydene.2010.02.056; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Reisner E, 2009, J AM CHEM SOC, V131, P18457, DOI 10.1021/ja907923r; Roseboom W, 2006, J BIOL INORG CHEM, V11, P102, DOI 10.1007/s00775-005-0040-2; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; Soboh B, 2006, J BIOL CHEM, V281, P36701, DOI 10.1074/jbc.M606820200; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; Woodward J, 2000, NATURE, V405, P1014, DOI 10.1038/35016633; Zhang YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000414	44	115	117	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15491	10.1371/journal.pone.0015491	http://dx.doi.org/10.1371/journal.pone.0015491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124800	Green Published, Green Submitted, gold			2022-12-25	WOS:000284572000030
J	Shi, YL; Nenadic, Z; Xu, XM				Shi, Yulin; Nenadic, Zoran; Xu, Xiangmin			Novel Use of Matched Filtering for Synaptic Event Detection and Extraction	PLOS ONE			English	Article							TURTLE VISUAL-CORTEX; PYRAMIDAL NEURONS; CORTICAL-NEURONS; LAMINAR; NETWORKS; CONNECTIVITY; ORGANIZATION; SPECIFICITY; RECORDINGS; RESOLUTION	Efficient and dependable methods for detection and measurement of synaptic events are important for studies of synaptic physiology and neuronal circuit connectivity. As the published methods with detection algorithms based upon amplitude thresholding and fixed or scaled template comparisons are of limited utility for detection of signals with variable amplitudes and superimposed events that have complex waveforms, previous techniques are not applicable for detection of evoked synaptic events in photostimulation and other similar experimental situations. Here we report on a novel technique that combines the design of a bank of approximate matched filters with the detection and estimation theory to automatically detect and extract photostimluation-evoked excitatory postsynaptic currents (EPSCs) from individually recorded neurons in cortical circuit mapping experiments. The sensitivity and specificity of the method were evaluated on both simulated and experimental data, with its performance comparable to that of visual event detection performed by human operators. This new technique was applied to quantify and compare the EPSCs obtained from excitatory pyramidal cells and fast-spiking interneurons. In addition, our technique has been further applied to the detection and analysis of inhibitory postsynaptic current (IPSC) responses. Given the general purpose of our matched filtering and signal recognition algorithms, we expect that our technique can be appropriately modified and applied to detect and extract other types of electrophysiological and optical imaging signals.	[Shi, Yulin; Xu, Xiangmin] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Nenadic, Zoran; Xu, Xiangmin] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Shi, YL (corresponding author), Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	znenadic@uci.edu; xiangmin.xu@uci.edu		Nenadic, Zoran/0000-0001-5569-3797	United States National Institutes of Health [DA023700, DA023700-04S1]; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA023700, R00DA023700] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the United States National Institutes of Health grants DA023700 and DA023700-04S1 to X.X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; BANKMAN IN, 1993, IEEE T BIO-MED ENG, V40, P836, DOI 10.1109/10.238472; Benitez R, 2008, IEEE T BIO-MED ENG, V55, P1344, DOI 10.1109/TBME.2007.912433; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; COCHRAN SL, 1993, J NEUROSCI METH, V50, P105, DOI 10.1016/0165-0270(93)90061-U; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hwang TN, 1999, J NEUROSCI METH, V92, P65, DOI 10.1016/S0165-0270(99)00095-3; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kay S. M., 1998, FUNDAMENTALS STAT SI; Li GH, 2007, J NEUROSCI METH, V164, P139, DOI 10.1016/j.jneumeth.2007.04.010; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; Nenadic Z, 2006, IEEE T BIO-MED ENG, V53, P941, DOI 10.1109/TBME.2005.863930; Nenadic Z, 2005, IEEE T BIO-MED ENG, V52, P74, DOI 10.1109/TBME.2004.839800; Nenadic Z, 2003, J COMPUT NEUROSCI, V14, P161, DOI 10.1023/A:1021954701494; Nenadic Z, 2002, IEEE T BIO-MED ENG, V49, P753, DOI [10.1109/TBME.2002.800753, 10.1109/FBME.2002.800753]; Nenadic Z, 2000, NEUROCOMPUTING, V32, P479, DOI 10.1016/S0925-2312(00)00202-2; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Oppenheim A.V., 2009, DISCRETE TIME SIGNAL; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; XU X, 2010, J NEUROPHYSIOL, V103; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	27	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15517	10.1371/journal.pone.0015517	http://dx.doi.org/10.1371/journal.pone.0015517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124805	Green Published, gold			2022-12-25	WOS:000284572000034
J	Schafer, A; Schomacher, L; Barreto, G; Doderlein, G; Niehrs, C				Schaefer, Andrea; Schomacher, Lars; Barreto, Guillermo; Doederlein, Gabi; Niehrs, Christof			Gemcitabine Functions Epigenetically by Inhibiting Repair Mediated DNA Demethylation	PLOS ONE			English	Article							EXCISION-REPAIR; DRUG-RESISTANCE; MISMATCH REPAIR; HUMAN-CELLS; CANCER; DAMAGE; METHYLATION; MECHANISM; CISPLATIN; 2',2'-DIFLUORODEOXYCYTIDINE	Gemcitabine is a cytotoxic cytidine analog, which is widely used in anti-cancer therapy. One mechanism by which gemcitabine acts is by inhibiting nucleotide excision repair (NER). Recently NER was implicated in Gadd45 mediated DNA demethylation and epigenetic gene activation. Here we analyzed the effect of gemcitabine on DNA demethylation. We find that gemcitabine inhibits specifically Gadd45a mediated reporter gene activation and DNA demethylation, similar to the topoisomerase I inhibitor camptothecin, which also inhibits NER. In contrast, base excision repair inhibitors had no effect on DNA demethylation. In Xenopus oocytes, gemcitabine inhibits DNA repair synthesis accompanying demethylation of oct4. In mammalian cells, gemcitabine induces DNA hypermethylation and silencing of MLH1. The results indicate that gemcitabine induces epigenetic gene silencing by inhibiting repair mediated DNA demethylation. Thus, gemcitabine can function epigenetically and provides a tool to manipulate DNA methylation.	[Schaefer, Andrea; Schomacher, Lars; Barreto, Guillermo; Doederlein, Gabi; Niehrs, Christof] Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, D-6900 Heidelberg, Germany; [Niehrs, Christof] Inst Mol Biol, Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Institute of Molecular Biology (IMB)	Schafer, A (corresponding author), Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, D-6900 Heidelberg, Germany.	Niehrs@DKFZ-Heidelberg.de	Schomacher, Lars/AAC-3462-2019; Barreto, Guillermo/U-5718-2017	Schomacher, Lars/0000-0002-3841-5258; Barreto, Guillermo/0000-0002-7777-4712	Deutsche Forschungsgemeinschaft [NI 286/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (NI 286/12-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2001, CANCER RES, V61, P8723; BAKER CH, 1991, J MED CHEM, V34, P1879, DOI 10.1021/jm00110a019; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BOUFFARD DY, 1991, ANTI-CANCER DRUG, V2, P49, DOI 10.1097/00001813-199102000-00007; Crul M, 2003, BIOCHEM PHARMACOL, V65, P275, DOI 10.1016/S0006-2952(02)01508-3; DOWNES CS, 1987, CARCINOGENESIS, V8, P1613, DOI 10.1093/carcin/8.11.1613; Gao Z, 2008, BIOORGAN MED CHEM, V16, P4331, DOI 10.1016/j.bmc.2008.02.071; HAJKOVA P, SCIENCE, V329, P78; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; HEINEMANN V, 1988, CANCER RES, V48, P4024; HEINEMANN V, 1995, SEMIN ONCOL, V22, P11; Horton TM, 2009, MOL CANCER THER, V8, P2232, DOI 10.1158/1535-7163.MCT-09-0142; HUANG P, 1991, CANCER RES, V51, P6110; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Moufarij MA, 2003, MOL PHARMACOL, V63, P862, DOI 10.1124/mol.63.4.862; NYCE J, 1989, CANCER RES, V49, P5829; Nyce JW, 1997, MUTAT RES-REV MUTAT, V386, P153, DOI 10.1016/S1383-5742(96)00051-8; Qu GZ, 1999, MUTAT RES-FUND MOL M, V423, P91, DOI 10.1016/S0027-5107(98)00229-2; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Stach D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng002; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Sun DY, 2002, CLIN CANCER RES, V8, P1189; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Toschi L, 2005, Future Oncol, V1, P7, DOI 10.1517/14796694.1.1.7; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Wade-Martins R, 1999, NUCLEIC ACIDS RES, V27, P1674, DOI 10.1093/nar/27.7.1674; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang LY, 2000, CLIN CANCER RES, V6, P773	37	197	198	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14060	10.1371/journal.pone.0014060	http://dx.doi.org/10.1371/journal.pone.0014060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124914	gold, Green Published, Green Submitted			2022-12-25	WOS:000284400100009
J	Lee, KW; Lee, DJ; Lee, JY; Kang, DH; Kwon, J; Kang, SW				Lee, Kyung Wha; Lee, Doo Jae; Lee, Joo Young; Kang, Dong Hoon; Kwon, Jongbum; Kang, Sang Won			Peroxiredoxin II Restrains DNA Damage-induced Death in Cancer Cells by Positively Regulating JNK-dependent DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; MAMMALIAN PEROXIREDOXIN; TUMOR-CELLS; C-MYC; ACTIVATION; RADIATION; APOPTOSIS; STRESS	The 2-Cys peroxiredoxins (Prx) belong to a family of antioxidant enzymes that detoxify reactive oxygen and nitrogen species and are distributed throughout the intracellular and extracellular compartments. However, the presence and role of 2-Cys Prxs in the nucleus have not been studied. This study demonstrates that the PrxII located in the nucleus protects cancer cells from DNA damage-induced cell death. Although the two cytosolic 2-Cys Prxs, PrxI and PrxII, were found in the nucleus, only PrxII knockdown selectively and markedly increased cell death in the cancer cells treated with DNA-damaging agents. The increased death was completely reverted by the nuclearly targeted expression of PrxII in an activity-independent manner. Furthermore, the antioxidant butylated hydroxyanisole did not influence the etoposide-induced cell death. Mechanistically, the knockdown of Prx II expression impaired the DNA repair process by reducing the activation of the JNK/c-Jun pathway. These results suggest that PrxII is likely to be attributed to a tumor survival factor positively regulating JNK-dependent DNA repair with its inhibition possibly sensitizing cancer cells to chemotherapeutic agents.	[Lee, Kyung Wha; Lee, Joo Young; Kwon, Jongbum; Kang, Sang Won] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Lee, Doo Jae; Kang, Dong Hoon; Kwon, Jongbum; Kang, Sang Won] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea; [Kwon, Jongbum; Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Kang, SW (corresponding author), 11-1 Daehyun Dong, Seoul 120750, South Korea.	kangsw@ewha.ac.kr			Ministry of Education, Science and Technology [2009-0054572, FPR08-B1-190]; KOSEF through the Center for Cell Signaling and Drug Discovery Research [R15-2006-020]; Brain Korea 21; LG Foundation	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); KOSEF through the Center for Cell Signaling and Drug Discovery Research; Brain Korea 21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); LG Foundation	This work was supported in part by Mid-career Researcher Program through National Research Foundation of Korea Grant 2009-0054572 funded by the Ministry of Education, Science and Technology, by 21C Frontier Functional Proteomics Project FPR08-B1-190 funded by the Ministry of Education, Science and Technology, and by KOSEF through the Center for Cell Signaling and Drug Discovery Research Grant R15-2006-020 at Ewha Womans University.; Recipient of the Brain Korea 21 grant.; Supported by Exchange Professor Program of LG Foundation. To whom correspondence should be addressed: 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea. Fax:82-2-3277-3760; E-mail: kangsw@ewha.ac.kr.	Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; CERUTTI PA, 1994, LANCET, V344, P862, DOI 10.1016/S0140-6736(94)92832-0; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen MF, 2006, INT J RADIAT ONCOL, V64, P581, DOI 10.1016/j.ijrobp.2005.10.012; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Halliwell B., 2007, FREE RADICAL BIO MED, P70; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kang SW, 2004, J BIOL CHEM, V279, P2535, DOI 10.1074/jbc.M307698200; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kurosu T, 2003, ONCOGENE, V22, P4459, DOI 10.1038/sj.onc.1206755; Lee JY, 2009, FREE RADICAL BIO MED, V47, P1162, DOI 10.1016/j.freeradbiomed.2009.07.027; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Low FM, 2008, ANTIOXID REDOX SIGN, V10, P1621, DOI 10.1089/ars.2008.2081; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Mizutani H, 2002, J BIOL CHEM, V277, P30684, DOI 10.1074/jbc.M204353200; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park SH, 2000, CLIN CANCER RES, V6, P4915; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Senturker S, 2002, ARCH BIOCHEM BIOPHYS, V397, P262, DOI 10.1006/abbi.2001.2681; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith-Pearson PS, 2008, FREE RADICAL BIO MED, V45, P1178, DOI 10.1016/j.freeradbiomed.2008.07.015; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang TL, 2005, CANCER RES, V65, P10338, DOI 10.1158/0008-5472.CAN-04-4614; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wu D, 2006, ONCOGENE, V25, P1153, DOI 10.1038/sj.onc.1209148; Yan Y, 2007, ONCOGENE, V26, P4689, DOI 10.1038/sj.onc.1210268; Yan Y, 2008, CANCER RES, V68, P5113, DOI 10.1158/0008-5472.CAN-07-5818; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhang B, 2005, J RADIAT RES, V46, P305, DOI 10.1269/jrr.46.305; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	54	45	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8394	8404		10.1074/jbc.M110.179416	http://dx.doi.org/10.1074/jbc.M110.179416			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21148313	hybrid, Green Published			2022-12-25	WOS:000288013300068
J	Rosenbaum, S; Kreft, S; Etich, J; Frie, C; Stermann, J; Grskovic, I; Frey, B; Mielenz, D; Poschl, E; Gaipl, U; Paulsson, M; Brachvogel, B				Rosenbaum, Sabrina; Kreft, Sandra; Etich, Julia; Frie, Christian; Stermann, Jacek; Grskovic, Ivan; Frey, Benjamin; Mielenz, Dirk; Poeschl, Ernst; Gaipl, Udo; Paulsson, Mats; Brachvogel, Bent			Identification of Novel Binding Partners (Annexins) for the Cell Death Signal Phosphatidylserine and Definition of Their Recognition Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELLS; DYING CELLS; A5; PHAGOCYTOSIS; PROTEIN; CALCIUM; MICE; PHOSPHOLIPIDS; MACROPHAGES; ENGULFMENT	Identification and clearance of apoptotic cells prevents the release of harmful cell contents thereby suppressing inflammation and autoimmune reactions. Highly conserved annexins may modulate the phagocytic cell removal by acting as bridging molecules to phosphatidylserine, a characteristic phagocytosis signal of dying cells. In this study five members of the structurally and functionally related annexin family were characterized for their capacity to interact with phosphatidylserine and dying cells. The results showed that AnxA3, AnxA4, AnxA13, and the already described interaction partner AnxA5 can bind to phosphatidylserine and apoptotic cells, whereas AnxA8 lacks this ability. Sequence alignment experiments located the essential amino residues for the recognition of surface exposed phosphatidylserine within the calcium binding motifs common to all annexins. These amino acid residues were missing in the evolutionary young AnxA8 and when they were reintroduced by site directed mutagenesis AnxA8 gains the capability to interact with phosphatidylserine containing liposomes and apoptotic cells. By defining the evolutionary conserved amino acid residues mediating phosphatidylserine binding of annexins we show that the recognition of dying cells represent a common feature of most annexins. Hence, the individual annexin repertoire bound to the cell surface of dying cells may fulfil opsonin-like function in cell death recognition.	[Rosenbaum, Sabrina; Kreft, Sandra; Etich, Julia; Frie, Christian; Stermann, Jacek; Grskovic, Ivan; Paulsson, Mats; Brachvogel, Bent] Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany; [Frey, Benjamin; Gaipl, Udo] Univ Hosp Erlangen, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Mielenz, Dirk] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Div Mol Immunol, D-91054 Erlangen, Germany; [Poeschl, Ernst] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Paulsson, Mats] CMMC, Cologne, Germany; [Paulsson, Mats] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	University of Cologne; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of East Anglia; University of Cologne; University of Cologne	Brachvogel, B (corresponding author), Univ Cologne, Ctr Biochem, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	bent.brachvogel@uni-koeln.de	Frey, Benjamin/D-9565-2017; Gaipl, Udo/AAE-1060-2020	Frey, Benjamin/0000-0001-6743-3351; Brachvogel, Bent/0000-0002-3923-0554; Etich, Julia/0000-0003-3238-6692	German Research Foundation [BR2304/4-1, GA1507/1-1]; MRC [G0802553] Funding Source: UKRI; Medical Research Council [G0802553] Funding Source: researchfish	German Research Foundation(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by Grants BR2304/4-1 and GA1507/1-1 from the German Research Foundation.	Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Balasubramanian K, 1998, J BIOL CHEM, V273, P29272, DOI 10.1074/jbc.273.44.29272; Blankenberg F, 2003, Q J NUCL MED, V47, P337; Blume KE, 2009, J IMMUNOL, V183, P8138, DOI 10.4049/jimmunol.0902250; Brachvogel B, 2003, MOL CELL BIOL, V23, P2907, DOI 10.1128/MCB.23.8.2907-2913.2003; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Fan XX, 2004, MOL BIOL CELL, V15, P2863, DOI 10.1091/mbc.E03-09-0670; Frey B, 2009, J CELL MOL MED, V13, P1391, DOI 10.1111/j.1582-4934.2008.00395.x; Gaipl US, 2007, AUTOIMMUNITY, V40, P254, DOI 10.1080/08916930701357331; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HIRATA F, 1981, P NATL ACAD SCI-BIOL, V78, P3190, DOI 10.1073/pnas.78.5.3190; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jin M, 2004, J BIOL CHEM, V279, P40351, DOI 10.1074/jbc.M405846200; Kenis H, 2006, EXP CELL RES, V312, P719, DOI 10.1016/j.yexcr.2005.11.023; Manfredi AA, 2002, APOPTOSIS, V7, P153, DOI 10.1023/A:1014366531885; MEERS P, 1993, BIOCHEMISTRY-US, V32, P5411, DOI 10.1021/bi00071a016; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morgan RO, 2004, BBA-MOL CELL RES, V1742, P133, DOI 10.1016/j.bbamcr.2004.09.010; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Munoz LE, 2007, J LEUKOCYTE BIOL, V81, P6, DOI 10.1189/jlb.0306166; NELSON MR, 1995, BIOCHEMISTRY-US, V34, P3121, DOI 10.1021/bi00009a044; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Platt N, 2000, J IMMUNOL, V164, P4861, DOI 10.4049/jimmunol.164.9.4861; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Stach CM, 2000, CELL DEATH DIFFER, V7, P911, DOI 10.1038/sj.cdd.4400715; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yona S, 2005, PROSTAG LEUKOTR ESS, V72, P95, DOI 10.1016/j.plefa.2004.10.008; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	39	39	42	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5708	5716		10.1074/jbc.M110.193086	http://dx.doi.org/10.1074/jbc.M110.193086			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21131363	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000287230600079
J	Runager, K; Basaiawmoit, RV; Deva, T; Andreasen, M; Valnickova, Z; Sorensen, CS; Karring, H; Thogersen, IB; Christiansen, G; Underhaug, J; Kristensen, T; Nielsen, NC; Klintworth, GK; Otzen, DE; Enghild, JJ				Runager, Kasper; Basaiawmoit, Rajiv V.; Deva, Taru; Andreasen, Maria; Valnickova, Zuzana; Sorensen, Charlotte S.; Karring, Henrik; Thogersen, Ida B.; Christiansen, Gunna; Underhaug, Jarl; Kristensen, Torsten; Nielsen, Niels Chr.; Klintworth, Gordon K.; Otzen, Daniel E.; Enghild, Jan J.			Human Phenotypically Distinct TGFBI Corneal Dystrophies Are Linked to the Stability of the Fourth FAS1 Domain of TGFBIp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CIRCULAR-DICHROISM SPECTRA; MATRIX PROTEIN BETA-IG-H3; CELL-ADHESION; GEL-ELECTROPHORESIS; SECONDARY STRUCTURE; KERATO-EPITHELIN; IN-VITRO; GENE; IDENTIFICATION	Mutations in the human TGFBI gene encoding TGFBIp have been linked to protein deposits in the cornea leading to visual impairment. The protein consists of an N-terminal Cys-rich EMI domain and four consecutive fasciclin 1 (FAS1) domains. We have compared the stabilities of wild-type (WT) human TGFBIp and six mutants known to produce phenotypically distinct deposits in the cornea. Amino acid substitutions in the first FAS1 (FAS1-1) domain (R124H, R124L, and R124C) did not alter the stability. However, substitutions within the fourth FAS1 (FAS1-4) domain (A546T, R555Q, and R555W) affected the overall stability of intact TGFBIp revealing the following stability ranking R555W>WT>R555Q>A546T. Significantly, the stability ranking of the isolated FAS1-4 domains mirrored the behavior of the intact protein. In addition, it was linked to the aggregation propensity as the least stable mutant (A546T) forms amyloid fibrils while the more stable variants generate non-amyloid amorphous deposits in vivo. Significantly, the data suggested that both an increase and a decrease in the stability of FAS1-4 may unleash a disease mechanism. In contrast, amino acid substitutions in FAS1-1 did not affect the stability of the intact TGFBIp suggesting that molecular the mechanism of disease differs depending on the FAS1 domain carrying the mutation.	[Runager, Kasper; Basaiawmoit, Rajiv V.; Deva, Taru; Andreasen, Maria; Valnickova, Zuzana; Sorensen, Charlotte S.; Thogersen, Ida B.; Underhaug, Jarl; Kristensen, Torsten; Nielsen, Niels Chr.; Otzen, Daniel E.; Enghild, Jan J.] Aarhus Univ, Ctr Insoluble Prot Struct InSPIN, DK-8000 Aarhus, Denmark; [Runager, Kasper; Basaiawmoit, Rajiv V.; Deva, Taru; Andreasen, Maria; Valnickova, Zuzana; Sorensen, Charlotte S.; Thogersen, Ida B.; Underhaug, Jarl; Kristensen, Torsten; Nielsen, Niels Chr.; Otzen, Daniel E.; Enghild, Jan J.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Deva, Taru] Univ Copenhagen, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark; [Karring, Henrik] Univ So Denmark, Inst Chem Engn Biotechnol & Environm Technol, DK-5230 Odense M, Denmark; [Christiansen, Gunna] Univ Aarhus, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark; [Klintworth, Gordon K.] Duke Univ, Dept Pathol & Ophthalmol, Med Ctr, Durham, NC 27710 USA	Aarhus University; Aarhus University; University of Copenhagen; University of Southern Denmark; Aarhus University; Duke University	Otzen, DE (corresponding author), Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	dao@mb.au.dk; jje@mb.au.dk	Basaiawmoit, Rajiv V/H-3961-2014	Basaiawmoit, Rajiv V/0000-0001-8114-1857; Underhaug, Jarl/0000-0003-0346-3986; Christiansen, Gunna/0000-0003-0540-1367; Otzen, Daniel/0000-0002-2918-8989; Enghild, Jan Johannes/0000-0001-9292-9172; Andreasen, Maria/0000-0002-6096-2995; Nielsen, Niels Chr./0000-0003-2978-4366; Karring, Henrik/0000-0002-4672-1503	National Eye Institute [R01 EY012712]; Danish National Research Foundation (inSPIN); NATIONAL EYE INSTITUTE [R01EY012712] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Danish National Research Foundation (inSPIN)(Danmarks Grundforskningsfond); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (R01 EY012712) and the Danish National Research Foundation (inSPIN).	Andersen RB, 2004, BIOCHEMISTRY-US, V43, P16374, DOI 10.1021/bi048589s; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clout NJ, 2003, STRUCTURE, V11, P197, DOI 10.1016/S0969-2126(03)00002-9; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; Ferguson JW, 2003, CELL TISSUE RES, V313, P93, DOI 10.1007/s00441-003-0743-z; Goldenberg D.P, 1989, PROTEIN STRUCTURE PR, P225; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; Hashimoto K, 1997, BBA-MOL CELL RES, V1355, P303, DOI 10.1016/S0167-4889(96)00147-4; HOLLECKER M, 1982, BIOCHIM BIOPHYS ACTA, V701, P395, DOI 10.1016/0167-4838(82)90243-6; Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kitahama S, 2000, BONE, V27, P61, DOI 10.1016/S8756-3282(00)00292-1; Klintworth GK, 1998, AM J PATHOL, V152, P743; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Konishi M, 2000, CURR EYE RES, V21, P891, DOI 10.1076/ceyr.21.5.891.5536; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; LEBARON RG, 1995, J INVEST DERMATOL, V104, P844, DOI 10.1111/1523-1747.ep12607024; Lee SH, 2003, KIDNEY INT, V64, P1012, DOI 10.1046/j.1523-1755.2003.00158.x; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MANAVALAN P, 1985, J BIOSCIENCE, V8, P141, DOI 10.1007/BF02703972; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mogensen JE, 2004, BIOCHEMISTRY-US, V43, P3357, DOI 10.1021/bi0358622; Ohno S, 2002, J DENT RES, V81, pA407; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Raffen R, 1999, PROTEIN SCI, V8, P509; Rawe IM, 1997, INVEST OPHTH VIS SCI, V38, P893; Reinboth B, 2006, J BIOL CHEM, V281, P7816, DOI 10.1074/jbc.M511316200; RUBENSTEIN DS, 1991, J BIOL CHEM, V266, P11252; Runager K, 2009, ACTA CRYSTALLOGR F, V65, P299, DOI 10.1107/S1744309109005016; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stix B, 2005, INVEST OPHTH VIS SCI, V46, P1133, DOI 10.1167/iovs.04-1319; Takacs L, 1998, EXP EYE RES, V66, P739, DOI 10.1006/exer.1998.0471; Yuan C, 2007, FEBS LETT, V581, P241, DOI 10.1016/j.febslet.2006.12.019	42	51	52	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4951	4958		10.1074/jbc.M110.181099	http://dx.doi.org/10.1074/jbc.M110.181099			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135107	Green Published, hybrid			2022-12-25	WOS:000287230600003
J	Spandl, J; Lohmann, D; Kuerschner, L; Moessinger, C; Thiele, C				Spandl, Johanna; Lohmann, Daniel; Kuerschner, Lars; Moessinger, Christine; Thiele, Christoph			Ancient Ubiquitous Protein 1 (AUP1) Localizes to Lipid Droplets and Binds the E2 Ubiquitin Conjugase G2 (Ube2g2) via Its G2 Binding Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CUE DOMAIN; MEMBRANE; DEGRADATION; IDENTIFICATION; PATHWAY; CELLS; DISLOCATION; REDUCTASE; BODIES	Lipid droplets (LDs), the major intracellular storage sites for neutral lipids, consist of a neutral lipid core surrounded by a phospholipid monolayer membrane. In addition to their function in lipid storage, LDs participate in lipid biosynthesis and recently were implicated in proteasomal protein degradation and autophagy. To identify components of the protein degradation machinery on LDs, we studied several candidates identified in previous LD proteome analyses. Here, we demonstrate that the highly conserved and broadly expressed ancient ubiquitous protein 1 (AUP1) localizes to LDs, where it integrates into the LD surface in a monotopic fashion with both termini facing the cytosol. AUP1 contains a C-terminal domain with strong homology to a domain known as G2BR, which binds E2 ubiquitin conjugases. We show that AUP1, by means of its G2BR domain, binds to Ube2g2. This binding is abolished by deletion or mutation of the G2BR domain, although the LD localization of AUP1 is not affected. The presence of the AUP1-Ube2g2 complex at LDs provides a direct molecular link between LDs and the cellular ubiquitination machinery.	[Spandl, Johanna; Lohmann, Daniel; Kuerschner, Lars; Moessinger, Christine; Thiele, Christoph] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany	University of Bonn	Thiele, C (corresponding author), Univ Bonn, Life & Med Sci Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	cthiele@uni-bonn.de			German National Academic Foundation; Deutsche Forschungsgemeinschaft [TR83, SFB645]; European Union	German National Academic Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by the German National Academic Foundation (to J. S.), Deutsche Forschungsgemeinschaft Grants TR83 (to C. M.) and SFB645 (to D. L.), and European Union Grant FP7 LipdomicNet (to C. T.).	Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; DiDonato D, 2003, J HISTOCHEM CYTOCHEM, V51, P773, DOI 10.1177/002215540305100608; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Fujimoto T, 2006, AUTOPHAGY, V2, P299, DOI 10.4161/auto.2904; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Jang WH, 1996, GENOMICS, V36, P366, DOI 10.1006/geno.1996.0477; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Karpisheva K V, 2002, Tsitologiia, V44, P846; Karpisheva K V, 2002, Tsitologiia, V44, P830; Karpisheva K V, 2002, Tsitologiia, V44, P839; Kato A, 2002, J BIOL CHEM, V277, P28934, DOI 10.1074/jbc.M204340200; Kato A, 2009, PLATELETS, V20, P105, DOI 10.1080/09537100802641507; Le Lay S, 2009, PROG LIPID RES, V48, P191, DOI 10.1016/j.plipres.2009.03.001; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Ohsaki Y, 2005, HISTOCHEM CELL BIOL, V124, P445, DOI 10.1007/s00418-005-0061-5; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Schrader M, 2001, J HISTOCHEM CYTOCHEM, V49, P1421, DOI 10.1177/002215540104901110; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200	59	78	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5599	5606		10.1074/jbc.M110.190785	http://dx.doi.org/10.1074/jbc.M110.190785			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127063	hybrid, Green Published			2022-12-25	WOS:000287230600069
J	Wang, A; Savas, U; Stout, CD; Johnson, EF				Wang, An; Savas, Uzen; Stout, C. David; Johnson, Eric F.			Structural Characterization of the Complex between alpha-Naphthoflavone and Human Cytochrome P450 1B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION; BINDING; CYP1B1; INHIBITORS; P4502C5; ADAPTATIONS; METABOLISM; INDUCTION; OXIDATION; ENZYMES	The atomic structure of human P450 1B1 was determined by x-ray crystallography to 2.7 angstrom resolution with alpha-naphthoflavone (ANF) bound in the active site cavity. Although the amino acid sequences of human P450s 1B1 and 1A2 have diverged significantly, both enzymes exhibit narrow active site cavities, which underlie similarities in their substrate profiles. Helix I residues adopt a relatively flat conformation in both enzymes, and a characteristic distortion of helix F places Phe(231) in 1B1 and Phe(226) in 1A2 in similar positions for pi-pi stacking with ANF. ANF binds in a distinctly different orientation in P450 1B1 from that observed for 1A2. This reflects, in part, divergent conformations of the helix B'-C loop that are stabilized by different hydrogen-bonding interactions in the two enzymes. Additionally, differences between the two enzymes for other amino acids that line the edges of the cavity contribute to distinct orientations of ANF in the two active sites. Thus, the narrow cavity is conserved in both P450 subfamily 1A and P450 subfamily 1B with sequence divergence around the edges of the cavity that modify substrate and inhibitor binding. The conservation of these P450 1B1 active site amino acid residues across vertebrate species suggests that these structural features are conserved.	[Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB8, La Jolla, CA 92037 USA.	dave@scripps.edu; johnson@scripps.edu			National Institutes of Health [GM031001]; United States Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources; NIGMS of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM031001 (to E.F.J.).; Portions of the research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the United States Department of Energy, Office of Biological and Environmental Research, and by the National Center for Research Resources, Biomedical Technology Program, and NIGMS of the National Institutes of Health.	ANDRIES MJ, 1990, MOL PHARMACOL, V37, P990; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUER E, 1995, CHEM RES TOXICOL, V8, P136, DOI 10.1021/tx00043a018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruno RD, 2007, BIOORGAN MED CHEM, V15, P5047, DOI 10.1016/j.bmc.2007.05.046; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; Choudhary D, 2009, XENOBIOTICA, V39, P606, DOI 10.1080/00498250903000198; Chun YJ, 2003, MED RES REV, V23, P657, DOI 10.1002/med.10050; Cosme J, 2000, J BIOL CHEM, V275, P2545, DOI 10.1074/jbc.275.4.2545; Goldstone HMH, 2006, J MOL EVOL, V62, P708, DOI 10.1007/s00239-005-0134-z; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Luch A, 1998, CHEM RES TOXICOL, V11, P686, DOI 10.1021/tx970236p; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Shimada T, 1998, CHEM RES TOXICOL, V11, P1048, DOI 10.1021/tx980090+; Sissung TM, 2006, MOL CANCER RES, V4, P135, DOI 10.1158/1541-7786.MCR-05-0101; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Tu Y, 2008, DRUG METAB DISPOS, V36, P2371, DOI 10.1124/dmd.108.022640; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; vonWachenfeldt C, 1997, ARCH BIOCHEM BIOPHYS, V339, P107, DOI 10.1006/abbi.1996.9859; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wester MR, 2003, BIOCHEMISTRY-US, V42, P9335, DOI 10.1021/bi034556l; Wester MR, 2003, BIOCHEMISTRY-US, V42, P6370, DOI 10.1021/bi0273922; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Zheng WC, 2003, ARCH BIOCHEM BIOPHYS, V416, P53, DOI 10.1016/S0003-9861(03)00282-0	31	127	130	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5736	5743		10.1074/jbc.M110.204420	http://dx.doi.org/10.1074/jbc.M110.204420			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21147782	Green Published, hybrid			2022-12-25	WOS:000287230600082
J	Lin, HL; Li, LT; Jia, XA; Ward, DM; Kaplan, J				Lin, Huilan; Li, Liangtao; Jia, Xuan; Ward, Diane McVey; Kaplan, Jerry			Genetic and Biochemical Analysis of High Iron Toxicity in Yeast IRON TOXICITY IS DUE TO THE ACCUMULATION OF CYTOSOLIC IRON AND OCCURS UNDER BOTH AEROBIC AND ANAEROBIC CONDITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; MITOCHONDRIAL; TRANSPORTER; SPECIFICITY; IDENTIFICATION; METABOLISM; EXPRESSION	Iron storage in yeast requires the activity of the vacuolar iron transporter Ccc1. Yeast with an intact CCC1 are resistant to iron toxicity, but deletion of CCC1 renders yeast susceptible to iron toxicity. We used genetic and biochemical analysis to identify suppressors of high iron toxicity in Delta ccc1 cells to probe the mechanism of high iron toxicity. All genes identified as suppressors of high iron toxicity in aerobically grown Delta ccc1 cells encode organelle iron transporters including mitochondrial iron transporters MRS3, MRS4, and RIM2. Overexpression of MRS3 suppressed high iron toxicity by decreasing cytosolic iron through mitochondrial iron accumulation. Under anaerobic conditions, Delta ccc1 cells were still sensitive to high iron toxicity, but overexpression of MRS3 did not suppress iron toxicity and did not result in mitochondrial iron accumulation. We conclude that Mrs3/Mrs4 can sequester iron within mitochondria under aerobic conditions but not anaerobic conditions. We show that iron toxicity in Delta ccc1 cells occurred under both aerobic and anaerobic conditions. Microarray analysis showed no evidence of oxidative damage under anaerobic conditions, suggesting that iron toxicity may not be solely due to oxidative damage. Deletion of TSA1, which encodes a peroxiredoxin, exacerbated iron toxicity in Delta ccc1 cells under both aerobic and anaerobic conditions, suggesting a unique role for Tsa1 in iron toxicity.	[Li, Liangtao; Jia, Xuan; Ward, Diane McVey; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA; [Lin, Huilan] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	Utah System of Higher Education; University of Utah; University of California System; University of California San Diego	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu	Lin, Huilan/B-7671-2013		National Institutes of Health [DK030534, DK052830]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030534, R01DK030534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK030534 and DK052830.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Iwai K, 2010, J BIOL CHEM, V285, P10597, DOI 10.1074/jbc.M109.090142; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jensen LT, 2004, J BIOL CHEM, V279, P29938, DOI 10.1074/jbc.M402795200; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kwast KE, 1998, J EXP BIOL, V201, P1177; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li LT, 1997, J BIOL CHEM, V272, P28485, DOI 10.1074/jbc.272.45.28485; Lin HL, 2009, BIOCHEM J, V422, P273, DOI 10.1042/BJ20090853; Lin HL, 2008, J BIOL CHEM, V283, P33865, DOI 10.1074/jbc.M804377200; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; Philpott CC, 1998, EMBO J, V17, P5026, DOI 10.1093/emboj/17.17.5026; Pictrangelo A, 2004, NAT CLIN PRACT GASTR, V1, P39, DOI 10.1038/ncpgasthep0019; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Trotter EW, 2005, EUKARYOT CELL, V4, P392, DOI 10.1128/EC.4.2.392-400.2005; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; VANDYCK E, 1995, MOL GEN GENET, V246, P426, DOI 10.1007/BF00290446; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	35	58	59	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3851	3862		10.1074/jbc.M110.190959	http://dx.doi.org/10.1074/jbc.M110.190959			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115478	Green Published, hybrid			2022-12-25	WOS:000286653200066
J	Jawhar, S; Wirths, O; Schilling, S; Graubner, S; Demuth, HU; Bayer, TA				Jawhar, Sadim; Wirths, Oliver; Schilling, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Bayer, Thomas A.			Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate A beta Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PEPTIDES IN-VITRO; ALZHEIMERS-DISEASE; TERMINAL HETEROGENEITY; TRANSGENIC MOUSE; SYNDROME BRAINS; PLAQUE CORE; DEPOSITS; MODEL; NEURODEGENERATION	Pyroglutamate-modified A beta (A beta pE3-42) peptides are gaining considerable attention as potential key players in the pathology of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity. Overexpressing A beta pE3-42 induced a severe neuron loss and neurological phenotype in TBA2 mice. In vitro and in vivo experiments have recently proven that the enzyme glutaminyl cyclase (QC) catalyzes the formation of A beta pE3-42. The aim of the present work was to analyze the role of QC in an AD mouse model with abundant A beta pE3-42 formation. 5XFAD mice were crossed with transgenic mice expressing human QC (hQC) under the control of the Thy1 promoter. 5XFAD/hQC bigenic mice showed significant elevation in TBS, SDS, and formic acid-soluble A beta pE3-42 peptides and aggregation in plaques. In 6-month-old 5XFAD/hQC mice, a significant motor and working memory impairment developed compared with 5XFAD. The contribution of endogenous QC was studied by generating 5XFAD/QC-KO mice (mouse QC knock-out). 5XFAD/QC-KO mice showed a significant rescue of the wild-type mice behavioral phenotype, demonstrating the important contribution of endogenous mouse QC and transgenic overexpressed QC. These data clearly demonstrate that QC is crucial for modulating A beta pE3-42 levels in vivo and prove on a genetic base the concept that reduction of QC activity is a promising new therapeutic approach for AD.	[Schilling, Stephan; Demuth, Hans-Ulrich] Probiodrug AG, D-06120 Halle, Saale, Germany; [Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.] Univ Med Goettingen, Dept Mol Psychiat, D-37075 Gottingen, Germany; [Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.] Univ Med Goettingen, Alzheimer PhD Grad Sch, D-37075 Gottingen, Germany; [Graubner, Sigrid] Ingenium Pharmaceut GmbH, D-82152 Munich, Germany	Vivoryon Therapeutics	Demuth, HU (corresponding author), Probiodrug AG, Weinbergweg 22, D-06120 Halle, Saale, Germany.	Hans-Ulrich.Demuth@probiodrug.de; tbayer@gwdg.de	Wirths, Oliver/C-7342-2019	Wirths, Oliver/0000-0002-4115-0334	German Federal Department of Education, Science and Technology [3013185]	German Federal Department of Education, Science and Technology	This work was supported by the German Federal Department of Education, Science and Technology, Grant 3013185 to a collaborative consortium led by H.-U. D.'s group, including T. A. B.'s team.	Breyhan H, 2009, ACTA NEUROPATHOL, V117, P677, DOI 10.1007/s00401-009-0539-7; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; GOREVIC PD, 1986, J NEUROPATH EXP NEUR, V45, P647, DOI 10.1097/00005072-198611000-00004; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Hartlage-Rubsamen M, 2009, INT J DEV NEUROSCI, V27, P825, DOI 10.1016/j.ijdevneu.2009.08.007; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Marcello A, 2011, NEUROBIOL AGING, V32, P1379, DOI 10.1016/j.neurobiolaging.2009.08.011; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; MORI H, 1992, J BIOL CHEM, V267, P17082; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Piccini A, 2007, ARCH NEUROL-CHICAGO, V64, P738, DOI 10.1001/archneur.64.5.738; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Russo C, 1997, FEBS LETT, V409, P411, DOI 10.1016/S0014-5793(97)00564-4; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Russo C, 2001, NEUROBIOL DIS, V8, P173, DOI 10.1006/nbdi.2000.0357; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Stephan A, 2009, FEBS J, V276, P6522, DOI 10.1111/j.1742-4658.2009.07337.x; Tekirian TL, 1998, J NEUROPATH EXP NEUR, V57, P76, DOI 10.1097/00005072-199801000-00009; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5	40	73	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4454	4460		10.1074/jbc.M110.185819	http://dx.doi.org/10.1074/jbc.M110.185819			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148560	Green Published, hybrid			2022-12-25	WOS:000286975700045
J	Maduzia, LL; Yu, E; Zhang, YH				Maduzia, Lisa L.; Yu, Evan; Zhang, Yinhua			Caenorhabditis elegans Galectins LEC-6 and LEC-10 Interact with Similar Glycoconjugates in the Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSIDE-BINDING-PROTEIN; MOLECULES IN-VIVO; FUSION PROTEINS; FUCOSYL-TRANSFERASE; GLYCOPROTEINS; CELLS; RECOGNITION; SPECIFICITY; DIVERSITY; MEMBRANE	Galectins are a family of metazoan proteins that show binding to various beta-galactoside-containing glycans. Because of a lack of proper tools, the interaction of galectins with their specific glycan ligands in the cells and tissues are largely unknown. We have investigated the localization of galectin ligands in Caenorhabditis elegans using a novel technology that relies on the high binding specificity between galectins and their endogenous ligands. Fluorescently labeled recombinant galectin fusions are found to bind to ligands located in diverse tissues including the intestine, pharynx, and the rectal valve. Consistent with their role as galactoside-binding proteins, the interaction with their ligands is inhibited by galactose or lactose. Two of the galectins, LEC-6 and LEC-10, recognize ligands that co-localize along the intestinal lumen. The ligands for LEC-6 and LEC-10 are absent in three glycosylation mutants bre-1, fut-8, and galt-1, which have been shown to be required to synthesize the Gal-beta 1,4-Fuc modifications of the core N-glycans unique to C. elegans and several other invertebrates. Both galectins pull down the same set of glycoproteins in a manner dependent on the presence of these carbohydrate modifications. Endogenous LEC-6 and LEC-10 are expressed in the intestinal cells, but they are localized to different subcellular compartments that do not appear to overlap with each other or with the location of their glycan targets. An altered subcellular distribution of these ligands is found in mutants lacking both galectins. These results suggest a model where LEC-6 and LEC-10 interact with glycoproteins through specific glycans to regulate their cellular fate.	[Maduzia, Lisa L.; Yu, Evan; Zhang, Yinhua] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Zhang, YH (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	zhangy@neb.com		Zhang, Yinhua/0000-0003-0592-9153	National Center for Research Resources of the National Institutes of Health	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Donald Comb and New England Bio-labs, Inc for encouragement and support. We thank Tilde Carlow, Ana Egana, Brendan Galvin, Bill Jack, Liz Li, and Paula Magnelli for critical reading of the manuscript. We thank Markus Kunzler for providing the galt-1(op497) strain and the CGL2 clone, and the Mitani Laboratory of the National Bioresource Project for providing deletion strains carrying lec-6(tm3706) and lec-10(tm1262). Some C. elegans strains were obtained from the Caenorhabditis Genetic Center, which is funded by the National Center for Research Resources of the National Institutes of Health.	Arata Y, 2001, J BIOL CHEM, V276, P3068, DOI 10.1074/jbc.M008602200; Barrows BD, 2007, J BIOL CHEM, V282, P3302, DOI 10.1074/jbc.M606621200; Bettinger JC, 1996, DEVELOPMENT, V122, P2517; BORGONIE G, 1995, FUND APPL NEMATOL, V18, P227; Bossinger O, 2004, DEV BIOL, V268, P448, DOI 10.1016/j.ydbio.2004.01.003; BRENNER S, 1974, GENETICS, V77, P71; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Cipollo JF, 2005, J BIOL CHEM, V280, P26063, DOI 10.1074/jbc.M503828200; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Cummings R.D., 2009, ESSENTIALS GLYCOBIOL, Vsecond, P475; Cummings R. D., 2009, ESSENTIALS GLYCOBIOL, P633; DeBose-Boyd RA, 1998, GLYCOBIOLOGY, V8, P905, DOI 10.1093/glycob/8.9.905; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Drickamer K, 1999, GLYCOBIOLOGY, V9, P1357, DOI 10.1093/glycob/9.12.1357; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Hara-Kuge S, 2002, J BIOL CHEM, V277, P16332, DOI 10.1074/jbc.M112188200; HIRABAYASHI J, 1992, J BIOL CHEM, V267, P15485; Hirabayashi J, 1996, J BIOL CHEM, V271, P2497, DOI 10.1074/jbc.271.5.2497; Hsu KL, 2008, MOL BIOSYST, V4, P654, DOI 10.1039/b800725j; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kaji H, 2007, MOL CELL PROTEOMICS, V6, P2100, DOI 10.1074/mcp.M600392-MCP200; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Keppler A, 2004, METHODS, V32, P437, DOI 10.1016/j.ymeth.2003.10.007; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Matsui T, 2005, TOXICON, V45, P1075, DOI 10.1016/j.toxicon.2005.02.023; MCGHEE JD, 2007, WORMBOOK C ELEGANS I, DOI DOI 10.1895/WORMB00K.1.133.1; Nemoto-Sasaki Y, 2008, BBA-GEN SUBJECTS, V1780, P1131, DOI 10.1016/j.bbagen.2008.07.003; Nemoto-Sasaki Y, 2009, BIOL PHARM BULL, V32, P1973, DOI 10.1248/bpb.32.1973; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; Pilobello Kanoelani T., 2007, V385, P193, DOI 10.1007/978-1-59745-426-1_14; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Takeuchi T, 2008, GLYCOBIOLOGY, V18, P882, DOI 10.1093/glycob/cwn077; Takeuchi T, 2009, GLYCOBIOLOGY, V19, P1503, DOI 10.1093/glycob/cwp125; TEICHBERG VI, 1975, P NATL ACAD SCI USA, V72, P1383, DOI 10.1073/pnas.72.4.1383; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; Walser PJ, 2005, FUNGAL GENET BIOL, V42, P293, DOI 10.1016/j.fgb.2004.12.004; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zheng Q, 2008, GLYCOBIOLOGY, V18, P290, DOI 10.1093/glycob/cwn007	46	29	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4371	4381		10.1074/jbc.M110.188581	http://dx.doi.org/10.1074/jbc.M110.188581			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115491	Green Published, hybrid			2022-12-25	WOS:000286975700037
J	Rajaiah, R; Puttabyatappa, M; Polumuri, SK; Moudgil, KD				Rajaiah, Rajesh; Puttabyatappa, Muraly; Polumuri, Swamy K.; Moudgil, Kamal D.			Interleukin-27 and Interferon-gamma Are Involved in Regulation of Autoimmune Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLLAGEN-INDUCED ARTHRITIS; GENE-ENVIRONMENT INTERACTIONS; IL-17-PRODUCING T-CELLS; CENTRAL-NERVOUS-SYSTEM; RHEUMATOID-ARTHRITIS; IFN-GAMMA; MULTIPLE-SCLEROSIS; MYCOBACTERIAL ADJUVANT; TERMINAL DETERMINANTS	Inflammation underlying immune pathology and tissue damage involves an intricate interplay between multiple immunological and biochemical mediators. Cytokines represent the key immune mediators that trigger a cascade of reactions that drive processes such as angiogenesis and proteolytic damage to tissues. IL-17 has now been shown to be a pivotal cytokine in many autoimmune diseases, supplanting the traditional Th1-Th2 paradigm. Also, the dual role of proinflammatory IFN-gamma has unraveled new complexities in the cytokine biology of such disorders. A major hurdle in fully understanding the effector pathways in these disorders is the lack of information regarding the temporal kinetics of the cytokines during the course of the disease, as well as the interplay among the key cytokines. Using an experimental model of arthritic inflammation, we demonstrate that the temporal expression of cytokines during the incubation phase is a critical determinant of disease susceptibility. The susceptible rats raised a vigorous IL-17 response early, followed by IFN-gamma and IL-27 response in that sequence, whereas the resistant rats displayed an early and concurrent response to these three cytokines. Accordingly, treatment with exogenous IFN-gamma/IL-27 successfully controlled arthritic inflammation and inhibited the defined mediators of inflammation, angiogenesis, cell survival, apoptosis, and tissue damage. Furthermore, IFN-gamma enhanced IL-27 secretion, revealing a cooperative interplay between the two cytokines. Our results offer a novel immunobiochemical perspective on the pathogenesis of autoimmune arthritis and its therapeutic control.	[Moudgil, Kamal D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Puttabyatappa, Muraly] Univ Maryland, Sch Med, Program Mol Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA; [Moudgil, Kamal D.] Univ Maryland, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Moudgil, KD (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, HSF-1,Suite 380,685 W Baltimore St, Baltimore, MD 21201 USA.	kmoud001@umaryland.edu	Puttabyatappa, Muraly/D-1592-2012; Rajaiah, rajesh/ABA-5509-2021; Rajaiah, Rajesh/A-3403-2012	Puttabyatappa, Muraly/0000-0002-1374-7619; 	National Institutes of Health [RO1AT004321, RO3AI076942]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI076942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AT004321 and RO3AI076942.	Afanasyeva M, 2005, P NATL ACAD SCI USA, V102, P180, DOI 10.1073/pnas.0408241102; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boissier MC, 2008, JOINT BONE SPINE, V75, P373, DOI 10.1016/j.jbspin.2008.04.005; Bush KA, 2002, ARTHRITIS RHEUM-US, V46, P802, DOI 10.1002/art.10173; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Chang YH, 2008, CLIN BIOCHEM, V41, P955, DOI 10.1016/j.clinbiochem.2008.04.012; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; Davidson A, 2010, NAT REV RHEUMATOL, V6, P13, DOI 10.1038/nrrheum.2009.240; de Carvalho Jozelio Freire, 2009, Front Biosci (Elite Ed), V1, P501; Di Paola R, 2008, AUTOIMMUN REV, V8, P73, DOI 10.1016/j.autrev.2008.07.029; Durai M, 2004, J IMMUNOL, V172, P2795, DOI 10.4049/jimmunol.172.5.2795; Eck SM, 2009, J AUTOIMMUN, V33, P214, DOI 10.1016/j.jaut.2009.09.011; Eriksson U, 2001, J IMMUNOL, V167, P5464, DOI 10.4049/jimmunol.167.9.5464; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Furlan Roberto, 2009, V549, P157, DOI 10.1007/978-1-60327-931-4_11; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Goldberg R, 2004, J IMMUNOL, V173, P1171, DOI 10.4049/jimmunol.173.2.1171; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; Handel AE, 2009, NAT REV ENDOCRINOL, V5, P655, DOI 10.1038/nrendo.2009.216; Hembry Rosalind M., 2007, V135, P227; Invernizzi P, 2009, J AUTOIMMUN, V33, P290, DOI 10.1016/j.jaut.2009.07.008; Jonsen A, 2007, AUTOIMMUNITY, V40, P613, DOI 10.1080/08916930701511051; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Kap YS, 2010, J NEUROIMMUNE PHARM, V5, P220, DOI 10.1007/s11481-009-9178-y; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Kim EY, 2008, CLIN IMMUNOL, V127, P98, DOI 10.1016/j.clim.2008.01.003; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Moudgil KD, 1997, J EXP MED, V185, P1307, DOI 10.1084/jem.185.7.1307; Murugaiyan G, 2010, P NATL ACAD SCI USA, V107, P11495, DOI 10.1073/pnas.1002099107; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; Nikoopour E, 2010, J IMMUNOL, V184, P4779, DOI 10.4049/jimmunol.0902822; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; PEARSON CM, 1963, AM J PATHOL, V42, P73; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Qin HY, 2004, INT IMMUNOL, V16, P1723, DOI 10.1093/intimm/dxh173; Stamp LK, 2009, J RHEUMATOL, V36, P2403, DOI 10.3899/jrheum.081304; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Szekanecz Z, 2009, AUTOIMMUNITY, V42, P563, DOI 10.1080/08916930903143083; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villarino AV, 2004, ARTHRITIS RES THER, V6, P225, DOI 10.1186/ar1227; Wang R, 2008, CELL MOL LIFE SCI, V65, P3851, DOI 10.1007/s00018-008-8540-1; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wildbaum G, 2010, AM J PATHOL, V176, P2764, DOI 10.2353/ajpath.2010.090855; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yu SG, 2002, J IMMUNOL, V169, P3999, DOI 10.4049/jimmunol.169.7.3999; Zhang LM, 2007, NAT MED, V13, P1114, DOI 10.1038/nm1608	55	61	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2817	2825		10.1074/jbc.M110.187013	http://dx.doi.org/10.1074/jbc.M110.187013			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21123181	hybrid, Green Published			2022-12-25	WOS:000286464300047
J	Moustafa, DA; Jain, N; Sriranganathan, N; Vemulapalli, R				Moustafa, Dina A.; Jain, Neeta; Sriranganathan, Nammalwar; Vemulapalli, Ramesh			Identification of a Single-Nucleotide Insertion in the Promoter Region Affecting the sodC Promoter Activity in Brucella neotomae	PLOS ONE			English	Article							ZN SUPEROXIDE-DISMUTASE; VOLE MICROTUS-ARVALIS; ABORTUS STRAIN RB51; ESCHERICHIA-COLI; IMMUNE-RESPONSES; B-ABORTUS; EXPRESSION; MICE; VIRULENCE; CLONING	Brucella neotomae is not known to be associated with clinical disease in any host species. Previous research suggested that B. neotomae might not express detectable levels of Cu/Zn superoxide dismutase ( SOD), a periplasmic enzyme known to be involved in protecting Brucella from oxidative bactericidal effects of host phagocytes. This study was undertaken to investigate the genetic basis for the disparity in SOD expression in B. neotomae. Our Western blot and SOD enzyme assay analyses indicated that B. neotomae does express SOD, but at a substantially reduced level. Nucleotide sequence analysis of region upstream to the sodC gene identified a single-nucleotide insertion in the potential promoter region. The same single-nucleotide insertion was also detected in the sodC promoter of B. suis strain Thomsen, belonging to biovar 2 in which SOD expression was undetectable previously. Examination of the sodC promoter activities using translational fusion constructs with E. coli beta-galactosidase demonstrated that the B. neotomae and B. suis biovar 2 promoters were very weak in driving gene expression. Site-directed mutation studies indicated that the insertion of A in the B. neotomae sodC promoter reduced the promoter activity. Increasing the level of SOD expression in B. neotomae through complementation with B. abortus sodC gene did not alter the bacterial survival in J774A.1 macrophage-like cells and in tissues of BALB/c and C57BL/6 mice. These results for the first time demonstrate the occurrence of a single-nucleotide polymorphism affecting promoter function and gene expression in Brucella.	[Moustafa, Dina A.; Vemulapalli, Ramesh] Purdue Univ, Dept Comparat Pathobiol, Indiana, PA USA; [Jain, Neeta; Sriranganathan, Nammalwar] Virginia Tech, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA	Purdue University System; Purdue University; Virginia Polytechnic Institute & State University	Moustafa, DA (corresponding author), Purdue Univ, Dept Comparat Pathobiol, Indiana, PA USA.	rvemulap@purdue.edu		Vemulapalli, Ramesh/0000-0002-2473-2906	Egyptian Cultural and Educational Bureau	Egyptian Cultural and Educational Bureau(Egyptian Cultural & Educational Bureau)	Dina Moustafa's PhD program was supported by a fellowship from Egyptian Cultural and Educational Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAL GA, 1959, AM J VET RES, V20, P872; BECK BL, 1990, BIOCHEMISTRY-US, V29, P372, DOI 10.1021/bi00454a010; BENOV LT, 1994, J BIOL CHEM, V269, P25310; BRICKER BJ, 1990, INFECT IMMUN, V58, P2935, DOI 10.1128/IAI.58.9.2935-2939.1990; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Cutler SJ, 2005, J APPL MICROBIOL, V98, P1270, DOI 10.1111/j.1365-2672.2005.02622.x; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Gee JM, 2005, INFECT IMMUN, V73, P2873, DOI 10.1128/IAI.73.5.2873-2880.2005; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Gronewold TMA, 2007, J BACTERIOL, V189, P1836, DOI 10.1128/JB.01618-06; Hengge-Aronis R, 2004, BULLETIN OF THE INTERNATIONAL DAIRY FEDERATION NO 392/2004, P31; Hubalek Z, 2007, VECTOR-BORNE ZOONOT, V7, P679, DOI 10.1089/vbz.2007.0143; Korshunov SS, 2002, MOL MICROBIOL, V43, P95, DOI 10.1046/j.1365-2958.2002.02719.x; McQuiston J R, 1995, Methods Mol Biol, V47, P143; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Muffler A, 1997, J BACTERIOL, V179, P445; Onate AA, 1999, INFECT IMMUN, V67, P986; Roop RM, 2003, ANNU REV MICROBIOL, V57, P57, DOI 10.1146/annurev.micro.57.030502.090803; Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0; Seleem MN, 2004, BIOTECHNIQUES, V37, P740, DOI 10.2144/04375BM05; STABEL TJ, 1994, VET MICROBIOL, V38, P307, DOI 10.1016/0378-1135(94)90149-X; Stermann M, 2004, J BACTERIOL, V186, P2856, DOI 10.1128/JB.186.9.2856-2861.2004; STOENNER HG, 1963, AM J VET RES, V24, P376; STOENNER HG, 1957, AM J VET RES, V18, P947; TATUM FM, 1992, INFECT IMMUN, V60, P2863, DOI 10.1128/IAI.60.7.2863-2869.1992; Vemulapalli R, 1999, CLIN DIAGN LAB IMMUN, V6, P760, DOI 10.1128/CDLI.6.5.760-764.1999; Vemulapalli R, 2000, INFECT IMMUN, V68, P3286, DOI 10.1128/IAI.68.6.3286-3289.2000; Vemulapalli R, 1998, INFECT IMMUN, V66, P5684, DOI 10.1128/IAI.66.12.5684-5691.1998; Vemullpalli R, 2000, INFECT IMMUN, V68, P3290, DOI 10.1128/IAI.68.6.3290-3296.2000; WISE DJ, 1998, NETWORKING BRUCELLOS, V2	32	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14112	10.1371/journal.pone.0014112	http://dx.doi.org/10.1371/journal.pone.0014112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124845	Green Submitted, Green Published, gold			2022-12-25	WOS:000284572000013
J	Kamat, A; Ancuta, P; Blumberg, RS; Gabuzda, D				Kamat, Anupa; Ancuta, Petronela; Blumberg, Richard S.; Gabuzda, Dana			Serological Markers for Inflammatory Bowel Disease in AIDS Patients with Evidence of Microbial Translocation	PLOS ONE			English	Article							ANTI-SACCHAROMYCES-CEREVISIAE; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; T-CELL DEPLETION; IMMUNODEFICIENCY-VIRUS-INFECTION; ULCERATIVE-COLITIS PATIENTS; MEMBRANE PORIN-C; CROHNS-DISEASE; MANNAN ANTIBODIES; IMMUNE-RESPONSES; DIAGNOSTIC-VALUE	Background: Breakdown of the gut mucosal barrier during chronic HIV infection allows translocation of bacterial products such as lipopolysaccharides (LPS) from the gut into the circulation. Microbial translocation also occurs in inflammatory bowel disease (IBD). IBD serological markers are useful in the diagnosis of IBD and to differentiate between Crohn's disease (CD) and ulcerative colitis (UC). Here, we evaluate detection of IBD serological markers in HIV-infected patients with advanced disease and their relationship to HIV disease markers. Methods: IBD serological markers (ASCA, pANCA, anti-OmpC, and anti-CBir1) were measured by ELISA in plasma from AIDS patients (n = 26) with low CD4 counts (<300 cells/mu l) and high plasma LPS levels, and results correlated with clinical data. For meta-analysis, relevant data were abstracted from 20 articles. Results: IBD serological markers were detected in approximately 65% of AIDS patients with evidence of microbial translocation. An antibody pattern consistent with IBD was detected in 46%; of these, 75% had a CD-like pattern. Meta-analysis of data from 20 published studies on IBD serological markers in CD, UC, and non-IBD control subjects indicated that IBD serological markers are detected more frequently in AIDS patients than in non-IBD disease controls and healthy controls, but less frequently than in CD patients. There was no association between IBD serological markers and HIV disease markers (plasma viral load and CD4 counts) in the study cohort. Conclusions: IBD serological markers may provide a non-invasive approach to monitor HIV-related inflammatory gut disease. Further studies to investigate their clinical significance in HIV-infected individuals are warranted.	[Kamat, Anupa; Gabuzda, Dana] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Blumberg, Richard S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Ancuta, Petronela] INSERM, U743, Montreal, PQ, Canada; [Ancuta, Petronela] Univ Montreal, Dept Microbiol & Immunol, Ctr Rech Ctr Hosp Univ Montreal CRCHUM, Montreal, PQ H3C 3J7, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal	Kamat, A (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	dana_gabuzda@dfci.harvard.edu			NIH [DA26322, MH083588, DK44319, DK51362, DK53056]; Harvard Digestive Diseases Center for AIDS Research and DFCI/Harvard Center for Cancer Research; Fonds de la Recherche en Sante Quebec (FRSQ); INSERM;  [MH59745];  [NS38841];  [MH59656];  [NS54591];  [MH59724]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053056, R37DK044319, R01DK044319, R56DK053056, R01DK051362, R01DK088199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH059656, R01MH083588, R24MH059745, U01MH083545, R24MH059724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS038841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center for AIDS Research and DFCI/Harvard Center for Cancer Research; Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH DA26322 and MH083588. R. B. was supported by NIH DK44319, DK51362, DK53056, and the Harvard Digestive Diseases Center. P.A. was supported by New Investigator Awards from Fonds de la Recherche en Sante Quebec (FRSQ) and INSERM. Core facilities were supported by the Harvard Center for AIDS Research and DFCI/Harvard Center for Cancer Research grants. NNTC sites were supported by MH59745, NS38841, MH59656, NS54591, and MH59724. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2008, AM J GASTROENTEROL, V103, P386, DOI 10.1111/j.1572-0241.2007.01577.x; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Arnott IDR, 2004, AM J GASTROENTEROL, V99, P2376, DOI 10.1111/j.1572-0241.2004.40417.x; Austin GL, 2006, AM J GASTROENTEROL, V101, P413, DOI 10.1111/j.1572-0241.2006.00475.x; Austin GL, 2007, CLIN GASTROENTEROL H, V5, P545, DOI 10.1016/j.cgh.2007.03.006; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Bjarnason I, 1996, AIDS, V10, P1385, DOI 10.1097/00002030-199610000-00011; Bossuyt X, 2006, CLIN CHEM, V52, P171, DOI 10.1373/clinchem.2005.058560; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Buckland MS, 2005, CLIN DIAGN LAB IMMUN, V12, P1328, DOI 10.1128/CDLI.12.11.1328-1330.2005; Caradonna L, 2000, AM J GASTROENTEROL, V95, P1495; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Chase A, 2006, TRENDS PHARMACOL SCI, V27, P4, DOI 10.1016/j.tips.2005.11.005; Cornely OA, 1999, INFECTION, V27, P92, DOI 10.1007/BF02560504; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; Davis MK, 2007, J PEDIATR GASTR NUTR, V45, P409, DOI 10.1097/MPG.0b013e31812f7f6e; Desir B, 2004, CLIN GASTROENTEROL H, V2, P139, DOI 10.1016/S1542-3565(03)00321-5; Devlin SM, 2007, GASTROENTEROLOGY, V132, P576, DOI 10.1053/j.gastro.2006.11.013; Dubinsky M, 2009, DIGEST DIS, V27, P259, DOI 10.1159/000228559; Dubinsky MC, 2008, INFLAMM BOWEL DIS, V14, pS185, DOI 10.1002/ibd.20585; Dubinsky MC, 2006, AM J GASTROENTEROL, V101, P360, DOI 10.1111/j.1572-0241.2006.00456.x; Dubinsky MC, 2001, AM J GASTROENTEROL, V96, P758; DUERR RH, 1991, GASTROENTEROLOGY, V100, P1590, DOI 10.1016/0016-5085(91)90657-7; Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043; Fleshner P, 2008, CLIN GASTROENTEROL H, V6, P561, DOI 10.1016/j.cgh.2008.01.002; Fleshner PR, 2001, GUT, V49, P671, DOI 10.1136/gut.49.5.671; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; GARDINER KR, 1995, GUT, V36, P897, DOI 10.1136/gut.36.6.897; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Haynes BF, 2006, NAT MED, V12, P1351, DOI 10.1038/nm1206-1351; HOFER U, 2009, SEMIN IMMUNOPATHOL; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Israeli E, 2005, GUT, V54, P1232, DOI 10.1136/gut.2004.060228; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kewenig S, 1999, GASTROENTEROLOGY, V116, P1115, DOI 10.1016/S0016-5085(99)70014-4; KLAASSEN RJL, 1992, CLIN EXP IMMUNOL, V87, P24, DOI 10.1111/j.1365-2249.1992.tb06408.x; Kotler DP, 2005, AIDS, V19, P107, DOI 10.1097/00002030-200501280-00002; Koutroubakis IE, 2001, AM J GASTROENTEROL, V96, P449; KUCHARZIK T, 1995, CLIN EXP IMMUNOL, V100, P452; Lackner AA, 2009, GASTROENTEROLOGY, V136, P1966, DOI 10.1053/j.gastro.2008.12.071; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Lautenbach E, 1997, J CLIN GASTROENTEROL, V25, P456, DOI 10.1097/00004836-199709000-00013; Linskens RK, 2002, EUR J GASTROEN HEPAT, V14, P1013, DOI 10.1097/00042737-200209000-00013; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mainardi E, 2007, DIGESTION, V75, P210, DOI 10.1159/000109928; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Markowitz J, 2009, INFLAMM BOWEL DIS, V15, P714, DOI 10.1002/ibd.20831; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mei L, 2006, GASTROENTEROLOGY, V130, P1078, DOI 10.1053/j.gastro.2006.02.013; Mitsuyama K, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/26875; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Murphy SJ, 2008, AM J GASTROENTEROL, V103, P397, DOI 10.1111/j.1572-0241.2007.01571.x; Mustila A, 2000, ARTHRITIS RHEUM-US, V43, P1371, DOI 10.1002/1529-0131(200006)43:6<1371::AID-ANR22>3.0.CO;2-R; Nikolova M, 2002, ISR MED ASSOC J, V4, P908; Olsson J, 2000, J INFECT DIS, V182, P1625, DOI 10.1086/317625; Paiardini M, 2008, AIDS REV, V10, P36; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Papadakis KA, 2007, INFLAMM BOWEL DIS, V13, P524, DOI 10.1002/ibd.20106; Papp M, 2008, AM J GASTROENTEROL, V103, P665, DOI 10.1111/j.1572-0241.2007.01652.x; Rojo OP, 2007, INFLAMM BOWEL DIS, V13, P269, DOI 10.1002/ibd.20019; Peeters M, 2001, AM J GASTROENTEROL, V96, P730, DOI 10.1111/j.1572-0241.2001.03613.x; Peyrin-Biroulet L, 2007, INFLAMM BOWEL DIS, V13, P1561, DOI 10.1002/ibd.20226; Quinton JF, 1998, GUT, V42, P788, DOI 10.1136/gut.42.6.788; Reese GE, 2006, AM J GASTROENTEROL, V101, P2410, DOI 10.1111/j.1572-0241.2006.00840.x; Rutgeerts P, 2000, LANCET, V356, P2117, DOI 10.1016/S0140-6736(00)03488-7; Sabery N, 2007, PEDIATRICS, V119, pE193, DOI 10.1542/peds.2006-1361; Sandborn WJ, 2001, INFLAMM BOWEL DIS, V7, P192, DOI 10.1097/00054725-200108000-00003; SAVIGE JA, 1993, ADV EXP MED BIOL, V336, P349; Seibold F, 2005, GUT, V54, P1212, DOI 10.1136/gut.2005.065227; Sharpstone D, 1999, GUT, V45, P70, DOI 10.1136/gut.45.1.70; Sharpstone DR, 1996, EUR J GASTROEN HEPAT, V8, P575, DOI 10.1097/00042737-199606000-00015; Shen C, 2008, INFLAMM BOWEL DIS, V14, P1641, DOI 10.1002/ibd.20645; Shih David Q, 2008, Curr Gastroenterol Rep, V10, P568, DOI 10.1007/s11894-008-0104-x; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Targan SR, 1999, INFLAMM BOWEL DIS, V5, P61, DOI 10.1097/00054725-199902000-00008; Vermeire S, 2001, INFLAMM BOWEL DIS, V7, P8, DOI 10.1097/00054725-200102000-00002; Vermeire S, 2001, GASTROENTEROLOGY, V120, P827, DOI 10.1053/gast.2001.22546; VIAZIS N, 2009, INFLAMM BOWEL DIS; WINTER HS, 1994, J PEDIATR-US, V125, P707, DOI 10.1016/S0022-3476(94)70061-3; Yoshida EM, 1996, J CLIN GASTROENTEROL, V23, P24, DOI 10.1097/00004836-199607000-00008; Zholudev A, 2004, AM J GASTROENTEROL, V99, P2235, DOI 10.1111/j.1572-0241.2004.40369.x	85	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15533	10.1371/journal.pone.0015533	http://dx.doi.org/10.1371/journal.pone.0015533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21125014	Green Published, gold, Green Submitted			2022-12-25	WOS:000284231800040
J	D'Addario, C; Johansson, S; Candeletti, S; Romualdi, P; Ogren, SO; Terenius, L; Ekstrom, TJ				D'Addario, Claudio; Johansson, Sofia; Candeletti, Sanzio; Romualdi, Patrizia; Ogren, Sven Ove; Terenius, Lars; Ekstrom, Tomas J.			Ethanol and acetaldehyde exposure induces specific epigenetic modifications in the prodynorphin gene promoter in a human neuroblastoma cell line	FASEB JOURNAL			English	Article						chromatin modification; DNA methylation; SH-SY5Y cells	HISTONE H3; DNA HYPERMETHYLATION; DOWN-REGULATION; METHYLATION; CHROMATIN; ALCOHOL; EXPRESSION; BINDING; QUANTIFICATION; PLURIPOTENT	Ethanol alters neural activity through interaction with multiple neurotransmitters and neuro-modulators. The endogenous opioid system seems to play a key role, since the opioid receptor antagonist naltrexone (ReVia (R)) attenuates craving for alcohol. We recently reported that ethanol and acetaldehyde, the first product of ethanol metabolism, affect transcription of opioid system genes in human SH-SY5Y neuroblastoma cells. In the current study, potential epigenetic mechanisms were investigated to clarify these effects on prodynorphin gene expression. DNA methylation was analyzed by bisulfite pyrosequencing, and chromatin immunoprecipitation was used to assess putative specific histone modifications at the prodynorphin gene promoter. The results demonstrated a temporal relationship between selective chromatin modifications induced by ethanol and acetaldehyde and changes in prodynorphin gene expression quantitated by real-time qPCR. DNA methylation was not altered in any of the experimental conditions used. The epigenetic changes may precede gene transcription, and histone modifications might keep the prodynorphin gene in a poised state for later reactivation. A link has been observed between gene expression alterations and selective epigenetic modulation in the prodynorphin promoter region, demonstrating a specificity of the changes induced by ethanol and acetaldehyde. The latter may be mediating ethanol effects at the genomic level.-D'Addario, C., Johansson, S., Candeletti, S., Romualdi, P., Ogren, S. O., Terenius, L., Ekstrom, T. J. Ethanol and acetaldehyde exposure induces specific epigenetic modifications in the prodynorphin gene promoter in a human neuroblastoma cell line. FASEB J. 25, 1069-1075 (2011). www.fasebj.org	[D'Addario, Claudio; Candeletti, Sanzio; Romualdi, Patrizia] Univ Bologna, Dept Pharmacol, I-40125 Bologna, Italy; [D'Addario, Claudio; Johansson, Sofia; Terenius, Lars; Ekstrom, Tomas J.] Karolinska Univ Hosp, Dept Clin Neurosci, Stockholm, Sweden; [Ogren, Sven Ove] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	University of Bologna; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	D'Addario, C (corresponding author), Univ Bologna, Dept Pharmacol, Via Irnerio 48, I-40125 Bologna, Italy.	claudio.daddario@unibo.it	Romualdi, Patrizia/AAR-7403-2021; Ekström, Tomas/B-7764-2013; DAddario, Claudio/A-5970-2010	Ogren, Sven Ove/0000-0003-2573-5276; Romualdi, Patrizia/0000-0002-3610-2928; d'addario, claudio/0000-0002-1275-098X	Alcohol Research Council of the Swedish Retailing Monopoly; Karolinska Institutet; Swedish Cancer Society; Swedish Labor Market Insurance (AFA); Swedish Science Research Council; University of Bologna [2007R93XF_004]	Alcohol Research Council of the Swedish Retailing Monopoly; Karolinska Institutet(Karolinska Institutet); Swedish Cancer Society(Swedish Cancer Society); Swedish Labor Market Insurance (AFA); Swedish Science Research Council; University of Bologna	This work was supported by grants from the Alcohol Research Council of the Swedish Retailing Monopoly, the Karolinska Institutet, the Swedish Cancer Society, the Swedish Labor Market Insurance (AFA), the Swedish Science Research Council, and the University of Bologna RFO 2008 and PRIN 2007 (2007R93XF_004). The authors declare no conflicts of interest.	Asher O, 2002, J PHARMACOL EXP THER, V301, P66, DOI 10.1124/jpet.301.1.66; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bleich S, 2006, ALCOHOL CLIN EXP RES, V30, P587, DOI 10.1111/j.1530-0277.2006.00068.x; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Bonsch D, 2005, NEUROREPORT, V16, P167; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cowen M. S., 2006, CNS & Neurological Disorders-Drug Targets, V5, P233, DOI 10.2174/187152706776359646; D'Addario C, 2008, FASEB J, V22, P662, DOI 10.1096/fj.07-8346com; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Furuta T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-39; GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x; GRUENBAUM Y, 1981, FEBS LETT, V124, P67, DOI 10.1016/0014-5793(81)80055-5; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jope RS, 1998, J NEUROCHEM, V70, P763; Kim JS, 2006, ALCOHOL ALCOHOLISM, V41, P126, DOI 10.1093/alcalc/agh248; Koob GF, 1998, ALCOHOL CLIN EXP RES, V22, P3, DOI 10.1097/00000374-199802000-00001; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee TD, 2004, ALCOHOL CLIN EXP RES, V28, P173, DOI 10.1097/01.ALC.0000108654.77178.03; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 1997, BRAIN RES, V770, P139, DOI 10.1016/S0006-8993(97)00762-2; Lyon E, 2001, CLIN CHEM, V47, P844; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; Mahadev K, 1998, NEUROCHEM RES, V23, P1179, DOI 10.1023/A:1020778018149; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pal-Bhadra M, 2007, LIFE SCI, V81, P979, DOI 10.1016/j.lfs.2007.07.030; Pan LN, 2007, CANCER, V109, P1676, DOI 10.1002/cncr.22585; Park PH, 2003, BIOCHEM BIOPH RES CO, V306, P501, DOI 10.1016/S0006-291X(03)01040-4; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rozen S, 2000, Methods Mol Biol, V132, P365; SHUKLA SD, 2007, NOVARTIS FDN S, V285; Shukla SD, 2006, WORLD J GASTROENTERO, V12, P5265, DOI 10.3748/wjg.v12.i33.5265; Yoshimura M, 2006, ALCOHOL CLIN EXP RES, V30, P1824, DOI 10.1111/j.1530-0277.2006.00219.x; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	41	31	31	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1069	1075		10.1096/fj.10-168534	http://dx.doi.org/10.1096/fj.10-168534			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21106935				2022-12-25	WOS:000287806200026
J	Mitra, AK; Sawada, K; Tiwari, P; Mui, K; Gwin, K; Lengyel, E				Mitra, A. K.; Sawada, K.; Tiwari, P.; Mui, K.; Gwin, K.; Lengyel, E.			Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis	ONCOGENE			English	Article						ovarian cancer; alpha(5)beta(1)-integrin; c-Met; Src; FAK; fibronectin	HEPATOCYTE GROWTH-FACTOR; FOCAL ADHESION KINASE; CONSTITUTIVE ACTIVATION; EMBRYOID BODIES; MMP-2 FUNCTIONS; CELL INVASION; INTEGRIN; DISSEMINATION; EXPRESSION; RECEPTOR	The role of the fibronectin receptor, alpha(5)beta(1)-integrin, as an adhesion receptor and in angiogenesis is well established. However, its role in cancer cell invasion and metastasis is less clear. We describe a novel mechanism by which fibronectin regulates ovarian cancer cell signaling and promotes metastasis. Fibronectin binding to alpha(5)beta(1)-integrin led to a direct association of alpha(5)-integrin with the receptor tyrosine kinase, c-Met, activating it in a hepatocyte growth factor/scatter factor (HGF/SF) independent manner. Subsequently, c-Met associated with Src, and activated Src and focal adhesion kinase (FAK). Inhibition of alpha(5)beta(1)-integrin decreased the phosphorylation of c-Met, FAK and Src, both in vitro and in vivo. Independent activation of c-Met by its native ligand, HGF/SF, or overexpression of a constitutively active FAK in HeyA8 cells could overcome the effect of alpha(5)beta(1)-integrin inhibition on tumor cell invasion, indicating that alpha(5)beta(1)-integrin is upstream of c-Met, Src and FAK. Inhibition of alpha(5)beta(1)-integrin on cancer cells in two xenograft models of ovarian cancer metastasis resulted in a significant decrease of tumor burden, which was independent of the effect of alpha(5)beta(1)-integrin on angiogenesis. These data suggest that fibronectin promotes ovarian cancer invasion and metastasis through an alpha(5)beta(1)-integrin/c-Met/FAK/Src-dependent signaling pathway, transducing signals through c-Met in an HGF/SF-independent manner. Oncogene (2011) 30, 1566-1576; doi: 10.1038/onc.2010.532; published online 29 November 2010	[Mitra, A. K.; Sawada, K.; Tiwari, P.; Mui, K.; Lengyel, E.] Univ Chicago, Dept Obstet & Gynecol, Gynecol Oncol Sect, Ctr Integrat Sci, Chicago, IL 60637 USA; [Gwin, K.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Lengyel, E (corresponding author), Univ Chicago, Dept Obstet & Gynecol, Gynecol Oncol Sect, Ctr Integrat Sci, 5841 S Maryland Ave,MC 2050, Chicago, IL 60637 USA.	elengyel@uchicago.edu	Lengyel, Ernst/D-9220-2014	Lengyel, Ernst/0000-0001-8624-1507; Tiwari, Payal/0000-0002-7822-6857	Facet Biotech Corp.; Burroughs Wellcome Fund; Ovarian Cancer Research Fund; NCI [RO1 CA111882]; NATIONAL CANCER INSTITUTE [R01CA111882] Funding Source: NIH RePORTER	Facet Biotech Corp.; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ovarian Cancer Research Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Facet Biotech Corp. provided funding and antibodies for the animal experiments (Figure 1).; We thank Dr Alan Horwitz, Department of Cell Biology, University of Virginia School of Medicine for providing us with the FAK constructs. We thank Gail Isenberg for critically reviewing the manuscript. We appreciate the inputs of Dr Vinay Bhaskar and Dr Vanitha Ramakrishnan during the initial part of the project. Funding: Ernst Lengyel holds a Clinical Scientist Award in Translational Research from the Burroughs Wellcome Fund and is supported by grants from the Ovarian Cancer Research Fund (Liz Tilberis Scholars Program), and the NCI (RO1 CA111882).	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bhaskar V, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-61; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brader KR, 1997, CLIN CANCER RES, V3, P2017; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Chan PC, 2006, J BIOMED SCI, V13, P215, DOI 10.1007/s11373-005-9061-7; CHAN PY, 1994, J BIOL CHEM, V269, P20567; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Franke FE, 2003, ANTICANCER RES, V23, P4261; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; HAFTER R, 1984, THROMB RES, V35, P53, DOI 10.1016/0049-3848(84)90312-8; Huttenlocher A, 1998, J CELL BIOL, V141, P515, DOI 10.1083/jcb.141.2.515; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin EJ, 2007, DEV BIOL, V308, P474, DOI 10.1016/j.ydbio.2007.06.003; Kenny HA, 2009, CELL CYCLE, V8, P683, DOI 10.4161/cc.8.5.7703; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Magnussen A, 2005, CANCER RES, V65, P2712, DOI 10.1158/0008-5472.CAN-04-2691; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nakamura Y, 2008, CANCER SCI, V99, P14, DOI 10.1111/j.1349-7006.2007.00640.x; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Rusciano D, 1996, J BIOL CHEM, V271, P20763, DOI 10.1074/jbc.271.34.20763; Saga Y, 2001, GENE THER, V8, P1450, DOI 10.1038/sj.gt.3301553; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Taverna D, 2001, CANCER RES, V61, P5255; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; WINGERTER P, 2005, AM J PATHOL, V167, P193; Wong AST, 2004, EXP CELL RES, V299, P248, DOI 10.1016/j.yexcr.2004.06.002; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yokoyama Y, 2007, CANCER RES, V67, P10813, DOI 10.1158/0008-5472.CAN-07-0172; Yu D, 1992, CANCER RES, V53, P891; Zillhardt M, 2010, NEOPLASIA, V12, P1, DOI 10.1593/neo.09948	38	189	194	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	13					1566	1576		10.1038/onc.2010.532	http://dx.doi.org/10.1038/onc.2010.532			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	743DU	21119598	Green Accepted			2022-12-25	WOS:000288998300007
J	Yang, L; Katchman, A; Morrow, JP; Doshi, D; Marx, SO				Yang, Lin; Katchman, Alexander; Morrow, John P.; Doshi, Darshan; Marx, Steven O.			Cardiac L-type calcium channel (Ca(v)1.2) associates with gamma subunits	FASEB JOURNAL			English	Article						ion channel; electrophysiology; immunoprecipitation; auxiliary subunit; macromolecular complex	GATED CA2+ CHANNELS; KINASE-C ISOFORMS; SKELETAL-MUSCLE; FUNCTIONAL-CHARACTERIZATION; AMPA RECEPTORS; BETA-SUBUNITS; GENE; EXPRESSION; FAMILY; CELLS	The cardiac voltage-gated Ca2+ channel, Ca(v)1.2, mediates excitation-contraction coupling in the heart. The molecular composition of the channel includes the pore-forming alpha 1 subunit and auxiliary alpha 2/delta-1 and beta subunits. Ca2+ channel gamma subunits, of which there are 8 isoforms, consist of 4 transmembrane domains with intracellular N- and C-terminal ends. The gamma 1 subunit was initially detected in the skeletal muscle Ca(v)1.1 channel complex, modulating current amplitude and activation and inactivation properties. The gamma 1 subunit also shifts the steady-state inactivation to more negative membrane potentials, accelerates current inactivation, and increases peak currents, when coexpressed with the cardiac alpha 1c subunit in Xenopus oocytes and human embryonic kidney (HEK) 293 cells. The gamma 1 subunit is not expressed, however, in cardiac muscle. We sought to determine whether gamma subunits that are expressed in cardiac tissue physically associate with and modulate Ca(v)1.2 function. We now demonstrate that gamma 4, gamma 6, gamma 7, and gamma 8 subunits physically interact with the Ca(v)1.2 complex. The gamma subunits differentially modulate Ca2+ channel function when coexpressed with the beta 1b and alpha 2/delta-1 subunits in HEK cells, altering both activation and inactivation properties. The effects of gamma on Ca(v)1.2 function are dependent on the subtype of beta subunit. Our results identify new members of the cardiac Ca(v)1.2 macromolecular complex and identify a mechanism by which to increase the functional diversity of Ca(v)1.2 channels.-Yang, L., Katchman, A., Morrow, J. P., Doshi, D., Marx, S. A. Cardiac L-type calcium channel (Ca(V)1.2) associates with gamma subunits. FASEB J. 25, 928-936 (2011). www.fasebj.org	[Yang, Lin; Katchman, Alexander; Morrow, John P.; Doshi, Darshan; Marx, Steven O.] Columbia Univ, Coll Phys & Surg, Div Cardiol, Dept Med, New York, NY 10032 USA; [Marx, Steven O.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University	Marx, SO (corresponding author), Columbia Univ, Coll Phys & Surg, Div Cardiol, Dept Med, 622 W 168th St,PH-3 Ctr, New York, NY 10032 USA.	sm460@columbia.edu		Morrow, John/0000-0002-9264-5273	U.S. National Institutes of Health [HL068093]; American Heart Association; Arlene and Arnold Goldstein Family Foundation; Louis V. Gerstner, Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068093] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Arlene and Arnold Goldstein Family Foundation; Louis V. Gerstner, Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Susumu Tomita (Yale University, New Haven, CT, USA) for the gamma 8 cDNA and Henry Colecraft (Columbia University, New York, NY, USA) for providing cDNA constructs for beta 1b and beta 2b and helpful discussions. S.O.M. is supported by grants from the U.S. National Institutes of Health (HL068093), the American Heart Association, and the Arlene and Arnold Goldstein Family Foundation. S.O.M. is an Established Investigator of the American Heart Association. J.P.M. is supported by the Louis V. Gerstner, Jr. Foundation.	Arikkath J, 2003, J BIOL CHEM, V278, P1212, DOI 10.1074/jbc.M208689200; Bangalore R, 1996, AM J PHYSIOL-HEART C, V270, pH1521, DOI 10.1152/ajpheart.1996.270.5.H1521; CAMPBELL KP, 1989, ANN NY ACAD SCI, V560, P251, DOI 10.1111/j.1749-6632.1989.tb24102.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chu PJ, 2001, GENE, V280, P37, DOI 10.1016/S0378-1119(01)00738-7; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; Eberst R, 1997, PFLUG ARCH EUR J PHY, V433, P633, DOI 10.1007/s004240050324; FABIATO A, 1979, ANNU REV PHYSIOL, V41, P473, DOI 10.1146/annurev.ph.41.030179.002353; Ferron L, 2008, J NEUROSCI, V28, P10604, DOI 10.1523/JNEUROSCI.2709-08.2008; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Freise D, 2000, J BIOL CHEM, V275, P14476, DOI 10.1074/jbc.275.19.14476; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen JP, 2004, J MOL CELL CARDIOL, V37, P1147, DOI 10.1016/j.yjmcc.2004.08.005; JAY SD, 1991, J BIOL CHEM, V266, P3287; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; Kang MG, 2003, J BIOL CHEM, V278, P21315, DOI 10.1074/jbc.R300004200; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; Lerche H, 1996, PFLUG ARCH EUR J PHY, V431, P461, DOI 10.1007/s004240050021; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Lin ZJ, 2008, J PHYSIOL-LONDON, V586, P5349, DOI 10.1113/jphysiol.2008.159111; Moss FJ, 2002, EMBO J, V21, P1514, DOI 10.1093/emboj/21.7.1514; POWERS PA, 1993, J BIOL CHEM, V268, P9275; Ren DJ, 1997, J BIOL CHEM, V272, P22393, DOI 10.1074/jbc.272.36.22393; Sandoval A, 2007, CELL MOL NEUROBIOL, V27, P901, DOI 10.1007/s10571-007-9210-9; SHARP AH, 1989, J BIOL CHEM, V264, P2816; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; WEI XY, 1991, J BIOL CHEM, V266, P21943; Yang L, 2005, J BIOL CHEM, V280, P207, DOI 10.1074/jbc.M410509200; Yang L, 2007, CIRC RES, V101, P465, DOI 10.1161/CIRCRESAHA.107.156976; Yang L, 2009, BIOCHEMISTRY-US, V48, P6674, DOI 10.1021/bi900322a	38	52	54	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2011	25	3					928	936		10.1096/fj.10-172353	http://dx.doi.org/10.1096/fj.10-172353			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21127204	Green Published			2022-12-25	WOS:000287806200013
J	Wei, L; Jiang, P; Xu, WX; Li, H; Zhang, H; Yan, LY; Chan-Park, MB; Liu, XW; Tang, K; Mu, YG; Pervushin, K				Wei, Lei; Jiang, Ping; Xu, Weixin; Li, Hai; Zhang, Hua; Yan, Liangyu; Chan-Park, Mary B.; Liu, Xue-Wei; Tang, Kai; Mu, Yuguang; Pervushin, Konstantin			The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; BETA-PROTEIN; ALPHA-SYNUCLEIN; NMR-SPECTROSCOPY; HUMAN AMYLIN; IN-VITRO; ALZHEIMERS-DISEASE; TRANSGENIC MICE; OLIGOMERS; INSULIN	Abnormal aggregation of islet amyloid polypeptide (IAPP) into amyloid fibrils is a hallmark of type 2 diabetes. In this study, we investigated the initial oligomerization and subsequent addition of monomers to growing aggregates of human IAPP at the residue-specific level using NMR, atomic force microscopy, mass spectroscopy, and computational simulations. We found that in solution IAPPs rapidly associate into transient low-order oligomers such as dimers and trimers via interactions between histidine 18 and tyrosine 37. This initial event is proceeded by slow aggregation into higher-order spherical oligomers and elongated fibrils. In these two morphologically distinct types of aggregates IAPPs adopt structures with markedly different residual flexibility. Here we show that the anti-amyloidogenic compound resveratrol inhibits oligomerization and amyloid formation via binding to histidine 18, supporting the finding that this residue is crucial for on-pathway oligomer formation.	[Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Li, Hai; Zhang, Hua] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Yan, Liangyu; Chan-Park, Mary B.] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Liu, Xue-Wei] Nanyang Technol Univ, Sch Phys & Math Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mu, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	ygmu@ntu.edu.sg; kpervushin@ntu.edu.sg	Zhang, Hua/A-1302-2009; Mu, Yuguang/A-9558-2010; xu, weixin/B-5519-2011; Chan-Park, Mary B/G-6196-2010; Li, Hai/E-7555-2011; Pervushin, Konstantin/AAJ-6580-2020; Tang, Kai/A-2194-2011	Zhang, Hua/0000-0001-9518-740X; Chan-Park, Mary B/0000-0003-3761-7517; Li, Hai/0000-0002-9659-1153; Pervushin, Konstantin/0000-0002-6393-4340; , Dahabada/0000-0002-5411-9264	MOE [T206B3210RS]; Singapore National Research Foundation [NRF-CRP2-2007-02]	MOE(Ministry of Higher Education & Scientific Research (MHESR)); Singapore National Research Foundation(National Research Foundation, Singapore)	This work was supported in part by AcRF Tier 2 by the MOE (T206B3210RS) (to Y. M. and K. P.) and a competitive research program grant from the Singapore National Research Foundation (NRF-CRP2-2007-02) (to M. B. C.-P.).	Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHARGE SBP, 1995, BIOCHEMISTRY-US, V34, P14588, DOI 10.1021/bi00044a038; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; Evers F, 2009, J AM CHEM SOC, V131, P9516, DOI 10.1021/ja8097417; Farrell D, 2010, PROTEINS, V78, P843, DOI 10.1002/prot.22611; FOX N, 1993, FEBS LETT, V323, P40, DOI 10.1016/0014-5793(93)81444-5; Giannakis E, 2008, BBA-BIOMEMBRANES, V1778, P1112, DOI 10.1016/j.bbamem.2008.01.012; Gilead S, 2006, ANGEW CHEM INT EDIT, V45, P6476, DOI 10.1002/anie.200602034; Gilead S, 2008, EXP DIABETES RES, DOI 10.1155/2008/256954; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jaikaran ETAS, 2004, BIOCHEM J, V377, P709, DOI 10.1042/bj20030852; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Kudva YC, 1998, BIOCHEM J, V331, P809, DOI 10.1042/bj3310809; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LeVine H, 1999, METHOD ENZYMOL, V309, P467; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Lomakin A, 2003, P NATL ACAD SCI USA, V100, P10254, DOI 10.1073/pnas.1334069100; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Peng Y, 2005, J PHYS CHEM B, V109, P15145, DOI 10.1021/jp0511956; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serpell LC, 2000, J MOL BIOL, V300, P1033, DOI 10.1006/jmbi.2000.3908; Sette M, 1999, RNA, V5, P82, DOI 10.1017/S1355838299981487; Smith AM, 2006, J MOL BIOL, V364, P9, DOI 10.1016/j.jmb.2006.08.081; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; SZYPERSKI T, 1994, BIOCHEMISTRY-US, V33, P9303, DOI 10.1021/bi00197a034; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; Vaiana SM, 2008, BIOPHYS J, V94, pL45, DOI 10.1529/biophysj.107.125146; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wei L, 2009, BIOCHEMISTRY-US, V48, P2368, DOI 10.1021/bi802097b; WESTERMARK P, 1973, ACTA PATH MICRO IM A, VA 81, P291; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Xu WX, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3123532; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899	58	93	94	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6291	6300		10.1074/jbc.M110.166678	http://dx.doi.org/10.1074/jbc.M110.166678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148563	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000287476400039
J	Cacciottolo, M; Belcastro, V; Laval, S; Bushby, K; di Bernardo, D; Nigro, V				Cacciottolo, Mafalda; Belcastro, Vincenzo; Laval, Steve; Bushby, Kate; di Bernardo, Diego; Nigro, Vincenzo			Reverse Engineering Gene Network Identifies New Dysferlin-interacting Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; TRANSCRIPT RELEASE FACTOR; MEMBRANE REPAIR; SKELETAL-MUSCLE; GENERALIZED LIPODYSTROPHY; POLYMERASE-I; PTRF-CAVIN; EXPRESSION; CAVEOLAE; PHOSPHORYLATION	Dysferlin (DYSF) is a type II transmembrane protein implicated in surface membrane repair of muscle. Mutations in dysferlin lead to Limb Girdle Muscular Dystrophy 2B (LGMD2B), Miyoshi Myopathy (MM), and Distal Myopathy with Anterior Tibialis onset (DMAT). The DYSF protein complex is not well understood, and only a few protein-binding partners have been identified thus far. To increase the set of interacting protein partners for DYSF we recovered a list of predicted interacting protein through a systems biology approach. The predictions are part of a "reverse-engineered" genome-wide human gene regulatory network obtained from experimental data by computational analysis. The reverse-engineering algorithm behind the analysis relates genes to each other based on changes in their expression patterns. DYSF and AHNAK were used to query the system and extract lists of potential interacting proteins. Among the 32 predictions the two genes share, we validated the physical interaction between DYSF protein with moesin (MSN) and polymerase I and transcript release factor (PTRF) in mouse heart lysate, thus identifying two novel Dysferlin-interacting proteins. Our strategy could be useful to clarify Dysferlin function in intracellular vesicles and its implication in muscle membrane resealing.	[Nigro, Vincenzo] TIGEM Telethon Inst Genet & Med, I-80131 Naples, Italy; [Laval, Steve; Bushby, Kate] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Nigro, Vincenzo] Seconda Univ Napoli, Dipartimento Patol Gen, Med Genet Lab, I-80138 Naples, Italy; [Nigro, Vincenzo] Seconda Univ Napoli, CIRM, I-80138 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Newcastle University - UK; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Nigro, V (corresponding author), TIGEM Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.	vincenzo.nigro@unina2.it	di Bernardo, Diego/I-9440-2012; Nigro, Vincenzo/AAB-2274-2022; di Bernardo, Diego/AAF-5881-2021	di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Diego/0000-0002-1911-7407; Belcastro, Vincenzo/0000-0003-3749-0018; Cacciottolo, Mafalda/0000-0003-3093-0535; Nigro, Vincenzo/0000-0002-3378-5006	Telethon [(TIGEM-TNP42TELC), FP7/2007-2013, 223143]; Ministero della Salute [(Ricerca Finalizzata RF-MUL-2007-666195)]; Telethon-UILDM; MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish	Telethon(Fondazione Telethon); Ministero della Salute(Ministry of Health, Italy); Telethon-UILDM(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by grants from Telethon (TIGEM-TNP42TELC) and FP7/2007-2013 under Grant agreement no. 223143 ( Project acronym: TECHGENE), from Ministero della Salute (Ricerca Finalizzata RF-MUL-2007-666195) and from Telethon-UILDM.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Ampong Beryl N, 2005, Acta Myol, V24, P134; Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Butte A J, 2000, Pac Symp Biocomput, P418; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Campanaro S, 2002, HUM MOL GENET, V11, P3283, DOI 10.1093/hmg/11.26.3283; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; de Luna N, 2006, J BIOL CHEM, V281, P17092, DOI 10.1074/jbc.M601885200; Dwianingsih EK, 2010, MOL GENET METAB, V101, P233, DOI 10.1016/j.ymgme.2010.06.016; Guan HT, 2008, ADV BIOCHEM ENG BIOT, V110, P1, DOI 10.1007/10_2007_092; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; Nigro V, 2003, Acta Myol, V22, P35; Paradas C, 2010, NEUROLOGY, V75, P316, DOI 10.1212/WNL.0b013e3181ea1564; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Santoro L, 2010, MUSCLE NERVE, V41, P392, DOI 10.1002/mus.21506; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; von der Hagen M, 2005, NEUROMUSCULAR DISORD, V15, P863, DOI 10.1016/j.nmd.2005.09.002; Walker WL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-494; Walter MC, 2003, J NEUROL, V250, P1431, DOI 10.1007/s00415-003-0234-x	46	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5404	5413		10.1074/jbc.M110.173559	http://dx.doi.org/10.1074/jbc.M110.173559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21119217	hybrid, Green Published			2022-12-25	WOS:000287230600049
J	Tajima, N; Itokazu, Y; Korpi, ER; Somerharju, P; Kakela, R				Tajima, Nobuyoshi; Itokazu, Yutaka; Korpi, Esa R.; Somerharju, Pentti; Kakela, Reijo			Activity of BKCa Channel Is Modulated by Membrane Cholesterol Content and Association with Na+/K+-ATPase in Human Melanoma IGR39 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; ENDOTHELIAL-CELLS; SIGNALING COMPLEX; LARGE-CONDUCTANCE; NA/K-ATPASE; MASS-SPECTROMETRY; GLIOMA-CELLS; ION CHANNELS; CANCER CELLS	Interaction of large conductance Ca2+- and voltage-activated K+ ( BKCa) channels with Na+/K+-ATPase, caveolin-1, and cholesterol was studied in human melanoma IGR39 cells. Functional BKCa channels were enriched in caveolin-rich and detergent-resistant membranes, i.e. rafts, and blocking of the channels by a specific BKCa blocker paxilline reduced proliferation of the cells. Disruption of rafts by selective depletion of cholesterol released BKCa channels from these domains with a consequent increase in their activity. Consistently, cholesterol enrichment of the cells increased the proportion of BKCa channels in rafts and decreased their activity. Immunocytochemical analysis showed that BKCa channels co-localize with Na+/K+-ATPase in a cholesterol-dependent manner, thus suggesting their co-presence in rafts. Supporting this, ouabain, a specific blocker of Na+/K+-ATPase, inhibited BKCa whole-cell current markedly in control cells but not in cholesterol-depleted ones. This inhibition required the presence of external Na+. Collectively, these data indicate that the presence of Na+/K+-ATPase in rafts is essential for efficient functioning of BKCa channels, presumably because the pump maintains a low intracellular Na+ proximal to the BKCa channel. In conclusion, cholesterol could play an important role in cellular ion homeostasis and thus modulate many cellular functions and cell proliferation.	[Tajima, Nobuyoshi; Itokazu, Yutaka; Somerharju, Pentti; Kakela, Reijo] Univ Helsinki, Inst Biomed, Dept Med Biochem & Dev Biol, FI-00014 Helsinki, Finland; [Korpi, Esa R.] Univ Helsinki, Dept Pharmacol, FI-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Kakela, R (corresponding author), Univ Helsinki, Dept Biosci, POB 65,Viikinkaari 1, FI-00014 Helsinki, Finland.	reijo.kakela@helsinki.fi		Korpi, Esa R./0000-0003-0683-4009	Academy of Finland [111261, 129148]	Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland Grants 111261 and 129148 (to R. K.).	Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; Allard B, 2000, J BIOL CHEM, V275, P25556, DOI 10.1074/jbc.M002327200; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Cornelius F, 2008, BIOCHEMISTRY-US, V47, P1652, DOI 10.1021/bi702128x; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Cuevas FJ, 2006, BIOCHEMISTRY-US, V45, P13855, DOI 10.1021/bi061351e; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAMBLE W, 1978, J LIPID RES, V19, P1068; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Han XB, 2007, APOPTOSIS, V12, P1837, DOI 10.1007/s10495-007-0101-9; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jha S, 2009, FEBS LETT, V583, P3109, DOI 10.1016/j.febslet.2009.08.039; Kakela R, 2003, J NEUROCHEM, V84, P1051, DOI 10.1046/j.1471-4159.2003.01602.x; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kockskamper J, 1997, BBA-BIOMEMBRANES, V1325, P197, DOI 10.1016/S0005-2736(96)00259-3; Kraft R, 2003, PFLUG ARCH EUR J PHY, V446, P248, DOI 10.1007/s00424-003-1012-4; Kuhlmann CRW, 2005, PLANTA MED, V71, P520, DOI 10.1055/s-2005-864152; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang GH, 2008, PFLUG ARCH EUR J PHY, V457, P67, DOI 10.1007/s00424-008-0490-9; Liu SI, 1998, BBA-BIOMEMBRANES, V1368, P256, DOI 10.1016/S0005-2736(97)00183-1; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Luedders DW, 2006, J CARDIOVASC PHARM, V47, P365; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Ma DWL, 2004, FASEB J, V18, P1040, DOI 10.1096/fj.03-1430fje; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Meyer R, 1999, J MEMBRANE BIOL, V171, P107, DOI 10.1007/s002329900563; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rudiger C, 2004, J AM SOC NEPHROL, V15, P868, DOI 10.1097/01.ASN.0000115782.77586.88; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCOTT RE, 1979, J CELL SCI, V35, P229; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Sullards M C, 2001, Sci STKE, V2001, ppl1; Tajima N, 2006, J PHYSIOL-LONDON, V571, P349, DOI 10.1113/jphysiol.2005.096818; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Yamamoto S, 1996, AM J PHYSIOL-CELL PH, V270, pC457, DOI 10.1152/ajpcell.1996.270.2.C457; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	70	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5624	5638		10.1074/jbc.M110.149898	http://dx.doi.org/10.1074/jbc.M110.149898			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135099	Green Published, hybrid			2022-12-25	WOS:000287230600072
J	van der Heide, LP; van Dinther, M; Moustakas, A; ten Dijke, P				van der Heide, Lars P.; van Dinther, Maarten; Moustakas, Aristidis; ten Dijke, Peter			TGF beta Activates Mitogen- and Stress-activated Protein Kinase-1 (MSK1) to Attenuate Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP KINASE; PHOSPHORYLATION SITES; INDUCED APOPTOSIS; EPITHELIAL-CELLS; SMAD PROTEINS; CANCER CELLS; CREB; EXPRESSION; RESPONSES; PROTEIN-KINASE-1	Transforming growth factor-beta (TGF beta) binding to its receptor leads to intracellular phosphorylation of Smad2 and Smad3, which oligomerize with Smad4. These complexes accumulate in the nucleus and induce gene transcription. Here we describe mitogen-and stress-activated kinase 1 (MSK1) as an antagonist of TGF beta-induced cell death. Induction of MSK1 activity by TGF beta depends on Smad4 and p38 MAPK activation. Knockdown of GADD45, a Smad4-induced upstream regulator of p38 MAPK prevents TGF beta-induced p38 and MSK1 activity. MSK1 functionally regulates pro-apoptotic BH3-only BCL2 proteins, as MSK1 knockdown reduces Bad phosphorylation and enhances Noxa and Bim expression, leading to enhanced TGF beta-induced caspase-3 activity and cell death. This finding suggests that MSK1 represents a pro-survival pathway bifurcating downstream of p38 and antagonizes the established pro-apoptotic p38 MAPK function. Furthermore, EGF could reverse all the effects observed after MSK1 knockdown. Monitoring the status of MSK1 activity in cancer promises new therapeutic targets as inactivating both MSK1 and EGF signaling may (re)-sensitize cells to TGF beta-induced cell death.	[van der Heide, Lars P.; Moustakas, Aristidis; ten Dijke, Peter] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, S-75124 Uppsala, Sweden; [van der Heide, Lars P.; van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [van der Heide, Lars P.; van Dinther, Maarten; ten Dijke, Peter] Leiden Univ, Ctr Biomed Genet, Med Ctr, NL-2300 RC Leiden, Netherlands; [Moustakas, Aristidis] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Uppsala University	van der Heide, LP (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Box 595, S-75124 Uppsala, Sweden.	lars.vdh@LICR.uu.se	Dijke, Peter ten/AAG-4660-2021	Dijke, Peter ten/0000-0002-7234-342X; van der Heide, Lars P./0000-0003-1779-425X	Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery [09 0773]	Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery	This work was supported by the Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program and Cancerfonden (Contract Number: 09 0773).	Abecassis L, 2004, J BIOL CHEM, V279, P30474, DOI 10.1074/jbc.M403294200; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Kim BC, 2002, MOL CELL BIOL, V22, P1369, DOI 10.1128/MCB.22.5.1369-1378.2002; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Olson CM, 2007, INFECT IMMUN, V75, P270, DOI 10.1128/IAI.01412-06; Piek E, 1999, J CELL SCI, V112, P4557; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; REILAND J, 1993, J CELL SCI, V105, P1085; Rosfjord EC, 1999, J MAMMARY GLAND BIOL, V4, P229, DOI 10.1023/A:1018789527533; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Schiller M, 2006, ONCOGENE, V25, P4449, DOI 10.1038/sj.onc.1209479; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	37	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5003	5011		10.1074/jbc.M110.167379	http://dx.doi.org/10.1074/jbc.M110.167379			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21106525	hybrid, Green Published			2022-12-25	WOS:000287230600008
J	Rahman, AKMNU; Bonsor, DA; Herfst, CA; Pollard, F; Peirce, M; Wyatt, AW; Kasper, KJ; Madrenas, J; Sundberg, EJ; McCormick, JK				Rahman, A. K. M. Nur-Ur; Bonsor, Daniel A.; Herfst, Christine A.; Pollard, Fraser; Peirce, Michael; Wyatt, Aaron W.; Kasper, Katherine J.; Madrenas, Joaquin; Sundberg, Eric J.; McCormick, John K.			The T Cell Receptor beta-Chain Second Complementarity Determining Region Loop (CDR2 beta) Governs T Cell Activation and V beta Specificity by Bacterial Superantigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIC-SHOCK-SYNDROME; MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; PYROGENIC EXOTOXIN-C; STAPHYLOCOCCAL-ENTEROTOXIN-B; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; MOLECULAR REQUIREMENTS; ALLELIC DISCRIMINATION; STRUCTURAL BASIS	Superantigens (SAgs) are microbial toxins defined by their ability to activate T lymphocytes in a T cell receptor (TCR) beta-chain variable domain (V beta)-specific manner. Although existing structural information indicates that diverse bacterial SAgs all uniformly engage the V beta second complementarity determining region (CDR2 beta) loop, the molecular rules that dictate SAg-mediated T cell activation and V beta specificity are not fully understood. Herein we report the crystal structure of human V beta 2.1 (hV beta 2.1) in complex with the toxic shock syndrome toxin-1 (TSST-1) SAg, and mutagenesis of hV beta 2.1 indicates that the non-canonical length of CDR2 beta is a critical determinant for recognition by TSST-1 as well as the distantly related SAg streptococcal pyrogenic exotoxin C. Frame work (FR) region 3 is uniquely critical for TSST-1 function explaining the fine V beta-specificity exhibited by this SAg. Furthermore, domain swapping experiments with SAgs, which use distinct domains to engage both CDR2 beta and FR3/4 beta revealed that the CDR2 beta contacts dictate T lymphocyte V beta-specificity. These findings demonstrate that the TCR CDR2 beta loop is the critical determinant for functional recognition and V beta-specificity by diverse bacterial SAgs.	[Rahman, A. K. M. Nur-Ur; Herfst, Christine A.; Pollard, Fraser; Peirce, Michael; Wyatt, Aaron W.; Kasper, Katherine J.; Madrenas, Joaquin; McCormick, John K.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Rahman, A. K. M. Nur-Ur; Madrenas, Joaquin; McCormick, John K.] Univ Western Ontario, Ctr Human Immunol, London, ON N6A 5C1, Canada; [Bonsor, Daniel A.; Sundberg, Eric J.] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Herfst, Christine A.; McCormick, John K.] Lawson Hlth Res Inst, London, ON N6A 4V2, Canada; [Madrenas, Joaquin] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Boston Biomedical Research Institute; Western University (University of Western Ontario); Western University (University of Western Ontario)	McCormick, JK (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada.	john.mccormick@schulich.uwo.ca	McCormick, John/E-4232-2015; Madrenas, Quim/P-5008-2019	Sundberg, Eric/0000-0003-0478-3033; McCormick, John/0000-0003-3742-7289	National Institutes of Health [AI065690]; Canadian Institutes of Health Research (CIHR); Schulich School of Medicine and Dentistry; Ontario Ministry of Research and Innovation; Canadian Foundation for Innovation; Ontario Innovation Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Schulich School of Medicine and Dentistry; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI065690 (to E.J.S.) and a Canadian Institutes of Health Research (CIHR) operating grant (to J.K.M.). Stipend support (to A.K.M.N.R.) was provided in part by scholarships from the Schulich School of Medicine and Dentistry and from an Early Research Award from The Ontario Ministry of Research and Innovation. Laboratory infrastructure was supported by a New Opportunities Fund award from the Canadian Foundation for Innovation and the Ontario Innovation Trust (to J.K.M.).	Andersen PS, 2002, BIOCHEMISTRY-US, V41, P5177, DOI 10.1021/bi0200209; Brouillard JNP, 2007, J MOL BIOL, V367, P925, DOI 10.1016/j.jmb.2007.01.024; Buonpane RA, 2005, J MOL BIOL, V353, P308, DOI 10.1016/j.jmb.2005.08.041; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Churchill HRO, 2000, J EXP MED, V191, P835, DOI 10.1084/jem.191.5.835; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; GAZDAR AF, 1980, BLOOD, V55, P409; Gluschankof P, 2002, VIROLOGY, V300, P160, DOI 10.1006/viro.2002.1531; GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403; Gunther S, 2007, J MOL BIOL, V371, P210, DOI 10.1016/j.jmb.2007.05.038; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; HURLEY JM, 1995, J EXP MED, V181, P2229, DOI 10.1084/jem.181.6.2229; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kasper KJ, 2008, J IMMUNOL, V181, P3384, DOI 10.4049/jimmunol.181.5.3384; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; Lavoie PM, 2001, J IMMUNOL, V166, P7229, DOI 10.4049/jimmunol.166.12.7229; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li PL, 1997, J EXP MED, V186, P375, DOI 10.1084/jem.186.3.375; Li YL, 2001, IMMUNITY, V14, P93, DOI 10.1016/S1074-7613(01)00092-9; MARRACK P, 1990, SCIENCE, V248, P1066; McCormick JK, 2003, J IMMUNOL, V171, P1385, DOI 10.4049/jimmunol.171.3.1385; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; MOLLICK JA, 1989, SCIENCE, V244, P817, DOI 10.1126/science.2658055; Moza B, 2007, EMBO J, V26, P1187, DOI 10.1038/sj.emboj.7601531; Moza B, 2006, P NATL ACAD SCI USA, V103, P9867, DOI 10.1073/pnas.0600220103; NORTON SD, 1990, J IMMUNOL, V144, P2089; Orwin PM, 2001, INFECT IMMUN, V69, P360, DOI 10.1128/IAI.69.1.360-366.2001; PAPAGEORGIOU AC, 1995, STRUCTURE, V3, P769, DOI 10.1016/S0969-2126(01)00212-X; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Rahman AKMNU, 2006, J IMMUNOL, V177, P8595, DOI 10.4049/jimmunol.177.12.8595; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Sambrook J, 2001, MOL CLONING LAB MANU; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Sundberg EJ, 2009, METHODS MOL BIOL, V524, P347, DOI 10.1007/978-1-59745-450-6_25; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripp TJ, 2003, INFECT IMMUN, V71, P1548, DOI 10.1128/IAI.71.3.1548-1550.2003; Wang LM, 2007, NAT STRUCT MOL BIOL, V14, P169, DOI 10.1038/nsmb1193; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	47	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4871	4881		10.1074/jbc.M110.189068	http://dx.doi.org/10.1074/jbc.M110.189068			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127057	Green Published, hybrid			2022-12-25	WOS:000286975700083
J	Chew, C; Eysenbach, G				Chew, Cynthia; Eysenbach, Gunther			Pandemics in the Age of Twitter: Content Analysis of Tweets during the 2009 H1N1 Outbreak	PLOS ONE			English	Article							RISK	Background: Surveys are popular methods to measure public perceptions in emergencies but can be costly and time consuming. We suggest and evaluate a complementary "infoveillance" approach using Twitter during the 2009 H1N1 pandemic. Our study aimed to: 1) monitor the use of the terms "H1N1" versus "swine flu" over time; 2) conduct a content analysis of "tweets"; and 3) validate Twitter as a real-time content, sentiment, and public attention trend-tracking tool. Methodology/Principal Findings: Between May 1 and December 31, 2009, we archived over 2 million Twitter posts containing keywords "swine flu," "swineflu," and/or "H1N1." using Infovigil, an infoveillance system. Tweets using "H1N1" increased from 8.8% to 40.5% (R-2 =.788; p<.001), indicating a gradual adoption of World Health Organization-recommended terminology. 5,395 tweets were randomly selected from 9 days, 4 weeks apart and coded using a tri-axial coding scheme. To track tweet content and to test the feasibility of automated coding, we created database queries for keywords and correlated these results with manual coding. Content analysis indicated resource-related posts were most commonly shared (52.6%). 4.5% of cases were identified as misinformation. News websites were the most popular sources (23.2%), while government and health agencies were linked only 1.5% of the time. 7/10 automated queries correlated with manual coding. Several Twitter activity peaks coincided with major news stories. Our results correlated well with H1N1 incidence data. Conclusions: This study illustrates the potential of using social media to conduct "infodemiology" studies for public health. 2009 H1N1-related tweets were primarily used to disseminate information from credible sources, but were also a source of opinions and experiences. Tweets can be used for real-time content analysis and knowledge translation research, allowing health authorities to respond to public concerns.	[Chew, Cynthia; Eysenbach, Gunther] Univ Hlth Network, Ctr Global eHlth Innovat, Toronto, ON, Canada; [Chew, Cynthia; Eysenbach, Gunther] Univ Toronto, Dept Hlth Policy Management & Evaluat, Fac Med, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Chew, C (corresponding author), Univ Hlth Network, Ctr Global eHlth Innovat, Toronto, ON, Canada.	geysenba@gmail.com	Eysenbach, Gunther/AAJ-7158-2020	Eysenbach, Gunther/0000-0001-6479-5330	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Mrs. Chew was generously supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Master's Award. Infovigil.com is a non-commercial project/website, partly funded by the Canadian Institutes of Health Research (CIHR) [Pandemics in the Age of Social Media: Content Analysis of Tweets for Infoveillance and Knowledge Translation Research, PI: Gunther Eysenbach]. Other parts of the project costs may in the future be defrayed by consulting and collaborating with commercial entities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS M, 2009, 10 SWIN FLU LIES TOL; *AG AUT, 2009, CBS REP PAR CONC H1N; Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42; Blendon RJ, 2003, J HEALTH COMMUN, V8, P83, DOI 10.1080/10810730390224884; *CBC, 2009, H POTT ACT REC SWIN; Center for Disease Control and Prevention, 2010, UPD CDC EST 2009 H1N; *CNN, 2009, 1 DOS H1N1 FLU VACC; Eysenbach G, 2002, BMJ-BRIT MED J, V324, P573, DOI 10.1136/bmj.324.7337.573; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; HUGHES A, 2009, P 6 INT ISCRAM C 200; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Kallan F V, 1997, Ugeskr Laeger, V159, P6528; Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004; Lau JTF, 2009, BRIT MED J, V338, pb4164, DOI DOI 10.1136/bmj.b4164; Lenhart A., 2009, TWITTER STATUS UPDAT; MASTRAPA G, 2009, PAX SWINE FLU OUTBRE; PICARD A, 2010, LESSONS H1N1 PREACH; Prue CE, 2003, J HEALTH COMMUN, V8, P35, DOI 10.1080/10810730390224866; Quantcast, 2010, TWITT DEM; Ripberger JT, 2010, CULTIVATING CURIOSIT; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Seale H, 2009, MED J AUSTRALIA, V191, P267, DOI 10.5694/j.1326-5377.2009.tb02781.x; STARBIRD K, 2010, P 7 INT ISCRAM C 201; STARBIRD K, 2010, P ACM 2010 COMP SUPP; SUTTER J, 2009, SWINE FLU CREATES CO; Sypsa V, 2009, EUROSURVEILLANCE, V14; Sysomos, 2010, EXPL US TWITT WORLD; Sysomos, 2009, INS TWITT IN DEPTH L; *TIM IND, 2009, CARB MON POIS CAN CR; Van D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-130; *WHO, 2009, CHRON INFL A H1N1; Woien G, 2009, EUROSURVEILLANCE, V14; Wong LP, 2010, PREV MED, V51, P92, DOI 10.1016/j.ypmed.2010.04.010; World Health Organization, 2009, WORLD NOW START 2009; 2009, PORK MAGAZINE	37	843	858	32	473	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14118	10.1371/journal.pone.0014118	http://dx.doi.org/10.1371/journal.pone.0014118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124761	Green Published, Green Submitted, gold			2022-12-25	WOS:000284686500008
J	Iyoda, M; Kasamatsu, A; Ishigami, T; Nakashima, D; Endo-Sakamoto, Y; Ogawara, K; Shiiba, M; Tanzawa, H; Uzawa, K				Iyoda, Manabu; Kasamatsu, Atsushi; Ishigami, Takashi; Nakashima, Dai; Endo-Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro			Epithelial Cell Transforming Sequence 2 in Human Oral Cancer	PLOS ONE			English	Article							CYTOKINESIS REGULATOR ECT2; LYMPH-NODE METASTASIS; RHO-GTPASES; ABERRANT EXPRESSION; G2/M PHASE; G(1) PHASE; CARCINOMA; CYCLE; PROGRESSION; OVEREXPRESSION	Background: Epithelial cell transforming sequence 2 (ECT2) is a guanine nucleotide exchange factor for Rho family GTPase, which has been implicated in the malignant phenotype of human cancers. Little is known about the effect of a high level of ECT2 in regulating oral cancer cell behavior. In this study, we investigated the involvement of ECT2 in oral squamous cell carcinoma (OSCC). Methodology/Principal Findings: We analyzed ECT2 expression in OSCC-derived cell lines and primary OSCCs compared with matched normal tissue (n = 96) by quantitative reverse transcriptase-polymerase chain reaction, Western blot, and immunohistochemistry. We then evaluated the correlation between the ECT2 expression status in primary OSCCs and the clinicopathological features. ECT2 expression was significantly up-regulated in OSCCs in vitro and in vivo (p<0.05). Among the clinical variables analyzed, higher ECT2 expression also was associated with the TNM stage grading (p<0.05). When we performed functional analyses of ECT2 in OSCC-derived cells using the shRNA system, the cellular proliferation of the ECT2 knockdown cells decreased significantly compared with the control cells (p<0.05). Cell cycle analysis by flow cytometry showed arrest of cell cycle progression at the G1 phase in the ECT2 knockdown cells. We also found up-regulation of the Cip/Kip family of the cyclin-dependent kinase inhibitors, p21(cip1) and p27(kip1), and down-regulation of cyclin D1, cyclin E, and CDK4. These data suggested that the elevated Cip/Kip family induced inhibition of the cyclin D1-CDK complex activity leading to cell cycle arrest at the G1 phase. Conclusions/Significance: Our results proposed for the first time that ECT2 is an indicator of cellular proliferation in OSCCs and that ECT2 might be a potential therapeutic target for the development of new treatments for OSCCs.	[Iyoda, Manabu; Kasamatsu, Atsushi; Ishigami, Takashi; Nakashima, Dai; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chiba, Japan; [Kasamatsu, Atsushi; Endo-Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Div Dent & Oral Maxillofacial Surg, Chiba, Japan	Chiba University; Chiba University	Iyoda, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chiba, Japan.	uzawak@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859	Ministry of Education, Culture, Sports, Science and Technology of Japan [20592353]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid Scientific Research (No. 20592353) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Coleman ML, 2006, ONCOGENE, V25, P2708, DOI 10.1038/sj.onc.1209322; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Hara T, 2006, ONCOGENE, V25, P566, DOI 10.1038/sj.onc.1209078; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Kato Y, 2007, INT J ONCOL, V31, P1021; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; MACFARLANE GJ, 1995, ORAL ONCOL, V31B, P181; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MASHBERG A, 1993, CANCER-AM CANCER SOC, V72, P1369, DOI 10.1002/1097-0142(19930815)72:4<1369::AID-CNCR2820720436>3.0.CO;2-L; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; Nomura H, 2009, HUM PATHOL, V40, P83, DOI 10.1016/j.humpath.2008.06.018; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Onda T, 2006, BRIT J CANCER, V94, P698, DOI 10.1038/sj.bjc.6602986; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Saito K, 2006, ONCOL REP, V15, P49; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Sakuma T, 2006, INT J ONCOL, V29, P117; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sano M, 2006, ONCOL REP, V16, P1093; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Sudbo J, 2005, INT J CANCER, V115, P339, DOI 10.1002/ijc.20896; TAM SW, 1994, ONCOGENE, V9, P2663; Tanaka C, 2003, J DENT RES, V82, P607, DOI 10.1177/154405910308200807; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; YAMAMOTO M, 1993, ONCOGENE, V8, P1449; Yamano Y, 2008, INT J ONCOL, V32, P1001; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; YONGLIU, 2010, J ATHEROSCLER T 0611; Zhang ML, 2008, HEPATOB PANCREAT DIS, V7, P533	47	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14082	10.1371/journal.pone.0014082	http://dx.doi.org/10.1371/journal.pone.0014082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124766	Green Submitted, Green Published, gold			2022-12-25	WOS:000284686500003
J	Schoep, TD; Fulurija, A; Good, F; Lu, W; Himbeck, RP; Schwan, C; Choi, SS; Berg, DE; Mittl, PRE; Benghezal, M; Marshall, BJ				Schoep, Tobias D.; Fulurija, Alma; Good, Fayth; Lu, Wei; Himbeck, Robyn P.; Schwan, Carola; Choi, Sung Sook; Berg, Douglas E.; Mittl, Peer R. E.; Benghezal, Mohammed; Marshall, Barry J.			Surface Properties of Helicobacter pylori Urease Complex Are Essential for Persistence	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; B-SUBUNIT; ACTIVATION; CD74; MHC; MACROPHAGES; INFECTION; MIGRATION; BINDS; PH	The enzymatic activity of Helicobacter pylori's urease neutralises stomach acidity, thereby promoting infection by this pathogen. Urease protein has also been found to interact with host cells in vitro, although this property's possible functional importance has not been studied in vivo. To test for a role of the urease surface in the host/pathogen interaction, surface exposed loops that display high thermal mobility were targeted for inframe insertion mutagenesis. H. pylori expressing urease with insertions at four of eight sites tested retained urease activity, which in three cases was at least as stable as was wild-type urease at pH 3. Bacteria expressing one of these four mutant ureases, however, failed to colonise mice for even two weeks, and a second had reduced bacterial titres after longer term (3 to 6 months) colonisation. These results indicate that a discrete surface of the urease complex is important for H. pylori persistence during gastric colonisation. We propose that this surface interacts directly with host components important for the host-pathogen interaction, immune modulation or other actions that underlie H. pylori persistence in its special gastric mucosal niche.	[Schoep, Tobias D.; Fulurija, Alma; Good, Fayth; Lu, Wei; Himbeck, Robyn P.; Schwan, Carola; Benghezal, Mohammed; Marshall, Barry J.] Ondek Pty Ltd, Nedlands, WA, Australia; [Schoep, Tobias D.; Fulurija, Alma; Good, Fayth; Lu, Wei; Himbeck, Robyn P.; Schwan, Carola; Benghezal, Mohammed; Marshall, Barry J.] Univ Western Australia, H Pylori Res Lab, Nedlands, WA 6009, Australia; [Mittl, Peer R. E.] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Choi, Sung Sook; Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Western Australia; University of Zurich; Washington University (WUSTL)	Schoep, TD (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	mohammed.benghezal@uwa.edu.au	Mittl, Peer/E-5352-2017	Benghezal, Mohammed/0000-0002-4207-0192; Schoep, Tobias/0000-0003-1083-292X; Marshall, Barry/0000-0003-4853-5015; Fulurija, Alma/0000-0003-1776-785X				Beswick EJ, 2006, INFECT IMMUN, V74, P1148, DOI 10.1128/IAI.74.2.1148-1155.2006; Casares S, 1997, VIRAL IMMUNOL, V10, P129, DOI 10.1089/vim.1997.10.129; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; DAILIDIENE D, 2006, COUNTERSELE IN PRESS; Dailidiene D, 2006, APPL ENVIRON MICROB, V72, P5908, DOI 10.1128/AEM.01135-06; Ding SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07; EATON KA, 1994, INFECT IMMUN, V62, P3604, DOI 10.1128/IAI.62.9.3604-3607.1994; Fan XJ, 2000, J IMMUNOL, V165, P1918, DOI 10.4049/jimmunol.165.4.1918; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; FERRERO RL, 1994, INFECT IMMUN, V62, P4981, DOI 10.1128/IAI.62.11.4981-4989.1994; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Harris PR, 1998, J INFECT DIS, V178, P1516, DOI 10.1086/314426; Harris PR, 1996, GASTROENTEROLOGY, V111, P419, DOI 10.1053/gast.1996.v111.pm8690207; HU LT, 1990, INFECT IMMUN, V58, P992, DOI 10.1128/IAI.58.4.992-998.1990; Jasanoff A, 1998, EMBO J, V17, P6812, DOI 10.1093/emboj/17.23.6812; Kleanthous H., 1995, Gut, V37, pA94; Kuwahara H, 2000, INFECT IMMUN, V68, P4378, DOI 10.1128/IAI.68.8.4378-4383.2000; MAI UEH, 1992, J EXP MED, V175, P517, DOI 10.1084/jem.175.2.517; Makristathis A, 1998, J INFECT DIS, V177, P803, DOI 10.1086/517814; Marcus EA, 2001, HELICOBACTER, V6, P93, DOI 10.1046/j.1523-5378.2001.00014.x; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Pinkse MWH, 2003, J MASS SPECTROM, V38, P315, DOI 10.1002/jms.443; Rokita E, 1998, J INFECT DIS, V178, P1521, DOI 10.1086/314459; Sambrook J, 2001, MOL CLONING LAB MANU; Schwartz JT, 2006, J LEUKOCYTE BIOL, V79, P1214, DOI 10.1189/jlb.0106030; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Shi Y, 2007, VACCINE, V25, P2583, DOI 10.1016/j.vaccine.2006.12.024; SUZUKI T, 2006, CARCINOGENESIS; Tanahashi T, 2000, INFECT IMMUN, V68, P664, DOI 10.1128/IAI.68.2.664-671.2000; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010844; Williams CL, 1996, FEMS IMMUNOL MED MIC, V13, P87, DOI 10.1111/j.1574-695X.1996.tb00220.x; Wroblewski LE, 2009, GASTROENTEROLOGY, V136, P236, DOI 10.1053/j.gastro.2008.10.011	32	44	49	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15042	10.1371/journal.pone.0015042	http://dx.doi.org/10.1371/journal.pone.0015042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124783	gold, Green Published, Green Submitted			2022-12-25	WOS:000284686500022
J	Su, RW; Lei, W; Liu, JL; Zhang, ZR; Jia, B; Feng, XH; Ren, G; Hu, SJ; Yang, ZM				Su, Ren-Wei; Lei, Wei; Liu, Ji-Long; Zhang, Zhi-Rong; Jia, Bo; Feng, Xu-Hui; Ren, Gang; Hu, Shi-Jun; Yang, Zeng-Ming			The Integrative Analysis of microRNA and mRNA Expression in Mouse Uterus under Delayed Implantation and Activation	PLOS ONE			English	Article							EMBRYO IMPLANTATION; GENE-EXPRESSION; MATRIX METALLOPROTEINASES; PERIIMPLANTATION PERIOD; UTERINE RECEPTIVITY; SERIAL ANALYSIS; MICE; DECIDUALIZATION; RECEPTOR; MIRNAS	Background: Delayed implantation is a developmental arrest at the blastocyst stage and a good model for embryo implantation. MicroRNAs (miRNAs) have been shown to be involved in mouse embryo implantation through regulating uterine gene expression. This study was to have an integrative analysis on global miRNA and mRNA expression in mouse uterus under delayed implantation and activation through Illumina sequencing. Methodology/Principal Findings: By deep sequencing and analysis, we found that there are 20 miRNAs up-regulated and 42 miRNAs down-regulated at least 1.2 folds, and 268 genes up-regulated and 295 genes down-regulated at least 2 folds under activation compared to delayed implantation, respectively. Many different forms of editing in mature miRNAs are detected. The percentage of editing at positions 4 and 5 of mature miRNAs is significantly higher under delayed implantation than under activation. Although the number of miR-21 reference sequence under activation is slightly lower than that under delayed implantation, the total level of miR-21 under activation is higher than that under delayed implantation. Six novel miRNAs are predicted and confirmed. The target genes of significantly up-regulated miRNAs under activation are significantly enriched. Conclusions: miRNA and mRNA expression patterns are closely related. The target genes of up-regulated miRNAs are significantly enriched. A high level of editing at positions 4 and 5 of mature miRNAs is detected under delayed implantation than under activation. Our data should be valuable for future study on delayed implantation.	[Su, Ren-Wei; Zhang, Zhi-Rong; Jia, Bo; Feng, Xu-Hui; Yang, Zeng-Ming] Xiamen Univ, Sch Life Sci, Minist Educ Cell Biol & Tumor Cell Engn, Key Lab, Xiamen, Peoples R China; [Su, Ren-Wei; Lei, Wei; Liu, Ji-Long; Ren, Gang; Hu, Shi-Jun] NE Agr Univ, Sch Sci, Harbin, Peoples R China	Xiamen University; Northeast Agricultural University - China	Su, RW (corresponding author), Xiamen Univ, Sch Life Sci, Minist Educ Cell Biol & Tumor Cell Engn, Key Lab, Xiamen, Peoples R China.	zmyang@xmu.edu.cn	Lei, Wei/I-3640-2014; feng, xuhui/D-9450-2017; Yang, ZM/G-4627-2010; Hu, Shijun/I-5818-2012; feng, xuhui/AAD-9832-2019; Lei, Wei/N-7611-2013; ZHANG, Zhirong/A-3422-2015	feng, xuhui/0000-0003-4649-183X; Lei, Wei/0000-0002-8342-8859; ZHANG, Zhirong/0000-0002-7331-783X; Ren, Gang/0000-0002-2555-7804; Hu, Shijun/0000-0002-0068-8429; Liu, Ji-Long/0000-0002-6948-2576	National Basic Research Program of China [2011CB944402]; Chinese National Natural Science Foundation [30770244, 30930013]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2011CB944402) and Chinese National Natural Science Foundation grants (30770244 and 30930013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bany BM, 2000, J REPROD FERTIL, V120, P125, DOI 10.1530/reprod/120.1.125; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;44::AID-DVG5&gt;3.0.CO;2-8; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Hanriot L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-418; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Hogh Annabeth Laursen, 2008, V387, P3; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; KAISER M, 1990, ENDOCRINOLOGY, V126, P2768, DOI 10.1210/endo-126-5-2768; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; Korgun ET, 2007, J MOL HISTOL, V38, P253, DOI 10.1007/s10735-007-9095-4; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Luu KC, 2004, P NATL ACAD SCI USA, V101, P8028, DOI 10.1073/pnas.0401069101; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Ma XH, 2006, J BIOL CHEM, V281, P9351, DOI 10.1074/jbc.M511512200; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MCLAREN A, 1968, J ENDOCRINOL, V42, P453, DOI 10.1677/joe.0.0420453; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Ni H, 2009, FERTIL STERIL, V91, P2123, DOI 10.1016/j.fertnstert.2008.04.053; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Reese J, 2001, J BIOL CHEM, V276, P44137, DOI 10.1074/jbc.M107563200; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Salamonsen LA, 1999, REV REPROD, V4, P11; Sharma N, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-61; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; SIMON C, 1994, ENDOCRINOLOGY, V134, P521, DOI 10.1210/en.134.2.521; Skrzypczak J, 2007, AM J REPROD IMMUNOL, V57, P40, DOI 10.1111/j.1600-0897.2006.00443.x; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tan Y, 2004, DEV BIOL, V265, P181, DOI 10.1016/j.ydbio.2003.09.019; Tranguch S, 2007, BIOL REPROD, V77, P425, DOI 10.1095/biolreprod.107.062414; Wang BQ, 2007, AM J PHYSIOL-HEART C, V293, pH1282, DOI 10.1152/ajpheart.00910.2006; Wang D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004421; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Yoshie M, 2006, MOL REPROD DEV, V73, P164, DOI 10.1002/mrd.20408; Zhao YC, 2008, ENDOCRINOLOGY, V149, P2325, DOI 10.1210/en.2007-1420; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	56	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15513	10.1371/journal.pone.0015513	http://dx.doi.org/10.1371/journal.pone.0015513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124741	Green Published, Green Submitted, gold			2022-12-25	WOS:000284686500043
J	Bisazza, A; Piffer, L; Serena, G; Agrillo, C				Bisazza, Angelo; Piffer, Laura; Serena, Giovanna; Agrillo, Christian			Ontogeny of Numerical Abilities in Fish	PLOS ONE			English	Article							ANALOG NUMBER REPRESENTATIONS; SEQUENTIALLY PRESENTED SETS; CHIMPANZEE PAN-TROGLODYTES; SMALL NUMEROSITIES; TRACKING MULTIPLE; OBJECT FILES; SHOAL SIZE; INFANTS; DISCRIMINATION; QUANTITY	Background: It has been hypothesised that human adults, infants, and non-human primates share two non-verbal systems for enumerating objects, one for representing precisely small quantities (up to 3-4 items) and one for representing approximately larger quantities. Recent studies exploiting fish's spontaneous tendency to join the larger group showed that their ability in numerical discrimination closely resembles that of primates but little is known as to whether these capacities are innate or acquired. Methodology/Principal Findings: We used the spontaneous tendency to join the larger shoal to study the limits of the quantity discrimination of newborn and juvenile guppies. One-day old fish chose the larger shoal when the choice was between numbers in the small quantity range, 2 vs. 3 fish, but not when they had to choose between large numbers, 4 vs. 8 or 4 vs. 12, although the numerical ratio was larger in the latter case. To investigate the relative role of maturation and experience in large number discrimination, fish were raised in pairs (with no numerical experience) or in large social groups and tested at three ages. Forty-day old guppies from both treatments were able to discriminate 4 vs. 8 fish while at 20 days this was only observed in fish grown in groups. Control experiments showed that these capacities were maintained after guppies were prevented from using non numerical perceptual variables that co-vary with numerosity. Conclusions/Significance: Overall, our results suggest the ability of guppies to discriminate small numbers is innate and is displayed immediately at birth while discrimination of large numbers emerges later as a result of both maturation and social experience. This developmental dissociation suggests that fish like primates might have separate systems for small and large number representation.	[Bisazza, Angelo; Piffer, Laura; Serena, Giovanna; Agrillo, Christian] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Bisazza, A (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	christian.agrillo@unipd.it		Agrillo, Christian/0000-0002-7391-8934; Bisazza, Angelo/0000-0003-0209-7638	ASAB; University of Padova to Angelo Bisazza [CPDA087853/08]	ASAB; University of Padova to Angelo Bisazza	This study was supported by an ASAB research grant to Christian Agrillo and 'Progetti di Ricerca di Ateneo', No. CPDA087853/08 from University of Padova to Angelo Bisazza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; ANTELL SE, 1983, CHILD DEV, V54, P695, DOI 10.2307/1130057; ATKINSON J, 1976, PERCEPTION, V5, P335, DOI 10.1068/p050335; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Beran MJ, 2008, AM J PRIMATOL, V70, P191, DOI 10.1002/ajp.20474; Beran MJ, 2007, J EXP PSYCHOL-ANIM B, V33, P42, DOI 10.1037/0097-7403.33.1.42; Beran MJ, 2004, PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2004.01502004.x; BIJELJACBABIC R, 1993, DEV PSYCHOL, V29, P711, DOI 10.1037/0012-1649.29.4.711; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Cantlon JF, 2010, DEVELOPMENTAL SCI, V13, P289, DOI 10.1111/j.1467-7687.2009.00887.x; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Cordes S, 2008, DEVELOPMENTAL SCI, V11, P803, DOI 10.1111/j.1467-7687.2008.00770.x; Cordes S, 2009, DEV PSYCHOL, V45, P1583, DOI 10.1037/a0015666; Cordes S, 2009, DEVELOPMENTAL SCI, V12, P453, DOI 10.1111/j.1467-7687.2008.00781.x; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; Dadda M, 2009, COGNITION, V112, P343, DOI 10.1016/j.cognition.2009.05.009; Demeyere N, 2010, NEUROCASE, V16, P219, DOI 10.1080/13554790903405719; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Flombaum JI, 2005, COGNITION, V97, P315, DOI 10.1016/j.cognition.2004.09.004; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P1, DOI 10.1007/s10071-010-0337-6; Gross HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004263; HAGER MC, 1991, BEHAV ECOL SOCIOBIOL, V29, P271, DOI 10.1007/BF00163984; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Hauser MD, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P853; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hauser MD, 2003, COGNITIVE PSYCHOL, V47, P367, DOI 10.1016/S0010-0285(03)00050-1; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Hyde DC, 2009, J COGNITIVE NEUROSCI, V21, P1039, DOI 10.1162/jocn.2009.21090; Irie-Sugimoto N, 2009, ANIM COGN, V12, P193, DOI 10.1007/s10071-008-0185-9; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Kobayashi T, 2005, DEVELOPMENTAL SCI, V8, P409, DOI 10.1111/j.1467-7687.2005.00429.x; Lewis KP, 2005, ANIM COGN, V8, P247, DOI 10.1007/s10071-004-0251-x; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Magellan K, 2009, J FISH BIOL, V74, P2329, DOI 10.1111/j.1095-8649.2009.02245.x; Matsuzawa T, 2009, CURR OPIN NEUROBIOL, V19, P92, DOI 10.1016/j.conb.2009.04.007; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Murofushi K, 1997, JPN PSYCHOL RES, V39, P140, DOI 10.1111/1468-5884.00050; OYAMA T, 1981, PERCEPT PSYCHOPHYS, V29, P106, DOI 10.3758/BF03207273; Pisa P, 2009, J ETHOL, V27, P289, DOI 10.1007/s10164-008-0121-0; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; PYLYSHYN Z, 1987, B PSYCHONOMIC SOC, V25, P332; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; Rugani R, 2008, J EXP PSYCHOL-ANIM B, V34, P388, DOI 10.1037/0097-7403.34.3.388; Rugani R, 2009, P ROY SOC B-BIOL SCI, V276, P2451, DOI 10.1098/rspb.2009.0044; Scholl BJ, 1999, COGNITIVE PSYCHOL, V38, P259, DOI 10.1006/cogp.1998.0698; Simon TJ, 1999, TRENDS COGN SCI, V3, P363, DOI 10.1016/S1364-6613(99)01383-2; Sokal R. R., 2012, BIOMETRY; Stevens JR, 2007, ANIM COGN, V10, P429, DOI 10.1007/s10071-007-0081-8; Tomonaga M, 2002, ANIM LEARN BEHAV, V30, P143, DOI 10.3758/BF03192916; TRICK LM, 1993, J EXP PSYCHOL HUMAN, V19, P331, DOI 10.1037/0096-1523.19.2.331; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Uller C, 1999, COGNITIVE DEV, V14, P1, DOI 10.1016/S0885-2014(99)80016-1; Uller C, 2003, ANIM COGN, V6, P105, DOI 10.1007/s10071-003-0167-x; Uller C, 2009, ANIM COGN, V12, P733, DOI 10.1007/s10071-009-0225-0; Van Herwegen J, 2008, DEVELOPMENTAL SCI, V11, P637, DOI 10.1111/j.1467-7687.2008.00711.x; vanMarle K, 2009, COGNITION, V111, P302, DOI 10.1016/j.cognition.2009.01.011; West RE, 2002, ANIM COGN, V5, P183, DOI 10.1007/s10071-002-0140-0; Wynn K, 1996, PSYCHOL SCI, V7, P164, DOI 10.1111/j.1467-9280.1996.tb00350.x; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Xu F, 2003, COGNITION, V89, pB15, DOI 10.1016/S0010-0277(03)00050-7; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Xu F, 2007, BRIT J DEV PSYCHOL, V25, P103, DOI 10.1348/026151005X90704	70	65	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15516	10.1371/journal.pone.0015516	http://dx.doi.org/10.1371/journal.pone.0015516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124802	Green Submitted, Green Published, gold			2022-12-25	WOS:000284572000033
J	Nelson, DE; Van der Pol, B; Dong, QF; Revanna, KV; Fan, B; Easwaran, S; Sodergren, E; Weinstock, GM; Diao, LX; Fortenberry, JD				Nelson, David E.; Van der Pol, Barbara; Dong, Qunfeng; Revanna, Kashi V.; Fan, Baochang; Easwaran, Shraddha; Sodergren, Erica; Weinstock, George M.; Diao, Lixia; Fortenberry, J. Dennis			Characteristic Male Urine Microbiomes Associate with Asymptomatic Sexually Transmitted Infection	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; TESTING 1ST-VOID URINE; LIGASE CHAIN-REACTION; CHLAMYDIA-TRACHOMATIS; NONGONOCOCCAL URETHRITIS; BACTERIAL VAGINOSIS; GUT MICROBIOME; MEN; WOMEN; COMMUNITIES	Background: The microbiome of the male urogenital tract is poorly described but it has been suggested that bacterial colonization of the male urethra might impact risk of sexually transmitted infection (STI). Previous cultivation-dependent studies showed that a variety of non-pathogenic bacteria colonize the urethra but did not thoroughly characterize these microbiomes or establish links between the compositions of urethral microbiomes and STI. Methodology/Findings: Here, we used 16S rRNA PCR and sequencing to identify bacteria in urine specimens collected from men who lacked symptoms of urethral inflammation but who differed in status for STI. All of the urine samples contained multiple bacterial genera and many contained taxa that colonize the human vagina. Uncultivated bacteria associated with female genital tract pathology were abundant in specimens from men who had STI. Conclusions: Urine microbiomes from men with STI were dominated by fastidious, anaerobic and uncultivated bacteria. The same taxa were rare in STI negative individuals. Our findings suggest that the composition of male urine microbiomes is related to STI.	[Nelson, David E.; Fan, Baochang; Easwaran, Shraddha] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Van der Pol, Barbara] Indiana Univ Sch Med, Div Infect Dis, Dept Med, Indianapolis, IN USA; [Dong, Qunfeng; Revanna, Kashi V.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Dong, Qunfeng] Univ N Texas, Dept Comp Sci & Engn, Denton, TX 76203 USA; [Sodergren, Erica; Weinstock, George M.] Washington Univ, Dept Genet, St Louis Sch Med, St Louis, MO 63110 USA; [Diao, Lixia] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Fortenberry, J. Dennis] Indiana Univ Sch Med, Sect Adolescent Med, Dept Pediat, Indiana, PA USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Saint Louis University; Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	Nelson, DE (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	nelsonde@indiana.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Van Der Pol, Barbara/0000-0003-3064-8564	National Institutes of Health [UH2KD083980, U54HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	JD Fortenberry and GM Weinstock were supported by National Institutes of Health grants UH2KD083980 and U54HG004968, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BIANCHI A, 1994, SEX TRANSM DIS, V21, P196, DOI 10.1097/00007435-199407000-00003; BOWIE WR, 1977, J CLIN INVEST, V59, P735, DOI 10.1172/JCI108694; BOWIE WR, 1977, J CLIN MICROBIOL, V6, P482; Bradshaw CS, 2006, J INFECT DIS, V193, P336, DOI 10.1086/499434; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHERNESKY MA, 1994, J CLIN MICROBIOL, V32, P2682, DOI 10.1128/JCM.32.11.2682-2685.1994; CHERNESKY MA, 1994, J INFECT DIS, V170, P1308, DOI 10.1093/infdis/170.5.1308; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Crotchfelt KA, 1997, J CLIN MICROBIOL, V35, P1536, DOI 10.1128/JCM.35.6.1536-1540.1997; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2001, CURR OPIN GASTROEN, V17, P52, DOI 10.1097/00001574-200101000-00010; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; FREUND JE, 1992, MATH STAT, P494; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; GOLDMAN RN, 1985, STAT INTRO, P72; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Ivanov Yuri Boris, 2007, Journal of Microbiology Immunology and Infection, V40, P157; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Marrazzo JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006; Mazuecos J, 1998, J EUR ACAD DERMATOL, V10, P237, DOI 10.1111/j.1468-3083.1998.tb00743.x; Ness RB, 2005, SEX TRANSM DIS, V32, P413, DOI 10.1097/01.olq.0000154493.87451.8d; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; RAVEL J, 2010, P NATL ACAD SCI US; Riemersma WA, 2003, J CLIN MICROBIOL, V41, P1977, DOI 10.1128/JCM.41.5.1977-1986.2003; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willen M, 1996, SCAND J UROL NEPHROL, V30, P387, DOI 10.3109/00365599609181315; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0	45	157	163	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14116	10.1371/journal.pone.0014116	http://dx.doi.org/10.1371/journal.pone.0014116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124791	Green Submitted, gold, Green Published			2022-12-25	WOS:000284572000014
J	Ramos, C; Rocha, S; Gaspar, C; Henrique, D				Ramos, Catarina; Rocha, Susana; Gaspar, Claudia; Henrique, Domingos			Two Notch Ligands, Dll1 and Jag1, Are Differently Restricted in Their Range of Action to Control Neurogenesis in the Mammalian Spinal Cord	PLOS ONE			English	Article							VENTRAL NEURAL-TUBE; EXPRESSION PATTERNS; LATERAL INHIBITION; NERVOUS-SYSTEM; INTERNEURONS; FRINGE; DELTA; SERRATE; DROSOPHILA; JAGGED1	Background: Notch signalling regulates neuronal differentiation in the vertebrate nervous system. In addition to a widespread function in maintaining neural progenitors, Notch signalling has also been involved in specific neuronal fate decisions. These functions are likely mediated by distinct Notch ligands, which show restricted expression patterns in the developing nervous system. Two ligands, in particular, are expressed in non-overlapping complementary domains of the embryonic spinal cord, with Jag1 being restricted to the V1 and dI6 progenitor domains, while Dll1 is expressed in the remaining domains. However, the specific contribution of different ligands to regulate neurogenesis in vertebrate embryos is still poorly understood. Methodology/Principal Findings: In this work, we investigated the role of Jag1 and Dll1 during spinal cord neurogenesis, using conditional knockout mice where the two genes are deleted in the neuroepithelium, singly or in combination. Our analysis showed that Jag1 deletion leads to a modest increase in V1 interneurons, while dI6 neurogenesis was unaltered. This mild Jag1 phenotype contrasts with the strong neurogenic phenotype detected in Dll1 mutants and led us to hypothesize that neighbouring Dll1-expressing cells signal to V1 and dI6 progenitors and restore neurogenesis in the absence of Jag1. Analysis of double Dll1;Jag1 mutant embryos revealed a stronger increase in V1-derived interneurons and overproduction of dI6 interneurons. In the presence of a functional Dll1 allele, V1 neurogenesis is restored to the levels detected in single Jag1 mutants, while dI6 neurogenesis returns to normal, thereby confirming that Dll1-mediated signalling compensates for Jag1 deletion in V1 and dI6 domains. Conclusions/Significance: Our results reveal that Dll1 and Jag1 are functionally equivalent in controlling the rate of neurogenesis within their expression domains. However, Jag1 can only activate Notch signalling within the V1 and dI6 domains, whereas Dll1 can signal to neural progenitors both inside and outside its domains of expression.	[Ramos, Catarina; Rocha, Susana; Gaspar, Claudia; Henrique, Domingos] Inst Mol Med, Fac Med Lisboa, Lisbon, Portugal	Universidade de Lisboa	Ramos, C (corresponding author), Inst Mol Med, Fac Med Lisboa, Lisbon, Portugal.	henrique@fm.ul.pt	Henrique, Domingos M/E-5460-2010; Gaspar, Claudia/I-6402-2013	Henrique, Domingos M/0000-0001-8869-1894; Gaspar, Claudia/0000-0003-1051-0998	Fundacao para a Ciencia e Tecnologia [PTDC/SAU-OBD/75106/2006]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by Fundacao para a Ciencia e Tecnologia (www.fct.mctes.pt), project PTDC/SAU-OBD/75106/2006. Catarina Ramos, Susana Rocha and Claudia Gaspar are supported with fellowships from Fundacao para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Carr PA, 1998, NEUROREPORT, V9, P2657, DOI 10.1097/00001756-199808030-00043; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Dottori M, 2001, DEVELOPMENT, V128, P4127; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; GU Y, 1995, DEVELOPMENT, V121, P855; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Liu B, 2007, DEV DYNAM, V236, P829, DOI 10.1002/dvdy.21061; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x; Marklund U, 2010, DEVELOPMENT, V137, P437, DOI 10.1242/dev.036806; Matise MP, 1997, J NEUROSCI, V17, P7805; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Morikawa Y, 2009, NEUROSCIENCE, V162, P1150, DOI 10.1016/j.neuroscience.2009.05.022; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Rocha SF, 2009, DEV BIOL, V328, P54, DOI 10.1016/j.ydbio.2009.01.011; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; VALSECCHI C, 1997, MECH DEV, V0069; Wu JY, 1999, CURR OPIN NEUROBIOL, V9, P537, DOI 10.1016/S0959-4388(99)00020-3; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Yang XD, 2006, DEV NEUROSCI-BASEL, V28, P102, DOI 10.1159/000090757; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	42	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15515	10.1371/journal.pone.0015515	http://dx.doi.org/10.1371/journal.pone.0015515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124801	Green Published, gold, Green Submitted			2022-12-25	WOS:000284572000032
J	Wickstead, B; Carrington, JT; Gluenz, E; Gull, K				Wickstead, Bill; Carrington, Jamie T.; Gluenz, Eva; Gull, Keith			The Expanded Kinesin-13 Repertoire of Trypanosomes Contains Only One Mitotic Kinesin Indicating Multiple Extra-Nuclear Roles	PLOS ONE			English	Article							CENTROMERE-ASSOCIATED KINESIN; INDUCIBLE EXPRESSION SYSTEM; CELL-CYCLE; MICROTUBULE DYNAMICS; BRUCEI; MCAK; PROTEIN; MINICHROMOSOMES; SEGREGATION; MITOSIS	Background: Kinesin-13 proteins have a critical role in animal cell mitosis, during which they regulate spindle microtubule dynamics through their depolymerisation activity. Much of what is known about Kinesin-13 function emanates from a relatively small sub-family of proteins containing MCAK and Kif2A/B. However, recent work on kinesins from the much more widely distributed, ancestral Kinesin-13 family, which includes human Kif24, have identified a second function in flagellum length regulation that may exist either alongside or instead of the mitotic role. Methodology/Principal Findings: The African trypanosome Trypanosoma brucei encodes 7 distinct Kinesin-13 proteins, allowing scope for extensive specialisation of roles. Here, we show that of all the trypanosomal Kinesin-13 proteins, only one is nuclear. This protein, TbKIN13-1, is present in the nucleoplasm throughout the cell cycle, but associates with the spindle during mitosis, which in trypanosomes is closed. TbKIN13-1 is necessary for the segregation of both large and minichromosomes in this organism and reduction in TbKIN13-1 levels mediated by RNA interference causes deflects in spindle disassembly with spindle-like structures persisting in non-mitotic cells. A second Kinesin-13 is localised to the flagellum tip, but the majority of the Kinesin-13 family members are in neither of these cellular locations. Conclusions/Significance: These data show that the expanded Kinesin-13 repertoire of trypanosomes is not associated with diversification of spindle-associated roles. TbKIN13-1 is required for correct spindle function, but the extra-nuclear localisation of the remaining paralogues suggests that the biological roles of the Kinesin-13 family is wider than previously thought.	[Wickstead, Bill; Carrington, Jamie T.; Gluenz, Eva; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Wickstead, B (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	bill.wickstead@path.ox.ac.uk		Wickstead, Bill/0000-0002-4620-9091; Carrington, Jamie/0000-0001-5437-1921; Gluenz, Eva/0000-0003-4346-8896	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2001, MOL BIOCHEM PARASIT, V113, P79, DOI 10.1016/S0166-6851(00)00388-1; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bessat M, 2009, MOL MICROBIOL, V71, P1371, DOI 10.1111/j.1365-2958.2009.06611.x; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; BRUN R, 1979, ACTA TROP, V36, P289; Buster DW, 2007, MOL BIOL CELL, V18, P3094, DOI 10.1091/mbc.E06-11-0994; Cameron LA, 2006, J CELL BIOL, V173, P173, DOI 10.1083/jcb.200601075; Cao MQ, 2009, METHOD CELL BIOL, V94, P333, DOI 10.1016/S0091-679X(08)94017-6; Chan KY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001050; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Dubessay P, 2006, MOL MICROBIOL, V59, P1162, DOI 10.1111/j.1365-2958.2005.05013.x; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Ersfeld K, 1999, PARASITOL TODAY, V15, P58, DOI 10.1016/S0169-4758(98)01378-7; Ersfeld K, 1997, SCIENCE, V276, P611, DOI 10.1126/science.276.5312.611; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gull K, 1998, TRENDS MICROBIOL, V6, P319, DOI 10.1016/S0966-842X(98)01314-6; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Jackson AP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-432; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Lu L, 2005, MOL BIOL CELL, V16, P811, DOI 10.1091/mbc.E04-05-0400; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Morfini G, 1997, J CELL BIOL, V138, P657, DOI 10.1083/jcb.138.3.657; NODA Y, 1995, J CELL BIOL, V129, P157, DOI 10.1083/jcb.129.1.157; Obado SO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r37; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Rizk RS, 2009, MOL BIOL CELL, V20, P1639, DOI 10.1091/mbc.E08-09-0985; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; SOLARI AJ, 1995, BIOCELL, V19, P65; Tikhonenko I, 2009, EUKARYOT CELL, V8, P723, DOI 10.1128/EC.00018-09; Vader G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-10; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Walczak CE, 2002, CURR BIOL, V12, P1885, DOI 10.1016/S0960-9822(02)01227-7; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wickstead B, 2003, MOL BIOCHEM PARASIT, V132, P97, DOI 10.1016/j.molbiopara.2003.08.007; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wickstead B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-110; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Wordeman L, 2005, CURR OPIN CELL BIOL, V17, P82, DOI 10.1016/j.ceb.2004.12.003; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120	69	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15020	10.1371/journal.pone.0015020	http://dx.doi.org/10.1371/journal.pone.0015020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124853	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000284527900017
J	Zimmerman, M; Yang, DF; Hu, XL; Liu, FY; Singh, N; Browning, D; Ganapathy, V; Chandler, P; Choubey, D; Abrams, SI; Liu, KB				Zimmerman, Mary; Yang, Dafeng; Hu, Xiaolin; Liu, Feiyan; Singh, Nagendra; Browning, Darren; Ganapathy, Vadivel; Chandler, Phillip; Choubey, Divaker; Abrams, Scott I.; Liu, Kebin			IFN-gamma Upregulates Survivin and Ifi202 Expression to Induce Survival and Proliferation of Tumor-Specific T Cells	PLOS ONE			English	Article							CTL ADOPTIVE IMMUNOTHERAPY; IN-VIVO PERSISTENCE; TRANSFER THERAPY; CUTTING EDGE; REPLICATIVE SENESCENCE; METASTATIC MELANOMA; NEGATIVE REGULATOR; ANTITUMOR IMMUNITY; CANCER REGRESSION; CLONAL EXPANSION	Background: A common procedure in human cytotoxic T lymphocyte (CTL) adoptive transfer immunotherapy is to expand tumor-specific CTLs ex vivo using CD3 mAb prior to transfer. One of the major obstacles of CTL adoptive immunotherapy is a lack of CTL persistence in the tumor-bearing host after transfer. The aim of this study is to elucidate the molecular mechanisms underlying the effects of stimulation conditions on proliferation and survival of tumor-specific CTLs. Methodology/Principal Findings: Tumor-specific CTLs were stimulated with either CD3 mAb or cognate Ag and analyzed for their proliferation and survival ex vivo and persistence in tumor-bearing mice. Although both Ag and CD3 mAb effectively induced the cytotoxic effecter molecules of the CTLs, we observed that Ag stimulation is essential for sustained CTL proliferation and survival. Further analysis revealed that Ag stimulation leads to greater proliferation rates and less apoptosis than CD3 mAb stimulation. Re-stimulation of the CD3 mAb-stimulated CTLs with Ag resulted in restored CTL proliferative potential, suggesting that CD3 mAb-induced loss of proliferative potential is reversible. Using DNA microarray technology, we identified that survivin and ifi202, two genes with known functions in T cell apoptosis and proliferation, are differentially induced between Ag- and CD3 mAb-stimulated CTLs. Analysis of the IFN-gamma signaling pathway activation revealed that Ag stimulation resulted in rapid phosphorylation of STAT1 (pSTAT1), whereas CD3 mAb stimulation failed to activate STAT1. Chromatin immunoprecipitation revealed that pSTAT1 is associated with the promoters of both survivin and ifi202 in T cells and electrophoresis mobility shift assay indicated that pSTAT1 directly binds to the gamma activation sequence element in the survivin and ifi202 promoters. Finally, silencing ifi202 expression significantly decreased T cell proliferation. Conclusions/Significance: Our findings delineate a new role of the IFN-gamma signaling pathway in regulating T cell proliferation and apoptosis through upregulating survivin and ifi202 expression.	[Zimmerman, Mary; Yang, Dafeng; Hu, Xiaolin; Liu, Feiyan; Singh, Nagendra; Browning, Darren; Ganapathy, Vadivel; Liu, Kebin] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA; [Chandler, Phillip] Georgia Hlth Sci Univ, Med Coll Georgia, Immunotherapy Ctr, Augusta, GA USA; [Choubey, Divaker] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Abrams, Scott I.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Ohio; University of Cincinnati; Roswell Park Cancer Institute	Zimmerman, M (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA.	Kliu@mcg.edu	Choubey, Divaker/A-4771-2008	Browning, Darren/0000-0003-0497-7620; Liu, Kebin/0000-0003-1965-7240	National Institutes of Health [CA133085]; American Cancer Society [RSG-09-209-01-TBG]; NATIONAL CANCER INSTITUTE [R01CA133085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (CA133085 to K.L.) and the American Cancer Society (RSG-09-209-01-TBG to K.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Caldwell SA, 2003, J IMMUNOL, V171, P2402, DOI 10.4049/jimmunol.171.5.2402; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Chen JM, 2008, IMMUNOL LETT, V118, P13, DOI 10.1016/j.imlet.2008.02.005; CHOUBEY D, 1993, J INTERFERON RES, V13, P43, DOI 10.1089/jir.1993.13.43; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; D'Souza S, 2001, J BIOL CHEM, V276, P298, DOI 10.1074/jbc.M007155200; Deeths MJ, 1999, J IMMUNOL, V163, P102; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Driessens G, 2009, IMMUNOL REV, V229, P126, DOI 10.1111/j.1600-065X.2009.00771.x; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Effros RB, 1997, IMMUNOL TODAY, V18, P450, DOI 10.1016/S0167-5699(97)01079-7; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Fallarino F, 1999, J IMMUNOL, V163, P4109; Fauce SR, 2008, J IMMUNOL, V181, P7400, DOI 10.4049/jimmunol.181.10.7400; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; June CH, 2009, NAT REV IMMUNOL, V9, P704, DOI 10.1038/nri2635; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Kobayashi Y, 2002, HUM IMMUNOL, V63, P101, DOI 10.1016/S0198-8859(01)00369-X; Kornacker M, 2001, IMMUNOL LETT, V76, P169, DOI 10.1016/S0165-2478(01)00186-9; Koul D, 1998, BIOCHEM BIOPH RES CO, V247, P379, DOI 10.1006/bbrc.1998.8804; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Leen AM, 2007, ANNU REV IMMUNOL, V25, P243, DOI 10.1146/annurev.immunol.25.022106.141527; Liu KB, 2006, J IMMUNOL, V176, P3374, DOI 10.4049/jimmunol.176.6.3374; McGough JM, 2008, MOL CANCER RES, V6, P1841, DOI 10.1158/1541-7786.MCR-08-0280; Mescher MF, 2007, SEMIN CANCER BIOL, V17, P299, DOI 10.1016/j.semcancer.2007.06.008; MUKHERJI B, 1989, J EXP MED, V169, P1961, DOI 10.1084/jem.169.6.1961; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Parry RV, 2003, J IMMUNOL, V171, P166, DOI 10.4049/jimmunol.171.1.166; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Rolle CE, 2008, CANCER RES, V68, P2984, DOI 10.1158/0008-5472.CAN-07-3040; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Ryan MH, 2001, J IMMUNOL, V167, P4286, DOI 10.4049/jimmunol.167.8.4286; Schumacher TNM, 2009, CURR OPIN IMMUNOL, V21, P187, DOI 10.1016/j.coi.2009.03.006; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shen XL, 2007, J IMMUNOTHER, V30, P123, DOI 10.1097/01.cji.0000211321.07654.b8; Song JX, 2008, CELL MOL IMMUNOL, V5, P239, DOI 10.1038/cmi.2008.30; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Strater J, 2005, GUT, V54, P661, DOI 10.1136/gut.2004.052696; Veeranki S, 2010, IMMUNOL LETT, V133, P1, DOI 10.1016/j.imlet.2010.06.008; WESSELBORG S, 1993, J IMMUNOL, V150, P4338; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; Winter H, 2001, J IMMUNOL, V166, P7370, DOI 10.4049/jimmunol.166.12.7370; Wrzesinski C, 2010, J IMMUNOTHER, V33, P1, DOI 10.1097/CJI.0b013e3181b88ffc; Xin H, 2003, ONCOGENE, V22, P4775, DOI 10.1038/sj.onc.1206780; Xin H, 2006, J IMMUNOL, V176, P5863, DOI 10.4049/jimmunol.176.10.5863; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Yang DF, 2008, INT J CANCER, V122, P350, DOI 10.1002/ijc.23090; Yang D, 2007, CLIN CANCER RES, V13, P5202, DOI 10.1158/1078-0432.CCR-07-1161; Yang DF, 2007, CANCER RES, V67, P3301, DOI 10.1158/0008-5472.CAN-06-4068; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zhao BH, 2009, J IMMUNOL, V182, P6744, DOI 10.4049/jimmunol.0804387; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046	60	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14076	10.1371/journal.pone.0014076	http://dx.doi.org/10.1371/journal.pone.0014076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124930	Green Submitted, Green Published, gold			2022-12-25	WOS:000284467200010
J	Sudo, Y; Ihara, K; Kobayashi, S; Suzuki, D; Irieda, H; Kikukawa, T; Kandori, H; Homma, M				Sudo, Yuki; Ihara, Kunio; Kobayashi, Shiori; Suzuki, Daisuke; Irieda, Hiroki; Kikukawa, Takashi; Kandori, Hideki; Homma, Michio			A Microbial Rhodopsin with a Unique Retinal Composition Shows Both Sensory Rhodopsin II and Bacteriorhodopsin-like Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHARAONIS PHOBORHODOPSIN; STRUCTURAL-CHANGES; PROTON PUMP; HALOBACTERIAL TRANSDUCER; PRIMARY PHOTOPRODUCT; STERIC CONSTRAINT; SIGNAL TRANSFER; PROTEIN; MECHANISM; BINDING	Rhodopsins possess retinal chromophore surrounded by seven transmembrane alpha-helices, are widespread in prokaryotes and in eukaryotes, and can be utilized as optogenetic tools. Although rhodopsins work as distinctly different photo-receptors in various organisms, they can be roughly divided according to their two basic functions, light-energy conversion and light-signal transduction. In microbes, light-driven proton transporters functioning as light-energy converters have been modified by evolution to produce sensory receptors that relay signals to transducer proteins to control motility. In this study, we cloned and characterized two newly identified microbial rhodopsins from Haloquadratum walsbyi. One of them has photochemical properties and a proton pumping activity similar to the well known proton pump bacteriorhodopsin (BR). The other, named middle rhodopsin (MR), is evolutionarily transitional between BR and the phototactic sensory rhodopsin II (SRII), having an SRII-like absorption maximum, a BR-like photocycle, and a unique retinal composition. The wild-type MR does not have a light-induced proton pumping activity. On the other hand, a mutant MR with two key hydrogen-bonding residues located at the interaction surface with the transducer protein HtrII shows robust phototaxis responses similar to SRII, indicating that MR is potentially capable of the signaling. These results demonstrate that color tuning and insertion of the critical threonine residue occurred early in the evolution of sensory rhodopsins. MR may be a missing link in the evolution from type 1 rhodopsins (microorganisms) to type 2 rhodopsins (animals), because it is the first microbial rhodopsin known to have 11-cis-retinal similar to type 2 rhodopsins.	[Sudo, Yuki; Kobayashi, Shiori; Suzuki, Daisuke; Irieda, Hiroki; Homma, Michio] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Sudo, Yuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Kikukawa, Takashi] Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; [Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan	Nagoya University; Japan Science & Technology Agency (JST); Nagoya University; Hokkaido University; Nagoya Institute of Technology	Sudo, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan.	z47867a@cc.nagoya-u.ac.jp	IHARA, Kunio/D-1952-2011; Sudo, Yuki/AGY-0493-2022; Kikukawa, Takashi/F-5266-2011; Irieda, Hiroki/N-8455-2015	Sudo, Yuki/0000-0001-8155-9356; Kikukawa, Takashi/0000-0002-6185-7281; Irieda, Hiroki/0000-0002-4545-9187	Ministry of Education, Culture, Sports, Science and Technology of Japan [477]; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [20108001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research (KAKENHI) on a priority area (area 477) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to Y. S., H. K., and M. H.).	Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; BOGOMOLNI RA, 1994, P NATL ACAD SCI USA, V91, P10188, DOI 10.1073/pnas.91.21.10188; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Brown LS, 2004, PHOTOCH PHOTOBIO SCI, V3, P555, DOI 10.1039/b315527g; Costanzi S, 2009, CURR PHARM DESIGN, V15, P3994, DOI 10.2174/138161209789824795; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Furutani Y, 2008, PHOTOCHEM PHOTOBIOL, V84, P874, DOI 10.1111/j.1751-1097.2008.00317.x; Furutani Y, 2006, BIOCHEMISTRY-US, V45, P11836, DOI 10.1021/bi0610597; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; HOFRICHTER J, 1989, BIOPHYS J, V56, P693, DOI 10.1016/S0006-3495(89)82716-X; Ito M, 2008, BIOCHEMISTRY-US, V47, P6208, DOI 10.1021/bi8003507; Jung KH, 2007, PHOTOCHEM PHOTOBIOL, V83, P63, DOI 10.1562/2006-03-20-IR-853; Kawanabe A, 2009, J AM CHEM SOC, V131, P16439, DOI 10.1021/ja904855g; Kitajima-Ihara T, 2008, J BIOL CHEM, V283, P23533, DOI 10.1074/jbc.M802990200; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MAEDA A, 1978, J BIOCHEM, V83, P661, DOI 10.1093/oxfordjournals.jbchem.a131957; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Mathias G, 2007, P NATL ACAD SCI USA, V104, P6980, DOI 10.1073/pnas.0609229104; Mizuide N, 2006, BIOCHEMISTRY-US, V45, P10674, DOI 10.1021/bi060958s; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Ruiz-Gonzalez MX, 2004, J MOL EVOL, V58, P348, DOI 10.1007/s00239-003-2557-8; Sasaki J, 1999, BIOPHYS J, V77, P2145, DOI 10.1016/S0006-3495(99)77055-4; Sasaki J, 2008, PHOTOCHEM PHOTOBIOL, V84, P863, DOI 10.1111/j.1751-1097.2008.00314.x; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036; Sharma AK, 2008, ENVIRON MICROBIOL, V10, P1039, DOI 10.1111/j.1462-2920.2007.01525.x; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; Spudich JL, 1996, CURR OPIN CELL BIOL, V8, P452, DOI 10.1016/S0955-0674(96)80020-2; SPUDICH JL, 1988, ANNU REV BIOPHYS BIO, V17, P193; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Spudich JL, 1995, ISR J CHEM, V35, P495; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Sudo Y, 2006, J MOL BIOL, V357, P1274, DOI 10.1016/j.jmb.2006.01.061; Sudo Y, 2005, J AM CHEM SOC, V127, P16036, DOI 10.1021/ja056203a; Sudo Y, 2003, BIOCHEMISTRY-US, V42, P14166, DOI 10.1021/bi035678g; Sudo Y, 2001, BIOPHYS J, V80, P916, DOI 10.1016/S0006-3495(01)76070-5; Sudo Y, 2008, BIOCHEMISTRY-US, V47, P2866, DOI 10.1021/bi701885k; Sudo Y, 2007, J BIOL CHEM, V282, P15550, DOI 10.1074/jbc.M701271200; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2006, J BIOL CHEM, V281, P34239, DOI 10.1074/jbc.M605907200; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P10136, DOI 10.1021/bi901338d; Suzuki D, 2010, SENSORS-BASEL, V10, P4010, DOI 10.3390/s100404010; Suzuki D, 2009, J MOL BIOL, V392, P48, DOI 10.1016/j.jmb.2009.06.050; Walter JM, 2010, CURR OPIN BIOTECH, V21, P265, DOI 10.1016/j.copbio.2010.03.007; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Yagasaki J, 2010, BIOCHEMISTRY-US, V49, P1183, DOI 10.1021/bi901824a; YAN B, 1991, BIOCHEMISTRY-US, V30, P10686, DOI 10.1021/bi00108a012; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	57	52	56	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5967	5976		10.1074/jbc.M110.190058	http://dx.doi.org/10.1074/jbc.M110.190058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135094	Green Published, hybrid			2022-12-25	WOS:000287476400004
J	Sato, T; Kudo, T; Ikehara, Y; Ogawa, H; Hirano, T; Kiyohara, K; Hagiwara, K; Togayachi, A; Ema, M; Takahashi, S; Kimata, K; Watanabe, H; Narimatsu, H				Sato, Takashi; Kudo, Takashi; Ikehara, Yuzuru; Ogawa, Hiroyasu; Hirano, Tomoko; Kiyohara, Katsue; Hagiwara, Kozue; Togayachi, Akira; Ema, Masatsugu; Takahashi, Satoru; Kimata, Koji; Watanabe, Hideto; Narimatsu, Hisashi			Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 Is Necessary for Normal Endochondral Ossification and Aggrecan Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA-SUPERFAMILY; MOLECULAR-CLONING; GLUCURONIC-ACID; IN-VIVO; CARTILAGE; MICE; GENE; ELONGATION; INITIATION; DELETION	Chondroitin sulfate (CS) is a glycosaminoglycan, consisting of repeating disaccharide units of N-acetylgalactosamine and glucuronic acid residues, and plays important roles in development and homeostasis of organs and tissues. Here, we generated and analyzed mice lacking chondroitin sulfate N-acetylgalactosaminyltransferase 1 (CSGalNAcT-1). Csgalnact1(-/-) mice were viable and fertile but exhibited slight dwarfism. Biochemically, the level of CS in Csgalnact1(-/-) cartilage was reduced to similar to 50% that of wild-type cartilage, whereas its chain length was similar to wild-type mice, indicating that CSGalNAcT-1 participates in the CS chain initiation as suggested in the previous study (Sakai, K., Kimata, K., Sato, T., Gotoh, M., Narimatsu, H., Shinomiya, K., and Watanabe, H. (2007) J. Biol. Chem. 282, 4152-4161). Histologically, the growth plate of Csgalnact1(-/-) mice contained shorter and slightly disorganized chondrocyte columns with a reduced volume of the extracellular matrix principally in the proliferative layer. Immunohistochemical analysis revealed that the level of both aggrecan and link protein 1 were decreased in Csgalnact1(-/-) cartilage. Western blot analysis demonstrated an increase in processed forms of aggrecan core protein. These results suggest that CSGalNAcT-1 is required for normal levels of CS biosynthesis in cartilage. Our observations suggest that CSGalNAcT-1 is necessary for normal levels of endochondral ossification, and the decrease in CS amount in the growth plate by its absence causes a rapid catabolism of aggrecan.	[Sato, Takashi; Ikehara, Yuzuru; Hirano, Tomoko; Kiyohara, Katsue; Togayachi, Akira; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Open Space Lab, Tsukuba, Ibaraki 3058568, Japan; [Kudo, Takashi; Hagiwara, Kozue; Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Life Syst Med Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; [Ogawa, Hiroyasu; Kimata, Koji; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan; [Ogawa, Hiroyasu] Gifu Univ, Grad Sch Med, Dept Orthopaed Surg, Gifu 5011194, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Aichi Medical University; Gifu University	Narimatsu, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Open Space Lab, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	h.narimatsu@aist.go.jp	Ikehara, yuzuru/L-7696-2018; Narimatsu, Hisashi/M-4757-2018; Sato, Takashi/M-2577-2018; Togayachi, Akira/M-4144-2018; Ikehara, yuzuru/R-2239-2019; Sato, Masa/P-6487-2019	Ikehara, yuzuru/0000-0002-1915-9172; Narimatsu, Hisashi/0000-0002-8402-133X; Sato, Takashi/0000-0002-9973-8923; Togayachi, Akira/0000-0003-3600-9149; Ikehara, yuzuru/0000-0002-1915-9172; Ema, Masatsugu/0000-0003-0645-6183; Kudo, Takashi/0000-0001-5477-7235; Watanabe, Hideto/0000-0001-5291-0696; Ogawa, Hiroyasu/0000-0002-4737-6481	New Energy and Industrial Technology Development Organization	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was performed as a part of the Medical Glycomics Project supported by the New Energy and Industrial Technology Development Organization. This work was supported in part by grants-in-aid for scientific research (B) (to H.W.) and grants-in-aid for priority areas (to H.W.).	AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gotoh M, 2002, J BIOL CHEM, V277, P38189, DOI 10.1074/jbc.M203619200; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; HASCALL VC, 1982, METHOD ENZYMOL, V82, P769; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Ishii M, 2008, J BIOL CHEM, V283, P32610, DOI 10.1074/jbc.M806331200; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; NIWA H, 1993, J BIOCHEM-TOKYO, V113, P343, DOI 10.1093/oxfordjournals.jbchem.a124049; Oshita H, 2004, BIOCHEM J, V382, P253, DOI 10.1042/BJ20040113; Pratta MA, 2000, J BIOL CHEM, V275, P39096, DOI 10.1074/jbc.M006201200; Sakai K, 2007, J BIOL CHEM, V282, P4152, DOI 10.1074/jbc.M606870200; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Tanimoto Y, 2008, COMPARATIVE MED, V58, P347; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; Watanabe H, 1998, J BIOCHEM, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200	36	53	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5803	5812		10.1074/jbc.M110.159244	http://dx.doi.org/10.1074/jbc.M110.159244			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148564	Green Published, hybrid			2022-12-25	WOS:000287230600089
J	Neess, D; Bloksgaard, M; Bek, S; Marcher, AB; Elle, IC; Helledie, T; Due, M; Pagmantidis, V; Finsen, B; Wilbertz, J; Kruhoffer, M; Faergeman, N; Mandrup, S				Neess, Ditte; Bloksgaard, Maria; Bek, Signe; Marcher, Ann-Britt; Elle, Ida C.; Helledie, Torben; Due, Marianne; Pagmantidis, Vasileios; Finsen, Bente; Wilbertz, Johannes; Kruhoffer, Mogens; Faergeman, Nils; Mandrup, Susanne			Disruption of the Acyl-CoA-binding Protein Gene Delays Hepatic Adaptation to Metabolic Changes at Weaning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; FATTY-ACID-METABOLISM; TRANSCRIPTIONAL ACTIVITY; DOWN-REGULATION; LIGAND-BINDING; CHOLESTEROL; ACBP; EXPRESSION; LIVER; COENZYME	The acyl-CoA-binding protein (ACBP)/diazepam binding inhibitor is an intracellular protein that binds C-14-C-22 acyl-CoA esters and is thought to act as an acyl-CoA transporter. In vitro analyses have indicated that ACBP can transport acyl-CoA esters between different enzymatic systems; however, little is known about the in vivo function in mammalian cells. We have generated mice with targeted disruption of ACBP (ACBP(-/-)). These mice are viable and fertile and develop normally. However, around weaning, the ACBP(-/-) mice go through a crisis with overall weakness and a slightly decreased growth rate. Using microarray analysis, we show that the liver of ACBP(-/-) mice displays a significantly delayed adaptation to weaning with late induction of target genes of the sterol regulatory element-binding protein (SREBP) family. As a result, hepatic de novo cholesterogenesis is decreased at weaning. The delayed induction of SREBP target genes around weaning is caused by a compromised processing and decreased expression of SREBP precursors, leading to reduced binding of SREBP to target sites in chromatin. In conclusion, lack of ACBP interferes with the normal metabolic adaptation to weaning and leads to delayed induction of the lipogenic gene program in the liver.	[Pagmantidis, Vasileios; Faergeman, Nils; Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Finsen, Bente] Univ So Denmark, Inst Mol Med, DK-5230 Odense M, Denmark; [Wilbertz, Johannes] Karolinska Inst, Karolinska Ctr Transgene Technol, S-17177 Stockholm, Sweden; [Kruhoffer, Mogens] AROS Appl Biotechnol AS, DK-8200 Aarhus N, Denmark	University of Southern Denmark; University of Southern Denmark; Karolinska Institutet	Mandrup, S (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.	s.mandrup@bmb.sdu.dk	Mandrup, Susanne/B-6693-2008	Bloksgaard, Maria/0000-0002-4474-9553; Faergeman, Nils/0000-0002-9281-5287; Finsen, Bente/0000-0002-8323-9329; Mandrup, Susanne/0000-0002-0961-5787; Marcher, Ann-Britt/0000-0002-4799-8870	Danish Natural Science Research Council; Lundbeck Foundation; Novo Nordisk Foundation; Novo Scholarship Program; Lundbeck Foundation [R7-2006-648] Funding Source: researchfish	Danish Natural Science Research Council(Danish Natural Science Research Council); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Scholarship Program; Lundbeck Foundation(Lundbeckfonden)	This project was supported by the Danish Natural Science Research Council, the Lundbeck Foundation, the Novo Nordisk Foundation, and the Novo Scholarship Program.	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; BHUIYAN J, 1995, METABOLISM, V44, P1185, DOI 10.1016/0026-0495(95)90013-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobard A, 2005, J BIOL CHEM, V280, P199, DOI 10.1074/jbc.M406522200; Botolin D, 2003, J BIOL CHEM, V278, P6959, DOI 10.1074/jbc.M212846200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Burton M, 2005, BIOCHEM J, V392, P299, DOI 10.1042/BJ20050664; Chao H, 2003, J LIPID RES, V44, P72, DOI 10.1194/jlr.M200191-JLR200; Chao H, 2002, BIOCHEMISTRY-US, V41, P10540, DOI 10.1021/bi0259498; COLE TG, 1982, J LIPID RES, V23, P81; Densupsoontorn N, 2007, LIPIDS, V42, P885, DOI 10.1007/s11745-007-3093-x; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Elholm M, 2000, J LIPID RES, V41, P538; Faergeman NJ, 2007, MOL CELL BIOCHEM, V299, P55, DOI 10.1007/s11010-005-9040-3; Faergeman NJ, 2004, BIOCHEM J, V380, P907, DOI 10.1042/BJ20031949; Faergeman NJ, 2002, BIOCHEM J, V368, P679, DOI 10.1042/BJ20021413; Faergeman NJ, 1996, BIOCHEMISTRY-US, V35, P14118, DOI 10.1021/bi960545z; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE179, DOI 10.1152/ajpendo.00282.2007; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; FYRST H, 1995, BIOCHEM J, V306, P793, DOI 10.1042/bj3060793; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Gossett RE, 1998, ARCH BIOCHEM BIOPHYS, V350, P201, DOI 10.1006/abbi.1997.0521; HANSEN HO, 1991, BIOCHEM J, V277, P341, DOI 10.1042/bj2770341; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Helledie T, 2000, J LIPID RES, V41, P1740; Helledie T, 2002, J BIOL CHEM, V277, P26821, DOI 10.1074/jbc.M111295200; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang H, 2005, BIOCHEMISTRY-US, V44, P10282, DOI 10.1021/bi0477891; Just M, 2006, BBA-MOL BASIS DIS, V1762, P666, DOI 10.1016/j.bbadis.2006.05.005; Kannan L, 2003, BBA-MOL CELL BIOL L, V1631, P12, DOI 10.1016/S1388-1981(02)00367-0; KNUDSEN J, 1994, BIOCHEM J, V302, P479, DOI 10.1042/bj3020479; KRAGELUND BB, 1993, J MOL BIOL, V230, P1260, DOI 10.1006/jmbi.1993.1240; Landrock D, 2010, LIPIDS, V45, P567, DOI 10.1007/s11745-010-3437-9; Lee L, 2007, J INVEST DERMATOL, V127, P16, DOI 10.1038/sj.jid.5700511; Lee PCW, 2007, J LIPID RES, V48, P1944, DOI 10.1194/jlr.M700225-JLR200; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; Loomis WF, 2010, J BIOL CHEM, V285, P21359, DOI 10.1074/jbc.M110.105858; Mandrup S, 1998, J BIOL CHEM, V273, P23897, DOI 10.1074/jbc.273.37.23897; MANDRUP S, 1992, J MOL BIOL, V228, P1011, DOI 10.1016/0022-2836(92)90888-Q; MANDRUP S, 1993, BIOCHEM J, V290, P369, DOI 10.1042/bj2900369; MANDRUP S, 1993, MOL CELL BIOCHEM, V123, P55, DOI 10.1007/BF01076475; MENDOZAFIGUEROA T, 1988, TOXICOLOGY, V52, P273, DOI 10.1016/0300-483X(88)90132-1; MIKKELSEN J, 1987, BIOCHEM J, V248, P709, DOI 10.1042/bj2480709; MOGENSEN IB, 1987, BIOCHEM J, V241, P189, DOI 10.1042/bj2410189; Neess D, 2006, MOL CELL BIOCHEM, V284, P149, DOI 10.1007/s11010-005-9039-9; Nielsen R, 2006, MOL CELL BIOL, V26, P5698, DOI 10.1128/MCB.02266-05; Oikari S, 2008, PFLUG ARCH EUR J PHY, V456, P369, DOI 10.1007/s00424-007-0416-y; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; RASMUSSEN JT, 1994, BIOCHEM J, V299, P165, DOI 10.1042/bj2990165; RASMUSSEN JT, 1993, BIOCHEM J, V292, P907, DOI 10.1042/bj2920907; RASMUSSEN JT, 1990, BIOCHEM J, V265, P849, DOI 10.1042/bj2650849; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Sandberg MB, 2005, J BIOL CHEM, V280, P5258, DOI 10.1074/jbc.M407515200; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Snyder MJ, 1997, CELL TISSUE RES, V288, P177, DOI 10.1007/s004410050804; Snyder MJ, 1998, CELL TISSUE RES, V294, P161, DOI 10.1007/s004410051166; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Vock C, 2010, CELL PHYSIOL BIOCHEM, V25, P675, DOI 10.1159/000315087; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200; Yang YY, 2001, LIPIDS, V36, P595, DOI 10.1007/s11745-001-0762-0	74	47	48	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3460	3472		10.1074/jbc.M110.161109	http://dx.doi.org/10.1074/jbc.M110.161109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106527	Green Published, hybrid			2022-12-25	WOS:000286653200032
J	Billam, P; Bonaparte, KL; Liu, J; Ruckwardt, TJ; Chen, M; Ryder, AB; Wang, R; Dash, P; Thomas, PG; Graham, BS				Billam, Padma; Bonaparte, Kathryn L.; Liu, Jie; Ruckwardt, Tracy J.; Chen, Man; Ryder, Alex B.; Wang, Rui; Dash, Pradyot; Thomas, Paul G.; Graham, Barney S.			T Cell Receptor Clonotype Influences Epitope Hierarchy in the CD8+T Cell Response to Respiratory Syncytial Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REPERTOIRE SELECTION; STRUCTURAL BASIS; V-BETA; IMMUNODOMINANCE; VACCINE; COMPLEX; MICE; IMMUNOGENETICS; DIVERSITY	CD8+ T cell responses are important for recognizing and resolving viral infections. To better understand the selection and hierarchy of virus-specific T cell responses, we compared the T cell receptor (TCR) clonotype in parent and hybrid strains of respiratory syncytial virus-infected mice. K(d)M2(82-90) (SYIGSINNI) in BALB/c and (DM187-195)-M-b (NAITNAKII) in C57B1/6 are both dominant epitopes in parent strains but assume a distinct hierarchy, with K(d)M2(82-90) dominant to (DM187-195)-M-b in hybrid CB6F1/J mice. The dominant K(d)M2(82-90) response is relatively public and is restricted primarily to the highly prevalent V beta 13.2 in BALB/c and hybrid mice, whereas (DM187-195)-M-b responses in C57BL/6 mice are relatively private and involve multiple V beta subtypes, some of which are lost in hybrids. A significant frequency of TCR CDR3 sequences in the (DM187-195)-M-b response have a distinct "(D/E) WG" motif formed by a limited number of recombination strategies. Modeling of the dominant epitope suggested a flat, featureless structure, but (DM187-195)-M-b showed a distinctive structure formed by Lys(7). The data suggest that common recombination events in prevalent V beta genes may provide a numerical advantage in the T cell response and that distinct epitope structures may impose more limited options for successful TCR selection. Defining how epitope structure is interpreted to inform T cell function will improve the design of future gene-based vaccines.	[Billam, Padma; Bonaparte, Kathryn L.; Liu, Jie; Ruckwardt, Tracy J.; Chen, Man; Ryder, Alex B.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Wang, Rui] NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Dash, Pradyot; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); St Jude Children's Research Hospital	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bldg 40,Rm 2502,40 Convent Dr,MSC 3017, Bethesda, MD 20892 USA.	bgraham@nih.gov	Thomas, Paul G./H-1063-2018; Graham, Barney S./AAC-5898-2019	Thomas, Paul G./0000-0001-7955-0256; Graham, Barney S./0000-0001-8112-0853; Dash, Pradyot/0000-0001-5467-0657	National Institutes of Health NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI077714, ZIAAI005027] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health NIAID Intramural Program.	Andreansky SS, 2005, J VIROL, V79, P4329, DOI 10.1128/JVI.79.7.4329-4339.2005; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Brandenburg AH, 2001, VACCINE, V19, P2769, DOI 10.1016/S0264-410X(00)00536-3; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; Chen WS, 2002, J VIROL, V76, P10332, DOI 10.1128/JVI.76.20.10332-10337.2002; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Cohen GB, 2002, VIROLOGY, V304, P474, DOI 10.1006/viro.2002.1743; Collins PL, 2002, VIROLOGY, V296, P204, DOI 10.1006/viro.2002.1437; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crotzer VL, 2000, J IMMUNOL, V164, P6120, DOI 10.4049/jimmunol.164.12.6120; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Driver L C, 1999, Pediatr Nurs, V25, P527; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Gavin MA, 1995, IMMUNITY, V3, P793, DOI 10.1016/1074-7613(95)90068-3; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; GOVERMAN J, 1985, CELL, V40, P859, DOI 10.1016/0092-8674(85)90345-9; GOVERMAN J, 1986, CELL, V45, P475, DOI 10.1016/0092-8674(86)90279-5; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hussell T, 1998, J IMMUNOL, V161, P6215; Jagannathan P, 2009, J VIROL, V83, P2728, DOI 10.1128/JVI.02128-08; Kedzierska K, 2008, MOL IMMUNOL, V45, P607, DOI 10.1016/j.molimm.2006.05.017; Kedzierska K, 2008, P NATL ACAD SCI USA, V105, P19408, DOI 10.1073/pnas.0810274105; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Koelle DM, 2003, P NATL ACAD SCI USA, V100, P12899, DOI 10.1073/pnas.2131705100; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; Lefranc Marie-Paule, 2003, Novartis Found Symp, V254, P126; Lefranc Marie-Paule, 2007, V409, P19, DOI 10.1007/978-1-60327-118-9_2; Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; Liu J, 2010, J VIROL, V84, P10501, DOI 10.1128/JVI.00963-10; LOMBARDI V, 1992, AIDS RES HUM RETROV, V8, P1081, DOI 10.1089/aid.1992.8.1081; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Munks MW, 2007, J IMMUNOL, V178, P7235, DOI 10.4049/jimmunol.178.11.7235; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; Openshaw PJM, 2001, VACCINE, V20, pS27, DOI 10.1016/S0264-410X(01)00301-2; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Peebles RS, 2003, VIRAL IMMUNOL, V16, P25, DOI 10.1089/088282403763635429; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ruckwardt TJ, 2010, J IMMUNOL, V185, P4673, DOI 10.4049/jimmunol.1001606; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Ruiz M, 2000, NUCLEIC ACIDS RES, V28, P219, DOI 10.1093/nar/28.1.219; Rutigliano JA, 2007, VIROLOGY, V362, P314, DOI 10.1016/j.virol.2006.12.023; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Stark JM, 2002, J MED VIROL, V67, P92, DOI 10.1002/jmv.2196; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Varga SM, 2002, VIROLOGY, V295, P203, DOI 10.1006/viro.2002.1382; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Venturi V, 2006, P NATL ACAD SCI USA, V103, P18691, DOI 10.1073/pnas.0608907103; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Yang OO, 2003, J IMMUNOL, V171, P3718, DOI 10.4049/jimmunol.171.7.3718; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6	73	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4829	4841		10.1074/jbc.M110.191437	http://dx.doi.org/10.1074/jbc.M110.191437			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21118816	Green Published, hybrid			2022-12-25	WOS:000286975700080
J	Carley, AN; Kleinfeld, AM				Carley, Andrew N.; Kleinfeld, Alan M.			Fatty Acid (FFA) Transport in Cardiomyocytes Revealed by Imaging Unbound FFA Is Mediated by an FFA Pump Modulated by the CD36 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CARDIAC MYOCYTES; MEMBRANE-TRANSPORT; SKELETAL-MUSCLE; PALMITATE UPTAKE; PLASMA-MEMBRANE; BINDING-PROTEIN; HEART MYOCYTES; OLEATE UPTAKE; METABOLISM; ADIPOCYTES	Free fatty acid (FFA) transport across the cardiomyocyte plasma membrane is essential to proper cardiac function, but the role of membrane proteins and FFA metabolism in FFA transport remains unclear. Metabolism is thought to maintain intracellular FFA at low levels, providing the driving force for FFA transport, but intracellular FFA levels have not been measured directly. We report the first measurements of the intracellular unbound FFA concentrations (FFA(i)) in cardiomyocytes. The fluorescent indicator of FFA, ADIFAB (acrylodan-labeled rat intestinal fatty acid-binding protein), was microinjected into isolated cardiomyocytes from wild type (WT) and FAT/CD36 null C57B1/6 mice. Quantitative imaging of ADIFAB fluorescence revealed the time courses of FFA influx and efflux. For WT mice, rate constants for efflux (similar to 0.02 s(-1)) were twice influx, and steady state FFA(i) were more than 3-fold larger than extracellular unbound FFA (FFA(o)). The concentration gradient and the initial rate of FFA influx saturated with increasing FFA(o). Similar characteristics were observed for oleate, palmitate, and arachidonate. FAT/CD36 null cells revealed similar characteristics, except that efflux was 2-3-fold slower than WT cells. Rate constants determined with intracellular ADIFAB were confirmed by measurements of intracellular pH. FFA uptake by suspensions of cardiomyocytes determined by monitoring FFA(o) using extracellular ADIFAB confirmed the influx rate constants determined from FFA(i) measurements and demonstrated that rates of FFA transport and etomoxir-sensitive metabolism are regulated independently. We conclude that FFA influx in cardiac myocytes is mediated by a membrane pump whose transport rate constants may be modulated by FAT/CD36.	[Carley, Andrew N.; Kleinfeld, Alan M.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA	Torrey Pines Institute for Molecular Studies, California	Kleinfeld, AM (corresponding author), Torrey Pines Inst Mol Studies, 3550 Gen Atom Court, San Diego, CA 92121 USA.	akleinfeld@tpims.org	Carley, Andrew/U-6218-2019	Carley, Andrew/0000-0002-4348-2770	National Institutes of Health (NIDDK) [DK058762]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058762] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK058762 (NIDDK).; Supported by a postdoctoral fellowship from the American Heart Association.	ANEL A, 1993, BIOCHEMISTRY-US, V32, P530, DOI 10.1021/bi00053a018; Apple F.S., 2004, CLIN PROTEOMICS, V1, P41, DOI [10.1385/CP:1:1:041, DOI 10.1385/CP:1:1:041]; Augustus AS, 2006, J BIOL CHEM, V281, P8716, DOI 10.1074/jbc.M509890200; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15; Brinkmann JFF, 2002, BIOCHEM J, V367, P561, DOI 10.1042/BJ20020747; Cantor WJ, 2008, J INVASIVE CARDIOL, V20, P186; Carley AN, 2004, AM J PHYSIOL-ENDOC M, V286, pE449, DOI 10.1152/ajpendo.00329.2003; Carley AN, 2009, BIOCHEMISTRY-US, V48, P10437, DOI 10.1021/bi901318a; Caserta F, 2001, AM J PHYSIOL-ENDOC M, V280, pE238, DOI 10.1152/ajpendo.2001.280.2.E238; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Cupp D, 2004, BIOCHEMISTRY-US, V43, P4473, DOI 10.1021/bi036335l; DEGRELLA RF, 1980, J BIOL CHEM, V255, P9731; Demant EJF, 2002, BIOCHEM J, V363, P809, DOI 10.1042/0264-6021:3630809; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; FORSDAHL K, 1995, J MOL CELL CARDIOL, V27, P893, DOI 10.1016/0022-2828(95)90039-X; Greenwood AI, 2006, CHEM PHYS LIPIDS, V143, P1, DOI 10.1016/j.chemphyslip.2006.04.002; Hamilton JA, 2007, PROSTAG LEUKOTR ESS, V77, P355, DOI 10.1016/j.plefa.2007.10.020; Huber AH, 2006, BIOCHEMISTRY-US, V45, P14263, DOI 10.1021/bi060703e; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Kampf JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1207, DOI 10.1152/ajpendo.00259.2007; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Kampf JP, 2006, J BIOL CHEM, V281, P21566, DOI 10.1074/jbc.M602067200; Kampf JP, 2004, J BIOL CHEM, V279, P35775, DOI 10.1074/jbc.M403630200; Kleinfeld AM, 2004, J AM SOC MASS SPECTR, V15, P1572, DOI 10.1016/j.jasms.2004.07.010; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; LORUSSO SM, 1992, CELL MOTIL CYTOSKEL, V21, P111, DOI 10.1002/cm.970210204; Luiken JJFP, 1997, J LIPID RES, V38, P745; Luiken JJFP, 2001, AM J PHYSIOL-ENDOC M, V281, pE704, DOI 10.1152/ajpendo.2001.281.4.E704; Luiken JJFP, 1999, J LIPID RES, V40, P1007; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; RICHIERI GV, 1992, J BIOL CHEM, V267, P23495; Richieri GV, 1999, MOL CELL BIOCHEM, V192, P87, DOI 10.1023/A:1006878421990; Sandoval A, 2008, ARCH BIOCHEM BIOPHYS, V477, P363, DOI 10.1016/j.abb.2008.06.010; Satoh H, 1996, BIOPHYS J, V70, pTUP57; SERAYDAR.MW, 1969, BIOCHIM BIOPHYS ACTA, V180, P264, DOI 10.1016/0005-2728(69)90113-3; SORRENTINO D, 1988, J CLIN INVEST, V82, P928, DOI 10.1172/JCI113700; SORRENTINO D, 1989, J CLIN INVEST, V84, P1325, DOI 10.1172/JCI114301; STREMMEL W, 1988, J CLIN INVEST, V81, P844, DOI 10.1172/JCI113393; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Tatsumi T, 2003, CARDIOVASC RES, V59, P428, DOI 10.1016/S0008-6363(03)00391-2; Turcotte LP, 2000, MOL CELL BIOCHEM, V210, P53, DOI 10.1023/A:1007046929776; VANDERVUSSE GJ, 1995, J APPL PHYSIOL, V78, P1839, DOI 10.1152/jappl.1995.78.5.1839; VANDERVUSSE GJ, 1983, BIOCHIM BIOPHYS ACTA, V752, P361, DOI 10.1016/0005-2760(83)90266-7; Wu ML, 2000, CIRC RES, V86, pE55	45	32	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4589	4597		10.1074/jbc.M110.182162	http://dx.doi.org/10.1074/jbc.M110.182162			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21147770	Green Published, hybrid			2022-12-25	WOS:000286975700059
J	Ciampa, EJ; Welch, RC; Vanoye, CG; George, AL				Ciampa, Erin J.; Welch, Richard C.; Vanoye, Carlos G.; George, Alfred L., Jr.			KCNE4 Juxtamembrane Region Is Required for Interaction with Calmodulin and for Functional Suppression of KCNQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; KS POTASSIUM CHANNEL; PATCH-CLAMP TECHNIQUES; LONG-QT-SYNDROME; I-KS; ATRIAL-FIBRILLATION; K+ CHANNELS; MEMBRANE PATCHES; CELLS; MODULATION	Voltage-gated potassium (K-v) channels, such as KCNQ1 (K(v)7.1), are modulated by accessory subunits and regulated by intracellular second messengers. Accessory subunits belonging to the KCNE family exert diverse functional effects on KCNQ1, have been implicated in the pathogenesis of various genetic disorders of heart rhythm, and contribute to transducing intracellular signaling events into changes in K-v channel activity. We investigated the interactions between calmodulin (CaM), the ubiquitous Ca2+-transducing protein that binds and confers Ca2+ sensitivity to the biophysical properties of KCNQ1, and KCNE4. These studies were motivated by the observed similarities between the suppression of KCNQ1 function by pharmacological disruption of KCNQ1-CaM interactions and the effects of KCNE4 co-expression on the channel. We determined that KCNE4, but not KCNE1, can biochemically interact with CaM and that this interaction is Ca2+-dependent and requires a tetraleucine motif in the juxtamembrane region of the KCNE4 C terminus. Furthermore, disruption of the KCNE4-CaM interaction either by mutagenesis of the tetraleucine motif or by acute Ca2+ chelation impairs the ability of KCNE4 to inhibit KCNQ1. Our findings have potential relevance to KCNQ1 regulation both by KCNE accessory subunits and by an important intracellular signaling molecule.	[Welch, Richard C.; Vanoye, Carlos G.; George, Alfred L., Jr.] Vanderbilt Univ, Div Med Genet, Dept Med, Nashville, TN 37232 USA; [Ciampa, Erin J.; George, Alfred L., Jr.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	George, AL (corresponding author), Vanderbilt Univ, Div Med Genet, Dept Med, 529 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	al.george@vanderbilt.edu		Ciampa, Erin/0000-0002-6153-1994	National Institutes of Health [HL077188]; NIGMS [T32 GM07347]; American Heart Association [09PRE2220323]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077188 (to A. L. G.) and USPHS Award T32 GM07347 from the NIGMS (to Vanderbilt Medical-Scientist Training Program). This work was also supported by American Heart Association Predoctoral Research Fellowship 09PRE2220323 (to E. J. C.).	Abbott GW, 2002, FASEB J, V16, DOI 10.1096/fj.01-0520hyp; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Boucherot A, 2001, J MEMBRANE BIOL, V182, P39, DOI 10.1007/s00232-001-0030-4; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Haitin Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001935; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; Kerst G, 2001, PFLUG ARCH EUR J PHY, V443, P146, DOI 10.1007/s004240100632; Kurokawa J, 2003, P NATL ACAD SCI USA, V100, P2122, DOI 10.1073/pnas.0434935100; Kurokawa J, 2009, CHANNELS, V3, P16, DOI 10.4161/chan.3.1.7387; Li HB, 2004, FEBS LETT, V559, P175, DOI 10.1016/S0014-5793(04)00067-5; Li HB, 2002, BIOCHEM J, V362, P499, DOI 10.1042/bj3620499; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Lundby A, 2008, CELL PHYSIOL BIOCHEM, V21, P47, DOI 10.1159/000113746; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Ma KJ, 2007, CHINESE MED J-PEKING, V120, P150, DOI 10.1097/00029330-200701020-00017; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; Manderfield LJ, 2009, J PHYSIOL-LONDON, V587, P303, DOI 10.1113/jphysiol.2008.161281; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Melman YF, 2002, J BIOL CHEM, V277, P25187, DOI 10.1074/jbc.M200564200; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Ravn LS, 2008, HEART RHYTHM, V5, P427, DOI 10.1016/j.hrthm.2007.12.019; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sah R, 2001, J PHYSIOL-LONDON, V533, P201, DOI 10.1111/j.1469-7793.2001.0201b.x; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Shen ZJ, 1998, HEARING RES, V123, P157, DOI 10.1016/S0378-5955(98)00110-5; Terrenoire C, 2009, J BIOL CHEM, V284, P9140, DOI 10.1074/jbc.M805366200; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; Vanoye CG, 2009, J GEN PHYSIOL, V134, P207, DOI 10.1085/jgp.200910234; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; Zhu MM, 2003, BIOCHEMISTRY-US, V42, P15388, DOI 10.1021/bi035188o	38	24	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4141	4149		10.1074/jbc.M110.158865	http://dx.doi.org/10.1074/jbc.M110.158865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21118809	Green Published, hybrid			2022-12-25	WOS:000286975700013
J	Tian, HB; Lu, Y; Shah, SP; Hong, S				Tian, Haibin; Lu, Yan; Shah, Shraddha P.; Hong, Song			14S,21R-Dihydroxydocosahexaenoic Acid Remedies Impaired Healing and Mesenchymal Stem Cell Functions in Diabetic Wounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; INCREASED ANGIOGENESIS; GROWTH-FACTORS; CDNA CLONING; EXPRESSION; BRAIN; 12R-LIPOXYGENASE; LIPOXYGENASE; REPAIR; MICE	Treatment of diabetes-impaired wound healing remains a major unresolved medical challenge. Here, we identified suppressed formation of a novel reparative lipid mediator 14S,21R-dihydroxydocosa-4Z,7Z,10Z,12E,16Z,19Z-hexaenoic acid (14S,21R-diHDHA) in cutaneous wounds of diabetic db/db mice. These results indicate that diabetes impedes the biosynthetic pathways of 14S,21R-diHDHA in skin wounds. Administration of exogenous 14S,21R-diHDHA to wounds in diabetic animals rescued healing and angiogenesis. When db/db mesenchymal stem cells (MSCs) were administered together with 14S,21R-diHDHA to wounds in diabetic animals, they coacted to accelerate wound re-epithelialization, granulation tissue formation, and synergistically improved vascularization. In the pivotal cellular processes of angiogenesis, 14S,21R-diHDHA enhanced VEGF release, vasculature formation, and migration of db/db dermal microvascular endothelial cells (DMVECs), as well as remedied paracrine angiogenic functions of db/db MSCs, including VEGF secretion and the promotion of DMVEC migration and vasculature formation. Our results show that 14S,21R-diHDHA activates the p38 MAPK pathway in wounds, db/db MSCs, and DMVECs. Overall, the impeded formation of 14S,21R-diHDHA described in this study suggests that diabetes could affect the generation of pro-healing lipid mediators in wound healing. By restoring wound healing and MSC functions, 14S,21R-diHDHA is a new lead for the development of better therapeutics used in treating wounds of diabetics.	[Tian, Haibin; Lu, Yan; Shah, Shraddha P.; Hong, Song] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci Excellence, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Hong, S (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci Excellence, Lions Bldg,2020 Gravier St,Ste D, New Orleans, LA 70112 USA.	shong@lsuhsc.edu			National Institutes of Health [1R01DK087800]; Neuroscience Center of Excellence, LSUHSC-NO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Center of Excellence, LSUHSC-NO; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant 1R01DK087800 (to S. H.) and by the Start-up Fund from the Neuroscience Center of Excellence, LSUHSC-NO (to S. H.).	Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617; Basselin M, 2010, J LIPID RES, V51, P1049, DOI 10.1194/jlr.M002469; Bazan Nicolas G., 2008, P349; Boeglin WE, 1998, P NATL ACAD SCI USA, V95, P6744, DOI 10.1073/pnas.95.12.6744; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; Broughton G, 2006, PLAST RECONSTR SURG, V117, p6S, DOI 10.1097/01.prs.0000225429.76355.dd; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cha ST, 2005, MICROVASC RES, V70, P198, DOI 10.1016/j.mvr.2005.08.002; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; CHEN XS, 1994, J BIOL CHEM, V269, P13979; ColvilleNash PR, 1997, MOL MED TODAY, V3, P14, DOI 10.1016/S1357-4310(96)10048-4; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Ding YX, 2000, AM J PHYSIOL-ENDOC M, V279, pE11, DOI 10.1152/ajpendo.2000.279.1.E11; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Furstenberger G, 2007, PROSTAG OTH LIPID M, V82, P128, DOI 10.1016/j.prostaglandins.2006.05.006; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Gronert K, 1999, METH MOL B, V120, P119; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Han XL, 2007, CURR OPIN MOL THER, V9, P586; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Huang Q, 2008, AM J PHYSIOL-CELL PH, V295, pC1647, DOI 10.1152/ajpcell.00322.2008; Javazon EH, 2007, WOUND REPAIR REGEN, V15, P350, DOI 10.1111/j.1524-475X.2007.00237.x; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnson EN, 1999, J INVEST DERMATOL, V112, P861, DOI 10.1046/j.1523-1747.1999.00595.x; Kampfer H, 2005, DIABETES, V54, P1543, DOI 10.2337/diabetes.54.5.1543; Kapoor M, 2006, CURR OPIN INVEST DR, V7, P418; KIM HY, 1990, PROSTAG OTH LIPID M, V40, P473, DOI 10.1016/0090-6980(90)90110-H; Kim IS, 2009, TISSUE ENG PT A, V15, P2411, DOI 10.1089/ten.tea.2008.0554; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Krieg P, 1998, BBA-LIPID LIPID MET, V1391, P7, DOI 10.1016/S0005-2760(97)00214-2; Kwon DS, 2008, INT WOUND J, V5, P453, DOI 10.1111/j.1742-481X.2007.00408.x; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Lin CD, 2008, PLAST RECONSTR SURG, V122, P1341, DOI 10.1097/PRS.0b013e318188217b; Liu JW, 2007, J THROMB HAEMOST, V5, P826, DOI 10.1111/j.1538-7836.2007.02381.x; Lu Y, 2010, J LIPID RES, V51, P923, DOI 10.1194/jlr.M000059; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; MARCUS AJ, 1984, P NATL ACAD SCI-BIOL, V81, P903, DOI 10.1073/pnas.81.3.903; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Mezentsev A, 2002, J BIOL CHEM, V277, P18670, DOI 10.1074/jbc.M201143200; Montori VM, 2000, DIABETES CARE, V23, P1407, DOI 10.2337/diacare.23.9.1407; Moran JL, 2007, J INVEST DERMATOL, V127, P1893, DOI 10.1038/sj.jid.5700825; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; Schneider C, 2007, METHOD ENZYMOL, V433, P145, DOI 10.1016/S0076-6879(07)33008-5; SCHWENK U, 1992, J BIOL CHEM, V267, P12482; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2000, J EXP MED, V192, pF5, DOI 10.1084/jem.192.3.F5; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Shingel KI, 2008, J TISSUE ENG REGEN M, V2, P383, DOI 10.1002/term.101; Siebert M, 2001, BIOCHEM J, V355, P97, DOI 10.1042/0264-6021:3550097; STEFFENRUD S, 1987, BIOMED ENVIRON MASS, V14, P313, DOI 10.1002/bms.1200140704; Stepanovic V, 2003, CIRC RES, V92, P1247, DOI 10.1161/01.RES.0000074906.98021.55; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Swanson HI, 2004, CHEM-BIOL INTERACT, V149, P69, DOI 10.1016/j.cbi.2004.08.006; Velazquez OC, 2007, J VASC SURG, V45, p39A, DOI 10.1016/j.jvs.2007.02.068; Wang XL, 2006, STEM CELLS, V24, P482, DOI 10.1634/stemcells.2005-0219; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yang PY, 2006, PROSTAG LEUKOTR ESS, V75, P385, DOI 10.1016/j.plefa.2006.07.015; Yu ZY, 2006, ARCH BIOCHEM BIOPHYS, V455, P188, DOI 10.1016/j.abb.2006.09.002	68	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4443	4453		10.1074/jbc.M110.100388	http://dx.doi.org/10.1074/jbc.M110.100388			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21112969	Green Published, hybrid			2022-12-25	WOS:000286975700044
J	Vasanth, S; ZeRuth, G; Kang, HS; Jetten, AM				Vasanth, Shivakumar; ZeRuth, Gary; Kang, Hong Soon; Jetten, Anton M.			Identification of Nuclear Localization, DNA Binding, and Transactivating Mechanisms of Kruppel-like Zinc Finger Protein Gli-Similar 2 (Glis2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL DIABETES-MELLITUS; TRANSCRIPTION; REPRESSOR; ROLES; DIFFERENTIATION; EXPRESSION; APOPTOSIS; SEQUENCES; FIBROSIS; DISEASE	Gli-similar 1-3 (Glis1-3) constitute a subfamily of Kruppel-like zinc finger (ZF) transcription factors that are closely related to the Gli protein family. Mutations in GLIS2 are linked to nephronophthisis, a chronic kidney disease characterized by renal fibrosis and atrophy in children and young adults. Currently, very little information exists about the mechanism of action of Glis2, its target genes, or the signaling pathways that regulate its activity. In this study, we show that a region within ZF3 is required for the nuclear localization of Glis2. Analysis of Glis2 DNA binding demonstrated that Glis2 binds effectively to the consensus Glis binding sequence (GlisBS) (G/C)TGGGGGGT(A/C). Although Glis2 was unable to induce transactivation of a GlisBS-dependent reporter, it effectively inhibited the GlisBS-mediated transactivation by Gli1. Mutations that disrupt the tetrahedral configuration of each ZF within Glis2 abolished Glis2 binding to GlisBS and also abrogated its inhibition of Gli1-mediated transactivation. In contrast, Glis2 was able to activate the murine insulin-2 (Ins2) promoter by binding directly to two GlisBS elements located at -263 and -99 within the Ins2 promoter. Phosphomimetic mutation of Ser(245) inhibited the binding of Glis2 to GlisBS and dramatically affected its transactivation of the Ins2 promoter and its ability to inhibit GlisBS-dependent transactivation by Gli1. In this study, we demonstrate that Glis2 can function as a transcriptional activator and that post-translational modification within its DNA-binding domain can regulate its transcriptional activity. This control may play a critical role in the Glis2-dependent regulation of target genes and renal function.	[Vasanth, Shivakumar; ZeRuth, Gary; Kang, Hong Soon; Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, Lab Resp Biol,NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jetten, AM (corresponding author), POB 12233,Mail Drop D2-01, Res Triangle Pk, NC 27709 USA.	jetten@niehs.nih.gov	Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445	National Institutes of Health of the NIEHS [Z01-ES-100485]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100485] Funding Source: NIH RePORTER	National Institutes of Health of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIEHS (Z01-ES-100485).	Ardura JA, 2010, J AM SOC NEPHROL, V21, P237, DOI 10.1681/ASN.2009050462; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Beak JY, 2008, NUCLEIC ACIDS RES, V36, P1690, DOI 10.1093/nar/gkn009; Beak JY, 2007, J BONE MINER RES, V22, P1234, DOI 10.1359/JBMR.070503; Bedard JEJ, 2007, HUM MOL GENET, V16, P187, DOI 10.1093/hmg/ddl461; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481, DOI 10.14670/HH-25.1481; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kim SC, 2005, NUCLEIC ACIDS RES, V33, P6805, DOI 10.1093/nar/gki985; Kim YS, 2008, MOL CELL BIOL, V28, P2358, DOI 10.1128/MCB.01722-07; Kim YS, 2007, FEBS LETT, V581, P858, DOI 10.1016/j.febslet.2007.01.058; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kramarenko II, 2010, MOL PHARMACOL, V78, P126, DOI 10.1124/mol.110.064840; Lamar E, 2001, DEVELOPMENT, V128, P1335; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Merzdorf CS, 2007, DEV DYNAM, V236, P922, DOI 10.1002/dvdy.21098; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; VORTKAMP A, 1995, DNA CELL BIOL, V14, P629, DOI 10.1089/dna.1995.14.629; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200	29	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4749	4759		10.1074/jbc.M110.165951	http://dx.doi.org/10.1074/jbc.M110.165951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127075	Green Published, hybrid			2022-12-25	WOS:000286975700073
J	Chen, FW; Li, CL; Ioannou, YA				Chen, Fannie W.; Li, Chunlei; Ioannou, Yiannis A.			Cyclodextrin Induces Calcium-Dependent Lysosomal Exocytosis	PLOS ONE			English	Article							CHOLESTEROL DEPLETION; GAMMA-CYCLODEXTRINS; ALPHA-CYCLODEXTRINS; BETA-CYCLODEXTRINS; CELL-SURFACE; RELEASE; MODEL; TRANSPORT; DISEASE; PROTEIN	Cyclodextrins (CDs) have long been used to manipulate cellular cholesterol levels both in vitro and in vivo, but their direct effects at a cellular level are not well characterized. Recently, CDs have garnered much interest because of their ability to clear stored cholesterol from Niemann Pick Type C (NPC) cells and markedly prolong the life of NPC1 disease mice. Here, we investigate the hypothesis that treatment with 2-hydroxypropyl- beta-cyclodextrin (HPB-CD) stimulates lysosomal exocytosis in a calcium-enhanced manner. We propose that this exocytosis is the mechanism by which HPB-CD ameliorates the endolysosomal cholesterol storage phenotype in NPC cells. These findings have significant implications for the use of HPB-CD in biochemical assays and data interpretation as well as for their use for the treatment for NPC and other disorders.	[Chen, Fannie W.; Li, Chunlei; Ioannou, Yiannis A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai	Chen, FW (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA.	Yiannis.Ioannou@mssm.edu			National Institutes of Health [DK082712]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK082712 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGLEY D, 2010, CYCLODEXTRIN BLOOD B; Blanc L, 2009, BLOOD, V114, P3928, DOI 10.1182/blood-2009-06-230086; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Christian AE, 1997, J LIPID RES, V38, P2264; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Dedkova E N, 2000, Membr Cell Biol, V13, P357; Giocondi MC, 2004, BIOPHYS J, V86, P861, DOI 10.1016/S0006-3495(04)74161-2; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Jaiswal JK, 2004, PLOS BIOL, V2, P1224, DOI 10.1371/journal.pbio.0020233; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Laulagnier K, 2004, FEBS LETT, V572, P11, DOI 10.1016/j.febslet.2004.06.082; LENCER WI, 1990, AM J PHYSIOL, V258, pC309, DOI 10.1152/ajpcell.1990.258.2.C309; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; MARCUS AD, 2009, WALL STREET J, pA13; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; McNeil PL, 2002, J CELL SCI, V115, P873; Monnaert V, 2004, J PHARMACOL EXP THER, V310, P745, DOI 10.1124/jpet.104.067512; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Taylor AR, 2007, DEV NEUROBIOL, V67, P1815, DOI 10.1002/dneu.20559; WANG MS, 2009, BIOCH BIOPHYS RES CO; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200	37	85	88	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15054	10.1371/journal.pone.0015054	http://dx.doi.org/10.1371/journal.pone.0015054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124786	Green Published, Green Submitted, gold			2022-12-25	WOS:000284686500026
J	Xiao, JH; Wang, NX; Li, YW; Murphy, RW; Wan, DG; Niu, LM; Hu, HY; Fu, YG; Huang, DW				Xiao, Jin-Hua; Wang, Ning-Xin; Li, Yan-Wei; Murphy, Robert W.; Wan, Dong-Guang; Niu, Li-Ming; Hu, Hao-Yuan; Fu, Yue-Guan; Huang, Da-Wei			Molecular Approaches to Identify Cryptic Species and Polymorphic Species within a Complex Community of Fig Wasps	PLOS ONE			English	Article							WOLBACHIA INFECTION; MITOCHONDRIAL GENE; POLLINATING WASPS; EVOLUTION; DNA; PHYLOGENIES; DIMORPHISM; DIVERSITY; PRECISION; SEQUENCES	Cryptic and polymorphic species can complicate traditional taxonomic research and both of these concerns are common in fig wasp communities. Species identification is very difficult, despite great effort and the ecological importance of fig wasps. Herein, we try to identify all chalcidoid wasp species hosted by one species of fig, using both morphological and molecular methods. We compare the efficiency of four different DNA regions and find that ITS2 is highly effective for species identification, while mitochondrial COI and Cytb regions appear less reliable, possibly due to the interference signals from either nuclear copies of mtDNA, i.e. NUMTs, or the effects of Wolbachia infections. The analyses suggest that combining multiple markers is the best choice for inferring species identifications as any one marker may be unsuitable in a given case.	[Xiao, Jin-Hua; Niu, Li-Ming; Hu, Hao-Yuan; Huang, Da-Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Wang, Ning-Xin; Li, Yan-Wei; Wan, Dong-Guang; Huang, Da-Wei] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Fu, Yue-Guan] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Danzhou, Hainan, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Shandong Agricultural University; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum; Chinese Academy of Tropical Agricultural Sciences	Xiao, JH (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	huangdw@ioz.ac.cn	Murphy, Robert W/D-8586-2011; li, yan/GTI-4638-2022	Murphy, Robert/0000-0001-8555-2338	National Natural Science Foundation of China (NSFC) [30900137, 30770302]; Chinese Academy of Sciences [KSCX2-YW-N-0807]; Ministry of Science and Technology of the People's Republic of China [2006FY110500]; National Science Fund for Fostering Talents in Basic Research [NSFC-J0930004]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science Fund for Fostering Talents in Basic Research	This project was supported by the National Natural Science Foundation of China (NSFC grant no. 30900137, 30770302), partially by Major Innovation Program of Chinese Academy of Sciences (KSCX2-YW-N-0807), Program of Ministry of Science and Technology of the People's Republic of China (2006FY110500), and by National Science Fund for Fostering Talents in Basic Research (Special Subjects in Animal Taxonomy, NSFC-J0930004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCTANDER P, 1995, P ROY SOC B-BIOL SCI, V262, P13, DOI 10.1098/rspb.1995.0170; Ballard JWO, 2000, J MOL EVOL, V51, P64, DOI 10.1007/s002390010067; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Chen LL, 2010, INSECT SCI, V17, P101, DOI 10.1111/j.1744-7917.2009.01291.x; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Cook JM, 2006, ANIM BEHAV, V71, P1095, DOI 10.1016/j.anbehav.2005.07.027; Danforth BN, 1998, MOL BIOL EVOL, V15, P225, DOI 10.1093/oxfordjournals.molbev.a025920; FRANK SA, 1987, TRENDS ECOL EVOL, V2, P259, DOI 10.1016/0169-5347(87)90029-2; GOLDMAN N, 1993, J MOL EVOL, V36, P182, DOI 10.1007/BF00166252; Haine ER, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-83; Haine ER, 2005, P ROY SOC B-BIOL SCI, V272, P421, DOI 10.1098/rspb.2004.2956; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herre EA, 1996, J BIOGEOGR, V23, P521, DOI 10.1111/j.1365-2699.1996.tb00014.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUELSENBECK JP, 2001, SYSTEMATIC BIOL, V50; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jiang ZF, 2006, MOL PHYLOGENET EVOL, V38, P306, DOI 10.1016/j.ympev.2005.11.008; Jousselin E, 2006, J EVOLUTION BIOL, V19, P253, DOI 10.1111/j.1420-9101.2005.00968.x; Kerdelhue C, 1999, MOL PHYLOGENET EVOL, V11, P401, DOI 10.1006/mpev.1998.0590; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leigh EG, 2007, J EVOLUTION BIOL, V20, P2075, DOI 10.1111/j.1420-9101.2007.01410.x; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Machado CA, 1996, J BIOGEOGR, V23, P531, DOI 10.1111/j.1365-2699.1996.tb00015.x; Machado CA, 2001, P ROY SOC B-BIOL SCI, V268, P685, DOI 10.1098/rspb.2000.1418; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; PAMILO P, 2007, MOL BIOL EVOLUTION; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rasplus JY, 1998, CR ACAD SCI III-VIE, V321, P517, DOI 10.1016/S0764-4469(98)80784-1; ROFF DA, 1986, EVOLUTION, V40, P1009, DOI 10.1111/j.1558-5646.1986.tb00568.x; Shoemaker DD, 2004, GENETICS, V168, P2049, DOI 10.1534/genetics.104.030890; Shuker DM, 2004, P NATL ACAD SCI USA, V101, P10363, DOI 10.1073/pnas.0308034101; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Weiblen GD, 2002, MOL ECOL, V11, P1573, DOI 10.1046/j.1365-294X.2002.01529.x; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WEIBLEN GD, 2001, SYSTEMATIC BIOL, V50; White T., 1990, PCR PROTOCOLS GUIDE, P315; Winker K, 2005, AUK, V122, P706, DOI 10.1642/0004-8038(2005)122[0706:SSWFRB]2.0.CO;2	38	31	37	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15067	10.1371/journal.pone.0015067	http://dx.doi.org/10.1371/journal.pone.0015067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124735	gold, Green Submitted, Green Published			2022-12-25	WOS:000284686500032
J	Matsuda, D; Mauro, VP				Matsuda, Daiki; Mauro, Vincent P.			Determinants of Initiation Codon Selection during Translation in Mammalian Cells	PLOS ONE			English	Article							MESSENGER-RNA DECAY; SHINE-DALGARNO SEQUENCE; RIBOSOME ENTRY SITE; LOCKED NUCLEIC-ACID; EUKARYOTIC RIBOSOMES; SECONDARY STRUCTURE; ESCHERICHIA-COLI; GENE-EXPRESSION; VIRUS-RNA; IN-VIVO	Factors affecting translation of mRNA contribute to the complexity of eukaryotic proteomes. In some cases, translation of a particular mRNA can generate multiple proteins. However, the factors that determine whether ribosomes initiate translation from the first AUG codon in the transcript, from a downstream codon, or from multiple sites are not completely understood. Various mRNA properties, including AUG codon-accessibility and 5' leader length have been proposed as potential determinants that affect where ribosomes initiate translation. To explore this issue, we performed studies using synthetic mRNAs with two in-frame AUG codons-both in excellent context. Open reading frames initiating at AUG1 and AUG2 encode large and small isoforms of a reporter protein, respectively. Translation of such an mRNA in COS-7 cells was shown to be 5' cap-dependent and to occur efficiently from both AUG codons. AUG codon-accessibility was modified by using two different elements: an antisense locked nucleic acid oligonucleotide and an exon-junction complex. When either element was used to mask AUG1, the ratio of the proteins synthesized changed, favoring the smaller (AUG2-initiated) protein. In addition, we observed that increased leader length by itself changed the ratio of the proteins and favored initiation at AUG1. These observations demonstrate that initiation codon selection is affected by various factors, including AUG codon-accessibility and 5' leader length, and is not necessarily determined by the order of AUG codons (5'-> 3'). The modulation of AUG codon accessibility may provide a powerful means of translation regulation in eukaryotic cells.	[Matsuda, Daiki] Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute	Matsuda, D (corresponding author), Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA.	vmauro@scripps.edu			National Institutes of Health [GM078071]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health Grant GM078071 and from the Skaggs Institute for Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry KE, 2010, RNA, V16, P1559, DOI 10.1261/rna.2197210; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P18077, DOI 10.1073/pnas.0608212103; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Gallie DR, 2000, NUCLEIC ACIDS RES, V28, P2943, DOI 10.1093/nar/28.15.2943; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Gu S, 2008, MOL PHARMACOL, V73, P1, DOI 10.1124/mol.107.036285; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JACKSON RJ, 1996, TRANSLATIONAL CONTRO, P71; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jin HN, 2006, MOL MICROBIOL, V60, P480, DOI 10.1111/j.1365-2958.2006.05110.x; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; KAMINSKI A, 1994, EMBO J, V13, P1673, DOI 10.1002/j.1460-2075.1994.tb06431.x; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; KOCH T, 2007, LOCKED NUCL ACID ANT, P519; Kochetov AV, 2006, MOL BIOL+, V40, P705, DOI 10.1134/S0026893306050049; Koh DC, 2009, RNA BIOL, V6, P54, DOI 10.4161/rna.6.1.7567; KOZAK M, 1991, GENE EXPRESSION, V1, P111; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Matsuda D, 2004, J VIROL, V78, P9325, DOI 10.1128/JVI.78.17.9325-9335.2004; Matsuda D, 2006, RNA, V12, P1338, DOI 10.1261/rna.67906; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Panopoulos P, 2008, J BIOL CHEM, V283, P33087, DOI 10.1074/jbc.M804904200; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pisarev AV, 2005, CR BIOL, V328, P589, DOI 10.1016/j.crvi.2005.02.004; Preiss T, 1998, NATURE, V392, P516, DOI 10.1038/33192; REDDY VB, 1978, NUCLEIC ACIDS RES, V5, P4195, DOI 10.1093/nar/5.11.4195; Rogers GW, 2004, P NATL ACAD SCI USA, V101, P2794, DOI 10.1073/pnas.0308576101; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Starck SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003460; Stockklausner C, 2006, NUCLEIC ACIDS RES, V34, P2355, DOI 10.1093/nar/gkl277; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wengel J, 1999, ACCOUNTS CHEM RES, V32, P301, DOI 10.1021/ar980051p; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826	46	12	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15057	10.1371/journal.pone.0015057	http://dx.doi.org/10.1371/journal.pone.0015057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124832	gold, Green Published, Green Submitted			2022-12-25	WOS:000284572000024
J	Priyadharshini, B; Welsh, RM; Greiner, DL; Gerstein, RM; Brehm, MA				Priyadharshini, Bhavana; Welsh, Raymond M.; Greiner, Dale L.; Gerstein, Rachel M.; Brehm, Michael A.			Maturation-Dependent Licensing of Naive T Cells for Rapid TNF Production	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RECENT THYMIC EMIGRANTS; FACTOR-ALPHA; CUTTING EDGE; IN-VIVO; PERIPHERAL-BLOOD; FACTOR RECEPTORS; VIRAL-INFECTION; DENDRITIC CELLS; TRANSGENIC MICE	The peripheral naive T cell pool is comprised of a heterogeneous population of cells at various stages of development, which is a process that begins in the thymus and is completed after a post-thymic maturation phase in the periphery. One hallmark of naive T cells in secondary lymphoid organs is their unique ability to produce TNF rapidly after activation and prior to acquiring other effector functions. To determine how maturation influences the licensing of naive T cells to produce TNF, we compared cytokine profiles of CD4(+) and CD8(+) single positive (SP) thymocytes, recent thymic emigrants (RTEs) and mature-naive (MN) T cells during TCR activation. SP thymocytes exhibited a poor ability to produce TNF when compared to splenic T cells despite expressing similar TCR levels and possessing comparable activation kinetics (upregulation of CD25 and CD69). Provision of optimal antigen presenting cells from the spleen did not fully enable SP thymocytes to produce TNF, suggesting an intrinsic defect in their ability to produce TNF efficiently. Using a thymocyte adoptive transfer model, we demonstrate that the ability of T cells to produce TNF increases progressively with time in the periphery as a function of their maturation state. RTEs that were identified in NG-BAC transgenic mice by the expression of GFP showed a significantly enhanced ability to express TNF relative to SP thymocytes but not to the extent of fully MN T cells. Together, these findings suggest that TNF expression by naive T cells is regulated via a gradual licensing process that requires functional maturation in peripheral lymphoid organs.	[Priyadharshini, Bhavana; Welsh, Raymond M.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Priyadharshini, Bhavana; Welsh, Raymond M.; Greiner, Dale L.; Gerstein, Rachel M.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Program Immunol & Virol, Worcester, MA 01605 USA; [Greiner, Dale L.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Greiner, Dale L.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA 01605 USA; [Gerstein, Rachel M.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Priyadharshini, B (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	michael.brehm@umassmed.edu		Brehm, Michael/0000-0001-6813-3262	National Institutes of Health [AI017672, AI081675, AI46629, AI43534, AI083911]; institutional Center for AIDS Research (CFAR) [AI042845]; Juvenile Diabetes Research Foundation; UMASS Diabetes Endocrinology Research Center (DERC) [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845, R01AI043534, R01AI017672, R21AI083911, R01AI081675, P01AI046629, R56AI043534, R37AI017672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); institutional Center for AIDS Research (CFAR); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); UMASS Diabetes Endocrinology Research Center (DERC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grants AI017672 and AI081675 to R. M. W., AI46629 to D. L. G., AI43534 to R. M. G., AI083911 to M. A. B., and an institutional Center for AIDS Research (CFAR) grant AI042845 and grants from the Juvenile Diabetes Research Foundation. R. M. W., D. L. G. and R. M. G. are members of the UMASS Diabetes Endocrinology Research Center (DERC) grant DK32520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Baseta JG, 2000, J IMMUNOL, V165, P5621, DOI 10.4049/jimmunol.165.10.5621; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; Berzins SP, 2002, TRENDS MOL MED, V8, P469, DOI 10.1016/S1471-4914(02)02415-2; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Brehm MA, 2005, J IMMUNOL, V175, P5043, DOI 10.4049/jimmunol.175.8.5043; Brehm MA, 2007, BLOOD, V109, P819, DOI 10.1182/blood-2006-03-008219; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Chen WF, 2004, CELL MOL IMMUNOL, V1, P3; Clark J, 2005, ANN RHEUM DIS, V64, P70, DOI 10.1136/ard.2005.042523; CRISPE IN, 1987, J IMMUNOL, V138, P2013; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Deman J, 1992, Dev Immunol, V2, P103, DOI 10.1155/1992/48713; Elkon KB, 1997, P NATL ACAD SCI USA, V94, P9814, DOI 10.1073/pnas.94.18.9814; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; GIROIR BP, 1992, P NATL ACAD SCI USA, V89, P4864, DOI 10.1073/pnas.89.11.4864; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Gunnlaugsdottir B, 2008, SCAND J IMMUNOL, V68, P624, DOI 10.1111/j.1365-3083.2008.02181.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Houston EG, 2008, J IMMUNOL, V181, P5213, DOI 10.4049/jimmunol.181.8.5213; Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kasahara S, 2003, J VIROL, V77, P2469, DOI 10.1128/JVI.77.4.2469-2476.2003; Kim EY, 2009, J IMMUNOL, V183, P6051, DOI 10.4049/jimmunol.0803482; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Kim EY, 2004, J IMMUNOL, V173, P4500, DOI 10.4049/jimmunol.173.7.4500; Kollias G, 1999, ANN RHEUM DIS, V58, P32, DOI 10.1136/ard.58.2008.i32; LEWICKI H, 1995, VIROLOGY, V210, P29, DOI 10.1006/viro.1995.1314; Liepinsh DJ, 2009, EUR J IMMUNOL, V39, P2906, DOI 10.1002/eji.200839191; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Makaroff LE, 2009, P NATL ACAD SCI USA, V106, P4799, DOI 10.1073/pnas.0812354106; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; McKarns SC, 2008, J IMMUNOL, V181, P1272, DOI 10.4049/jimmunol.181.2.1272; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MURPHY M, 1993, J IMMUNOL, V150, P5696; MURPHY M, 1992, J IMMUNOL, V149, P2506; MURPHY M, 1992, CLIN IMMUNOL IMMUNOP, V62, P245, DOI 10.1016/0090-1229(92)90079-4; Notley CA, 2008, J EXP MED, V205, P2491, DOI 10.1084/jem.20072707; Opiela SJ, 2009, BLOOD, V113, P5635, DOI 10.1182/blood-2008-08-173658; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Pang LP, 2008, J RHEUMATOL, V35, P2220, DOI 10.3899/jrheum.080219; Perez AR, 2007, BRAIN BEHAV IMMUN, V21, P890, DOI 10.1016/j.bbi.2007.02.004; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Proietto AI, 2008, IMMUNOL CELL BIOL, V86, P700, DOI 10.1038/icb.2008.63; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Sims TN, 2002, IMMUNOL REV, V186, P100, DOI 10.1034/j.1600-065X.2002.18610.x; Singh A, 2007, J LEUKOCYTE BIOL, V82, P1201, DOI 10.1189/jlb.0407240; Singh A, 2007, J VIROL, V81, P6502, DOI 10.1128/JVI.00163-07; Smyth MJ, 2000, MICROSC RES TECHNIQ, V50, P196, DOI 10.1002/1097-0029(20000801)50:3<196::AID-JEMT3>3.0.CO;2-9; Suresh M, 2005, J VIROL, V79, P202, DOI 10.1128/JVI.79.1.202-213.2005; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Trevejo JM, 2001, P NATL ACAD SCI USA, V98, P12162, DOI 10.1073/pnas.211423598; Tuma RA, 2002, CURR OPIN IMMUNOL, V14, P348, DOI 10.1016/S0952-7915(02)00338-2; Uldrich AP, 2006, J IMMUNOL, V176, P4553, DOI 10.4049/jimmunol.176.8.4553; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; VERNACHIO J, 1989, J IMMUNOL, V142, P48; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Yang Y, 1998, J EXP MED, V188, P247, DOI 10.1084/jem.188.2.247; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	75	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15038	10.1371/journal.pone.0015038	http://dx.doi.org/10.1371/journal.pone.0015038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124839	Green Published, gold			2022-12-25	WOS:000284572000022
J	Skovran, E; Crowther, GJ; Guo, XF; Yang, S; Lidstrom, ME				Skovran, Elizabeth; Crowther, Gregory J.; Guo, Xiaofeng; Yang, Song; Lidstrom, Mary E.			A Systems Biology Approach Uncovers Cellular Strategies Used by Methylobacterium extorquens AM1 During the Switch from Multi- to Single-Carbon Growth	PLOS ONE			English	Article							BETA-HYDROXYBUTYRATE BIOSYNTHESIS; ENZYME-ACTIVITIES; PSEUDOMONAS AM1; METABOLISM; FORMALDEHYDE; DEHYDROGENASE; PATHWAY; FORMATE; RECONSTRUCTION; IDENTIFICATION	Background: When organisms experience environmental change, how does their metabolic network reset and adapt to the new condition? Methylobacterium extorquens is a bacterium capable of growth on both multi-and single-carbon compounds. These different modes of growth utilize dramatically different central metabolic pathways with limited pathway overlap. Methodology/Principal Findings: This study focused on the mechanisms of metabolic adaptation occurring during the transition from succinate growth (predicted to be energy-limited) to methanol growth (predicted to be reducing-power-limited), analyzing changes in carbon flux, gene expression, metabolites and enzymatic activities over time. Initially, cells experienced metabolic imbalance with excretion of metabolites, changes in nucleotide levels and cessation of cell growth. Though assimilatory pathways were induced rapidly, a transient block in carbon flow to biomass synthesis occurred, and enzymatic assays suggested methylene tetrahydrofolate dehydrogenase as one control point. This "downstream priming'' mechanism ensures that significant carbon flux through these pathways does not occur until they are fully induced, precluding the buildup of toxic intermediates. Most metabolites that are required for growth on both carbon sources did not change significantly, even though transcripts and enzymatic activities required for their production changed radically, underscoring the concept of metabolic setpoints. Conclusions/Significance: This multi-level approach has resulted in new insights into the metabolic strategies carried out to effect this shift between two dramatically different modes of growth and identified a number of potential flux control and regulatory check points as a further step toward understanding metabolic adaptation and the cellular strategies employed to maintain metabolic setpoints.	[Skovran, Elizabeth; Crowther, Gregory J.; Guo, Xiaofeng; Yang, Song; Lidstrom, Mary E.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA; [Lidstrom, Mary E.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Skovran, E (corresponding author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.	eskovran@u.washington.edu		Skovran, Elizabeth/0000-0002-1737-5621; Crowther, Gregory/0000-0003-0530-9130	National Institute of General Medical Sciences [GM58933]; Ruth Kirschstein National Research Service Award [08FGM78835A, 5F32GM070297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070297, R01GM058933] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from National Institute of General Medical Sciences (GM58933 to MEL) and the Ruth Kirschstein National Research Service Award, 08FGM78835A to ES, and 5F32GM070297 to GJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony C., 1982, BIOCH METHYLOTROPHS; BERGMEYER HU, 1974, METHOD ENZYMAT AN, V1, P501; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; Chistoserdova L, 2004, J BACTERIOL, V186, P22, DOI 10.1128/JB.186.1.22-28.2004; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2007, J BACTERIOL, V189, P9076, DOI 10.1128/JB.01229-07; Chistoserdova L, 2007, J BACTERIOL, V189, P4020, DOI 10.1128/JB.00045-07; CORPE WA, 1989, FEMS MICROBIOL ECOL, V62, P243, DOI 10.1111/j.1574-6968.1989.tb03698.x; Crowther GJ, 2008, J BACTERIOL, V190, P5057, DOI 10.1128/JB.00228-08; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; GOLDBERG I, 1976, BIOTECHNOL BIOENG, V18, P1657, DOI 10.1002/bit.260181202; GREEN PN, 1991, PROKARYOTES, P2342; GRUER MJ, 1994, MICROBIOL-SGM, V140, P2531, DOI 10.1099/00221287-140-10-2531; Guo XF, 2008, BIOTECHNOL BIOENG, V99, P929, DOI 10.1002/bit.21652; Guo XF, 2006, ARCH MICROBIOL, V186, P139, DOI 10.1007/s00203-006-0131-7; HARDER W, 1971, BIOCHEM J, V121, P763, DOI 10.1042/bj1210763; HARDER W, 1971, BIOCHEM J, V121, P753, DOI 10.1042/bj1210753; HEPINSTALL J, 1970, BIOCHEM J, V117, P563; Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Korotkova N, 2002, J BACTERIOL, V184, P6174, DOI 10.1128/JB.184.22.6174-6181.2002; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; Korotkova N, 2001, J BACTERIOL, V183, P1038, DOI 10.1128/JB.183.3.1038-1046.2001; Kromer JO, 2004, J BACTERIOL, V186, P1769, DOI 10.1128/JB.186.6.1769-1784.2004; LARGE PJ, 1963, BIOCHEM J, V87, P386, DOI 10.1042/bj0870386; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; Lee IY, 1996, BIOTECHNOL BIOENG, V52, P707, DOI 10.1002/(SICI)1097-0290(19961220)52:6<707::AID-BIT8>3.0.CO;2-S; Lee YH, 1996, J MICROBIOL BIOTECHN, V6, P120; LIDSTROM ME, 2001, PROKARYOTES, P223; Mangos TJ, 1997, ANAL BIOCHEM, V244, P357, DOI 10.1006/abio.1996.9908; Marx CJ, 2005, PLOS BIOL, V3, P244, DOI 10.1371/journal.pbio.0030016; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; Marx CJ, 2004, MICROBIOL-SGM, V150, P9, DOI 10.1099/mic.0.26587-0; MCNERNEY T, 1980, APPL ENVIRON MICROB, V40, P370, DOI 10.1128/AEM.40.2.370-375.1980; MILLER JA, 2009, THESIS U WASHINGTON; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; SALEM AR, 1974, J GEN MICROBIOL, V81, P525, DOI 10.1099/00221287-81-2-525; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; Skovran E, 2000, J BACTERIOL, V182, P3896, DOI 10.1128/JB.182.14.3896-3903.2000; SPENCER ME, 1973, J BACTERIOL, V114, P563, DOI 10.1128/JB.114.2.563-570.1973; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Van Dien SJ, 2003, MICROBIOL-SGM, V149, P601, DOI 10.1099/mic.0.25955-0; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200; Vorholt JA, 1998, J BACTERIOL, V180, P5351, DOI 10.1128/JB.180.20.5351-5356.1998; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; Yang S, 2009, J CHROMATOGR A, V1216, P3280, DOI 10.1016/j.chroma.2009.02.030; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	51	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14091	10.1371/journal.pone.0014091	http://dx.doi.org/10.1371/journal.pone.0014091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124828	gold, Green Published, Green Submitted			2022-12-25	WOS:000284572000002
J	McDonald, AT; Kirkland, JI; DeBlieux, DD; Madsen, SK; Cavin, J; Milner, ARC; Panzarin, L				McDonald, Andrew T.; Kirkland, James I.; DeBlieux, Donald D.; Madsen, Scott K.; Cavin, Jennifer; Milner, Andrew R. C.; Panzarin, Lukas			New Basal Iguanodonts from the Cedar Mountain Formation of Utah and the Evolution of Thumb-Spiked Dinosaurs	PLOS ONE			English	Article							CRETACEOUS AGE; ORNITHISCHIA; ORNITHOPODA; CHINA; PHYLOGENY; TAXONOMY; ENGLAND; TEXAS	Background: Basal iguanodontian dinosaurs were extremely successful animals, found in great abundance and diversity almost worldwide during the Early Cretaceous. In contrast to Europe and Asia, the North American record of Early Cretaceous basal iguanodonts has until recently been limited largely to skulls and skeletons of Tenontosaurus tilletti. Methodology/Principal Findings: Herein we describe two new basal iguanodonts from the Yellow Cat Member of the Cedar Mountain Formation of eastern Utah, each known from a partial skull and skeleton. Iguanacolossus fortis gen. et sp. nov. and Hippodraco scutodens gen. et sp. nov. are each diagnosed by a single autapomorphy and a unique combination of characters. Conclusions/Significance: Iguanacolossus and Hippodraco add greatly to our knowledge of North American basal iguanodonts and prompt a new comprehensive phylogenetic analysis of basal iguanodont relationships. This analysis indicates that North American Early Cretaceous basal iguanodonts are more basal than their contemporaries in Europe and Asia.	[McDonald, Andrew T.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Kirkland, James I.; DeBlieux, Donald D.; Madsen, Scott K.] Utah Geol Survey, Salt Lake City, UT USA; [Cavin, Jennifer] John Day Fossil Beds Natl Monument, Kimberly, OR USA; [Milner, Andrew R. C.] Johnson Farm, St George Dinosaur Discovery Site, St George, UT USA	University of Pennsylvania	McDonald, AT (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	mcandr@sas.upenn.edu			Utah Geological Survey; Quest Grant	Utah Geological Survey; Quest Grant	Excavation and preparation of the specimens was supported by funds provided by the Utah Geological Survey (http://geology.utah.gov/) with excavations at Don's Ridge funded in part by a Quest Grant to JIK administered by the Discovery Channel (http://dsc.discovery.com/convergence/quest/quest.html). ATM thanks the Evolving Earth Foundation (http://www.evolvingearth.org/), Jurassic Foundation (http://jurassicfoundation.org/index.html), University of Pennsylvania Paleobiology Summer Stipend (http://www.sas.upenn.edu/earth/graduate.htm), and Utah Friends of Paleontology (http://www.utahpaleo.org/utahvalley.html) for funding his research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2003, CR PALEVOL, V2, P27, DOI 10.1016/S1631-0683(03)00002-2; Barrett PM, 2009, ACTA PALAEONTOL POL, V54, P35, DOI 10.4202/app.2009.0105; BARTHOLOMAI A, 1981, Memoirs of the Queensland Museum, V20, P319; Brill Kathleen, 2007, P49; Britt B.B., 2007, GEOLOGICAL SOC AM AB, V39, P16; Carpenter K, 2008, ANN CARNEGIE MUS, V76, P227, DOI 10.2992/0097-4463(2008)76[227:ANSOCO]2.0.CO;2; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Deblieux D, 2008, J VERTEBR PALEONTOL, V28, p70A; DiCroce Tony, 2001, P183; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Garrison JR, 2007, CRETACEOUS RES, V28, P461, DOI 10.1016/j.cretres.2006.07.007; Gilmore C. W., 1909, P US NATIONAL MUSEUM, V36, P197, DOI DOI 10.5479/SI.00963801.36-1666.197; Gilpin David, 2007, P79; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2008, NEWSL STRATIGR, V43, P5, DOI 10.1127/0078-0421/2008/0043-0005; Head JJ, 1998, J VERTEBR PALEONTOL, V18, P718, DOI 10.1080/02724634.1998.10011101; Kirkland James I., 1997, Brigham Young University Geology Studies, V42, P69; KIRKLAND JI, 1998, NEW MEXICO MUSEUM NA, V14, P283; Kirkland JI, 2007, UTAH GEOLOGICAL ASS, V35, P1; Kobayashi Y, 2003, J VERTEBR PALEONTOL, V23, P166, DOI 10.1671/0272-4634(2003)23[166:ANIDOF]2.0.CO;2; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mcdonald AT, 2010, ZOOTAXA, P1; Molnar Ralph E., 1996, Memoirs of the Queensland Museum, V39, P639; Naish D, 2008, J GEOL SOC LONDON, V165, P613, DOI 10.1144/0016-76492007-154; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB, 2010, ZOOTAXA, P47; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; NORMAN DB, 1980, I ROYAL SCI NATURELL, V178, P1; OSTROM JH, 1970, PEABODY MUSEUM NATUR, V35, P1; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Paul GS, 2008, CRETACEOUS RES, V29, P192, DOI 10.1016/j.cretres.2007.04.009; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Schnyder J, 2009, PALAEOGEOGR PALAEOCL, V281, P79, DOI 10.1016/j.palaeo.2009.07.014; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P. C, 2005, STEM ARCHOSAURIA VER; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; TSCHUDY R.H., 1984, US GEOL SURV PROF PA, V1281, P1; Weishampel D.B., 1989, Journal of Vertebrate Paleontology, V9, P56; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; WILKINSON M, 1992, CLADISTICS, V8, P375, DOI 10.1111/j.1096-0031.1992.tb00079.x; Wilkinson M, 2001, TAXEQ3 SOFTWARE DOCU; Wilkinson M, 2001, REDCON 3 0 SOFTWARE; Winkler DA, 1997, J VERTEBR PALEONTOL, V17, P330, DOI 10.1080/02724634.1997.10010978; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X	47	64	68	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14075	10.1371/journal.pone.0014075	http://dx.doi.org/10.1371/journal.pone.0014075			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124919	Green Published, Green Submitted, gold			2022-12-25	WOS:000284467200009
J	Leung, ELH; Fiscus, RR; Tung, JW; Tin, VPC; Cheng, LC; Sihoe, ADL; Fink, LM; Ma, YP; Wong, MP				Leung, Elaine Lai-Han; Fiscus, Ronald R.; Tung, James W.; Tin, Vicky Pui-Chi; Cheng, Lik Cheung; Sihoe, Alan Dart-Loon; Fink, Louis M.; Ma, Yupo; Wong, Maria Pik			Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties	PLOS ONE			English	Article							COLON-CANCER; FLOW-CYTOMETRY; IDENTIFICATION; HYALURONAN; MARKER; PLURIPOTENCY; POPULATION; CD133(+); GROWTH; TUMORS	Background: The cancer stem cell theory hypothesizes that cancers are perpetuated by cancer stem cells (CSC) or tumor initiating cells (TIC) possessing self-renewal and other stem cell-like properties while differentiated non-stem/initiating cells have a finite life span. To investigate whether the hypothesis is applicable to lung cancer, identification of lung CSC and demonstration of these capacities is essential. Methodology/Principal Finding: The expression profiles of five stem cell markers (CD34, CD44, CD133, BMI1 and OCT4) were screened by flow cytometry in 10 lung cancer cell lines. CD44 was further investigated by testing for in vitro and in vivo tumorigenecity. Formation of spheroid bodies and in vivo tumor initiation ability were demonstrated in CD44(+) cells of 4 cell lines. Serial in vivo tumor transplantability in nude mice was demonstrated using H1299 cell line. The primary xenografts initiated from CD44(+) cells consisted of mixed CD44(+) and CD44(-) cells in similar ratio as the parental H1299 cell line, supporting in vivo differentiation. Semi-quantitative Real-Time PCR (RT-PCR) showed that both freshly sorted CD44(+) and CD44(+) cells derived from CD44(+)-initiated tumors expressed the pluripotency genes OCT4/POU5F1, NANOG, SOX2. These stemness markers were not expressed by CD44(-) cells. Furthermore, freshly sorted CD44(+) cells were more resistant to cisplatin treatment with lower apoptosis levels than CD44(-) cells. Immunohistochemical analysis of 141 resected non-small cell lung cancers showed tumor cell expression of CD44 in 50.4% of tumors while no CD34, and CD133 expression was observed in tumor cells. CD44 expression was associated with squamous cell carcinoma but unexpectedly, a longer survival was observed in CD44-expressing adenocarcinomas. Conclusion/Significance: Overall, our results demonstrated that stem cell-like properties are enriched in CD44-expressing subpopulations of some lung cancer cell lines. Further investigation is required to clarify the role of CD44 in tumor cell renewal and cancer propagation in the in vivo environment.	[Leung, Elaine Lai-Han; Tin, Vicky Pui-Chi; Wong, Maria Pik] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Fiscus, Ronald R.] Nevada Canc Inst, Canc Mol Biol Sect, Las Vegas, NV USA; [Fiscus, Ronald R.] Univ So Nevada, Coll Pharm, Henderson, NV USA; [Tung, James W.; Fink, Louis M.; Ma, Yupo] Nevada Canc Inst, Div Lab Med, Las Vegas, NV USA; [Cheng, Lik Cheung; Sihoe, Alan Dart-Loon] Queen Mary Hosp, Cardiothorac Surg Unit, Hong Kong, Hong Kong, Peoples R China; [Ma, Yupo] Stony Brook Univ Med Ctr, Dept Pathol, Stony Brook, NY USA	University of Hong Kong; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Hong Kong; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Leung, ELH (corresponding author), Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	mwpik@hkucc.hku.hk			HKU [10400863, 200907176141]; China Medical Board, University of Hong Kong; National Institutes of Health [R01HL087948]; National Cancer Institute [R21CA131522]; DOE at Nevada Cancer Institute [DOE-FG02-08ER64608]; Nevada Cancer Institute; University of Southern Nevada; NATIONAL CANCER INSTITUTE [R21CA131522] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087948] Funding Source: NIH RePORTER	HKU(University of Hong Kong); China Medical Board, University of Hong Kong(University of Hong Kong); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOE at Nevada Cancer Institute(United States Department of Energy (DOE)); Nevada Cancer Institute(University of California System); University of Southern Nevada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Seed Fund for Basic Research (HKU 10400863 to M. P. Wong), a small project grant (HKU 200907176141 to E. L. Leung) and an overseas research training grant from China Medical Board, University of Hong Kong, awarded to E. L. Leung. This work was also supported in part by National Institutes of Health Grants R01HL087948, National Cancer Institute Grant R21CA131522 (to Y. Ma). DOE Funding DOE-FG02-08ER64608 at Nevada Cancer Institute (to L. M. Fink), a Startup Funding from the Nevada Cancer Institute and the University of Southern Nevada (to R. R. Fiscus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; DICK JE, 1994, RES IMMUNOL, V145, P380, DOI 10.1016/S0923-2494(94)80203-3; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fasano M, 1997, CANCER, V80, P34, DOI 10.1002/(SICI)1097-0142(19970701)80:1<34::AID-CNCR5>3.0.CO;2-F; Gai H, 2009, CELL BIOL INT, V33, P1184, DOI 10.1016/j.cellbi.2009.08.008; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lam DCL, 2006, J THORAC ONCOL, V1, P932, DOI 10.1097/01243894-200611000-00003; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; MA L, ACTA BIOCH BIOPHYS S, V42, P593; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Madjd Zahra, 2009, Cancer Immun, V9, P4; Marhaba R, 2008, CURR MOL MED, V8, P784, DOI 10.2174/156652408786733667; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; PENNO MB, 1994, CANCER RES, V54, P1381; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STUELTEN C, 2010, STEM CELLS; Takanami I, 2000, ONCOL REP, V7, P1065; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; TIRINO V, 2009, EUR J CARDIOTHORAC S; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; Tung JW, 2007, CLIN LAB MED, V27, P453, DOI 10.1016/j.cll.2007.05.001; Ucar D, 2009, CHEM-BIOL INTERACT, V178, P48, DOI 10.1016/j.cbi.2008.09.029; WU Y, 2009, STEM CELLS DEV; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	48	329	345	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14062	10.1371/journal.pone.0014062	http://dx.doi.org/10.1371/journal.pone.0014062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124918	gold, Green Published, Green Submitted			2022-12-25	WOS:000284400100011
J	Park, J; Jeon, Y; In, D; Fishel, R; Ban, C; Lee, JB				Park, Jonghyun; Jeon, Yongmoon; In, Daekil; Fishel, Richard; Ban, Changill; Lee, Jong-Bong			Single-Molecule Analysis Reveals the Kinetics and Physiological Relevance of MutL-ssDNA Binding	PLOS ONE			English	Article							DNA MISMATCH REPAIR; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN MUTS; COMPLEX; TIME; ATP; REPLICATION; ALPHA	DNA binding by MutL homologs (MLH/PMS) during mismatch repair (MMR) has been considered based on biochemical and genetic studies. Bulk studies with MutL and its yeast homologs Mlh1-Pms1 have suggested an integral role for a single-stranded DNA (ssDNA) binding activity during MMR. We have developed single-molecule Forster resonance energy transfer (smFRET) and a single-molecule DNA flow-extension assays to examine MutL interaction with ssDNA in real time. The smFRET assay allowed us to observe MutL-ssDNA association and dissociation. We determined that MutL-ssDNA binding required ATP and was the greatest at ionic strength below 25 mM (K(D) = 29 nM) while it dramatically decreases above 100 mM (K(D)>2 mM). Single-molecule DNA flow-extension analysis suggests that multiple MutL proteins may bind ssDNA at low ionic strength but this activity does not enhance stability at elevated ionic strengths. These studies are consistent with the conclusion that a stable MutL-ssDNA interaction is unlikely to occur at physiological salt eliminating a number of MMR models. However, the activity may infer some related dynamic DNA transaction process during MMR.	[Park, Jonghyun; Jeon, Yongmoon; In, Daekil; Lee, Jong-Bong] Pohang Univ Sci & Technol POSTECH, Dept Phys, Pohang, Kyungbuk, South Korea; [Fishel, Richard] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Ban, Changill] Pohang Univ Sci & Technol POSTECH, Dept Chem, Pohang, Kyungbuk, South Korea; [Lee, Jong-Bong] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, Kyungbuk, South Korea	Pohang University of Science & Technology (POSTECH); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Park, J (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Phys, Pohang, Kyungbuk, South Korea.	rfishel@osu.edu; ciban@postech.ac.kr; jblee@postech.ac.kr	Ban, Changill/F-5426-2013; Lee, Jong-Bong/AAH-4669-2020		Republic of Korea government (Ministry of Education, Science and Technology) [2008-0061211, 2009-0091507]; National Institutes of Health [CA067007]; NATIONAL CANCER INSTITUTE [R01CA067007] Funding Source: NIH RePORTER	Republic of Korea government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Brain Korea 21, the National Research Foundation of Korea grant funded by the Republic of Korea government (Ministry of Education, Science and Technology) (No. 2008-0061211, 2009-0091507), and National Institutes of Health grant CA067007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; BENDE SM, 1991, NUCLEIC ACIDS RES, V19, P1549, DOI 10.1093/nar/19.7.1549; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Drotschmann K, 1998, NUCLEIC ACIDS RES, V26, P948, DOI 10.1093/nar/26.4.948; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Joo C., 2008, SINGLE MOL TECHNIQUE; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kim SJ, 2007, NAT METHODS, V4, P397, DOI 10.1038/NMETH1037; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Robertson A, 2006, J BIOL CHEM, V281, P8399, DOI 10.1074/jbc.M509184200; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; VONHIPPE PH, 1972, ANNU REV BIOCHEM, V41, P231, DOI 10.1146/annurev.bi.41.070172.001311; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018	32	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15496	10.1371/journal.pone.0015496	http://dx.doi.org/10.1371/journal.pone.0015496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103398	Green Submitted, Green Published, gold			2022-12-25	WOS:000284147700035
J	Egawa, N; Yamamoto, K; Inoue, H; Hikawa, R; Nishi, K; Mori, K; Takahashi, R				Egawa, Naohiro; Yamamoto, Keisuke; Inoue, Haruhisa; Hikawa, Rie; Nishi, Katsunori; Mori, Kazutoshi; Takahashi, Ryosuke			The Endoplasmic Reticulum Stress Sensor, ATF6 alpha, Protects against Neurotoxin-induced Dopaminergic Neuronal Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ATF6; PARKINSONS-DISEASE; RESPONSE-ELEMENT; OXIDATIVE STRESS; CELL-DEATH; BINDING-PROTEIN; ALPHA-SYNUCLEIN; P38; ACTIVATION; KINASE	Oxidative stress and endoplasmic reticulum (ER) stress are thought to contribute to the pathogenesis of various neurodegenerative diseases including Parkinson disease (PD), however, the relationship between these stresses remains unclear. ATF6 alpha is an ER-membrane-bound transcription factor that is activated by protein misfolding in the ER and functions as a critical regulator of ER quality control proteins in mammalian cells. The goal of this study was to explore the cause-effect relationship between oxidative stress and ER stress in the pathogenesis of neurotoxin-induced model of PD. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin known to produce oxidative stress, activated ATF6 alpha and increased ER chaperones and ER-associated degradation (ERAD) component in dopaminergic neurons. Importantly, MPTP induced formation of ubiquitin-immunopositive inclusions and loss of dopaminergic neurons more prominently in mice deficient in ATF6 alpha than in wild-type mice. Cultured cell experiments revealed that 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress not only promoted phosphorylation of p38 mitogen-activated protein kinase (p38MAPK) but also enhanced interaction between phosphorylated p38MAPK and ATF6 alpha, leading to increment in transcriptional activator activity of ATF6 alpha. Thus, our results revealed a link between oxidative stress and ER stress by showing the importance of ATF6 alpha in the protection of the dopaminergic neurons from MPTP that occurs through oxidative stress-induced activation of ATF6 alpha and p38MAPK-mediated enhancement of ATF6 alpha transcriptional activity.	[Egawa, Naohiro; Hikawa, Rie; Mori, Kazutoshi; Takahashi, Ryosuke] Japan Sci & Technol Corp, CREST, Tokyo, Japan; [Yamamoto, Keisuke; Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Yamamoto, Keisuke] Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; [Inoue, Haruhisa] Kyoto Univ, CiRA, Kyoto 6068507, Japan; [Nishi, Katsunori] Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan; [Egawa, Naohiro; Hikawa, Rie; Takahashi, Ryosuke] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto 6068507, Japan	Japan Science & Technology Agency (JST); Kyoto University; Tokushima University; Kyoto University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Kyoto University	Takahashi, R (corresponding author), Kyoto Univ, Dept Neurol, Grad Sch Med, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	ryosuket@kuhp.kyoto-u.ac.jp	Mori, Kazutoshi/AAW-5449-2020; Mori, Kazutoshi/K-6106-2015	Inoue, Haruhisa/0000-0003-4736-9537	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant-in-aid for scientific research on Priority Areas-Research on Pathomechanisms of Brain Disorders from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a Grant-in-aid from the Ministry of Health, Labor, and Welfare of Japan.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Holtz WA, 2006, J NEUROCHEM, V99, P54, DOI 10.1111/j.1471-4159.2006.04025.x; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Junn E, 2001, J NEUROCHEM, V78, P374, DOI 10.1046/j.1471-4159.2001.00425.x; Karunakaran S, 2008, J NEUROSCI, V28, P12500, DOI 10.1523/JNEUROSCI.4511-08.2008; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Newhouse K, 2004, TOXICOL SCI, V79, P137, DOI 10.1093/toxsci/kfh089; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Shimoji M, 2005, MOL BRAIN RES, V134, P103, DOI 10.1016/j.molbrainres.2005.01.012; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang HQ, 2008, J NEUROCHEM, V107, P171, DOI 10.1111/j.1471-4159.2008.05607.x; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yokoyama H, 2008, NEUROL SCI, V29, P293, DOI 10.1007/s10072-008-0986-2; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	35	101	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7947	7957		10.1074/jbc.M110.156430	http://dx.doi.org/10.1074/jbc.M110.156430			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21131360	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000288013300025
J	McGlinchey, RP; Shewmaker, F; Hu, KN; McPhie, P; Tycko, R; Wickner, RB				McGlinchey, Ryan P.; Shewmaker, Frank; Hu, Kan-nian; McPhie, Peter; Tycko, Robert; Wickner, Reed B.			Repeat Domains of Melanosome Matrix Protein Pmel17 Orthologs Form Amyloid Fibrils at the Acidic Melanosomal pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; BETA-SHEET STRUCTURE; PINK-EYED DILUTION; SECONDARY-STRUCTURE; EXPERIMENTAL CONSTRAINTS; MURINE MELANOMA; POLAR ZIPPERS; PRION; PARALLEL	Most amyloids are pathological, but fragments of Pmel17 form a functional amyloid in vertebrate melanosomes essential for melanin synthesis and deposition. We previously reported that only at the mildly acidic pH (4-5.5) typical of melanosomes, the repeat domain (RPT) of human Pmel17 can form amyloid in vitro. Combined with the known presence of RPT in the melanosome filaments and the requirement of this domain for filament formation, we proposed that RPT may be the core of the amyloid formed in vivo. Although most of Pmel17 is highly conserved across a broad range of vertebrates, the RPT domains vary dramatically, with no apparent homology in some cases. Here, we report that the RPT domains of mouse and zebrafish, as well as a small splice variant of human Pmel17, all form amyloid specifically at mildly acid pH (pH similar to 5.0). Protease digestion, mass per unit length measurements, and solid-state NMR experiments suggest that amyloid of the mouse RPT has an in-register parallel beta-sheet architecture with two RPT molecules per layer, similar to amyloid of the A beta peptide. Although there is no sequence conservation between human and zebrafish RPT, amyloid formation at acid pH is conserved.	[McGlinchey, Ryan P.; Shewmaker, Frank; McPhie, Peter; Wickner, Reed B.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA; [Hu, Kan-nian; Tycko, Robert] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wickner, RB (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bldg 8,Rm 225,8 Ctr Dr,MSC0830, Bethesda, MD 20892 USA.	wickner@helix.nih.gov	Hu, Kan-Nian/AAH-2411-2020		National Institutes of Health NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024964, ZIADK024950, ZIADK075031, ZIADK075018] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Intramural Program.	ADEMA GJ, 1993, AM J PATHOL, V143, P1579; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; BHATNAGAR V, 1993, ARCH BIOCHEM BIOPHYS, V307, P183, DOI 10.1006/abbi.1993.1577; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Chan JCC, 2005, BIOCHEMISTRY-US, V44, P10669, DOI 10.1021/bi050724t; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; DEVI CC, 1987, EUR J BIOCHEM, V166, P705, DOI 10.1111/j.1432-1033.1987.tb13569.x; Dunn LC, 1930, J HERED, V21, P495, DOI 10.1093/oxfordjournals.jhered.a103275; HEARING VJ, 1973, J ULTRA MOL STRUCT R, V43, P88, DOI 10.1016/S0022-5320(73)90072-5; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Ishii Y, 2001, J CHEM PHYS, V114, P8473, DOI 10.1063/1.1359445; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; KWON BS, 1991, P NATL ACAD SCI USA, V88, P9228, DOI 10.1073/pnas.88.20.9228; Leonhardt RM, 2010, J BIOL CHEM, V285, P16166, DOI 10.1074/jbc.M109.097725; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; McPhie P, 2001, ANAL BIOCHEM, V293, P109, DOI 10.1006/abio.2001.5113; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Petkova AT, 2002, J MAGN RESON, V155, P293, DOI 10.1006/jmre.2002.2519; Pfefferkorn C. M., 2010, P NATL ACAD IN PRESS; Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; SAEKI H, 1983, J CELL PHYSIOL, V116, P93, DOI 10.1002/jcp.1041160114; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; Valencia JC, 2006, PIGM CELL RES, V19, P250, DOI 10.1111/j.1600-0749.2006.00308.x; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wosten HAB, 2000, BBA-REV BIOMEMBRANES, V1469, P79, DOI 10.1016/S0304-4157(00)00002-2; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29	55	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8385	8393		10.1074/jbc.M110.197152	http://dx.doi.org/10.1074/jbc.M110.197152			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21148556	Green Published, hybrid			2022-12-25	WOS:000288013300067
J	Engels, B; Heinig, U; Grothe, T; Stadler, M; Jennewein, S				Engels, Benedikt; Heinig, Uwe; Grothe, Torsten; Stadler, Marc; Jennewein, Stefan			Cloning and Characterization of an Armillaria gallica cDNA Encoding Protoilludene Synthase, Which Catalyzes the First Committed Step in the Synthesis of Antimicrobial Melleolides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARISTOLOCHENE SYNTHASE; CRYSTAL-STRUCTURE; SESQUITERPENE SYNTHASES; TRICHODIENE SYNTHASE; ASPERGILLUS-TERREUS; DITERPENE CYCLASE; TERPENE SYNTHASES; GENE-CLUSTER; CYCLIZATION; BIOSYNTHESIS	Melleolides and related fungal sesquiterpenoid aryl esters are antimicrobial and cytotoxic natural products derived from cultures of the Homobasidiomycetes genus Armillaria. The initial step in the biosynthesis of all melleolides involves cyclization of the universal sesquiterpene precursor farnesyl diphosphate to produce protoilludene, a reaction catalyzed by protoilludene synthase. We achieved the partial purification of protoilludene synthase from a mycelial culture of Armillaria gallica and found that 6-protoilludene was its exclusive reaction product. Therefore, a further isomerization reaction is necessary to convert the 6-7 double bond into the 7-8 double bond found in melleolides. We expressed an A. gallica protoilludene synthase cDNA in Escherichia coli, and this also led to the exclusive production of 6-protoilludene. Sequence comparison of the isolated sesquiterpene synthase revealed a distant relationship to other fungal terpene synthases. The isolation of the genomic sequence identified the 6-protoilludene synthase to be present as a single copy gene in the genome of A. gallica, possessing an open reading frame interrupted with eight introns.	[Engels, Benedikt; Heinig, Uwe; Jennewein, Stefan] Fraunhofer Inst Mol & Angew Okol, D-52074 Aachen, Germany; [Grothe, Torsten; Stadler, Marc] Intermed Discovery, D-44227 Dortmund, Germany; [Stadler, Marc] Univ Bayreuth, Dept Mycol, D-95440 Bayreuth, Germany	Fraunhofer Gesellschaft; University of Bayreuth	Jennewein, S (corresponding author), Fraunhofer Inst Mol & Angew Okol, Forckenbeckstr 6, D-52074 Aachen, Germany.	stefan.jennewein@ime.fraunhofer.de	Stadler, Marc/AHB-7016-2022; Stadler, Marc/P-8882-2014	Stadler, Marc/0000-0002-7284-8671; Stadler, Marc/0000-0002-7284-8671; GROTHE, TORSTEN/0000-0003-3298-4924	Arbeitsgemeinschaft industrielle Forschungsvereinigungen (Otto von Guericke) Pro Inno II	Arbeitsgemeinschaft industrielle Forschungsvereinigungen (Otto von Guericke) Pro Inno II	This work was supported by a grant from Arbeitsgemeinschaft industrielle Forschungsvereinigungen (Otto von Guericke) Pro Inno II.	Abraham WR, 2001, CURR MED CHEM, V8, P583, DOI 10.2174/0929867013373147; Agger S, 2009, MOL MICROBIOL, V72, P1181, DOI 10.1111/j.1365-2958.2009.06717.x; ARNONE A, 1986, PHYTOCHEMISTRY, V25, P471, DOI 10.1016/S0031-9422(00)85503-X; AYER WA, 1981, TETRAHEDRON, V37, P2199, DOI 10.1016/S0040-4020(01)97979-7; Cane DE, 2000, ARCH BIOCHEM BIOPHYS, V376, P354, DOI 10.1006/abbi.2000.1734; CANE DE, 1995, BIOCHEMISTRY-US, V34, P2480, DOI 10.1021/bi00008a011; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Conolly JD, 1991, DICT TERPENOIDS; Dairi T, 2001, J BACTERIOL, V183, P6085, DOI 10.1128/JB.183.20.6085-6094.2001; Davis EM, 2000, TOP CURR CHEM, V209, P53; Hamano Y, 2002, J BIOL CHEM, V277, P37098, DOI 10.1074/jbc.M206382200; HEINZL S, 2006, CHEMOTHER J, V15, P40; HOHN TM, 1989, GENE, V79, P131, DOI 10.1016/0378-1119(89)90098-X; HOHN TM, 1995, MOL GEN GENET, V248, P95, DOI 10.1007/BF02456618; HOHN TM, 1989, ARCH BIOCHEM BIOPHYS, V272, P137, DOI 10.1016/0003-9861(89)90204-X; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Joulain D., 1998, ATLAS SPECTRAL DATA; Kawaide H, 2006, BIOSCI BIOTECH BIOCH, V70, P583, DOI 10.1271/bbb.70.583; Kawaide H, 1997, J BIOL CHEM, V272, P21706, DOI 10.1074/jbc.272.35.21706; Kirk PM, 2008, DICT FUNGI; Laatsch H., 2010, ANTIBASE 2010 NATURA; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Lopez-Gallego F, 2010, CHEMBIOCHEM, V11, P1093, DOI 10.1002/cbic.200900671; Lorenzen K, 1998, CURR ORG CHEM, V2, P329; NOZOE S, 1977, TETRAHEDRON LETT, P1381; OBUCHI T, 1990, PLANTA MED, V56, P198, DOI 10.1055/s-2006-960925; ODURO KA, 1976, T BRIT MYCOL SOC, V66, P195, DOI 10.1016/S0007-1536(76)80045-9; Pinedo C, 2008, ACS CHEM BIOL, V3, P791, DOI 10.1021/cb800225v; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; Stadler Marc, 2003, Mycological Progress, V2, P95, DOI 10.1007/s11557-006-0048-1; Tainter F.H., 1996, PRINCIPLES FOREST PA; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Toyomasu T, 2004, BIOSCI BIOTECH BIOCH, V68, P146, DOI 10.1271/bbb.68.146; Toyomasu T, 2007, P NATL ACAD SCI USA, V104, P3084, DOI 10.1073/pnas.0608426104; Trapp SC, 2001, GENETICS, V158, P811; Vedula LS, 2008, ARCH BIOCHEM BIOPHYS, V469, P184, DOI 10.1016/j.abb.2007.10.015	40	51	68	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6871	6878		10.1074/jbc.M110.165845	http://dx.doi.org/10.1074/jbc.M110.165845			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21148562	Green Published, hybrid			2022-12-25	WOS:000287737300002
J	Kwak, HB; Kim, JH; Joshi, K; Yeh, A; Martinez, DA; Lawler, JM				Kwak, Hyo-Bum; Kim, Jong-hee; Joshi, Kumar; Yeh, Alvin; Martinez, Daniel A.; Lawler, John M.			Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart	FASEB JOURNAL			English	Article						TIMP-1; collagen; remodeling	COLLAGEN CROSS-LINKING; EXTRACELLULAR-MATRIX; MYOCARDIAL COLLAGEN; CARDIAC FIBROBLASTS; CALORIC RESTRICTION; DIASTOLIC FUNCTION; PHYSICAL-ACTIVITY; GENE-EXPRESSION; LEFT-VENTRICLE; GROWTH-FACTOR	Aging impairs function in the nonischemic heart and is associated with mechanical remodeling. This process includes accumulation of collagen (i.e., fibrosis) and dysregulation of active matrix metalloproteinases (MMPs). Exercise training (ET) improves cardiac function, but the pathways of protection remain poorly understood. Young (3 mo) and old (31 mo) FBNF1 rats were assigned into sedentary and exercise groups, with ET group rats training on a treadmill 45 min/d, 5 d/wk for 12 wk. Nonlinear optical microscopy (NLOM), histology, immunohistochemistry (IHC), and Western blot analyses were performed on the left ventricle and septum. NLOM, IHC, and histological imaging revealed that ET reduced age-associated elevation of collagen type I fibers. Active MMP-1, active MMP-2, and MMP-14 in the ECM fraction of the left ventricle were reduced by aging, an effect abrogated by ET. Tissue inhibitor of MMP (TIMP-1) was elevated with age but protected by ET. Transforming growth factor-beta (TGF-beta), upstream regulator of TIMP-1, increased with age but was attenuated by ET. Therefore, exercise training could protect the aging heart against dysregulation of MMPs and fibrosis by suppressing elevation of TIMP-1 and TGF-beta.-Kwak, H.-B., Kim, J.-H., Joshi, K., Yeh, A., Martinez, D. A., Lawler, J. M. Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart. FASEB J. 25, 1106-1117 (2011). www.fasebj.org	[Lawler, John M.] Texas A&M Univ, Redox Biol & Cell Signaling Lab, Dept Hlth & Kinesiol, Dept Biomed Engn, College Stn, TX 77843 USA; [Kwak, Hyo-Bum] E Carolina Univ, E Carolina Diabet & Obes Inst, Dept Exercise & Sports Sci, Dept Physiol,Brody Sch Med, Greenville, NC USA; [Martinez, Daniel A.] Univ Houston, Dept Mech Engn, Connect Tissue Physiol Lab, Houston, TX USA	Texas A&M University System; Texas A&M University College Station; University of North Carolina; East Carolina University; University of Houston System; University of Houston	Lawler, JM (corresponding author), Texas A&M Univ, Redox Biol & Cell Signaling Lab, Dept Hlth & Kinesiol, Dept Biomed Engn, 276B Read Bldg, College Stn, TX 77843 USA.	jml2621@neo.tamu.edu		Kwak, Hyo Bum/0000-0003-0451-4554	American Heart Association [0555064Y, 0855158F]; U.S. National Institutes of Health [AR054084]; Sydney and J. L. Huffines Institute for Sports Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054084] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sydney and J. L. Huffines Institute for Sports Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this study was provided by support from the American Heart Association (0555064Y, 0855158F), the U.S. National Institutes of Health (AR054084), and the Sydney and J. L. Huffines Institute for Sports Medicine.	Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74; Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215; BERLEW BS, 2004, AM J GERIATR CARDIOL, V13, P29; Bing Oscar H L, 2002, Heart Fail Rev, V7, P71; Bonnema DD, 2007, J CARD FAIL, V13, P530, DOI 10.1016/j.cardfail.2007.04.010; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; CAPASSO JM, 1990, AM J PHYSIOL, V259, pH1086, DOI 10.1152/ajpheart.1990.259.4.H1086; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Choi SY, 2009, J KOREAN MED SCI, V24, P32, DOI 10.3346/jkms.2009.24.1.32; Chung EH, 2006, FASEB J, V20, pA1447; de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486; Debessa CRG, 2001, MECH AGEING DEV, V122, P1049; DICENTURIONE L, 2005, MECH AGEING DEV, V124, P957; EGHBALI M, 1989, CARDIOVASC RES, V23, P723, DOI 10.1093/cvr/23.8.723; Fedak PWM, 2003, AM J PHYSIOL-HEART C, V284, pH626, DOI 10.1152/ajpheart.00684.2002; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gielen Stephan, 2005, Heart Fail Monit, V4, P130; Goldsmith EC, 2002, J CARD FAIL, V8, pS314, DOI 10.1054/jcaf.2002.129258; Goldspink DF, 2005, ERGONOMICS, V48, P1334, DOI 10.1080/00140130500101247; Hwang HS, 2007, J GERONTOL A-BIOL, V62, P382, DOI 10.1093/gerona/62.4.382; Jin HK, 2000, AM J PHYSIOL-HEART C, V279, pH2994, DOI 10.1152/ajpheart.2000.279.6.H2994; Jugdutt Bodh I., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P1, DOI 10.2174/1568006033337276; Kassiri Z, 2005, THROMB HAEMOSTASIS, V93, P212, DOI 10.1160/TH04-08-0522; Kim JH, 2008, EXP GERONTOL, V43, P317, DOI 10.1016/j.exger.2007.12.012; KWAK HB, 2008, FASEB J, V22; Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje; Lalu MM, 2005, EUR HEART J, V26, P27, DOI 10.1093/eurheratj/ehi007; Lawler JM, 2009, AM J PHYSIOL-REG I, V296, pR1496, DOI 10.1152/ajpregu.90314.2008; Lee PF, 2009, EXP CELL RES, V315, P396, DOI 10.1016/j.yexcr.2008.10.040; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Lumens J, 2006, AM J PHYSIOL-HEART C, V291, pH1573, DOI 10.1152/ajpheart.00074.2006; Lunardi M, 1993, G Ital Cardiol, V23, P673; Martinez DA, 2007, AM J PHYSIOL-REG I, V293, pR1552, DOI 10.1152/ajpregu.00423.2007; Masson S, 2005, MED INTELL UNIT, P97; Nottin S, 2004, ACTA PHYSIOL SCAND, V181, P209, DOI 10.1111/j.1365-201X.2004.01284.x; Olfert IM, 2004, J GERONTOL A-BIOL, V59, P801; Prasad A, 2007, AM J CARDIOL, V99, P1629, DOI 10.1016/j.amjcard.2007.01.050; Pugh KG, 2001, DRUG AGING, V18, P263, DOI 10.2165/00002512-200118040-00004; Quindry J, 2005, EXP GERONTOL, V40, P416, DOI 10.1016/j.exger.2005.03.010; Robert V, 1997, LAB INVEST, V76, P729; Rohrbach S, 2006, EXP GERONTOL, V41, P525, DOI 10.1016/j.exger.2006.02.001; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; Starnes JW, 2003, AM J PHYSIOL-HEART C, V285, pH347, DOI 10.1152/ajpheart.00952.2002; Stewart S, 2003, HEART, V89, P49, DOI 10.1136/heart.89.1.49; TAKEMOTO KA, 1992, AM HEART J, V124, P143, DOI 10.1016/0002-8703(92)90932-L; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; Taylor RP, 2003, ACTA PHYSIOL SCAND, V178, P107, DOI 10.1046/j.1365-201X.2003.01132.x; Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708; Thomas DP, 2000, J APPL PHYSIOL, V89, P1462, DOI 10.1152/jappl.2000.89.4.1462; Thomas DP, 2001, EUR J APPL PHYSIOL, V85, P164, DOI 10.1007/s004210100447; Tikellis C, 2004, ENDOCRINOLOGY, V145, P860, DOI 10.1210/en.2003-0967; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Tsuruda T, 2004, HEART FAIL REV, V9, P53, DOI 10.1023/B:HREV.0000011394.34355.bb; Tsutsui H, 2007, HYPERTENS RES, V30, P439, DOI 10.1291/hypres.30.439; Van Linthout S, 2008, BASIC RES CARDIOL, V103, P319, DOI 10.1007/s00395-008-0715-2; VINCENTI MP, 2001, MATRIX METALLOPROTEI, V151, P5; Woodiwiss AJ, 1998, EUR J APPL PHYSIOL, V78, P148, DOI 10.1007/s004210050400; Zheng DH, 2001, J APPL PHYSIOL, V91, P1073, DOI 10.1152/jappl.2001.91.3.1073	61	68	77	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1106	1117		10.1096/fj.10-172924	http://dx.doi.org/10.1096/fj.10-172924			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21148111	Green Published			2022-12-25	WOS:000287806200030
J	Zhao, HW; Zhou, D; Haddad, GG				Zhao, Huiwen W.; Zhou, Dan; Haddad, Gabriel G.			Antimicrobial Peptides Increase Tolerance to Oxidant Stress in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; LUNG EPITHELIAL-CELLS; BUTHIONINE SULFOXIMINE; OXIDATIVE DAMAGE; SUPEROXIDE-DISMUTASE; REDOX STATE; NEUTROPHIL DEFENSINS; ENDOTHELIAL-CELLS; O-2 DEPRIVATION; HYPEROXIA	It is well appreciated that reactive oxygen species (ROS) are deleterious to mammals, including humans, especially when generated in abnormally large quantities from cellular metabolism. Whereas the mechanisms leading to the production of ROS are rather well delineated, the mechanisms underlying tissue susceptibility or tolerance to oxidant stress remain elusive. Through an experimental selection over many generations, we have previously generated Drosophila melanogaster flies that tolerate tremendous oxidant stress and have shown that the family of antimicrobial peptides (AMPs) is over-represented in these tolerant flies. Furthermore, we have also demonstrated that overexpression of even one AMP at a time (e. g. Diptericin) allows wild-type flies to survive much better in hyperoxia. In this study, we used a number of experimental approaches to investigate the potential mechanisms underlying hyperoxia tolerance in flies with AMP overexpression. We demonstrate that flies with Diptericin overexpression resist oxidative stress by increasing antioxidant enzyme activities and preventing an increase in ROS levels after hyperoxia. Depleting the GSH pool using buthionine sulfoximine limits fly survival, thus confirming that enhanced survival observed in these flies is related to improved redox homeostasis. We conclude that 1) AMPs play an important role in tolerance to oxidant stress, 2) overexpression of Diptericin changes the cellular redox balance between oxidant and antioxidant, and 3) this change in redox balance plays an important role in survival in hyperoxia.	[Zhao, Huiwen W.; Zhou, Dan; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA 92123 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Haddad, GG (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu		Zhou, Dan/0000-0001-6401-9040	National Institutes of Health [RO1NS037756, PO1HD032573]; American Heart Association [0835188N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS037756 and PO1HD032573 (to G. G. H.). This work was also supported by American Heart Association Grant 0835188N (to D. Z.).	Abbott DA, 2009, APPL ENVIRON MICROB, V75, P2320, DOI 10.1128/AEM.00009-09; ABRAHAM SK, 1993, MUTAT RES, V301, P255, DOI 10.1016/0165-7992(93)90066-5; AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332; Anderson CP, 1999, EXP CELL RES, V246, P183, DOI 10.1006/excr.1998.4303; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Barker GF, 2006, AM J RESP CELL MOL, V35, P277, DOI 10.1165/rcmb.2005-0340OC; Bhandari V, 2007, J IMMUNOL, V178, P4993, DOI 10.4049/jimmunol.178.8.4993; Carnesecchi S, 2009, AM J RESP CRIT CARE, V180, P972, DOI 10.1164/rccm.200902-0296OC; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Droge W, 2002, EXP GERONTOL, V37, P1333, DOI 10.1016/S0531-5565(02)00175-4; Gorter AD, 1998, J INFECT DIS, V178, P1067, DOI 10.1086/515667; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Huang B, 2009, LUNG, V187, P421, DOI 10.1007/s00408-009-9177-z; Ilizarov AM, 2001, AM J RESP CELL MOL, V24, P436, DOI 10.1165/ajrcmb.24.4.4240; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Ketterer B, 2001, CHEM-BIOL INTERACT, V138, P27, DOI 10.1016/S0009-2797(01)00277-0; Khurana V, 2008, J ALZHEIMERS DIS, V15, P541; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Li HM, 2008, INSECT MOL BIOL, V17, P325, DOI 10.1111/j.1365-2583.2008.00808.x; LINDAUSHEPARD B, 1994, J CELL PHYSIOL, V161, P237, DOI 10.1002/jcp.1041610207; LINDAUSHEPARD BA, 1993, FREE RADICAL BIO MED, V15, P581, DOI 10.1016/0891-5849(93)90160-V; Liu L, 2007, EUR J HEART FAIL, V9, P762, DOI 10.1016/j.ejheart.2007.03.007; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Mantell LL, 2000, MOL GENET METAB, V71, P359, DOI 10.1006/mgme.2000.3046; Marengo B, 2008, FREE RADICAL BIO MED, V44, P474, DOI 10.1016/j.freeradbiomed.2007.10.031; Masalunga C, 2007, PEDIATR RES, V62, P78, DOI 10.1203/PDR.0b013e3180674dc6; Mockett RJ, 1999, FASEB J, V13, P1733, DOI 10.1096/fasebj.13.13.1733; MOORE AJ, 1994, PEPTIDE RES, V7, P265; Nagato A, 2009, EXP LUNG RES, V35, P713, DOI 10.3109/01902140902853184; Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; PARKES TL, 1993, GENOME, V36, P1007, DOI 10.1139/g93-134; Rebrin I, 2006, MECH AGEING DEV, V127, P869, DOI 10.1016/j.mad.2006.09.001; REED DJ, 1990, ENVIRON HEALTH PERSP, V84, P113, DOI 10.2307/3430712; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; Ross CR, 2007, CHEM BIOL DRUG DES, V70, P154, DOI 10.1111/j.1747-0285.2007.00540.x; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S; SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0; SULLIVAN SJ, 1991, J CELL PHYSIOL, V147, P427, DOI 10.1002/jcp.1041470307; Suttmann Henrik, 2008, BMC Urol, V8, P5, DOI 10.1186/1471-2490-8-5; Taglialatela G, 1998, FREE RADICAL BIO MED, V25, P936, DOI 10.1016/S0891-5849(98)00131-2; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; THANISLASS J, 1995, BIOCHEM PHARMACOL, V50, P229, DOI 10.1016/0006-2952(95)00123-H; Tupling AR, 2007, J APPL PHYSIOL, V103, P1921, DOI 10.1152/japplphysiol.00529.2007; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P411, DOI 10.1016/0003-9861(82)90519-7; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Udomsinprasert R, 2004, BIOCHEM J, V383, P483, DOI 10.1042/BJ20040519; Usui S, 2009, MOL THER, V17, P778, DOI 10.1038/mt.2009.47; van Wetering S, 1999, J ALLERGY CLIN IMMUN, V104, P1131, DOI 10.1016/S0091-6749(99)70004-7; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; WEBSTER NR, 1987, BRIT J ANAESTH, V59, P760, DOI 10.1093/bja/59.6.760; Wong YL, 2001, TOXICOL LETT, V123, P179, DOI 10.1016/S0378-4274(01)00397-6; Wu JP, 2004, CIRCULATION, V109, P1660, DOI 10.1161/01.CIR.0000124067.35915.E0; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Zhao HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011701	67	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6211	6218		10.1074/jbc.M110.181206	http://dx.doi.org/10.1074/jbc.M110.181206			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148307	Green Published, hybrid			2022-12-25	WOS:000287476400030
J	Cojocaru, M; Bouchard, A; Cloutier, P; Cooper, JJ; Varzavand, K; Price, DH; Coulombe, B				Cojocaru, Marilena; Bouchard, Annie; Cloutier, Philippe; Cooper, Jeff J.; Varzavand, Katayoun; Price, David H.; Coulombe, Benoit			Transcription Factor IIS Cooperates with the E3 Ligase UBR5 to Ubiquitinate the CDK9 Subunit of the Positive Transcription Elongation Factor B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TEFB-MEDIATED PHOSPHORYLATION; PROTEIN-INTERACTION NETWORK; TUMOR-SUPPRESSOR GENE; CLEAVAGE FACTOR TFIIS; FACTOR S-II; P-TEFB; HYPERPLASTIC-DISCS; SACCHAROMYCES-CEREVISIAE; PRODUCTIVE ELONGATION	Elongation of transcription by mammalian RNA polymerase II (RNAPII) is regulated by specific factors, including transcription factor IIS (TFIIS) and positive transcription elongation factor b (P-TEFb). We show that the E3 ubiquitin ligase UBR5 associates with the CDK9 subunit of positive transcription elongation factor b to mediate its polyubiquitination in human cells. TFIIS also binds UBR5 to stimulate CDK9 polyubiquitination. Co-localization of UBR5, CDK9, and TFIIS along specific regions of the gamma fibrinogen (gamma FBG) gene indicates that a ternary complex involving these factors participates in the transcriptional regulation of this gene. In support of this notion, overexpression of TFIIS not only modifies the ubiquitination pattern of CDK9 in vivo but also increases the association of CDK9 with various regions of the gamma FBG gene. Notably, the TFIIS-mediated increase in CDK9 loading is obtained during both basal and activated transcription of the gamma FBG gene. This increased CDK9 binding is paralleled by an increase in the recruitment of RNAPII along the gamma FBG gene and the phosphorylation of the C-terminal domain of the RNAPII largest subunit RPB1 on Ser-2, a known target of CDK9. Together, these results identify UBR5 as a novel E3 ligase that regulates transcription and define an additional function of TFIIS in the regulation of CDK9.	[Coulombe, Benoit] Inst Rech Clin Montreal, Gene Transcript & Prote Lab, Montreal, PQ H2W 1R7, Canada; [Cooper, Jeff J.; Varzavand, Katayoun; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Iowa	Coulombe, B (corresponding author), Inst Rech Clin Montreal, Gene Transcript & Prote Lab, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	benoit.coulombe@ircm.qc.ca		Price, David/0000-0002-5597-385X	Canadian Institutes for Health Research, Genome Canada, Genome Quebec; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canadian Institutes of Health Research; Fonds de Recherche en Sante du Quebec; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI074392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	Canadian Institutes for Health Research, Genome Canada, Genome Quebec(Genome CanadaCanadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants from the Canadian Institutes for Health Research, Genome Canada, Genome Quebec, the Natural Sciences and Engineering Research Council of Canada, and the Canadian Foundation for Innovation.; Recipient of studentships from the Canadian Institutes of Health Research and the Fonds de Recherche en Sante du Quebec.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Barboric M, 2005, J VIROL, V79, P11135, DOI 10.1128/JVI.79.17.11135-11141.2005; Brasier AR, 2008, CELL CYCLE, V7, P2661, DOI 10.4161/cc.7.17.6594; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Cloutier P, 2009, METHODS, V48, P381, DOI 10.1016/j.ymeth.2009.05.005; Cojocaru M, 2008, BIOCHEM J, V409, P139, DOI 10.1042/BJ20070751; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Gagnon D, 2009, J VIROL, V83, P4127, DOI 10.1128/JVI.02468-08; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hou T, 2007, J BIOL CHEM, V282, P37091, DOI 10.1074/jbc.M706458200; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Ito T, 2006, MOL CELL BIOL, V26, P3194, DOI 10.1128/MCB.26.8.3194-3203.2006; Jeronimo C, 2004, MOL CELL BIOL, V24, P7043, DOI 10.1128/MCB.24.16.7043-7058.2004; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Lindstrom DL, 2001, GENETICS, V159, P487; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Nickels BE, 2004, CELL, V118, P281, DOI 10.1016/j.cell.2004.07.021; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Prather DA, 2005, MOL CELL BIOL, V25, P2650, DOI 10.1128/MCB.25.7.2650-2659.2005; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SEKIMIZU K, 1976, BIOCHEMISTRY-US, V15, P5064, DOI 10.1021/bi00668a018; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Umehara T, 1995, GENE, V167, P297, DOI 10.1016/0378-1119(95)00634-6; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Wery M, 2004, EMBO J, V23, P4232, DOI 10.1038/sj.emboj.7600326; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	48	32	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5012	5022		10.1074/jbc.M110.176628	http://dx.doi.org/10.1074/jbc.M110.176628			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127351	Green Published, hybrid			2022-12-25	WOS:000287230600009
J	Carrasco-Marin, E; Fernandez-Prieto, L; Rodriguez-Del Rio, E; Madrazo-Toca, F; Reinheckel, T; Saftig, P; Alvarez-Dominguez, C				Carrasco-Marin, Eugenio; Fernandez-Prieto, Lorena; Rodriguez-Del Rio, Estela; Madrazo-Toca, Fidel; Reinheckel, Thomas; Saftig, Paul; Alvarez-Dominguez, Carmen			LIMP-2 Links Late Phagosomal Trafficking with the Onset of the Innate Immune Response to Listeria monocytogenes A ROLE IN MACROPHAGE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCOCEREBROSIDASE; MURINE MACROPHAGES; INTERFERON-GAMMA; RNAI SCREEN; CATHEPSIN-D; MATURATION; RECEPTOR; RECOGNITION; FUSION; CELLS	The innate immune response to Listeria monocytogenes depends on phagosomal bacterial degradation by macrophages. Here, we describe the role of LIMP-2, a lysosomal type III transmembrane glycoprotein and scavenger-like protein, in Listeria phagocytosis. LIMP-2-deficient mice display a macrophage-related defect in Listeria innate immunity. They produce less acute phase pro-inflammatory cytokines/chemokines, MCP-1, TNF-alpha, and IL-6 but normal levels of IL-12, IL-10, and IFN-gamma and a 25-fold increase in susceptibility to Listeria infection. This macrophage defect results in a low listericidal potential, poor response to TNF-alpha activation signals, impaired phago-lysosome transformation into antigen-processing compartments, and uncontrolled LM cytosolic growth that fails to induce normal levels of acute phase pro-inflammatory cytokines. LIMP-2 transfection of CHO cells confirmed that LIMP-2 participates in the degradation of Listeria within phagosomes, controls the late endosomal/lysosomal fusion machinery, and is linked to the activation of Rab5a. Therefore, the role of LIMP-2 appears to be connected to the TNF-alpha-dependent and early activation of Listeria macrophages through internal signals linking the regulation of late trafficking events with the onset of the innate Listeria immune response.	[Carrasco-Marin, Eugenio; Fernandez-Prieto, Lorena; Rodriguez-Del Rio, Estela; Madrazo-Toca, Fidel; Alvarez-Dominguez, Carmen] Hosp Santa Cruz Liencres, Serv Inmunol, Liencres 39120, Cantabria, Spain; [Carrasco-Marin, Eugenio; Fernandez-Prieto, Lorena; Rodriguez-Del Rio, Estela; Madrazo-Toca, Fidel; Alvarez-Dominguez, Carmen] Fdn Marques de Valdecilla, Inst Formac & Invest Marques de Valdecilla, Liencres 39120, Spain; [Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Zellforsch, D-79104 Freiburg, Germany	Hospital Universitario Marques de Valdecilla (HUMV); University of Kiel; University of Freiburg	Carrasco-Marin, E (corresponding author), Hosp Santa Cruz Liencres, Serv Inmunol, Barrio de las Mazas 17, Liencres 39120, Cantabria, Spain.	deicme@humv.es; psaftig@biochem.uni-kiel.de; calvarez@humv.es	Marin, Eugenio Carrasco/AAG-1578-2021; Saftig, Paul/A-7966-2010; Alvarez-Dominguez, Carmen/J-4675-2014; Reinheckel, Thomas/AAL-9761-2021	Marin, Eugenio Carrasco/0000-0002-3556-9227; Alvarez-Dominguez, Carmen/0000-0002-4585-6959; Reinheckel, Thomas/0000-0001-9866-9105	Fondo de Investigaciones Sanitarias [FIS-ISCIII-00/3073, PI01/3128, PI03-1009, PI07-0289, PI04-0324, CA06-0062]; Ministerio de Ciencia, Investigacion e Innovacion [BIO2002-0628, SAF-2006-08968, SAF2009-08695]; Deutsche Forschungsgemeinschaft [SA683/6-1]; Cluster of Excellence "Inflammation at Interfaces"; Fundacion Marques de Valdecilla-Instituto de Formacion e Investigacion Marques de Valdecilla [API09-SAF2009-08695]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Ciencia, Investigacion e Innovacion; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; Fundacion Marques de Valdecilla-Instituto de Formacion e Investigacion Marques de Valdecilla	This work was supported in part by Fondo de Investigaciones Sanitarias Grants FIS-ISCIII-00/3073, PI01/3128, PI03-1009, and PI07-0289 (to E. C.-M.); grants from Ministerio de Ciencia, Investigacion e Innovacion (BIO2002-0628, SAF-2006-08968, and SAF2009-08695) and from Fondo de Investigaciones Sanitarias PI04-0324 (to C. A.-D.); Deutsche Forschungsgemeinschaft Grant SA683/6-1 and the Cluster of Excellence "Inflammation at Interfaces" (to P. S.); and Fondo de Investigaciones Sanitarias Contract CA06-0062 and Fundacion Marques de Valdecilla-Instituto de Formacion e Investigacion Marques de Valdecilla Grant API09-SAF2009-08695 (to L. F.-P.).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; AlvarezDominguez C, 1997, J CELL SCI, V110, P731; AlvarezDominguez C, 1997, INFECT IMMUN, V65, P78; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Binker MG, 2007, CELL MICROBIOL, V9, P2153, DOI 10.1111/j.1462-5822.2007.00946.x; Blanz J, 2010, HUM MOL GENET, V19, P563, DOI 10.1093/hmg/ddp523; BLUM JS, 1991, ADV EXP MED BIOL, V306, P281; Carrasco-Marin E, 2009, MOL MICROBIOL, V72, P668, DOI 10.1111/j.1365-2958.2009.06673.x; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Crombie R, 1998, J BIOL CHEM, V273, P4855, DOI 10.1074/jbc.273.9.4855; DECHASTELLIER C, 1994, INFECT IMMUN, V62, P543, DOI 10.1128/IAI.62.2.543-553.1994; del Cerro-Vadillo E, 2006, J IMMUNOL, V176, P1321, DOI 10.4049/jimmunol.176.3.1321; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Forestier C, 2000, J IMMUNOL, V165, P5202, DOI 10.4049/jimmunol.165.9.5202; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jutras I, 2008, MOL CELL PROTEOMICS, V7, P697, DOI 10.1074/mcp.M700267-MCP200; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kuronita T, 2005, TRAFFIC, V6, P895, DOI 10.1111/j.1600-0854.2005.00325.x; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Prada-Delgado A, 2005, TRAFFIC, V6, P252, DOI 10.1111/j.1600-0854.2005.00265.x; Prada-Delgado A, 2001, J BIOL CHEM, V276, P19059, DOI 10.1074/jbc.M101639200; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; Schaible UE, 1998, J IMMUNOL, V160, P1290; Schramm M, 2008, CELL MICROBIOL, V10, P1839, DOI 10.1111/j.1462-5822.2008.01169.x; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103; von Delwig A, 2005, SCAND J IMMUNOL, V62, P243, DOI 10.1111/j.1365-3083.2005.01664.x; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	41	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3332	3341		10.1074/jbc.M110.146761	http://dx.doi.org/10.1074/jbc.M110.146761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123180	hybrid, Green Published			2022-12-25	WOS:000286653200019
J	Gao, S; Rao, VB				Gao, Song; Rao, Venigalla B.			Specificity of Interactions among the DNA-packaging Machine Components of T4-related Bacteriophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL DOMAINS; SMALL TERMINASE; LARGE SUBUNIT; PROTEIN GP17; ATPASE; NUCLEASE; BINDING; LAMBDA; MOTOR; PURIFICATION	Tailed bacteriophages use powerful molecular motors to package the viral genome into a preformed capsid. Packaging at a rate of up to similar to 2000 bp/s and generating a power density twice that of an automobile engine, the phage T4 motor is the fastest and most powerful reported to date. Central to DNA packaging are dynamic interactions among the packaging components, capsid (gp23), portal (gp20), motor (gp17, large "terminase"), and regulator (gp16, small terminase), leading to precise orchestration of the packaging process, but the mechanisms are poorly understood. Here we analyzed the interactions between small and large terminases of T4-related phages. Our results show that the gp17 packaging ATPase is maximally stimulated by homologous, but not heterologous, gp16. Multiple interaction sites are identified in both gp16 and gp17. The specificity determinants in gp16 are clustered in the diverged N- and C-terminal domains (regions I-III). Swapping of diverged region(s), such as replacing C-terminal RB49 region III with that of T4, switched ATPase stimulation specificity. Two specificity regions, amino acids 37-52 and 290-315, are identified in or near the gp17-ATPase "transmission" subdomain II. gp16 binding at these sites might cause a conformational change positioning the ATPase-coupling residues into the catalytic pocket, triggering ATP hydrolysis. These results lead to a model in which multiple weak interactions between motor and regulator allow dynamic assembly and disassembly of various packaging complexes, depending on the functional state of the packaging machine. This might be a general mechanism for regulation of the phage packaging machine and other complex molecular machines.	[Gao, Song; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Catholic University of America	Rao, VB (corresponding author), Catholic Univ Amer, Dept Biol, 620 Michigan Ave NE, Washington, DC 20064 USA.	rao@cua.edu		Rao, Venigalla/0000-0002-0777-6587	National Institutes of Health, NIAID [R56AI081726]; National Science Foundation [MCB-0923873]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081726, R01AI081726] Funding Source: NIH RePORTER; Direct For Biological Sciences [0923873] Funding Source: National Science Foundation	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant R56AI081726. This work was also supported by National Science Foundation Grant MCB-0923873.	Al-Zahrani AS, 2009, J BIOL CHEM, V284, P24490, DOI 10.1074/jbc.M109.025007; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baumann RG, 2003, J BIOL CHEM, V278, P4618, DOI 10.1074/jbc.M208574200; Black LW, 2006, J BIOL CHEM, V281, P25635, DOI 10.1074/jbc.M602093200; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; CHAI SH, 1994, VIROLOGY, V202, P930, DOI 10.1006/viro.1994.1415; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019; FRACKMAN S, 1985, J MOL BIOL, V183, P225, DOI 10.1016/0022-2836(85)90215-3; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Goldberg E, 1983, MOL BIOL BACTERIOPHA, P32; Golz S, 1999, J MOL BIOL, V285, P1131, DOI 10.1006/jmbi.1998.2399; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; Kondabagil KR, 2006, J MOL BIOL, V363, P786, DOI 10.1016/j.jmb.2006.08.054; Kondabagil KR, 2006, J MOL BIOL, V358, P67, DOI 10.1016/j.jmb.2006.01.078; Kuebler D, 1998, J MOL BIOL, V281, P803, DOI 10.1006/jmbi.1998.1952; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Lin H, 1997, J BIOL CHEM, V272, P3495, DOI 10.1074/jbc.272.6.3495; Lin HC, 1998, VIROLOGY, V242, P118, DOI 10.1006/viro.1997.9019; LUFTIG RB, 1972, J VIROL, V10, P545, DOI 10.1128/JVI.10.3.545-554.1972; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Nemecek D, 2008, J MOL BIOL, V383, P494, DOI 10.1016/j.jmb.2008.08.050; RAO VB, 1988, J MOL BIOL, V200, P475, DOI 10.1016/0022-2836(88)90537-2; Rao VB, 2001, J MOL BIOL, V314, P401, DOI 10.1006/jmbi.2001.5169; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Rentas FJ, 2003, J MOL BIOL, V334, P37, DOI 10.1016/j.jmb.2003.09.028; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Smits C, 2009, EMBO REP, V10, P592, DOI 10.1038/embor.2009.53; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Tetart F, 2001, J BACTERIOL, V183, P358, DOI 10.1128/JB.183.1.358-366.2001; Tsay JM, 2010, J BIOL CHEM, V285, P24282, DOI 10.1074/jbc.M110.129395; van Duijn E, 2010, J AM SOC MASS SPECTR, V21, P971, DOI 10.1016/j.jasms.2009.12.010; Yang Q, 1999, BIOCHEMISTRY-US, V38, P465, DOI 10.1021/bi981271d; YEO A, 1995, J MOL BIOL, V245, P141, DOI 10.1006/jmbi.1994.0013; Zhao HY, 2010, P NATL ACAD SCI USA, V107, P1971, DOI 10.1073/pnas.0908569107	46	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3944	3956		10.1074/jbc.M110.196907	http://dx.doi.org/10.1074/jbc.M110.196907			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127059	Green Published, hybrid			2022-12-25	WOS:000286653200075
J	Horn, PJ; Ledbetter, NR; James, CN; Hoffman, WD; Case, CR; Verbeck, GF; Chapman, KD				Horn, Patrick J.; Ledbetter, Nicole R.; James, Christopher N.; Hoffman, William D.; Case, Charlene R.; Verbeck, Guido F.; Chapman, Kent D.			Visualization of Lipid Droplet Composition by Direct Organelle Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OIL BODIES; FATTY-ACIDS; IONIZATION; TRIACYLGLYCEROLS; FLUORESCENCE; EXTRACTION; MICROSCOPY; OLEOSINS; REVEALS; PLANTS	An expanding appreciation for the varied functions of neutral lipids in cellular organisms relies on a more detailed understanding of the mechanisms of lipid production and packaging into cytosolic lipid droplets (LDs). Conventional lipid profiling procedures involve the analysis of tissue extracts and consequently lack cellular or subcellular resolution. Here, we report an approach that combines the visualization of individual LDs, microphase extraction of lipid components from droplets, and the direct identification of lipid composition by nanospray mass spectrometry, even to the level of a single LD. The triacylglycerol (TAG) composition of LDs from several plant sources (mature cotton (Gossypium hirsutum) embryos, roots of cotton seedlings, and Arabidopsis thaliana seeds and leaves) were examined by direct organelle mass spectrometry and revealed the heterogeneity of LDs derived from different plant tissue sources. The analysis of individual LDs makes possible organellar resolution of molecular compositions and will facilitate new studies of LD biogenesis and functions, especially in combination with analysis of morphological and metabolic mutants. Furthermore, direct organelle mass spectrometry could be applied to the molecular analysis of other subcellular compartments and macromolecules.	[Verbeck, Guido F.; Chapman, Kent D.] Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, Denton, TX 76203 USA; [Ledbetter, Nicole R.; Hoffman, William D.; Verbeck, Guido F.] Univ N Texas, Dept Chem, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Chapman, KD (corresponding author), Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, 1155 Union Circle 305220, Denton, TX 76203 USA.	chapman@unt.edu	Verbeck, Guido/AAF-3774-2019; Hoffmann, William/M-9122-2016; Horn, Patrick/G-1013-2013	Verbeck, Guido/0000-0002-3317-9911; Hoffmann, William/0000-0002-7516-1437; Horn, Patrick/0000-0002-1057-4708; Chapman, Kent/0000-0003-0489-3072	Zyvex Instrument [GN1371]; University of North Texas [G33598]; United States Department of Energy [08-395, DE-SC0000797]	Zyvex Instrument; University of North Texas; United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Zyvex Instrument Research Grant GN1371 and University of North Texas Faculty Research Grant G33598 (to G. F. V.).; Supported in part by Cotton Incorporated Research Grant 08-395 and Grant DE-SC0000797 from the United States Department of Energy. To whom correspondence should be addressed: University of North Texas, 1155 Union Circle #305220, Denton, TX 76203-5017. Tel.: 940-565-2969; Fax: 940-369-8656; E-mail: chapman@unt.edu.	Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; Brown JM, 2010, ANAL BIOCHEM, V398, P7, DOI 10.1016/j.ab.2009.10.044; Brunelle A, 2009, ANAL BIOANAL CHEM, V393, P31, DOI 10.1007/s00216-008-2367-3; Byrdwell WC, 2005, LIPIDS, V40, P383, DOI 10.1007/s11745-006-1398-9; CHAPMAN KD, 1991, J CELL BIOL, V115, P995, DOI 10.1083/jcb.115.4.995; Chapman KD, 2001, J AM OIL CHEM SOC, V78, P941, DOI 10.1007/s11746-001-0368-y; Chapman KD, 2008, CROP SCI, V48, P1470, DOI 10.2135/cropsci2007.11.0618; Cheng CF, 1998, ANAL CHEM, V70, P4417, DOI 10.1021/ac9805192; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; Dill AL, 2009, J CHROMATOGR B, V877, P2883, DOI 10.1016/j.jchromb.2008.12.058; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Fukumoto S, 2002, HISTOCHEM CELL BIOL, V118, P423, DOI 10.1007/s00418-002-0462-7; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Ledbetter NL, 2010, J FORENSIC SCI, V55, P1218, DOI 10.1111/j.1556-4029.2010.01406.x; Leprince O, 1998, PLANTA, V204, P109, DOI 10.1007/s004250050236; Lisa M, 2008, J CHROMATOGR A, V1198, P115, DOI 10.1016/j.chroma.2008.05.037; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Robenek H, 2009, BBA-MOL CELL BIOL L, V1791, P408, DOI 10.1016/j.bbalip.2008.12.001; Schmelzer K, 2007, METHOD ENZYMOL, V432, P171, DOI 10.1016/S0076-6879(07)32007-7; SCHMID KM, 1988, PHYTOCHEMISTRY, V27, P2831, DOI 10.1016/0031-9422(88)80672-1; SLACK CR, 1980, BIOCHEM J, V190, P551, DOI 10.1042/bj1900551; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; TZEN JTC, 1990, PLANT PHYSIOL, V94, P1282, DOI 10.1104/pp.94.3.1282; van Manen HJ, 2005, P NATL ACAD SCI USA, V102, P10159, DOI 10.1073/pnas.0502746102; Yang ZL, 2009, PLANT PHYSIOL, V150, P1981, DOI 10.1104/pp.109.140491; Zehethofer N, 2008, ANAL CHIM ACTA, V627, P62, DOI 10.1016/j.aca.2008.06.045; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	36	66	67	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3298	3306		10.1074/jbc.M110.186353	http://dx.doi.org/10.1074/jbc.M110.186353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118810	hybrid, Green Published			2022-12-25	WOS:000286653200015
J	Kodama, S; Negishi, M				Kodama, Susumu; Negishi, Masahiko			Pregnane X Receptor PXR Activates the GADD45 beta Gene, Eliciting the p38 MAPK Signal and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NUCLEAR RECEPTORS; CROSS-TALK; TGF-BETA; HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; KINASE ACTIVATION; PROTEIN-KINASE; EXPRESSION; CAR	Pregnane X receptor (PXR) was originally characterized as a transcription factor that induces hepatic drug metabolism by activating cytochrome P450 genes. Here we have now demonstrated a novel function of PXR, that of eliciting p38 mitogen-activated protein kinase (MAPK) phosphorylation for cell migration. Upon xenobiotic activation of ectopic human PXR, human hepatocellular carcinoma HepG2 cells were found to exhibit increased phosphorylation of p38 MAPK and to subsequently change morphology and migrate. p38 MAPK was responsible for the regulation of these morphological changes and cell migration because the p38 MAPK inhibitor SB239063 repressed both. Prior to this phosphorylation, PXR directly activated the early response GADD45 beta gene by binding to a distal direct repeat 4 site of the GADD45 beta promoter. Ectopic expression of GADD45 beta increased p38 MAPK phosphorylation, whereas siRNA knockdown of GADD45 beta decreased the PXR-induced p38 MAPK phosphorylation, confirming that GADD45 beta can regulate PXR-induced p38 MAPK phosphorylation in HepG2 cells. These results indicate that PXR activates the GADD45 beta gene, increasing p38 MAPK phosphorylation, and leading HepG2 cells to change morphology and migrate. The GADD45 beta gene is a direct target for PXR, eliciting cell signals to regulate various cellular functions.	[Kodama, Susumu; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	National Institutes of Health through NIEHS [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, ZICES102445] Funding Source: NIH RePORTER	National Institutes of Health through NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant Z01ES1005-01 through the NIEHS.	Bakin AV, 2002, J CELL SCI, V115, P3193; Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883; Dai GL, 2008, HEPATOLOGY, V47, P1277, DOI 10.1002/hep.22129; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Kakizaki S, 2008, CURR DRUG METAB, V9, P614, DOI 10.2174/138920008785821666; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Koyano S, 2004, DRUG METAB DISPOS, V32, P149, DOI 10.1124/dmd.32.1.149; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Liu X, 2010, J GASTROEN HEPATOL, V25, P420, DOI 10.1111/j.1440-1746.2009.05981.x; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Musch A, 2005, DIGESTION, V71, P78, DOI 10.1159/000084523; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Papa S, 2008, J CLIN INVEST, V118, P1911, DOI 10.1172/JCI33913; Sipeki S, 1999, CELL SIGNAL, V11, P885, DOI 10.1016/S0898-6568(99)00060-1; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Vairapandi M, 1996, ONCOGENE, V12, P2579; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Yamamoto Y, 2008, DRUG METAB DISPOS, V36, P1189, DOI 10.1124/dmd.108.020628; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010121; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou Changcheng, 2009, Nucl Recept Signal, V7, pe001, DOI 10.1621/nrs.07001; Zhou J, 2008, MOL ENDOCRINOL, V22, P868, DOI 10.1210/me.2007-0197; Zucchini N, 2005, BBA-MOL CELL RES, V1745, P48, DOI 10.1016/j.bbamcr.2005.02.005	37	44	44	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3570	3578		10.1074/jbc.M110.179812	http://dx.doi.org/10.1074/jbc.M110.179812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127053	hybrid, Green Published			2022-12-25	WOS:000286653200041
J	Novak, JF; Stirnberg, M; Roenneke, B; Marin, K				Novak, Jens F.; Stirnberg, Marit; Roenneke, Benjamin; Marin, Kay			A Novel Mechanism of Osmosensing, a Salt-dependent Protein-Nucleic Acid Interaction in the Cyanobacterium Synechocystis Species PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSYLGLYCEROL-PHOSPHATE SYNTHASE; SP PCC-6803; ESCHERICHIA-COLI; COMPATIBLE SOLUTES; IN-VIVO; ACTIVATION; TREHALOSE; OSMOREGULATION; ACCUMULATION; STRESS	The de novo synthesis of compatible solutes is an essential part of the cellular osmotic stress response. Upon an osmotic challenge, it is regulated by the immediate biochemical activation of preformed enzymes and by activation of gene expression. Whereas the transcriptional response has been investigated intensively, the mechanisms by which enzymes are activated in osmotic stress situations are still elusive. Here, we address this topic for the moderately halotolerant cyanobacterium Synechocystis sp. PCC 6803, which synthesizes glucosylglycerol as a compatible solute. The key enzyme of the glucosylglycerol pathway (GgpS) is inhibited by nucleic acids in a sequence-and length-independent manner. The protein binds DNA, RNA, and heparin via a salt-dependent electrostatic interaction with the negatively charged backbone of the polyanions. Mechanistically, DNA binding to the enzyme causes noncompetitive inhibition of GgpS activity. The interaction of the enzyme and nucleic acids under in vivo conditions is indicated by the co-purification of both after cross-linking in Synechocystis cells. We propose a novel mechanism of activity regulation by the nonspecific salt-dependent binding of an enzyme to nucleic acids.	[Novak, Jens F.; Stirnberg, Marit; Roenneke, Benjamin; Marin, Kay] Univ Cologne, Inst Biochem, D-50547 Cologne, Germany	University of Cologne	Marin, K (corresponding author), Univ Cologne, Inst Biochem, Zuelpicher Str 47, D-50674 Cologne, Germany.	kay.marin@uni-koeln.de			International Max Planck Research School; Deutsche Forschungsgemeinschaft [MA 4159/1-1]	International Max Planck Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by an International Max Planck Research School fellowship.; Supported by Deutsche Forschungsgemeinschaft Grant MA 4159/1-1. To whom correspondence should be addressed: Inst. of Biochemistry, University of Cologne, Zuelpicher Str. 47, 50674 Cologne, Germany. Tel.: 49-221-470-6476; Fax: 49-221-470-5091; E-mail: kay.marin@uni-koeln.de.	BLUMWALD E, 1983, PLANT PHYSIOL, V73, P377, DOI 10.1104/pp.73.2.377; BOROWITZKA LJ, 1980, SCIENCE, V210, P650, DOI 10.1126/science.210.4470.650; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; Cardoso FS, 2007, MICROBIOL-SGM, V153, P270, DOI 10.1099/mic.0.29262-0; Conrad H. E., 1998, HEPARIN BINDING PROT; da Costa M. S., 1998, V61, P117; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Empadinhas N, 2008, INT MICROBIOL, V11, P151, DOI 10.2436/20.1501.01.55; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hagemann M, 1996, J PLANT PHYSIOL, V149, P746, DOI 10.1016/S0176-1617(96)80101-5; HAGEMANN M, 1994, CURR MICROBIOL, V28, P201, DOI 10.1007/BF01575962; HAGEMANN M, 1994, MICROBIOL-SGM, V140, P1427, DOI 10.1099/00221287-140-6-1427; Hagemann M, 2001, CURR MICROBIOL, V43, P278, DOI 10.1007/s002840010301; Herzberg C, 2007, PROTEOMICS, V7, P4032, DOI 10.1002/pmic.200700491; Hincha DK, 2004, BIOCHEM J, V383, P277, DOI 10.1042/BJ20040746; Jones LS, 2004, MOL CELL PROTEOMICS, V3, P746, DOI 10.1074/mcp.R400008-MCP200; Marin K, 2006, MICROBIOL-SGM, V152, P2023, DOI 10.1099/mic.0.28771-0; Morohoshi T, 2002, APPL ENVIRON MICROB, V68, P4107, DOI 10.1128/AEM.68.8.4107-4110.2002; Pan YT, 2002, EUR J BIOCHEM, V269, P6091, DOI 10.1046/j.1432-1033.2002.03327.x; REED RH, 1985, FEMS MICROBIOL LETT, V28, P225, DOI 10.1016/0378-1097(85)90086-2; Schoor A, 1999, ARCH MICROBIOL, V171, P101, DOI 10.1007/s002030050684; Stirnberg M, 2007, MOL MICROBIOL, V63, P86, DOI 10.1111/j.1365-2958.2006.05495.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527, DOI 10.1099/00221287-136-12-2527; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002	28	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3235	3241		10.1074/jbc.M110.157032	http://dx.doi.org/10.1074/jbc.M110.157032			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123179	Green Published, hybrid			2022-12-25	WOS:000286653200008
J	Chen, Q; Zhang, Y; Peng, HY; Lei, L; Kuang, HB; Zhang, L; Ning, LN; Cao, YJ; Duan, EK				Chen, Qi; Zhang, Ying; Peng, Hongying; Lei, Li; Kuang, Haibin; Zhang, Li; Ning, Lina; Cao, Yujing; Duan, Enkui			Transient beta(2)-Adrenoceptor Activation Confers Pregnancy Loss by Disrupting Embryo Spacing at Implantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; MYOMETRIAL ACTIVITY; MOUSE BLASTOCYSTS; LIFE EVENTS; EXPRESSION; UTERUS; COMPLICATIONS; INVOLVEMENT; DEFICIENCY; ADRENALINE	Pregnancy loss is a serious social and medical issue, with one important cause associated with aberrant embryo implantation during early pregnancy. However, whether and how the process of embryo implantation is affected by environmental factors such as stress-induced sympathetic activation remained elusive. Here we report an unexpected, transient effect of beta(2)-adrenoreceptor (beta(2)-AR) activation (day 4 postcoitus) in disrupting embryo spacing at implantation, leading to substantially increased midterm pregnancy loss. The abnormal embryo spacing could be prevented by pretreatment of beta(2)-AR antagonist or genetic ablation of beta(2)-AR. Similar beta(2)-AR activation at day 5 postcoitus, when implantation sites have been established, did not affect embryo spacing or pregnancy outcome, indicating that the adverse effect of beta(2)-AR activation is limited to the preimplantation period before embryo attachment. In vitro and in vivo studies demonstrated that the transient beta(2)-AR activation abolished normal preimplantation uterine contractility without adversely affecting blastocyst quality. The contractility inhibition is mediated by activation of the cAMP-PKA pathway and accompanied by specific down-regulation of lpa3, a gene previously found to be critical for uterine contraction and embryo spacing. These results indicated that normal uterine contraction-mediated correct intrauterine embryo distribution is crucial for successful ongoing pregnancy. Abnormal beta(2)-AR activation at early pregnancy provided a molecular clue in explaining how maternal stress at early stages could adversely affect the pregnancy outcome.	[Duan, Enkui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Chen, Qi; Zhang, Ying; Lei, Li; Kuang, Haibin; Zhang, Li] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, EK (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	duane@ioz.ac.cn	Chen, Qi/K-4059-2019; Chen, Qi/W-1759-2019	Chen, Qi/0000-0001-6353-9589; Zhang, Ying/0000-0003-4082-5026; Kuang, haibin/0000-0003-4711-5449	National Basic Research Program of China [2011CB710905, 2007CB947401, 2011CB944401]; Chinese Academy of Sciences [KSCX2-YW-R-080]; National Natural Science Foundation of China [30770819]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2011CB710905 (to E. D.) and 2007CB947401 and 2011CB944401 (to Y. C.), Chinese Academy of Sciences Knowledge Innovation Program KSCX2-YW-R-080 (to E. D.), and National Natural Science Foundation of China Grant 30770819 (to Y. C.).	Allix S, 2008, BIOL REPROD, V79, P510, DOI 10.1095/biolreprod.107.066373; Berkman ND, 2003, AM J OBSTET GYNECOL, V188, P1648, DOI 10.1067/mob.2003.356; BRANDON JM, 1990, J REPROD FERTIL, V88, P151; Bulletti C, 2006, CURR OPIN OBSTET GYN, V18, P472, DOI 10.1097/01.gco.0000233946.20414.af; CRANE LH, 1991, REPROD FERT DEVELOP, V3, P233, DOI 10.1071/RD9910233; Dey SK, 2005, NATURE, V435, P34, DOI 10.1038/435034a; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dey SK, 2010, J CLIN INVEST, V120, P952, DOI 10.1172/JCI42380; Ferry B, 1999, BIOL PSYCHIAT, V46, P1140, DOI 10.1016/S0006-3223(99)00157-2; Gold KJ, 2007, GEN HOSP PSYCHIAT, V29, P207, DOI 10.1016/j.genhosppsych.2007.02.002; Hama K, 2007, BIOL REPROD, V77, P954, DOI 10.1095/biolreprod.107.060293; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Heuser CF, 1941, CONTRIB EMBRYOL, V29; Houdeau E, 1998, J COMP NEUROL, V399, P403; Im YB, 1998, J AUTON PHARMACOL, V18, P149, DOI 10.1046/j.1365-2680.1998.1830149.x; Irie K, 2001, BRIT J PHARMACOL, V133, P237, DOI 10.1038/sj.bjp.0704073; KENNEDY TG, 1977, BIOL REPROD, V16, P286, DOI 10.1095/biolreprod16.3.286; Kuang HB, 2009, J CELL PHYSIOL, V221, P448, DOI 10.1002/jcp.21877; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; Neugebauer R, 1996, AM J EPIDEMIOL, V143, P588; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; OHare T, 1995, BRIT J PSYCHIAT, V167, P799, DOI 10.1192/bjp.167.6.799; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P55, DOI 10.1073/pnas.90.1.55; Paria BC, 1999, DEVELOPMENT, V126, P1997; Pinborg A, 2006, BRIT J HOSP MED, V67, P417, DOI 10.12968/hmed.2006.67.8.21976; PUSEY J, 1980, BIOL REPROD, V23, P394, DOI 10.1095/biolreprod23.2.394; RESTALL BJ, 1971, J REPROD FERTIL, V24, P423, DOI 10.1530/jrf.0.0240423; Shumay E, 2007, J BIOL CHEM, V282, P21529, DOI 10.1074/jbc.M701998200; Song DK, 2000, BRIT J PHARMACOL, V130, P41, DOI 10.1038/sj.bjp.0703273; Song H, 2002, DEVELOPMENT, V129, P2879; van Oppenraaij RHF, 2009, HUM REPROD UPDATE, V15, P409, DOI 10.1093/humupd/dmp009; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang J, 2000, DEVELOPMENT, V127, P33; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; WIMSATT WA, 1975, BIOL REPROD, V12, P1, DOI 10.1095/biolreprod12.1.1; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yoshino O, 2010, HUM REPROD, V25, P2475, DOI 10.1093/humrep/deq222; Zhao P, 2008, ENDOCRINOLOGY, V149, P2782, DOI 10.1210/en.2007-1662	41	38	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4349	4356		10.1074/jbc.M110.197202	http://dx.doi.org/10.1074/jbc.M110.197202			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148315	Green Published, hybrid			2022-12-25	WOS:000286975700034
J	Damiani, MJ; Nostedt, JJ; O'Neill, MA				Damiani, Michael J.; Nostedt, Jordan J.; O'Neill, Melanie A.			Impact of the N5-proximal Asn on the Thermodynamic and Kinetic Stability of the Semiquinone Radical in Photolyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA PHOTOLYASE; COUPLED ELECTRON-TRANSFER; FLAVIN MONONUCLEOTIDE-BINDING; NITRIC-OXIDE SYNTHASE; REDOX PROPERTIES; METHYLOPHILUS-METHYLOTROPHUS; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; CRYPTOCHROME; PHOTORECEPTOR	Flavoproteins can dramatically adjust the thermodynamics and kinetics of electron transfer at their flavin cofactor. A versatile regulatory tool is proton transfer. Here, we demonstrate the significance of proton-coupled electron transfer to redox tuning and semiquinone (sq) stability in photolyases (PLs) and cryptochromes (CRYs). These light-responsive proteins share homologous overall architectures and FAD-binding pockets, yet they have evolved divergent functions that include DNA repair, photomorphogenesis, regulation of circadian rhythm, and magnetoreception. We report the first measurement of both FAD redox potentials for cyclobutane pyrimidine dimer PL (CPD-PL, Anacystis nidulans). These values, E-1(hq/sq) = -140 mV and E-2(sq/ox) = -219 mV, where hq is FAD hydroquinone and ox is oxidized FAD, establish that the sq is not thermodynamically stabilized (Delta E = E-2 - E-1 = -79 mV). Results with N386D CPD-PL support our earlier hypothesis of a kinetic barrier to sq oxidation associated with proton transfer. Both E-1 and E-2 are upshifted by similar to 100 mV in this mutant; replacing the N5-proximal Asn with Asp decreases the driving force for sq oxidation. However, this Asp alleviates the kinetic barrier, presumably by acting as a proton shuttle, because the sq in N386D CPD-PL oxidizes orders of magnitude more rapidly than wild type. These data clearly reveal, as suggested for plant CRYs, that an N5-proximal Asp can switch on proton transfer and modulate sq reactivity. However, the effect is context-dependent. More generally, we propose that PLs and CRYs tune the properties of their N5-proximal residue to adjust the extent of proton transfer, H-bonding patterns, and changes in protein conformation associated with electron transfer at the flavin.	[Damiani, Michael J.; Nostedt, Jordan J.; O'Neill, Melanie A.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	O'Neill, MA (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	maoneill@sfu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Michael Smith Foundation for Health Research (MSFHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Michael Smith Foundation for Health Research (MSFHR).	Astuti Y, 2004, J AM CHEM SOC, V126, P8001, DOI 10.1021/ja0496470; Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; BYRON CM, 1989, BIOCHEMISTRY-US, V28, P8582, DOI 10.1021/bi00447a047; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Chen HC, 2008, BIOCHEMISTRY-US, V47, P13788, DOI 10.1021/bi800954h; Chen KS, 2000, NATURE, V405, P814, DOI 10.1038/35015610; Costentin C, 2008, CHEM REV, V108, P2145, DOI 10.1021/cr068065t; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Damiani MJ, 2009, BIOCHEMISTRY-US, V48, P11399, DOI 10.1021/bi901371s; Dutton P L, 1978, Methods Enzymol, V54, P411; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Garnaud PE, 2004, BIOCHEMISTRY-US, V43, P11035, DOI 10.1021/bi049312v; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Henbest KB, 2008, P NATL ACAD SCI USA, V105, P14395, DOI 10.1073/pnas.0803620105; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; Iwata T, 2010, BIOCHEMISTRY-US, V49, P8882, DOI 10.1021/bi1009979; JORNS MS, 1984, BIOCHEMISTRY-US, V23, P2673, DOI 10.1021/bi00307a021; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Kottke T, 2006, BIOCHEMISTRY-US, V45, P2472, DOI 10.1021/bi051964b; Langenbacher T, 2009, J AM CHEM SOC, V131, P14274, DOI 10.1021/ja901628y; Li HY, 2008, J BIOL CHEM, V283, P34762, DOI 10.1074/jbc.M806949200; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; O'Farrell PA, 1998, BIOCHEMISTRY-US, V37, P8405, DOI 10.1021/bi973193k; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Sokolowsky K, 2010, J PHYS CHEM B, V114, P7121, DOI 10.1021/jp102275r; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Talfournier F, 2001, J BIOL CHEM, V276, P20190, DOI 10.1074/jbc.M010853200; Tamada T, 1997, NAT STRUCT BIOL, V4, P887, DOI 10.1038/nsb1197-887; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; Xu L, 2008, BIOCHEMISTRY-US, V47, P8736, DOI 10.1021/bi800391j; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	47	24	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4382	4391		10.1074/jbc.M110.194696	http://dx.doi.org/10.1074/jbc.M110.194696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131361	Green Published, hybrid			2022-12-25	WOS:000286975700038
J	Ferrari, E; Tinti, M; Costa, S; Corallino, S; Nardozza, AP; Chatraryamontri, A; Ceol, A; Cesareni, G; Castagnoli, L				Ferrari, Emanuela; Tinti, Michele; Costa, Stefano; Corallino, Salvatore; Nardozza, Aurelio Pio; Chatraryamontri, Andrew; Ceol, Arnaud; Cesareni, Gianni; Castagnoli, Luisa			Identification of New Substrates of the Protein-tyrosine Phosphatase PTP1B by Bayesian Integration of Proteome Evidence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; INSULIN-RECEPTOR; PHOSPHORYLATION SITES; ADAPTER PROTEIN; IN-VIVO; TC-PTP; 1B; ACTIVATION; CELLS; GAB1	There is growing evidence that tyrosine phosphatases display an intrinsic enzymatic preference for the sequence context flanking the target phosphotyrosines. On the other hand, substrate selection in vivo is decisively guided by the enzyme-substrate connectivity in the protein interaction network. We describe here a system wide strategy to infer physiological substrates of protein-tyrosine phosphatases. Here we integrate, by a Bayesian model, proteome wide evidence about in vitro substrate preference, as determined by a novel high-density peptide chip technology, and "closeness" in the protein interaction network. This allows to rank candidate substrates of the human PTP1B phosphatase. Ultimately a variety of in vitro and in vivo approaches were used to verify the prediction that the tyrosine phosphorylation levels of five high-ranking substrates, PLC-gamma 1, Gab1, SHP2, EGFR, and SHP1, are indeed specifically modulated by PTP1B. In addition, we demonstrate that the PTP1B-mediated dephosphorylation of Gab1 negatively affects its EGF-induced association with the phosphatase SHP2. The dissociation of this signaling complex is accompanied by a decrease of ERK MAP kinase phosphorylation and activation.	[Ferrari, Emanuela; Tinti, Michele; Costa, Stefano; Corallino, Salvatore; Nardozza, Aurelio Pio; Chatraryamontri, Andrew; Ceol, Arnaud; Cesareni, Gianni; Castagnoli, Luisa] Univ Roma Tor Vergata, Dept Biol, I-00144 Rome, Italy; [Cesareni, Gianni] IRCCS Fdn Santa Lucia, I-00143 Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia	Castagnoli, L (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00144 Rome, Italy.	cesareni@uniroma2.it; castagnoli@uniroma2.it	Ceol, Arnaud/H-3386-2012; Cesareni, Gianni/AAW-1382-2020	Ceol, Arnaud/0000-0001-9533-4246; Castagnoli, Luisa/0000-0001-5283-8671; Corallino, Salvatore/0000-0003-1911-6276; Tinti, Michele/0000-0002-0051-017X	Italian Association for Cancer Research (AIRC); Telethon; European Network of Excellence ENFIN	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); European Network of Excellence ENFIN	This work was supported by grants from the Italian Association for Cancer Research (AIRC), Telethon, and the European Network of Excellence ENFIN.	Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Dadke S, 2001, MOL CELL BIOCHEM, V221, P147, DOI 10.1023/A:1010909031310; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Easty D, 2006, CURR CANCER DRUG TAR, V6, P519, DOI 10.2174/156800906778194603; Edouard T, 2010, MOL CELL BIOL, V30, P2498, DOI 10.1128/MCB.00646-09; Espanel X, 2002, PROTEIN SCI, V11, P2326, DOI 10.1110/ps.0213402; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Garaud M, 2007, J AM CHEM SOC, V129, P5366, DOI 10.1021/ja071275i; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; LaMontagne KR, 1998, MOL CELL BIOL, V18, P2965, DOI 10.1128/MCB.18.5.2965; LaMontagne KR, 1998, P NATL ACAD SCI USA, V95, P14094, DOI 10.1073/pnas.95.24.14094; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; Schreiber TB, 2008, PROTEOMICS, V8, P4416, DOI 10.1002/pmic.200800132; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vetter SW, 2000, J BIOL CHEM, V275, P2265, DOI 10.1074/jbc.275.4.2265; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Zhu S, 2007, CANCER RES, V67, P10129, DOI 10.1158/0008-5472.CAN-06-4338	45	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4173	4185		10.1074/jbc.M110.157420	http://dx.doi.org/10.1074/jbc.M110.157420			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123182	Green Published, hybrid			2022-12-25	WOS:000286975700016
J	Han, KD; Matsuura, A; Ahn, HC; Kwon, AR; Min, YH; Park, HJ; Won, HS; Park, SJ; Kim, DY; Lee, BJ				Han, Kyung-Doo; Matsuura, Atsushi; Ahn, Hee-Chul; Kwon, Ae-Ran; Min, Yu-Hong; Park, Hyo-Ju; Won, Hyung-Sik; Park, Sung-Jean; Kim, Do-Young; Lee, Bong-Jin			Functional Identification of Toxin-Antitoxin Molecules from Helicobacter pylori 26695 and Structural Elucidation of the Molecular Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MESSENGER-RNA INTERFERASE; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; TRANSCRIPTIONAL AUTOREPRESSION; CRYSTAL-STRUCTURE; YEFM ANTITOXIN; ACTIVE-SITE; PROTEIN; CLEAVAGE	Bacterial toxin-antitoxin (TA) systems are associated with many important cellular processes including antibiotic resistance and microorganism virulence. Here, we identify and structurally characterize TA molecules from the gastric pathogen, Helicobacter pylori. The HP0894 protein had been previously suggested, through our structural genomics approach, to be a putative toxin molecule. In this study, the intrinsic RNase activity and the bacterial cell growth-arresting activity of HP0894 were established. The RNA-binding surface was identified at three residue clusters: (Lys(8) and Ser(9)), (Lys(50)-Lys(54) and Glu(58)), and (Arg(80) and His(84)-Phe(88)). In particular, the -UA- and -CA- sequences in RNA were preferentially cleaved by HP0894, and residues Lys(52), Trp(53), and Ser(85)-Lys(87) were observed to be the main contributors to sequence recognition. The action of HP0894 could be inhibited by the HP0895 protein, and the HP0894-HP0895 complex formed an oligomer with a binding stoichiometry of 1:1. The N and C termini of HP0894 constituted the binding sites to HP0895. In contrast, the unstructured C-terminal region of HP0895 was responsible for binding to HP0894 and underwent a conformational change in the process. Finally, DNA binding activity was observed for both HP0895 and the HP0894-0895 complex but not for HP0894 alone. Taken together, it is concluded that the HP0894-HP0895 protein couple is a TA system in H. pylori, where HP0894 is a toxin with an RNase function, whereas HP0895 is an antitoxin functioning by binding to both the toxin and DNA.	[Han, Kyung-Doo; Matsuura, Atsushi; Kwon, Ae-Ran; Park, Hyo-Ju; Lee, Bong-Jin] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Ahn, Hee-Chul] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul 136791, South Korea; [Kwon, Ae-Ran; Min, Yu-Hong] Daegu Haany Univ, Dept Herbal Skin Care, Gyongsan 712715, Gyeongsangbuk, South Korea; [Won, Hyung-Sik] Konkuk Univ, Sch Med, Chungju 380701, Chungcheongbuk, South Korea; [Park, Sung-Jean] Gachon Univ, Sch Med & Sci, Grad Sch Med, Inchon 406799, South Korea; [Kim, Do-Young] Davidson Coll, Davidson, NC 28035 USA	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Daegu Haany University; Konkuk University; Konkuk University Medical Center; Gachon University; Davidson College	Lee, BJ (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea.	lbj@nmr.snu.ac.kr	Lee, Bong-Jin/AAQ-1609-2020	Lee, Bong-Jin/0000-0001-7896-2961	Korean government (Ministry of Education, Science and Technology (MEST) [20100001707]; New Drug Target [3700-20070095]; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A084420, A092006]; Brain Korea 21 Project for Medicine, Dentistry, and Pharmacy	Korean government (Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); New Drug Target; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Brain Korea 21 Project for Medicine, Dentistry, and Pharmacy(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by National Research Foundation (NRF) of Korea Grant 20100001707 funded by the Korean government (Ministry of Education, Science and Technology (MEST)) and New Drug Target Discovery Grant 3700-20070095. This work was also supported by Grants A084420 and A092006 of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea. This work was supported in part by the 2009 Brain Korea 21 Project for Medicine, Dentistry, and Pharmacy.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Cherny I, 2007, BIOCHEMISTRY-US, V46, P12152, DOI 10.1021/bi701037e; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2004, TRENDS MICROBIOL, V12, P66, DOI 10.1016/j.tim.2003.12.008; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Graham JE, 2002, GASTROENTEROLOGY, V123, P1637, DOI 10.1053/gast.2002.36589; Han KD, 2005, PROTEINS, V61, P1114, DOI 10.1002/prot.20691; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Lah J, 2003, J BIOL CHEM, V278, P14101, DOI 10.1074/jbc.M209855200; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Megraud F, 2004, GUT, V53, P1374, DOI 10.1136/gut.2003.022111; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Rothenbacher D, 2003, MICROBES INFECT, V5, P693, DOI 10.1016/S1286-4579(03)00111-4; Sachs G, 2003, ANNU REV PHYSIOL, V65, P349, DOI 10.1146/annurev.physiol.65.092101.142156; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Sevcik J, 1996, ACTA CRYSTALLOGR D, V52, P327, DOI 10.1107/S0907444995007669; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson DN, 2005, NAT STRUCT MOL BIOL, V12, P282, DOI 10.1038/nsmb0405-282; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Yakovlev GI, 2003, PROTEIN SCI, V12, P2367, DOI 10.1110/ps.03176803; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	46	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4842	4853		10.1074/jbc.M109.097840	http://dx.doi.org/10.1074/jbc.M109.097840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123184	Green Published, hybrid			2022-12-25	WOS:000286975700081
J	Kirabo, A; Embury, J; Kiss, R; Polgar, T; Gali, M; Majumder, A; Bisht, KS; Cogle, CR; Keseru, GM; Sayeski, PP				Kirabo, Annet; Embury, Jennifer; Kiss, Robert; Polgar, Timea; Gali, Meghanath; Majumder, Anurima; Bisht, Kirpal S.; Cogle, Christopher R.; Keseru, Gyoergy M.; Sayeski, Peter P.			The Stilbenoid Tyrosine Kinase Inhibitor, G6, Suppresses Jak2-V617F-mediated Human Pathological Cell Growth in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; POLYCYTHEMIA-VERA; JAK2 INHIBITOR; MYELOPROLIFERATIVE DISORDERS; ACTIVATING MUTATION; MURINE MODEL; MYELOFIBROSIS; APOPTOSIS; IDENTIFICATION; RESVERATROL	Using structure-based virtual screening, we previously identified a novel stilbenoid inhibitor of Jak2 tyrosine kinase named G6. Here, we hypothesized that G6 suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo. We found that G6 inhibited proliferation of the Jak2-V617F expressing human erythroleukemia (HEL) cell line by promoting marked cell cycle arrest and inducing apoptosis. The G6-dependent increase in apoptosis levels was concomitant with increased caspase 3/7 activity and cleavage of PARP. G6 also selectively inhibited phosphorylation of STAT5, a downstream signaling target of Jak2. Using a mouse model of Jak2-V617F-mediated hyperplasia, we found that G6 significantly decreased the percentage of blast cells in the peripheral blood, reduced splenomegaly, and corrected a pathologically low myeloid to erythroid ratio in the bone marrow by eliminating HEL cell engraftment in this tissue. In addition, drug efficacy correlated with the presence of G6 in the plasma, marrow, and spleen. Collectively, these data demonstrate that the stilbenoid compound, G6, suppresses Jak2-V617F-mediated aberrant cell growth. As such, G6 may be a potential therapeutic lead candidate against Jak2-mediated, human disease.	[Kirabo, Annet; Majumder, Anurima; Sayeski, Peter P.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Embury, Jennifer] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Kiss, Robert] Heriot Watt Univ, Dept Chem Engn, Edinburgh EH14 4A5, Midlothian, Scotland; [Polgar, Timea; Keseru, Gyoergy M.] Budapest Univ Technol & Econ, Dept Gen & Analyt Chem, H-1111 Budapest, Hungary; [Gali, Meghanath; Bisht, Kirpal S.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Cogle, Christopher R.] Univ Florida, Coll Med, Dept Med, Div Hematol & Oncol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Heriot Watt University; Budapest University of Technology & Economics; State University System of Florida; University of South Florida; State University System of Florida; University of Florida	Sayeski, PP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, POB 100274, Gainesville, FL 32610 USA.	psayeski@ufl.edu	Cogle, Christopher/H-1746-2016; Polgár, Tímea/A-2089-2013	Cogle, Christopher/0000-0001-5422-6863; Polgár, Tímea/0000-0002-1367-6128; Keseru, Gyorgy M/0000-0003-1039-7809; Kiss, Robert/0000-0002-2879-6325	National Institutes of Health [R01-HL67277]; American Heart Association Greater Southeast Affiliate [0855361E]; University of Florida; University of Florida/Moffitt Cancer Center Collaborative Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK067359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Greater Southeast Affiliate(American Heart Association); University of Florida(University of Florida); University of Florida/Moffitt Cancer Center Collaborative Initiative(University of Florida); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL67277, an American Heart Association Greater Southeast Affiliate Grant in Aid (0855361E), a University of Florida Opportunity Fund Award, and a University of Florida/Moffitt Cancer Center Collaborative Initiative Award.	Antonysamy S, 2009, BIOORG MED CHEM LETT, V19, P279, DOI 10.1016/j.bmcl.2008.08.064; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Ferrajoli A, 2007, CANCER RES, V67, P11291, DOI 10.1158/0008-5472.CAN-07-0593; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Gozgit JM, 2008, J BIOL CHEM, V283, P32334, DOI 10.1074/jbc.M803813200; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kimura Y, 2005, IN VIVO, V19, P37; Koppikar P, 2010, BLOOD, V115, P2919, DOI 10.1182/blood-2009-04-218842; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Larrosa M, 2003, J AGR FOOD CHEM, V51, P4576, DOI 10.1021/jf030073c; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lipka DB, 2008, MOL CANCER THER, V7, P1176, DOI 10.1158/1535-7163.MCT-07-2215; Majumder A, 2010, J BIOL CHEM, V285, P31399, DOI 10.1074/jbc.M110.168211; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; Pardanani A, 2009, LEUKEMIA, V23, P1441, DOI 10.1038/leu.2009.50; Sandberg EM, 2005, J MED CHEM, V48, P2526, DOI 10.1021/jm049470k; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Sayyah J, 2008, MOL CANCER THER, V7, P2308, DOI 10.1158/1535-7163.MCT-08-0279; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Swanson-Mungerson M, 2003, J ANTIMICROB CHEMOTH, V52, P152, DOI 10.1093/jac/dkg306; Szabo G, 2009, BIOORG MED CHEM LETT, V19, P3471, DOI 10.1016/j.bmcl.2009.05.010; Tyner JW, 2010, BLOOD, V115, P5232, DOI 10.1182/blood-2009-05-223727; Wadleigh Martha, 2010, Clin Adv Hematol Oncol, V8, P557; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	32	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4280	4291		10.1074/jbc.M110.200774	http://dx.doi.org/10.1074/jbc.M110.200774			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127060	Green Published, hybrid			2022-12-25	WOS:000286975700027
J	Saito, A; Ochiai, K; Kondo, S; Tsumagari, K; Murakami, T; Cavener, DR; Imaizumi, K				Saito, Atsushi; Ochiai, Kimiko; Kondo, Shinichi; Tsumagari, Kenji; Murakami, Tomohiko; Cavener, Douglas R.; Imaizumi, Kazunori			Endoplasmic Reticulum Stress Response Mediated by the PERK-eIF2 alpha-ATF4 Pathway Is Involved in Osteoblast Differentiation Induced by BMP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLCOTT-RALLISON-SYNDROME; CIS-ACTING ELEMENT; TRANSLATIONAL CONTROL; MAMMALIAN-CELLS; INITIATION FACTOR-2-ALPHA; TRANSCRIPTION FACTOR; OSTEOCALCIN GENE; MESSENGER-RNA; KINASE; EXPRESSION	To avoid excess accumulation of unfolded proteins in the endoplasmic reticulum (ER), eukaryotic cells have signaling pathways from the ER to the cytosol or nucleus. These processes are collectively termed the ER stress response. Double stranded RNA activated protein kinase (PKR)-like endoplasmic reticulum kinase (PERK) is a major transducer of the ER stress response and directly phosphorylates eIF2 alpha, resulting in translational attenuation. Phosphorylated eIF2 alpha specifically promotes the translation of the transcription factor ATF4. ATF4 plays important roles in osteoblast differentiation and bone formation. Perk(-/-) mice are reported to exhibit severe osteopenia, and the phenotypes observed in bone tissues are very similar to those of Atf4(-/-) mice. However, the involvement of the PERK-eIF2 alpha-ATF4 signaling pathway in osteogenesis is unclear. Phosphorylated eIF2 alpha and ATF4 protein levels were attenuated in Perk(-/-) calvariae, and the gene expression levels of osteocalcin (Ocn) and bone sialoprotein (Bsp), which are targets for ATF4, were also down-regulated. Treatment of wild-type primary osteoblasts with BMP2, which is required for osteoblast differentiation, induced ER stress, leading to an increase in ATF4 protein expression levels. In contrast, the level of ATF4 in Perk(-/-) osteoblasts was severely diminished. The results indicate that PERK signaling is required for ATF4 activation during osteoblast differentiation. Perk(-/-) osteoblasts exhibited decreased alkaline phosphatase activities and delayed mineralized nodule formation relative to wild-type cultures. These abnormalities were almost completely restored by the introduction of ATF4 into Perk(-/-) osteoblasts. Taken together, ER stress occurs during osteoblast differentiation and activates the PERK-eIF2 alpha-ATF4 signaling pathway followed by the promotion of gene expression essential for osteogenesis, such as Ocn and Bsp.	[Saito, Atsushi; Kondo, Shinichi; Tsumagari, Kenji; Imaizumi, Kazunori] Hiroshima Univ, Grad Sch Biomed Sci, Div Genome Radiobiol & Med Sci, Dept Biochem, Hiroshima 7348553, Japan; [Ochiai, Kimiko; Murakami, Tomohiko] Miyazaki Univ, Fac Med, Dept Anat, Div Mol & Cellular Biol, Miyazaki 8891692, Japan; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Hiroshima University; University of Miyazaki; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Imaizumi, K (corresponding author), 1-2-3 Kasumi,Minami Ku, Hiroshima 7348553, Japan.	imaizumi@hiroshima-u.ac.jp	Cavener, Douglas R/E-3524-2010		Japan Society for the Promotion of Science KAKENHI [22020030, 21790323, 21790174, 22800049]; Mochida Memorial Foundation for Medical and Pharmaceutical; Senri Life Science Foundation; Uehara Memorial Foundation; Toray Science Foundation; Takeda Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mochida Memorial Foundation for Medical and Pharmaceutical; Senri Life Science Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Toray Science Foundation(Toray Industries, Inc.); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partly supported by grants from the Japan Society for the Promotion of Science KAKENHI (Grants 22020030, 21790323, 21790174, and 22800049), the Mochida Memorial Foundation for Medical and Pharmaceutical, the Senri Life Science Foundation, The Uehara Memorial Foundation, the Toray Science Foundation, and the Takeda Science Foundation.	Biason-Lauber A, 2002, DIABETES, V51, P2301, DOI 10.2337/diabetes.51.7.2301; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Iyer S, 2004, ACTA PAEDIATR, V93, P1195, DOI 10.1080/08035250410029362; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	33	193	212	4	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4809	4818		10.1074/jbc.M110.152900	http://dx.doi.org/10.1074/jbc.M110.152900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21135100	hybrid, Green Published			2022-12-25	WOS:000286975700078
J	Shinkyo, R; Guengerich, FP				Shinkyo, Raku; Guengerich, F. Peter			Cytochrome P450 7A1 Cholesterol 7 alpha-Hydroxylation INDIVIDUAL REACTION STEPS IN THE CATALYTIC CYCLE AND RATE-LIMITING FERRIC IRON REDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER MICROSOMAL CYTOCHROME-P-450; BILE-ACID BIOSYNTHESIS; P450 REDUCTASE; OXIDATION REACTIONS; KINETIC-ANALYSIS; KEY ENZYME; BINDING; HYDROXYLATION; SUBSTRATE; 3A4	Cytochrome P450 (P450) 7A1 is well known as the cholesterol 7 alpha-hydroxylase, the first enzyme involved in bile acid synthesis from cholesterol. The human enzyme has been reported to have the highest catalytic activity of any mammalian P450. Analyses of individual steps of cholesterol 7 alpha-hydroxylation reaction revealed several characteristics of this reaction: (i) two-step binding of cholesterol to ferric P450, with an apparent K-d of 0.51 mu M, (ii) a rapid reduction rate in the presence of cholesterol (similar to 10 s(-1) for the fast phase), (iii) rapid formation of a ferrous P450-cholesterol-O-2 complex (29 s(-1)), (iv) the lack of a non-competitive kinetic deuterium isotope effect, (v) the lack of a kinetic burst, and (vi) the lack of a deuterium isotope effect when the reaction was initiated with the ferrous P450-cholesterol complex. A minimum kinetic model was developed and is consistent with all of the observed phenomena and the rates of cholesterol 7 alpha-hydroxylation and H2O and H2O2 formation. The results indicate that the first electron transfer step, although rapid, becomes rate-limiting in the overall P450 7A1 reaction. This is a different phenomenon compared with other P450s that have much lower rates of catalysis, attributed to the much more efficient substrate oxidation steps in this reaction.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Shinkyo, Raku/HIK-2997-2022		National Institutes of Health [R37 CA090426, P30 ES000267]; Eisai Co., Ltd.; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eisai Co., Ltd.(Eisai Co Ltd); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426 and P30 ES000267 (to F. P. G.). This work was also supported by Eisai Co., Ltd. (to R. S.).	BERGSTROM S, 1958, J AM CHEM SOC, V80, P2337, DOI 10.1021/ja01542a081; Brunel JM, 2005, TETRAHEDRON-ASYMMETR, V16, P3036, DOI 10.1016/j.tetasy.2005.08.024; COREY EJ, 1959, J AM CHEM SOC, V81, P3127, DOI 10.1021/ja01521a053; CUNNINGHAM IM, 1974, J CHEM SOC PERK T 1, P2458, DOI 10.1039/p19740002458; Denisov IG, 2006, J BIOL CHEM, V281, P23313, DOI 10.1074/jbc.M605511200; DIEHL H, 1970, H-S Z PHYSIOL CHEM, V351, P1359, DOI 10.1515/bchm2.1970.351.2.1359; Dierks EA, 1998, BIOCHEMISTRY-US, V37, P1839, DOI 10.1021/bi972458s; EINARSSON K, 1989, J LIPID RES, V30, P1477; ESTABROOK RW, 1971, METABOLISM, V20, P187, DOI 10.1016/0026-0495(71)90091-6; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; GIGON PL, 1969, MOL PHARMACOL, V5, P109; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Guengerich FP, 2002, J BIOL CHEM, V277, P33711, DOI 10.1074/jbc.M205146200; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P6019, DOI 10.1021/bi00266a045; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Krauser JA, 2005, J BIOL CHEM, V280, P19496, DOI 10.1074/jbc.M501854200; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Loughran PA, 2000, BIOCHEMISTRY-US, V39, P15110, DOI 10.1021/bi001522u; MAEDA Y, 1995, EUR J BIOCHEM, V228, P144, DOI 10.1111/j.1432-1033.1995.0144o.x; MARTIN KO, 1993, J LIPID RES, V34, P581; Mast N, 2005, J LIPID RES, V46, P1561, DOI 10.1194/jlr.D500008-JLR200; Mast N, 2005, BIOCHEMISTRY-US, V44, P3259, DOI 10.1021/bi047566a; Mueller Ernest J., 1995, P83; Nakayama K, 2001, J BIOL CHEM, V276, P31459, DOI 10.1074/jbc.M103943200; Norlin M, 2000, J BIOL CHEM, V275, P34046, DOI 10.1074/jbc.M002663200; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; OPRIAN DD, 1983, J BIOL CHEM, V258, P8684; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Shaw PM, 1997, ARCH BIOCHEM BIOPHYS, V348, P107, DOI 10.1006/abbi.1997.0378; Sligar SG, 2005, BIOCHEM BIOPH RES CO, V338, P346, DOI 10.1016/j.bbrc.2005.08.094; Sohl CD, 2008, J BIOL CHEM, V283, P7293, DOI 10.1074/jbc.M709783200; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Tang ZM, 2010, ANAL CHEM, V82, P7706, DOI 10.1021/ac1015497; Wilson WK, 1996, J LIPID RES, V37, P1529; YAMAZAKI H, 1995, BIOCHEMISTRY-US, V34, P8380, DOI 10.1021/bi00026a020; Yamazaki H, 1996, BIOCHEM PHARMACOL, V52, P301, DOI 10.1016/0006-2952(96)00208-0; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Yun CH, 2000, BIOCHEMISTRY-US, V39, P11319, DOI 10.1021/bi000869u	50	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4632	4643		10.1074/jbc.M110.193409	http://dx.doi.org/10.1074/jbc.M110.193409			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21147774	hybrid, Green Published			2022-12-25	WOS:000286975700063
J	Sun, LY; Shi, L; Wang, F; Huangyang, PW; Si, WZ; Yang, J; Yao, Z; Shang, YF				Sun, Luyang; Shi, Lei; Wang, Feng; Huangyang, Peiwei; Si, Wenzhe; Yang, Jie; Yao, Zhi; Shang, Yongfeng			Substrate Phosphorylation and Feedback Regulation in JFK-promoted p53 Destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEINS; COP9 SIGNALOSOME; UBIQUITIN LIGASE; CYTOPLASMIC LOCALIZATION; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; NUCLEAR EXPORT; C-MYC	The p53 tumor suppressor plays a central role in integrating cellular responses to various stresses. Tight regulation of p53 is thus essential for the maintenance of genome integrity and normal cell proliferation. Previously, we reported that JFK, the only Kelch domain-containing F-box protein in human, promotes ubiquitination and degradation of p53 and that unlike the other E3 ligases for p53, all of which possess an intrinsic ubiquitin ligase activity, JFK destabilizes p53 through the assembly of a Skp1-Cul1-F-box complex. Here, we report that the substrate recognition by JFK requires phosphorylation of p53 in its central core region by CSN (COP9 signalosome)associated kinase. Significantly, inhibition of CSN-associated kinase activity or knockdown of CSN5 impairs JFK-promoted p53 degradation, enhances p53-dependent transcription, and promotes cell growth suppression, G(1) arrest, and apoptosis. Moreover, we showed that JFK is transcriptionally regulated by p53 and forms an auto-regulatory negative feedback loop with p53. These data may shed new light on the functional connection between CSN, Skp1-Cul1-F-box ubiquitin ligase, and p53 and provide a molecular mechanism for the regulation of JFK-promoted p53 degradation.	[Yang, Jie; Yao, Zhi; Shang, Yongfeng] Tianjin Med Univ, Tianjin 300070, Peoples R China; [Sun, Luyang; Shi, Lei; Wang, Feng; Huangyang, Peiwei; Si, Wenzhe; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & translat Res, Dept Biochem & Mol Biol,Minist Educ, Beijing 100191, Peoples R China	Tianjin Medical University; Peking University	Yao, Z (corresponding author), Tianjin Med Univ, Tianjin 300070, Peoples R China.	yaozhi@tijmu.edu.cn	Huangyang, Peiwei/AAS-8905-2021; HUANG, YANGPEIWEI/AAS-7683-2021	HUANG, YANGPEIWEI/0000-0002-9131-3891	National Natural Science Foundation of China [30830032, 30921062, 81071673]; Ministry of Science and Technology of China [2007CB914503, 2011CB504204, 2009CB918903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 30830032 and 30921062 (to Y. S.) and 81071673 (to L. S.) from the National Natural Science Foundation of China and Grants 973 Program 2007CB914503 and 2011CB504204 (to Y. S.) and 2009CB918903 (to Z. Y.) from the Ministry of Science and Technology of China.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Corcoran CA, 2004, CANCER BIOL THER, V3, P721, DOI 10.4161/cbt.3.8.1068; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kim JH, 2009, J CELL BIOCHEM, V107, P557, DOI 10.1002/jcb.22157; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee EW, 2006, MOL CELLS, V22, P133; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; LUNA RMD, 1995, NATURE, V378, P203; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Sun LY, 2009, P NATL ACAD SCI USA, V106, P10195, DOI 10.1073/pnas.0901864106; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang XP, 2003, PLANT CELL, V15, P1071, DOI 10.1105/tpc.009936; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang XC, 2008, J CELL BIOCHEM, V103, P1219, DOI 10.1002/jcb.21504	50	18	19	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4226	4235		10.1074/jbc.M110.195115	http://dx.doi.org/10.1074/jbc.M110.195115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127074	Green Published, hybrid			2022-12-25	WOS:000286975700021
J	Mun, GI; Kim, IS; Lee, BH; Boo, YC				Mun, Gyeong In; Kim, In-San; Lee, Byung-Heon; Boo, Yong Chool			Endothelial Argininosuccinate Synthetase 1 Regulates Nitric Oxide Production and Monocyte Adhesion under Static and Laminar Shear Stress Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; GENE-EXPRESSION; SYNTHASE EXPRESSION; DEPENDENT REGULATION; C-SRC; ARGININE; NO; CELLS; ACID; REGENERATION	Laminar shear stress (LSS) is known to increase endothelial nitric oxide (NO) production, which is essential for vascular health, through expression and activation of nitric oxide synthase 3 (NOS3). Recent studies demonstrated that LSS also increases the expression of argininosuccinate synthetase 1 (ASS1) that regulates the provision of L-arginine, the substrate of NOS3. It was thus hypothesized that ASS1 might contribute to vascular health by enhancing NO production in response to LSS. This hypothesis was pursued in the present study by modulating NOS3 and ASS1 levels in cultured endothelial cells. Exogenous expression of either NOS3 or ASS1 in human umbilical vein endothelial cells increased NO production and decreased monocyte adhesion stimulated by tumor necrosis factor-alpha (TNF-alpha). The latter effect of overexpressed ASS1 was reduced when human umbilical vein endothelial cells were co-treated with small interfering RNAs (siRNAs) for ASS1 or NOS3. SiRNAs of NOS3 and ASS1 attenuated the increase of NO production in human aortic endothelial cells stimulated by LSS (12 dynes.cm(-2)) for 24 h. LSS inhibited monocyte adhesion to human aortic endothelial cells stimulated by TNF-alpha, but this effect of LSS was abrogated by siRNAs of NOS3 and ASS1 that recovered the expression of vascular cell adhesion molecule-1. The current study suggests that the expression of ASS1 harmonized with that of NOS3 may be important for the optimized endothelial NO production and the prevention of the inflammatory monocyte adhesion to endothelial cells.	[Mun, Gyeong In; Boo, Yong Chool] Kyungpook Natl Univ, Sch Med, Dept Mol Med, Taegu 700422, South Korea; [Kim, In-San; Lee, Byung-Heon] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol,Cell & Matrix Res Inst, Med Educ Program Human Resources BK21, Taegu 700422, South Korea	Kyungpook National University; Kyungpook National University	Boo, YC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Mol Med, 101 Dongindong 2 Ga, Taegu 700422, South Korea.	ycboo@knu.ac.kr	김, 인산/I-8988-2014; Kim, In-San/D-3956-2017	Boo, Yong Chool/0000-0001-9895-2066	Ministry of Education, Science and Technology, Republic of Korea [2009-0071171]; Ministry of Knowledge Economy, Republic of Korea [RTI 04-01-01]	Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric)	This work was supported by grants from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, Republic of Korea (Grant 2009-0071171) and by the Regional Technology Innovation Program of the Ministry of Knowledge Economy, Republic of Korea (Grant RTI 04-01-01).	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BAYDOUN AR, 1990, BIOCHEM BIOPH RES CO, V173, P940, DOI 10.1016/S0006-291X(05)80876-9; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; Boo YC, 2003, FREE RADICAL BIO MED, V35, P729, DOI 10.1016/S0891-5849(03)00397-6; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Boo YC, 2007, NITRIC OXIDE-BIOL CH, V16, P306, DOI 10.1016/j.niox.2006.09.004; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; Brasse-Lagnel C, 2003, J BIOL CHEM, V278, P52504, DOI 10.1074/jbc.M306752200; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, p334A; Chen BPC, 2001, PHYSIOL GENOMICS, V7, P55, DOI 10.1152/physiolgenomics.2001.7.1.55; Cooke JP, 1997, CIRCULATION, V95, P311; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Davis ME, 2003, AM J PHYSIOL-HEART C, V284, pH1449, DOI 10.1152/ajpheart.00918.2002; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Duan WL, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-16; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; Flam BR, 2007, NITRIC OXIDE-BIOL CH, V17, P115, DOI 10.1016/j.niox.2007.07.001; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Hardy TA, 2002, FREE RADICAL BIO MED, V32, P122, DOI 10.1016/S0891-5849(01)00781-X; HATTORI Y, 1994, J BIOL CHEM, V269, P9405; Hayashi T, 2005, P NATL ACAD SCI USA, V102, P13681, DOI 10.1073/pnas.0506595102; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Kim HJ, 2006, BIOCHEM BIOPH RES CO, V345, P1657, DOI 10.1016/j.bbrc.2006.05.090; Kurz S, 1997, J CLIN INVEST, V99, P369, DOI 10.1172/JCI119166; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; McDonald KK, 1997, J BIOL CHEM, V272, P31213, DOI 10.1074/jbc.272.50.31213; MORIGI M, 1995, BLOOD, V85, P1696, DOI 10.1182/blood.V85.7.1696.bloodjournal8571696; Mun GI, 2008, AM J PHYSIOL-HEART C, V295, pH1966, DOI 10.1152/ajpheart.00727.2008; Mun GI, 2010, AM J PHYSIOL-HEART C, V298, pH2102, DOI 10.1152/ajpheart.00835.2009; Mun GI, 2009, FREE RADICAL BIO MED, V47, P291, DOI 10.1016/j.freeradbiomed.2009.04.032; Padilla J, 2008, VASC MED, V13, P105, DOI 10.1177/1358863x07086671; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Rieder MJ, 1997, CIRC RES, V80, P312, DOI 10.1161/01.RES.80.3.312; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Szabados E, 1999, FREE RADICAL BIO MED, V27, P1103, DOI 10.1016/S0891-5849(99)00151-3; Tsao PS, 1996, CIRCULATION, V94, P1682, DOI 10.1161/01.CIR.94.7.1682; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Widder JD, 2007, CIRC RES, V101, P830, DOI 10.1161/CIRCRESAHA.107.153809; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Xie LJ, 1997, J BIOL CHEM, V272, P16624, DOI 10.1074/jbc.272.26.16624	48	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2536	2542		10.1074/jbc.M110.180489	http://dx.doi.org/10.1074/jbc.M110.180489			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21106532	Green Published, hybrid			2022-12-25	WOS:000286464300018
J	Zhong, SP; Machida, K; Tsukamoto, H; Johnson, DL				Zhong, Shuping; Machida, Keigo; Tsukamoto, Hide; Johnson, Deborah L.			Alcohol Induces RNA Polymerase III-dependent Transcription through c-Jun by Co-regulating TATA-binding Protein (TBP) and Brf1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENIC TRANSFORMATION; CELL-PROLIFERATION; INHIBITION; ACTIVATION; STRESS; TFIIIB; ELK-1; JNK1	Chronic alcohol consumption is associated with steatohepatitis and cirrhosis, enhancing the risk for hepatocellular carcinoma. RNA polymerase (pol) III transcribes a variety of small, untranslated RNAs, including tRNAs and 5S rRNAs, which determine the biosynthetic capacity of cells. Increased RNA pol III-dependent transcription, observed in transformed cells and human tumors, is required for oncogenic transformation. Given that alcohol consumption increases risk for liver cancer, we examined whether alcohol regulates this class of genes. Ethanol induces RNA pol III-dependent transcription in both HepG2 cells and primary mouse hepatocytes in a manner that requires ethanol metabolism and the activation of JNK1. This regulatory event is mediated, at least in part, through the ability of ethanol to induce expression of the TFIIIB components, Brf1, and the TATA-binding protein (TBP). Induction of TBP, Brf1, and RNA pol III-dependent gene expression is driven by enhanced c-Jun expression. Ethanol promotes a marked increase in the direct recruitment of c-Jun to TBP, Brf1, and tRNA gene promoters. Chronic alcohol administration in mice leads to enhanced expression of TBP, Brf1, tRNA, and 5S rRNA gene transcription in the liver. These alcohol-dependent increases are more pronounced in transgenic animals that express the HCV NS5A protein that display increased incidence of liver tumors. Together, these results identify a new class of genes that are regulated by alcohol through the co-regulation of TFIIIB components and define a central role for c-Jun in this process.	[Tsukamoto, Hide] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Tsukamoto, Hide] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Machida, Keigo] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Zhong, Shuping; Johnson, Deborah L.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Zhong, Shuping; Johnson, Deborah L.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhong, SP (corresponding author), 2011 Zonal Ave,HMR 605 MC 9097, Los Angeles, CA 90033 USA.	szhong@usc.edu			National Institutes of Health through the Southern California Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis [P50 AA011999]; National Institutes of Health [AA017288, CA108614]; NATIONAL CANCER INSTITUTE [R01CA108614, R01CA074138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, R21AA017288] Funding Source: NIH RePORTER	National Institutes of Health through the Southern California Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 AA011999 (to S.Z.) through the Southern California Research Center for Alcoholic Liver and Pancreatic Diseases and Cirrhosis and National Institutes of Health Grants AA017288 (to S.Z.) and CA108614 (to D.L.J.).	Cabarcas S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-74; Clemens DL, 2002, HEPATOLOGY, V35, P1196, DOI 10.1053/jhep.2002.32668; COLGAN J, 1992, GENE DEV, V6, P304, DOI 10.1101/gad.6.2.304; Crighton D, 2003, EMBO J, V22, P2810, DOI 10.1093/emboj/cdg265; de Alwis NMW, 2007, SEMIN LIVER DIS, V27, P44, DOI 10.1055/s-2006-960170; Fromm JA, 2008, MOL CELL BIOL, V28, P6483, DOI 10.1128/MCB.00288-08; Johnson DL, 2008, SCIENCE, V320, P461, DOI 10.1126/science.1158680; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Johnson SAS, 2000, MOL CELL BIOL, V20, P5000, DOI 10.1128/MCB.20.14.5000-5009.2000; Johnson SAS, 2003, MOL CELL BIOL, V23, P3043, DOI 10.1128/MCB.23.9.3043-3051.2003; Li TH, 1999, GENE, V239, P367, DOI 10.1016/S0378-1119(99)00384-4; Machida K, 2009, P NATL ACAD SCI USA, V106, P1548, DOI 10.1073/pnas.0807390106; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Nishitani Y, 2006, FEBS LETT, V580, P9, DOI 10.1016/j.febslet.2005.11.030; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; SADOVSKY Y, 1995, MOL CELL BIOL, V15, P1554; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Yeligar SM, 2009, J IMMUNOL, V183, P5964, DOI 10.4049/jimmunol.0901564; Ying TH, 2008, CELL BIOL INT, V32, P210, DOI 10.1016/j.cellbi.2007.08.027; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005; Zhong SP, 2007, MOL CELL BIOL, V27, P54, DOI 10.1128/MCB.01365-06; Zhong SP, 2009, P NATL ACAD SCI USA, V106, P12682, DOI 10.1073/pnas.0904843106; Zhong SP, 2004, MOL CELL BIOL, V24, P5119, DOI 10.1128/MCB.24.12.5119-5129.2004	27	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2393	2401		10.1074/jbc.M110.192955	http://dx.doi.org/10.1074/jbc.M110.192955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21106530	hybrid, Green Published			2022-12-25	WOS:000286464300003
J	Semo, M; Gias, C; Ahmado, A; Sugano, E; Allen, AE; Lawrence, JM; Tomita, H; Coffey, PJ; Vugler, AA				Semo, Ma'ayan; Gias, Carlos; Ahmado, Ahmad; Sugano, Eriko; Allen, Annette E.; Lawrence, Jean M.; Tomita, Hiroshi; Coffey, Peter J.; Vugler, Anthony A.			Dissecting a Role for Melanopsin in Behavioural Light Aversion Reveals a Response Independent of Conventional Photoreception	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; SUPERIOR COLLICULUS; MICE LACKING; PUPILLARY CONSTRICTION; OCULAR PHOTORECEPTORS; RETROSPLENIAL CORTEX; VISUAL-CORTEX; MOUSE MODEL; NON-CONE; NON-ROD	Melanopsin photoreception plays a vital role in irradiance detection for non-image forming responses to light. However, little is known about the involvement of melanopsin in emotional processing of luminance. When confronted with a gradient in light, organisms exhibit spatial movements relative to this stimulus. In rodents, behavioural light aversion (BLA) is a well-documented but poorly understood phenomenon during which animals attribute salience to light and remove themselves from it. Here, using genetically modified mice and an open field behavioural paradigm, we investigate the role of melanopsin in BLA. While wildtype (WT), melanopsin knockout (Opn4(-/-)) and rd/rd cl (melanopsin only (MO)) mice all exhibit BLA, our novel methodology reveals that isolated melanopsin photoreception produces a slow, potentiating response to light. In order to control for the involvement of pupillary constriction in BLA we eliminated this variable with topical atropine application. This manipulation enhanced BLA in WT and MO mice, but most remarkably, revealed light aversion in triple knockout (TKO) mice, lacking three elements deemed essential for conventional photoreception (Opn4(-/-) Gnat1(-/-) Cnga3(-/-)). Using a number of complementary strategies, we determined this response to be generated at the level of the retina. Our findings have significant implications for the understanding of how melanopsin signalling may modulate aversive responses to light in mice and humans. In addition, we also reveal a clear potential for light perception in TKO mice.	[Semo, Ma'ayan; Gias, Carlos; Ahmado, Ahmad; Lawrence, Jean M.; Coffey, Peter J.; Vugler, Anthony A.] UCL, Dept Ocular Biol & Therapeut, Inst Ophthalmol, London, England; [Sugano, Eriko; Tomita, Hiroshi] Tohoku Univ, Inst Int Adv Interdisciplinary Res, Aoba Ku, Sendai, Miyagi 980, Japan; [Allen, Annette E.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of London; University College London; Tohoku University; University of Manchester	Semo, M (corresponding author), UCL, Dept Ocular Biol & Therapeut, Inst Ophthalmol, London, England.	m.semo@ucl.ac.uk; a.vugler@ucl.ac.uk	Tomita, Hiroshi/O-2135-2018; Ahmado, Ahmad/R-5537-2019	Tomita, Hiroshi/0000-0003-1051-2301; Allen, Annette/0000-0003-0214-7076; Semo, Ma'ayan/0000-0002-3890-721X; Coffey, Peter/0000-0002-5427-2939	London Project to Cure Blindness; Lincy Foundation	London Project to Cure Blindness; Lincy Foundation	This work was funded by the London Project to Cure Blindness (www.thelondonproject.org/) and the Lincy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015063; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; ALTMAN J, 1962, AM J PHYSIOL, V202, P1208, DOI 10.1152/ajplegacy.1962.202.6.1208; ARAI M, 1993, BRAIN RES, V613, P341, DOI 10.1016/0006-8993(93)90924-C; Barnard AR, 2004, VISUAL NEUROSCI, V21, P675, DOI 10.1017/S0952523804215024; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Crozier WJ, 1927, J GEN PHYSIOL, V10, P407, DOI 10.1085/jgp.10.3.407; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Del Cano GG, 2000, J COMP NEUROL, V425, P393, DOI 10.1002/1096-9861(20000925)425:3<393::AID-CNE5>3.0.CO;2-G; DRUMMOND PD, 1986, HEADACHE, V26, P465, DOI 10.1111/j.1526-4610.1986.hed2609465.x; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; FLYNN JP, 1952, J COMP PHYSIOL PSYCH, V45, P336, DOI 10.1037/h0054587; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; GARCIAFERNANDEZ JM, 1995, NEUROSCI LETT, V187, P33; Gobersztejn F, 1996, BRAZ J MED BIOL RES, V29, P1507; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hetherington L, 2000, INVEST OPHTH VIS SCI, V41, P3979; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jimenez AJ, 1996, CELL TISSUE RES, V284, P193, DOI 10.1007/s004410050579; Keller FS, 1941, PSYCHOL REC, V4, P235, DOI 10.1007/BF03393248; KING V, 1972, J AM OPTOM ASSOC, V43, P53; LAU KC, 1992, J NEUROL SCI, V113, P70, DOI 10.1016/0022-510X(92)90267-O; Lebensohn JE, 1934, ARCH OPHTHALMOL-CHIC, V12, P380; LEBENSOHN JE, 1951, AM J OPHTHALMOL, V34, P1294, DOI 10.1016/0002-9394(51)91866-1; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; MACLEAN PD, 1949, PSYCHOSOM MED, V11, P338, DOI 10.1097/00006842-194911000-00003; May CA, 2002, INVEST OPHTH VIS SCI, V43, P2206; MISSLIN R, 1989, BEHAV PROCESS, V18, P119, DOI 10.1016/S0376-6357(89)80010-5; MISSLIN R, 1986, BEHAV PROCESS, V12, P45, DOI 10.1016/0376-6357(86)90069-0; Mojumder DK, 2010, INVEST OPHTH VIS SCI, V51, P567, DOI 10.1167/iovs.09-4168; Moulton EA, 2009, PAIN, V145, P358, DOI 10.1016/j.pain.2009.07.018; Mrosovsky N, 2002, NATURWISSENSCHAFTEN, V89, P525, DOI 10.1007/s00114-002-0369-0; Mrosovsky N, 1997, NEUROSCI LETT, V222, P204, DOI 10.1016/S0304-3940(97)13374-2; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Ochsner KN, 2007, TRENDS COGN SCI, V11, P317, DOI 10.1016/j.tics.2007.06.008; Okamoto K, 2010, PAIN, V149, P235, DOI 10.1016/j.pain.2010.02.004; ONAIVI ES, 1989, PROG NEURO-PSYCHOPH, V13, P963, DOI 10.1016/0278-5846(89)90047-X; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Papez JW, 1937, ARCH NEURO PSYCHIATR, V38, P725, DOI 10.1001/archneurpsyc.1937.02260220069003; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; READER AL, 1977, AM J OPHTHALMOL, V84, P263, DOI 10.1016/0002-9394(77)90861-3; Recober A, 2010, NEUROPHARMACOLOGY, V58, P156, DOI 10.1016/j.neuropharm.2009.07.009; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Russo Andrew F, 2009, Mol Cell Pharmacol, V1, P264; Schmucker C, 2005, INVEST OPHTH VIS SCI, V46, P398, DOI 10.1167/iovs.04-0959; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Semo M, 2003, EUR J NEUROSCI, V17, P1793, DOI 10.1046/j.1460-9568.2003.02616.x; Semo M, 2003, EUR J NEUROSCI, V18, P3007, DOI 10.1111/j.1460-9568.2003.03061.x; Sliney DH, 1997, DEV OPHTHALMOL, V27, P63; Stringham JM, 2004, INVEST OPHTH VIS SCI, V45, P3838, DOI 10.1167/iovs.04-0038; Stringham JM, 2003, J OPT SOC AM A, V20, P1852, DOI 10.1364/JOSAA.20.001852; Sugano E, 2005, INVEST OPHTH VIS SCI, V46, P3341, DOI 10.1167/iovs.04-1351; Thiels E, 2008, CURR EYE RES, V33, P483, DOI 10.1080/02713680802130347; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Tomita H, 2010, EXP EYE RES, V90, P429, DOI 10.1016/j.exer.2009.12.006; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Van der Gucht E, 2007, CEREB CORTEX, V17, P2805, DOI 10.1093/cercor/bhm012; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Vugler AA, 2003, EXP NEUROL, V184, P464, DOI 10.1016/S0014-4886(03)00267-X; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; WELKER WI, 1959, J COMP PHYSIOL PSYCH, V52, P106, DOI 10.1037/h0042241; WYSS JM, 1992, HIPPOCAMPUS, V2, P1; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034	80	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15009	10.1371/journal.pone.0015009	http://dx.doi.org/10.1371/journal.pone.0015009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124784	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500014
J	Wang, MX; Bai, J; Chen, WN; Ching, CB				Wang, Mingxuan; Bai, Jing; Chen, Wei Ning; Ching, Chi Bun			Metabolomic Profiling of Cellular Responses to Carvedilol Enantiomers in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LC-MS/MS; PROTEOMIC ANALYSIS; HEART-FAILURE; L-SERINE; GC-MS; MECHANISMS; SPECTROMETRY; PROPRANOLOL; ENDOTHELIUM	Carvedilol is a non-selective beta-blocker indicated in the treatment of hypertension and heart failure. Although the differential pharmacological effects of individual Carvedilol enantiomer is supported by preceding studies, the cellular response to each enantiomer is not well understood. Here we report the use of GC-MS metabolomic profiling to study the effects of Carvedilol enantiomers on vascular smooth muscle cells (A7r5) and to shed new light on molecular events underlying Carvedilol treatment. The metabolic analysis revealed alternations in the levels of 8 intracellular metabolites and 5 secreted metabolites in A7r5 cells incubated separately with S-and R-Carvedilol. Principal component analysis of the metabolite data demonstrated the characteristic metabolic signatures in S- and R-Carvedilol-treated cells. A panel of metabolites, including L-serine, L-threonine, 5-oxoproline, myristic acid, palmitic acid and inositol are closely correlated to the vascular smooth muscle contraction. Our findings reveal the differentiating metabolites for A7r5 cells incubated with individual enantiomer of Carvedilol, which opens new perspectives to employ metabolic profiling platform to study chiral drug-cell interactions and aid their incorporation into future improvement of beta-blocker therapy.	[Wang, Mingxuan; Bai, Jing; Chen, Wei Ning; Ching, Chi Bun] Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Wang, MX (corresponding author), Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore, Singapore.	WNChen@ntu.edu.sg	bai, jing/R-1506-2016	, Yang/0000-0002-6620-8897	Ministry of Education, Singapore	Ministry of Education, Singapore(Ministry of Education, Singapore)	Financial support was provided by Academic Research Funds, Ministry of Education, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTSCH W, 1990, EUR J CLIN PHARMACOL, V38, pS104, DOI 10.1007/BF01409475; Bian K, 2008, J CLIN HYPERTENS, V10, P304, DOI 10.1111/j.1751-7176.2008.06632.x; BOLTON TB, 1979, PHYSIOL REV, V59, P606, DOI 10.1152/physrev.1979.59.3.606; Chrysanthopoulos PK, 2010, METAB ENG, V12, P212, DOI 10.1016/j.ymben.2009.11.001; Danielsson APH, 2010, ANAL BIOCHEM, V404, P30, DOI 10.1016/j.ab.2010.04.013; Devantier R, 2005, BIOTECHNOL BIOENG, V90, P703, DOI 10.1002/bit.20457; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Fernandez C, 2008, J PROTEOME RES, V7, P400, DOI 10.1021/pr070547d; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Filipiak W, 2010, CANCER EPIDEM BIOMAR, V19, P182, DOI 10.1158/1055-9965.EPI-09-0162; FILO RS, 1965, SCIENCE, V147, P1581, DOI 10.1126/science.147.3665.1581; Gagyi L, 2008, J BIOCHEM BIOPH METH, V70, P1268, DOI 10.1016/j.jbbm.2007.10.004; Jalil JE, 2008, HYPERTENSION, V51, P626, DOI 10.1161/HYPERTENSIONAHA.107.104133; Koller A, 2003, BIOCHEM BIOPH RES CO, V300, P155, DOI 10.1016/S0006-291X(02)02799-7; Kumar A, 2010, J BIOSCIENCES, V35, P21, DOI 10.1007/s12038-010-0004-8; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Mal M, 2009, RAPID COMMUN MASS SP, V23, P487, DOI 10.1002/rcm.3898; Mayr M, 2008, CIRC RES, V102, P1046, DOI 10.1161/CIRCRESAHA.108.174623; Mishra RC, 2008, HYPERTENSION, V51, P791, DOI 10.1161/HYPERTENSIONAHA.107.099598; Nakajima T, 2003, JPN HEART J, V44, P963, DOI 10.1536/jhj.44.963; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; ODDIS CV, 1995, BIOCHEM BIOPH RES CO, V213, P1002, DOI 10.1006/bbrc.1995.2228; OHLSTEIN EH, 1993, P NATL ACAD SCI USA, V90, P6189, DOI 10.1073/pnas.90.13.6189; Rainaldi G, 2008, RADIAT RES, V169, P170, DOI 10.1667/RR0958.1; RAVNIKAR PD, 1987, J BACTERIOL, V169, P2611, DOI 10.1128/jb.169.6.2611-2617.1987; Ruffolo RR, 1997, CARDIOVASC DRUG THER, V11, P247; SMITH DF, 1989, PHARMACOL TOXICOL, V65, P321, DOI 10.1111/j.1600-0773.1989.tb01182.x; Sui JJ, 2008, MOL PHARMACEUT, V5, P885, DOI 10.1021/mp800012x; Sui JJ, 2008, MOL CELL PROTEOMICS, V7, P1007, DOI 10.1074/mcp.M700485-MCP200; Sui JJ, 2007, J PROTEOME RES, V6, P1643, DOI 10.1021/pr0605926; Sui J, 2010, RAPID COMMUN MASS SP, V24, P1717, DOI 10.1002/rcm.4565; Taccetta-Chapnick Marie, 2002, Crit Care Nurse, V22, P36; TACCETTACHAPNIC.M, 2002, CRIT CARE NURSE, V22, P48; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; TAKEDA S, 1993, ANTICANCER RES, V13, P193; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315; Wallukat G, 2002, HERZ, V27, P683, DOI 10.1007/s00059-002-2434-z; Wang MX, 2010, J PROTEOMICS, V73, P1601, DOI 10.1016/j.jprot.2010.03.015; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003; Zhu WF, 2005, J BIOL CHEM, V280, P29543, DOI 10.1074/jbc.M501238200; 1996, CIRCULATION, V94, P592	42	18	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15441	10.1371/journal.pone.0015441	http://dx.doi.org/10.1371/journal.pone.0015441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124793	Green Published, gold, Green Submitted			2022-12-25	WOS:000284572000026
J	Adamaszek, M; Khaw, AV; Buck, U; Andresen, B; Thomasius, R				Adamaszek, Michael; Khaw, Alexander V.; Buck, Ulrike; Andresen, Burghard; Thomasius, Rainer			Evidence of Neurotoxicity of Ecstasy: Sustained Effects on Electroencephalographic Activity in Polydrug Users	PLOS ONE			English	Article							COGNITIVE PERFORMANCE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; EEG; IMPAIRMENT; MOOD	Objective: According to previous EEG reports of indicative disturbances in Alpha and Beta activities, a systematic search for distinct EEG abnormalities in a broader population of Ecstasy users may especially corroborate the presumed specific neurotoxicity of Ecstasy in humans. Methods: 105 poly-drug consumers with former Ecstasy use and 41 persons with comparable drug history without Ecstasy use, and 11 drug naives were investigated for EEG features. Conventional EEG derivations of 19 electrodes according to the 10-20-system were conducted. Besides standard EEG bands, quantitative EEG analyses of 1-Hz-subdivided power ranges of Alpha, Theta and Beta bands have been considered. Results: Ecstasy users with medium and high cumulative Ecstasy doses revealed an increase in Theta and lower Alpha activities, significant increases in Beta activities, and a reduction of background activity. Ecstasy users with low cumulative Ecstasy doses showed a significant Alpha activity at 11 Hz. Interestingly, the spectral power of low frequencies in medium and high Ecstasy users was already significantly increased in the early phase of EEG recording. Statistical analyses suggested the main effect of Ecstasy to EEG results. Conclusions: Our data from a major sample of Ecstasy users support previous data revealing alterations of EEG frequency spectrum due rather to neurotoxic effects of Ecstasy on serotonergic systems in more detail. Accordingly, our data may be in line with the observation of attentional and memory impairments in Ecstasy users with moderate to high misuse. Despite the methodological problem of polydrug use also in our approach, our EEG results may be indicative of the neuropathophysiological background of the reported memory and attentional deficits in Ecstasy abusers. Overall, our findings may suggest the usefulness of EEG in diagnostic approaches in assessing neurotoxic sequela of this common drug abuse.	[Adamaszek, Michael] Univ Leipzig, Neurol Rehabil Zentrum Leipzig, Bennewitz, Germany; [Adamaszek, Michael; Andresen, Burghard; Thomasius, Rainer] Univ Med Ctr Hamburg Eppendorf, Clin Psychiat & Psychotherapy, Hamburg, Germany; [Khaw, Alexander V.] Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany; [Buck, Ulrike] Hosp Rissen, Dept Psychiat, Hamburg, Germany; [Thomasius, Rainer] Univ Med Ctr Hamburg Eppendorf, Deutsch Zentrum Suchtfragen Kindes & Jugendalter, Hamburg, Germany	Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; University Medical Center Hamburg-Eppendorf	Adamaszek, M (corresponding author), Univ Leipzig, Neurol Rehabil Zentrum Leipzig, Bennewitz, Germany.	michael.adamaszek@sachsenklinik.de			Federal Institute for Drugs and Medical Devices, Germany [FZ: Z12.01-68503-206]	Federal Institute for Drugs and Medical Devices, Germany	The study was supported by the Federal Institute for Drugs and Medical Devices (FZ: Z12.01-68503-206), Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTE D, 1982, ORGANIC PSYCHOSYNDRO; Capela JP, 2007, NEUROTOXICOLOGY, V28, P868, DOI 10.1016/j.neuro.2007.04.005; Cowan RL, 2007, PSYCHOPHARMACOLOGY, V189, P539, DOI 10.1007/s00213-006-0467-3; Croft RJ, 2001, AM J PSYCHIAT, V158, P1687, DOI 10.1176/appi.ajp.158.10.1687; Dafters RI, 1999, PSYCHOPHARMACOLOGY, V145, P82, DOI 10.1007/s002130051035; de Sola S, 2008, PSYCHOPHARMACOLOGY, V200, P425, DOI 10.1007/s00213-008-1217-5; DOLAN RJ, 1997, HUMAN BRAIN FUNCTION, P405; FISCHER C, 1995, J NEUROSCI, V15, P5476; Gamma A, 2000, NEUROREPORT, V11, P157, DOI 10.1097/00001756-200001170-00031; Gouzoulis-Mayfrank E, 2000, J NEUROL NEUROSUR PS, V68, P719, DOI 10.1136/jnnp.68.6.719; Gouzoulis-Mayfrank E, 2006, J PSYCHOPHARMACOL, V20, P188, DOI 10.1177/0269881106059939; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; HERRMANN WM, 1988, Z GERONTOPSYCHOL PSY, V1, P1; INSEL TR, 1989, J PHARMACOL EXP THER, V249, P713; LUCAS RA, 1992, INT J OBESITY, V16, pS49; LUU P, 2003, COGNITIVE ELECTROPHY, P199; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; MCKENNA DJ, 1990, J NEUROCHEM, V54, P14, DOI 10.1111/j.1471-4159.1990.tb13277.x; Meyer JS, 2006, ANN NY ACAD SCI, V1074, P365, DOI 10.1196/annals.1369.036; Morgan MJ, 1999, PSYCHOPHARMACOLOGY, V141, P30, DOI 10.1007/s002130050803; NYSTROM C, 1988, ACTA PSYCHIAT SCAND, V77, P457, DOI 10.1111/j.1600-0447.1988.tb05151.x; OKEN BS, 1992, J CLIN NEUROPHYSIOL, V9, P480, DOI 10.1097/00004691-199210000-00003; Olbrich S, 2009, NEUROIMAGE, V45, P319, DOI 10.1016/j.neuroimage.2008.11.014; Reneman L, 2006, J PSYCHOPHARMACOL, V20, P164, DOI 10.1177/0269881106061515; RICAURTE GA, 1988, BRAIN RES, V446, P165, DOI 10.1016/0006-8993(88)91309-1; Robbins Trevor W., 1995, P703; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; SATO N, NEUROREPORT; Struder HK, 2001, INT J SPORTS MED, V22, P482, DOI 10.1055/s-2001-17606; Thomasius R, 2006, J PSYCHOPHARMACOL, V20, P211, DOI 10.1177/0269881106059486; Thomasius R, 1997, FORTSCHR NEUROL PSYC, V65, P49, DOI 10.1055/s-2007-996309; THOMASIUS R, 2000, ECSTASY STUDY HLTH P; Tuchtenhagen F, 2000, NEUROPSYCHOPHARMACOL, V22, P608, DOI 10.1016/S0893-133X(99)00140-2; Verkes RJ, 2001, PSYCHOPHARMACOLOGY, V153, P196, DOI 10.1007/s002130000563; Zakzanis KK, 2001, NEUROLOGY, V56, P966, DOI 10.1212/WNL.56.7.966	35	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14097	10.1371/journal.pone.0014097	http://dx.doi.org/10.1371/journal.pone.0014097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124854	Green Published, Green Submitted, gold			2022-12-25	WOS:000284527900010
J	Cao, F; Chen, Y; Cierpicki, T; Liu, YF; Basrur, V; Lei, M; Dou, YL				Cao, Fang; Chen, Yong; Cierpicki, Tomasz; Liu, Yifan; Basrur, Venkatesha; Lei, Ming; Dou, Yali			An Ash2L/RbBP5 Heterodimer Stimulates the MLL1 Methyltransferase Activity through Coordinated Substrate Interactions with the MLL1 SET Domain	PLOS ONE			English	Article							LINEAGE LEUKEMIA PROTEIN-1; H3 LYSINE 4; HISTONE H3; STRUCTURAL BASIS; TRANSCRIPTIONAL REGULATION; CORE COMPLEX; METHYLATION; RECOGNITION; SPECIFICITY; MECHANISMS	Histone H3 lysine 4 (K4) methylation is a prevalent mark associated with transcription activation and is mainly catalyzed by the MLL/SET1 family histone methyltransferases. A common feature of the mammalian MLL/SET1 complexes is the presence of three core components (RbBP5, Ash2L and WDR5) and a catalytic subunit containing a SET domain. Unlike most other histone lysine methyltransferases, all four proteins are required for efficient H3 K4 methylation. Despite extensive efforts, mechanisms for how three core components regulate MLL/SET1 methyltransferase activity remain elusive. Here we show that a heterodimer of Ash2L and RbBP5 has intrinsic histone methyltransferase activity. This activity requires the highly conserved SPRY domain of Ash2L and a short peptide of RbBP5. We demonstrate that both Ash2L and the MLL1 SET domain are capable of binding to S-adenosyl-L- [methyl-(3)H] methionine in the MLL1 core complex. Mutations in the MLL1 SET domain that fail to support overall H3 K4 methylation also compromise SAM binding by Ash2L. Taken together, our results show that the Ash2L/RbBP5 heterodimer plays a critical role in the overall catalysis of MLL1 mediated H3 K4 methylation. The results we describe here provide mechanistic insights for unique regulation of the MLL1 methyltransferase activity. It suggests that both Ash2L/RbBP5 and the MLL1 SET domain make direct contacts with the substrates and contribute to the formation of a joint catalytic center. Given the shared core configuration among all MLL/SET1 family HMTs, it will be interesting to test whether the mechanism we describe here can be generalized to other MLL/SET1 family members in the future.	[Cao, Fang; Cierpicki, Tomasz; Liu, Yifan; Basrur, Venkatesha; Dou, Yali] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chen, Yong; Lei, Ming; Dou, Yali] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Lei, Ming] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Cao, F (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	leim@umich.edu; yalid@umich.edu	cao, fang/G-4926-2012; Chen, Yong/AAF-9915-2020	Chen, Yong/0000-0001-5857-6086; Liu, Yifan/0000-0002-3896-0002	NIH [R01GM082856]; American Cancer Society [RSG-10-150-01-DMC]; American Association for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082856] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Association for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Dou is supported by grants from NIH (R01GM082856), American Cancer Society (RSG-10-150-01-DMC) and American Association for Cancer Research. Dr. Lei is an early-stage investigator of Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dou YL, 2008, INT J HEMATOL, V87, P10, DOI 10.1007/s12185-007-0009-8; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kuang ZH, 2009, J MOL BIOL, V386, P662, DOI 10.1016/j.jmb.2008.12.078; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Odho Z, 2010, J BIOL CHEM, V285, P32967, DOI 10.1074/jbc.M110.159921; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu ZJ, 2009, J CELL BIOL, V186, P343, DOI 10.1083/jcb.200902146; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	39	74	81	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14102	10.1371/journal.pone.0014102	http://dx.doi.org/10.1371/journal.pone.0014102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124902	gold, Green Published, Green Submitted			2022-12-25	WOS:000284527900014
J	Hayashi, Y; Chan, TC; Warashina, M; Fukuda, M; Ariizumi, T; Okabayashi, K; Takayama, N; Otsu, M; Eto, K; Furue, MK; Michiue, T; Ohnuma, K; Nakauchi, H; Asashima, M				Hayashi, Yohei; Chan, Techuan; Warashina, Masaki; Fukuda, Masakazu; Ariizumi, Takashi; Okabayashi, Koji; Takayama, Naoya; Otsu, Makoto; Eto, Koji; Furue, Miho Kusuda; Michiue, Tatsuo; Ohnuma, Kiyoshi; Nakauchi, Hiromitsu; Asashima, Makoto			Reduction of N-Glycolylneuraminic Acid in Human Induced Pluripotent Stem Cells Generated or Cultured under Feeder- and Serum-Free Defined Conditions	PLOS ONE			English	Article							HUMAN FIBROBLASTS; GROWTH; INDUCTION	Background: The successful establishment of human induced pluripotent stem cells (hiPSCs) has increased the possible applications of stem cell research in biology and medicine. In particular, hiPSCs are a promising source of cells for regenerative medicine and pharmacology. However, one of the major obstacles to such uses for hiPSCs is the risk of contamination from undefined pathogens in conventional culture conditions that use serum replacement and mouse embryonic fibroblasts as feeder cells. Methodology/Principal Findings: Here we report a simple method for generating or culturing hiPSCs under feeder- and serum-free defined culture conditions that we developed previously for human embryonic stem cells. The defined culture condition comprises a basal medium with a minimal number of defined components including five highly purified proteins and fibronectin as a substrate. First, hiPSCs, which were generated using Yamanaka's four factors and conventional undefined culture conditions, adapted to the defined culture conditions. These adapted cells retained the property of self renewal as evaluated morphologically, the expression of self-renewal marker proteins, standard growth rates, and pluripotency as evaluated by differentiation into derivatives of all three primary germ layers in vitro and in vivo (teratoma formation in immunodeficient mice). Moreover, levels of nonhuman N-glycolylneuraminic acid (Neu5Gc), which is a xenoantigenic indicator of pathogen contamination in human iPS cell cultures, were markedly decreased in hiPSCs cultured under the defined conditions. Second, we successfully generated hiPSCs using adult dermal fibroblast under the defined culture conditions from the reprogramming step. For a long therm culture, the generated cells also had the property of self renewal and pluripotency, they carried a normal karyotype, and they were Neu5Gc negative. Conclusion/Significance: This study suggested that generation or adaption culturing under defined culture conditions can eliminate the risk posed by undefined pathogens. This success in generating hiPSCs using adult fibroblast would be beneficial for clinical application.	[Hayashi, Yohei; Chan, Techuan; Ariizumi, Takashi; Okabayashi, Koji; Michiue, Tatsuo; Ohnuma, Kiyoshi; Asashima, Makoto] Univ Tokyo, Dept Life Sci Biol, Grad Sch Arts & Sci, Tokyo, Japan; [Warashina, Masaki] Wako Pure Chem Ind Ltd, Genome Res Labs, Hyogo, Japan; [Fukuda, Masakazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Takayama, Naoya; Otsu, Makoto; Eto, Koji; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell & Regenerat Med, Div Stem Cell Therapy, Tokyo 113, Japan; [Furue, Miho Kusuda] Natl Inst Biomed Innovat, Dept Dis Bioresources, Lab Cell Cultures, Osaka, Japan; [Ohnuma, Kiyoshi] Nagaoka Univ Technol, Top Runner Incubat Ctr Acad Ind Fus, Nagaoka, Niigata 94021, Japan; [Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Ibaraki, Japan	University of Tokyo; University of Tokyo; University of Tokyo; National Institute of Health Sciences - Japan; Nagaoka University of Technology; National Institute of Advanced Industrial Science & Technology (AIST)	Hayashi, Y (corresponding author), Univ Tokyo, Dept Life Sci Biol, Grad Sch Arts & Sci, Tokyo, Japan.	kohnuma@vos.nagaokaut.ac.jp; asashi@bio.c.u-tokyo.ac.jp	Okabayashi, Koji/G-6317-2013; Hayashi, Yohei/AAF-6059-2020; Asashima, Makoto/O-8389-2018; Hayashi, Yohei/L-8190-2019	Hayashi, Yohei/0000-0001-5490-7052; Asashima, Makoto/0000-0002-0012-026X; Ohnuma, Kiyoshi/0000-0002-2272-3643; Furue, Miho/0000-0001-5032-9953; Otsu, Makoto/0000-0002-9769-0217	Ministry of Education, Science, Sports, Culture and Technology (MEXT) of Japan; Ministry of Health, Labor, and Welfare of Japan; Promotion of Independent Research Environment for Young researchers; Grants-in-Aid for Scientific Research [21390321] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Promotion of Independent Research Environment for Young researchers; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research and the Project for Realization of Regenerative Medicine from the Ministry of Education, Science, Sports, Culture and Technology (MEXT) of Japan, by grants from the Ministry of Health, Labor, and Welfare of Japan to M.K.F. and by Promotion of Independent Research Environment for Young researchers to K. Oh. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Furue MK, 2010, IN VITRO CELL DEV-AN, V46, P573, DOI 10.1007/s11626-010-9317-z; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; ODORICO J, 2005, HUMAN EMBRYONIC STEM; Okabe M, 2009, BLOOD, V114, P1764, DOI 10.1182/blood-2009-02-203695; Price PJ, 1998, International Publication, Patent No. [WO/1998/30679, 199830679]; Price PJ, 1998, International Application, Patent No. [PCT/US1998/ 000467, 1998000467]; Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248; Ross PJ, 2010, STEM CELLS DEV, V19, P1221, DOI 10.1089/scd.2009.0459; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	39	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14099	10.1371/journal.pone.0014099	http://dx.doi.org/10.1371/journal.pone.0014099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124894	Green Published, Green Submitted, gold			2022-12-25	WOS:000284527900011
J	Wang, CL; Chen, YH; Ku, LX; Wang, TG; Sun, ZH; Cheng, FF; Wu, LC				Wang, Cuiling; Chen, Yanhui; Ku, Lixia; Wang, Tiegu; Sun, Zhaohui; Cheng, Fangfang; Wu, Liancheng			Mapping QTL Associated with Photoperiod Sensitivity and Assessing the Importance of QTLxEnvironment Interaction for Flowering Time in Maize	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; X ENVIRONMENT INTERACTIONS; TROPICAL MAIZE; PLANT HEIGHT; GENETIC ARCHITECTURE; IDENTIFICATION; TEMPERATURE; RESISTANCE; CULTIVARS; PROGENY	Background: An understanding of the genetic determinism of photoperiod response of flowering is a prerequisite for the successful exchange of germplasm across different latitudes. In order to contribute to resolve the genetic basis of photoperiod sensitivity in maize, a set of 201 recombinant inbred lines (RIL), derived from a temperate and tropical inbred line cross were evaluated in 5 field trials spread in short-and long-day environments. Methodology/Principal Findings: Firstly, QTL analyses for flowering time and photoperiod sensitivity in maize were conducted in individual photoperiod environments separately, and then, the total genetic effect was partitioned into additive effect (A) and additive-by-environment interaction effect (AE) by using a mixed-model-based composite interval mapping (MCIM) method. Conclusions/Significance: Seven putative QTL were found associated with DPS thermal time based on the data estimated in individual environments. Nine putative QTL were found associated with DPS thermal time across environments and six of them showed significant QTLxenviroment (QE) interactions. Three QTL for photoperiod sensitivity were identified on chromosome 4, 9 and 10, which had the similar position to QTL for DPS thermal time in the two long-day environment. The major photoperiod sensitive loci qDPS10 responded to both short and long-day photoperiod environments and had opposite effects in different photoperiod environment. The QTL qDPS3, which had the greatest additive effect exclusively in the short-day environment, were photoperiod independent and should be classified in autonomous promotion pathway.	[Wang, Cuiling; Chen, Yanhui; Ku, Lixia; Wang, Tiegu; Sun, Zhaohui; Cheng, Fangfang; Wu, Liancheng] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China; [Wang, Cuiling] Henan Univ Sci & Technol, Coll Agron, Luoyang, Peoples R China; [Wang, Tiegu] Henan Inst Sci & Technol, Coll Life Sci, Xinxiang, Peoples R China; [Cheng, Fangfang] Gongyi Meteorol Off, Gongyi, Peoples R China	Henan Agricultural University; Henan University of Science & Technology; Henan Institute of Science & Technology	Wang, CL (corresponding author), Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China.	chy989@sohu.com		Wang, Cuiling/0000-0001-8918-195X	National Natural Science Foundation of China [30571167, 30971789]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (No. 30571167 and No. 30971789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DF, 2001, THEOR APPL GENET, V102, P163, DOI 10.1007/s001220051632; Balint-Kurti PJ, 2007, GENETICS, V176, P645, DOI 10.1534/genetics.106.067892; BEAVIS WD, 1994, CROP SCI, V34, P882, DOI 10.2135/cropsci1994.0011183X003400040010x; Birch CJ, 1998, FIELD CROP RES, V55, P93, DOI 10.1016/S0378-4290(97)00062-2; Bohn M, 1997, CROP SCI, V37, P1892, DOI 10.2135/cropsci1997.0011183X003700060038x; BONHOMME R, 1994, CROP SCI, V34, P156, DOI 10.2135/cropsci1994.0011183X003400010028x; Bouchez A, 2002, GENETICS, V162, P1945; Briggs WH, 2007, GENETICS, V177, P1915, DOI 10.1534/genetics.107.076497; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Chardon F, 2005, THEOR APPL GENET, V112, P1, DOI 10.1007/s00122-005-0050-z; Chen YanHui, 2003, Scientia Agricultura Sinica, V36, P248; COLES ND, 2009, GENETICS, V162, P2169; Doerge RW, 1996, GENETICS, V142, P285; Ducrocq S, 2008, GENETICS, V178, P2433, DOI 10.1534/genetics.107.084830; ELLIS RH, 1992, CROP SCI, V32, P1225, DOI 10.2135/cropsci1992.0011183X003200050033x; FRANCIS CA, 1969, CROP SCI, V9, P675, DOI 10.2135/cropsci1969.0011183X000900050054x; Giauffret C, 2000, CROP SCI, V40, P1004, DOI 10.2135/cropsci2000.4041004x; Goodman MM, 2000, MAYDICA, V45, P221; Gouesnard B, 2002, GENET RESOUR CROP EV, V49, P471, DOI 10.1023/A:1020982827604; Jiang C, 1999, THEOR APPL GENET, V99, P1106, DOI 10.1007/s001220051315; Khairallah MM, 1998, PLANT BREEDING, V117, P309, DOI 10.1111/j.1439-0523.1998.tb01947.x; KINIRY JR, 1983, AGRON J, V75, P687, DOI 10.2134/agronj1983.00021962007500040026x; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; KOESTER RP, 1993, CROP SCI, V33, P1209, DOI 10.2135/cropsci1993.0011183X003300060020x; Kozumplik V, 1996, MAYDICA, V41, P211; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liu Guifu, 2007, Journal of Genetics and Genomics, V34, P608, DOI 10.1016/S1673-8527(07)60069-1; Moutiq R., 2002, P257, DOI 10.1079/9780851996011.0257; Ribaut JM, 2007, MOL BREEDING, V20, P15, DOI 10.1007/s11032-006-9041-2; Ribaut JM, 1996, THEOR APPL GENET, V92, P905, DOI 10.1007/BF00221905; RUSSEL WK, 1983, AGRON J, V75, P795; Salvi S, 2002, PLANT MOL BIOL, V48, P601, DOI 10.1023/A:1014838024509; Searle S., 1992, VARIANCE COMPONENTS; STUBER CW, 1992, GENETICS, V132, P823; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; van Nocker S, 2000, PLANT MOL BIOL, V44, P107, DOI 10.1023/A:1006472929800; Veldboom LR, 1996, CROP SCI, V36, P1320, DOI 10.2135/cropsci1996.0011183X003600050041x; Vladutu C, 1999, GENETICS, V153, P993; Wang CL, 2008, THEOR APPL GENET, V117, P1129, DOI 10.1007/s00122-008-0851-y; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; ZHANG KP, 2008, J GENET GENOMICS, V35, P119, DOI DOI 10.1016/S1673-8527(08)60017-X; Zhang KP, 2009, EUPHYTICA, V165, P471, DOI 10.1007/s10681-008-9756-8	44	19	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14068	10.1371/journal.pone.0014068	http://dx.doi.org/10.1371/journal.pone.0014068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124912	Green Published, gold, Green Submitted			2022-12-25	WOS:000284400100015
J	Wang, ZY; Matsudaira, P; Gong, ZY				Wang, Zhengyuan; Matsudaira, Paul; Gong, Zhiyuan			STORM: A General Model to Determine the Number and Adaptive Changes of Epithelial Stem Cells in Teleost, Murine and Human Intestinal Tracts	PLOS ONE			English	Article							COLORECTAL-CANCER; MOLECULAR-BIOLOGY; COLONIC CRYPT; GOBLET CELLS; DIFFERENTIATION; PROLIFERATION; ZEBRAFISH; MIGRATION; LINEAGE; GROWTH	Intestinal stem cells play a pivotal role in the epithelial tissue renewal, homeostasis and cancer development. The lack of a general marker for intestinal stem cells across species has hampered analysis of stem cell number in different species and their adaptive changes upon intestinal lesions or during development of cancer. Here a two-dimensional model, named STORM, has been developed to address this issue. By optimizing epithelium renewal dynamics, the model examines the epithelial stem cell number by taking experimental input information regarding epithelium proliferation and differentiation. As the results suggest, there are 2.0-4.1 epithelial stem cells on each pocket section of zebrafish intestine, 2.0-4.1 stem cells on each crypt section of murine small intestine and 1.8-3.5 stem cells on each crypt section of human duodenum. The model is able to provide quick results for stem cell number and its adaptive changes, which is not easy to measure through experiments. Its general applicability to different species makes it a valuable tool for analysis of intestinal stem cells under various pathological conditions.	[Wang, Zhengyuan; Matsudaira, Paul; Gong, Zhiyuan] Singapore MIT Alliance, Singapore, Singapore; [Wang, Zhengyuan; Matsudaira, Paul; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Wang, Zhengyuan; Matsudaira, Paul] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117548, Singapore	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National University of Singapore	Wang, ZY (corresponding author), Singapore MIT Alliance, Singapore, Singapore.	wzhengyuan@gmail.com	wang, zhengyuan/HGA-0435-2022; Gong, Zhiyuan/H-8794-2012; Wang, Zhengyuan/GWV-6069-2022; Matsudaira, Paul/H-1475-2012	wang, zhengyuan/0000-0002-8447-9674; Gong, Zhiyuan/0000-0002-9660-5260; Matsudaira, Paul/0000-0002-8399-3276	Singapore-MIT Alliance and Department of Biological Sciences of National University of Singapore	Singapore-MIT Alliance and Department of Biological Sciences of National University of Singapore	The authors would like to thank Singapore-MIT Alliance and Department of Biological Sciences of National University of Singapore for support of this work.	Ahuja V, 2006, CURR OPIN GASTROEN, V22, P90, DOI 10.1097/01.mog.0000203865.25384.65; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Barker N, 2007, GASTROENTEROLOGY, V133, P1755, DOI 10.1053/j.gastro.2007.10.029; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Biasco G, 2004, HUM PATHOL, V35, P622, DOI 10.1016/j.humpath.2004.01.018; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098; Boman BM, 2001, CANCER RES, V61, P8408; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Booth C, 2004, CELL PROLIFERAT, V37, P385, DOI 10.1111/j.1365-2184.2004.00320.x; BRANSOM CJ, 1981, GUT, V22, P277, DOI 10.1136/gut.22.4.277; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; d'Onofrio A, 2007, J THEOR BIOL, V244, P367, DOI 10.1016/j.jtbi.2006.08.022; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; GALHAARD H, 1972, EXP CELL RES, V72, P197; Gerike TG, 1998, CELL PROLIFERAT, V31, P93, DOI 10.1046/j.1365-2184.1998.00113.x; GORELICK F, 1979, GASTROENTEROLOGY, V76, P1141; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; He XC, 2005, ANN NY ACAD SCI, V1049, P28, DOI 10.1196/annals.1334.005; Ishizuya-Oka A, 2007, DEV GROWTH DIFFER, V49, P99, DOI 10.1111/j.1440-169x.2007.00913.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Li X, 2007, PHYSIOL GENOMICS, V29, P290, DOI 10.1152/physiolgenomics.00269.2006; LI YQ, 1994, J CELL SCI, V107, P3271; LOEFFLER M, 1988, CELL TISSUE KINET, V21, P247, DOI 10.1111/j.1365-2184.1988.tb00784.x; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; McGarvey MA, 2007, DIGEST DIS SCI, V52, P2087, DOI 10.1007/s10620-006-9197-y; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Michor F, 2005, SEMIN CANCER BIOL, V15, P484, DOI 10.1016/j.semcancer.2005.06.005; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; PAULUS U, 1992, CELL PROLIFERAT, V25, P559, DOI 10.1111/j.1365-2184.1992.tb01460.x; PAULUS U, 1993, J CELL SCI, V106, P473; Pinto D, 2005, BIOL CELL, V97, P185; POTTEN C, 2004, APOPTOSIS LIFE DEATH, P136; POTTEN CS, 1984, SCAND J GASTROENTERO, V19, P3; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; RIJKE RPC, 1976, GASTROENTEROLOGY, V71, P786; Rubin DC, 2007, CURR OPIN GASTROEN, V23, P111, DOI 10.1097/MOG.0b013e3280145082; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; TOMLINSON IPM, 1995, P NATL ACAD SCI USA, V92, P11130, DOI 10.1073/pnas.92.24.11130; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Walters JRF, 2004, CURR OPIN GASTROEN, V20, P70, DOI 10.1097/00001574-200403000-00004; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; [No title captured]	60	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14063	10.1371/journal.pone.0014063	http://dx.doi.org/10.1371/journal.pone.0014063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124758	Green Published, gold, Green Submitted			2022-12-25	WOS:000284400100012
J	Yovel, Y; Au, WWL				Yovel, Yossi; Au, Whitlow W. L.			How Can Dolphins Recognize Fish According to Their Echoes? A Statistical Analysis of Fish Echoes	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; PREY SELECTION; ECHOLOCATION; BAT; DISCRIMINATION; TARGETS	Echo-based object classification is a fundamental task of animals that use a biosonar system. Dolphins and porpoises should be able to rely on echoes to discriminate a predator from a prey or to select a desired prey from an undesired object. Many studies have shown that dolphins and porpoises can discriminate between objects according to their echoes. All of these studies however, used unnatural objects that can be easily characterized in human terminologies (e. g., metallic spheres, disks, cylinders). In this work, we collected real fish echoes from many angles of acquisition using a sonar system that mimics the emission properties of dolphins and porpoises. We then tested two alternative statistical approaches in classifying these echoes. Our results suggest that fish species can be classified according to echoes returning from porpoise- and dolphin-like signals. These results suggest how dolphins and porpoises can classify fish based on their echoes and provide some insight as to which features might enable the classification.	[Yovel, Yossi] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Au, Whitlow W. L.] Univ Hawaii, Hawaii Inst Marine Biol, Marine Mammal Res Program, Kailua, HI USA	Tel Aviv University; University of Hawaii System	Yovel, Y (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	yossiyovel@hotmail.com		Yovel, Yossi/0000-0001-5429-9245	US Office of Naval Research; Netherlands Ministry for Agriculture, Nature, and Food Quality [418]	US Office of Naval Research(Office of Naval Research); Netherlands Ministry for Agriculture, Nature, and Food Quality	This work was supported by the US Office of Naval Research, Mardi Hastings, Program Manager, and the Netherlands Ministry for Agriculture, Nature, and Food Quality (DKW-program 418: North Sea and Coast). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, LEARNING KERNELS; Au W.W.L., 2008, PRINCIPLES MARINE BI; Au WWL, 2009, J ACOUST SOC AM, V126, P460, DOI 10.1121/1.3147497; Aubauer R, 2000, J ACOUST SOC AM, V107, P2750, DOI 10.1121/1.428661; Boonman A, 2007, BIOL CYBERN, V97, P159, DOI 10.1007/s00422-007-0164-2; Cristianini N, 2000, INTRO SUPPORT VECTOR; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Ibsen SD, 2009, J ACOUST SOC AM, V125, P1214, DOI 10.1121/1.3050274; McCabe EJB, 2010, MAR BIOL, V157, P931, DOI 10.1007/s00227-009-1371-2; Muller R, 2000, J ACOUST SOC AM, V108, P836, DOI 10.1121/1.429617; Popov VV, 1997, J ACOUST SOC AM, V102, P1169, DOI 10.1121/1.419935; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; SIMMONS JA, 1971, J EXP ZOOL, V176, P315, DOI 10.1002/jez.1401760307; Witteveen BH, 2008, MAR MAMMAL SCI, V24, P516, DOI 10.1111/j.1748-7692.2008.00193.x; Yovel Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000032; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000429; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000400	18	13	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14054	10.1371/journal.pone.0014054	http://dx.doi.org/10.1371/journal.pone.0014054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124908	Green Published, Green Submitted, gold			2022-12-25	WOS:000284400100006
J	Du, JA; Zhao, F; Zhou, Y; Yan, H; Duan, XG; Liang, SQ; Wang, YL; Fu, QX; Wang, XH; Peng, JC; Zhan, LS				Du, Juan; Zhao, Fang; Zhou, Yong; Yan, Hu; Duan, Xiang-guo; Liang, Sheng-qiang; Wang, Ying-li; Fu, Qiu-xia; Wang, Xiao-hui; Peng, Jian-chun; Zhan, Lin-sheng			Bioluminescence Imaging Allows Monitoring Hepatitis C Virus Core Protein Inhibitors in Mice	PLOS ONE			English	Article							SMALL INTERFERING RNAS; TAIL VEIN INJECTION; GENOMIC INTEGRATION; GENE-EXPRESSION; PHI-C31 INTEGRASE; TRANSGENIC MICE; PLASMID DNA; CELLS; REPLICATION; DELIVERY	Background: The development of small molecule inhibitors of hepatitis C virus (HCV) core protein as antiviral agents has been intensively pursued as a viable strategy to eradicate HCV infection. However, lack of a robust and convenient small animal model has hampered the assessment of in vivo efficacy of any antiviral compound. Methodology/Principal Findings: The objective of this work was to develop a novel method to screen anti-core protein siRNA in the mouse liver by bioluminescence imaging. The inhibitory effect of two shRNAs targeting the highly conserved core region of the HCV genome, shRNA452 and shRNA523, was examined using this method. In the transient mouse model, the effect of shRNA-523 was detectable at as early as 24 h and became even more pronounced at later time points. The effect of shRNA-452 was not detectable until 48 h post-transduction. In a stable mouse model, shRNA523 reduced luciferase levels by up to 76.4 +/- 26.0% and 91.8 +/- 8.0% at 6 h and 12 h after injection respectively, and the inhibitory effect persisted for 1 day after a single injection while shRNA-Scramble did not seem to have an effect on the luciferase activity in vivo. Conclusions/Significance: Thus, we developed a simple and quantitative assay for real-time monitoring of HCV core protein inhibitors in mice.	[Du, Juan; Zhao, Fang; Zhou, Yong; Yan, Hu; Liang, Sheng-qiang; Wang, Ying-li; Fu, Qiu-xia; Wang, Xiao-hui; Peng, Jian-chun; Zhan, Lin-sheng] Beijing Inst Transfus Med, Beijing, Peoples R China; [Duan, Xiang-guo] Ningxia Med Univ, Yinchuan, Peoples R China	Ningxia Medical University	Du, JA (corresponding author), Beijing Inst Transfus Med, Beijing, Peoples R China.	lszhan91@yahoo.com	ZHANG, LIN/GYD-9123-2022; Zhan, Linsheng/AAR-5687-2021; zhan, lin/AAP-5149-2020		National Nature Science Foundation of China [30700757, 30771919, 30900824]; Mega-Project of Science Research for the 11th FiveYear Plan [2009ZX10004-4001]; High Technology Research and Development Program of China [2008AA02Z132]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega-Project of Science Research for the 11th FiveYear Plan; High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by funding under the National Nature Science Foundation of China (30700757, 30771919 and 30900824), Mega-Project of Science Research for the 11th FiveYear Plan (#2009ZX10004-4001) and High Technology Research and Development Program of China (#2008AA02Z132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja MK, 2007, J GENE MED, V9, P967, DOI 10.1002/jgm.1090; Bertoni C, 2006, P NATL ACAD SCI USA, V103, P419, DOI 10.1073/pnas.0504505102; Budker VG, 2006, J GENE MED, V8, P874, DOI 10.1002/jgm.920; BUKH J, 1994, P NATL ACAD SCI USA, V91, P8239, DOI 10.1073/pnas.91.17.8239; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Held PK, 2005, MOL THER, V11, P399, DOI 10.1016/j.ymthe.2004.11.001; Ishikawa T, 2003, COMP IMMUNOL MICROB, V26, P115, DOI 10.1016/S0147-9571(02)00038-3; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; Keravala A, 2009, MOL THER, V17, P112, DOI 10.1038/mt.2008.241; Kim M, 2006, VIRUS RES, V122, P1, DOI 10.1016/j.virusres.2006.05.003; Kronke J, 2004, J VIROL, V78, P3436, DOI 10.1128/JVI.78.7.3436-3446.2004; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lecocq M, 2003, J GENE MED, V5, P142, DOI 10.1002/jgm.328; Lewis DL, 2005, METHOD ENZYMOL, V392, P336, DOI 10.1016/S0076-6879(04)92020-4; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu QY, 1997, J VIROL, V71, P657, DOI 10.1128/JVI.71.1.657-662.1997; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295; Sacco R, 2003, VIROLOGY, V317, P24, DOI 10.1016/j.virol.2003.08.028; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Siavoshian S, 2005, J MED VIROL, V75, P402, DOI 10.1002/jmv.20283; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; Suzuki H, 2008, FEBS LETT, V582, P3085, DOI 10.1016/j.febslet.2008.07.056; Suzuki H, 2007, NUCLEOS NUCLEOT NUCL, V26, P815, DOI 10.1080/15257770701503787; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998; Yokota T, 2003, EMBO REP, V4, P602, DOI 10.1038/sj.embor.embor840; Zhao F, 2010, VIRUS RES, V149, P162, DOI 10.1016/j.virusres.2010.01.012	35	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14043	10.1371/journal.pone.0014043	http://dx.doi.org/10.1371/journal.pone.0014043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124971	Green Published, gold, Green Submitted			2022-12-25	WOS:000284356900006
J	Johnson, JA; Talbot, SL; Sage, GK; Burnham, KK; Brown, JW; Maechtle, TL; Seegar, WS; Yates, MA; Anderson, B; Mindell, DP				Johnson, Jeff A.; Talbot, Sandra L.; Sage, George K.; Burnham, Kurt K.; Brown, Joseph W.; Maechtle, Tom L.; Seegar, William S.; Yates, Michael A.; Anderson, Bud; Mindell, David P.			The Use of Genetics for the Management of a Recovering Population: Temporal Assessment of Migratory Peregrine Falcons in North America	PLOS ONE			English	Article							MICROSATELLITE DNA; ALLELE FREQUENCIES; ENVIRONMENTAL CONTAMINANTS; EFFECTIVE SIZE; CENSUS SIZE; CONSERVATION; PROGRAM; DIVERSITY; G(ST); DIFFERENTIATION	Background: Our ability to monitor populations or species that were once threatened or endangered and in the process of recovery is enhanced by using genetic methods to assess overall population stability and size over time. This can be accomplished most directly by obtaining genetic measures from temporally-spaced samples that reflect the overall stability of the population as given by changes in genetic diversity levels (allelic richness and heterozygosity), degree of population differentiation (F-ST and D-EST), and effective population size (Ne). The primary goal of any recovery effort is to produce a long-term self-sustaining population, and these genetic measures provide a metric by which we can gauge our progress and help make important management decisions. Methodology/Principal Findings: The peregrine falcon in North America (Falco peregrinus tundrius and anatum) was delisted in 1994 and 1999, respectively, and its abundance will be monitored by the species Recovery Team every three years until 2015. Although the United States Fish and Wildlife Service makes a distinction between tundrius and anatum subspecies, our genetic results based on eleven microsatellite loci suggest limited differentiation that can be attributed to an isolation by distance relationship and warrant no delineation of these two subspecies in its northern latitudinal distribution from Alaska through Canada into Greenland. Using temporal samples collected at Padre Island, Texas during migration (seven temporal time periods between 1985-2007), no significant differences in genetic diversity or significant population differentiation in allele frequencies between time periods were observed and were indistinguishable from those obtained from tundrius/anatum breeding locations throughout their northern distribution. Estimates of harmonic mean Ne were variable and imprecise, but always greater than 500 when employing multiple temporal genetic methods. Conclusions/Significance: These results, including those from simulations to assess the power of each method to estimate Ne, suggest a stable or growing population, which is consistent with ongoing field-based monitoring surveys. Therefore, historic and continuing efforts to prevent the extinction of the peregrine falcon in North America appear successful with no indication of recent decline, at least from the northern latitude range-wide perspective. The results also further highlight the importance of archiving samples and their use for continual assessment of population recovery and long-term viability.	[Johnson, Jeff A.] Univ N Texas, Inst Appl Sci, Dept Biol Sci, Denton, TX 76203 USA; [Talbot, Sandra L.; Sage, George K.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Burnham, Kurt K.] High Arctic Inst, Orion, IL USA; [Brown, Joseph W.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Maechtle, Tom L.] Sheridan, Sheridan, WY USA; [Seegar, William S.] Edgewood Res Dev & Engn Ctr, Dept Army, Aberdeen Proving Ground, MD USA; [Yates, Michael A.] Boise State Univ, Raptor Res Ctr, Minden, NV USA; [Anderson, Bud] Falcon Res Grp, Bow, WA USA; [Mindell, David P.] Calif Acad Sci, San Francisco, CA 94118 USA	University of North Texas System; University of North Texas Denton; United States Department of the Interior; United States Geological Survey; Idaho; University of Idaho; Idaho; Boise State University; California Academy of Sciences	Johnson, JA (corresponding author), Univ N Texas, Inst Appl Sci, Dept Biol Sci, Denton, TX 76203 USA.	jajohnson@unt.edu	Brown, Joseph W/A-7713-2009; Talbot, Sandra L/C-9433-2011	Brown, Joseph W/0000-0002-3835-8062; 	U.S. Army's Edgewood Research Development and Engineering Center; Wolf Creek Charitable Foundation; Grassland Charitable Foundation; Ruth and Brian Mutch; North American Falconers' Association; Offield Family Foundation; Peregrine Fund; U.S. Geological Survey Alaska Science Center	U.S. Army's Edgewood Research Development and Engineering Center; Wolf Creek Charitable Foundation; Grassland Charitable Foundation; Ruth and Brian Mutch; North American Falconers' Association; Offield Family Foundation; Peregrine Fund; U.S. Geological Survey Alaska Science Center(United States Geological Survey)	Funding for field work and sample collection was generously provided by the U.S. Army's Edgewood Research Development and Engineering Center, The Wolf Creek Charitable Foundation, The Grassland Charitable Foundation, Ruth and Brian Mutch, the North American Falconers' Association, The Offield Family Foundation, and The Peregrine Fund. Funding for the genetic portion of this study was provided by The Peregrine Fund and the U.S. Geological Survey Alaska Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE RE, 2003, RETURN PEREGRINE, P189; Antao T, 2011, EVOL APPL, V4, P144, DOI 10.1111/j.1752-4571.2010.00150.x; Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Balloux F, 2000, EVOLUTION, V54, P1414, DOI 10.1111/j.0014-3820.2000.tb00573.x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Berger D. D., 1969, P165; BERRY RB, 2003, RETURN PEREGRINE, P35; Berthier P, 2002, GENETICS, V160, P741; Brown JW, 2007, MOL ECOL, V16, P327, DOI 10.1111/j.1365-294X.2007.03151.x; BURNHAM KK, 2010, BIOSCIENCE IN PRESS; BURNHAM W, 2003, RETURN PEREGRINE, P127; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; CABALLERO IC, 2006, FORTH N AM ORN C VER; Cade T. J., 1982, FALCONS WORLD; CADE TJ, 1971, SCIENCE, V172, P955, DOI 10.1126/science.172.3986.955; Cade TJ, 2003, RETURN PEREGRINE N A; CADE TJ, 2000, REINTRODUCTION NEWS, V19, P19; Cade Tom J., 1996, P3, DOI 10.1016/B978-012100130-8/50003-1; CHAO A, SPADE; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Dawnay N, 2009, FORENSIC SCI INT-GEN, V3, pE63, DOI 10.1016/j.fsigen.2008.07.001; De Barba M, 2010, MOL ECOL, V19, P3938, DOI 10.1111/j.1365-294X.2010.04791.x; Demandt MH, 2010, CONSERV GENET, V11, P249, DOI 10.1007/s10592-009-0027-6; DeYoung RW, 2003, MOL ECOL, V12, P3237, DOI 10.1046/j.1365-294X.2003.01996.x; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Eldridge WH, 2007, MOL ECOL, V16, P2407, DOI 10.1111/j.1365-294X.2007.03271.x; Enderson J. H., 1969, P73; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing SR, 2008, CONSERV BIOL, V22, P395, DOI 10.1111/j.1523-1739.2008.00884.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falk K., 1988, P37; Falush D, 2003, GENETICS, V164, P1567; Farmer Christopher J., 2008, P303; Ferguson-Lees J, 2001, RAPTORS WORLD; Fitzpatrick BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-176; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Fraser DJ, 2007, MOL ECOL, V16, P3866, DOI 10.1111/j.1365-294X.2007.03453.x; Fuller MR, 1998, J AVIAN BIOL, V29, P433, DOI 10.2307/3677162; Fyfe R., 1969, P101; FYFE R W, 1976, Canadian Field-Naturalist, V90, P228; Gautschi B, 2003, HEREDITY, V91, P9, DOI 10.1038/sj.hdy.6800278; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Green M., 2006, BIOL TECHNICAL PUBLI; Groombridge JJ, 2000, NATURE, V403, P616, DOI 10.1038/35001148; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Halbert ND, 2008, MOL ECOL, V17, P4963, DOI 10.1111/j.1365-294X.2008.03973.x; HALL D, 2005, COMMUNICATION   0127; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Henny CJ, 2009, J RAPTOR RES, V43, P37, DOI 10.3356/JRR-08-45.1; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jacobsen F, 2008, CONSERV GENET, V9, P581, DOI 10.1007/s10592-007-9373-4; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JEFFERIES D. J., 1966, BRIT BIRDS, V59, P49; JENSEN JL, BMC GENETICS, V6, P13; Johnson JA, 2004, MOL ECOL, V13, P2617, DOI 10.1111/j.1365-294X.2004.02264.x; Johnson JA, 2008, BIOL CONSERV, V141, P2403, DOI 10.1016/j.biocon.2008.07.001; Johnson JA, 2007, MOL ECOL, V16, P3145, DOI 10.1111/j.1365-294X.2007.03373.x; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Kiff L.F., 1988, P123; KRIMBAS CB, 1971, EVOLUTION, V25, P454, DOI 10.1111/j.1558-5646.1971.tb01904.x; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Laikre L, 2010, CONSERV BIOL, V24, P86, DOI 10.1111/j.1523-1739.2009.01425.x; Laikre L, 2009, CONSERV BIOL, V23, P1378, DOI 10.1111/j.1523-1739.2009.01360.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Leberg P, 2005, J WILDLIFE MANAGE, V69, P1385, DOI 10.2193/0022-541X(2005)69[1385:GAFETE]2.0.CO;2; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; LERNER HRL, 2009, PLOS ONE, V4, pNI102, DOI DOI 10.1371/J0URNAL.P0NE.0007336); Lewis PO, 2001, GENETIC DATA ANAL GD; Lindberg P., 1988, P619; Lott CA, 2006, J RAPTOR RES, V40, P200, DOI 10.3356/0892-1016(2006)40[200:ANRMMS]2.0.CO;2; Luikart G, 1999, CONSERV BIOL, V13, P523, DOI 10.1046/j.1523-1739.1999.98133.x; Martinez-Cruz B, 2007, MOL ECOL, V16, P477, DOI 10.1111/j.1365-294X.2007.03147.x; MASEVEU OB, 2009, TUNDRA TROPICS CONNE, P171; McGrady MJ, 2002, CONDOR, V104, P39, DOI 10.1650/0010-5422(2002)104[0039:MAROPF]2.0.CO;2; Mora M, 2002, ENVIRON POLLUT, V116, P169, DOI 10.1016/S0269-7491(01)00207-X; Mora MA, 2007, SOUTHWEST NAT, V52, P54, DOI 10.1894/0038-4909(2007)52[54:FAOECI]2.0.CO;2; MORGENWECK R, 2005, COMMUNICATION   0311; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; NELSON RW, 1990, CAN FIELD NAT, V104, P193; Nesje M, 2000, ANIM CONSERV, V3, P267; Nesje M, 2000, MOL ECOL, V9, P53, DOI 10.1046/j.1365-294x.2000.00834.x; Newton I., 1988, P761; Ortego J, 2007, BIOL LETTERS, V3, P585, DOI 10.1098/rsbl.2007.0268; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; PEAKALL DB, 1976, BIRD STUDY, V23, P183; Pertoldi C, 2001, P ROY SOC B-BIOL SCI, V268, P1775, DOI 10.1098/rspb.2001.1762; POLLAK E, 1983, GENETICS, V104, P531; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; RATCLIFF.DA, 1967, NATURE, V215, P208, DOI 10.1038/215208a0; Ratcliffe D.A., 1993, PEREGRINE FALCON; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; SCHMUTZ JK, 1991, WILSON BULL, V103, P44; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; Septon Greg, 2000, P455; SMITH JP, 2008, SERIES ORNITHOLOGY, V3, P253; Soule ME, 2005, BIOSCIENCE, V55, P168, DOI 10.1641/0006-3568(2005)055[0168:SISCPM]2.0.CO;2; Spencer CC, 2000, MOL ECOL, V9, P1517, DOI 10.1046/j.1365-294x.2000.01031.x; TALBOT SL, 2010, AVIAN BIOL IN PRESS; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Temple S.A., 1988, P843; TEMPLE SA, 1988, P INT S RAPT REINTR, P17; Tordoff HB, 1997, J RAPTOR RES, V31, P339; Tordoff HB, 2001, CONSERV BIOL, V15, P528, DOI 10.1046/j.1523-1739.2001.015002528.x; Turner TF, 2006, P R SOC B, V273, P3065, DOI 10.1098/rspb.2006.3677; Turner TF, 2001, CONSERV GENET, V2, P297, DOI 10.1023/A:1012538611944; *US FISH WILD SERV, 2003, MON PLAN AM PER FALC; *US FISH WILDL SER, 2008, FIN ENV ASS MAN PLAN; Vernesi C, 2003, MOL ECOL, V12, P585, DOI 10.1046/j.1365-294X.2003.01763.x; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Wakamiya SM, 2009, BIOL CONSERV, V142, P1767, DOI 10.1016/j.biocon.2009.03.015; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Wang JL, 1999, HEREDITY, V82, P212, DOI 10.1038/sj.hdy.6884670; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WAPLES RS, 1990, J HERED, V81, P277, DOI 10.1093/oxfordjournals.jhered.a110990; WAPLES RS, 1989, GENETICS, V121, P379; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White C.M., 1988, P789; White C. M., 2002, BIRDS N AM; WHITE CM, 1973, CONDOR, V75, P306, DOI 10.2307/1366171; WHITE CM, 1968, AUK, V85, P179, DOI 10.2307/4083579; 2008, FED REG, V73, P74508	143	16	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14042	10.1371/journal.pone.0014042	http://dx.doi.org/10.1371/journal.pone.0014042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124969	Green Submitted, gold, Green Published			2022-12-25	WOS:000284356900005
J	Dietrich, EA; Jones-Engel, L; Hu, SL				Dietrich, Elizabeth A.; Jones-Engel, Lisa; Hu, Shiu-Lok			Evolution of the Antiretroviral Restriction Factor TRIMCyp in Old World Primates	PLOS ONE			English	Article							CYCLOPHILIN-A; TRIM5-ALPHA RESTRICTION; MOLECULAR PHYLOGENY; RETROTRANSPOSITION; CERCOPITHECIDAE; RETROVIRUS; RESISTANCE; SELECTION; PROTEINS; HISTORY	The retroviral restriction factor TRIMCyp, which is a fusion protein derived from the TRIM5 gene, blocks replication at a post-entry step. Among Old World primates, TRIMCyp has been found in four species of Asian macaques, but not in African monkeys. To further define the evolutionary origin of Old World TRIMCyp, we examined two species of baboons (genus Papio) and three additional macaque species, including M. sylvanus, which is the only macaque species found outside Asia, and represents the earliest diverging branch of the macaque lineage. None of four P. cynocephalus anubis, one P. hamadryas, and 36 M. sylvanus had either TRIMCyp mRNA or the genetic features required for its expression. M. sylvanus genomic sequences indicated that the lack of TRIMCyp in this species was not due to genetic homogeneity among specimens studied and revealed the existence of four TRIM5 alpha alleles, all distinct from M. mulatta and Papio counterparts. Together with existing data on macaque evolution, our findings indicate that TRIMCyp evolved in the ancestors of Asian macaques approximately 5-6 million years before present (ybp), likely as a result of a retroviral threat. TRIMCyp then became fixed in the M. nemestrina lineage after it diverged from M. nigra, approximately 2 million ybp. The macaque lineage is unique among primates studied so far due to the presence and diversity of both TRIM5 and TRIMCyp restriction factors. Studies of these antiviral proteins may provide valuable information about natural antiviral mechanisms, and give further insight into the factors that shaped the evolution of macaque species.	[Dietrich, Elizabeth A.; Hu, Shiu-Lok] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Jones-Engel, Lisa; Hu, Shiu-Lok] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Hu, Shiu-Lok] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dietrich, EA (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	hus@uw.edu		Jones-Engel, Lisa/0000-0001-6912-494X; Dietrich, Elizabeth/0000-0002-1698-9568	NIH [P51 RR000166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by NIH grant P51 RR000166 to the Washington National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan G, 2007, J VIROL, V81, P12210, DOI 10.1128/JVI.02499-06; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; DELSON E, 1996, INT S EV AS PRIM IN; Diaz-Griffero F, 2009, J VIROL, V83, P10737, DOI 10.1128/JVI.01307-09; Drummond AJ, 2009, GENEIOUS 4 8; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; Engel GA, 2008, EMERG INFECT DIS, V14, P1112, DOI [10.3201/eid1407.071643, 10.3201/eid1407.071673]; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; Kanthaswamy S, 2008, INT J PRIMATOL, V29, P1295, DOI 10.1007/s10764-008-9295-0; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kohler M, 2000, J HUM EVOL, V38, P447, DOI 10.1006/jhev.1999.0388; Kuang YQ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-58; Li J, 2009, GENE, V448, P242, DOI 10.1016/j.gene.2009.05.013; Liao CH, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000304692.09143.1b; Modolo L, 2005, P NATL ACAD SCI USA, V102, P7392, DOI 10.1073/pnas.0502186102; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Newman RM, 2006, P NATL ACAD SCI USA, V103, P19134, DOI 10.1073/pnas.0605838103; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Page SL, 1999, MOL PHYLOGENET EVOL, V13, P348, DOI 10.1006/mpev.1999.0653; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ribeiro IP, 2005, J VIROL, V79, P14998, DOI 10.1128/JVI.79.23.14998-15003.2005; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tosi AJ, 2003, EVOLUTION, V57, P1419; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Ziegler T, 2007, MOL PHYLOGENET EVOL, V42, P807, DOI 10.1016/j.ympev.2006.11.015	37	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14019	10.1371/journal.pone.0014019	http://dx.doi.org/10.1371/journal.pone.0014019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103414	Green Submitted, gold, Green Published			2022-12-25	WOS:000284257400018
J	Weyrich, P; Staiger, H; Stancakova, A; Machicao, F; Machann, J; Schick, F; Stefan, N; Kuusisto, J; Laakso, M; Schafer, S; Fritsche, A; Haring, HU				Weyrich, Peter; Staiger, Harald; Stancakova, Alena; Machicao, Fausto; Machann, Juergen; Schick, Fritz; Stefan, Norbert; Kuusisto, Johanna; Laakso, Markku; Schaefer, Silke; Fritsche, Andreas; Haering, Hans-Ulrich			The D299G/T399I Toll-Like Receptor 4 Variant Associates with Body and Liver Fat: Results from the TULIP and METSIM Studies	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; FUNCTIONAL CONSEQUENCES; TLR4 POLYMORPHISMS; METABOLIC SYNDROME; TOLL-LIKE-RECEPTOR-4; GLUCOSE; OBESITY; EXPRESSION; MUTATIONS	Background: Toll-like-receptor 4 (TLR) is discussed to provide a molecular link between obesity, inflammation and insulin resistance. Genetic studies with replications in non-diabetic individuals in regard to their fat distribution or insulin resistance according to their carrier status of a common toll-like receptor 4 (TLR4) variant (TLR4(D299G/T399I)) are still lacking. Methodology/Principal Findings: We performed a cross-sectional analysis in individuals phenotyped for prediabetic traits as body fat composition (including magnetic resonance imaging), blood glucose levels and insulin resistance (oral glucose tolerance testing, euglycemic hyperinsulinemic clamp), according to TLR4 genotype determined by candidate SNP analyses (rs4986790). We analyzed N = 1482 non-diabetic individuals from the TUF/TULIP cohort (South Germany, aged 39 +/- 13 y, BMI 28.5 +/- 7.9, mean +/- SD) and N = 5327 non-diabetic participants of the METSIM study (Finland, males aged 58 +/- 6 y, BMI 26.8 +/- 3.8) for replication purposes. German TLR4(D299G/T399I) carriers had a significantly increased body fat (XG in rs4986790: +6.98%, p=0.03, dominant model, adjusted for age, gender) and decreased insulin sensitivity (XG: -15.3%, Matsuda model, p=0.04; XG: -20.6%, p=0.016, clamp; both dominant models adjusted for age, gender, body fat). In addition, both liver fat (AG: +49.7%; p=0.002) and visceral adipose tissue (AG: +8.2%; p=0.047, both adjusted for age, gender, body fat) were significantly increased in rs4986790 minor allele carriers, and the effect on liver fat remained significant also after additional adjustment for visceral fat (p=0.014). The analysis in METSIM confirmed increased body fat content in association with the rare G allele in rs4986790 (AG: +1.26%, GG: +11.0%; p=0.010, additive model, adjusted for age) and showed a non-significant trend towards decreased insulin sensitivity (AG: -0.99%, GG: -10.62%). Conclusions/Significance: TLR4(D299G/T399I) associates with increased total body fat, visceral fat, liver fat and decreased insulin sensitivity in non-diabetic Caucasians and may contribute to diabetes risk. This finding supports the role of TLR4 as a molecular link between obesity and insulin resistance.	[Weyrich, Peter; Staiger, Harald; Machicao, Fausto; Stefan, Norbert; Schaefer, Silke; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Paul Langerhans Inst Tubingen, Div Endocrinol, D-7400 Tubingen, Germany; [Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Machann, Juergen; Schick, Fritz] Univ Tubingen, Sect Expt Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Kuopio University Hospital; University of Eastern Finland; Eberhard Karls University of Tubingen	Weyrich, P (corresponding author), Univ Tubingen, Dept Internal Med, Paul Langerhans Inst Tubingen, Div Endocrinol, D-7400 Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de	Stancakova, Alena/AAN-6723-2020; Staiger, Harald/N-5871-2014	Stancakova, Alena/0000-0002-1375-0252; Schick, Fritz/0000-0002-4231-3406; Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595	European Community [LSHM-CT-2004-512013]; German Federal Ministry of Education and Research (BMBF)	European Community(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was in part supported by a grant from the European Community's FP6 EUGENE2 (LSHM-CT-2004-512013, see also: http://www.eugene2.com) and by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; BAGAROLLI RA, 2009, J DIABETES COMPLICAT; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Buraczynska M, 2009, HUM IMMUNOL, V70, P121, DOI 10.1016/j.humimm.2008.12.003; de Mello VDF, 2008, DIABETOLOGIA, V51, P2060, DOI 10.1007/s00125-008-1132-7; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; FESSLER MB, 2009, CURR OPIN LIPIDOL; Feterowski C, 2003, IMMUNOLOGY, V109, P426, DOI 10.1046/j.1365-2567.2003.01674.x; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Illig T, 2003, DIABETES, V52, P2861, DOI 10.2337/diabetes.52.11.2861; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kolz M, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-9; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; MacLaren R, 2008, ADV EXP MED BIOL, V632, P1, DOI 10.1007/978-0-387-78952-1_1; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Steinhardt AP, 2010, METABOLISM, V59, P711, DOI 10.1016/j.metabol.2009.09.015; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Rudofsky G, 2004, DIABETES CARE, V27, P179, DOI 10.2337/diacare.27.1.179; Schafer S, 2007, EUR J CLIN INVEST, V37, P535, DOI 10.1111/j.1365-2362.2007.01820.x; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Thamer C, 2007, OBESITY, V15, P531, DOI 10.1038/oby.2007.568; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; van der Graaf C, 2005, CYTOKINE, V30, P264, DOI 10.1016/j.cyto.2005.02.001; Weyrich P, 2007, DIABETOLOGIA, V50, P2097, DOI 10.1007/s00125-007-0788-8; WONG SW, 2009, J BIOL CHEM; ZHA JM, 2009, ENDOCR J; ZHANG HM, 2009, NUTR METAB CARDIOVAS; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	49	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13980	10.1371/journal.pone.0013980	http://dx.doi.org/10.1371/journal.pone.0013980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21125016	gold, Green Published, Green Submitted			2022-12-25	WOS:000284231800010
J	de Mol, P; Krabbe, HG; de Vries, ST; Fokkert, MJ; Dikkeschei, BD; Rienks, R; Bilo, KM; Bilo, HJG				de Mol, Pieter; Krabbe, Hans G.; de Vries, Suzanna T.; Fokkert, Marion J.; Dikkeschei, Bert D.; Rienks, Rienk; Bilo, Karin M.; Bilo, Henk J. G.			Accuracy of Handheld Blood Glucose Meters at High Altitude	PLOS ONE			English	Article							PERFORMANCE; SYSTEMS	Background: Due to increasing numbers of people with diabetes taking part in extreme sports (e. g., high-altitude trekking), reliable handheld blood glucose meters (BGMs) are necessary. Accurate blood glucose measurement under extreme conditions is paramount for safe recreation at altitude. Prior studies reported bias in blood glucose measurements using different BGMs at high altitude. We hypothesized that glucose-oxidase based BGMs are more influenced by the lower atmospheric oxygen pressure at altitude than glucose dehydrogenase based BGMs. Methodology/Principal Findings: Glucose measurements at simulated altitude of nine BGMs (six glucose dehydrogenase and three glucose oxidase BGMs) were compared to glucose measurement on a similar BGM at sea level and to a laboratory glucose reference method. Venous blood samples of four different glucose levels were used. Moreover, two glucose oxidase and two glucose dehydrogenase based BGMs were evaluated at different altitudes on Mount Kilimanjaro. Accuracy criteria were set at a bias <15% from reference glucose (when >6.5 mmol/L) and <1 mmol/L from reference glucose (when <6.5 mmol/L). No significant difference was observed between measurements at simulated altitude and sea level for either glucose oxidase based BGMs or glucose dehydrogenase based BGMs as a group phenomenon. Two GDH based BGMs did not meet set performance criteria. Most BGMs are generally overestimating true glucose concentration at high altitude. Conclusion: At simulated high altitude all tested BGMs, including glucose oxidase based BGMs, did not show influence of low atmospheric oxygen pressure. All BGMs, except for two GDH based BGMs, performed within predefined criteria. At true high altitude one GDH based BGM had best precision and accuracy.	[de Mol, Pieter] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands; [Krabbe, Hans G.; Fokkert, Marion J.; Dikkeschei, Bert D.] Isala Clin, Dept Clin Chem, Zwolle, Netherlands; [de Vries, Suzanna T.] Isala Clin, Dept Cardiol, Zwolle, Netherlands; [Rienks, Rienk] Dutch Airforce, Ctr Human Aviat, Soesterberg, Netherlands; [Bilo, Karin M.; Bilo, Henk J. G.] Isala Clin, Dept Internal Med, Zwolle, Netherlands; [Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands	Canisius-Wilhelmina Hospital; Isala Clinics; Isala Clinics; Isala Clinics; University of Groningen	de Mol, P (corresponding author), Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands.	P.deMol@aig.umcn.nl			Isala Clinics, Zwolle, The Netherlands	Isala Clinics, Zwolle, The Netherlands(Netherlands Government)	This study was funded by the Isala Clinics, Zwolle, The Netherlands. The funders had no role in study design, data collection and analysis, decisions to publish or preparation of the manuscript.	Bilen H., 2007, Journal of Medical Engineering & Technology, V31, P152, DOI 10.1080/03091900600861590; CHAN AYW, 1989, CLIN CHEM, V35, P315; CLARKE WL, 1987, DIABETES CARE, V10, P622, DOI 10.2337/diacare.10.5.622; Fink Kenneth S, 2002, Diabetes Technol Ther, V4, P627, DOI 10.1089/152091502320798259; GAULTIER JF, 1996, DIABETES CARE, V19, P1430; Ginsberg Barry H, 2009, J Diabetes Sci Technol, V3, P903; Moore K, 2001, DIABETIC MED, V18, P749, DOI 10.1046/j.0742-3071.2001.00568.x; Oberg D, 2005, DIABETES CARE, V28, P1261, DOI 10.2337/diacare.28.5.1261; Pecchio O, 2000, DIABETES CARE, V23, P129, DOI 10.2337/diacare.23.1.129a	9	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15485	10.1371/journal.pone.0015485	http://dx.doi.org/10.1371/journal.pone.0015485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103399	Green Published, gold, Green Submitted			2022-12-25	WOS:000284147700033
J	Melo, FR; Waern, I; Ronnberg, E; Abrink, M; Lee, DM; Schlenner, SM; Feyerabend, TB; Rodewald, HR; Turk, B; Wernersson, S; Pejler, G				Melo, Fabio Rabelo; Waern, Ida; Ronnberg, Elin; Abrink, Magnus; Lee, David M.; Schlenner, Susan M.; Feyerabend, Thorsten B.; Rodewald, Hans-Reimer; Turk, Boris; Wernersson, Sara; Pejler, Gunnar			A Role for Serglycin Proteoglycan in Mast Cell Apoptosis Induced by a Secretory Granule-mediated Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE METHYL-ESTER; LYSOSOMAL MEMBRANE PERMEABILIZATION; DIPEPTIDYL PEPTIDASE-I; CARBOXYPEPTIDASE-A; T-LYMPHOCYTES; GRANZYME-B; CYTOTOXIC LYMPHOCYTES; DEATH; ACTIVATION; PROTEASES	Mast cell secretory granules (secretory lysosomes) contain large amounts of fully active proteases bound to serglycin proteoglycan. Damage to the granule membrane will thus lead to the release of serglycin and serglycin-bound proteases into the cytosol, which potentially could lead to proteolytic activation of cytosolic pro-apoptotic compounds. We therefore hypothesized that mast cells are susceptible to apoptosis induced by permeabilization of the granule membrane and that this process is serglycin-dependent. Indeed, we show that wild-type mast cells are highly sensitive to apoptosis induced by granule permeabilization, whereas serglycin-deficient cells are largely resistant. The reduced sensitivity of serglycin(-/-) cells to apoptosis was accompanied by reduced granule damage, reduced release of proteases into the cytosol, and defective caspase-3 activation. Mechanistically, the apoptosis-promoting effect of serglycin involved serglycin-dependent proteases, as indicated by reduced sensitivity to apoptosis and reduced caspase-3 activation in cells lacking individual mast cell-specific proteases. Together, these findings implicate serglycin proteoglycan as a novel player in mast cell apoptosis.	[Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, SE-75123 Uppsala, Sweden; [Abrink, Magnus] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Lee, David M.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Lee, David M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Schlenner, Susan M.; Feyerabend, Thorsten B.; Rodewald, Hans-Reimer] Univ Ulm, Inst Immunol, D-89081 Ulm, Germany; [Turk, Boris] Univ Ljubljana, Dept Biochem & Mol & Struct Biol, Jozef Stefan Inst, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia	Swedish University of Agricultural Sciences; Uppsala University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ulm University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Ljubljana	Pejler, G (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, Box 575, SE-75123 Uppsala, Sweden.	Gunnar.Pejler@afb.slu.se	Ronnberg, Elin/ABA-8898-2020; Wernersson, Sara/D-4580-2011; Åbrink, Magnus/AAK-8346-2020; Wernersson, Sara/N-8830-2019; Melo, Fabio Rabelo/GQP-0844-2022; Schlenner, Susan/P-7905-2017	Ronnberg, Elin/0000-0002-4628-9968; Wernersson, Sara/0000-0003-3067-7875; Wernersson, Sara/0000-0003-3067-7875; Schlenner, Susan/0000-0002-8553-3388; Abrink, Magnus/0000-0002-1335-3927; Turk, Boris/0000-0002-9007-5764	National Institutes of Health [R01 AI 059746]; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; Swedish Cancer Foundation; CAPES-Brazil; Vardal Foundation; Swedish Society of Medicine; Slovene Research Agency [P1-0140, J1-711]; European Research Council [FP7/2007-2013), 233074]; Deutsche Forschungsgemeinschaft [754-2-2]; Formas; King Gustaf V 80-Year Anniversary Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; Swedish Cancer Foundation; CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Vardal Foundation; Swedish Society of Medicine; Slovene Research Agency(Slovenian Research Agency - Slovenia); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Formas(Swedish Research Council Formas); King Gustaf V 80-Year Anniversary Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI 059746. This work was also supported by grants from Swedish Research Council, Formas, King Gustaf V 80-Year Anniversary Fund, Torsten and Ragnar Soderberg Foundation, Swedish Cancer Foundation, CAPES-Brazil, Vardal Foundation, Swedish Society of Medicine, Slovene Research Agency Grants P1-0140 and J1-711, European Research Council (FP7/2007-2013)/ERC grant agreement no. 233074, and Deutsche Forschungsgemeinschaft 754-2-2.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Alfredsson J, 2005, CELL DEATH DIFFER, V12, P136, DOI 10.1038/sj.cdd.4401537; Berent-Maoz B, 2006, J IMMUNOL, V176, P2272, DOI 10.4049/jimmunol.176.4.2272; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; CHARLEY M, 1986, J CLIN INVEST, V78, P1415, DOI 10.1172/JCI112730; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dragonetti A, 2000, J CELL SCI, V113, P3289; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Grujic M, 2008, J IMMUNOL, V181, P1043, DOI 10.4049/jimmunol.181.2.1043; Hallgren J, 2004, J IMMUNOL, V173, P1868, DOI 10.4049/jimmunol.173.3.1868; Henningsson F, 2005, J CELL SCI, V118, P2035, DOI 10.1242/jcs.02333; Henningsson F, 2003, BIOL CHEM, V384, P1527, DOI 10.1515/BC.2003.169; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Huang CF, 1998, J IMMUNOL, V160, P1910; Ida H, 2003, EUR J IMMUNOL, V33, P3284, DOI 10.1002/eji.200324376; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; Karra L, 2009, CURR OPIN IMMUNOL, V21, P708, DOI 10.1016/j.coi.2009.09.010; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kobayashi Y, 2000, BIOCHEM BIOPH RES CO, V272, P687, DOI 10.1006/bbrc.2000.2836; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Laforge M, 2006, J IMMUNOL, V176, P3966, DOI 10.4049/jimmunol.176.7.3966; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Michallet MC, 2004, J IMMUNOL, V172, P5405, DOI 10.4049/jimmunol.172.9.5405; Mirghomizadeh F, 2009, EXP CELL RES, V315, P3064, DOI 10.1016/j.yexcr.2009.07.019; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Pejler G, 1999, BIOCHEMISTRY-US, V38, P12187, DOI 10.1021/bi991046b; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; THIELE DL, 1990, P NATL ACAD SCI USA, V87, P83, DOI 10.1073/pnas.87.1.83; THIELE DL, 1986, J IMMUNOL, V136, P1038; Tran TM, 2009, APOPTOSIS, V14, P320, DOI 10.1007/s10495-009-0311-4; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; van Nierop K, 2006, J HISTOCHEM CYTOCHEM, V54, P1425, DOI 10.1369/jhc.6A6967.2006; Wernersson S, 2009, J LEUKOCYTE BIOL, V85, P401, DOI 10.1189/jlb.1008670; Wolters PJ, 2000, AM J RESP CELL MOL, V22, P183, DOI 10.1165/ajrcmb.22.2.3767; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703	56	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5423	5433		10.1074/jbc.M110.176461	http://dx.doi.org/10.1074/jbc.M110.176461			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21123167	Green Published, hybrid			2022-12-25	WOS:000287230600051
J	Chi, CN; Bach, A; Engstrom, A; Stromgaard, K; Lundstrom, P; Ferguson, N; Jemth, P				Chi, Celestine N.; Bach, Anders; Engstrom, Ake; Stromgaard, Kristian; Lundstrom, Patrik; Ferguson, Neil; Jemth, Per			Biophysical Characterization of the Complex between Human Papillomavirus E6 Protein and Synapse-associated Protein 97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE TUMOR-SUPPRESSOR; PDZ-DOMAIN; HPV E6; POSTSYNAPTIC DENSITY; MEDIATED DEGRADATION; ADENOVIRUS E4-ORF1; BINDING MECHANISM; CERVICAL-CANCER; MOLECULAR-BASIS; CELL-LINES	The E6 protein of human papillomavirus (HPV) exhibits complex interaction patterns with several host proteins, and their roles in HPV-mediated oncogenesis have proved challenging to study. Here we use several biophysical techniques to explore the binding of E6 to the three PDZ domains of the tumor suppressor protein synapse-associated protein 97 (SAP97). All of the potential binding sites in SAP97 bind E6 with micromolar affinity. The dissociation rate constants govern the different affinities of HPV16 and HPV18 E6 for SAP97. Unexpectedly, binding is not mutually exclusive, and all three PDZ domains can simultaneously bind E6. Intriguingly, this quaternary complex has the same apparent hydrodynamic volume as the unliganded PDZ region, suggesting that a conformational change occurs in the PDZ region upon binding, a conclusion supported by kinetic experiments. Using NMR, we discovered a new mode of interaction between E6 and PDZ: a subset of residues distal to the canonical binding pocket in the PDZ(2) domain exhibited noncanonical interactions with the E6 protein. This is consistent with a larger proportion of the protein surface defining binding specificity, as compared with that reported previously.	[Lundstrom, Patrik] Linkoping Univ, Div Mol Biotechnol, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden; [Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Bach, Anders; Stromgaard, Kristian] Univ Copenhagen, Dept Med Chem, DK-2100 Copenhagen, Denmark; [Ferguson, Neil] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland	Linkoping University; Uppsala University; University of Copenhagen; University College Dublin	Lundstrom, P (corresponding author), Linkoping Univ, Div Mol Biotechnol, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden.	patlu@ifm.liu.se; neil.ferguson@ucd.ie; Per.Jemth@imbim.uu.se		Bach, Anders/0000-0003-4305-9910; Stromgaard, Kristian/0000-0003-2206-4737	Swedish Research Council; Jeansson's Foundation; Clas Groschinskys Minnesfond; Science Foundation Ireland [07/SK/B1224, 09/YI/B1682]; University College Dublin	Swedish Research Council(Swedish Research CouncilEuropean Commission); Jeansson's Foundation; Clas Groschinskys Minnesfond; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); University College Dublin	This work was supported by funds from the Swedish Research Council (to P. J. and P. L.), Jeansson's Foundation (to P. J.), Clas Groschinskys Minnesfond (to P. J.), Science Foundation Ireland Awards 07/SK/B1224and 09/YI/B1682 (to N. F.), and a start-up award from University College Dublin (to N. F.).	ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; BANKS L, 1987, J GEN VIROL, V68, P1351, DOI 10.1099/0022-1317-68-5-1351; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Boulet G, 2007, INT J BIOCHEM CELL B, V39, P2006, DOI 10.1016/j.biocel.2007.07.004; CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774; Chi CN, 2006, J BIOL CHEM, V281, P36811, DOI 10.1074/jbc.M607883200; Chi CN, 2010, J BIOL CHEM, V285, P28252, DOI 10.1074/jbc.M110.124040; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEVILLIERS EM, 1987, LANCET, V2, P703; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fehrmann F, 2003, ONCOGENE, V22, P5201, DOI 10.1038/sj.onc.1206554; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P341, DOI 10.1021/bi602457q; Gardiol D, 1999, ONCOGENE, V18, P5487, DOI 10.1038/sj.onc.1202920; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2006, STRUCTURE, V14, P1801, DOI 10.1016/j.str.2006.10.010; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Goult BT, 2007, BIOCHEMISTRY-US, V46, P14117, DOI 10.1021/bi701257z; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Lee SS, 2000, J VIROL, V74, P9680, DOI 10.1128/JVI.74.20.9680-9693.2000; Liu YQ, 2008, FRONT BIOSCI-LANDMRK, V13, P121, DOI 10.2741/2664; Liu YQ, 2009, J MOL BIOL, V386, P1123, DOI 10.1016/j.jmb.2009.01.018; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Mammas IN, 2008, PATHOL ONCOL RES, V14, P345, DOI 10.1007/s12253-008-9056-6; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Niu XG, 2007, BIOCHEMISTRY-US, V46, P15042, DOI 10.1021/bi701303p; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Nomine Y, 2001, PROTEIN EXPRES PURIF, V23, P22, DOI 10.1006/prep.2001.1451; Nomine Y, 2001, PROTEIN ENG, V14, P297, DOI 10.1093/protein/14.4.297; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Thomas M, 2001, ONCOGENE, V20, P5431, DOI 10.1038/sj.onc.1204719; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Thomas M, 1998, ONCOGENE, V17, P2943, DOI 10.1038/sj.onc.1202223; Thomas M, 2008, VIROLOGY, V376, P371, DOI 10.1016/j.virol.2008.03.021; Tong XA, 1997, P NATL ACAD SCI USA, V94, P4412, DOI 10.1073/pnas.94.9.4412; Tungteakkhun SS, 2008, ARCH VIROL, V153, P397, DOI 10.1007/s00705-007-0022-5; Wise-Draper TM, 2008, FRONT BIOSCI-LANDMRK, V13, P1003, DOI 10.2741/2739; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zhang Y, 2007, J VIROL, V81, P3618, DOI 10.1128/JVI.02044-06; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	47	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3597	3606		10.1074/jbc.M110.190264	http://dx.doi.org/10.1074/jbc.M110.190264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21113079	hybrid, Green Published			2022-12-25	WOS:000286653200044
J	Ertas, B; Kiger, L; Blank, M; Marden, MC; Burmester, T				Ertas, Beyhan; Kiger, Laurent; Blank, Miriam; Marden, Michael C.; Burmester, Thorsten			A Membrane-bound Hemoglobin from Gills of the Green Shore Crab Carcinus maenas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING PROPERTIES; GLOBIN-COUPLED SENSORS; MYRISTOYLATED PROTEINS; ARTHROPOD HEMOCYANINS; N-MYRISTOYLATION; EVOLUTION; NEUROGLOBIN; DROSOPHILA; MYOGLOBIN; CRUSTACEA	O-2 Most hemoglobins serve for the transport or storage of O-2. Although hemoglobins are widespread in "entomostracan" Crustacea, malacostracans harbor the copper-containing hemocyanin in their hemolymph. Usually, only one type of respiratory protein occurs within a single species. Here, we report the identification of a hemoglobin of the shore crab Carcinus maenas (Malacostraca, Brachyura). In contrast to the do-decameric hemocyanin of this species, C. maenas hemoglobin does not reside in the hemolymph but is restricted to the gills. Immunofluorescence studies and cell fractioning showed that C. maenas hemoglobin resides in the membrane of the chief cells of the gill. To the best of our knowledge, this is the first time that a membrane-bound hemoglobin has been identified in eukaryotes. Bioinformatic evaluation suggests that C. maenas hemoglobin is anchored in the membrane by N-myristoylation. Recombinant C. maenas hemoglobin has a hexacoordinate binding scheme at the Fe2+ and an oxygen affinity of P-50 = 0.5 Torr. A rapid autoxidation rate precludes a function as oxygen carrier. We rather speculate that, analogous to prokaryotic membrane-globins, C. maenas hemoglobin carries out enzymatic functions to protect the lipids in cell membrane from reactive oxygen species. Sequence comparisons and phylogenetic studies suggested that the ancestral arthropod hemoglobin was most likely an N-myristoylated protein that did not have an O-2 supply function. True respiratory hemoglobins of arthropods, however, evolved independently in chironomid midges and branchiopod crustaceans.	[Burmester, Thorsten] Univ Hamburg, Inst Zool, Bioctr Grindel, D-20146 Hamburg, Germany; Univ Hamburg, Zool Museum, D-20146 Hamburg, Germany; [Kiger, Laurent; Marden, Michael C.] INSERM, U779, F-94275 Le Kremlin Bicetre, France	University of Hamburg; University of Hamburg; Institut National de la Sante et de la Recherche Medicale (Inserm)	Burmester, T (corresponding author), Univ Hamburg, Inst Zool, Bioctr Grindel, Martin Luther King Pl 3, D-20146 Hamburg, Germany.	thorsten.burmester@uni-hamburg.de	Götting, Miriam/I-8222-2014; Marden, Michael/AAA-5923-2020; Kiger, Laurent/Q-1686-2018; Marden, Michael C/G-3139-2012; Burmester, Thorsten/I-7225-2013	Götting, Miriam/0000-0001-5336-1422; Marden, Michael C/0000-0002-5254-6385; Burmester, Thorsten/0000-0002-5772-7863	German Research Foundation (Deutsche Forschungsgemeinschaft) [Bu956/9]; INSERM	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work has been supported in part by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft Bu956/9) and INSERM.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERGTROM G, 1977, INSECT BIOCHEM, V7, P313, DOI 10.1016/0020-1790(77)90031-2; Bonamore A, 2003, BIOCHEMISTRY-US, V42, P5792, DOI 10.1021/bi0206311; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burmester T, 1999, MOL BIOL EVOL, V16, P1809, DOI 10.1093/oxfordjournals.molbev.a026093; Burmester T, 2006, FEBS J, V273, P468, DOI 10.1111/j.1742-4658.2005.05073.x; Burmester T, 2001, MOL BIOL EVOL, V18, P184, DOI 10.1093/oxfordjournals.molbev.a003792; Burmester T, 2002, J COMP PHYSIOL B, V172, P95, DOI 10.1007/s00360-001-0247-7; Burmester T, 2007, J INSECT PHYSIOL, V53, P285, DOI 10.1016/j.jinsphys.2006.12.006; Burmester T, 2007, INSECT MOL BIOL, V16, P133, DOI 10.1111/j.1365-2583.2006.00706.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Di Giulio A, 2008, METHOD ENZYMOL, V436, P239, DOI 10.1016/S0076-6879(08)36013-3; Ertas B, 2009, MOL BIOL EVOL, V26, P2711, DOI 10.1093/molbev/msp186; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Flogel U, 2004, FASEB J, V18, P1156, DOI 10.1096/fj.03-1382fje; FOX HM, 1957, NATURE, V179, P148, DOI 10.1038/179148a0; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gleixner E, 2008, FEBS J, V275, P5108, DOI 10.1111/j.1742-4658.2008.06642.x; GOODMAN SH, 1990, CELL TISSUE RES, V260, P495, DOI 10.1007/BF00297229; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hankeln T, 2002, J BIOL CHEM, V277, P29012, DOI 10.1074/jbc.M204009200; Hankeln T, 2006, J INSECT PHYSIOL, V52, P701, DOI 10.1016/j.jinsphys.2006.03.010; Hardison R, 1998, J EXP BIOL, V201, P1099; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ILAN E, 1979, COMP BIOCHEM PHYS B, V63, P303, DOI 10.1016/0305-0491(79)90253-0; Lieb B, 2006, P NATL ACAD SCI USA, V103, P12011, DOI 10.1073/pnas.0601861103; Liong EC, 2001, J BIOL CHEM, V276, P9093, DOI 10.1074/jbc.M008593200; Liu C, 2004, BIOCHEM BIOPH RES CO, V316, P1163, DOI 10.1016/j.bbrc.2004.02.170; MANGUM CP, 1983, BIOL CRUSTACEA, V5, P373; Marden MC, 2007, GENE, V398, P35, DOI 10.1016/j.gene.2007.01.036; MARKL J, 1979, J COMP PHYSIOL, V133, P167, DOI 10.1007/BF00691462; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; MARKL J, 1986, BIOL BULL, V171, P90, DOI 10.2307/1541909; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; OSMULSKI PA, 1986, COMP BIOCHEM PHYS B, V85, P701, DOI 10.1016/0305-0491(86)90166-5; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Ramandeep, 2001, J BIOL CHEM, V276, P24781, DOI 10.1074/jbc.M009808200; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rinaldi AC, 2006, BIOCHEMISTRY-US, V45, P4069, DOI 10.1021/bi052277n; Sowa AW, 1998, P NATL ACAD SCI USA, V95, P10317, DOI 10.1073/pnas.95.17.10317; Terwilliger N. B., 2008, PROTEIN REV DIOXYGEN, P203; Terwilliger NB, 2006, BIOL BULL-US, V210, P38, DOI 10.2307/4134535; TERWILLIGER NB, 1991, STRUCTURE AND FUNCTION OF INVERTEBRATE OXYGEN CARRIERS, P59; Terwilliger NB, 1998, J EXP BIOL, V201, P1085; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	59	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3185	3193		10.1074/jbc.M110.160341	http://dx.doi.org/10.1074/jbc.M110.160341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118803	hybrid, Green Published			2022-12-25	WOS:000286653200002
J	Fletcher, CM; Coyne, MJ; Comstock, LE				Fletcher, C. Mark; Coyne, Michael J.; Comstock, Laurie E.			Theoretical and Experimental Characterization of the Scope of Protein O-Glycosylation in Bacteroides fragilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; TOPOLOGY; PREDICTION; SURFACE; STARCH; BLAST	Among bacterial species demonstrated to have protein O-glycosylation systems, that of Bacteroides fragilis and related species is unique in that extracytoplasmic proteins are glycosylated at serine or threonine residues within the specific three-amino acid motif D(S/T)(A/I/L/M/T/V). This feature allows for computational analysis of the proteome to identify candidate glycoproteins. With the criteria of a signal peptidase I or II cleavage site or a predicted transmembrane-spanning region and the presence of at least one glycosylation motif, we identified 1021 candidate glycoproteins of B. fragilis. In addition to the eight glycoproteins identified previously, we confirmed that another 12 candidate glycoproteins are in fact glycosylated. These included four glycoproteins that are predicted to localize to the inner membrane, a compartment not previously shown to include glycosylated proteins. In addition, we show that four proteins involved in cell division and chromosomal segregation, two of which are encoded by candidate essential genes, are glycosylated. To date, we have not identified any extracytoplasmic proteins containing a glycosylation motif that are not glycosylated. Therefore, based on the list of 1021 candidate glycoproteins, it is likely that hundreds of proteins, comprising more than half of the extracytoplasmic proteins of B. fragilis, are glycosylated. Site-directed mutagenesis of several glycoproteins demonstrated that all are glycosylated at the identified glycosylation motif. By engineering glycosylation motifs into a naturally unglycosylated protein, we are able to bring about site-specific glycosylation at the engineered sites, suggesting that this glycosylation system may have applications for glycoengineering.	[Fletcher, C. Mark; Coyne, Michael J.; Comstock, Laurie E.] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Comstock, LE (corresponding author), Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, 181 Longwood Ave, Boston, MA 02115 USA.	lcomstock@rics.bwh.harvard.edu			National Institutes of Health [AI067711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI067711.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; BOWLER LD, 1989, MOL MICROBIOL, V3, P1277, DOI 10.1111/j.1365-2958.1989.tb00278.x; CARSON MJ, 1991, J BACTERIOL, V173, P2187, DOI 10.1128/JB.173.7.2187-2195.1991; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Espitia C, 2010, MOL BIOSYST, V6, P775, DOI 10.1039/b916394h; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; GILL DR, 1987, MOL GEN GENET, V210, P504, DOI 10.1007/BF00327204; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Gromiha MM, 2004, J COMPUT CHEM, V25, P762, DOI 10.1002/jcc.10386; HUG I, 2010, GLYCOBIOLOGY    0924, DOI DOI 10.1093/GLYC0B/CWQ148; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Jervis AJ, 2010, J BACTERIOL, V192, P5228, DOI 10.1128/JB.00211-10; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Martelli Pier Luigi, 2002, Bioinformatics, V18 Suppl 1, pS46; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Reeves AR, 1996, J BACTERIOL, V178, P823, DOI 10.1128/jb.178.3.823-830.1996; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	35	38	40	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3219	3226		10.1074/jbc.M110.194506	http://dx.doi.org/10.1074/jbc.M110.194506			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115495	Green Published, hybrid			2022-12-25	WOS:000286653200006
J	Soohoo, CY; Shi, R; Lee, TH; Huang, PY; Lu, KP; Zhou, XZ				Soohoo, Christina Y.; Shi, Rong; Lee, Tae Ho; Huang, Pengyu; Lu, Kun Ping; Zhou, Xiao Zhen			Telomerase Inhibitor PinX1 Provides a Link between TRF1 and Telomerase to Prevent Telomere Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN-CELLS; DNA-DAMAGE RESPONSE; CATALYTIC SUBUNIT; BINDING-PROTEIN; FISSION YEAST; LIFE-SPAN; HEPATOCELLULAR-CARCINOMA; CELLULAR SENESCENCE; HUMAN-CHROMOSOMES; HUMAN FIBROBLASTS	Telomere maintenance is essential for protecting chromosome ends. Aberrations in telomere length have been implicated in cancer and aging. Telomere elongation by human telomerase is inhibited in cis by the telomeric protein TRF1 and its associated proteins. However, the link between TRF1 and inhibition of telomerase elongation of telomeres remains elusive because TRF1 has no direct effect on telomerase activity. We have previously identified one Pin2/TRF1-interacting protein, PinX1, that has the unique property of directly binding and inhibiting telomerase catalytic activity (Zhou, X. Z., and Lu, K. P. (2001) Cell 107, 347-359). However, nothing is known about the role of the PinX1-TRF1 interaction in the regulation of telomere maintenance. By identifying functional domains and key amino acid residues in PinX1 and TRF1 responsible for the PinX1-TRF1 interaction, we show that the TRF homology domain of TRF1 interacts with a minimal 20-amino acid sequence of PinX1 via hydrophilic and hydrophobic interactions. Significantly, either disrupting this interaction by mutating the critical Leu-291 residue in PinX1 or knocking down endogenous TRF1 by RNAi abolishes the ability of PinX1 to localize to telomeres and to inhibit telomere elongation in cells even though neither has any effect on telomerase activity per se. Thus, the telomerase inhibitor PinX1 is recruited to telomeres by TRF1 and provides a critical link between TRF1 and telomerase inhibition to prevent telomere elongation and help maintain telomere homeostasis.	[Zhou, Xiao Zhen] Harvard Univ, Sch Med, Div Hematol Oncol,Beth Israel Deaconess Med Ctr, Canc Biol Program,Ctr Life Sci, Boston, MA 02115 USA; [Shi, Rong] So Med Univ, Inst Genet Engn, Guangzhou 510515, Guangdong, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Southern Medical University - China	Zhou, XZ (corresponding author), Harvard Univ, Sch Med, Div Hematol Oncol,Beth Israel Deaconess Med Ctr, Canc Biol Program,Ctr Life Sci, Rm 0413, Boston, MA 02115 USA.	xzhou@bidmc.harvard.edu	Lee, Tae Ho/AAT-1721-2020		National Institutes of Health [R01CA122434]; NATIONAL CANCER INSTITUTE [R01CA122434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA122434 ( to X. Z. Z.).	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Banik SSR, 2004, J BIOL CHEM, V279, P51745, DOI 10.1074/jbc.M408131200; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Farazi PA, 2003, CANCER RES, V63, P5021; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Guo CH, 2001, J UROLOGY, V166, P694, DOI 10.1016/S0022-5347(05)66045-4; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kishi S, 2002, J BIOL CHEM, V277, P7420, DOI 10.1074/jbc.M111365200; Kishi S, 2001, ONCOGENE, V20, P1497, DOI 10.1038/sj.onc.1204229; Krauskopf A, 1996, NATURE, V383, P354, DOI 10.1038/383354a0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Liao C, 2002, WORLD J GASTROENTERO, V8, P1050, DOI 10.3748/wjg.v8.i6.1050; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Lin J, 2004, GENE DEV, V18, P387, DOI 10.1101/gad.1171804; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Oh BK, 2007, GENE, V400, P35, DOI 10.1016/j.gene.2007.05.015; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Qi L, 2003, CANCER RES, V63, P8188; Reaper PM, 2004, CELL CYCLE, V3, P543; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zhou XZ, 2003, J CELL BIOCHEM, V89, P19, DOI 10.1002/jcb.10496; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu QB, 2009, J CELL BIOL, V185, P827, DOI 10.1083/jcb.200812121	106	32	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3894	3906		10.1074/jbc.M110.180174	http://dx.doi.org/10.1074/jbc.M110.180174			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21119197	Green Published, hybrid			2022-12-25	WOS:000286653200070
J	Stalder, D; Barelli, H; Gautier, R; Macia, E; Jackson, CL; Antonny, B				Stalder, Daniele; Barelli, Helene; Gautier, Romain; Macia, Eric; Jackson, Catherine L.; Antonny, Bruno			Kinetic Studies of the Arf Activator Arno on Model Membranes in the Presence of Arf Effectors Suggest Control by a Positive Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; PLECKSTRIN-HOMOLOGY DOMAINS; ADP-RIBOSYLATION FACTOR-1; COILED-COIL DOMAIN; SMALL G-PROTEINS; STRUCTURAL BASIS; PH DOMAIN; FAMILY; BINDING; SEC7	Proteins of the cytohesin/Arno/Grp1 family of Arf activators are positive regulators of the insulin-signaling pathway and control various remodeling events at the plasma membrane. Arno has a catalytic Sec7 domain, which promotes GDP to GTP exchange on Arf, followed by a pleckstrin homology (PH) domain. Previous studies have revealed two functions of the PH domain: inhibition of the Sec7 domain and membrane targeting. Interestingly, the Arno PH domain interacts not only with a phosphoinositide (phosphatidylinositol 4,5-bisphosphate or phosphatidylinositol 3,4,5-trisphosphate) but also with an activating Arf family member, such as Arf6 or Arl4. Using the full-length membrane-bound forms of Arf1 and Arf6 instead of soluble forms, we show here that the membrane environment dramatically affects the mechanism of Arno activation. First, Arf6-GTP stimulates Arno at nanomolar concentrations on liposomes compared with micromolar concentrations in solution. Second, mutations in the PH domain that abolish interaction with Arf6-GTP render Arno completely inactive when exchange reactions are reconstituted on liposomes but have no effect on Arno activity in solution. Third, Arno is activated by its own product Arf1-GTP in addition to a distinct activating Arf isoform. Consequently, Arno activity is strongly modulated by competition with Arf effectors. These results show that Arno behaves as a bistable switch, having an absolute requirement for activation by an Arf protein but, once triggered, becoming highly active through the positive feedback effect of Arf1-GTP. This property of Arno might provide an explanation for its function in signaling pathways that, once triggered, must move forward decisively.	[Stalder, Daniele; Barelli, Helene; Gautier, Romain; Macia, Eric; Antonny, Bruno] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, F-06560 Valbonne, France; [Jackson, Catherine L.] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Antonny, B (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, 660 Route Lucioles, F-06560 Valbonne, France.	antonny@ipmc.cnrs.fr	Macia, Eric/AAW-2964-2021; Jackson, Catherine/T-5688-2019; Jackson, Catherine/A-3421-2013; Antonny, Bruno/ABH-7434-2020	Jackson, Catherine/0000-0002-0843-145X; Antonny, Bruno/0000-0002-9166-8668; BARELLI, Helene/0000-0001-6376-863X; GAUTIER, Romain/0000-0001-6678-132X; macia, eric/0000-0003-3686-2000	Agence Nationale de la Recherche [ANR-08-BLAN-0060-01]; Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by Agence Nationale de la Recherche Grant ANR-08-BLAN-0060-01.; Supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	ALBERTY RA, 1953, J AM CHEM SOC, V75, P1928, DOI 10.1021/ja01104a045; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Chavrier P, 2001, METHOD ENZYMOL, V329, P272; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; El Annan J, 2004, AM J PHYSIOL-CELL PH, V286, pC768, DOI 10.1152/ajpcell.00250.2003; Franco M, 1998, P NATL ACAD SCI USA, V95, P9926, DOI 10.1073/pnas.95.17.9926; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Li HS, 2003, BMC CELL BIOL, V4, P1, DOI 10.1186/1471-2121-4-13; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Macia E, 2000, BIOCHEMISTRY-US, V39, P5893, DOI 10.1021/bi992795w; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; Mansour M, 2002, J BIOL CHEM, V277, P32302, DOI 10.1074/jbc.M202898200; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; Moss J, 2002, ARCH BIOCHEM BIOPHYS, V397, P156, DOI 10.1006/abbi.2001.2661; Nagel WG, 1998, MOL BIOL CELL, V9, P1981, DOI 10.1091/mbc.9.8.1981; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Ogasawara M, 2000, J BIOL CHEM, V275, P3221, DOI 10.1074/jbc.275.5.3221; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 1999, CURR BIOL, V9, P1173, DOI 10.1016/S0960-9822(00)80019-6; Shmuel M, 2006, J BIOL CHEM, V281, P13300, DOI 10.1074/jbc.M513723200; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; White DT, 2010, MOL BIOL CELL, V21, P562, DOI 10.1091/mbc.E09-03-0217	58	57	57	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3873	3883		10.1074/jbc.M110.145532	http://dx.doi.org/10.1074/jbc.M110.145532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118813	Green Published, hybrid			2022-12-25	WOS:000286653200068
J	Yasmin, S; Andrews, SC; Moore, GR; Le Brun, NE				Yasmin, Samina; Andrews, Simon C.; Moore, Geoffrey R.; Le Brun, Nick E.			A New Role for Heme, Facilitating Release of Iron from the Bacterioferritin Iron Biomineral	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI BACTERIOFERRITIN; HORSE SPLEEN FERRITIN; PSEUDOMONAS-AERUGINOSA; MAMMALIAN FERRITIN; AZOTOBACTER-VINELANDII; BACTERIAL FERRITIN; REDUCTION; FERROZINE; MOBILIZATION; BINDING	Bacterioferritin (BFR) from Escherichia coli is a member of the ferritin family of iron storage proteins and has the capacity to store very large amounts of iron as an Fe3+ mineral inside its central cavity. The ability of organisms to tap into their cellular stores in times of iron deprivation requires that iron must be released from ferritin mineral stores. Currently, relatively little is known about the mechanisms by which this occurs, particularly in prokaryotic ferritins. Here we show that the bis-Met-coordinated heme groups of E. coli BFR, which are not found in other members of the ferritin family, play an important role in iron release from the BFR iron biomineral: kinetic iron release experiments revealed that the transfer of electrons into the internal cavity is the rate-limiting step of the release reaction and that the rate and extent of iron release were significantly increased in the presence of heme. Despite previous reports that a high affinity Fe2+ chelator is required for iron release, we show that a large proportion of BFR core iron is released in the absence of such a chelator and further that chelators are not passive participants in iron release reactions. Finally, we show that the catalytic ferroxidase center, which is central to the mechanism of mineralization, is not involved in iron release; thus, core mineralization and release processes utilize distinct pathways.	Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Andrews, Simon C.] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	University of East Anglia; University of Reading		n.le-brun@uea.ac.uk	Andrews, Simon C/H-4758-2019	Andrews, Simon C/0000-0003-4295-2686; Le Brun, Nick/0000-0001-9780-4061	United Kingdom Biotechnology and Biological Sciences Research Council [BB/D001943/1, BB/D002435/1]; Wellcome Trust; BBSRC [BB/D001943/1, BB/D002435/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D002435/1, BB/D001943/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the United Kingdom Biotechnology and Biological Sciences Research Council Grants BB/D001943/1 (to N. E. L. B. and G. R. M.) and BB/D002435/1 (to S. C. A.) and a JIF grant from the Wellcome Trust.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; Baaghil S, 2002, J CHEM SOC DALTON, P811, DOI 10.1039/b107288a; BAUMINGER ER, 1991, BIOCHIM BIOPHYS ACTA, V1118, P48, DOI 10.1016/0167-4838(91)90440-B; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; BOYER RF, 1988, J INORG BIOCHEM, V32, P171, DOI 10.1016/0162-0134(88)80025-4; Chasteen ND, 1998, MET IONS BIOL SYST, V35, P479; CHASTEEN ND, 1991, ANAL BIOCHEM, V195, P296, DOI 10.1016/0003-2697(91)90333-O; CHEESMAN MR, 1990, NATURE, V346, P771, DOI 10.1038/346771a0; CHEESMAN MR, 1993, BIOCHEM J, V292, P47, DOI 10.1042/bj2920047; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Expert D, 2008, J BIOL CHEM, V283, P36564, DOI 10.1074/jbc.M807749200; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Fu XP, 2010, BIOCHEM J, V427, P313, DOI 10.1042/BJ20100015; FUNK F, 1985, EUR J BIOCHEM, V152, P167, DOI 10.1111/j.1432-1033.1985.tb09177.x; Garg RP, 1996, BIOCHEMISTRY-US, V35, P6297, DOI 10.1021/bi9600862; GIBBS CR, 1976, ANAL CHEM, V48, P1197, DOI 10.1021/ac50002a034; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; JACOBS DL, 1989, BIOCHEMISTRY-US, V28, P1650, DOI 10.1021/bi00430a033; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; KONTOGHIORGHES GJ, 1986, BIOCHEM J, V233, P299, DOI 10.1042/bj2330299; LAULHERE JP, 1993, BIOCHEM J, V290, P693, DOI 10.1042/bj2900693; Laulhere JP, 1996, BIOMETALS, V9, P303, DOI 10.1007/BF00817931; Lawson TL, 2009, BIOCHEMISTRY-US, V48, P9031, DOI 10.1021/bi900869x; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; LEBRUN NE, 1995, BIOCHEM J, V312, P385, DOI 10.1042/bj3120385; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XS, 2007, J BIOL CHEM, V282, P31821, DOI 10.1074/jbc.C700153200; Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539; MOORE GR, 1994, BIOCHEM J, V304, P493, DOI 10.1042/bj3040493; MOORE GR, 1992, J INORG BIOCHEM, V47, P175, DOI 10.1016/0162-0134(92)84063-S; Quail MA, 1996, BIOCHEM BIOPH RES CO, V229, P635, DOI 10.1006/bbrc.1996.1856; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Richards TD, 1996, J INORG BIOCHEM, V61, P1, DOI 10.1016/0162-0134(95)00029-1; Saini A, 2010, BIOCHEMISTRY-US, V49, P9402, DOI 10.1021/bi1011546; Sillen L, 1964, STABILITY CONSTANTS; SIRIVECH S, 1974, BIOCHEM J, V143, P311, DOI 10.1042/bj1430311; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STIEFEL EI, 1979, NATURE, V279, P81, DOI 10.1038/279081a0; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Theil EC, 2006, J BIOL INORG CHEM, V11, P803, DOI 10.1007/s00775-006-0125-6; THOMPSEN JC, 1984, ANAL CHEM, V56, P755, DOI 10.1021/ac00268a037; WATT GD, 1988, P NATL ACAD SCI USA, V85, P7457, DOI 10.1073/pnas.85.20.7457; WATT GD, 1985, P NATL ACAD SCI USA, V82, P3640, DOI 10.1073/pnas.82.11.3640; WATT GD, 1992, BIOCHEMISTRY-US, V31, P5672, DOI 10.1021/bi00139a035; Weeratunga SK, 2009, BIOCHEMISTRY-US, V48, P7420, DOI 10.1021/bi900561a; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Yang XK, 1996, BIOPHYS J, V71, P1587, DOI 10.1016/S0006-3495(96)79361-X; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f	57	45	47	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3473	3483		10.1074/jbc.M110.175034	http://dx.doi.org/10.1074/jbc.M110.175034			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106523	Green Published, hybrid			2022-12-25	WOS:000286653200033
J	Jeong, YS; Park, JS; Ko, Y; Kang, YK				Jeong, Young Sun; Park, Jung Sun; Ko, Yong; Kang, Yong-Kook			JHDM3A Module as an Effector Molecule in Guide-directed Modification of Target Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; HISTONE H3 LYSINE-9; SILENCED GENES; JMJD2 FAMILY; GENOME; METHYLATION; CANCER; 5-AZA-2'-DEOXYCYTIDINE; DEMETHYLATION; TRICHOSTATIN	With the objective of returning cells to their undifferentiated state through alteration of epigenetic states, small molecules have been used that specifically inhibit proteins involved in sustaining the epigenetic system. However, this chemical-based approach can cause chaotic epigenomic states due to random actions of the inhibitors. We investigated whether JHDM3A/JMJD2A, a trimethylated histone H3-lysine 9 (H3K9me3)-specific demethylase, could function as an effector molecule to selectively demethylate target chromatin, with the aid of a guide protein to serve as a delivery vehicle. JHDM3A, which normally locates in euchromatin, spread out to heterochromatin when it was fused to heterochromatin protein-1 alpha (HP1 alpha) or HP1 beta; in these cells, demethylation efficiency was also markedly increased. Two truncated modules, JHDM3A(GFP)(406) and JHDM3A(GFP)(701), had contrasting modes and efficiencies of H3K9me3 demethylation; JHDM3A(GFP)(406) showed a very uniform rate (similar to 80%) of demethylation, whereas JHDM3A(GFP)(701) had a broad methylation range of 4-80%. The methylation values were highly dependent on the presence of the guide proteins OCT4, CTCF, and HP1. Chromatin immunoprecipitation detected reduced H3K9me3 levels at OCT4 regulatory loci in the cells expressing OCT4-tagged JHDM3A(GFP)(701). Derepression of the Sox2 gene was observed in JHDM3A(GFP)(701)OCT4-expressing cells, but not in cells that expressed the JHDM3A(GFP)(701) module alone. JHDM3A(GFP)(701)-assisted OCT4 more efficiently turned on stem cell-related microRNAs than GFP-OCT4 itself. These results suggest that JHDM3A(GFP)(701) is a suitable catalytic module that can be targeted, under the control of a guide protein, to specific loci where the chromatin H3K9me3 status and the milieu of gene expression are to be modified.	[Jeong, Young Sun; Park, Jung Sun; Kang, Yong-Kook] KRIBB, Dev & Differentiat Res Ctr, Taejon 305806, South Korea; [Jeong, Young Sun; Ko, Yong] Korea Univ, Div Biotechnol, Coll Life Sci & Biotechnol, Seoul 136713, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea University	Kang, YK (corresponding author), 111 Gwahangno, Taejon 305806, South Korea.	ykkang@kribb.re.kr		Ko, Yong/0000-0001-5397-9695	Biogreen21 program; NRF [2010-0020563]; National Research foundation of Korea initiative	Biogreen21 program(Rural Development Administration (RDA), Republic of Korea); NRF; National Research foundation of Korea initiative(National Research Foundation of Korea)	This work was supported by the Biogreen21 program, the NRF program (2010-0020563), and the National Research foundation of Korea initiative program.	Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Chae JI, 2009, PROTEOMICS, V9, P1128, DOI 10.1002/pmic.200800234; Chavez L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-314; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Grant S, 2009, CLIN CANCER RES, V15, P7111, DOI 10.1158/1078-0432.CCR-09-2399; Heller G, 2008, CANCER RES, V68, P44, DOI 10.1158/0008-5472.CAN-07-2531; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kang YK, 1999, J BIOL CHEM, V274, P36585, DOI 10.1074/jbc.274.51.36585; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07; Yang ZQ, 2000, CANCER RES, V60, P4735; Yeo S, 2005, MOL CELLS, V20, P423	31	1	1	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4461	4470		10.1074/jbc.M110.176040	http://dx.doi.org/10.1074/jbc.M110.176040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148561	Green Published, hybrid			2022-12-25	WOS:000286975700046
J	Lee, S; Augustin, S; Tatsuta, T; Gerdes, F; Langer, T; Tsai, FTF				Lee, Sukyeong; Augustin, Steffen; Tatsuta, Takashi; Gerdes, Florian; Langer, Thomas; Tsai, Francis T. F.			Electron Cryomicroscopy Structure of a Membrane-anchored Mitochondrial AAA Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPASTIC PARAPLEGIA; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; FTSH; TRANSLOCATION; ATPASE; DEGRADATION; PORE; METALLOPROTEASE; INTERMEDIATE	FtsH-related AAA proteases are conserved membrane-anchored, ATP-dependent molecular machines, which mediate the processing and turnover of soluble and membrane-embedded proteins in eubacteria, mitochondria, and chloroplasts. Homo-and hetero-oligomeric proteolytic complexes exist, which are composed of homologous subunits harboring an ATPase domain of the AAA family and an H41 metallopeptidase domain. Mutations in subunits of mitochondrial m-AAA proteases have been associated with different neurodegenerative disorders in human, raising questions on the functional differences between homo-and hetero-oligomeric AAA proteases. Here, we have analyzed the hetero-oligomeric yeast m-AAA protease composed of homologous Yta10 and Yta12 subunits. We combined genetic and structural approaches to define the molecular determinants for oligomer assembly and to assess functional similarities between Yta10 and Yta12. We demonstrate that replacement of only two amino acid residues within the metallopeptidase domain of Yta12 allows its assembly into homo-oligomeric complexes. To provide a molecular explanation, we determined the 12A resolution structure of the intact yeast m-AAA protease with its transmembrane domains by electron cryomicroscopy (cryo-EM) and atomic structure fitting. The full-length m-AAA protease has a bipartite structure and is a hexamer in solution. We found that residues in Yta12, which facilitate homo-oligomerization when mutated, are located at the interface between neighboring protomers in the hexamer ring. Notably, the transmembrane and intermembrane space domains are separated from the main body, creating a passage on the matrix side, which is wide enough to accommodate unfolded but not folded polypeptides. These results suggest a mechanism regarding how proteins are recognized and degraded by m-AAA proteases.	[Lee, Sukyeong; Tsai, Francis T. F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Lee, Sukyeong; Tsai, Francis T. F.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Augustin, Steffen; Tatsuta, Takashi; Gerdes, Florian; Langer, Thomas] Univ Cologne, Inst Genet, Ctr Mol Med Cologne, D-50674 Cologne, Germany; [Langer, Thomas] Max Planck Inst Biol Aging, D-50931 Cologne, Germany	Baylor College of Medicine; Baylor College of Medicine; University of Cologne; Max Planck Society	Lee, S (corresponding author), Baylor Coll Med, Dept Biochem, 1 Baylor Plaza,MS BCM125, Houston, TX 77030 USA.	slee@bcm.edu; ftsai@bcm.edu		Langer, Thomas/0000-0003-1250-1462	National Institutes of Health [R01-AI076239]; Welch Foundation [Q-1530]; Department of Defense; American Cancer Society; American Heart Association Texas Affiliate; Deutsche Forschungsgemeinschaft; European Research Council; German-Israeli-Project DIP [F.5.1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); American Heart Association Texas Affiliate(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German-Israeli-Project DIP; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant R01-AI076239, by Welch Foundation Grant Q-1530, Department of Defense, and American Cancer Society (to F. T. F. T.), by a grant from the American Heart Association Texas Affiliate (to S. L.), and by Deutsche Forschungsgemeinschaft and European Research Council grants and German-Israeli-Project DIP Grant F.5.1. (to T. L.).	Akiyama Y, 2000, EMBO J, V19, P3888, DOI 10.1093/emboj/19.15.3888; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Graef M, 2007, MOL CELL BIOL, V27, P2476, DOI 10.1128/MCB.01721-06; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Tatsuta T, 2009, RES MICROBIOL, V160, P711, DOI 10.1016/j.resmic.2009.09.005; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027	28	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4404	4411		10.1074/jbc.M110.158741	http://dx.doi.org/10.1074/jbc.M110.158741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21147776	Green Published, hybrid			2022-12-25	WOS:000286975700040
J	Le Nouen, C; Hillyer, P; Munir, S; Winter, CC; McCarty, T; Bukreyev, A; Collins, PL; Rabin, RL; Buchholz, UJ				Le Nouen, Cyril; Hillyer, Philippa; Munir, Shirin; Winter, Christine C.; McCarty, Thomas; Bukreyev, Alexander; Collins, Peter L.; Rabin, Ronald L.; Buchholz, Ursula J.			Effects of Human Respiratory Syncytial Virus, Metapneumovirus, Parainfluenza Virus 3 and Influenza Virus on CD4+T Cell Activation by Dendritic Cells	PLOS ONE			English	Article							T-HELPER TYPE-1; IN-VITRO; DIFFERENTIAL RESPONSE; CILIATED CELLS; HUMAN NAIVE; INFECTION; CD4(+); MEMORY; INTERFERON; LYMPHOCYTES	Background: Human respiratory syncytial virus (HRSV), and to a lesser extent human metapneumovirus (HMPV) and human parainfluenza virus type 3 (HPIV3), re-infect symptomatically throughout life without antigenic change, suggestive of incomplete immunity. One causative factor is thought to be viral interference with dendritic cell (DC)-mediated stimulation of CD4+ T cells. Methodology, Principal Findings: We infected human monocyte-derived DC with purified HRSV, HMPV, HPIV3, or influenza A virus (IAV) and compared their ability to induce activation and proliferation of autologous CD4+ T cells in vitro. IAV was included because symptomatic re-infection without antigenic change is less frequent, suggesting that immune protection is more complete and durable. We examined virus-specific memory responses and superantigen-induced responses by multiparameter flow cytometry. Live virus was more stimulatory than inactivated virus in inducing DC-mediated proliferation of virus-specific memory CD4+ T cells, suggesting a lack of strong suppression by live virus. There were trends of increasing proliferation in the order: HMPV, HRSV, HPIV3, IAV, and greater production of interferon-gamma c and tumor necrosis factor-alpha by proliferating cells in response to IAV, but differences were not significant. Exposure of DC to HRSV, HPIV3, or IAV reduced CD4+ T cell proliferation in response to secondary stimulus with superantigen, but the effect was transitory and greatest for IAV. T cell cytokine production was similar, with no evidence of Th2 or Th17 skewing. Conclusions, Significance: Understanding the basis for the ability of HRSV in particular to symptomatically re-infect without significant antigenic change is of considerable interest. The present results show that these common respiratory viruses are similar in their ability to induce DC to activate CD4+ T cells. Thus, the results do not support the common model in which viral suppression of CD4+ T cell activation and proliferation by HRSV, HMPV, and HPIV3 is a major factor in the difference in re-infectability compared to IAV.	[Le Nouen, Cyril; Munir, Shirin; Winter, Christine C.; McCarty, Thomas; Bukreyev, Alexander; Collins, Peter L.; Buchholz, Ursula J.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Hillyer, Philippa; Rabin, Ronald L.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA)	Le Nouen, C (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.	ubuchholz@niaid.nih.gov	Munir, Shirin/AAA-7943-2021; McCarty, Tom/ABG-6003-2020; Buchholz, Ursula/AAA-4547-2022; McCarty, Thomas/GVU-0812-2022	McCarty, Tom/0000-0001-5815-2531; Buchholz, Ursula/0000-0002-2329-3198; McCarty, Thomas/0000-0001-5815-2531; Tripp, Ralph/0000-0002-2924-9956; Rabin, Ronald/0000-0003-3496-0504	NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000372] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIAID, NIH. Disclaimer: The views expressed in this report are the personal opinions of the authors and are not the official opinion of the U.S. Food and Drug Administration, the National Institutes of Health, or the Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz H, 2003, IMMUNOLOGY, V109, P49, DOI 10.1046/j.1365-2567.2003.01629.x; Biacchesi S, 2004, VIROLOGY, V321, P247, DOI 10.1016/j.virol.2003.12.020; Biacchesi S, 2007, J VIROL, V81, P6057, DOI 10.1128/JVI.00128-07; BUYNAK EB, 1978, P SOC EXP BIOL MED, V157, P636; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Chaiwatpongsakorn S, 2011, FIELDS VIROLOGY, V85, P3968; Chi B, 2006, J VIROL, V80, P5032, DOI 10.1128/JVI.80.10.5032-5040.2006; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; DiNapoli JM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-105; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Fulton RB, 2008, J VIROL, V82, P7799, DOI 10.1128/JVI.00840-08; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; GEISSMANN F, 2008, IMMUNOL CELL BIOL; Geissmann F, 2007, NAT IMMUNOL, V8, P558, DOI 10.1038/ni0607-558; Gimeno R, 2005, MOL CELL BIOL, V25, P5456, DOI 10.1128/MCB.25.13.5456-5465.2005; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Hamelin ME, 2004, CLIN INFECT DIS, V38, P983, DOI 10.1086/382536; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jones A, 2006, CLIN EXP IMMUNOL, V143, P513, DOI 10.1111/j.1365-2249.2005.03004.x; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; LENOUEN C, 2009, VIROLOGY; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; MacLeod MKL, 2009, SEMIN IMMUNOL, V21, P53, DOI 10.1016/j.smim.2009.02.006; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; PRESTON FM, 1995, J INFECT DIS, V172, P919, DOI 10.1093/infdis/172.4.919; PRESTON FM, 1992, J INFECT DIS, V165, P819, DOI 10.1093/infdis/165.5.819; ROBERTS NJ, 1982, INFECT IMMUN, V35, P1142, DOI 10.1128/IAI.35.3.1142-1146.1982; Rothoeft T, 2007, CLIN EXP IMMUNOL, V150, P263, DOI 10.1111/j.1365-2249.2007.03497.x; SALKIND AR, 1991, J CLIN INVEST, V88, P505, DOI 10.1172/JCI115332; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Schlender J, 2002, J VIROL, V76, P1163, DOI 10.1128/JVI.76.3.1163-1170.2002; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sieg S, 1996, J VIROL, V70, P4845, DOI 10.1128/JVI.70.7.4845-4848.1996; SIEG S, 1994, P NATL ACAD SCI USA, V91, P6293, DOI 10.1073/pnas.91.14.6293; Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; WELLIVER RC, 1986, AM J DIS CHILD, V140, P34, DOI 10.1001/archpedi.1986.02140150036029; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138; 2008, MMWR MORB MORTAL WKL, V59, P230	60	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15017	10.1371/journal.pone.0015017	http://dx.doi.org/10.1371/journal.pone.0015017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124776	Green Submitted, gold, Green Published			2022-12-25	WOS:000284686500016
J	Schmerbach, K; Pfab, T; Zhao, Y; Culman, J; Mueller, S; Villringer, A; Muller, DN; Hocher, B; Unger, T; Thoene-Reineke, C				Schmerbach, Kristin; Pfab, Thiemo; Zhao, Yi; Culman, Juraj; Mueller, Susanne; Villringer, Arno; Muller, Dominik N.; Hocher, Berthold; Unger, Thomas; Thoene-Reineke, Christa			Effects of Aliskiren on Stroke in Rats Expressing Human Renin and Angiotensinogen Genes	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; TRANSGENIC RATS; ISCHEMIC-STROKE; ORGAN DAMAGE; RENAL DAMAGE; PRONE RATS; BRAIN; CANDESARTAN; INHIBITOR; HYPERTENSION	Objective: Pre-treatment with angiotensin receptor blockers is known to improve neurological outcome after stroke. This study investigated for the first time, whether the renin inhibitor aliskiren has similar neuroprotective effects. Methods: Since aliskiren specifically blocks human renin, double transgenic rats expressing human renin and angiotensinogen genes were used. To achieve a systolic blood pressure of 150 or 130 mmHg animals were treated with aliskiren (7.5 or 12.5 mg/kg*d) or candesartan (1.5 or 10 mg/kg*d) via osmotic minipump starting five days before middle cerebral artery occlusion with reperfusion. Infarct size was determined by magnetic resonance imaging. mRNA of inflammatory marker genes was studied in different brain regions. Results: The mortality of 33.3% (7 of 21 animals) in the vehicle group was reduced to below 10% by treatment with candesartan or aliskiren (p<0.05). Aliskiren-treated animals had a better neurological outcome 7 days post-ischemia, compared to candesartan (Garcia scale: 9.9+/-0.7 vs. 7.3+/-0.7; p<0.05). The reduction of infarct size in the aliskiren group did not reach statistical significance compared to candesartan and vehicle (24 h post-ischemia: 314+/-81 vs. 377+/-70 and 403+/-70 mm(3) respectively). Only aliskiren was able to significantly reduce stroke-induced gene expression of CXC chemokine ligand 1, interleukin-6 and tumor necrosis factor-alpha in the ischemic core. Conclusions: Head-to-head comparison suggests that treatment with aliskiren before and during cerebral ischemia is at least as effective as candesartan in double transgenic rats. The improved neurological outcome in the aliskiren group was blood pressure independent. Whether this effect is due to primary anti-inflammatory mechanisms has to be investigated further.	[Schmerbach, Kristin; Pfab, Thiemo; Hocher, Berthold; Unger, Thomas; Thoene-Reineke, Christa] Charite, Inst Pharmacol, Cardiovasc Res Ctr, Berlin, Germany; [Pfab, Thiemo] Charite Campus Benjamin Franklin, Dept Nephrol, Berlin, Germany; [Zhao, Yi; Culman, Juraj] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, Kiel, Germany; [Mueller, Susanne] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Muller, Dominik N.] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Thoene-Reineke, Christa] Charite, Dept Expt Med FEM, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Schleswig Holstein University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmerbach, K (corresponding author), Charite, Inst Pharmacol, Cardiovasc Res Ctr, Berlin, Germany.	christa.thoene-reineke@charite.de	Hocher, Berthold/AAC-3510-2020; Zhao, Yi/A-8806-2010	Mueller, Susanne/0000-0002-5053-2211; Hocher, Berthold/0000-0001-8143-0579; Villringer, Arno/0000-0003-2604-2404; Muller, Dominik N/0000-0003-3650-5644	Novartis AG ( Basel, Switzerland)	Novartis AG ( Basel, Switzerland)	This study was supported by Novartis AG ( Basel, Switzerland). The study design was set up together with Novartis AG. Novartis AG had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Blezer ELA, 1998, STROKE, V29, P167, DOI 10.1161/01.STR.29.1.167; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Dai WJ, 1999, STROKE, V30, P2391, DOI 10.1161/01.STR.30.11.2391; Dandona P, 2003, J CLIN ENDOCR METAB, V88, P4496, DOI 10.1210/jc.2002-021836; Dechend R, 2007, J RENIN-ANGIO-ALDO S, V8, P81, DOI 10.3317/jraas.2007.008; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; GANTEN D, 1992, P NATL ACAD SCI USA, V89, P7806, DOI 10.1073/pnas.89.16.7806; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gelosa P, 2009, J HYPERTENS, V27, P2444, DOI 10.1097/HJH.0b013e3283311ba1; Gohlke P, 2002, J HYPERTENS, V20, P909, DOI 10.1097/00004872-200205000-00026; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/00004872-200311000-00028; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Ino J, 2009, ARTERIOSCL THROM VAS, V29, P1858, DOI 10.1161/ATVBAHA.108.182519; Krikov M, 2008, J HYPERTENS, V26, P544, DOI 10.1097/HJH.0b013e3282f2dac9; Li J, 2005, FASEB J, V19, P617, DOI 10.1096/fj.04-2960fje; Loos M, 2003, NEUROSCIENCE, V122, P373, DOI 10.1016/S0306-4522(03)00498-6; Losy J, 2005, FOLIA NEUROPATHOL, V43, P97; McCarthy CA, 2009, STROKE, V40, P1482, DOI 10.1161/STROKEAHA.108.531509; Muller DN, 2008, J MOL MED, V86, P659, DOI 10.1007/s00109-008-0330-6; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Pilz B, 2005, HYPERTENSION, V46, P569, DOI 10.1161/01.HYP.0000179573.91016.3f; Quaschning T, 2007, J AM SOC NEPHROL, V18, P730, DOI 10.1681/ASN.2006050541; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sanoski CA, 2009, PHARMACOTHERAPY, V29, P193, DOI 10.1592/phco.29.2.193; Schmerbach K, 2008, BRAIN RES, V1208, P225, DOI 10.1016/j.brainres.2008.02.032; Shagdarsuren E, 2005, CIRC RES, V97, P716, DOI 10.1161/01.RES.0000182677.89816.38; Thone-Reineke C, 2006, J HYPERTENS, V24, pS115; Yang GY, 1998, NEUROREPORT, V9, P2131, DOI 10.1097/00001756-199806220-00041	29	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15052	10.1371/journal.pone.0015052	http://dx.doi.org/10.1371/journal.pone.0015052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124781	Green Published, Green Accepted, gold			2022-12-25	WOS:000284686500025
J	Albrecht, I; Kopfstein, L; Strittmatter, K; Schomber, T; Falkevall, A; Hagberg, CE; Lorentz, P; Jeltsch, M; Alitalo, K; Eriksson, U; Christofori, G; Pietras, K				Albrecht, Imke; Kopfstein, Lucie; Strittmatter, Karin; Schomber, Tibor; Falkevall, Annelie; Hagberg, Carolina E.; Lorentz, Pascal; Jeltsch, Michael; Alitalo, Kari; Eriksson, Ulf; Christofori, Gerhard; Pietras, Kristian			Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; VEGF-B; ANGIOGENIC SWITCH; CELL LINES; FACTOR-C; FACTOR-A; EXPRESSION; MICE; GENE; RECEPTOR	Background: The family of vascular endothelial growth factors (VEGF) contains key regulators of blood and lymph vessel development, including VEGF-A, -B, -C, -D, and placental growth factor. The role of VEGF-B during physiological or pathological angiogenesis has not yet been conclusively delineated. Herein, we investigate the function of VEGF-B by the generation of mouse models of cancer with transgenic expression of VEGF-B or homozygous deletion of Vegfb. Methodology/Principal Findings: Ectopic expression of VEGF-B in the insulin-producing beta-cells of the pancreas did not alter the abundance or architecture of the islets of Langerhans. The vasculature from transgenic mice exhibited a dilated morphology, but was of similar density as that of wildtype mice. Unexpectedly, we found that transgenic expression of VEGF-B in the RIP1-Tag2 mouse model of pancreatic neuroendocrine tumorigenesis retarded tumor growth. Conversely, RIP1-Tag2 mice deficient for Vegfb presented with larger tumors. No differences in vascular density, perfusion or immune cell infiltration upon altered Vegfb gene dosage were noted. However, VEGF-B acted to increase blood vessel diameter both in normal pancreatic islets and in RIP1-Tag2 tumors. Conclusions/Significance: Taken together, our results illustrate the differences in biological function between members of the VEGF family, and highlight the necessity of in-depth functional studies of VEGF-B to fully understand the effects of VEGFR-1 inhibitors currently used in the clinic.	[Albrecht, Imke; Kopfstein, Lucie; Schomber, Tibor; Lorentz, Pascal; Christofori, Gerhard] Univ Basel, Dept Biomed, Inst Biochem & Genet, Basel, Switzerland; [Strittmatter, Karin] German Canc Res Ctr Heidelberg DKFZ, Heidelberg, Germany; [Jeltsch, Michael; Alitalo, Kari] Univ Helsinki, Mol & Canc Biol Program, Biomedicum, Helsinki, Finland; [Falkevall, Annelie; Hagberg, Carolina E.; Eriksson, Ulf; Pietras, Kristian] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, Stockholm, Sweden; [Falkevall, Annelie; Hagberg, Carolina E.; Eriksson, Ulf] Karolinska Inst, Ludwig Inst Canc Res Ltd, Stockholm Branch, Stockholm, Sweden	University of Basel; Helmholtz Association; German Cancer Research Center (DKFZ); University of Helsinki; Karolinska Institutet; Karolinska Institutet; Ludwig Institute for Cancer Research	Albrecht, I (corresponding author), Univ Basel, Dept Biomed, Inst Biochem & Genet, Basel, Switzerland.	Kristian.Pietras@ki.se	Pietras, Kristian/ABG-2097-2021; Alitalo, Kari K/J-5013-2014; Pietras, Kristian/ABE-8727-2020; Jeltsch, Michael/I-5340-2012	Pietras, Kristian/0000-0001-6738-4705; Alitalo, Kari K/0000-0002-7331-0902; Jeltsch, Michael/0000-0003-2890-7790; Lorentz, Pascal/0000-0002-9910-2052; Hagberg, Carolina/0000-0002-5497-2855	Swedish Cancer Society; Karolinska Institutet Cancer network; Swedish Childhood Cancer Foundation; Jeansson's Foundation; Swedish Research Council; EU [LSHG-CT-2004-503573]; National Centre of Competence in Research (NCCR) Molecular Oncology of the Swiss National Science Foundation; Swiss Cancer League; Novo Nordisk Foundation; Dr. Peter Wallenbergs Foundation for Economics and Technology; Solderberg's Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet Cancer network; Swedish Childhood Cancer Foundation(European Commission); Jeansson's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); National Centre of Competence in Research (NCCR) Molecular Oncology of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Swiss Cancer League; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Dr. Peter Wallenbergs Foundation for Economics and Technology; Solderberg's Foundation; Karolinska Institutet(Karolinska Institutet)	KP is supported by a Young Investigator Award by the Swedish Cancer Society, as well as by grants from the Karolinska Institutet Cancer network, the Swedish Childhood Cancer Foundation, Jeansson's Foundation and a Linnaeus grant to the STARGET consortium from the Swedish Research Council. GC received support by the EU-FP6 framework programme LYMPHANGIOGENOMICS LSHG-CT-2004-503573, the National Centre of Competence in Research (NCCR) Molecular Oncology of the Swiss National Science Foundation, and a Comprehensive Cancer Research Project (CCRP) of the Swiss Cancer League. UE was supported by The Novo Nordisk Foundation, The Swedish Cancer Society, The Swedish Research Council, Dr. Peter Wallenbergs Foundation for Economics and Technology, Solderberg's Foundation and the Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase K, 2001, CIRCULATION, V104, P358, DOI 10.1161/01.CIR.104.3.358; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Compagni A, 2000, CANCER RES, V60, P7163; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Gannon G, 2002, CANCER RES, V62, P603; Gunningham SP, 2001, J PATHOL, V193, P325, DOI 10.1002/path.814; Gunningham SP, 2001, CANCER RES, V61, P3206; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanrahan V, 2003, J PATHOL, V200, P183, DOI 10.1002/path.1339; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kawakami M, 2003, J EXP CLIN CANC RES, V22, P229; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; LABOSKY PA, 1994, CIBA F SYMP, V182, P157; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Li Y, 2008, J CLIN INVEST, V118, P913, DOI 10.1172/JCI33673; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Mylona E, 2007, GYNECOL ONCOL, V104, P557, DOI 10.1016/j.ygyno.2006.09.031; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; OHZATO H, 1991, TRANSPLANTATION, V51, P566, DOI 10.1097/00007890-199103000-00004; Olofsson B, 1996, J BIOL CHEM, V271, P19310, DOI 10.1074/jbc.271.32.19310; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Petrova TV, 2008, CANCER CELL, V13, P554, DOI 10.1016/j.ccr.2008.04.022; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Schomber T, 2007, CANCER RES, V67, P10840, DOI 10.1158/0008-5472.CAN-07-1034; Serini G, 2009, ANGIOGENESIS, V12, P187, DOI 10.1007/s10456-009-9138-4; Shimabukuro M, 1997, J CLIN INVEST, V100, P290, DOI 10.1172/JCI119534; Shintani S, 2004, ORAL ONCOL, V40, P13, DOI 10.1016/S1368-8375(03)00127-1; Strauss LG, 2008, J NUCL MED, V49, P1238, DOI 10.2967/jnumed.108.051599; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	50	41	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14109	10.1371/journal.pone.0014109	http://dx.doi.org/10.1371/journal.pone.0014109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124841	gold, Green Submitted, Green Published			2022-12-25	WOS:000284572000011
J	Safdie, G; Farrah, IY; Yahia, R; Marva, E; Wilamowski, A; Sawalha, SS; Wald, N; Schmiedel, J; Moter, A; Gobel, UB; Bercovier, H; Abdeen, Z; Assous, MV; Fishman, Y				Safdie, Gracia; Farrah, Iba Y.; Yahia, Reem; Marva, Esther; Wilamowski, Amos; Sawalha, Samer S.; Wald, Naama; Schmiedel, Judith; Moter, Annette; Goebel, Ulf B.; Bercovier, Herve; Abdeen, Ziad; Assous, Marc V.; Fishman, Yolanta			Molecular Characterization of Borrelia persica, the Agent of Tick Borne Relapsing Fever in Israel and the Palestinian Authority	PLOS ONE			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE GLPQ; LARGE PHYLOGENIES; PURINE SALVAGE; FORGOTTEN; DIVERSITY; DISEASE; TREE	The identification of the Tick Borne Relapsing Fever (TBRF) agent in Israel and the Palestinian Authority relies on the morphology and the association of Borrelia persica with its vector Ornithodoros tholozani. Molecular based data on B. persica are very scarce as the organism is still non-cultivable. In this study, we were able to sequence three complete 16S rRNA genes, 12 partial flaB genes, 18 partial glpQ genes, 16 rrs-ileT intergenic spacers (IGS) from nine ticks and ten human blood samples originating from the West Bank and Israel. In one sample we sequenced 7231 contiguous base pairs that covered completely the region from the 5'end of the 16S rRNA gene to the 5'end of the 23S rRNA gene comprising the whole 16S rRNA (rrs), and the following genes: Ala tRNA (alaT), Ile tRNA (ileT), adenylosuccinate lyase (purB), adenylosuccinate synthetase (purA), methylpurine-DNA glycosylase (mag), hypoxanthine-guanine phosphoribosyltransferase (hpt), an hydrolase (HAD superfamily) and a 135 bp 5' fragment of the 23S rRNA (rrlA) genes. Phylogenic sequence analysis defined all the Borrelia isolates from O. tholozani and from human TBRF cases in Israel and the West Bank as B. persica that clustered between the African and the New World TBRF species. Gene organization of the intergenic spacer between the 16S rRNA and the 23S rRNA was similar to that of other TBRF Borrelia species and different from the Lyme disease Borrelia species. Variants of B. persica were found among the different genes of the different isolates even in the same sampling area.	[Safdie, Gracia; Farrah, Iba Y.; Yahia, Reem; Wald, Naama; Bercovier, Herve; Assous, Marc V.; Fishman, Yolanta] Hebrew Univ Jerusalem, Dept Mol Genet & Microbiol, Fac Med, Jerusalem, Israel; [Marva, Esther; Wilamowski, Amos] Cent State Labs, Minist Hlth, Jerusalem, Israel; [Sawalha, Samer S.] Palestinian Minist Hlth, Dept Primary Hlth Care, Ramallah, Palestine; [Schmiedel, Judith; Moter, Annette; Goebel, Ulf B.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Farrah, Iba Y.; Abdeen, Ziad] Al Quds Univ, Dept Community Hlth, Sch Med, Jerusalem, Israel; [Assous, Marc V.] Shaare Zedek Med Ctr, Lab Microbiol & Immunol, Jerusalem, Israel	Hebrew University of Jerusalem; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Safdie, G (corresponding author), Hebrew Univ Jerusalem, Dept Mol Genet & Microbiol, Fac Med, Jerusalem, Israel.	yolaf@ekmd.huji.ac.il	Abdeen, Ziad/AAC-7889-2019; ASSOUS, Marc Victor/CAH-0946-2022; Bercovier, Herve/AHC-6851-2022	Kikhney, Judith/0000-0002-4849-7947; Moter, Annette/0000-0003-1318-5780	DFG, German Research Foundation [GO 363/11-1]	DFG, German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant number GO 363/11-1 from the DFG, German Research Foundation: http://www.dfg.de/en/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assous MV, 2009, CLIN MICROBIOL INFEC, V15, P407, DOI 10.1111/j.1469-0691.2009.02767.x; Assous MV, 2006, EMERG INFECT DIS, V12, P1740, DOI 10.3201/eid1211.060715; Barbour AG, 2005, INFECT IMMUN, V73, P6165, DOI 10.1128/IAI.73.9.6165-6168.2005; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Cutler SJ, 2010, J APPL MICROBIOL, V108, P1115, DOI 10.1111/j.1365-2672.2009.04598.x; Cutler SJ, 2008, INT J MED MICROBIOL, V298, P193, DOI 10.1016/j.ijmm.2007.11.011; De Zulueta J, 1971, Ann Trop Med Parasitol, V65, P491; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halperin T, 2006, ACTA TROP, V98, P189, DOI 10.1016/j.actatropica.2006.04.004; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Morrison DA, 1996, INT J PARASITOL, V26, P589, DOI 10.1016/0020-7519(96)00044-6; Pettersson J, 2007, INFECT IMMUN, V75, P3877, DOI 10.1128/IAI.00199-07; PICKEN RN, 1992, J CLIN MICROBIOL, V30, P99, DOI 10.1128/JCM.30.1.99-114.1992; Porcella SF, 2000, J CLIN MICROBIOL, V38, P3561, DOI 10.1128/JCM.38.10.3561-3571.2000; Ras NM, 1996, INT J SYST BACTERIOL, V46, P859; RODHAIN F, 1976, B I PASTEUR, V74, P173; Sarih M, 2009, EMERG INFECT DIS, V15, P1626, DOI 10.3201/eid1510.090403; Schwan TG, 2003, J BACTERIOL, V185, P1346, DOI 10.1128/JB.185.4.1346-1356.2003; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; Schwan TG, 2007, EMERG INFECT DIS, V13, P436, DOI 10.3201/eid1303.060958; Scott JC, 2005, EMERG INFECT DIS, V11, P1722, DOI 10.3201/eid1111.050483; Sidi G, 2005, EMERG INFECT DIS, V11, P1784, DOI 10.3201/eid1111.050521; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toledo A, 2010, J CLIN MICROBIOL, V48, P2484, DOI 10.1128/JCM.00541-10	29	18	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14105	10.1371/journal.pone.0014105	http://dx.doi.org/10.1371/journal.pone.0014105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124792	gold, Green Published, Green Submitted			2022-12-25	WOS:000284572000007
J	Lorenz, AJ; Hamblin, MT; Jannink, JL				Lorenz, Aaron J.; Hamblin, Martha T.; Jannink, Jean-Luc			Performance of Single Nucleotide Polymorphisms versus Haplotypes for Genome-Wide Association Analysis in Barley	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; HEAD BLIGHT RESISTANCE; LINKAGE DISEQUILIBRIUM; PHENOTYPIC ASSOCIATIONS; POPULATION-STRUCTURE; MODEL; MARKERS; POWER	Genome-wide association studies (GWAS) may benefit from utilizing haplotype information for making marker-phenotype associations. Several rationales for grouping single nucleotide polymorphisms (SNPs) into haplotype blocks exist, but any advantage may depend on such factors as genetic architecture of traits, patterns of linkage disequilibrium in the study population, and marker density. The objective of this study was to explore the utility of haplotypes for GWAS in barley (Hordeum vulgare) to offer a first detailed look at this approach for identifying agronomically important genes in crops. To accomplish this, we used genotype and phenotype data from the Barley Coordinated Agricultural Project and constructed haplotypes using three different methods. Marker-trait associations were tested by the efficient mixed-model association algorithm (EMMA). When QTL were simulated using single SNPs dropped from the marker dataset, a simple sliding window performed as well or better than single SNPs or the more sophisticated methods of blocking SNPs into haplotypes. Moreover, the haplotype analyses performed better 1) when QTL were simulated as polymorphisms that arose subsequent to marker variants, and 2) in analysis of empirical heading date data. These results demonstrate that the information content of haplotypes is dependent on the particular mutational and recombinational history of the QTL and nearby markers. Analysis of the empirical data also confirmed our intuition that the distribution of QTL alleles in nature is often unlike the distribution of marker variants, and hence utilizing haplotype information could capture associations that would elude single SNPs. We recommend routine use of both single SNP and haplotype markers for GWAS to take advantage of the full information content of the genotype data.	[Lorenz, Aaron J.; Jannink, Jean-Luc] Cornell Univ, USDA ARS, RW Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Hamblin, Martha T.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA	Cornell University; United States Department of Agriculture (USDA); Cornell University	Lorenz, AJ (corresponding author), Cornell Univ, USDA ARS, RW Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.	jeanluc.jannink@ars.usda.gov		Jannink, Jean-Luc/0000-0003-4849-628X	United States Department of Agriculture, National Institute of Food and Agriculture [2009-85606-05701]	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	United States Department of Agriculture, National Institute of Food and Agriculture Grant No. 2009-85606-05701, "Barley Coordinated Agricultural Project: Leveraging Genomics, Genetics, and Breeding for Gene Discovery and Barley Improvement." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardel C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-24; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calus MPL, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-11; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Dimas AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000244; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grapes L, 2004, GENETICS, V166, P1561, DOI 10.1534/genetics.166.3.1561; Hagenblad J, 2004, GENETICS, V168, P1627, DOI 10.1534/genetics.104.029470; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Hamon SC, 2006, HUM HERED, V61, P87, DOI 10.1159/000093384; Hartigan J., 1975, CLUSTERING ALGORITHM; Hayes BJ, 2007, GENET RES, V89, P215, DOI 10.1017/S0016672307008865; HAYES PM, 1993, THEOR APPL GENET, V87, P392, DOI 10.1007/BF01184929; Horsley RD, 2006, CROP SCI, V46, P145, DOI 10.2135/cropsci2005.0247; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Long AD, 1999, GENOME RES, V9, P720; Lu X, 2003, GENOME RES, V13, P2112, DOI 10.1101/gr.586803; Meuwissen THE, 2000, GENETICS, V155, P421; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Nduulu LM, 2007, THEOR APPL GENET, V115, P561, DOI 10.1007/s00122-007-0590-5; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Pillen K, 2004, THEOR APPL GENET, V108, P1591, DOI 10.1007/s00122-004-1586-z; Posada D, 2005, BIOINFORMATICS, V21, P2130, DOI 10.1093/bioinformatics/bti293; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Shim Heejung, 2009, BMC Proc, V3 Suppl 7, pS35; TEMPLETON AR, 1987, GENETICS, V117, P343; THOMAS WTB, 1995, THEOR APPL GENET, V91, P1037, DOI 10.1007/BF00223917; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799; Zhao H, 2005, GENET RES, V86, P77, DOI 10.1017/S001667230500769X; Zhao HH, 2007, GENETICS, V175, P1975, DOI 10.1534/genetics.106.066480; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	46	92	94	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14079	10.1371/journal.pone.0014079	http://dx.doi.org/10.1371/journal.pone.0014079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124933	Green Submitted, gold, Green Published			2022-12-25	WOS:000284467200012
J	Antunes, FM; Nelken, I; Covey, E; Malmierca, MS				Antunes, Flora M.; Nelken, Israel; Covey, Ellen; Malmierca, Manuel S.			Stimulus-Specific Adaptation in the Auditory Thalamus of the Anesthetized Rat	PLOS ONE			English	Article							MEDIAL GENICULATE-BODY; FREQUENCY-RESPONSE AREAS; INFERIOR COLLICULUS; MISMATCH NEGATIVITY; BARN OWL; CORTICOFUGAL MODULATION; CORTICAL-NEURONS; SINGLE UNITS; CORTEX; PROJECTIONS	The specific adaptation of neuronal responses to a repeated stimulus (Stimulus-specific adaptation, SSA), which does not fully generalize to other stimuli, provides a mechanism for emphasizing rare and potentially interesting sensory events. Previous studies have demonstrated that neurons in the auditory cortex and inferior colliculus show SSA. However, the contribution of the medial geniculate body (MGB) and its main subdivisions to SSA and detection of rare sounds remains poorly characterized. We recorded from single neurons in the MGB of anaesthetized rats while presenting a sequence composed of a rare tone presented in the context of a common tone (oddball sequences). We demonstrate that a significant percentage of neurons in MGB adapt in a stimulus-specific manner. Neurons in the medial and dorsal subdivisions showed the strongest SSA, linking this property to the non-lemniscal pathway. Some neurons in the non-lemniscal regions showed strong SSA even under extreme testing conditions (e. g., a frequency interval of 0.14 octaves combined with a stimulus onset asynchrony of 2000 ms). Some of these neurons were able to discriminate between two very close frequencies (frequency interval of 0.057 octaves), revealing evidence of hyperacuity in neurons at a subcortical level. Thus, SSA is expressed strongly in the rat auditory thalamus and contribute significantly to auditory change detection.	[Antunes, Flora M.; Malmierca, Manuel S.] Univ Salamanca, Inst Neurosci Castilla & Leon, Lab Neurobiol Hearing, Auditory Neurophysiol Unit, E-37008 Salamanca, Spain; [Malmierca, Manuel S.] Univ Salamanca, Fac Med, Dept Cell Biol & Pathol, E-37008 Salamanca, Spain; [Nelken, Israel] Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Covey, Ellen] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Salamanca; University of Salamanca; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Washington; University of Washington Seattle	Antunes, FM (corresponding author), Univ Salamanca, Inst Neurosci Castilla & Leon, Lab Neurobiol Hearing, Auditory Neurophysiol Unit, E-37008 Salamanca, Spain.	msm@usal.es	Malmierca, Manuel S./K-9285-2014; Nelken, Israel/B-7753-2011; Antunes, Flora M/AAI-4560-2021	Malmierca, Manuel S./0000-0003-0168-7572; Nelken, Israel/0000-0002-6645-107X; Antunes, Flora M/0000-0001-8740-3539	Spanish MEC [BFU2009-07286, BES-2007-15642]; EU [EUI2009-04083]; JCYL-UE [GR221]; Israeli Science Foundation (ISF); NSF [IOS-0719295]; NIH (NIDCD) [P30DC004661]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004661] Funding Source: NIH RePORTER	Spanish MEC(Spanish Government); EU(European Commission); JCYL-UE(Junta de Castilla y Leon); Israeli Science Foundation (ISF)(Israel Science Foundation); NSF(National Science Foundation (NSF)); NIH (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Financial support was provided by the Spanish MEC (BFU2009-07286), EU (EUI2009-04083) and JCYL-UE (GR221) to MSM, the EU (EUI2009-04083) and the Israeli Science Foundation (ISF) to IN and the NSF (IOS-0719295) to EC. Support for software development was provided by NIH (NIDCD P30DC004661); FMA held a fellowship from the Spanish MEC (BES-2007-15642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; ANTUNES F, 2009, FRONT HUM NEUROSCI, DOI DOI 10.3389/CONF.NEURO.09.2009.05.144; ANTUNES F, 2009, ARO ABSTR, V32, P35; Antunes FM, 2010, NEUROPHYSIOLOGICAL BASES OF AUDITORY PERCEPTION, P535, DOI 10.1007/978-1-4419-5686-6_49; BAEUERLE P, 2009, ARO ABSTR, V33, P646; BORDI F, 1994, EXP BRAIN RES, V98, P261, DOI 10.1007/BF00228414; BORDI F, 1994, EXP BRAIN RES, V98, P275, DOI 10.1007/BF00228415; Carrasco A, 2009, J NEUROSCI, V29, P8350, DOI 10.1523/JNEUROSCI.6001-08.2009; CLERICI WJ, 1990, J COMP NEUROL, V297, P14, DOI 10.1002/cne.902970103; COSTAFAIDELLA J, 2010, PSYCHOPHYSI IN PRESS; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Drew PJ, 2006, P NATL ACAD SCI USA, V103, P8876, DOI 10.1073/pnas.0600676103; Edeline JM, 1999, HEARING RES, V131, P135, DOI 10.1016/S0378-5955(99)00026-X; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Faure PA, 2003, J NEUROSCI, V23, P3052; GRIMM S, 2010, PSYCHOPHYSI IN PRESS; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; He JF, 2003, EXP BRAIN RES, V153, P579, DOI 10.1007/s00221-003-1680-5; He JF, 2003, J NEUROPHYSIOL, V89, P367, DOI 10.1152/jn.00593.2002; Hernandez O, 2005, NEUROSCIENCE, V132, P203, DOI 10.1016/j.neuroscience.2005.01.001; Jaaskelainen IP, 2007, TRENDS NEUROSCI, V30, P653, DOI 10.1016/j.tins.2007.09.003; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kimura A, 2003, NEUROSCIENCE, V117, P1003, DOI 10.1016/S0306-4522(02)00949-1; Kimura A, 2009, EUR J NEUROSCI, V30, P783, DOI 10.1111/j.1460-9568.2009.06880.x; KRAUS N, 1994, J NEUROPHYSIOL, V72, P1270, DOI 10.1152/jn.1994.72.3.1270; Lee CC, 2005, CEREB CORTEX, V15, P1804, DOI 10.1093/cercor/bhi057; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Malmierca MS, 2008, J NEUROSCI, V28, P4767, DOI 10.1523/JNEUROSCI.0238-08.2008; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Malmierca MS, 2005, EUR J NEUROSCI, V21, P2701, DOI 10.1111/j.1460-9568.2005.04103.x; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Malmierca MS, 2003, EXP BRAIN RES, V153, P522, DOI 10.1007/s00221-003-1615-1; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1979, BIOL PSYCHOL, V8, P81, DOI 10.1016/0301-0511(79)90053-X; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Oliver DL, 1999, NEUROSCIENCE, V93, P643, DOI 10.1016/S0306-4522(99)00143-8; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Perez-Gonzalez D, 2006, J NEUROPHYSIOL, V95, P823, DOI 10.1152/jn.00741.2005; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Peruzzi D, 1997, J NEUROSCI, V17, P3766; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; Reches A, 2010, J NEUROSCI, V30, P6991, DOI 10.1523/JNEUROSCI.5723-09.2010; Reches A, 2009, J NEUROSCI, V29, P9602, DOI 10.1523/JNEUROSCI.6117-08.2009; Rees A, 1997, J NEUROPHYSIOL, V77, P2945, DOI 10.1152/jn.1997.77.6.2945; Rees A, 1990, J PHYSL, V430, P2; Sambeth A, 2004, INT J PSYCHOPHYSIOL, V53, P197, DOI 10.1016/j.ijpsycho.2004.04.004; Sambeth A, 2004, NEUROSCI LETT, V359, P143, DOI 10.1016/j.neulet.2004.01.064; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; WEINBERGER NM, 2010, HEAR RES; Winer JA, 1999, HEARING RES, V130, P19, DOI 10.1016/S0378-5955(98)00216-0; Winer JA, 2001, J COMP NEUROL, V430, P27; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373	66	178	179	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14071	10.1371/journal.pone.0014071	http://dx.doi.org/10.1371/journal.pone.0014071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124913	Green Published, gold, Green Submitted			2022-12-25	WOS:000284400100016
J	da Silva, MAS; Tee, JM; Paridaen, J; Brouwers, A; Runtuwene, V; Zivkovic, D; Diks, SH; Guardavaccaro, D; Peppelenbosch, MP				da Silva, Maria A. Sartori; Tee, Jin-Ming; Paridaen, Judith; Brouwers, Anke; Runtuwene, Vincent; Zivkovic, Danica; Diks, Sander H.; Guardavaccaro, Daniele; Peppelenbosch, Maikel P.			Essential Role for the d-Asb11 cul5 Box Domain for Proper Notch Signaling and Neural Cell Fate Decisions In Vivo	PLOS ONE			English	Article							SOCS-BOX; ANKYRIN REPEAT; CUL5-RBX2 MODULES; PROTEIN-SYNTHESIS; GENE; EXPRESSION; DIFFERENTIATION; UBIQUITINATION; TRANSCRIPTION; NEUROGENIN1	ECS (Elongin BC-Cul2/Cul5-SOCS-box protein) ubiquitin ligases recruit substrates to E2 ubiquitin-conjugating enzymes through a SOCS-box protein substrate receptor, an Elongin BC adaptor and a cullin (Cul2 or Cul5) scaffold which interacts with the RING protein. In vitro studies have shown that the conserved amino acid sequence of the cullin box in SOCS-box proteins is required for complex formation and function. However, the in vivo importance of cullin boxes has not been addressed. To explore the biological functions of the cullin box domain of ankyrin repeat and SOCS-box containing protein 11 (d-Asb11), a key mediator of canonical Delta-Notch signaling, we isolated a zebrafish mutant lacking the Cul5 box (Asb11(Cul)). We found that homozygous zebrafish mutants for this allele were defective in Notch signaling as indicated by the impaired expression of Notch target genes. Importantly, asb11(Cul) fish were not capable to degrade the Notch ligand DeltaA during embryogenesis, a process essential for the initiation of Notch signaling during neurogenesis. Accordingly, proper cell fate specification within the neurogenic regions of the zebrafish embryo was impaired. In addition, Asb11(Cul) mRNA was defective in the ability to transactivate a her4::gfp reporter DNA when injected in embryos. Thus, our study reporting the generation and the characterization of a metazoan organism mutant in the conserved cullin binding domain of the SOCS-box demonstrates a hitherto unrecognized importance of the SOCS-box domain for the function of this class of cullin-RING ubiquitin ligases and establishes that the d-Asb11 cullin box is required for both canonical Notch signaling and proper neurogenesis.	[da Silva, Maria A. Sartori; Tee, Jin-Ming; Paridaen, Judith; Brouwers, Anke; Runtuwene, Vincent; Zivkovic, Danica; Guardavaccaro, Daniele] Hubrecht Inst KNAW, Utrecht, Netherlands; [da Silva, Maria A. Sartori; Tee, Jin-Ming; Paridaen, Judith; Brouwers, Anke; Runtuwene, Vincent; Zivkovic, Danica; Guardavaccaro, Daniele] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Diks, Sander H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Peppelenbosch, Maikel P.] Erasmus MC Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Groningen; Erasmus University Rotterdam; Erasmus MC	da Silva, MAS (corresponding author), Hubrecht Inst KNAW, Utrecht, Netherlands.	M.Peppelenbosch@erasmusmc.nl	Sartori, Maria A/R-9317-2016; Paridaen, Judith/O-1159-2015	Sartori, Maria A/0000-0002-6474-280X; Paridaen, Judith/0000-0003-3253-6646; Guardavaccaro, Daniele/0000-0002-4517-1765; Peppelenbosch, Maikel/0000-0001-9112-6028	Algemene Levens Wetenschappen [817.02.002, 81502006]; Top Institute Pharma [T1-215, T3-103]	Algemene Levens Wetenschappen; Top Institute Pharma	MASdS and JMT are paid by Algemene Levens Wetenschappen Grant #817.02.002 and #81502006 respectively (www.nwo.nl) and SHD and MPP receive financial support from Top Institute Pharma grant T1-215 and T3-103 (http://www.tipharma.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 1998, DEVELOPMENT, V125, P371; Appel B, 1999, CURR BIOL, V9, P247, DOI 10.1016/S0960-9822(99)80113-4; Beatus P, 1999, DEVELOPMENT, V126, P3925; Blader P, 1997, DEVELOPMENT, V124, P4557; Boengler K, 2003, BIOCHEM BIOPH RES CO, V302, P17, DOI 10.1016/S0006-291X(03)00095-0; Braat H, 2005, J MOL MED, V83, P601, DOI 10.1007/s00109-005-0685-x; Chung AS, 2005, MOL CELL BIOL, V25, P4716, DOI 10.1128/MCB.25.11.4716-4726.2005; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Diks SH, 2008, NAT CELL BIOL, V10, P1190, DOI 10.1038/ncb1779; Diks SH, 2006, J CELL BIOL, V174, P581, DOI 10.1083/jcb.200601081; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Geling A, 2004, DEVELOPMENT, V131, P1993, DOI 10.1242/dev.01093; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Hans S, 2004, DEVELOPMENT, V131, P2957, DOI 10.1242/dev.01167; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Katoh M, 2007, INT J ONCOL, V31, P461; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kile BT, 2001, MOL CELL BIOL, V21, P6189, DOI 10.1128/MCB.21.18.6189-6197.2001; Kim KS, 2004, ZYGOTE, V12, P151, DOI 10.1017/S0967199404002722; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Krebs DL, 2000, J CELL SCI, V113, P2813; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; McDaneld TG, 2008, J ANIM SCI, V86, P2897, DOI 10.2527/jas.2008-1076; McDaneld TG, 2006, AM J PHYSIOL-REG I, V290, pR1672, DOI 10.1152/ajpregu.00239.2005; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Peppelenbosch M, 1999, J IMMUNOL, V162, P837; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; So JH, 2009, BIOCHEM BIOPH RES CO, V379, P22, DOI 10.1016/j.bbrc.2008.11.149; Takke C, 1999, DEVELOPMENT, V126, P3005; Versteeg HH, 2002, J BIOL CHEM, V277, P27065, DOI 10.1074/jbc.M110325200; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14023	10.1371/journal.pone.0014023	http://dx.doi.org/10.1371/journal.pone.0014023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124961	Green Published, gold, Green Submitted			2022-12-25	WOS:000284400100003
J	Jia, WW; Wang, SW; Horner, JW; Wang, N; Wang, HY; Gunther, EJ; DePinho, RA; Zhu, JY				Jia, Wenwen; Wang, Shuwen; Horner, James W.; Wang, Ning; Wang, Huayan; Gunther, Edward J.; DePinho, Ronald A.; Zhu, Jiyue			A BAC transgenic reporter recapitulates in vivo regulation of human telomerase reverse transcriptase in development and tumorigenesis	FASEB JOURNAL			English	Article						transgenic mouse; hTERT gene; mammary tumor; bioluminescent imaging	MOUSE TELOMERASE; STEM-CELLS; CATALYTIC SUBUNIT; IMMORTAL CELLS; HTERT GENE; C-MYC; CANCER; EXPRESSION; MICE; ACTIVATION	Telomerase is tightly regulated in humans relative to mice, owing to the differential regulation of TERT genes. To explore hTERT regulation in vivo, we engineered mice with a 160-kb transgenic bacterial artificial chromosome (BAC) spanning the hTERT locus with a Renilla luciferase (Rluc) cassette downstream of its promoter. Analysis of multiple founder lines revealed that the Rluc expression profile from the transgenic hTERT reporter locus reproduced that of the native hTERT gene in all tissues and organs examined, demonstrating that genetic sequence determined the species-specific developmental regulation of the hTERT gene and that mouse epigenetic and transcription machineries faithfully regulated hTERT transcription. Thus, these mice allowed detailed analyses of developmental hTERT regulation. Both the transgenic hTERT reporter and the endogenous mTERT locus were expressed in early embryonic stages, and their mRNA levels progressively decreased throughout embryonic and postnatal development. Whereas hTERT transcription was much lower than mTERT expression in most organs, it increased significantly during postnatal development of thymus, testis, and ovary. In testis, the Rluc mRNA was enriched in elongating spermatids of seminiferous tubules. In addition, the transcription of transgenic hTERT reporter, but surprisingly not the endogenous mTERT gene, was activated during Wnt1-induced mammary tumorigenesis, allowing the monitoring of tumor development via noninvasive bioluminescent imaging. Collectively, our results demonstrate that the hTERT transgenic reporter system recapitulates the developmental regulation of the hTERT gene in a chromosomal position-independent manner and serves as a legitimate model to explore telomerase regulation in the development of normal and neoplastic tissues in vivo.-Jia, W., Wang, S., Horner, J. W., Wang, N., Wang, H., Gunther, E. J., DePinho, R. A., Zhu, J. A BAC transgenic reporter recapitulates in vivo regulation of human telomerase reverse transcriptase in development and tumorigenesis. FASEB J. 25, 979-989 (2011). www.fasebj.org	[Jia, Wenwen; Wang, Huayan] NW Agr & Forestry A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cell Engn & Technol, Yangling, Shaanxi, Peoples R China; [Jia, Wenwen; Wang, Shuwen; Wang, Ning; Zhu, Jiyue] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Gunther, Edward J.] Penn State Univ, Coll Med, Jake Gittlen Canc Res Fdn, Hershey, PA 17033 USA; [Horner, James W.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Zhu, JY (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr,C4605, Hershey, PA 17033 USA.	jozl@psu.edu	zhu, ji/HDM-1538-2022	DePinho, Ronald/0000-0002-5625-577X	U.S. National Institutes of Health [R21CA106470, R01GM071725]; Chinese National Programs for Fundamental Research and Development [2009CB941002]; Chinese Ministry of Education; NATIONAL CANCER INSTITUTE [R21CA106470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071725] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Programs for Fundamental Research and Development; Chinese Ministry of Education(Ministry of Education, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Longgui Chen for technical assistance, Aimin Liu for RNA in situ hybridization, and Kang Li for the preparation of tissue cryosections. The authors also thank the Macromolecular and Molecular Genetics Core Facilities at Penn State College of Medicine for the excellent services. The work was supported in part by U.S. National Institutes of Health grants R21CA106470 and R01GM071725 (J.Z.), a 973 grant (2009CB941002) from the Chinese National Programs for Fundamental Research and Development (H.W.), and a Ph.D. student scholarship from the Chinese Ministry of Education (W.J.). None of the authors have professional or financial affiliations that can be perceived to bias the presentation of this work.	Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Bieche I, 2000, CLIN CANCER RES, V6, P452; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Coussens M, 2006, BIOL REPROD, V75, P785, DOI 10.1095/biolreprod.106.052167; De Rooij DG, 1998, INT J EXP PATHOL, V79, P67, DOI 10.1046/j.1365-2613.1998.00057.x; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Ducrest AL, 2001, CANCER RES, V61, P7594; Forsyth NR, 2005, MECH AGEING DEV, V126, P685, DOI 10.1016/j.mad.2005.01.003; Gestl SA, 2007, MOL CELL BIOL, V27, P195, DOI 10.1128/MCB.01525-06; Greenberg RA, 1998, ONCOGENE, V16, P1723, DOI 10.1038/sj.onc.1201933; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; HESS RA, 1998, ENCY REPROD, V4, P539; Horikawa L, 2005, P NATL ACAD SCI USA, V102, P18437, DOI 10.1073/pnas.0508964102; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Mathew R, 2010, FASEB J, V24, P2702, DOI 10.1096/fj.09-148973; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Nash SR, 1998, RECEPTOR CHANNEL, V6, P113; Nissim S, 2007, DEV BIOL, V304, P9, DOI 10.1016/j.ydbio.2006.12.010; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Ritz JM, 2005, CANCER RES, V65, P1187, DOI 10.1158/0008-5472.CAN-04-3046; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Russell L. D., 1990, HISTOLOGICAL HISTOPA; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Tanemura K, 2005, DEV BIOL, V281, P196, DOI 10.1016/j.ydbio.2005.02.025; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Vooijs M, 2002, CANCER RES, V62, P1862; Wang SW, 2007, MOL BIOL CELL, V18, P669, DOI 10.1091/mbc.E06-09-0840; Wang SW, 2009, MOL BIOTECHNOL, V42, P110, DOI 10.1007/s12033-009-9142-3; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Wang SW, 2004, J BIOL CHEM, V279, P55401, DOI 10.1074/jbc.M411352200; Wang SW, 2003, J BIOL CHEM, V278, P18842, DOI 10.1074/jbc.M209544200; Weng NP, 2008, MECH AGEING DEV, V129, P60, DOI 10.1016/j.mad.2007.11.005; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wright WE, 1996, DEV GENET, V18, P173; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Zhu JY, 2010, PROTEIN CELL, V1, P22, DOI 10.1007/s13238-010-0014-1	50	20	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					979	989		10.1096/fj.10-173989	http://dx.doi.org/10.1096/fj.10-173989			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21135040	Green Published			2022-12-25	WOS:000287806200018
J	Wang, C; Kane, MA; Napoli, JL				Wang, Chao; Kane, Maureen A.; Napoli, Joseph L.			Multiple Retinol and Retinal Dehydrogenases Catalyze All-trans-retinoic Acid Biosynthesis in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; RELATIONAL MEMORY DEFICIT; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; VITAMIN-A-DEFICIENCY; HIPPOCAMPAL-NEURONS; BINDING-PROTEIN; ALDEHYDE DEHYDROGENASE; ALCOHOL-DEHYDROGENASE; SYNAPTIC PLASTICITY	All-trans-retinoic acid (atRA) stimulates neurogenesis, dendritic growth of hippocampal neurons, and higher cognitive functions, such as spatial learning and memory formation. Although astrocyte-derived atRA has been considered a key factor in neurogenesis, little direct evidence identifies hippocampus cell types and the enzymes that biosynthesize atRA. Here we show that primary rat astrocytes, but not neurons, biosynthesize atRA using multiple retinol dehydrogenases (Rdh) of the short chain dehydrogenase/reductase gene family and retinaldehyde dehydrogenases (Raldh). Astrocytes secrete atRA into their medium; neurons sequester atRA. The first step, conversion of retinol into retinal, is rate-limiting. Neurons and astrocytes both synthesize retinyl esters and reduce retinal into retinol. siRNA knockdown indicates that Rdh10, Rdh2 (mRdh1), and Raldh1, -2, and -3 contribute to atRA production. Knockdown of the Rdh Dhrs9 increased atRA synthesis similar to 40% by increasing Raldh1 expression. Immunocytochemistry revealed cytosolic and nuclear expression of Raldh1 and cytosol and perinuclear expression of Raldh2. atRA autoregulated its concentrations by inducing retinyl ester synthesis via lecithin: retinol acyltransferase and stimulating its catabolism via inducing Cyp26B1. These data show that adult hippocampus astrocytes rely on multiple Rdh and Raldh to provide a paracrine source of atRA to neurons, and atRA regulates its own biosynthesis in astrocytes by directing flux of retinol. Observation of cross-talk between Dhrs9 and Raldh1 provides a novel mechanism of regulating atRA biosynthesis.	[Wang, Chao; Kane, Maureen A.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Napoli, JL (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 119 Morgan Hall,MC 3104, Berkeley, CA 94720 USA.	jna@berkeley.edu	Wang, Chao/A-4626-2016	Wang, Chao/0000-0003-0357-4096	National Institutes of Health [DK36870]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036870, R01DK090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant DK36870.	Akita J, 2002, BRAIN RES, V954, P286, DOI 10.1016/S0006-8993(02)03356-5; ALLIOT F, 1988, DEV BRAIN RES, V44, P247, DOI 10.1016/0165-3806(88)90223-4; Asson-Batres MA, 2006, J COMP NEUROL, V496, P149, DOI 10.1002/cne.20904; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; Brodeur H, 2003, J LIPID RES, V44, P303, DOI 10.1194/jlr.M200359-JLR200; CHAI XY, 1995, J BIOL CHEM, V270, P3900, DOI 10.1074/jbc.270.8.3900; Chandrasekaran V, 2000, J NEUROBIOL, V42, P383, DOI 10.1002/(SICI)1097-4695(200003)42:4<383::AID-NEU1>3.0.CO;2-9; Chen N, 2008, J BIOL CHEM, V283, P20841, DOI 10.1074/jbc.M802314200; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chetyrkin SV, 2001, J BIOL CHEM, V276, P22278, DOI 10.1074/jbc.M102076200; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Connor MJ, 1997, MOL CHEM NEUROPATHOL, V30, P239, DOI 10.1007/BF02815101; COOPER DL, 1993, ADV EXP MED BIOL, V328, P169; Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; EDWARDS RB, 1992, EXP EYE RES, V54, P481, DOI 10.1016/0014-4835(92)90126-D; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Grun F, 2000, J BIOL CHEM, V275, P41210, DOI 10.1074/jbc.M007376200; Halilagic A, 2007, DEV BIOL, V303, P362, DOI 10.1016/j.ydbio.2006.11.021; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jette C, 2004, J BIOL CHEM, V279, P34397, DOI 10.1074/jbc.M314021200; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; Jurukovski V, 1999, MOL GENET METAB, V67, P62, DOI 10.1006/mgme.1999.2840; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; KLANN RC, 1982, CELL TISSUE KINET, V15, P473, DOI 10.1111/j.1365-2184.1982.tb01570.x; Kornyei Z, 2007, FASEB J, V21, P2496, DOI 10.1096/fj.06-7756com; LABRECQUE J, 1993, BIOCHEM CELL BIOL, V71, P85, DOI 10.1139/o93-013; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Levison S. W., 2005, DEV NEUROBIOLOGY; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; McCaffery P, 2004, DEV BRAIN RES, V153, P233, DOI 10.1016/j.devbrainres.2004.09.003; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Nakayama T, 2003, NEUROSCI RES, V46, P241, DOI 10.1016/S0168-0102(03)00063-4; Napoli J. L., 2011, ENCY BIOL CHEM; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; ONG DE, 1988, J BIOL CHEM, V263, P5789; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Rexer BN, 2002, BIOL REPROD, V67, P1555, DOI 10.1095/biolreprod.102.007021; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Rodnight R, 1997, BRAZ J MED BIOL RES, V30, P325, DOI 10.1590/S0100-879X1997000300005; Ross AC, 2004, J NUTR, V134, p269S, DOI 10.1093/jn/134.1.269S; Ross AC, 2003, J NUTR, V133, p271S, DOI 10.1093/jn/133.1.271S; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Shearer KD, 2010, J NEUROCHEM, V112, P246, DOI 10.1111/j.1471-4159.2009.06455.x; Shudo K, 2009, CURR ALZHEIMER RES, V6, P302, DOI 10.2174/156720509788486581; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Soref CM, 2001, J BIOL CHEM, V276, P24194, DOI 10.1074/jbc.M100332200; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Toresson H, 1999, DEVELOPMENT, V126, P1317; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; Vaccarino FM, 2007, NEUROSCIENTIST, V13, P173, DOI 10.1177/1073858406298336; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; WUARIN L, 1990, INT J DEV NEUROSCI, V8, P317, DOI 10.1016/0736-5748(90)90038-4; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; YOST RW, 1988, J BIOL CHEM, V263, P18693; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	72	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6542	6553		10.1074/jbc.M110.198382	http://dx.doi.org/10.1074/jbc.M110.198382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21138835	hybrid, Green Published			2022-12-25	WOS:000287476400064
J	Kny, M; Standera, S; Hartmann-Petersen, R; Kloetzel, PM; Seeger, M				Kny, Melanie; Standera, Sybille; Hartmann-Petersen, Rasmus; Kloetzel, Peter-Michael; Seeger, Michael			Herp Regulates Hrd1-mediated Ubiquitylation in a Ubiquitin-like Domain-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HUMAN HRD1; ER; DEGRADATION; PATHWAY; LIGASE; COMPLEX; PROTEASOME; CYTOSOL	Accumulation of aberrant proteins in the endoplasmic reticulum (ER) triggers the unfolded protein response pathway that helps the cell to survive under these stress conditions. Herp is a mammalian ubiquitin domain protein, which is strongly induced by the unfolded protein response. It is involved in ER-associated protein degradation (ERAD) and interacts directly with the ubiquitin ligase Hrd1, which is found in high molecular mass complexes of the ER membrane. Here we present the first evidence that Herp regulates Hrd1-mediated ubiquitylation in a ubiquitin-like (UBL) domain-dependent manner. We found that upon exposure of cells to ER stress, elevation of Herp steady state levels is accompanied by an enhanced association of Herp with pre-existing Hrd1. Hrd1-associated Herp is rapidly degraded and substituted by de novo synthesized Herp, suggesting a continuous turnover of the protein at Hrd1 complexes. Further analysis revealed the presence of multiple Hrd1 copies in a single complex enabling binding of a variable number of Herp molecules. Efficient ubiquitylation of the Hrd1-specific ERAD substrate alpha 1-antitrypsin null Hong Kong (NHK) required the presence of the Herp UBL domain, which was also necessary for NHK degradation. In summary, we propose that binding of Herp to Hrd1-containing ERAD complexes positively regulates the ubiquitylation activity of these complexes, thus permitting survival of the cell during ER stress.	[Kny, Melanie; Standera, Sybille; Kloetzel, Peter-Michael; Seeger, Michael] Charite, Inst Biochem, D-13347 Berlin, Germany; [Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, Prot Sci Sect, DK-2200 Copenhagen N, Denmark	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Copenhagen	Seeger, M (corresponding author), Charite, Inst Biochem, CC 2 Grundlagenmed,Oudenarder Str 16, D-13347 Berlin, Germany.	michael.seeger@charite.de	Hartmann-Petersen, Rasmus/K-4434-2014	Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Kny, Melanie/0000-0001-7132-8079	Deutsche Forschungsgemeinschaft [SE 938/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SE 938/3).	Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007604; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Shen YX, 2007, BIOCHEM BIOPH RES CO, V352, P919, DOI 10.1016/j.bbrc.2006.11.121; van Laar T, 2000, FEBS LETT, V469, P123, DOI 10.1016/S0014-5793(00)01253-9; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	28	50	50	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5151	5156		10.1074/jbc.M110.134551	http://dx.doi.org/10.1074/jbc.M110.134551			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149444	Green Published, hybrid			2022-12-25	WOS:000287230600023
J	Sengle, G; Ono, RN; Sasaki, T; Sakai, LY				Sengle, Gerhard; Ono, Robert N.; Sasaki, Takako; Sakai, Lynn Y.			Prodomains of Transforming Growth Factor beta (TGF beta) Superfamily Members Specify Different Functions EXTRACELLULAR MATRIX INTERACTIONS AND GROWTH FACTOR BIOAVAILABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; PERLECAN; FIBRILLIN-1; DOMAIN; ACTIVATION; EXPRESSION; RECEPTORS; FIBULIN-2; MYOSTATIN; MEMBRANE	The specific functions of the prodomains of TGF beta superfamily members are largely unknown. Interactions are known between prodomains of TGF beta-1-3 and latent TGF beta-binding proteins and between prodomains of BMP-2, -4, -7, and -10 and GDF-5 and fibrillins, raising the possibility that latent TGF beta-binding proteins and fibrillins may mediate interactions with all other prodomains of this superfamily. This possibility is tested in this study. Results show that the prodomain of BMP-5 interacts with the N-terminal regions of fibrillin-1 and -2 in a site similar to the binding sites for other bone morphogenetic proteins. However, in contrast, the prodomain of GDF-8 (myostatin) interacts with the glycosaminoglycan side chains of perlecan. The binding site for the GDF-8 prodomain is likely the heparan sulfate chain present on perlecan domain V. These results support and extend the emerging concept that TGF beta superfamily prodomains target their growth factor dimers to extracellular matrix macromolecules. In addition, biochemical studies of prodomain.growth factor complexes were performed to identify inactive complexes. For some members of the superfamily, the prodomain is noncovalently associated with its growth factor dimer in an inactive complex; for others, the prodomain.growth factor complex is active, even though the prodomain is noncovalently associated with its growth factor dimer. Results show that the BMP-10 prodomain, in contrast to BMP-4, -5, and -7 prodomains, can inhibit the bioactivity of the BMP-10 growth factor and suggest that the BMP-10 complex is like TGF beta and GDF-8 complexes, which can be activated by cleavage of the associated prodomain.	[Sengle, Gerhard; Ono, Robert N.; Sasaki, Takako; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Sengle, Gerhard; Sasaki, Takako; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Sakai, LY (corresponding author), Oregon Hlth & Sci Univ, Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lys@shcc.org			National Institutes of Health [P01 AR049698]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 AR049698 (to L. Y. S.). This work was also supported by Shriners Hospitals for Children (to L. Y. S.).	Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Costell M, 1996, FEBS LETT, V396, P127, DOI 10.1016/0014-5793(96)01082-4; Costell M, 1997, EUR J BIOCHEM, V243, P115, DOI 10.1111/j.1432-1033.1997.t01-1-00115.x; De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hawke D. H., 1987, APPL BIOSYSTEMS USER; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; Jiang XN, 2003, J HISTOCHEM CYTOCHEM, V51, P1393, DOI 10.1177/002215540305101101; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Newfeld SJ, 1999, GENETICS, V152, P783; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; PAULSSON M, 1987, J MOL BIOL, V197, P297, DOI 10.1016/0022-2836(87)90125-2; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Schulze B, 1996, MATRIX BIOL, V15, P349, DOI 10.1016/S0945-053X(96)90138-9; Sengle G., 2008, PRIMER METABOLIC BON; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Wakefield LM, 1989, GROWTH FACTORS, V1, P203, DOI 10.3109/08977198908997997; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Xu Z, 2010, MATRIX BIOL, V29, P461, DOI 10.1016/j.matbio.2010.06.001	41	127	132	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5087	5099		10.1074/jbc.M110.188615	http://dx.doi.org/10.1074/jbc.M110.188615			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135108	Green Published, hybrid			2022-12-25	WOS:000287230600016
J	Suryadinata, R; Sadowski, M; Steel, R; Sarcevic, B				Suryadinata, Randy; Sadowski, Martin; Steel, Rohan; Sarcevic, Boris			Cyclin-dependent Kinase-mediated Phosphorylation of RBP1 and pRb Promotes Their Dissociation to Mediate Release of the SAP30 center dot mSin3 center dot HDAC Transcriptional Repressor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; CELL-CYCLE; RETINOBLASTOMA PROTEIN; HISTONE DEACETYLASE; BREAST-CANCER; DIFFERENTIAL PHOSPHORYLATION; GROWTH ARREST; IDENTIFICATION; PROGRESSION; INHIBITOR	Eukaryotic cell cycle progression is mediated by phosphorylation of protein substrates by cyclin-dependent kinases (CDKs). A critical substrate of CDKs is the product of the retinoblastoma tumor suppressor gene, pRb, which inhibits G(1)-S phase cell cycle progression by binding and repressing E2F transcription factors. CDK-mediated phosphorylation of pRb alleviates this inhibitory effect to promote G1-S phase cell cycle progression. pRb represses transcription by binding to the E2F transactivation domain and recruiting the mSin3 center dot histone deacetylase (HDAC) transcriptional repressor complex via the retinoblastoma-binding protein 1 (RBP1). RBP1 binds to the pocket region of pRb via an LXCXE motif and to the SAP30 subunit of the mSin3 center dot HDAC complex and, thus, acts as a bridging protein in this multisubunit complex. In the present study we identified RBP1 as a novel CDK substrate. RBP1 is phosphorylated by CDK2 on serines 864 and 1007, which are N- and C-terminal to the LXCXE motif, respectively. CDK2-mediated phosphorylation of RBP1 or pRb destabilizes their interaction in vitro, with concurrent phosphorylation of both proteins leading to their dissociation. Consistent with these findings, RBP1 phosphorylation is increased during progression from G1 into S-phase, with a concurrent decrease in its association with pRb in MCF-7 breast cancer cells. These studies provide new mechanistic insights into CDK-mediated regulation of the pRb tumor suppressor during cell cycle progression, demonstrating that CDK-mediated phosphorylation of both RBP1 and pRb induces their dissociation to mediate release of the mSin3 center dot HDAC transcriptional repressor complex from pRb to alleviate transcriptional repression of E2F.	[Suryadinata, Randy; Sadowski, Martin; Sarcevic, Boris] St Vincents Inst Med Res, Cell Cycle & Canc Unit, Fitzroy, Vic 3065, Australia; [Steel, Rohan] St Vincents Inst Med Res, Prot Chem Unit, Fitzroy, Vic 3065, Australia; [Sarcevic, Boris] Univ Melbourne, Dept Med, St Vincents Hosp, Melbourne, Vic 3065, Australia	St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne	Sarcevic, B (corresponding author), St Vincents Inst Med Res, Cell Cycle & Canc Unit, 9 Princes St, Fitzroy, Vic 3065, Australia.	bsarcevic@svi.edu.au	Suryadinata, Randy/C-2819-2013	/0000-0002-0423-6120; Sarcevic, Boris/0000-0002-8063-1050	Cancer Council Victoria; Department of Defense Breast Cancer Research [BC020800]	Cancer Council Victoria(Cancer Council VictoriaCanadian Institutes of Health Research (CIHR)); Department of Defense Breast Cancer Research(United States Department of Defense)	This work was supported by grants from the Cancer Council Victoria and the Department of Defense Breast Cancer Research Program (BC020800).	Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Brown VD, 1999, MOL CELL BIOL, V19, P3246; Burke JR, 2010, J BIOL CHEM, V285, P16286, DOI 10.1074/jbc.M110.108167; Campbell DH, 1999, CANCER RES, V59, P5376; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; JESSUS C, 1992, CELL, V68, P323, DOI 10.1016/0092-8674(92)90473-P; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lai A, 2001, J BIOL CHEM, V276, P25823, DOI 10.1074/jbc.M100925200; Lai A, 1999, ONCOGENE, V18, P2091, DOI 10.1038/sj.onc.1202520; Laj A, 1999, MOL CELL BIOL, V19, P6632; Lee EY, 2002, CANCER CELL, V2, P463, DOI 10.1016/S1535-6108(02)00207-6; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Paro R, 1993, CURR OPIN CELL BIOL, V5, P999, DOI 10.1016/0955-0674(93)90084-4; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Sadowski M, 2007, BIOCHEM J, V405, P569, DOI 10.1042/BJ20061812; Sadowski M, 2010, MOL CELL BIOL, V30, P2316, DOI 10.1128/MCB.01094-09; Sarcevic B, 1997, J BIOL CHEM, V272, P33327, DOI 10.1074/jbc.272.52.33327; Sarcevic B, 2002, EMBO J, V21, P2009, DOI 10.1093/emboj/21.8.2009; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; SRINIVASAN J, 1995, BIOCHEM J, V309, P927, DOI 10.1042/bj3090927; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; Sutherland R.L., 1999, HUMAN CELL CULTURE, P79; SUZUKITAKAHASHI I, 1995, ONCOGENE, V10, P1691; Taya Y, 1997, TRENDS BIOCHEM SCI, V22, P14, DOI 10.1016/S0968-0004(96)10070-0; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhao JY, 1998, GENE DEV, V12, P456, DOI 10.1101/gad.12.4.456; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	61	21	22	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5108	5118		10.1074/jbc.M110.198473	http://dx.doi.org/10.1074/jbc.M110.198473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148318	Green Published, hybrid			2022-12-25	WOS:000287230600018
J	Ti, SC; Pollard, TD				Ti, Shih-Chieh; Pollard, Thomas D.			Purification of Actin from Fission Yeast Schizosaccharomyces pombe and Characterization of Functional Differences from Muscle Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND ADENOSINE 5'-TRIPHOSPHATE; POLY-L-PROLINE; F-ACTIN; NUCLEOTIDE EXCHANGE; ATP-ACTIN; ADP-ACTIN; CRYSTAL-STRUCTURES; FILAMENT TURNOVER; ARP2/3 COMPLEX; FORMIN CDC12P	Fission yeast Schizosaccharomyces pombe is an important genetic model organism for studying the mechanisms of endocytosis and cytokinesis. However, most work on the biochemical properties of fission yeast actin-binding proteins has been done with skeletal muscle actin for matters of convenience. When simulations of mathematical models of the mechanism of endocytosis were compared with events in live cells, some of the reactions appeared to be much faster than observed in biochemical experiments with muscle actin. Here, we used gelsolin affinity chromatography to purify actin from fission yeast. S. pombe actin shares many properties with skeletal muscle actin but has higher intrinsic nucleotide exchange rate, faster trimer nucleus formation, faster phosphate dissociation rate from polymerized actin, and faster nucleation of actin filaments with Arp2/3 complex. These properties close the gap between the biochemistry and predictions made by mathematical models of endocytosis in S. pombe cells.	[Ti, Shih-Chieh; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Ti, Shih-Chieh; Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu		Ti, Shih-Chieh/0000-0002-0517-0899	National Institutes of Health [GM-026338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM-026338 (to T.D.P.).	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; BERTAZZON A, 1990, BIOCHEMISTRY-US, V29, P291, DOI 10.1021/bi00453a040; Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; Bryan KE, 2005, J BIOL CHEM, V280, P1696, DOI 10.1074/jbc.M410180200; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; CARLIER MF, 1988, J BIOL CHEM, V263, P817; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CARLIER MF, 1986, BIOCHEMISTRY-US, V25, P7789, DOI 10.1021/bi00372a001; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Christensen HEM, 1996, PLANT J, V10, P269, DOI 10.1046/j.1365-313X.1996.10020269.x; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; DE LA CRUZ EM, 1995, BIOCHEMISTRY-US, V34, P5452, DOI 10.1021/bi00016a016; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Ezezika OC, 2009, J BIOL CHEM, V284, P2088, DOI 10.1074/jbc.M807073200; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; GOLDSCHMIDTCLERMONT PJ, 1991, J CELL BIOL, V113, P1081, DOI 10.1083/jcb.113.5.1081; HADDAD JG, 1990, P NATL ACAD SCI USA, V87, P1381, DOI 10.1073/pnas.87.4.1381; HELMERHORST E, 1980, ANAL BIOCHEM, V104, P130, DOI 10.1016/0003-2697(80)90287-0; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2000, PLANT CELL, V12, P583, DOI 10.1105/tpc.12.4.583; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; Ohki T, 2009, BIOCHEM BIOPH RES CO, V383, P146, DOI 10.1016/j.bbrc.2009.03.144; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Schuler H, 2000, EUR J BIOCHEM, V267, P476, DOI 10.1046/j.1432-1327.2000.01023.x; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; SIPICZKI M, 1995, ANTON LEEUW INT J G, V68, P119, DOI 10.1007/BF00873099; Sipiczki M, 2000, GENOME BIOL, V1, DOI DOI 10.1186/GB-2000-1-2-REVIEWS1011; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Takaine M, 2007, J BIOL CHEM, V282, P21683, DOI 10.1074/jbc.M611371200; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200	52	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5784	5792		10.1074/jbc.M110.199794	http://dx.doi.org/10.1074/jbc.M110.199794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148484	Green Published, hybrid			2022-12-25	WOS:000287230600087
J	Kingston, IJ; Yung, JSY; Singleton, MR				Kingston, Isabel J.; Yung, Jasmine S. Y.; Singleton, Martin R.			Biophysical Characterization of the Centromere-specific Nucleosome from Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-A; CORE PARTICLE; FISSION YEAST; HISTONE H3; IN-VITRO; CHROMATIN; DNA; RECONSTITUTION; DEPOSITION; PROTEINS	The centromeric DNA of all eukaryotes is assembled upon a specialized nucleosome containing a histone H3 variant known as CenH3. Despite the importance and conserved nature of this protein, the characteristics of the centromeric nucleosome are still poorly understood. In particular, the stoichiometry and DNA-binding properties of the CenH3 nucleosome have been the subject of some debate. We have characterized the budding yeast centromeric nucleosome by biochemical and biophysical methods and show that it forms a stable octamer containing two copies of the Cse4 protein and wraps DNA in a left-handed supercoil, similar to the canonical H3 nucleosome. The DNA-binding properties of the recombinant nucleosome are identical to those observed in vivo demonstrating that the octameric structure is physiologically relevant.	[Kingston, Isabel J.; Singleton, Martin R.] Canc Res UK London Res Inst, Macromol Struct & Funct Lab, London WC2A 3LY, England; [Yung, Jasmine S. Y.] Univ London Imperial Coll Sci Technol & Med, Div Canc, Dept Surg & Canc, London SW7 2AZ, England	Cancer Research UK; Imperial College London	Singleton, MR (corresponding author), Canc Res UK London Res Inst, Macromol Struct & Funct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	Martin.Singleton@cancer.org.uk		Singleton, Martin/0000-0001-5716-7715	Cancer Research UK; Cancer Research UK [15656] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Dechassa ML, 2009, CELL, V138, P22, DOI 10.1016/j.cell.2009.06.037; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Lavelle C, 2009, CELL, V139, P1216, DOI 10.1016/j.cell.2009.12.014; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Muecke M, 2008, STRUCTURE, V16, P837, DOI 10.1016/j.str.2008.04.008; POLIZZI C, 1991, J CELL BIOL, V112, P191, DOI 10.1083/jcb.112.2.191; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Visnapuu ML, 2009, NAT STRUCT MOL BIOL, V16, P1056, DOI 10.1038/nsmb.1655; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	23	66	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					4021	4026		10.1074/jbc.M110.189340	http://dx.doi.org/10.1074/jbc.M110.189340			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115484	hybrid, Green Published			2022-12-25	WOS:000286653200082
J	Lin, HH; Lai, SC; Chau, LY				Lin, Heng-Huei; Lai, Shao-Chuan; Chau, Lee-Young			Heme Oxygenase-1/Carbon Monoxide Induces Vascular Endothelial Growth Factor Expression via p38 Kinase-dependent Activation of Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR GENE; TRANSCRIPTIONAL REGULATION; CARBON-MONOXIDE; PROTEIN-KINASES; UP-REGULATION; PHOSPHORYLATION; ANGIOGENESIS; INDUCTION; HYPOXIA	Heme oxygenase-1 (HO-1) is a stress-inducible enzyme catalyzing the oxidative degradation of heme to free iron, CO, and biliverdin. Previous studies demonstrated that HO-1 overexpression promoted VEGF expression and angiogenesis in the ischemic heart. However, the underlying mechanism remained elusive. Here we show that adenovirus-mediated HO-1 transduction of rat primary cardiomyocytes and H9C2 myocytes resulted in significant induction of VEGF expression, and a similar effect was seen in cells directly exposed to CO gas or a CO-releasing compound, tricarbonyldichlororuthenium (II) dimer. HO-1/CO-induced VEGF expression was significantly suppressed by pharmacological inhibition of p38 kinase, but not of AKT, activation. VEGF promoter-luciferase reporter assays, electrophoretic mobility shift assays, supershift assay, and chromatin immunoprecipitation showed that CO-induced VEGF promoter activation requires the binding of the Sp1 transcriptional factor to a cis-regulatory sequence located at the VEGF promoter. Western blot analysis and immunostaining experiments demonstrated that HO-1/CO induced p38-dependent phosphorylation of Sp1 at Thr-453 and Thr-739 both in vitro and in vivo. Overexpression of Sp1 protein with an alanine mutation at Thr-453 or Thr-739 suppressed CO-induced Sp1 binding to the VEGF promoter and its transcriptional activation. Collectively, these data suggest that p38-dependent phosphorylation of Sp1 at Thr-453/Thr-739 is crucial for HO-1/CO-induced VEGF expression in myocytes.	[Lin, Heng-Huei; Lai, Shao-Chuan; Chau, Lee-Young] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan	Chau, LY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	lyc@ibms.sinica.edu.tw	Chau, Lee-Young/N-7659-2018	Chau, Lee-Young/0000-0002-6316-2328	National Science Council of Taiwan [NSC-96-2320-B-001-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from National Science Council of Taiwan Grant NSC-96-2320-B-001-001 and an investigatorship from the Academia Sinica (to L.-Y.C.).	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Chang HJ, 2006, INT J ONCOL, V28, P135; Deramaudt BMJM, 1998, J CELL BIOCHEM, V68, P121, DOI 10.1002/(SICI)1097-4644(19980101)68:1<121::AID-JCB12>3.0.CO;2-K; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dulak J, 2002, ANTIOXID REDOX SIGN, V4, P229, DOI 10.1089/152308602753666280; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Duyndam MCA, 2003, J BIOL CHEM, V278, P6885, DOI 10.1074/jbc.M206320200; Fong GH, 2009, J MOL MED-JMM, V87, P549, DOI 10.1007/s00109-009-0458-z; Gao N, 2002, J BIOL CHEM, V277, P45041, DOI 10.1074/jbc.M202775200; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hu CM, 2004, CIRCULATION, V110, P309, DOI 10.1161/01.CIR.0000135475.35758.23; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Juan SH, 2001, CIRCULATION, V104, P1519, DOI 10.1161/hc3801.095663; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Lin HH, 2008, J MOL CELL CARDIOL, V45, P44, DOI 10.1016/j.yjmcc.2008.04.011; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Suzuki M, 2003, BIOCHEM BIOPH RES CO, V302, P138, DOI 10.1016/S0006-291X(03)00114-1; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tanaka T, 2000, J MOL CELL CARDIOL, V32, P1955, DOI 10.1006/jmcc.2000.1228; Volti GL, 2005, ANTIOXID REDOX SIGN, V7, P704, DOI 10.1089/ars.2005.7.704; Xiong SB, 2001, CANCER RES, V61, P1727; Yin YM, 2009, BIOMED PHARMACOTHER, V63, P429, DOI 10.1016/j.biopha.2009.04.045	29	50	53	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3829	3838		10.1074/jbc.M110.168831	http://dx.doi.org/10.1074/jbc.M110.168831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115498	Green Published, hybrid			2022-12-25	WOS:000286653200064
J	Lindsay, J; McDade, SS; Pickard, A; McCloskey, KD; McCance, DJ				Lindsay, Jaime; McDade, Simon S.; Pickard, Adam; McCloskey, Karen D.; McCance, Dennis J.			Role of Delta Np63 gamma in Epithelial to Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; EPIDERMAL MORPHOGENESIS; RETINOBLASTOMA PROTEIN; P63 EXPRESSION; BREAST-CANCER; P53 HOMOLOG; CELLS; MECHANISM; IDENTIFICATION; PROGRESSION	Although members of the p63 family of transcription factors are known for their role in the development and differentiation of epithelial surfaces, their function in cancer is less clear. Here, we show that depletion of the Delta Np63 alpha and beta isoforms, leaving only Delta Np63 gamma, results in epithelial to mesenchymal transition (EMT) in the normal breast cell line MCF10A. EMT can be rescued by the expression of the Delta Np63 alpha isoform. We also show that Delta Np63 gamma expressed in a background where all the other Delta Np63 are knocked down causes EMT with an increase in TGF beta-1, -2, and -3 and downstream effectors Smads2/3/4. In addition, a p63 binding site in intron 1 of TGF beta was identified. Inhibition of the TGF beta response with a specific inhibitor results in reversion of EMT in Delta Np63 alpha- and beta-depleted cells. In summary, we show that p63 is involved in inhibiting EMT and reduction of certain p63 isoforms may be important in the development of epithelial cancers.	[Lindsay, Jaime; McDade, Simon S.; Pickard, Adam; McCloskey, Karen D.; McCance, Dennis J.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	McCance, DJ (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	d.mccance@qub.ac.uk	McDade, Simon/AAE-5031-2020; McDade, Simon S/E-5730-2017	McDade, Simon/0000-0002-3024-4773; McDade, Simon S/0000-0002-3024-4773; McCloskey, Karen/0000-0002-9135-9013; pickard, adam/0000-0001-9757-143X	Medical Research Council [MRC G0700754]; Medical Research Council [G0700754] Funding Source: researchfish; MRC [G0700754] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by Medical Research Council Grant MRC G0700754.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x; CARNEY DN, 1985, CANCER RES, V45, P2913; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Crook T, 2000, ONCOGENE, V19, P3439, DOI 10.1038/sj.onc.1203656; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; De Rosa L, 2009, J BIOL CHEM, V284, P30574, DOI 10.1074/jbc.M109.049619; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Hay ED, 1995, ACTA ANAT, V154, P8; Herfs M, 2010, AM J PATHOL, V176, P1941, DOI 10.2353/ajpath.2010.090804; Higashikawa K, 2009, INT J CANCER, V124, P2837, DOI 10.1002/ijc.24280; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; McDade SS, 2010, BIOCHEM SOC T, V38, P223, DOI 10.1042/BST0380223; Menges CW, 2006, CANCER RES, V66, P5555, DOI 10.1158/0008-5472.CAN-06-0499; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Park BJ, 2000, CANCER RES, V60, P3370; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Senoo M, 2001, BRIT J CANCER, V84, P1235, DOI 10.1054/bjoc.2000.1735; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; SOULE HD, 1990, CANCER RES, V50, P6075; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; VANDERHAEGEN BA, 1993, IN VITRO CELL DEV-AN, V29A, P180, DOI 10.1007/BF02634177; Wang XH, 2002, J UNIV SCI TECHNOL B, V9, P9; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Wu GJ, 2005, CANCER RES, V65, P758; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	36	50	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3915	3924		10.1074/jbc.M110.162511	http://dx.doi.org/10.1074/jbc.M110.162511			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127042	Green Published, hybrid			2022-12-25	WOS:000286653200072
J	Martins, IM; Cortes, JCG; Munoz, J; Moreno, MB; Ramos, M; Clemente-Ramos, JA; Duran, A; Ribas, JC				Martins, Ivone M.; Cortes, Juan C. G.; Munoz, Javier; Belen Moreno, M.; Ramos, Mariona; Clemente-Ramos, Jose A.; Duran, Angel; Ribas, Juan C.			Differential Activities of Three Families of Specific beta(1,3) Glucan Synthase Inhibitors in Wild-type and Resistant Strains of Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; CELL-WALL; NATURAL-PRODUCTS; FKS1 GENE; ECHINOCANDIN; SUBUNIT; SUSCEPTIBILITY; CASPOFUNGIN; HOMOLOG; MUTATIONS	Three specific beta(1,3) glucan synthase (GS) inhibitor families, papulacandins, acidic terpenoids, and echinocandins, have been analyzed in Schizosaccharomyces pombe wild-type and papulacandin-resistant cells and GS activities. Papulacandin and enfumafungin produced similar in vivo effects, different from that of echinocandins. Also, papulacandin was the strongest in vitro GS inhibitor (IC50 10(3)-10(4)-fold lower than with enfumafungin or pneumocandin), but caspofungin was by far the most efficient antifungal because of the following. 1) It was the only drug that affected resistant cells (minimal inhibitory concentration close to that of the wild type). 2) It was a strong inhibitor of wild-type GS (IC50 close to that of papulacandin). 3) It was the best inhibitor of mutant GS. Moreover, caspofungin showed a special effect for two GS inhibition activities, of high and low affinity, separated by 2 log orders, with no increase in inhibition. pbr1-8 and pbr1-6 resistances are due to single substitutions in the essential Bgs4 GS, located close to the resistance hot spot 1 region described in Saccharomyces and Candida Fks mutants. Bgs4(pbr1-8) contains the E700V change, four residues N-terminal from hot spot 1 defining a larger resistance hot spot 1-1 of 13 amino acids. Bgs4(pbr1-6) contains the W760S substitution, defining a new resistance hot spot 1-2. We observed spontaneous revertants of the spherical pbr1-6 phenotype and found that an additional A914V change is involved in the recovery of the wild-type cell shape, but it maintains the resistance phenotype. A better understanding of the mechanism of action of the antifungals available should help to improve their activity and to identify new antifungal targets.	[Martins, Ivone M.; Cortes, Juan C. G.; Munoz, Javier; Belen Moreno, M.; Ramos, Mariona; Clemente-Ramos, Jose A.; Duran, Angel; Ribas, Juan C.] Univ Salamanca, Inst Microbiol Bioquim, CSIC, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Ribas, JC (corresponding author), Univ Salamanca, Inst Microbiol Bioquim, CSIC, Edificio Dept,Rm 222,Campus Miguel de Unamuno, Salamanca 37007, Spain.	ribas@usal.es	Cortes, Juan Garcia/G-8773-2015; Ribas, Juan C/C-9864-2015; Martins, Ivone M/G-1752-2012	Cortes, Juan Garcia/0000-0002-2395-6668; Ribas, Juan C/0000-0001-6430-0895; Martins, Ivone M/0000-0002-3412-9377; Moreno, Maria Belen/0000-0002-5557-0575; Munoz-Garcia, Javier/0000-0002-2978-1192; Clemente-Ramos, Jose Angel/0000-0001-6872-6412	Ministerio de Educacion y Ciencia [BIO2006-13566]; Ministerio de Ciencia e Innovacion [BIO2009-10597]; Junta de Castilla y Leon, Spain [GR231]; Fundacao para a Ciencia e a Tecnologia, Portugal; Consejo Superior de Investigaciones Cientificas, Spain; Junta de Castilla y Leon, Spain; Ministerio de Ciencia e Innovacion, Spain	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Consejo Superior de Investigaciones Cientificas, Spain; Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in part by Grants BIO2006-13566 from Ministerio de Educacion y Ciencia, BIO2009-10597 from Ministerio de Ciencia e Innovacion, and GR231 from Junta de Castilla y Leon, Spain.; Supported by a fellowship from Fundacao para a Ciencia e a Tecnologia, Portugal.; Supported by a fellowship from Consejo Superior de Investigaciones Cientificas, Spain.; Supported by a fellowship from Junta de Castilla y Leon, Spain.; Supported by a fellowship from Ministerio de Ciencia e Innovacion, Spain.	Alfa C, 1993, EXPT FISSION YEAST L; Balashov SV, 2006, ANTIMICROB AGENTS CH, V50, P2058, DOI 10.1128/AAC.01653-05; Barrett D, 2002, BBA-MOL BASIS DIS, V1587, P224, DOI 10.1016/S0925-4439(02)00085-6; BARTIZAL K, 1992, ANTIMICROB AGENTS CH, V36, P1648, DOI 10.1128/AAC.36.8.1648; CASTRO C, 1995, J BACTERIOL, V177, P5732, DOI 10.1128/jb.177.20.5732-5739.1995; Chapman Stanley W, 2008, Trans Am Clin Climatol Assoc, V119, P197; Cleary JD, 2008, ANTIMICROB AGENTS CH, V52, P2263, DOI 10.1128/AAC.01568-07; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; DEMORA JF, 1991, ANTIMICROB AGENTS CH, V35, P2596, DOI 10.1128/AAC.35.12.2596; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Desnos-Ollivier M, 2008, ANTIMICROB AGENTS CH, V52, P3092, DOI 10.1128/AAC.00088-08; Douglas CM, 1997, ANTIMICROB AGENTS CH, V41, P2471, DOI 10.1128/AAC.41.11.2471; DOUGLAS CM, 1994, J BACTERIOL, V176, P5686, DOI 10.1128/JB.176.18.5686-5696.1994; Duran A, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P269; EGEL R, 1984, CURR GENET, V8, P199, DOI 10.1007/BF00417816; ELSHERBEINI M, 1995, ANTIMICROB AGENTS CH, V39, P200, DOI 10.1128/AAC.39.1.200; Eschenauer Gregory, 2007, Ther Clin Risk Manag, V3, P71, DOI 10.2147/tcrm.2007.3.1.71; Fleischhacker M, 2008, EUR J CLIN MICROBIOL, V27, P127, DOI 10.1007/s10096-007-0411-4; Garcia-Effron G, 2008, ANTIMICROB AGENTS CH, V52, P2305, DOI 10.1128/AAC.00262-08; Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P3690, DOI 10.1128/AAC.00443-09; Garcia-Effron G, 2009, ANTIMICROB AGENTS CH, V53, P112, DOI 10.1128/AAC.01162-08; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; KANG MS, 1986, CARBOHYD RES, V149, P13, DOI 10.1016/S0008-6215(00)90365-3; Katiyar S, 2006, ANTIMICROB AGENTS CH, V50, P2892, DOI 10.1128/AAC.00349-06; Katiyar SK, 2009, ANTIMICROB AGENTS CH, V53, P1772, DOI 10.1128/AAC.00020-09; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kondoh O, 2002, J BIOL CHEM, V277, P41744, DOI 10.1074/jbc.M206734200; Kurtz MB, 1996, INFECT IMMUN, V64, P3244, DOI 10.1128/IAI.64.8.3244-3251.1996; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Martin V, 2000, MOL MICROBIOL, V38, P308, DOI 10.1046/j.1365-2958.2000.02118.x; Martin V, 2003, EUKARYOT CELL, V2, P159, DOI 10.1128/EC.2.1.159-169.2003; Montravers P, 2006, INT J ANTIMICROB AG, V27, P1, DOI 10.1016/j.ijantimicag.2005.11.002; Moreno MB, 2000, YEAST, V16, P861; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Onishi J, 2000, ANTIMICROB AGENTS CH, V44, P368, DOI 10.1128/AAC.44.2.368-377.2000; Park S, 2005, ANTIMICROB AGENTS CH, V49, P3264, DOI 10.1128/AAC.49.8.3264-3273.2005; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; RIBAS JC, 1991, J BACTERIOL, V173, P3456, DOI 10.1128/jb.173.11.3456-3462.1991; RIBAS JC, 1991, FEMS MICROBIOL LETT, V79, P263, DOI 10.1016/0378-1097(91)90096-S; Rocha EMF, 2007, ANTIMICROB AGENTS CH, V51, P4174, DOI 10.1128/AAC.00917-07; Sambrook J, 2001, MOL CLONING LAB MANU; Shao PL, 2007, INT J ANTIMICROB AG, V30, P487, DOI 10.1016/j.ijantimicag.2007.07.019; Stone EA, 2002, CLIN THER, V24, P351, DOI 10.1016/S0149-2918(02)85039-1; Thompson JR, 1999, J BACTERIOL, V181, P444, DOI 10.1128/JB.181.2.444-453.1999; Verma DPS, 2001, PLANT MOL BIOL, V47, P693, DOI 10.1023/A:1013679111111; Vicente MF, 2003, CLIN MICROBIOL INFEC, V9, P15, DOI 10.1046/j.1469-0691.2003.00489.x; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; Wiederhold NR, 2007, CURR OPIN INFECT DIS, V20, P574, DOI 10.1097/QCO.0b013e3282f1be7f	52	35	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3484	3496		10.1074/jbc.M110.174300	http://dx.doi.org/10.1074/jbc.M110.174300			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115488	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000286653200034
J	Wu, FM; Nguyen, JV; Rankin, S				Wu, Frank M.; Nguyen, Judy V.; Rankin, Susannah			A Conserved Motif at the C Terminus of Sororin Is Required for Sister Chromatid Cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ACETYLATION; PROTEIN; COMPLEX; ASSOCIATION; EXPRESSION; BINDING; SMC3; SCC2; WAPL	Sororin is a positive regulator of sister chromatid cohesion that interacts with the cohesin complex. Sororin is required for the increased stability of the cohesin complex on chromatin following DNA replication and sister chromatid cohesion during G(2). The mechanism by which sororin ensures cohesion is currently unknown. Because the primary sequence of sororin does not contain any previously characterized structural or functional motifs, we have undertaken a structure-function analysis of the sororin protein. Using a series of mutant derivatives of sororin, we show that the ability of sororin to bind to chromatin is separable from both its role in sister chromatid cohesion and its interaction with the cohesin complex. We also show that derivatives of sororin with deletions or mutations in the conserved C terminus fail to rescue the loss-of-cohesion phenotype caused by sororin RNAi and that these mutations also abrogate the association of sororin with the cohesin complex. Our data suggest that the interaction of the highly conserved motif at the C terminus of sororin with the cohesin complex is critical to its ability to mediate sister chromatid cohesion.	[Rankin, Susannah] Oklahoma Med Res Fdn, Program Cell Cycle & Canc Biol, Oklahoma City, OK 73104 USA; [Wu, Frank M.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Cell Biol, Oklahoma City, OK 73126 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rankin, S (corresponding author), Oklahoma Med Res Fdn, Program Cell Cycle & Canc Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Susannah-Rankin@omrf.org		Rankin, Susannah/0000-0002-4056-6610	National Institutes of Health through NCRR [RR016478]; Oklahoma Center for the Advancement of Science and Technology [HR06-175S]; J. Donald Capra predoctoral fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER	National Institutes of Health through NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Oklahoma Center for the Advancement of Science and Technology; J. Donald Capra predoctoral fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR016478 through the NCRR. This work was also supported by Oklahoma Center for the Advancement of Science and Technology Grant HR06-175S.; Supported by a J. Donald Capra predoctoral fellowship.	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Pfleger CM, 2000, GENE DEV, V14, P655; Rankin S, 2005, CELL CYCLE, V4, P1039, DOI 10.4161/cc.4.8.1926; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	22	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3579	3586		10.1074/jbc.M110.196758	http://dx.doi.org/10.1074/jbc.M110.196758			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115494	Green Published, hybrid			2022-12-25	WOS:000286653200042
J	Sauzeau, V; Carvajal-Gonzalez, JM; Riolobos, AS; Sevilla, MA; Menacho-Marquez, M; Roman, AC; Abad, A; Montero, MJ; Fernandez-Salguero, P; Bustelo, XR				Sauzeau, Vincent; Carvajal-Gonzalez, Jose M.; Riolobos, Adelaida S.; Sevilla, Maria A.; Menacho-Marquez, Mauricio; Roman, Angel C.; Abad, Antonio; Montero, Maria J.; Fernandez-Salguero, Pedro; Bustelo, Xose R.			Transcriptional Factor Aryl Hydrocarbon Receptor (Ahr) Controls Cardiovascular and Respiratory Functions by Regulating the Expression of the Vav3 Proto-oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIOXIN-RECEPTOR; BLOOD-PRESSURE; NULL MICE; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; CONSTITUTIVE EXPRESSION; NUCLEAR TRANSLOCATOR; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; AXON GUIDANCE; CDNA CLONING	Aryl hydrocarbon receptor (Ahr) is a transcriptional factor involved in detoxification responses to pollutants and in intrinsic biological processes of multicellular organisms. We recently described that Vav3, an activator of Rho/Rac GTPases, is an Ahr transcriptional target in embryonic fibroblasts. These results prompted us to compare the Ahr(-/-) and Vav3(-/-) mouse phenotypes to investigate the implications of this functional interaction in vivo. Here, we show that Ahr is important for Vav3 expression in kidney, lung, heart, liver, and brainstem regions. This process is not affected by the administration of potent Ahr ligands such as benzo[a]pyrene. We also report that Ahr- and Vav3-deficient mice display hypertension, tachypnea, and sympathoexcitation. The Ahr gene deficiency also induces the GABAergic transmission defects present in the Vav3(-/-) ventrolateral medulla, a main cardiorespiratory brainstem center. However, Ahr(-/-) mice, unlike Vav3-deficient animals, display additional defects in fertility, perinatal growth, liver size and function, closure, spleen size, and peripheral lymphocytes. These results demonstrate that Vav3 is a bona fide Ahr target that is in charge of a limited subset of the developmental and physiological functions controlled by this transcriptional factor. Our data also reveal the presence of sympathoexcitation and new cardiorespiratory defects in Ahr(-/-) mice.	[Carvajal-Gonzalez, Jose M.; Roman, Angel C.; Fernandez-Salguero, Pedro] Univ Extremadura, Dept Bioquim & Biol Mol, E-06071 Badajoz, Spain; [Sauzeau, Vincent; Sevilla, Maria A.; Menacho-Marquez, Mauricio; Abad, Antonio; Montero, Maria J.; Bustelo, Xose R.] Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, Salamanca 37007, Spain; [Riolobos, Adelaida S.; Sevilla, Maria A.; Montero, Maria J.] Univ Salamanca, Dept Fisiol & Farmacol, Salamanca 37007, Spain; [Riolobos, Adelaida S.] Univ Salamanca, Inst Neurociencias Castilla & Leon, Salamanca 37007, Spain	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca	Fernandez-Salguero, P (corresponding author), Univ Extremadura, Dept Bioquim & Biol Mol, E-06071 Badajoz, Spain.	pmfersal@unex.es; xbustelo@usal.es	Bustelo, Xose R./AAD-2081-2022; Sevilla, M Angeles/J-8146-2017; S.Riolobos, Adelaida/B-3729-2017; Montero, María José MJ/C-3084-2018; Fernandez-Salguero, Pedro M./J-8437-2014; Sauzeau, Vincent/D-3548-2015; Bustelo, Xose R./A-9526-2010; Carvajal-Gonzalez, Jose Maria/ABC-6780-2020	Bustelo, Xose R./0000-0001-9398-6072; Sevilla, M Angeles/0000-0003-2960-8514; Montero, María José MJ/0000-0003-2125-0378; Fernandez-Salguero, Pedro M./0000-0003-2839-5027; Bustelo, Xose R./0000-0001-9398-6072; Carvajal-Gonzalez, Jose Maria/0000-0001-6576-830X; Abad de Blas, Antonio Luis/0000-0001-8019-2775; Sauzeau, Vincent/0000-0002-6187-0312	National Institutes of Health [R01CA073735]; Spanish Ministry of Science and Innovation [SAF2009-07172, RD06/0020/0001, SAF2008-00462, RD06/0020/1016]; Castilla y Leon Autonomous Government [GR97]; Asociacion Espanola Contra el Cancer; Junta de Extremadura [GRU08012, GRU09001]; NATIONAL CANCER INSTITUTE [R01CA073735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Castilla y Leon Autonomous Government; Asociacion Espanola Contra el Cancer; Junta de Extremadura; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA073735. This work was also supported by Spanish Ministry of Science and Innovation Grants SAF2009-07172 and RD06/0020/0001, Castilla y Leon Autonomous Government Grant GR97, and the Asociacion Espanola Contra el Cancer (to X. R. B.), Spanish Ministry of Science and Innovation Grants SAF2008-00462 and RD06/0020/1016, and Junta de Extremadura Grants GRU08012 and GRU09001 (to P. F.-S.).	Abbott BD, 1999, TOXICOL APPL PHARM, V155, P62, DOI 10.1006/taap.1998.8601; Andreola F, 2004, J BIOL CHEM, V279, P3434, DOI 10.1074/jbc.M305832200; Auyeung DJ, 2003, MOL PHARMACOL, V63, P119, DOI 10.1124/mol.63.1.119; Baba T, 2005, MOL CELL BIOL, V25, P10040, DOI 10.1128/MCB.25.22.10040-10051.2005; Backlund M, 2005, CELL SIGNAL, V17, P39, DOI 10.1016/j.cellsig.2004.05.010; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; BLESSING WW, 1988, AM J PHYSIOL, V254, pH686, DOI 10.1152/ajpheart.1988.254.4.H686; Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Carvajal-Gonzalez JM, 2009, J CELL SCI, V122, P1823, DOI 10.1242/jcs.047274; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; CHEVILLARD C, 1988, EUR J PHARMACOL, V147, P23, DOI 10.1016/0014-2999(88)90629-2; Corchero J, 2004, INT J EXP PATHOL, V85, P295, DOI 10.1111/j.0959-9673.2004.00397.x; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Fletcher N, 2005, TOXICOL APPL PHARM, V207, P1, DOI 10.1016/j.taap.2004.12.003; Flores O, 1998, EXP NEPHROL, V6, P39; FRANKIN BJ, 1996, MOUSE BRAIN STEREOTA; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gomez-Duran A, 2008, J MOL BIOL, V380, P1, DOI 10.1016/j.jmb.2008.04.056; GONZALEZ FJ, 1985, NUCLEIC ACIDS RES, V13, P7269, DOI 10.1093/nar/13.20.7269; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Huang X, 2004, DEVELOPMENT, V131, P819, DOI 10.1242/dev.00959; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; Ikuta T, 2006, EXP CELL RES, V312, P3585, DOI 10.1016/j.yexcr.2006.08.002; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Kim MD, 2006, GENE DEV, V20, P2806, DOI 10.1101/gad.1459706; KIMURA S, 1986, MOL CELL BIOL, V6, P1471, DOI 10.1128/MCB.6.5.1471; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; Leung YK, 2002, BIOCHEM PHARMACOL, V63, P767, DOI 10.1016/S0006-2952(01)00902-9; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lund AK, 2003, TOXICOL APPL PHARM, V193, P177, DOI 10.1016/j.taap.2003.08.008; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; MOLINOFF PB, 1971, ANNU REV BIOCHEM, V40, P465, DOI 10.1146/annurev.bi.40.070171.002341; Movilla N, 1999, MOL CELL BIOL, V19, P7870; MUFTI NA, 1995, BIOCHEM BIOPH RES CO, V208, P144, DOI 10.1006/bbrc.1995.1316; Munzel PA, 2003, BIOCHEM PHARMACOL, V66, P841, DOI 10.1016/S0006-2952(03)00389-7; Nakata A, 2009, EMBO REP, V10, P622, DOI 10.1038/embor.2009.35; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Quevedo C, 2010, MOL BIOL CELL, V21, P1125, DOI 10.1091/mbc.E09-04-0292; Santiago-Josefat B, 2004, J CELL SCI, V117, P849, DOI 10.1242/jcs.00932; Sato S, 2008, TOXICOL APPL PHARM, V229, P10, DOI 10.1016/j.taap.2007.12.029; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Sauzeau V, 2007, MOL BIOL CELL, V18, P943, DOI 10.1091/mbc.E06-09-0877; Sauzeau V, 2010, MOL BIOL CELL, V21, P4251, DOI 10.1091/mbc.E10-07-0639; Sauzeau V, 2010, J CLIN INVEST, V120, P315, DOI 10.1172/JCI38356; SAVAS U, 1994, J BIOL CHEM, V269, P14905; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; SHEN ZY, 1994, DNA CELL BIOL, V13, P763, DOI 10.1089/dna.1994.13.763; Sindrilaru A, 2009, BLOOD, V113, P5266, DOI 10.1182/blood-2008-07-166702; SUTTER TR, 1991, SCIENCE, V254, P415, DOI 10.1126/science.1925598; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; Thrasher TN, 2005, AM J PHYSIOL-REG I, V288, pR819, DOI 10.1152/ajpregu.00813.2004; Tolentino-Silva FP, 2000, J APPL PHYSIOL, V89, P437, DOI 10.1152/jappl.2000.89.2.437; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Yang XH, 2005, ONCOGENE, V24, P7869, DOI 10.1038/sj.onc.1208938; Yoshida S, 2002, CIRC J, V66, P197, DOI 10.1253/circj.66.197	70	48	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2896	2909		10.1074/jbc.M110.187534	http://dx.doi.org/10.1074/jbc.M110.187534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21115475	Green Published, hybrid			2022-12-25	WOS:000286464300054
J	van Bemmel, JG; Pagie, L; Braunschweig, U; Brugman, W; Meuleman, W; Kerkhoven, RM; van Steensel, B				van Bemmel, Joke G.; Pagie, Ludo; Braunschweig, Ulrich; Brugman, Wim; Meuleman, Wouter; Kerkhoven, Ron M.; van Steensel, Bas			The Insulator Protein SU(HW) Fine-Tunes Nuclear Lamina Interactions of the Drosophila Genome	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; CHROMATIN DOMAIN BOUNDARY; ENHANCER-BLOCKING; IN-VIVO; BITHORAX COMPLEX; TRANSCRIPTION; POSITION; BINDING; GENES; DNA	Specific interactions of the genome with the nuclear lamina (NL) are thought to assist chromosome folding inside the nucleus and to contribute to the regulation of gene expression. High-resolution mapping has recently identified hundreds of large, sharply defined lamina-associated domains (LADs) in the human genome, and suggested that the insulator protein CTCF may help to demarcate these domains. Here, we report the detailed structure of LADs in Drosophila cells, and investigate the putative roles of five insulator proteins in LAD organization. We found that the Drosophila genome is also organized in discrete LADs, which are about five times smaller than human LADs but contain on average a similar number of genes. Systematic comparison to new and published insulator binding maps shows that only SU(HW) binds preferentially at LAD borders and at specific positions inside LADs, while GAF, CTCF, BEAF-32 and DWG are mostly absent from these regions. By knockdown and overexpression studies we demonstrate that SU(HW) weakens genome -NL interactions through a local antagonistic effect, but we did not obtain evidence that it is essential for border formation. Our results provide insights into the evolution of LAD organization and identify SU(HW) as a fine-tuner of genome -NL interactions.	[van Bemmel, Joke G.; Pagie, Ludo; Braunschweig, Ulrich; Meuleman, Wouter; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Meuleman, Wouter] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Brugman, Wim; Kerkhoven, Ron M.] Netherlands Canc Inst, Cent Microarray Facil, Amsterdam, Netherlands; [Meuleman, Wouter] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology	van Bemmel, JG (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands.	b.v.steensel@nki.nl	Braunschweig, Ulrich/I-1070-2019	Braunschweig, Ulrich/0000-0001-6653-0926; Meuleman, Wouter/0000-0002-1196-5401	Netherlands Genomics Initiative; European Young Investigator Award	Netherlands Genomics Initiative; European Young Investigator Award	This work was financially supported by the Netherlands Genomics Initiative and a European Young Investigator Award to BvS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adryan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r167; [Anonymous], 2010, R LANG ENV STAT COMP; BELMONT AS, 1993, J CELL BIOL, V123, P1671, DOI 10.1083/jcb.123.6.1671; Blanton J, 2003, GENE DEV, V17, P664, DOI 10.1101/gad.1052003; Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Byrd K, 2003, J CELL BIOL, V162, P565, DOI 10.1083/jcb.200305013; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; de Wit E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000045; Fedorova E, 2009, CURR OPIN GENET DEV, V19, P166, DOI 10.1016/j.gde.2009.02.003; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Gaszner M, 1999, GENE DEV, V13, P2098, DOI 10.1101/gad.13.16.2098; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gauhar Z, 2009, GENOME RES, V19, P1006, DOI 10.1101/gr.081349.108; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hagstrom K, 1996, GENE DEV, V10, P3202, DOI 10.1101/gad.10.24.3202; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Kyrchanova O, 2008, NUCLEIC ACIDS RES, V36, P7019, DOI 10.1093/nar/gkn781; Lankenau DH, 2000, CHROMOSOMA, V109, P148, DOI 10.1007/s004120050423; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Ohtsuki S, 1998, GENE DEV, V12, P3325, DOI 10.1101/gad.12.21.3325; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Parnell TJ, 2003, P NATL ACAD SCI USA, V100, P13436, DOI 10.1073/pnas.2333111100; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2010, GENOME RES, V20, P190, DOI 10.1101/gr.098822.109; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; [No title captured]	62	72	75	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15013	10.1371/journal.pone.0015013	http://dx.doi.org/10.1371/journal.pone.0015013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124834	gold, Green Published, Green Submitted			2022-12-25	WOS:000284572000017
J	von Ballmoos, MW; Yang, ZJ; Volzmann, J; Baumgartner, I; Kalka, C; Di Santo, S				von Ballmoos, Moritz Wyler; Yang, Zijiang; Voelzmann, Jan; Baumgartner, Iris; Kalka, Christoph; Di Santo, Stefano			Endothelial Progenitor Cells Induce a Phenotype Shift in Differentiated Endothelial Cells towards PDGF/PDGFR beta Axis-Mediated Angiogenesis	PLOS ONE			English	Article							FACTOR RECEPTOR-BETA	Background: Endothelial Progenitor Cells (EPC) support neovascularization and regeneration of injured endothelium both by providing a proliferative cell pool capable of differentiation into mature vascular endothelial cells and by secretion of angiogenic growth factors. Objective: The aim of this study was to investigate the role of PDGF-BB and PDGFR beta in EPC-mediated angiogenesis of differentiated endothelial cells. Methods and Results: Conditioned medium from human EPC (EPC-CM) cultured in hypoxic conditions contained substantially higher levels of PDGF-BB as compared to normoxic conditions (P < 0.01). EPC-CM increased proliferation (1.39-fold; P < 0.001) and migration (2.13-fold; P < 0.001) of isolated human umbilical vein endothelial cells (HUVEC), as well as sprouting of vascular structures from ex vivo cultured aortic rings (2.78-fold increase; P = 0.01). The capacity of EPC-CM to modulate the PDGFRb expression in HUVEC was assessed by western blot and RT-PCR. All the pro-angiogenic effects of EPC-CM on HUVEC could be partially inhibited by inactivation of PDGFR beta (P < 0.01). EPC-CM triggered a distinct up-regulation of PDGFRb (2.5 +/- 0.5; P<0.05) and its phosphorylation (3.6 +/- 0.6; P<0.05) in HUVEC. This was not observed after exposure of HUVEC to recombinant human PDGF-BB alone. Conclusion: These data indicate that EPC-CM sensitize endothelial cells and induce a pro-angiogenic phenotype including the up-regulation of PDGFR beta, thereby turning the PDGF/PDGFR beta signaling-axis into a critical element of EPC-induced endothelial angiogenesis. This finding may be utilized to enhance EPC-based therapy of ischemic tissue in future.	[von Ballmoos, Moritz Wyler] Childrens Hosp, Dept Cardiac Surg, Boston, MA 02115 USA; [von Ballmoos, Moritz Wyler] Harvard Univ, Sch Med, Boston, MA USA; [von Ballmoos, Moritz Wyler; Yang, Zijiang; Voelzmann, Jan; Baumgartner, Iris; Kalka, Christoph; Di Santo, Stefano] Univ Bern, Inselspital, Div Vasc Med, Swiss Cardiovasc Ctr,Bern Univ Hosp, CH-3010 Bern, Switzerland	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Bern; University Hospital of Bern	von Ballmoos, MW (corresponding author), Childrens Hosp, Dept Cardiac Surg, 300 Longwood Ave, Boston, MA 02115 USA.	Vascmed.unibe@gmail.com	Di Santo, Stefano/K-5739-2014; Di Santo, Stefano/P-2433-2019; Reardon, Michael/ABF-8880-2021; Yang, Zijiang/E-8837-2012	Di Santo, Stefano/0000-0002-4032-999X; Di Santo, Stefano/0000-0002-4032-999X; 	Swiss Foundation for Medical- Biological Grants (SSMBS) [PASMP3_129387]; Swiss National Science Foundation [PASMP3_129387, 406340_128124]; Novartis [PASMP3_129387]	Swiss Foundation for Medical- Biological Grants (SSMBS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis(Novartis)	Moritz Wyler von Ballmoos received a fellowship grant jointly sponsored by the Swiss Foundation for Medical- Biological Grants (SSMBS), Swiss National Science Foundation, and Novartis (Grant Number: PASMP3_129387). This work was supported in part by the Swiss National Science Foundation (NRP63 Grant Number: 406340_128124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Di Santo S, 2008, BIOCHEM BIOPH RES CO, V373, P528, DOI 10.1016/j.bbrc.2008.06.066; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Di Santo S, 2009, THROMB HAEMOSTASIS, V101, P460, DOI 10.1160/TH08-07-0453; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kovalenko M, 1997, BIOCHEMISTRY-US, V36, P6260, DOI 10.1021/bi962553l; Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; PLATE KH, 1992, LAB INVEST, V67, P529; Pula G, 2009, CIRC RES, V104, P32, DOI 10.1161/CIRCRESAHA.108.182261; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rolny C, 2006, BLOOD, V108, P1877, DOI 10.1182/blood-2006-04-014894; SCHEUBEL RJ, 2008, INT J CARDI IN PRESS; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; YANG Z, ATHEROSCLEROSIS; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Yang Z, 2009, VASC PHARMACOL, V51, P268, DOI 10.1016/j.vph.2009.07.001; Zisch AH, 2004, CURR OPIN BIOTECH, V15, P424, DOI 10.1016/j.copbio.2004.08.005	28	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14107	10.1371/journal.pone.0014107	http://dx.doi.org/10.1371/journal.pone.0014107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124835	Green Published, gold, Green Submitted			2022-12-25	WOS:000284572000009
J	Quiding-Jarbrink, M; Raghavan, S; Sundquist, M				Quiding-Jarbrink, Marianne; Raghavan, Sukanya; Sundquist, Malin			Enhanced M1 Macrophage Polarization in Human Helicobacter pylori-Associated Atrophic Gastritis and in Vaccinated Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN DENDRITIC CELLS; REGULATORY T-CELLS; IN-VIVO; ALTERNATIVE ACTIVATION; INFECTED CHILDREN; IMMUNE-RESPONSE; INFLAMMATION; TUBERCULOSIS; RECEPTOR	Background: Infection with Helicobacter pylori triggers a chronic gastric inflammation that can progress to atrophy and gastric adenocarcinoma. Polarization of macrophages is a characteristic of both cancer and infection, and may promote progression or resolution of disease. However, the role of macrophages and their polarization during H. pylori infection has not been well defined. Methodology/Principal Findings: By using a mouse model of infection and gastric biopsies from 29 individuals, we have analyzed macrophage recruitment and polarization during H. pylori infection by flow cytometry and real-time PCR. We found a sequential recruitment of neutrophils, eosinophils and macrophages to the gastric mucosa of infected mice. Gene expression analysis of stomach tissue and sorted macrophages revealed that gastric macrophages were polarized to M1 after H. pylori infection, and this process was substantially accelerated by prior vaccination. Human H. pylori infection was characterized by a mixed M1/M2 polarization of macrophages. However, in H. pylori-associated atrophic gastritis, the expression of inducible nitric oxide synthase was markedly increased compared to uncomplicated gastritis, indicative of an enhanced M1 macrophage polarization in this pre-malignant lesion. Conclusions/Significance: These results show that vaccination of mice against H. pylori amplifies M1 polarization of gastric macrophages, and that a similar enhanced M1 polarization is present in human H. pylori-induced atrophic gastritis.	[Quiding-Jarbrink, Marianne; Raghavan, Sukanya; Sundquist, Malin] Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg, Sweden	University of Gothenburg	Quiding-Jarbrink, M (corresponding author), Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg, Sweden.	malin.sundquist@immuno.gu.se	Quiding-JÃrbrink, Marianne/AAU-5746-2021	Quiding-JÃrbrink, Marianne/0000-0002-1978-8091	Swedish Foundation for Strategic Research; Adlerbert Research Foundation; Wilhelm & Martina Lundgren's foundation; Inga-Britt & Arne Lundberg's foundation; Sahlgrenska University Hospital	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Adlerbert Research Foundation; Wilhelm & Martina Lundgren's foundation; Inga-Britt & Arne Lundberg's foundation; Sahlgrenska University Hospital	This study was supported by the centre of excellence MIVAC, funded by the Swedish Foundation for Strategic Research, the Adlerbert Research Foundation, Wilhelm & Martina Lundgren's foundation, Inga-Britt & Arne Lundberg's foundation, and the Sahlgrenska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Asim M, 2010, J BIOL CHEM, V285, P20343, DOI 10.1074/jbc.M110.116988; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bergin PJ, 2004, HELICOBACTER, V9, P201, DOI 10.1111/j.1083-4389.2004.00232.x; Bergquist C, 2000, J IMMUNOL METHODS, V234, P51, DOI 10.1016/S0022-1759(99)00213-6; Bimczok D, 2010, MUCOSAL IMMUNOL, V3, P260, DOI 10.1038/mi.2010.10; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; Dixon MF, 1997, HELICOBACTER, V2, pS17; Dzierzanowska-Fangrat K, 2008, EUR J GASTROEN HEPAT, V20, P314, DOI 10.1097/MEG.0b013e3282f340da; Garhart CA, 2003, INFECT IMMUN, V71, P910, DOI 10.1128/IAI.71.2.910-921.2003; Ghiara P, 1997, INFECT IMMUN, V65, P4996, DOI 10.1128/IAI.65.12.4996-5002.1997; Hafsi N, 2004, J IMMUNOL, V173, P1249, DOI 10.4049/jimmunol.173.2.1249; Hansson M, 2006, MICROBES INFECT, V8, P841, DOI 10.1016/j.micinf.2005.10.007; Ihrig M, 2005, INFECT IMMUN, V73, P1664, DOI 10.1128/IAI.73.3.1664-1670.2005; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Kaparakis M, 2008, INFECT IMMUN, V76, P2235, DOI 10.1128/IAI.01481-07; Kranzer K, 2004, INFECT IMMUN, V72, P4416, DOI 10.1128/IAI.72.8.4416-4423.2004; Kusugami K, 1999, J GASTROEN HEPATOL, V14, P20, DOI 10.1046/j.1440-1746.1999.01810.x; Leung SY, 2004, GASTROENTEROLOGY, V127, P457, DOI 10.1053/j.gastro.2004.05.031; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; MAI UEH, 1991, J CLIN INVEST, V87, P894, DOI 10.1172/JCI115095; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mattsson A, 1998, CLIN DIAGN LAB IMMUN, V5, P288, DOI 10.1128/CDLI.5.3.288-293.1998; MCGARRY MP, 1991, J LEUKOCYTE BIOL, V50, P471, DOI 10.1002/jlb.50.5.471; Mitchell P, 2007, INFECT IMMUN, V75, P810, DOI 10.1128/IAI.00228-06; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nam KT, 2004, GUT, V53, P1250, DOI 10.1136/gut.2003.030684; Pignatelli B, 2001, AM J GASTROENTEROL, V96, P1758, DOI 10.1111/j.1572-0241.2001.03869.x; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; RAGHAVAN S, 2010, INFECT IMMUN; Redente EF, 2010, J LEUKOCYTE BIOL, V88, P159, DOI 10.1189/jlb.0609378; Sarsfield P, 1996, J PATHOL, V180, P18; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Tatemichi M, 2005, CANCER LETT, V217, P197, DOI 10.1016/j.canlet.2004.09.002; Touati E, 2003, GASTROENTEROLOGY, V124, P1408, DOI 10.1016/S0016-5085(03)00266-X; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Whitney AE, 2000, DIGEST DIS SCI, V45, P1337, DOI 10.1023/A:1005551903029; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zu YL, 2000, ULTRASTRUCT PATHOL, V24, P319, DOI 10.1080/019131200750035049	51	65	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15018	10.1371/journal.pone.0015018	http://dx.doi.org/10.1371/journal.pone.0015018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124899	Green Submitted, Green Published, gold			2022-12-25	WOS:000284527900016
J	Geyer, T; Mol, X; Blass, S; Helms, V				Geyer, Tihamer; Mol, Xavier; Blass, Sarah; Helms, Volkhard			Bridging the Gap: Linking Molecular Simulations and Systemic Descriptions of Cellular Compartments	PLOS ONE			English	Article							RHODOBACTER-SPHAEROIDES; CHROMATOPHORE VESICLES; PHOTOSYNTHETIC GROWTH; ELECTRON-TRANSFER; REACTION CENTERS; PUFX PROTEIN; Q(B) SITE; MODEL; PROTON; DRIVEN	Metabolic processes in biological cells are commonly either characterized at the level of individual enzymes and metabolites or at the network level. Often these two paradigms are considered as mutually exclusive because concepts from neither side are suited to describe the complete range of scales. Additionally, when modeling metabolic or regulatory cellular systems, often a large fraction of the required kinetic parameters are unknown. This even applies to such simple and extensively studied systems like the photosynthetic apparatus of purple bacteria. Using the chromatophore vesicles of Rhodobacter sphaeroides as a model system, we show that a consistent kinetic model emerges when fitting the dynamics of a molecular stochastic simulation to a set of time dependent experiments even though about two thirds of the kinetic parameters in this system are not known from experiment. Those kinetic parameters that were previously known all came out in the expected range. The simulation model was built from independent protein units composed of elementary reactions processing single metabolites. This pools-and-proteins approach naturally compiles the wealth of available molecular biological data into a systemic model and can easily be extended to describe other systems by adding new protein or nucleic acid types. The automated parameter optimization, performed with an evolutionary algorithm, reveals the sensitivity of the model to the value of each parameter and the relative importances of the experiments used. Such an analysis identifies the crucial system parameters and guides the setup of new experiments that would add most knowledge for a systemic understanding of cellular compartments. The successful combination of the molecular model and the systemic parametrization presented here on the example of the simple machinery for bacterial photosynthesis shows that it is actually possible to combine molecular and systemic modeling. This framework can now straightforwardly be applied to other currently less well characterized but biologically more relevant systems.	[Geyer, Tihamer; Mol, Xavier; Blass, Sarah; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, D-6600 Saarbrucken, Germany	Saarland University	Geyer, T (corresponding author), Univ Saarland, Ctr Bioinformat, D-6600 Saarbrucken, Germany.	tihamer.geyer@bioinformatik.uni-saarland.de		Helms, Volkhard/0000-0002-2180-9154				Alberts B, 2002, MOL BIOL CELL; BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15248, DOI 10.1021/bi00046a033; BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15235, DOI 10.1021/bi00046a032; BLANKENSHIP RE, 1995, ANOXYGENIC PHOTOSYNT; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; BOXER SG, 1989, J PHYS CHEM-US, V93, P8280, DOI 10.1021/j100363a004; Chandler DE, 2008, BIOPHYS J, V95, P2822, DOI 10.1529/biophysj.108.132852; Chandler DE, 2009, BIOPHYS J, V97, P2978, DOI 10.1016/j.bpj.2009.09.007; CLAYTON RE, 1978, PHOTOSYNTHETIC BACTE; Crofts AR, 2004, PHOTOSYNTH RES, V80, P223, DOI 10.1023/B:PRES.0000030444.52579.10; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Feniouk BA, 2004, BIOPHYS J, V86, P4094, DOI 10.1529/biophysj.103.036962; Feniouk BA, 2002, BIOPHYS J, V82, P1115, DOI 10.1016/S0006-3495(02)75470-2; Gerencser L, 1999, BIOCHEMISTRY-US, V38, P16866, DOI 10.1021/bi991563u; Geyer T, 2007, J BIOTECHNOL, V129, P212, DOI 10.1016/j.jbiotec.2006.12.018; Geyer T, 2006, BIOPHYS J, V91, P927, DOI 10.1529/biophysj.105.067561; Geyer T, 2006, BIOPHYS J, V91, P921, DOI 10.1529/biophysj.105.078501; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldstein B, 2004, NAT REV IMMUNOL, V4, P445, DOI 10.1038/nri1374; Helms V, 2008, PRINCIPLES COMPUTATI; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; Milano F, 2003, EUR J BIOCHEM, V270, P4595, DOI 10.1046/j.1432-1033.2003.03845.x; Mulkidjanian AY, 2006, BBA-BIOENERGETICS, V1757, P415, DOI 10.1016/j.bbabio.2006.04.023; MULKIDJANIAN AY, 1994, FEBS LETT, V353, P189, DOI 10.1016/0014-5793(94)01031-5; PADDOCK ML, 1988, PHOTOSYNTH RES, V17, P75, DOI 10.1007/BF00047682; Rechenberg I., 1973, EVOLUTIONSSTRATEGIE; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Sener MK, 2007, P NATL ACAD SCI USA, V104, P15723, DOI 10.1073/pnas.0706861104; Stein M, 2007, CURR OPIN STRUC BIOL, V17, P166, DOI 10.1016/j.sbi.2007.03.014; STRYER L, 1996, BIOCHEMIE; Sturgis JN, 2009, BIOCHEMISTRY-US, V48, P3679, DOI 10.1021/bi900045x; TURINA P, 1991, EUR J BIOCHEM, V196, P225, DOI 10.1111/j.1432-1033.1991.tb15808.x; Xiao KH, 2000, J BIOL CHEM, V275, P38597, DOI 10.1074/jbc.M007444200; [No title captured], DOI DOI 10.1142/S0218339094000131	36	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14070	10.1371/journal.pone.0014070	http://dx.doi.org/10.1371/journal.pone.0014070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124924	gold, Green Submitted, Green Published			2022-12-25	WOS:000284467200007
J	Krichevsky, A; Meyers, B; Vainstein, A; Maliga, P; Citovsky, V				Krichevsky, Alexander; Meyers, Benjamin; Vainstein, Alexander; Maliga, Pal; Citovsky, Vitaly			Autoluminescent Plants	PLOS ONE			English	Article							BACTERIAL BIOLUMINESCENCE; MOLECULAR-BIOLOGY; FLAVIN REDUCTASE; GENES; EXPRESSION; PHOTOBACTERIUM; TRANSFORMATION; CHLOROPLASTS; EVOLUTION; VECTORS	Prospects of obtaining plants glowing in the dark have captivated the imagination of scientists and layman alike. While light emission has been developed into a useful marker of gene expression, bioluminescence in plants remained dependent on externally supplied substrate. Evolutionary conservation of the prokaryotic gene expression machinery enabled expression of the six genes of the lux operon in chloroplasts yielding plants that are capable of autonomous light emission. This work demonstrates that complex metabolic pathways of prokaryotes can be reconstructed and function in plant chloroplasts and that transplastomic plants can emit light that is visible by naked eye.	[Krichevsky, Alexander; Meyers, Benjamin; Citovsky, Vitaly] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Vainstein, Alexander] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; [Maliga, Pal] Rutgers State Univ, Waksman Inst, Piscataway, NJ USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hebrew University of Jerusalem; Rutgers State University New Brunswick	Krichevsky, A (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	akrichevsky@notes.cc.sunysb.edu		Citovsky, Vitaly/0000-0003-2024-6844	National Institutes of Health; United States Department of Agriculture; National Science Foundation; Binational Agricultural Research and Development Fund; Binational Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Binational Agricultural Research and Development Fund; Binational Science Foundation(US-Israel Binational Science Foundation)	The work is supported by grants from the National Institutes of Health, United States Department of Agriculture, National Science Foundation, Binational Agricultural Research and Development Fund, and Binational Science Foundation to Vitaly Citovsky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2004, PLANT CELL PHYSIOL, V45, P1176, DOI 10.1093/pcp/pch139; BAUMANN P, 1983, ANNU REV MICROBIOL, V37, P369, DOI 10.1146/annurev.mi.37.100183.002101; Bock Ralph, 2007, V19, P29, DOI 10.1007/4735_2007_0223; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; GREER LF, 2002, LUMINESC, V17; Hagemann R, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P93, DOI 10.1007/978-1-4020-3166-3_4; Lin JW, 1998, BIOCHEM BIOPH RES CO, V246, P446, DOI 10.1006/bbrc.1998.8641; Lutz KA, 2007, PLANT PHYSIOL, V145, P1201, DOI 10.1104/pp.107.106963; Lutz KA, 2006, NAT PROTOC, V1, P900, DOI 10.1038/nprot.2006.118; Maliga P, 2003, TRENDS BIOTECHNOL, V21, P20, DOI 10.1016/S0167-7799(02)00007-0; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Nijvipakul S, 2008, J BACTERIOL, V190, P1531, DOI 10.1128/JB.01660-07; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Shapiro E, 2005, PROTEIN ENG DES SEL, V18, P581, DOI 10.1093/protein/gzi066; SLABAS AR, 1992, PLANT MOL BIOL, V19, P169, DOI 10.1007/BF00015613; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; SVAB Z, 1991, MOL GEN GENET, V228, P316, DOI 10.1007/BF00282483; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Wilson T, 1998, ANNU REV CELL DEV BI, V14, P197, DOI 10.1146/annurev.cellbio.14.1.197; Zerges W, 2000, BIOCHIMIE, V82, P583, DOI 10.1016/S0300-9084(00)00603-9	28	55	59	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15461	10.1371/journal.pone.0015461	http://dx.doi.org/10.1371/journal.pone.0015461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103397	Green Submitted, Green Published, gold			2022-12-25	WOS:000284147700031
J	Ehata, S; Johansson, E; Katayama, R; Koike, S; Watanabe, A; Hoshino, Y; Katsuno, Y; Komuro, A; Koinuma, D; Kano, MR; Yashiro, M; Hirakawa, K; Aburatani, H; Fujita, N; Miyazono, K				Ehata, S.; Johansson, E.; Katayama, R.; Koike, S.; Watanabe, A.; Hoshino, Y.; Katsuno, Y.; Komuro, A.; Koinuma, D.; Kano, M. R.; Yashiro, M.; Hirakawa, K.; Aburatani, H.; Fujita, N.; Miyazono, K.			Transforming growth factor-beta decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells	ONCOGENE			English	Article						ABCG2; cancer-initiating cell; diffuse type gastric carcinoma; SP cell; TGF-beta	STEM-CELLS; TGF-BETA; SIDE-POPULATION; SCIRRHOUS CARCINOMA; METASTATIC MODEL; TUMOR-GROWTH; PROTEIN; GROWTH-FACTOR-BETA-1; DIFFERENTIATION; OVEREXPRESSION	Stem cells in normal tissues and cancer-initiating cells (CICs) are known to be enriched in side population (SP) cells. However, the factors responsible for the regulation of expression of ABCG2, involved in efflux of dyes, in SP cells have not been fully investigated. Here, we characterized the SP cells within diffuse-type gastric carcinoma, and examined the effects of transforming growth factor-beta (TGF-beta) on SP cells. Diffuse-type gastric carcinoma cells established from four independent patients universally contained SP cells between 1 and 4% of total cells, which displayed greater tumorigenicity than non-SP cells did. TGF-beta repressed the transcription of ABCG2 through direct binding of Smad2/3 to its promoter/enhancer, and the number of SP cells and the tumor-forming ability of cancer cells were decreased by TGF-beta, although ABCG2 is not directly involved in the tumor-forming ability of SP cells. Cancer cells from metastatic site expressed much higher levels of ABCG2 and included a greater percentage of SP cells than parental cancer cells did. SP cells are thus responsible for the progression of diffuse-type gastric carcinoma, and TGF-beta negatively contributes to maintain the CICs within the cancer. Oncogene (2011) 30, 1693-1705; doi:10.1038/onc.2010.546; published online 6 December 2010	[Ehata, S.; Johansson, E.; Hoshino, Y.; Katsuno, Y.; Komuro, A.; Koinuma, D.; Kano, M. R.; Miyazono, K.] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Ehata, S.; Katayama, R.; Koike, S.; Fujita, N.] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 170, Japan; [Watanabe, A.; Aburatani, H.] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Tokyo, Japan; [Yashiro, M.; Hirakawa, K.] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 558, Japan	University of Tokyo; Japanese Foundation for Cancer Research; University of Tokyo; Osaka Metropolitan University	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	Koinuma, Daizo/Y-8716-2018; Katayama, Ryohei/K-8537-2014; Fujita, Naoya/A-7349-2010	Koinuma, Daizo/0000-0001-5611-2122; Katayama, Ryohei/0000-0001-7394-895X; Fujita, Naoya/0000-0002-9631-9264; Ehata, Shogo/0000-0002-6740-9391; Kano, Mitsunobu/0000-0003-1593-1855	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Dr H Miyoshi (RIKEN) for the lentivirus vector system and Dr K Yanagihara (Yasuda Women's University) for HSC-43 cells. This study was supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Grants-in-Aid for Young Scientists (Start-up) from the Japan Society for the Promotion of Science.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Fujihara T, 1998, CLIN EXP METASTAS, V16, P389; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Gradhand U, 2008, DRUG METAB REV, V40, P317, DOI [10.1080/03602530801952617, 10.1080/03602530801952617 ]; Grady William M., 2008, P889; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Inoue T, 1997, JPN J CANCER RES, V88, P152, DOI 10.1111/j.1349-7006.1997.tb00360.x; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Katayama R, 2009, CANCER SCI, V100, P2060, DOI 10.1111/j.1349-7006.2009.01288.x; Kinugasa S, 1998, ONCOLOGY-BASEL, V55, P582, DOI 10.1159/000011916; Kiyono K, 2009, CANCER SCI, V100, P1809, DOI 10.1111/j.1349-7006.2009.01248.x; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Komuro A, 2009, JNCI-J NATL CANCER I, V101, P592, DOI 10.1093/jnci/djp058; LABOISSE CL, 1981, CANCER RES, V41, P310; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mishra L, 2005, ONCOGENE, V24, P5775, DOI 10.1038/sj.onc.1208924; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; MIZOI T, 1993, CANCER RES, V53, P183; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rabindran SK, 2000, CANCER RES, V60, P47; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Takemura S, 2004, CANCER SCI, V95, P893, DOI 10.1111/j.1349-7006.2004.tb02199.x; Vagenas K, 2007, J SURG RES, V139, P182, DOI 10.1016/j.jss.2006.10.005; Velamakanni S, 2007, J BIOENERG BIOMEMBR, V39, P465, DOI 10.1007/s10863-007-9122-x; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; YANAGIHARA K, 1993, INT J CANCER, V54, P200, DOI 10.1002/ijc.2910540207; YASHIRO M, 1994, JPN J CANCER RES, V85, P883, DOI 10.1111/j.1349-7006.1994.tb02963.x; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685; Yashiro M, 2009, INT J ONCOL, V35, P997, DOI 10.3892/ijo_00000414; Yin LQ, 2008, CANCER RES, V68, P800, DOI 10.1158/0008-5472.CAN-07-2545; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	55	62	64	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	14					1693	1705		10.1038/onc.2010.546	http://dx.doi.org/10.1038/onc.2010.546			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	746IS	21132002				2022-12-25	WOS:000289239400007
J	Kazi, A; Sun, JZ; Doi, K; Sung, SS; Takahashi, Y; Yin, H; Rodriguez, JM; Becerril, J; Berndt, N; Hamilton, AD; Wang, HG; Sebti, SM				Kazi, Aslamuzzaman; Sun, Jiazhi; Doi, Kenichiro; Sung, Shen-Shu; Takahashi, Yoshinori; Yin, Hang; Rodriguez, Johanna M.; Becerril, Jorge; Berndt, Norbert; Hamilton, Andrew D.; Wang, Hong-Gang; Sebti, Said M.			The BH3 alpha-Helical Mimic BH3-M6 Disrupts Bcl-X-L, Bcl-2, and MCL-1 Protein-Protein Interactions with Bax, Bak, Bad, or Bim and Induces Apoptosis in a Bax- and Bim-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; MIMETIC ABT-737; PROTEASOME INHIBITOR; FAMILY PROTEINS; CONFORMATIONAL-CHANGE; ACCURATE DOCKING; IN-VITRO; CANCER; RESISTANCE; EXPRESSION	A critical hallmark of cancer cell survival is evasion of apoptosis. This is commonly due to overexpression of anti-apoptotic proteins such as Bcl-2, Bcl-X-L, and Mcl-1, which bind to the BH3 alpha-helical domain of pro-apoptotic proteins such as Bax, Bak, Bad, and Bim, and inhibit their function. We designed a BH3 alpha-helical mimetic BH3-M6 that binds to Bcl-X-L and Mcl-1 and prevents their binding to fluorescently labeled Bak- or Bim-BH3 peptides in vitro. Using several approaches, we demonstrate that BH3-M6 is a pan-Bcl-2 antagonist that inhibits the binding of Bcl-X-L, Bcl-2, and Mcl-1 to multi-domain Bax or Bak, or BH3-only Bim or Bad in cell-free systems and in intact human cancer cells, freeing up pro-apoptotic proteins to induce apoptosis. BH3-M6 disruption of these protein-protein interactions is associated with cytochrome c release from mitochondria, caspase-3 activation and PARP cleavage. Using caspase inhibitors and Bax and Bak siRNAs, we demonstrate that BH3-M6-induced apoptosis is caspase- and Bax-, but not Bak-dependent. Furthermore, BH3-M6 disrupts Bcl-X-L/Bim, Bcl-2/Bim, and Mcl-1/Bim protein-protein interactions and frees up Bim to induce apoptosis in human cancer cells that depend for tumor survival on the neutralization of Bim with Bcl-X-L, Bcl-2, or Mcl-1. Finally, BH3-M6 sensitizes cells to apoptosis induced by the proteasome inhibitor CEP-1612.	[Kazi, Aslamuzzaman; Sun, Jiazhi; Sung, Shen-Shu; Takahashi, Yoshinori; Berndt, Norbert; Wang, Hong-Gang; Sebti, Said M.] Univ S Florida, Drug Discovery Dept, H Lee Moffitt Canc Ctr, Tampa, FL 33612 USA; [Kazi, Aslamuzzaman; Sun, Jiazhi; Sung, Shen-Shu; Takahashi, Yoshinori; Berndt, Norbert; Wang, Hong-Gang; Sebti, Said M.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA; [Kazi, Aslamuzzaman; Sun, Jiazhi; Sung, Shen-Shu; Takahashi, Yoshinori; Berndt, Norbert; Wang, Hong-Gang; Sebti, Said M.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Doi, Kenichiro] Penn State Univ, Dept Pharmacol, Hershey, PA 17033 USA; [Yin, Hang; Rodriguez, Johanna M.; Becerril, Jorge; Hamilton, Andrew D.] Yale Univ, Dept Chem, New Haven, CT 06511 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Yale University	Sebti, SM (corresponding author), 12902 Magnolia Dr,SRB3-DRDIS, Tampa, FL 33612 USA.	said.sebti@moffitt.org	Wang, Hong-Gang/A-3018-2015; YIN, HANG/O-2097-2014	Wang, Hong-Gang/0000-0003-0551-0571; YIN, HANG/0000-0002-9762-4818; Takahashi, Yoshinori/0000-0002-8004-4817	National Institutes of Health [CA118210, GM69850]; NATIONAL CANCER INSTITUTE [P30CA076292, P01CA118210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded, in whole or in part, by National Institutes of Health P01 Grants CA118210 and GM69850.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Amundson SA, 2000, CANCER RES, V60, P6101; Azmi AS, 2009, J CELL PHYSIOL, V218, P13, DOI 10.1002/jcp.21567; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Iqbal J, 2006, J CLIN ONCOL, V24, P961, DOI 10.1200/JCO.2005.03.4264; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kazi A, 2002, MOL PHARMACOL, V62, P765, DOI 10.1124/mol.62.4.765; Kazi A, 2009, CELL CYCLE, V8, P1940, DOI 10.4161/cc.8.12.8798; Kazi A, 2009, MOL CELL BIOL, V29, P2254, DOI 10.1128/MCB.01029-08; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Kutzki O, 2002, J AM CHEM SOC, V124, P11838, DOI 10.1021/ja026861k; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Miller LA, 2009, J INVEST DERMATOL, V129, P964, DOI 10.1038/jid.2008.327; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paoluzzi L, 2008, BLOOD, V112, P2906, DOI 10.1182/blood-2007-12-130781; Paoluzzi L, 2008, BLOOD, V111, P5350, DOI 10.1182/blood-2007-12-129833; Pellecchia M, 2004, CURR PHARM DESIGN, V10, P1387, DOI 10.2174/1381612043384880; Reed JC, 1996, J CELL BIOCHEM, V60, P23, DOI 10.1002/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.3.CO;2-3; Saxena A, 2004, AM J HEMATOL, V75, P22, DOI 10.1002/ajh.10453; Sun JZ, 2001, CANCER RES, V61, P1280; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang JL, 2000, CANCER RES, V60, P1498; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yin H, 2005, J AM CHEM SOC, V127, P10191, DOI 10.1021/ja050122x; Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870	50	97	106	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9382	9392		10.1074/jbc.M110.203638	http://dx.doi.org/10.1074/jbc.M110.203638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21148306	hybrid, Green Published			2022-12-25	WOS:000288247700067
J	Bakiri, L; Reschke, MO; Gefroh, HA; Idarraga, MH; Polzer, K; Zenz, R; Schett, G; Wagner, EF				Bakiri, L.; Reschke, M. O.; Gefroh, H. A.; Idarraga, M. H.; Polzer, K.; Zenz, R.; Schett, G.; Wagner, E. F.			Functions of Fos phosphorylation in bone homeostasis, cytokine response and tumourigenesis	ONCOGENE			English	Article						AP-1; Fos; knock-in; mouse; phosphorylation	ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; SKIN TUMOR-DEVELOPMENT; LACKING C-FOS; TRANSCRIPTIONAL ACTIVATION; PROTEASOMAL DEGRADATION; TRANSFORMING ACTIVITY; TRANSGENIC MICE; GROWTH-FACTOR; GENE	Mice lacking c-fos develop osteopetrosis due to a block in osteoclast differentiation. Carboxy-terminal phosphorylation of Fos on serine 374 by ERK1/2 and serine 362 by RSK1/2 regulates Fos stability and transactivation potential in vitro. To assess the physiological relevance of Fos phosphorylation in vivo, serine 362 and/or serine 374 was replaced by alanine (Fos362A, Fos374A and FosAA) or by phospho-mimetic aspartic acid (FosDD). Homozygous mutants were healthy and skeletogenesis was largely unaffected. Fos C-terminal phosphorylation, predominantly on serine 374, was found important for osteoclast differentiation in vitro and affected lipopolysaccharide (LPS)-induced cytokine response in vitro and in vivo. Importantly, skin papilloma development was delayed in FosAA, Fos362A and Rsk2-deficient mice, accelerated in FosDD mice and unaffected in Fos374A mutants. Furthermore, the related Fos protein and putative RSK2 target Fra1 failed to substitute for Fos in papilloma development. This indicates that phosphorylation of serines 362 and 374 exerts context-dependent roles in modulating Fos activity in vivo. Inhibition of Fos C-terminal phosphorylation on serine 362 by targeting RSK2 might be of therapeutic relevance for skin tumours. Oncogene (2011) 30, 1506-1517; doi: 10.1038/onc.2010.542; published online 29 November 2010	[Bakiri, L.; Reschke, M. O.; Gefroh, H. A.; Idarraga, M. H.; Polzer, K.; Zenz, R.; Schett, G.; Wagner, E. F.] CNIO, Canc Cell Biol Programme, F BBVA, Genes Dev & Dis Grp, E-28029 Madrid, Spain; [Idarraga, M. H.] Research Inst Mol Pathol IMP, Vienna, Austria; [Polzer, K.; Schett, G.] Univ Erlangen Nurenberg, Dept Internal Med 3, Erlangen, Germany	Centro Nacional de Investigaciones Oncologicas (CNIO); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Erlangen Nuremberg	Wagner, EF (corresponding author), CNIO, Canc Cell Biol Programme, F BBVA, Genes Dev & Dis Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	ewagner@cnio.es	Bakiri, Latifa/AAP-1674-2020; Bakiri, Latifa/N-5780-2014	Wagner, Erwin F/0000-0001-7872-0196; bakiri, latifa/0000-0002-6300-2420	Boehringer Ingelheim (BI); BBVA-Foundation; ERC; EMBO; European Community [LSHM-CT-2003-504468]	Boehringer Ingelheim (BI)(Boehringer Ingelheim); BBVA-Foundation(BBVA Foundation); ERC(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); European Community(European Commission)	We are very grateful to Drs K Matsuo, Y Takada and R Khokha for critical comments and helpful suggestions, Drs F Mulero and RP Marshall for help with micro-computed tomography, U Moehle-Steinlein, E Andres, HC Theussl and V Komnenovic for technical assistance. The project was initiated at the IMP, which is funded by Boehringer Ingelheim (BI). EFW is funded by the BBVA-Foundation and by an ERC advanced Grant. Part of this work was funded by an EMBO postdoctoral fellowship to LB and the NoE Cells into Organs (LSHM-CT-2003-504468) program of the European Community.	Bakiri L, 2007, BONE, V40, P867, DOI 10.1016/j.bone.2006.11.005; BARBER JR, 1987, MOL CELL BIOL, V7, P2201, DOI 10.1128/MCB.7.6.2201; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Casalino L, 2007, EMBO J, V26, P1878, DOI 10.1038/sj.emboj.7601617; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen RH, 1996, ONCOGENE, V12, P1493; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; CURRAN T, 1984, CELL, V36, P259; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Durchdewald M, 2008, CANCER RES, V68, P6877, DOI 10.1158/0008-5472.CAN-08-0299; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Fleischmann A, 2003, CANCER CELL, V4, P477, DOI 10.1016/S1535-6108(03)00280-0; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; GIUS D, 1990, MOL CELL BIOL, V10, P4243, DOI 10.1128/MCB.10.8.4243; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; OFIR R, 1990, NATURE, V348, P80, DOI 10.1038/348080a0; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pellegrino MJ, 2006, J NEUROCHEM, V99, P1480, DOI 10.1111/j.1471-4159.2006.04250.x; Ray N, 2006, INT IMMUNOL, V18, P671, DOI 10.1093/intimm/dxl004; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Takada Y, 2010, J IMMUNOL, V184, P1014, DOI 10.4049/jimmunol.0901196; TRATNER I, 1992, MOL CELL BIOL, V12, P998, DOI 10.1128/MCB.12.3.998; WANG ZQ, 1995, CANCER RES, V55, P6244; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8	43	10	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	13					1506	1517		10.1038/onc.2010.542	http://dx.doi.org/10.1038/onc.2010.542			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	743DU	21119595	Green Accepted			2022-12-25	WOS:000288998300002
J	Tian, YM; Kongsuphol, P; Hug, M; Ousingsawat, J; Witzgall, R; Schreiber, R; Kunzelmann, K				Tian, Yuemin; Kongsuphol, Patthara; Hug, Martin; Ousingsawat, Jiraporn; Witzgall, Ralph; Schreiber, Rainer; Kunzelmann, Karl			Calmodulin-dependent activation of the epithelial calcium-dependent chloride channel TMEM16A	FASEB JOURNAL			English	Article						Ca2+ -activated Cl- channels; anoctamin 1; exocytosis; SK4; 1-EBIO; cystic fibrosis	CA2+-ACTIVATED K+ CHANNEL; STIMULATES CL-SECRETION; INTERMEDIATE-CONDUCTANCE; SMOOTH-MUSCLE; INTERSTITIAL-CELLS; CYSTIC-FIBROSIS; PROTEIN-KINASE; CA CHANNEL; EXPRESSION; BENZIMIDAZOLONES	TMEM16A (anoctamin 1, Ano1), a member of a family of 10 homologous proteins, has been shown to form an essential component of Ca2+ -activated Cl- channels. TMEM16A-null mice exhibit severe defects in epithelial transport along with tracheomalacia and death within 1 mo after birth. Despite its outstanding physiological significance, the mechanisms for activation of TMEM16A remain obscure. TMEM16A is activated on increase in intracellular Ca2+, but it is unclear whether Ca2+ binds directly to the channel or whether additional components are required. We demonstrate that TMEM16A is strictly membrane localized and requires cytoskeletal interactions to be fully activated. Despite the need for cytosolic ATP for full activation, phosphorylation by protein kinases is not required. In contrast, the Ca2+ binding protein calmodulin appears indispensable and interacts physically with TMEM16A. Openers of small-and intermediate-conductance Ca2+ -activated potassium channels known to interact with calmodulin, such as 1-EBIO, DCEBIO, or riluzole, also activated TMEM16A. These results reinforce the use of these compounds for activation of electrolyte secretion in diseases such as cystic fibrosis.-Tian, Y., Kongsuphol, P., Hug, M., Ousingsawat, J., Witzgall, R., Schreiber, R., Kunzelmann, K. Calmodulin-dependent activation of the epithelial calcium-dependent chloride channel TMEM16A. FASEB J. 25, 1058-1068 (2011). www.fasebj.org	[Tian, Yuemin; Kongsuphol, Patthara; Ousingsawat, Jiraporn; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Hug, Martin] Apotheke Univ Klin Freiburg, Freiburg, Germany; [Witzgall, Ralph] Univ Regensburg, Inst Anat, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@vkl.uni-regensburg.de	Tian, Yuemin/AAE-8827-2021	Witzgall, Ralph/0000-0002-5283-4846; Kunzelmann, Karl/0000-0002-4583-7037	Deutsche Forschungsgemeinschaft (DFG) [SFB699 A7]; German Mukoviszidose eV; EU [EU-FP6-2005-LH-037365]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Mukoviszidose eV; EU(European Commission)	This study was supported by the Deutsche Forschungsgemeinschaft (DFG SFB699 A7), German Mukoviszidose eV, and the EU TargetScreen2 project (EU-FP6-2005-LH-037365). The authors thank Christine Meese and Karin Schadendorf for their excellent technical support in performing the ReAsH analysis of TMEM16A. The authors thank Hoechst/Aventis for providing the benzimidazolinone compound S0011198.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Alvarez LJ, 2005, AM J PHYSIOL-CELL PH, V289, pC138, DOI 10.1152/ajpcell.00190.2004; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CHAN HC, 1994, J BIOL CHEM, V269, P32464; Chorna NE, 2007, J CELL PHYSIOL, V211, P410, DOI 10.1002/jcp.20946; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL785, DOI 10.1152/ajplung.1996.271.5.L785; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Greenwood IA, 2001, J PHYSIOL-LONDON, V534, P395, DOI 10.1111/j.1469-7793.2001.00395.x; Hamilton KL, 2006, AM J PHYSIOL-CELL PH, V290, pC152, DOI 10.1152/ajpcell.00187.2005; Hamilton KL, 1999, PFLUG ARCH EUR J PHY, V439, P158, DOI 10.1007/s004240051140; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Ho MWY, 2001, J BIOL CHEM, V276, P18673, DOI 10.1074/jbc.M101128200; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; HUG T, 1995, PFLUG ARCH EUR J PHY, V429, P682, DOI 10.1007/BF00373989; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jensen BS, 2001, CURR DRUG TARGETS, V2, P401, DOI 10.2174/1389450013348173; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; KOLB HA, 1990, REV PHYSIOL BIOCH P, V115, P51; Kunzelmann Karl, 2003, Am J Respir Med, V2, P299; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Maruyama Y, 1996, J PHYSIOL-LONDON, V492, P807, DOI 10.1113/jphysiol.1996.sp021347; Mazzochi C, 2006, AM J PHYSIOL-RENAL, V291, pF1113, DOI 10.1152/ajprenal.00195.2006; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Saleh SN, 2007, J PHARMACOL EXP THER, V321, P1075, DOI 10.1124/jpet.106.118786; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Skals M, 2010, J BIOL CHEM, V285, P15557, DOI 10.1074/jbc.M109.082578; Strobaek D, 2004, BBA-BIOMEMBRANES, V1665, P1, DOI 10.1016/j.bbamem.2004.07.006; Syme CA, 2000, AM J PHYSIOL-CELL PH, V278, pC570, DOI 10.1152/ajpcell.2000.278.3.C570; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; von Hahn T, 2001, CELL PHYSIOL BIOCHEM, V11, P219, DOI 10.1159/000051936; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; Wang YX, 1997, P NATL ACAD SCI USA, V94, P14918, DOI 10.1073/pnas.94.26.14918; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; Wiwchar M, 2009, BRIT J PHARMACOL, V158, P1356, DOI 10.1111/j.1476-5381.2009.00405.x; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	59	112	116	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1058	1068		10.1096/fj.10-166884	http://dx.doi.org/10.1096/fj.10-166884			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21115851				2022-12-25	WOS:000287806200025
J	Veyrac, A; Bakker, J				Veyrac, Alexandra; Bakker, Julie			Postnatal and adult exposure to estradiol differentially influences adult neurogenesis in the main and accessory olfactory bulb of female mice	FASEB JOURNAL			English	Article						aromatase-knockout mice; neuronal survival; functional integration	NEWLY-GENERATED NEURONS; EXPERIENCE-DEPENDENT SURVIVAL; DENTATE GYRUS; CELL-PROLIFERATION; SEXUAL-DIFFERENTIATION; GRANULE NEURONS; NEWBORN NEURONS; MEADOW VOLES; CYP19 GENE; STIMULATED NEUROGENESIS	Neurons incorporated into the adult main olfactory bulb (MOB) and accessory olfactory bulb (AOB) derive from the subventricular zone (SVZ). Despite some recent studies on the role of olfactory neurogenesis in sociosexual behaviors mediated by hormones, data on the implication of estrogens are still lacking. Taking advantage of female aromatase-knockout (ArKO) mice, which are unable to produce estradiol across their life span, we investigated the role of estradiol exposure during early postnatal and adult periods on adult neurogenesis in the MOB and AOB. We found that proliferation of progenitor cells in the adult female SVZ was not influenced by estradiol. However, whereas adult exposure to estradiol influences the turnover of MOB newborn neurons, the survival of those in the AOB depends on exposure to estradiol during the early postnatal period. Finally, based on their expression of Zif268, we showed that newborn neurons in the MOB responded to sociosexual odors, albeit to a lesser extent in ArKO females, suggesting a contribution of estradiol during the early postnatal period to this response. Together, these results suggest that the survival and functional integration of newborn neurons in the adult female MOB and AOB are differentially influenced by estrogens from the early postnatal period to adulthood.-Veyrac, A., Bakker, J. Postnatal and adult exposure to estradiol differentially influences adult neurogenesis in the main and accessory olfactory bulb of female mice. FASEB J. 25, 1048-1057 (2011). www.fasebj.org	[Veyrac, Alexandra; Bakker, Julie] Univ Liege, Grp Interdisciplinaire Genoproteom Appl GIGA Neur, B-4000 Liege, Belgium	University of Liege	Bakker, J (corresponding author), Univ Liege, Grp Interdisciplinaire Genoproteom Appl GIGA Neur, Ave Lhop 1,B36, B-4000 Liege, Belgium.	jbakker@ulg.ac.be	Veyrac, Alexandra/G-8313-2017	VEYRAC, Alexandra/0000-0002-8063-4016	U.S. National Institutes of Health [HD-044897]; University of Liege [C-06/89]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044897] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Liege(University of Liege); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Drs. Michael Baum, Serge Laroche, and Silvia DeMarchis for comments on an earlier version of the manuscript; Marie Tsampalas for technical assistance; and Frederic Levy and Matthieu Keller for using the Mercator software. This work was supported by U.S. National Institutes of Health grant HD-044897 and grants from the University of Liege (C-06/89 to J.B. and A.V.). J.B. is a research associate at the Fonds National de la Recherche Scientifique.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Bakker J, 2002, HORM BEHAV, V42, P158, DOI 10.1006/hbeh.2002.1805; Bakker J, 2003, J NEUROENDOCRINOL, V15, P615, DOI 10.1046/j.1365-2826.2003.01036.x; Bakker J, 2002, J NEUROSCI, V22, P9104; Bakker J, 2008, FRONT NEUROENDOCRIN, V29, P1, DOI 10.1016/j.yfrne.2007.06.001; Banasr M, 2001, EUR J NEUROSCI, V14, P1417, DOI 10.1046/j.0953-816x.2001.01763.x; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Britt KL, 2001, J STEROID BIOCHEM, V79, P181, DOI 10.1016/S0960-0760(01)00158-3; Brock O, 2010, NEUROSCIENCE, V166, P368, DOI 10.1016/j.neuroscience.2009.12.050; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Guerin D, 2009, NEUROBIOL AGING, V30, P272, DOI 10.1016/j.neurobiolaging.2007.05.020; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; HOWARD C, 1998, UNBIASED STEREOLOGY, P41; Hoyk Z, 2006, NEUROSCIENCE, V141, P1919, DOI 10.1016/j.neuroscience.2006.05.053; Huang LY, 2002, HORM BEHAV, V41, P343, DOI 10.1006/hbeh.2002.1767; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Keller M, 2006, EUR J NEUROSCI, V23, P521, DOI 10.1111/j.1460-9568.2005.04589.x; Keller M, 2009, BEHAV BRAIN RES, V200, P268, DOI 10.1016/j.bbr.2009.01.020; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Kowase T, 2007, ENDOCRINOLOGY, V148, P6083, DOI 10.1210/en.2007-0407; Larsen CM, 2008, HORM BEHAV, V53, P509, DOI 10.1016/j.yhbeh.2007.11.020; LARSEN CM, ENDOCRINOLOGY, V151, P3805; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Mak GK, 2010, NAT NEUROSCI, V13, P753, DOI 10.1038/nn.2550; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; MANNAN MA, 1991, J ENDOCRINOL, V130, P101, DOI 10.1677/joe.0.1300101; Martel KL, 2007, EUR J NEUROSCI, V26, P463, DOI 10.1111/j.1460-9568.2007.05651.x; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Oboti L, 2009, EUR J NEUROSCI, V29, P679, DOI 10.1111/j.1460-9568.2009.06614.x; Ormerod BK, 2003, J NEUROBIOL, V55, P247, DOI 10.1002/neu.10181; Ormerod BK, 2004, NEUROSCIENCE, V128, P645, DOI 10.1016/j.neuroscience.2004.06.039; Ormerod BK, 2001, NEUROSCIENCE, V102, P369, DOI 10.1016/S0306-4522(00)00474-7; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pierman S, 2008, EUR J NEUROSCI, V27, P423, DOI 10.1111/j.1460-9568.2007.06016.x; Quadros PS, 2002, ENDOCRINOLOGY, V143, P3727, DOI 10.1210/en.2002-211438; Quadros PS, 2002, J NEUROBIOL, V51, P24, DOI 10.1002/neu.10040; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Slade JP, 2000, J NEUROENDOCRINOL, V12, P671; Smith MT, 2001, HORM BEHAV, V39, P11, DOI 10.1006/hbeh.2000.1630; Spencer JL, 2008, FRONT NEUROENDOCRIN, V29, P219, DOI 10.1016/j.yfrne.2007.08.006; SULTAN S, FASEB J, V24, P2355; Suzuki S, 2007, J COMP NEUROL, V500, P1064, DOI 10.1002/cne.21240; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tanapat P, 2005, J COMP NEUROL, V481, P252, DOI 10.1002/cne.20385; Toda K, 2001, J ENDOCRINOL, V170, P99, DOI 10.1677/joe.0.1700099; Veyrac A, 2009, NEUROPSYCHOPHARMACOL, V34, P786, DOI 10.1038/npp.2008.191; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	68	31	31	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1048	1057		10.1096/fj.10-172635	http://dx.doi.org/10.1096/fj.10-172635			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21148416	Green Published, Green Submitted			2022-12-25	WOS:000287806200024
J	Boncela, J; Przygodzka, P; Papiewska-Pajak, I; Wyroba, E; Osinska, M; Cierniewski, CS				Boncela, Joanna; Przygodzka, Patrycja; Papiewska-Pajak, Izabela; Wyroba, Elzbieta; Osinska, Magdalena; Cierniewski, Czeslaw S.			Plasminogen Activator Inhibitor Type 1 Interacts with alpha 3 Subunit of Proteasome and Modulates Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; INTERMEDIATE-FILAMENT; TUMOR-GROWTH; PROTEIN; ANGIOGENESIS; PROTEOLYSIS; APOPTOSIS; UBIQUITIN; PROLIFERATION; DEGRADATION	Plasminogen activator inhibitor type-1 (PAI-1), a multifunctional protein, is an important physiological regulator of fibrinolysis, extracellular matrix homeostasis, and cell motility. Recent observations show that PAI-1 may also be implicated in maintaining integrity of cells, especially with respect to cellular proliferation or apoptosis. In the present study we provide evidence that PAI-1 interacts with proteasome and affects its activity. First, by using the yeast two-hybrid system, we found that the alpha 3 subunit of proteasome directly interacts with PAI-1. Then, to ensure that the PAI-1-proteasome complex is formed in vivo, both proteins were coimmunoprecipitated from endothelial cells and identified with specific antibodies. The specificity of this interaction was evidenced after transfection of HeLa cells with pCMV-PAI-1 and coimmunoprecipitation of both proteins with anti-PAI-1 antibodies. Subsequently, cellular distribution of the PAI-1-proteasome complexes was established by immunogold staining and electron microscopy analyses. Both proteins appeared in a diffuse cytosolic pattern but also could be found in a dense perinuclear and nuclear location. Furthermore, PAI-1 induced formation of aggresomes freely located in endothelial cytoplasm. Increased PAI-1 expression abrogated degradation of degron analyzed after cotransfection of HeLa cells with pCMV-PAI-1 and pd2EGFP-N1 and prevented degradation of p53 as well as I kappa B alpha, as evidenced both by confocal microscopy and Western immunoblotting.	[Papiewska-Pajak, Izabela; Cierniewski, Czeslaw S.] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Cierniewski, Czeslaw S.] Polish Acad Sci, Inst Med Biol, PL-93232 Lodz, Poland; [Wyroba, Elzbieta; Osinska, Magdalena] Polish Acad Sci, Nencki Inst Expt Biol, PL-02093 Warsaw, Poland	Medical University Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	czeslaw.cierniewski@umed.lodz.pl	Wyroba, Elzbieta/R-7525-2016; Wyroba, Elzbieta/P-4434-2019; Boncela, Joanna/AAU-4481-2020	Boncela, Joanna/0000-0001-8419-7012; Papiewska-Pajak, Izabela/0000-0001-6116-3418; Przygodzka, Patrycja/0000-0001-7529-8815	Polish Ministry of Science and Higher Education [N301 3386 33, N301 4392 38]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Polish Ministry of Science and Higher Education Projects N301 3386 33 (to J. B.) and N301 4392 38 (to C. S. C.).	ALIZADEH H, 1995, CURR EYE RES, V14, P449, DOI 10.3109/02713689509003755; Arcangeletti C, 1997, J STRUCT BIOL, V119, P35, DOI 10.1006/jsbi.1997.3871; Bajou K, 2004, ONCOGENE, V23, P6986, DOI 10.1038/sj.onc.1207859; Balsara RD, 2006, J BIOL CHEM, V281, P22527, DOI 10.1074/jbc.M512819200; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bess KL, 2003, BIOCHEM J, V374, P667, DOI 10.1042/BJ20030769; BIANCHI E, 1995, INT J CANCER, V60, P597, DOI 10.1002/ijc.2910600505; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; Boncela J, 2001, J BIOL CHEM, V276, P35305, DOI 10.1074/jbc.M104028200; CAJOT JF, 1990, P NATL ACAD SCI USA, V87, P6939, DOI 10.1073/pnas.87.18.6939; Chen SC, 2008, MOL CANCER THER, V7, P1227, DOI 10.1158/1535-7163.MCT-08-0051; Chen YB, 2006, ARTERIOSCL THROM VAS, V26, P1777, DOI 10.1161/01.ATV.0000227514.50065.2a; Chen YB, 2004, J CELL BIOCHEM, V92, P178, DOI 10.1002/jcb.20058; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Duval Helene, 2003, Angiogenesis, V6, P171, DOI 10.1023/B:AGEN.0000021390.09275.bc; Fay WP, 2007, ARTERIOSCL THROM VAS, V27, P1231, DOI 10.1161/ATVBAHA.107.140046; Gerards WLH, 1998, J MOL BIOL, V275, P113, DOI 10.1006/jmbi.1997.1429; Horowitz JC, 2008, AM J RESP CELL MOL, V38, P78, DOI 10.1165/rcmb.2007-0174OC; Isogai C, 2001, CANCER RES, V61, P5587; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kruithof E. K. O., 1983, PROGR FIBRINOLYSIS, V6, P356; KRUITHOF EKO, 1984, BLOOD, V64, P907; Lindstedt KA, 2004, ARTERIOSCL THROM VAS, V24, P1350, DOI 10.1161/01.ATV.0000135322.78008.55; Ma GPM, 2006, CARDIOVASC PATHOL, V15, P3, DOI 10.1016/j.carpath.2005.08.012; OLINKCOUX M, 1994, J CELL SCI, V107, P353; Pedroja BS, 2009, J BIOL CHEM, V284, P20708, DOI 10.1074/jbc.M109.018804; Ploplis VA, 2004, J BIOL CHEM, V279, P6143, DOI 10.1074/jbc.M307297200; Sage E, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-19; Shu FJ, 2003, MOL CELL BIOCHEM, V254, P157, DOI 10.1023/A:1027317014159; Soeda S, 2001, MOL BRAIN RES, V91, P96, DOI 10.1016/S0169-328X(01)00133-4; Soff GA, 1995, J CLIN INVEST, V96, P2593, DOI 10.1172/JCI118323; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Wojcik C, 2002, J CELL MOL MED, V6, P25, DOI 10.1111/j.1582-4934.2002.tb00309.x; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zoellner H, 1998, THROMB RES, V91, P209, DOI 10.1016/S0049-3848(98)00087-5; Zwickl P, 2002, ADV PROTEIN CHEM, V59, P187	38	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6820	6831		10.1074/jbc.M110.173781	http://dx.doi.org/10.1074/jbc.M110.173781			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135093	hybrid, Green Published			2022-12-25	WOS:000287476400089
J	Hamacher-Brady, A; Stein, HA; Turschner, S; Toegel, I; Mora, R; Jennewein, N; Efferth, T; Eils, R; Brady, NR				Hamacher-Brady, Anne; Stein, Henning A.; Turschner, Simon; Toegel, Ina; Mora, Rodrigo; Jennewein, Nina; Efferth, Thomas; Eils, Roland; Brady, Nathan R.			Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA/REPERFUSION INJURY; MEMBRANE PERMEABILIZATION; ANTIMALARIAL-DRUG; OXIDATIVE STRESS; TUMOR-CELLS; IN-VIVO; CYSTEINE CATHEPSINS; ARTEMISININ; AUTOPHAGY; PROTEIN	The antimalarial agent artesunate (ART) activates programmed cell death (PCD) in cancer cells in a manner dependent on the presence of iron and the generation of reactive oxygen species. In malaria parasites, ART cytotoxicity originates from interactions with heme-derived iron within the food vacuole. The analogous digestive compartment of mammalian cells, the lysosome, similarly contains high levels of redox-active iron and in response to specific stimuli can initiate mitochondrial apoptosis. We thus investigated the role of lysosomes in ART-induced PCD and determined that in MCF-7 breast cancer cells ART activates lysosome-dependent mitochondrial outer membrane permeabilization. ART impacted endolysosomal and autophagosomal compartments, inhibiting autophagosome turnover and causing perinuclear clustering of autophagosomes, early and late endosomes, and lysosomes. Lysosomal iron chelation blocked all measured parameters of ART-induced PCD, whereas lysosomal iron loading enhanced death, thus identifying lysosomal iron as the lethal source of reactive oxygen species upstream of mitochondrial outer membrane permeabilization. Moreover, lysosomal inhibitors chloroquine and bafilomycin A1 reduced ART-activated PCD, evidencing a requirement for lysosomal function during PCD signaling. ART killing did not involve activation of the BH3-only protein, Bid, yet ART enhanced TNF-mediated Bid cleavage. We additionally demonstrated the lysosomal PCD pathway in T47D and MDA-MB-231 breast cancer cells. Importantly, non-tumorigenic MCF-10A cells resisted ART-induced PCD. Together, our data suggest that ART triggers PCD via engagement of distinct, interconnected PCD pathways, with hierarchical signaling from lysosomes to mitochondria, suggesting a potential clinical use of ART for targeting lysosomes in cancer treatment.	[Hamacher-Brady, Anne; Turschner, Simon; Mora, Rodrigo; Eils, Roland; Brady, Nathan R.] German Canc Res Ctr, Div Theoret Bioinformat, Appl Syst Biol Grp, D-69120 Heidelberg, Germany; [Hamacher-Brady, Anne; Toegel, Ina; Jennewein, Nina; Eils, Roland] German Canc Res Ctr, Inst Pharm & Mol Biotechnol, BioQuant Ctr, D-69120 Heidelberg, Germany; [Efferth, Thomas] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Biol, Inst Pharm, D-55128 Mainz, Germany; [Stein, Henning A.; Brady, Nathan R.] Heidelberg Univ, Dept Surg, Fac Med, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Appl Syst Biol Grp, D-69120 Heidelberg, Germany.	r.eils@dkfz.de; n.brady@dkfz.de	Brady, Nathan/H-2452-2013; Hamacher-Brady, Anne/G-4268-2013; Eils, Roland/B-6121-2009	Eils, Roland/0000-0002-0034-4036; Brady, Nathan/0000-0002-1901-5996; Efferth, Thomas/0000-0002-3096-3292; Hamacher-Brady, Anne/0000-0001-5042-1338	Helmholtz Association; Bundesministerium fur Bildung und Forschung (BMBF); ENDOCYTE Marie Curie Research Training Network	Helmholtz Association(Helmholtz Association); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); ENDOCYTE Marie Curie Research Training Network(European Commission)	This work was supported by SBCancer within the Helmholtz Alliance on Systems Biology, funded by the Initiative and Networking Fund of the Helmholtz Association.; Supported by the Bundesministerium fur Bildung und Forschung (BMBF)-funded ForSys Centre Viroquant. To whom correspondence may be addressed. E-mail: r.eils@dkfz.de.; Supported by a fellowship from the ENDOCYTE Marie Curie Research Training Network. To whom correspondence may be addressed. E-mail: n.brady@dkfz.de.	Berger TG, 2005, ONCOL REP, V14, P1599; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Brady NR, 2006, BBA-BIOENERGETICS, V1757, P667, DOI 10.1016/j.bbabio.2006.04.011; BRIDGES KR, 1987, J BIOL CHEM, V262, P14773; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cable H, 1999, J PHARM PHARMACOL, V51, P131, DOI 10.1211/0022357991772231; Chen H, 2009, ANTI-CANCER DRUG, V20, P131, DOI 10.1097/CAD.0b013e3283212ade; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Dell'Eva R, 2004, BIOCHEM PHARMACOL, V68, P2359, DOI 10.1016/j.bcp.2004.08.021; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Efferth T, 2005, IN VIVO, V19, P225; Efferth T, 2004, FREE RADICAL BIO MED, V37, P998, DOI 10.1016/j.freeradbiomed.2004.06.023; Efferth T, 2003, INT J ONCOL, V23, P1231; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2001, INT J ONCOL, V18, P767; Efferth T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000693; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kelter G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000798; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Konkimalla VB, 2009, CURR CANCER DRUG TAR, V9, P72, DOI 10.2174/156800909787314020; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Kurz T, 2007, ARCH BIOCHEM BIOPHYS, V462, P220, DOI 10.1016/j.abb.2007.01.013; Lai H, 2005, LIFE SCI, V76, P1267, DOI 10.1016/j.lfs.2004.08.020; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li PCH, 2008, CANCER RES, V68, P4347, DOI 10.1158/0008-5472.CAN-07-2970; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; MIURA T, 1993, BIOCHEM MOL BIOL INT, V31, P125; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Orrell C, 2008, EUR J CLIN PHARMACOL, V64, P683, DOI 10.1007/s00228-007-0452-8; Ortiz-Ferron G, 2006, CELL DEATH DIFFER, V13, P1857, DOI 10.1038/sj.cdd.4401875; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Plantin-Carrenard E, 2003, CELL BIOL TOXICOL, V19, P121, DOI 10.1023/A:1023311307034; Rasheed SAK, 2010, INT J CANCER, V127, P1475, DOI 10.1002/ijc.25315; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Steffan JJ, 2010, J CELL SCI, V123, P1151, DOI 10.1242/jcs.063644; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Swift LM, 2000, AM J PHYSIOL-HEART C, V278, pH982, DOI 10.1152/ajpheart.2000.278.3.H982; Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Vasiljeva O, 2008, BIOCHIMIE, V90, P380, DOI 10.1016/j.biochi.2007.10.004; Werneburg N, 2004, AM J PHYSIOL-GASTR L, V287, pG436, DOI 10.1152/ajpgi.00019.2004; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; WOERDENBAG HJ, 1993, J NAT PROD, V56, P849, DOI 10.1021/np50096a007; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wu GD, 2004, VASC PHARMACOL, V41, P205, DOI 10.1016/j.vph.2004.11.001; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Yang SH, 2007, ONCOL REP, V17, P1229; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Youns M, 2009, BIOCHEM PHARMACOL, V78, P273, DOI 10.1016/j.bcp.2009.04.014; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	77	165	181	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6587	6601		10.1074/jbc.M110.210047	http://dx.doi.org/10.1074/jbc.M110.210047			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149439	Green Published, hybrid			2022-12-25	WOS:000287476400068
J	Nagashima, K; Shumway, SD; Sathyanarayanan, S; Chen, AH; Dolinski, B; Xu, YY; Keilhack, H; Thi, N; Wiznerowicz, M; Li, LX; Lutterbach, BA; Chi, A; Paweletz, C; Allison, T; Yan, YW; Munshi, SK; Klippel, A; Kraus, M; Bobkova, EV; Deshmukh, S; Xu, ZW; Mueller, U; Szewczak, AA; Pan, BS; Richon, V; Pollock, R; Blume-Jensen, P; Northrup, A; Andersen, JN				Nagashima, Kumiko; Shumway, Stuart D.; Sathyanarayanan, Sriram; Chen, Albert H.; Dolinski, Brian; Xu, Youyuan; Keilhack, Heike; Thi Nguyen; Wiznerowicz, Maciej; Li, Lixia; Lutterbach, Bart A.; Chi, An; Paweletz, Cloud; Allison, Timothy; Yan, Youwei; Munshi, Sanjeev K.; Klippel, Anke; Kraus, Manfred; Bobkova, Ekaterina V.; Deshmukh, Sujal; Xu, Zangwei; Mueller, Uwe; Szewczak, Alexander A.; Pan, Bo-Sheng; Richon, Victoria; Pollock, Roy; Blume-Jensen, Peter; Northrup, Alan; Andersen, Jannik N.			Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells CHARACTERIZATION OF A SELECTIVE ALLOSTERIC KINASE INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; PHOSPHATIDYLINOSITOL 3-KINASE; STRUCTURAL MECHANISM; TUMOR-SUPPRESSOR; AGC KINASES; PROTEIN; ACTIVATION; PATHWAY; SPECIFICITY; MUTATIONS	Phosphoinositide-dependent kinase 1 (PDK1) is a critical activator of multiple prosurvival and oncogenic protein kinases and has garnered considerable interest as an oncology drug target. Despite progress characterizing PDK1 as a therapeutic target, pharmacological support is lacking due to the prevalence of nonspecific inhibitors. Here, we benchmark literature and newly developed inhibitors and conduct parallel genetic and pharmacological queries into PDK1 function in cancer cells. Through kinase selectivity profiling and x-ray crystallographic studies, we identify an exquisitely selective PDK1 inhibitor (compound 7) that uniquely binds to the inactive kinase conformation (DFG-out). In contrast to compounds 1-5, which are classical ATP-competitive kinase inhibitors (DFG-in), compound 7 specifically inhibits cellular PDK1 T-loop phosphorylation (Ser-241), supporting its unique binding mode. Interfering with PDK1 activity has minimal antiproliferative effect on cells growing as plastic-attached monolayer cultures (i.e. standard tissue culture conditions) despite reduced phosphorylation of AKT, RSK, and S6RP. However, selective PDK1 inhibition impairs anchorage-independent growth, invasion, and cancer cell migration. Compound 7 inhibits colony formation in a subset of cancer cell lines (four of 10) and primary xenograft tumor lines (nine of 57). RNAi-mediated knockdown corroborates the PDK1 dependence in cell lines and identifies candidate biomarkers of drug response. In summary, our profiling studies define a uniquely selective and cell-potent PDK1 inhibitor, and the convergence of genetic and pharmacological phenotypes supports a role of PDK1 in tumorigenesis in the context of three-dimensional in vitro culture systems.	[Nagashima, Kumiko; Shumway, Stuart D.; Sathyanarayanan, Sriram; Chen, Albert H.; Dolinski, Brian; Xu, Youyuan; Keilhack, Heike; Thi Nguyen; Wiznerowicz, Maciej; Li, Lixia; Lutterbach, Bart A.; Chi, An; Paweletz, Cloud; Klippel, Anke; Kraus, Manfred; Bobkova, Ekaterina V.; Deshmukh, Sujal; Xu, Zangwei; Mueller, Uwe; Szewczak, Alexander A.; Pan, Bo-Sheng; Richon, Victoria; Pollock, Roy; Blume-Jensen, Peter; Northrup, Alan; Andersen, Jannik N.] Merck Res Labs, Boston, MA 02115 USA; [Allison, Timothy; Yan, Youwei; Munshi, Sanjeev K.] Merck & Co Inc, West Point, PA 19486 USA	Merck & Company; Merck & Company	Andersen, JN (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, 44 Binney St, Boston, MA 02115 USA.	jannik_andersen@dfci.harvard.edu						Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Ananthanarayanan B, 2007, J BIOL CHEM, V282, P36634, DOI 10.1074/jbc.M706227200; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bayascas JR, 2005, CURR BIOL, V15, P1839, DOI 10.1016/j.cub.2005.08.066; Bilanges B, 2005, BIOCHEM J, V388, P573, DOI 10.1042/BJ20041956; Bilodeau MT, 2008, BIOORG MED CHEM LETT, V18, P3178, DOI 10.1016/j.bmcl.2008.04.074; Boyle R. G., 2005, PCT Int. Appl., Patent No. [2005028474, WO 2005028474 A2]; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Collins BJ, 2005, J CELL SCI, V118, P5023, DOI 10.1242/jcs.02617; Dar AC, 2008, CHEM BIOL, V15, P1015, DOI 10.1016/j.chembiol.2008.09.007; Edelman MJ, 2007, CLIN CANCER RES, V13, P2667, DOI 10.1158/1078-0432.CCR-06-1832; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Haga S, 2009, HEPATOLOGY, V49, P204, DOI 10.1002/hep.22583; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Islam I, 2007, BIOORG MED CHEM LETT, V17, P3814, DOI 10.1016/j.bmcl.2007.04.071; Islam I, 2007, BIOORG MED CHEM LETT, V17, P3819, DOI 10.1016/j.bmcl.2007.05.060; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Komander D, 2003, BIOCHEM J, V375, P255, DOI 10.1042/BJ20031119; Kozina E., 2010, U.S. Patent, Patent No. [2010/0160309, 20100160309]; Leenders F, 2004, EMBO J, V23, P3303, DOI 10.1038/sj.emboj.7600345; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Lind K. E., 2008, Patent No. 2008005457; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Mora A, 2005, BIOCHEM J, V385, P639, DOI 10.1042/BJ20041782; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; SHOEMAKER RH, 1985, CANCER RES, V45, P2145; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Sternberger M, 2002, ANTISENSE NUCLEIC A, V12, P131, DOI 10.1089/108729002760220734; Sun DY, 2010, COMB CHEM HIGH T SCR, V13, P16, DOI 10.2174/138620710790218186; Tamguney T, 2008, EXP CELL RES, V314, P2299, DOI 10.1016/j.yexcr.2008.04.006; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; WALMSLEY DL, 2006, Patent No. 2006134318; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Weisberg E, 2008, BLOOD, V111, P3723, DOI 10.1182/blood-2007-09-114454; Welch S, 2007, GYNECOL ONCOL, V106, P305, DOI 10.1016/j.ygyno.2007.02.018; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Xu ZW, 2009, J BIOMOL SCREEN, V14, P1257, DOI 10.1177/1087057109349356; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063	71	50	53	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6433	6448		10.1074/jbc.M110.156463	http://dx.doi.org/10.1074/jbc.M110.156463			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21118801	hybrid, Green Published			2022-12-25	WOS:000287476400054
J	Bloom, J; Cristea, IM; Procko, AL; Lubkov, V; Chait, BT; Snyder, M; Cross, FR				Bloom, Joanna; Cristea, Ileana M.; Procko, Andrea L.; Lubkov, Veronica; Chait, Brian T.; Snyder, Michael; Cross, Frederick R.			Global Analysis of Cdc14 Phosphatase Reveals Diverse Roles in Mitotic Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PROTEIN PHOSPHATASE; MICROTUBULE ORIENTATION; EXIT; ANAPHASE; LOCALIZATION; CYTOKINESIS	Cdc14 phosphatase regulates multiple events during anaphase and is essential for mitotic exit in budding yeast. Cdc14 is regulated in both a spatial and temporal manner. It is sequestered in the nucleolus for most of the cell cycle by the nucleolar protein Net1 and is released into the nucleus and cytoplasm during anaphase. To identify novel binding partners of Cdc14, we used affinity purification of Cdc14 and mass spectrometric analysis of interacting proteins from strains in which Cdc14 localization or catalytic activity was altered. To alter Cdc14 localization, we used a strain deleted for NET1, which causes full release of Cdc14 from the nucleolus. To alter Cdc14 activity, we generated mutations in the active site of Cdc14 (C283S or D253A), which allow binding of substrates, but not dephosphorylation, by Cdc14. Using this strategy, we identified new interactors of Cdc14, including multiple proteins involved in mitotic events. A subset of these proteins displayed increased affinity for catalytically inactive mutants of Cdc14 compared with the wild-type version, suggesting they are likely substrates of Cdc14. We have also shown that several of the novel Cdc14-interacting proteins, including Kar9 (a protein that orients the mitotic spindle) and Bni1 and Bnr1 (formins that nucleate actin cables and may be important for actomyosin ring contraction) are specifically dephosphorylated by Cdc14 in vitro and in vivo. Our findings suggest the dephosphorylation of the formins may be important for their observed localization change during exit from mitosis and indicate that Cdc14 targets proteins involved in wide-ranging mitotic events.	[Bloom, Joanna; Cristea, Ileana M.; Procko, Andrea L.; Lubkov, Veronica; Chait, Brian T.; Cross, Frederick R.] Rockefeller Univ, New York, NY 10065 USA; [Bloom, Joanna; Snyder, Michael] Yale Univ, New Haven, CT 06511 USA	Rockefeller University; Yale University	Cross, FR (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	fcross@rockefeller.edu		Lubkov, Veronica/0000-0002-5264-7549	National Institutes of Health; American Cancer Society [PF-06-017-01-CCG]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health (to F. R. C.) and a postdoctoral fellowship (PF-06-017-01-CCG) from the American Cancer Society (to J. B.).	Anderson VE, 2007, MOL BIOL CELL, V18, P2047, DOI 10.1091/mbc.E06-10-0918; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bailly E, 2003, J CELL SCI, V116, P4119, DOI 10.1242/jcs.00706; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Bembenek J, 2005, CELL CYCLE, V4, P961, DOI 10.4161/cc.4.7.1798; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Bloom J, 2007, MOL CELL BIOL, V27, P842, DOI 10.1128/MCB.01069-06; Burton JL, 2000, MOL CELL BIOL, V20, P4614, DOI 10.1128/MCB.20.13.4614-4625.2000; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fraschini R, 2004, MOL BIOL CELL, V15, P3796, DOI 10.1091/mbc.E04-02-0094; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Kikyo M, 1999, ONCOGENE, V18, P7046, DOI 10.1038/sj.onc.1203184; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Li S, 2006, J CELL BIOL, V173, P867, DOI 10.1083/jcb.200603153; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Lim HH, 2003, MOL BIOL CELL, V14, P4734, DOI 10.1091/mbc.E03-04-0238; Lu Y, 2009, MOL BIOL CELL, V20, P1576, DOI 10.1091/mbc.E08-10-1042; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; Maekawa H, 2004, GENE DEV, V18, P1709, DOI 10.1101/gad.298704; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Miller RK, 1999, J CELL BIOL, V144, P963, DOI 10.1083/jcb.144.5.963; Moore JK, 2007, MOL BIOL CELL, V18, P1187, DOI 10.1091/mbc.E06-04-0360; Moore JK, 2006, MOL BIOL CELL, V17, P178, DOI 10.1091/mbc.e05-06-0565; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Ross KE, 2004, DEV CELL, V6, P729, DOI 10.1016/S1534-5807(04)00128-5; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Seshan A, 2002, CURR BIOL, V12, P2098, DOI 10.1016/S0960-9822(02)01388-X; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Surana U, 2002, BIOESSAYS, V24, P659, DOI 10.1002/bies.10106; Taylor GS, 1997, J BIOL CHEM, V272, P24054, DOI 10.1074/jbc.272.38.24054; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; Traverso EE, 2001, J BIOL CHEM, V276, P21924, DOI 10.1074/jbc.M011689200; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Wang WQ, 2004, J BIOL CHEM, V279, P30459, DOI 10.1074/jbc.M402217200; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Yoshida S, 2002, CURR BIOL, V12, P944, DOI 10.1016/S0960-9822(02)00870-9; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747	68	54	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5434	5445		10.1074/jbc.M110.205054	http://dx.doi.org/10.1074/jbc.M110.205054			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127052	Green Published, hybrid			2022-12-25	WOS:000287230600052
J	Cuello, F; Bardswell, SC; Haworth, RS; Ehler, E; Sadayappan, S; Kentish, JC; Avkiran, M				Cuello, Friederike; Bardswell, Sonya C.; Haworth, Robert S.; Ehler, Elisabeth; Sadayappan, Sakthivel; Kentish, Jonathan C.; Avkiran, Metin			Novel Role for p90 Ribosomal S6 Kinase in the Regulation of Cardiac Myofilament Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-C; NA+-H+ EXCHANGER; TROPONIN-I PHOSPHORYLATION; HEART-FAILURE; VENTRICULAR MYOCYTES; EMERGING ROLES; ERK PATHWAY; RSK; ACTIVATION; INHIBITOR	In myocardium, the 90-kDa ribosomal S6 kinase (RSK) is activated by diverse stimuli and regulates the sarcolemmal Na+/H+ exchanger through direct phosphorylation. Only limited information is available on other cardiac RSK substrates and functions. We evaluated cardiac myosin-binding protein C (cMyBP-C), a sarcomeric regulatory phosphoprotein, as a potential RSK substrate. In rat ventricular myocytes, RSK activation by endothelin 1 (ET1) increased cMyBP-C phosphorylation at Ser(282), which was inhibited by the selective RSK inhibitor D1870. Neither ET1 nor D1870 affected the phosphorylation status of Ser(273) or Ser(302), cMyBP-C residues additionally targeted by cAMP-dependent protein kinase (PKA). Complementary genetic gain- and loss-of-function experiments, through the adenoviral expression of wild-type or kinase-inactive RSK isoforms, confirmed RSK-mediated phosphorylation of cMyBP-C at Ser(282). Kinase assays utilizing as substrate wild-type or mutated (S273A, S282A, S302A) recombinant cMyBP-C fragments revealed direct and selective Ser(282) phosphorylation by RSK. Immunolabeling with a Ser(P)(282) antibody and confocal fluorescence microscopy showed RSK-mediated phosphorylation of cMyBP-C across the C-zones of sarcomeric A-bands. In chemically permeabilized mouse ventricular muscles, active RSK again induced selective Ser(282) phosphorylation in cMyBP-C, accompanied by significant reduction in Ca2+ sensitivity of force development and significant acceleration of cross-bridge cycle kinetics, independently of troponin I phosphorylation at Ser(22)/Ser(23). The magnitudes of these RSK-induced changes were comparable with those induced by PKA, which phosphorylated cMyBP-C additionally at Ser(273) and Ser(302). We conclude that Ser(282) in cMyBP-C is a novel cardiac RSK substrate and its selective phosphorylation appears to regulate cardiac myofilament function.	[Avkiran, Metin] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, St Thomas Hosp,Rayne Inst, London SE1 7EH, England; [Sadayappan, Sakthivel] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Loyola University Chicago	Avkiran, M (corresponding author), Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, St Thomas Hosp,Rayne Inst, London SE1 7EH, England.	metin.avkiran@kcl.ac.uk	Cuello, Friederike/A-9642-2016	Sadayappan, Sakthivel/0000-0003-2006-7678; Ehler, Elisabeth/0000-0001-5646-5964; Avkiran, Metin/0000-0003-2392-6343	British Heart Foundation; Medical Research Council; Centre of Research Excellence Award; MRC [G0800206, G0400153, G0001112] Funding Source: UKRI; Medical Research Council [G0400153, G0001112, G0800206] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre of Research Excellence Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the British Heart Foundation, including a Centre of Research Excellence Award, and the Medical Research Council.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Avkiran M, 2002, J AM COLL CARDIOL, V39, P747, DOI 10.1016/S0735-1097(02)01693-5; Avkiran M, 2008, CURR OPIN PHARMACOL, V8, P133, DOI 10.1016/j.coph.2007.12.007; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; Cingolani HE, 2007, CIRCULATION, V115, P1090, DOI 10.1161/CIRCULATIONAHA.106.626929; Cuello F, 2007, MOL PHARMACOL, V71, P799, DOI 10.1124/mol.106.029900; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Haworth RS, 2003, J BIOL CHEM, V278, P31676, DOI 10.1074/jbc.M304400200; Itoh S, 2006, CIRCULATION, V113, P1787, DOI 10.1161/CIRCULATIONAHA.105.578278; Itoh S, 2005, J BIOL CHEM, V280, P24135, DOI 10.1074/jbc.M413015200; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lu Z, 2008, CIRC RES, V103, P269, DOI 10.1161/CIRCRESAHA.107.166678; Maekawa N, 2006, CIRCULATION, V113, P2516, DOI 10.1161/CIRCULATIONAHA.105.563486; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2009, CIRCULATION, V120, pS870; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sheffler DJ, 2006, P NATL ACAD SCI USA, V103, P4717, DOI 10.1073/pnas.0600585103; Smith JA, 2005, CANCER RES, V65, P1027; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Snabaitis AK, 2005, CELL SIGNAL, V17, P655, DOI 10.1016/j.cellsig.2004.10.008; Snabaitis AK, 2002, CARDIOVASC RES, V53, P470, DOI 10.1016/S0008-6363(01)00464-3; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Takeishi Y, 1999, CIRC RES, V85, P1164; Takeishi Y, 2002, CARDIOVASC RES, V53, P131, DOI 10.1016/S0008-6363(01)00438-2; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672	48	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5300	5310		10.1074/jbc.M110.202713	http://dx.doi.org/10.1074/jbc.M110.202713			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148481	Green Published, hybrid			2022-12-25	WOS:000287230600038
J	Yung, SC; Parenti, D; Murphy, PM				Yung, Sunny C.; Parenti, David; Murphy, Philip M.			Host Chemokines Bind to Staphylococcus aureus and Stimulate Protein A Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANTON-VALENTINE LEUKOCIDIN; SURFACE-PROTEINS; UNITED-STATES; CUTTING EDGE; CELL-WALL; ANTIMICROBIAL ACTIVITY; COMPLEMENT ACTIVATION; CUTANEOUS INFECTION; GAMMA-INTERFERON; AUGUST 2009	There are few examples of host signals that are beneficial to bacteria during infection. Here we found that 31 out of 42 host immunoregulatory chemokines were able to induce release of the virulence factor protein A (SPA) from a strain of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Detailed study of chemokine CXCL9 revealed that SPA release occurred through a post-translational mechanism and was inversely proportional to bacterial density. CXCL9 bound specifically to the cell membrane of CA-MRSA, and the related SPA-releasing chemokine CXCL10 bound to both cell wall and cell membrane. Clinical samples from patients infected with S. aureus and samples from a mouse model of CA-MRSA skin abscess all contained extracellular SPA. Further, SPA-releasing chemokines were present in mouse skin lesions infected with CA-MRSA. Our data identify a potential new mode of immune evasion, in which the pathogen exploits a host defense factor to release a virulence factor; moreover, chemokine binding may serve a scavenging function in immune evasion by S. aureus.	[Yung, Sunny C.; Murphy, Philip M.] NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Parenti, David] George Washington Univ, Dept Med, Med Ctr, Washington, DC 20037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University	Murphy, PM (corresponding author), NIAID, Mol Signaling Sect, Lab Mol Immunol, NIH, Bldg 10,Rm 11N113, Bethesda, MD 20892 USA.	pmm@nih.gov			Division of Intramural Research of the NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER	Division of Intramural Research of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research of the NIAID, National Institutes of Health.	[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P1071; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P941; [Anonymous], 2005, PRINCIPLES PRACTICE; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; FOMENKO GA, 1980, ZH MIKROB EPID IMMUN, P57; FORSGREN A, 1970, Infection and Immunity, V2, P672; GALE EF, 1953, BIOCHEM J, V53, P493, DOI 10.1042/bj0530493; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Goodyear CS, 2007, J IMMUNOL, V178, P2636, DOI 10.4049/jimmunol.178.5.2636; Goodyear CS, 2004, P NATL ACAD SCI USA, V101, P11392, DOI 10.1073/pnas.0404382101; GROV A, 1968, ACTA PATHOL MIC SC, V73, P400; Hartleib J, 2000, BLOOD, V96, P2149; Horne K, 2009, INFLAMM RES, V58, P431, DOI 10.1007/s00011-009-0023-9; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kielian T, 2001, J IMMUNOL, V166, P4634, DOI 10.4049/jimmunol.166.7.4634; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; LINDMARK R, 1977, EUR J BIOCHEM, V74, P623, DOI 10.1111/j.1432-1033.1977.tb11431.x; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; McLoughlin RM, 2006, P NATL ACAD SCI USA, V103, P10408, DOI 10.1073/pnas.0508961103; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; MOVITZ J, 1976, EUR J BIOCHEM, V68, P291, DOI 10.1111/j.1432-1033.1976.tb10788.x; NAKANE A, 1995, INFECT IMMUN, V63, P1165, DOI 10.1128/IAI.63.4.1165-1172.1995; Otto M, 2001, PEPTIDES, V22, P1603, DOI 10.1016/S0196-9781(01)00495-8; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; PARFENTJEV IA, 1964, J BACTERIOL, V88, P1, DOI 10.1002/path.1700880102; Patel M, 2009, CURR MOL MED, V9, P86, DOI 10.2174/156652409787314480; Pruenster M, 2006, BIOCHEM SOC T, V34, P1005, DOI 10.1042/BST0341005; SANFORD BA, 1986, J CLIN MICROBIOL, V24, P131, DOI 10.1128/JCM.24.1.131-136.1986; Sasaki S, 2000, INFECT IMMUN, V68, P2424, DOI 10.1128/IAI.68.5.2424-2430.2000; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SPIKA JS, 1981, INFECT IMMUN, V34, P455, DOI 10.1128/IAI.34.2.455-460.1981; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; VERBRUGH HA, 1979, IMMUNOLOGY, V37, P615; Verdrengh M, 1997, INFECT IMMUN, V65, P2517, DOI 10.1128/IAI.65.7.2517-2521.1997; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024	54	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5069	5077		10.1074/jbc.M110.195180	http://dx.doi.org/10.1074/jbc.M110.195180			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21138841	Green Published, hybrid			2022-12-25	WOS:000287230600014
J	Aoyagi, S; Archer, TK				Aoyagi, Sayura; Archer, Trevor K.			Differential Glucocorticoid Receptor-mediated Transcription Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; RNA-POLYMERASE; IN-VIVO; NUCLEAR RECEPTORS; BINDING; ACTIVATION; PROMOTER; GENOME; CELLS; SUPERFAMILY	Nuclear receptors such as the glucocorticoid receptor (GR) are ligand-dependent transcription factors that mediate transcription of target genes by recruiting factors that modulate chromatin structure. In this study, curcumin, a compound known to inhibit GR-mediated transcription, was used to examine the different mechanisms by which GR regulates transcription. The mechanisms of transcription regulation of metallothioneine-2A (MT2A) and solute carrier family 19 member 2 (SLC19A2), two GR target genes where the hormone-dependent gene activation is inhibited or unaffected by curcumin treatment, respectively, were analyzed by chromatin immunoprecipitation and RT-PCR experiments. The data suggest that the loss of hormone-dependent MT2A gene expression is due to the inhibition of continued transcription activity after initial assembly of the transcription machinery. In contrast, the hormone-dependent SLC19A2 gene expression is maintained because the continued transcription output after assembly of transcription machinery is unaffected by curcumin. These results suggest that the two GR target genes use alternate mechanisms to regulate expression levels at the level of continued transcription output after transcription machinery assembly.	[Aoyagi, Sayura; Archer, Trevor K.] NIEHS, Chromatin & Gene Express Sect, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Archer, TK (corresponding author), NIEHS, Chromatin & Gene Express Sect, Mol Carcinogenesis Lab, NIH, 111 Alexander Dr,POB 12233,MD D4-01, Res Triangle Pk, NC 27709 USA.	archer1@niehs.nih.gov	Archer, Trevor K/E-5191-2019	Archer, Trevor K/0000-0001-7651-3644	National Institutes of Health of the NIEHS [Z01 ES071006-10]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006, ZIAES071006] Funding Source: NIH RePORTER	National Institutes of Health of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Project Z01 ES071006-10 through the Intramural Research Program of the NIEHS (to T. K. A.).	Alonso-Gonzalez C, 2008, TOXICOL LETT, V181, P190, DOI 10.1016/j.toxlet.2008.07.021; Aoyagi S, 2008, MOL CELL BIOL, V28, P30, DOI 10.1128/MCB.01158-07; Aoyagi S, 2007, MOL ENDOCRINOL, V21, P843, DOI 10.1210/me.2006-0244; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Cheung E, 2010, ANNU REV PHYSIOL, V72, P191, DOI 10.1146/annurev-physiol-021909-135840; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Giglia-Mari G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000220; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Kinyamu HK, 2008, ENVIRON MOL MUTAGEN, V49, P83, DOI 10.1002/em.20360; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; LAGANIE REJ, 2005, P NATL ACAD SCI USA, V102, P11651; Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; LEE HL, 1994, MOL CELL BIOL, V14, P32, DOI 10.1128/MCB.14.1.32; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; MYMRYK JS, 1995, GENE DEV, V9, P1366, DOI 10.1101/gad.9.11.1366; MYMRYK JS, 1995, MOL ENDOCRINOL, V9, P1825, DOI 10.1210/me.9.12.1825; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Reinecke F, 2006, BIOCHEM J, V395, P405, DOI 10.1042/BJ20051253; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; White RJ, 2010, TRENDS GENET, V26, P214, DOI 10.1016/j.tig.2010.02.004; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	38	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4610	4619		10.1074/jbc.M110.195040	http://dx.doi.org/10.1074/jbc.M110.195040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127044	Green Published, hybrid			2022-12-25	WOS:000286975700061
J	Costello, JL; Stead, JA; Feigenbutz, M; Jones, RM; Mitchell, P				Costello, Joe L.; Stead, Jonathan A.; Feigenbutz, Monika; Jones, Rebecca M.; Mitchell, Phil			The C-terminal Region of the Exosome-associated Protein Rrp47 Is Specifically Required for Box C/D Small Nucleolar RNA 3 '-Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA; QUALITY-CONTROL; POLY(A) POLYMERASE; NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; BIDIRECTIONAL PROMOTERS; EUKARYOTIC EXOSOME; BINDING-PROTEIN; YEAST NUCLEAR; CORE EXOSOME	Cells lacking the exosome-associated protein Rrp47 show similar defects in stable RNA processing to those observed in the absence of the catalytic subunit Rrp6, but the precise mechanism(s) by which Rrp47 functions together with Rrp6 remains unclear. Deletion complementation analyses defined an N-terminal region of Rrp47, largely coincident with the bioinformatically defined Sas10/C1D domain, which was sufficient for protein function in vivo. In vitro protein interaction studies demonstrated that this domain of Rrp47 binds the PMC2NT domain of Rrp6. Expression of the N-terminal domain of Rrp47 in yeast complemented most RNA-processing defects associated with the rrp47 Delta mutant but failed to complement the defect observed in 3'-end maturation of box C/D small nucleolar RNAs. Consistent with these results, protein capture assays revealed an interaction between the C-terminal region of Rrp47 and the small nucleolar ribonucleoproteins Nop56 and Nop58. Filter binding assays demonstrated that deletion of the lysine-rich sequence at the C terminus of Rrp47 blocked RNA binding in vitro. Furthermore, a protein mutated both at the C terminus and within the N-terminal domain showed a synergistic defect in RNA binding without impacting on its ability to interact with Rrp6. These studies provide evidence for a role of Rrp47 in registering a small nucleolar ribonucleoprotein particle assembly, functionally characterize the Sas10/C1D domain of Rrp47, and show that both the C terminus of Rrp47 and the N-terminal domain contribute to its RNA-binding activity.	[Costello, Joe L.; Stead, Jonathan A.; Feigenbutz, Monika; Jones, Rebecca M.; Mitchell, Phil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Mitchell, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	p.j.mitchell@shef.ac.uk		Jones, Rebecca M/0000-0002-5310-8475; Costello, Joseph/0000-0002-2867-1864; Stead, Jonathan/0000-0002-8133-3733; Mitchell, Phil/0000-0002-3178-0439	Biotechnology and Biological Sciences Research Council [BB/D001161]; Yorkshire Cancer Research; Wellcome Trust [088306/Z/09/Z]; University of Sheffield; BBSRC [BB/D001161/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001161/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Yorkshire Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); University of Sheffield; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Research Grant BB/D001161 (to J. A. S.), by Yorkshire Cancer Research and Wellcome Trust Research Grant 088306/Z/09/Z (to M. F.), by a Biotechnology and Biological Sciences Research Council Ph.D. studentship (to J. L. C.), and by a University of Sheffield Ph.D. studentship (to R. M. J.).	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Belostotsky D, 2009, CURR OPIN CELL BIOL, V21, P352, DOI 10.1016/j.ceb.2009.04.011; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Chapon C, 1997, RNA, V3, P1337; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kamakaka RT, 1998, GENETICS, V149, P903; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; Lafontaine DLJ, 2000, MOL CELL BIOL, V20, P2650, DOI 10.1128/MCB.20.8.2650-2659.2000; Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 2010, BIOCHEM SOC T, V38, P1088, DOI 10.1042/BST0381088; Nehls P, 1998, NUCLEIC ACIDS RES, V26, P1160, DOI 10.1093/nar/26.5.1160; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; PIPER PW, 1983, EMBO J, V2, P353, DOI 10.1002/j.1460-2075.1983.tb01430.x; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Reinisch KM, 2007, CURR OPIN STRUC BIOL, V17, P209, DOI 10.1016/j.sbi.2007.03.012; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Synowsky SA, 2009, J MOL BIOL, V385, P1300, DOI 10.1016/j.jmb.2008.11.011; Tomecki R, 2010, CHEMBIOCHEM, V11, P938, DOI 10.1002/cbic.201000025; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Wiederkehr T, 1998, RNA, V4, P1357, DOI 10.1017/S1355838298980955; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; YEH LCC, 1990, J MOL BIOL, V211, P699, DOI 10.1016/0022-2836(90)90071-S	55	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4535	4543		10.1074/jbc.M110.162826	http://dx.doi.org/10.1074/jbc.M110.162826			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21135092	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000286975700054
J	Ma, C; D'Mello, SR				Ma, Chi; D'Mello, Santosh R.			Neuroprotection by Histone Deacetylase-7 (HDAC7) Occurs by Inhibition of c-jun Expression through a Deacetylase-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; NEURONAL APOPTOSIS; PROTECTS NEURONS; SURVIVAL; NEURODEGENERATION; TRANSCRIPTION; REPRESSION; DISEASE; HISTONE-DEACETYLASE-7; TOXICITY	Histone deacetylase (HDAC) 7 is a member of the HDAC family of deacetylases. Although some of the HDAC proteins have been shown to regulate neuronal survival and death, whether HDAC7 has a similar role is not known. In this study, we show that HDAC7 protects neurons from apoptosis. In cerebellar granule neurons (CGNs) primed to undergo apoptosis by low potassium treatment, expression of HDAC7 protein is reduced. Reduced expression is also observed in CGNs induced to die by pharmacological inhibition of the proteasome, in cortical neurons treated with homocysteic acid, and in the striatum of R6/2 transgenic mice, a commonly used genetic model of Huntington disease. Forced expression of HDAC7 in cultured CGNs blocks low potassium-induced death, and shRNA-mediated suppression of its expression induces death in otherwise healthy neurons. HDAC7-mediated neuroprotection does not require its catalytic domain and cannot be inhibited by chemical inhibitors of HDACs. Moreover, pharmacological inhibitors of the PI3K-Akt or Raf-MEK-ERK signaling pathways or that of PKA, PKC, and Ca2+/calmodulin-dependent protein kinase fail to reduce neuroprotection by HDAC7. We show that stimulation of c-jun expression, an essential feature of neuronal death, is prevented by HDAC7. shRNA-mediated suppression of HDAC7 expression leads to an increase in c-jun expression. Inhibition of c-jun expression by HDAC7 is mediated at the transcriptional level by its direct association with the c-jun gene promoter. Taken together, our results indicate that HDAC7 is a neuroprotective protein acting by a mechanism that is independent of its deacetylase activity but involving the inhibition of c-jun expression.	[Ma, Chi; D'Mello, Santosh R.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas	D'Mello, SR (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, 2601 N Floyd Rd, Richardson, TX 75083 USA.	dmello@utdallas.edu	D'Mello, Santosh/AAM-3644-2020; D'Mello, Santosh/AAO-7192-2020	D'Mello, Santosh/0000-0002-7652-1334; , Chi/0000-0002-4171-0813	National Institutes of Health [NS047201, NS040408]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047201, R01NS040408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047201 and NS040408.	Benn CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005747; Boutillier AL, 2002, ANN NY ACAD SCI, V973, P438, DOI 10.1111/j.1749-6632.2002.tb04679.x; Boutillier AL, 2003, J NEUROCHEM, V84, P814, DOI 10.1046/j.1471-4159.2003.01581.x; Butts BD, 2005, MOL CELL NEUROSCI, V30, P279, DOI 10.1016/j.mcn.2005.07.011; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chen HM, 2008, EUR J NEUROSCI, V28, P2003, DOI 10.1111/j.1460-9568.2008.06491.x; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; D'Mello SR, 2005, CNS NEUROL DISORD-DR, V4, P3, DOI 10.2174/1568007053005118; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; D'Mello SR, 2000, J NEUROSCI RES, V59, P24, DOI 10.1002/(SICI)1097-4547(20000101)59:1<24::AID-JNR4>3.3.CO;2-#; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Herdegen T, 2001, ONCOGENE, V20, P2424, DOI 10.1038/sj.onc.1204387; Jensen ED, 2009, J BIOL CHEM, V284, P2225, DOI 10.1074/jbc.M800586200; Kao HY, 2000, GENE DEV, V14, P55; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kundel M, 2009, J NEUROSCI, V29, P13630, DOI 10.1523/JNEUROSCI.2910-08.2009; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Salminen A, 1998, MOL BRAIN RES, V61, P203, DOI 10.1016/S0169-328X(98)00210-1; Scott FL, 2008, J BIOL CHEM, V283, P19499, DOI 10.1074/jbc.M800331200; Sleiman SF, 2009, EXPERT OPIN INV DRUG, V18, P573, DOI [10.1517/13543780902810345, 10.1517/13543780902810345 ]; Watson A, 1998, J NEUROSCI, V18, P751; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	35	62	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4819	4828		10.1074/jbc.M110.146860	http://dx.doi.org/10.1074/jbc.M110.146860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21118817	Green Published, hybrid			2022-12-25	WOS:000286975700079
J	Tumusiime, S; Zhang, C; Overstreet, MS; Liu, ZC				Tumusiime, Sylvester; Zhang, Chen; Overstreet, Melissa S.; Liu, Zhengchang			Differential Regulation of Transcription Factors Stp1 and Stp2 in the Ssy1-Ptr3-Ssy5 Amino Acid Sensing Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ACTIVATED PROTEOLYSIS; UBIQUITIN-LIGASE COMPLEX; SACCHAROMYCES-CEREVISIAE; ENDOPROTEOLYTIC ACTIVATION; SSY1P-PTR3P-SSY5P SENSOR; SCFGRR1 TARGETS; GENE-EXPRESSION; AGP1 GENE; YEAST; PROTEIN	Stp1 and Stp2 are two homologous transcription factors activated in response to extracellular amino acid stimuli. Here we show that both ubiquitin-dependent degradation of Stp1 and Stp2 and their intracellular localization are differentially regulated. We have found that the E2 ubiquitin-conjugating enzyme Cdc34 is required for degradation of both full-length and processed Stp1, but not Stp2. We have also found that Grr1, the F-box component of the SCFGrr1 E3 ubiquitin ligase, is the primary factor in degradation of full-length Stp1, whereas both Grr1 and Cdc4 are required for degradation of processed Stp1. Our localization studies showed that full-length Stp1 is localized both in the cytoplasm and at the cell periphery, whereas full-length Stp2 is localized only diffusely in the cytoplasm. We identified two nuclear localization signals of Stp1 and found that the N-terminal domain of Stp1 is required for localization of full-length Stp1 to the cell periphery. We also found that Stp2 is the primary factor involved in basal activation of target gene expression. Our results indicate that the functions of two seemingly redundant transcription factors can be separated by differential degradation and distinct cellular localization.	[Tumusiime, Sylvester; Zhang, Chen; Overstreet, Melissa S.; Liu, Zhengchang] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Zhang, Chen] Shanghai Univ Tradit Chinese Med, Dept Pathol, Shanghai 201203, Peoples R China	University of Louisiana System; University of New Orleans; Shanghai University of Traditional Chinese Medicine	Liu, ZC (corresponding author), 2000 Lakeshore Dr, New Orleans, LA 70148 USA.	zliu5@uno.edu			University of New Orleans; Board of Regents of the State of Louisiana [LEQSF(2008-11)-RD-A-31]	University of New Orleans; Board of Regents of the State of Louisiana	This work was supported by the University of New Orleans and Board of Regents of the State of Louisiana Grant LEQSF(2008-11)-RD-A-31.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Abdel-Sater F, 2004, GENETICS, V166, P1727, DOI 10.1534/genetics.166.4.1727; Amberg DC., 2005, METHODS YEAST GENETI; Andreasson C, 2004, MOL CELL BIOL, V24, P7503, DOI 10.1128/MCB.24.17.7503-7513.2004; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; Bernard F, 2001, MOL MICROBIOL, V41, P489, DOI 10.1046/j.1365-2958.2001.02538.x; Bernard F, 2001, FEBS LETT, V496, P81, DOI 10.1016/S0014-5793(01)02412-7; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Blondel M, 2005, EMBO J, V24, P1440, DOI 10.1038/sj.emboj.7600627; Boban M, 2006, J CELL BIOL, V173, P695, DOI 10.1083/jcb.200601011; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; de Boer M, 2000, NUCLEIC ACIDS RES, V28, P974; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Eckert-Boulet N, 2006, EUKARYOT CELL, V5, P174, DOI 10.1128/EC.5.1.174-179.2006; Eckert-Boulet N, 2004, YEAST, V21, P635, DOI 10.1002/yea.1120; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Forsberg H, 2001, MOL MICROBIOL, V42, P215, DOI 10.1046/j.1365-2958.2001.02627.x; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Liu ZC, 2005, MOL BIOL CELL, V16, P4893, DOI 10.1091/mbc.E05-06-0516; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; Poulsen P, 2006, EUKARYOT CELL, V5, P601, DOI 10.1128/EC.5.3.601-608.2006; Poulsen P, 2005, BIOCHEM SOC T, V33, P261, DOI 10.1042/BST0330261; Poulsen P, 2005, EUKARYOT CELL, V4, P1116, DOI 10.1128/EC.4.6.1116-1124.2005; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SEUFERT W, 1990, EMBO J, V9, P4535, DOI 10.1002/j.1460-2075.1990.tb07905.x; Shin CS, 2009, J CELL SCI, V122, P2089, DOI 10.1242/jcs.047191; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Wielemans K, 2010, J BIOL CHEM, V285, P855, DOI 10.1074/jbc.M109.015263; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Zargari A, 2007, J BIOL CHEM, V282, P594, DOI 10.1074/jbc.M609201200	48	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4620	4631		10.1074/jbc.M110.195313	http://dx.doi.org/10.1074/jbc.M110.195313			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127045	hybrid, Green Published			2022-12-25	WOS:000286975700062
J	Andersen, LG; Angquist, L; Eriksson, JG; Forsen, T; Gamborg, M; Osmond, C; Baker, JL; Sorensen, TIA				Andersen, Lise Geisler; Angquist, Lars; Eriksson, Johan G.; Forsen, Tom; Gamborg, Michael; Osmond, Clive; Baker, Jennifer L.; Sorensen, Thorkild I. A.			Birth Weight, Childhood Body Mass Index and Risk of Coronary Heart Disease in Adults: Combined Historical Cohort Studies	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PARENTAL RECALL; YOUNG ADULTHOOD; FETAL ORIGINS; INFANT GROWTH; STROKE; DEATH; BORN; LIFE; AGE	Background: Low birth weight and high childhood body mass index (BMI) is each associated with an increased risk of coronary heart disease (CHD) in adult life. We studied individual and combined associations of birth weight and childhood BMI with the risk of CHD in adulthood. Methods/Principal Findings: Birth weight and BMI at age seven years were available in 216,771 Danish and Finnish individuals born 1924-1976. Linkage to national registers for hospitalization and causes of death identified 8,805 CHD events during up to 33 years of follow-up (median = 24 years) after age 25 years. Analyses were conducted with Cox regression based on restricted cubic splines. Using median birth weight of 3.4 kg as reference, a non-linear relation between birth weight and CHD was found. It was not significantly different between cohorts, or between men and women, nor was the association altered by childhood BMI. For birth weights below 3.4 kg, the risk of CHD increased linearly and reached 1.28 (95% confidence limits: 1.13 to 1.44) at 2 kg. Above 3.4 kg the association weakened, and from about 4 kg there was virtually no association. BMI at age seven years was strongly positively associated with the risk of CHD and the relation was not altered by birth weight. The excess risk in individuals with a birth weight of 2.5 kg and a BMI of 17.7 kg/m(2) at age seven years was 44% (95% CI: 30% to 59%) compared with individuals with median values of birth weight (3.4 kg) and BMI (15.3 kg/m(2)). Conclusions/Significance: Birth weight and BMI at age seven years appeared independently associated with the risk of CHD in adulthood. From a public health perspective we suggest that particular attention should be paid to children with a birth weight below the average in combination with excess relative weight in childhood.	[Andersen, Lise Geisler; Angquist, Lars; Gamborg, Michael; Baker, Jennifer L.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Eriksson, Johan G.; Forsen, Tom] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.; Forsen, Tom] Natl Inst Hlth & Welf, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [Forsen, Tom] Vasa Hlth Care Ctr, Vaasa, Finland; [Osmond, Clive] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Copenhagen; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; Finland National Institute for Health & Welfare; University of Southampton	Andersen, LG (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	lg@ipm.regionh.dk	Baker, Jennifer/F-1917-2010; Bjerregaard, Lise Geisler/F-3818-2014; Baker, Jennifer L./AAH-4693-2020	Baker, Jennifer/0000-0002-9649-6615; Bjerregaard, Lise Geisler/0000-0001-8471-0832; Baker, Jennifer L./0000-0002-9649-6615; Eriksson, Johan/0000-0002-2516-2060; Angquist, Lars/0000-0002-9516-4424; Osmond, Clive/0000-0002-9054-4655	NordForsk [50440]; Danish Medical Research Council; Danish National Science Foundation; Academy of Finland; British Heart Foundation; Finska Lakaresallskapet; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Yrjo Jahnsson Foundation; Samfundet Folkhalsan; Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Nordic Research Council; Medical Research Council [U1475000004] Funding Source: researchfish	NordForsk; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Science Foundation(Danmarks Grundforskningsfond); Academy of Finland(Academy of Finland); British Heart Foundation(British Heart Foundation); Finska Lakaresallskapet; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Yrjo Jahnsson Foundation; Samfundet Folkhalsan; Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Nordic Research Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study is part of the Nordic longitudinal epidemiologic research program "Prenatal and Childhood Growth in Relation to Cardiovascular Disease" (the NordNet Study), which is a Nordic collaborative research project using existing Nordic cohorts, supported by the Nordic Research Council, NordForsk, grant no 50440. The building-up of the included cohorts has been based on support from many granting bodies (the Danish cohort has primarily been built on support from the Danish Medical Research Council and the Danish National Science Foundation, and the Helsinki Birth Cohort Study was supported by the Academy of Finland, British Heart Foundation, Finska Lakaresallskapet, Paivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, Yrjo Jahnsson Foundation, Samfundet Folkhalsan, The Diabetes Research Foundation, and The Finnish Foundation for Cardiovascular Research). The current activity is part of the Danish Obesity Research Centre (DanORC, http://www.danorc.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Andersen TF, 1999, DAN MED BULL, V46, P263; Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Byrne CD, 2000, J CLIN PATHOL, V53, P822, DOI 10.1136/jcp.53.11.822; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Cleves M., 2008, INTRO SURVIVAL ANAL; COX DR, 1972, J R STAT SOC B, V34, P187; Eriksson J, 2002, HORM METAB RES, V34, P72, DOI 10.1055/s-2002-20518; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eriksson JG, 2002, ANN MED, V34, P157, DOI 10.1080/713782141; Falkstedt D, 2007, INT J OBESITY, V31, P777, DOI 10.1038/sj.ijo.0803480; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Forsen T, 2004, HEART, V90, P20, DOI 10.1136/heart.90.1.20; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; Forsen TJ, 2004, ANN MED, V36, P389, DOI 10.1080/07853890410028438; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gunnarsdottir I, 2002, AM J CLIN NUTR, V76, P1290, DOI 10.1093/ajcn/76.6.1290; Haennel RG, 2002, CAN FAM PHYSICIAN, V48, P65; Harrell FE, 2001, REGRESSION MODELING; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Juel K, 1999, DAN MED BULL, V46, P354; Kaijser M, 2008, CIRCULATION, V117, P405, DOI 10.1161/CIRCULATIONAHA.107.710715; Kajantie E, 2008, INT J EPIDEMIOL, V37, P280, DOI 10.1093/ije/dyn012; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; Lawlor DA, 2006, AM J CLIN NUTR, V83, P767, DOI 10.1093/ajcn/83.4.767; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mahonen M, 1997, EUR J EPIDEMIOL, V13, P403, DOI 10.1023/A:1007306110822; Meas T, 2008, J CLIN ENDOCR METAB, V93, P3804, DOI 10.1210/jc.2008-0488; O'Sullivan JJ, 2000, ARCH DIS CHILD, V82, P202, DOI 10.1136/adc.82.3.202; Osler M, 2009, EUR J EPIDEMIOL, V24, P57, DOI 10.1007/s10654-008-9301-z; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Rapola JM, 1997, EUR J EPIDEMIOL, V13, P133, DOI 10.1023/A:1007380408729; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Solomons NW, 2009, NUTR REV, V67, pS12, DOI 10.1111/j.1753-4887.2009.00152.x; Therneau TM, 2000, MODELING SURVIVAL DA; Tzoulaki I, 2008, EUR HEART J, V29, P1049, DOI 10.1093/eurheartj/ehn105; Walton KA, 2000, EUR J EPIDEMIOL, V16, P793, DOI 10.1023/A:1007625030509; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yang L, 2008, J INTERN MED, V264, P39, DOI 10.1111/j.1365-2796.2007.01907.x	51	78	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14126	10.1371/journal.pone.0014126	http://dx.doi.org/10.1371/journal.pone.0014126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124730	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000284686500012
J	Wandernoth, PM; Raubuch, M; Mannowetz, N; Becker, HM; Deitmer, JW; Sly, WS; Wennemuth, G				Wandernoth, Petra M.; Raubuch, Michael; Mannowetz, Nadja; Becker, Holger M.; Deitmer, Joachim W.; Sly, William S.; Wennemuth, Gunther			Role of Carbonic Anhydrase IV in the Bicarbonate-Mediated Activation of Murine and Human Sperm	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; MOUSE SPERMATOZOA; PLASMA-MEMBRANE; O-18 EXCHANGE; CA-IV; CAPACITATION; EXPRESSION; FLAGELLAR; FLUID; EPIDIDYMIS	HCO(3)(-) is the signal for early activation of sperm motility. In vivo, this occurs when sperm come into contact with the HCO(3)(-) containing fluids in the reproductive tract. The activated motility enables sperm to travel the long distance to the ovum. In spermatozoa HCO(3)(-) stimulates the atypical sperm adenylyl cyclase (sAC) to promote the cAMP-mediated pathway that increases flagellar beat frequency. Stimulation of sAC may occur when HCO(3)(-) enters spermatozoa either directly by anion transport or indirectly via diffusion of CO(2) with subsequent hydration by intracellular carbonic anhydrase (CA). We here show that murine sperm possess extracellular CA IV that is transferred to the sperm surface as the sperm pass through the epididymis. Comparison of CA IV expression by qRT PCR analysis confirms that the transfer takes place in the corpus epididymidis. We demonstrate murine and human sperm respond to CO(2) with an increase in beat frequency, an effect that can be inhibited by ethoxyzolamide. Comparing CA activity in sperm from wild-type and CA IV(-/-) mice we found a 32.13% reduction in total CA activity in the latter. The CA IV(-/-) sperm also have a reduced response to CO(2). While the beat frequency of wild-type sperm increases from 2.86 +/- 0.12 Hz to 6.87 +/- 0.34 Hz after CO(2) application, beat frequency of CA IV(-/-) sperm only increases from 3.06 +/- 0.20 Hz to 5.29 +/- 0.47 Hz. We show, for the first time, a physiological role of CA IV that supplies sperm with HCO(3)(-), which is necessary for stimulation of sAC and hence early activation of spermatozoa.	[Wandernoth, Petra M.; Raubuch, Michael; Mannowetz, Nadja; Wennemuth, Gunther] Univ Saarland, Dept Anat & Cell Biol, D-6650 Homburg, Saar, Germany; [Becker, Holger M.] Univ Kaiserslautern, Div Zool Membrane Transport, Dept Biol, Kaiserslautern, Germany; [Deitmer, Joachim W.] Univ Kaiserslautern, Div Gen Zool, Dept Biol, Kaiserslautern, Germany; [Sly, William S.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saarland University; University of Kaiserslautern; University of Kaiserslautern; Saint Louis University	Wandernoth, PM (corresponding author), Univ Saarland, Dept Anat & Cell Biol, D-6650 Homburg, Saar, Germany.	angwen@uks.eu	Becker, Holger/AAB-4322-2020	Wennemuth, Gunther/0000-0003-3313-2475	HOMFOR [T201 00 044]	HOMFOR	The study was supported by HOMFOR T201 00 044 to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AU CL, 1980, J PHYSIOL-LONDON, V309, P419, DOI 10.1113/jphysiol.1980.sp013517; BADGER MR, 1989, PLANT PHYSIOL, V89, P51, DOI 10.1104/pp.89.1.51; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; BOATMAN DE, 1991, BIOL REPROD, V44, P806, DOI 10.1095/biolreprod44.5.806; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; DAVID A, 1969, J REPROD FERTIL, V19, P285, DOI 10.1530/jrf.0.0190285; DAVID A, 1973, FERTIL STERIL, V24, P227; Ekstedt E, 2004, J MOL HISTOL, V35, P167; Flesch FM, 2001, MOL REPROD DEV, V60, P107, DOI 10.1002/mrd.1067; Gadella BM, 2000, DEVELOPMENT, V127, P2407; Kaunisto K, 1999, BIOL REPROD, V61, P1521, DOI 10.1095/biolreprod61.6.1521; KAUNISTO K, 1995, BIOL REPROD, V52, P1350, DOI 10.1095/biolreprod52.6.1350; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; PARKKILA S, 1993, J HISTOCHEM CYTOCHEM, V41, P751, DOI 10.1177/41.5.8468457; Schuh SM, 2007, BIOL REPROD, V77, P960, DOI 10.1095/biolreprod.107.062562; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; SULTEMEYER DF, 1990, PLANT PHYSIOL, V94, P1250, DOI 10.1104/pp.94.3.1250; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svichar N, 2006, GLIA, V53, P241, DOI 10.1002/glia.20277; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; WAHEED A, 1992, ARCH BIOCHEM BIOPHYS, V294, P550, DOI 10.1016/0003-9861(92)90724-B; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Zhang H, 2003, J ANDROL, V24, P51	27	34	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15061	10.1371/journal.pone.0015061	http://dx.doi.org/10.1371/journal.pone.0015061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124840	Green Submitted, Green Published, gold			2022-12-25	WOS:000284572000025
J	Nduati, EW; Ng, DHL; Ndungu, FM; Gardner, P; Urban, BC; Langhorne, J				Nduati, Eunice W.; Ng, Dorothy H. L.; Ndungu, Francis M.; Gardner, Peter; Urban, Britta C.; Langhorne, Jean			Distinct Kinetics of Memory B-Cell and Plasma-Cell Responses in Peripheral Blood Following a Blood-Stage Plasmodium chabaudi Infection in Mice	PLOS ONE			English	Article							MALARIA-ENDEMIC AREA; BONE-MARROW; FALCIPARUM-MALARIA; IMMUNE-RESPONSE; NEGATIVE SELECTION; HUMORAL IMMUNITY; ANTIGEN; EXPRESSION; LYMPHOCYTES; ACTIVATION	B cell and plasma cell responses take place in lymphoid organs, but because of the inaccessibility of these organs, analyses of human responses are largely performed using peripheral blood mononuclear cells (PBMC). To determine whether PBMC are a useful source of memory B cells and plasma cells in malaria, and whether they reflect Plasmodium-specific B cell responses in spleen or bone marrow, we have investigated these components of the humoral response in PBMC using a model of Plasmodium chabaudi blood-stage infections in C57BL/6 mice. We detected memory B cells, defined as isotype-switched IgD(-) IgM(-) CD19(+) B cells, and low numbers of Plasmodium chabaudi Merozoite Surface Protein-1 (MSP1)-specific memory B cells, in PBMC at all time points sampled for up to 90 days following primary or secondary infection. By contrast, we only detected CD138(+) plasma cells and MSP1-specific antibody-secreting cells within a narrow time frame following primary (days 10 to 25) or secondary (day 10) infection. CD138(+) plasma cells in PBMC at these times expressed CD19, B220 and MHC class II, suggesting that they were not dislodged bone-marrow long-lived plasma cells, but newly differentiated migratory plasmablasts migrating to the bone marrow; thus reflective of an ongoing or developing immune response. Our data indicates that PBMC can be a useful source for malaria-specific memory B cells and plasma cells, but extrapolation of the results to human malaria infections suggests that timing of sampling, particularly for plasma cells, may be critical. Studies should therefore include multiple sampling points, and at times of infection/immunisation when the B-cell phenotypes of interest are likely to be found in peripheral blood.	[Nduati, Eunice W.; Urban, Britta C.] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Collaborat Res Programme, Kilifi, Kenya; [Nduati, Eunice W.; Ng, Dorothy H. L.; Ndungu, Francis M.; Gardner, Peter; Langhorne, Jean] MRC Natl Inst Med Res, Div Parasitol, London, England; [Urban, Britta C.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	MRC National Institute for Medical Research; Liverpool School of Tropical Medicine; University of Liverpool	Nduati, EW (corresponding author), Ctr Geog Med Res Coast, KEMRI Wellcome Trust Collaborat Res Programme, Kilifi, Kenya.	jlangho@nimr.mrc.ac.uk	Ndungu, Francis Maina/C-2199-2019; Urban, Britta/W-6087-2018	Ndungu, Francis Maina/0000-0002-8977-0030; Urban, Britta/0000-0002-4197-8393; Langhorne, Jean/0000-0002-2257-9733; Gardner, Pete/0000-0002-4940-2639	Medical Research Council, UK [U117584248]; BioMalPar PhD fellowship; A*STAR, Singapore; MRC; Wellcome Trust [07908]; Priority 1 "Life Sciences, Genomics and Biotechnology for Health" [LSHP-CT-2004-503578]; Evimalar European Network of Excellence; MRC [MC_U117584248] Funding Source: UKRI; Medical Research Council [MC_U117584248] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BioMalPar PhD fellowship; A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Priority 1 "Life Sciences, Genomics and Biotechnology for Health"; Evimalar European Network of Excellence; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, UK (File reference, U117584248). Eunice W. Nduati was the recipient of a BioMalPar PhD fellowship, Dorothy H. L. Ng is a recipient of an A*STAR MBBS-PhD National Science Scholarship (A*STAR, Singapore) and Peter Gardner a recipient of an MRC PhD studentship. Britta Urban is supported by a Wellcome Trust Senior Fellowship (Grant number 07908). This work is part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the sixth framework, and Evimalar European Network of Excellence in the seventh Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2003, J IMMUNOL, V171, P317, DOI 10.4049/jimmunol.171.1.317; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blanchard-Rohner G, 2009, BLOOD, V114, P4998, DOI 10.1182/blood-2009-03-211052; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Cadman ET, 2008, INFECT IMMUN, V76, P3924, DOI 10.1128/IAI.00372-08; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Cervenak L, 2001, IMMUNOL LETT, V78, P89, DOI 10.1016/S0165-2478(01)00239-5; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Cyster JG, 2002, ADV EXP MED BIOL, V512, P35; DILOSA RM, 1991, J IMMUNOL, V146, P4071; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; ELHASSAN IM, 1994, AM J TROP MED HYG, V51, P372, DOI 10.4269/ajtmh.1994.51.372; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Han SH, 1996, SCIENCE, V274, P2094, DOI 10.1126/science.274.5295.2094; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; Helmby H, 2000, INFECT IMMUN, V68, P1485, DOI 10.1128/IAI.68.3.1485-1490.2000; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; HO M, 1986, J INFECT DIS, V153, P763, DOI 10.1093/infdis/153.4.763; HVIID L, 1991, EUR J IMMUNOL, V21, P1249, DOI 10.1002/eji.1830210523; KELSO A, 1984, J IMMUNOL, V132, P2924; KUMARARATNE DS, 1987, CLIN EXP IMMUNOL, V68, P65; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; LANGHORNE J, 1991, J IMMUNOL, V146, P2771; Lanzavecchia A, 2006, IMMUNOL REV, V211, P303, DOI 10.1111/j.0105-2896.2006.00403.x; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Mamani-Matsuda M, 2008, BLOOD, V111, P4653, DOI 10.1182/blood-2007-11-123844; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; MELCHERS F, 1995, CURR OPIN IMMUNOL, V7, P214, DOI 10.1016/0952-7915(95)80006-9; Murasawa M, 2002, EUR J IMMUNOL, V32, P291, DOI 10.1002/1521-4141(200201)32:1<291::AID-IMMU291>3.0.CO;2-L; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Nagaoka H, 2000, CURR OPIN IMMUNOL, V12, P187, DOI 10.1016/S0952-7915(99)00070-9; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; OSMOND DG, 1986, IMMUNOL REV, V93, P103, DOI 10.1111/j.1600-065X.1986.tb01504.x; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023; TROYEBLOMBERG M, 1983, CLIN EXP IMMUNOL, V53, P335; vonderWeid T, 1996, J IMMUNOL, V156, P2510; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510	66	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15007	10.1371/journal.pone.0015007	http://dx.doi.org/10.1371/journal.pone.0015007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124900	gold, Green Published, Green Accepted			2022-12-25	WOS:000284527900015
J	Oikawa, A; Joshi, HJ; Rennie, EA; Ebert, B; Manisseri, C; Heazlewood, JL; Scheller, HV				Oikawa, Ai; Joshi, Hiren J.; Rennie, Emilie A.; Ebert, Berit; Manisseri, Chithra; Heazlewood, Joshua L.; Scheller, Henrik Vibe			An Integrative Approach to the Identification of Arabidopsis and Rice Genes Involved in Xylan and Secondary Wall Development	PLOS ONE			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; GENOME-WIDE ANALYSIS; REDUCING END-GROUPS; SUBCELLULAR-LOCALIZATION; ARABINOGALACTAN PROTEINS; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; CELLULOSE SYNTHESIS; BIOSYNTHESIS; EXPRESSION	Xylans constitute the major non-cellulosic component of plant biomass. Xylan biosynthesis is particularly pronounced in cells with secondary walls, implying that the synthesis network consists of a set of highly expressed genes in such cells. To improve the understanding of xylan biosynthesis, we performed a comparative analysis of co-expression networks between Arabidopsis and rice as reference species with different wall types. Many co-expressed genes were represented by orthologs in both species, which implies common biological features, while some gene families were only found in one of the species, and therefore likely to be related to differences in their cell walls. To predict the subcellular location of the identified proteins, we developed a new method, PFANTOM ((p) under bar lant protein (fa) under bar mily i (n) under bar formation-based predic (to) under barr for endo (m) under bar embrane), which was shown to perform better for proteins in the endomembrane system than other available prediction methods. Based on the combined approach of co-expression and predicted cellular localization, we propose a model for Arabidopsis and rice xylan synthesis in the Golgi apparatus and signaling from plasma membrane to nucleus for secondary cell wall differentiation. As an experimental validation of the model, we show that an Arabidopsis mutant in the PGSIP1 gene encoding one of the Golgi localized candidate proteins has a highly decreased content of glucuronic acid in secondary cell walls and substantially reduced xylan glucuronosyltransferase activity.	[Oikawa, Ai; Joshi, Hiren J.; Rennie, Emilie A.; Ebert, Berit; Manisseri, Chithra; Heazlewood, Joshua L.; Scheller, Henrik Vibe] Joint BioEnergy Inst, Feedstocks Div, Emeryville, CA USA; [Oikawa, Ai; Joshi, Hiren J.; Ebert, Berit; Manisseri, Chithra; Heazlewood, Joshua L.; Scheller, Henrik Vibe] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Rennie, Emilie A.; Scheller, Henrik Vibe] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Oikawa, A (corresponding author), Joint BioEnergy Inst, Feedstocks Div, Emeryville, CA USA.	HScheller@lbl.gov	Scheller, Henrik/AAH-4770-2020; Ebert, Berit/F-1856-2016; Manisseri, Chithra/ABD-2712-2021; Scheller, Henrik V/A-8106-2008; Ebert, Berit/C-1748-2019; Heazlewood, Joshua L/A-2554-2008; Joshi, Hiren/B-5739-2016	Scheller, Henrik/0000-0002-6702-3560; Ebert, Berit/0000-0002-6914-5473; Manisseri, Chithra/0000-0002-9402-4577; Scheller, Henrik V/0000-0002-6702-3560; Ebert, Berit/0000-0002-6914-5473; Heazlewood, Joshua L/0000-0002-2080-3826; Joshi, Hiren/0000-0002-8192-2829; Oikawa, Ai/0000-0003-4581-0974	US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; Japanese Yamada Science Foundation; National Institutes of Health (NIH)	US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Japanese Yamada Science Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 with Lawrence Berkeley National Laboratory. A.O. was additionally supported by funds from Japanese Yamada Science Foundation, and E.A.R. was supported by a National Institutes of Health (NIH) Pre-doctoral Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-1; ANDERSSON SI, 1983, CARBOHYD RES, V111, P283, DOI 10.1016/0008-6215(83)88312-8; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; Boevink P, 1996, PLANT J, V10, P935, DOI 10.1046/j.1365-313X.1996.10050935.x; Brembu T, 2005, J EXP BOT, V56, P2465, DOI 10.1093/jxb/eri239; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown DM, 2007, PLANT J, V52, P1154, DOI 10.1111/j.1365-313X.2007.03307.x; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Chatterjee M, 2005, PLANT SCI, V168, P501, DOI 10.1016/j.plantsci.2004.09.015; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gu Y, 2005, J CELL BIOL, V169, P127, DOI 10.1083/jcb.200409140; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hermans C, 2010, PLANT PHYSIOL, V152, P904, DOI 10.1104/pp.109.149849; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; JOHANSSON MH, 1977, WOOD SCI TECHNOL, V11, P251, DOI 10.1007/BF00356924; Jung KH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000164; Kaundal R, 2010, PLANT PHYSIOL, V154, P36, DOI 10.1104/pp.110.156851; Kinoshita K, 2009, BIOINFORMATICS, V25, P2677, DOI 10.1093/bioinformatics/btp442; Ko JH, 2006, MOL GENET GENOMICS, V276, P517, DOI 10.1007/s00438-006-0157-1; Konishi T, 2007, GLYCOBIOLOGY, V17, P345, DOI 10.1093/glycob/cwl081; Kzhyshkowska J, 2006, BLOOD, V107, P3221, DOI 10.1182/blood-2005-07-2843; Lafarguette F, 2004, NEW PHYTOL, V164, P107, DOI 10.1111/j.1469-8137.2004.01175.x; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1624, DOI 10.1093/pcp/pcm135; Li XM, 2004, PLANT PHYSIOL, V134, P940, DOI 10.1104/pp.103.036285; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; Liepman AH, 2010, PLANT J, V61, P1107, DOI 10.1111/j.1365-313X.2010.04161.x; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Liu DQ, 2008, PLANT MOL BIOL REP, V26, P98, DOI 10.1007/s11105-008-0026-7; Mitchell RAC, 2007, PLANT PHYSIOL, V144, P43, DOI 10.1104/pp.106.094995; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Mutwil M, 2009, MOL PLANT, V2, P1015, DOI 10.1093/mp/ssp055; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Piston F, 2010, PLANTA, V231, P677, DOI 10.1007/s00425-009-1077-1; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Rastogi S, 2010, METHODS MOL BIOL, V619, P285, DOI 10.1007/978-1-60327-412-8_17; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Shibolet O, 2007, J BIOL CHEM, V282, P35308, DOI 10.1074/jbc.M704426200; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Toole GA, 2010, PLANTA, V232, P677, DOI 10.1007/s00425-010-1199-5; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P1779, DOI 10.1093/bioinformatics/btn309; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x; Wrzeszczynski KO, 2004, CELL MOL LIFE SCI, V61, P1341, DOI 10.1007/s00018-004-4005-3; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Wu G, 2001, PLANT CELL, V13, P2841, DOI 10.1105/tpc.13.12.2841; Yang TB, 2004, J BIOL CHEM, V279, P42552, DOI 10.1074/jbc.M402830200; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; York WS, 2008, CURR OPIN PLANT BIOL, V11, P258, DOI 10.1016/j.pbi.2008.02.007; Zhang DS, 2004, PLANT MOL BIOL, V54, P353, DOI 10.1023/B:PLAN.0000036369.55253.dd; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001	82	70	85	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15481	10.1371/journal.pone.0015481	http://dx.doi.org/10.1371/journal.pone.0015481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124849	Green Submitted, gold, Green Published			2022-12-25	WOS:000284527900020
J	de Medina-Redondo, M; Arnaiz-Pita, Y; Clavaud, C; Fontaine, T; del Rey, F; Latge, JP; de Aldana, CRV				de Medina-Redondo, Maria; Arnaiz-Pita, Yolanda; Clavaud, Cecile; Fontaine, Thierry; del Rey, Francisco; Latge, Jean Paul; Vazquez de Aldana, Carlos R.			beta(1,3)-Glucanosyl-Transferase Activity Is Essential for Cell Wall Integrity and Viability of Schizosaccharomyces pombe	PLOS ONE			English	Article							1,3-BETA-GLUCAN SYNTHASE SUBUNIT; PH-REGULATED GENE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; CANDIDA-ALBICANS; ASCOSPORE WALL; CROSS-LINKING; ASPERGILLUS-FUMIGATUS; HETEROLOGOUS MODULES; POLARIZED GROWTH	Background: The formation of the cell wall in Schizosaccharomyces pombe requires the coordinated activity of enzymes involved in the biosynthesis and modification of beta-glucans. The beta(1,3)-glucan synthase complex synthesizes linear beta(1,3)glucans, which remain unorganized until they are cross-linked to other beta(1,3)-glucans and other cell wall components. Transferases of the GH72 family play important roles in cell wall assembly and its rearrangement in Saccharomyces cerevisiae and Aspergillus fumigatus. Four genes encoding beta(1,3)-glucanosyl-transferases -gas1(+), gas2(+), gas4(+) and gas5(+)-are present in S. pombe, although their function has not been analyzed. Methodology/Principal Findings: Here, we report the characterization of the catalytic activity of gas1p, gas2p and gas5p together with studies directed to understand their function during vegetative growth. From the functional point of view, gas1p is essential for cell integrity and viability during vegetative growth, since gas1 Delta mutants can only grow in osmotically supported media, while gas2p and gas5p play a minor role in cell wall construction. From the biochemical point of view, all of them display beta(1,3)-glucanosyl-transferase activity, although they differ in their specificity for substrate length, cleavage point and product size. In light of all the above, together with the differences in expression profiles during the life cycle, the S. pombe GH72 proteins may accomplish complementary, non-overlapping functions in fission yeast. Conclusions/Significance: We conclude that beta(1,3)-glucanosyl-transferase activity is essential for viability in fission yeast, being required to maintain cell integrity during vegetative growth.	[de Medina-Redondo, Maria; Arnaiz-Pita, Yolanda; del Rey, Francisco; Vazquez de Aldana, Carlos R.] Univ Salamanca, CSIC, Inst Microbiol Bioquim, Dept Microbiol & Genet, E-37008 Salamanca, Spain; [Clavaud, Cecile; Fontaine, Thierry; Latge, Jean Paul] Inst Pasteur, Unite Aspergillus, Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	de Medina-Redondo, M (corresponding author), Univ Salamanca, CSIC, Inst Microbiol Bioquim, Dept Microbiol & Genet, E-37008 Salamanca, Spain.	cvazquez@usal.es	Latge, Jean Paul/C-9846-2014; Fontaine, Thierry/F-8227-2011; Fontaine, thierry/Q-2201-2018; del Rey, Francisco/L-7132-2014; de Aldana, Carlos Vazquez/B-7772-2008	Fontaine, thierry/0000-0002-8184-789X; del Rey, Francisco/0000-0002-6517-7400; de Aldana, Carlos Vazquez/0000-0002-4513-3654	Comision Interministerial de Ciencia y Tecnologia [BFU2004-00778]; Junta de Castilla y Leon [GR231]; European Community [LSHB-CT-2004-511952]; Ministerio de Educacion y Ciencia	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Junta de Castilla y Leon(Junta de Castilla y Leon); European Community(European Commission); Ministerio de Educacion y Ciencia(Spanish Government)	This research was supported by grants from the Comision Interministerial de Ciencia y Tecnologia (BFU2004-00778) and Junta de Castilla y Leon (GR231) to C. R. V-A and from the European Community (LSHB-CT-2004-511952) to C.R.V-A. and J.P.L. M. M-R. held a fellowship from the Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barral P, 2005, BIOCHEM J, V390, P77, DOI 10.1042/BJ20050456; BUSH DA, 1974, J GEN MICROBIOL, V81, P199, DOI 10.1099/00221287-81-1-199; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Carotti C, 2004, EUR J BIOCHEM, V271, P3635, DOI 10.1111/j.1432-1033.2004.04297.x; Carotti C, 2002, YEAST, V19, P1113, DOI 10.1002/yea.905; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; de Medina-Redondo M, 2008, MOL MICROBIOL, V68, P1283, DOI 10.1111/j.1365-2958.2008.06233.x; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fonzi WA, 1999, J BACTERIOL, V181, P7070, DOI 10.1128/JB.181.22.7070-7079.1999; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Hartland RP, 1996, J BIOL CHEM, V271, P26843, DOI 10.1074/jbc.271.43.26843; HORISBERGER M, 1985, EXPERIENTIA, V41, P748, DOI 10.1007/BF02012578; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; Kapteyn JC, 1997, J BACTERIOL, V179, P6279, DOI 10.1128/JB.179.20.6279-6284.1997; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; KIPPERT F, 1995, FEMS MICROBIOL LETT, V132, P215; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Liu JH, 2000, FEBS LETT, V478, P105, DOI 10.1016/S0014-5793(00)01828-7; Liu JH, 1999, GENETICS, V153, P1193; Liu JH, 2002, MOL BIOL CELL, V13, P989, DOI 10.1091/mbc.01-12-0581; MANNERS DJ, 1977, CARBOHYD RES, V57, P189, DOI 10.1016/S0008-6215(00)81930-8; Martin V, 2000, MOL MICROBIOL, V38, P308, DOI 10.1046/j.1365-2958.2000.02118.x; Martin V, 2003, EUKARYOT CELL, V2, P159, DOI 10.1128/EC.2.1.159-169.2003; Moreno MB, 2000, YEAST, V16, P861; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; NURSE P, 1994, MOL BIOL CELL, V5, P613, DOI 10.1091/mbc.5.6.613; Osumi M, 1998, MICRON, V29, P207; Papaleo E, 2006, J MOL MODEL, V12, P237, DOI 10.1007/s00894-005-0025-7; POPOLO L, 1993, J BACTERIOL, V175, P1879, DOI 10.1128/JB.175.7.1879-1885.1993; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ragni E, 2007, EUKARYOT CELL, V6, P302, DOI 10.1128/EC.00321-06; Ram AFJ, 1998, J BACTERIOL, V180, P1418, DOI 10.1128/JB.180.6.1418-1424.1998; Rolli E, 2009, MOL BIOL CELL, V20, P4856, DOI 10.1091/mbc.E08-11-1155; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SAPORITOIRWIN SM, 1995, MOL CELL BIOL, V15, P601; VAI M, 1990, BIOCHIM BIOPHYS ACTA, V1038, P277, DOI 10.1016/0167-4838(90)90237-A; Valdivieso MH, 2000, J BACTERIOL, V182, P4752, DOI 10.1128/JB.182.17.4752-4757.2000; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zverlov VV, 1997, MICROBIOL-SGM, V143, P1701, DOI 10.1099/00221287-143-5-1701	49	25	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14046	10.1371/journal.pone.0014046	http://dx.doi.org/10.1371/journal.pone.0014046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124977	Green Published, gold, Green Submitted			2022-12-25	WOS:000284356900009
J	Ferandon, C; Moukha, S; Callac, P; Benedetto, JP; Castroviejo, M; Barroso, G				Ferandon, Cyril; Moukha, Serge; Callac, Philippe; Benedetto, Jean-Pierre; Castroviejo, Michel; Barroso, Gerard			The Agaricus bisporus cox1 Gene: The Longest Mitochondrial Gene and the Largest Reservoir of Mitochondrial Group I Introns	PLOS ONE			English	Article							BASIDIOMYCOTA AGROCYBE-AEGERITA; HORIZONTAL TRANSFER; RIBOSOMAL-RNA; COX1 GENE; SEQUENCE; ENDONUCLEASE; EVOLUTION; ORGANIZATION; HISTORY; GENOME	In eukaryotes, introns are located in nuclear and organelle genes from several kingdoms. Large introns (up to 5 kbp) are frequent in mitochondrial genomes of plant and fungi but scarce in Metazoa, even if these organisms are grouped with fungi among the Opisthokonts. Mitochondrial introns are classified in two groups (I and II) according to their RNA secondary structure involved in the intron self-splicing mechanism. Most of these mitochondrial group I introns carry a 'Homing Endonuclease Gene'' (heg) encoding a DNA endonuclease acting in transfer and site-specific integration ("homing'') and allowing intron spreading and gain after lateral transfer even between species from different kingdoms. Opposed to this gain mechanism, is another which implies that introns, which would have been abundant in the ancestral genes, would mainly evolve by loss. The importance of both mechanisms (loss and gain) is matter of debate. Here we report the sequence of the cox1 gene of the button mushroom Agaricus bisporus, the most widely cultivated mushroom in the world. This gene is both the longest mitochondrial gene (29,902 nt) and the largest group I intron reservoir reported to date with 18 group I and 1 group II. An exhaustive analysis of the group I introns available in cox1 genes shows that they are mobile genetic elements whose numerous events of loss and gain by lateral transfer combine to explain their wide and patchy distribution extending over several kingdoms. An overview of intron distribution, together with the high frequency of eroded heg, suggests that they are evolving towards loss. In this landscape of eroded and lost intron sequences, the A. bisporus cox1 gene exhibits a peculiar dynamics of intron keeping and catching, leading to the largest collection of mitochondrial group I introns reported to date in a Eukaryote.	[Ferandon, Cyril; Benedetto, Jean-Pierre; Castroviejo, Michel; Barroso, Gerard] Univ Victor Segalen Bordeaux 2, CNRS, UMR 5234, Bordeaux, France; [Moukha, Serge] Univ Victor Segalen Bordeaux 2, UFR Sci Pharmaceut, Lab Toxicol & Hyg Appl, Bordeaux, France; [Moukha, Serge; Callac, Philippe] INRA, UR Mycol & Securite Aliments 1264, Villenave Dornon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Ferandon, C (corresponding author), Univ Victor Segalen Bordeaux 2, CNRS, UMR 5234, Bordeaux, France.	gerard.barroso@u-bordeaux2.fr	Barroso, Gérard/AAB-5828-2021	Callac, Philippe/0000-0001-6860-0983				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; CUMMINGS DJ, 1989, CURR GENET, V16, P381, DOI 10.1007/BF00340719; Cusimano N, 2008, MOL BIOL EVOL, V25, P265, DOI 10.1093/molbev/msm241; DAMBERGER SH, 1994, NUCLEIC ACIDS RES, V22, P3508, DOI 10.1093/nar/22.17.3508; Fukami H, 2007, J MOL EVOL, V64, P591, DOI 10.1007/s00239-006-0279-4; FUKUMASANAKAI Y, 1992, REPT TOTTORI MYCOL I, V30, P60; Goddard MR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000003; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Gonzalez P, 1999, NUCLEIC ACIDS RES, V27, P1754, DOI 10.1093/nar/27.7.1754; Gonzalez P, 1998, GENE, V220, P45, DOI 10.1016/S0378-1119(98)00421-1; Haridas S, 2010, FEMS MICROBIOL LETT, V308, P29, DOI 10.1111/j.1574-6968.2010.01979.x; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; LOIZOS N, 1994, P NATL ACAD SCI USA, V91, P11983, DOI 10.1073/pnas.91.25.11983; MANIATIS T, 1982, MOL CLONING LAB MANU; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Nesbo CL, 2003, P NATL ACAD SCI USA, V100, P10806, DOI 10.1073/pnas.1434268100; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; Pellenz S, 2002, J MOL EVOL, V55, P302, DOI 10.1007/s00239-001-2327-4; RAPER JR, 1974, HDB GENETICS, V1, P597; Rot C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-71; Saguez C, 2000, NUCLEIC ACIDS RES, V28, P1299, DOI 10.1093/nar/28.6.1299; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; Sanchez-Puerta MV, 2008, MOL BIOL EVOL, V25, P1762, DOI 10.1093/molbev/msn129; Sandegren L, 2004, J BIOL CHEM, V279, P22218, DOI 10.1074/jbc.M400929200; Santamaria M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S15; Seligman LM, 1997, GENETICS, V147, P1653; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; WESSELS JGH, 1987, J GEN MICROBIOL, V133, P2557	38	65	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14048	10.1371/journal.pone.0014048	http://dx.doi.org/10.1371/journal.pone.0014048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124976	gold, Green Submitted, Green Published			2022-12-25	WOS:000284356900011
J	Sjolinder, H; Jonsson, AB				Sjolinder, Hong; Jonsson, Ann-Beth			Olfactory Nerve-A Novel Invasion Route of Neisseria meningitidis to Reach the Meninges	PLOS ONE			English	Article							CEREBROSPINAL-FLUID TRANSPORT; COFACTOR PROTEIN MCP; BLOOD-BRAIN-BARRIER; MENINGOCOCCAL DISEASE; ENDOTHELIAL-CELLS; INFLUENZA-VIRUS; INFECTION; CD46; MICE; INTRANASAL	Neisseria meningitidis is a human-specific pathogen with capacity to cause septic shock and meningitis. It has been hypothesized that invasion of the central nervous system (CNS) is a complication of a bacteremic condition. In this study, we aimed to characterize the invasion route of N. meningitidis to the CNS. Using an intranasally challenged mouse disease model, we found that twenty percent of the mice developed lethal meningitis even though no bacteria could be detected in blood. Upon bacterial infection, epithelial lesions and redistribution of intracellular junction protein N-cadherin were observed at the nasal epithelial mucosa, especially at the olfactory epithelium, which is functionally and anatomically connected to the CNS. Bacteria were detected in the submucosa of the olfactory epithelium, along olfactory nerves in the cribriform plate, at the olfactory bulb and subsequently at the meninges and subarachnoid space. Furthermore, our data suggest that a threshold level of bacteremia is required for the development of meningococcal sepsis. Taken together, N. meningitidis is able to pass directly from nasopharynx to meninges through the olfactory nerve system. This study enhances our understanding how N. meningitidis invades the meninges. The nasal olfactory nerve system may be a novel target for disease prevention that can improve outcome and survival.	[Sjolinder, Hong; Jonsson, Ann-Beth] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Stockholm University	Sjolinder, H (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	Hong.Sjolinder@gmt.su.se			Swedish Research Council [2006-2911, 2006-6304, 2006-4112, 2006-5073, 2007-3369, 2008-2572, 2008-3367, 2009-5679]; Swedish Cancer Society; Knut och Alice Wallenbergs Foundation; Torsten and Ragnar Soderbergs Foundation; Swedish Society for Medicine; Magnus Bergvalls Foundation; Olga Jeanssons Foundation; Lars Hiertas Minne Foundation; Harald och Greta Jeanssons Foundation; Petrus och Augusta Hedlunds Foundation; Anna Brita och Bo Castegrens Minne Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut och Alice Wallenbergs Foundation(Knut & Alice Wallenberg Foundation); Torsten and Ragnar Soderbergs Foundation; Swedish Society for Medicine; Magnus Bergvalls Foundation; Olga Jeanssons Foundation; Lars Hiertas Minne Foundation; Harald och Greta Jeanssons Foundation; Petrus och Augusta Hedlunds Foundation; Anna Brita och Bo Castegrens Minne Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	This work was supported by the Swedish Research Council (Grant nr 2006-2911, 2006-6304, 2006-4112, 2006-5073, 2007-3369, 2008-2572, 2008-3367 and 2009-5679), The Swedish Cancer Society, Knut och Alice Wallenbergs Foundation, Torsten and Ragnar Soderbergs Foundation, Swedish Society for Medicine, Magnus Bergvalls Foundation, Olga Jeanssons Foundation, Lars Hiertas Minne Foundation, Harald och Greta Jeanssons Foundation, Petrus och Augusta Hedlunds Foundation, Anna Brita och Bo Castegrens Minne Foundation, Tore Nilsons Foundation, Ake Wiberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DR, 1972, AM J ANAT, V133, P37, DOI 10.1002/aja.1001330104; BRODEUR BR, 1985, INFECT IMMUN, V50, P510, DOI 10.1128/IAI.50.2.510-516.1985; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Filippidis A, 2009, MED HYPOTHESES, V72, P694, DOI 10.1016/j.mehy.2008.10.031; Iwasaki T, 2004, ACTA NEUROPATHOL, V108, P485, DOI 10.1007/s00401-004-0909-0; Jarolim KL, 2000, J PARASITOL, V86, P50, DOI 10.1645/0022-3395(2000)086[0050:ALMSOT]2.0.CO;2; Johansson L, 2005, J IMMUNOL, V175, P433, DOI 10.4049/jimmunol.175.1.433; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Johnson JB, 2009, J VIROL, V83, P7602, DOI 10.1128/JVI.00713-09; Johnston M, 2002, NEWS PHYSIOL SCI, V17, P227, DOI 10.1152/nips.01400.2002; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Lovkvist L, 2008, INFECT IMMUN, V76, P3951, DOI 10.1128/IAI.00109-08; MACKINNON FG, 1992, MICROB PATHOGENESIS, V12, P415, DOI 10.1016/0882-4010(92)90004-8; Marra A, 2001, INFECT IMMUN, V69, P7318, DOI 10.1128/IAI.69.12.7318-7325.2001; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Mori I, 2005, J NEUROVIROL, V11, P129, DOI 10.1080/13550280590922793; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; Muenzner P, 2000, INFECT IMMUN, V68, P3601, DOI 10.1128/IAI.68.6.3601-3607.2000; Nagra G, 2006, AM J PHYSIOL-REG I, V291, pR1383, DOI 10.1152/ajpregu.00235.2006; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; Nikulin J, 2006, INT J MED MICROBIOL, V296, P553, DOI 10.1016/j.ijmm.2006.06.006; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Park CH, 2002, ARCH VIROL, V147, P1425, DOI 10.1007/s00705-001-0750-x; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Sjolinder H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000241; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Tubbs RS, 2007, J NEUROSURG-SPINE, V7, P328, DOI 10.3171/SPI-07/09/328; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; van Ginkel FW, 2003, P NATL ACAD SCI USA, V100, P14363, DOI 10.1073/pnas.2235844100; Yi K, 2003, INFECT IMMUN, V71, P1849, DOI 10.1128/IAI.71.4.1849-1855.2003; Zakharov Andrei, 2004, Lymphat Res Biol, V2, P139, DOI 10.1089/1539685042564372	36	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14034	10.1371/journal.pone.0014034	http://dx.doi.org/10.1371/journal.pone.0014034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124975	gold, Green Published, Green Submitted			2022-12-25	WOS:000284356900003
J	Ye, BP; Rui, Q; Wu, QL; Wang, DY				Ye, Boping; Rui, Qi; Wu, Qiuli; Wang, Dayong			Metallothioneins Are Required for Formation of Cross-Adaptation Response to Neurobehavioral Toxicity from Lead and Mercury Exposure in Nematodes	PLOS ONE			English	Article							LONG-LIVED MUTANTS; CAENORHABDITIS-ELEGANS; BEHAVIORAL DEFECTS; END-POINTS; C-ELEGANS; LIFE-SPAN; TRANSFERABLE PROPERTIES; ADAPTIVE RESPONSE; HYDROGEN-PEROXIDE; HUMAN-LYMPHOCYTES	Metallothioneins (MTs) are small, cysteine-rich polypeptides, but the role of MTs in inducing the formation of adaptive response is still largely unknown. We investigated the roles of metallothionein genes (mtl-1 and mtl-2) in the formation of cross-adaptation response to neurobehavioral toxicity from metal exposure in Caenorhabditis elegans. Pre-treatment with mild heat-shock at L2-larva stage effectively prevented the formation of the neurobehavioral defects and the activation of severe stress response in metal exposed nematodes at concentrations of 50 and 100 mM, but pre-treatment with mild heat-shock did not prevent the formation of neurobehavioral defects in 200 mM of metal exposed nematodes. During the formation of cross-adaptation response, the induction of mtl-1 and mtl-2 promoter activity and subsequent GFP gene expression were sharply increased in 50 mu M or 100 mM of metal exposed Pmtl-1::GFP and Pmtl-2::GFP transgenic adult animals after mild heat-shock treatment compared with those treated with mild heat-shock or metal exposure alone. Moreover, after pre-treatment with mild heat-shock, no noticeable increase of locomotion behaviors could be observed in metal exposed mtl-1 or mtl-2 mutant nematodes compared to those without mild heat-shock pre-treatment. The defects of adaptive response to neurobehavioral toxicity induced by metal exposure formed in mtl-1 and mtl-2 mutants could be completely rescued by the expression of mtl-1 and mtl-2 with the aid of their native promoters. Furthermore, overexpression of MTL-1 and MTL-2 at the L2-larval stage significantly suppressed the toxicity on locomotion behaviors from metal exposure at all examined concentrations. Therefore, the normal formation of cross-adaptation response to neurobehavioral toxicity induced by metal exposure may need the enough accumulation of MTs protein in animal tissues.	[Ye, Boping; Rui, Qi; Wu, Qiuli; Wang, Dayong] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Peoples R China; [Ye, Boping] China Pharmaceut Univ, Coll Life Sci & Technol, Nanjing 210009, Peoples R China; [Rui, Qi] Nanjing Agr Univ, Coll Life Sci, Nanjing, Peoples R China	Southeast University - China; China Pharmaceutical University; Nanjing Agricultural University	Ye, BP (corresponding author), Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Peoples R China.	dayongw@seu.edu.cn			National Natural Science Foundation of China [30870810]; Program for New Century Excellent Talents in University of China; NIH National Center for Research Resource, USA	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); NIH National Center for Research Resource, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the grants from the National Natural Science Foundation of China (No. 30870810) and the Program for New Century Excellent Talents in University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some strains used in this study were provided by the Caenorhabdits Genetics Center (funded by the NIH National Center for Research Resource, USA) and the Mitani laboratory (Tokyo Women's Medical University School of Medicine, Japan). We thank Dan Chase for the pCL40 (Pdop-1::rfp) vector, and King L. Chow for the KC136 strain.	Anderson GL, 2004, ENVIRON TOXICOL CHEM, V23, P1235, DOI 10.1897/03-264; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P3049, DOI 10.1897/02-565; BRENNER S, 1974, GENETICS, V77, P71; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Chu KW, 2002, AQUAT TOXICOL, V61, P53, DOI 10.1016/S0166-445X(02)00017-6; Cypser J, 2001, HUM EXP TOXICOL, V20, P295, DOI 10.1191/096032701701548070; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; Dhawan R, 1999, J TOXICOL ENV HEAL A, V58, P451, DOI 10.1080/009841099157179; DOMINGUEZ I, 1993, MUTAT RES, V301, P135, DOI 10.1016/0165-7992(93)90036-U; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Harada H, 2007, ECOTOX ENVIRON SAFE, V66, P378, DOI 10.1016/j.ecoenv.2006.02.017; Hughes S, 2007, ENVIRON POLLUT, V145, P395, DOI 10.1016/j.envpol.2006.06.003; Hughes SL, 2009, J PROTEOME RES, V8, P3512, DOI 10.1021/pr9001806; IMAGAWA M, 1990, BIOCHEM J, V268, P237, DOI 10.1042/bj2680237; Knapen D, 2005, COMP BIOCHEM PHYS C, V140, P347, DOI 10.1016/j.cca.2005.03.002; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Ma HB, 2009, ENVIRON TOXICOL CHEM, V28, P1311, DOI 10.1897/08-496.1; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; MORGAN RW, 1986, P NATL ACAD SCI USA, V83, P8059, DOI 10.1073/pnas.83.21.8059; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Peredney CL, 2000, ARCH ENVIRON CON TOX, V39, P113; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Priess J. R., 1997, C ELEGANS 2; SAMSON L, 1980, NATURE, V287, P861, DOI 10.1038/287861a0; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; SLICE LW, 1990, J BIOL CHEM, V265, P256; STEPHAN W, 1994, GENETICS, V138, P135, DOI 10.1093/genetics/138.1.135; Swain SC, 2004, J MOL BIOL, V341, P951, DOI 10.1016/j.jmb.2004.06.050; Ura K, 2002, J HEALTH SCI, V48, P583, DOI 10.1248/jhs.48.583; Wang DY, 2008, ARCH ENVIRON CON TOX, V54, P447, DOI 10.1007/s00244-007-9050-0; Wang DY, 2007, J ENVIRON SCI, V19, P1367, DOI 10.1016/S1001-0742(07)60223-X; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9; Wang DY, 2008, ENVIRON POLLUT, V151, P585, DOI 10.1016/j.envpol.2007.04.003; Wang D, 2007, ENVIRON TOXICOL PHAR, V24, P223, DOI 10.1016/j.etap.2007.05.009; Wang DY, 2010, ENVIRON TOXICOL PHAR, V29, P213, DOI 10.1016/j.etap.2010.01.002; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P423, DOI 10.1016/j.ecoenv.2009.12.014; Wang DY, 2009, ENVIRON TOXICOL PHAR, V28, P459, DOI 10.1016/j.etap.2009.07.008; Wang Y, 2007, ENVIRON TOXICOL CHEM, V26, P2405, DOI 10.1897/06-646R1.1; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Xing XJ, 2009, ECOTOX ENVIRON SAFE, V72, P1819, DOI 10.1016/j.ecoenv.2009.06.006; Yanase S, 1999, MUTAT RES-FUND MOL M, V426, P31, DOI 10.1016/S0027-5107(99)00079-2; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Yoshida M, 2006, TOXICOL LETT, V161, P210, DOI 10.1016/j.toxlet.2005.09.007; Yoshida M, 2005, TOXICOL LETT, V155, P361, DOI 10.1016/j.toxlet.2004.11.001	49	23	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14052	10.1371/journal.pone.0014052	http://dx.doi.org/10.1371/journal.pone.0014052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124968	gold, Green Published, Green Submitted			2022-12-25	WOS:000284356900014
J	Guldevall, K; Vanherberghen, B; Frisk, T; Hurtig, J; Christakou, AE; Manneberg, O; Lindstrom, S; Andersson-Svahn, H; Wiklund, M; Onfelt, B				Guldevall, Karolin; Vanherberghen, Bruno; Frisk, Thomas; Hurtig, Johan; Christakou, Athanasia E.; Manneberg, Otto; Lindstrom, Sara; Andersson-Svahn, Helene; Wiklund, Martin; Onfelt, Bjorn			Imaging Immune Surveillance of Individual Natural Killer Cells Confined in Microwell Arrays	PLOS ONE			English	Article							T-CELLS; SINGLE CELLS; IMMUNOLOGICAL SYNAPSE; MICROFLUIDIC DEVICE; LYMPH-NODE; ON-CHIP; ACTIVATION; PLATFORM; SEGREGATION; CYTOMETRY	New markers are constantly emerging that identify smaller and smaller subpopulations of immune cells. However, there is a growing awareness that even within very small populations, there is a marked functional heterogeneity and that measurements at the population level only gives an average estimate of the behaviour of that pool of cells. New techniques to analyze single immune cells over time are needed to overcome this limitation. For that purpose, we have designed and evaluated microwell array systems made from two materials, polydimethylsiloxane (PDMS) and silicon, for high-resolution imaging of individual natural killer (NK) cell responses. Both materials were suitable for short-term studies (<4 hours) but only silicon wells allowed long-term studies (several days). Time-lapse imaging of NK cell cytotoxicity in these microwell arrays revealed that roughly 30% of the target cells died much more rapidly than the rest upon NK cell encounter. This unexpected heterogeneity may reflect either separate mechanisms of killing or different killing efficiency by individual NK cells. Furthermore, we show that high-resolution imaging of inhibitory synapse formation, defined by clustering of MHC class I at the interface between NK and target cells, is possible in these microwells. We conclude that live cell imaging of NK-target cell interactions in multi-well microstructures are possible. The technique enables novel types of assays and allow data collection at a level of resolution not previously obtained. Furthermore, due to the large number of wells that can be simultaneously imaged, new statistical information is obtained that will lead to a better understanding of the function and regulation of the immune system at the single cell level.	[Guldevall, Karolin; Vanherberghen, Bruno; Christakou, Athanasia E.; Wiklund, Martin; Onfelt, Bjorn] Royal Inst Technol, Dept Appl Phys, Stockholm, Sweden; [Frisk, Thomas; Onfelt, Bjorn] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hurtig, Johan] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Manneberg, Otto] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Lindstrom, Sara; Andersson-Svahn, Helene] Royal Inst Technol, Dept Biotechnol, Stockholm, Sweden	Royal Institute of Technology; Karolinska Institutet; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Royal Institute of Technology	Guldevall, K (corresponding author), Royal Inst Technol, Dept Appl Phys, Stockholm, Sweden.	onfelt@kth.se	Manneberg, Otto/C-7708-2011; Manneberg, Otto/O-7012-2014; Hurtig, Johan/C-2634-2009; Hurtig, Johan/AGO-2079-2022; Önfelt, Björn/X-3302-2019	Manneberg, Otto/0000-0002-4720-2756; Hurtig, Johan/0000-0003-0167-5416; Guldevall, Karolin/0000-0003-1016-2460; Wiklund, Martin/0000-0002-3247-1945; Frisk, Thomas/0000-0002-3996-9279	Stiftelsen for Strategisk Forskning (SSF) [F06-0020]; Swedish Research Council [2009-2734, 2007-5520]; Hellmuth Hertz' Foundation	Stiftelsen for Strategisk Forskning (SSF)(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Hellmuth Hertz' Foundation	Stiftelsen for Strategisk Forskning (SSF), www.stratresearch.se, grant number: F06-0020. The Swedish Research Council, www.vr.se, grant numbers: 2009-2734 and 2007-5520. Hellmuth Hertz' Foundation, www.gustafssonsstiftelse.se, www.jeanssonsstiftelser.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Arcibal IG, 2007, ANAL BIOANAL CHEM, V387, P51, DOI 10.1007/s00216-006-0690-0; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Bodas D, 2006, MICROELECTRON ENG, V83, P1277, DOI 10.1016/j.mee.2006.01.195; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Delamarche E, 2001, ADV MATER, V13, P1164; Di Carlo D, 2006, ANAL CHEM, V78, P7918; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Faley S, 2008, LAB CHIP, V8, P1700, DOI 10.1039/b719799c; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P729; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Harnett MM, 2007, NAT REV IMMUNOL, V7, P897, DOI 10.1038/nri2188; Hosokawa K, 1999, ANAL CHEM, V71, P4781, DOI 10.1021/ac990571d; Jewett A, 1996, J IMMUNOL, V156, P907; JEWETT A, 1995, CELL IMMUNOL, V160, P91, DOI 10.1016/0008-8749(95)80013-9; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Kehr J, 2003, CURR OPIN PLANT BIOL, V6, P617, DOI 10.1016/j.pbi.2003.09.002; Kim J, 2000, J COLLOID INTERF SCI, V226, P231, DOI 10.1006/jcis.2000.6817; LAERMER F, 1994, VERFAHREN ANISOTROPE; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; NOBLE PB, 1979, CAN J PHYSIOL PHARM, V57, P108, DOI 10.1139/y79-016; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b; Revzin A, 2005, LAB CHIP, V5, P30, DOI 10.1039/b405557h; Schiffenbauer YS, 2009, LAB CHIP, V9, P2965, DOI 10.1039/b904778f; Sims CE, 2007, LAB CHIP, V7, P423, DOI 10.1039/b615235j; Song Q, 2010, ANAL CHEM, V82, P473, DOI 10.1021/ac9024363; Svahn HA, 2007, LAB CHIP, V7, P544, DOI 10.1039/b704632b; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vanherberghen B, 2010, LAB CHIP, V10, P2727, DOI 10.1039/c004707d; Villas B H, 1998, Cell Vis, V5, P56; Voldman J, 2006, CURR OPIN BIOTECH, V17, P532, DOI 10.1016/j.copbio.2006.07.001; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Wulfing C, 2003, P NATL ACAD SCI USA, V100, P7767, DOI 10.1073/pnas.1336920100; Yamamura S, 2005, ANAL CHEM, V77, P8050, DOI 10.1021/ac0515632; Yu MC, 2008, NAT IMMUNOL, V9, P898, DOI 10.1038/ni.1635; Zhu H, 2009, ANAL CHEM, V81, P8150, DOI 10.1021/ac901390j	53	52	52	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15453	10.1371/journal.pone.0015453	http://dx.doi.org/10.1371/journal.pone.0015453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103395	Green Published, gold, Green Submitted			2022-12-25	WOS:000284147700028
J	Lim, SP; Sonntag, LS; Noble, C; Nilar, SH; Ng, RH; Zou, G; Monaghan, P; Chung, KY; Dong, HP; Liu, BP; Bodenreider, C; Lee, G; Ding, M; Chan, WL; Wang, G; Jian, YL; Chao, AT; Lescar, J; Yin, Z; Vedananda, TR; Keller, TH; Shi, PY				Lim, Siew Pheng; Sonntag, Louis Sebastian; Noble, Christian; Nilar, Shahul H.; Ng, Ru Hui; Zou, Gang; Monaghan, Paul; Chung, Ka Yan; Dong, Hongping; Liu, Boping; Bodenreider, Christophe; Lee, Gladys; Ding, Mei; Chan, Wai Ling; Wang, Gang; Jian, Yap Li; Chao, Alexander Theodore; Lescar, Julien; Yin, Zheng; Vedananda, T. R.; Keller, Thomas H.; Shi, Pei-Yong			Small Molecule Inhibitors That Selectively Block Dengue Virus Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NS5; MECHANISM	Crystal structure analysis of Flavivirus methyltransferases uncovered a flavivirus-conserved cavity located next to the binding site for its cofactor, S-adenosyl-methionine (SAM). Chemical derivatization of S-adenosyl-homocysteine (SAH), the product inhibitor of the methylation reaction, with substituents that extend into the identified cavity, generated inhibitors that showed improved and selective activity against dengue virus methyltransferase (MTase), but not related human enzymes. Crystal structure of dengue virus MTase with a bound SAH derivative revealed that its N6-substituent bound in this cavity and induced conformation changes in residues lining the pocket. These findings demonstrate that one of the major hurdles for the development of methyltransferase-based therapeutics, namely selectivity for disease-related methyltransferases, can be overcome.	[Monaghan, Paul; Dong, Hongping; Liu, Boping; Bodenreider, Christophe; Lee, Gladys; Ding, Mei; Keller, Thomas H.; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore, Singapore; [Chung, Ka Yan; Jian, Yap Li; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Vedananda, T. R.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA	Novartis; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Novartis		siew_pheng.lim@novartis.com; pei_yong.shi@novartis.com	Zou, Gang/J-1833-2014; Lim, Siew Pheng/P-8528-2016; yin, zheng/A-4825-2012; Liu, Bo/HCG-9782-2022; Pheng, Lim Siew/AAG-4368-2021	Zou, Gang/0000-0001-9607-7827; yin, zheng/0000-0002-7346-6325; Liu, Bo/0000-0003-1685-7968; Pheng, Lim Siew/0000-0002-7377-5662; Keller, Thomas/0000-0002-7553-6235	BMRC [06/1/22/19/447]	BMRC(Agency for Science Technology & Research (A*STAR))	This work was supported in part by BMRC Grant 06/1/22/19/447 (to J. L.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; BORCHARDT RT, 1980, J MED CHEM, V23, P347, DOI 10.1021/jm00178a001; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197; Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrega C, 2004, MOL CELL, V13, P77, DOI 10.1016/S1097-2765(03)00522-7; FINNEY DJ, 1976, BIOMETRICS, V32, P721, DOI 10.2307/2529258; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; HASOBE M, 1989, ANTIMICROB AGENTS CH, V33, P828, DOI 10.1128/AAC.33.6.828; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Saavedra OM, 2009, BIOORG MED CHEM LETT, V19, P2747, DOI 10.1016/j.bmcl.2009.03.113; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	24	120	125	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6233	6240		10.1074/jbc.M110.179184	http://dx.doi.org/10.1074/jbc.M110.179184			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21147775	Green Published, hybrid			2022-12-25	WOS:000287476400033
J	Aresta-Branco, F; Cordeiro, AM; Marinho, HS; Cyrne, L; Antunes, F; de Almeida, RFM				Aresta-Branco, Francisco; Cordeiro, Andre M.; Marinho, H. Susana; Cyrne, Lusa; Antunes, Fernando; de Almeida, Rodrigo F. M.			Gel Domains in the Plasma Membrane of Saccharomyces cerevisiae HIGHLY ORDERED, ERGOSTEROL-FREE, AND SPHINGOLIPID-ENRICHED LIPID RAFTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; MULTIPLE FUNCTIONS; CELL-SURFACE; FATTY-ACIDS; FLUORESCENCE; PHASE; METABOLISM; H2O2; PERMEABILITY; CHOLESTEROL	The plasma membrane of Saccharomyces cerevisiae was studied using the probes trans-parinaric acid and diphenylhexatriene. Diphenylhexatriene anisotropy is a good reporter of global membrane order. The fluorescence lifetimes of transparinaric acid are particularly sensitive to the presence and nature of ordered domains, but thus far they have not been measured in yeast cells. A long lifetime typical of the gel phase (>30 ns) was found in wild-type (WT) cells from two different genetic backgrounds, at 24 and 30 degrees C, providing the first direct evidence for the presence of gel domains in living cells. To understand their nature and location, the study of WT cells was extended to spheroplasts, the isolated plasma membrane, and liposomes from total lipid and plasma membrane lipid extracts (with or without ergosterol extraction by cyclodextrin). It is concluded that the plasma membrane is mostly constituted by ordered domains and that the gel domains found in living cells are predominantly at the plasma membrane and are formed by lipids. To understand their composition, strains with mutations in sphingolipid and ergosterol metabolism and in the glycosylphosphatidylinositol anchor remodeling pathway were also studied. The results strongly indicate that the gel domains are not ergosterol-enriched lipid rafts; they are mainly composed of sphingolipids, possibly inositol phosphorylceramide, and contain glycosylphosphatidylinositol-anchored proteins, suggesting an important role in membrane traffic and signaling, and interactions with the cell wall. The abundance of the sphingolipid-enriched gel domains was inversely related to the cellular membrane system global order, suggesting their involvement in the regulation of membrane properties.	[Aresta-Branco, Francisco; Cordeiro, Andre M.; Marinho, H. Susana; Cyrne, Lusa; Antunes, Fernando; de Almeida, Rodrigo F. M.] Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, P-1749016 Lisbon, Portugal; [Marinho, H. Susana; Cyrne, Lusa; Antunes, Fernando] Univ Lisbon, Dept Quim & Bioquim, Ctr Quim & Bioquim, P-1749016 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	de Almeida, RFM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, Ed C8, P-1749016 Lisbon, Portugal.	Rodrigo.almeida@fc.ul.pt	Antunes, Fernando/A-1030-2009; Marinho, H. Susana/A-1357-2009; Cyrne, Luisa/A-1358-2009; Cordeiro, André/B-8310-2016; de Almeida, Rodrigo/D-8629-2012	Antunes, Fernando/0000-0002-4192-2840; Marinho, H. Susana/0000-0002-4625-2516; Cyrne, Luisa/0000-0002-0183-7713; Cordeiro, André/0000-0002-7299-8944; de Almeida, Rodrigo/0000-0002-9748-7083	Fundacao para a Ciencia e a Tecnologia, Portugal [PPCDT/BIA-MIC/59925/2004, PTDC/QUI-BIQ/104311/2008]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Grants PPCDT/BIA-MIC/59925/2004 and PTDC/QUI-BIQ/104311/2008 from Fundacao para a Ciencia e a Tecnologia, Portugal.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Asanov A, 2010, BBA-MOL CELL BIOL L, V1801, P147, DOI 10.1016/j.bbalip.2009.10.004; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Bosson R, 2007, BIOCHEM SOC SYMP, V74, P199, DOI 10.1042/BSS2007c17; Branco MR, 2004, J BIOL CHEM, V279, P6501, DOI 10.1074/jbc.M311818200; Castro BM, 2007, BIOPHYS J, V93, P1639, DOI 10.1529/biophysj.107.107714; Castro BM, 2009, J BIOL CHEM, V284, P22978, DOI 10.1074/jbc.M109.026567; Cerantola V, 2009, MOL MICROBIOL, V71, P1523, DOI 10.1111/j.1365-2958.2009.06628.x; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; de Almeida RFM, 2009, CHEM PHYS LIPIDS, V157, P61, DOI 10.1016/j.chemphyslip.2008.07.011; de Sampaio G, 1999, MOL MICROBIOL, V34, P247, DOI 10.1046/j.1365-2958.1999.01585.x; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; FOLCH J, 1957, J BIOL CHEM, V226, P497; Folmer V, 2008, BBA-BIOMEMBRANES, V1778, P1141, DOI 10.1016/j.bbamem.2007.12.008; Fujita M, 2006, MOL BIOL CELL, V17, P5253, DOI 10.1091/mbc.E06-08-0715; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; HEIDEPRIEM RW, 1992, J STEROID BIOCHEM, V43, P741, DOI 10.1016/0960-0760(92)90300-8; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Hsueh YW, 2007, BIOPHYS J, V92, P1606, DOI 10.1529/biophysj.106.097345; Klose C, 2010, J BIOL CHEM, V285, P30224, DOI 10.1074/jbc.M110.123554; Lagane B, 2000, J BIOL CHEM, V275, P33197, DOI 10.1074/jbc.C000576200; Leber A, 1997, FEBS LETT, V411, P211, DOI 10.1016/S0014-5793(97)00692-3; Lentz B. R., 1988, MEMBRANE FLUIDITY AN, P13; LESTER RL, 1993, J BIOL CHEM, V268, P845; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; MATEO CR, 1993, BIOPHYS J, V65, P2237, DOI 10.1016/S0006-3495(93)81257-8; MATEO CR, 1995, BIOPHYS J, V68, P978, DOI 10.1016/S0006-3495(95)80273-0; MATEO CR, 1991, EUR BIOPHYS J, V20, P41; Megha M, 2006, J BIOL CHEM, V281, P21903, DOI 10.1074/jbc.M600395200; Obeid LA, 2002, BBA-MOL CELL BIOL L, V1585, P163, DOI 10.1016/S1388-1981(02)00337-2; Opekarova M, 2005, BBA-BIOMEMBRANES, V1711, P87, DOI 10.1016/j.bbamem.2005.02.015; Panaretou Barry, 2006, Methods Mol Biol, V313, P27; Pedroso N, 2009, FREE RADICAL BIO MED, V46, P289, DOI 10.1016/j.freeradbiomed.2008.10.039; Ragoonanan V, 2008, BBA-BIOMEMBRANES, V1778, P2283, DOI 10.1016/j.bbamem.2008.06.006; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; SCHROEDER F, 1984, J NEUROCHEM, V43, P526, DOI 10.1111/j.1471-4159.1984.tb00931.x; SCHROEDER F, 1983, EUR J BIOCHEM, V132, P509, DOI 10.1111/j.1432-1033.1983.tb07391.x; SCHULTHESS G, 1995, MOL MEMBR BIOL, V12, P105, DOI 10.3109/09687689509038504; Scolari S, 2009, J BIOL CHEM, V284, P15708, DOI 10.1074/jbc.M900437200; Silva L, 2006, BIOPHYS J, V90, P3625, DOI 10.1529/biophysj.105.075408; Silva LC, 2007, BIOPHYS J, V92, P502, DOI 10.1529/biophysj.106.091876; SKLAR LA, 1977, BIOCHEMISTRY-US, V16, P819, DOI 10.1021/bi00624a002; Sousa-Lopes A, 2004, FEBS LETT, V578, P152, DOI 10.1016/j.febslet.2004.10.090; Swain E, 2002, J BIOL CHEM, V277, P26177, DOI 10.1074/jbc.M204115200; Valachovic M, 2006, GENETICS, V173, P1893, DOI 10.1534/genetics.105.053025; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; Vieira CR, 2010, CHEM BIOL, V17, P766, DOI 10.1016/j.chembiol.2010.05.023; Watanabe R, 2002, J BIOL CHEM, V277, P49538, DOI 10.1074/jbc.M206209200; WELTI R, 1981, J BIOL CHEM, V256, P7528; WOLF DE, 1995, MOL MEMBR BIOL, V12, P101, DOI 10.3109/09687689509038503; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002	63	77	79	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5043	5054		10.1074/jbc.M110.154435	http://dx.doi.org/10.1074/jbc.M110.154435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127065	Green Published, hybrid			2022-12-25	WOS:000287230600012
J	Granneman, JG; Moore, HPH; Mottillo, EP; Zhu, ZX; Zhou, L				Granneman, James G.; Moore, Hsiao-Ping H.; Mottillo, Emilio P.; Zhu, Zhengxian; Zhou, Li			Interactions of Perilipin-5 (Plin5) with Adipose Triglyceride Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANARIN-DORFMAN-SYNDROME; HORMONE-SENSITIVE LIPASE; LIPID DROPLET PROTEIN; CGI-58; FAMILY; LIPOLYSIS; CELLS; ACCUMULATION; ADIPOCYTES; METABOLISM	Members of the perilipin family of lipid droplet scaffold proteins are thought to play important roles in tissue-specific regulation of triglyceride metabolism, but the mechanisms involved are not fully understood. Present results indicate that adipose triglyceride lipase (Atgl) interacts with perilipin-5 (Plin5) but not perilipin-1 (Plin1). Protein interaction assays in live cells and in situ binding experiments showed that Atgl and its protein activator, alpha-beta-hydrolase domain-containing 5 (Abhd5), each bind Plin5. Surprisingly, competition experiments indicated that individual Plin5 molecules bind Atgl or Abhd5 but not both simultaneously. Thus, the ability of Plin5 to concentrate these proteins at droplet surfaces involves binding to different Plin5 molecules, possibly in an oligomeric complex. The association of Plin5-Abhd5 complexes on lipid droplet surfaces was more stable than Plin5-Atgl complexes, and oleic acid treatment selectively promoted the interaction of Plin5 and Abhd5. Analysis of chimeric and mutant perilipin proteins demonstrated that amino acids 200-463 are necessary and sufficient to bind both Atgl and Abhd5 and that the C-terminal 64 amino acids of Plin5 are critical for the differential binding of Atgl to Plin5 and Plin1. Mutant Plin5 that binds Abhd5 but not Atgl was defective in preventing neutral lipid accumulation compared with wild type Plin5, indicating that the ability of Plin5 to concentrate these proteins on lipid droplets is critical to functional Atgl activity in cells.	[Granneman, James G.; Mottillo, Emilio P.; Zhu, Zhengxian; Zhou, Li] Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Sch Med, Detroit, MI 48201 USA; [Moore, Hsiao-Ping H.] Lawrence Technol Univ, Southfield, MI 48075 USA	Wayne State University	Granneman, JG (corresponding author), Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Sch Med, 550 E Canfield, Detroit, MI 48201 USA.	jgranne@med.wayne.edu			National Institutes of Health [DK62292, DK76629]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076629, R01DK062292, R56DK062292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK62292 and DK76629. This work was also supported by the Department of Veterans Affairs.	Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Caviglia JM, 2009, BBA-MOL CELL BIOL L, V1791, P198, DOI 10.1016/j.bbalip.2008.12.018; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200	24	146	153	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5126	5135		10.1074/jbc.M110.180711	http://dx.doi.org/10.1074/jbc.M110.180711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148142	Green Published, hybrid			2022-12-25	WOS:000287230600020
J	Yip, CY; Harbour, ME; Jayawardena, K; Fearnley, IM; Sazanov, LA				Yip, Chui-ying; Harbour, Michael E.; Jayawardena, Kamburapola; Fearnley, Ian M.; Sazanov, Leonid A.			Evolution of Respiratory Complex I "SUPERNUMERARY" SUBUNITS ARE PRESENT IN THE alpha-PROTEOBACTERIAL ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; CYTOCHROME-C-OXIDASE; BOVINE HEART-MITOCHONDRIA; PARACOCCUS-DENITRIFICANS; ESCHERICHIA-COLI; QUINONE OXIDOREDUCTASE; MEMBRANE DOMAIN; THERMUS-THERMOPHILUS; HYDROPHILIC DOMAIN; MASS-SPECTROMETRY	Modern alpha-proteobacteria are thought to be closely related to the ancient symbiont of eukaryotes, an ancestor of mitochondria. Respiratory complex I from alpha-proteobacteria and mitochondria is well conserved at the level of the 14 "core" subunits, consistent with that notion. Mitochondrial complex I contains the core subunits, present in all species, and up to 31 "supernumerary" subunits, generally thought to have originated only within eukaryotic lineages. However, the full protein composition of an alpha-proteobacterial complex I has not been established previously. Here, we report the first purification and characterization of complex I from the alpha-proteobacterium Paracoccus denitrificans. Single particle electron microscopy shows that the complex has a well defined L-shape. Unexpectedly, in addition to the 14 core subunits, the enzyme also contains homologues of three supernumerary mitochondrial subunits as follows: B17.2, AQDQ/18, and 13 kDa ( bovine nomenclature). This finding suggests that evolution of complex I via addition of supernumerary or "accessory" subunits started before the original endosymbiotic event that led to the creation of the eukaryotic cell. It also provides further confirmation that alpha-proteobacteria are the closest extant relatives of mitochondria.	[Yip, Chui-ying; Harbour, Michael E.; Jayawardena, Kamburapola; Fearnley, Ian M.; Sazanov, Leonid A.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Sazanov, LA (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sazanov@mrc-mbu.cam.ac.uk	Sazanov, Leonid A/ABF-2125-2021	Sazanov, Leonid A/0000-0002-0977-7989	Medical Research Council; Medical Research Council [MC_U105674180] Funding Source: researchfish; MRC [MC_U105674180] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.	Andersson SGE, 1999, CURR OPIN MICROBIOL, V2, P535, DOI 10.1016/S1369-5274(99)00013-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brockmann C, 2004, STRUCTURE, V12, P1645, DOI 10.1016/j.str.2004.06.021; Carroll J, 2006, P NATL ACAD SCI USA, V103, P16170, DOI 10.1073/pnas.0607719103; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Carroll J, 2009, ANAL BIOCHEM, V395, P249, DOI 10.1016/j.ab.2009.08.006; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Dupuis A, 1998, BBA-BIOENERGETICS, V1364, P147, DOI 10.1016/S0005-2728(98)00025-5; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Giachini L, 2007, FEBS LETT, V581, P5645, DOI 10.1016/j.febslet.2007.11.019; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grivennikova VG, 2003, BBA-BIOENERGETICS, V1607, P79, DOI 10.1016/j.bbabio.2003.09.001; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; LUDWIG B, 1986, METHOD ENZYMOL, V126, P153; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Murray J, 2003, J BIOL CHEM, V278, P37223, DOI 10.1074/jbc.M305694200; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Peng GH, 2003, BIOCHEMISTRY-US, V42, P3032, DOI 10.1021/bi026876v; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2003, J BIOL CHEM, V278, P19483, DOI 10.1074/jbc.M208959200; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Scacco S, 2000, J BIOL CHEM, V275, P17578, DOI 10.1074/jbc.M001174200; Sharpley MS, 2006, J BIOL CHEM, V281, P34803, DOI 10.1074/jbc.M607389200; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; XU XM, 1993, BIOCHEMISTRY-US, V32, P968, DOI 10.1021/bi00054a030; YAGI T, 1993, J BIOENERG BIOMEMBR, V25, P339, DOI 10.1007/BF00762459; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b	53	68	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5023	5033		10.1074/jbc.M110.194993	http://dx.doi.org/10.1074/jbc.M110.194993			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21115482	Green Published, hybrid			2022-12-25	WOS:000287230600010
J	Ollivierre, JN; Sikora, JL; Beuning, PJ				Ollivierre, Jaylene N.; Sikora, Jacquelyn L.; Beuning, Penny J.			The Dimeric SOS Mutagenesis Protein UmuD Is Active as a Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECA-MEDIATED CLEAVAGE; INTRINSICALLY UNSTRUCTURED PROTEINS; DAMAGE-INDUCED MUTAGENESIS; BETA-PROCESSIVITY CLAMP; ESCHERICHIA-COLI; DNA-POLYMERASE; TRANSLESION SYNTHESIS; PLASMID TP110; UV PROTECTION; INTACT UMUD	The homodimeric umuD gene products play key roles in regulating the cellular response to DNA damage in Escherichia coli. UmuD(2) is composed of 139-amino acid subunits and is up-regulated as part of the SOS response. Subsequently, damage-induced RecA.ssDNA nucleoprotein filaments mediate the slow self-cleavage of the N-terminal 24-amino acid arms yielding UmuD'(2). UmuD(2) and UmuD'(2) make a number of distinct protein-protein contacts that both prevent and facilitate mutagenic translesion synthesis. Wild-type UmuD(2) and UmuD'(2) form exceptionally tight dimers in solution; however, we show that the single amino acid change N41D generates stable, active UmuD and UmuD' monomers that functionally mimic the dimeric wild-type proteins. The UmuD N41D monomer is proficient for cleavage and interacts physically with DNA polymerase IV (DinB) and the beta clamp. Furthermore, the N41D variants facilitate UV-induced mutagenesis and promote overall cell viability. Taken together, these observations show that a monomeric form of UmuD retains substantial function in vivo and in vitro.	[Beuning, Penny J.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Beuning, Penny J.] Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA	Northeastern University; Northeastern University	Beuning, PJ (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, 360 Huntington Ave,102 Hurtig Hall, Boston, MA 02115 USA.	beuning@neu.edu			Camille and Henry Dreyfus Foundation; National Science Foundation [MCB-0845033]; Northeastern University Office of the Provost	Camille and Henry Dreyfus Foundation; National Science Foundation(National Science Foundation (NSF)); Northeastern University Office of the Provost	This work was supported by a New Faculty Award from the Camille and Henry Dreyfus Foundation (to P. J. B.), the National Science Foundation (CAREER Award, MCB-0845033 to P. J. B.), and the Northeastern University Office of the Provost.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], DYNAMICS BACTERIAL C; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BATTISTA JR, 1990, P NATL ACAD SCI USA, V87, P7190, DOI 10.1073/pnas.87.18.7190; Becherel OJ, 1999, J MOL BIOL, V294, P299, DOI 10.1006/jmbi.1999.3272; Beuning PJ, 2006, METHOD ENZYMOL, V408, P318, DOI 10.1016/S0076-6879(06)08020-7; Beuning PJ, 2009, J BACTERIOL, V191, P5910, DOI 10.1128/JB.00292-09; Beuning PJ, 2006, J BIOL CHEM, V281, P9633, DOI 10.1074/jbc.M511101200; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Courcelle CT, 2006, P NATL ACAD SCI USA, V103, P9154, DOI 10.1073/pnas.0600785103; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Duzen JIM, 2004, DNA REPAIR, V3, P301, DOI 10.1016/j.dnarep.2003.11.008; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fang J, 2010, J MOL BIOL, V398, P40, DOI 10.1016/j.jmb.2010.02.040; Ferentz AE, 1997, NAT STRUCT BIOL, V4, P979, DOI 10.1038/nsb1297-979; Ferentz AE, 2001, EMBO J, V20, P4287, DOI 10.1093/emboj/20.15.4287; Finger C, 2006, J MOL BIOL, V358, P1221, DOI 10.1016/j.jmb.2006.02.065; Foti JJ, 2010, J BIOL CHEM, V285, P23084, DOI 10.1074/jbc.M110.115774; Frank EG, 1996, P NATL ACAD SCI USA, V93, P10291, DOI 10.1073/pnas.93.19.10291; Freidberg E. C., 2005, DNA REPAIR MUTAGENES; Fujii S, 2004, J MOL BIOL, V341, P405, DOI 10.1016/j.jmb.2004.06.017; GIMBLE FS, 1989, J MOL BIOL, V206, P29, DOI 10.1016/0022-2836(89)90521-4; GLAZEBROOK JA, 1986, J BACTERIOL, V168, P251, DOI 10.1128/jb.168.1.251-256.1986; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Gonzalez M, 2002, BIOESSAYS, V24, P141, DOI 10.1002/bies.10040; Gonzalez M, 1998, GENE DEV, V12, P3889, DOI 10.1101/gad.12.24.3889; Goodrich J., 2007, BINDING KINETICS MOL; Guzzo A, 1996, J BACTERIOL, V178, P7295, DOI 10.1128/jb.178.24.7295-7303.1996; HO C, 1993, J BACTERIOL, V175, P5411, DOI 10.1128/JB.175.17.5411-5419.1993; KULAEVA OI, 1995, J BACTERIOL, V177, P2737, DOI 10.1128/jb.177.10.2737-2743.1995; Lee MH, 1996, J BACTERIOL, V178, P7304, DOI 10.1128/jb.178.24.7304-7307.1996; LITTLE JW, 1993, J BACTERIOL, V175, P4943, DOI 10.1128/JB.175.16.4943-4950.1993; LODWICK D, 1990, NUCLEIC ACIDS RES, V18, P5045, DOI 10.1093/nar/18.17.5045; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; McDonald JP, 1998, P NATL ACAD SCI USA, V95, P1478, DOI 10.1073/pnas.95.4.1478; McLenigan M, 1998, J BACTERIOL, V180, P4658, DOI 10.1128/JB.180.17.4658-4666.1998; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; Ohta T, 1999, J BACTERIOL, V181, P177, DOI 10.1128/JB.181.1.177-185.1999; Ollivierre JN, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/947680; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Opperman T, 1996, J BACTERIOL, V178, P4400, DOI 10.1128/jb.178.15.4400-4411.1996; Peat TS, 1996, STRUCTURE, V4, P1401, DOI 10.1016/S0969-2126(96)00148-7; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; PERRY KL, 1985, P NATL ACAD SCI USA, V82, P4331, DOI 10.1073/pnas.82.13.4331; PERRY KL, 1982, NATURE, V300, P278, DOI 10.1038/300278a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Sambrook J., 2002, MOL CLONING LAB MANU; SAUER RT, 1982, NATURE, V298, P447, DOI 10.1038/298447a0; Schlacher K, 2007, NAT REV MOL CELL BIO, V8, P587, DOI 10.1038/nrm2198; SHIBA T, 1990, MOL GEN GENET, V224, P169, DOI 10.1007/BF00271549; Simon SM, 2008, P NATL ACAD SCI USA, V105, P1152, DOI 10.1073/pnas.0706067105; Singleton SF, 2002, PROTEIN EXPRES PURIF, V26, P476, DOI 10.1016/S1046-5928(02)00571-5; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; SOMMER S, 1993, MOL GEN GENET, V239, P137, DOI 10.1007/BF00281612; Sutton MD, 1999, P NATL ACAD SCI USA, V96, P12373, DOI 10.1073/pnas.96.22.12373; Sutton MD, 2002, DNA REPAIR, V1, P77, DOI 10.1016/S1568-7864(01)00006-4; Sutton MD, 2002, P NATL ACAD SCI USA, V99, P5307, DOI 10.1073/pnas.082322099; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002	71	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3607	3617		10.1074/jbc.M110.167254	http://dx.doi.org/10.1074/jbc.M110.167254			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118802	Green Published, hybrid			2022-12-25	WOS:000286653200045
J	Qi, H; Watanabe, T; Ku, HY; Liu, N; Zhong, M; Lin, HF				Qi, Hongying; Watanabe, Toshiaki; Ku, Hsueh-Yen; Liu, Na; Zhong, Mei; Lin, Haifan			The Yb Body, a Major Site for Piwi-associated RNA Biogenesis and a Gateway for Piwi Expression and Transport to the Nucleus in Somatic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY PIRNA BIOGENESIS; PLANARIAN STEM-CELLS; DROSOPHILA-MELANOGASTER; SELF-RENEWAL; FLAMENCO GENE; MALE GERMLINE; HIWI GENE; PROTEIN; ARMITAGE; HOMOLOG	Despite exciting progress in understanding the Piwi-interacting RNA (piRNA) pathway in the germ line, less is known about this pathway in somatic cells. We showed previously that Piwi, a key component of the piRNA pathway in Drosophila, is regulated in somatic cells by Yb, a novel protein containing an RNA helicase-like motif and a Tudor-like domain. Yb is specifically expressed in gonadal somatic cells and regulates piwi in somatic niche cells to control germ line and somatic stem cell self-renewal. However, the molecular basis of the regulation remains elusive. Here, we report that Yb recruits Armitage (Armi), a putative RNA helicase involved in the piRNA pathway, to the Yb body, a cytoplasmic sphere to which Yb is exclusively localized. Moreover, co-immunoprecipitation experiments show that Yb forms a complex with Armi. In Yb mutants, Armi is dispersed throughout the cytoplasm, and Piwi fails to enter the nucleus and is rarely detectable in the cytoplasm. Furthermore, somatic piRNAs are drastically diminished, and soma-expressing transposons are desilenced. These observations indicate a crucial role of Yb and the Yb body in piRNA biogenesis, possibly by regulating the activity of Armi that controls the entry of Piwi into the nucleus for its function. Finally, we discovered putative endo-siRNAs in the flamenco locus and the Yb dependence of their expression. These observations further implicate a role for Yb in transposon silencing via both the piRNA and endo-siRNA pathways.	Yale Univ, Sch Med, Stem Cell Ctr, New Haven, CT 06511 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06511 USA	Yale University; Yale University	Lin, HF (corresponding author), Yale Univ, Stem Cell Ctr, 10 Amistad St, New Haven, CT 06509 USA.	haifan.lin@yale.edu	qi, hongying/G-7862-2012		National Institutes of Health [R01HD33760, DP1OD006825]; Mathers Award; Japan Society for the Promotion of Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033760] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174418] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Award; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01HD33760 and DP1OD006825 (to H.L.). This work was also supported by the Mathers Award (to H.L.) and a fellowship from the Japan Society for the Promotion of Science (to T.W.).	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Desset S, 2003, GENETICS, V164, P501; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Harris AN, 2001, DEVELOPMENT, V128, P2823; JOHNSON E, 1995, GENETICS, V140, P207; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; King FJ, 1999, DEVELOPMENT, V126, P1833; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lin H, 2008, COLD SH Q B, V73, P273, DOI 10.1101/sqb.2008.73.056; LIN HF, 1994, DEVELOPMENT, V120, P947; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu XY, 2006, INT J CANCER, V118, P1922, DOI 10.1002/ijc.21575; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Rossi L, 2006, DEV GENES EVOL, V216, P335, DOI 10.1007/s00427-006-0060-0; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Szakmary A, 2009, J CELL BIOL, V185, P613, DOI 10.1083/jcb.200903034; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	43	92	97	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3789	3797		10.1074/jbc.M110.193888	http://dx.doi.org/10.1074/jbc.M110.193888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106531	Green Published, hybrid			2022-12-25	WOS:000286653200060
J	Yamashita, H; Ueda, K; Kioka, N				Yamashita, Hiroshi; Ueda, Kazumitsu; Kioka, Noriyuki			WAVE2 Forms a Complex with PKA and Is Involved in PKA Enhancement of Membrane Protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CELL-MIGRATION; ANCHORING PROTEINS; ACTIN REORGANIZATION; ARP2/3 COMPLEX; PHOSPHORYLATION; WASP; RAC; ACTIVATION; ADHESION	PKA contributes to many physiological processes, including glucose homeostasis and cell migration. The substrate specificity of PKA is low compared with other kinases; thus, complex formation with A-kinase-anchoring proteins is important for the localization of PKA in specific subcellular regions and the phosphorylation of specific substrates. Here, we show that PKA forms a complex with WAVE2 (Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2) in MDA-MB-231 breast cancer cells and mouse brain extracts. Two separate regions of WAVE2 are involved in WAVE2-PKA complex formation. This complex localizes to the leading edge of MDA-MB-231 cells. PKA activation results in enlargement of the membrane protrusion. WAVE2 depletion impairs PKA localization at membrane protrusions and the enlargement of membrane protrusion induced by PKA activation. Together, these results suggest that WAVE2 works as an A-kinase-anchoring protein that recruits PKA at membrane protrusions and plays a role in the enlargement of membrane protrusions induced by PKA activation.	[Yamashita, Hiroshi; Ueda, Kazumitsu; Kioka, Noriyuki] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Kioka, N (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	nkioka@kais.kyoto-u.ac.jp		Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X	Naito Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Bio-oriented Technology Research Advancement Institution; Grants-in-Aid for Scientific Research [20228001] Funding Source: KAKEN	Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bio-oriented Technology Research Advancement Institution; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by The Naito Foundation, a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, research fellowships from the Japan Society for the Promotion of Science for Young Scientists, and a grant from the Bio-oriented Technology Research Advancement Institution.	Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; BUTT E, 1994, J BIOL CHEM, V269, P14509; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Danson CM, 2007, J CELL SCI, V120, P4144, DOI 10.1242/jcs.013714; Deming PB, 2008, J BIOL CHEM, V283, P35199, DOI 10.1074/jbc.M804448200; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gustafsdottir SM, 2005, ANAL BIOCHEM, V345, P2, DOI 10.1016/j.ab.2005.01.018; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2002, J BIOL CHEM, V277, P38121, DOI 10.1074/jbc.M205379200; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Langeberg LK, 2005, J CELL SCI, V118, P3217, DOI 10.1242/jcs.02416; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Machesky LM, 1998, CURR BIOL, V8, pR202, DOI 10.1016/S0960-9822(98)70125-3; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Mitsushima M, 2006, GENES CELLS, V11, P281, DOI 10.1111/j.1365-2443.2006.00932.x; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Pocha SM, 2009, CELL MOTIL CYTOSKEL, V66, P36, DOI 10.1002/cm.20323; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Rawe VY, 2004, HUM REPROD, V19, P2594, DOI 10.1093/humrep/deh513; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Takahashi H, 2005, BIOCHEM BIOPH RES CO, V336, P239, DOI 10.1016/j.bbrc.2005.08.064; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311	41	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3907	3914		10.1074/jbc.M110.145409	http://dx.doi.org/10.1074/jbc.M110.145409			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21119216	Green Published, hybrid			2022-12-25	WOS:000286653200071
J	Rathinavelan, T; Tang, C; De Guzman, RN				Rathinavelan, Thenmalarchelvi; Tang, Chun; De Guzman, Roberto N.			Characterization of the Interaction between the Salmonella Type III Secretion System Tip Protein SipD and the Needle Protein PrgI by Paramagnetic Relaxation Enhancement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL; BURKHOLDERIA-PSEUDOMALLEI; SHIGELLA-FLEXNERI; NMR STRUCTURE; V-ANTIGEN; IPAD; VISUALIZATION; INJECTISOME; COMPLEX; DOMAIN	Many Gram-negative bacteria that cause major diseases and mortality worldwide require the type III secretion system (T3SS) to inject virulence proteins into their hosts and cause infections. A structural component of the T3SS is the needle apparatus, which consists of a base, an external needle, and a tip complex. In Salmonella typhimurium, the external needle is assembled by the polymerization of the needle protein PrgI. On top of this needle sits a tip complex, which is partly formed by the tip protein SipD. How SipD interacts with PrgI during the assembly of the T3SS needle apparatus remains unknown. The central region of PrgI forms an alpha-helical hairpin, whereas SipD has a long central coiled-coil, which is a defining structural feature of other T3SS tip proteins as well. Using NMR paramagnetic relaxation enhancement, we have identified a specific region on the SipD coiled-coil that interacts directly with PrgI. We present a model of how SipD might dock at the tip of the needle based on our paramagnetic relaxation enhancement results, thus offering new insight about the mechanism of assembly of the T3SS needle apparatus.	[Rathinavelan, Thenmalarchelvi; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Tang, Chun] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Phys & Atom Mol Phys, Wuhan 430071, Hubei Province, Peoples R China	University of Kansas; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	rdguzman@ku.edu	Tang, Chun/P-4060-2019	Tang, Chun/0000-0001-6477-6500	NIH [RR017708, R01AI074856]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074856] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grants RR017708 and R01AI074856 (to R. N. D.).	Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chatterjee S, 2011, PROTEIN SCI, V20, P75, DOI 10.1002/pro.537; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; Erskine PT, 2006, J MOL BIOL, V363, P125, DOI 10.1016/j.jmb.2006.07.069; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galkin VE, 2010, J MOL BIOL, V396, P1392, DOI 10.1016/j.jmb.2010.01.001; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Kiss RS, 1999, BIOCHEMISTRY-US, V38, P4327, DOI 10.1021/bi982597p; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mota LJ, 2006, TRENDS MICROBIOL, V14, P197, DOI 10.1016/j.tim.2006.02.010; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Poyraz O, 2010, NAT STRUCT MOL BIOL, V17, P788, DOI 10.1038/nsmb.1822; Sani M, 2007, BBA-GEN SUBJECTS, V1770, P307, DOI 10.1016/j.bbagen.2006.10.007; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Tang C, 2008, NATURE, V455, P693, DOI 10.1038/nature07342; Tang C, 2008, J AM CHEM SOC, V130, P4048, DOI 10.1021/ja710493m; Wang Y, 2008, J BIOL CHEM, V283, P28297, DOI 10.1074/jbc.M804869200; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Wang Y, 2010, BIOCHEMISTRY-US, V49, P4220, DOI 10.1021/bi100335u; Zhang L, 2007, J BIOL CHEM, V282, P32144, DOI 10.1074/jbc.M703403200; Zhang LL, 2006, J MOL BIOL, V359, P322, DOI 10.1016/j.jmb.2006.03.028; ZHOU NE, 1992, BIOPOLYMERS, V32, P419, DOI 10.1002/bip.360320419	34	28	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4922	4930		10.1074/jbc.M110.159434	http://dx.doi.org/10.1074/jbc.M110.159434			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21138848	Green Published, hybrid			2022-12-25	WOS:000286975700088
J	Weeks, SD; Grasty, KC; Hernandez-Cuebas, L; Loll, PJ				Weeks, Stephen D.; Grasty, Kimberly C.; Hernandez-Cuebas, Lisa; Loll, Patrick J.			Crystal Structure of a Josephin-Ubiquitin Complex EVOLUTIONARY RESTRAINTS ON ATAXIN-3 DEUBIQUITINATING ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGLUTAMINE DISEASE PROTEIN; DEUBIQUITINATING ENZYME; DIFFRACTION DATA; OXYANION HOLE; ATAXIN-3; DOMAIN; CHAINS; NEURODEGENERATION; PROTEASOME; MECHANISM	The Josephin domain is a conserved cysteine protease domain found in four human deubiquitinating enzymes: ataxin-3, the ataxin-3-like protein (ATXN3L), Josephin-1, and Josephin-2. Josephin domains from these four proteins were purified and assayed for their ability to cleave ubiquitin substrates. Reaction rates differed markedly both among the different proteins and for different substrates with a given protein. The ATXN3L Josephin domain is a significantly more efficient enzyme than the ataxin-3 domain despite their sharing 85% sequence identity. To understand the structural basis of this difference, the 2.6 angstrom x-ray crystal structure of the ATXN3L Josephin domain in complex with ubiquitin was determined. Although ataxin-3 and ATXN3L adopt similar folds, they bind ubiquitin in different, overlapping sites. Mutations were made in ataxin-3 at selected positions, introducing the corresponding ATXN3L residue. Only three such mutations are sufficient to increase the catalytic activity of the ataxin-3 domain to levels comparable with that of ATXN3L, suggesting that ataxin-3 has been subject to evolutionary restraints that keep its deubiquitinating activity in check.	[Weeks, Stephen D.; Grasty, Kimberly C.; Hernandez-Cuebas, Lisa; Loll, Patrick J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Hernandez-Cuebas, Lisa] Drexel Univ, Coll Med, Grad Program Biochem, Philadelphia, PA 19102 USA	Drexel University; Drexel University	Loll, PJ (corresponding author), 245 N 15th St,MS 497, Philadelphia, PA 19102 USA.	pat.loll@drexel.edu	Weeks, Stephen/N-4813-2019; Weeks, Stephen D/G-6150-2017	Weeks, Stephen/0000-0002-1360-0852; Weeks, Stephen D/0000-0002-1360-0852	National Institutes of Health (NINDS) [R01NS065140]; NIGMS, National Institutes of Health [GM-0080]; United States Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065140] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS065140 (NINDS).; We gratefully acknowledge crystallization advice from Dr. Virginie Nahoum and thank Drs. Roger Greenberg, Randy Pittman, Shahri Raasi, and Wai-Kwan Tang for sharing reagents. Diffraction data were collected at the National Synchrotron Light Source, X6A beam line, funded by the NIGMS, National Institutes of Health under agreement GM-0080. The National Synchrotron Light Source at Brookhaven National Laboratory is supported by the United States Department of Energy under contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alves S, 2010, HUM MOL GENET, V19, P2380, DOI 10.1093/hmg/ddq111; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Chow MKM, 2004, BIOCHEM BIOPH RES CO, V322, P387, DOI 10.1016/j.bbrc.2004.07.131; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hubener J, 2010, NEUROBIOL DIS, V38, P116, DOI 10.1016/j.nbd.2010.01.005; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lindner HA, 2007, VIROLOGY, V362, P245, DOI 10.1016/j.virol.2006.12.035; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; MENARD R, 1991, BIOCHEMISTRY-US, V30, P8924, DOI 10.1021/bi00101a002; MENARD R, 1995, BIOCHEMISTRY-US, V34, P464, DOI 10.1021/bi00002a010; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2006, J BIOMOL NMR, V36, P267, DOI 10.1007/s10858-006-9092-z; Nicastro G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012430; Nicastro G, 2009, BIOPOLYMERS, V91, P1203, DOI 10.1002/bip.21210; Ovaa H, 2005, METHOD ENZYMOL, V399, P468, DOI 10.1016/S0076-6879(05)99032-0; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Scheel H, 2003, HUM MOL GENET, V12, P2845, DOI 10.1093/hmg/ddg297; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tzvetkov N, 2007, BIOL CHEM, V388, P973, DOI 10.1515/BC.2007.107; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	49	36	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4555	4565		10.1074/jbc.M110.177360	http://dx.doi.org/10.1074/jbc.M110.177360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21118805	Green Published, hybrid			2022-12-25	WOS:000286975700056
J	Wruck, CJ; Streetz, K; Pavic, G; Gotz, ME; Tohidnezhad, M; Brandenburg, LO; Varoga, D; Eickelberg, O; Herdegen, T; Trautwein, C; Cha, KM; Kan, YW; Pufe, T				Wruck, Christoph Jan; Streetz, Konrad; Pavic, Goran; Goetz, Mario E.; Tohidnezhad, Mersedeh; Brandenburg, Lars-Ove; Varoga, Deike; Eickelberg, Oliver; Herdegen, Thomas; Trautwein, Christian; Cha, Kaimin; Kan, Yuet Wai; Pufe, Thomas			Nrf2 Induces Interleukin-6 (IL-6) Expression via an Antioxidant Response Element within the IL-6 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASED OXIDATIVE STRESS; LIVER-INJURY; MEDIATED EXPRESSION; GENE-EXPRESSION; CELLS; ACTIVATION; INDUCTION; PATHWAY; MICE; SURVIVAL	IL-6 gene expression is controlled by a promoter region containing multiple regulatory elements such as NF-kappa B, NF-IL6, CRE, GRE, and TRE. In this study, we demonstrated that TRE, found within the IL-6 promoter, is embedded in a functional antioxidant response element (ARE) matching an entire ARE consensus sequence. Further, point mutations of the ARE consensus sequence in the IL-6 promoter construct selectively eliminate ARE but not TRE activity. Nrf2 is a redox-sensitive transcription factor which provides cytoprotection against electrophilic and oxidative stress and is the most potent activator of ARE-dependent transcription. Using Nrf2 knock-out mice we demonstrate that Nrf2 is a potent activator of IL-6 gene transcription in vivo. Moreover, we show evidence that Nrf2 is the transcription factor that activates IL6 expression in a cholestatic hepatitis mouse model. Our findings suggest a possible role of IL-6 in oxidative stress defense and also give indication about an important function for Nrf2 in the regulation of hematopoietic and inflammatory processes.	[Wruck, Christoph Jan; Pavic, Goran; Tohidnezhad, Mersedeh; Brandenburg, Lars-Ove; Pufe, Thomas] Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Fac Med, D-52074 Aachen, Germany; [Streetz, Konrad; Trautwein, Christian] Univ Hosp Aachen, Dept Med 3, D-52074 Aachen, Germany; [Goetz, Mario E.] Fed Inst Risk Assessment, Dept Expt Toxicol, D-14191 Berlin, Germany; [Varoga, Deike] Dept Orthopaed Trauma Surg, D-24105 Kiel, Germany; [Eickelberg, Oliver] Ludwig Maximilians Univ Munchen, Comprehens Pneumol Ctr, Inst Lung Biol & Dis ILBD, D-81377 Neuherberg, Germany; [Eickelberg, Oliver] Helmholtz Zentrum Munchen, D-81377 Neuherberg, Germany; [Herdegen, Thomas] Univ Hosp Schleswig Holstein, Inst Pharmacol, D-24105 Kiel, Germany; [Cha, Kaimin] Queen Mary Hosp, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China; [Kan, Yuet Wai] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; Federal Institute for Risk Assessment; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Schleswig Holstein University Hospital; University of Hong Kong; University of California System; University of California San Francisco	Wruck, CJ (corresponding author), Rhein Westfal TH Aachen, Dept Anat & Cell Biol, Fac Med, D-52074 Aachen, Germany.	cwruck@ukaachen.de	Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360; Pavic, Goran/0000-0002-8104-1108	Deutsche Forschungsgemeinschaft [Pu 214/3-2, Pu 214/4-2, Pu 214/5-2, SFB617]; Faculty of Medicine, RWTH Aachen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Faculty of Medicine, RWTH Aachen	We acknowledge funding from the Deutsche Forschungsgemeinschaft Pu 214/3-2, Pu 214/4-2, and Pu 214/5-2, and SFB617. This research project was also supported by the START-Program of the Faculty of Medicine, RWTH Aachen.	Bernardi F, 2008, J OBSTET GYNAECOL RE, V34, P948, DOI 10.1111/j.1447-0756.2008.00803.x; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Bissonnette CJ, 2004, NEUROSCI LETT, V361, P40, DOI 10.1016/j.neulet.2004.01.005; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; de Araujo EG, 2009, ANN NY ACAD SCI, V1153, P57, DOI 10.1111/j.1749-6632.2008.03974.x; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Dhakshinamoorthy S, 2002, ONCOGENE, V21, P5301, DOI 10.1038/sj.onc.1205642; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fischer CP, 2004, J PHYSIOL-LONDON, V558, P633, DOI 10.1113/jphysiol.2004.066779; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Higdon JV, 2003, ARTERIOSCL THROM VAS, V23, P365, DOI 10.1161/01.ATV.0000063608.43095.E2; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; JAISWAL AK, 1994, BIOCHEM PHARMACOL, V48, P439, DOI 10.1016/0006-2952(94)90272-0; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; Kida H, 2005, AM J PHYSIOL-LUNG C, V288, pL342, DOI 10.1152/ajplung.00016.2004; Kolliputi N, 2009, AM J PHYSIOL-LUNG C, V297, pL6, DOI 10.1152/ajplung.90381.2008; Kong L, 2007, J NEUROCHEM, V101, P1041, DOI 10.1111/j.1471-4159.2007.04481.x; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Lee J, 2005, FASEB J, V19, pA955; Lee PC, 2005, TOXICOL SCI, V85, P541, DOI 10.1093/toxsci/kfi101; Li Jiang, 2007, V399, P67, DOI 10.1007/978-1-59745-504-6_6; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; McMahon M, 2001, CANCER RES, V61, P3299; Nakajima A, 2002, FREE RADICAL BIO MED, V32, P1324, DOI 10.1016/S0891-5849(02)00845-6; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Plum W, 2010, AM J PATHOL, V176, P2236, DOI 10.2353/ajpath.2010.090469; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Simeonova PP, 1997, J IMMUNOL, V159, P3921; Streetz KL, 2003, GASTROENTEROLOGY, V125, P532, DOI 10.1016/S0016-5085(03)00901-6; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Tacchini L, 2006, FREE RADICAL RES, V40, P1206, DOI 10.1080/10715760600885432; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Vassilakopoulos T, 2003, J APPL PHYSIOL, V94, P1025, DOI 10.1152/japplphysiol.00735.2002; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Wruck CJ, 2008, MOL PHARMACOL, V73, P1785, DOI 10.1124/mol.107.042499; Wruck CJ, 2009, HISTOPATHOLOGY, V55, P102, DOI 10.1111/j.1365-2559.2009.03339.x; XIE T, 1995, J BIOL CHEM, V270, P6894, DOI 10.1074/jbc.270.12.6894; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720	49	99	101	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4493	4499		10.1074/jbc.M110.162008	http://dx.doi.org/10.1074/jbc.M110.162008			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127061	Green Published, hybrid			2022-12-25	WOS:000286975700049
J	Allen, AE; Cameron, MA; Brown, TM; Vugler, AA; Lucas, RJ				Allen, Annette E.; Cameron, Morven A.; Brown, Timothy M.; Vugler, Anthony A.; Lucas, Robert J.			Visual Responses in Mice Lacking Critical Components of All Known Retinal Phototransduction Cascades	PLOS ONE			English	Article							SIGNALING PATHWAY; CONE TRANSDUCIN; ROD TRANSDUCIN; MELANOPSIN; PHOTORECEPTORS; ANTAGONIST; MUTATION	The mammalian visual system relies upon light detection by outer-retinal rod/cone photoreceptors and melanopsin-expressing retinal ganglion cells. Gnat1(-/-); Cnga3(-/-); Opn4(-/-) mice lack critical elements of each of these photoreceptive mechanisms via targeted disruption of genes encoding rod alpha transducin (Gnat1); the cone-specific alpha 3 cyclic nucleotide gated channel subunit (Cnga3); and melanopsin (Opn4). Although assumed blind, we show here that these mice retain sufficiently widespread retinal photoreception to drive a reproducible flash electroretinogram (ERG). The threshold sensitivity of this ERG is similar to that of cone-based responses, however it is lost under light adapted conditions. Its spectral efficiency is consistent with that of rod opsin, but not cone opsins or melanopsin, indicating that it originates with light absorption by the rod pigment. The TKO light response survives intravitreal injection of U73122 (a phospholipase C antagonist), but is inhibited by a missense mutation of cone alpha transducin (Gnat2(cpfl3)), suggesting Gnat2-dependence. Visual responses in TKO mice extend beyond the retina to encompass the lateral margins of the lateral geniculate nucleus and components of the visual cortex. Our data thus suggest that a Gnat1-independent phototransduction mechanism downstream of rod opsin can support relatively widespread responses in the mammalian visual system. This anomalous rod opsin-based vision should be considered in experiments relying upon Gnat1 knockout to silence rod phototransduction.	[Allen, Annette E.; Cameron, Morven A.; Brown, Timothy M.; Lucas, Robert J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Vugler, Anthony A.] UCL, Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England	University of Manchester; University of London; University College London	Allen, AE (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	robert.lucas@manchester.ac.uk	Cameron, Morven/B-4128-2012	Lucas, Robert/0000-0002-1088-8029; Allen, Annette/0000-0003-0214-7076; Cameron, Morven/0000-0002-2277-7035; Brown, Timothy/0000-0002-5625-4750	Wellcome Trust; Biotechnology and Biological Sciences Research Council; Your Manchester Fund; Lincy Foundation; London Project to Cure Blindness	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Your Manchester Fund; Lincy Foundation; London Project to Cure Blindness	This work was supported by the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, and the Your Manchester Fund (to RJL), and The Lincy Foundation and The London Project to Cure Blindness (to AAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; BROWN KT, 1964, NATURE, V201, P626, DOI 10.1038/201626a0; Brown TM, 2011, VISION RES, V51, P280, DOI 10.1016/j.visres.2010.08.010; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; Dyka FM, 2004, J NEUROCHEM, V90, P190, DOI 10.1111/j.1471-4159.2004.02474.x; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Kohara A, 2005, J PHARMACOL EXP THER, V315, P163, DOI 10.1124/jpet.105.087171; KOJIMA D, 1992, P NATL ACAD SCI USA, V89, P6841, DOI 10.1073/pnas.89.15.6841; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peng YW, 1997, P NATL ACAD SCI USA, V94, P1995, DOI 10.1073/pnas.94.5.1995; Porter RHP, 2005, J PHARMACOL EXP THER, V315, P711, DOI 10.1124/jpet.105.089839; Semo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015009; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; SZEL A, 1988, VISION RES, V28, P1297, DOI 10.1016/0042-6989(88)90060-0; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Van der Gucht E, 2007, CEREB CORTEX, V17, P2805, DOI 10.1093/cercor/bhm012; Woodruff ML, 2004, J PHYSIOL-LONDON, V557, P821, DOI 10.1113/jphysiol.2004.064014; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Ying SX, 2000, MOL VIS, V6, P101	33	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15063	10.1371/journal.pone.0015063	http://dx.doi.org/10.1371/journal.pone.0015063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124780	Green Published, Green Submitted, gold			2022-12-25	WOS:000284686500030
J	Shenoy, C; Boura, J; Orshaw, P; Harjai, KJ				Shenoy, Chetan; Boura, Judy; Orshaw, Pamela; Harjai, Kishore J.			Drug-Eluting Stents in Patients with Chronic Kidney Disease: A Prospective Registry Study	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MODERATE RENAL-INSUFFICIENCY; RANDOMIZED CLINICAL-TRIALS; BARE-METAL STENTS; MYOCARDIAL-INFARCTION; ANGIOGRAPHIC OUTCOMES; DIALYSIS PATIENTS; THROMBOSIS; IMPACT; IMPLANTATION	Background: Chronic kidney disease (CKD) is strongly associated with adverse outcomes after percutaneous coronary intervention (PCI). There are limited data on the effectiveness of drug-eluting stents (DES) in patients with CKD. Methodology/Principal Findings: Of 3,752 consecutive patients enrolled in the Guthrie PCI Registry between 2001 and 2006, 436 patients with CKD - defined as a creatinine clearance <60 mL/min - were included in this study. Patients who received DES were compared to those who received bare metal stents (BMS). Patients were followed for a mean duration of 3 years after the index PCI to determine the prognostic impact of stent type. Study end-points were all-cause death, myocardial infarction (MI), target vessel revascularization (TVR), stent thrombosis (ST) and the composite of major adverse cardiovascular events (MACE), defined as death, MI or TVR. Patients receiving DES in our study, by virtue of physician selection, had more stable coronary artery disease and had lower baseline risk of thrombotic or restenotic events. Kaplan-Meier estimates of proportions of patients reaching the end-points were significantly lower for DES vs. BMS for all-cause death (p = 0.0008), TVR (p = 0.029) and MACE (p = 0.0015), but not MI (p = 0.945) or ST (p = 0.88). Multivariable analysis with propensity adjustment demonstrated that DES implantation was an independent predictor of lower rates of all-cause death (hazard ratio [HR] 0.48, 95% confidence interval [CI] 0.25-0.92), TVR (HR 0.50, 95% CI 0.27-0.94) and MACE (HR 0.62, 95% CI 0.41-0.94). Conclusions: In a contemporary PCI registry, selective use of DES in patients with CKD was safe and effective in the long term, with lower risk of all-cause death, TVR and MACE and similar risk of MI and ST as compared with BMS. The mortality benefit may be a result of selection bias and residual confounding, or represent a true finding; a hypothesis that warrants clarification by randomized clinical trials.	[Shenoy, Chetan; Orshaw, Pamela; Harjai, Kishore J.] Guthrie Clin, Sayre, PA USA; [Boura, Judy] William Beaumont Hosp, Royal Oak, MI 48072 USA	Beaumont Health	Shenoy, C (corresponding author), Guthrie Clin, Sayre, PA USA.	harjai_kishore@guthrie.org	Shenoy, Chetan/AAF-9363-2020	Shenoy, Chetan/0000-0001-8877-4999				Appleby CE, 2009, CIRC-CARDIOVASC INTE, V2, P309, DOI 10.1161/CIRCINTERVENTIONS.108.828954; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Hage FG, 2009, J AM COLL CARDIOL, V53, P2129, DOI 10.1016/j.jacc.2009.02.047; Halkin A, 2005, AM HEART J, V150, P1163, DOI 10.1016/j.ahj.2005.01.032; Harjai KJ, 2009, HEART, V95, P1579, DOI 10.1136/hrt.2009.169896; Himmelfarb J, 2007, JAMA-J AM MED ASSOC, V297, P2630, DOI 10.1001/jama.297.23.2630; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Ishio N, 2007, CIRC J, V71, P1525, DOI 10.1253/circj.71.1525; Jensen LO, 2007, J AM COLL CARDIOL, V50, P463, DOI 10.1016/j.jacc.2007.06.002; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Lasala JM, 2009, CIRC-CARDIOVASC INTE, V2, P285, DOI 10.1161/CIRCINTERVENTIONS.109.852178.109.852178; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mellord C, 2008, J AM COLL CARDIOL, V51, P991, DOI 10.1016/j.jacc.2007.11.045; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nakazawa G, 2007, CATHETER CARDIO INTE, V69, P808, DOI 10.1002/ccd.21016; *NAT CARD DAT REG, TECHN DOWNL RISK ADJ; Novak JE, 2008, J AM SOC NEPHROL, V19, P2, DOI 10.1681/ASN.2007101136; Okada T, 2008, CIRC J, V72, P1430, DOI 10.1253/circj.CJ-08-0010; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Shenoy C, 2009, J INTERV CARDIOL, V22, P156, DOI 10.1111/j.1540-8183.2009.00424.x; Spaulding C, 2010, HEART, V96, P1073, DOI 10.1136/hrt.2008.161422; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; US Renal Data System: USRDS, 2009, ANN DAT REP ATL CHRO; Widimsky P, 2010, HEART, V96, P86, DOI 10.1136/hrt.2008.161034; Zhang RY, 2006, CHINESE MED J-PEKING, V119, P1176, DOI 10.1097/00029330-200607020-00007	33	27	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15070	10.1371/journal.pone.0015070	http://dx.doi.org/10.1371/journal.pone.0015070			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124771	gold, Green Published, Green Submitted			2022-12-25	WOS:000284686500033
J	Waddell, JN; Zhang, PJ; Wen, YF; Gupta, SK; Yevtodiyenko, A; Schmidt, JV; Bidwell, CA; Kumar, A; Kuang, SH				Waddell, Jolena N.; Zhang, Peijing; Wen, Yefei; Gupta, Sanjay K.; Yevtodiyenko, Aleksey; Schmidt, Jennifer V.; Bidwell, Christopher A.; Kumar, Ashok; Kuang, Shihuan			Dlk1 Is Necessary for Proper Skeletal Muscle Development and Regeneration	PLOS ONE			English	Article							SATELLITE CELL-DIFFERENTIATION; FACTOR-KAPPA-B; MYOGENIC DIFFERENTIATION; IMPRINTED GENES; SELF-RENEWAL; STEM-CELLS; INFLAMMATORY CYTOKINES; CALLIPYGE REGION; PROGENITOR CELLS; EXPRESSION	Delta-like 1homolog (Dlk1) is an imprinted gene encoding a transmembrane protein whose increased expression has been associated with muscle hypertrophy in animal models. However, the mechanisms by which Dlk1 regulates skeletal muscle plasticity remain unknown. Here we combine conditional gene knockout and over-expression analyses to investigate the role of Dlk1 in mouse muscle development, regeneration and myogenic stem cells (satellite cells). Genetic ablation of Dlk1 in the myogenic lineage resulted in reduced body weight and skeletal muscle mass due to reductions in myofiber numbers and myosin heavy chain IIB gene expression. In addition, muscle-specific Dlk1 ablation led to postnatal growth retardation and impaired muscle regeneration, associated with augmented myogenic inhibitory signaling mediated by NF-kappa B and inflammatory cytokines. To examine the role of Dlk1 in satellite cells, we analyzed the proliferation, self-renewal and differentiation of satellite cells cultured on their native host myofibers. We showed that ablation of Dlk1 inhibits the expression of the myogenic regulatory transcription factor MyoD, and facilitated the self-renewal of activated satellite cells. Conversely, Dlk1 over-expression inhibited the proliferation and enhanced differentiation of cultured myoblasts. As Dlk1 is expressed at low levels in satellite cells but its expression rapidly increases upon myogenic differentiation in vitro and in regenerating muscles in vivo, our results suggest a model in which Dlk1 expressed by nascent or regenerating myofibers non-cell autonomously promotes the differentiation of their neighbor satellite cells and therefore leads to muscle hypertrophy.	[Waddell, Jolena N.; Zhang, Peijing; Wen, Yefei; Bidwell, Christopher A.; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Gupta, Sanjay K.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Yevtodiyenko, Aleksey] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA; [Schmidt, Jennifer V.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Louisville; Stanford University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Waddell, JN (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	skuang@purdue.edu	Gupta/ABE-4368-2020; liang, yan/H-3894-2011	Kumar, Ashok/0000-0001-8571-2848; Wen, Yefei/0000-0002-2121-7538; Kuang, Shihuan/0000-0001-9180-3180; Zhang, Peijing/0000-0003-1586-8710	National Institutes of Health [1R01AR060652-01A1, HD042013]; Muscular Dystrophy Association [92478]; United States Department of Agriculture - National Research Initiative [2009-35206-05218]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); United States Department of Agriculture - National Research Initiative(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was funded by National Institutes of Health grant # 1R01AR060652-01A1 to SK and grant # HD042013 to JVS; Muscular Dystrophy Association grant # 92478 to SK; United States Department of Agriculture - National Research Initiative Grant # 2009-35206-05218 to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; Andersen DC, 2009, STEM CELLS, V27, P898, DOI 10.1634/stemcells.2008-0826; Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bidwell CA, 2001, ANIM GENET, V32, P248, DOI 10.1046/j.1365-2052.2001.00776.x; Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Brennan K, 1999, CURR BIOL, V9, P707, DOI 10.1016/S0960-9822(99)80313-3; Carpenter E, 1996, J ANIM SCI, V74, P388; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Charge SBP, 2002, AM J PHYSIOL-CELL PH, V283, pC1228, DOI 10.1152/ajpcell.00206.2002; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Espina AG, 2009, MOL BIOL CELL, V20, P3353, DOI 10.1091/mbc.E08-09-0965; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Freking BA, 1998, J ANIM SCI, V76, P2549; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Jackson SP, 1997, J ANIM SCI, V75, P133; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Khoury H, 2010, BLOOD, V115, P2260, DOI 10.1182/blood-2009-03-212746; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; LABORDA J, 1993, J BIOL CHEM, V268, P3817; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li L, 2005, ONCOGENE, V24, P4472, DOI 10.1038/sj.onc.1208637; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Monsalve E, 2009, EUR J IMMUNOL, V39, P2556, DOI 10.1002/eji.200838722; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Moresi V, 2008, STEM CELLS, V26, P997, DOI 10.1634/stemcells.2007-0493; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Murphy SK, 2005, MAMM GENOME, V16, P171, DOI 10.1007/s00335-004-2421-1; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Perkins AC, 2006, ANIM GENET, V37, P535, DOI 10.1111/j.1365-2052.2006.01518.x; Raghunandan R, 2008, STEM CELLS DEV, V17, P495, DOI 10.1089/scd.2007.0102; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Rusconi JC, 1998, MECH DEVELOP, V79, P39, DOI 10.1016/S0925-4773(98)00170-1; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schmidt JV, 2000, GENE DEV, V14, P1997; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takeda H, 2006, P NATL ACAD SCI USA, V103, P8119, DOI 10.1073/pnas.0602844103; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Thaloor D, 1999, AM J PHYSIOL-CELL PH, V277, pC320, DOI 10.1152/ajpcell.1999.277.2.C320; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Vuocolo T, 2005, AUST J EXP AGR, V45, P879, DOI 10.1071/EA05049; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; WIGSTON DJ, 1992, J NEUROBIOL, V23, P61, DOI 10.1002/neu.480230107; YANAI H, 2010, J BIOCH; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	88	92	97	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15055	10.1371/journal.pone.0015055	http://dx.doi.org/10.1371/journal.pone.0015055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124733	Green Published, Green Submitted, gold			2022-12-25	WOS:000284686500027
J	Geng, EH; Bwana, MB; Kabakyenga, J; Muyindike, W; Emenyonu, NI; Musinguzi, N; Mugyenyi, P; Martin, JN; Bangsberg, DR				Geng, Elvin H.; Bwana, Mwebesa B.; Kabakyenga, Jerome; Muyindike, Winnie; Emenyonu, Nneka I.; Musinguzi, Nicholas; Mugyenyi, Peter; Martin, Jeffrey N.; Bangsberg, David R.			Diminishing Availability of Publicly Funded Slots for Antiretroviral Initiation among HIV-Infected ART-Eligible Patients in Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ADHERENCE; IMPACT	Background: The impact of flat-line funding in the global scale up of antiretroviral therapy (ART) for HIV-infected patients in Africa has not yet been well described. Methods: We evaluated ART-eligible patients and patients starting ART at a prototypical scale up ART clinic in Mbarara, Uganda between April 1, 2009 and May 14, 2010 where four stakeholders sponsor treatment - two PEPFAR implementing organizations, the Ugandan Ministry of Health - Global Fund (MOH-GF) and a private foundation named the Family Treatment Fund (FTF). We assessed temporal trends in the number of eligible patients, the number starting ART and tabulated the distribution of the stakeholders supporting ART initiation by month and quartile of time during this interval. We used survival analyses to assess changes in the rate of ART initiation over calendar time. Findings: A total of 1309 patients who were eligible for ART made visits over the 14 month period of the study and of these 819 started ART. The median number of ART eligible patients each month was 88 (IQR: 74 to 115). By quartile of calendar time, PEPFAR and MOH sponsored 290, 192, 180, and 49 ART initiations whereas the FTF started 1, 2, 1 and 104 patients respectively. By May of 2010 (the last calendar month of observation) FTF sponsored 88% of all ART initiations. Becoming eligible for ART in the 3(rd) (HR = 0.58, 95% 0.45-0.74) and 4(th) quartiles (HR = 0.49, 95% CI: 0.36-0.65) was associated with delay in ART initiation compared to the first quartile in multivariable analyses. Interpretation: During a period of flat line funding from multinational donors for ART programs, reductions in the number of ART initiations by public programs (i.e., PEPFAR and MOH-GF) and delays in ART initiation became apparent at the a large prototypical scale-up ART clinic in Uganda.	[Geng, Elvin H.; Martin, Jeffrey N.] San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94110 USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bwana, Mwebesa B.; Kabakyenga, Jerome; Muyindike, Winnie; Emenyonu, Nneka I.; Musinguzi, Nicholas; Mugyenyi, Peter; Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Emenyonu, Nneka I.; Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ragon Inst,Massachusetts Inst Technol & Harvard,C, Boston, MA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Mbarara University of Science & Technology; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Geng, EH (corresponding author), San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94110 USA.	dbangsberg@partners.org	Muyindike, Winnie/W-2892-2019		National Institutes of Health [K23 AI084544, U01 AI069911, R01 MH054907, P30 AI027763, K24 MH87227]; Mark and Lisa Schwartz Family Foundation; United States President's Emergency Plan for AIDS Relief (PEPFAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U01AI069911, K23AI084544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, R01MH054907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mark and Lisa Schwartz Family Foundation; United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health (K23 AI084544, U01 AI069911, R01 MH054907, P30 AI027763, K24 MH87227), The Mark and Lisa Schwartz Family Foundation, and the United States President's Emergency Plan for AIDS Relief (PEPFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FOX M, 2010, TIME EFFICIENCY FIGH; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; KATABIRA ET, 2009, HLTH MO; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; MWAGOMBA B, PLOS ONE, V5; Nguyen VK, 2007, AIDS, V21, pS31, DOI 10.1097/01.aids.0000298100.48990.58; *OFF US GLOB AIDS, POW PARTN PRES EM PL; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Soni A, 2009, HEALTH AFFAIR, V28, P1617, DOI 10.1377/hlthaff.28.6.1617; Thirumurthy H, 2008, J HUM RESOUR, V43, P511, DOI 10.3368/jhr.43.3.511; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; PEPFAR UGANDA ART HA; NO TIME QUITE HIV AI	14	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14098	10.1371/journal.pone.0014098	http://dx.doi.org/10.1371/journal.pone.0014098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124842	Green Submitted, Green Published, gold			2022-12-25	WOS:000284572000004
J	Redon, CE; Nakamura, AJ; Gouliaeva, K; Rahman, A; Blakely, WF; Bonner, WM				Redon, Christophe E.; Nakamura, Asako J.; Gouliaeva, Ksenia; Rahman, Arifur; Blakely, William F.; Bonner, William M.			The Use of Gamma-H2AX as a Biodosimeter for Total-Body Radiation Exposure in Non-Human Primates	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PERIPHERAL-BLOOD LYMPHOCYTES; IONIZING-RADIATION; DNA-DAMAGE; IN-VIVO; HAIR-FOLLICLES; FOCI; BIOMARKER; SKIN; FRAGMENTATION	Background: There is a crucial shortage of methods capable of determining the extent of accidental exposures of human beings to ionizing radiation. However, knowledge of individual exposures is essential for early triage during radiological incidents to provide optimum possible life-sparing medical procedures to each person. Methods and Findings: We evaluated immunocytofluorescence-based quantitation of gamma-H2AX foci as a biodosimeter of total-body radiation exposure (Co-60 gamma-rays) in a rhesus macaque (Macaca mulatta) model. Peripheral blood lymphocytes and plucked hairs were collected from 4 cohorts of macaques receiving total body irradiation doses ranging from 1 Gy to 8.5 Gy. Each cohort consisted of 6 experimental and 2 control animals. Numbers of residual gamma-H2AX foci were proportional to initial irradiation doses and statistically significant responses were obtained until 1 day after 1 Gy, 4 days after 3.5 and 6.5 Gy, and 14 days after 8.5 Gy in lymphocytes and until 1 day after 1 Gy, at least 2 days after 3.5 and 6.5 Gy, and 9 days after 8.5 Gy in plucked hairs. Conclusion: These findings indicate that quantitation of gamma-H2AX foci may make a robust biodosimeter for analyzing total-body exposure to ionizing radiation in humans. This tool would help clinicians prescribe appropriate types of medical intervention for optimal individual outcome. These results also demonstrate that the use of a high throughput gamma-H2AX biodosimeter would be useful for days post-exposure in applications like large-scale radiological events or radiation therapy. In addition, this study validates a possibility to use plucked hair in future clinical trials investigating genotoxic effects of drugs and radiation treatments.	[Redon, Christophe E.; Nakamura, Asako J.; Gouliaeva, Ksenia; Bonner, William M.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Rahman, Arifur; Blakely, William F.] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Redon, CE (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	redonc@mail.nih.gov			NIAID; National Cancer Institute, Center for Cancer Research, NIH; Armed Forces Radiobiology Research Institute [BD-13 (RBB4AR)]; NATIONAL CANCER INSTITUTE [ZIABC006140] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, Center for Cancer Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Armed Forces Radiobiology Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the NIAID Radiation/Nuclear Countermeasures Program, the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH and under Armed Forces Radiobiology Research Institute under research work unit number BD-13 (RBB4AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beels L, 2009, CIRCULATION, V120, P1903, DOI 10.1161/CIRCULATIONAHA.109.880385; Belyaev IY, 2010, MUTAT RES-REV MUTAT, V704, P132, DOI 10.1016/j.mrrev.2010.01.011; Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boxman ILA, 1999, J CLIN MICROBIOL, V37, P2270, DOI 10.1128/JCM.37.7.2270-2273.1999; Cai ZL, 2009, INT J RADIAT BIOL, V85, P262, DOI 10.1080/09553000902748757; Camidge DR, 2005, BRIT J CANCER, V92, P1837, DOI 10.1038/sj.bjc.6602558; Conklin WC, 2005, HEALTH PHYS, V89, P457, DOI 10.1097/01.HP.0000178546.37526.c8; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Garty G, 2010, HEALTH PHYS, V98, P209, DOI 10.1097/HP.0b013e3181ab3cb6; Geisel D, 2008, RADIOLOGY, V248, P852, DOI 10.1148/radiol.2483071686; Goans RE, 1997, HEALTH PHYS, V72, P513, DOI 10.1097/00004032-199704000-00001; Gonzalez AJ, 2005, HEALTH PHYS, V89, P418, DOI 10.1097/01.HP.0000179340.57348.26; GREEN MR, 1986, J INVEST DERMATOL, V87, P768, DOI 10.1111/1523-1747.ep12457348; Hou YN, 2009, RADIAT RES, V171, P360, DOI 10.1667/RR1349.1; Kuefner MA, 2009, INVEST RADIOL, V44, P440, DOI 10.1097/RLI.0b013e3181a654a5; Kyoizumi S, 1998, RADIAT RES, V149, P11, DOI 10.2307/3579676; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Martin PR, 2007, RADIAT MEAS, V42, P1119, DOI 10.1016/j.radmeas.2007.05.021; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Nakamura AJ, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-6; Ohnishi T, 2009, BIOCHEM BIOPH RES CO, V390, P485, DOI 10.1016/j.bbrc.2009.09.114; Porcedda P, 2006, DNA REPAIR, V5, P904, DOI 10.1016/j.dnarep.2006.05.002; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Roch-Lefevre S, 2010, RADIAT RES, V174, P185, DOI 10.1667/RR1775.1; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rothkamm K, 2007, RADIOLOGY, V242, P244, DOI 10.1148/radiol.2421060171; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Sak A, 2007, INT J RADIAT BIOL, V83, P639, DOI 10.1080/09553000701596118; SIEBER VK, 1992, BRIT J RADIOL, V65, P148, DOI 10.1259/0007-1285-65-770-148; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015	33	106	112	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15544	10.1371/journal.pone.0015544	http://dx.doi.org/10.1371/journal.pone.0015544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124906	Green Submitted, Green Published, gold			2022-12-25	WOS:000284527900027
J	Yao, QO; Zhang, DW; Tang, B; Chen, J; Chen, J; Lu, LA; Zhang, WQ				Yao, Qiong; Zhang, Daowei; Tang, Bin; Chen, Jie; Chen, Jing; Lu, Liang; Zhang, Wenqing			Identification of 20-Hydroxyecdysone Late-Response Genes in the Chitin Biosynthesis Pathway	PLOS ONE			English	Article							ECDYSONE RECEPTOR ISOFORMS; STAGE-SPECIFIC EXPRESSION; DROSOPHILA-MELANOGASTER; MOLECULAR-CLONING; SYNTHASE GENE; PUFF CONTAINS; POLYTENE CHROMOSOMES; TREHALASE ACTIVITY; SPODOPTERA-EXIGUA; MATRIX FORMATION	Background: 20-hydroxyecdysone (20E) and its receptor complex ecdysone receptor (EcR) and ultraspiracle (USP) play a crucial role in controlling development, metamorphosis, reproduction and diapause. The ligand-receptor complex 20E-EcR/USP directly activates a small set of early-response genes and a much larger set of late-response genes. However, ecdysone-responsive genes have not been previously characterized in the context of insect chitin biosynthesis. Principal Findings: Here, we show that injection-based RNA interference (RNAi) directed towards a common region of the two isoforms of SeEcR in a lepidopteron insect Spodoptera exigua was effective, with phenotypes including a high mortality prior to pupation and developmental defects. After gene specific RNAi, chitin contents in the cuticle of an abnormal larva significantly decreased. The expression levels of five genes in the chitin biosynthesis pathway, SeTre-1, SeG6PI, SeUAP, SeCHSA and SeCHSB, were significantly reduced, while there was no difference in the expression of SeTre-2 prior to 72 hr after injection of EcR dsRNA. Meanwhile, injection of 20E in vivo induced the expression of the five genes mentioned above. Moreover, the SeTre-1, SeG6PI, SeUAP and SeCHSB genes showed late responses to the hormone and the induction of SeTre1, SeG6PI, SeUAP and SeCHSB genes by 20E were able to be inhibited by the protein synthesis inhibitor cycloheximide in vitro indicating these genes are 20E late-response genes. Conclusions: We conclude that SeTre-1, SeG6PI, SeUAP and SeCHSB in the chitin biosynthesis pathway are 20E late-response genes and 20E and its specific receptors plays a key role in the regulation of chitin biosynthesis via inducing their expression.	[Yao, Qiong; Zhang, Daowei; Tang, Bin; Chen, Jie; Chen, Jing; Lu, Liang; Zhang, Wenqing] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Bin] Hangzhou Normal Univ, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China	Sun Yat Sen University; Hangzhou Normal University	Yao, QO (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	Lsszwq@mail.sysu.edu.cn	zhang, wenqing/GYA-0786-2022		National Natural Science Foundation of China [30871634]; National Basic Research Program of China [2006CB102001]; Science Foundation of the State Key Laboratory of Biocontrol [SKLBC 10A 01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science Foundation of the State Key Laboratory of Biocontrol	This work was supported by National Natural Science Foundation of China (30871634), National Basic Research Program of China (2006CB102001) and Science Foundation of the State Key Laboratory of Biocontrol (SKLBC 10A 01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES AJ, 1992, TRENDS GENET, V8, P132, DOI 10.1016/0168-9525(92)90079-J; ANDRES AJ, 1995, DEVELOPMENT, V121, P2667; APPLE RT, 1991, DEV BIOL, V146, P569, DOI 10.1016/0012-1606(91)90257-4; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; ASHBURNER M, 1976, DEV BIOL, V54, P241, DOI 10.1016/0012-1606(76)90302-X; ASHBURNER M, 1990, CELL, V61, P1, DOI 10.1016/0092-8674(90)90205-S; ASHBURNER M, 1974, DEV BIOL, V39, P141, DOI 10.1016/S0012-1606(74)80016-3; Basso LR, 2006, GENESIS, V44, P505, DOI 10.1002/dvg.20239; Basso LR, 2002, MECH DEVELOP, V110, P15, DOI 10.1016/S0925-4773(01)00589-5; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; BINNINGTON KC, 1985, TISSUE CELL, V17, P131, DOI 10.1016/0040-8166(85)90021-7; Braquart C, 1996, EUR J BIOCHEM, V240, P336, DOI 10.1111/j.1432-1033.1996.0336h.x; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Chen XF, 2007, INSECT BIOCHEM MOLEC, V37, P409, DOI 10.1016/j.ibmb.2007.01.006; Davis MB, 2005, DEV BIOL, V282, P385, DOI 10.1016/j.ydbio.2005.03.019; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Gagou ME, 2002, INSECT BIOCHEM MOLEC, V32, P141, DOI 10.1016/S0965-1748(01)00101-1; Gariou-Papalexiou A, 2001, GENOME, V44, P752, DOI 10.1139/gen-44-5-752; HUET F, 1993, DEVELOPMENT, V118, P613; HUET F, 1995, DEVELOPMENT, V121, P1195; Kamimura M, 1997, EUR J BIOCHEM, V248, P786, DOI 10.1111/j.1432-1033.1997.t01-1-00786.x; Kapitskaya MZ, 2000, MOL CELL ENDOCRINOL, V160, P25, DOI 10.1016/S0303-7207(99)00253-1; Kato N, 2006, INSECT BIOCHEM MOLEC, V36, P1, DOI 10.1016/j.ibmb.2005.09.003; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kumar NS, 2008, COMP BIOCHEM PHYS B, V149, P447, DOI 10.1016/j.cbpb.2007.11.005; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; Li TR, 2000, DEVELOPMENT, V127, P2897; Martin D, 2001, MOL CELL ENDOCRINOL, V173, P75, DOI 10.1016/S0303-7207(00)00413-5; Minakuchi C, 2002, INSECT BIOCHEM MOLEC, V32, P999, DOI 10.1016/S0965-1748(02)00036-X; Perera SC, 1999, MOL CELL ENDOCRINOL, V152, P73, DOI 10.1016/S0303-7207(99)00058-1; PORCHERON P, 1991, ARCH INSECT BIOCHEM, V16, P257, DOI 10.1002/arch.940160405; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Singtripop T, 2002, J INSECT PHYSIOL, V48, P817, DOI 10.1016/S0022-1910(02)00104-X; Song QS, 1997, INSECT BIOCHEM MOLEC, V27, P973, DOI 10.1016/S0965-1748(97)00080-5; Stowers RS, 2000, DEV BIOL, V221, P23, DOI 10.1006/dbio.2000.9685; Stowers RS, 1999, DEV BIOL, V213, P116, DOI 10.1006/dbio.1999.9358; Tan A, 2008, MOL CELL ENDOCRINOL, V291, P42, DOI 10.1016/j.mce.2008.05.006; Tang B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-51; Tatun N, 2008, INSECT BIOCHEM MOLEC, V38, P788, DOI 10.1016/j.ibmb.2008.05.003; Tatun N, 2008, J INSECT PHYSIOL, V54, P351, DOI 10.1016/j.jinsphys.2007.10.006; Thummel CS, 2002, INSECT BIOCHEM MOLEC, V32, P113, DOI 10.1016/S0965-1748(01)00112-6; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tonning A, 2006, DEVELOPMENT, V133, P331, DOI 10.1242/dev.02206; Wright LG, 1996, J MOL BIOL, V255, P387, DOI 10.1006/jmbi.1996.0032; YAMAMOTO KR, 1976, ANNU REV BIOCHEM, V45, P721, DOI 10.1146/annurev.bi.45.070176.003445; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zimoch L, 2005, INSECT BIOCHEM MOLEC, V35, P515, DOI 10.1016/j.ibmb.2005.01.008	49	73	86	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14058	10.1371/journal.pone.0014058	http://dx.doi.org/10.1371/journal.pone.0014058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124981	Green Submitted, gold, Green Published			2022-12-25	WOS:000284356900015
J	Grubb, DR; Iliades, P; Cooley, N; Yu, YL; Luo, JT; Filtz, TM; Woodcock, EA				Grubb, David R.; Iliades, Peter; Cooley, Nicola; Yu, Yen Lin; Luo, Jieting; Filtz, Theresa M.; Woodcock, Elizabeth A.			Phospholipase C beta 1b associates with a Shank3 complex at the cardiac sarcolemma	FASEB JOURNAL			English	Article						compartmentalized signaling; alpha-fodrin; light membrane rafts; proline-rich domain; SH3 domain	NEONATAL-RAT CARDIOMYOCYTES; SCAFFOLDING PROTEIN SHANK3; B-SPLICE VARIANT; POSTSYNAPTIC DENSITY; PARATHYROID-HORMONE; C-BETA; RECEPTOR; FAMILY; MUTATIONS; DOMAIN	Activation of the heterotrimeric G protein Gq causes cardiomyocyte hypertrophy in vivo and in cell models. Our previous studies have shown that responses to activated Gq in cardiomyocytes are mediated exclusively by phospholipase C beta 1b (PLC beta 1b), because only this PLC beta subtype localizes at the cardiac sarcolemma. In the current study, we investigated the proteins involved in targeting PLC beta 1b to the sarcolemma in neonatal rat cardiomyocytes. PLC beta 1b, but not PLC beta 1a, coimmunoprecipitated with the high-MW scaffolding protein SH3 and ankyrin repeat protein 3 (Shank3), as well as the known Shank3-interacting protein alpha-fodrin. The 32-aa splice-variant-specific C-terminal tail of PLC beta 1b also associated with Shank3 and alpha-fodrin, indicating that PLC beta 1b binds via the C-terminal sequence. Shank3 colocalized with PLC beta 1b at the sarcolemma, and both proteins were enriched in the light membrane fractions. Knockdown of Shank3 using siRNA reduced PLC activation and downstream hypertrophic responses, demonstrating the importance of sarcolemmal localization for PLC signaling. These data indicate that PLC beta 1b associates with a Shank3 complex at the cardiac sarcolemma via its splice-variant-specific C-terminal tail. Sarcolemmmal localization is central to PLC activation and subsequent downstream signaling following Gq-coupled receptor activation.-Grubb, D. R., Iliades, P., Cooley, N., Yu, Y. L., Luo, J., Filtz, T. M., Woodcock, E. A. Phospholipase C beta 1b associates with a Shank3 complex at the cardiac sarcolemma. FASEB J. 25, 1040-1047 (2011). www.fasebj.org	[Grubb, David R.; Iliades, Peter; Cooley, Nicola; Yu, Yen Lin; Luo, Jieting; Woodcock, Elizabeth A.] Baker Int Diabet Inst IDI, Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Filtz, Theresa M.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA	Oregon State University	Woodcock, EA (corresponding author), Baker Int Diabet Inst IDI, Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia.	liz.woodcock@bakeridi.edu.au		Filtz, Theresa/0000-0002-5348-1114	National Health and Medical Research Council (NHMRC) of Australia [526621, 526623]; Australian National Heart Foundation [GM08-3695]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian National Heart Foundation(National Heart Foundation of Australia)	This work was supported by grants in aid from the National Health and Medical Research Council (NHMRC) of Australia (526621 and 526623), as well as the Australian National Heart Foundation (GM08-3695). E.A.W. is a Principal Research Fellow of the NHMRC (586621).	Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Arthur JF, 2001, J BIOL CHEM, V276, P37341, DOI 10.1074/jbc.M106572200; BAHK YY, 1994, J BIOL CHEM, V269, P8240; Beri S, 2007, J NEUROCHEM, V101, P1380, DOI 10.1111/j.1471-4159.2007.04539.x; Bertaso F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009755; Bockers TM, 2001, J BIOL CHEM, V276, P40104, DOI 10.1074/jbc.M102454200; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; Cai Y, 2005, ONCOGENE, V24, P4293, DOI 10.1038/sj.onc.1208593; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Grubb DR, 2008, FASEB J, V22, P2768, DOI 10.1096/fj.07-102558; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kreienkamp H-J., 2008, V186, P365, DOI 10.1007/978-3-540-72843-6_15; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Morris JB, 2006, J MOL CELL CARDIOL, V41, P17, DOI 10.1016/j.yjmcc.2006.03.011; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham TM, 2003, J MOL CELL CARDIOL, V35, P287, DOI 10.1016/S0022-2828(03)00009-9; Saavedra MV, 2008, NEUROREPORT, V19, P1123, DOI 10.1097/WNR.0b013e3283086797; Schlundt A, 2009, MOL CELL PROTEOMICS, V8, P2474, DOI 10.1074/mcp.M800337-MCP200; Schotten U, 2003, PROG BIOPHYS MOL BIO, V82, P151, DOI 10.1016/S0079-6107(03)00012-9; Schuetz G, 2004, J CELL BIOL, V167, P945, DOI 10.1083/jcb.200404108; Sheng M, 2000, J CELL SCI, V113, P1851; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Sun C, 2005, J PEPT RES, V65, P411, DOI 10.1111/j.1399-3011.2005.00240.x; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Woodcock EA, 2009, J MOL CELL CARDIOL, V47, P676, DOI 10.1016/j.yjmcc.2009.08.020; Zhang W, 2006, J BIOL CHEM, V281, P5811, DOI 10.1074/jbc.M507871200	36	22	21	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1040	1047		10.1096/fj.10-171470	http://dx.doi.org/10.1096/fj.10-171470			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21148417				2022-12-25	WOS:000287806200023
J	Jin, Z; Selaru, FM; Cheng, Y; Kan, T; Agarwal, R; Mori, Y; Olaru, AV; Yang, J; David, S; Hamilton, JP; Abraham, JM; Harmon, J; Duncan, M; Montgomery, EA; Meltzer, SJ				Jin, Z.; Selaru, F. M.; Cheng, Y.; Kan, T.; Agarwal, R.; Mori, Y.; Olaru, A. V.; Yang, J.; David, S.; Hamilton, J. P.; Abraham, J. M.; Harmon, J.; Duncan, M.; Montgomery, E. A.; Meltzer, S. J.			MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro	ONCOGENE			English	Article						microRNA-192 and-215; gastric cancer; ALCAM	CELL-ADHESION MOLECULE; TUMOR PROGRESSION; GENE-EXPRESSION; MESSENGER-RNAS; CYCLE ARREST; METASTASIS; INVOLVEMENT; STATISTICS; MECHANISM; INVASION	The dismal outcome of gastric cancer patients highlights the need for diagnostic biomarkers and effective therapeutic targets, such as microRNAs. We sought to discover microRNAs involved in gastric cancer, and to elucidate their downstream target mechanisms. Both cultured gastric epithelial cells (HFE145 and NCI-N87) and primary human gastric tissues (31 non-neoplastic stomach (NS) and 25 gastric carcinomas (GC)) were studied. MicroRNA microarrays and quantitative RT-PCR were applied to discover and verify differentially expressed microRNAs. in vitro cell migration and invasion, cell proliferation, cell cycle and apoptosis assays were executed to elucidate biological effects of microRNA-192 and -215. Western blotting and luciferase assays were performed to confirm direct messenger RNA targeting by microRNA-192 and -215. MicroRNA microarray analyses revealed that 25 and 20 microRNAs were upregulated and downregulated in GC vs NS, respectively. Expression levels of both microRNA-192 and -215 were significantly higher in GC than in NS (P < 0.05). Luciferase assays suggested that microRNA-215 inhibits activated leukocyte cell adhesion molecule (ALCAM) expression at the posttranscriptional level. In addition, expression levels of ALCAM were significantly lower in GC than in NS. Mimics and inhibitors, respectively, of microRNA-192 or -215 exerted no effect on cell cycle or apoptosis in the immortalized normal gastric cell line HFE145 or the gastric cancer cell line NCI-N87. However, mimics of microRNA-192 or -215 significantly increased growth rates in HFE145 cells, whereas inhibitors of microRNA-192 or -215 caused significant decreases in growth rates in NCI-N87 cells. ALCAM knockdown by an ALCAM-specific siRNA significantly increased cell growth in HFE145 cells. Both transfection of mimics of microRNA-192 or -215 and ALCAM knockdown by an ALCAM-specific siRNA significantly increased the migration of HFE145 cells. In conclusion, in gastric cancer, both microRNA-192 and 215 are overexpressed in vivo and exert cell growth and migration-promoting effects in vitro, thus representing potential microRNAs with a role in cancer in the human stomach. Oncogene (2011) 30, 1577-1585; doi: 10.1038/onc.2010.534; published online 29 November 2010	[Jin, Z.; Selaru, F. M.; Cheng, Y.; Kan, T.; Agarwal, R.; Mori, Y.; Olaru, A. V.; Yang, J.; David, S.; Hamilton, J. P.; Abraham, J. M.; Meltzer, S. J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21287 USA; [Harmon, J.; Duncan, M.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA; [Montgomery, E. A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Meltzer, S. J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Jin, Z (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, 1503 E Jefferson St,Rm 101A, Baltimore, MD 21287 USA.	zjin1@jhmi.edu		Selaru, Florin/0000-0001-7990-8238	NCI NIH HHS [P30 CA006973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Agarwal R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008002; Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Carbone M, 1997, NAT MED, V3, P908, DOI 10.1038/nm0897-908; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jezierska A, 2006, MED SCI MONITOR, V12, pBR245; Jezierska A, 2009, MED SCI MONITOR, V15, pRA32; Khushalani NI, 2008, MAYO CLIN PROC, V83, P712; KIM JH, 1991, J NATL CANCER I, V83, P938, DOI 10.1093/jnci/83.13.938; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kimura Y, 2004, MODERN PATHOL, V17, P1328, DOI 10.1038/modpathol.3800180; Kristiansen G, 2003, PROSTATE, V54, P34, DOI 10.1002/pros.10161; Li ZR, 2006, BIOCHEM BIOPH RES CO, V348, P229, DOI 10.1016/j.bbrc.2006.07.043; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Motoyama K, 2008, CLIN CANCER RES, V14, P2334, DOI 10.1158/1078-0432.CCR-07-4667; Noguchi T, 2001, AM J CLIN PATHOL, V115, P828; Ofori-Acquah SF, 2008, TRANSL RES, V151, P122, DOI 10.1016/j.trsl.2007.09.006; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; van Kempen LCLT, 2004, J INVEST DERMATOL, V122, P1293, DOI 10.1111/j.0022-202X.2004.22531.x; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Z, 2008, INT J CANCER, V123, P1439, DOI 10.1002/ijc.23643; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Zhou X, 2009, GENETICA, V137, P159, DOI 10.1007/s10709-009-9378-7	35	95	107	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	13					1577	1585		10.1038/onc.2010.534	http://dx.doi.org/10.1038/onc.2010.534			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	743DU	21119604	Green Accepted			2022-12-25	WOS:000288998300008
J	Guan, L; Nurva, S; Ankeshwarapu, SP				Guan, Lan; Nurva, Shailika; Ankeshwarapu, Siva P.			Mechanism of Melibiose/Cation Symport of the Melibiose Permease of Salmonella typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; RESONANCE ENERGY-TRANSFER; MEMBRANE-SPANNING SEGMENTS; ESCHERICHIA-COLI; SUGAR BINDING; ACTIVE-TRANSPORT; LACTOSE PERMEASE; KLEBSIELLA-PNEUMONIAE; DEPENDENT BINDING; CHARGED RESIDUES	The MelB permease of Salmonella typhimurium (MelB-ST) catalyzes the coupled symport of melibiose and Na+, Li+, or H+. In right-side-out membrane vesicles, melibiose efflux is inhibited by an inwardly directed gradient of Na+ or Li+ and stimulated by equimolar concentrations of internal and external Na+ or Li+. Melibiose exchange is faster than efflux in the presence of H+ or Na+ and stimulated by an inwardly directed Na+ gradient. Thus, sugar is released from MelB-ST externally prior to the release of cation in agreement with current models proposed for MelB of Escherichia coli (MelB-EC) and LacY. Although Li+ stimulates efflux, and an outwardly directed Li+ gradient increases exchange, it is striking that internal and external Li+ with no gradient inhibits exchange. Furthermore, Trp -> dansyl FRET measurements with a fluorescent sugar (2'-(N-dansyl) aminoalkyl-1-thio-beta-D-galactopyranoside) demonstrate that MelB-ST, in the presence of Na+ or Li+, exhibits K-app(d) values of similar to 1 mM for melibiose. Na+ and Li+ compete for a common binding pocket with activation constants for FRET of similar to 1 mM, whereas Rb+ or Cs+ exhibits little or no effect. Taken together, the findings indicate that MelB-ST utilizes H+ in addition to Na+ and Li+. FRET studies also show symmetrical emission maximum at similar to 500 nm with MelB-ST in the presence of 2'-(N-dansyl) aminoalkyl-1-thio-beta-D-galactopyranoside and Na+, Li+, or H+, which implies a relatively homogeneous distribution of conformers of MelB-ST ternary complexes in the membrane.	[Guan, Lan; Nurva, Shailika; Ankeshwarapu, Siva P.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Guan, L (corresponding author), 3601 4th St,5A163,STOP 6551, Lubbock, TX 79430 USA.	Lan.Guan@ttuhsc.edu			National Institutes of Health [R21HL087895, R01GM095538]; Texas Norman Hackerman Advanced Research Program [010674-0034-2009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL087895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Norman Hackerman Advanced Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21HL087895 and R01GM095538 (to L. G.). This work was also supported by Texas Norman Hackerman Advanced Research Program Grant 010674-0034-2009 (to L. G.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; BASSILANA M, 1988, J BIOL CHEM, V263, P9663; BASSILANA M, 1987, J BIOL CHEM, V262, P16865; BOTFIELD MC, 1992, J BIOL CHEM, V267, P1818; Cordat E, 1998, J BIOL CHEM, V273, P33198, DOI 10.1074/jbc.273.50.33198; DAMIANOFORANO E, 1986, J BIOL CHEM, V261, P6893; Dayem MA, 2003, J BIOL CHEM, V278, P1518, DOI 10.1074/jbc.M210053200; Ding PZ, 2001, BIOCHEM BIOPH RES CO, V285, P348, DOI 10.1006/bbrc.2001.5200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Franco PJ, 1999, J BACTERIOL, V181, P6377, DOI 10.1128/JB.181.20.6377-6386.1999; Franco PJ, 2001, BBA-BIOMEMBRANES, V1510, P231, DOI 10.1016/S0005-2736(00)00353-9; Ganea C, 2001, BIOCHEMISTRY-US, V40, P13744, DOI 10.1021/bi011223k; Garcia-Celma JJ, 2008, LANGMUIR, V24, P8119, DOI 10.1021/la800428h; Garcia-Celma JJ, 2010, BIOCHEMISTRY-US, V49, P6115, DOI 10.1021/bi100492p; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Guan L, 2009, BIOCHEMISTRY-US, V48, P9250, DOI 10.1021/bi9014067; Gwizdek C, 1997, BIOCHEMISTRY-US, V36, P8522, DOI 10.1021/bi970312n; Hacksell I, 2002, EMBO J, V21, P3569, DOI 10.1093/emboj/cdf378; HAMA H, 1994, J BIOL CHEM, V269, P1063; HAMA H, 1993, J BIOL CHEM, V268, P10060; Hirayama BA, 1997, J BIOL CHEM, V272, P2110; Kaback H R, 1974, Methods Enzymol, V31, P698; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KACZOROWSKI GJ, 1979, BIOCHEMISTRY-US, V18, P3691, DOI 10.1021/bi00584a009; KONINGS WN, 1971, J BIOL CHEM, V246, P5857; Leon X, 2005, BIOCHEMISTRY-US, V44, P3506, DOI 10.1021/bi048301z; Leon X, 2006, BIOPHYS J, V91, P4440, DOI 10.1529/biophysj.106.090241; Leon X, 2009, BIOPHYS J, V96, P4877, DOI 10.1016/j.bpj.2009.03.025; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; LOPILATO J, 1978, J BACTERIOL, V134, P147, DOI 10.1128/JB.134.1.147-156.1978; Maehrel C, 1998, J BIOL CHEM, V273, P33192, DOI 10.1074/jbc.273.50.33192; Matsuzaki S, 1999, BBA-BIOMEMBRANES, V1420, P63, DOI 10.1016/S0005-2736(99)00087-5; Meyer-Lipp K, 2006, J BIOL CHEM, V281, P25882, DOI 10.1074/jbc.M601259200; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; MIZUSHIMA K, 1992, MOL GEN GENET, V234, P74, DOI 10.1007/BF00272347; MUSVETEAU I, 1995, BIOCHEMISTRY-US, V34, P6775, DOI 10.1021/bi00020a024; NIIYA S, 1980, J BACTERIOL, V144, P192, DOI 10.1128/JB.144.1.192-199.1980; POURCHER T, 1991, BIOCHEM BIOPH RES CO, V178, P1176, DOI 10.1016/0006-291X(91)91016-6; POURCHER T, 1993, J BIOL CHEM, V268, P3209; POURCHER T, 1995, BIOCHEMISTRY-US, V34, P4412, DOI 10.1021/bi00013a033; Pourcher T, 1996, BIOCHEMISTRY-US, V35, P4161, DOI 10.1021/bi9527496; Purhonen P, 2005, J STRUCT BIOL, V152, P76, DOI 10.1016/j.jsb.2005.07.003; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; SCHULDINER S, 1975, J BIOL CHEM, V250, P1361; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; SCHULDINER S, 1975, BIOCHEMISTRY-US, V14, P5451, DOI 10.1021/bi00696a011; SHORT SA, 1974, P NATL ACAD SCI USA, V71, P1461, DOI 10.1073/pnas.71.4.1461; Smirnova IN, 2006, BIOCHEMISTRY-US, V45, P15279, DOI 10.1021/bi061632m; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; TOKUDA H, 1978, BIOCHEMISTRY-US, V17, P698, DOI 10.1021/bi00597a022; TOKUDA H, 1977, BIOCHEMISTRY-US, V16, P2130, DOI 10.1021/bi00629a013; TSUCHIYA T, 1978, MEMBRANE BIOCHEM, V2, P63, DOI 10.3109/09687687809063858; TSUCHIYA T, 1977, BIOCHEM BIOPH RES CO, V76, P26, DOI 10.1016/0006-291X(77)91663-1; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; WILSON DM, 1987, BIOCHIM BIOPHYS ACTA, V904, P191, DOI 10.1016/0005-2736(87)90368-3; Wilson TH, 2001, BBA-BIOENERGETICS, V1505, P121, DOI 10.1016/S0005-2728(00)00282-6; Yousef MS, 2009, P NATL ACAD SCI USA, V106, P15291, DOI 10.1073/pnas.0905516106; ZANI ML, 1993, J BIOL CHEM, V268, P3216; ZANI ML, 1994, J BIOL CHEM, V269, P24883	62	51	51	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6367	6374		10.1074/jbc.M110.206227	http://dx.doi.org/10.1074/jbc.M110.206227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148559	hybrid, Green Published			2022-12-25	WOS:000287476400047
J	Muskett, FW; Thouta, S; Thomson, SJ; Bowen, A; Stansfeld, PJ; Mitcheson, JS				Muskett, Frederick W.; Thouta, Samrat; Thomson, Steven J.; Bowen, Alexander; Stansfeld, Phillip J.; Mitcheson, John S.			Mechanistic Insight into Human ether-a-go-go-related Gene (hERG) K+ Channel Deactivation Gating from the Solution Structure of the EAG Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; TORSION ANGLE DYNAMICS; HUMAN INWARD RECTIFIER; AMINO-TERMINAL DOMAIN; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; I-KR; MOLECULAR DETERMINANTS; XENOPUS OOCYTES; PAS DOMAIN	Human ether-a-go-go-related gene (hERG) K+ channels have a critical role in cardiac repolarization. hERG channels close (deactivate) very slowly, and this is vital for regulating the time course and amplitude of repolarizing current during the cardiac action potential. Accelerated deactivation is one mechanism by which inherited mutations cause long QT syndrome and potentially lethal arrhythmias. hERG deactivation is highly dependent upon an intact EAG domain (the first 135 amino acids of the N terminus). Importantly, deletion of residues 2-26 accelerates deactivation to a similar extent as removing the entire EAG domain. These and other experiments suggest the first 26 residues (NT1-26) contain structural elements required to slow deactivation by stabilizing the open conformation of the pore. Residues 26-135 form a Per-Arnt-Sim domain, but a structure for NT1-26 has not been forthcoming, and little is known about its site of interaction on the channel. In this study, we present an NMR structure for the entire EAG domain, which reveals that NT1-26 is structurally independent from the Per-Arnt-Sim domain and contains a stable amphipathic helix with one face being positively charged. Mutagenesis and electrophysiological studies indicate that neutralizing basic residues and breaking the amphipathic helix dramatically accelerate deactivation. Furthermore, scanning mutagenesis and molecular modeling studies of the cyclic nucleotide binding domain suggest that negatively charged patches on its cytoplasmic surface form an interface with the NT1-26 domain. We propose a model in which NT1-26 obstructs gating motions of the cyclic nucleotide binding domain to allosterically stabilize the open conformation of the pore.	[Muskett, Frederick W.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Thouta, Samrat; Thomson, Steven J.; Bowen, Alexander; Mitcheson, John S.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Stansfeld, Phillip J.] Univ Oxford, Oxford OX1 3QU, England	University of Leicester; University of Leicester; University of Oxford	Muskett, FW (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	fwm1@le.ac.uk; jm109@le.ac.uk	Stansfeld, Phillip James/AAA-9228-2020; Stansfeld, Phill/C-6213-2011	Stansfeld, Phillip James/0000-0001-8800-7669; Stansfeld, Phill/0000-0001-8800-7669; Mitcheson, John/0000-0002-2683-2839; Thouta, Samrat/0000-0002-0460-6187	Biotechnology and Biological Sciences Research Council; Novartis Institutes for Biomedical Research, Horsham, UK; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Novartis Institutes for Biomedical Research, Horsham, UK; Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by a Biotechnology and Biological Sciences Research Council Collaborative Awards in Science and Engineering Ph.D. studentship sponsored by Novartis Institutes for Biomedical Research, Horsham, UK.; Supported by the Wellcome Trust.	Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Hancox JC, 1998, BIOCHEM BIOPH RES CO, V253, P719, DOI 10.1006/bbrc.1998.9837; Hancox JC, 1998, PFLUG ARCH EUR J PHY, V436, P843, DOI 10.1007/s004240050713; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu J, 2003, J GEN PHYSIOL, V121, P599, DOI 10.1085/jgp.200308788; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; Muskett F. W., 2011, BIOMOL NMR IN PRESS; Muskett FW, 2003, BIOCHEMISTRY-US, V42, P15139, DOI 10.1021/bi030182k; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Perry M, 2004, MOL PHARMACOL, V66, P240, DOI 10.1124/mol.104.000117; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Roden DM, 1996, AM J CARDIOL, V78, P12, DOI 10.1016/S0002-9149(96)00448-1; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; YANG T, 1995, CIRCULATION, V91, P1799, DOI 10.1161/01.CIR.91.6.1799; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	61	76	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6184	6191		10.1074/jbc.M110.199364	http://dx.doi.org/10.1074/jbc.M110.199364			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135103	Green Published, hybrid			2022-12-25	WOS:000287476400027
J	Teupser, D; Weber, O; Rao, TN; Sass, K; Thiery, J; Fehling, HJ				Teupser, Daniel; Weber, Odile; Rao, Tata Nageswara; Sass, Kristina; Thiery, Joachim; Fehling, Hans Joerg			No Reduction of Atherosclerosis in C-reactive Protein (CRP)-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E GENE; E-DEFICIENT MICE; BRACHIOCEPHALIC ARTERY; TRANSGENIC MICE; KNOCKOUT MICE; MOUSE MODELS; AORTIC ROOT; HYPERCHOLESTEROLEMIA; MODIFIERS	C-reactive protein (CRP), a phylogenetically highly conserved plasma protein, is the classical acute phase reactant in humans. Upon infection, inflammation, or tissue damage, its plasma level can rise within hours > 1000-fold, providing an early, nonspecific disease indicator of prime clinical importance. In recent years, another aspect of CRP expression has attracted much scientific and public attention. Apart from transient, acute phase-associated spikes in plasma concentration, highly sensitive measurements have revealed stable interindividual differences of baseline CRP values in healthy persons. Strikingly, even modest elevations in stable baseline CRP plasma levels have been found to correlate with a significantly increased risk of future cardiovascular disease. These observations have triggered intense controversies about potential atherosclerosis-promoting properties of CRP. To directly assess potential effects of CRP on atherogenesis, we have generated CRP-deficient mice via gene targeting and introduced the inactivated allele into atherosclerosis-susceptible ApoE(-/-) and LDLR-/- mice, two well established mouse models of atherogenesis. Morphometric analyses of atherosclerotic plaques in CRP-deficient animals revealed equivalent or increased atherosclerotic lesions compared with controls, an experimental result, which does not support a proatherogenic role of CRP. In fact, our data suggest that mouse CRP may even mediate atheroprotective effects, adding a cautionary note to the idea of targeting CRP as therapeutic intervention against progressive cardiovascular disease.	Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04103 Leipzig, Germany; [Teupser, Daniel; Sass, Kristina; Thiery, Joachim] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, D-04103 Leipzig, Germany; [Weber, Odile; Rao, Tata Nageswara; Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, D-89081 Ulm, Germany	Leipzig University; Leipzig University; Ulm University	Fehling, HJ (corresponding author), Albert Einstein Allee 11, D-89081 Ulm, Germany.	Joerg.fehling@uni-ulm.de		Tata, Nageswara Rao/0000-0002-9928-5944; Fehling, Hans Joerg/0000-0002-4580-1990	Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes, and Environment at the Universitat Leipzig; European Union; European Regional Development Fund; Free State of Saxony;  [SFB451-Teilprojekt B12]	Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes, and Environment at the Universitat Leipzig; European Union(European Commission); European Regional Development Fund(European Commission); Free State of Saxony; 	This work was supported by SFB451-Teilprojekt B12 and by the Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes, and Environment at the Universitat Leipzig. LIFE is funded by the European Union, the European Regional Development Fund, and the Free State of Saxony within the framework of the excellence initiative.	Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; Davignon J, 2005, ARTERIOSCL THROM VAS, V25, P267, DOI 10.1161/01.ATV.0000154570.50696.2c; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Knowles JW, 2000, ARTERIOSCL THROM VAS, V20, P2336, DOI 10.1161/01.ATV.20.11.2336; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kovacs A, 2007, P NATL ACAD SCI USA, V104, P13768, DOI 10.1073/pnas.0706027104; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Nilsson J, 2005, ARTERIOSCL THROM VAS, V25, P1527, DOI 10.1161/01.ATV.0000174796.81443.3f; Paffen E, 2006, CARDIOVASC RES, V71, P30, DOI 10.1016/j.cardiores.2006.03.004; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; Pepys MB, 2008, NAT CLIN PRACT NEPHR, V4, P234, DOI 10.1038/ncpneph0778; PEPYS MB, 1979, IMMUNOLOGY, V37, P637; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Reifenberg K, 2005, ARTERIOSCL THROM VAS, V25, P1641, DOI 10.1161/01.ATV.0000171983.95612.90; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Scirica BM, 2006, CIRCULATION, V113, P2128, DOI 10.1161/CIRCULATIONAHA.105.611350; Smith Jonathan D, 2006, Expert Rev Cardiovasc Ther, V4, P703, DOI 10.1586/14779072.4.5.703; Su ZG, 2006, GENETICS, V172, P1799, DOI 10.1534/genetics.105.051912; Tennent GA, 2008, ATHEROSCLEROSIS, V196, P248, DOI 10.1016/j.atherosclerosis.2007.05.010; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Torzewski M, 2008, THROMB HAEMOSTASIS, V99, P196, DOI 10.1160/TH07-10-0595; Trion A, 2005, ARTERIOSCL THROM VAS, V25, P1635, DOI 10.1161/01.ATV.0000171992.36710.1e; Verma S, 2006, CIRCULATION, V113, P2135; Verma S, 2005, NAT CLIN PRACT CARD, V2, P29, DOI 10.1038/ncpcardio0074; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	38	61	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6272	6279		10.1074/jbc.M110.161414	http://dx.doi.org/10.1074/jbc.M110.161414			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149301	hybrid, Green Published			2022-12-25	WOS:000287476400037
J	Wang, JF; Zurawski, TH; Meng, JH; Lawrence, G; Olango, WM; Finn, DP; Wheeler, L; Dolly, JO				Wang, Jiafu; Zurawski, Tomas H.; Meng, Jianghui; Lawrence, Gary; Olango, Weredeselam M.; Finn, David P.; Wheeler, Larry; Dolly, J. Oliver			A Dileucine in the Protease of Botulinum Toxin A Underlies Its Long-lived Neuroparalysis TRANSFER OF LONGEVITY TO A NOVEL POTENTIAL THERAPEUTIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTOXIN-A; NEUROMUSCULAR-TRANSMISSION; NERVE-TERMINALS; SYNAPTOTAGMIN-I; SENSORY NEURONS; TRANSLOCATION; EXOCYTOSIS; PERSISTENCE; INHIBITION; INJECTION	Blockade of neurotransmitter release by botulinum neurotoxin type A (BoNT(A)) underlies the severe neuroparalytic symptoms of human botulism, which can last a few years. The structural basis for this remarkable persistence remains unclear. Herein, recombinant BoNT(A) was found to match the neurotoxicity of that from Clostridium botulinum, producing persistent cleavage of synaptosomal-associated protein of 25 kDa (SNAP-25) and neuromuscular paralysis. When two leucines near the C terminus of the protease light chain of A (LCA) were mutated, its inhibition of exocytosis was followed by fast recovery of intact SNAP-25 in cerebellar neurons and neuromuscular transmission in vivo. Deletion of 6-7 N terminus residues diminished BoNT(A) activity but did not alter the longevity of its SNAP-25 cleavage and neuromuscular paralysis. Furthermore, genetically fusing LCE to a BoNT(A) enzymically inactive mutant (BoTIM(A)) yielded a novel LCE-BoTIM(A) protein that targets neurons, and the BoTIM(A) moiety also delivers and stabilizes the inhibitory LCE, giving a potent and persistent cleavage of SNAP-25 with associated neuromuscular paralysis. Moreover, its neurotropism was extended to sensory neurons normally insensitive to BoNT(E). LCE-BoTIM(A)(AA) with the above-identified dileucine mutated gave transient neuromuscular paralysis similar to BoNT(E), reaffirming that these residues are critical for the persistent action of LCE-BoTIM(A) as well as BoNT(A). LCE-BoTIM(A) inhibited release of calcitonin gene-related peptide from sensory neurons mediated by transient receptor potential vanilloid type 1 and attenuated capsaicin-evoked nociceptive behavior in rats, following intraplantar injection. Thus, a long acting, versatile composite toxin has been developed with therapeutic potential for pain and conditions caused by overactive cholinergic nerves.	[Wang, Jiafu; Zurawski, Tomas H.; Meng, Jianghui; Lawrence, Gary; Dolly, J. Oliver] Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland; [Olango, Weredeselam M.; Finn, David P.] Natl Univ Ireland, Sch Med, Galway, Ireland; [Olango, Weredeselam M.; Finn, David P.] Natl Univ Ireland, Ctr Pain Res, Galway, Ireland; [Wheeler, Larry] Allergan Pharmaceut Inc, Irvine, CA 92623 USA	Dublin City University; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; AbbVie; Allergan	Dolly, JO (corresponding author), Dublin City Univ, Int Ctr Neurotherapeut, Dublin 9, Ireland.	oliver.dolly@dcu.ie	Dolly, Oliver/G-1532-2012; Meng, Jianghui/H-4302-2014; Wang, Jiafu/AAX-9388-2020; Dolly, Oliver/ABH-6677-2020	Dolly, Oliver/0000-0002-0861-5320; Wang, Jiafu/0000-0002-3654-4400; Dolly, Oliver/0000-0002-0861-5320; Finn, David/0000-0001-6186-621X; Meng, Jianghui/0000-0002-3107-4200	Science Foundation Ireland; Irish Research Council for Science, Engineering and Technology; Irish Higher Education Authority under the neuroscience section of "Target-driven Therapeutics and Theranostics"	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Irish Higher Education Authority under the neuroscience section of "Target-driven Therapeutics and Theranostics"	This work was supported in part by a research professorship award from Science Foundation Ireland (to J. O. D.) and a grant to D. P. F., plus a studentship to W. M. O. from the Irish Research Council for Science, Engineering and Technology, and the Programme for Research in Third-Level Institutions Cycle four (PRTLI 4) Grant from the Irish Higher Education Authority under the neuroscience section of "Target-driven Therapeutics and Theranostics."	Adler M, 2001, TOXICON, V39, P233, DOI 10.1016/S0041-0101(00)00120-3; Aoki KR, 2001, TOXICON, V39, P1815, DOI 10.1016/S0041-0101(01)00101-5; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Barnes MP, 2007, CLINICAL USES OF BOTULINUM TOXINS, P1, DOI 10.1017/CBO9780511544842.001; BLACK JD, 1986, J CELL BIOL, V103, P535, DOI 10.1083/jcb.103.2.535; Christoph T, 2007, NEUROCHEM INT, V50, P281, DOI 10.1016/j.neuint.2006.08.017; Costantin L, 2005, J NEUROSCI, V25, P1943, DOI 10.1523/JNEUROSCI.4402-04.2005; CULLCANDY SG, 1976, J PHYSIOL-LONDON, V260, P177, DOI 10.1113/jphysiol.1976.sp011510; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Dolly JO, 2007, CLINICAL USES OF BOTULINUM TOXINS, P9, DOI 10.1017/CBO9780511544842.002; Dolly JO, 2009, CURR OPIN PHARMACOL, V9, P326, DOI 10.1016/j.coph.2009.03.004; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Eleopra R, 1998, NEUROSCI LETT, V256, P135, DOI 10.1016/S0304-3940(98)00775-7; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; Honda K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-59; Jakubowski M, 2006, PAIN, V125, P286, DOI 10.1016/j.pain.2006.09.012; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Kim HY, 2009, PAIN, V145, P332, DOI 10.1016/j.pain.2009.06.035; Kim SH, 2009, J BIOL CHEM, V284, P32803, DOI 10.1074/jbc.M109.039149; Lawrence G, 2007, J PHARMACOL EXP THER, V320, P410, DOI 10.1124/jpet.106.108829; Lawrence GW, 2002, J CELL SCI, V115, P2791; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MAISEY EA, 1988, EUR J BIOCHEM, V177, P683, DOI 10.1111/j.1432-1033.1988.tb14423.x; Meng JH, 2007, J CELL SCI, V120, P2864, DOI 10.1242/jcs.012211; Meng JH, 2009, J NEUROSCI, V29, P4981, DOI 10.1523/JNEUROSCI.5490-08.2009; Meunier FA, 2003, MOL CELL NEUROSCI, V22, P454, DOI 10.1016/S1044-7431(02)00016-7; MOLGO J, 1980, EUR J PHARMACOL, V61, P25, DOI 10.1016/0014-2999(80)90378-7; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Shi XR, 2009, J CELL BIOCHEM, V108, P660, DOI 10.1002/jcb.22300; Sloop RR, 1997, NEUROLOGY, V49, P189, DOI 10.1212/WNL.49.1.189; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang JF, 2008, J BIOL CHEM, V283, P16993, DOI 10.1074/jbc.M710442200; Witting N, 2000, PAIN, V84, P407, DOI 10.1016/S0304-3959(99)00231-6	39	63	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6375	6385		10.1074/jbc.M110.181784	http://dx.doi.org/10.1074/jbc.M110.181784			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21138836	hybrid, Green Published			2022-12-25	WOS:000287476400048
J	Chavez, A; Agrawal, V; Johnson, FB				Chavez, Alejandro; Agrawal, Vishesh; Johnson, F. Brad			Homologous Recombination-dependent Rescue of Deficiency in the Structural Maintenance of Chromosomes (Smc) 5/6 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; COMPLEMENTATION GROUP-M; STRAND-BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; PROTEINS PROMOTE; GENETIC-ANALYSIS; CROSSING-OVER; YEAST; HELICASE	The essential and evolutionarily conserved Smc5-Smc6 complex (Smc5/6) is critical for the maintenance of genome stability. Partial loss of Smc5/6 function yields several defects in DNA repair, which are rescued by inactivation of the homologous recombination (HR) machinery. Thus HR is thought to be toxic to cells with defective Smc5/6. Recent work has highlighted a role for Smc5/6 and the Sgs1 DNA helicase in preventing the accumulation of unresolved HR intermediates. Here we investigate how deletion of MPH1, encoding the orthologue of the human FANCM DNA helicase, rescues the DNA damage sensitivity of smc5/6 but not sgs1 Delta mutants. We find that MPH1 deletion diminishes accumulation of HR intermediates within both smc5/6 and sgs1 Delta cells, suggesting that MPH1 deletion is sufficient to decrease the use of template switch recombination (TSR) to bypass DNA lesions. We further explain how avoidance of TSR is nonetheless insufficient to rescue defects in sgs1 Delta mutants, by demonstrating a requirement for Sgs1, along with the post-replicative repair (PRR) and HR machinery, in a pathway that operates in mph1 Delta mutants. In addition, we map the region of Mph1 that binds Smc5, and describe a novel allele of MPH1 encoding a protein unable to bind Smc5 (mph1-Delta 60). Remarkably, mph1-Delta 60 supports normal growth and responses to DNA damaging agents, indicating that Smc5/6 does not simply restrain the recombinogenic activity of Mph1 via direct binding. These data as a whole highlight a role for Smc5/6 and	[Johnson, F. Brad] Univ Penn, Stellar Chance Labs 405A, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA; [Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Cell & Mol Biol Grp, Sch Med, Philadelphia, PA 19104 USA; [Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Inst Aging, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Johnson, FB (corresponding author), Univ Penn, Stellar Chance Labs 405A, Dept Pathol & Lab Med, Sch Med, 422 Curie Blvd, Philadelphia, PA 19104 USA.	johnsonb@mail.med.upenn.edu			National Institutes of Health [R01-AG021521, P01-AG031862, T32-AG000255]; NATIONAL INSTITUTE ON AGING [P01AG031862, T32AG000255, R01AG021521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG021521 and P01-AG031862 (to F. B. J.) and T32-AG000255 (to A. C.).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Bakker ST, 2009, HUM MOL GENET, V18, P3484, DOI 10.1093/hmg/ddp297; Bernstein KA, 2009, EMBO J, V28, P915, DOI 10.1038/emboj.2009.28; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; Chen YH, 2009, P NATL ACAD SCI USA, V106, P21252, DOI 10.1073/pnas.0908258106; Choi KY, 2010, MOL BIOL CELL, V21, P2306, DOI 10.1091/mbc.E10-01-0050; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Frei C, 2000, GENE DEV, V14, P81; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Komori K, 2004, J BIOL CHEM, V279, P53175, DOI 10.1074/jbc.M409243200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee KY, 2008, MOL CELLS, V26, P5; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Mankouri HW, 2009, MOL BIOL CELL, V20, P1683, DOI 10.1091/mbc.E08-08-0877; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Mullen JR, 2000, GENETICS, V154, P1101; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Potts PR, 2009, DNA REPAIR, V8, P499, DOI 10.1016/j.dnarep.2009.01.009; PRAKASH S, 1977, GENETICS, V87, P229; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Scheller J, 2000, GENETICS, V155, P1069; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054	50	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5119	5125		10.1074/jbc.M110.201608	http://dx.doi.org/10.1074/jbc.M110.201608			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21138837	Green Published, hybrid			2022-12-25	WOS:000287230600019
J	Disse, J; Petersen, HH; Larsen, KS; Persson, E; Esmon, N; Esmon, CT; Teyton, L; Petersen, LC; Ruf, W				Disse, Jennifer; Petersen, Helle Heibroch; Larsen, Katrine S.; Persson, Egon; Esmon, Naomi; Esmon, Charles T.; Teyton, Luc; Petersen, Lars C.; Ruf, Wolfram			The Endothelial Protein C Receptor Supports Tissue Factor Ternary Coagulation Initiation Complex Signaling through Protease-activated Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR CYTOPLASMIC DOMAIN; FACTOR VIIA; FACTOR-XA; GROWTH-FACTOR; GLA DOMAIN; DISULFIDE-ISOMERASE; CRYSTAL-STRUCTURE; FACTOR EXPRESSION; BINDING	Protease-activated receptor (PAR) signaling is closely linked to the cellular activation of the pro- and anticoagulant pathways. The endothelial protein C receptor (EPCR) is crucial for signaling by activated protein C through PAR1, but EPCR may have additional roles by interacting with the 4-carboxyglutamic acid domains of procoagulant coagulation factors VII (FVII) and X (FX). Here we show that soluble EPCR regulates the interaction of FX with human or mouse tissue factor (TF)-FVIIa complexes. Mutagenesis of the FVIIa 4-carboxyglutamic acid domain and dose titrations with FX showed that EPCR interacted primarily with FX to attenuate FX activation in lipid-free assay systems. In human cell models of TF signaling, antibody inhibition of EPCR selectively blocked PAR activation by the ternary TF-FVIIa-FXa complex but not by the non-coagulant TF-FVIIa binary complex. Heterologous expression of EPCR promoted PAR1 and PAR2 cleavage by FXa in the ternary complex but did not alter PAR2 cleavage by TF-FVIIa. In murine smooth muscle cells that constitutively express EPCR and TF, thrombin and FVIIa/FX but not FVIIa alone induced PAR1-dependent signaling. Although thrombin signaling was unchanged, cells with genetically reduced levels of EPCR no longer showed a signaling response to the ternary complex. These results demonstrate that EPCR interacts with the ternary TF coagulation initiation complex to enable PAR signaling and suggest that EPCR may play a role in regulating the biology of TF-expressing extravascular and vessel wall cells that are exposed to limited concentrations of FVIIa and FX provided by ectopic synthesis or vascular leakage.	[Disse, Jennifer; Petersen, Helle Heibroch; Larsen, Katrine S.; Teyton, Luc; Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Petersen, Helle Heibroch; Larsen, Katrine S.; Persson, Egon; Petersen, Lars C.] Novo Nordisk, Dept Haemostasis Biol, DK-2760 Malov, Denmark; [Esmon, Naomi; Esmon, Charles T.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma City, OK 73104 USA	Scripps Research Institute; Novo Nordisk; Oklahoma Medical Research Foundation; Howard Hughes Medical Institute	Ruf, W (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ruf@scripps.edu		Persson, Egon/0000-0003-3005-4926	National Institutes of Health, NHLBI [HL077753, HL100115]; NHLBI [HL100115]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100115, R01HL077753] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077753 and HL100115 from the NHLBI.	Ahamed J, 2004, J BIOL CHEM, V279, P23038, DOI 10.1074/jbc.M401376200; Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Albrektsen T, 2007, J THROMB HAEMOST, V5, P1588, DOI 10.1111/j.1538-7836.2007.02603.x; Bae JS, 2007, BLOOD, V110, p520A; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Bergum PW, 2001, J BIOL CHEM, V276, P10063, DOI 10.1074/jbc.M009116200; Bretschneider E, 2007, CIRC RES, V100, P255, DOI 10.1161/01.RES.0000255685.06922.c7; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Camerer E, 2000, J BIOL CHEM, V275, P6580, DOI 10.1074/jbc.275.9.6580; Camerer E, 2002, J BIOL CHEM, V277, P16081, DOI 10.1074/jbc.M108555200; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Castellino FJ, 2002, THROMB HAEMOSTASIS, V88, P462; Centelles MN, 2010, THROMB HAEMOSTASIS, V103, P1239, DOI 10.1160/TH09-11-0750; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Demetz G, 2010, ATHEROSCLEROSIS, V212, P466, DOI 10.1016/j.atherosclerosis.2010.07.017; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Elphick GF, 2009, BLOOD, V113, P4078, DOI 10.1182/blood-2008-09-180968; Esmon CT, 2006, CURR OPIN HEMATOL, V13, P382, DOI 10.1097/01.moh.0000239712.93662.35; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; GASIC GP, 1992, P NATL ACAD SCI USA, V89, P2317, DOI 10.1073/pnas.89.6.2317; Ghosh S, 2007, J BIOL CHEM, V282, P11849, DOI 10.1074/jbc.M609283200; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P301, DOI 10.1111/j.1538-7836.2009.03696.x; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hoffman M, 2007, J THROMB HAEMOST, V5, P1403, DOI 10.1111/j.1538-7836.2007.02576.x; Kerschen E, 2010, J CLIN INVEST, V120, P3167, DOI 10.1172/JCI42629; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Koo BH, 2002, FEBS LETT, V523, P85, DOI 10.1016/S0014-5793(02)02948-4; Larsen KS, 2010, J BIOL CHEM, V285, P19959, DOI 10.1074/jbc.M110.101030; Li WH, 2005, BLOOD, V106, P2716, DOI 10.1182/blood-2005-01-0406; Liaw PCY, 2001, J BIOL CHEM, V276, P8364, DOI 10.1074/jbc.M010572200; Lopez-Sagaseta J, 2007, J THROMB HAEMOST, V5, P1817, DOI 10.1111/j.1538-7836.2007.02648.x; Lopez-Sagaseta J, 2009, PROTEIN EXPRES PURIF, V64, P194, DOI 10.1016/j.pep.2008.11.002; Luther T, 1996, AM J PATHOL, V149, P101; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mueller BM, 1998, J CLIN INVEST, V101, P1372, DOI 10.1172/JCI930; Nayak RC, 2009, BLOOD, V114, P1974, DOI 10.1182/blood-2009-03-208900; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Oganesyan V, 2002, J BIOL CHEM, V277, P24851, DOI 10.1074/jbc.C200163200; Pendurthi UR, 2000, J BIOL CHEM, V275, P14632, DOI 10.1074/jbc.275.19.14632; Persson E, 2007, J THROMB HAEMOST, V5, P1977, DOI 10.1111/j.1538-7836.2007.02661.x; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Persson E, 2008, THROMB RES, V123, P171, DOI 10.1016/j.thromres.2008.04.012; Petersen LC, 2005, THROMB RES, V116, P75, DOI 10.1016/j.thromres.2004.11.003; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Puy C, 2010, BRIT J HAEMATOL, V149, P111, DOI 10.1111/j.1365-2141.2009.08060.x; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Ruf W, 1998, TRENDS CARDIOVAS MED, V8, P350, DOI 10.1016/S1050-1738(98)00031-0; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Schaffner F, 2010, BLOOD, V116, P6106, DOI 10.1182/blood-2010-06-289314; Schecter AD, 1997, J CLIN INVEST, V100, P2276, DOI 10.1172/JCI119765; Schuepbach RA, 2010, J THROMB HAEMOST, V8, P379, DOI 10.1111/j.1538-7836.2009.03682.x; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Sen P, 2010, J BIOL CHEM, V285, P20410, DOI 10.1074/jbc.M110.111575; Shikamoto Y, 2003, J BIOL CHEM, V278, P24090, DOI 10.1074/jbc.M300650200; Shinagawa K, 2007, AM J RESP CRIT CARE, V175, P136, DOI 10.1164/rccm.200608-1097OC; Siegbahn A, 2000, BLOOD, V96, P3452, DOI 10.1182/blood.V96.10.3452.h8003452_3452_3458; Stanssens P, 1996, P NATL ACAD SCI USA, V93, P2149, DOI 10.1073/pnas.93.5.2149; STONE MJ, 1995, BIOCHEM J, V310, P605, DOI 10.1042/bj3100605; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Versteeg HH, 2007, J BIOL CHEM, V282, P25416, DOI 10.1074/jbc.M702410200; Xu J, 2009, J THROMB HAEMOST, V7, P851, DOI 10.1111/j.1538-7836.2009.03333.x; Xue ML, 2007, J BIOL CHEM, V282, P13610, DOI 10.1074/jbc.M610740200; Xue ML, 2005, J INVEST DERMATOL, V125, P1279, DOI 10.1111/j.0022-202X.2005.23952.x; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106; Zhang Q, 2009, PROTEINS, V77, P559, DOI 10.1002/prot.22468; Zheng X, 2007, J THROMB HAEMOST, V5, P1394, DOI 10.1111/j.1538-7836.2007.02592.x	75	79	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5756	5767		10.1074/jbc.M110.201228	http://dx.doi.org/10.1074/jbc.M110.201228			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149441	Green Published, hybrid			2022-12-25	WOS:000287230600084
J	Froese, N; Kattih, B; Breitbart, A; Grund, A; Geffers, R; Molkentin, JD; Kispert, A; Wollert, KC; Drexler, H; Heineke, J				Froese, Natali; Kattih, Badder; Breitbart, Astrid; Grund, Andrea; Geffers, Robert; Molkentin, Jeffery D.; Kispert, Andreas; Wollert, Kai C.; Drexler, Helmut; Heineke, Joerg			GATA6 Promotes Angiogenic Function and Survival in Endothelial Cells by Suppression of Autocrine Transforming Growth Factor beta/Activin Receptor-like Kinase 5 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; IN-VITRO; ADHESION MOLECULE-1; DIFFERENTIATION; HEART; BETA; IDENTIFICATION; INHIBITOR	Understanding the transcriptional regulation of angiogenesis could lead to the identification of novel therapeutic targets. We showed here that the transcription factor GATA6 is expressed in different human primary endothelial cells as well as in vascular endothelial cells of mice in vivo. Activation of endothelial cells was associated with GATA6 nuclear translocation, chromatin binding, and enhanced GATA6-dependent transcriptional activation. siRNA-mediated down-regulation of GATA6 after growth factor stimulation led to a dramatically reduced capacity of macro-and microvascular endothelial cells to proliferate, migrate, or form capillary-like structures on Matrigel. Adenoviral overexpression of GATA6 in turn enhanced angiogenic function, especially in cardiac endothelial microvascular cells. Furthermore, GATA6 protected endothelial cells from undergoing apoptosis during growth factor deprivation. Mechanistically, down-regulation of GATA6 in endothelial cells led to increased expression of transforming growth factor (TGF) beta 1 and TGF beta 2, whereas enhanced GATA6 expression, accordingly, suppressed Tgfb1 promoter activity. High TGF beta 1/beta 2 expression in GATA6-depleted endothelial cells increased the activation of the activin receptor-like kinase 5 (ALK5) and SMAD2, and suppression of this signaling axis by TGF beta neutralizing antibody or ALK5 inhibition restored angiogenic function and survival in endothelial cells with reduced GATA6 expression. Together, these findings indicate that GATA6 plays a crucial role for endothelial cell function and survival, at least in part, by suppressing autocrine TGF beta expression and ALK5-dependent signaling.	[Froese, Natali; Kattih, Badder; Breitbart, Astrid; Grund, Andrea; Wollert, Kai C.; Drexler, Helmut; Heineke, Joerg] Hannover Med Sch, Klin Kardiol & Angiol, D-30625 Hannover, Germany; [Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; [Geffers, Robert] HCI Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Molkentin, Jeffery D.] Univ Cincinnati, Howard Hughes Med Inst, Dept Pediat, Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45229 USA	Hannover Medical School; Hannover Medical School; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati	Heineke, J (corresponding author), Hannover Med Sch, Klin Kardiol & Angiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Heineke.Joerg@Mh-Hannover.de	Murakami, Iwanori/O-4913-2018	Murakami, Iwanori/0000-0001-7913-5327; Grund, Andrea/0000-0001-6423-7398; Molkentin, Jeffery/0000-0002-3558-6529	Deutsche Forschungsgemeinschaft through the Cluster of Excellence Rebirth [EXC 62/1]; Solvay Foundation; Klinische Forschergruppe 136 Deutsche Forschungsgemeinschaft [HE 3658/3-1]; Howard Hughes Medical Institute; National Institutes of Health	Deutsche Forschungsgemeinschaft through the Cluster of Excellence Rebirth; Solvay Foundation(Solvay SA); Klinische Forschergruppe 136 Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Deutsche Forschungsgemeinschaft through the Cluster of Excellence Rebirth (EXC 62/1, to J.H.), the Solvay Foundation (to J.H.), and the Klinische Forschergruppe 136 Deutsche Forschungsgemeinschaft HE 3658/3-1 (to J.H.).; Funded by grants from the Howard Hughes Medical Institute and the National Institutes of Health.	Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Collavin L, 2004, P NATL ACAD SCI USA, V101, P8870, DOI 10.1073/pnas.0308605101; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; Fuchshofer R, 2009, EXP EYE RES, V88, P1020, DOI 10.1016/j.exer.2009.01.002; German Z, 2000, J BIOL CHEM, V275, P8183, DOI 10.1074/jbc.275.11.8183; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Gumina RJ, 1997, BLOOD, V89, P1260, DOI 10.1182/blood.V89.4.1260; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Kessler T, 2010, RECENT RESULTS CANC, V180, P137, DOI 10.1007/978-3-540-78281-0_9; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Lepore JJ, 2006, J CLIN INVEST, V116, P929, DOI 10.1172/JCi27363; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Mano T, 1999, CIRC RES, V84, P647, DOI 10.1161/01.RES.84.6.647; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nakano N, 2007, J IMMUNOL, V178, P3067, DOI 10.4049/jimmunol.178.5.3067; Ochiai N, 2003, BLOOD, V102, P3349, DOI 10.1182/blood-2003-03-0851; Ota T, 2002, J CELL PHYSIOL, V193, P299, DOI 10.1002/jcp.10170; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; PEPPER MS, 1993, EXP CELL RES, V204, P356, DOI 10.1006/excr.1993.1043; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Song HH, 2009, J BIOL CHEM, V284, P29109, DOI 10.1074/jbc.M109.041145; Umetani M, 2001, ARTERIOSCL THROM VAS, V21, P917, DOI 10.1161/01.ATV.21.6.917; Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122; YAMAGATA T, 1995, MOL CELL BIOL, V15, P3830; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723	38	23	25	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5680	5690		10.1074/jbc.M110.176925	http://dx.doi.org/10.1074/jbc.M110.176925			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127043	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000287230600077
J	Qureshi, HY; Paudel, HK				Qureshi, Hamid Y.; Paudel, Hemant K.			Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser(262) and Destabilize Microtubule Cytoskeleton in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINERGIC-NEURONS; DISEASE; MICE; KINASE; GENE; MODEL; ASSOCIATION; DEMENTIA; SITES; COLOCALIZATION	In Parkinson disease (PD) brain, a progressive loss of dopaminergic neurons leads to dopamine depletion in the striatum and reduced motor function. Lewy bodies, the characteristic neuropathological lesions found in the brain of PD patients, are composed mainly of alpha-synuclein protein. Three point mutations in the alpha-synuclein gene are associated with familial PD. In addition, genome-wide association studies indicate that alpha-synuclein and Tau protein synergistically increase disease susceptibility in the human population. To determine the mechanism by which alpha-synuclein and Tau act together, we have used PD-causing neurotoxin MPTP and pathogenic alpha-synuclein mutants A30P, E46K, and A53T as models. We found that exposure of human neuroblastoma M17 cells to MPTP enhances the intracellular alpha-synuclein protein level, stimulates Tau protein phosphorylation at Ser(262), and induces apoptosis. In mouse brain, ablation of alpha-synuclein function significantly suppresses Tau phosphorylation at Ser(262). In vitro, alpha-synuclein binds to phosphorylated Ser(214) of Tau and stimulates PKA-catalyzed Tau phosphorylation at Ser(262). PD-associated alpha-synuclein mutations increase alpha-synuclein binding to Tau and stimulate Tau phosphorylation at Ser(262). In HEK-293 cells, alpha-synuclein and its all PD-associated mutants destabilize the microtubule cytoskeleton in a similar extent. In contrast, when co-expressed with Tau, these PD-associated mutants destabilize microtubules with significantly higher potency than WT. Our results demonstrate that alpha-synuclein is an in vivo regulator of Tau protein phosphorylation at Ser(262) and suggest that PD-associated risk factors such as environmental toxins and alpha-synuclein mutations promote Tau phosphorylation at Ser(262), causing microtubule instability, which leads to loss of dopaminergic neurons in PD brain.	McGill Univ, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research; Alzheimer's Society of Canada; National Scientific and Engineering Research Council of Canada (NSERC); Parkinson's Society of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada; National Scientific and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Parkinson's Society of Canada	This work was supported in part by operating grants from Canadian Institute for Health Research, The Alzheimer's Society of Canada, and National Scientific and Engineering Research Council of Canada (NSERC).; Recipient of a postdoctoral fellowship from the Parkinson's Society of Canada.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Alim MA, 2002, J BIOL CHEM, V277, P2112, DOI 10.1074/jbc.M102981200; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Arima K, 1999, BRAIN RES, V843, P53, DOI 10.1016/S0006-8993(99)01848-X; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BOLLER F, 1980, ANN NEUROL, V7, P329, DOI 10.1002/ana.410070408; BOTELHO LHP, 1988, METHOD ENZYMOL, V159, P159; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Cappelletti G, 2005, FEBS LETT, V579, P4781, DOI 10.1016/j.febslet.2005.07.058; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Geddes JW, 2005, EXP NEUROL, V192, P244, DOI 10.1016/j.expneurol.2004.12.002; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2003, ACTA NEUROPATHOL, V106, P243, DOI 10.1007/s00401-003-0726-x; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goris A, 2007, ANN NEUROL, V62, P145, DOI 10.1002/ana.21192; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kim CY, 2008, J NEUROCHEM, V107, P303, DOI 10.1111/j.1471-4159.2008.05612.x; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuhn K, 2003, EUR J NEUROSCI, V17, P1, DOI 10.1046/j.1460-9568.2003.02408.x; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Paudel HK, 1997, J BIOL CHEM, V272, P1777; Pittman AM, 2006, HUM MOL GENET, V15, pR188, DOI 10.1093/hmg/ddl190; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; Song W, 2009, J NEUROCHEM, V110, P719, DOI 10.1111/j.1471-4159.2009.06165.x; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; WANG JZ, 1995, J BIOL CHEM, V270, P4854, DOI 10.1074/jbc.270.9.4854; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	65	56	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5055	5068		10.1074/jbc.M110.178905	http://dx.doi.org/10.1074/jbc.M110.178905			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127069	hybrid, Green Published			2022-12-25	WOS:000287230600013
J	Jia, LJ; Bickel, JS; Wu, JX; Morgan, MA; Li, H; Yang, J; Yu, XC; Chan, RC; Sun, Y				Jia, Lijun; Bickel, Jeremy S.; Wu, Jiaxue; Morgan, Meredith A.; Li, Hua; Yang, Jie; Yu, Xiaochun; Chan, Raymond C.; Sun, Yi			RBX1 (RING Box Protein 1) E3 Ubiquitin Ligase Is Required for Genomic Integrity by Modulating DNA Replication Licensing Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; CELL-CYCLE CONTROL; S-PHASE; DAMAGE CHECKPOINT; CULLIN PARTNERS; C. ELEGANS; HUMAN CDT1; REREPLICATION; PROTEOLYSIS; INHIBITOR	RBX1 (RING box protein 1), also known as ROC1 (Regulator of Cullin 1), is an essential component of SCF (Skp1/Cullins/F-box) E3 ubiquitin ligases, which target diverse proteins for proteasome-mediated degradation. Our recent study showed that RBX1 silencing triggered a DNA damage response (DDR) leading to G(2)-M arrest, senescence, and apoptosis, with the mechanism remaining elusive. Here, we show that, in human cancer cells, RBX1 silencing causes the accumulation of DNA replication licensing proteins CDT1 and ORC1, leading to DNA double-strand breaks, DDR, G(2) arrest, and, eventually, aneuploidy. Whereas CHK1 activation by RBX1 silencing is responsible for the G(2) arrest, enhanced DNA damage renders cancer cells more sensitive to radiation. In Caenorhabditis elegans, RBX-1 silencing causes CDT-1 accumulation, triggering DDR in intestinal cells, which is largely abrogated by simultaneous CDT-1 silencing. RBX-1 silencing also induces lethality during development of embryos and in adulthood. Thus, RBX1 E3 ligase is essential for the maintenance of mammalian genome integrity and the proper development and viability in C. elegans.	[Jia, Lijun; Morgan, Meredith A.; Li, Hua; Yang, Jie; Sun, Yi] Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA; [Bickel, Jeremy S.; Chan, Raymond C.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Jia, Lijun] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200032, Peoples R China; [Wu, Jiaxue; Yu, Xiaochun; Chan, Raymond C.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fudan University; University of Michigan System; University of Michigan	Jia, LJ (corresponding author), Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA.	jialijun2002@yahoo.com.cn; rchan@umich.edu; sunyi@umich.edu	Sun, Yi/K-1025-2014	Sun, Yi/0000-0002-5841-4287; Chan, Raymond/0000-0003-3397-2351	NCI [CA111554, CA118762]; Chinese National Nature Sciences Foundation [31071204]; Fudan University in China; NATIONAL CANCER INSTITUTE [R01CA111554, R01CA118762] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chinese National Nature Sciences Foundation; Fudan University in China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA111554 and CA118762 from NCI (to Y. S.). This work was also supported by Chinese National Nature Sciences Foundation Grant 31071204 and a grant from Fudan University in China (to L. J.).	Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; Bickel JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001028; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Dutta A, 2007, NAT GENET, V39, P10, DOI 10.1038/ng0107-10; Gao MX, 2008, CELL DEATH DIFFER, V15, P1054, DOI 10.1038/cdd.2008.30; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gartner Anton, 2004, Methods Mol Biol, V280, P257; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Hook SS, 2007, CURR OPIN CELL BIOL, V19, P663, DOI 10.1016/j.ceb.2007.10.007; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Mehrotra S, 2008, GENE DEV, V22, P3158, DOI 10.1101/gad.1710208; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Merlet J, 2010, DEVELOPMENT, V137, P3857, DOI 10.1242/dev.054866; Moore R, 2004, GENESIS, V38, P1, DOI 10.1002/gene.10243; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Ohta T, 1999, ONCOGENE, V18, P6758, DOI 10.1038/sj.onc.1203115; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Petropoulou C, 2008, FRONT BIOSCI, V13, P4485, DOI 10.2741/3018; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rialland M, 2002, J CELL SCI, V115, P1435; Sasagawa Y, 2003, GENES CELLS, V8, P857, DOI 10.1046/j.1365-2443.2003.00682.x; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Starostina NG, 2010, DEV CELL, V19, P753, DOI 10.1016/j.devcel.2010.10.013; Swaroop M, 2000, ONCOGENE, V19, P2855, DOI 10.1038/sj.onc.1203635; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Wilson GD, 2004, CANCER METAST REV, V23, P209, DOI 10.1023/B:CANC.0000031762.91306.b4; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	52	41	45	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3379	3386		10.1074/jbc.M110.188425	http://dx.doi.org/10.1074/jbc.M110.188425			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115485	Green Published, hybrid			2022-12-25	WOS:000286653200024
J	Zhou, HN; Brock, J; Casarotto, MG; Oakley, AJ; Board, PG				Zhou, Huina; Brock, Joseph; Casarotto, Marco G.; Oakley, Aaron J.; Board, Philip G.			Novel Folding and Stability Defects Cause a Deficiency of Human Glutathione Transferase Omega 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-AT-ONSET; S-TRANSFERASE; EQUILIBRIUM DENATURATION; ARSENIC METABOLISM; PARKINSON-DISEASE; ALZHEIMER-DISEASE; POLYMORPHISMS; GLUTATHIONE-TRANSFERASE-OMEGA-1-1; INTERMEDIATE; ALA140ASP	The polymorphic deletion of Glu-155 from human glutathione transferase omega1 (GSTO1-1) occurs in most populations. Although the recombinant Delta Glu-155 enzyme expressed in Escherichia coli is active, the deletion causes a deficiency of the active enzyme in vivo. The crystal structure and the folding/unfolding kinetics of the Delta Glu-155 variant were determined in order to investigate the cause of the rapid loss of the enzyme in human cells. The crystal structure revealed altered packing around the Glu-155 deletion, an increase in the predicted solvent-accessible area and a corresponding reduction in the buried surface area. This increase in solvent accessibility was consistent with an elevated Stern-Volmer constant. The unfolding of both the wild type and Delta Glu-155 enzyme in urea is best described by a three-state model, and there is evidence for the more pronounced population of an intermediate state by the Delta Glu-155 enzymes. Studies using intrinsic fluorescence revealed a free energy change around 14.4 kcal/mol for the wild type compared with around 8.6 kcal/mol for the Delta Glu-155 variant, which indicates a decrease in stability associated with the Glu-155 deletion. Urea induced unfolding of the wild type GSTO1-1 was reversible through an initial fast phase followed by a second slow phase. In contrast, the Delta Glu-155 variant lacks the slow phase, indicating a refolding defect. It is possible that in some conditions in vivo, the increased solvent-accessible area and the low stability of the Delta Glu-155 variant may promote its unfolding, whereas the refolding defect limits its refolding, resulting in GSTO1-1 deficiency.	[Zhou, Huina; Casarotto, Marco G.; Board, Philip G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Brock, Joseph; Oakley, Aaron J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Board, PG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Philip.Board@anu.edu.au	Oakley, Aaron/A-9464-2013; Brock, Joseph/P-6663-2018; Casarotto, Marco/D-8704-2011; Brock, Joseph/AAE-9483-2020	Oakley, Aaron/0000-0002-4764-014X; Brock, Joseph/0000-0003-3476-9478; Brock, Joseph/0000-0003-3476-9478; Casarotto, Marco/0000-0002-0571-7671	National Health and Medical Research Council [366731]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Project Grant 366731.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Board PG, 2007, CHEM RES TOXICOL, V20, P149, DOI 10.1021/tx600305y; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERHARDT J, 1995, EUR J BIOCHEM, V230, P614; Gloss LM, 1997, BIOCHEMISTRY-US, V36, P5612, DOI 10.1021/bi970056e; Grimsley JK, 1997, BIOCHEMISTRY-US, V36, P14366, DOI 10.1021/bi971596e; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kolsch H, 2007, STROKE, V38, P2847, DOI 10.1161/STROKEAHA.107.484162; Kolsch H, 2004, NEUROLOGY, V63, P2255, DOI 10.1212/01.WNL.0000147294.29309.47; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Li YJ, 2006, NEUROBIOL AGING, V27, P1087, DOI 10.1016/j.neurobiolaging.2005.05.013; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Marnell LL, 2003, CHEM RES TOXICOL, V16, P1507, DOI 10.1021/tx034149a; Mukherjee B, 2006, DRUG METAB DISPOS, V34, P1237, DOI 10.1124/dmd.106.009613; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paiva L, 2008, PHARMACOGENET GENOM, V18, P1, DOI 10.1097/FPC.0b013e3282f29663; Schmuck EM, 2005, PHARMACOGENET GENOM, V15, P493, DOI 10.1097/01.fpc.0000165725.81559.e3; Schmuck E, 2008, INT J BIOCHEM CELL B, V40, P2553, DOI 10.1016/j.biocel.2008.04.017; Szpikowska BK, 1996, ARCH BIOCHEM BIOPHYS, V335, P173, DOI 10.1006/abbi.1996.0495; Tanaka-Kagawa T, 2003, BIOCHEM BIOPH RES CO, V301, P516, DOI 10.1016/S0006-291X(02)03066-8; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Whitbread AK, 2003, PHARMACOGENETICS, V13, P131, DOI 10.1097/00008571-200303000-00003; Yu LZ, 2003, ENVIRON HEALTH PERSP, V111, P1421, DOI 10.1289/ehp.6420; Zakharyan RA, 2001, CHEM RES TOXICOL, V14, P1051, DOI 10.1021/tx010052h	35	23	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4271	4279		10.1074/jbc.M110.197822	http://dx.doi.org/10.1074/jbc.M110.197822			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21106529	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000286975700026
J	Mathurin, K; Gallant, MA; Germain, P; Allard-Chamard, H; Brisson, J; Iorio-Morin, C; Fernandes, AD; Caron, MG; Laporte, SA; Parent, JL				Mathurin, Karine; Gallant, Maxime A.; Germain, Pascale; Allard-Chamard, Hugues; Brisson, Jessy; Iorio-Morin, Christian; Fernandes, Artur de Brum; Caron, Marc G.; Laporte, Stephane A.; Parent, Jean-Luc			An Interaction between L-prostaglandin D Synthase and Arrestin Increases PGD(2) Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC SELENIUM-COMPOUNDS; LIPOCALIN-TYPE; BETA-ARRESTIN; D SYNTHETASE; RAT-BRAIN; INDUCIBLE CYCLOOXYGENASE; PPAR-GAMMA; RECEPTOR; ACTIVATION; D-2	L-type prostaglandin synthase (L-PGDS) produces PGD(2), a lipid mediator involved in neuromodulation and inflammation. Here, we show that L-PGDS and arrestin-3 (Arr3) interact directly and can be co-immunoprecipitated endogenously from MG-63 osteoblasts. Perinuclear L-PGDS/Arr3 co-localization is observed in PGD(2)-producing MG-63 cells and is induced by the addition of the L-PGDS substrate or co-expression of COX-2 in HEK293 cells. Inhibition of L-PGDS activity in MG-63 cells triggers redistribution of Arr3 and L-PGDS to the cytoplasm. Perinuclear localization of L-PGDS is detected in wild-type mouse embryonic fibroblasts (MEFs) but is more diffused in MEFs-arr-2(-/-) -arr-3(-/-). Arrestin-3 promotes PGD(2) production by L-PGDS in vitro. IL-1 beta-induced PGD(2) production is significantly lower in MEFs-arr-2(-/-) -arr-3(-/-) than in wild-type MEFs but can be rescued by expressing Arr2 or Arr3. A peptide corresponding to amino acids 86-100 of arrestin-3 derived from its L-PGDS binding domain stimulates L-PGDS-mediated PGD(2) production in vitro and in MG-63 cells. We report the first characterization of an interactor/modulator of a PGD(2) synthase and the identification of a new function for arrestin, which may open new opportunities for improving therapies for the treatment of inflammatory diseases.	[Iorio-Morin, Christian; Fernandes, Artur de Brum; Parent, Jean-Luc] Univ Sherbrooke, Serv Rhumatol, Dept Med, Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada; [Mathurin, Karine; Gallant, Maxime A.; Germain, Pascale; Allard-Chamard, Hugues; Brisson, Jessy; Iorio-Morin, Christian; Fernandes, Artur de Brum; Parent, Jean-Luc] Ctr Rech Clin Etienne Lebel, Sherbrooke, PQ J1H 5N4, Canada; [Mathurin, Karine; Gallant, Maxime A.; Germain, Pascale; Allard-Chamard, Hugues; Brisson, Jessy; Iorio-Morin, Christian; Fernandes, Artur de Brum; Parent, Jean-Luc] Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Laporte, Stephane A.] McGill Univ, Hormones & Canc Res Unit, Dept Med, Montreal, PQ H3A 1A1, Canada; [Laporte, Stephane A.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3A 1A1, Canada	University of Sherbrooke; Duke University; McGill University; McGill University	Parent, JL (corresponding author), Univ Sherbrooke, Fac Med, Div Rheumatol, 3001,12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Jean-Luc.Parent@Usherbrooke.ca	Iorio-Morin, Christian/I-8696-2019; Laporte, Stephane A/F-3282-2012; Laporte, Stephane/ABC-4228-2021; Allard-Chamard, H/J-2827-2019	Iorio-Morin, Christian/0000-0003-2995-7255; Laporte, Stephane/0000-0002-0633-543X; Allard-Chamard, H/0000-0001-7850-2658	Canadian Institutes of Health Research; Fonds de la recherche en sante du Quebec; Canadian Arthritis Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network	This work was supported by a grant from Canadian Institutes of Health Research (to A. d. B. F. and J.- L. P.).; Recipient of studentships from the Fonds de la recherche en sante du Quebec.; Supported by fellowships from the Canadian Arthritis Network for part of this work.	Amirand C, 1998, J CELL SCI, V111, P3551; Aritake K, 2006, J BIOL CHEM, V281, P15277, DOI 10.1074/jbc.M506431200; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Beuckmann CT, 1996, J NEUROSCI, V16, P6119; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Blodorn B, 1996, NEUROSCI LETT, V209, P117, DOI 10.1016/0304-3940(96)12614-8; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; Farrell CJ, 2004, P NATL ACAD SCI USA, V101, P4625, DOI 10.1073/pnas.0306482101; Fujimori K, 2000, J BIOL CHEM, V275, P40511, DOI 10.1074/jbc.M007688200; Gallant MA, 2005, J BONE MINER RES, V20, P672, DOI 10.1359/JBMR.041211; Gallant MA, 2010, J RHEUMATOL, V37, P644, DOI 10.3899/jrheum.090622; Gerena RL, 2000, J ANDROL, V21, P848; Gietz R D, 2002, Methods Mol Biol, V185, P471; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GILES H, 1988, PROSTAGLANDINS, V35, P277, DOI 10.1016/0090-6980(88)90093-7; Gilroy DW, 2003, FASEB J, V17, P2269, DOI 10.1096/fj.02-1162fje; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; HARDY CC, 1984, NEW ENGL J MED, V311, P209, DOI 10.1056/NEJM198407263110401; Ianaro A, 2001, FEBS LETT, V508, P61, DOI 10.1016/S0014-5793(01)03035-6; Ide T, 2003, THROMB RES, V110, P311, DOI 10.1016/S0049-3848(03)00418-3; Inui T, 2003, J BIOL CHEM, V278, P2845, DOI 10.1074/jbc.M209934200; Ishizuka T, 2004, CARDIOVASC DRUG REV, V22, P71; ITO S, 1989, PROSTAG LEUKOTR ESS, V37, P219, DOI 10.1016/0952-3278(89)90033-1; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Li L, 2006, CYTOKINE GROWTH F R, V17, P203, DOI 10.1016/j.cytogfr.2006.01.005; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MATSUMURA H, 1991, P NATL ACAD SCI USA, V88, P9046, DOI 10.1073/pnas.88.20.9046; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mifflin RC, 2002, AM J PHYSIOL-CELL PH, V282, pC824, DOI 10.1152/ajpcell.00388.2001; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; Molina-Holgado E, 2000, BRIT J PHARMACOL, V131, P152, DOI 10.1038/sj.bjp.0703557; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Nagasaka T, 2004, HISTOCHEM CELL BIOL, V121, P483, DOI 10.1007/s00418-004-0658-0; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Pierroz DD, 2009, J BONE MINER RES, V24, P775, DOI [10.1359/JBMR.081237, 10.1359/jbmr.081237]; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Ram A, 1997, BRAIN RES, V751, P81, DOI 10.1016/S0006-8993(96)01401-1; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; TAKAHATA R, 1993, BRAIN RES, V623, P65, DOI 10.1016/0006-8993(93)90010-K; Tanaka K, 2000, J IMMUNOL, V164, P2277, DOI 10.4049/jimmunol.164.5.2277; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; UENO R, 1983, P NATL ACAD SCI-BIOL, V80, P1735, DOI 10.1073/pnas.80.6.1735; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; URADE Y, 1987, J BIOL CHEM, V262, P15132; URADE Y, 1985, J BIOL CHEM, V260, P2410; URADE Y, 1990, J BIOL CHEM, V265, P371; Vong L, 2010, P NATL ACAD SCI USA, V107, P12023, DOI 10.1073/pnas.1004982107; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294	59	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2696	2706		10.1074/jbc.M110.178277	http://dx.doi.org/10.1074/jbc.M110.178277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21112970	Green Published, hybrid			2022-12-25	WOS:000286464300036
J	Filone, CM; Hanna, SL; Caino, MC; Bambina, S; Doms, RW; Cherry, S				Filone, Claire Marie; Hanna, Sheri L.; Caino, M. Cecilia; Bambina, Shelly; Doms, Robert W.; Cherry, Sara			Rift Valley Fever Virus Infection of Human Cells and Insect Hosts Is Promoted by Protein Kinase C Epsilon	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; GENOME; ENTRY; INHIBITION; MACROPINOCYTOSIS; MOSQUITO; REVEALS; PKC; PHOSPHORYLATION	As an arthropod-borne human pathogen, Rift Valley fever virus (RVFV) cycles between an insect vector and mammalian hosts. Little is known about the cellular requirements for infection in either host. Here we developed a tissue culture model for RVFV infection of human and insect cells that is amenable to high-throughput screening. Using this approach we screened a library of 1280 small molecules with pharmacologically defined activities and identified 59 drugs that inhibited RVFV infection with 15 inhibiting RVFV replication in both human and insect cells. Amongst the 15 inhibitors that blocked infection in both hosts was a subset that inhibits protein kinase C. Further studies found that infection is dependent upon the novel protein kinase C isozyme epsilon (PKC epsilon) in both human and insect cells as well as in adult flies. Altogether, these data show that inhibition of cellular factors required for early steps in the infection cycle including PKC epsilon can block RVFV infection, and may represent a starting point for the development of anti-RVFV therapeutics.	[Filone, Claire Marie; Hanna, Sheri L.; Bambina, Shelly; Doms, Robert W.; Cherry, Sara] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Cherry, Sara] Univ Penn, Sch Med, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Caino, M. Cecilia] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Filone, CM (corresponding author), USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.	cherrys@mail.med.upenn.edu		Filone, Claire Marie/0000-0002-4041-3948; cherry, sara/0000-0003-3956-6610; Caino, M. Cecilia/0000-0001-8294-8070	MARCE [U54 AI 057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	MARCE; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the MARCE U54 AI 057168 to RD and SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broughton SJ, 1996, J CELL BIOCHEM, V60, P584, DOI 10.1002/(SICI)1097-4644(19960315)60:4<584::AID-JCB14>3.0.CO;2-H; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Chu JJH, 2006, VIROLOGY, V349, P463, DOI 10.1016/j.virol.2006.01.022; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Coyne CB, 2007, EMBO J, V26, P4016, DOI 10.1038/sj.emboj.7601831; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; ELLIS DS, 1988, J MED VIROL, V24, P161, DOI 10.1002/jmv.1890240205; Ennaciri J, 2007, J LEUKOCYTE BIOL, V81, P625, DOI 10.1189/jlb.0806507; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; GAD AM, 1987, T ROY SOC TROP MED H, V81, P694, DOI 10.1016/0035-9203(87)90460-3; Garcia S, 2001, J CLIN MICROBIOL, V39, P4456, DOI 10.1128/JCM.39.12.4456-4461.2001; Gerrard SR, 2002, J VIROL, V76, P12200, DOI 10.1128/JVI.76.23.12200-12210.2002; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; JUPP PG, 1988, J AM MOSQUITO CONTR, V4, P4; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mitzner D, 2009, CELL MICROBIOL, V11, P1502, DOI 10.1111/j.1462-5822.2009.01343.x; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Perrimon N, 1998, P NATL ACAD SCI USA, V95, P9716, DOI 10.1073/pnas.95.17.9716; PETERS CJ, 1986, ANTIVIR RES, V6, P285, DOI 10.1016/0166-3542(86)90024-0; Pinheiro VB, 2006, CELL MICROBIOL, V8, P545, DOI 10.1111/j.1462-5822.2006.00693.x; Prekeris R, 1998, J BIOL CHEM, V273, P26790, DOI 10.1074/jbc.273.41.26790; Ramanathan HN, 2008, VIROLOGY, V374, P138, DOI 10.1016/j.virol.2007.12.030; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; Schmaljohn C.S., 2001, FIELDS VIROLOGY; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Vialat P, 1997, VIRUS RES, V52, P43, DOI 10.1016/S0168-1702(97)00097-X; Volmer R, 2006, PLOS PATHOG, V2, P195, DOI 10.1371/journal.ppat.0020019; WASMOEN TL, 1988, VIROLOGY, V166, P275, DOI 10.1016/0042-6822(88)90174-2; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Zhang XHD, 2006, PHARMACOGENOMICS, V7, P299, DOI 10.2217/14622416.7.3.299	44	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15483	10.1371/journal.pone.0015483	http://dx.doi.org/10.1371/journal.pone.0015483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124804	Green Published, gold, Green Submitted			2022-12-25	WOS:000284572000028
J	Morris, M; Epstein, H; Wawer, M				Morris, Martina; Epstein, Helen; Wawer, Maria			Timing Is Everything: International Variations in Historical Sexual Partnership Concurrency and HIV Prevalence	PLOS ONE			English	Article							RACIAL DISPARITIES; BEHAVIOR PATTERNS; PUBLIC-HEALTH; UNITED-STATES; SOUTH-AFRICA; RISK-FACTORS; INFECTION; TRANSMISSION; YOUNG; MEN	Background: Higher prevalence of concurrent partnerships is one hypothesis for the severity of the HIV epidemic in the countries of Southern Africa. But measures of the prevalence of concurrency alone do not adequately capture the impact concurrency will have on transmission dynamics. The importance of overlap duration and coital exposure are examined here. Methodology/Principal Findings: We conducted a comparison of data from three studies of sexual behavior carried out in the early 1990s in Uganda, Thailand and the US. Using cumulative concurrency measures, the three countries appeared somewhat similar. Over 50% of both Thai and Ugandan men reported a concurrency within the last three partnerships and over 20% reported a concurrency in the last year, the corresponding rates among US men were nearly 20% for Blacks and Hispanics, and about 10% for other racial/ethnic groups. Concurrency measures that were more sensitive to overlap duration, however, showed large differences. The point prevalence of concurrency on the day of interview was over 10% among Ugandan men compared to 1% for Thai men. Ugandan concurrencies were much longer duration - a median of about two years - than either the Thai (1 day) or US concurrencies (4-9 months across all groups), and involved 5-10 times more coital risk exposure with the less frequent partner. In the US, Blacks and Hispanics reported higher prevalence, longer duration and greater coital exposure than Whites, but were lower than Ugandans on nearly every measure. Together, the differences in the prevalence, duration and coital exposure of concurrent partnerships observed align with the HIV prevalence differentials seen in these populations at the time the data were collected. Conclusions/Significance: There were substantial variations in the patterns of concurrent partnerships within and between populations. More long-term overlapping partnerships, with regular coital exposure, were found in populations with greater HIV epidemic severity.	[Morris, Martina] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Morris, Martina] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Wawer, Maria] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Morris, M (corresponding author), Univ Washington, Dept Stat, Seattle, WA 98195 USA.	morris@stat.washington.edu	Franzeck, Fabian C/B-5055-2011; Morris, Martina/I-7510-2012		National Institutes of Health (NIH) [R01DA12831, R01HD41877, R24 HD056799, P30 AI027757]; Robert Wood Johnson Foundation; Henry J. Kaiser Family Foundation; Rockefeller Foundation; Andrew Mellon Foundation; John D. and Catherine T. MacArthur Foundation; New York Community Trust; American Foundation for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041877, R24HD056799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083034, P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012831] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Henry J. Kaiser Family Foundation; Rockefeller Foundation; Andrew Mellon Foundation; John D. and Catherine T. MacArthur Foundation; New York Community Trust; American Foundation for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants R01DA12831, R01HD41877, R24 HD056799 and P30 AI027757 (www.nih.gov); Robert Wood Johnson Foundation (http://www.rwjf.org/); The Henry J. Kaiser Family Foundation (http://www.kff.org/); The Rockefeller Foundation (http://www.rockefellerfoundation.org/); Andrew Mellon Foundation (http://www.mellon.org/); The John D. and Catherine T. MacArthur Foundation (http://www.macfound.org); The New York Community Trust (www.nycommunitytrust.org); and The American Foundation for AIDS Research (http://www.amfar.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2002, EPIDEMIOLOGY, V13, P320, DOI 10.1097/00001648-200205000-00013; Adimora AA, 2007, AM J PUBLIC HEALTH, V97, P2230, DOI 10.2105/AJPH.2006.099069; Bohl DD, 2009, SEX TRANSM INFECT, V85, P367, DOI 10.1136/sti.2009.036723; CARAEL M, 1995, SOC AS AIDS, P75; *CDCP, 2004, STD SURV 2004 STDS R; *CDCP, 1994, HIV AIDS SURV REP CD; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; *DISTR COL DEP HLT, 2009, DISTR COL HIV AIDS E; Durant T., 2007, Morbidity and Mortality Weekly Report, V56, P189; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Epstein H, 2010, AIDS BEHAV, V14, P29, DOI 10.1007/s10461-009-9627-x; Gregson S., 2010, INT J EPIDEMIOL; Guwatudde D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004145; Hallfors DD, 2007, AM J PUBLIC HEALTH, V97, P125, DOI 10.2105/AJPH.2005.075747; HAMILTON D, 2009, CONSISTENCY SELF REP; HUDSON CP, 1993, INT J STD AIDS, V4, P249, DOI 10.1177/095646249300400501; Hudson CP, 1996, INT J STD AIDS, V7, P236, DOI 10.1258/0956462961917906; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1455, DOI 10.1093/ije/dyl217; Johnson KM, 2003, AIDS, V17, P605, DOI 10.1097/00002030-200303070-00016; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; KELLY R, 2000, CONCURRENT NONCONCUR; Kirby D, 2008, SEX TRANSM INFECT, V84, pII35, DOI 10.1136/sti.2008.029892; Koumans EH, 2001, SEX TRANSM DIS, V28, P497, DOI 10.1097/00007435-200109000-00004; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Lurie MN, 2010, AIDS BEHAV, V14, P34, DOI 10.1007/s10461-009-9640-0; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Mattson CL, 2007, SEX TRANSM DIS, V34, P731, DOI 10.1097/01.olq.0000261335.42480.89; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Mills S, 1997, AIDS, V11, pS43; MISHRA V, 2009, CONCURRENT SEXUAL PA; MORRIS M, 1993, NATURE, V365, P437, DOI 10.1038/365437a0; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Morris M, 2001, SEX TRANSM DIS, V28, P504, DOI 10.1097/00007435-200109000-00005; Morris M, 2004, NETWORK EPIDEMIOLOGY; MORRIS M, 2010, INT J EPIDEMIOL; MORRIS M, 1994, CONNECTIONS, V17, P31; Morris M, 2006, AM J PUBLIC HEALTH, V96, P1091, DOI 10.2105/AJPH.2004.054759; Morris M, 2010, AIDS BEHAV, V14, P31, DOI 10.1007/s10461-009-9639-6; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Nunn AJ, 1997, BRIT MED J, V315, P767, DOI 10.1136/bmj.315.7111.767; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Potterat JJ, 1999, AM J EPIDEMIOL, V150, P1331, DOI 10.1093/oxfordjournals.aje.a009965; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Reniers G, 2010, AIDS, V24, P299, DOI 10.1097/QAD.0b013e328333af03; Sawers L, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-34; SEWANKAMBO NK, 1994, AIDS, V8, P1707, DOI 10.1097/00002030-199412000-00011; Shisana O., 2009, S AFRICAN NATL HIV P; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; UNAIDS, 2007, ANN REP KNOW YOUR EP; UNAIDS Reference Grp Estimates Mod, 2010, LANCET, V375, P621, DOI 10.1016/S0140-6736(09)62040-7; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8	55	97	97	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14092	10.1371/journal.pone.0014092	http://dx.doi.org/10.1371/journal.pone.0014092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124829	Green Published, gold			2022-12-25	WOS:000284572000003
J	Fernagut, PO; Li, Q; Dovero, S; Chan, P; Wu, T; Ravenscroft, P; Hill, M; Chen, ZW; Bezard, E				Fernagut, Pierre-Olivier; Li, Qin; Dovero, Sandra; Chan, Piu; Wu, Tao; Ravenscroft, Paula; Hill, Michael; Chen, Zhenwen; Bezard, Erwan			Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys	PLOS ONE			English	Article							PARKINSONS-DISEASE PROGRESSION; LEVODOPA-INDUCED DYSKINESIA; IN-VIVO BINDING; MACAQUE MODEL; NIGROSTRIATAL DEGENERATION; RAT STRIATUM; REAL-PET; BETA-CIT; SPECT; AVAILABILITY	Background: Radiotracer imaging of the presynaptic nigrostriatal dopaminergic system is used to assess disease progression in Parkinson's disease (PD) and may provide a useful adjunct to clinical assessment during therapeutic trials of potential neuroprotective agents. Several clinical trials comparing dopamine agonists to L-DOPA or early vs. late L-DOPA have revealed differences between clinical assessment and imaging of the presynaptic dopaminergic system, hence questioning the comparability of these measures as neuroprotection outcome variables. Thus, results of these studies may have been affected by factors other than the primary biological process investigated. Methodology/Principal Findings: We tested the possibility that L-DOPA might interfere with DAT binding. Post-mortem DAT binding was conducted in normal and MPTP-treated macaque monkeys that were administered L-DOPA, acutely or chronically. In parallel, DAT SPECT was conducted in MPTP-treated animals that were administered chronic L-DOPA. [99mTc]TRODAT-1 SPECT binding was similarly reduced in all MPTP monkeys regardless of L-DOPA treatment. L-DOPA had no significant effect on post-mortem DAT binding either in saline or in MPTP-lesioned animals. Conclusions/Significance: These data indicate that L-DOPA does not induce modifications of DAT expression detectable by SPECT of by DAT binding autoradiography, suggesting that differences between clinical assessment and radiotracer imaging in clinical trials may not be specifically related to L-DOPA treatment.	[Fernagut, Pierre-Olivier; Dovero, Sandra; Bezard, Erwan] Univ Bordeaux 2, CNRS, UMR 5227, Bordeaux Inst Neurosci, F-33076 Bordeaux, France; [Li, Qin; Ravenscroft, Paula] Motac Neurosci Ltd, Manchester, Lancs, England; [Li, Qin; Bezard, Erwan] China Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Chan, Piu; Wu, Tao] Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Chen, Zhenwen] Capital Med Univ, Dept Lab Anim Sci, Beijing, Peoples R China	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Capital Medical University; Capital Medical University	Fernagut, PO (corresponding author), Univ Bordeaux 2, CNRS, UMR 5227, Bordeaux Inst Neurosci, F-33076 Bordeaux, France.	pierre-olivier.fernagut@u-bordeaux2.fr	Bezard, Erwan/A-8173-2008; Chan, Piu/I-4580-2016; Bezard, Erwan/ABD-5153-2021; Wu, Tao/S-4505-2019	Chan, Piu/0000-0003-1346-881X; Bezard, Erwan/0000-0002-0410-4638; DOVERO, Sandra/0000-0002-5781-1328; Fernagut, Pierre-Olivier/0000-0002-7737-5439	Agence Nationale de la Recherche [ANR-07-JCJC-0090, ANR-08-MNP-018, ANR-07-MNP-Trafinlid]; National High Technology Research and Development Program of China [2006AA02A116]; Motac Neuroscience Ltd	Agence Nationale de la Recherche(French National Research Agency (ANR)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Motac Neuroscience Ltd	This work was supported by Agence Nationale de la Recherche grants (ANR-07-JCJC-0090; ANR-08-MNP-018; ANR-07-MNP-Trafinlid) and the National High Technology Research and Development Program of China, No. 2006AA02A116. Funding for the research was provided by Motac Neuroscience Ltd to MH and PR who are employees of Motac Neuroscience. The funders had a role in study design, data collection and analysis.	Ahlskog JE, 2003, NEUROLOGY, V60, P381, DOI 10.1212/01.WNL.0000044047.58984.2F; AHMED MR, SCI TRANSL MED, V2; Bezard E, 1997, BRAIN RES, V766, P107, DOI 10.1016/S0006-8993(97)00531-3; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 2003, NAT MED, V9, P762, DOI 10.1038/nm875; Bezard E, 2006, NEUROBIOL DIS, V23, P77, DOI 10.1016/j.nbd.2006.02.003; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Brotchie JM, 1999, MOVEMENT DISORD, V14, P40; Chen PS, 2008, NEUROIMAGE, V40, P275, DOI 10.1016/j.neuroimage.2007.11.007; Dresel SHJ, 1998, EUR J NUCL MED, V25, P31; Emond P, 1997, J MED CHEM, V40, P1366, DOI 10.1021/jm960795d; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Francois C, 1996, BRAIN RES BULL, V41, P151, DOI 10.1016/0361-9230(96)00161-X; GNANALINGHAM KK, 1994, BRAIN RES, V640, P185, DOI 10.1016/0006-8993(94)91872-4; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; Gordon I, 1996, EUR J PHARMACOL, V298, P27, DOI 10.1016/0014-2999(95)00770-9; Guigoni C, 2005, EUR J NEUROSCI, V22, P283, DOI 10.1111/j.1460-9568.2005.04196.x; Hall H, 1999, NEUROIMAGE, V9, P108, DOI 10.1006/nimg.1998.0366; Hill MP, 2004, J PHARMACOL EXP THER, V310, P386, DOI 10.1124/jpet.104.066191; IKAWA K, 1993, EUR J PHARMACOL, V250, P261, DOI 10.1016/0014-2999(93)90390-4; Imbert C, 2000, J NEUROSCI METH, V96, P71, DOI 10.1016/S0165-0270(99)00184-3; Innis RB, 1999, MOVEMENT DISORD, V14, P436, DOI 10.1002/1531-8257(199905)14:3<436::AID-MDS1008>3.0.CO;2-J; LARUELLE M, 1993, SYNAPSE, V13, P295, DOI 10.1002/syn.890130402; Marek K, 2002, EUR J NEUROL, V9, P15, DOI 10.1046/j.1468-1331.9.s3.2.x; Marek K, 2001, NEUROLOGY, V57, P2089, DOI 10.1212/WNL.57.11.2089; Meissner W, 2003, MOL NEUROBIOL, V28, P209, DOI 10.1385/MN:28:3:209; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Montgomery EB, 2003, NEUROLOGY, V61, P1462, DOI 10.1212/WNL.61.10.1462; Moody CA, 1996, NEUROSCI LETT, V217, P55; Morrish PK, 2003, ANN NEUROL, V54, P692, DOI 10.1002/ana.10774; Morrish PK, 2003, MOVEMENT DISORD, V18, pS63, DOI 10.1002/mds.10581; Morrish PK, 2003, MOVEMENT DISORD, V18, P839, DOI 10.1002/mds.10448; Morrish PK, 1998, J NEUROL NEUROSUR PS, V64, P314, DOI 10.1136/jnnp.64.3.314; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; Newberg A, 2007, CLIN NUCL MED, V32, P452, DOI 10.1097/01.rlu.0000262980.98342.dd; Nurmi E, 2000, ANN NEUROL, V47, P804, DOI 10.1002/1531-8249(200006)47:6<804::AID-ANA14>3.0.CO;2-F; Parish CL, 2002, EUR J NEUROSCI, V16, P787, DOI 10.1046/j.1460-9568.2002.02132.x; PARKINSON, 2002, JAMA-J AM MED ASSOC, V287, P1653; Pearce RKB, 1995, MOVEMENT DISORD, V10, P731, DOI 10.1002/mds.870100606; Pirker W, 2002, MOVEMENT DISORD, V17, P45, DOI 10.1002/mds.1265; Prunier C, 2003, NEUROIMAGE, V19, P810, DOI 10.1016/S1053-8119(03)00163-0; Ravina B, 2005, NEUROLOGY, V64, P208, DOI 10.1212/01.WNL.0000149403.14458.7F; Rioux L, 1997, MOVEMENT DISORD, V12, P148, DOI 10.1002/mds.870120204; Scheller D, 2007, EXP NEUROL, V203, P415, DOI 10.1016/j.expneurol.2006.08.026; Scherfler C, 2002, NEUROIMAGE, V17, P128, DOI 10.1006/nimg.2002.1158; Schillaci O, 2005, EUR J NUCL MED MOL I, V32, P1452, DOI 10.1007/s00259-005-1922-9; Stanic D, 2003, J NEUROCHEM, V86, P329, DOI 10.1046/j.1471-4159.2003.01843.x; Thibaut F, 1996, NEUROSCI LETT, V205, P145, DOI 10.1016/0304-3940(96)12399-5; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; van Dyck CH, 2005, J NUCL MED, V46, P745; Weintraub D, 2005, J NUCL MED, V46, P227; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609; Winogrodzka A, 2005, PARKINSONISM RELAT D, V11, P475, DOI 10.1016/j.parkreldis.2005.08.001; Winogrodzka A, 2001, J NEURAL TRANSM, V108, P1011, DOI 10.1007/s007020170019; Zigmond MJ, 1997, NEUROBIOL DIS, V4, P247, DOI 10.1006/nbdi.1997.0157	56	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14053	10.1371/journal.pone.0014053	http://dx.doi.org/10.1371/journal.pone.0014053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124922	Green Published, gold, Green Submitted			2022-12-25	WOS:000284467200003
J	Nodari, LR; Ferrari, D; Giani, F; Bossi, M; Rodriguez-Menendez, V; Tredici, G; Delia, D; Vescovi, AL; De Filippis, L				Nodari, Laura Rota; Ferrari, Daniela; Giani, Fabrizio; Bossi, Mario; Rodriguez-Menendez, Virginia; Tredici, Giovanni; Delia, Domenico; Vescovi, Angelo Luigi; De Filippis, Lidia			Long-Term Survival of Human Neural Stem Cells in the Ischemic Rat Brain upon Transient Immunosuppression	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SUBVENTRICULAR ZONE; PROGENITOR CELLS; NEURONAL DAMAGE; ADULT BRAIN; HUMAN CNS; TRANSPLANTATION; MODEL; NEUROPROTECTION; NEUROGENESIS	Understanding the physiology of human neural stem cells (hNSCs) in the context of cell therapy for neurodegenerative disorders is of paramount importance, yet large-scale studies are hampered by the slow-expansion rate of these cells. To overcome this issue, we previously established immortal, non-transformed, telencephalic-diencephalic hNSCs (IhNSCs) from the fetal brain. Here, we investigated the fate of these IhNSC's immediate progeny (i.e. neural progenitors; IhNSC-Ps) upon unilateral implantation into the corpus callosum or the hippocampal fissure of adult rat brain, 3 days after global ischemic injury. One month after grafting, approximately one fifth of the IhNSC-Ps had survived and migrated through the corpus callosum, into the cortex or throughout the dentate gyrus of the hippocampus. By the fourth month, they had reached the ipsilateral subventricular zone, CA1-3 hippocampal layers and the controlateral hemisphere. Notably, these results could be accomplished using transient immunosuppression, i.e administering cyclosporine for 15 days following the ischemic event. Furthermore, a concomitant reduction of reactive microglia (Iba1+ cells) and of glial, GFAP+ cells was also observed in the ipsilateral hemisphere as compared to the controlateral one. IhNSC-Ps were not tumorigenic and, upon in vivo engraftment, underwent differentiation into GFAP+ astrocytes, and beta-tubulinIII+ or MAP2+ neurons, which displayed GABAergic and GLUTAmatergic markers. Electron microscopy analysis pointed to the formation of mature synaptic contacts between host and donor-derived neurons, showing the full maturation of the IhNSC-P-derived neurons and their likely functional integration into the host tissue. Thus, IhNSC-Ps possess long-term survival and engraftment capacity upon transplantation into the globally injured ischemic brain, into which they can integrate and mature into neurons, even under mild, transient immunosuppressive conditions. Most notably, transplanted IhNSC-P can significantly dampen the inflammatory response in the lesioned host brain. This work further supports hNSCs as a reliable and safe source of cells for transplantation therapy in neurodegenerative disorders.	[Nodari, Laura Rota; Ferrari, Daniela; Giani, Fabrizio; Vescovi, Angelo Luigi; De Filippis, Lidia] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Bossi, Mario; Rodriguez-Menendez, Virginia; Tredici, Giovanni] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Milan, Italy; [Delia, Domenico] Fdn IRCSS Ist Nazl Tumori, Dept Expt Oncol, Milan, Italy; [Vescovi, Angelo Luigi] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy	University of Milano-Bicocca; University of Milano-Bicocca; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Casa Sollievo Della Sofferenza	Nodari, LR (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	angelo.vescovi@unimib.it; lidia.defilippis@unimib.it	Vescovi, Angelo Luigi/A-4919-2015; Ferrari, Daniela/AHE-7647-2022; De Filippis, Lidia/H-3098-2017	Vescovi, Angelo Luigi/0000-0002-1742-4112; Ferrari, Daniela/0000-0001-7251-9854; De Filippis, Lidia/0000-0002-2196-9430; Giani, Fabrizio/0000-0003-0031-3157	CARIPLO Foundation; Neurothon ONLUS Foundation; Italian Association for Cancer Research (AIRC); Italian Ministry of Health Ricerca Finalizzata	CARIPLO Foundation(Fondazione Cariplo); Neurothon ONLUS Foundation; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy)	This work was supported by CARIPLO Foundation; Neurothon ONLUS Foundation; Italian Association for Cancer Research (AIRC); Italian Ministry of Health Ricerca Finalizzata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bendel O, 2005, BRAIN RES, V1033, P135, DOI 10.1016/j.brainres.2004.11.033; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Boockvar J, 2005, NEUROSURGERY, V56, pN6; Bueters T, 2008, EXP NEUROL, V209, P114, DOI 10.1016/j.expneurol.2007.09.005; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Craig CG, 1996, J NEUROSCI, V16, P2649; DAADI MM, 2010, STROKE; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Givogri MI, 2008, DEV NEUROSCI-BASEL, V30, P340, DOI 10.1159/000150127; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; GRITTI A, 1995, NEUROSCI LETT, V185, P151, DOI 10.1016/0304-3940(95)11247-T; Gritti A, 1996, J NEUROSCI, V16, P1091; GU W, 2009, STEM CELL RES; Hurelbrink CB, 2002, EUR J NEUROSCI, V15, P1255, DOI 10.1046/j.1460-9568.2002.01959.x; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Le Belle JE, 2004, J NEUROSCI RES, V76, P174, DOI 10.1002/jnr.20035; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7; Neri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010145; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Olstorn H, 2007, NEUROSURGERY, V60, P1089, DOI 10.1227/01.NEU.0000255461.91892.0D; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; POPAWAGNER A, 2009, AGEING RES REV; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Wennersten A, 2006, EXP NEUROL, V199, P339, DOI 10.1016/j.expneurol.2005.12.035; Wong AM, 2005, BRAIN RES, V1063, P140, DOI 10.1016/j.brainres.2005.09.049	53	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14035	10.1371/journal.pone.0014035	http://dx.doi.org/10.1371/journal.pone.0014035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124963	gold, Green Published, Green Submitted			2022-12-25	WOS:000284400100004
J	How, PC; Shields, D				How, Poh Choo; Shields, Dennis			Tethering Function of the Caspase Cleavage Fragment of Golgi Protein p115 Promotes Apoptosis via a p53-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; ENDOPLASMIC-RETICULUM; MITOTIC PHOSPHORYLATION; MEDIATED CLEAVAGE; GENE-EXPRESSION; REGULATES GOLGI; P53 ACTIVATION; KINASE; GRASP65; GM130	The Golgi apparatus undergoes extensive fragmentation during apoptosis due in part to caspase-mediated cleavage of its structural proteins. Significantly, the Golgi-vesicle-tethering protein p115 is cleaved at Asp(757) early during apoptosis and the nuclear translocation of its 205 amino acid C-terminal fragment (CTF) precedes observable Golgi fragmentation. Nuclear localization of the p115 CTF induces apoptosis. The regulation of CTF nuclear translocation and the mechanism of its apoptotic activity however, remain unknown. Here, we demonstrate that nuclear translocation of the CTF is regulated by SUMOylation. CTF-induced apoptosis is transcription dependent and mediated by the tumor suppressor, p53. Expression of the CTF led to the phosphorylation and stabilization of p53 and results in the expression of PUMA, a pro-apoptotic target of p53. CTF-induced stabilization of p53 is sensitive to the MEK/ERK inhibitor U0126. Co-immunoprecipitation studies indicate that the p115 CTF can bind to both p53 and ERK1. The CTF is also able to form dimers and its dimerization is dependent on residues 859-884, previously determined to be required for apoptosis. Indeed, CTF expression promotes p53-ERK interaction, which is diminished upon deletion of residues 859-884. Together, our results indicate a conserved tethering function of the Golgi protein p115 CTF which promotes p53-ERK interaction for the amplification of the apoptotic signal.	[How, Poh Choo; Shields, Dennis] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Shields, Dennis] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	How, PC (corresponding author), Chanin 501,1300 Morris Pk Ave, Bronx, NY 10461 USA.	pohchoo.how@med.einstein.yu.edu			National Institutes of Health [DK21860]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK021860, R01DK021860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK21860 (to D. S.).	Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Brantley-Finley C, 2003, BIOCHEM PHARMACOL, V66, P459, DOI 10.1016/S0006-2952(03)00255-7; Brown L, 2006, J BIOL CHEM, V281, P3832, DOI 10.1074/jbc.M507951200; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Dirac-Svejstrup AB, 2000, J CELL BIOL, V150, P475, DOI 10.1083/jcb.150.3.475; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Hicks SW, 2002, J BIOL CHEM, V277, P35833, DOI 10.1074/jbc.M206280200; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lowe M, 2004, J CELL SCI, V117, P1139, DOI 10.1242/jcs.00950; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Maag RS, 2005, MOL BIOL CELL, V16, P3019, DOI 10.1091/mbc.E04-11-0971; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Mukherjee S, 2009, J BIOL CHEM, V284, P1709, DOI 10.1074/jbc.M807263200; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Novakovic P, 2006, CARCINOGENESIS, V27, P916, DOI 10.1093/carcin/bgi312; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sablina AA, 2001, ONCOGENE, V20, P899, DOI 10.1038/sj.onc.1204156; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Sbodio JI, 2006, J BIOL CHEM, V281, P27924, DOI 10.1074/jbc.M603276200; Shaul YD, 2006, J CELL BIOL, V172, P885, DOI 10.1083/jcb.200509063; Shaul YD, 2009, GENE DEV, V23, P1779, DOI 10.1101/gad.523909; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Warren G, 1998, CURR OPIN CELL BIOL, V10, P493, DOI 10.1016/S0955-0674(98)80064-1; Wei Jen-Hsuan, 2009, Commun Integr Biol, V2, P35; Wiencke JK, 2005, CANCER EPIDEM BIOMAR, V14, P1774, DOI 10.1158/1055-9965.EPI-05-0089; Yang T, 2001, J BIOL CHEM, V276, P39569, DOI 10.1074/jbc.M102961200; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189	54	20	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8565	8576		10.1074/jbc.M110.175174	http://dx.doi.org/10.1074/jbc.M110.175174			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21147777	Green Published, hybrid			2022-12-25	WOS:000288013300083
J	Morgan, MR; Jazayeri, M; Ramsay, AG; Thomas, GJ; Boulanger, MJ; Hart, IR; Marshall, JF				Morgan, M. R.; Jazayeri, M.; Ramsay, A. G.; Thomas, G. J.; Boulanger, M. J.; Hart, I. R.; Marshall, J. F.			Psoriasin (S100A7) associates with integrin beta 6 subunit and is required for alpha v beta 6-dependent carcinoma cell invasion	ONCOGENE			English	Article						alpha v beta 6; integrins; invasion; psoriasin; cancer; oral SCC	TUMOR PROGRESSION; BINDING-PROTEIN; BREAST-CANCER; TERMINAL DIFFERENTIATION; CYTOPLASMIC DOMAIN; PROMOTES MIGRATION; COLON-CARCINOMA; ORAL-CAVITY; IN-SITU; EXPRESSION	Expression of the integrin alpha v beta 6 is upregulated in a variety of carcinomas where it appears to be involved in malignant progression, although the biology of this integrin is not fully explored. We have generated oral carcinoma cells that express alpha v beta 6 composed of wild-type alpha v and a mutant beta 6 that lacks the unique C-terminal 11 amino acids (aa). We found that these residues, although not required for alpha v beta 6-dependent adhesion or migration, are essential for alpha v beta 6-dependent invasive activity. We have used a proteomic approach to identify novel binding partners for the beta 6 subunit cytoplasmic tail and report that psoriasin (Psor) (S100A7) bound preferentially to the recombinant beta 6 cytoplasmic domain, though not in the absence of the unique C-terminal 11aa. Endogenous cellular Psor co-precipitated with endogenous beta 6 and colocalised with alpha v beta 6 at the cell membrane and intracellular vesicles. Knockdown of Psor, with small interfering RNA, had no effect on alpha v beta 6-dependent adhesion or migration but abrogated alpha v beta 6-mediated oral carcinoma cell invasion both in Transwell and, the more physiologically relevant, organotypic invasion assays, recapitulating the behaviour of the beta 6-mutant cell line. Membrane-permeant Tat-peptides encoding the unique C-terminal residues of beta 6, bound directly to recombinant Psor and inhibited cellular Psor binding to beta 6; this blocked alpha v beta 6-dependent, but not alpha v beta 6-independent, invasion. These data identify a novel interaction between Psor and beta 6 and demonstrate that it is required for alpha v beta 6-dependent invasion by carcinoma cells. Inhibition of this interaction may represent a novel therapeutic strategy to target carcinoma invasion. Oncogene (2011) 30, 1422-1435; doi:10.1038/onc.2010.535; published online 6 December 2010	[Ramsay, A. G.; Marshall, J. F.] Univ London, Barts & London Sch Med & Dent, John Vane Sci Ctr, Inst Canc,Ctr Med Oncol, London EC1M 6BQ, England; [Morgan, M. R.; Jazayeri, M.; Ramsay, A. G.; Thomas, G. J.; Hart, I. R.; Marshall, J. F.] London Sch Med & Dent, John Vane Sci Ctr, Tumor Biol Ctr, London, England; [Boulanger, M. J.] Dept Biochem & Microbiol, Victoria, BC, Canada	University of London; Queen Mary University London; University of London; Queen Mary University London	Marshall, JF (corresponding author), Univ London, Barts & London Sch Med & Dent, John Vane Sci Ctr, Inst Canc,Ctr Med Oncol, Charterhouse Sq, London EC1M 6BQ, England.	j.f.marshall@qmul.ac.uk	Ramsay, Alan G/A-8374-2015	Ramsay, Alan G/0000-0002-0452-0420; Morgan, Mark/0000-0001-7728-9883; Marshall, John/0000-0002-0494-2295				AGREZ M, 1994, J CELL BIOL, V127, P547, DOI 10.1083/jcb.127.2.547; Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Banerjee AG, 2005, MOL CANCER THER, V4, P865, DOI 10.1158/1535-7163.MCT-05-0033; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; BREUSS JM, 1995, J CELL SCI, V108, P2241; BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; BUSK M, 1992, J BIOL CHEM, V267, P5790; Clark RAF, 1996, BRIT J DERMATOL, V135, P46; Elayadi AN, 2007, CANCER RES, V67, P5889, DOI 10.1158/0008-5472.CAN-07-0245; Emberley ED, 2005, CANCER RES, V65, P5696, DOI 10.1158/0008-5472.CAN-04-3927; Emberley ED, 2004, BREAST CANCER RES, V6, pR308, DOI 10.1186/bcr791; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Haapasalmi K, 1996, J INVEST DERMATOL, V106, P42, DOI 10.1111/1523-1747.ep12327199; Hazelbag S, 2007, J PATHOL, V212, P316, DOI 10.1002/path.2168; Jiang WG, 2004, INT J ONCOL, V25, P81; Jones J, 1996, ONCOGENE, V12, P119; Jones J, 1997, J ORAL PATHOL MED, V26, P63, DOI 10.1111/j.1600-0714.1997.tb00023.x; Kesting MR, 2009, ORAL ONCOL, V45, P731, DOI 10.1016/j.oraloncology.2008.11.012; Krop I, 2005, CANCER RES, V65, P11326, DOI 10.1158/0008-5472.CAN-05-1523; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Larjava H, 1996, Oral Dis, V2, P77; Leon R, 2009, BIOCHEMISTRY-US, V48, P10591, DOI 10.1021/bi901330g; Li XW, 2003, J BIOL CHEM, V278, P41646, DOI 10.1074/jbc.M306274200; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Morgan MR, 2004, J BIOL CHEM, V279, P26533, DOI 10.1074/jbc.M401736200; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Niu J, 2002, INT J CANCER, V99, P529, DOI 10.1002/ijc.10397; Niu J, 2001, INT J CANCER, V92, P40, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1157>3.0.CO;2-B; Nystrom ML, 2006, CANCER RES, V66, P10833, DOI 10.1158/0008-5472.CAN-06-1640; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; Paruchuri V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001741; Petersson S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-205; PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154; PRIME SS, 1990, J PATHOL, V160, P259, DOI 10.1002/path.1711600313; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ramos DM, 2002, MATRIX BIOL, V21, P297, DOI 10.1016/S0945-053X(02)00002-1; Ramsay AG, 2007, CANCER RES, V67, P5275, DOI 10.1158/0008-5472.CAN-07-0318; Regezi JA, 2002, ORAL ONCOL, V38, P332, DOI 10.1016/S1368-8375(01)00062-8; RESKA AA, 1992, J CELL BIOL, V117, P1321; Ruse M, 2003, J INVEST DERMATOL, V121, P132, DOI 10.1046/j.1523-1747.2003.12309.x; SUGIYAMA M, 1993, CARCINOGENESIS, V14, P2171, DOI 10.1093/carcin/14.10.2171; Thomas GJ, 2006, J ORAL PATHOL MED, V35, P1, DOI 10.1111/j.1600-0714.2005.00374.x; Thomas GJ, 2002, BRIT J CANCER, V87, P859, DOI 10.1038/sj.bjc.6600545; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; Thomas GJ, 2001, J INVEST DERMATOL, V117, P67, DOI 10.1046/j.0022-202x.2001.01379.x; Thomas GJ, 2001, J INVEST DERMATOL, V116, P898, DOI 10.1046/j.1523-1747.2001.01352.x; Wang J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2105; WEINACKER A, 1994, J BIOL CHEM, V269, P6940; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Zhou G, 2008, ONCOGENE, V27, P3527, DOI 10.1038/sj.onc.1211015	51	27	29	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	12					1422	1435		10.1038/onc.2010.535	http://dx.doi.org/10.1038/onc.2010.535			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	739UM	21132011				2022-12-25	WOS:000288743800005
J	Naylor, J; Al-Shawaf, E; Mckeown, L; Manna, PT; Porter, KE; O'Regan, D; Muraki, K; Beech, DJ				Naylor, Jacqueline; Al-Shawaf, Eman; Mckeown, Lynn; Manna, Paul T.; Porter, Karen E.; O'Regan, David; Muraki, Katsuhiko; Beech, David J.			TRPC5 Channel Sensitivities to Antioxidants and Hydroxylated Stilbenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL; CATION CHANNEL; RESVERATROL; RECEPTOR; CELL; STIMULATION; CURRENTS; AGONIST; INFLUX; WINE	Transient receptor potential canonical 5 (TRPC5) forms cationic channels that are polymodal sensors of factors including oxidized phospholipids, hydrogen peroxide, and reduced thioredoxin. The aim of this study was to expand knowledge of the chemical-sensing capabilities of TRPC5 by investigating dietary antioxidants. Human TRPC5 channels were expressed in HEK 293 cells and studied by patch clamp and intracellular Ca2+ recording. GFP- and HA-tagged channels were used to quantify plasma membrane localization. Gallic acid and vitamin C suppressed TRPC5 activity if it was evoked by exogenous hydrogen peroxide or lanthanide ions but not by lysophosphatidylcholine or carbachol. Catalase mimicked the effects, suggesting that lanthanide-evoked activity depended on endogenous hydrogen peroxide. Trans-resveratrol, by contrast, inhibited all modes of TRPC5, and its effect was additive with that of vitamin C, suggesting antioxidant-independent action. The IC50 was similar to 10 mu M. Diethylstilbestrol, a related hydroxylated stilbene, inhibited TRPC5 with a similar IC50, but its action contrasted sharply with that of resveratrol in outside-out membrane patches where diethylstilbestrol caused strong and reversible inhibition and resveratrol had no effect, suggesting indirect modulation by resveratrol. Resveratrol did not affect channel surface density, but its effect was calcium-sensitive, indicating an action via a calcium-dependent intermediate. The data suggest previously unrecognized chemical-sensing properties of TRPC5 through multiple mechanisms: (i) inhibition by scavengers of reactive oxygen species because a mode of TRPC5 activity depends on endogenous hydrogen peroxide; (ii) direct channel blockade by diethylstilbestrol; and (iii) indirect, antioxidant-independent inhibition by resveratrol.	[Naylor, Jacqueline; Al-Shawaf, Eman; Mckeown, Lynn; Manna, Paul T.; Beech, David J.] Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Naylor, Jacqueline; Al-Shawaf, Eman; Mckeown, Lynn; Manna, Paul T.; Porter, Karen E.; Beech, David J.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England; [Porter, Karen E.] Univ Leeds, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [O'Regan, David] Leeds Gen Infirm, Dept Cardiac Surg, Leeds LS1 3EX, W Yorkshire, England; [Muraki, Katsuhiko] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan	University of Leeds; University of Leeds; University of Leeds; Leeds General Infirmary; University of Leeds; Aichi Gakuin University	Beech, DJ (corresponding author), Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Garstang Bldg, Leeds LS2 9JT, W Yorkshire, England.	d.j.beech@leeds.ac.uk	McKeown, Lynn/AAC-6037-2020	McKeown, Lynn/0000-0003-2326-7595; Beech, David/0000-0002-7683-9422; Manna, Paul Thomas/0000-0002-2260-2075	Wellcome Trust; Japan Society for the Promotion of Science (JSPS)	Wellcome Trust(Wellcome TrustEuropean Commission); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by the Wellcome Trust and a Japan Society for the Promotion of Science (JSPS) International Collaboration Program grant.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Al-Shawaf E, 2010, ARTERIOSCL THROM VAS, V30, P1453, DOI 10.1161/ATVBAHA.110.205666; Beech D. J., 2007, V179, P109; Beech DJ, 2009, CELL CALCIUM, V45, P583, DOI 10.1016/j.ceca.2009.02.006; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Chaudhuri P, 2008, MOL BIOL CELL, V19, P3203, DOI 10.1091/mbc.E07-08-0765; Chen WP, 2007, EUR J PHARMACOL, V568, P269, DOI 10.1016/j.ejphar.2007.04.062; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Dobrydneva Y, 1999, BRIT J PHARMACOL, V128, P149, DOI 10.1038/sj.bjp.0702749; Dobrydneva Y, 2010, J CARDIOVASC PHARM, V55, P522, DOI 10.1097/FJC.0b013e3181d64b33; Fauconneau B, 1997, LIFE SCI, V61, P2103, DOI 10.1016/S0024-3205(97)00883-7; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Goswami SK, 2009, CANCER LETT, V284, P1, DOI 10.1016/j.canlet.2009.01.041; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Hui H, 2006, J PHYSIOL-LONDON, V572, P165, DOI 10.1113/jphysiol.2005.102889; Jakab M, 2008, CELL PHYSIOL BIOCHEM, V22, P567, DOI 10.1159/000185541; Jiang L. H., 2011, CURRENT DRU IN PRESS; Lee KP, 2010, J BIOL CHEM, V285, P38666, DOI 10.1074/jbc.M110.155036; Nath AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004221; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Penumathsa SV, 2009, CAN J PHYSIOL PHARM, V87, P275, DOI 10.1139/Y09-013; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Semtner M, 2007, J BIOL CHEM, V282, P33868, DOI 10.1074/jbc.M702577200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sukumar P, 2010, BIOCHEM BIOPH RES CO, V393, P50, DOI 10.1016/j.bbrc.2010.01.074; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Veurink M, 2005, PHARM WORLD SCI, V27, P139, DOI 10.1007/s11096-005-3663-z; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Wong CO, 2010, PFLUG ARCH EUR J PHY, V460, P121, DOI 10.1007/s00424-010-0823-3; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zakharov SI, 2004, MOL PHARMACOL, V66, P702; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391	41	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5078	5086		10.1074/jbc.M110.196956	http://dx.doi.org/10.1074/jbc.M110.196956			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127073	hybrid, Green Published			2022-12-25	WOS:000287230600015
J	Gupta, N; Ragsdale, SW				Gupta, Nirupama; Ragsdale, Stephen W.			Thiol-disulfide Redox Dependence of Heme Binding and Heme Ligand Switching in Nuclear Hormone Receptor Rev-erb beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN CIRCADIAN CLOCK; OXIDATIVE STRESS; REGULATORY MOTIFS; CARBON-MONOXIDE; ESCHERICHIA-COLI; DNA-BINDING; PAS DOMAIN; PROTEIN; TRANSCRIPTION; ALPHA	Rev-erb beta is a heme-binding nuclear hormone receptor that represses a broad spectrum of target genes involved in regulating metabolism, the circadian cycle, and proinflammatory responses. Here, we demonstrate that a thiol-disulfide redox switch controls the interaction between heme and the ligand-binding domain of Rev-erb beta. The reduced dithiol state of Rev-erb beta binds heme 5-fold more tightly than the oxidized disulfide state. By means of site-directed mutagenesis and by UV-visible and EPR spectroscopy, we also show that the ferric heme of reduced (dithiol) Rev-erb beta can undergo a redox-triggered switch from imidazole/thiol ligation (via His-568 and Cys-384, based on a prior crystal structure) to His/neutral residue ligation upon oxidation to the disulfide form. On the other hand, we find that change in the redox state of iron has no effect on heme binding to the ligand-binding domain of the protein. The low dissociation constant for the complex between Fe3+ - or Fe2+-heme and the reduced dithiol state of the protein (K-d = similar to 20 nM) is in the range of the intracellular free heme concentration. We also determined that the Fe2+-heme bound to the ligand-binding domain of Rev-erb beta has high affinity for CO (K-d = 60 nM), which replaces one of the internal ligands when bound. We suggest that this thiol-disulfide redox switch is one mechanism by which oxidative stress is linked to circadian and/or metabolic imbalance. Heme dissociation from Rev-erb beta has been shown to derepress the expression of target genes in response to changes in intracellular redox conditions. We propose that oxidative stress leads to oxidation of cysteine(s), thus releasing heme from Rev-erb beta and altering its transcriptional activity.	[Ragsdale, Stephen W.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu	gupta, nirupama/H-2297-2012		National Institutes of Health [R21 HL089837, R01 HL102662]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102662, R21HL089837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HL089837 and R01 HL102662.	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P43; Artinian LR, 2001, EXP NEUROL, V171, P293, DOI 10.1006/exnr.2001.7781; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Boehning D, 2002, SCIENCE, V298, P2339, DOI 10.1126/science.1080339; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; de Rosny E, 2006, BIOCHEMISTRY-US, V45, P9727, DOI 10.1021/bi060537a; de Rosny E, 2008, BIOCHEMISTRY-US, V47, P13252, DOI 10.1021/bi801691b; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Downes M, 1996, NUCLEIC ACIDS RES, V24, P4379, DOI 10.1093/nar/24.22.4379; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Elswaifi Shaadi F., 2009, Infectious Disorders - Drug Targets, V9, P445; Garrick MD, 1999, BBA-MOL CELL RES, V1449, P125, DOI 10.1016/S0167-4889(99)00006-3; Gupta N, 2008, J BIOL CHEM, V283, P28721, DOI 10.1074/jbc.M800630200; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Igarashi J, 2008, ACTA CHIM SLOV, V55, P67; Ignarro L. J., 2000, NITRIC OXIDE BIOL PA, P386; Inagaki S, 2005, J BIOL CHEM, V280, P3269, DOI 10.1074/jbc.M409884200; Ishitsuka Y, 2008, BIOCHEMISTRY-US, V47, P8874, DOI 10.1021/bi800248c; Ito S, 2009, J INORG BIOCHEM, V103, P1380, DOI 10.1016/j.jinorgbio.2009.07.012; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kitanishi K, 2008, BIOCHEMISTRY-US, V47, P6157, DOI 10.1021/bi7023892; Kooter IM, 1999, J BIOL CHEM, V274, P26794, DOI 10.1074/jbc.274.38.26794; Kovac J, 2009, MOL CELLS, V28, P75, DOI 10.1007/s10059-009-0113-0; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Kuzelova K, 1997, BBA-GEN SUBJECTS, V1336, P497, DOI 10.1016/S0304-4165(97)00062-7; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; LIU SC, 1988, BLOOD, V71, P1755; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; Marvin KA, 2008, BIOCHEMISTRY-US, V47, P9016, DOI 10.1021/bi800486x; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Pop SM, 2006, J BIOL CHEM, V281, P26382, DOI 10.1074/jbc.M602158200; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan Sathiya N, 2006, Nucl Recept Signal, V4, pe009; Ramakrishnan SN, 2009, BIOCHEM BIOPH RES CO, V388, P654, DOI 10.1016/j.bbrc.2009.08.045; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; RETNAKARAN R, 1994, MOL ENDOCRINOL, V8, P1234, DOI 10.1210/me.8.9.1234; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sassa S, 2006, J CLIN BIOCHEM NUTR, V38, P138, DOI 10.3164/jcbn.38.138; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Sharifian Akbar, 2005, J Circadian Rhythms, V3, P15, DOI 10.1186/1740-3391-3-15; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Steiner H, 1996, J BIOL CHEM, V271, P32605, DOI 10.1074/jbc.271.51.32605; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tanaka H, 2000, ONCOLOGY-BASEL, V59, P13, DOI 10.1159/000055282; TAYLOR MF, 1990, BIOCHEMISTRY-US, V29, P6911, DOI 10.1021/bi00481a022; Terenzi H, 1996, PROTEIN EXPRES PURIF, V8, P313, DOI 10.1006/prep.1996.0106; Tsubaki M, 1997, J BIOL CHEM, V272, P23206, DOI 10.1074/jbc.272.37.23206; Uchida T, 2005, J BIOL CHEM, V280, P21358, DOI 10.1074/jbc.M412350200; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang JD, 2008, BBA-MOL CELL RES, V1783, P224, DOI 10.1016/j.bbamcr.2007.09.004; Wang JD, 2007, FEBS J, V274, P5370, DOI 10.1111/j.1742-4658.2007.06062.x; Watanabe K, 2009, ACTA PHYSIOL HUNG, V96, P277, DOI 10.1556/APhysiol.96.2009.3.3; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yamashita T, 2004, J BIOL CHEM, V279, P21394, DOI 10.1074/jbc.M400512200; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2010, J BIOL CHEM, V285, P20117, DOI 10.1074/jbc.M110.116483; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	83	76	81	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4392	4403		10.1074/jbc.M110.193466	http://dx.doi.org/10.1074/jbc.M110.193466			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123168	Green Published, hybrid			2022-12-25	WOS:000286975700039
J	Nadanaka, S; Kinouchi, H; Taniguchi-Morita, K; Tamura, J; Kitagawa, H				Nadanaka, Satomi; Kinouchi, Hiroki; Taniguchi-Morita, Kayo; Tamura, Jun-ichi; Kitagawa, Hiroshi			Down-regulation of Chondroitin 4-O-Sulfotransferase-1 by Wnt Signaling Triggers Diffusion of Wnt-3a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; E-DISACCHARIDE EXPRESSION; CELL-SURFACE; MORPHOGEN GRADIENTS; TOUT-VELU; PROTEIN; GENE; SULFOTRANSFERASES; GLYCOSYLATION; BIOSYNTHESIS	During metazoan development, Wnt molecules are secreted from Wnt-producing cells, diffuse to target cells, and determine cell fates; therefore, Wnt secretion is tightly regulated. However, the molecular mechanisms controlling Wnt diffusion are not fully elucidated. The specific chondroitin sulfate (CS) structure synthesized by chondroitin-4-O-sulfotransferase- 1 (C4ST-1) binds to Wnt-3a with high affinity (Nadanaka, S., Ishida, M., Ikegami, M., and Kitagawa, H. (2008) J. Biol. Chem. 283, 27333-27343). In this study we tested whether Wnt signaling regulates sulfation patterns of cell-associated CS chains by suppressing expression of C4ST-1 to trigger release of Wnt molecules from Wnt-producing cells. C4ST-1 expression was dramatically reduced in L cells that stably expressed Wnt-3a (L-Wnt-3a cells) and had CS with low affinity for Wnt-3a. Forced expression of C4ST-1 in L-Wnt-3a cells inhibited diffusion of Wnt-3a due to structural alterations in CS chains mediated by C4ST-1. Furthermore, sustained Wnt signaling negatively regulated C4ST-1 expression in a cell-autonomous and non-cell autonomous fashion. These results demonstrated that C4ST-1 is a key downstream target of Wnt signaling that regulates Wnt diffusion from Wnt-producing cells.	[Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Taniguchi-Morita, Kayo; Tamura, Jun-ichi] Tottori Univ, Fac Reg Sci, Dept Reg Environm, Tottori 6808551, Japan	Kobe Pharmaceutical University; Tottori University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Private School Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390025, 20790081]	Japan Private School Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Scientific Research Promotion Fund from the Japan Private School Promotion Foundation and Grant-in-aid for Scientific Research-B 21390025 (to H. Kitagawa), and Grant-in-aid for Young Scientists (B) 20790081 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. N.).	Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Ikenoue T, 2002, JPN J CANCER RES, V93, P1213, DOI 10.1111/j.1349-7006.2002.tb01226.x; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Kalathas D, 2009, ONCOL REP, V22, P369, DOI 10.3892/or_00000447; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kluppel M, 2002, MECH DEVELOP, V118, P77, DOI 10.1016/S0925-4773(02)00198-3; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Neumann S, 2009, TRAFFIC, V10, P334, DOI 10.1111/j.1600-0854.2008.00872.x; Ohtake S, 2008, BBA-GEN SUBJECTS, V1780, P687, DOI 10.1016/j.bbagen.2008.01.004; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Rodriguez-Carballo E., 2010, J BONE MINE IN PRESS; Schmidt HH, 2004, ONCOGENE, V23, P6991, DOI 10.1038/sj.onc.1207934; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tamura J, 1997, CARBOHYD RES, V305, P43, DOI 10.1016/S0008-6215(97)00225-5; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; Ueda Y, 2002, INT J CANCER, V99, P681, DOI 10.1002/ijc.10418; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	32	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4199	4208		10.1074/jbc.M110.155093	http://dx.doi.org/10.1074/jbc.M110.155093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123170	hybrid, Green Published			2022-12-25	WOS:000286975700018
J	Quach, JM; Walker, EC; Allan, E; Solano, M; Yokoyama, A; Kato, S; Sims, NA; Gillespie, MT; Martin, TJ				Quach, Julie M.; Walker, Emma C.; Allan, Elizabeth; Solano, Melissa; Yokoyama, Atsushi; Kato, Shigeaki; Sims, Natalie A.; Gillespie, Matthew T.; Martin, T. John			Zinc Finger Protein 467 Is a Novel Regulator of Osteoblast and Adipocyte Commitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; INCREASES BONE-FORMATION; PARATHYROID-HORMONE PTH; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; ADIPOSE-TISSUE; ONCOSTATIN-M; PPAR-GAMMA; GENE-EXPRESSION; IN-VIVO	Osteoblasts and adipocytes are derived from common mesenchymal progenitor cells. The bone loss of osteoporosis is associated with altered progenitor differentiation from an osteoblastic to an adipocytic lineage. cDNA microarrays and quantitative real-time PCR (Q-PCR) were carried out in a differentiating mouse stromal osteoblastic cell line, Kusa 4b10, to identify gene targets of factors that stimulate osteoblast differentiation including parathyroid hormone (PTH) and gp130-binding cytokines, oncostatin M (OSM) and cardiotrophin-1 (CT-1). Zinc finger protein 467 (Zfp467) was rapidly down-regulated by PTH, OSM, and CT-1. Retroviral overexpression and RNA interference for Zfp467 in mouse stromal cells showed that this factor stimulated adipocyte formation and inhibited osteoblast commitment compared with controls. Regulation of adipocyte markers, including peroxisome proliferator-activated receptor (PPAR) gamma, C/EBP alpha, adiponectin, and resistin, and late osteoblast/osteocyte markers (osteocalcin and sclerostin) by Zfp467 was confirmed by Q-PCR. Intra-tibial injection of calvarial cells transduced with retroviral Zfp467 doubled the number of marrow adipocytes in C57Bl/6 mice compared with vector control-transduced cells, providing in vivo confirmation of a pro-adipogenic role of Zfp467. Furthermore, Zfp467 transactivated a PPAR-response element reporter construct and recruited a histone deacetylase complex. Thus Zfp467 is a novel co-factor that promotes adipocyte differentiation and suppresses osteoblast differentiation. This has relevance to therapeutic interventions in osteoporosis, including PTH-based therapies currently available, and may be of relevance for the use of adipose-derived stem cells for tissue engineering.	[Sims, Natalie A.; Gillespie, Matthew T.; Martin, T. John] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Quach, Julie M.; Sims, Natalie A.; Gillespie, Matthew T.; Martin, T. John] St Vincents Hosp Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Solano, Melissa; Gillespie, Matthew T.] Monash Med Ctr, Prince Henrys Inst, Clayton, Vic 3168, Australia; [Yokoyama, Atsushi; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; Monash University; Prince Henry's Institute of Medical Research; University of Tokyo	Martin, TJ (corresponding author), St Vincents Inst Med Res, 9 Princes St, Fitzroy, Vic 3065, Australia.	jmartin@svi.edu.au	Yokoyama, Atsushi/W-3519-2019; Sims, Natalie Ann/A-7192-2012	Sims, Natalie Ann/0000-0003-1421-8468; Yokoyama, Atsushi/0000-0003-2842-4334; Gillespie, Matthew/0000-0001-6543-8909	National Health and Medical Research Council (Australia) [345401]	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council (Australia) Program Grant 345401 (to M. T. G., N. A. S., and T. J. M.).	Ahdjoudj S, 2002, J BONE MINER RES, V17, P668, DOI 10.1359/jbmr.2002.17.4.668; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI [10.1359/jbmr.080324, 10.1359/JBMR.080324]; Amizuka N, 1996, DEV BIOL, V175, P166, DOI 10.1006/dbio.1996.0104; Askmyr M, 2009, TRENDS ENDOCRIN MET, V20, P303, DOI 10.1016/j.tem.2009.03.004; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Cho HH, 2005, J CELL BIOCHEM, V96, P533, DOI 10.1002/jcb.20544; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; Diallo EM, 2007, MOL CELL ENDOCRINOL, V264, P149, DOI 10.1016/j.mce.2006.11.004; DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632; Duque G, 2009, EXP GERONTOL, V44, P183, DOI 10.1016/j.exger.2008.10.004; Fisher JL, 2002, CELL TISSUE RES, V307, P337, DOI 10.1007/s00441-001-0503-x; Ganss B, 2004, CRIT REV ORAL BIOL M, V15, P282, DOI 10.1177/154411130401500504; GREENFIELD EM, 1993, J BONE MINER RES, V8, pS164; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Hozumi A, 2009, BIOCHEM BIOPH RES CO, V382, P780, DOI 10.1016/j.bbrc.2009.03.111; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kanazawa A, 2005, DIABETOLOGIA, V48, P1315, DOI 10.1007/s00125-005-1797-0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2092, DOI 10.1210/en.139.4.2092; Kerr JM, 2005, MOL CELL ENDOCRINOL, V238, P57, DOI 10.1016/j.mce.2005.03.004; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim HN, 2009, EUR J PHARMACOL, V623, P22, DOI 10.1016/j.ejphar.2009.09.025; Kodama Y, 1998, J BONE MINER RES, V13, P1370, DOI 10.1359/jbmr.1998.13.9.1370; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kushida T, 2001, BLOOD, V97, P3292, DOI 10.1182/blood.V97.10.3292; Liston A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r12; LOWE C, 1991, J BONE MINER RES, V6, P1277; Malaval L, 2005, J CELL PHYSIOL, V204, P585, DOI 10.1002/jcp.20312; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MARTIN RB, 1990, CALCIFIED TISSUE INT, V46, P189, DOI 10.1007/BF02555043; MARTIN TJ, 1987, METHOD ENZYMOL, V145, P324; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakayama K, 2002, EMBO J, V21, P6174, DOI 10.1093/emboj/cdf596; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; ONYIA JE, 1995, BONE, V17, P479, DOI 10.1016/8756-3282(95)00332-2; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PEAR WS, 1996, CURRENT PROTOCOLS S, V36; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Rickard DJ, 2006, BONE, V39, P1361, DOI 10.1016/j.bone.2006.06.010; Romas E, 1996, J EXP MED, V183, P2581, DOI 10.1084/jem.183.6.2581; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Sims NA, 2007, BONE, V40, pS126; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Song HY, 2007, J CELL BIOCHEM, V101, P1238, DOI 10.1002/jcb.21245; Song HY, 2007, INT J BIOCHEM CELL B, V39, P439, DOI 10.1016/j.biocel.2006.07.014; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Takagi K, 2008, J BONE MINER METAB, V26, P13, DOI 10.1007/s00774-007-0787-3; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Udagawa N, 1997, J EXP MED, V185, P1005, DOI 10.1084/jem.185.6.1005; Ueda Y, 2007, STEM CELLS, V25, P1356, DOI 10.1634/stemcells.2006-0811; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Walker EC, 2009, BONE, V44, pS32, DOI 10.1016/j.bone.2009.01.081; Walker EC, 2008, J BONE MINER RES, V23, pS377; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	76	55	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4186	4198		10.1074/jbc.M110.178251	http://dx.doi.org/10.1074/jbc.M110.178251			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123171	hybrid, Green Published			2022-12-25	WOS:000286975700017
J	Espinoza, C; Degenkolbe, T; Caldana, C; Zuther, E; Leisse, A; Willmitzer, L; Hincha, DK; Hannah, MA				Espinoza, Carmen; Degenkolbe, Thomas; Caldana, Camila; Zuther, Ellen; Leisse, Andrea; Willmitzer, Lothar; Hincha, Dirk K.; Hannah, Matthew A.			Interaction with Diurnal and Circadian Regulation Results in Dynamic Metabolic and Transcriptional Changes during Cold Acclimation in Arabidopsis	PLOS ONE			English	Article							LOW-TEMPERATURE; FREEZING TOLERANCE; SUBCELLULAR VOLUMES; GENE-EXPRESSION; STRESS; CLOCK; TIME; MALTOSE; RNA; DISRUPTION	In plants, there is a large overlap between cold and circadian regulated genes and in Arabidopsis, we have shown that cold (4 degrees C) affects the expression of clock oscillator genes. However, a broader insight into the significance of diurnal and/or circadian regulation of cold responses, particularly for metabolic pathways, and their physiological relevance is lacking. Here, we performed an integrated analysis of transcripts and primary metabolites using microarrays and gas chromatography-mass spectrometry. As expected, expression of diurnally regulated genes was massively affected during cold acclimation. Our data indicate that disruption of clock function at the transcriptional level extends to metabolic regulation. About 80% of metabolites that showed diurnal cycles maintained these during cold treatment. In particular, maltose content showed a massive night-specific increase in the cold. However, under free-running conditions, maltose was the only metabolite that maintained any oscillations in the cold. Furthermore, although starch accumulates during cold acclimation we show it is still degraded at night, indicating significance beyond the previously demonstrated role of maltose and starch breakdown in the initial phase of cold acclimation. Levels of some conventional cold induced metabolites, such as c-aminobutyric acid, galactinol, raffinose and putrescine, exhibited diurnal and circadian oscillations and transcripts encoding their biosynthetic enzymes often also cycled and preceded their cold-induction, in agreement with transcriptional regulation. However, the accumulation of other cold-responsive metabolites, for instance homoserine, methionine and maltose, did not have consistent transcriptional regulation, implying that metabolic reconfiguration involves complex transcriptional and post-transcriptional mechanisms. These data demonstrate the importance of understanding cold acclimation in the correct day-night context, and are further supported by our demonstration of impaired cold acclimation in a circadian mutant.	[Espinoza, Carmen; Degenkolbe, Thomas; Caldana, Camila; Zuther, Ellen; Leisse, Andrea; Willmitzer, Lothar; Hincha, Dirk K.; Hannah, Matthew A.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Max Planck Society	Espinoza, C (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	matthew.hannah@bayer.com	Willmitzer, Lothar/F-7377-2011; Zuther, Ellen/H-9814-2019; Caldana, Camila/C-4660-2012	Caldana, Camila/0000-0003-3639-0621; Hannah, Matthew/0000-0002-4889-490X; Zuther, Ellen/0000-0002-7446-0515; Espinoza, Carmen/0000-0003-1469-9492	Max-Planck Society	Max-Planck Society(Max Planck SocietyFoundation CELLEX)	The work was supported by the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ADV PLANAR LIPID BIL, DOI DOI 10.1016/S1554-4516(05)03006-1; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Benkeblia N, 2007, METABOLOMICS, V3, P297, DOI 10.1007/s11306-007-0078-y; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; CROWE JH, 1990, CRYOBIOLOGY, V27, P219, DOI 10.1016/0011-2240(90)90023-W; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; Curien G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.29; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2006, PLANT J, V48, P962, DOI 10.1111/j.1365-313X.2006.02933.x; Dong CH, 2009, MOL PLANT, V2, P59, DOI 10.1093/mp/ssn063; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Fukushima A, 2009, P NATL ACAD SCI USA, V106, P7251, DOI 10.1073/pnas.0900952106; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Gray GR, 2005, PHYSIOL PLANTARUM, V124, P236, DOI 10.1111/j.1399-3054.2005.00507.x; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hannah MA, 2008, NAT BIOTECHNOL, V26, P741, DOI 10.1038/nbt0708-741; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; HEBER U, 1971, BIOCHIM BIOPHYS ACTA, V241, P578, DOI 10.1016/0005-2736(71)90056-3; Hincha DK, 2002, GLYCOBIOLOGY, V12, P103, DOI 10.1093/glycob/12.2.103; IBANEZ C, 2010, PLANT PHYSIOL; Ibanez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003567; JONES MGK, 1977, PLANT PHYSIOL, V60, P379, DOI 10.1104/pp.60.3.379; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Knowles SM, 2008, J BIOL RHYTHM, V23, P463, DOI 10.1177/0748730408326749; Lee M, 2005, PLANT J, V41, P685, DOI 10.1111/j.1365-313X.2004.02329.x; LEIDREITER K, 1995, BOT ACTA, V108, P439, DOI 10.1111/j.1438-8677.1995.tb00518.x; Less H, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-14; Lewandowska M, 2008, ACTA BIOCHIM POL, V55, P457, DOI 10.18388/abp.2008_3051; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lu SX, 2009, PLANT PHYSIOL, V150, P834, DOI 10.1104/pp.108.133272; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Nakamichi N, 2009, PLANT CELL PHYSIOL, V50, P447, DOI 10.1093/pcp/pcp004; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Ptitsyn A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S18; Ramos A, 2005, P NATL ACAD SCI USA, V102, P7037, DOI 10.1073/pnas.0408549102; Rohde P, 2004, PLANT J, V38, P790, DOI 10.1111/j.1365-313X.2004.02080.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schafer J, 2006, R NEWS, V6, P50; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sirko A, 2004, J EXP BOT, V55, P1881, DOI 10.1093/jxb/erh151; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Stitt M, 2007, German Patent Application, Patent No. [08146. 0025U1, 081460025]; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; STRAUSS G, 1986, P NATL ACAD SCI USA, V83, P2422, DOI 10.1073/pnas.83.8.2422; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Uemura M, 2003, PLANT PHYSIOL, V131, P1800, DOI 10.1104/pp.102.013227; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Weise SE, 2004, PLANTA, V218, P474, DOI 10.1007/s00425-003-1128-y; Wilkins O, 2010, PLANT J, V63, P715, DOI 10.1111/j.1365-313X.2010.04274.x; WINTER H, 1993, PLANTA, V191, P180, DOI 10.1007/BF00199748; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yano R, 2005, PLANT PHYSIOL, V138, P837, DOI 10.1104/pp.104.056374; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zuther E, 2004, FEBS LETT, V576, P169, DOI 10.1016/j.febslet.2004.09.006; Zuther E, 2004, PLANTA, V218, P759, DOI 10.1007/s00425-003-1148-7	90	120	121	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14101	10.1371/journal.pone.0014101	http://dx.doi.org/10.1371/journal.pone.0014101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124901	Green Published, gold, Green Submitted			2022-12-25	WOS:000284527900013
J	Capmany, A; Damiani, MT				Capmany, Anahi; Teresa Damiani, Maria			Chlamydia trachomatis Intercepts Golgi-Derived Sphingolipids through a Rab14-Mediated Transport Required for Bacterial Development and Replication	PLOS ONE			English	Article							RAB GTPASES; MEMBRANE-PROTEIN; INTRACELLULAR DEVELOPMENT; LIPID DROPLETS; INCLUSION; FUSION; TRAFFICKING; PHAGOSOME; APPARATUS; CELLS	Chlamydia trachomatis are obligate intracellular bacteria that survive and replicate in a bacterial-modified phagosome called inclusion. As other intracellular parasites, these bacteria subvert the phagocytic pathway to avoid degradation in phagolysosomes and exploit trafficking pathways to acquire both energy and nutrients essential for their survival. Rabs are host proteins that control intracellular vesicular trafficking. Rab14, a Golgi-related Rab, controls Golgi to endosomes transport. Since Chlamydia establish a close relationship with the Golgi apparatus, the recruitment and participation of Rab14 on inclusion development and bacteria growth were analyzed. Time course analysis revealed that Rab14 associated with inclusions by 10 h post infection and was maintained throughout the entire developmental cycle. The recruitment was bacterial protein synthesis-dependent but independent of microtubules and Golgi integrity. Overexpression of Rab14 dominant negative mutants delayed inclusion enlargement, and impaired bacteria replication as determined by IFU. Silencing of Rab14 by siRNA also decreased bacteria multiplication and infectivity. By electron microscopy, aberrant bacteria were observed in cells overexpressing the cytosolic negative Rab14 mutant. Our results showed that Rab14 facilitates the delivery of sphingolipids required for bacterial development and replication from the Golgi to chlamydial inclusions. Novel anti-chlamydial therapies could be developed based on the knowledge of how bacteria subvert host vesicular transport events through Rabs manipulation.	[Capmany, Anahi; Teresa Damiani, Maria] Univ Cuyo, Fac Med, Cell Biol Lab, Dept Biochem,IHEM CONICET, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Capmany, A (corresponding author), Univ Cuyo, Fac Med, Cell Biol Lab, Dept Biochem,IHEM CONICET, Mendoza, Argentina.	tdamiani@fcm.uncu.edu.ar			PICT-ANPCyT; PIP-CONICET; Sepcyt-UNCuyo	PICT-ANPCyT(ANPCyT); PIP-CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sepcyt-UNCuyo	This work was supported by grants from PICT-ANPCyT, PIP-CONICET and Sepcyt-UNCuyo to M. T. Damiani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr FA, 2009, SEMIN CELL DEV BIOL, V20, P780, DOI 10.1016/j.semcdb.2009.03.007; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; BEATTY WL, 1993, P NATL ACAD SCI USA, V90, P3998, DOI 10.1073/pnas.90.9.3998; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Dautry-Varsat A, 2004, TRAFFIC, V5, P561, DOI 10.1111/j.1398-9219.2004.00207.x; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Fields KA, 2002, INFECT IMMUN, V70, P3816, DOI 10.1128/IAI.70.7.3816-3823.2002; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Harris E, 2002, J CELL SCI, V115, P3703, DOI 10.1242/jcs.00050; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; Kitt KN, 2008, TRAFFIC, V9, P1218, DOI 10.1111/j.1600-0854.2008.00752.x; KRAMER MJ, 1971, INFECT IMMUN, V3, P333, DOI 10.1128/IAI.3.2.333-341.1971; KREIS TE, 1990, CELL MOTIL CYTOSKEL, V15, P67, DOI 10.1002/cm.970150202; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Leiva N, 2006, EXP CELL RES, V312, P1843, DOI 10.1016/j.yexcr.2006.02.015; Linstedt AD, 2004, CELL, V118, P271, DOI 10.1016/j.cell.2004.07.015; Moore ER, 2008, TRAFFIC, V9, P2130, DOI 10.1111/j.1600-0854.2008.00828.x; Moorhead AR, 2007, INFECT IMMUN, V75, P781, DOI 10.1128/IAI.01447-06; Palmer KJ, 2005, BIOCHEM SOC SYMP, V72, P1; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Proikas-Cezanne T, 2006, FEBS LETT, V580, P5241, DOI 10.1016/j.febslet.2006.08.053; Rejman L.A., 2009, PLOS PATHOG, V5; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Rzomp KA, 2006, INFECT IMMUN, V74, P5362, DOI 10.1128/IAI.00539-06; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scidmore MA, 1996, INFECT IMMUN, V64, P5366, DOI 10.1128/IAI.64.12.5366-5372.1996; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Subtil A, 2004, CURR OPIN MICROBIOL, V7, P85, DOI 10.1016/j.mib.2003.12.012; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003	47	76	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14084	10.1371/journal.pone.0014084	http://dx.doi.org/10.1371/journal.pone.0014084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124879	gold, Green Published, Green Submitted			2022-12-25	WOS:000284467200015
J	He, KL; Sui, GZ; Xiong, HB; Broekman, MJ; Huang, BH; Marcus, AJ; Hajjar, KA				He, Kai-Li; Sui, Guangzhi; Xiong, Huabao; Broekman, M. Johan; Huang, Bihui; Marcus, Aaron J.; Hajjar, Katherine A.			Feedback Regulation of Endothelial Cell Surface Plasmin Generation by PKC-dependent Phosphorylation of Annexin A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PERIPHERAL MONOCYTES; PROTEIN-KINASE-C; IN-VITRO PHOSPHORYLATION; 5-LIPOXYGENASE PATHWAY; FIBRINOLYTIC RECEPTOR; THROMBOLYTIC THERAPY; EMBOLIC STROKE; ACTIVATION; BINDING; HETEROTETRAMER	In response to blood vessel injury, hemostasis is initiated by platelet activation, advanced by thrombin generation, and tempered by fibrinolysis. The primary fibrinolytic protease, plasmin, can be activated either on a fibrin-containing thrombus or on cells. Annexin A2 (A2) heterotetramer (A2.p11)(2) is a key profibrinolytic complex that assembles plasminogen and tissue plasminogen activator and promotes plasmin generation. We now report that, in endothelial cells, plasmin specifically induces activation of conventional PKC, which phosphorylates serine 11 and serine 25 of A2, triggering dissociation of the (A2.p11)(2) tetramer. The resulting free p11 undergoes ubiquitin-mediated proteasomal degradation, thus preventing further translocation of A2 to the cell surface. In vivo, pretreatment of A2(+/+) but not A2(-/-) mice with a conventional PKC inhibitor significantly reduced thrombosis in a carotid artery injury model. These results indicate that augmentation of fibrinolytic vascular surveillance by blockade of serine phosphorylation is A2-dependent. We also demonstrate that plasmin-induced phosphorylation of A2 requires both cleavage of A2 and activation of Toll-like receptor 4 on the cell surface. We propose that plasmin can limit its own generation by triggering a finely tuned "feedback" mechanism whereby A2 becomes serine-phosphorylated, dissociates from p11, and fails to translocate to the cell surface.	[He, Kai-Li; Huang, Bihui; Hajjar, Katherine A.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Broekman, M. Johan; Marcus, Aaron J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Marcus, Aaron J.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Sui, Guangzhi] Albert Einstein Coll Med, Dept Med, New York, NY 10461 USA; [Xiong, Huabao] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Broekman, M. Johan; Marcus, Aaron J.] Vet Affairs New York Harbor Healthcare Syst, Thrombosis Res Lab, New York, NY 10010 USA	Cornell University; Cornell University; Cornell University; Yeshiva University; Icahn School of Medicine at Mount Sinai	Hajjar, KA (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, 1300 York Ave,Box 45, New York, NY 10065 USA.	khajjar@med.cornell.edu		Huang, Bihui/0000-0003-3084-7096	National Institutes of Health, NHLBI [HL042493, HL090895, HL046403, HL047073, HL089521]; Department of Veterans Affairs; Cancer Research and Treatment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042493, R37HL047073, R01HL090895, P01HL046403, R01HL089521, R01HL047073] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); Cancer Research and Treatment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants HL042493 and HL090895 (to K. A. H.), HL046403 (to K. A. H., A. J. M., and M. J. B.), and HL047073 and HL089521 (to A. J. M. and M. J. B.).; Recipient of a Merit Review Grant from the Department of Veterans Affairs and a grant from the Cancer Research and Treatment Fund.	Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Cesarman-Maus G, 2006, BLOOD, V107, P4375, DOI 10.1182/blood-2005-07-2636; Dassah M, 2009, GEN PHYSIOL BIOPHYS, V28, pF20; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; DUBOIS T, 1995, BIOCHEM J, V310, P243, DOI 10.1042/bj3100243; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HAJJAR KA, 1990, J BIOL CHEM, V265, P2908; HAJJAR KA, 1986, J BIOL CHEM, V261, P1656; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hajjar KA, 2010, WILLIAMS HEMATOLOGY, P2219; HALL SW, 1991, J BIOL CHEM, V266, P12329; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Ishii H, 2001, CIRC RES, V89, P1240, DOI 10.1161/hh2401.101066; Jacovina AT, 2009, J CLIN INVEST, V119, P3384, DOI 10.1172/JCI39591; JOHNSSON N, 1986, EMBO J, V5, P3455, DOI 10.1002/j.1460-2075.1986.tb04669.x; Jost M, 1996, BBA-MOL CELL RES, V1313, P283, DOI 10.1016/0167-4889(96)00101-2; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kassam G, 1998, J BIOL CHEM, V273, P4790, DOI 10.1074/jbc.273.8.4790; Kopp HG, 2006, J CLIN INVEST, V116, P3277, DOI 10.1172/JCI29314; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; MacLeod TJ, 2003, J BIOL CHEM, V278, P25577, DOI 10.1074/jbc.M301017200; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Nagashima M, 2002, J CLIN INVEST, V109, P101, DOI 10.1172/JCI12119; Peterson EA, 2003, J CELL SCI, V116, P2399, DOI 10.1242/jcs.00434; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349; REGNOUF F, 1995, J BIOL CHEM, V270, P27143, DOI 10.1074/jbc.270.45.27143; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; Swisher JFA, 2010, BLOOD, V115, P549, DOI 10.1182/blood-2009-06-226944; Syrovets T, 1997, BLOOD, V89, P4574, DOI 10.1182/blood.V89.12.4574; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; Tanaka Y, 2007, BRAIN RES, V1165, P135, DOI 10.1016/j.brainres.2007.06.039; THIEL C, 1992, J CELL SCI, V103, P733; Weide I, 1996, THROMB HAEMOSTASIS, V76, P561; WEIDE I, 1994, BLOOD, V83, P1941; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Zhu HH, 2010, J CEREBR BLOOD F MET, V30, P1137, DOI 10.1038/jcbfm.2009.279	51	47	47	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15428	15439		10.1074/jbc.M110.185058	http://dx.doi.org/10.1074/jbc.M110.185058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21115493	Green Published, hybrid			2022-12-25	WOS:000289788300072
J	Emde, A; Pradeep, CR; Ferraro, DA; Ben-Chetrit, N; Sela, M; Ribba, B; Kam, Z; Yarden, Y				Emde, A.; Pradeep, C-R; Ferraro, D. A.; Ben-Chetrit, N.; Sela, M.; Ribba, B.; Kam, Z.; Yarden, Y.			Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growth	ONCOGENE			English	Article						breast cancer; growth factor; trastuzumab; tyrosine kinase; 3D culture	HUMAN-BREAST-CANCER; ANTI-ERBB-2 MONOCLONAL-ANTIBODIES; FACTOR RECEPTOR; IN-VIVO; TYROSINE KINASES; NEU ONCOGENE; ERBB2; CELL; TRASTUZUMAB; PROGRESSION	Monoclonal antibodies (mAbs) to HER2 are currently used to treat breast cancer, but low clinical efficacy, along with primary and acquired resistance to therapy, commonly limit clinical applications. We previously reported that combinations of antibodies directed at non-overlapping epitopes of HER2 are endowed with enhanced antitumor effects, probably due to accelerated receptor degradation. Here, we extend these observations to three-dimensional mammary cell models, and compare the effects of single mAbs with the effects of antibody combinations. Collectively, our in vitro assays and computational image analyses indicate that combining mAbs against different epitopes of HER2 better inhibits invasive growth. Importantly, while growth factors are able to reduce intraluminal apoptosis and induce an invasive phenotype, combinations of mAbs better than single mAbs can reverse the growth factor-induced phenotypes of HER2-overexpressing spheroids. In conclusion, our studies propose that mAb combinations negate the biological effects of growth factors on invasive growth of HER2-overexpressing cells. Hence, combining mAbs offers a therapeutic strategy, potentially able to enhance clinical efficacy of existing antireceptor immunotherapeutics. Oncogene (2011) 30, 1631-1642; doi:10.1038/onc.2010.547; published online 6 December 2010	[Emde, A.; Pradeep, C-R; Ferraro, D. A.; Ben-Chetrit, N.; Yarden, Y.] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Sela, M.] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Ribba, B.] Ecole Normale Super Lyon, Project Team NUMED, INRIA Rhone Alpes, F-69364 Lyon, France; [Kam, Z.] Weizmann Inst Sci, Dept Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Ecole Normale Superieure de Lyon (ENS de LYON); Weizmann Institute of Science	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, Candiotty Bldg,Room 302,1 Hertzl St, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	YARDEN, YOSEF/K-1467-2012		Minerva Foundation; Centre Leon-Berard; Canceropole Lyon Auvegne Rhone-Alpes; Weizmann Institute; National Cancer Institute [CA072981]; European Commission; Cooperation (DIP/DFG); Israel Cancer Research Fund; Dr Miriam and Sheldon G Adelson Medical Research Foundation; Kekst Family Institute for Medical Genetics; Kirk Center for Childhood Cancer and Immunological Disorders; Bennett-Pritzker Endowment Fund; Marvelle Koffler Program for Breast Cancer Research; Estate of John M, Lang and the MD Moross Institute for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA072981, R37CA072981] Funding Source: NIH RePORTER	Minerva Foundation; Centre Leon-Berard; Canceropole Lyon Auvegne Rhone-Alpes; Weizmann Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Commission(European CommissionEuropean Commission Joint Research Centre); Cooperation (DIP/DFG)(German Research Foundation (DFG)); Israel Cancer Research Fund; Dr Miriam and Sheldon G Adelson Medical Research Foundation; Kekst Family Institute for Medical Genetics; Kirk Center for Childhood Cancer and Immunological Disorders; Bennett-Pritzker Endowment Fund; Marvelle Koffler Program for Breast Cancer Research; Estate of John M, Lang and the MD Moross Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of our group for insightful comments. AE is supported by a post-doctoral fellowship of the Minerva Foundation. YY is the incumbent of the Harold and Zelda Goldenberg Professorial Chair, and MS is the incumbent of the W Garfield Weston Professorial Chair in Immunolgy. Our work is supported by a collaborative program between Centre Leon-Berard, Canceropole Lyon Auvegne Rhone-Alpes and the Weizmann Institute, as well as by grants from the National Cancer Institute (CA072981), the European Commission, the German-Israeli Project Cooperation (DIP/DFG), the Israel Cancer Research Fund, the Dr Miriam and Sheldon G Adelson Medical Research Foundation, the Kekst Family Institute for Medical Genetics, the Kirk Center for Childhood Cancer and Immunological Disorders, the Women's Health Research Center funded by Bennett-Pritzker Endowment Fund, the Marvelle Koffler Program for Breast Cancer Research, the Estate of John M, Lang and the MD Moross Institute for Cancer Research.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Ben-Kasus T, 2007, MOL ONCOL, V1, P42, DOI 10.1016/j.molonc.2007.01.003; Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DREBIN JA, 1988, ONCOGENE, V2, P273; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; HOU L, 1992, CANCER LETT, V65, P215, DOI 10.1016/0304-3835(92)90234-M; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; KASPRZYK PG, 1992, CANCER RES, V52, P2771; Klapper LN, 1997, ONCOGENE, V14, P2099, DOI 10.1038/sj.onc.1201029; Lemieux J, 2009, CURR ONCOL, V16, P316; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nahta R, 2006, CANCER LETT, V232, P123, DOI 10.1016/j.canlet.2005.01.041; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; SCHNEIDER PM, 1989, CANCER RES, V49, P4968; Seton-Rogers SE, 2004, CELL CYCLE, V3, P597, DOI 10.4161/cc.3.5.886; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spangler JB, 2010, P NATL ACAD SCI USA, V107, P13252, DOI 10.1073/pnas.0913476107; Spiridon CI, 2002, CLIN CANCER RES, V8, P1720; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; WEINER DB, 1990, CANCER RES, V50, P421; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Xia WY, 1997, CLIN CANCER RES, V3, P3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yip YL, 2001, J IMMUNOL, V166, P5271, DOI 10.4049/jimmunol.166.8.5271; YOSHIDA K, 1989, VIRCHOWS ARCH B, V57, P285, DOI 10.1007/BF02899093; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081	38	15	18	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	14					1631	1642		10.1038/onc.2010.547	http://dx.doi.org/10.1038/onc.2010.547			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	746IS	21132012	Green Accepted			2022-12-25	WOS:000289239400002
J	Chen, S; Evans, HG; Evans, DR				Chen, Song; Evans, Hedeel Guy; Evans, David R.			FAM129B/MINERVA, a Novel Adherens Junction-associated Protein, Suppresses Apoptosis in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL CARCINOGENESIS; SIGNALING PATHWAYS; DRUG-RESISTANCE; ALPHA-CATENIN; BETA-CATENIN; E-CADHERIN; EXPRESSION; MELANOMA; CLEAVAGE; CANCER	Arecent proteomics study identified FAM129B or MINERVA as a target of the MAP kinase (Erk1/2) signaling cascade in human melanoma cells. Phosphorylation of the protein was found to promote cell invasion and the dissociation of the protein from the cell-cell junctions. Suppression of apoptosis during metastasis is a prerequisite for the survival and spread of cancer cells. During apoptosis, the adherens junctions are disassembled as the dying cell retracts, and new contacts are formed between normal neighboring cells. In this study, we show that FAM129B was cytosolic in exponentially growing HeLa cells but was translocated to the adherens junctions where it colocalized with beta-catenin whenever contact between two or more cells was established. Silencing the FAM129B gene expression by specific siRNAs did not induce apoptosis or inhibit the growth of HeLa cells. However, when apoptosis was induced by exposure to TNF alpha/cycloheximide or other apoptotic signaling molecules, the onset of apoptosis was accelerated 3-4-fold when FAM129B was depleted. Annexin V binding, the inactivation of the DNA repair enzyme, poly(ADP-ribose) polymerase, and the activation of the caspases occurred more rapidly in the cells lacking FAM129B. The rapid induction of apoptosis in FAM129B knockdown cells was reversed by co-transfection with recombinant FAM129B, indicating that its effect on apoptosis was specific. As apoptosis proceeded, FAM129B was degraded and disappeared from the plasma membrane. Thus, one crucial facet of the mechanism by which FAM129B promotes cancer cell invasion is likely to be the suppression of apoptosis.	[Evans, Hedeel Guy] Eastern Michigan Univ, Dept Chem, Ypsilanti, MI 48197 USA; [Chen, Song; Evans, Hedeel Guy; Evans, David R.] Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48201 USA	Eastern Michigan University; Wayne State University	Evans, HG (corresponding author), Eastern Michigan Univ, Dept Chem, 225 Mark, Ypsilanti, MI 48197 USA.	hevans@emich.edu			National Institutes of Health [GM/CA60371, P30CA22453]; Office of the Provost (Wayne State University); NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Provost (Wayne State University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant GM/CA60371. This work was also supported by internal funds from the Office of the Provost (Wayne State University). The Microscopy, Imaging and Cytometry Resource Core is supported in part by NIH Center Grant P30CA22453 to the Karmanos Cancer Institute, Wayne State University, and the Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University.	Adachi H, 2004, ONCOGENE, V23, P3495, DOI 10.1038/sj.onc.1207468; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Antonsson A, 2009, ANTICANCER RES, V29, P2893; Boyd RS, 2003, LEUKEMIA, V17, P1605, DOI 10.1038/sj.leu.2402993; Brancolini C, 1997, J CELL BIOL, V139, P759, DOI 10.1083/jcb.139.3.759; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Green DR, 2000, METHOD ENZYMOL, V322, P15; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HAGUE A, 1994, ONCOGENE, V9, P3367; HOFFMAN B, 1994, ONCOGENE, V9, P1807; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; Kim HA, 2003, J RHEUMATOL, V30, P550; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Majima S, 2000, JPN J CANCER RES, V91, P869, DOI 10.1111/j.1349-7006.2000.tb01027.x; Matsumoto F, 2006, HUM PATHOL, V37, P1592, DOI 10.1016/j.humpath.2006.06.022; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schmitt CA, 1999, J PATHOL, V187, P127; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Suzanne Magali, 2009, Journal of Biology (London), V8, P49, DOI 10.1186/jbiol152; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Townson JL, 2003, CURR MOL MED, V3, P631, DOI 10.2174/1566524033479483; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Wyllie A H, 1980, Int Rev Cytol, V68, P251	37	26	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10201	10209		10.1074/jbc.M110.175273	http://dx.doi.org/10.1074/jbc.M110.175273			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21148485	Green Published, hybrid			2022-12-25	WOS:000288547000036
J	Seong, HA; Manoharan, R; Ha, H				Seong, Hyun-A; Manoharan, Ravi; Ha, Hyunjung			B-MYB Positively Regulates Serine-Threonine Kinase Receptor-associated Protein (STRAP) Activity through Direct Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION INHIBITORY FACTOR; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; PHYSICAL INTERACTION; CELL-LINES; APOPTOSIS; GENE; P53; CANCER; PROLIFERATION	Serine-threonine kinase receptor-associated protein (STRAP) functions as a regulator of both TGF-beta and p53 signaling. However, the regulatory mechanism of STRAP activity is not understood. In this study, we report that B-MYB is a new STRAP-interacting protein, and that an amino-terminal DNA-binding domain and an area (amino acids 373-468) between the acidic and conserved regions of B-MYB mediate the B-MYB.STRAP interaction. Functionally, B-MYB enhances STRAP-mediated inhibition of TGF-beta signaling pathways, such as apoptosis and growth inhibition, by modulating complex formation between the TGF-beta receptor and SMAD3 or SMAD7. Furthermore, coexpression of B-MYB results in a dose-dependent increase in STRAP-mediated stimulation of p53-induced apoptosis and cell cycle arrest via direct interaction. Confocal microscopy showed that B-MYB prevents the normal translocation of SMAD3 in response to TGF-beta 1 and stimulates p53 nuclear translocation. These results suggest that B-MYB acts as a positive regulator of STRAP.	[Seong, Hyun-A; Manoharan, Ravi; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr	Manoharan, Ravi/AAI-4139-2021	Manoharan, Ravi/0000-0002-3494-2173	National Research Foundation (NRF) of Korea [R0A-2007-000-20006-0]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation (NRF) of Korea Grant R0A-2007-000-20006-0.	Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; ARSURA M, 1992, BLOOD, V79, P2708; BIES J, 1995, CANCER RES, V55, P501; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Haider SK, 2006, CANCER RES, V66, P6156, DOI 10.1158/0008-5472.CAN-05-3261; Joaquin M, 2003, CELL MOL LIFE SCI, V60, P2389, DOI 10.1007/s00018-003-3037-4; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung HY, 2010, J BIOL CHEM, V285, P54, DOI 10.1074/jbc.M109.045229; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kim T, 1999, FEBS LETT, V460, P363, DOI 10.1016/S0014-5793(99)01375-7; Lang G, 2005, IMMUNOLOGY, V114, P25, DOI 10.1111/j.1365-2567.2004.02073.x; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; LIN D, 1994, P NATL ACAD SCI USA, V91, P10079, DOI 10.1073/pnas.91.21.10079; Lipsick JS, 1996, ONCOGENE, V13, P223; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; LOTEM J, 1990, BLOOD, V76, P1315; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; RASCHELLA G, 1995, J BIOL CHEM, V270, P8540, DOI 10.1074/jbc.270.15.8540; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; SALA A, 1992, P NATL ACAD SCI USA, V89, P10415, DOI 10.1073/pnas.89.21.10415; Sala A, 1996, J BIOL CHEM, V271, P9363, DOI 10.1074/jbc.271.16.9363; Santilli G, 2005, J BIOL CHEM, V280, P15628, DOI 10.1074/jbc.M411747200; SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2003, J BIOL CHEM, V278, P9655, DOI 10.1074/jbc.M207478200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	37	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7439	7456		10.1074/jbc.M110.184382	http://dx.doi.org/10.1074/jbc.M110.184382			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21148321	hybrid, Green Published			2022-12-25	WOS:000287737300059
J	Avdic, V; Zhang, P; Lanouette, S; Voronova, A; Skerjanc, I; Couture, JF				Avdic, Vanja; Zhang, Pamela; Lanouette, Sylvain; Voronova, Anastassia; Skerjanc, Ilona; Couture, Jean-Francois			Fine-tuning the stimulation of MLL1 methyltransferase activity by a histone H3-based peptide mimetic	FASEB JOURNAL			English	Article						epigenetics; chromatin biology; nucleosomes; SET1 family of methyltransferases	MIXED LINEAGE LEUKEMIA; STRUCTURAL BASIS; MOLECULAR RECOGNITION; LYSINE METHYLATION; PROTEIN WDR5; CORE COMPLEX; HOX GENES; H3; DOMAIN; CELLS	The SET1 family of methyltransferases carries out the bulk of histone H3 Lys-4 methylation in vivo. One of the common features of this family is the regulation of their methyltransferase activity by a tripartite complex composed of WDR5, RbBP5, and Ash2L. To selectively probe the role of the SET1 family of methyltransferases, we have developed a library of histone H3 peptide mimetics and report herein the characterization of an N alpha acetylated form of histone H3 peptide (N alpha H3). Binding and inhibition studies reveal that the addition of an acetyl moiety to the N terminus of histone H3 significantly enhances its binding to WDR5 and prevents the stimulation of MLL1 methyltransferase activity by the WDR5-RbBP5-Ash2L complex. The crystal structure of N alpha H3 in complex with WDR5 reveals that a high-affinity hydrophobic pocket accommodates the binding of the acetyl moiety. These results provide the structural basis to control WDR5-RbBP5-Ash2L-MLL1 activity and a tool to manipulate stem cell differentiation programs.-Avdic, V., Zhang, P., Lanouette, S., Voronova, A., Skerjanc, I., Couture, J.-F. Fine-tuning the stimulation of MLL1 methyltransferase activity by a histone H3-based peptide mimetic. FASEB J. 25, 960-967 (2011). www.fasebj.org	[Avdic, Vanja; Zhang, Pamela; Lanouette, Sylvain; Couture, Jean-Francois] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Avdic, Vanja; Zhang, Pamela; Lanouette, Sylvain; Voronova, Anastassia; Skerjanc, Ilona; Couture, Jean-Francois] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Couture, JF (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, 451 Smyth Rd,Roger Guindon Hall, Ottawa, ON K1H 8M5, Canada.	jean-francois.couture@uottawa.ca	Voronova, Anastassia/GLR-8891-2022; Skerjanc, Ilona/AAN-3318-2020	Voronova, Anastassia/0000-0001-7504-1905	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Dr. Alexandre Blais for reviewing this manuscript. This work was supported by a Canadian Institutes of Health Research grant to J.-F.C. J.-F.C. holds a Canadian Research Chair in Structural Biology and Epigenetics. The coordinates for the WDR5-NaH3 complex have been deposited in the Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank under accession number 3PSL.pdb.	Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Dai Y, 2010, CLIN EXP RHEUMATOL, V28, P158; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao JM, 2009, NAT STRUCT MOL BIOL, V16, P684, DOI 10.1038/nsmb.1610; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Karatas H, 2010, J MED CHEM, V53, P5179, DOI 10.1021/jm100139b; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Martens JHA, 2010, FEBS LETT, V584, P2662, DOI 10.1016/j.febslet.2010.04.002; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mendez AJ, 2010, CURR OPIN ENDOCRINOL, V17, P171, DOI 10.1097/MED.0b013e3283373cb5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Popovic R, 2005, J CELL BIOCHEM, V95, P234, DOI 10.1002/jcb.20430; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Yang HB, 2009, BIOCHEM CELL BIOL, V87, P151, DOI 10.1139/O08-131; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	36	13	13	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					960	967		10.1096/fj.10-171959	http://dx.doi.org/10.1096/fj.10-171959			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21135039				2022-12-25	WOS:000287806200016
J	Smart, CE; Wronski, A; French, JD; Edwards, SL; Asselin-Labat, ML; Waddell, N; Peters, K; Brewster, BL; Brooks, K; Simpson, K; Manning, N; Lakhani, SR; Grimmond, S; Lindeman, GJ; Visvader, JE; Brown, MA				Smart, C. E.; Wronski, A.; French, J. D.; Edwards, S. L.; Asselin-Labat, M-L; Waddell, N.; Peters, K.; Brewster, B. L.; Brooks, K.; Simpson, K.; Manning, N.; Lakhani, S. R.; Grimmond, S.; Lindeman, G. J.; Visvader, J. E.; Brown, M. A.			Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit	ONCOGENE			English	Article						Brca1; mammary gland; mammary epithelial morphogenesis; luminal progenitor; expression profiling; c-kit	EPITHELIAL-CELLS; STEM-CELL; MUTATION CARRIERS; TRANSGENIC MICE; TUMOR-FORMATION; BREAST-TUMORS; CANCER CELLS; EXPRESSION; GENE; RECEPTOR	Disruption of the breast cancer susceptibility gene Brca1 results in defective lobular-alveolar development in the mammary gland and a predisposition to breast tumourigenesis in humans and in mice. Recent evidence suggests that BRCA1 loss in humans is associated with an expansion of the luminal progenitor cell compartment in the normal breast and tumours with a luminal progenitor-like expression profile. To further investigate the role of BRCA1 in the mammary gland, we examined the consequences of Brca1 loss in mouse mammary epithelial cells in vitro and in vivo. Here, we show that Brca1 loss is associated with defective morphogenesis of SCp2 and HC11 mouse mammary epithelial cell lines and that in the MMTV-Cre Brca1(Co/Co) mouse model of Brca1 loss, there is an accumulation of luminal progenitor (CD61(+)CD29(lo)CD24(+)) cells during pregnancy. By day 1 of lactation, there are marked differences in the expression of 1379 genes, with most significantly altered pathways and networks, including lactation, the immune response and cancer. One of the most differentially expressed genes was the luminal progenitor marker, c-kit. Immunohistochemical analysis revealed that the increase in c-kit levels is associated with an increase in c-kit positivity. Interestingly, an inverse association between Brca1 and c-kit expression was also observed during mammary epithelial differentiation, and small interfering RNA-mediated knockdown of Brca1 resulted in a significant increase in c-kit mRNA levels. We found no evidence that c-kit plays a direct role in regulating differentiation of HC11 cells, suggesting that Brca1-mediated induction of c-kit probably contributes to Brca1-associated tumourigenesis via another cellular process, and that c-kit is likely to be a marker rather than a mediator of defective lobular-alveolar development resulting from Brca1 loss. Oncogene (2011) 30, 1597-1607; doi: 10.1038/onc.2010.538; published online 6 December 2010	[Smart, C. E.; Wronski, A.; French, J. D.; Edwards, S. L.; Peters, K.; Brewster, B. L.; Brooks, K.; Brown, M. A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Smart, C. E.; Lakhani, S. R.] Univ Queensland, Royal Brisbane & Womens Hosp, Clin Res Ctr, Herston, Qld, Australia; [Smart, C. E.; Lakhani, S. R.] Sch Med, Herston, Qld, Australia; [Asselin-Labat, M-L; Lindeman, G. J.; Visvader, J. E.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Waddell, N.; Grimmond, S.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Simpson, K.; Manning, N.; Brown, M. A.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia	University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Queensland; University of Melbourne	Brown, MA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Coopers Rd, St Lucia, Qld 4072, Australia.	melissa.brown@uq.edu.au	Grimmond, Sean M/J-5304-2016; Lakhani, Sunil R/I-1970-2018; French, Juliet D/A-4982-2011; Brown, Melissa A/F-1451-2010; Edwards, Stacey/A-4980-2011; Smart, Chanel E/C-9583-2011; Grimmond, Sean/K-3246-2019; French, Juliet/AAV-4435-2020; Waddell, Nicola/H-4929-2015; Brooks, Kelly M/F-8248-2017	Grimmond, Sean M/0000-0002-8102-7998; Lakhani, Sunil R/0000-0003-4067-2760; Grimmond, Sean/0000-0002-8102-7998; French, Juliet/0000-0002-9770-0198; Waddell, Nicola/0000-0002-3950-2476; Brooks, Kelly M/0000-0002-9751-5961; Simpson, Kaylene/0000-0001-9136-1781; Lindeman, Geoffrey/0000-0001-9386-2416; Brown, Melissa/0000-0002-2830-9259; Edwards, Stacey/0000-0001-7428-4139; Manning, Nathan/0000-0002-9914-6311	National Breast Cancer Foundation of Australia; University of Queensland; NBCF; NHMRC	National Breast Cancer Foundation of Australia; University of Queensland(University of Queensland); NBCF; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We are grateful to Bob Simpson for advice on real-time PCR, Kym Kelly-Taylor for animal husbandry, Vani Selvarajan for mouse genotyping and Lynne Reid for cryosectioning. We acknowledge the ARC Special Research Centre for Functional and Applied Genomics at The Institute of Molecular Bioscience, University of Queensland for support with microarray profiling and analysis. This work was supported by a National Breast Cancer Foundation of Australia and The University of Queensland. JF was supported by an NBCF Training fellowship, SE was supported by an NHMRC CJ Martin Fellowship and JV, GL and SG are Research Fellows of the National Health and Medical Research Council of Australia.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bektas N, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2117; Bogorad RL, 2008, P NATL ACAD SCI USA, V105, P14533, DOI 10.1073/pnas.0800685105; Brown MA, 2002, TRANSGENIC RES, V11, P467, DOI 10.1023/A:1020348025139; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Cui Y, 2002, J BIOL CHEM, V277, P17830, DOI 10.1074/jbc.M200186200; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Jernstrom H, 1998, BREAST, V7, P320, DOI 10.1016/S0960-9776(98)90074-1; Kijima T, 2002, CANCER RES, V62, P6304; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Lakhani SR, 1998, JNCI-J NATL CANCER I, V90, P1138, DOI 10.1093/jnci/90.15.1138; LaMarca HL, 2008, ENDOCRINOLOGY, V149, P4317, DOI 10.1210/en.2008-0450; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddison K, 2005, J PATHOL, V205, P181, DOI 10.1002/path.1698; Maia CJB, 2008, MOL CELL BIOCHEM, V314, P113, DOI 10.1007/s11010-008-9771-z; Master SR, 2002, MOL ENDOCRINOL, V16, P1185, DOI 10.1210/me.16.6.1185; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Naylor MJ, 2005, MOL ENDOCRINOL, V19, P1868, DOI 10.1210/me.2004-0254; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Raafat A, 2007, ONCOGENE, V26, P662, DOI 10.1038/sj.onc.1209823; Russo J, 2001, Breast J, V7, P278, DOI 10.1046/j.1524-4741.2001.21033.x; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shakya R, 2008, P NATL ACAD SCI USA, V105, P7040, DOI 10.1073/pnas.0711032105; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smalley MJ, 2005, CYTOTHERAPY, V7, P497, DOI 10.1080/14653240500361145; Smart CE, 2008, BREAST CANCER RES TR, V112, P237, DOI 10.1007/s10549-007-9859-2; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Triplett AA, 2008, NEOPLASIA, V10, P1325, DOI 10.1593/neo.08524; Tsai MH, 2007, CANCER RES, V67, P3845, DOI 10.1158/0008-5472.CAN-06-4250; Tsuda H, 2005, CANCER SCI, V96, P333, DOI 10.1111/j.1349-7006.2005.00060.x; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Vandenbark GR, 1996, CELL GROWTH DIFFER, V7, P1383; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Wright MH, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-29; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yamaji D, 2009, GENE DEV, V23, P2382, DOI 10.1101/gad.1840109	55	19	21	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2011	30	13					1597	1607		10.1038/onc.2010.538	http://dx.doi.org/10.1038/onc.2010.538			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	743DU	21132007	hybrid			2022-12-25	WOS:000288998300010
J	Carew, JS; Espitia, CM; Esquivel, JA; Mahalingam, D; Kelly, KR; Reddy, G; Giles, FJ; Nawrocki, ST				Carew, Jennifer S.; Espitia, Claudia M.; Esquivel, Juan A., II; Mahalingam, Devalingam; Kelly, Kevin R.; Reddy, Guru; Giles, Francis J.; Nawrocki, Steffan T.			Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE PERMEABILIZATION; MALIGNANT GLIOMA-CELLS; BREAST-CANCER CELLS; DEATH; CHLOROQUINE; INDUCTION; DRUG; TUMORIGENESIS; DEGRADATION; SUPPRESSION	Cellular stress induced by nutrient deprivation, hypoxia, and exposure to many chemotherapeutic agents activates an evolutionarily conserved cell survival pathway termed autophagy. This pathway enables cancer cells to undergo self-digestion to generate ATP and other essential biosynthetic molecules to temporarily avoid cell death. Therefore, disruption of autophagy may sensitize cancer cells to cell death and augment chemotherapy-induced apoptosis. Chloroquine and its analog hydroxychloroquine are the only clinically relevant autophagy inhibitors. Because both of these agents induce ocular toxicity, novel inhibitors of autophagy with a better therapeutic index are needed. Here we demonstrate that the small molecule lucanthone inhibits autophagy, induces lysosomal membrane permeabilization, and possesses significantly more potent activity in breast cancer models compared with chloroquine. Exposure to lucanthone resulted in processing and recruitment of microtubule-associated protein 1 light chain 3 (LC3) to autophagosomes, but impaired autophagic degradation as revealed by transmission electron microscopy and the accumulation of p62/SQSTM1. Microarray analysis, qRT-PCR, and immunoblotting determined that lucanthone stimulated a large induction in cathepsin D, which correlated with cell death. Accordingly, knockdown of cathepsin D reduced lucanthone-mediated apoptosis. Subsequent studies using p53(+/+) and p53(-/-) HCT116 cells established that lucanthone induced cathepsin D expression and reduced cancer cell viability independently of p53 status. In addition, lucanthone enhanced the anticancer activity of the histone deacetylase inhibitor vorinostat. Collectively, our results demonstrate that lucanthone is a novel autophagic inhibitor that induces apoptosis via cathepsin D accumulation and enhances vorinostat-mediated cell death in breast cancer models.	[Carew, Jennifer S.; Espitia, Claudia M.; Esquivel, Juan A., II; Mahalingam, Devalingam; Kelly, Kevin R.; Giles, Francis J.; Nawrocki, Steffan T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78245 USA; [Reddy, Guru] Spectrum Pharmaceut, Irvine, CA 92618 USA	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Nawrocki, ST (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Inst Drug Dev, Canc Therapy & Res Ctr, 14960 Omicron Dr, San Antonio, TX 78245 USA.	Nawrocki@uthscsa.edu			San Antonio Area Foundation; Spectrum Pharmaceuticals	San Antonio Area Foundation; Spectrum Pharmaceuticals	This work was supported by a grant from the Martha and Frank Herberth Memorial Fund and Beta and Melvin Leazar Memorial Fund and Robert F. and Anna M. Harper Memorial Fund of the San Antonio Area Foundation and funds provided by Spectrum Pharmaceuticals. G. R. is employed at Spectrum Pharmaceuticals. This study was funded in part by Spectrum Pharmaceuticals.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Apel A, 2009, INT J CANCER, V125, P991, DOI 10.1002/ijc.24500; Beaujouin M, 2006, ONCOGENE, V25, P1967, DOI 10.1038/sj.onc.1209221; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Carew JS, 2007, AUTOPHAGY, V3, P464, DOI 10.4161/auto.4311; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Carew Jennifer S, 2008, Biologics, V2, P201; Carew JS, 2010, J CELL MOL MED, V14, P2448, DOI 10.1111/j.1582-4934.2009.00832.x; CLARKSON J, 1984, J HELMINTHOL, V58, P59, DOI 10.1017/S0022149X00028066; Dassonneville L, 1999, BIOCHEM PHARMACOL, V58, P1307, DOI 10.1016/S0006-2952(99)00221-X; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Emert-Sedlak L, 2005, MOL CANCER THER, V4, P733, DOI 10.1158/1535-7163.MCT-04-0301; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; GLAUMANN H, 1987, EXP MOL PATHOL, V47, P346, DOI 10.1016/0014-4800(87)90018-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Khraishi MM, 1996, LUPUS, V5, pS41, DOI 10.1177/096120339600500110; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Lin XJ, 2001, CANCER RES, V61, P1508; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo MH, 2004, ANTICANCER RES, V24, P2127; Mahalingam D, 2010, CLIN CANCER RES, V16, P141, DOI 10.1158/1078-0432.CCR-09-1385; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; MILLIGAN AJ, 1978, J NATL CANCER I, V60, P1023, DOI 10.1093/jnci/60.5.1023; Myint HY, 2004, T ROY SOC TROP MED H, V98, P73, DOI 10.1016/S0035-9203(03)00014-2; Nawrocki ST, 2008, BLOOD, V112, P2917, DOI 10.1182/blood-2007-12-130823; Paglin S, 2001, CANCER RES, V61, P439; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Romanelli F, 2004, CURR PHARM DESIGN, V10, P2643, DOI 10.2174/1381612043383791; Savarino A, 2006, LANCET ONCOL, V7, P792, DOI 10.1016/S1470-2045(06)70875-0; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tehrani Rodney, 2008, Semin Ophthalmol, V23, P201, DOI 10.1080/08820530802049962; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	52	107	107	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6602	6613		10.1074/jbc.M110.151324	http://dx.doi.org/10.1074/jbc.M110.151324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148553	Green Published, hybrid			2022-12-25	WOS:000287476400069
J	Ikawa, M; Tokuhiro, K; Yamaguchi, R; Benham, AM; Tamura, T; Wada, I; Satouh, Y; Inoue, N; Okabe, M				Ikawa, Masahito; Tokuhiro, Keizo; Yamaguchi, Ryo; Benham, Adam M.; Tamura, Taku; Wada, Ikuo; Satouh, Yuhkoh; Inoue, Naokazu; Okabe, Masaru			Calsperin Is a Testis-specific Chaperone Required for Sperm Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; MOUSE SPERM; CALRETICULIN; CALNEXIN; CALMEGIN; IDENTIFICATION; DEFICIENT; ADAM3	Calnexin (CANX) and calreticulin (CALR) are homologous lectin chaperones located in the endoplasmic reticulum and cooperate to mediate nascent glycoprotein folding. In the testis, calmegin (CLGN) and calsperin (CALR3) are expressed as germ cell-specific counterparts of CANX and CALR, respectively. Here, we show that Calr3(-/-) males produced apparently normal sperm but were infertile because of defective sperm migration from the uterus into the oviduct and defective binding to the zona pellucida. Whereas CLGN was required for ADAM1A/ADAM2 dimerization and subsequent maturation of ADAM3, a sperm membrane protein required for fertilization, we show that CALR3 is a lectin-deficient chaperone directly required for ADAM3 maturation. Our results establish the client specificity of CALR3 and demonstrate that the germ cell-specific CALR-like endoplasmic reticulum chaperones have contrasting functions in the development of male fertility. The identification and understanding of the maturation mechanisms of key sperm proteins will pave the way toward novel approaches for both contraception and treatment of unexplained male infertility.	[Ikawa, Masahito; Tokuhiro, Keizo; Yamaguchi, Ryo; Benham, Adam M.; Satouh, Yuhkoh; Inoue, Naokazu; Okabe, Masaru] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Yamaguchi, Ryo; Okabe, Masaru] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Satouh, Yuhkoh; Okabe, Masaru] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Benham, Adam M.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Tamura, Taku; Wada, Ikuo] Fukushima Med Univ, Inst Biomed Sci, Fukushima 9601295, Japan	Osaka University; Osaka University; Osaka University; Durham University; Fukushima Medical University	Ikawa, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ikawa@biken.osaka-u.ac.jp	Tokuhiro, Keizo/HDM-4295-2022; ikawa, masahito/A-5315-2009; Satouh, Yuhkoh/A-9917-2009; Benham, Adam/AAC-6606-2019; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Satouh, Yuhkoh/0000-0001-9207-9374; Benham, Adam/0000-0002-0919-7431; Tamura, Taku/0000-0001-6074-9273; Okabe, Masaru/0000-0002-0803-9044; Inoue, Naokazu/0000-0002-6187-8293; Wada, Ikuo/0000-0001-5668-6994	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [20670006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; CLERMONT Y, 1969, FERTIL STERIL, V20, P805; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Hammarstrom P, 2009, FEBS LETT, V583, P2579, DOI 10.1016/j.febslet.2009.07.016; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hickox JR, 2001, J BIOL CHEM, V276, P41502, DOI 10.1074/jbc.M106795200; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Inoue Naokazu, 2008, V475, P335, DOI 10.1007/978-1-59745-250-2_19; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Kim E, 2006, J BIOL CHEM, V281, P5634, DOI 10.1074/jbc.M510558200; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2002, GENE, V291, P67, DOI 10.1016/S0378-1119(02)00540-1; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Persson S, 2002, GENE, V297, P151, DOI 10.1016/S0378-1119(02)00880-6; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; van Lith M, 2005, J BIOL CHEM, V280, P1376, DOI 10.1074/jbc.M408651200; van Lith M, 2007, MOL BIOL CELL, V18, P2795, DOI 10.1091/mbc.E07-02-0147; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; WATANABE D, 1995, FEBS LETT, V368, P509, DOI 10.1016/0014-5793(95)00729-S; WATANABE D, 1992, MOL REPROD DEV, V33, P307, DOI 10.1002/mrd.1080330312; Yamagata K, 2002, DEV BIOL, V250, P348, DOI 10.1006/dbio.2002.0803; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yamaguchi R, 2009, BIOL REPROD, V81, P142, DOI 10.1095/biolreprod.108.074021; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	44	95	105	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5639	5646		10.1074/jbc.M110.140152	http://dx.doi.org/10.1074/jbc.M110.140152			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21131354	Green Published, hybrid			2022-12-25	WOS:000287230600073
J	Johnson, JL; Hong, H; Monfregola, J; Kiosses, WB; Catz, SD				Johnson, Jennifer L.; Hong, Hong; Monfregola, Jlenia; Kiosses, William B.; Catz, Sergio D.			Munc13-4 Restricts Motility of Rab27a-expressing Vesicles to Facilitate Lipopolysaccharide-induced Priming of Exocytosis in Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; GRANULE SECRETION; RAB27A; MECHANISMS; MEMBRANE; EFFECTOR; CELLS; EXPRESSION; PROTEASES; FUSION	LPS is an efficient sensitizer of the neutrophil exocytic response to a second stimulus. Although neutrophil exocytosis in response to pathogen-derived molecules plays an important role in the innate immune response to infections, the molecular mechanism underlying LPS-dependent regulation of neutrophil exocytosis is currently unknown. The small GTPase Rab27a and its effector Munc13-4 regulate exocytosis in hematopoietic cells. Whether Rab27a and Munc13-4 modulate discrete steps or the same steps during exocytosis also remains unknown. Here, using Munc13-4- and Rab27a-deficient neutrophils, we analyzed the mechanism of lipopolysaccharide-dependent vesicular priming to amplify exocytosis of azurophilic granules. We found that both Munc13-4 and Rab27a are necessary to mediate LPS-dependent priming of exocytosis. However, we show that LPS-induced mobilization of a small population of readily releasable vesicles is a Munc13-4-dependent but Rab27a-independent process. LPS-induced priming regulation could not be fully explained by secretory organelle maturation as the redistribution of the secretory proteins Rab27a or Munc13-4 in response to LPS treatment was minimal. Using total internal reflection fluorescence microscopy and a novel mouse model expressing EGFP-Rab27a under the endogenous Rab27a promoter but lacking Munc13-4, we demonstrate that Munc13-4 is essential for the mechanism of LPS-dependent exocytosis in neutrophils and unraveled a novel mechanism of vesicular dynamics in which Munc13-4 restricts motility of Rab27a-expressing vesicles to facilitate lipopolysaccharide-induced priming of exocytosis.	[Johnson, Jennifer L.; Hong, Hong; Monfregola, Jlenia; Catz, Sergio D.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kiosses, William B.] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Catz, SD (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	scatz@scripps.edu	Monfregola, Jlenia/AAW-9055-2021	Hong, Hong/0000-0002-1009-3621; Catz, Sergio/0000-0002-1873-0277	U. S. Public Health Service [HL088256]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088256] Funding Source: NIH RePORTER	U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL088256 from the U. S. Public Health Service (to S. D. C.).	BAINTON DF, 1987, J EXP MED, V166, P1641, DOI 10.1084/jem.166.6.1641; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Brovkovych V, 2008, AM J PHYSIOL-LUNG C, V295, pL96, DOI 10.1152/ajplung.00450.2007; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; Brzezinska AA, 2009, IMMUNOLOGY, V127, P386, DOI 10.1111/j.1365-2567.2008.02980.x; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; KUIJPERS TW, 1991, BLOOD, V78, P1105; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Munafo DB, 2007, BIOCHEM J, V402, P229, DOI 10.1042/BJ20060950; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Pivot-Pajot C, 2008, J IMMUNOL, V180, P6786, DOI 10.4049/jimmunol.180.10.6786; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wood SM, 2009, BLOOD, V114, P4117, DOI 10.1182/blood-2009-06-225359	29	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5647	5656		10.1074/jbc.M110.184762	http://dx.doi.org/10.1074/jbc.M110.184762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148308	Green Published, hybrid			2022-12-25	WOS:000287230600074
J	Kalhan, SC; Uppal, SO; Moorman, JL; Bennett, C; Gruca, LL; Parimi, PS; Dasarathy, S; Serre, D; Hanson, RW				Kalhan, Satish C.; Uppal, Sonal O.; Moorman, Jillian L.; Bennett, Carole; Gruca, Lourdes L.; Parimi, Prabhu S.; Dasarathy, Srinivasan; Serre, David; Hanson, Richard W.			Metabolic and Genomic Response to Dietary Isocaloric Protein Restriction in the Rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SYNTHASE ACTIVITY; AMINO-ACID-METABOLISM; 3-PHOSPHOGLYCERATE DEHYDROGENASE; HUMAN-PREGNANCY; IN-VIVO; METHIONINE METABOLISM; TRANSCRIPTION FACTORS; SECRETORY PROTEINS; MAMMALIAN-CELLS; SKELETAL-MUSCLE	We have examined hepatic, genomic, and metabolic responses to dietary protein restriction in the non-pregnant Sprague-Dawley rat. Animals were pair-fed either a 6 or 24% casein-based diet for 7-10 days. At the end of the dietary period, a microarray analysis of the liver was performed, followed by validation of the genes of interest. The rates of appearance of phenylalanine, methionine, serine, and glucose and the contribution of pyruvate to serine and glucose were quantified using tracer methods. Plasma and tissue amino acid levels, enzyme activities, and metabolic intermediates were measured. Protein restriction resulted in significant differential expression of a number of genes involved in cell cycle, cell differentiation, transport, transcription, and metabolic processes. RTPCR showed that the expression of genes involved in serine biosynthesis and fatty acid oxidation was higher, and those involved in fatty acid synthesis and urea synthesis were lower in the liver of protein-restricted animals. Free serine and glycine levels were higher and taurine levels lower in all tissues examined. Tracer isotope studies showed an similar to 50% increase in serine de novo synthesis. Pyruvate was the primary (similar to 90%) source of serine in both groups. Transmethylation of methionine was significantly higher in the protein-restricted group. This was associated with a higher S-adenosylmethionine/S-adenosylhomocysteine ratio and lower cystathione beta-synthase and cystathionine gamma-lyase activity. Dietary isocaloric protein restriction results in profound changes in hepatic one-carbon metabolism within a short period. These may be related to high methylation demands placed on the organism and caused by possible changes in cellular osmolarity as a result of the efflux of the intracellular taurine.	Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Dasarathy, Srinivasan] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44195 USA; [Serre, David] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Hanson, Richard W.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Kalhan, SC (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave,NE40, Cleveland, OH 44195 USA.	sck@case.edu		Kalhan, Satish/0000-0002-8012-4171	National Institutes of Health [DK079937, DK58620]; Cleveland Clinic Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058620, R01DK079937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Clinic Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079937 (to S.C.K.) and DK58620 (to R.W.H.). This work was also supported by institutional support (to S.C.K.) from the Cleveland Clinic Foundation.	Achouri Y, 1999, BIOCHEM J, V344, P15, DOI 10.1042/0264-6021:3440015; ADIBI SA, 1973, AM J PHYSIOL, V225, P408, DOI 10.1152/ajplegacy.1973.225.2.408; Afolabi PR, 2004, AM J PHYSIOL-ENDOC M, V287, pE327, DOI 10.1152/ajpendo.00036.2004; BALLARD FJ, 1967, BIOCHEM J, V102, P952, DOI 10.1042/bj1020952; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; BROSNAN JT, 1989, CAN J PHYSIOL PHARM, V67, P1058, DOI 10.1139/y89-167; Chen JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004950; Courtney-Martin G, 2008, J NUTR, V138, P2172, DOI 10.3945/jn.108.093302; Dasarathy J, 2010, AM J CLIN NUTR, V91, P357, DOI 10.3945/ajcn.2009.28457; Dasarathy S, 2007, AM J PHYSIOL-GASTR L, V292, pG1105, DOI 10.1152/ajpgi.00529.2006; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; FRASCA V, 1988, BIOCHEMISTRY-US, V27, P8458, DOI 10.1021/bi00422a025; Fux R, 2005, AM J PHYSIOL-RENAL, V289, pF786, DOI 10.1152/ajprenal.00465.2004; Gaine PC, 2006, METABOLISM, V55, P501, DOI 10.1016/j.metabol.2005.10.012; Garcia AJ, 2002, J CHROMATOGR B, V779, P359, DOI 10.1016/S1570-0232(02)00401-4; GLAMOUR TS, 1995, AM J PHYSIOL-ENDOC M, V268, pE789, DOI 10.1152/ajpendo.1995.268.4.E789; Hall WL, 2003, BRIT J NUTR, V89, P239, DOI 10.1079/BJN2002760; Haussinger D, 1996, BIOCHEM J, V313, P697; HEINONEN K, 1973, BIOCHEM J, V136, P1011, DOI 10.1042/bj1361011; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Ingenbleek Y, 2002, NUTRITION, V18, P40, DOI 10.1016/S0899-9007(01)00783-3; Jackson AA, 2001, AM J PHYSIOL-GASTR L, V281, pG1179, DOI 10.1152/ajpgi.2001.281.5.G1179; Jun DY, 2008, GENE, V414, P106, DOI 10.1016/j.gene.2008.02.018; Kalhan SC, 2003, AM J PHYSIOL-ENDOC M, V284, pE733, DOI 10.1152/ajpendo.00167.2002; KALHAN SC, 1995, J MASS SPECTROM, V30, P1588, DOI 10.1002/jms.1190301111; Kalhan SC, 2001, AM J PHYSIOL-ENDOC M, V281, pE991, DOI 10.1152/ajpendo.2001.281.5.E991; Kalhan SC, 1998, AM J PHYSIOL-ENDOC M, V275, pE423, DOI 10.1152/ajpendo.1998.275.3.E423; Kang J, 1999, KIDNEY INT, V56, P452, DOI 10.1046/j.1523-1755.1999.00562.x; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; LANDAU BR, 1995, J CLIN INVEST, V95, P172, DOI 10.1172/JCI117635; LARIVIERE F, 1992, AM J PHYSIOL, V263, pE173, DOI 10.1152/ajpendo.1992.263.1.E173; LARIVIERE F, 1994, METABOLISM, V43, P462, DOI 10.1016/0026-0495(94)90077-9; Ling PR, 2004, AM J PHYSIOL-REG I, V287, pR801, DOI 10.1152/ajpregu.00715.2003; Merali S, 2000, J BIOL CHEM, V275, P14958, DOI 10.1074/jbc.275.20.14958; Mitoma J, 2004, GENE, V334, P15, DOI 10.1016/j.gene.2004.03.015; MUDD SH, 1965, J BIOL CHEM, V240, P4382; Nagao K, 2009, AMINO ACIDS, V36, P555, DOI 10.1007/s00726-008-0117-7; Noguchi Y, 2008, PHYSIOL GENOMICS, V34, P315, DOI 10.1152/physiolgenomics.00007.2008; Ohuchi S, 2009, J NUTR SCI VITAMINOL, V55, P178, DOI 10.3177/jnsv.55.178; Ozanne SE, 1999, BIOCHEM SOC T, V27, P94, DOI 10.1042/bst0270094; Parimi PS, 2004, PEDIATR RES, V56, P423, DOI 10.1203/01.PDR.0000136277.10365.84; Parimi PS, 2003, PEDIATR RES, V53, P325, DOI [10.1203/01.PDR.0000047643.26484.48, 10.1203/00006450-200302000-00020]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao S, 2003, EUR J CLIN NUTR, V57, P531, DOI 10.1038/sj.ejcn.1601582; Reynolds RM, 2007, J CLIN ENDOCR METAB, V92, P2208, DOI 10.1210/jc.2007-0071; Rowling MJ, 2002, J NUTR, V132, P2545, DOI 10.1093/jn/132.9.2545; Shan J., 2010, PHYSL GENOM IN PRESS; SKETCHER RD, 1974, BRIT J NUTR, V32, P615, DOI 10.1079/BJN19740114; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; STIPANUK MH, 1979, J NUTR, V109, P2126, DOI 10.1093/jn/109.12.2126; van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Yamamoto N, 1996, J NUTR SCI VITAMINOL, V42, P589, DOI 10.3177/jnsv.42.589; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	59	51	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5266	5277		10.1074/jbc.M110.185991	http://dx.doi.org/10.1074/jbc.M110.185991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21147771	Green Published, hybrid			2022-12-25	WOS:000287230600035
J	Ikeda, M; Andoo, A; Shimono, M; Takamatsu, N; Taki, A; Muta, K; Matsushita, W; Uechi, T; Matsuzaki, T; Kenmochi, N; Takata, K; Sasaki, S; Ito, K; Ishibashi, K				Ikeda, Masahiro; Andoo, Ayaka; Shimono, Mariko; Takamatsu, Natsuko; Taki, Asaka; Muta, Kanako; Matsushita, Wataru; Uechi, Tamayo; Matsuzaki, Toshiyuki; Kenmochi, Naoya; Takata, Kuniaki; Sasaki, Sei; Ito, Katsuaki; Ishibashi, Kenichi			The NPC Motif of Aquaporin-11, Unlike the NPA Motif of Known Aquaporins, Is Essential for Full Expression of Molecular Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR INTRINSIC PROTEIN; WATER CHANNEL; MIP; MUTATIONS; CELLS; AQP11	The recently identified molecule aquaporin-11 (AQP11) has a unique amino acid sequence pattern that includes an Asn-Pro- Cys (NPC) motif, corresponding to the N-terminal Asn-Pro- Ala (NPA) signature motif of conventional AQPs. In this study, we examined the effect of the mutation of the NPC motif on the subcellular localization, oligomerization, and water permeability of AQP11 in transfected mammalian cells. Furthermore, the effect was also assessed using zebrafish. Site-directed mutation at the NPC motif did not affect the subcellular localization of AQP11 but reduced its oligomerization. A cell swelling assay revealed that cells expressing AQP11 with a mutated NPC motif had significantly lower osmotic water permeability than cells expressing wild-type AQP11. Zebrafish deficient in endogenous AQP11 showed a deformity in the tail region at an early stage of development. This phenotype was dramatically rescued by injection of human wild-type AQP11 mRNA, whereas the effect of mRNA for AQP11 with a mutated NPC motif was less marked. Although the NPA motif is known to be important for formation of water-permeable pores by conventional AQPs, our observations suggest that the corresponding NPC motif of AQP11 is essential for full expression of molecular function.	[Ikeda, Masahiro] Miyazaki Univ, Fac Agr, Dept Vet Pharmacol, Miyazaki 8892192, Japan; [Uechi, Tamayo; Kenmochi, Naoya] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki 8892192, Japan; [Matsuzaki, Toshiyuki; Takata, Kuniaki] Gunma Univ, Grad Sch Med, Dept Anat & Cell Biol, Maebashi, Gunma 3718511, Japan; [Sasaki, Sei] Tokyo Med & Dent Univ, Dept Nephrol, Tokyo 1138519, Japan; [Ishibashi, Kenichi] Meiji Pharmaceut Univ, Dept Med Physiol, Tokyo 2048588, Japan	University of Miyazaki; University of Miyazaki; Gunma University; Tokyo Medical & Dental University (TMDU); Meiji Pharmaceutical University	Ikeda, M (corresponding author), Miyazaki Univ, Fac Agr, Dept Vet Pharmacol, Gakuenkibanadai Nishi 1-1, Miyazaki 8892192, Japan.	a0d302u@cc.miyazaki-u.ac.jp	Kenmochi, Naoya/ABF-3564-2021	Ikeda, Masahiro/0000-0003-2539-8812	Japan Society for the Promotion of Science [17580259, 19580342]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 17580259 (to M. I.) and 19580342 (to M. I.).	Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Brand M, 1996, DEVELOPMENT, V123, P129; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; CARBREY JM, 2009, HDB EXP PHARM, V190, P3, DOI DOI 10.1007/978-3-540-79885-9_; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Duchesne L, 2002, J BIOL CHEM, V277, P20598, DOI 10.1074/jbc.M201179200; Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920; Geyer DD, 2006, AM J OPHTHALMOL, V141, P761, DOI 10.1016/j.ajo.2005.11.008; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Gorelick Daniel A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-14; Gu F, 2007, MOL VIS, V13, P1651; Hannah MJ, 1998, METHODS, V16, P170, DOI 10.1006/meth.1998.0664; Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Ikeda M, 2006, CELL PHYSIOL BIOCHEM, V18, P9, DOI 10.1159/000095133; Ishibashi K, 2009, J MED INVESTIG, V56, P312, DOI 10.2152/jmi.56.312; Itoh T, 2005, BIOCHEM BIOPH RES CO, V330, P832, DOI 10.1016/j.bbrc.2005.03.046; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kohli G, 2003, ENDOCRINOLOGY, V144, P1931, DOI 10.1210/en.2002-0126; Larsen HS, 2010, EUR J ORAL SCI, V118, P9, DOI 10.1111/j.1600-0722.2009.00708.x; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Morishita Y, 2005, MOL CELL BIOL, V25, P7770, DOI 10.1128/MCB.25.17.7770-7779.2005; MORRICAL SO, 2006, J AM SOC NEPHROL   S, V17, pA538; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Okada S, 2008, FASEB J, V22, P3672, DOI 10.1096/fj.08-111872; Pang YF, 2002, ENDOCRINOLOGY, V143, P47, DOI 10.1210/en.143.1.47; Tchekneva EE, 2008, J AM SOC NEPHROL, V19, P1955, DOI 10.1681/ASN.2008030296; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Walz Thomas, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-79885-9_2; Yakata K, 2007, BBA-BIOMEMBRANES, V1768, P688, DOI 10.1016/j.bbamem.2006.11.005; Yeung CH, 2010, REPRODUCTION, V139, P209, DOI 10.1530/REP-09-0298	35	58	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3342	3350		10.1074/jbc.M110.180968	http://dx.doi.org/10.1074/jbc.M110.180968			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118806	Green Published, hybrid			2022-12-25	WOS:000286653200020
J	Jang, YH; Min, DS				Jang, Young Hoon; Min, Do Sik			Nuclear Localization of Phospholipase D1 Mediates the Activation of Nuclear Protein Kinase C alpha and Extracellular Signal-regulated Kinase Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; LEUKEMIA-CELLS; EXPRESSION; MATRIX; TRANSLOCATION; TRANSDUCTION; METABOLISM; APOPTOSIS; INVASION; DOMAINS	Recent studies highlight the existence of a nuclear lipid metabolism related to cellular proliferation. However, the importance of nuclear phosphatidylcholine (PC) metabolism is poorly understood. Therefore, we were interested in nuclear PC as a source of second messengers and, particularly, nuclear localization of PC-specific phospholipase D (PLD). In the present study we have identified the nuclear localization sequence (NLS) of PLD1 whose mutation abolished its nuclear import. Recently, we reported that caspase-mediated cleavage of PLD1 generates the N-terminal fragment (NF-PLD1) and C-terminal fragment (CF-PLD1). Here we show that CF-PLD1 but not NF-PLD1, is exclusively imported into the nucleus via its functional NLS, whereas only some portions of intact PLD1 were localized into the nucleus. The NLS of intact PLD1 or CF-PLD1 is required for interaction with importin-beta, which is known to mediate nuclear import. The amount of intact PLD1 or CF-PLD1 translocated into nucleus is correlated with its binding affinity with importin-beta. Ultimately, nuclear localization of intact PLD1 but not CF-PLD1 mediates the activation of nuclear protein kinase C alpha and extracellular signal-regulated kinase signaling pathways. Taken together, we propose that nuclear localization of PLD1 via the NLS and its interaction with importin-beta may provide new insights on the functional role of nuclear PLD1 signaling.	[Jang, Young Hoon; Min, Do Sik] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea	Pusan National University	Min, DS (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, 30 Jangjeon Dong, Pusan 609735, South Korea.	minds@pusan.ac.kr		Jang, Younghoon/0000-0002-5705-4945	Ministry for Health, Welfare, and Family Affairs, Republic of Korea [0920050]; Translational Research Center for Protein Function Control, NSF, Republic of Korea [2009-0092960]; Korea government (MEST) [20100014590]	Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Translational Research Center for Protein Function Control, NSF, Republic of Korea; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by National R&D Program for Cancer Control, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant 0920050, by Translational Research Center for Protein Function Control, NSF Grant 2009-0092960, Republic of Korea, and by National Research Foundation of Korea funded by the Korea government (MEST) Grant 20100014590.	Ahn BH, 2003, MOL CELL BIOL, V23, P3103, DOI 10.1128/MCB.23.9.3103-3115.2003; ALBI E, 1994, LIPIDS, V29, P715, DOI 10.1007/BF02538916; Antony P, 2003, FEBS LETT, V541, P93, DOI 10.1016/S0014-5793(03)00313-2; BALBOA MA, 1995, J BIOL CHEM, V270, P29843; Baldassare JJ, 1997, J BIOL CHEM, V272, P4911, DOI 10.1074/jbc.272.8.4911; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Cockcroft S, 2009, BBA-MOL CELL BIOL L, V1791, P905, DOI 10.1016/j.bbalip.2009.03.007; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Gayral S, 2006, CIRC RES, V99, P132, DOI 10.1161/01.RES.0000232323.86227.8b; Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4; Hunt AN, 2006, J CELL BIOCHEM, V97, P244, DOI 10.1002/jcb.20691; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Jang YH, 2008, CELL DEATH DIFFER, V15, P1782, DOI 10.1038/cdd.2008.111; JARPE MB, 1994, BIOCHEMISTRY-US, V33, P526, DOI 10.1021/bi00168a018; Kang DW, 2011, INT J CANCER, V128, P805, DOI 10.1002/ijc.25402; Kim J, 2006, CANCER RES, V66, P784, DOI 10.1158/0008-5472.CAN-05-1316; Maraldi NM, 1999, J CELL PHYSIOL, V181, P203, DOI 10.1002/(SICI)1097-4652(199911)181:2<203::AID-JCP3>3.0.CO;2-O; Martelli AM, 2006, BBA-MOL CELL BIOL L, V1761, P542, DOI 10.1016/j.bbalip.2006.02.009; Martelli AM, 1999, PROG LIPID RES, V38, P273, DOI 10.1016/S0163-7827(99)00009-0; Martelli AM, 2004, CELL MOL LIFE SCI, V61, P1143, DOI 10.1007/s00018-004-3414-7; Martelli AM, 1999, CANCER RES, V59, P3961; Min DS, 2001, NEUROPHARMACOLOGY, V41, P384, DOI 10.1016/S0028-3908(01)00070-3; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; NEITCHEVA T, 1995, INT J BIOCHEM CELL B, V27, P995, DOI 10.1016/1357-2725(95)00087-6; Neri LM, 2002, MOL BIOL CELL, V13, P947, DOI 10.1091/mbc.01-02-0086; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rudge SA, 2009, BBA-MOL CELL BIOL L, V1791, P856, DOI 10.1016/j.bbalip.2009.04.008; Tabellini G, 2003, EXP CELL RES, V287, P143, DOI 10.1016/S0014-4827(03)00115-0; Tamiya-Koizumi K, 2002, J BIOCHEM, V132, P13, DOI 10.1093/oxfordjournals.jbchem.a003190; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	37	12	12	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4680	4689		10.1074/jbc.M110.162602	http://dx.doi.org/10.1074/jbc.M110.162602			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21113078	Green Published, hybrid			2022-12-25	WOS:000286975700067
J	Meseguer, S; Mudduluru, G; Escamilla, JM; Allgayer, H; Barettino, D				Meseguer, Salvador; Mudduluru, Giridhar; Manuel Escamilla, Juan; Allgayer, Heike; Barettino, Domingo			MicroRNAs-10a and-10b Contribute to Retinoic Acid-induced Differentiation of Neuroblastoma Cells and Target the Alternative Splicing Regulatory Factor SFRS1 (SF2/ASF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-RISK NEUROBLASTOMA; NEURO-BLASTOMA CELLS; GENE-EXPRESSION; SIGNALING PATHWAY; MIRNA EXPRESSION; METASTASIS; INVASION; MIGRATION; ACTIVATION; PROTEINS	MicroRNAs (miRNAs) are an emerging class of non-coding endogenous RNAs involved in multiple cellular processes, including cell differentiation. Treatment with retinoic acid (RA) results in neural differentiation of neuroblastoma cells. We wanted to elucidate whether miRNAs contribute to the gene expression changes induced by RA in neuroblastoma cells and whether miRNA regulation is involved in the transduction of the RA signal. We show here that RA treatment of SH-SY5Y neuroblastoma cells results in profound changes in the expression pattern of miRNAs. Up to 42 different miRNA species significantly changed their expression (26 up-regulated and 16 down-regulated). Among them, the closely related miR-10a and -10b showed the most prominent expression changes. Induction of miR-10a and -10b by RA also could be detected in LA-N-1 neuroblastoma cells. Loss of function experiments demonstrated that miR-10a and -10b are essential mediators of RA-induced neuroblastoma differentiation and of the associated changes in migration, invasion, and in vivo metastasis. In addition, we found that the SR-family splicing factor SFRS1 (SF2/ASF) is a target for miR-10a -and -10b in HeLa and SH-SY5Y neuroblastoma cells. We show here that changes in miR10a and -10b expression levels may regulate SFRS1-dependent alternative splicing and translational functions. Taken together, our results give support to the idea that miRNA regulation plays a key role in RA-induced neuroblastoma cell differentiation. The discovery of SFRS1 as direct target of miR-10a and -10b supports the emerging functional interaction between two post-transcriptional mechanisms, microRNAs and splicing, in the neuronal differentiation context.	[Mudduluru, Giridhar; Allgayer, Heike] Heidelberg Univ, Mannheim Med Fac, Dept Expt Surg Mol Oncol Solid Tumors, Collaborat Unit DKFZ Heidelberg, D-68135 Mannheim, Germany; [Meseguer, Salvador; Manuel Escamilla, Juan; Barettino, Domingo] CSIC, Biol Hormone Act Unit, Dept Mol & Cellular Pathol & Therapy, Inst Biomed Valencia, E-46010 Valencia, Spain	Ruprecht Karls University Heidelberg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Allgayer, H (corresponding author), Heidelberg Univ, Mannheim Med Fac, Dept Expt Surg Mol Oncol Solid Tumors, Collaborat Unit DKFZ Heidelberg, Theodor Kutzer Ufer 1-3, D-68135 Mannheim, Germany.	dbarettino@ibv.csic.es	Meseguer, Salvador/K-7137-2014; ESCAMILLA-HONRUBIA, JUAN MANUEL/L-5884-2014	Meseguer, Salvador/0000-0002-2718-4351; ESCAMILLA-HONRUBIA, JUAN MANUEL/0000-0003-0154-6569	Spanish former Ministry of Education and Science; Ministry of Science and Innovation [SAF2006-00647, SAF2007-60780]; Generalitat Valenciana [ACOMP 09/212]; Genoma Espana; Alfried Krupp von Bohlen und Halbach Foundation (Essen); Hella-Buhler-Foundation (Heidelberg); Dr. Ingrid zu Solms Foundatio (Frankfurt/Main); Hector Foundation (Weinheim); FRONTIER Excellence Initiative of the University of Heidelberg; Federal Ministry of Education and Research (BMBF), Germany; Walter Schulz Foundation, Munich, Germany; European Association for Cancer Research; Consejo Superior de Investigaciones Cientificas	Spanish former Ministry of Education and Science; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Genoma Espana; Alfried Krupp von Bohlen und Halbach Foundation (Essen); Hella-Buhler-Foundation (Heidelberg); Dr. Ingrid zu Solms Foundatio (Frankfurt/Main); Hector Foundation (Weinheim); FRONTIER Excellence Initiative of the University of Heidelberg; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Walter Schulz Foundation, Munich, Germany; European Association for Cancer Research; Consejo Superior de Investigaciones Cientificas	This work was supported by Spanish former Ministry of Education and Science and Ministry of Science and Innovation Grants SAF2006-00647 and SAF2007-60780 and Generalitat Valenciana (ACOMP 09/212) and Genoma Espana (to D. B.) and by the Alfried Krupp von Bohlen und Halbach Foundation (Award for Young Full Professors) (Essen), Hella-Buhler-Foundation (Heidelberg), Dr. Ingrid zu Solms Foundatio (Frankfurt/Main), the Hector Foundation (Weinheim), the FRONTIER Excellence Initiative of the University of Heidelberg, the Federal Ministry of Education and Research (BMBF), Germany, and the Walter Schulz Foundation, Munich, Germany (to H. A.). This work was also supported by an European Association for Cancer Research training and travel fellowship award (to S. M.) for the purpose of training in microRNA research.; Recipient of a Consejo Superior de Investigaciones Cientificas I3P predoctoral fellowship/contract.	ALBINI A, 1987, CANCER RES, V47, P3239; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Ciarapica R, 2009, ONCOGENE, V28, P1881, DOI 10.1038/onc.2009.56; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Esposito CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001643; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Giannini G, 1997, J BIOL CHEM, V272, P26693, DOI 10.1074/jbc.272.42.26693; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; INO M, 1986, DEV BRAIN RES, V30, P120, DOI 10.1016/0165-3806(86)90140-9; Jeong H, 2006, J NEUROCHEM, V98, P386, DOI 10.1111/j.1471-4159.2006.03866.x; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Joshi S, 2006, ONCOGENE, V25, P240, DOI 10.1038/sj.onc.1209027; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Kondo S, 2004, GENES CELLS, V9, P121, DOI 10.1111/j.1356-9597.2004.00709.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Laserna EJ, 2009, MOL ENDOCRINOL, V23, P1799, DOI 10.1210/me.2009-0165; Lau P, 2010, BRAIN RES, V1338, P14, DOI 10.1016/j.brainres.2010.04.002; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Loya CM, 2010, GENE DEV, V24, P625, DOI 10.1101/gad.1907710; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Marti D, 2005, AM J PHYSIOL-HEART C, V289, pH1923, DOI 10.1152/ajpheart.00288.2005; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 2000, BRIT J CANCER, V83, P1121, DOI 10.1054/bjoc.2000.1430; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Mueller S, 2009, CURR ONCOL REP, V11, P431, DOI 10.1007/s11912-009-0059-6; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Oppenheimer O, 2007, MOL CANCER THER, V6, P1300, DOI 10.1158/1535-7163.MCT-06-0587; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Palmieri A, 2008, IMPLANT DENT, V17, P100, DOI 10.1097/ID.0b013e318166d182; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Petrocca F, 2009, RNA BIOL, V6, P335, DOI 10.4161/rna.6.3.9013; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; Schulte JH, 2009, CANCER LETT, V274, P10, DOI 10.1016/j.canlet.2008.06.010; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; SIDELL N, 1982, J NATL CANCER I, V68, P589; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; TAHIRA T, 1991, ONCOGENE, V6, P2333; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Ting Y, 2010, BIOCHEM BIOPH RES CO, V394, P606, DOI 10.1016/j.bbrc.2010.03.030; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; TSOKOS M, 1987, AM J PATHOL, V128, P484; van der Horst EH, 2004, BIOTECHNIQUES, V37, P940, DOI 10.2144/04376ST02; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Voigt A, 2003, MED PEDIATR ONCOL, V40, P205, DOI 10.1002/mpo.10250; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Yamada S, 2007, NEUROREPORT, V18, P359, DOI 10.1097/WNR.0b013e32801299b4; Zijlstra A, 2002, CANCER RES, V62, P7083	85	87	92	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4150	4164		10.1074/jbc.M110.167817	http://dx.doi.org/10.1074/jbc.M110.167817			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21118818	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000286975700014
J	Nelson, CD; Reinhardt, TA; Beitz, DC; Lippolis, JD				Nelson, Corwin D.; Reinhardt, Timothy A.; Beitz, Donald C.; Lippolis, John D.			In Vivo Activation of the Intracrine Vitamin D Pathway in Innate Immune Cells and Mammary Tissue during a Bacterial Infection	PLOS ONE			English	Article							1-ALPHA,25-DIHYDROXYVITAMIN D-3; INTRAMAMMARY INFECTION; BOVINE-MILK; MASTITIS; TUBERCULOSIS; HYDROXYLASE; METABOLITES; MONOCYTES; HEALTH; FARMS	In Numerous in vitro studies have shown that toll-like receptor signaling induces 25-hydroxyvitamin D-3 1 alpha-hydroxylase (1 alpha-OHase; CYP27B1) expression in macrophages from various species. 1 alpha-OHase is the primary enzyme that converts 25-hydroxyvitamin D-3 to 1,25-dihydroxyvitamin D-3 (1,25(OH) D-2(3)). Subsequently, synthesis of 1,25(OH)(2)D-3 by 1 alpha-OHase in macrophages has been shown to modulate innate immune responses of macrophages. Despite the numerous in vitro studies that have shown 1 alpha-OHase expression is induced in macrophages, however, evidence that 1 alpha-OHase expression is induced by pathogens in vivo is limited. The objective of this study was to evaluate 1 alpha-OHase gene expression in macrophages and mammary tissue during an in vivo bacterial infection with Streptococcus uberis. In tissue and secreted cells from the infected mammary glands, 1 alpha-OHase gene expression was significantly increased compared to expression in tissue and cells from the healthy mammary tissue. Separation of the cells by FACS9 revealed that 1 alpha-OHase was predominantly expressed in the CD14(+) cells isolated from the infected mammary tissue. The 24-hydroxylase gene, a gene that is highly upregulated by 1,25(OH)(2)D-3, was significantly more expressed in tissue and cells from the infected mammary tissue than from the healthy uninfected mammary tissue thus indicating significant local 1,25(OH)(2)D-3 production at the infection site. In conclusion, this study provides the first in vivo evidence that 1 alpha-OHase expression is upregulated in macrophages in response to bacterial infection and that 1 alpha-OHase at the site of infection provides 1,25(OH)(2)D-3 for local regulation of vitamin D responsive genes.	[Nelson, Corwin D.; Reinhardt, Timothy A.; Lippolis, John D.] ARS, Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Nelson, Corwin D.; Beitz, Donald C.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Beitz, Donald C.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	United States Department of Agriculture (USDA); Iowa State University; Iowa State University	Nelson, CD (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	john.lippolis@ars.usda.gov	Reinhardt, Timothy/A-7536-2009	Reinhardt, Timothy/0000-0001-5552-2509; Nelson, Corwin/0000-0003-0195-5610; Lippolis, John/0000-0003-2314-4384	USDA	USDA(United States Department of Agriculture (USDA))	Research was conducted at a USDA research facility and all funding was internal USDA research dollars. This project is an intramural project of the U. S. Department of Agriculture, Agricultural Research Service, National Animal Disease Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Bannerman DD, 2004, VET RES, V35, P681, DOI 10.1051/vetres:2004040; Brodersen R, 1998, VET IMMUNOL IMMUNOP, V64, P1, DOI 10.1016/S0165-2427(98)00117-2; Bruce D, 2010, EXP BIOL MED, V235, P921, DOI 10.1258/ebm.2010.010061; De Schepper S, 2008, VET RES, V39, DOI 10.1051/vetres:2007044; DELUCA HF, 1975, AM J MED, V58, P39, DOI 10.1016/0002-9343(75)90531-8; Endsley JJ, 2009, VET IMMUNOL IMMUNOP, V128, P199, DOI 10.1016/j.vetimm.2008.10.312; ENGSTROM GW, 1987, J DAIRY SCI, V70, P2266, DOI 10.3168/jds.S0022-0302(87)80286-2; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Hogan J, 2003, VET RES, V34, P507, DOI 10.1051/vetres:2003022; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; HOLLIS BW, 1981, J NUTR, V111, P1240, DOI 10.1093/jn/111.7.1240; Horst RL, 2005, J MAMMARY GLAND BIOL, V10, P141, DOI 10.1007/s10911-005-5397-x; HORST RL, 1983, J DAIRY SCI, V66, P661, DOI 10.3168/jds.S0022-0302(83)81844-X; Horst RL, 2003, ACTA VET SCAND, P35; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCDERMOTT CM, 1985, J DAIRY SCI, V68, P1959, DOI 10.3168/jds.S0022-0302(85)81057-2; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; Petrovski KR, 2009, NEW ZEAL VET J, V57, P109, DOI 10.1080/00480169.2009.36887; Reinhardt TA, 1999, ARCH BIOCHEM BIOPHYS, V368, P244, DOI 10.1006/abbi.1999.1335; Reinhardt TA, 2006, J DAIRY RES, V73, P406, DOI 10.1017/S0022029906001889; Riekerink RGMO, 2008, J DAIRY SCI, V91, P1366, DOI 10.3168/jds.2007-0757; Riollet C, 2000, ADV EXP MED BIOL, V480, P247; Sampimon O, 2009, J DAIRY RES, V76, P129, DOI 10.1017/S0022029908003762; Stoffels K, 2007, J STEROID BIOCHEM, V103, P567, DOI 10.1016/j.jsbmb.2006.12.091; Stoffels K, 2006, J BONE MINER RES, V21, P37, DOI 10.1359/JBMR.050908; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Van Rhijn I, 2008, MICROBES INFECT, V10, P711, DOI 10.1016/j.micinf.2008.04.005; Wagner CL, 2008, BREASTFEED MED, V3, P239, DOI 10.1089/bfm.2008.9984	35	45	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15469	10.1371/journal.pone.0015469	http://dx.doi.org/10.1371/journal.pone.0015469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124742	gold, Green Published, Green Submitted			2022-12-25	WOS:000284686500041
J	Kromrey, S; Maestri, M; Hauffen, K; Bart, E; Hegde, J				Kromrey, Sarah; Maestri, Matthew; Hauffen, Karin; Bart, Evgeniy; Hegde, Jay			Fragment-Based Learning of Visual Object Categories in Non-Human Primates	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; NEURAL REPRESENTATION; AREA V2; ACUITY; RECOGNITION; INFORMATION; CORTEX; PERCEPTION; FEATURES; MONKEYS	When we perceive a visual object, we implicitly or explicitly associate it with an object category we know. Recent research has shown that the visual system can use local, informative image fragments of a given object, rather than the whole object, to classify it into a familiar category. We have previously reported, using human psychophysical studies, that when subjects learn new object categories using whole objects, they incidentally learn informative fragments, even when not required to do so. However, the neuronal mechanisms by which we acquire and use informative fragments, as well as category knowledge itself, have remained unclear. Here we describe the methods by which we adapted the relevant human psychophysical methods to awake, behaving monkeys and replicated key previous psychophysical results. This establishes awake, behaving monkeys as a useful system for future neurophysiological studies not only of informative fragments in particular, but also of object categorization and category learning in general.	[Kromrey, Sarah; Maestri, Matthew; Hauffen, Karin; Hegde, Jay] Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Kromrey, Sarah; Maestri, Matthew; Hauffen, Karin; Hegde, Jay] Med Coll Georgia, Vis Discovery Inst, Augusta, GA 30912 USA; [Bart, Evgeniy] Palo Alto Res Ctr PARC, Intelligent Syst Lab, Palo Alto, CA USA; [Hegde, Jay] Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Kromrey, S (corresponding author), Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.	jay@hegde.us						Anstis S, 1998, PERCEPTION, V27, P817, DOI 10.1068/p270817; ANSTIS SM, 1974, VISION RES, V14, P589, DOI 10.1016/0042-6989(74)90049-2; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; BART E, 2008, COSYNE, P121; Bart E, 2008, IEEE T PATTERN ANAL, V30, P1618, DOI 10.1109/TPAMI.2007.70818; Brady MJ, 2003, J VISION, V3, P413, DOI 10.1167/3.6.2; COHEN C, 2005, HDB CATEGORIZATION C; COWEY A, 1974, EXP BRAIN RES, V21, P447; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DRASDO N, 1989, VISION RES, V29, P985, DOI 10.1016/0042-6989(89)90113-2; DRASDO N, 1977, NATURE, V266, P554, DOI 10.1038/266554a0; Duda R.O., 2006, PATTERN CLASSIFICATI; Freedman DJ, 2008, NEUROSCI BIOBEHAV R, V32, P311, DOI 10.1016/j.neubiorev.2007.07.011; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Grether WF, 1941, J COMP PSYCHOL, V31, P23, DOI 10.1037/h0060652; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Harel A, 2007, VISION RES, V47, P2010, DOI 10.1016/j.visres.2007.04.004; Harris C., 1988, P 4 ALV VIS C, V15, P147, DOI DOI 10.5244/C.2.23; Hegde J, 2005, J NEUROPHYSIOL, V93, P620, DOI 10.1152/jn.00039.2004; Hegde J, 2004, J NEUROPHYSIOL, V92, P3030, DOI 10.1152/jn.00822.2003; Hegde J, 2000, J NEUROSCI, V20, part. no.; Hegde J, 2008, CURR BIOL, V18, P597, DOI 10.1016/j.cub.2008.03.058; Hegde J, 2007, CEREB CORTEX, V17, P1100, DOI 10.1093/cercor/bhl020; Joyce CA, 2006, VISION RES, V46, P800, DOI 10.1016/j.visres.2005.09.016; Kadir T, 2001, INT J COMPUT VISION, V45, P83, DOI 10.1023/A:1012460413855; KRUSKAL J.B., 1978, MULTIDIMENSIONAL SCA; Lerner Y, 2008, J COGNITIVE NEUROSCI, V20, P1189, DOI 10.1162/jocn.2008.20082; Markman AB, 2003, PSYCHOL BULL, V129, P592, DOI 10.1037/0033-2909.129.4.592; McGraw PV, 1999, EXP BRAIN RES, V125, P122, DOI 10.1007/s002210050667; MERVIS CB, 1981, ANNU REV PSYCHOL, V32, P89, DOI 10.1146/annurev.ps.32.020181.000513; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Mikolajczyk K, 2002, LECT NOTES COMPUT SC, V2350, P128, DOI 10.1007/3-540-47969-4_9; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Palmeri TJ, 2004, NAT REV NEUROSCI, V5, P291, DOI 10.1038/nrn1364; Palmeri TJ, 1999, PSYCHON B REV, V6, P495, DOI 10.3758/BF03210840; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; ROLLS ET, 1970, EXP BRAIN RES, V10, P298; ROSCH EH, 1973, COGNITIVE PSYCHOL, V4, P328, DOI 10.1016/0010-0285(73)90017-0; SEGER CA, ANN REV NEUROSCI, V33, P203; Smith EE, 1981, CATEGORIES CONCEPTS; Smith ML, 2007, NEUROIMAGE, V37, P974, DOI 10.1016/j.neuroimage.2007.05.030; Suzuki WA, 2009, NEURON, V61, P657, DOI 10.1016/j.neuron.2009.02.008; Suzuki WA, 2009, NEURON, V61, P678, DOI 10.1016/j.neuron.2009.02.009; Ullman S, 2004, NEURAL NETWORKS, V17, P833, DOI 10.1016/j.neunet.2004.01.006; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; WERTHEIM T, 1980, AM J OPTOM PHYS OPT, V57, P915	49	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15444	10.1371/journal.pone.0015444	http://dx.doi.org/10.1371/journal.pone.0015444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124837	Green Published, Green Submitted, gold			2022-12-25	WOS:000284572000027
J	Okeke, IN; Wallace-Gadsden, F; Simons, HR; Matthews, N; Labar, AS; Hwang, J; Wain, J				Okeke, Iruka N.; Wallace-Gadsden, Faith; Simons, Hannah R.; Matthews, Nicholas; Labar, Amy S.; Hwang, Jennifer; Wain, John			Multi-Locus Sequence Typing of Enteroaggregative Escherichia coli Isolates from Nigerian Children Uncovers Multiple Lineages	PLOS ONE			English	Article							CLONAL GROUP; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; PATHOGENICITY ISLAND; SHIGELLA-FLEXNERI; VIRULENCE; STRAINS; ADHERENCE; DIARRHEA; PLASMID	Background: Enteroaggregative Escherichia coli (EAEC) are defined by their stacked-brick adherence pattern to human epithelial cells. There is no all-encompassing genetic marker for EAEC. The category is commonly implicated in diarrhea but research is hampered by perplexing heterogeneity. Methodology/Principal Findings: To identify key EAEC lineages, we applied multilocus sequence typing to 126 E. coli isolates from a Nigerian case-control study that showed aggregative adherence in the HEp-2 adherence assay, and 24 other EAEC strains from diverse locations. EAEC largely belonged to the A, B1 and D phylogenetic groups and only 7 (4.6%) isolates were in the B2 cluster. As many as 96 sequence types (STs) were identified but 60 (40%) of the EAEC strains belong to or are double locus variants of STs 10, 31, and 394. The remainder did not belong to predominant complexes. The most common ST complex, with predicted ancestor ST10, included 32 (21.3%) of the isolates. Significant age-related distribution suggests that weaned children in Nigeria are at risk for diarrhea from of ST10-complex EAEC. Phylogenetic group D EAEC strains, predominantly from ST31- and ST394 complexes, represented 38 (25.3%) of all isolates, include genome-sequenced strain 042, and possessed conserved chromosomal loci. Conclusions/Significance: We have developed a molecular phylogenetic framework, which demonstrates that although grouped by a shared phenotype, the category of 'EAEC' encompasses multiple pathogenic lineages. Principal among isolates from Nigeria were ST10-complex EAEC that were associated with diarrhea in children over one year and ECOR D strains that share horizontally acquired loci.	[Okeke, Iruka N.; Wallace-Gadsden, Faith; Simons, Hannah R.; Labar, Amy S.; Hwang, Jennifer] Haverford Coll, Dept Biol, Haverford, PA 19041 USA; [Matthews, Nicholas; Wain, John] Wellcome Trust Sanger Inst, Cambridge, England; [Wain, John] Hlth Protect Agcy, London, England	Haverford College; Wellcome Trust Sanger Institute; Health Protection Agency	Okeke, IN (corresponding author), Haverford Coll, Dept Biol, Haverford, PA 19041 USA.	iokeke@haverford.edu	Okeke, Iruka N/N-1595-2019; Wain, John/B-3446-2013	Okeke, Iruka N/0000-0002-1694-7587; Wain, John/0000-0002-1257-1148	National Science Foundation [0516591]; Society of Science; Wellcome Trust; Howard Hughes Medical Institute; Div Of Molecular and Cellular Bioscience [0948460] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Society of Science; Wellcome Trust(Wellcome Trust); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by National Science Foundation (www.nsf.org) grant RUI #0516591, by a Branco Weiss Fellowship from the Society of Science (http://www.society-in-science.ethz.ch/) to INO and by Wellcome Trust (http://www.wellcome.ac.uk/) support to JW and NM. We thank the Howard Hughes Medical Institute for support of Haverford College undergraduate researchers FW-G and ASL (http://www.haverford.edu/kinsc/HHMI/). FW-G is also a Mellon-Mays Undergraduate Research Fellow (www.mmuf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDRY B, 1990, J INFECT DIS, V161, P1249, DOI 10.1093/infdis/161.6.1249; Bean DC, 2009, ANTIMICROB AGENTS CH, V53, P1088, DOI 10.1128/AAC.00800-08; Bhargava S, 2009, J BACTERIOL, V191, P4934, DOI 10.1128/JB.01831-08; Brinkley C, 2006, INFECT IMMUN, V74, P5408, DOI 10.1128/IAI.01840-05; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Cohen MB, 2005, J PEDIATR-US, V146, P54, DOI 10.1016/j.jpeds.2004.08.059; Czeczulin JR, 1999, INFECT IMMUN, V67, P2692, DOI 10.1128/IAI.67.6.2692-2699.1999; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Donnenberg MS, 2001, J CLIN INVEST, V107, P539, DOI 10.1172/JCI12404; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Dudley EG, 2006, INFECT IMMUN, V74, P2102, DOI 10.1128/IAI.74.4.2102-2114.2006; Elias WP, 2002, EPIDEMIOL INFECT, V129, P49, DOI 10.1017/S0950268802007136; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fernandez-Prada C, 1998, INFECT IMMUN, V66, P3918, DOI 10.1128/IAI.66.8.3918-3924.1998; Gassama A, 2004, MICROB DRUG RESIST, V10, P27, DOI 10.1089/107662904323047763; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Guerrant RL, 2005, CLIN INFECT DIS, V41, pS524, DOI 10.1086/432946; Harrington SM, 2006, FEMS MICROBIOL LETT, V254, P12, DOI 10.1111/j.1574-6968.2005.00005.x; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Huang DB, 2006, J MED MICROBIOL, V55, P1303, DOI 10.1099/jmm.0.46674-0; Huang DB, 2006, CLIN INFECT DIS, V43, P556, DOI 10.1086/505869; Hwang J, 2010, INFECT IMMUN, V78, P4068, DOI 10.1128/IAI.00014-10; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546, DOI 10.1128/JCM.35.10.2546-2550.1997; Jenkins C, 2005, FEMS MICROBIOL LETT, V253, P119, DOI 10.1016/j.femsle.2005.09.040; Jenkins C, 2006, J MED MICROBIOL, V55, P1493, DOI 10.1099/jmm.0.46683-0; Jiang ZD, 2003, J INFECT DIS, V188, P506, DOI 10.1086/377102; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Joo LM, 2007, J BACTERIOL, V189, P3793, DOI 10.1128/JB.01764-06; Jun L, 2002, PLASMID, V48, P24, DOI 10.1016/S0147-619X(02)00007-0; Kahali S, 2004, J CLIN MICROBIOL, V42, P4111, DOI 10.1128/JCM.42.9.4111-4120.2004; Lacher DW, 2007, J BACTERIOL, V189, P342, DOI 10.1128/JB.01472-06; Lang P, 2010, APPL ENVIRON MICROB, V76, P1913, DOI 10.1128/AEM.01753-09; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Lescat M, 2009, ANTIMICROB AGENTS CH, V53, P2283, DOI 10.1128/AAC.00123-09; Luck SN, 2004, J BACTERIOL, V186, P5551, DOI 10.1128/JB.186.16.5551-5554.2004; MATHEWSON JJ, 1986, J INFECT DIS, V154, P524, DOI 10.1093/infdis/154.3.524; Arancibia EM, 2009, J ANTIMICROB CHEMOTH, V64, P343, DOI 10.1093/jac/dkp178; Mendez-Arancibia E, 2008, AM J TROP MED HYG, V78, P985, DOI 10.4269/ajtmh.2008.78.985; Nataro JP, 2006, EMERG INFECT DIS, V12, P696, DOI 10.3201/eid1204.060125; Nataro JP, 2005, CURR OPIN GASTROEN, V21, P4; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; *NCCLS, 1990, M7A4 NCCLS; Okeke I N, 2001, Lancet Infect Dis, V1, P304, DOI 10.1016/S1473-3099(01)00144-X; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; Okeke IN, 2004, J CLIN MICROBIOL, V42, P36, DOI 10.1128/JCM.42.1.36-44.2004; Okeke IN, 2003, J CLIN MICROBIOL, V41, P4525, DOI 10.1128/JCM.41.10.4525-4530.2003; Okeke IN, 2002, J CLIN MICROBIOL, V40, P301, DOI 10.1128/JCM.40.1.301-305.2002; Okeke IN, 2000, J CLIN MICROBIOL, V38, P7; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parks AR, 2009, PLASMID, V61, P1, DOI 10.1016/j.plasmid.2008.09.008; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Regua-Mangia AH, 2009, J MED MICROBIOL, V58, P414, DOI 10.1099/jmm.0.006502-0; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Robinson DA, 2010, BACTERIAL POPULATION; SAADI S, 1987, J BACTERIOL, V169, P1836, DOI 10.1128/jb.169.5.1836-1846.1987; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Sheikh J, 2001, MOL MICROBIOL, V41, P983, DOI 10.1046/j.1365-2958.2001.02512.x; Sheikh J, 2006, MOL MICROBIOL, V61, P338, DOI 10.1111/j.1365-2958.2006.05234.x; SIMONSEN CC, 1983, J BACTERIOL, V155, P1001, DOI 10.1128/JB.155.3.1001-1008.1983; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; SUNDSTROM L, 1988, MOL GEN GENET, V213, P191, DOI 10.1007/BF00339581; Tartof SY, 2005, J CLIN MICROBIOL, V43, P5860, DOI 10.1128/JCM.43.12.5860-5864.2005; Tobe T, 1999, INFECT IMMUN, V67, P5455, DOI 10.1128/IAI.67.10.5455-5462.1999; Tompkins D S, 1999, Commun Dis Public Health, V2, P108; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Vila J, 1999, ANTIMICROB AGENTS CH, V43, P3022, DOI 10.1128/AAC.43.12.3022; Wallace-Gadsden F, 2007, EMERG INFECT DIS, V13, P757, DOI 10.3201/eid1305.061057; WEST A, 2005, DNA SEQUENCING OPTIM, pR29; Whittam TS, 1996, REV MICROBIOL, V27, P7; Wirth T, 2007, GENOME RES, V17, P1647, DOI 10.1101/gr.6122607; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; YAMAMOTO T, 1992, J INFECT DIS, V165, P744, DOI 10.1093/infdis/165.4.744	84	64	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14093	10.1371/journal.pone.0014093	http://dx.doi.org/10.1371/journal.pone.0014093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124856	Green Published, gold, Green Submitted			2022-12-25	WOS:000284527900008
J	Bell, CG; Finer, S; Lindgren, CM; Wilson, GA; Rakyan, VK; Teschendorff, AE; Akan, P; Stupka, E; Down, TA; Prokopenko, I; Morison, IM; Mill, J; Pidsley, R; Deloukas, P; Frayling, TM; Hattersley, AT; McCarthy, MI; Beck, S; Hitman, GA				Bell, Christopher G.; Finer, Sarah; Lindgren, Cecilia M.; Wilson, Gareth A.; Rakyan, Vardhman K.; Teschendorff, Andrew E.; Akan, Pelin; Stupka, Elia; Down, Thomas A.; Prokopenko, Inga; Morison, Ian M.; Mill, Jonathan; Pidsley, Ruth; Deloukas, Panos; Frayling, Timothy M.; Hattersley, Andrew T.; McCarthy, Mark I.; Beck, Stephan; Hitman, Graham A.		Int Type 2 Diabet 1q Consortium	Integrated Genetic and Epigenetic Analysis Identifies Haplotype-Specific Methylation in the FTO Type 2 Diabetes and Obesity Susceptibility Locus	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; HISTONE MODIFICATIONS; TESTING ASSOCIATION; POSITIVE SELECTION; VARIANTS; IMPACT; RISK; EPIGENOMICS; NUCLEOTIDE	Recent multi-dimensional approaches to the study of complex disease have revealed powerful insights into how genetic and epigenetic factors may underlie their aetiopathogenesis. We examined genotype-epigenotype interactions in the context of Type 2 Diabetes (T2D), focussing on known regions of genomic susceptibility. We assayed DNA methylation in 60 females, stratified according to disease susceptibility haplotype using previously identified association loci. CpG methylation was assessed using methylated DNA immunoprecipitation on a targeted array (MeDIP-chip) and absolute methylation values were estimated using a Bayesian algorithm (BATMAN). Absolute methylation levels were quantified across LD blocks, and we identified increased DNA methylation on the FTO obesity susceptibility haplotype, tagged by the rs8050136 risk allele A (p = 9.40 x 10(-4), permutation p = 1.0 x 10(-3)). Further analysis across the 46 kb LD block using sliding windows localised the most significant difference to be within a 7.7 kb region (p = 1.13 x 10(-7)). Sequence level analysis, followed by pyrosequencing validation, revealed that the methylation difference was driven by the co-ordinated phase of CpG-creating SNPs across the risk haplotype. This 7.7 kb region of haplotype-specific methylation (HSM), encapsulates a Highly Conserved Non-Coding Element (HCNE) that has previously been validated as a long-range enhancer, supported by the histone H3K4me1 enhancer signature. This study demonstrates that integration of Genome-Wide Association (GWA) SNP and epigenomic DNA methylation data can identify potential novel genotype-epigenotype interactions within disease-associated loci, thus providing a novel route to aid unravelling common complex diseases.	[Bell, Christopher G.; Wilson, Gareth A.; Teschendorff, Andrew E.; Stupka, Elia; Beck, Stephan] UCL, UCL Canc Inst, London, England; [Finer, Sarah; Rakyan, Vardhman K.; Stupka, Elia; Hitman, Graham A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England; [Lindgren, Cecilia M.; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Akan, Pelin; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Down, Thomas A.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Down, Thomas A.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Morison, Ian M.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand; [Mill, Jonathan; Pidsley, Ruth] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Frayling, Timothy M.; Hattersley, Andrew T.] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England	University of London; University College London; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Otago; University of London; King's College London; University of Exeter	Bell, CG (corresponding author), UCL, UCL Canc Inst, London, England.	christopher.bell@ucl.ac.uk	Stupka, Elia/J-6279-2012; Mill, Jonathan S/B-3276-2010; Mill, Jonathan/B-5678-2014; Bell, Christopher/C-1585-2008; Pidsley, Ruth E/D-8127-2012; Deloukas, Panos/B-2922-2013; Leslie, Richard/AAF-6977-2020; Morison, Ian M/A-1236-2008; Prokopenko, Inga/AAU-9895-2020; Pidsley, Ruth/B-2540-2013; Prokopenko, Inga/H-3241-2014; Sahlen, Pelin/AAJ-1824-2021; McCarthy, Mark/M-3763-2015	Stupka, Elia/0000-0003-3154-4011; Mill, Jonathan S/0000-0003-1115-3224; Mill, Jonathan/0000-0003-1115-3224; Bell, Christopher/0000-0003-4601-1242; Deloukas, Panos/0000-0001-9251-070X; Leslie, Richard/0000-0002-1786-1531; Morison, Ian M/0000-0003-3616-0025; Prokopenko, Inga/0000-0003-1624-7457; McCarthy, Mark/0000-0002-4393-0510; Finer, Sarah/0000-0002-2684-4653; Hattersley, Andrew/0000-0001-5620-473X; Lindgren, Cecilia/0000-0002-4903-9374; Pidsley, Ruth/0000-0002-1386-1374	Wellcome Trust [084071, WT086596/Z/08/Z]; Heller Research Fellowship; Medical Research Council; Barts and the London Charity; NIDDK [DK-073490]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073490] Funding Source: NIH RePORTER; Medical Research Council [G0800441] Funding Source: researchfish; National Institute for Health Research [ACF-2006-19-002] Funding Source: researchfish; MRC [G0800441] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Heller Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Barts and the London Charity; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CGB and SB were funded by the Wellcome Trust (084071). AET was supported by a Heller Research Fellowship. CML is funded by WT086596/Z/08/Z (Wellcome Trust Research Career Development Fellowship). SF was funded by the Medical Research Council and Barts and the London Charity. Additional funding was from NIDDK (DK-073490).	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Arndt PF, 2003, MOL BIOL EVOL, V20, P1887, DOI 10.1093/molbev/msg204; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck-Nielsen H, 2003, BEST PRACT RES CL EN, V17, P445, DOI 10.1016/S1521-690X(03)00041-1; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Caqueret A, 2006, DEV BIOL, V298, P95, DOI 10.1016/j.ydbio.2006.06.019; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glaser RL, 2006, NUCLEIC ACIDS RES, V34, pD29, DOI 10.1093/nar/gkj101; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jowett JBM, 2010, DIABETES, V59, P726, DOI 10.2337/db09-1277; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; McCarthy MI, 2008, HUM MOL GENET, V17, pR100, DOI 10.1093/hmg/ddn298; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Murrell A, 2005, HUM MOL GENET, V14, pR3, DOI 10.1093/hmg/ddi110; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Rakyan VK, 2006, CURR OPIN GENET DEV, V16, P573, DOI 10.1016/j.gde.2006.09.002; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Walser JC, 2008, GENOME RES, V18, P1403, DOI 10.1101/gr.076455.108; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zeggini E, 2006, DIABETES, V55, pA83; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; Zheng M, 2007, BIOMETRICS, V63, P787, DOI 10.1111/j.1541-0420.2007.00768.x	79	178	188	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14040	10.1371/journal.pone.0014040	http://dx.doi.org/10.1371/journal.pone.0014040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124985	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000284356900004
J	Thiemann, C; Theis, F; Grady, D; Brune, R; Brockmann, D				Thiemann, Christian; Theis, Fabian; Grady, Daniel; Brune, Rafael; Brockmann, Dirk			The Structure of Borders in a Small World	PLOS ONE			English	Article							COMMUNITY STRUCTURE; DYNAMICS; NETWORK; TECHNOLOGY; EPIDEMICS; INFLUENZA	Territorial subdivisions and geographic borders are essential for understanding phenomena in sociology, political science, history, and economics. They influence the interregional flow of information and cross-border trade and affect the diffusion of innovation and technology. However, it is unclear if existing administrative subdivisions that typically evolved decades ago still reflect the most plausible organizational structure of today. The complexity of modern human communication, the ease of long-distance movement, and increased interaction across political borders complicate the operational definition and assessment of geographic borders that optimally reflect the multi-scale nature of today's human connectivity patterns. What border structures emerge directly from the interplay of scales in human interactions is an open question. Based on a massive proxy dataset, we analyze a multi-scale human mobility network and compute effective geographic borders inherent to human mobility patterns in the United States. We propose two computational techniques for extracting these borders and for quantifying their strength. We find that effective borders only partially overlap with existing administrative borders, and show that some of the strongest mobility borders exist in unexpected regions. We show that the observed structures cannot be generated by gravity models for human traffic. Finally, we introduce the concept of link significance that clarifies the observed structure of effective borders. Our approach represents a novel type of quantitative, comparative analysis framework for spatially embedded multi-scale interaction networks in general and may yield important insight into a multitude of spatiotemporal phenomena generated by human activity.	[Thiemann, Christian; Grady, Daniel; Brune, Rafael; Brockmann, Dirk] Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; [Thiemann, Christian; Brune, Rafael] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Theis, Fabian] Helmholtz Ctr Munich, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Theis, Fabian] Univ Technol Munich, Dept Math, Garching, Germany; [Brockmann, Dirk] NW Inst Complex Syst, Evanston, IL USA	Northwestern University; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Thiemann, C (corresponding author), Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA.	brockmann@northwestern.edu	Brockmann, Dirk A/B-7342-2009; Theis, Fabian J/ABD-5212-2021; Grady, Daniel/E-9789-2015	Theis, Fabian J/0000-0002-2419-1943; Grady, Daniel/0000-0002-2446-2096	Helmholtz Alliance on Systems Biology; Volkswagen Foundation; EU	Helmholtz Alliance on Systems Biology; Volkswagen Foundation(Volkswagen); EU(European Commission)	F.T. acknowledges financial support by the Helmholtz Alliance on Systems Biology (project "CoReNe''). D. B. acknowledges support from the Volkswagen Foundation and EU-FP7 grant Epiwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1979, AM ECON REV, V69, P106; [Anonymous], [No title captured]; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockmann D, 2008, IEEE PERVAS COMPUT, V7, P28, DOI 10.1109/MPRV.2008.77; Buzna L, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056107; COCHRANE RA, 1975, J TRANSP ECON POLICY, V9, P34; Colizza V, 2006, B MATH BIOL, V68, P1893, DOI 10.1007/s11538-006-9077-9; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eaton J, 2002, ECONOMETRICA, V70, P1741, DOI 10.1111/1468-0262.00352; Ernst D, 2002, RES POLICY, V31, P1417, DOI 10.1016/S0048-7333(02)00072-0; Everitt B. S., 2001, CLUSTER ANAL; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Keller W, 2004, J ECON LIT, V42, P752, DOI 10.1257/0022051042177685; Labov W., 2006, PHONOLOGY SOUND CHAN; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Lloyd AL, 2004, MATH BIOSCI, V188, P1, DOI 10.1016/j.mbs.2003.09.003; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	34	113	117	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e15422	10.1371/journal.pone.0015422	http://dx.doi.org/10.1371/journal.pone.0015422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	681XH	21124970	Green Submitted, Green Published, gold			2022-12-25	WOS:000284356900017
J	Tato, I; Bartrons, R; Ventura, F; Rosa, JL				Tato, Irantzu; Bartrons, Ramon; Ventura, Francesc; Luis Rosa, Jose			Amino Acids Activate Mammalian Target of Rapamycin Complex 2 (mTORC2) via PI3K/Akt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; MUSCLE PROTEIN-SYNTHESIS; FOXO TRANSCRIPTION FACTORS; ISOLATED RAT HEPATOCYTES; CELL-SURVIVAL; LIFE-SPAN; PHOSPHOINOSITIDE 3-KINASE; INSULIN-RESISTANCE; COLORECTAL-CANCER; IN-VIVO	The activity of mammalian target of rapamycin (mTOR) complexes regulates essential cellular processes, such as growth, proliferation, or survival. Nutrients such as amino acids are important regulators of mTOR complex 1 (mTORC1) activation, thus affecting cell growth, protein synthesis, and autophagy. Here, we show that amino acids may also activate mTOR complex 2 (mTORC2). This activation is mediated by the activity of class I PI3K and of Akt. Amino acids induced a rapid phosphorylation of Akt at Thr-308 and Ser-473. Whereas both phosphorylations were dependent on the presence of mTOR, only Akt phosphorylation at Ser-473 was dependent on the presence of rictor, a specific component of mTORC2. Kinase assays confirmed mTORC2 activation by amino acids. This signaling was functional, as demonstrated by the phosphorylation of Akt substrate FOXO3a. Interestingly, using different starvation conditions, amino acids can selectively activate mTORC1 or mTORC2. These findings identify a new signaling pathway used by amino acids underscoring the crucial importance of these nutrients in cell metabolism and offering new mechanistic insights.	[Tato, Irantzu; Bartrons, Ramon; Ventura, Francesc; Luis Rosa, Jose] Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Dept Ciencies Fisiol 2, E-08907 Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Rosa, JL (corresponding author), Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Dept Ciencies Fisiol 2, Campus Bellvitge, E-08907 Barcelona, Spain.	joseluisrosa@ub.edu	Ventura, Francesc/ABG-2285-2020; Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Bartrons, Ramon/0000-0001-9349-5847	Ministerio de Educacion y Ciencia (MEC) [BFU2008-02084/BMC]; Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud [RD06/0020]; Generalitat de Catalunya [2009SGR1059]; Juan de la Cierva Program	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); Juan de la Cierva Program	This work was supported in part by Ministerio de Educacion y Ciencia (MEC) Grant BFU2008-02084/BMC, Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud Grant RD06/0020 and Generalitat de Catalunya Grant 2009SGR1059.; Supported by the Juan de la Cierva Program.	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Billottet C, 2006, ONCOGENE, V25, P6648, DOI 10.1038/sj.onc.1209670; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Campbell LE, 1999, BIOCHEM J, V344, P433, DOI 10.1042/0264-6021:3440433; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Casas-Terradellas E, 2006, ELECTROPHORESIS, V27, P3935, DOI 10.1002/elps.200600141; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1374, DOI 10.1152/japplphysiol.91397.2008; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Krebs M, 2005, EUR J CLIN INVEST, V35, P351, DOI 10.1111/j.1365-2362.2005.01506.x; Kritchevsky D, 2001, J NUTR SCI VITAMINOL, V47, P13, DOI 10.3177/jnsv.47.13; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Mrkonjic M, 2009, BRIT J CANCER, V100, P1966, DOI 10.1038/sj.bjc.6605097; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Ruckle T, 2004, J MED CHEM, V47, P6921, DOI 10.1021/jm031112e; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Sadhu C, 2003, BIOCHEM BIOPH RES CO, V308, P764, DOI 10.1016/S0006-291X(03)01480-3; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Thompson HJ, 2003, J MAMMARY GLAND BIOL, V8, P133, DOI 10.1023/A:1025743607445; Toden S, 2007, CARCINOGENESIS, V28, P2355, DOI 10.1093/carcin/bgm216; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao L, 2010, CELL DEATH DIFFER, V17, P1448, DOI 10.1038/cdd.2010.16; Yamaoka I, 2009, BIOCHEM BIOPH RES CO, V386, P252, DOI 10.1016/j.bbrc.2009.06.031; Yoshizawa F, 2004, BIOCHEM BIOPH RES CO, V313, P417, DOI 10.1016/j.bbrc.2003.07.013; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	87	128	133	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6128	6142		10.1074/jbc.M110.166991	http://dx.doi.org/10.1074/jbc.M110.166991			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21131356	hybrid, Green Published			2022-12-25	WOS:000287476400022
J	Zaferani, A; Vives, RR; van der Pol, P; Hakvoort, JJ; Navis, GJ; van Goor, H; Daha, MR; Lortat-Jacob, H; Seelen, MA; van den Born, J				Zaferani, Azadeh; Vives, Romain R.; van der Pol, Pieter; Hakvoort, Jelleke J.; Navis, Gerjan J.; van Goor, Harry; Daha, Mohamed R.; Lortat-Jacob, Hugues; Seelen, Marc A.; van den Born, Jacob			Identification of Tubular Heparan Sulfate as a Docking Platform for the Alternative Complement Component Properdin in Proteinuric Renal Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULES; BRUSH-BORDER; TUBULOINTERSTITIAL INJURY; PATHWAY ACTIVATION; BINDING; CELLS; PROTEOGLYCANS; DAMAGE; KIDNEY; GLYCOSAMINOGLYCANS	Properdin binds to proximal tubular epithelial cells (PTEC) and activates the complement system via the alternative pathway in vitro. Cellular ligands for properdin in the kidney have not yet been identified. Because properdin interacts with solid-phase heparin, we investigated whether heparan sulfate proteoglycans (HSPG) could be the physiological ligands of properdin. Kidneys from proteinuric rats showed colocalization of syndecan-1, a major epithelial HSPG, and properdin in the apical membranes of PTEC, which was not seen in control renal tissue. In vitro, PTEC did not constitutively express properdin. However, exogenous properdin binds to these cells in a dose-dependent fashion. Properdin binding was prevented by heparitinase pretreatment of the cells and was dose-dependently inhibited by exogenous heparin. ELISA and surface plasmon resonance spectroscopy (BIAcore) showed a strong dose-dependent interaction between heparan sulfate (HS) and properdin (K-d = 128 nM). Pretreatment of HSPG with heparitinase abolished this interaction in ELISA. Competition assays, using a library of HS-like polysaccharides, showed that sulfation pattern, chain length, and backbone composition determine the interaction of properdin with glycosaminogly-cans. Interestingly, two nonanticoagulant heparin derivatives inhibited properdin-HS interaction in ELISA and BIAcore. Incubation of PTEC with human serum as complement source led to complement activation and deposition of C3 on the cells. This C3 deposition is dependent on the binding of properdin to HS as shown by heparitinase pretreatment of the cells. Our data identify tubular HS as a novel docking platform for alternative pathway activation via properdin, which might play a role in proteinuric renal damage. Our study also suggests nonanticoagulant heparinoids may provide renoprotection in complement-dependent renal diseases.	[Zaferani, Azadeh; Hakvoort, Jelleke J.; Navis, Gerjan J.; Daha, Mohamed R.; Seelen, Marc A.; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 GZ Groningen, Netherlands; [Vives, Romain R.; Lortat-Jacob, Hugues] Univ Grenoble, Inst Biol Struct, F-38027 Grenoble, France; [van der Pol, Pieter; Daha, Mohamed R.] Leiden Univ, Dept Nephrol, NL-2300 RC Leiden, Netherlands; [van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, NL-9713 GZ Groningen, Netherlands	University of Groningen; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Leiden University; Leiden University - Excl LUMC; University of Groningen	Zaferani, A (corresponding author), Expt Nephrol Lab, Antonius Deusinglaan 1,Fb-20, NL-9713 AV Groningen, Netherlands.	a.zaferani@med.umcg.nl	Vives, Romain/I-9372-2012; van+Goor, Harry/AAS-7712-2020	van Goor, Harry/0000-0002-6670-1577	Dutch Kidney Foundation [NSN C03-6014]	Dutch Kidney Foundation	This work was supported by Dutch Kidney Foundation Grant NSN C03-6014.	BIANCONE L, 1994, KIDNEY INT, V45, P451, DOI 10.1038/ki.1994.59; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Buelli S, 2009, KIDNEY INT, V75, P1050, DOI 10.1038/ki.2009.8; Burg M, 1997, LAB INVEST, V76, P505; CAMUSSI G, 1985, CLIN NEPHROL, V23, P134; CAMUSSI G, 1982, J IMMUNOL, V128, P1659; CAMUSSI G, 1983, ANN NY ACAD SCI, V420, P321, DOI 10.1111/j.1749-6632.1983.tb22219.x; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Celie JWAM, 2008, AM J PHYSIOL-RENAL, V294, pF253, DOI 10.1152/ajprenal.00429.2007; Ceol M, 2003, J NEPHROL, V16, P210; Ceol M, 2000, J AM SOC NEPHROL, V11, P2324, DOI 10.1681/ASN.V11122324; DANISHEF.V, 1965, BIOCHIM BIOPHYS ACTA, V101, P37; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FARRIES TC, 1988, BIOCHEM J, V252, P47, DOI 10.1042/bj2520047; Gaarkeuken H, 2008, AM J PHYSIOL-RENAL, V295, pF1397, DOI 10.1152/ajprenal.90313.2008; Gottmann U, 2007, TRANSPL INT, V20, P542, DOI 10.1111/j.1432-2277.2007.00471.x; Gradowska Liliana, 1993, Archivum Immunologiae et Therapiae Experimentalis, V41, P133; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hsu SIH, 2003, J AM SOC NEPHROL, V14, pS186, DOI 10.1097/01.ASN.0000070032.58017.20; IVERIUS PH, 1971, BIOCHEM J, V124, P677, DOI 10.1042/bj1240677; JACOBSSON I, 1979, J BIOL CHEM, V254, P2975; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Kemper C, 2008, MOL IMMUNOL, V45, P4048, DOI 10.1016/j.molimm.2008.06.034; Kimura Y, 2008, BLOOD, V111, P732, DOI 10.1182/blood-2007-05-089821; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Matsuo S, 1998, NEPHROL DIAL TRANSPL, V13, P2723, DOI 10.1093/ndt/13.11.2723; Morita Y, 1997, J AM SOC NEPHROL, V8, P1363; MURATA K, 1975, CLIN CHIM ACTA, V63, P157; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; REJ RN, 1991, CARBOHYD RES, V210, P299, DOI 10.1016/0008-6215(91)80130-F; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Rook M, 2005, NEPHROL DIAL TRANSPL, V20, P59, DOI 10.1093/ndt/gfh579; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; Sheerin NS, 1999, KIDNEY BLOOD PRESS R, V22, P47, DOI 10.1159/000025908; Siezenga MA, 2010, NEPHROL DIAL TRANSPL, V25, P1157, DOI 10.1093/ndt/gfp630; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Striker GE, 1997, KIDNEY INT, pS120; Tang S, 2002, KIDNEY BLOOD PRESS R, V25, P120, DOI 10.1159/000063520; van Timmeren MM, 2006, AM J PHYSIOL-RENAL, V291, pF456, DOI 10.1152/ajprenal.00403.2005; vanBruggen MCJ, 1996, KIDNEY INT, V50, P1555, DOI 10.1038/ki.1996.471; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Wang JG, 2002, INFLAMM RES, V51, P435, DOI 10.1007/PL00012403; WEILER JM, 1992, J IMMUNOL, V148, P3210; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Yu HN, 2005, BBA-GEN SUBJECTS, V1726, P168, DOI 10.1016/j.bbagen.2005.08.003; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9	50	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5359	5367		10.1074/jbc.M110.167825	http://dx.doi.org/10.1074/jbc.M110.167825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135110	hybrid, Green Published			2022-12-25	WOS:000287230600044
J	Li, DJ; D'Angelo, L; Chavez, M; Woulfe, DS				Li, Dongjun; D'Angelo, Lauren; Chavez, Massiel; Woulfe, Donna S.			Arrestin-2 Differentially Regulates PAR4 and ADP Receptor Signaling in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT PHOSPHORYLATION; BETA-ARRESTINS; ACTIVATION; SRC; MICE; AGGREGATION; THROMBIN; KINASE; PATHWAYS; ROLES	Arrestins can facilitate desensitization or signaling by G protein-coupled receptors (GPCR) in many cells, but their roles in platelets remain uncharacterized. Because of recent reports that arrestins can serve as scaffolds to recruit phosphatidylinositol-3 kinases (PI3K)s to GPCRs, we sought to determine whether arrestins regulate PI3K-dependent Akt signaling in platelets, with consequences for thrombosis. Co-immuno-precipitation experiments demonstrate that arrestin-2 associates with p85 PI3K alpha/beta subunits in thrombin-stimulated platelets, but not resting cells. The association is inhibited by inhibitors of P2Y12 and Src family kinases (SFKs). The function of arrestin-2 in platelets is agonist-specific, as PAR4-dependent Akt phosphorylation and fibrinogen binding were reduced in arrestin-2 knock-out platelets compared with WT controls, but ADP-stimulated signaling to Akt and fibrinogen binding were unaffected. ADP receptors regulate arrestin recruitment to PAR4, because co-immunoprecipitates of arrestin-2 with PAR4 are disrupted by inhibitors of P2Y1 or P2Y12. P2Y1 may regulate arrestin-2 recruitment to PAR4 through protein kinase C (PKC) activation, whereas P2Y12 directly interacts with PAR4 and therefore, may help to recruit arrestin-2 to PAR4. Finally, arrestin2(-/-) mice are less sensitive to ferric chloride-induced thrombosis than WT mice, suggesting that arrestin-2 can regulate thrombus formation in vivo. In conclusion, arrestin-2 regulates PAR4-dependent signaling pathways, but not responses to ADP alone, and contributes to thrombus formation in vivo.	[Li, Dongjun; D'Angelo, Lauren; Chavez, Massiel; Woulfe, Donna S.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	University of Delaware	Woulfe, DS (corresponding author), Univ Delaware, Dept Biol Sci, Rm 329 Wolf Hall,105 Green, Newark, DE 19716 USA.	dswoulfe@udel.edu			National Institutes of Health [R01 HL081241]; Pennsylvania Tobacco Formula Fund [080-37807]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Formula Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL081241 and Pennsylvania Tobacco Formula Fund Grant 080-37807.	Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; Ciccarelli M, 2007, CELL SIGNAL, V19, P1949, DOI 10.1016/j.cellsig.2007.05.007; Conner DA, 1997, CIRC RES, V81, P1021; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dittrich M, 2006, THROMB HAEMOSTASIS, V95, P643, DOI 10.1160/TH05-11-0764; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Goel R, 2004, J BIOL CHEM, V279, P6701, DOI 10.1074/jbc.M308753200; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Guidetti GF, 2008, J BIOL CHEM, V283, P28795, DOI 10.1074/jbc.M801588200; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Lodeiro M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004686; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Novi F, 2005, J BIOL CHEM, V280, P19768, DOI 10.1074/jbc.M411281200; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Small KM, 2006, BIOCHEMISTRY-US, V45, P4760, DOI 10.1021/bi052074z; TORTI M, 1992, BIOCHEM BIOPH RES CO, V186, P440, DOI 10.1016/S0006-291X(05)80827-7; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Xiang B, 2010, J THROMB HAEMOST, V8, P2032, DOI 10.1111/j.1538-7836.2010.03969.x; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561	34	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3805	3814		10.1074/jbc.M110.118018	http://dx.doi.org/10.1074/jbc.M110.118018			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106537	Green Published, hybrid			2022-12-25	WOS:000286653200062
J	Singh, K; Chaturvedi, R; Barry, DP; Coburn, LA; Asim, M; Lewis, ND; Piazuelo, MB; Washington, MK; Vitek, MP; Wilson, KT				Singh, Kshipra; Chaturvedi, Rupesh; Barry, Daniel P.; Coburn, Lori A.; Asim, Mohammad; Lewis, Nuruddeen D.; Piazuelo, M. Blanca; Washington, M. Kay; Vitek, Michael P.; Wilson, Keith T.			The Apolipoprotein E-Mimetic Peptide COG112 Inhibits NF-kappa B Signaling, Proinflammatory Cytokine Expression, and Disease Activity in Murine Models of Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CITROBACTER-RODENTIUM INFECTION; NITRIC-OXIDE SYNTHASE; INTESTINAL INFLAMMATION; CROHNS-DISEASE; TNF-ALPHA; MACROPHAGE APOPTOSIS; MONOCLONAL-ANTIBODY; ULCERATIVE-COLITIS; HOST-DEFENSE	Inflammatory bowel disease (IBD), consisting of Crohn's disease and ulcerative colitis, is a source of substantial morbidity and remains difficult to treat. New strategies for beneficial anti-inflammatory therapies would be highly desirable. Apolipoprotein (apo) E has immunomodulatory effects and synthetically derived apoE-mimetic peptides are beneficial in models of sepsis and neuroinflammation. We have reported that the antennapedia-linked apoE-mimetic peptide COG112 inhibits the inflammatory response to the colitis-inducing pathogen Citrobacter rodentium in vitro by inhibiting NF-kappa B activation. We now determined the effect of COG112 in mouse models of colitis. Using C. rodentium as an infection model, and dextran sulfate sodium (DSS) as an injury model, mice were treated with COG112 by intraperitoneal injection. With C. rodentium, COG112 improved the clinical parameters of survival, body weight, colon weight, and histologic injury. With DSS, COG112 ameliorated the loss of body weight, reduction in colon length, and histologic injury, whether administered concurrently with induction of colitis, during induction plus recovery, or only during the recovery phase of disease. In both colitis models, COG112 inhibited colon tissue inducible nitric-oxide synthase (iNOS), KC, TNF-alpha, IFN-gamma, and IL-17 mRNA expression, and reduced nuclear translocation of NF-kappa B, as determined by immunoblot and immunofluorescence confocal microscopy. I kappa B kinase (IKK) activity was also reduced, which is necessary for activation of the canonical NF-kappa B pathway. Isolated colonic epithelial cells exhibited marked attenuation of expression of iNOS and the CXC chemokines KC and MIP-2. These studies indicate that apoE-mimetic peptides such as COG112 are novel potential therapies for IBD.	[Wilson, Keith T.] Vanderbilt Univ, Sch Med, Med Ctr, Div Gastroenterol,Dept Med, Nashville, TN 37232 USA; [Washington, M. Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Lewis, Nuruddeen D.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Singh, Kshipra; Chaturvedi, Rupesh; Coburn, Lori A.; Asim, Mohammad; Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Vitek, Michael P.] Cognosci Inc, Res Triangle Pk, NC 27709 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Wilson, KT (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr, Div Gastroenterol,Dept Med, 1030C MRB IV,2215 Garland Ave, Nashville, TN 37232 USA.	keith.wilson@vanderbilt.edu	Barry, Daniel P/B-5647-2008	Barry, Daniel P/0000-0002-3972-3914; Lewis, Nuruddeen/0000-0002-1233-6607; Vitek, Michael/0000-0001-8140-8048; Wilson, Keith/0000-0003-4421-1830; Coburn, Lori/0000-0003-3249-9806	National Institutes of Health [R41DK075161, R01DK053620, R01AT004821, 3R01AT004821S1, P01CA028842, F31GM083500, T32CA009592, T32DK007673, P30DK058404]; Office of Medical Research, Dept. of Veterans Affairs; NATIONAL CANCER INSTITUTE [T32CA009592, P01CA028842] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007673, P30DK058404, R41DK075161, R01DK053620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM083500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Medical Research, Dept. of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R41DK075161 (to K. T. W. and M. P. V.), R01DK053620, R01AT004821, and 3R01AT004821S1 (to K. T. W.), P01CA028842 (to K. T. W.), F31GM083500 (to N. D. L), T32CA009592 (N. D. L.), T32DK007673 (D. P. B.), the Flow Cytometry Core, and the Cell Imaging Core of the Vanderbilt University Digestive Disease Research Center supported by National Institutes of Health Grant P30DK058404; and a Merit Review Grant from the Office of Medical Research, Dept. of Veterans Affairs (to K. T. W.).	Asim M, 2010, J BIOL CHEM, V285, P20343, DOI 10.1074/jbc.M110.116988; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Clark M, 2007, GASTROENTEROLOGY, V133, P312, DOI 10.1053/j.gastro.2007.05.006; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; D'Haens GR, 1999, ITAL J GASTROENTEROL, V31, P519; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DOMEK MJ, 1995, SCAND J GASTROENTERO, V30, P1089, DOI 10.3109/00365529509101612; Edelblum KL, 2008, GASTROENTEROLOGY, V135, P539, DOI 10.1053/j.gastro.2008.04.025; Fichtner-Feigl S, 2005, J CLIN INVEST, V115, P3057, DOI 10.1172/JCI24792; Gobert AP, 2004, J IMMUNOL, V173, P2109, DOI 10.4049/jimmunol.173.3.2109; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hacker H., 2006, SCI STKE, V13; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Hyams JS, 2000, J PEDIATR-US, V137, P192, DOI 10.1067/mpd.2000.107161; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Kim YH, 2008, INT IMMUNOPHARMACOL, V8, P1695, DOI 10.1016/j.intimp.2008.08.003; Kirman I, 2004, EUR J GASTROEN HEPAT, V16, P639, DOI 10.1097/01.meg.0000108345.41221.c2; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Laskowitz DT, 2000, J LIPID RES, V41, P613; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; McCaffery DM, 1999, GUT, V45, P864, DOI 10.1136/gut.45.6.864; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mouser JF, 1999, CLIN THER, V21, P932; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Murthy S, 1999, ALIMENT PHARM THER, V13, P251; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Present DH, 1999, ALIMENT PHARM THERAP, V13, P23, DOI 10.1046/j.1365-2036.1999.00026.x; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Shibata W, 2007, J IMMUNOL, V179, P2681, DOI 10.4049/jimmunol.179.5.2681; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033; Vallance BA, 2002, INFECT IMMUN, V70, P2070, DOI 10.1128/IAI.70.4.2070-2081.2002; Van Oosten MV, 2001, J BIOL CHEM, V276, P8820, DOI 10.1074/jbc.M009915200; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470	67	61	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3839	3850		10.1074/jbc.M110.176719	http://dx.doi.org/10.1074/jbc.M110.176719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115487	Green Published, hybrid			2022-12-25	WOS:000286653200065
J	Schwetz, TA; Norring, SA; Ednie, AR; Bennett, ES				Schwetz, Tara A.; Norring, Sarah A.; Ednie, Andrew R.; Bennett, Eric S.			Sialic Acids Attached to O-Glycans Modulate Voltage-gated Potassium Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAGAS HEART-DISEASE; U-TYPE INACTIVATION; SODIUM-CHANNEL; K+ CHANNELS; LINKED GLYCOSYLATION; CONGENITAL DISORDERS; N-GLYCOSYLATION; NA+ CHANNEL; MUCIN-TYPE; VENTRICULAR MYOCYTES	Neuronal, cardiac, and skeletal muscle action potentials are produced and conducted through the highly regulated activity of several types of voltage-gated ion channels. Voltage-gated potassium (K-v) channels are responsible for action potential repolarization. Glycans can be attached to glycoproteins through N-and O-linkages. Previous reports described the impact of N-glycans on voltage-gated ion channel function. Here, we show that sialic acids attached through O-linkages modulate gating of K(v)2.1, K(v)4.2, and K(v)4.3. The conductance-voltage (G-V) relationships for each isoform were shifted uniquely by a depolarizing 8-16 mV under conditions of reduced sialylation. The data indicate that sialic acids modulate K-v channel activation through apparent electrostatic mechanisms that promote channel activity. Voltage-dependent steady-state inactivation was unaffected by changes in sialylation. N-Linked sialic acids cannot be responsible for the G-V shifts because K(v)4.2 and K(v)4.3 cannot be N-glycosylated, and immunoblot analysis confirmed K(v)2.1 is not N-glycosylated. Glycosidase gel shift analysis suggested that K(v)2.1, K(v)4.2, and K(v)4.3 were O-glycosylated and sialylated. To confirm this, azide-modified sugar residues involved specifically in O-glycan and sialic acid biosynthesis were shown to incorporate into all three K-v channel isoforms using Cu(I)-catalyzed cycloaddition chemistry. Together, the data indicate that sialic acids attached to O-glycans uniquely modulate gating of three K-v channel isoforms that are not N-glycosylated. These data provide the first evidence that external O-glycans, with core structures distinct from N-glycans in type and number of sugar residues, can modulate K-v channel function and thereby contribute to changes in electrical signaling that result from regulated ion channel expression and/or O-glycosylation.	[Schwetz, Tara A.; Norring, Sarah A.; Ednie, Andrew R.; Bennett, Eric S.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Bennett, Eric S.] Univ S Florida, Coll Med, Program Neurosci, Tampa, FL 33612 USA; [Bennett, Eric S.] Univ S Florida, Coll Med, Program Cardiovasc Sci, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Bennett, ES (corresponding author), Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, 12901 Bruce B Downs Blvd,MDC 8, Tampa, FL 33612 USA.	esbennet@health.usf.edu			American Heart Association; James and Esther King Biomedical Research Program	American Heart Association(American Heart Association); James and Esther King Biomedical Research Program	This work was supported by an American Heart Association predoctoral fellowship (to T. A. S.), an American Heart Association grant-in-aid (to E. S. B.), and Bridge and Challenge grants from the James and Esther King Biomedical Research Program (to E. S. B.).	Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Bennett ES, 2002, J PHYSIOL-LONDON, V538, P675, DOI 10.1113/jphysiol.2001.013285; Bertil H., 2001, ION CHANNELS EXCITAB; Bocksteins E, 2009, AM J PHYSIOL-CELL PH, V296, pC1271, DOI 10.1152/ajpcell.00088.2009; Bustamante JM, 2005, INT J CARDIOL, V102, P211, DOI 10.1016/j.ijcard.2004.05.014; Cerbai E, 1996, CIRCULATION, V94, P1674, DOI 10.1161/01.CIR.94.7.1674; Clancy CE, 2005, PHYSIOL REV, V85, P33, DOI 10.1152/physrev.00005.2004; Colbert CM, 1999, J NEUROSCI, V19, P8163; Dai XQ, 2009, J CELL SCI, V122, P775, DOI 10.1242/jcs.036632; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Higuchi MD, 2003, CARDIOVASC RES, V60, P96, DOI 10.1016/S0008-6363(03)00361-4; HILLE B, 1975, J PHYSIOL-LONDON, V250, pP34; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Johnson D, 2004, J BIOL CHEM, V279, P44303, DOI 10.1074/jbc.M408900200; Johnson D, 2008, PFLUG ARCH EUR J PHY, V456, P393, DOI 10.1007/s00424-007-0378-0; Johnson D, 2006, J BIOL CHEM, V281, P25875, DOI 10.1074/jbc.M605060200; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Klemic KG, 2001, BIOPHYS J, V81, P814, DOI 10.1016/S0006-3495(01)75743-8; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kranz C, 2007, AM J MED GENET A, V143A, P1371, DOI 10.1002/ajmg.a.31791; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Laughlin ST, 2006, METHOD ENZYMOL, V415, P230, DOI 10.1016/S0076-6879(06)15015-6; Leroy JG, 2006, PEDIATR RES, V60, P643, DOI 10.1203/01.pdr.0000246802.57692.ea; LIBBY P, 1986, J CLIN INVEST, V77, P127, DOI 10.1172/JCI112266; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lvov A, 2009, J BIOL CHEM, V284, P28276, DOI 10.1074/jbc.M109.028761; MAGUIRE JH, 1987, CIRCULATION, V75, P1140, DOI 10.1161/01.CIR.75.6.1140; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martinez-Duncker I, 2005, BLOOD, V105, P2671, DOI 10.1182/blood-2004-09-3509; McEwen DP, 2008, MOL PHARMACOL, V73, P678, DOI 10.1124/mol.107.042093; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Plotnikov AN, 2004, CIRCULATION, V110, P489, DOI 10.1161/01.CIR.0000137823.64947.52; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Schwetz TA, 2010, BBA-BIOMEMBRANES, V1798, P367, DOI 10.1016/j.bbamem.2009.11.018; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; SHI GY, 1994, J BIOL CHEM, V269, P23204; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Sternick EB, 2006, J CARDIOVASC ELECTR, V17, P113, DOI 10.1111/j.1540-8167.2005.00315.x; Stocker PJ, 2006, J GEN PHYSIOL, V127, P253, DOI 10.1085/jgp.200509423; Thornhill WB, 1996, J BIOL CHEM, V271, P19093, DOI 10.1074/jbc.271.32.19093; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Ufret-Vincenty CA, 2001, AM J PHYSIOL-CELL PH, V281, pC464, DOI 10.1152/ajpcell.2001.281.2.C464; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; Yacoub S, 2008, HEART, V94, P244, DOI 10.1136/hrt.2007.132316; Yoshida M, 2010, BIOCHEM BIOPH RES CO, V396, P304, DOI 10.1016/j.bbrc.2010.04.088; Yoshida M, 2009, FEBS LETT, V583, P2225, DOI 10.1016/j.febslet.2009.05.050; ZHANG JF, 1992, NEURON, V9, P97, DOI 10.1016/0896-6273(92)90224-2; Zhu J, 2003, BIOCHEM J, V375, P769, DOI 10.1042/BJ20030517	66	36	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4123	4132		10.1074/jbc.M110.171322	http://dx.doi.org/10.1074/jbc.M110.171322			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115483	Green Published, hybrid			2022-12-25	WOS:000286975700011
J	Thompson, MG; Foley, DA; Swartzentruber, KG; Colley, KJ				Thompson, Matthew G.; Foley, Deirdre A.; Swartzentruber, Kristin G.; Colley, Karen J.			Sequences at the Interface of the Fifth Immunoglobulin Domain and First Fibronectin Type III Repeat of the Neural Cell Adhesion Molecule Are Critical for Its Polysialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID SYNTHASE; NERVOUS-SYSTEM; HUMAN POLYSIALYLTRANSFERASE; GLYCAN POLYSIALYLATION; BRAIN-DEVELOPMENT; WILMS TUMOR; RAT-BRAIN; ST8SIA II; N-CAM; NCAM	Polysialic acid is an anti-adhesive glycan that modifies a select group of mammalian proteins. The primary substrate of the polysialyltransferases (polySTs) is the neural cell adhesion molecule (NCAM). Polysialic acid negatively regulates cell adhesion, is required for proper brain development, and is expressed in specific areas of the adult brain where it promotes on-going cell migration and synaptic plasticity. The first fibronectin type III repeat (FN1) of NCAM is required for polysialylation of the N-glycans on the adjacent immunoglobulin-like domain (Ig5), and acidic residues on the surface of FN1 play a role in polyST recognition. Recent work demonstrated that the FN1 domain from the unpolysialylated olfactory cell adhesion molecule (OCAM) was able to partially replace NCAM FN1 (Foley, D. A., Swartzentruber, K. G., Thompson, M. G., Mendiratta, S. S., and Colley, K. J. (2010) J. Biol. Chem. 285, 35056-35067). Here we demonstrate that individually replacing three identical regions shared by NCAM and OCAM FN1, (PSSP503)-P-500 (PSSP), (526)GGVPI(530) (GGVPI), and (580)NGKG(583) (NGKG), dramatically reduces NCAM polysialylation. In addition, we show that the polyST, ST8SiaIV/PST, specifically binds NCAM and that this binding requires the FN1 domain. Replacing the FN1 PSSP sequences and the acidic patch residues decreases NCAM-polyST binding, whereas replacing the GGVPI and NGKG sequences has no effect. The location of GGVPI and NGKG in loops that flank the Ig5-FN1 linker and the proximity of PSSP to this linker suggest that GGVPI and NGKG sequences may be critical for stabilizing the Ig5-FN1 linker, whereas PSSP may play a dual role maintaining the Ig5-FN1 interface and a polyST recognition site.	[Thompson, Matthew G.; Foley, Deirdre A.; Swartzentruber, Kristin G.; Colley, Karen J.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			National Institutes of Health [RO1 GM063843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM063843 (to K. J. C.).	Angata K, 2002, J BIOL CHEM, V277, P36808, DOI 10.1074/jbc.M204632200; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Carafoli F, 2008, J MOL BIOL, V377, P524, DOI 10.1016/j.jmb.2008.01.030; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Durbec P, 2001, MOL NEUROBIOL, V24, P53; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Foley DA, 2010, J BIOL CHEM, V285, P35056, DOI 10.1074/jbc.M110.170209; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1998, PATHOL INT, V48, P665, DOI 10.1111/j.1440-1827.1998.tb03967.x; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ranheim TS, 1996, P NATL ACAD SCI USA, V93, P4071, DOI 10.1073/pnas.93.9.4071; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tanaka F, 2000, CANCER RES, V60, P3072; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; ZUBER C, 1992, J BIOL CHEM, V267, P9965	50	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4525	4534		10.1074/jbc.M110.200386	http://dx.doi.org/10.1074/jbc.M110.200386			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131353	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000286975700053
J	Choi, S; Kim, W; Chung, J				Choi, Sekyu; Kim, Wonho; Chung, Jongkyeong			Drosophila Salt-inducible Kinase (SIK) Regulates Starvation Resistance through cAMP-response Element-binding Protein (CREB)-regulated Transcription Coactivator (CRTC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS RESISTANCE; RAPID-DETERMINATION; GENE-EXPRESSION; CREB; ABLATION; FAMILY; TORC2	Salt-inducible kinase (SIK), one of the AMP-activated kinase (AMPK)-related kinases, has been suggested to play important functions in glucose homeostasis by inhibiting the cAMP-response element-binding protein (CREB)-regulated transcription coactivator (CRTC). To examine the role of SIK in vivo, we generated Drosophila SIK mutant and found that the mutant flies have higher amounts of lipid and glycogen stores and are resistant to starvation. Interestingly, SIK transcripts are highly enriched in the brain, and we found that neuron-specific expression of exogenous SIK fully rescued lipid and glycogen storage phenotypes as well as starvation resistance of the mutant. Using genetic and biochemical analyses, we demonstrated that CRTC Ser-157 phosphorylation by SIK is critical for inhibiting CRTC activity in vivo. Furthermore, double mutants of SIK and CRTC became sensitive to starvation, and the Ser-157 phosphomimetic mutation of CRTC reduced lipid and glycogen levels in the SIK mutant, suggesting that CRTC mediates the effects of SIK signaling. Collectively, our results strongly support the importance of the SIK-CRTC signaling axis that functions in the brain to maintain energy homeostasis in Drosophila.	[Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Choi, Sekyu; Kim, Wonho] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Choi, Sekyu; Kim, Wonho; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 151742, South Korea; [Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151742, South Korea	Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU)	Chung, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, San 56-1 Sillim Dong, Seoul 151742, South Korea.	jkc@snu.ac.kr		Choi, Sekyu/0000-0003-2928-0942	Korean Ministry of Education, Science and Technology [2010-0018291]	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Creative Research Initiatives Grant 2010-0018291 from the Korean Ministry of Education, Science and Technology.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Feldman JD, 2000, J NEUROCHEM, V74, P2227, DOI 10.1046/j.1471-4159.2000.0742227.x; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Iijima K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008498; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P299; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P302; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5	30	36	39	5	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2658	2664		10.1074/jbc.C110.119222	http://dx.doi.org/10.1074/jbc.C110.119222			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21127058	Green Published, hybrid			2022-12-25	WOS:000286464300031
J	Rahelinirina, S; Leon, A; Harstskeerl, RA; Sertour, N; Ahmed, A; Raharimanana, C; Ferquel, E; Garnier, M; Chartier, L; Duplantier, JM; Rahalison, L; Cornet, M				Rahelinirina, Soanandrasana; Leon, Albertine; Harstskeerl, Rudy A.; Sertour, Natacha; Ahmed, Ahmed; Raharimanana, Claudine; Ferquel, Elisabeth; Garnier, Martine; Chartier, Loic; Duplantier, Jean-Marc; Rahalison, Lila; Cornet, Muriel			First Isolation and Direct Evidence for the Existence of Large Small-Mammal Reservoirs of Leptospira sp in Madagascar	PLOS ONE			English	Article							WEILS DISEASE; INTERROGANS; ANTIBODIES; CARRIAGE; ASSAY; RATS	Background: Leptospirosis has long been a major public health concern in the southwestern Indian Ocean. However, in Madagascar, only a few, old studies have provided indirect serological evidence of the disease in humans or animals. Methodology/Principal Findings: We conducted a large animal study focusing on small-mammal populations. Five field trapping surveys were carried out at five sites, from April 2008 to August 2009. Captures consisted of Rattus norvegicus (35.8%), R. rattus (35.1%), Mus musculus (20.5%) and Suncus murinus (8.6%). We used microbiological culture, serodiagnosis tests (MAT) and real-time PCR to assess Leptospira infection. Leptospira carriage was detected by PCR in 91 (33.9%) of the 268 small mammals, by MAT in 17 of the 151 (11.3%) animals for which serum samples were available and by culture in 9 of the 268 animals (3.3%). Rates of infection based on positive PCR results were significantly higher in Moramanga (54%), Toliara (48%) and Mahajanga (47.4%) than in Antsiranana (8.5%) and Toamasina (14%) (p = 0.001). The prevalence of Leptospira carriage was significantly higher in R. norvegicus (48.9%), S. murinus (43.5%) and R. rattus (30.8%) than in M. musculus (9.1%) (p < 0.001). The MAT detected antibodies against the serogroups Canicola and Icterohaemorrhagiae. Isolates were characterized by serology, secY sequence-based phylogeny, partial sequencing of rrs, multi-locus VNTR analysis and pulsed field gel electrophoresis. The 10 isolates obtained from nine rats were all identified as species L. interrogans serogroup Canicola serovar Kuwait and all had identical partial rrs and secY sequences. Conclusions/Significance: We present here the first direct evidence of widespread leptospiral carriage in small mammals in Madagascar. Our results strongly suggest a high level of environmental contamination, consistent with probable transmission of the infection to humans. This first isolation of pathogenic Leptospira strains in this country may significantly improve the detection of specific antibodies in human cases.	[Rahelinirina, Soanandrasana; Raharimanana, Claudine; Rahalison, Lila] Inst Pasteur, Plague Unit, Antananarivo, Madagascar; [Leon, Albertine] IFR 146 ICORE, Frank Duncombe Lab, Caen, France; [Harstskeerl, Rudy A.; Ahmed, Ahmed] WHO FAO OIE, Amsterdam, Netherlands; [Harstskeerl, Rudy A.; Ahmed, Ahmed] KIT Biomed Res, Natl Leptospirosis Reference Ctr, Amsterdam, Netherlands; [Sertour, Natacha; Ferquel, Elisabeth; Garnier, Martine; Cornet, Muriel] Inst Pasteur, Natl Reference Ctr Borrelia, Paris, France; [Chartier, Loic] Inst Pasteur, Epidemiol Unit, Paris, France; [Duplantier, Jean-Marc] UMR CBGP INRA IRD Cirad Montpellier SupAgro, IRD, Montferrier Sur Lez, France; [Cornet, Muriel] Univ Grenoble 1, Parasitol Mycol Lab, CHU Grenoble, Grenoble, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Food & Agriculture Organization of the United Nations (FAO); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Rahelinirina, S (corresponding author), Inst Pasteur, Plague Unit, Antananarivo, Madagascar.	MCornet@chu-grenoble.fr	Cornet, Muriel/M-6563-2014	Cornet, Muriel/0000-0003-4155-3675	Reseau International des Instituts Pasteur; ANR	Reseau International des Instituts Pasteur; ANR(French National Research Agency (ANR))	This work was supported by a grant from the Reseau International des Instituts Pasteur (Actions Concertees Inter Pasteuriennes, 2007). Some of the surveys in the field were financed by the ANR-SEST project "DiffusPeste". The funders played no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Berlioz-Arthaud A, 2007, T ROY SOC TROP MED H, V101, P714, DOI 10.1016/j.trstmh.2007.02.022; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Boisier P, 2002, EMERG INFECT DIS, V8, P311, DOI 10.3201/eid0803.010250; Bourhy P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000724; Branger C, 2005, FEMS MICROBIOL LETT, V243, P437, DOI 10.1016/j.femsle.2005.01.007; BRYGOO E. R., 1966, Arch. Inst. Pasteur Madagascar, V35, P9; BRYGOO E R, 1956, Bull Soc Pathol Exot Filiales, V49, P686; Cerqueira GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015335; Collares-Pereira M, 1997, Cent Afr J Med, V43, P234; de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005; Duplantier J.-M., 2003, P158; Duval P, 1999, LANCET, V353, P2068, DOI 10.1016/S0140-6736(99)00103-8; Faine S., 1982, Guidelines for the control of leptospirosis.; GEAR J, 1958, S Afr Med J, V32, P94; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; HEATH CW, 1965, NEW ENGL J MED, V273, P857, DOI 10.1056/NEJM196510142731606; Henrmann-Storck C, 2005, W INDIAN MED J, V54, P42; Herrmann-Storck C, 2010, EMERG INFECT DIS, V16, P331, DOI 10.3201/eid1602.090139; Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660; KMETY D, 1978, METHOD MICROBIOL, P260; Koizumi N, 2008, JPN J INFECT DIS, V61, P465; KOTEESWARAN A, 2006, INDIAN J MICROBIOL, V27, P329; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; LHUILLIER M, 1978, Archives de l'Institut Pasteur de Madagascar, V46, P429; Matthias MA, 2002, W INDIAN MED J, V51, P10; Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213; *NAT REF CTR LEPT, 2008, EP LEPT FRANC; PAGANIN F, 2007, INTENS CARE MED, V17, P17; Postic D, 2000, BIOL DIAGNOSIS LEPTO, P181; Priya CG, 2007, J POSTGRAD MED, V53, P236; Ralaiarijaona R. L., 2001, Archives de l'Institut Pasteur de Madagascar, V67, P34; Salaun L, 2006, J CLIN MICROBIOL, V44, P3954, DOI 10.1128/JCM.00336-06; Salles P, 1955, ARCH I PASTEUR MADAG, V19, P23; SEEDAT YK, 1974, S AFR MED J, V48, P2012; SILVERIE R, 1968, Bulletin de la Societe de Pathologie Exotique, V61, P346; Sunbul M, 2001, SCAND J INFECT DIS, V33, P896, DOI 10.1080/00365540110076796; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR P, 2007, 10 INT S SMALL MAMM; TERPSTRA WJ, 1987, ZBL BAKT-INT J MED M, V266, P412; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002; WILES WA, 1979, CENT AFR J MED, V25, P261; Yersin C, 1998, AM J TROP MED HYG, V59, P933, DOI 10.4269/ajtmh.1998.59.933; Yersin C, 1999, TROP MED INT HEALTH, V4, P38, DOI 10.1046/j.1365-3156.1999.00352.x	46	44	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14111	10.1371/journal.pone.0014111	http://dx.doi.org/10.1371/journal.pone.0014111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124843	Green Published, gold			2022-12-25	WOS:000284572000012
J	Dobrovolny, HM; Baron, MJ; Gieschke, R; Davies, BE; Jumbe, NL; Beauchemin, CAA				Dobrovolny, Hana M.; Baron, Marc J.; Gieschke, Ronald; Davies, Brian E.; Jumbe, Nelson L.; Beauchemin, Catherine A. A.			Exploring Cell Tropism as a Possible Contributor to Influenza Infection Severity	PLOS ONE			English	Article							A VIRUS-INFECTION; ADAPTIVE IMMUNE-RESPONSE; HEPATITIS-B-VIRUS; DYNAMICS IN-VIVO; VIRAL DYNAMICS; H5N1 VIRUSES; CYTOKINE RESPONSES; EPITHELIAL-CELLS; MODEL; HEMAGGLUTININ	Several mechanisms have been proposed to account for the marked increase in severity of human infections with avian compared to human influenza strains, including increased cytokine expression, poor immune response, and differences in target cell receptor affinity. Here, the potential effect of target cell tropism on disease severity is studied using a mathematical model for in-host influenza viral infection in a cell population consisting of two different cell types. The two cell types differ only in their susceptibility to infection and rate of virus production. We show the existence of a parameter regime which is characterized by high viral loads sustained long after the onset of infection. This finding suggests that differences in cell tropism between influenza strains could be sufficient to cause significant differences in viral titer profiles, similar to those observed in infections with certain strains of influenza A virus. The two target cell mathematical model offers good agreement with experimental data from severe influenza infections, as does the usual, single target cell model albeit with biologically unrealistic parameters. Both models predict that while neuraminidase inhibitors and adamantanes are only effective when administered early to treat an uncomplicated seasonal infection, they can be effective against more severe influenza infections even when administered late.	[Dobrovolny, Hana M.; Baron, Marc J.; Beauchemin, Catherine A. A.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Gieschke, Ronald; Jumbe, Nelson L.] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland; [Davies, Brian E.] F Hoffmann La Roche Inc, Nutley, NJ USA	Toronto Metropolitan University; Roche Holding; Roche Holding	Dobrovolny, HM (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.	cbeau@ryerson.ca	Beauchemin, Catherine AA/G-4619-2011; Dobrovolny, Hana M./A-2447-2013	Beauchemin, Catherine AA/0000-0003-0599-0069; Dobrovolny, Hana M./0000-0003-3592-6770; Tripp, Ralph/0000-0002-2924-9956	Natural Sciences and Engineering Research Council of Canada; F. Hoffmann-La Roche Ltd	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche)	This work was supported in part by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (CAAB), with additional support provided by F. Hoffmann-La Roche Ltd. The project was developed jointly by F. Hoffmann-La Roche Ltd and Dr. Beauchemin's research group. However, F. Hoffmann-La Roche Ltd had no role in data collection and analysis. F. Hoffmann-La Roche Ltd was involved in the decision to publish and in the preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Bajaria SH, 2002, J ACQ IMMUN DEF SYND, V30, P41, DOI 10.1097/00042560-200205010-00006; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Coombes R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3092; Crystal RJ, 1991, LUNG SCI FDN; Dahari H, 2005, J HEPATOL, V42, P491, DOI 10.1016/j.jhep.2004.12.017; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DIEKMANN O, 1990, J MATH BIOL, V28, P365; EATON JW, 2008, GNU OCTAVE VERSION 3; Eizenberg P, 2009, MED J AUSTRALIA, V191, P151, DOI 10.5694/j.1326-5377.2009.tb02725.x; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Gallaher WR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-51; Ganusov VV, 2002, EVOLUTION, V56, P213, DOI 10.1111/j.0014-3820.2002.tb01332.x; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; HANDEL A, 2007, PLOS COMPUT BIOL, V3; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; HETHCOTE HW, 1987, MATH BIOSCI, V84, P85, DOI 10.1016/0025-5564(87)90044-7; Hindmarsh AC, 1983, IMACS T SCI COMPUTAT, V1, P55; HOLDER BP, 2010, BMC PUBLIC IN PRESS; Hsieh SM, 2006, J IMMUNOL, V176, P4530, DOI 10.4049/jimmunol.176.8.4530; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Kaufman MA, 2009, MED J AUSTRALIA, V191, P154, DOI 10.5694/j.1326-5377.2009.tb02726.x; Kogure T, 2006, GLYCOCONJUGATE J, V23, P101, DOI 10.1007/s10719-006-5442-z; Larson RC, 2007, OPER RES, V55, P399, DOI 10.1287/opre.1070.0399; Lee HY, 2009, J VIROL, V83, P7151, DOI 10.1128/JVI.00098-09; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Ning ZY, 2009, VET RES COMMUN, V33, P895, DOI 10.1007/s11259-009-9307-3; Nowak M. A., 2000, VIRUS DYNAMICS MATH; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; PAYNE RJH, 1994, MATH BIOSCI, V123, P25, DOI 10.1016/0025-5564(94)90017-5; PAYNE RJH, 1992, J THEOR BIOL, V159, P215, DOI 10.1016/S0022-5193(05)80703-9; Pekosz A, 2009, VIROLOGY, V386, P61, DOI 10.1016/j.virol.2009.01.005; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Seber G., 1989, NONLINEAR REGRESSION; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; van den Driessche P, 2008, LECT NOTES MATH, V1945, P159; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	63	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e13811	10.1371/journal.pone.0013811	http://dx.doi.org/10.1371/journal.pone.0013811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124892	Green Submitted, Green Published, gold			2022-12-25	WOS:000284527900002
J	Hoshida, Y				Hoshida, Yujin			Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; STATISTICAL-ANALYSIS; PROFILES; MICROARRAYS; SIGNATURE; DISCOVERY; OUTCOMES	Gene-expression signature-based disease classification and clinical outcome prediction has not been widely introduced in clinical medicine as initially expected, mainly due to the lack of extensive validation needed for its clinical deployment. Obstacles include variable measurement in microarray assay, inconsistent assay platform, analytical requirement for comparable pair of training and test datasets, etc. Furthermore, as medical device helping clinical decision making, the prediction needs to be made for each single patient with a measure of its reliability. To address these issues, there is a need for flexible prediction method less sensitive to difference in experimental and analytical conditions, applicable to each single patient, and providing measure of prediction confidence. The nearest template prediction (NTP) method provides a convenient way to make class prediction with assessment of prediction confidence computed in each single patient's gene-expression data using only a list of signature genes and a test dataset. We demonstrate that the method can be flexibly applied to cross-platform, cross-species, and multiclass predictions without any optimization of analysis parameters.	[Hoshida, Yujin] MIT, Broad Inst, Canc Program, Cambridge, MA 02139 USA; [Hoshida, Yujin] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Hoshida, Y (corresponding author), MIT, Broad Inst, Canc Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hoshida@broadinstitute.org	Hoshida, Yujin/R-7513-2019		Charles A. King fellowship	Charles A. King fellowship	Yujin Hoshida is supported by a Charles A. King fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Fan JQ, 2006, CLIN CANCER RES, V12, P4469, DOI 10.1158/1078-0432.CCR-06-1033; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Pittman J, 2004, BIOSTATISTICS, V5, P587, DOI 10.1093/biostatistics/kxh011; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Zervakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-53	26	151	158	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15543	10.1371/journal.pone.0015543	http://dx.doi.org/10.1371/journal.pone.0015543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124904	gold, Green Submitted, Green Published			2022-12-25	WOS:000284527900026
J	Ye, ZQ; Niu, S; Yu, Y; Yu, H; Liu, BH; Li, RX; Xiao, HS; Zeng, R; Li, YX; Wu, JR; Li, YY				Ye, Zhi-Qiang; Niu, Shen; Yu, Yang; Yu, Hui; Liu, Bao-Hong; Li, Rong-Xia; Xiao, Hua-Sheng; Zeng, Rong; Li, Yi-Xue; Wu, Jia-Rui; Li, Yuan-Yuan			Analyses of Copy Number Variation of GK Rat Reveal New Putative Type 2 Diabetes Susceptibility Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL; ULTRACONSERVED ELEMENTS; EXPRESSION; IDENTIFICATION; GENES	Large efforts have been taken to search for genes responsible for type 2 diabetes (T2D), but have resulted in only about 20 in humans due to its complexity and heterogeneity. The GK rat, a spontanous T2D model, offers us a superior opportunity to search for more diabetic genes. Utilizing array comparative genome hybridization (aCGH) technology, we identifed 137 non-redundant copy number variation (CNV) regions from the GK rats when using normal Wistar rats as control. These CNV regions (CNVRs) covered approximately 36 Mb nucleotides, accounting for about 1% of the whole genome. By integrating information from gene annotations and disease knowledge, we investigated the CNVRs comprehensively for mining new T2D genes. As a result, we prioritized 16 putative protein-coding genes and two microRNA genes (rno-mir-30b and rno-mir-30d) as good candidates. The catalogue of CNVRs between GK and Wistar rats identified in this work served as a repository for mining genes that might play roles in the pathogenesis of T2D. Moreover, our efforts in utilizing bioinformatics methods to prioritize good candidate genes provided a more specific set of putative candidates. These findings would contribute to the research into the genetic basis of T2D, and thus shed light on its pathogenesis.	[Ye, Zhi-Qiang; Niu, Shen; Yu, Yang; Yu, Hui; Li, Rong-Xia; Xiao, Hua-Sheng; Zeng, Rong; Li, Yi-Xue; Wu, Jia-Rui; Li, Yuan-Yuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Ye, Zhi-Qiang; Yu, Hui; Liu, Bao-Hong; Li, Yi-Xue; Li, Yuan-Yuan] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Ye, ZQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	wujr@sibs.ac.cn; yyli@scbit.org	Yu, Hui/A-4131-2011; Ye, Zhi-Qiang/N-8513-2014; Yu, Hui/B-3787-2018	Ye, Zhi-Qiang/0000-0002-8822-6148; 	National '863' Hi-Tech Research and Development Program of China [2009AA022710]; National '973' Basic Research Program [2010CB529206]; National Natural Science Foundation of China [30770497, 30800641]; China Postdoctoral Science Foundation [20090460669]; Chinese Academy of Sciences [KSCX2-YW-R-112]; Shanghai Committee of Science and Technology [2009B105]; SA-SIBS (Sanofi Aventis - Shanghai Institutes for Biological Sciences)	National '863' Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National '973' Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); SA-SIBS (Sanofi Aventis - Shanghai Institutes for Biological Sciences)	This work was supported by grants from the National '863' Hi-Tech Research and Development Program of China (2009AA022710), the National '973' Basic Research Program (2010CB529206), the National Natural Science Foundation of China (30770497, 30800641), China Postdoctoral Science Foundation (20090460669), the Research Program of Chinese Academy of Sciences (KSCX2-YW-R-112), the Shanghai Committee of Science and Technology (2009B105) and the SA-SIBS (Sanofi Aventis - Shanghai Institutes for Biological Sciences) Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-320; Almon RR, 2009, J ENDOCRINOL, V200, P331, DOI [10.1677/JOE-80-0404, 10.1677/JOE-08-0404]; Awad IAB, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-151; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Dwinell MR, 2009, NUCLEIC ACIDS RES, V37, pD744, DOI 10.1093/nar/gkn842; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Elbein SC, 2009, DIABETES, V58, P268, DOI 10.2337/db08-0931; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GOTO Y, 1975, P JPN ACAD, V51, P80, DOI 10.2183/pjab1945.51.80; Granhall C, 2006, GENETICS, V174, P1565, DOI 10.1534/genetics.106.062208; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Huang B, 2009, ACTA BIOCH BIOPH SIN, V41, P472, DOI 10.1093/abbs/gmp035; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim SJ, 2007, J BIOL REG HOMEOS AG, V21, P63; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Lovis P, 2008, DIABETES, V57, P2728, DOI 10.2337/db07-1252; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Movassat J, 2007, DIABETES OBES METAB, V9, P187, DOI 10.1111/j.1463-1326.2007.00786.x; Neuvial P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-264; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Smith M.L., 2006, BIOCONDUCTOR; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stocker R, 2009, CURR OPIN LIPIDOL, V20, P227, DOI 10.1097/MOL.0b013e32832aee68; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Teber ET, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S69; Tiffin N, 2006, NUCLEIC ACIDS RES, V34, P3067, DOI 10.1093/nar/gkl381; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; World Health Organisation, 2008, WHO DIAB FACT SHEET; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	62	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14077	10.1371/journal.pone.0014077	http://dx.doi.org/10.1371/journal.pone.0014077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124896	Green Submitted, Green Published, gold			2022-12-25	WOS:000284527900003
J	Guibert, F; Richard-Yris, MA; Lumineau, S; Kotrschal, K; Guemene, D; Bertin, A; Mostl, E; Houdelier, C				Guibert, Floriane; Richard-Yris, Marie-Annick; Lumineau, Sophie; Kotrschal, Kurt; Guemene, Daniel; Bertin, Aline; Moestl, Erich; Houdelier, Cecilia			Social Instability in Laying Quail: Consequences on Yolk Steroids and Offspring's Phenotype	PLOS ONE			English	Article							JAPANESE-QUAIL; TESTOSTERONE LEVELS; MATERNAL TESTOSTERONE; PRENATAL STRESS; SEX-DIFFERENCES; EMOTIONAL REACTIVITY; MALE ATTRACTIVENESS; HORMONE DEPOSITION; AGONISTIC BEHAVIOR; ANDROGEN LEVELS	Individual phenotypic characteristics of many species are influenced by non-genetic maternal effects. Female birds can influence the development of their offspring before birth via the yolk steroid content of their eggs. We investigated this prenatal maternal effect by analysing the influence of laying females' social environment on their eggs' hormonal content and on their offspring's development. Social instability was applied to groups of laying Japanese quail females. We evaluated the impact of this procedure on laying females, on yolk steroid levels and on the general development of chicks. Agonistic interactions were more frequent between females kept in an unstable social environment (unstable females) than between females kept in a stable social environment (stable females). Testosterone concentrations were higher in unstable females' eggs than in those of stable females. Unstable females' chicks hatched later and developed more slowly during their first weeks of life than those of stable females. The emotional reactivity of unstable females' chicks was higher than that of stable females' chicks. In conclusion, our study showed that social instability applied to laying females affected, in a non-genetic way, their offspring's development, thus stressing the fact that females' living conditions during laying can have transgenerational effects.	[Guibert, Floriane; Richard-Yris, Marie-Annick; Lumineau, Sophie; Houdelier, Cecilia] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Kotrschal, Kurt] Univ Vienna, Konrad Lorenz Forsch Stelle, Grunau, Austria; [Guemene, Daniel] INRA, Unite Rech Avicoles, UR83, F-37380 Nouzilly, France; [Guemene, Daniel] INRA Tours Nouzilly, URA UR83, Nouzilly, France; [Bertin, Aline] Univ Tours Haras Nationaux, CNRS, UMR Physiol Reprod & Comportements 85, INRA, Nouzilly, France; [Moestl, Erich] Univ Vet Med, Dept Nat Sci Biochem, Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; University of Vienna; INRAE; INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE; University of Veterinary Medicine Vienna	Guibert, F (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	floriane.guibert@univ-rennes1.fr		Lumineau, Sophie/0000-0002-2076-9947	CNRS; French Ministry of Research and Egide association [17289VE]	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research and Egide association	This work was supported by grants from the CNRS, the French Ministry of Research and Egide association (Partenariat Hubert Curien "Amadeus" number 17289VE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Archer J., 1976, P231; AUBRAIS O, 1986, Gibier Faune Sauvage, V3, P317; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P2165, DOI 10.1098/rspb.2005.3194; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Bertin A, 2005, J EXP ZOOL PART A, V303A, P792, DOI 10.1002/jez.a.202; Bertin A, 2004, APPL ANIM BEHAV SCI, V89, P215, DOI 10.1016/j.applanim.2004.06.004; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Bertin A, 2009, HORM BEHAV, V56, P416, DOI 10.1016/j.yhbeh.2009.07.008; Braastad BO, 1998, APPL ANIM BEHAV SCI, V61, P159, DOI 10.1016/S0168-1591(98)00188-9; Calatayud F, 2004, PHYSIOL BEHAV, V80, P465, DOI 10.1016/j.physbeh.2003.10.001; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Daisley JN, 2005, HORM BEHAV, V47, P185, DOI 10.1016/j.yhbeh.2004.09.006; DEMINIERE JM, 1992, BRAIN RES, V586, P135, DOI 10.1016/0006-8993(92)91383-P; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; Downing JA, 2008, PHYSIOL BEHAV, V95, P381, DOI 10.1016/j.physbeh.2008.07.001; EDENS FW, 1983, POULTRY SCI, V62, P1647, DOI 10.3382/ps.0621647; EDENS FW, 1987, COMP BIOCHEM PHYS A, V86, P469, DOI 10.1016/0300-9629(87)90527-5; EDENS FW, 1987, COMP BIOCHEM PHYS A, V86, P473, DOI 10.1016/0300-9629(87)90528-7; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, GEN COMP ENDOCR, V132, P241, DOI 10.1016/S0016-6480(03)00090-X; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; ETCHES RJ, 1976, STEROIDS, V28, P763, DOI 10.1016/0039-128X(76)90028-3; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Formanek L, 2008, ETHOLOGY, V114, P817, DOI 10.1111/j.1439-0310.2008.01536.x; Formanek L, 2008, APPL ANIM BEHAV SCI, V112, P174, DOI 10.1016/j.applanim.2007.07.004; Formanek L, 2009, CHRONOBIOL INT, V26, P396, DOI 10.1080/07420520902892433; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Francis DD, 1999, ANN NY ACAD SCI, V896, P66, DOI 10.1111/j.1749-6632.1999.tb08106.x; Gil D, 2004, HORM BEHAV, V45, P64, DOI 10.1016/j.yhbeh.2003.08.005; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Groothuis TG, 2002, FUNCT ECOL, V16, P281; Groothuis TGG, 2005, BIOL LETTERS, V1, P78, DOI 10.1098/rsbl.2004.0233; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guyomarc'h J.C., 1998, BWP UPDATE, V2, P27; GUYOMARCH JC, 1986, BM ONC, V104, P15; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; Hayward LS, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1026, DOI 10.1086/432854; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; HAZARD D, 2004, 8 INT S AV END SCOTT; Hegyi G, 2010, J AVIAN BIOL, V41, P258, DOI 10.1111/j.1600-048X.2009.04787.x; HEMON YA, 1988, B MENS ONC, V127, P29; Hirschenhauser K, 2008, PHYSIOL BEHAV, V95, P457, DOI 10.1016/j.physbeh.2008.07.013; Hirschenhauser K, 1999, GEN COMP ENDOCR, V114, P67, DOI 10.1006/gcen.1998.7236; Jablonka E, 2005, EVOLUTION 4 DIMENSIO; Janczak AM, 2006, APPL ANIM BEHAV SCI, V96, P69, DOI 10.1016/j.applanim.2005.04.020; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; JONES RB, 1988, BEHAV PROCESS, V16, P75; JONES RB, 1987, COGNITIVE ASPECTS SO, P40; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kendrick KM, 2001, HORM BEHAV, V40, P322, DOI 10.1006/hbeh.2001.1672; Kingma SA, 2009, BEHAV ECOL, V20, P172, DOI 10.1093/beheco/arn130; LAUNAY F, 1993, THESIS U RENNES 1 FR; Lipar JL, 1999, GEN COMP ENDOCR, V115, P220, DOI 10.1006/gcen.1999.7296; Lipar JL, 2000, P ROY SOC B-BIOL SCI, V267, P2005, DOI 10.1098/rspb.2000.1242; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Marshall RC, 2005, J EXP BIOL, V208, P4593, DOI 10.1242/jeb.01949; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Mazuc J, 2003, ECOL LETT, V6, P1084, DOI 10.1046/j.1461-0248.2003.00535.x; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; MILLS AD, 1986, BIOL BEHAV, V11, P235; MILLS AD, 1993, PHYSIOL BEHAV, V53, P183, DOI 10.1016/0031-9384(93)90029-F; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Muller W, 2002, P ROY SOC B-BIOL SCI, V269, P2249, DOI 10.1098/rspb.2002.2159; Navara KJ, 2006, FUNCT ECOL, V20, P449, DOI 10.1111/j.1365-2435.2006.01114.x; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; NICHOLS CR, 1991, THESIS U BRIT COLUMB; Okuliarova M, 2007, ACTA VET BRNO, V76, P325, DOI 10.2754/avb200776030325; PALME R, 1993, P 5 S AN STER, P111; Pilz KM, 2004, HORM BEHAV, V46, P179, DOI 10.1016/j.yhbeh.2004.03.004; Pilz KM, 2004, FUNCT ECOL, V18, P58, DOI 10.1111/j.1365-2435.2004.00811.x; Pilz KM, 2003, ANIM BEHAV, V65, P841, DOI 10.1006/anbe.2003.2094; Reed WL, 2001, OECOLOGIA, V128, P164, DOI 10.1007/s004420100642; Rettenbacher S, 2009, GEN COMP ENDOCR, V164, P125, DOI 10.1016/j.ygcen.2009.05.019; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P549, DOI 10.1007/s00265-005-0080-1; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Sauveur B., 1987, Egg quality - current problems and recent advances., P219; Schwabl H, 1996, J EXP ZOOL, V276, P157, DOI 10.1002/(SICI)1097-010X(19961001)276:2<157::AID-JEZ9>3.3.CO;2-Y; Schwabl H, 1997, NATURWISSENSCHAFTEN, V84, P406, DOI 10.1007/s001140050418; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; Schweitzer C, 2010, ANIM BEHAV, V79, P571, DOI 10.1016/j.anbehav.2009.11.023; Schweitzer C, 2009, DEV PSYCHOBIOL, V51, P311, DOI 10.1002/dev.20370; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Summers CH, 2005, EUR J PHARMACOL, V526, P21, DOI 10.1016/j.ejphar.2005.09.059; Tanvez A, 2008, ANIM BEHAV, V75, P929, DOI 10.1016/j.anbehav.2007.08.006; Tobler M, 2007, HORM BEHAV, V52, P640, DOI 10.1016/j.yhbeh.2007.07.016; Vallee M, 1997, J NEUROSCI, V17, P2626; von Engelhardt N, 2006, P ROY SOC B-BIOL SCI, V273, P65, DOI 10.1098/rspb.2005.3274; von Engelhardt N, 2009, GEN COMP ENDOCR, V163, P175, DOI 10.1016/j.ygcen.2009.04.004; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Wewers D, 2005, BEHAV BRAIN RES, V158, P89, DOI 10.1016/j.bbr.2004.08.009; Whittingham LA, 2002, ANIM BEHAV, V63, P63, DOI 10.1006/anbe.2001.1889; Williams TD, 2004, GEN COMP ENDOCR, V136, P346, DOI 10.1016/j.ygcen.2004.01.010; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wingfield John C., 1994, P303	104	44	45	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14069	10.1371/journal.pone.0014069	http://dx.doi.org/10.1371/journal.pone.0014069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124926	Green Published, gold, Green Submitted			2022-12-25	WOS:000284467200006
J	DiDonato, RJ; Young, ND; Butler, JE; Chin, KJ; Hixson, KK; Mouser, P; Lipton, MS; DeBoy, R; Methe, BA				DiDonato, Raymond J., Jr.; Young, Nelson D.; Butler, Jessica E.; Chin, Kuk-Jeong; Hixson, Kim K.; Mouser, Paula; Lipton, Mary S.; DeBoy, Robert; Methe, Barbara A.			Genome Sequence of the Deltaproteobacterial Strain NaphS2 and Analysis of Differential Gene Expression during Anaerobic Growth on Naphthalene	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SULFATE-REDUCING BACTERIUM; MARINE HARBOR SEDIMENTS; QUANTIFYING EXPRESSION; DENITRIFYING BACTERIUM; ENRICHMENT CULTURE; INITIAL REACTION; DEGRADATION; GEOBACTERACEAE; TOLUENE	Background: Anaerobic polycyclic hydrocarbon (PAH) degradation coupled to sulfate reduction may be an important mechanism for in situ remediation of contaminated sediments. Steps involved in the anaerobic degradation of 2-methylnaphthalene have been described in the sulfate reducing strains NaphS3, NaphS6 and N47. Evidence from N47 suggests that naphthalene degradation involves 2-methylnaphthalene as an intermediate, whereas evidence in NaphS2, NaphS3 and NaphS6 suggests a mechanism for naphthalene degradation that does not involve 2-methylnaphthalene. To further characterize pathways involved in naphthalene degradation in NaphS2, the draft genome was sequenced, and gene and protein expression examined. Results: Draft genome sequencing, gene expression analysis, and proteomic analysis revealed that NaphS2 degrades naphthoyl-CoA in a manner analogous to benzoyl-CoA degradation. Genes including the previously characterized NmsA, thought to encode an enzyme necessary for 2-methylnaphthalene metabolism, were not upregulated during growth of NaphS2 on naphthalene, nor were the corresponding protein products. NaphS2 may possess a non-classical dearomatizing enzyme for benzoate degradation, similar to one previously characterized in Geobacter metallireducens. Identification of genes involved in toluene degradation in NaphS2 led us to determine that NaphS2 degrades toluene, a previously unreported capacity. The genome sequence also suggests that NaphS2 may degrade other monoaromatic compounds. Conclusion: This study demonstrates that steps leading to the degradation of 2-naphthoyl-CoA are conserved between NaphS2 and N47, however while NaphS2 possesses the capacity to degrade 2-methylnaphthalene, naphthalene degradation likely does not proceed via 2-methylnaphthalene. Instead, carboxylation or another form of activation may serve as the first step in naphthalene degradation. Degradation of toluene and 2-methylnaphthalene, and the presence of at least one bss-like and bbs-like gene cluster in this organism, suggests that NaphS2 degrades both compounds via parallel mechanisms. Elucidation of the key genes necessary for anaerobic naphthalene degradation may provide the ability to track naphthalene degradation through in situ transcript monitoring.	[DiDonato, Raymond J., Jr.; Young, Nelson D.; Butler, Jessica E.; Mouser, Paula] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Chin, Kuk-Jeong] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Hixson, Kim K.; Lipton, Mary S.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [DeBoy, Robert; Methe, Barbara A.] J Craig Venter Inst, Rockville, MD USA	University of Massachusetts System; University of Massachusetts Amherst; University System of Georgia; Georgia State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; J. Craig Venter Institute	DiDonato, RJ (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	rdidonat@hotmail.com	Hixson, Kim/AAJ-7714-2020; Hixson, Kim/AAW-2332-2020; Lipton, Mary S/H-3913-2012	Hixson, Kim/0000-0003-3716-0326; Hixson, Kim/0000-0003-3915-7040; Mouser, Paula/0000-0003-2316-0915	Office of Naval [N000140310315]	Office of Naval(Office of Naval Research)	This research was funded by the Office of Naval Research grant N000140310315. ONR's website is http://www.onr.navy.mil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AECKERSBERG F, 1991, ARCH MICROBIOL, V156, P5, DOI 10.1007/BF00418180; Annweiler E, 2002, APPL ENVIRON MICROB, V68, P852, DOI 10.1128/AEM.68.2.852-858.2002; Bamforth SM, 2005, J CHEM TECHNOL BIOT, V80, P723, DOI 10.1002/jctb.1276; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Butler JE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-180; Chin KJ, 2008, MICROB ECOL, V55, P489, DOI 10.1007/s00248-007-9294-2; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Coates JD, 1996, APPL ENVIRON MICROB, V62, P1099, DOI 10.1128/AEM.62.3.1099-1101.1996; Coates JD, 1997, APPL ENVIRON MICROB, V63, P3589, DOI 10.1128/AEM.63.9.3589-3593.1997; Coates JD, 1996, ENVIRON SCI TECHNOL, V30, P2784, DOI 10.1021/es9600441; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Freitag TE, 2009, APPL ENVIRON MICROB, V75, P6679, DOI 10.1128/AEM.01021-09; Galushko A, 1999, ENVIRON MICROBIOL, V1, P415; HAFT DH, 2003, NUCLEIC ACIDS RES, V31, P41; Hayes LA, 1999, ORG GEOCHEM, V30, P937, DOI 10.1016/S0146-6380(99)00077-7; Holmes DE, 2004, APPL ENVIRON MICROB, V70, P7251, DOI 10.1128/AEM.70.12.7251-7259.2004; Holmes DE, 2005, APPL ENVIRON MICROB, V71, P6870, DOI 10.1128/AEM.71.11.6870-6877.2005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kube M, 2004, ARCH MICROBIOL, V181, P182, DOI 10.1007/s00203-003-0627-3; Kuhner S, 2005, J BACTERIOL, V187, P1493, DOI 10.1128/JB.187.4.1493-1503.2005; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; Lee PKH, 2006, APPL ENVIRON MICROB, V72, P6161, DOI 10.1128/AEM.01070-06; Meckenstock RU, 2000, APPL ENVIRON MICROB, V66, P2743, DOI 10.1128/AEM.66.7.2743-2747.2000; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Musat F, 2009, ENVIRON MICROBIOL, V11, P209, DOI 10.1111/j.1462-2920.2008.01756.x; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; N'Guessan AL, 2010, ISME J, V4, P253, DOI 10.1038/ismej.2009.115; O'Neil RA, 2008, ENVIRON MICROBIOL, V10, P1218, DOI 10.1111/j.1462-2920.2007.01537.x; Postier B, 2008, J MICROBIOL METH, V74, P26, DOI 10.1016/j.mimet.2007.07.004; Rabus R, 1995, ARCH MICROBIOL, V164, P448, DOI 10.1007/BF02529744; RABUS R, 1993, APPL ENVIRON MICROB, V59, P1444, DOI 10.1128/AEM.59.5.1444-1451.1993; Rothermich MM, 2002, ENVIRON SCI TECHNOL, V36, P4811, DOI 10.1021/es0200241; Safinowski M, 2006, ENVIRON MICROBIOL, V8, P347, DOI 10.1111/j.1462-2920.2005.00900.x; Safinowski M, 2004, FEMS MICROBIOL LETT, V240, P99, DOI 10.1016/j.femsle.2004.09.014; Selesi D, 2010, J BACTERIOL, V192, P295, DOI 10.1128/JB.00874-09; Widdel F., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_2; Wischgoll S, 2005, MOL MICROBIOL, V58, P1238, DOI 10.1111/j.1365-2958.2005.04909.x; Zhang XM, 1997, APPL ENVIRON MICROB, V63, P4759, DOI 10.1128/AEM.63.12.4759-4764.1997; Zhang XM, 2000, BIODEGRADATION, V11, P117, DOI 10.1023/A:1011128109670	41	69	70	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14072	10.1371/journal.pone.0014072	http://dx.doi.org/10.1371/journal.pone.0014072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124915	Green Published, gold, Green Submitted			2022-12-25	WOS:000284400100017
J	Ladouceur, M; Leslie, WD; Dastani, Z; Goltzman, D; Richards, JB				Ladouceur, Martin; Leslie, William D.; Dastani, Zari; Goltzman, David; Richards, J. Brent			An Efficient Paradigm for Genetic Epidemiology Cohort Creation	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURES; SALIVA; DNA; DENSITY	Development of novel methodologies to efficiently create large genetic epidemiology cohorts is needed. Here we describe a rapid, precise and cost-efficient method for collection of DNA from cases previously experiencing an osteoporotic fracture by identifying cases using and administrative health-care databases. Over the course of 14 months we collected DNA from 1,130 women experiencing an osteoporotic fracture, at a cost of $54 per sample. This cohort is among the larger DNA osteoporotic fracture collections in the world. The novel method described addresses a major unmet health care research need and is widely applicable to any disease that can be identified accurately through administrative data.	[Ladouceur, Martin; Richards, J. Brent] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Ladouceur, Martin; Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Leslie, William D.] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Leslie, William D.] Univ Manitoba, Dept Radiol, Winnipeg, MB, Canada; [Dastani, Zari; Richards, J. Brent] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Dastani, Zari; Richards, J. Brent] McGill Univ, Dept Biostat, Montreal, PQ, Canada; [Dastani, Zari; Richards, J. Brent] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada; [Goltzman, David] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goltzman, David] McGill Univ Hlth Ctr, Montreal, PQ, Canada; [Richards, J. Brent] Kings Coll London, London WC2R 2LS, England	McGill University; McGill University; University of Manitoba; University of Manitoba; McGill University; McGill University; McGill University; McGill University; McGill University; University of London; King's College London	Ladouceur, M (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	brent.richards@mcgill.ca	Richards, J Brent/AAF-4225-2019	Richards, J Brent/0000-0002-3746-9086; Leslie, William/0000-0002-1056-1691	Canadian Foundation for Innovation; Canadian Institutes of Health Research (CIHR); Fonds de la recherche en sante du Quebec; Jewish General Hospital	Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Jewish General Hospital(General Electric)	This work was supported by grants from the Canadian Foundation for Innovation, the Canadian Institutes of Health Research (CIHR), Fonds de la recherche en sante du Quebec and the Jewish General Hospital. Drs. Ladouceur, Richards and Dastani are supported by the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grymonpre R, 2006, MED CARE, V44, P471, DOI 10.1097/01.mlr.0000207817.32496.cb; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Kreiger N, 1999, CAN J AGING, V18, P376, DOI 10.1017/S0714980800009934; LESLIE WD, 2009, OSTEOPOROS INT; Leslie WD, 2007, J CLIN ENDOCR METAB, V92, P77, DOI 10.1210/jc.2006-1415; Ng DPK, 2006, CLIN CHIM ACTA, V367, P81, DOI 10.1016/j.cca.2005.11.024; Nishita DM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-71; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rogers NL, 2007, AM J HUM BIOL, V19, P319, DOI 10.1002/ajhb.20586; Rylander-Rudqvist T, 2006, CANCER EPIDEM BIOMAR, V15, P1742, DOI 10.1158/1055-9965.EPI-05-0706; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	11	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14045	10.1371/journal.pone.0014045	http://dx.doi.org/10.1371/journal.pone.0014045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124974	gold, Green Published, Green Submitted			2022-12-25	WOS:000284356900008
J	Cerqueira, GM; McBride, AJA; Hartskeerl, RA; Ahmed, N; Dellagostin, OA; Eslabao, MR; Nascimento, ALTO				Cerqueira, Gustavo M.; McBride, Alan J. A.; Hartskeerl, Rudy A.; Ahmed, Niyaz; Dellagostin, Odir A.; Eslabao, Marcus R.; Nascimento, Ana L. T. O.			Bioinformatics Describes Novel Loci for High Resolution Discrimination of Leptospira Isolates	PLOS ONE			English	Article							SP NOV.; IDENTIFICATION; PROTEINS; SEROVARS	Background: Leptospirosis is one of the most widespread zoonoses in the world and with over 260 pathogenic serovars there is an urgent need for a molecular system of classification. The development of multilocus sequence typing (MLST) schemes for Leptospira spp. is addressing this issue. The aim of this study was to identify loci with potential to enhance Leptospira strain discrimination by sequencing-based methods. Methodology and Principal Findings: We used bioinformatics to evaluate pre-existing loci with the potential to increase the discrimination of outbreak strains. Previously deposited sequence data were evaluated by phylogenetic analyses using either single or concatenated sequences. We identified and evaluated the applicability of the ligB, secY, rpoB and lipL41 loci, individually and in combination, to discriminate between 38 pathogenic Leptospira strains and to cluster them according to the species they belonged to. Pairwise identity among the loci ranged from 82.0-92.0%, while interspecies identity was 97.7-98.5%. Using the ligB-secY-rpoB-lipL41 superlocus it was possible to discriminate 34/38 strains, which belong to six pathogenic Leptospira species. In addition, the sequences were concatenated with the superloci from 16 sequence types from a previous MLST scheme employed to study the association of a leptospiral clone with an outbreak of human leptospirosis in Thailand. Their use enhanced the discriminative power of the existing scheme. The lipL41 and rpoB loci raised the resolution from 81.0-100%, but the enhanced scheme still remains limited to the L. interrogans and L. kirschneri species. Conclusions: As the first aim of our study, the ligB-secY-rpoB-lipL41 superlocus demonstrated a satisfactory level of discrimination among the strains evaluated. Second, the inclusion of the rpoB and lipL41 loci to a MLST scheme provided high resolution for discrimination of strains within L. interrogans and L. kirschneri and might be useful in future epidemiological studies.	[Cerqueira, Gustavo M.; Nascimento, Ana L. T. O.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [McBride, Alan J. A.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil; [Hartskeerl, Rudy A.] World Org Anim Hlth WHO FAO OIE, Royal Trop Inst, Dept Biomed Res, Food & Agr Org,UN,WHO, Amsterdam, Netherlands; [Hartskeerl, Rudy A.] Natl Leptospirosis Reference Ctr, Amsterdam, Netherlands; [Ahmed, Niyaz] Univ Hyderabad, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Dellagostin, Odir A.; Eslabao, Marcus R.] Univ Fed Pelotas, Ctr Biotecnol, Pelotas, Brazil; [Nascimento, Ana L. T. O.] Univ Sao Paulo, Inst Ciencias Biomed, Interunidades Biotecnol, BR-09500900 Sao Paulo, Brazil	Instituto Butantan; Fundacao Oswaldo Cruz; Food & Agriculture Organization of the United Nations (FAO); World Health Organization; University of Hyderabad; Universidade Federal de Pelotas; Universidade de Sao Paulo	Cerqueira, GM (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	cerqueiragm@yahoo.com.br	Dellagostin, Odir/C-2331-2009; Cerqueira, Gustavo/B-7180-2015; Ahmed, Niyaz/D-2589-2010; Nascimento, Ana L. T. O./E-8488-2012; McBride, Alan/D-4106-2012	Dellagostin, Odir/0000-0003-2803-4088; Cerqueira, Gustavo/0000-0002-3029-6899; Ahmed, Niyaz/0000-0001-6425-7583; Nascimento, Ana L. T. O./0000-0003-4851-0870; McBride, Alan/0000-0001-9682-540X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Research Support Foundation for the State of Bahia (FAPESB) [PES-0092/2008]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Butantan	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Research Support Foundation for the State of Bahia (FAPESB); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan	This study did not receive any designated funding. Gustavo M. Cerqueira holds a postdoctoral fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). Alan J.A. McBride would like to acknowledge the support from the Research Support Foundation for the State of Bahia (FAPESB), grant PES-0092/2008. Ana L.T.O. Nascimento would like to acknowledge the support from the FAPESP, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Butantan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; DRUMMOND AJ, 2007, GENEIOUS V 3 5; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Eslabao MR, 2010, INFECT GENET EVOL, V10, P586, DOI 10.1016/j.meegid.2010.02.014; Faine S., 1999, LEPTOSPIRA LEPTOSPIR; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; KMETY E, 1993, CLASSIFICATION SPECI, P17; La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x; Levett PN, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000120; Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Pavon ABI, 2009, METHODS MOL BIOL, V551, P129, DOI 10.1007/978-1-60327-999-4_11; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; SILVA EF, 2009, EMERG INFECT DIS, V15, P3; Slack AT, 2009, INT J SYST EVOL MICR, V59, P705, DOI 10.1099/ijs.0.002766-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; YASUDA PH, 1987, INT J SYST BACTERIOL, V37, P407, DOI 10.1099/00207713-37-4-407	37	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e15335	10.1371/journal.pone.0015335	http://dx.doi.org/10.1371/journal.pone.0015335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	21124728	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000283043700030
J	Kochert, K; Ullrich, K; Kreher, S; Aster, JC; Kitagawa, M; Johrens, K; Anagnostopoulos, I; Jundt, F; Lamprecht, B; Zimber-Strobl, U; Stein, H; Janz, M; Dorken, B; Mathas, S				Koechert, K.; Ullrich, K.; Kreher, S.; Aster, J. C.; Kitagawa, M.; Joehrens, K.; Anagnostopoulos, I.; Jundt, F.; Lamprecht, B.; Zimber-Strobl, U.; Stein, H.; Janz, M.; Doerken, B.; Mathas, S.			High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas	ONCOGENE			English	Article						Mastermind-like; NOTCH; lymphoma; Hodgkin	ACUTE LYMPHOBLASTIC-LEUKEMIA; CLASSICAL HODGKIN LYMPHOMA; TRANSCRIPTION FACTOR E2A; NEOPLASTIC B-CELLS; STERNBERG CELLS; HUMAN HOMOLOG; COMPLEX; COACTIVATORS; RESISTANCE; INHIBITION	Inappropriate activation of the NOTCH signaling pathway, for example, by activating mutations, contributes to the pathogenesis of various human malignancies. Here, we demonstrate that aberrant expression of an essential NOTCH coactivator of the Mastermind-like (MAML) family provides an alternative mechanism to activate NOTCH signaling in human lymphoma cells. We detected high-level MAML2 expression in several B cell-derived lymphoma types, including classical Hodgkin lymphoma (cHL) cells, relative to normal B cells. Inhibition of MAML-protein activity by a dominant negative form of MAML or by small hairpin RNAs targeting MAML2 in cHL cells resulted in downregulation of the NOTCH target genes HES7 and HEY1, which we identified as overexpressed in cHL cells, and in reduced proliferation. Furthermore, a NOTCH gene-expression signature in cHL cells confirmed their cell-autonomous NOTCH activity. Finally, in line with the essential role of MAML proteins for assembly and activity of the NOTCH transcriptional complex (NTC), we show that MAML-derived small-peptide constructs block NOTCH activity and disrupt NTC formation in vitro. These data strongly suggest direct targeting of the NTC as treatment strategy for NOTCH-dependent malignancies. Oncogene (2011) 30, 1831-1840; doi:10.1038/onc.2010.544; published online 29 November 2010	[Koechert, K.; Ullrich, K.; Kreher, S.; Jundt, F.; Lamprecht, B.; Janz, M.; Doerken, B.; Mathas, S.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Koechert, K.; Ullrich, K.; Kreher, S.; Jundt, F.; Lamprecht, B.; Janz, M.; Doerken, B.; Mathas, S.] Charite, CVK, D-13125 Berlin, Germany; [Aster, J. C.; Stein, H.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kitagawa, M.] Chiba Univ, Grad Sch Med, Dept Mol & Tumor Pathol, Chiba, Japan; [Joehrens, K.; Anagnostopoulos, I.] Charite, Inst Pathol, D-13125 Berlin, Germany; [Zimber-Strobl, U.] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Dept Gene Vectors, Munich, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Brigham & Women's Hospital; Chiba University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Mathas, S (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	stephan.mathas@charite.de	Zimber-Strobl, Ursula/M-4618-2014; Jundt, Franziska/E-9748-2014; Mathas, Stephan/I-5589-2015	Zimber-Strobl, Ursula/0000-0002-9765-5251; Jundt, Franziska/0000-0002-8661-7110; Kochert, Karl/0000-0002-5548-2022; Kitagawa, Motoo/0000-0003-1036-840X; Janz, Martin/0000-0002-1127-0044	Deutsche Forschungsgemeinschaft; Berliner Krebsgesellschaft; Wilhelm Sander-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Berliner Krebsgesellschaft; Wilhelm Sander-Stiftung	We thank Caroline Gartner (Berlin), Melanie Manzke (Berlin) and Simone Kressmann (Berlin) for outstanding technical assistance, and Peter Rahn (Berlin) for cell sorting. We thank Raphael Kopan (Washington) for the Hes1-pGL2 reporter construct, Lizi Wu (Gainesville, Florida) for the MAML3 expression construct, Karin Zimmermann (Berlin) and Ulf Leser (Berlin) for helpful suggestions in regard to gene set analysis, and Ariane Buchal and Benedikt Sedlmaier (both Berlin, Germany) for providing human tonsil material. This work was supported in part by grants from the Deutsche Forschungsgemeinschaft, the Berliner Krebsgesellschaft and the Wilhelm Sander-Stiftung.	Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Janz M, 2006, BLOOD, V107, P2536, DOI 10.1182/blood-2005-07-2694; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Jin BF, 2010, J BIOL CHEM, V285, P14356, DOI 10.1074/jbc.M109.078865; Jundt F, 2008, LEUKEMIA, V22, P1587, DOI 10.1038/leu.2008.101; Jundt F, 2004, BLOOD, V103, P3511, DOI 10.1182/blood-2003-07-2254; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kapp U, 1999, J EXP MED, V189, P1939, DOI 10.1084/jem.189.12.1939; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee SY, 2009, CANCER SCI, V100, P920, DOI 10.1111/j.1349-7006.2009.01130.x; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; Lietz A, 2007, BRIT J HAEMATOL, V137, P342, DOI 10.1111/j.1365-2141.2007.06583.x; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Mathas S, 2006, NAT IMMUNOL, V7, P207, DOI 10.1038/ni1285; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oyama T, 2007, P NATL ACAD SCI USA, V104, P9764, DOI 10.1073/pnas.0700240104; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; STANELLE J, 2010, BLOOD, DOI DOI 10.1182/BLOOD2010-01-265827; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu L, 2007, BLOOD, V110, P3618, DOI 10.1182/blood-2007-06-097030; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644	41	37	38	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	15					1831	1840		10.1038/onc.2010.544	http://dx.doi.org/10.1038/onc.2010.544			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	749ZM	21119597				2022-12-25	WOS:000289512200010
J	Meng, L; Hsu, JK; Tsai, RYL				Meng, L.; Hsu, J. K.; Tsai, R. Y. L.			GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest	ONCOGENE			English	Article						colorectal carcinoma; G2/M arrest; GNL3L; MDM2; nucleostemin; p53	CELL-CYCLE ARREST; RIBOSOMAL-PROTEIN L23; STEM-CELLS; ACTIVATES P53; NUCLEOSTEMIN; DEGRADATION; INHIBITION; STABILIZES; PROLIFERATION; PROGRESSION	Guanine nucleotide binding protein-like 3-like (GNL3L) is a nucleolar protein and the vertebrate paralogue of nucleostemin (NS). We previously reported that nucleoplasmic mobilization of NS stabilizes MDM2 (mouse double minute 2). Here, we investigated the role of GNL3L as a novel MDM2 regulator. We found that GNL3L binds MDM2 in vivo and displays the same function as NS in stabilizing MDM2 protein and preventing its ubiquitylation. The interaction between GNL3L and MDM2 also takes place in the nucleoplasm. However, the MDM2 regulatory activity of GNL3L occurs constitutively and does not so much depend on the nucleolar release mechanism as NS does. GNL3L depletion triggers G2/M arrest in the p53-wild-type HCT116 cells more than in the p53-null cells, and upregulates specific p53 targets (that is, Bax, 14-3-3 sigma and p21) without affecting the ubiquitylation or stability of p53 proteins. The inhibitory activity of GNL3L on p53-mediated transcription correlates with the increased expression of GNL3L and reduced expression of 14-3-3 sigma and p21 in human gastrointestinal tumors. This work shows that in contrast to most nucleolar proteins that negatively control MDM2, GNL3L and NS are the only two that are designed to stabilize MDM2 protein under basal or induced condition, respectively, and may act as tumor-promoting genes. Oncogene (2011) 30, 1716-1726; doi:10.1038/onc.2010.550; published online 6 December 2010	[Meng, L.; Hsu, J. K.; Tsai, R. Y. L.] Texas A&M Hlth Sci Ctr, Alkek Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Tsai, RYL (corresponding author), Texas A&M Hlth Sci Ctr, Alkek Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	rtsai@ibt.tamhsc.edu	Hsu, Joseph Kuang-Wu/N-2847-2013	Tsai, Robert/0000-0002-8357-0812	NCI-PHS [R01 CA113750]; NATIONAL CANCER INSTITUTE [R01CA113750] Funding Source: NIH RePORTER	NCI-PHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge Bert Vogelstein of the Johns Hopkins Oncology Center for providing the HCT116 cells. This work is supported by NCI-PHS grant R01 CA113750 to RY Tsai.	Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kubbutat MHG, 1999, CELL GROWTH DIFFER, V10, P87; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Maki N, 2007, DEV DYNAM, V236, P941, DOI 10.1002/dvdy.21027; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; Meng LJ, 2006, J CELL SCI, V119, P5124, DOI 10.1242/jcs.03292; Meng LJ, 2008, J CELL SCI, V121, P4037, DOI 10.1242/jcs.037952; Nikpour P, 2009, CELL PROLIFERAT, V42, P762, DOI 10.1111/j.1365-2184.2009.00635.x; Ohmura M, 2008, STEM CELLS, V26, P3237, DOI 10.1634/stemcells.2008-0506; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Siddiqi S, 2008, CIRC RES, V103, P89, DOI 10.1161/CIRCRESAHA.107.169334; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tsai RYL, 2009, INT J BIOCHEM CELL B, V41, P2122, DOI 10.1016/j.biocel.2009.05.020; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Yasumoto H, 2007, J CELL SCI, V120, P2532, DOI 10.1242/jcs.009878; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06; Zhu QB, 2009, J CELL BIOL, V185, P827, DOI 10.1083/jcb.200812121	30	25	31	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	14					1716	1726		10.1038/onc.2010.550	http://dx.doi.org/10.1038/onc.2010.550			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	746IS	21132010	Green Accepted			2022-12-25	WOS:000289239400009
J	Holley, RJ; Pickford, CE; Rushton, G; Lacaud, G; Gallagher, JT; Kouskoff, V; Merry, CLR				Holley, Rebecca J.; Pickford, Claire E.; Rushton, Graham; Lacaud, Georges; Gallagher, John T.; Kouskoff, Valerie; Merry, Catherine L. R.			Influencing Hematopoietic Differentiation of Mouse Embryonic Stem Cells using Soluble Heparin and Heparan Sulfate Saccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE STREAK; MITOGENIC ACTIVITY; ENDOTHELIAL-CELLS; PROGENITOR CELLS; SELF-RENEWAL; IN-VITRO; EXPRESSION; MICE; WNT; ACTIVATION	Heparan sulfate proteoglycans (HSPG) encompass some of the most abundant macromolecules on the surface of almost every cell type. Heparan sulfate (HS) chains provide a key interaction surface for the binding of numerous proteins such as growth factors and morphogens, helping to define the ability of a cell to respond selectively to environmental cues. The specificity of HS-protein interactions are governed predominantly by the order and positioning of sulfate groups, with distinct cell types expressing unique sets of HS epitopes. Embryos deficient in HS-synthesis (Ext1(-/-)) exhibit pre-gastrulation lethality and lack recognizable organized mesoderm and extraembryonic tissues. Here we demonstrate that embryonic stem cells (ESCs) derived from Ext1(-/-) embryos are unable to differentiate into hematopoietic lineages, instead retaining ESC marker expression throughout embryoid body (EB) culture. However hematopoietic differentiation can be restored by the addition of soluble heparin. Consistent with specific size and composition requirements for HS: growth factor signaling, chains measuring at least 12 saccharides were required for partial rescue of hematopoiesis with longer chains (18 saccharides or more) required for complete rescue. Critically N- and 6-O-sulfate groups were essential for rescue. Heparin addition restored the activity of multiple signaling pathways including bone morphogenic protein (BMP) with activation of phospho-SMADs re-established by the addition of heparin. Heparin addition to wild-type cultures also altered the outcome of differentiation, promoting hematopoiesis at low concentrations, yet inhibiting blood formation at high concentrations. Thus altering the levels of HS and HS sulfation within differentiating ESC cultures provides an attractive and accessible mechanism for influencing cell fate.	[Merry, Catherine L. R.] Univ Manchester, Sch Mat, Ctr Mat Sci, Stem Cell Glycobiol Grp, Manchester M13 9PL, Lancs, England; [Rushton, Graham; Lacaud, Georges; Gallagher, John T.; Kouskoff, Valerie] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England	University of Manchester; Paterson Institute for Cancer Research; University of Manchester	Merry, CLR (corresponding author), Univ Manchester, Sch Mat, Ctr Mat Sci, Stem Cell Glycobiol Grp, Manchester M13 9PL, Lancs, England.	Catherine.merry@manchester.ac.uk	Merry, Catherine/B-5713-2013; lacaud, Georges/ABH-5215-2020; Pickford, Claire/C-9815-2013	Lacaud, Georges/0000-0002-5630-2417; merry, catherine/0000-0002-3490-2809	Cancer Research UK; Human Frontier Science Program; Medical Research Council; MRC [G0701165] Funding Source: UKRI; Cancer Research UK [12486, 12487] Funding Source: researchfish; Medical Research Council [G0701165] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by Cancer Research UK (to V. K., J. T. G., G. R., and G. L.), The Human Frontier Science Program (to R. J. H. and C. L. R. M.), and The Medical Research Council (to C. E. P. and C. L. R. M.). John Gallagher is CEO of Iduron plc, the supplier of the oligosaccharides used in this study.	Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; CONLON FL, 1994, DEVELOPMENT, V120, P1919; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; JONES CM, 1991, DEVELOPMENT, V111, P531; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Kraushaar DC, 2010, J BIOL CHEM, V285, P5907, DOI 10.1074/jbc.M109.066837; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Palis J, 1999, DEVELOPMENT, V126, P5073; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Pearson S, 2008, DEVELOPMENT, V135, P1525, DOI 10.1242/dev.011767; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Robson P, 2001, DEV BIOL, V234, P317, DOI 10.1006/dbio.2001.0274; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Ward CM, 2003, J CELL SCI, V116, P4533, DOI 10.1242/jcs.00767; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	41	37	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6241	6252		10.1074/jbc.M110.178483	http://dx.doi.org/10.1074/jbc.M110.178483			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148566	Green Published, hybrid			2022-12-25	WOS:000287476400034
J	Machwe, A; Lozada, E; Wold, MS; Li, GM; Orren, DK				Machwe, Amrita; Lozada, Enerlyn; Wold, Marc S.; Li, Guo-Min; Orren, David K.			Molecular Cooperation between the Werner Syndrome Protein and Replication Protein A in Relation to Replication Fork Blockage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ROTHMUND-THOMSON-SYNDROME; S-PHASE; SYNDROME HELICASE; CELL-CYCLE; BIOCHEMICAL-CHARACTERIZATION; ANNEALING ACTIVITIES; RPA PHOSPHORYLATION; HUMAN RECQ5-BETA; BINDING PROTEIN	The premature aging and cancer-prone disease Werner syndrome is caused by loss of function of the RecQ helicase family member Werner syndrome protein (WRN). At the cellular level, loss of WRN results in replication abnormalities and chromosomal aberrations, indicating that WRN plays a role in maintenance of genome stability. Consistent with this notion, WRN possesses annealing, exonuclease, and ATPase-dependent helicase activity on DNA substrates, with particularly high affinity for and activity on replication and recombination structures. After certain DNA-damaging treatments, WRN is recruited to sites of blocked replication and co-localizes with the human single-stranded DNA-binding protein replication protein A (RPA). In this study we examined the physical and functional interaction between WRN and RPA specifically in relation to replication fork blockage. Co-immunoprecipitation experiments demonstrated that damaging treatments that block DNA replication substantially increased association between WRN and RPA in vivo, and a direct interaction between purified WRN and RPA was confirmed. Furthermore, we examined the combined action of RPA (unmodified and hyperphosphorylation mimetic) and WRN on model replication fork and gapped duplex substrates designed to bind RPA. Even with RPA bound stoichiometrically to this gap, WRN efficiently catalyzed regression of the fork substrate. Further analysis showed that RPA could be displaced from both substrates by WRN. RPA displacement by WRN was independent of its ATPase-and helicase-dependent remodeling of the fork. Taken together, our results suggest that, upon replication blockage, WRN and RPA functionally interact and cooperate to help properly resolve replication forks and maintain genome stability.	[Machwe, Amrita; Lozada, Enerlyn; Li, Guo-Min; Orren, David K.] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Li, Guo-Min; Orren, David K.] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Wold, Marc S.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Kentucky; University of Kentucky; University of Iowa	Orren, DK (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, 356 Hlth Sci Res Bldg,1095 VAD, Lexington, KY 40536 USA.	dkorre2@uky.edu		Li, Guo-Min/0000-0002-9842-4578; Wold, Marc/0000-0002-4580-1624	National Institutes of Health [R01 CA113371]; NIA [AG027258]; NIA, National Institutes of Health [R01 AG026534]; NATIONAL CANCER INSTITUTE [R01CA113371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027258, R01AG026534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA113371 and by AG027258 (NIA) (to D. K. O.).; Supported in part by NIA, National Institutes of Health Grant R01 AG026534.	Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Anantha RW, 2009, CELL CYCLE, V8, P357, DOI 10.4161/cc.8.3.7496; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Binz SK, 2003, J BIOL CHEM, V278, P35584, DOI 10.1074/jbc.M305388200; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5; Guo SL, 2006, J BIOL CHEM, V281, P21607, DOI 10.1074/jbc.M603504200; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Karmakar P, 2005, MECH AGEING DEV, V126, P1146, DOI 10.1016/j.mad.2005.06.004; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lee SJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000801; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-6; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Machwe A, 2002, J BIOL CHEM, V277, P4492, DOI 10.1074/jbc.M108880200; Machwe A, 2007, NUCLEIC ACIDS RES, V35, P5729, DOI 10.1093/nar/gkm561; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; MITSIS PG, 1995, DEV BIOL, V170, P445, DOI 10.1006/dbio.1995.1228; Nasheuer HP, 2002, PROG NUCLEIC ACID RE, V72, P41, DOI 10.1016/S0079-6603(02)72067-9; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Oakley GG, 2001, MOL BIOL CELL, V12, P1199, DOI 10.1091/mbc.12.5.1199; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Poot M, 2001, FASEB J, V15, P1224, DOI 10.1096/fj.00-0611fje; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Rodriguez-Lopez AM, 2002, AGING CELL, V1, P30, DOI 10.1046/j.1474-9728.2002.00002.x; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; STATES JC, 1993, CARCINOGENESIS, V14, P1643, DOI 10.1093/carcin/14.8.1643; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	74	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3497	3508		10.1074/jbc.M110.105411	http://dx.doi.org/10.1074/jbc.M110.105411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21107010	Green Published, hybrid			2022-12-25	WOS:000286653200035
J	Morrone, A; McCully, ME; Bryan, PN; Brunori, M; Daggett, V; Gianni, S; Travaglini-Allocatelli, C				Morrone, Angela; McCully, Michelle E.; Bryan, Philip N.; Brunori, Maurizio; Daggett, Valerie; Gianni, Stefano; Travaglini-Allocatelli, Carlo			The Denatured State Dictates the Topology of Two Proteins with Almost Identical Sequence but Different Native Structure and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FOLDING TRANSITION-STATE; CHYMOTRYPSIN INHIBITOR-2; HOMOLOGOUS PROTEINS; SECONDARY STRUCTURE; NUCLEIC-ACIDS; ALPHA-HELIX; PATHWAY; INTERMEDIATE; MECHANISM	The protein folding problem is often studied by comparing the mechanisms of proteins sharing the same structure but different sequence. The recent design of the two proteins G(A)88 and G(B)88, displaying different structures and functions while sharing 88% sequence identity (49 out of 56 amino acids), allows the unique opportunity for a complementary approach. At which stage of its folding pathway does a protein commit to a given topology? Which residues are crucial in directing folding mechanisms to a given structure? By using a combination of biophysical and computational techniques, we have characterized the folding of both G(A)88 and G(B)88. We show that, contrary to expectation, G(B)88, characterized by a native alpha+beta fold, displays in the denatured state a content of native-like helical structure greater than G(A)88, which is all-alpha in its native state. Both experiments and simulations indicate that such residual structure may be tuned by changing pH. Thus, despite the high sequence identity, the folding pathways for these two proteins appear to diverge as early as in the denatured state. Our results suggest a mechanism whereby protein topology is committed very early along the folding pathway, being imprinted in the residual structure of the denatured state.	[McCully, Michelle E.; Daggett, Valerie] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA; [McCully, Michelle E.; Daggett, Valerie] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Morrone, Angela; Brunori, Maurizio; Gianni, Stefano; Travaglini-Allocatelli, Carlo] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Ist Biol & Patol Mol CNR, I-00185 Rome, Italy; [Morrone, Angela; Brunori, Maurizio; Gianni, Stefano; Travaglini-Allocatelli, Carlo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Bryan, Philip N.] Univ Maryland, Dept Bioengn, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Daggett, V (corresponding author), Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA.	daggett@u.washington.edu; stefano.gianni@uniroma1.it	gianni, stefano/C-8536-2009	Travaglini-Allocatelli, Carlo/0000-0001-8735-1126; Brunori, Maurizio/0000-0002-7795-1635; Gianni, Stefano/0000-0003-1653-1925	Italian Ministero dell'Istruzione dell'Universita e della Ricerca [2007B57EAB_004, 20074TJ3ZB_005, RBRN07BMCT_007]; National Institutes of Health [GM50789, GM062154]; Department of Defense through the National Defense Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050789, R01GM062154, R01GM050789] Funding Source: NIH RePORTER	Italian Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense through the National Defense Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by grants from the Italian Ministero dell'Istruzione dell'Universita e della Ricerca (Grants 2007B57EAB_004, 20074TJ3ZB_005, and RBRN07BMCT_007). This work was supported, in whole or in part, by National Institutes of Health Grants GM50789 (to V. D.) and GM062154 (to P. N. B.). This work was also supported by a grant from the Department of Defense through the National Defense Science and Engineering Graduate Fellowship Program (to M. E. M.) for the MD studies.	Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; Alexander PA, 2009, P NATL ACAD SCI USA, V106, P21149, DOI 10.1073/pnas.0906408106; [Anonymous], 2005, SCIENCE, V309, P78; Beck DAC, 2004, METHODS, V34, P112, DOI 10.1016/j.ymeth.2004.03.008; Calosci N, 2008, P NATL ACAD SCI USA, V105, P19241, DOI 10.1073/pnas.0804774105; Chi CN, 2007, FEBS LETT, V581, P1109, DOI 10.1016/j.febslet.2007.02.011; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Dalal S, 1997, NAT STRUCT BIOL, V4, P548, DOI 10.1038/nsb0797-548; Davidson AR, 2008, P NATL ACAD SCI USA, V105, P2759, DOI 10.1073/pnas.0800030105; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Friel CT, 2003, J MOL BIOL, V326, P293, DOI 10.1016/S0022-2836(02)01249-4; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; He Y, 2008, P NATL ACAD SCI USA, V105, P14412, DOI 10.1073/pnas.0805857105; Hubner IA, 2006, J MOL BIOL, V359, P1075, DOI 10.1016/j.jmb.2006.04.015; Ivarsson Y, 2008, PROTEIN ENG DES SEL, V21, P155, DOI 10.1093/protein/gzm077; Ivarsson Y, 2009, J AM CHEM SOC, V131, P11727, DOI 10.1021/ja900438b; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Levitt M, 1997, J PHYS CHEM B, V101, P5051, DOI 10.1021/jp964020s; LEVITT M, 1995, COMPUT PHYS COMMUN, V91, P215, DOI 10.1016/0010-4655(95)00049-L; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; Li AJ, 1996, J MOL BIOL, V257, P412, DOI 10.1006/jmbi.1996.0172; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; ROSE GD, 1994, PROTEINS, V19, P1, DOI 10.1002/prot.340190102; Ruan B, 2004, BIOCHEMISTRY-US, V43, P14539, DOI 10.1021/bi048177j; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scott KA, 2007, BIOCHEMISTRY-US, V46, P1545, DOI 10.1021/bi061904l; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Travaglini-Allocatelli C, 2005, J BIOL CHEM, V280, P25729, DOI 10.1074/jbc.M502628200; Travaglini-Allocatelli C, 2003, J BIOL CHEM, V278, P41136, DOI 10.1074/jbc.M303990200; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; Wensley BG, 2009, J MOL BIOL, V390, P1074, DOI 10.1016/j.jmb.2009.05.010; White GWN, 2005, J MOL BIOL, V350, P757, DOI 10.1016/j.jmb.2005.05.005; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550	48	35	35	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3863	3872		10.1074/jbc.M110.155911	http://dx.doi.org/10.1074/jbc.M110.155911			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118804	Green Published, hybrid			2022-12-25	WOS:000286653200067
J	Mares, CA; Sharma, J; Ojeda, SS; Li, Q; Campos, JA; Morris, EG; Coalson, JJ; Teale, JM				Mares, Chris A.; Sharma, Jyotika; Ojeda, Sandra S.; Li, Qun; Campos, Jocelyn A.; Morris, Elizabeth G.; Coalson, Jacqueline J.; Teale, Judy M.			Attenuated Response of Aged Mice to Respiratory Francisella novicida Is Characterized by Reduced Cell Death and Absence of Subsequent Hypercytokinemia	PLOS ONE			English	Article							INNATE IMMUNITY; SEVERE SEPSIS; OLD MICE; TULARENSIS; INFECTION; TULAREMIA; ADULT; IMMUNOSENESCENCE; TUBERCULOSIS; RESISTANCE	Background: Pneumonia and pulmonary infections are major causes of mortality among the growing elderly population. Age associated attenuations of various immune parameters, involved with both innate and adaptive responses are collectively known as immune senescence. These changes are likely to be involved with differences in host susceptibility to disease between young and aged individuals. Methodology/Principal Findings: The objective of this study was to assess potential age related differences in the pulmonary host response in mice to the Gram-negative respiratory pathogen, Francisella novicida. We intranasally infected mice with F. novicida and compared various immune and pathological parameters of the pulmonary host response in both young and aged mice. Conclusions/Significance: We observed that 20% of aged mice were able to survive an intranasal challenge with F. novicida while all of their younger cohorts died consistently within 4 to 6 days post infection. Further experiments revealed that all of the aged mice tested were initially able to control bacterial replication in the lungs as well as at distal sites of replication compared with young mice. In addition, the small cohort of aged survivors did not progress to a severe sepsis syndrome with hypercytokinemia, as did all of the young adult mice. Finally, a lack of widespread cell death in potential aged survivors coupled with a difference in cell types recruited to sites of infection within the lung confirmed an altered host response to Francisella in aged mice.	[Mares, Chris A.; Ojeda, Sandra S.; Teale, Judy M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Sharma, Jyotika; Li, Qun; Campos, Jocelyn A.; Morris, Elizabeth G.; Teale, Judy M.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Sharma, Jyotika; Li, Qun; Campos, Jocelyn A.; Morris, Elizabeth G.; Teale, Judy M.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Coalson, Jacqueline J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio	Mares, CA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	judy.teale@utsa.edu		Mares, Chris/0000-0002-5160-7326	National Institutes of Health (NIH) [AI 59703, 1P01A10157986, NS35974, T32AI7271]; National Institute of Aging [1R36AG033400-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007271, R01AI059703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R36AG033400] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by awards AI 59703, 1P01A10157986, NS35974, from the National Institutes of Health (NIH). C.A.M. was also supported through departmental training grant T32AI7271 from the NIH and 1R36AG033400-01 from the National Institute of Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantel H, 2009, CRIT CARE, V13, DOI 10.1186/cc7966; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Butcher S, 2000, IMMUNOLOGY, V100, P411, DOI 10.1046/j.1365-2567.2000.00079.x; Christova I, 2004, SCAND J INFECT DIS, V36, P785, DOI 10.1080/00365540410021199; COALSON JJ, 1983, ANAT REC, V205, P233, DOI 10.1002/ar.1092050214; COOPER AM, 1995, INFECT IMMUN, V63, P3259, DOI 10.1128/IAI.63.9.3259-3265.1995; Ehrchen J, 2004, INFECT IMMUN, V72, P5106, DOI 10.1128/IAI.72.9.5106-5114.2004; EVANS ME, 1985, MEDICINE, V64, P251, DOI 10.1097/00005792-198507000-00006; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Ginaldi L, 2000, GERONTOLOGY, V46, P242, DOI 10.1159/000022167; Ginaldi L, 2001, MICROBES INFECT, V3, P851, DOI 10.1016/S1286-4579(01)01443-5; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013; High KP, 2007, BIOGERONTOLOGY, V8, P583, DOI 10.1007/s10522-007-9106-6; High KP, 2004, AGEING RES REV, V3, P1, DOI 10.1016/j.arr.2003.08.001; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Kaplan V, 2003, CRIT CARE CLIN, V19, P729, DOI 10.1016/S0749-0704(03)00057-5; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; MARES CA, 2009, EXP GERONTOL; Mares CA, 2008, INFECT IMMUN, V76, P3001, DOI 10.1128/IAI.00215-08; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Meyer Keith C, 2005, Proc Am Thorac Soc, V2, P433, DOI 10.1513/pats.200508-081JS; Ojeda SS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-215; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pawelec G, 2004, TRENDS IMMUNOL, V25, P406, DOI 10.1016/j.it.2004.05.006; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Sebastian C, 2005, IMMUNOBIOLOGY, V210, P121, DOI 10.1016/j.imbio.2005.05.006; Sharma J, 2009, INFECT IMMUN, V77, P4314, DOI 10.1128/IAI.00654-09; Sharma J, 2009, J LEUKOCYTE BIOL, V86, P491, DOI 10.1189/jlb.1208728; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Solana R, 2006, IMMUNITY, V24, P491, DOI 10.1016/j.immuni.2006.05.003; TAYLOR JP, 1991, AM J EPIDEMIOL, V133, P1032, DOI 10.1093/oxfordjournals.aje.a115812; Turner J, 2002, INFECT IMMUN, V70, P4628, DOI 10.1128/IAI.70.8.4628-4637.2002; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007	39	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14088	10.1371/journal.pone.0014088	http://dx.doi.org/10.1371/journal.pone.0014088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124895	Green Published, gold, Green Submitted			2022-12-25	WOS:000284527900006
J	Hutson, SL; Mui, E; Kinsley, K; Witola, WH; Behnke, MS; El Bissati, K; Muench, SP; Rohrman, B; Liu, SR; Wollmann, R; Ogata, Y; Sarkeshik, A; Yates, JR; McLeod, R				Hutson, Samuel L.; Mui, Ernest; Kinsley, Karen; Witola, William H.; Behnke, Michael S.; El Bissati, Kamal; Muench, Stephen P.; Rohrman, Brittany; Liu, Susan R.; Wollmann, Robert; Ogata, Yuko; Sarkeshik, Ali; Yates, John R., III; McLeod, Rima			T. gondii RP Promoters & Knockdown Reveal Molecular Pathways Associated with Proliferation and Cell-Cycle Arrest	PLOS ONE			English	Article							PARASITE TOXOPLASMA-GONDII; ACTIVATED PROTEIN PHOSPHATASE; TRANSCRIPTION FACTORS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; RIBOSOME BIOGENESIS; G(1) ARREST; DNA-BINDING; STAGE; MECHANISM	Molecular pathways regulating rapid proliferation and persistence are fundamental for pathogens but are not elucidated fully in Toxoplasma gondii. Promoters of T. gondii ribosomal proteins (RPs) were analyzed by EMSAs and ChIP. One RP promoter domain, known to bind an Apetela 2, bound to nuclear extract proteins. Promoter domains appeared to associate with histone acetyl transferases. To study effects of a RP gene's regulation in T. gondii, mutant parasites (Delta rps13) were engineered with integration of tetracycline repressor (TetR) response elements in a critical location in the rps13 promoter and transfection of a yellow fluorescent-tetracycline repressor (YFP-TetR). This permitted conditional knockdown of rps13 expression in a tightly regulated manner. Delta rps13 parasites were studied in the presence (+ATc) or absence of anhydrotetracycline (-ATc) in culture. -ATc, transcription of the rps13 gene and expression of RPS13 protein were markedly diminished, with concomitant cessation of parasite replication. Study of Delta rps13 expressing Myc-tagged RPL22, -ATc, showed RPL22 diminished but at a slower rate. Quantitation of RNA showed diminution of 18S RNA. Depletion of RPS13 caused arrest of parasites in the G1 cell cycle phase, thereby stopping parasite proliferation. Transcriptional differences +/- ATc implicate molecules likely to function in regulation of these processes. In vitro, -ATc, Delta rps13 persists for months and the proliferation phenotype can be rescued with ATc. In vivo, however, Delta rps13 could only be rescued when ATc was given simultaneously and not at any time after 1 week, even when L-NAME and ATc were administered. Immunization with Delta rps13 parasites protects mice completely against subsequent challenge with wildtype clonal Type 1 parasites, and robustly protects mice against wildtype clonal Type 2 parasites. Our results demonstrate that G1 arrest by ribosomal protein depletion is associated with persistence of T. gondii in a model system in vitro and immunization with Delta rps13 protects mice against subsequent challenge with wildtype parasites.	[Hutson, Samuel L.; Mui, Ernest; Kinsley, Karen; Witola, William H.; El Bissati, Kamal; Rohrman, Brittany; Liu, Susan R.; McLeod, Rima] Univ Chicago, Dept Surg Ophthalmol, Chicago, IL 60637 USA; [Behnke, Michael S.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; [Muench, Stephen P.] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England; [Wollmann, Robert] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Ogata, Yuko] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Sarkeshik, Ali; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [McLeod, Rima] Univ Chicago, Dept Pediat Infect Dis, Chicago, IL 60637 USA; [McLeod, Rima] Univ Chicago, Inst Genom & Syst Biol, Comm Immunol, The Coll, Chicago, IL 60637 USA; [McLeod, Rima] Univ Chicago, Inst Genom & Syst Biol, Comm Mol Med, The Coll, Chicago, IL 60637 USA; [McLeod, Rima] Univ Chicago, Inst Genom & Syst Biol, Comm Genet, The Coll, Chicago, IL 60637 USA	University of Chicago; Montana State University System; Montana State University Bozeman; University of Leeds; University of Chicago; Center for Infectious Disease Research; Scripps Research Institute; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Hutson, SL (corresponding author), Univ Chicago, Dept Surg Ophthalmol, Chicago, IL 60637 USA.	rmcleod@midway.uchicago.edu	Witola, WIlliam Harold/AAD-6647-2020; Behnke, Michael S/R-8839-2016; Muench, Stephen/AAI-9529-2020	Behnke, Michael S/0000-0002-4668-8109; Muench, Stephen/0000-0001-6869-4414; EL BISSATI, KAMAL/0000-0001-9341-4162	Fin Charity Trust; Rooney Aldens, Peter Mann and Dominique Cornwell Family Trust; Intervet/Schering Plough; Toxoplasmosis Research Institute; Research to Prevent Blindness Foundation; Howard Hughes Foundation; National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R01AI043228, U01 AI082180-01, U01 AI 77887, R01 AI071319-01, NIH P41RR0118232]; Morel family; Jackson family; Orlinsky family; Goldberg family; Taub family; Kapnick family; Schilling family; Kiewit family; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043228, R01AI071319, U01AI077887, U01AI082180] Funding Source: NIH RePORTER	Fin Charity Trust; Rooney Aldens, Peter Mann and Dominique Cornwell Family Trust; Intervet/Schering Plough(Merck & CompanySchering Plough Corporation); Toxoplasmosis Research Institute; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Howard Hughes Foundation(Howard Hughes Medical Institute); National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Morel family; Jackson family; Orlinsky family; Goldberg family; Taub family; Kapnick family; Schilling family; Kiewit family; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge support of this work by gifts from the Fin Charity Trust, the Rooney Aldens, the Peter Mann and Dominique Cornwell Family Trust, the Morel, Jackson, Orlinsky, Goldberg, Taub, Kapnick, Schilling, and Kiewit families, Intervet/Schering Plough, Toxoplasmosis Research Institute, The Research to Prevent Blindness Foundation, The Howard Hughes Foundation Undergraduate Summer Research Program in Neurosciences (BR), and National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases R01AI043228, U01 AI082180-01, U01 AI 77887, R01 AI071319-01 (RM), NIH P41RR0118232 (JY). The funders had no role in study design, data collection and analysis, or decision to publish.	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Ball HL, 2009, HUM MOL GENET, V18, P3684, DOI 10.1093/hmg/ddp316; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Cech TR, 2000, SCIENCE, V289, P878, DOI 10.1126/science.289.5481.878; COCIORVA D, 2006, CURRENT PROTOCOLS S, V16; Connolly LE, 2009, CELL HOST MICROBE, V6, P1, DOI 10.1016/j.chom.2009.07.001; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Deitsch K, 2007, AM J TROP MED HYG, V77, P201; Diaz-Martin J, 2005, PLANT PHYSIOL, V139, P1483, DOI 10.1104/pp.105.069963; Diop SB, 2008, EMBO REP, V9, P260, DOI 10.1038/embor.2008.8; Donald RGK, 1998, MOL BIOCHEM PARASIT, V91, P295, DOI 10.1016/S0166-6851(97)00210-7; Eaton MS, 2006, INT J PARASITOL, V36, P107, DOI 10.1016/j.ijpara.2005.08.014; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferguson DJP, 2005, EUKARYOT CELL, V4, P814, DOI 10.1128/EC.4.4.814-826.2005; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Ferreira-Cerca S, 2009, NATURE, V459, P46, DOI 10.1038/459046a; Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; GOSSEN M, 1993, NUCLEIC ACIDS RES, V21, P4411, DOI 10.1093/nar/21.18.4411; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Howitt CA, 2009, MOL MICROBIOL, V73, P1171, DOI 10.1111/j.1365-2958.2009.06846.x; Ito T, 2000, PLANT J, V22, P257, DOI 10.1046/j.1365-313x.2000.00728.x; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kasper DC, 2009, DIAGN MICR INFEC DIS, V63, P10, DOI 10.1016/j.diagmicrobio.2008.09.009; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kibe MK, 2005, NUCLEIC ACIDS RES, V33, P1722, DOI 10.1093/nar/gki314; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LINDNER SE, 2009, J MOL BIOL; MACK DG, 1984, ANTIMICROB AGENTS CH, V26, P26, DOI 10.1128/AAC.26.1.26; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; McCourt PC, 2009, J BIOL CHEM, V284, P11930, DOI 10.1074/jbc.M900857200; MCLEOD R, 1988, J IMMUNOL, V140, P1632; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Mui EJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000190; Mullapudi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r34; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Opferman JT, 2006, CELL DEATH DIFFER, V13, P898, DOI 10.1038/sj.cdd.4401923; Radke JR, 2003, MOL BIOCHEM PARASIT, V131, P119, DOI 10.1016/S0166-6851(03)00198-1; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Radke JR, 1998, MOL BIOCHEM PARASIT, V94, P237, DOI 10.1016/S0166-6851(98)00074-7; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Roberts F, 2000, PARASITE IMMUNOL, V22, P1, DOI 10.1046/j.1365-3024.2000.00259.x; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schaap D, 2005, MOL BIOCHEM PARASIT, V139, P239, DOI 10.1016/j.molbiopara.2004.11.011; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Smith AT, 2005, EUKARYOT CELL, V4, P2057, DOI 10.1128/EC.4.12.2057-2065.2005; Stockinger EJ, 2001, NUCLEIC ACIDS RES, V29, P1524, DOI 10.1093/nar/29.7.1524; Sullivan WJ, 2009, MEM I OSWALDO CRUZ, V104, P155, DOI 10.1590/S0074-02762009000200005; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Van Poppel NFJ, 2006, PARASITOLOGY, V133, P19, DOI 10.1017/S0031182006009954; van Poppel NFJ, 2006, INT J PARASITOL, V36, P443, DOI 10.1016/j.ijpara.2006.01.005; VANPOPPEL NF, 2005, TRANSCRIPTIONAL REGU, P110; Vonlaufen N, 2008, CELL MICROBIOL, V10, P2387, DOI 10.1111/j.1462-5822.2008.01210.x; Vonlaufen N, 2010, J BIOL CHEM, V285, P11154, DOI 10.1074/jbc.M109.066134; Yonath A, 2006, NATURE, V444, P435, DOI 10.1038/444435a; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	77	23	23	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14057	10.1371/journal.pone.0014057	http://dx.doi.org/10.1371/journal.pone.0014057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124925	Green Submitted, Green Published, gold			2022-12-25	WOS:000284467200004
J	Lee, C; Mayfield, RD; Harris, RA				Lee, Changhoon; Mayfield, R. Dayne; Harris, R. Adron			Intron 4 Containing Novel GABAB1 Isoforms Impair GABAB Receptor Function	PLOS ONE			English	Article							N-TERMINAL VARIANT; AMINOBUTYRIC-ACID RECEPTOR; GENE-EXPRESSION; ALTERNATIVE PROMOTERS; FRONTAL-CORTEX; SUBUNIT; PROTEIN; IDENTIFICATION; MEMBRANE; PATTERNS	Background: Gamma-aminobutyric acid type B (GABAB) receptors decrease neural activity through G protein signaling. There are two subunits, GABAB1 and GABAB2. Alternative splicing provides GABAB1 with structural and functional diversity. cDNA microarrays showed strong signals from human brain RNA using GABAB1 intron 4 region probes. Therefore, we predicted the existence of novel splice variants. Methodology/Principal Findings: Based on the probe sequence analysis, we proposed two possible splice variants, GABAB1j and GABAB1k. The existence of human GABAB1j was verified by quantitative real-time PCR, and mouse GABAB1j was found from a microarray probe set based on human GABAB1j sequence. GABAB1j open reading frames (ORF) and expression patterns are not conserved across species, and they do not have any important functional domains except sushi domains. Thus, we focused on another possible splice variant, GABAB1k. After obtaining PCR evidence for GABAB1k existence from human, mouse, and rat, it was cloned from human and mouse by PCR along with three additional isoforms, GABAB1l, GABAB1m, and GABAB1n. Their expression levels by quantitative real-time PCR are relatively low in brain although they may be expressed in specific cell types. GABAB1l and GABAB1m inhibit GABAB receptor-induced G protein-activated inwardly rectifying K(+) channel (GIRK) currents at Xenopus oocyte two-electrode voltage clamp system. Conclusions/Significance: This study supports previous suggestions that intron 4 of GABAB1 gene is a frequent splicing spot across species. Like GABAB1e, GABAB1l and GABAB1m do not have transmembrane domains but have a dimerization motif. So, they also could be secreted and bind GABAB2 dominantly instead of GABAB1a. However, only GABAB1l and GABAB1m are N- and C-terminal truncated splicing variants and impair receptor function. This suggests that the intron 4 containing N-terminal truncation is necessary for the inhibitory action of the new splice variants.	[Lee, Changhoon] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lee, C (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Neurobiol Sect, Austin, TX 78712 USA.	ninolee00@mail.utexas.edu		Lee, Chang Hoon/0000-0002-4031-3795	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [AA06399]; NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA)-West consortium; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA006399, R01AA006399, R01AA012404, R28AA012725] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA)-West consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)Instituto de Investigacion Agropecuaria (INIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant AA06399 and by the NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA)-West consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Billinton A, 2001, TRENDS NEUROSCI, V24, P277, DOI 10.1016/S0166-2236(00)01815-4; Bulanova E, 2007, J BIOL CHEM, V282, P13167, DOI 10.1074/jbc.M610036200; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; Chang WH, 2007, J BIOL CHEM, V282, P25030, DOI 10.1074/jbc.M700924200; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Crofts LA, 1998, P NATL ACAD SCI USA, V95, P10529, DOI 10.1073/pnas.95.18.10529; Ezzat S, 2001, BIOCHEM BIOPH RES CO, V287, P60, DOI 10.1006/bbrc.2001.5546; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Holter J, 2005, J MOL NEUROSCI, V26, P99, DOI 10.1385/JMN:26:1:099; Huang JM, 2009, EXP CELL RES, V315, P1200, DOI 10.1016/j.yexcr.2009.01.004; LAMOND AI, 1985, CELL, V40, P319, DOI 10.1016/0092-8674(85)90146-1; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Liu JW, 2004, J NEUROCHEM, V90, P1050, DOI 10.1111/j.1471-4159.2004.02570.x; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; Park H, 2005, J NEUROSCI, V25, P9037, DOI 10.1523/JNEUROSCI.1989-05.2005; Ponomarev I, 2006, J NEUROSCI, V26, P5673, DOI 10.1523/JNEUROSCI.0860-06.2006; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004; Sunn KL, 2001, MOL ENDOCRINOL, V15, P1599, DOI 10.1210/me.15.9.1599; Tiao JY, 2008, J BIOL CHEM, V283, P31005, DOI 10.1074/jbc.M804464200; Travers MT, 2003, BBA-MOL CELL BIOL L, V1634, P97, DOI 10.1016/j.bbalip.2003.09.005; Uezono Y, 2006, AM J PHYSIOL-CELL PH, V290, pC200, DOI 10.1152/ajpcell.00269.2005; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; VOLIVA CF, 1992, MOL CELL BIOL, V12, P2383, DOI 10.1128/MCB.12.5.2383; Wang Z, 1996, J BIOL CHEM, V271, P7835, DOI 10.1074/jbc.271.13.7835; Wei KR, 2001, MOL BRAIN RES, V89, P103, DOI 10.1016/S0169-328X(01)00068-7	32	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14044	10.1371/journal.pone.0014044	http://dx.doi.org/10.1371/journal.pone.0014044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124972	Green Published, Green Submitted, gold			2022-12-25	WOS:000284356900007
J	Papaconstantinou, M; Pepper, AN; Wu, Y; Kasimer, D; Westwood, T; Campos, AR; Bedard, PA				Papaconstantinou, Maria; Pepper, Alicia N.; Wu, Ying; Kasimer, Dahlia; Westwood, Tim; Campos, Ana Regina; Bedard, Pierre-Andre			Menin Links the Stress Response to Genome Stability in Drosophila melanogaster	PLOS ONE			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; HISTONE METHYLTRANSFERASE COMPLEX; TUMOR-SUPPRESSOR PROTEIN; DNA-DAMAGE; HEAT-SHOCK; GENE-EXPRESSION; TYPE-1; TRANSCRIPTION; INTERACTS; REPAIR	Background: The multiple endocrine neoplasia type I gene functions as a tumor suppressor gene in humans and mouse models. In Drosophila melanogaster, mutants of the menin gene (Mnn1) are hypersensitive to mutagens or gamma irradiation and have profound defects in the response to several stresses including heat shock, hypoxia, hyperosmolarity and oxidative stress. However, it is not known if the function of menin in the stress response contributes to genome stability. The objective of this study was to examine the role of menin in the control of the stress response and genome stability. Methodology/Principal Findings: Using a test of loss-of-heterozygosity, we show that Drosophila strains lacking a functional Mnn1 gene or expressing a Mnn1 dsRNA display increased genome instability in response to non-lethal heat shock or hypoxia treatments. This is also true for strains lacking all Hsp70 genes, implying that a precise control of the stress response is required for genome stability. While menin is required for Hsp70 expression, the results of epistatic studies indicate that the increase in genome instability observed in Mnn1 lack-of-function mutants cannot be accounted for by mis-expression of Hsp70. Therefore, menin may promote genome stability by controlling the expression of other stress-responsive genes. In agreement with this notion, gene profiling reveals that Mnn1 is required for sustained expression of all heat shock protein genes but is dispensable for early induction of the heat shock response. Conclusions/Significance: Mutants of the Mnn1 gene are hypersensitive to several stresses and display increased genome instability when subjected to conditions, such as heat shock, generally regarded as non-genotoxic. In this report, we describe a role for menin as a global regulator of heat shock gene expression and critical factor in the maintenance of genome integrity. Therefore, menin links the stress response to the control of genome stability in Drosophila melanogaster.	[Papaconstantinou, Maria; Pepper, Alicia N.; Wu, Ying; Campos, Ana Regina; Bedard, Pierre-Andre] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Kasimer, Dahlia; Westwood, Tim] Univ Toronto, Dept Cell & Syst Biol, Mississauga, ON L5L 1C6, Canada; [Kasimer, Dahlia; Westwood, Tim] Univ Toronto, Canadian Drosophila Microarray Ctr, Mississauga, ON L5L 1C6, Canada	McMaster University; University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Mississauga	Papaconstantinou, M (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	abedard@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [MOP-84359]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	JTW and DK were supported by Discovery and Major Facility Access grants from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). This work was funded by a grant from the Canadian Institutes of Health Research to PAB and ARC (MOP-84359; www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Agarwal SK, 2005, HORM METAB RES, V37, P369, DOI 10.1055/s-2005-870139; BAKER BS, 1978, GENETICS, V90, P531; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brodsky MH, 2000, GENE DEV, V14, P666; Busygina V, 2004, HUM MOL GENET, V13, P2399, DOI 10.1093/hmg/ddh271; Busygina V, 2006, CANCER RES, V66, P8397, DOI 10.1158/0008-5472.CAN-06-0061; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; GUSTAVSON KH, 1983, CLIN GENET, V23, P143; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jin SH, 2003, CANCER RES, V63, P4204; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Kim H, 2003, CANCER RES, V63, P6135; Krebs RA, 1998, J INSECT PHYSIOL, V44, P1091, DOI 10.1016/S0022-1910(98)00059-6; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Marek LR, 2008, DNA REPAIR, V7, P476, DOI 10.1016/j.dnarep.2007.12.009; Neal SJ, 2003, GENOME, V46, P879, DOI 10.1139/G03-056; Papaconstantinou M, 2005, MOL CELL BIOL, V25, P9960, DOI 10.1128/MCB.25.22.9960-9972.2005; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; SCAPPATICCI S, 1991, CANCER GENET CYTOGEN, V52, P85, DOI 10.1016/0165-4608(91)90057-2; Semotok JL, 2008, METHOD ENZYMOL, V448, P299, DOI 10.1016/S0076-6879(08)02616-5; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Sukhodolets KE, 2003, MOL CELL BIOL, V23, P493, DOI 10.1128/MCB.23.2.493-509.2003; TOMASSETTI P, 1995, CANCER GENET CYTOGEN, V79, P123, DOI 10.1016/0165-4608(95)98126-J; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025	39	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14049	10.1371/journal.pone.0014049	http://dx.doi.org/10.1371/journal.pone.0014049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124979	gold, Green Published, Green Submitted			2022-12-25	WOS:000284356900012
J	Edderkaoui, M; Nitsche, C; Zheng, L; Pandol, SJ; Gukovsky, I; Gukovskaya, AS				Edderkaoui, Mouad; Nitsche, Claudia; Zheng, Ling; Pandol, Stephen J.; Gukovsky, Ilya; Gukovskaya, Anna S.			NADPH Oxidase Activation in Pancreatic Cancer Cells Is Mediated through Akt-dependent Up-regulation of p22(phox)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; AORTIC SMOOTH-MUSCLE; FACTOR-I RECEPTOR; ENDOTHELIAL-CELLS; GROWTH; NOX4; APOPTOSIS; ALPHA; EXPRESSION; GENERATION	We recently showed that Nox4 NADPH oxidase is highly expressed in pancreatic ductal adenocarcinoma and that it is activated by growth factors and plays a pro-survival, antiapoptotic role. Here we investigate the mechanisms through which insulin-like growth factor I and serum (FBS) activate NADPH oxidase in pancreatic cancer (PaCa) cells. We show that in PaCa cells, NADPH oxidase is composed of Nox4 and p22(phox) catalytic subunits, which are both required for NADPH oxidase activity. Insulin-like growth factor I and FBS activate NADPH oxidase through transcriptional up-regulation of p22(phox). This involves activation of the transcription factor NF-kappa B mediated by Akt kinase. Up-regulation of p22(phox) by the growth factors results in increased Nox4-p22(phox) complex formation and activation of NADPH oxidase. This mechanism is different from that for receptor-induced activation of phagocytic NADPH oxidase, which is mediated by phosphorylation of its regulatory subunits. Upregulation of p22(phox) represents a novel pro-survival mechanism through which growth factors and Akt inhibit apoptosis in PaCa cells.	[Gukovskaya, Anna S.] Vet Affairs Greater Los Angeles Healthcare Syst, W Los Angeles Healthcare Ctr, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Gukovskaya, AS (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, W Los Angeles Healthcare Ctr, 11301 Wilshire Blvd,Bldg 258,Rm 340, Los Angeles, CA 90073 USA.	agukovsk@ucla.edu		Edderkaoui, Mouad/0000-0002-2549-8242; Gukovskaya, Anna/0000-0003-3737-5335	National Institutes of Health through NCI [R01CA119025]; NCCAM [AT003960]; Department of Veterans Affairs Merit Review; CURE-Digestive Diseases Research Center; NATIONAL CANCER INSTITUTE [R01CA119025] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P01AT003960] Funding Source: NIH RePORTER	National Institutes of Health through NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); CURE-Digestive Diseases Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA119025 through the NCI (to A. S. G.) and AT003960 through the NCCAM (to S. J. P.). This study was also supported by the Department of Veterans Affairs Merit Review (to A. S. G.) and the CURE-Digestive Diseases Research Center Pilot and Feasibility Award (to M. E.).	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Dusi S, 2001, EUR J IMMUNOL, V31, P929, DOI 10.1002/1521-4141(200103)31:3<929::AID-IMMU929>3.0.CO;2-M; Edderkaoui M, 2005, AM J PHYSIOL-GASTR L, V289, pG1137, DOI 10.1152/ajpgi.00197.2005; Edderkaoui M, 2007, J BIOL CHEM, V282, P26646, DOI 10.1074/jbc.M702836200; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lee JK, 2007, GASTROENTEROLOGY, V133, P1637, DOI 10.1053/j.gastro.2007.08.022; Maccarrone M, 2001, CELL DEATH DIFFER, V8, P776, DOI 10.1038/sj.cdd.4400908; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Manea A., 2007, Archives of Physiology and Biochemistry, V113, P163, DOI 10.1080/13813450701531235; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Min YF, 2003, CANCER RES, V63, P6432; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Moe KT, 2006, J CELL MOL MED, V10, P231, DOI 10.1111/j.1582-4934.2006.tb00304.x; Mouria M, 2002, INT J CANCER, V98, P761, DOI 10.1002/ijc.10202; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Xu H, 2008, FREE RADICAL BIO MED, V44, P1656, DOI 10.1016/j.freeradbiomed.2008.01.023	32	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7779	7787		10.1074/jbc.M110.200063	http://dx.doi.org/10.1074/jbc.M110.200063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21118808	Green Published, hybrid			2022-12-25	WOS:000288013300009
J	Katsuyama, Y; Miyazono, K; Tanokura, M; Ohnishi, Y; Horinouchi, S				Katsuyama, Yohei; Miyazono, Ken-ichi; Tanokura, Masaru; Ohnishi, Yasuo; Horinouchi, Sueharu			Structural and Biochemical Elucidation of Mechanism for Decarboxylative Condensation of beta-Keto Acid by Curcumin Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III POLYKETIDE SYNTHASE; CHALCONE SYNTHASE; BIOSYNTHESIS; SPECIFICITY; COENZYME; PQSD	The typical reaction catalyzed by type III polyketide synthases (PKSs) is a decarboxylative condensation between acyl-CoA (starter substrate) and malonyl-CoA (extender substrate). In contrast, curcumin synthase 1 (CURS1), which catalyzes curcumin synthesis by condensing feruloyl-CoA with a diketide-CoA, uses a beta-keto acid (which is derived from diketide-CoA) as an extender substrate. Here, we determined the crystal structure of CURS1 at 2.32 angstrom resolution. The overall structure of CURS1 was very similar to the reported structures of type III PKSs and exhibited the alpha beta alpha beta alpha fold. However, CURS1 had a unique hydrophobic cavity in the CoA-binding tunnel. Replacement of Gly-211 with Phe greatly reduced the enzyme activity. The crystal structure of the G211F mutant (at 2.5 angstrom resolution) revealed that the side chain of Phe-211 occupied the hydrophobic cavity. Biochemical studies demonstrated that CURS1 catalyzes the decarboxylative condensation of a beta-keto acid using a mechanism identical to that for normal decarboxylative condensation of malonyl-CoA by typical type III PKSs. Furthermore, the extender substrate specificity of CURS1 suggested that hydrophobic interaction between CURS1 and a beta-keto acid may be important for CURS1 to use an extender substrate lacking the CoA moiety. From these results and a modeling study on substrate binding, we concluded that the hydrophobic cavity is responsible for the hydrophobic interaction between CURS1 and a beta-keto acid, and this hydrophobic interaction enables the beta-keto acid moiety to access the catalytic center of CURS1 efficiently.	[Katsuyama, Yohei; Ohnishi, Yasuo; Horinouchi, Sueharu] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Miyazono, Ken-ichi; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Ohnishi, Y (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.	ayasuo@mail.ecc.u-tokyo.ac.jp	Miyazono, Kenichi/P-9654-2019	Miyazono, Kenichi/0000-0002-9354-2604; Tanokura, Masaru/0000-0001-5072-2480; Katsuyama, Yohei/0000-0003-4905-5320; Ohnishi, Yasuo/0000-0001-7633-9236	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Supported by the Japan Society for the Promotion of Science.	Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Bera AK, 2009, BIOCHEMISTRY-US, V48, P8644, DOI 10.1021/bi9009055; Brand S, 2006, PLANTA, V224, P413, DOI 10.1007/s00425-006-0228-x; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kamo T, 2000, BIOSCI BIOTECH BIOCH, V64, P2089, DOI 10.1271/bbb.64.2089; Katsuyama Y, 2007, J BIOL CHEM, V282, P37702, DOI 10.1074/jbc.M707569200; Katsuyama Y, 2009, FEBS LETT, V583, P2799, DOI 10.1016/j.febslet.2009.07.029; Katsuyama Y, 2009, J BIOL CHEM, V284, P11160, DOI 10.1074/jbc.M900070200; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Morita H, 2010, P NATL ACAD SCI USA, V107, P669, DOI 10.1073/pnas.0909982107; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ramirez-Ahumada MD, 2006, PHYTOCHEMISTRY, V67, P2017, DOI 10.1016/j.phytochem.2006.06.028; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3842, DOI 10.1128/AEM.00433-10; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zhang YM, 2008, J BIOL CHEM, V283, P28788, DOI 10.1074/jbc.M804555200	25	18	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6659	6668		10.1074/jbc.M110.196279	http://dx.doi.org/10.1074/jbc.M110.196279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148316	hybrid, Green Published			2022-12-25	WOS:000287476400074
J	Xiong, SQ; Salazar, G; Patrushev, N; Alexander, RW				Xiong, Shiqin; Salazar, Gloria; Patrushev, Nikolay; Alexander, R. Wayne			FoxO1 Mediates an Autofeedback Loop Regulating SIRT1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; SMALL-MOLECULE ACTIVATORS; TRANSCRIPTION FACTORS; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; LIFE-SPAN; DEPENDENT REGULATION; MAMMALIAN SIRTUINS; INSULIN-RESISTANCE; CELL-SURVIVAL	Forkhead transcription factor FoxO1 and the NAD(+) dependent histone deacetylase SIRT1 are evolutionarily conserved regulators of the development of aging, oxidative stress resistance, insulin resistance, and metabolism in species ranging from invertebrates to mammals. SIRT1 deacetylates FoxO1 and enables activation of FoxO1 transcription in multiple systems. The functional consequences of the interactions between FoxO1 and SIRT1 remain incompletely understood. Here, we demonstrate that the 1.5-kb rat sirt1 promoter region contains a cluster of five putative FoxO1 core binding repeat motifs (5xIRS-1) and a forkhead-like consensus binding site (FKHD-L). Luciferase promoter assays demonstrate that FoxO1 directly activates SIRT1 promoter activity and that both the IRS-1 and FKHD-L enable FoxO1-dependent SIRT1 transcription. Electrophoretic mobility shift and chromatin immunoprecipitation assays show that FoxO1 binds to the IRS-1 and FKHD-L sites of the SIRT1 promoter. Consistently, FoxO1 overexpression increases SIRT1 expression, and FoxO1 depletion by siRNA reduces SIRT1 expression at both the messenger RNA and protein levels in vascular smooth muscle cells and HEK293 cells. Thus, endogenous FoxO1 is a positive transcriptional regulator of SIRT1. Conversely, SIRT1 promotes FoxO1-driven SIRT1 autotranscription through interacting with and deacetylating FoxO1. Moreover, resveratrol, a plant polyphenol activator of SIRT1, increases FoxO1-dependent SIRT1 transcription activity and thus induces its expression. These findings suggest that positive feedback mechanisms regulate FoxO1-dependent SIRT1 transcription and indicate a previously unappreciated function for FoxO1. This signaling network may coordinate multiple pathways acting upon immune, inflammatory, regenerative, and metabolic processes.	[Alexander, R. Wayne] Emory Univ, Sch Med, Emory Univ Hosp, Div Cardiol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA	Emory University; Emory University	Alexander, RW (corresponding author), Emory Univ, Sch Med, Emory Univ Hosp, Div Cardiol, Suite H-153,1364 Clifton Rd NE, Atlanta, GA 30322 USA.	ralexan@emory.edu			National Institutes of Health [UO1 HL80711, HL60728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060728, U01HL080711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants UO1 HL80711 and HL60728.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen W, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2061222; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GRIENDLING KK, 1989, J CARDIOVASC PHARM, V14, pS27, DOI 10.1097/00005344-198906146-00008; GRIENDLING KK, 1988, CLIN EXP PHARMACOL P, V15, P105, DOI 10.1111/j.1440-1681.1988.tb01051.x; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; GUNTHER S, 1982, J CELL BIOL, V92, P289, DOI 10.1083/jcb.92.2.289; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Schilling MM, 2006, NATURE, V443, pE10, DOI 10.1038/nature05288; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Um J. H., DIABETES, V59, P554; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Xiong SQ, 2010, J BIOL CHEM, V285, P2474, DOI 10.1074/jbc.M109.065235; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	54	153	157	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5289	5299		10.1074/jbc.M110.163667	http://dx.doi.org/10.1074/jbc.M110.163667			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149440	Green Published, hybrid			2022-12-25	WOS:000287230600037
J	Haglund, L; Tillgren, V; Addis, L; Wenglen, C; Recklies, A; Heinegard, D				Haglund, Lisbet; Tillgren, Viveka; Addis, Laura; Wenglen, Christina; Recklies, Anneliese; Heinegard, Dick			Identification and Characterization of the Integrin alpha(2)beta(1) Binding Motif in Chondroadherin Mediating Cell Attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE MATRIX PROTEIN; RICH REPEAT PROTEIN; COLLAGEN; RECOGNITION; EXPRESSION; RECEPTOR; SURFACE; DOMAIN; PROTEOGLYCANS; ADHESION	Chondroadherin is a leucine-rich repeat protein known to mediate adhesion of isolated cells via the integrin alpha(2)beta(1) and to interact with collagen. In this work, we show that cell adhesion to chondroadherin leads to activation of MAPKs but does not result in cell spreading and division. This is in contrast to the spreading and dividing of cells grown on collagen, although the binding is mediated via the same alpha(2)beta(1) receptor. We identified a cell binding motif, CQLRGLRRWLEAK(318) by mass spectrometry after protease digestion of chondroadherin. Cells adhering to the synthetic peptide CQLRGLRRWLEAK(318) remained round, as was observed when they bound to the intact protein. The peptide added in solution was able to inhibit cell adhesion to the intact protein in a dose-dependent manner and was also verified to bind to the alpha(2)beta(1) integrin. A cyclic peptide, CQLRGLRRWLEAKASRPDATC(326), mimicking the structural constraints of this sequence in the intact protein, showed similar efficiency in inhibiting binding to chondroadherin. The unique peptide motif responsible for cellular binding is primarily located in the octamer sequence LRRWLEAK(318). Binding of cells to the active peptide or to chondroadherin immobilized on cell culture plates rapidly induces intracellular signaling (i.e. ERK phosphorylation). Thus, chondroadherin interaction with cells may be central for maintaining the adult chondrocyte phenotype and cartilage homeostasis. The peptides, particularly the more stable cyclic peptide, open new opportunities to modulate cell behavior in situations of tissue pathology.	[Haglund, Lisbet; Tillgren, Viveka; Addis, Laura; Wenglen, Christina; Heinegard, Dick] Lund Univ, Dept Clin Sci Lund, SE-22184 Lund, Sweden; [Recklies, Anneliese] Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada	Lund University; McGill University	Heinegard, D (corresponding author), Lund Univ, Dept Clin Sci Lund, BMC Plan C12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se	Addis, Laura/R-1385-2016; Haglund, Lisbet/N-3095-2013	Addis, Laura/0000-0001-8455-4278; Haglund, Lisbet/0000-0002-1288-2149	Swedish Research Council; King Gustaf V: 80 Years Fund; Crafoord Foundation for Research in Rheumatology; Greta and Johan Kock's Foundations; Royal Physiographic Society; Osterlund Foundation; ANAMAR; IngaBritt and Arne Lundbergs Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V: 80 Years Fund; Crafoord Foundation for Research in Rheumatology; Greta and Johan Kock's Foundations; Royal Physiographic Society; Osterlund Foundation; ANAMAR; IngaBritt and Arne Lundbergs Research Foundation	This work was supported by the Swedish Research Council, King Gustaf V: 80 Years Fund, the Crafoord Foundation for Research in Rheumatology, Greta and Johan Kock's Foundations, the Royal Physiographic Society, the Osterlund Foundation, and ANAMAR. Funding of mass spectrometers was through a grant from the IngaBritt and Arne Lundbergs Research Foundation. A patent application has been submitted for use of the identified active peptides to modulate cell activity.	Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; CHEN Q, 1995, MOL BIOL CELL, V6, P1743, DOI 10.1091/mbc.6.12.1743; Hagg P, 1998, J BIOL CHEM, V273, P15590, DOI 10.1074/jbc.273.25.15590; HARDINGHAM TE, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P5; HEINEGARD D, 1985, BIOCHEM J, V225, P95, DOI 10.1042/bj2250095; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Makihira S, 1999, J BIOL CHEM, V274, P11417, DOI 10.1074/jbc.274.16.11417; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; Mansson B, 2001, ANN RHEUM DIS, V60, P27, DOI 10.1136/ard.60.1.27; MAROUDAS A, 1968, BIOPHYS J, V8, P575, DOI 10.1016/S0006-3495(68)86509-9; MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P4903, DOI 10.1021/bi00776a005; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; PAULSSON M, 1981, BIOCHEM J, V197, P367, DOI 10.1042/bj1970367; RECKLIES AD, 1992, ARTHRITIS RHEUM, V35, P1510, DOI 10.1002/art.1780351215; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Shen ZX, 1998, BIOCHEM J, V330, P549, DOI 10.1042/bj3300549; SOMMARIN Y, 1989, EXP CELL RES, V184, P181, DOI 10.1016/0014-4827(89)90376-5; SOMMARIN Y, 1983, BIOCHEM J, V214, P777, DOI 10.1042/bj2140777; SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200	30	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3925	3934		10.1074/jbc.M110.161141	http://dx.doi.org/10.1074/jbc.M110.161141			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127050	hybrid, Green Published			2022-12-25	WOS:000286653200073
J	Karlberg, H; Tan, YJ; Mirazimi, A				Karlberg, Helen; Tan, Yee-Joo; Mirazimi, Ali			Induction of Caspase Activation and Cleavage of the Viral Nucleocapsid Protein in Different Cell Types during Crimean-Congo Hemorrhagic Fever Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; MAMMALIAN-CELLS; DEATH; EXPRESSION; REPLICATION; DISEASE; BIOLOGY	Regulation of apoptosis during infection has been observed for several viral pathogens. Programmed cell death and regulation of apoptosis in response to a viral infection are important factors for host or virus survival. It is not known whether Crimean-Congo hemorrhagic fever virus (CCHFV) infection regulates the apoptosis process in vitro. This study for the first time suggests that CCHFV induces apoptosis, which may be dependent on caspase-3 activation. This study also shows that the coding sequence of the S segment of CCHFV contains a proteolytic cleavage site, DEVD, which is conserved in all CCHFV strains. By using different recombinant expression systems and site-directed mutagenesis, we demonstrated that this motif is subject to caspase cleavage. We also demonstrate that CCHFV nucleocapsid protein (NP) is cleaved into a 30-kDa fragment at the same time as caspase activity is induced during infection. Using caspase inhibitors and cells lacking caspase-3, we clearly demonstrate that the cleavage of NP is caspase-3-dependent. We also show that the inhibition of apoptosis induced progeny viral titers of similar to 80-90%. Thus, caspase-3-dependent cleavage of NP may represent a host defense mechanism against lytic CCHFV infection. Taken together, these data suggest that the most abundant protein of CCHFV, which has several essential functions such as protection of viral RNA and participation in various processes in the replication cycle, can be subjected to cleavage by host cell caspases.	[Karlberg, Helen; Mirazimi, Ali] Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden; [Karlberg, Helen; Mirazimi, Ali] Karolinska Inst, Inst Microbiol Tumor & Cell Biol, SE-17772 Stockholm, Sweden; [Tan, Yee-Joo] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore	Swedish Institute for Infectious Disease Control; Karolinska Institutet; National University of Singapore	Mirazimi, A (corresponding author), Inst Infect Dis Control, SE-17182 Solna, Sweden.	Ali.Mirazimi@smi.se		Tan, Yee-Joo/0000-0002-2278-4497; , Ali/0000-0003-2371-6055	Swedish Medical Research Council [K2010-57X-0349-01-3]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This work was supported in part by Swedish Medical Research Council Grant K2010-57X-0349-01-3 (to A.M.).	Acrani GO, 2010, VIRUS RES, V149, P56, DOI 10.1016/j.virusres.2009.12.013; Akhmatova Nelly K, 2003, Russ J Immunol, V8, P37; Andersson I, 2004, J VIROL, V78, P4323, DOI 10.1128/JVI.78.8.4323-4329.2004; Andersson I, 2004, J MED VIROL, V72, P83, DOI 10.1002/jmv.10560; Andersson I, 2008, J MED VIROL, V80, P1397, DOI 10.1002/jmv.21222; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018; Bray Mike, 2006, Expert Rev Anti Infect Ther, V4, P917, DOI 10.1586/14787210.4.6.917; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; Eleouet JF, 2000, J VIROL, V74, P3975, DOI 10.1128/JVI.74.9.3975-3983.2000; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Gadaleta P, 2002, VIRUS RES, V86, P87, DOI 10.1016/S0168-1702(02)00049-7; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hardestam J, 2005, J MED VIROL, V76, P234, DOI 10.1002/jmv.20347; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Kang JI, 1999, VIROLOGY, V264, P99, DOI 10.1006/viro.1999.9896; Kohl A, 2003, J VIROL, V77, P7999, DOI 10.1128/JVI.77.14.7999-8008.2003; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Majerciak V, 2010, J BIOL CHEM, V285, P11297, DOI 10.1074/jbc.M109.068221; Ontiveros SJ, 2010, VIROLOGY, V401, P165, DOI 10.1016/j.virol.2010.02.018; Pekosz A, 1996, J VIROL, V70, P5329, DOI 10.1128/JVI.70.8.5329-5335.1996; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; TARODI B, 1994, VIROLOGY, V201, P404, DOI 10.1006/viro.1994.1309; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Zhirnov OP, 1999, J VIROL, V73, P10158, DOI 10.1128/JVI.73.12.10158-10163.1999; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	35	48	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3227	3234		10.1074/jbc.M110.149369	http://dx.doi.org/10.1074/jbc.M110.149369			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123175	hybrid, Green Published			2022-12-25	WOS:000286653200007
J	Ma, YJ; Doni, A; Skjoedt, MO; Honore, C; Arendrup, M; Mantovani, A; Garred, P				Ma, Ying Jie; Doni, Andrea; Skjoedt, Mikkel-Ole; Honore, Christian; Arendrup, Maiken; Mantovani, Alberto; Garred, Peter			Heterocomplexes of Mannose-binding Lectin and the Pentraxins PTX3 or Serum Amyloid P Component Trigger Cross-activation of the Complement System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; INNATE IMMUNITY; INVASIVE CANDIDIASIS; A-CHAIN; RECOGNITION; PATHWAY; FICOLIN-2; BACTERIA; DISEASE; HEAD	The long pentraxin 3 (PTX3), serum amyloid P component (SAP), and C-reactive protein belong to the pentraxin family of pattern recognition molecules involved in tissue homeostasis and innate immunity. They interact with C1q from the classical complement pathway. Whether this also occurs via the analogous mannose-binding lectin (MBL) from the lectin complement pathway is unknown. Thus, we investigated the possible interaction between MBL and the pentraxins. We report that MBL bound PTX3 and SAP partly via its collagen-like domain but not C-reactive protein. MBL-PTX3 complex formation resulted in recruitment of C1q, but this was not seen for the MBL-SAP complex. However, both MBL-PTX3 and MBL-SAP complexes enhanced C4 and C3 deposition and opsonophagocytosis of Candida albicans by polymorphonuclear leukocytes. Interaction between MBL and PTX3 led to communication between the lectin and classical complement pathways via recruitment of C1q, whereas SAP-enhanced complement activation occurs via a hitherto unknown mechanism. Taken together, MBL-pentraxin heterocomplexes trigger cross-activation of the complement system.	[Ma, Ying Jie; Skjoedt, Mikkel-Ole; Honore, Christian; Garred, Peter] Univ Copenhagen, Mol Med Lab, Dept Clin Immunol, Fac Hlth Sci,Rigshosp,Sect 7631, DK-2100 Copenhagen, Denmark; [Doni, Andrea; Mantovani, Alberto] Ist Ricovero & Cura Carattere Sci, Ist Clin Humanitas, Lab Immunol & Inflammat, I-20089 Milan, Italy; [Arendrup, Maiken] Statens Serum Inst, Unit Mycol, DK-2300 Copenhagen, Denmark; [Mantovani, Alberto] Univ Milan, Dept Translat Med, I-20089 Milan, Italy	Rigshospitalet; University of Copenhagen; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Humanitas Research Hospital; Statens Serum Institut; University of Milan	Garred, P (corresponding author), Univ Copenhagen, Mol Med Lab, Dept Clin Immunol, Fac Hlth Sci,Rigshosp,Sect 7631, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk	Jie, Ying/AAJ-4697-2021; Mantovani, Alberto/HCI-7449-2022	Jie, Ying/0000-0003-4003-2579; Mantovani, Alberto/0000-0001-5578-236X; Doni, Andrea/0000-0001-9203-5814; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Honore, Christian/0000-0003-4846-1319; Arendrup, Maiken Cavling/0000-0002-4747-0144; Garred, Peter/0000-0002-2876-8586	Benzon Foundation; Lundbeck foundation; Carlsberg Foundation; Rigshospitalet; Capital Region of Denmark; Novo Nordisk Foundation; European Commission; Telethon; Italian Ministry of Health	Benzon Foundation; Lundbeck foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); Rigshospitalet; Capital Region of Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Commission(European CommissionEuropean Commission Joint Research Centre); Telethon(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from The Benzon Foundation, The Lundbeck foundation, The Carlsberg Foundation, Rigshospitalet, The Capital Region of Denmark, The Novo Nordisk Foundation, The European Commission (Project Tolerage), Telethon, and the Italian Ministry of Health.	Arendrup MC, 2008, CLIN MICROBIOL INFEC, V14, P487, DOI 10.1111/j.1469-0691.2008.01954.x; Baruah P, 2006, J LEUKOCYTE BIOL, V80, P87, DOI 10.1189/jlb.0805445; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Brouwer N, 2008, J IMMUNOL, V180, P4124, DOI 10.4049/jimmunol.180.6.4124; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; de Haas CJC, 2000, INFECT IMMUN, V68, P1753, DOI 10.1128/IAI.68.4.1753-1759.2000; Devyatyrova-Johnson M, 2000, INFECT IMMUN, V68, P3894, DOI 10.1128/IAI.68.7.3894-3899.2000; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Hirschfield GM, 2003, QJM-INT J MED, V96, P793, DOI 10.1093/qjmed/hcg134; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Koneti A, 2008, INFECT IMMUN, V76, P994, DOI 10.1128/IAI.01185-07; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Leon C, 2009, CRIT CARE MED, V37, P1624, DOI 10.1097/CCM.0b013e31819daa14; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Oh Hana, 2008, J Vis Exp, DOI 10.3791/745; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Polotsky VY, 1996, INFECT IMMUN, V64, P380, DOI 10.1128/IAI.64.1.380-383.1996; Roumenina LT, 2006, BIOCHEMISTRY-US, V45, P4093, DOI 10.1021/bi052646f; Selander B, 2006, J CLIN INVEST, V116, P1425, DOI 10.1172/JCI25982; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Skjoedt MO, 2010, IMMUNOBIOLOGY, V215, P921, DOI 10.1016/j.imbio.2009.10.006; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Tanio M, 2009, MOL IMMUNOL, V47, P215, DOI 10.1016/j.molimm.2009.09.032; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Van Asbeck EC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-229; YING SC, 1993, J IMMUNOL, V150, P169; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	44	95	97	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3405	3417		10.1074/jbc.M110.190637	http://dx.doi.org/10.1074/jbc.M110.190637			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106539	Green Published, hybrid			2022-12-25	WOS:000286653200027
J	Verbruggen, P; Ruf, M; Blakqori, G; Overby, AK; Heidemann, M; Eick, D; Weber, F				Verbruggen, Paul; Ruf, Marius; Blakqori, Gjon; Oeverby, Anna K.; Heidemann, Martin; Eick, Dirk; Weber, Friedemann			Interferon Antagonist NSs of La Crosse Virus Triggers a DNA Damage Response-like Degradation of Transcribing RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN NSS; DOUBLE-STRANDED-RNA; NF-KAPPA-B; RIG-I; GENE-EXPRESSION; TRANSCRIPTIONAL ELONGATION; PROTEASOMAL DEGRADATION; INDUCED UBIQUITINATION; ANTIVIRAL RESPONSES; VIRAL ENCEPHALITIS	La Crosse encephalitis virus (LACV) is a mosquito-borne member of the negative-strand RNA virus family Bunyaviridae. We have previously shown that the virulence factor NSs of LACV is an efficient inhibitor of the antiviral type I interferon system. A recombinant virus unable to express NSs (rLACVdelNSs) strongly induced interferon transcription, whereas the corresponding wt virus (rLACV) suppressed it. Here, we show that interferon induction by rLACVdelNSs mainly occurs through the signaling pathway leading from the pattern recognition receptor RIG-I to the transcription factor IRF-3. NSs expressed by rLACV, however, acts downstream of IRF-3 by specifically blocking RNA polymerase II-dependent transcription. Further investigations revealed that NSs induces proteasomal degradation of the mammalian RNA polymerase II subunit RPB1. NSs thereby selectively targets RPB1 molecules of elongating RNA polymerase II complexes, the so-called IIo form. This phenotype has similarities to the cellular DNA damage response, and NSs was indeed found to transactivate the DNA damage response gene pak6. Moreover, NSs expressed by rLACV boosted serine 139 phosphorylation of histone H2A. X, one of the earliest cellular reactions to damaged DNA. However, other DNA damage response markers such as up-regulation and serine 15 phosphorylation of p53 or serine 1524 phosphorylation of BRCA1 were not triggered by LACV infection. Collectively, our data indicate that the strong suppression of interferon induction by LACV NSs is based on a shutdown of RNA polymerase II transcription and that NSs achieves this by exploiting parts of the cellular DNA damage response pathway to degrade IIo-borne RPB1 subunits.	[Weber, Friedemann] Univ Marburg, Inst Virol, D-35043 Marburg, Germany; [Verbruggen, Paul; Ruf, Marius; Blakqori, Gjon; Oeverby, Anna K.; Weber, Friedemann] Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, D-79008 Freiburg, Germany; [Heidemann, Martin; Eick, Dirk] Ctr Integrated Prot Sci, Helmholtz Ctr Environm Hlth, Dept Mol Epigenet, D-81377 Munich, Germany	Philipps University Marburg; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Weber, F (corresponding author), Univ Marburg, Inst Virol, Hans Meerwein Str 2, D-35043 Marburg, Germany.	friedemann.weber@staff.uni-marburg.de	Weber, Friedemann/AAB-3425-2019	Weber, Friedemann/0000-0001-9737-337X	 [We2616/2-3];  [SFB 593];  [SFB-Transregio5]	; ; 	This work was supported by Grants We2616/2-3 and SFB 593 (to F. W.) and SFB-Transregio5 (to D.E.).	Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bennett RS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-25; Blakqori G, 2005, J VIROL, V79, P10420, DOI 10.1128/JVI.79.16.10420-10428.2005; Blakqori G, 2003, J GEN VIROL, V84, P1207, DOI 10.1099/vir.0.18876-0; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; Borucki MK, 2002, MICROBES INFECT, V4, P341, DOI 10.1016/S1286-4579(02)01547-2; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; *CDCP, 2005, CONF PROB CAL SER VI; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Clement JQ, 1999, RNA, V5, P206, DOI 10.1017/S1355838299981190; Colon-Ramos DA, 2003, MOL BIOL CELL, V14, P4162, DOI 10.1091/mbc.E03-03-0139; Dai-Ju JQ, 2006, J VIROL, V80, P3567, DOI 10.1128/JVI.80.7.3567-3581.2006; Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Fraser KA, 2007, J VIROL, V81, P5091, DOI 10.1128/JVI.00184-07; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Heine GF, 2008, J BIOL CHEM, V283, P9555, DOI 10.1074/jbc.M707700200; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KOLAKOFSKY D, 1987, COLD SPRING HARB SYM, V52, P373, DOI 10.1101/SQB.1987.052.01.043; KONTERMANN RE, 1995, BIOL CHEM H-S, V376, P473, DOI 10.1515/bchm3.1995.376.8.473; Lambert AJ, 2010, EMERG INFECT DIS, V16, P856, DOI 10.3201/eid1605.100170; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Leonard VHJ, 2006, J VIROL, V80, P9667, DOI 10.1128/JVI.00822-06; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001491; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik S, 2008, J BIOL CHEM, V283, P6897, DOI 10.1074/jbc.M707649200; McJunkin JE, 1998, INFECT DIS CLIN N AM, V12, P83, DOI 10.1016/S0891-5520(05)70410-4; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; PATTERSON JL, 1984, J VIROL, V52, P215, DOI 10.1128/JVI.52.1.215-222.1984; PETERSON SR, 1992, GENE DEV, V6, P426, DOI 10.1101/gad.6.3.426; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; RAJU R, 1988, J VIROL, V62, P27, DOI 10.1128/JVI.62.1.27-32.1988; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Rodriguez A, 2009, J VIROL, V83, P11166, DOI 10.1128/JVI.01439-09; Rust RS, 1999, J CHILD NEUROL, V14, P1, DOI 10.1177/088307389901400101; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; SOLLNERWEBB B, 1986, ANNU REV BIOCHEM, V55, P801, DOI 10.1146/annurev.bi.55.070186.004101; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Svejstrup JQ, 2007, TRENDS BIOCHEM SCI, V32, P165, DOI 10.1016/j.tibs.2007.02.005; Thomas D, 2004, J BIOL CHEM, V279, P31471, DOI 10.1074/jbc.M400938200; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Vreede FT, 2010, VIROLOGY, V396, P125, DOI 10.1016/j.virol.2009.10.003; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Weber F, 2007, BIOCHIMIE, V89, P836, DOI 10.1016/j.biochi.2007.01.005; Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhang M, 2010, PROSTATE, V70, P807, DOI 10.1002/pros.21114	81	65	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3681	3692		10.1074/jbc.M110.154799	http://dx.doi.org/10.1074/jbc.M110.154799			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118815	Green Published, hybrid			2022-12-25	WOS:000286653200051
J	Leung, CCY; Gong, ZH; Chen, JJ; Glover, JNM				Leung, Charles Chung Yun; Gong, Zihua; Chen, Junjie; Glover, J. N. Mark			Molecular Basis of BACH1/FANCJ Recognition by TopBP1 in DNA Replication Checkpoint Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOSERINE/THREONINE-BINDING DOMAINS; C-TERMINAL DOMAINS; BRCT DOMAINS; STRUCTURAL BASIS; FANCONI-ANEMIA; PHOSPHOPEPTIDE RECOGNITION; CONFORMATIONAL-CHANGE; BACH1 PHOSPHOPEPTIDE; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE	The diverse roles of TopBP1 in DNA replication and checkpoint signaling are associated with the scaffolding ability of TopBP1 to initiate various protein-protein interactions. The recognition of the BACH1/FANCJ helicase by TopBP1 is critical for the activation of the DNA replication checkpoint at stalled replication forks and is facilitated by the C-terminal tandem BRCT7/8 domains of TopBP1 and a phosphorylated Thr(1133) binding motif in BACH1. Here we provide the structural basis for this interaction through analysis of the x-ray crystal structures of TopBP1 BRCT7/8 both free and in complex with a BACH1 phospho-peptide. In contrast to canonical BRCT-phospho-peptide recognition, TopBP1 BRCT7/8 undergoes a dramatic conformational change upon BACH1 binding such that the two BRCT repeats pivot about the central BRCT-BRCT interface to provide an extensive and deep peptide-binding cleft. Additionally, we provide the first structural mechanism for Thr(P) recognition among BRCT domains. Together with systematic mutagenesis studies, we highlight the role of key contacts in governing the unique specificity of the TopBP1-BACH1 interaction.	[Leung, Charles Chung Yun; Glover, J. N. Mark] Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Gong, Zihua; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Alberta; University of Texas System; UTMD Anderson Cancer Center	Glover, JNM (corresponding author), Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada.	mark.glover@ualberta.ca	Classen, Scott/AAY-8176-2020		National Institutes of Health [CA92584, CA089239]; Canadian Cancer Society; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society(Canadian Cancer Society (CCS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92584 (to J. N. M. G.) and CA089239 (to J. C.). This work was also supported by grants from the Canadian Cancer Society and the Howard Hughes Medical Institute International Scholar program (to J. N. M. G.).	Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burrows AE, 2008, GENE DEV, V22, P1416, DOI 10.1101/gad.1685108; Campbell SJ, 2010, STRUCTURE, V18, P167, DOI 10.1016/j.str.2009.12.008; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Cescutti R, 2010, EMBO J, V29, P3723, DOI 10.1038/emboj.2010.238; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Ekblad CMS, 2002, J MOL BIOL, V320, P431, DOI 10.1016/S0022-2836(02)00478-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Huo YG, 2010, BIOCHEM BIOPH RES CO, V401, P401, DOI 10.1016/j.bbrc.2010.09.066; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kobayashi M, 2006, J BIOL CHEM, V281, P4308, DOI 10.1074/jbc.M511090200; Kobayashi M, 2010, J BIOL CHEM, V285, P10087, DOI 10.1074/jbc.M109.054106; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Leung CCY, 2010, PROTEIN SCI, V19, P162, DOI 10.1002/pro.290; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Liang XY, 2008, ACCOUNTS CHEM RES, V41, P991, DOI 10.1021/ar700148u; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nomine Y, 2008, BIOCHEMISTRY-US, V47, P9866, DOI 10.1021/bi702247d; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; RAPPAS M, 2010, NUCL ACIDS IN PRESS; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen Y, 2008, BIOCHEMISTRY-US, V47, P5767, DOI 10.1021/bi800314m; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Varma AK, 2005, BIOCHEMISTRY-US, V44, P10941, DOI 10.1021/bi0509651; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wollmann Y, 2007, J CELL BIOCHEM, V102, P171, DOI 10.1002/jcb.21292; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yamane K, 1997, EUR J BIOCHEM, V250, P794, DOI 10.1111/j.1432-1033.1997.00794.x; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	70	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4292	4301		10.1074/jbc.M110.189555	http://dx.doi.org/10.1074/jbc.M110.189555			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127055	Green Published, hybrid			2022-12-25	WOS:000286975700028
J	Shi, ZC; Cai, ZY; Sanchez, A; Zhang, TT; Wen, S; Wang, J; Yang, JH; Fu, SB; Zhang, DK				Shi, Zhongcheng; Cai, Zhenyu; Sanchez, Amir; Zhang, Tingting; Wen, Shu; Wang, Jun; Yang, Jianhua; Fu, Songbin; Zhang, Dekai			A Novel Toll-like Receptor That Recognizes Vesicular Stomatitis Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-SYSTEM; PATTERN-RECOGNITION; ANTIVIRAL RESPONSE; SIGNALING PATHWAYS; ADAPTIVE IMMUNITY; STRANDED-RNA; RIG-I; ACTIVATION; PROTEIN; INFECTION	Toll-like receptors (TLRs) are the key molecular sensors used by the mammalian innate immune system to detect various types of pathogens. Tlr13 is a novel and uncharacterized member of the mammalian TLR family. Here we report the cloning and characterization of tlr13. Tlr13 is predominantly expressed in the spleen, particularly in dendritic cells and macrophages. Tlr13 appears to activate a MyD88- and TAK1-dependent TLR signaling pathway, inducing the activation of NF-kappa B. This receptor can also activate type 1 interferon through IRF7. Furthermore, Tlr13 seems to be another intracellular TLR. Remarkably, cells expressing tlr13 fail to respond to known TLR ligands but instead respond specifically to vesicular stomatitis virus. Cells with the knockdown of tlr13 are highly susceptible to vesicular stomatitis virus infection. Thus, these results provide an important insight into the potential role of the novel Toll-like receptor tlr13 in the recognition of viral infection.	[Shi, Zhongcheng; Fu, Songbin] Harbin Med Coll, Med Genet Lab, Harbin 150081, Peoples R China; [Zhang, Dekai] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Yang, Jianhua] Baylor Coll Med, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA	Harbin Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Texas Children's Cancer Center	Fu, SB (corresponding author), Harbin Med Coll, Med Genet Lab, Harbin 150081, Peoples R China.	fusb@ems.hrbmu.edu.cn; dzhang@ibt.tamhsc.edu			National Institutes of Health [AI085164]; Texas AM University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AM University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI085164 (to D. Z.). This study was also supported by Texas A&M University (to D. Z.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burger-Kentischer A, 2010, J IMMUNOL METHODS, V358, P93, DOI 10.1016/j.jim.2010.03.020; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Shi ZC, 2009, J BIOL CHEM, V284, P20540, DOI 10.1074/jbc.M109.022541; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhou SH, 2007, J IMMUNOL, V178, P5173, DOI 10.4049/jimmunol.178.8.5173	30	119	145	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4517	4524		10.1074/jbc.M110.159590	http://dx.doi.org/10.1074/jbc.M110.159590			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131352	Green Published, hybrid			2022-12-25	WOS:000286975700052
J	Blood, AJ; Iosifescu, DV; Makris, N; Perlis, RH; Kennedy, DN; Dougherty, DD; Kim, BW; Lee, MJ; Wu, S; Lee, S; Calhoun, J; Hodge, SM; Fava, M; Rosen, BR; Smoller, JW; Gasic, GP; Breiter, HC				Blood, Anne J.; Iosifescu, Dan V.; Makris, Nikos; Perlis, Roy H.; Kennedy, David N.; Dougherty, Darin D.; Kim, Byoung Woo; Lee, Myung Joo; Wu, Shirley; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Fava, Maurizio; Rosen, Bruce R.; Smoller, Jordan W.; Gasic, Gregory P.; Breiter, Hans C.		Phenotype Genotype Project Addicti	Microstructural Abnormalities in Subcortical Reward Circuitry of Subjects with Major Depressive Disorder	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; LATE-LIFE DEPRESSION; WHITE-MATTER MICROSTRUCTURE; ANTERIOR CINGULATE; DIFFUSION ANISOTROPY; EXPECTANCY BIAS; 1ST EPISODE; RESPONSES; AMYGDALA; NEUROBIOLOGY	Background: Previous studies of major depressive disorder (MDD) have focused on abnormalities in the prefrontal cortex and medial temporal regions. There has been little investigation in MDD of midbrain and subcortical regions central to reward/aversion function, such as the ventral tegmental area/substantia nigra (VTA/SN), and medial forebrain bundle (MFB). Methodology/Principal Findings: We investigated the microstructural integrity of this circuitry using diffusion tensor imaging (DTI) in 22 MDD subjects and compared them with 22 matched healthy control subjects. Fractional anisotropy (FA) values were increased in the right VT and reduced in dorsolateral prefrontal white matter in MDD subjects. Follow-up analysis suggested two distinct subgroups of MDD patients, which exhibited non-overlapping abnormalities in reward/aversion circuitry. The MDD subgroup with abnormal FA values in VT exhibited significantly greater trait anxiety than the subgroup with normal FA values in VT, but the subgroups did not differ in levels of anhedonia, sadness, or overall depression severity. Conclusions/Significance: These findings suggest that MDD may be associated with abnormal microstructure in brain reward/aversion regions, and that there may be at least two subtypes of microstructural abnormalities which each impact core symptoms of depression.	[Blood, Anne J.; Iosifescu, Dan V.; Makris, Nikos; Perlis, Roy H.; Dougherty, Darin D.; Kim, Byoung Woo; Lee, Myung Joo; Wu, Shirley; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Fava, Maurizio; Smoller, Jordan W.; Gasic, Gregory P.; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Lab Neuroimaging & Genet, Depress Clin & Res Program, Boston, MA 02114 USA; [Blood, Anne J.; Iosifescu, Dan V.; Makris, Nikos; Perlis, Roy H.; Dougherty, Darin D.; Kim, Byoung Woo; Lee, Myung Joo; Wu, Shirley; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Fava, Maurizio; Smoller, Jordan W.; Gasic, Gregory P.; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Lab Neuroimaging & Genet, Mood & Motor Control Lab,Addict Res Program, Boston, MA 02114 USA; [Blood, Anne J.; Iosifescu, Dan V.; Makris, Nikos; Perlis, Roy H.; Kennedy, David N.; Dougherty, Darin D.; Kim, Byoung Woo; Lee, Myung Joo; Wu, Shirley; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Fava, Maurizio; Rosen, Bruce R.; Smoller, Jordan W.; Gasic, Gregory P.; Breiter, Hans C.] Harvard Univ, Sch Med, Boston, MA USA; [Perlis, Roy H.; Fava, Maurizio; Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodevelopmental Genet Unit, Boston, MA 02114 USA; [Perlis, Roy H.; Fava, Maurizio; Smoller, Jordan W.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Blood, Anne J.; Kim, Byoung Woo; Lee, Myung Joo; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Rosen, Bruce R.; Gasic, Gregory P.; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Radiol, MENC, Boston, MA 02114 USA; [Blood, Anne J.; Kim, Byoung Woo; Lee, Myung Joo; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Rosen, Bruce R.; Gasic, Gregory P.; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Makris, Nikos; Kennedy, David N.; Hodge, Steven M.] Massachusetts Gen Hosp, Ctr Morphometr Anal, Boston, MA 02114 USA; [Makris, Nikos; Kennedy, David N.; Hodge, Steven M.] Massachusetts Gen Hosp, Ctr Integrat Informat, Boston, MA 02114 USA; [Blood, Anne J.; Kennedy, David N.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Iosifescu, Dan V.] Mt Sinai Sch Med, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai	Blood, AJ (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Lab Neuroimaging & Genet, Depress Clin & Res Program, Boston, MA 02114 USA.	hbreiter@partners.org	Dougherty, Darin D./G-9896-2012; Iosifescu, Dan Vlad/L-3305-2019; Fava, Maurizio/AAH-3548-2020; Kennedy, David N/H-3627-2012	Iosifescu, Dan Vlad/0000-0002-2512-2835; Lee, Myungjoo/0000-0003-3722-9565	NIDA, Bethesda, MD [R01 14118, R21 026104, P20 026002]; Office of National Drug Control Policy - Counterdrug Technology Assessment Center (ONDCP-CTAC), Washington, [DABK39-03-C-0098]; NINDS [R01 NS052368]; NCRR [P41RR14075]; Mental Illness and Neuroscience Discovery (MIND) Institute; MGH Department of Radiology; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027804, R33DA026104, P20DA026002] Funding Source: NIH RePORTER	NIDA, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Office of National Drug Control Policy - Counterdrug Technology Assessment Center (ONDCP-CTAC), Washington,; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mental Illness and Neuroscience Discovery (MIND) Institute; MGH Department of Radiology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant to H.C.B. (R01 14118, R21 026104, P20 026002) from NIDA, Bethesda, MD, and a grant (DABK39-03-C-0098; The Phenotype Genotype Project in Addiction and Depression) from the Office of National Drug Control Policy - Counterdrug Technology Assessment Center (ONDCP-CTAC), Washington, D.C. Further support was provided by a grant to A.J.B. (R01 NS052368) from NINDS, by the MGH Department of Radiology to H.C.B., by NCRR (P41RR14075), and by the Mental Illness and Neuroscience Discovery (MIND) Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie HC, 1998, NEUROREPORT, V9, P3301, DOI 10.1097/00001756-199810050-00028; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; BAINS JS, 2007, TRENDS NEUROSCI M; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2006, NEUROREPORT, V17, P1251, DOI 10.1097/01.wnr.0000230500.03330.01; Blood Anne J, 2008, Biosci Hypotheses, V1, P14, DOI 10.1016/j.bihy.2008.01.006; Bogdan R, 2006, BIOL PSYCHIAT, V60, P1147, DOI 10.1016/j.biopsych.2006.03.037; Boska MD, 2007, NEUROBIOL DIS, V26, P590, DOI 10.1016/j.nbd.2007.02.010; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; Breiter HC, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1043; Breiter Hans C., 2006, P763; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chan CKY, 1996, J ABNORM PSYCHOL, V105, P637, DOI 10.1037/0021-843X.105.4.637; Chan LL, 2007, J NEUROL NEUROSUR PS, V78, P1383, DOI 10.1136/jnnp.2007.121525; COMPTON RJ, 2007, BRAIN COGN; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Diaconescu AO, 2010, BRAIN RES, V1313, P143, DOI 10.1016/j.brainres.2009.11.064; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; EDWARDS E, 1992, NEUROCHEM INT, V21, P29, DOI 10.1016/0197-0186(92)90065-Y; Fava M, 1997, BIOL PSYCHIAT, V42, P568, DOI 10.1016/S0006-3223(96)00440-4; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Fava Maurizio, 2007, Ann Clin Psychiatry, V19, P187, DOI 10.1080/10401230701465178; First M. B., 1997, STRUCTURED CLIN INTE; Forbes EE, 2009, BIOL PSYCHIAT, V66, P199, DOI 10.1016/j.biopsych.2009.05.001; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Frodl T, 2002, AM J PSYCHIAT, V159, P1112, DOI 10.1176/appi.ajp.159.7.1112; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; GUIARD BP, 2009, CURR DRUG TARGETS; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Haber SN, 2000, J NEUROSCI, V20, P2369; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Harsan LA, 2007, J NEUROSCI RES, V85, P935, DOI 10.1002/jnr.21201; JANSEN JF, 2008, NEUROBIOL DIS; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Kim BW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010613; Langguth B, 2007, NEUROENDOCRINOL LETT, V28, P633; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Levita L, 2009, NEUROIMAGE, V44, P1178, DOI 10.1016/j.neuroimage.2008.09.039; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; McCabe C, 2009, PSYCHOPHARMACOLOGY, V205, P667, DOI 10.1007/s00213-009-1573-9; Menon M, 2007, BIOL PSYCHIAT, V62, P765, DOI 10.1016/j.biopsych.2006.10.020; Milak MS, 2009, PSYCHIAT RES-NEUROIM, V173, P63, DOI 10.1016/j.pscychresns.2008.09.004; Mintun MA, 2004, BIOL PSYCHIAT, V55, P217, DOI 10.1016/j.biopsych.2003.08.015; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nobre MJ, 2004, BRAIN RES, V999, P124, DOI 10.1016/j.brainres.2003.12.001; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxena S, 2001, BIOL PSYCHIAT, V50, P159, DOI 10.1016/S0006-3223(01)01123-4; SCHLAEPFER TE, 2007, NEUROPSYCHOPHARMACOL; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Treadway MT, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004887, 10.1371/journal.pone.0006598]; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van der Kouwe AJW, 2005, NEUROIMAGE, V27, P222, DOI 10.1016/j.neuroimage.2005.03.035; Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058; WAINER H, 1978, PSYCHOMETRIKA, V43, P203, DOI 10.1007/BF02293863; Wiedemann G, 2001, J ANXIETY DISORD, V15, P401, DOI 10.1016/S0887-6185(01)00072-X; Wise R A, 1985, Psychiatr Med, V3, P445; WISE RA, 1978, BRAIN RES, V152, P215, DOI 10.1016/0006-8993(78)90253-6; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004	95	98	100	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e13945	10.1371/journal.pone.0013945	http://dx.doi.org/10.1371/journal.pone.0013945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124764	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500001
J	Galletti, C; Breveglieri, R; Lappe, M; Bosco, A; Ciavarro, M; Fattori, P				Galletti, Claudio; Breveglieri, Rossella; Lappe, Markus; Bosco, Annalisa; Ciavarro, Marco; Fattori, Patrizia			Covert Shift of Attention Modulates the Ongoing Neural Activity in a Reaching Area of the Macaque Dorsomedial Visual Stream	PLOS ONE			English	Article							FRONTAL EYE FIELD; MEDIAL PARIETOOCCIPITAL CORTEX; LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; SPATIAL ATTENTION; SUPERIOR COLLICULUS; NEURONAL RESPONSES; COGNITIVE CONTROL; MONKEY; V6A	Background: Attention is used to enhance neural processing of selected parts of a visual scene. It increases neural responses to stimuli near target locations and is usually coupled to eye movements. Covert attention shifts, however, decouple the attentional focus from gaze, allowing to direct the attention to a peripheral location without moving the eyes. We tested whether covert attention shifts modulate ongoing neuronal activity in cortical area V6A, an area that provides a bridge between visual signals and arm-motor control. Methodology/Principal Findings: We performed single cell recordings from 3 Macaca Fascicularis trained to fixate straight-head, while shifting attention outward to a peripheral cue and inward again to the fixation point. We found that neurons in V6A are influenced by spatial attention. The attentional modulation occurs without gaze shifts and cannot be explained by visual stimulations. Visual, motor, and attentional responses can occur in combination in single neurons. Conclusions/Significance: This modulation in an area primarily involved in visuo-motor transformation for reaching may form a neural basis for coupling attention to the preparation of reaching movements. Our results show that cortical processes of attention are related not only to eye-movements, as many studies have shown, but also to arm movements, a finding that has been suggested by some previous behavioral findings. Therefore, the widely-held view that spatial attention is tightly intertwined with-and perhaps directly derived from-motor preparatory processes should be extended to a broader spectrum of motor processes than just eye movements.	[Galletti, Claudio; Breveglieri, Rossella; Bosco, Annalisa; Ciavarro, Marco; Fattori, Patrizia] Univ Bologna, Dipartimento Fisiol Umana & Gen, Bologna, Italy; [Lappe, Markus] Univ Munster, Dept Psychol, Munster, Germany; [Lappe, Markus] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany	University of Bologna; University of Munster; University of Munster	Galletti, C (corresponding author), Univ Bologna, Dipartimento Fisiol Umana & Gen, Bologna, Italy.	patrizia.fattori@unibo.it	Ciavarro, Marco/AAA-7142-2022; Fattori, Patrizia/Q-8947-2017; breveglieri, rossella/C-2014-2014	Ciavarro, Marco/0000-0001-6611-6266; Fattori, Patrizia/0000-0002-0079-3755; breveglieri, rossella/0000-0001-5059-1441; BOSCO, ANNALISA/0000-0003-3032-9571; GALLETTI, CLAUDIO/0000-0001-8927-3408	European Union [FP7-ICT-217077-EYESHOTS]; Ministero dell'Universita e della Ricerca; Fondazione del Monte di Bologna e Ravenna, Italy	European Union(European Commission); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondazione del Monte di Bologna e Ravenna, Italy(Fondazione del Monte di Bologna e Ravenna)	This research was supported by European Union FP7-ICT-217077-EYESHOTS (http://www.eyeshots.it/), Ministero dell'Universita e della Ricerca (www.miur.it), and Fondazione del Monte di Bologna e Ravenna, Italy (http://www.fondazionedelmonte.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; BISLEY JW, 2010, ANN REV NEUROSCI; BOWMAN EM, 1993, J NEUROPHYSIOL, V70, P431, DOI 10.1152/jn.1993.70.1.431; Bremmer F, 1998, EUR J NEUROSCI, V10, P153; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Chiu YC, 2009, J NEUROSCI, V29, P3930, DOI 10.1523/JNEUROSCI.5737-08.2009; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Conner CE, 1997, J NEUROSCI, V17, P3201; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Constantinidis C, 2006, REV NEUROSCIENCE, V17, P415; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Deubel H, 1998, VIS COGN, V5, P81, DOI 10.1080/713756776; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Esterman M, 2009, P NATL ACAD SCI USA, V106, P17974, DOI 10.1073/pnas.0903593106; Fattori P, 2005, EUR J NEUROSCI, V22, P956, DOI 10.1111/j.1460-9568.2005.04288.x; FISCHER B, 1985, BRAIN RES, V345, P111, DOI 10.1016/0006-8993(85)90841-8; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GALLETTI C, 1979, ARCH ITAL BIOL, V117, P231; GOLDBERG ME, 2006, PROG BRAIN RES, P155; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; Herrington TM, 2010, J NEUROSCI, V30, P3287, DOI 10.1523/JNEUROSCI.6025-09.2010; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Kodaka Y, 1997, NEUROSCI RES, V28, P291, DOI 10.1016/S0168-0102(97)00055-2; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kutz DF, 2005, J NEUROPHYSIOL, V93, P3674, DOI 10.1152/jn.01292.2004; Kutz DF, 2003, EXP BRAIN RES, V149, P83, DOI 10.1007/s00221-002-1337-9; LUI Y, 2010, NAT NEUROSCI, V13, P495; Luppino G, 2005, EUR J NEUROSCI, V21, P3056, DOI 10.1111/j.1460-9568.2005.04149.x; Marzocchi N, 2008, EUR J NEUROSCI, V27, P775, DOI 10.1111/j.1460-9568.2008.06021.x; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Mountcastle VB, 1981, BRAIN MECH PERCEPTUA, P67; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, P531; Raffi M, 2005, J NEUROSCI, V25, P5171, DOI 10.1523/JNEUROSCI.5201-04.2005; Rawley JB, 2010, J VISION, V10, DOI 10.1167/10.1.12; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006	50	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15078	10.1371/journal.pone.0015078	http://dx.doi.org/10.1371/journal.pone.0015078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124734	Green Published, Green Submitted, gold			2022-12-25	WOS:000284686500035
J	Lees, J; Nudds, R; Stokkan, KA; Folkow, L; Codd, J				Lees, John; Nudds, Robert; Stokkan, Karl-Arne; Folkow, Lars; Codd, Jonathan			Reduced Metabolic Cost of Locomotion in Svalbard Rock Ptarmigan (Lagopus muta hyperborea) during Winter	PLOS ONE			English	Article							GENERATING MUSCULAR FORCE; TERRESTRIAL LOCOMOTION; ENERGETIC COST; BODY-MASS; SEASONAL-CHANGES; PREDATION RISK; FOOD-INTAKE; KINEMATIC PARAMETERS; BIPEDAL LOCOMOTION; PREFERRED SPEED	The Svalbard rock ptarmigan, Lagopus muta hyperborea experiences extreme photoperiodic and climatic conditions on the Arctic archipelago of Svalbard. This species, however, is highly adapted to live in this harsh environment. One of the most striking adaptations found in these birds is the deposition, prior to onset of winter, of fat stores which may comprise up to 32% of body mass and are located primarily around the sternum and abdominal region. This fat, while crucial to the birds' survival, also presents a challenge in that the bird must maintain normal physiological function with this additional mass. In particular these stores are likely to constrain the respiratory system, as the sternum and pelvic region must be moved during ventilation and carrying this extra load may also impact upon the energetic cost of locomotion. Here we demonstrate that winter birds have a reduced cost of locomotion when compared to summer birds. A remarkable finding given that during winter these birds have almost twice the body mass of those in summer. These results suggest that Svalbard ptarmigan are able to carry the additional winter fat without incurring any energetic cost. As energy conservation is paramount to these birds, minimising the costs of moving around when resources are limited would appear to be a key adaptation crucial for their survival in the barren Arctic environment.	[Lees, John; Nudds, Robert; Codd, Jonathan] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Stokkan, Karl-Arne; Folkow, Lars] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway	University of Manchester; UiT The Arctic University of Tromso	Lees, J (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	jonathan.codd@manchester.ac.uk		Lees, John/0000-0002-9627-1790; Codd, Jonathan/0000-0003-0211-1786	Biotechnology and Biological Science Research Council (BBSRC) [G01138/1]; British Pharmacological Society; Higher Education Funding Council for Englan; Medical Research Council, UK; Natural Environment Research Council; BBSRC [BB/G011338/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G011338/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Pharmacological Society; Higher Education Funding Council for Englan(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Biotechnology and Biological Science Research Council (BBSRC) (G01138/1) and also supported by a capacity building award in Integrative Biology awarded to the University of Manchester funded by the BBSRC, British Pharmacological Society, Higher Education Funding Council for Englan and the Medical Research Council, UK. JJL is supported by a Natural Environment Research Council DTA award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; Abourachid A, 2001, COMP BIOCHEM PHYS A, V131, P113, DOI 10.1016/S1095-6433(01)00471-8; BAMFORD OS, 1980, J APPL PHYSIOL, V49, P491, DOI 10.1152/jappl.1980.49.3.491; Bastien GJ, 2005, SCIENCE, V308, P1755, DOI 10.1126/science.1111513; BAUDINETTE RV, 1992, AM J PHYSIOL, V262, pR771, DOI 10.1152/ajpregu.1992.262.5.R771; Baudinette RV, 1998, NATURE, V395, P653, DOI 10.1038/27111; Bechtold DA, 2007, ENDOCRINOLOGY, V148, P3605, DOI 10.1210/en.2007-0596; BIEWENER AA, 1989, BIOSCIENCE, V39, P776, DOI 10.2307/1311183; Biewener AA, 2006, J EXP ZOOL PART A, V305A, P899, DOI 10.1002/jez.a.334; Blem Charles R., 1990, V7, P59; BLEM CR, 1976, AM ZOOL, V16, P671; Blix A.S., 1989, P117; Blix A.S., 2007, POLAR RES-SWEDEN, V26, DOI [10.3402/polar.v26i1.6209, DOI 10.3402/POLAR.V26I1.6209]; BRACKENBURY JH, 1981, J EXP BIOL, V93, P317; Brody S., 1945, BIOENERGETICS GROWTH; Browning RC, 2006, J APPL PHYSIOL, V100, P390, DOI 10.1152/japplphysiol.00767.2005; Browning RC, 2005, OBES RES, V13, P891, DOI 10.1038/oby.2005.103; Bruinzeel LW, 1999, ARDEA, V87, P199; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Chappell MA, 2004, J EXP BIOL, V207, P3839, DOI 10.1242/jeb.01213; Claessens LPAM, 2009, J EXP ZOOL PART A, V311A, P586, DOI 10.1002/jez.501; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; FEDAK MA, 1982, J EXP BIOL, V97, P23; FEDAK MA, 1979, NATURE, V282, P713, DOI 10.1038/282713a0; Fuglei E, 1999, J COMP PHYSIOL B, V169, P361, DOI 10.1007/s003600050232; Fuglesteg BN, 2006, POLAR BIOL, V29, P308, DOI 10.1007/s00300-005-0054-9; Fujita M, 2004, COMP BIOCHEM PHYS A, V139, P117, DOI 10.1016/j.cbpb.2004.07.005; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 1998, CLIN EXP PHARMACOL P, V25, P736, DOI 10.1111/j.1440-1681.1998.tb02287.x; GOLDSTEIN DL, 1988, AM ZOOL, V28, P829; Griffin TM, 2000, NATURE, V408, P929, DOI 10.1038/35050167; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; Hancock JA, 2007, IBIS, V149, P605, DOI 10.1111/j.1474-919X.2007.00688.x; HEGLUND NC, 1995, NATURE, V375, P52, DOI 10.1038/375052a0; HERREID CF, 1967, COMP BIOCHEM PHYSIOL, V21, P405, DOI 10.1016/0010-406X(67)90802-X; Houston AI, 1997, OIKOS, V78, P331, DOI 10.2307/3546301; Hoyt DF, 2000, J EXP BIOL, V203, P221; Hoyt DF, 2006, J EXP ZOOL PART A, V305A, P912, DOI 10.1002/jez.a.335; Hutchinson JR, 2006, J EXP BIOL, V209, P3812, DOI 10.1242/jeb.02443; Iriarte-Diaz J, 2006, J EXP BIOL, V209, P4061, DOI 10.1242/jeb.02473; Kram R, 1996, J EXP BIOL, V199, P609; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; Landis WJ, 2002, COMP BIOCHEM PHYS A, V133, P1135, DOI 10.1016/S1095-6433(02)00248-9; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; LINDGARD K, 1989, ORNIS SCAND, V20, P176, DOI 10.2307/3676910; MALOIY GMO, 1986, NATURE, V319, P668, DOI 10.1038/319668a0; Marsh RL, 2006, J EXP BIOL, V209, P2050, DOI 10.1242/jeb.02226; McGowan CP, 2006, J APPL PHYSIOL, V101, P1060, DOI 10.1152/japplphysiol.01538.2005; McKechnie AE, 2002, CONDOR, V104, P705, DOI 10.1650/0010-5422(2002)104[0705:AFHRAR]2.0.CO;2; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V261, P395, DOI 10.1098/rspb.1995.0165; MORTENSEN A, 1983, ORNIS SCAND, V14, P144, DOI 10.2307/3676018; MORTENSEN A, 1989, ORNIS SCAND, V20, P22, DOI 10.2307/3676703; MORTENSEN A, 1986, ORNIS SCAND, V17, P8, DOI 10.2307/3676746; NILSSEN KJ, 1984, AM J PHYSIOL, V247, pR837, DOI 10.1152/ajpregu.1984.247.5.R837; Nudds RL, 2010, COMP BIOCHEM PHYS A, V156, P318, DOI 10.1016/j.cbpa.2010.01.023; Odum E. P., 1958, Bird-Banding, V29, P105; ODUM EP, 1951, PHYSIOL ZOOL, V24, P216, DOI 10.1086/physzool.24.3.30152115; Pedersen AO, 2006, ARCTIC, V59, P61; Pette D, 2001, J APPL PHYSIOL, V90, P1119, DOI 10.1152/jappl.2001.90.3.1119; Peyrot N, 2009, J APPL PHYSIOL, V106, P1763, DOI 10.1152/japplphysiol.91240.2008; PINSHOW B, 1977, SCIENCE, V195, P592, DOI 10.1126/science.835018; POHL H, 1973, COMP BIOCHEM PHYSIOL, V45, P851, DOI 10.1016/0300-9629(73)90088-1; POND CM, 1978, ANNU REV ECOL SYST, V9, P519, DOI 10.1146/annurev.es.09.110178.002511; Reierth E, 1998, J BIOL RHYTHM, V13, P393, DOI 10.1177/074873098129000219; Reierth E, 1998, CAN J ZOOL, V76, P2031, DOI 10.1139/cjz-76-11-2031; Reierth E, 1999, J BIOL RHYTHM, V14, P314, DOI 10.1177/074873099129000731; REIMERS E, 1983, ACTA ZOOL FENN, V175, P69; Roberts TJ, 1998, J EXP BIOL, V201, P2745; ROGERS CM, 1987, ECOLOGY, V68, P1051, DOI 10.2307/1938377; Rubenson J, 2004, P ROY SOC B-BIOL SCI, V271, P1091, DOI 10.1098/rspb.2004.2702; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; SCOTT I, 1994, P NUTR SOC, V53, P521, DOI 10.1079/PNS19940062; Silver FH, 2000, BIOMACROMOLECULES, V1, P180, DOI 10.1021/bm9900139; STOKKAN KA, 1992, ORNIS SCAND, V23, P366, DOI 10.2307/3676662; STOKKAN KA, 1995, J COMP PHYSIOL B, V165, P359, DOI 10.1007/BF00387306; STOKKAN KA, 1986, AM J PHYSIOL, V251, pR264, DOI 10.1152/ajpregu.1986.251.2.R264; STOKKAN KA, 1985, GEN COMP ENDOCR, V58, P76, DOI 10.1016/0016-6480(85)90137-6; TAYLOR CR, 1980, J EXP BIOL, V86, P9; TAYLOR CR, 1974, AM J PHYSIOL, V227, P848, DOI 10.1152/ajplegacy.1974.227.4.848; TAYLOR CR, 1971, AM J PHYSIOL, V221, P597, DOI 10.1152/ajplegacy.1971.221.2.597; TAYLOR CR, 1982, J EXP BIOL, V97, P1; Tickle P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005667; Tickle PG, 2007, J EXP BIOL, V210, P3955, DOI 10.1242/jeb.008953; TICKLE PG, 2010, COMP BIOCH PHYSL A; Tolkamp BJ, 2002, ANIM BEHAV, V64, P945, DOI 10.1006/anbe.2002.2008; Usherwood J, 2008, J EXP BIOL, V211, DOI 10.1242/jeb.010769; Veasey JS, 1998, ANIM BEHAV, V56, P883, DOI 10.1006/anbe.1998.0880; White CR, 2008, J COMP PHYSIOL B, V178, P745, DOI 10.1007/s00360-008-0265-9; Withers PC, 2001, AUST J ZOOL, V49, P445, DOI 10.1071/ZO00057; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; WUNDER AB, 1969, COMP BIOCH PHYSL, V33, P821	95	17	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15490	10.1371/journal.pone.0015490	http://dx.doi.org/10.1371/journal.pone.0015490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21125015	Green Published, Green Submitted, gold			2022-12-25	WOS:000284231800037
J	Zhi, HY; Hou, SW; Li, RS; Basir, Z; Xiang, Q; Szabo, A; Chen, G				Zhi, H-Y; Hou, S-W; Li, R-S; Basir, Z.; Xiang, Q.; Szabo, A.; Chen, G.			PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization	ONCOGENE			English	Article						PTPH1; VDR; VDR cytoplasmic translocation; mutual stabilization; breast cancer	PROTEIN-TYROSINE-PHOSPHATASE; RETINOID-X-RECEPTOR; ESTROGEN-RECEPTOR; NUCLEAR IMPORT; EXPRESSION; CELLS; TRANSFORMATION; ACTIVATION; RAS; 1B	Tyrosine phosphorylation is tightly regulated by protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs), and has a critical role in malignant transformation and progression. Although PTKs have a well-established role in regulating breast cancer growth, contribution of PTPs remains mostly unknown. Here, we report that the tyrosine phosphatase PTPH1 stimulates breast cancer growth through regulating vitamin D receptor (VDR) expression. PTPH1 was shown to be overexpressed in 49% of primary breast cancer and levels of its protein expression positively correlate with the clinic metastasis, suggesting its oncogenic activity. Indeed, PTPH1 promotes breast cancer growth by a mechanism independent of its phosphatase activity, but dependent of its stimulatory effect on the nuclear receptor VDR protein expression and depletion of induced VDR abolishes the PTPH1 oncogenic activity. Additional analyses showed that PTPH1 binds VDR and increases its cytoplasmic accumulation, leading to their mutual stabilization and stable expression of a nuclear localization-deficient VDR abolishes the growth-inhibitory activity of the receptor independent of 1,25-dihydroxyvitamin D3. These results reveal a new paradigm in which a PTP may stimulate breast cancer growth through increasing cytoplasmic translocation of a nuclear receptor, leading to their mutual stabilization. Oncogene (2011) 30, 1706-1715; doi:10.1038/onc.2010.543; published online 29 November 2010	[Zhi, H-Y; Hou, S-W; Chen, G.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Li, R-S; Basir, Z.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Xiang, Q.; Szabo, A.] Med Coll Wisconsin, Div Biostat, Milwaukee, WI 53226 USA; [Chen, G.] Zablocki Vet Affairs Med Ctr, Res Serv, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Chen, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	gchen@mcw.edu	Szabo, Aniko/F-9656-2012	Szabo, Aniko/0000-0002-8129-0614	National Institutes of Health [2R01 CA91576]; Department of Veterans Affairs; Cancer Center of Medical College of Wisconsin; NATIONAL CANCER INSTITUTE [R01CA091576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Cancer Center of Medical College of Wisconsin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from National Institutes of Health (2R01 CA91576), Department of Veterans Affairs (Merit Review), and Cancer Center of Medical College of Wisconsin (GC). We thank Drs Nicholas K Tonks, JoEllen Welsh, Jiahuai Han, Leonard Freedman, David Shapiro, Lawrence A Donehower and Carol E Lange for providing various reagents that made this work possible. We also appreciate Justin Reitsman and Dr Xiaomei Qi for the technical support and Chen's lab members for suggestions and discussions.	Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869; Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; BROWNSHIMER S, 1992, CANCER RES, V52, P478; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Campbell MJ, 2000, ONCOGENE, V19, P5091, DOI 10.1038/sj.onc.1203888; CHEN G, 1994, BIOCHEM PHARMACOL, V47, P1079, DOI 10.1016/0006-2952(94)90420-0; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; Garay E, 2007, J CELL PHYSIOL, V213, P816, DOI 10.1002/jcp.21150; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Korkola JE, 2003, CANCER RES, V63, P7167; Kure S, 2009, CANCER EPIDEM BIOMAR, V18, P2765, DOI 10.1158/1055-9965.EPI-09-0490; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Li QP, 2007, J BIOL CHEM, V282, P1544, DOI 10.1074/jbc.M604052200; Liu F, 1998, MOL CELL BIOL, V18, P250, DOI 10.1128/MCB.18.1.250; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; Menezes RJ, 2008, CANCER EPIDEM BIOMAR, V17, P1104, DOI 10.1158/1055-9965.EPI-07-2713; MHUIRCHEARTAIGH JN, 2006, BRIT J SURG, V95, P827; Obrero M, 2002, J BIOL CHEM, V277, P45695, DOI 10.1074/jbc.M208092200; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Prufer K, 2002, MOL ENDOCRINOL, V16, P961, DOI 10.1210/me.16.5.961; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Prufer K, 2000, J BIOL CHEM, V275, P41114, DOI 10.1074/jbc.M003791200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2004, J BIOL CHEM, V279, P6769, DOI 10.1074/jbc.M311492200; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; Racz A, 1999, J BIOL CHEM, V274, P19352, DOI 10.1074/jbc.274.27.19352; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Ward JO, 2001, BLOOD, V98, P3290, DOI 10.1182/blood.V98.12.3290; WIENER JR, 1994, J NATL CANCER I, V86, P372, DOI 10.1093/jnci/86.5.372; Yang LM, 2001, J CELL PHYSIOL, V188, P383, DOI 10.1002/jcp.1125; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; Yasmin R, 2005, J BIOL CHEM, V280, P40152, DOI 10.1074/jbc.M507708200; Yip SS, 2000, INT J CANCER, V88, P363, DOI 10.1002/1097-0215(20001101)88:3<363::AID-IJC7>3.0.CO;2-4; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhang SH, 1999, J BIOL CHEM, V274, P17806, DOI 10.1074/jbc.274.25.17806; Zinser GM, 2003, MOL CELL ENDOCRINOL, V200, P67, DOI 10.1016/S0303-7207(02)00416-1	42	31	34	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	14					1706	1715		10.1038/onc.2010.543	http://dx.doi.org/10.1038/onc.2010.543			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	746IS	21119599	Green Accepted			2022-12-25	WOS:000289239400008
J	Liu, LQ; Parameswaran, S; Liu, J; Kim, S; Wojcik, EJ				Liu, Liqiong; Parameswaran, Sreeja; Liu, Jing; Kim, Sunyoung; Wojcik, Edward J.			Loop 5-directed Compounds Inhibit Chimeric Kinesin-5 Motors IMPLICATIONS FOR CONSERVED ALLOSTERIC MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTROPY-ENTHALPY COMPENSATION; TRITYL-L-CYSTEINE; SMALL-MOLECULE INHIBITOR; SPINDLE PROTEIN KSP; MITOTIC KINESIN; MICROTUBULE-BINDING; ATP HYDROLYSIS; HUMAN EG5; MONASTROL; LIGAND	The human Eg5 (HsEg5) protein is unique in its sensitivity to allosteric agents even among phylogenetic kin. For example, S-trityl-L-cysteine (STC) and monastrol are HsEg5 inhibitors that bind to a surface pocket created by the L5 loop, but neither compound inhibits the Drosophila Kinesin-5 homologue (Klp61F). Herein we ask whether or not drug sensitivity can be designed into Klp61F. Two chimeric Klp61F motor domains were engineered, bacterially expressed, and purified to test this idea. We report that effector binding can elicit a robust allosteric response comparable with HsEg5 in both motor domain chimeras. Furthermore, isothermal titration calorimetry confirms that the Klp61F chimeras have de novo binding affinities for both STC and monastrol. These data show that the mechanism of intramolecular communication between the three ligand binding sites is conserved in the Kinesin-5 family, and reconstitution of a drug binding cassette within the L5 pocket is sufficient to restore allosteric inhibition. However, the two compounds were not equivalent in their allosteric inhibition. This surprising disparity in the response between the chimeras to monastrol and STC suggests that there is more than one allosteric communication network for these effectors.	[Liu, Liqiong; Parameswaran, Sreeja; Liu, Jing; Kim, Sunyoung; Wojcik, Edward J.] LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wojcik, EJ (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	ewojci@lsuhsc.edu		Wojcik, Edward/0000-0002-3023-0312	National Institutes of Health [GM066328]; Louisiana Board of Regents; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097350, R01GM066328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066328 (to E. J. W.). This work was also supported by a Louisiana Board of Regents grant (to S. K.).	Bharatham K, 2008, J COMPUT AID MOL DES, V22, P925, DOI 10.1007/s10822-008-9229-0; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Brier S, 2004, BIOCHEMISTRY-US, V43, P13072, DOI 10.1021/bi049264e; Brier S, 2006, J MOL BIOL, V360, P360, DOI 10.1016/j.jmb.2006.04.062; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Cox CD, 2008, J MED CHEM, V51, P4239, DOI 10.1021/jm800386y; Crevel IMTC, 2004, CURR BIOL, V14, pR411, DOI 10.1016/j.cub.2004.05.030; Dam TK, 2008, J BIOL CHEM, V283, P31366, DOI 10.1074/jbc.M806473200; Deavours BE, 1998, CELL MOTIL CYTOSKEL, V40, P408, DOI 10.1002/(SICI)1097-0169(1998)40:4<408::AID-CM8>3.0.CO;2-6; DeBonis S, 2004, MOL CANCER THER, V3, P1079; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; DeBonis S, 2008, J MED CHEM, V51, P1115, DOI 10.1021/jm070606z; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Fisicaro E, 2004, PHYS CHEM CHEM PHYS, V6, P4156, DOI 10.1039/b404327h; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Gallicchio E, 1998, J AM CHEM SOC, V120, P4526, DOI 10.1021/ja974061h; Garcia-Saez I, 2007, J BIOL CHEM, V282, P9740, DOI 10.1074/jbc.M608883200; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Lakamper S, 2010, J MOL BIOL, V399, P1, DOI 10.1016/j.jmb.2010.03.009; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Learman SS, 2009, BIOCHEMISTRY-US, V48, P1754, DOI 10.1021/bi801291q; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lewis JA, 2008, CURR OPIN CHEM BIOL, V12, P269, DOI 10.1016/j.cbpa.2008.02.014; Luo LS, 2004, BIOCHEMISTRY-US, V43, P15258, DOI 10.1021/bi048282t; Luo LS, 2008, J AM CHEM SOC, V130, P7584, DOI 10.1021/ja710889h; Luo L, 2007, NAT CHEM BIOL, V3, P722, DOI 10.1038/nchembio.2007.34; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Maliga Z, 2006, J BIOL CHEM, V281, P7977, DOI 10.1074/jbc.M511955200; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Marshall CG, 2009, ARCH BIOCHEM BIOPHYS, V484, P1, DOI 10.1016/j.abb.2009.01.015; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Roecker AJ, 2007, BIOORG MED CHEM LETT, V17, P5677, DOI 10.1016/j.bmcl.2007.07.074; Schiemann K, 2010, BIOORG MED CHEM LETT, V20, P1491, DOI 10.1016/j.bmcl.2010.01.110; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Sheth PR, 2010, BIOCHEMISTRY-US, V49, P8350, DOI 10.1021/bi1005283; Sheth PR, 2009, BIOCHEMISTRY-US, V48, P11045, DOI 10.1021/bi900946r; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Tcherniuk S, 2010, BIOCHEM PHARMACOL, V79, P864, DOI 10.1016/j.bcp.2009.11.001; Whitesides GM, 2005, Q REV BIOPHYS, V38, P385, DOI 10.1017/S0033583506004240; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Zhang B, 2008, BIOCHEM BIOPH RES CO, V372, P565, DOI 10.1016/j.bbrc.2008.05.074; Zhang XY, 2007, J AM CHEM SOC, V129, P3812, DOI 10.1021/ja069098t; Zhao YC, 2010, J BIOL CHEM, V285, P25213, DOI 10.1074/jbc.M110.123067	58	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6201	6210		10.1074/jbc.M110.154989	http://dx.doi.org/10.1074/jbc.M110.154989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21127071	Green Published, hybrid			2022-12-25	WOS:000287476400029
J	Lu, YH; Guan, ZQ; Zhao, JS; Raetz, CRH				Lu, Yi-Hsueh; Guan, Ziqiang; Zhao, Jinshi; Raetz, Christian R. H.			Three Phosphatidylglycerol-phosphate Phosphatases in the Inner Membrane of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNDECAPRENYL PYROPHOSPHATE PHOSPHATASE; CDP-DIGLYCERIDE SYNTHETASE; EXPRESSION CLONING; BOUND PHOSPHATASES; CHROMOSOMAL GENES; OUTER-MEMBRANE; MULTIPLE GENES; PCR PRODUCTS; PGPB GENE; MUTANT	The phospholipids of Escherichia coli consist mainly of phosphatidylethanolamine, phosphatidylglycerol (PG), and cardiolipin. PG makes up similar to 25% of the cellular phospholipid and is essential for growth in wild-type cells. PG is synthesized on the inner surface of the inner membrane from cytidine diphosphate-diacylglycerol and glycerol 3-phosphate, generating the precursor phosphatidylglycerol-phosphate (PGP). This compound is present at low levels (similar to 0.1% of the total lipid). Dephosphorylation of PGP to PG is catalyzed by several PGP-phosphatases. The pgpA and pgpB genes, which encode structurally distinct PGP-phosphatases, were identified previously. Double deletion mutants lacking pgpA and pgpB are viable and still make PG, suggesting the presence of additional phosphatase( s). We have identified a third PGP-phosphatase gene (previously annotated as yfhB but renamed pgpC) using an expression cloning strategy. A mutant with deletions in all three phosphatase genes is not viable unless covered by a plasmid expressing either pgpA, pgpB, or pgpC. When the triple mutant is covered with the temperature-sensitive plasmid pMAK705 expressing any one of the three pgp genes, the cells grow at 30 but not 42 degrees C. As growth slows at 42 degrees C, PGP accumulates to high levels, and the PG content declines. PgpC orthologs are present in many other bacteria.	[Lu, Yi-Hsueh; Guan, Ziqiang; Zhao, Jinshi; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	raetz@biochem.duke.edu	Guan, Ziqiang/AAE-5110-2019		National Institutes of Health [GM-51796, GM-069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051796, U54GM069338, R37GM051796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-51796 (to C. R. H. R.) and the Large Scale Collaborative Grant GM-069338 (to Z. G. and the Lipid MAPS mass spectrometry facility at Duke University).	Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHANG YY, 1967, J LIPID RES, V8, P456; Chung HS, 2010, BIOCHEMISTRY-US, V49, P4126, DOI 10.1021/bi100343e; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Doerrler WT, 2005, J BIOL CHEM, V280, P27679, DOI 10.1074/jbc.M504796200; Doublet B, 2008, J MICROBIOL METH, V75, P359, DOI 10.1016/j.mimet.2008.06.010; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; El Ghachi M, 2005, J BIOL CHEM, V280, P18689, DOI 10.1074/jbc.M412277200; FUNK CR, 1992, J BACTERIOL, V174, P205, DOI 10.1128/jb.174.1.205-213.1992; GANONG BR, 1980, J BIOL CHEM, V255, P1623; Garrett TA, 1998, J BIOL CHEM, V273, P12457, DOI 10.1074/jbc.273.20.12457; GOPALAKRISHNAN AS, 1986, J BIOL CHEM, V261, P1329; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; ICHO T, 1985, J BIOL CHEM, V260, P2078; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; ICHO T, 1988, J BACTERIOL, V170, P5117, DOI 10.1128/jb.170.11.5117-5124.1988; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; KANFER J, 1964, J BIOL CHEM, V239, P1720; Karbarz MJ, 2003, J BIOL CHEM, V278, P39269, DOI 10.1074/jbc.M305830200; KENNEDY EUGENE P., 1962, HARVEY LECTURES, V57, P143; Kikuchi S, 2000, J BACTERIOL, V182, P371, DOI 10.1128/JB.182.2.371-376.2000; Kumaran D, 2006, PROTEINS, V64, P851, DOI 10.1002/prot.21039; Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x; Metzger LE, 2010, BIOCHEMISTRY-US, V49, P6715, DOI 10.1021/bi1008744; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Miller J.H., 1972, EXPT MOL GENETICS; NEUWALD AF, 1985, NUCLEIC ACIDS RES, V13, P7025, DOI 10.1093/nar/13.19.7025; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; RAETZ CRH, 1972, J BIOL CHEM, V247, P2008; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; RAETZ CRH, 1973, J BIOL CHEM, V248, P1098; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; SHIBUYA I, 1992, PROG LIPID RES, V31, P245, DOI 10.1016/0163-7827(92)90010-G; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song S, 1993, Chin J Biotechnol, V9, P197; Touze T, 2008, J BIOL CHEM, V283, P16573, DOI 10.1074/jbc.M800394200; USUI M, 1994, J BACTERIOL, V176, P3389, DOI 10.1128/jb.176.11.3389-3392.1994; Wang XY, 2006, J BIOL CHEM, V281, P9321, DOI 10.1074/jbc.M600435200; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Zhang YM, 2008, J LIPID RES, V49, P1867, DOI 10.1194/jlr.R800005-JLR200	54	64	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5506	5518		10.1074/jbc.M110.199265	http://dx.doi.org/10.1074/jbc.M110.199265			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148555	hybrid, Green Published			2022-12-25	WOS:000287230600060
J	Beckman, JD; Chen, CS; Nguyen, J; Thayanithy, V; Subramanian, S; Steer, CJ; Vercellotti, GM				Beckman, Joan D.; Chen, Chunseng; Nguyen, Julia; Thayanithy, Venugopal; Subramanian, Subbaya; Steer, Clifford J.; Vercellotti, Gregory M.			Regulation of Heme Oxygenase-1 Protein Expression by miR-377 in Combination with miR-217	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION REPRESSOR BACH1; SICKLE-CELL-DISEASE; OXIDATIVE STRESS; CARBON-MONOXIDE; MESSENGER-RNAS; MICRORNAS; INFLAMMATION; MICE; DEFICIENCY; INDUCTION	Heme oxygenase-1 (HO-1) enzyme plays a critical role in metabolizing the excess heme generated during hemolysis. Our previous studies suggested that during intravascular hemolysis the expression of HO-1 protein is not sufficient to reduce the oxidative burden of free heme in the vasculature. This led us to hypothesize that a post-translational mechanism of control exists for HO-1 expression. Micro-RNAs (miRNA) affect gene expression by post-transcriptional gene regulation of transcripts. We performed in silico analysis for the human HMOX1-3' untranslated region (3' UTR) and identified candidate miRNA binding sites. Two candidate miRNAs, miR-377 and miR-217, were cloned and co-transfected with a luciferase vector containing the human HMOX1-3'UTR region. The combination of miR-377 and miR-217 produced a 58% reduction in HMOX1-3'UTR luciferase reporter expression compared with controls. The same constructs were then used to assess how overexpression of miR-217 and miR-377 affected HO-1 levels after induction with hemin. Cells transfected with the combination of miR-377 and miR-217 exhibited no change in HMOX1 mRNA levels, but a significant reduction in HMOX1 (HO-1) protein expression and enzyme activity compared with non-transfected hemin-stimulated controls. Transfection with either miR-377 or miR-217 alone did not produce a significant decrease in HO-1 protein expression or enzyme activity. Knockdown of miR-217 and miR-377 in combination leads to up-regulation of HO-1 protein. Exposure to hemin induced a significant reduction in miR-217 expression and a trend toward decreased miR-377 expression in two different cells lines. In summary, these data suggests that the combination of miR-377 and miR-217 help regulate HO-1 protein expression in the presence of hemin.	[Vercellotti, Gregory M.] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Vercellotti, GM (corresponding author), Rm D495 Mayo,MMC 480,420 Delaware St SE, Minneapolis, MN 55455 USA.	verce001@umn.edu	Thayanithy, Venugopal/C-2777-2013; Beckman, Joan/V-2579-2019; Beckman, Joan/D-4174-2015	Beckman, Joan/0000-0001-7903-944X; Beckman, Joan/0000-0001-7903-944X; Subramanian, Subbaya/0000-0002-2544-480X	NIA [F30AG030909]; NHLBI [R01 HL67367, P01HL055552]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067367, P01HL055552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG030909] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants F30AG030909 from the NIA (to J. D. B.) and R01 HL67367 and P01HL055552 from the NHLBI (to G. M. V. and R. P. Hebbel).	BALLA G, 1991, LAB INVEST, V64, P648; BALLA G, 1992, J BIOL CHEM, V267, P18148; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Beckman JD, 2009, AM J PHYSIOL-HEART C, V297, pH1243, DOI 10.1152/ajpheart.00327.2009; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belcher JD, 2010, J MOL MED, V88, P665, DOI 10.1007/s00109-010-0613-6; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hinton A, 2010, STEM CELLS DEV, V19, P797, DOI 10.1089/scd.2009.0224; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Mraz M, 2009, BIOCHEM BIOPH RES CO, V390, P1, DOI 10.1016/j.bbrc.2009.09.061; Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Piantadosi CA, 2006, FREE RADICAL BIO MED, V40, P1332, DOI 10.1016/j.freeradbiomed.2005.11.020; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Shan Y, 2007, GASTROENTEROLOGY, V133, P1166, DOI 10.1053/j.gastro.2007.08.002; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x	43	73	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3194	3202		10.1074/jbc.M110.148726	http://dx.doi.org/10.1074/jbc.M110.148726			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106538	Green Published, hybrid			2022-12-25	WOS:000286653200003
J	Nalaskowski, MM; Fliegert, R; Ernst, O; Brehm, MA; Fanick, W; Windhorst, S; Lin, HY; Giehler, S; Hein, JM; Lin, YN; Mayr, GW				Nalaskowski, Marcus M.; Fliegert, Ralf; Ernst, Olga; Brehm, Maria A.; Fanick, Werner; Windhorst, Sabine; Lin, Hongying; Giehler, Susanne; Hein, Jamin; Lin, Yuan-Na; Mayr, Georg W.			Human Inositol 1,4,5-Trisphosphate 3-Kinase Isoform B (IP3KB) Is a Nucleocytoplasmic Shuttling Protein Specifically Enriched at Cortical Actin Filaments and at Invaginations of the Nuclear Envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; CA2+ OSCILLATIONS; MOLECULAR-CLONING; GENE-EXPRESSION; EXPORT SIGNALS; MESSENGER-RNA; HELA-CELLS; 1,3,4,5-TETRAKISPHOSPHATE; ITPKB; IDENTIFICATION	Recent studies have shown that inositol 1,4,5-trisphosphate 3-kinase isoform B (IP3KB) possesses important roles in the development of immune cells. IP3KB can be targeted to multiple cellular compartments, among them nuclear localization and binding in close proximity to the plasma membrane. The B isoform is the only IP3K that is almost ubiquitously expressed in mammalian cells. Detailed mechanisms of its targeting regulation will be important in understanding the role of Ins(1,4,5)P-3 phosphorylation on subcellular calcium signaling and compartment-specific initiation of pathways leading to regulatory active higher phosphorylated inositol phosphates. Here, we identified an exportin 1-dependent nuclear export signal ((134)LQRELQNVQV) and characterized the amino acids responsible for nuclear localization of IP3KB ((RKLR)-R-129). These two targeting domains regulate the amount of nuclear IP3KB in cells. We also demonstrated that the localization of IP3KB at the plasma membrane is due to its binding to cortical actin structures. Intriguingly, all three of these targeting activities reside in one small polypeptide segment (amino acids 104-165), which acts as a multitargeting domain (MTD). Finally, a hitherto unknown subnuclear localization of IP3KB could be demonstrated in rapidly growing H1299 cells. IP3KB is specifically enriched at nuclear invaginations extending perpendicular between the apical and basal surface of the nucleus of these flat cells. Such nuclear invaginations are known to be involved in Ins(1,4,5)P-3-mediated Ca2+ signaling of the nucleus. Our findings indicate that IP3KB not only regulates cytoplasmic Ca2+ signals by phosphorylation of subplasmalemmal and cytoplasmic Ins(1,4,5)P-3 but may also be involved in modulating nuclear Ca2+ signals generated from these nuclear envelope invaginations.	[Nalaskowski, Marcus M.; Fliegert, Ralf; Ernst, Olga; Brehm, Maria A.; Fanick, Werner; Windhorst, Sabine; Lin, Hongying; Giehler, Susanne; Hein, Jamin; Lin, Yuan-Na; Mayr, Georg W.] Univ Med Ctr Hamburg Eppendorf, Inst Biochem Mol Biol I Cellular Signal Transduct, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Nalaskowski, MM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Biochem Mol Biol I Cellular Signal Transduct, Martinistr 52, D-20246 Hamburg, Germany.	nalaskowski@uke.uni-hamburg.de		Brehm, Maria Alexandra/0000-0003-0416-8233; Hein, Jamin/0000-0002-2887-5082	Deutsche Forschungsgemeinschaft [MA 989/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MA 989/3-1 (to G. W. M.).	Barrat FJ, 1997, GENOMICS, V43, P111, DOI 10.1006/geno.1997.4785; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Brehm MA, 2004, BIOCHEM J, V382, P353, DOI 10.1042/BJ20031751; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; Clubb BH, 1998, TISSUE CELL, V30, P684, DOI 10.1016/S0040-8166(98)80087-6; Dewaste V, 2003, BIOCHEM J, V374, P41, DOI 10.1042/BJ20021963; Dewaste V, 2002, BIOCHEM BIOPH RES CO, V291, P400, DOI 10.1006/bbrc.2002.6456; Dewaste V, 2000, BIOCHEM J, V352, P343, DOI 10.1042/0264-6021:3520343; Dupont G, 1997, CELL CALCIUM, V22, P321, DOI 10.1016/S0143-4160(97)90017-8; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; ERNEUX C, 1992, GENOMICS, V14, P546, DOI 10.1016/S0888-7543(05)80265-4; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Gyorffy B, 2007, J INVEST DERMATOL, V127, P394, DOI 10.1038/sj.jid.5700543; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Henao-Mejia J, 2009, EXP CELL RES, V315, P3381, DOI 10.1016/j.yexcr.2009.07.011; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Huang YH, 2008, EXPERT OPIN THER TAR, V12, P391, DOI 10.1517/14728222.12.4.391 ; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jia YH, 2008, P NATL ACAD SCI USA, V105, P4739, DOI 10.1073/pnas.0800218105; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Johnson N, 2003, DIFFERENTIATION, V71, P414, DOI 10.1046/j.1432-0436.2003.7107003.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Lui PPY, 2003, BIOCHEM BIOPH RES CO, V308, P826, DOI 10.1016/S0006-291X(03)01469-4; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Malviya AN, 2006, CAN J PHYSIOL PHARM, V84, P403, DOI 10.1139/Y05-130; Marechal Y, 2007, P NATL ACAD SCI USA, V104, P13978, DOI 10.1073/pnas.0704312104; Millard TH, 2000, BIOCHEM J, V352, P709, DOI 10.1042/0264-6021:3520709; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Nalaskowski MM, 2006, BIOL CHEM, V387, P583, DOI 10.1515/BC.2006.075; Nalaskowski MM, 2003, J BIOL CHEM, V278, P19765, DOI 10.1074/jbc.M211059200; Nalaskowski MM, 2002, BIOCHEM J, V366, P549, DOI 10.1042/BJ20020327; Pattni K, 2003, BIOCHEM J, V375, P643, DOI 10.1042/BJ20030505; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Tajouri L, 2005, BRAIN RES PROTOC, V15, P79, DOI 10.1016/j.brainresprot.2005.04.003; TAKAZAWA K, 1991, BIOCHEM J, V278, P883, DOI 10.1042/bj2780883; Tripathi K, 2008, J BIOSCIENCES, V33, P345, DOI 10.1007/s12038-008-0054-3; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Windhorst S, 2010, J BIOL CHEM, V285, P5541, DOI 10.1074/jbc.M109.047050; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yu JCH, 2005, BIOCHEM J, V392, P435, DOI 10.1042/BJ20050829; Zeidman R, 2002, MOL BIOL CELL, V13, P12, DOI 10.1091/mbc.01-04-0210	50	27	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4500	4510		10.1074/jbc.M110.173062	http://dx.doi.org/10.1074/jbc.M110.173062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148483	Green Published, hybrid			2022-12-25	WOS:000286975700050
J	Novgorodov, SA; Chudakova, DA; Wheeler, BW; Bielawski, J; Kindy, MS; Obeid, LM; Gudz, TI				Novgorodov, Sergei A.; Chudakova, Daria A.; Wheeler, Brian W.; Bielawski, Jacek; Kindy, Mark S.; Obeid, Lina M.; Gudz, Tatyana I.			Developmentally Regulated Ceramide Synthase 6 Increases Mitochondrial Ca2+ Loading Capacity and Promotes Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; NERVE GROWTH-FACTOR; BRAIN MITOCHONDRIA; CELL-DEATH; CYSTINE/GLUTAMATE ANTIPORTER; (DIHYDRO)CERAMIDE SYNTHASE; SUBSTRATE-SPECIFICITY; N-ACYLTRANSFERASE; CALPAIN INHIBITOR; CNS MITOCHONDRIA	Ceramides, which are membrane sphingolipids and key mediators of cell-stress responses, are generated by a family of (dihydro) ceramide synthases (Lass1-6/CerS1-6). Here, we report that brain development features significant increases in sphingomyelin, sphingosine, and most ceramide species. In contrast, C-16:0-ceramide was gradually reduced and CerS6 was down-regulated in mitochondria, thereby implicating CerS6 as a primary ceramide synthase generating C-16:0-ceramide. Investigations into the role of CerS6 in mitochondria revealed that ceramide synthase down-regulation is associated with dramatically decreased mitochondrial Ca2+-loading capacity, which could be rescued by addition of ceramide. Selective CerS6 complexing with the inner membrane component of the mitochondrial permeability transition pore was detected by immunoprecipitation. This suggests that CerS6-generated ceramide could prevent mitochondrial permeability transition pore opening, leading to increased Ca2+ accumulation in the mitochondrial matrix. We examined the effect of high CerS6 expression on cell survival in primary oligodendrocyte (OL) precursor cells, which undergo apoptotic cell death during early postnatal brain development. Exposure of OLs to glutamate resulted in apoptosis that was prevented by inhibitors of de novo ceramide biosynthesis, myriocin and fumonisin B1. Knockdown of CerS6 with siRNA reduced glutamate-triggered OL apoptosis, whereas knockdown of CerS5 had no effect: the pro-apoptotic role of CerS6 was not stimulus-specific. Knockdown of CerS6 with siRNA improved cell survival in response to nerve growth factor-induced OL apoptosis. Also, blocking mitochondrial Ca2+ uptake or decreasing Ca2+-dependent protease calpain activity with specific inhibitors prevented OL apoptosis. Finally, knocking down CerS6 decreased calpain activation. Thus, our data suggest a novel role for CerS6 in the regulation of both mitochondrial Ca2+ homeostasis and calpain, which appears to be important in OL apoptosis during brain development.	[Obeid, Lina M.; Gudz, Tatyana I.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Chudakova, Daria A.; Wheeler, Brian W.; Kindy, Mark S.; Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Novgorodov, Sergei A.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Novgorodov, Sergei A.; Bielawski, Jacek; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Gudz, TI (corresponding author), 114 Doughty St, Charleston, SC 29425 USA.	gudz@musc.edu	Chudakova, Daria/ABB-3032-2020	obeid, lina/0000-0002-0734-0847	National Institutes of Health for NCCR COBRE in Lipidomics and Pathobiology [P20 RR 17677, AG16583]; Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health for NCCR COBRE in Lipidomics and Pathobiology; Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR 17677 for NCCR COBRE in Lipidomics and Pathobiology (to T. I. G.), Grant AG16583 (to L. M. O.), and Veterans Affairs Rehabilitation Research and Development Merit Awards (to T. I. G. and M. S. K.).	Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Blochl A, 2007, J NEUROCHEM, V102, P289, DOI 10.1111/j.1471-4159.2007.04496.x; Brann AB, 1999, J NEUROSCI, V19, P8199; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Das A, 2005, J NEUROSCI RES, V81, P551, DOI 10.1002/jnr.20581; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 2001, J BIOL CHEM, V276, P16758, DOI 10.1074/jbc.M009331200; Elce JS, 1997, J BIOL CHEM, V272, P11268; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Goldberg MP, 2003, STROKE, V34, P330, DOI 10.1161/01.STR.0000054048.22626.B9; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Gu CH, 1999, J NEUROSCI, V19, P3043; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Hoppe UC, 2010, FEBS LETT, V584, P1975, DOI 10.1016/j.febslet.2010.04.017; Iemata M, 2007, J CELL PHYSIOL, V213, P721, DOI 10.1002/jcp.21145; Ishihara I, 2000, NEUROSCI LETT, V279, P97, DOI 10.1016/S0304-3940(99)00960-X; Joshi A, 2009, EXP NEUROL, V218, P221, DOI 10.1016/j.expneurol.2009.04.013; Kar P, 2008, ARCH BIOCHEM BIOPHYS, V470, P176, DOI 10.1016/j.abb.2007.11.018; Kar P, 2010, ARCH BIOCHEM BIOPHYS, V495, P1, DOI 10.1016/j.abb.2009.12.020; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Kristian T, 2007, J NEUROCHEM, V102, P1346, DOI 10.1111/j.1471-4159.2007.04626.x; Kushnareva YE, 2005, J BIOL CHEM, V280, P28894, DOI 10.1074/jbc.M503090200; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; LAMPI KJ, 1992, TOXICOL APPL PHARM, V117, P53, DOI 10.1016/0041-008X(92)90216-F; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; MORELL P, 1970, J BIOL CHEM, V245, P342; NICHOLLS DG, 1985, PROG BRAIN RES, V63, P97; Noureddine L, 2008, PROSTAG OTH LIPID M, V86, P49, DOI 10.1016/j.prostaglandins.2008.02.003; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; Novgorodov SA, 1996, J BIOENERG BIOMEMBR, V28, P139, DOI 10.1007/BF02110644; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Noygorodov SA, 2009, J CARDIOVASC PHARM, V53, P198, DOI 10.1097/FJC.0b013e31819b52d5; Ozaki T, 2009, BBA-MOL CELL RES, V1793, P1848, DOI 10.1016/j.bbamcr.2009.10.002; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; SHIMENO H, 1995, BIOL PHARM BULL, V18, P1335; Sot J, 2005, BIOPHYS J, V88, p72A; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; TSUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201, DOI 10.1016/S0006-291X(88)81355-X; ULLMAN MD, 1972, ARCH BIOCHEM BIOPHYS, V152, P767, DOI 10.1016/0003-9861(72)90272-X; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wang LY, 2006, J BIOL CHEM, V281, P24553, DOI 10.1074/jbc.M600939200; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200	79	62	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4644	4658		10.1074/jbc.M110.164392	http://dx.doi.org/10.1074/jbc.M110.164392			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148554	hybrid, Green Published			2022-12-25	WOS:000286975700064
J	Trikha, P; Sharma, N; Opavsky, R; Reyes, A; Pena, C; Ostrowski, MC; Roussel, MF; Leone, G				Trikha, Prashant; Sharma, Nidhi; Opavsky, Rene; Reyes, Andres; Pena, Clarissa; Ostrowski, Michael C.; Roussel, Martine F.; Leone, Gustavo			E2f1-3 Are Critical for Myeloid Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; CELLULAR PROLIFERATION; S-PHASE; C-MYC; RETINOBLASTOMA GENE; GROWTH ARREST; C/EBP-ALPHA; TRANSCRIPTION; EXPRESSION; CSF-1	Hematopoietic development involves the coordinated activity of differentiation and cell cycle regulators. In current models of mammalian cell cycle control, E2f activators (E2f1, E2f2, and E2f3) are portrayed as the ultimate transcriptional effectors that commit cells to enter and progress through S phase. Using conditional gene knock-out strategies, we show that E2f1-3 are not required for the proliferation of early myeloid progenitors. Rather, these E2fs are critical for cell survival and proliferation at two distinct steps of myeloid development. First, E2f1-3 are required as transcriptional repressors for the survival of CD11b(+) myeloid progenitors, and then they are required as activators for the proliferation of CD11b(+) macrophages. In bone marrow macrophages, we show that E2f1-3 respond to CSF1-Myc mitogenic signals and serve to activate E2f target genes and promote their proliferation. Together, these findings expose dual functions for E2f1-3 at distinct stages of myeloid development in vivo, first as repressors in cell survival and then as activators in cell proliferation. In summary, this work places E2f1-3 in a specific signaling cascade that is critical for myeloid development in vivo.	[Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Trikha, Prashant; Sharma, Nidhi; Opavsky, Rene; Reyes, Andres; Pena, Clarissa; Leone, Gustavo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Coll Med & Publ Hlth, Columbus, OH 43210 USA; [Trikha, Prashant; Sharma, Nidhi; Opavsky, Rene; Reyes, Andres; Pena, Clarissa; Leone, Gustavo] Ohio State Univ, Dept Mol Genet, Coll Biol Sci, Columbus, OH 43210 USA; [Ostrowski, Michael C.] Ohio State Univ, Dept Mol Cellular Biochem, Coll Med & Publ Hlth, Columbus, OH 43210 USA; [Roussel, Martine F.] St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA; [Roussel, Martine F.] St Jude Childrens Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Leone, G (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, 12th Ave, Columbus, OH 43210 USA.	Gustavo.Leone@osumc.edu	Trikha, Prashant/B-5897-2012; Roussel, Martine F/F-1469-2016; Ostrowski, Michael/H-3108-2011	Roussel, Martine F/0000-0002-1740-8139; Ostrowski, Michael/0000-0003-2948-6297	National Institutes of Health [R01CA85619, R01CA82259, R01HD04470, P01CA097189, R01CA053271, CA71907, CA91765, CA 106196-06]; American Lebanese Syrian-Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P01CA097189, R01CA085619, T32CA106196, P01CA071907, R01CA082259, R01CA053271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian-Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA85619, R01CA82259, R01HD04470, and P01CA097189 (to G. L.); R01CA053271 and P01CA097189 (to M. C. O.); and CA71907 and CA91765. This work was also supported by the American Lebanese Syrian-Associated Charities of St. Jude Children's Research Hospital (to M. F. R.).; Recipient of National Institutes of Health T32 Fellowship CA 106196-06.	Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Himes SR, 2005, ONCOGENE, V24, P5278, DOI 10.1038/sj.onc.1208657; Humbert PO, 2000, GENE DEV, V14, P690; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Li FX, 2003, MOL CELL BIOL, V23, P3607, DOI 10.1128/MCB.23.10.3607-3622.2003; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; ROUSSEL MF, 1995, P NATL ACAD SCI USA, V92, P6837, DOI 10.1073/pnas.92.15.6837; ROUSSEL MF, 1991, NATURE, V353, P361, DOI 10.1038/353361a0; ROUSSEL MF, 1994, J CELL SCI, P105; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsai SY, 2008, NATURE, V454, P1137, DOI 10.1038/nature07066; TUSHINSKI RJ, 1985, J CELL PHYSIOL, V122, P221, DOI 10.1002/jcp.1041220210; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	48	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4783	4795		10.1074/jbc.M110.182733	http://dx.doi.org/10.1074/jbc.M110.182733			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115501	hybrid, Green Published			2022-12-25	WOS:000286975700076
J	Knecht, DA; LaFleur, RA; Kahsai, AW; Argueta, CE; Beshir, AB; Fenteany, G				Knecht, David A.; LaFleur, Rebecca A.; Kahsai, Alem W.; Argueta, Christian E.; Beshir, Anwar B.; Fenteany, Gabriel			Cucurbitacin I Inhibits Cell Motility by Indirectly Interfering with Actin Dynamics	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; BREAST-CANCER CELLS; DICTYOSTELIUM-DISCOIDEUM; F-ACTIN; GLIOBLASTOMA-MULTIFORME; COLLAGEN PRODUCTION; CARCINOMA-CELLS; MONOMERIC RED; CYCLE ARREST; APOPTOSIS	Background: Cucurbitacins are plant natural products that inhibit activation of the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway by an unknown mechanism. They are also known to cause changes in the organization of the actin cytoskeleton. Methodology/Principal Findings: We show that cucurbitacin I potently inhibits the migration of Madin-Darby canine kidney (MDCK) cell sheets during wound closure, as well as the random motility of B16-F1 mouse melanoma cells, but has no effect on movement of Dictyostelium discoideum amoebae. Upon treatment of MDCK or B16-F1 cells with cucurbitacin I, there is a very rapid cessation of motility and gradual accumulation of filamentous actin aggregates. The cellular effect of the compound is similar to that observed when cells are treated with the actin filament-stabilizing agent jasplakinolide. However, we found that, unlike jasplakinolide or phallacidin, cucurbitacin I does not directly stabilize actin filaments. In in vitro actin depolymerization experiments, cucurbitacin I had no effect on the rate of actin filament disassembly at the nanomolar concentrations that inhibit cell migration. At elevated concentrations, the depolymerization rate was also unaffected, although there was a delay in the initiation of depolymerization. Therefore, cucurbitacin I targets some factor involved in cellular actin dynamics other than actin itself. Two candidate proteins that play roles in actin depolymerization are the actin-severing proteins cofilin and gelsolin. Cucurbitacin I possesses electrophilic reactivity that may lead to chemical modification of its target protein, as suggested by structure-activity relationship data. However, mass spectrometry revealed no evidence for modification of purified cofilin or gelsolin by cucurbitacin I. Conclusions/Significance: Cucurbitacin I results in accumulation of actin filaments in cells by a unique indirect mechanism. Furthermore, the proximal target of cucurbitacin I relevant to cell migration is unlikely to be the same one involved in activation of the JAK2/STAT3 pathway.	[Knecht, David A.; LaFleur, Rebecca A.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Kahsai, Alem W.; Argueta, Christian E.; Beshir, Anwar B.; Fenteany, Gabriel] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Knecht, DA (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	david.knecht@uconn.edu; gabriel.fenteany@uconn.edu	Fenteany, Gabriel/F-4944-2018	Fenteany, Gabriel/0000-0001-7407-2195; Knecht, David/0000-0001-6103-4296; Fenteany, Gabriel/0000-0003-0335-4587	American Cancer Society [RSG-02-250-01-DDC]; U.S. National Institutes of Health (NIH) [GM077622]; NIH [GM040599]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040599, R01GM077622] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society grant RSG-02-250-01-DDC and U.S. National Institutes of Health (NIH) grant GM077622 to GF and NIH grant GM040599 to DAK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Blaskovich MA, 2003, CANCER RES, V63, P1270; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Christine R, 2005, CANCER RES, V65, P195; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Dinan L, 1997, BIOCHEM J, V327, P643, DOI 10.1042/bj3270643; Duncan KLK, 1996, BIOCHEM PHARMACOL, V52, P1553, DOI 10.1016/S0006-2952(96)00557-6; Duncan MD, 1997, J SURG RES, V69, P55, DOI 10.1006/jsre.1997.5028; Escandell JM, 2008, BIOCHEM PHARMACOL, V76, P198, DOI 10.1016/j.bcp.2008.05.004; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Graness A, 2006, BIOCHEM PHARMACOL, V72, P32, DOI 10.1016/j.bcp.2006.04.001; Haritunians T, 2008, LEUKEMIA RES, V32, P1366, DOI 10.1016/j.leukres.2008.01.019; KNECHT DA, 1987, DEV BIOL, V121, P277, DOI 10.1016/0012-1606(87)90160-6; Knetsch MLW, 2002, J MUSCLE RES CELL M, V23, P605, DOI 10.1023/A:1024498805771; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lazaro-Dieguez F, 2008, J CELL SCI, V121, P1415, DOI 10.1242/jcs.017665; Lee DH, 2010, THESCIENTIFICWORLDJO, V10, P413, DOI 10.1100/tsw.2010.44; Lee E, 1998, CELL MOTIL CYTOSKEL, V39, P122, DOI 10.1002/(SICI)1097-0169(1998)39:2<122::AID-CM3>3.0.CO;2-8; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; Maloney KN, 2008, J NAT PROD, V71, P1927, DOI 10.1021/np8005259; Mc Henry KT, 2002, CHEMBIOCHEM, V3, P1105, DOI 10.1002/1439-7633(20021104)3:11<1105::AID-CBIC1105>3.0.CO;2-S; Momma K, 2008, CYTOTECHNOLOGY, V56, P33, DOI 10.1007/s10616-007-9100-5; MUSZA LL, 1994, J NAT PRODUCTS, V57, P1498, DOI 10.1021/np50113a004; Nakashima S, 2010, BIOORG MED CHEM LETT, V20, P2994, DOI 10.1016/j.bmcl.2010.02.062; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Park CS, 2004, J PHARMACOL EXP THER, V309, P705, DOI 10.1124/jpet.103.063693; Park G, 2008, J INVEST DERMATOL, V128, P2429, DOI 10.1038/jid.2008.103; Peters RR, 1997, PLANTA MED, V63, P525, DOI 10.1055/s-2006-957755; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Recio MC, 2004, PLANTA MED, V70, P414, DOI 10.1055/s-2004-818968; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shi XZ, 2006, BRIT J HAEMATOL, V135, P26, DOI 10.1111/j.1365-2141.2006.06259.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Su YH, 2008, CANCER BIOL THER, V7, P1243, DOI 10.4161/cbt.7.8.6263; SUSSMAN R, 1967, BIOCHEM BIOPH RES CO, V29, P53, DOI 10.1016/0006-291X(67)90539-6; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; van Kester MS, 2008, J INVEST DERMATOL, V128, P1691, DOI 10.1038/sj.jid.5701246; Wakimoto N, 2008, CANCER SCI, V99, P1793, DOI 10.1111/j.1349-7006.2008.00899.x; Washington RW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-10; YESILADA E, 1988, J NAT PROD, V51, P504, DOI 10.1021/np50057a008; Yin D, 2008, INT J CANCER, V123, P1364, DOI 10.1002/ijc.23648; Zhang MX, 2009, CANCER CHEMOTH PHARM, V63, P635, DOI 10.1007/s00280-008-0780-0	46	41	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14039	10.1371/journal.pone.0014039	http://dx.doi.org/10.1371/journal.pone.0014039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124831	Green Submitted, Green Published, gold			2022-12-25	WOS:000284572000001
J	Ehnert, S; Baur, J; Schmitt, A; Neumaier, M; Lucke, M; Dooley, S; Vester, H; Wildemann, B; Stockle, U; Nussler, AK				Ehnert, Sabrina; Baur, Johannes; Schmitt, Andreas; Neumaier, Markus; Lucke, Martin; Dooley, Steven; Vester, Helen; Wildemann, Britt; Stoeckle, Ulrich; Nussler, Andreas K.			TGF-beta(1) As Possible Link between Loss of Bone Mineral Density and Chronic Inflammation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; IGF-I; MORPHOGENETIC PROTEIN-2; OSTEOBLAST ADHESION; EXPRESSION; STIMULATION; CELLS; POLY(D,L-LACTIDE); MECHANISMS	Background: The TGF family plays a key role in bone homeostasis. Systemic or topic application of proteins of this family apparently positively affects bone healing in vivo. However, patients with chronic inflammation, having increased TGF-beta(1) serum-levels, often show reduced bone mineral content and disturbed bone healing. Therefore, we wanted to identify intracellular mechanisms induced by chronic presence of TGF-beta(1) and their possible role in bone homeostasis in primary human osteoblasts. Methodology/Principal Findings: Osteoblasts were isolated from femur heads of patients undergoing total hip replacement. Adenoviral reporter assays showed that in primary human osteoblasts TGF-beta(1) mediates its signal via Smad2/3 and not Smad1/5/8. It induces proliferation as an intermediate response but decreases AP-activity and inorganic matrix production as a late response. In addition, expression levels of osteoblastic markers were strongly regulated (AP down arrow; Osteocalcin down arrow; Osteopontin up arrow; MGP down arrow; BMP 2 down arrow; BSP2 down arrow; OSF2 down arrow; Osteoprotegerin down arrow; RANKL up arrow) towards an osteoclast recruiting phenotype. All effects were blocked by inhibition of Smad2/3 signaling with the Alk5-Inhibitor (SB431542). Interestingly, a rescue experiment showed that reduced AP-activities did not recover to base line levels, even 8 days after stopping the TGF-beta(1) application. Conclusions/Significance: In spite of the initial positive effects on cell proliferation, it is questionable if continuous Smad2/3 phosphorylation is beneficial for bone healing, because decreased AP-activity and BMP2 levels indicate a loss of function of the osteoblasts. Thus, inhibition of Smad2/3 phosphorylation might positively influence functional activity of osteoblasts in patients with chronically elevated TGF-beta(1) levels and thus, could lead to an improved bone healing in vivo.	[Ehnert, Sabrina; Baur, Johannes; Schmitt, Andreas; Neumaier, Markus; Lucke, Martin; Vester, Helen; Stoeckle, Ulrich; Nussler, Andreas K.] Tech Univ Munich, Dept Traumatol, MRI, Munich, Germany; [Dooley, Steven] Heidelberg Univ, Dept Med 2, Univ Hosp Mannheim, Heidelberg, Germany; [Wildemann, Britt] Charite, Julius Wolff Inst, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ehnert, S (corresponding author), Tech Univ Munich, Dept Traumatol, MRI, Munich, Germany.	ehnert@uchir.me.tum.de	Dooley, Steven/T-6491-2018; Wildemann, Britt/G-7732-2012; Nussler, Andreas/H-3557-2019; Ehnert, Sabrina/AAE-8163-2019	Dooley, Steven/0000-0002-4840-6240; Wildemann, Britt/0000-0002-8365-1188; Nussler, Andreas/0000-0002-6666-6791; Ehnert, Sabrina/0000-0003-4347-1702	Fresenius Foundation; Freunde der TU Munchen	Fresenius Foundation; Freunde der TU Munchen	This work was partially supported by the Fresenius Foundation and 'Freunde der TU Munchen'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DIEUDONNE SC, 1991, J BONE MINER RES, V6, P479; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; El-Amin SF, 2006, J BIOMED MATER RES A, V76A, P439, DOI 10.1002/jbm.a.30411; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Fedulov AV, 2005, IMMUNOL INVEST, V34, P143, DOI 10.1081/IMM-200055807; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482; HARRIS SE, 1994, J BONE MINER RES, V9, P855; HATTERSLEY G, 1991, J BONE MINER RES, V6, P165; IGNOTZ RA, 1987, CELL, V51, P189, DOI 10.1016/0092-8674(87)90146-2; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JOYCE ME, 1990, ORTHOP CLIN N AM, V21, P199; Kaneda T, 2000, J IMMUNOL, V165, P4254, DOI 10.4049/jimmunol.165.8.4254; Kanzler S, 2001, J VIRAL HEPATITIS, V8, P430, DOI 10.1046/j.1365-2893.2001.00314.x; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Lind M, 1998, ACTA ORTHOP SCAND, V69, P2; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P49, DOI 10.1002/jbmr.5650050109; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; ROSEN CJ, 1994, J CELL BIOCHEM, V56, P348, DOI 10.1002/jcb.240560311; ROSEN D, 1994, BONE, V15, P355, DOI 10.1016/8756-3282(94)90300-X; Rosier RN, 1998, CLIN ORTHOP RELAT R, pS294; Schmidmaier Gerhard, 2006, J Long Term Eff Med Implants, V16, P61; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Thirunavukkarasu K, 2001, J BIOL CHEM, V276, P36241, DOI 10.1074/jbc.M104319200; Wildemann B, 2004, CALCIFIED TISSUE INT, V74, P388, DOI 10.1007/s00223-003-0117-2; Wildemann B, 2004, BIOMATERIALS, V25, P3639, DOI 10.1016/j.biomaterials.2003.10.058; WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915	49	65	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14073	10.1371/journal.pone.0014073	http://dx.doi.org/10.1371/journal.pone.0014073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124921	Green Submitted, gold, Green Published			2022-12-25	WOS:000284467200008
J	Verguet, S; Holt, BY; Szeri, AJ				Verguet, Stephane; Holt, Bethany Young; Szeri, Andrew J.			Increasing the Effectiveness of Vaginal Microbicides: A Biophysical Framework to Rethink Behavioral Acceptability	PLOS ONE			English	Article							PHASE-I TRIAL; HIV PREVENTION; TOPICAL MICROBICIDES; SEXUAL PLEASURE; WOMEN; GEL; SAFETY; PREFERENCES; EXPERIENCES; CHALLENGES	Background: Microbicide candidates delivered via gel vehicles are intended to coat the vaginal epithelium after application. The coating process depends on intrinsic biophysical properties of the gel texture, which restricts the potential choices for an effective product: the gel first must be physically synthesizable, then acceptable to the user, and finally applied in a manner promoting timely adequate coating, so that the user adherence is optimized. We present a conceptual framework anchoring microbicide behavioral acceptability within the fulfillment of the product biophysical requirements. Methods: We conducted a semi-qualitative/quantitative study targeting women aged 18-55 in Northern California to assess user preferences for microbicide gel attributes. Attributes included: (i) the wait time between application and intercourse, (ii) the gel texture and (iii) the trade-off between wait time and gel texture. Wait times were assessed using a mathematical model determining coating rates depending upon the gel's physical attributes. Results: 71 women participated. Results suggest that women would independently prefer a gel spreading rapidly, in 2 to 15 minutes (P<0.0001), as well as one that is thick or slippery (P<0.02). Clearly, thick gels do not spread rapidly; hence the motivation to study the trade-off. When asked the same question 'constrained' by the biophysical reality, women indicated no significant preference for a particular gel thickness (and therefore waiting time) (P>0.10) for use with a steady partner, a preference for a watery gel spreading rapidly rather than one having intermediate properties for use with a casual partner (P=0.024). Conclusions: Biophysical constraints alter women's preferences regarding acceptable microbicide attributes. Product developers should offer a range of formulations in order to address all preferences. We designed a conceptual framework to rethink behavioral acceptability in terms of biophysical requirements that can help improve adherence in microbicide use ultimately enhancing microbicide effectiveness.	[Verguet, Stephane] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Holt, Bethany Young] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Holt, Bethany Young] Inst Publ Hlth, Coalit Adv Multipurpose Innovat, Folsom, CA USA; [Szeri, Andrew J.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; Public Health Institute; University of California System; University of California Berkeley	Verguet, S (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	verguet@uw.edu		Szeri, Andrew/0000-0003-0407-2645	California HIV/AIDS Research Program	California HIV/AIDS Research Program	Support for the project was provided by the California HIV/AIDS Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Barnhart K, 2009, CONTRACEPTION, V79, P297, DOI 10.1016/j.contraception.2008.11.001; Bentley ME, 2004, AM J PUBLIC HEALTH, V94, P1159, DOI 10.2105/AJPH.94.7.1159; Coggins C, 2000, SEX TRANSM INFECT, V76, P480, DOI 10.1136/sti.76.6.480; Darroch JE, 1999, FAM PLANN PERSPECT, V31, P16, DOI 10.2307/2991552; El-Sadr WM, 2006, AIDS, V20, P1109, DOI 10.1097/01.aids.0000226950.72223.5f; Garg Anita B, 2009, Antivir Chem Chemother, V19, P143; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Gupta KM, 2007, J PHARM SCI-US, V96, P670, DOI 10.1002/jps.20752; Hardy E, 1998, CONTRACEPTION, V58, P245, DOI 10.1016/S0010-7824(98)00104-8; Hendrix CW, 2009, ANNU REV PHARMACOL, V49, P349, DOI 10.1146/annurev.pharmtox.48.113006.094906; Holt BY, 2006, J WOMENS HEALTH, V15, P281, DOI 10.1089/jwh.2006.15.281; Holt BY, 2010, CONTRACEPTION, V81, P177, DOI 10.1016/j.contraception.2009.11.009; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2009, 2009, AIDS EP UPD DEC 2009; Jones HE, 2009, J WOMENS HEALTH, V18, P1003, DOI 10.1089/jwh.2008.0862; Karim QA, 2010, SCI EXPRESS; Kieweg SL, 2006, J BIOMECH ENG-T ASME, V128, P540, DOI 10.1115/1.2206198; Koo HP, 2005, J SOC ISSUES, V61, P67, DOI 10.1111/j.0022-4537.2005.00394.x; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; Morrow K, 2003, J WOMENS HEALTH, V12, P655, DOI 10.1089/154099903322404302; MORROW K, 2010, MICR 2010 PITTSB MAY; Morrow KM, 2008, AIDS BEHAV, V12, P272, DOI 10.1007/s10461-007-9266-z; Morrow KM, 2007, JAIDS-J ACQ IMM DEF, V45, P93, DOI 10.1097/QAI.0b013e3180415ded; Nuttall J, 2007, INFECT DIS CLIN N AM, V21, P219, DOI 10.1016/j.idc.2007.01.009; Owen DH, 2007, J PHARM SCI-US, V96, P661, DOI 10.1002/jps.20736; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Ramjee G, 2001, INT FAM PLAN PERSPEC, V27, P164, DOI 10.2307/2673851; Ramjee G, 2010, CURR OPIN HIV AIDS, V5, P316, DOI 10.1097/COH.0b013e32833a9f66; Romano J, 2008, CURR OPIN HIV AIDS, V3, P558, DOI 10.1097/COH.0b013e328305b96e; Rosen RK, 2008, J WOMENS HEALTH, V17, P383, DOI 10.1089/jwh.2006.0325; Severy LJ, 2005, AIDS BEHAV, V9, P121, DOI 10.1007/s10461-005-1687-y; Short MB, 2007, SEX TRANSM DIS, V34, P362, DOI 10.1097/01.olq.0000243619.51895.bd; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; Stone A., 2010, MICROBICIDES WAYS FO; Szeri AJ, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2973188; Tanner AE, 2008, J ADOLESCENT HEALTH, V43, P349, DOI 10.1016/j.jadohealth.2008.02.017; Tanner A, 2009, J SEX RES, V46, P15, DOI 10.1080/00224490802398407; Ventuneac A, 2010, AIDS BEHAV, V14, P618, DOI 10.1007/s10461-009-9611-5; Weeks MR, 2004, SEX TRANSM DIS, V31, P682, DOI 10.1097/01.olq.0000143113.04524.a5; Weiss HA, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-8; Woodsong C, 2008, AIDS EDUC PREV, V20, P171, DOI 10.1521/aeap.2008.20.2.171; Zubowicz EA, 2006, J WOMENS HEALTH, V15, P952, DOI 10.1089/jwh.2006.15.952	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e15501	10.1371/journal.pone.0015501	http://dx.doi.org/10.1371/journal.pone.0015501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	683HW	21124931	Green Submitted, Green Published, gold			2022-12-25	WOS:000284467200019
J	Fischer, E; De Vlas, S; Meima, A; Habbema, D; Richardus, J				Fischer, Egil; De Vlas, Sake; Meima, Abraham; Habbema, Dik; Richardus, Jan			Different Mechanisms for Heterogeneity in Leprosy Susceptibility Can Explain Disease Clustering within Households	PLOS ONE			English	Article							RISK-FACTORS; EPIDEMIOLOGY; CONTACTS; MODEL; BCG	The epidemiology of leprosy is characterized by heterogeneity in susceptibility and clustering of disease within households. We aim to assess the extent to which different mechanisms for heterogeneity in leprosy susceptibility can explain household clustering as observed in a large study among contacts of leprosy patients. We used a microsimulation model, parameterizing it with data from over 20,000 contacts of leprosy patients in Bangladesh. We simulated six mechanisms producing heterogeneity in susceptibility: (1) susceptibility was allocated at random to persons (i.e. no additional mechanism), (2) a household factor, (3, 4) a genetic factor (dominant or recessive), or (5, 6) half a household factor and half genetic. We further assumed that a fraction of 5%, 10%, and 20% of the population was susceptible, leading to a total of 18 scenarios to be fitted to the data. We obtained an acceptable fit for each of the six mechanisms, thereby excluding none of the possible underlying mechanisms for heterogeneity of susceptibility to leprosy. However, the distribution of leprosy among contacts did differ between mechanisms, and predicted trends in the declining leprosy case detection were dependent on the assumed mechanism, with genetic-based susceptibility showing the slowest decline. Clustering of leprosy within households is partially caused by an increased transmission within households independent of the leprosy susceptibility mechanism. Even a large and detailed data set on contacts of leprosy patients could not unequivocally reveal the mechanism most likely responsible for heterogeneity in leprosy susceptibility.	[Fischer, Egil; De Vlas, Sake; Meima, Abraham; Habbema, Dik; Richardus, Jan] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Fischer, E (corresponding author), Cent Vet Inst WUR, Dept Epidemiol Crisis Management & Diagnost, Lelystad, Netherlands.	j.richardus@erasmusmc.nl	Fischer, Egil A.J./A-1913-2010; Fischer, Egil Andreas Joor/F-6125-2010; Richardus, Jan Hendrik/AAE-1278-2021	Fischer, Egil A.J./0000-0002-0599-701X; Fischer, Egil Andreas Joor/0000-0002-0599-701X; Richardus, Jan Hendrik/0000-0003-0564-6313; de Vlas, Sake J./0000-0002-1830-5668	Netherlands Leprosy Relief	Netherlands Leprosy Relief	EF, AM and JR were supported by a grant from the Netherlands Leprosy Relief (www.leprastichting.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL L, 1995, GENET EPIDEMIOL, V12, P63, DOI 10.1002/gepi.1370120107; BAGSHAWE A, 1989, B WORLD HEALTH ORGAN, V67, P389; Bakker MI, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-40; Bakker MI, 2002, TROP MED INT HEALTH, V7, P780, DOI 10.1046/j.1365-3156.2002.00931.x; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; de Oliveira MLW, 1998, WHO TECH REP SER, V874, P1; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fine PEM, 1997, AM J EPIDEMIOL, V146, P91, DOI 10.1093/oxfordjournals.aje.a009195; FINE PEM, 1982, EPIDEMIOL REV, V4, P161, DOI 10.1093/oxfordjournals.epirev.a036245; Fischer EAJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-125; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; FISCHER EAJ, 2008, COMPUTER METHODS PRO; Hiebeler DE, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.022901; Kerr-Pontes LRS, 2004, INT J EPIDEMIOL, V33, P262, DOI 10.1093/ije/dyh002; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; LAW AM, 2000, EXPT DESIGN SENSITIV, P622; Meima A, 2004, B WORLD HEALTH ORGAN, V82, P373; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; MIRA MT, 2004, NATURE; Moet FJ, 2008, BMJ-BRIT MED J, V336, P761, DOI 10.1136/bmj.39500.885752.BE; Moet FJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000198; Moet FJ, 2006, J INFECT DIS, V193, P346, DOI 10.1086/499278; Nicholls PG, 2003, LEPROSY REV, V74, P349; NOORDEEN SK, 1985, LEPROSY; SCHURING RP, 2009, VACCINE; Setia MS, 2006, LANCET INFECT DIS, V6, P162, DOI 10.1016/S1473-3099(06)70412-1; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; Smith T, 2006, AM J TROP MED HYG, V75, P1; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; *UNSTATS, 2000, MILL DEV GOAL IND; van Beers SM, 1999, INT J LEPROSY, V67, P119; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; WADE H. W., 1952, INTERNATL JOUR LEPROSY, V20, P1; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P333; *WHO, 2007, WHO UNICEF REV NAT I; 2002, INT J LEPROSY OTH S, V70, pS1	36	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14061	10.1371/journal.pone.0014061	http://dx.doi.org/10.1371/journal.pone.0014061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124916	gold, Green Submitted, Green Published			2022-12-25	WOS:000284400100010
J	Cox, JL; Mallanna, SK; Luo, X; Rizzino, A				Cox, Jesse L.; Mallanna, Sunil K.; Luo, Xu; Rizzino, Angie			Sox2 Uses Multiple Domains to Associate with Proteins Present in Sox2-Protein Complexes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INTERACTION NETWORK; TRANSCRIPTION FACTORS; CARCINOMA-CELLS; DIFFERENTIATION; EXPRESSION; OCT4; GENE; PLURIPOTENCY; BINDING	Master regulators, such as Sox2, Oct4 and Nanog, control complex gene networks necessary for the self-renewal and pluripotency of embryonic stem cells (ESC). These master regulators associate with co-activators and co-repressors to precisely control their gene targets. Recent studies using proteomic analysis have identified a large, diverse group of coactivators and co-repressors that associate with master regulators, including Sox2. In this report, we examined the size distribution of nuclear protein complexes containing Sox2 and its associated proteins HDAC1, Sall4 and Lin28. Interestingly, we determined that Sox2 and HDAC1 associate with protein complexes that vary greatly in size; whereas, Lin28 primarily associates with smaller complexes, and Sall4 primarily associates with larger complexes. Additionally, we examined the domains of Sox2 necessary to mediate its association with its partner proteins Sall4, HDAC1 and HDAC2. We determined that Sox2 uses multiple and distinct domains to associate with its partner proteins. We also examined the domains of Sox2 necessary to mediate its self-association, and we determined that Sox2 self-association is mediated through multiple domains. Collectively, these studies provide novel insights into how Sox2 is able to associate with a wide array of nuclear proteins that control gene transcription.	[Cox, Jesse L.; Mallanna, Sunil K.; Luo, Xu; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Rizzino, Angie] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Cox, JL (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	arizzino@unmc.edu			National Institutes of Health [GM080751]; National Cancer Institute Cancer Center [CA009476]; NATIONAL CANCER INSTITUTE [T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (GM080751). Core facilities of the Eppley Institute were supported in part by an National Cancer Institute Cancer Center Support Grant (CA009476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; CHAKRAVARTHY H, 2010, FASEB J IN PRESS; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Gao FR, 2009, J BIOL CHEM, V284, P22263, DOI 10.1074/jbc.M109.033118; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; KELLY D, 1995, MOL REPROD DEV, V40, P135, DOI 10.1002/mrd.1080400202; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kopp JL, 2007, J BIOL CHEM, V282, P3027, DOI 10.1074/jbc.M609907200; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lamb K, 1996, MOL REPROD DEV, V44, P460; Li J, 2007, J BIOL CHEM, V282, P19481, DOI 10.1074/jbc.M702056200; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MALLANNA SK, 2010, STEM CELLS      0804; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284	37	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15486	10.1371/journal.pone.0015486	http://dx.doi.org/10.1371/journal.pone.0015486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103394	Green Published, Green Submitted, gold			2022-12-25	WOS:000284147700034
J	Ou, WB; Corson, JM; Flynn, DL; Lu, WP; Wise, SC; Bueno, R; Sugarbaker, DJ; Fletcher, JA				Ou, W-B; Corson, J. M.; Flynn, D. L.; Lu, W-P; Wise, S. C.; Bueno, R.; Sugarbaker, D. J.; Fletcher, J. A.			AXL regulates mesothelioma proliferation and invasiveness	ONCOGENE			English	Article						AXL; receptor tyrosine kinases; proliferation; invasiveness; mesothelioma	RECEPTOR TYROSINE KINASE; MALIGNANT PLEURAL MESOTHELIOMA; GASTROINTESTINAL STROMAL TUMORS; ENDOTHELIAL GROWTH-FACTOR; FACTOR SCATTER FACTOR; MET RECEPTOR; CELL-LINE; FACTOR-I; C-MET; EXPRESSION	Mesothelioma is an asbestos-associated and notoriously chemotherapy-resistant neoplasm. Activation of the receptor tyrosine kinases (RTKs), epidermal growth factor receptor and MET, has been described in subsets of mesothelioma, suggesting that TKs might represent therapeutic targets in this highly lethal disease. We employed proteomic screening by phosphotyrosine immunoaffinity purification and tandem mass spectrometry to characterize RTK activation in mesothelioma cell lines. These assays demonstrated expression and activation of the AXL protein, which is an RTK with known oncogenic properties in non-mesothelial cancer types. AXL was expressed and activated strongly in 8 of 9 mesothelioma cell lines and 6 of 12 mesothelioma biopsies, including each of 12 mesotheliomas with spindle-cell histology. Somatic AXL mutations were not found, but all mesotheliomas expressed an alternatively spliced AXL transcript with in-frame deletion of exon 10, and six of seven mesothelioma cell lines expressed the AXL ligand, growth arrest-specific 6 (GAS6). GAS6 expression appeared to be functionally relevant, as indicated by modulation of AXL tyrosine phosphorylation by knockdown of endogeneous GAS6, and by administration of exogenous GAS6. AXL silencing by lentivirus-mediated short hairpin RNA suppressed mesothelioma migration and cellular proliferation due to G1 arrest. The AXL inhibitor DP-3975 inhibited cell migration and proliferation in mesotheliomas with strong AXL activation. DP-3975 response in these tumors was characterized by inhibition of PI3-K/AKT/mTOR and RAF/MAPK signaling. AXL inhibition suppressed mesothelioma anchorage-independent growth, with reduction in colony numbers and size. These studies suggest that AXL inhibitors warrant clinical evaluation in mesothelioma. Oncogene (2011) 30, 1643-1652; doi:10.1038/onc.2010.555; published online 6 December 2010	[Ou, W-B; Corson, J. M.; Fletcher, J. A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ou, W-B; Corson, J. M.; Fletcher, J. A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lu, W-P; Wise, S. C.] Deciphera Pharmaceut LLC, Dept Res Discovery, Lawrence, KS USA; [Bueno, R.; Sugarbaker, D. J.] Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ou, WB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	wou@rics.bwh.harvard.edu; jfletcher@partners.org	Ou, Wen-Bin/J-1142-2019	, Wenbin/0000-0002-6311-9442	Brigham and Women's Hospital	Brigham and Women's Hospital	This research was supported by funding from the International Mesothelioma Program at Brigham and Women's Hospital.	Burchert A, 1998, ONCOGENE, V16, P3177, DOI 10.1038/sj.onc.1201865; CARBONE M, 1994, ONCOGENE, V9, P1781; Catalano A, 2002, ONCOGENE, V21, P2896, DOI 10.1038/sj.onc.1205382; CRAIGHEAD JE, 1982, NEW ENGL J MED, V306, P1446, DOI 10.1056/NEJM198206173062403; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; DEMETRI GD, 1989, BLOOD, V74, P940; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Harir N, 2008, BLOOD, V112, P2463, DOI 10.1182/blood-2007-09-115477; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Ito T, 1999, THYROID, V9, P563, DOI 10.1089/thy.1999.9.563; Jacob ANK, 1999, CANCER DETECT PREV, V23, P325; Jagadeeswaran R, 2006, CANCER RES, V66, P352, DOI 10.1158/0008-5472.CAN-04-4567; Janne PA, 2002, CANCER RES, V62, P5242; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; Klominek J, 1998, INT J CANCER, V76, P240, DOI 10.1002/(SICI)1097-0215(19980413)76:2<240::AID-IJC12>3.0.CO;2-G; Lay JD, 2007, CANCER RES, V67, P3878, DOI 10.1158/0008-5472.CAN-06-3191; LEE TC, 1993, CANCER RES, V53, P2858; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Meric F, 2002, CLIN CANCER RES, V8, P361; Mukohara T, 2005, CLIN CANCER RES, V11, P8122, DOI 10.1158/1078-0432.CCR-05-1191; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; Pache JC, 1998, AM J PATHOL, V152, P333; Pass HI, 2004, CLIN CANCER RES, V10, P849, DOI 10.1158/1078-0432.CCR-0607-3; Pass HI, 1996, CANCER RES, V56, P4044; QUONG RYY, 1994, MELANOMA RES, V4, P313, DOI 10.1097/00008390-199410000-00008; Rubin BP, 2001, CANCER RES, V61, P8118; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Tolnay E, 1998, J CANCER RES CLIN, V124, P291, DOI 10.1007/s004320050171; Tsao AS, 2007, MOL CANCER THER, V6, P1962, DOI 10.1158/1535-7163.MCT-07-0052; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Wimmel A, 2001, EUR J CANCER, V37, P2264, DOI 10.1016/S0959-8049(01)00271-4; Xia GB, 2005, CLIN CANCER RES, V11, P4305, DOI 10.1158/1078-0432.CCR-04-2109; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929	43	61	63	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	14					1643	1652		10.1038/onc.2010.555	http://dx.doi.org/10.1038/onc.2010.555			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	746IS	21132014				2022-12-25	WOS:000289239400003
J	Fleming, FE; Graham, KL; Takada, Y; Coulson, BS				Fleming, Fiona E.; Graham, Kate L.; Takada, Yoshikazu; Coulson, Barbara S.			Determinants of the Specificity of Rotavirus Interactions with the alpha 2 beta 1 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ADHESION SITE; I-DOMAIN; ECHOVIRUS 1; 3-DIMENSIONAL STRUCTURE; MONOCLONAL-ANTIBODIES; MEMBRANE PENETRATION; DIFFERENT MECHANISMS; COLLAGEN RECEPTOR; LIGAND SEQUENCES; RHESUS ROTAVIRUS	The human alpha 2 beta 1 integrin binds collagen and acts as a cellular receptor for rotaviruses and human echovirus 1. These ligands require the inserted (I) domain within the alpha 2 subunit of alpha 2 beta 1 for binding. Previous studies have identified the binding sites for collagen and echovirus 1 in the alpha 2 I domain. We used CHO cells expressing mutated alpha 2 beta 1 to identify amino acids involved in binding to human and animal rotaviruses. Residues where mutation affected rotavirus binding were located in several exposed loops and adjacent regions of the alpha 2 I domain. Binding by all rotaviruses was eliminated by mutations in the activation-responsive alpha C-alpha 6 and alpha F helices. This is a novel feature that distinguishes rotavirus from other alpha 2 beta 1 ligands. Mutation of residues that co-ordinate the metal ion (Ser-153, Thr-221, and Glu-256 in alpha 2 and Asp-130 in beta 1) and nearby amino acids (Ser-154, Gln-215, and Asp-219) also inhibited rotavirus binding. The importance of most of these residues was greatest for binding by human rotaviruses. These mutations inhibit collagen binding to alpha 2 beta 1 (apart from Glu-256) but do not affect echovirus binding. Overall, residues where mutation affected both rotavirus and collagen recognition are located at one side of the metal ion-dependent adhesion site, whereas those important for collagen alone cluster nearby. Mutations eliminating rotavirus and echovirus binding are distinct, consistent with the respective preference of these viruses for activated or inactive alpha 2 beta 1. In contrast, rotavirus and collagen utilize activated alpha 2 beta 1 and show an overlap in alpha 2 beta 1 residues important for binding.	[Fleming, Fiona E.; Graham, Kate L.; Coulson, Barbara S.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Takada, Yoshikazu] Univ Calif Davis, Dept Dermatol, Sch Med, Sacramento, CA 95817 USA	University of Melbourne; University of California System; University of California Davis	Coulson, BS (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Gate 11, Parkville, Vic 3010, Australia.	barbarac@unimelb.edu.au		Coulson, Barbara/0000-0002-2110-8147; takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [1R01CA131015-01A2]; National Health and Medical Research Council of Australia (NHMRC) [350252, 350253, 509006, 628319]; NATIONAL CANCER INSTITUTE [R01CA131015, P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA131015-01A2 (to Y. T.) and Grants 350252, 350253, 509006, and 628319 (to B. S. C.) from the National Health and Medical Research Council of Australia (NHMRC).	Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; BASS DM, 1991, VIROLOGY, V183, P602, DOI 10.1016/0042-6822(91)90989-O; BERGELSON JM, 1994, CELL ADHES COMMUN, V2, P455, DOI 10.3109/15419069409004455; BERGELSON JM, 1993, J CLIN INVEST, V92, P232, DOI 10.1172/JCI116555; Blanchard H, 2007, J MOL BIOL, V367, P1215, DOI 10.1016/j.jmb.2007.01.028; Ciarlet M, 2002, J VIROL, V76, P1109, DOI 10.1128/JVI.76.3.1109-1123.2002; COHEN J, 1979, ARCH VIROL, V60, P177, DOI 10.1007/BF01317489; Connors WL, 2007, J BIOL CHEM, V282, P14675, DOI 10.1074/jbc.M700759200; Coulson B. S., 1997, LEUKOCYTE TYPING; Coulson BS, 1997, P NATL ACAD SCI USA, V94, P5389, DOI 10.1073/pnas.94.10.5389; COULSON BS, 1991, J VIROL, V65, P5968, DOI 10.1128/JVI.65.11.5968-5974.1991; COULSON BS, 1993, J CLIN MICROBIOL, V31, P1; Dickeson SK, 1999, J BIOL CHEM, V274, P32182, DOI 10.1074/jbc.274.45.32182; Dormitzer PR, 2004, NATURE, V430, P1053, DOI 10.1038/nature02836; EDELMAN JM, 1994, CELL ADHES COMMUN, V2, P131, DOI 10.3109/15419069409004432; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; GAMBLE JR, 1993, J CELL BIOL, V121, P931, DOI 10.1083/jcb.121.4.931; Graham KL, 2006, J GEN VIROL, V87, P1275, DOI 10.1099/vir.0.81580-0; Graham KL, 2005, J GEN VIROL, V86, P3397, DOI 10.1099/vir.0.81102-0; Graham KL, 2004, J VIROL, V78, P11786, DOI 10.1128/JVI.78.21.11786-11797.2004; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Halasz P, 2008, J VIROL, V82, P148, DOI 10.1128/JVI.01980-07; Haselhorst T, 2009, NAT CHEM BIOL, V5, P91, DOI 10.1038/nchembio.134; Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000; Holloway G, 2006, J VIROL, V80, P10624, DOI 10.1128/JVI.00390-06; Horii K, 2004, J MOL BIOL, V341, P519, DOI 10.1016/j.jmb.2004.06.036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Jafri M, 2008, AM J PHYSIOL-GASTR L, V295, pG16, DOI 10.1152/ajpgi.00442.2007; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Jokinen J, 2010, EMBO J, V29, P196, DOI 10.1038/emboj.2009.326; KALJOT KT, 1988, J VIROL, V62, P1136, DOI 10.1128/JVI.62.4.1136-1144.1988; Kamata T, 1999, J BIOL CHEM, V274, P32108, DOI 10.1074/jbc.274.45.32108; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KAMATA T, 1994, J BIOL CHEM, V269, P9659; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; King SL, 1997, J BIOL CHEM, V272, P28518, DOI 10.1074/jbc.272.45.28518; Kirkwood CD, 1998, J VIROL, V72, P9348, DOI 10.1128/JVI.72.11.9348-9352.1998; Lambert LJ, 2008, J BIOL CHEM, V283, P16665, DOI 10.1074/jbc.M710483200; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Londrigan SL, 2003, J VIROL, V77, P9486, DOI 10.1128/JVI.77.17.9486-9501.2003; Ludert JE, 1996, J VIROL, V70, P487, DOI 10.1128/JVI.70.1.487-493.1996; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; OCONNELL PJ, 1991, IMMUNOL CELL BIOL, V69, P103, DOI 10.1038/icb.1991.16; Pellicci DG, 2005, J IMMUNOL, V175, P4416, DOI 10.4049/jimmunol.175.7.4416; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; Seo NS, 2008, P NATL ACAD SCI USA, V105, P8811, DOI 10.1073/pnas.0803934105; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; TENCHINI ML, 1993, CELL ADHES COMMUN, V1, P55, DOI 10.3109/15419069309095681; Trask S. D., J VIROL, V84, P1764; Triantafilou K, 2001, CRIT REV IMMUNOL, V21, P311; Tuckwell DS, 2000, BIOCHEM J, V350, P485, DOI 10.1042/0264-6021:3500485; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Xing L, 2004, J BIOL CHEM, V279, P11632, DOI 10.1074/jbc.M312441200; YEAGER M, 1990, J CELL BIOL, V110, P2133, DOI 10.1083/jcb.110.6.2133; Yoder JD, 2006, EMBO J, V25, P1559, DOI 10.1038/sj.emboj.7601034; Zarate S, 2000, VIROLOGY, V278, P50, DOI 10.1006/viro.2000.0660	63	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6165	6174		10.1074/jbc.M110.142992	http://dx.doi.org/10.1074/jbc.M110.142992			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21138834	Green Published, hybrid			2022-12-25	WOS:000287476400025
J	Lee, JH; Lu, H				Lee, Jun-Ho; Lu, Hua			14-3-3 gamma Inhibition of MDMX-mediated p21 Turnover Independent of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REG-GAMMA-PROTEASOME; DNA-DAMAGE; RIBOSOMAL STRESS; ACTIVATES P53; BREAST-CANCER; DEGRADATION; UBIQUITIN; PROTEIN; P21(WAF1/CIP1); EXPRESSION	The stability of p21, a cyclin-dependent kinase inhibitor, is highly regulated by various protein molecules through the cell cycle and in response to extracellular signals. One of the p21 regulators is MDMX, which can directly bind to p21 and mediate its proteasomal degradation in an ubiquitination-independent fashion. The fact that 14-3-3 gamma binds to the MDMX domain adjacent to p21 binding suggests that this 14-3-3 gamma may affect MDMX-mediated p21 proteasomal turnover. Indeed, we found that overexpression of 14-3-3 gamma increased the level of both endogenous and exogenous p21 in p53-null cells by extending its half-life, leading to p21-dependent G1 arrest. Also, 14-3-3 gamma excluded p21 from binding to MDMX in a dose-dependent manner as determined by co-immunroprecipitation in vitro using purified proteins and in cells. In response to DNA damage, the level of the 14-3-3 gamma-MDMX complex increased whereas that of the MDMX-p21 complex declined as detected by co-immunoprecipitation assays, leading to the induction of p21 in p53-null cells. Knockdown of 14-3-3 gamma inversely alleviated the induction of p21 levels by DNA damage. Hence, our study as presented here unravels a new role for 14-3-3 gamma in protecting p21 from MDMX-mediated proteasomal turnover, which may partially account for DNA damage-induced elevation of p21 levels independent of p53.	Indiana Univ, Dept Biochem & Mol Biol, Sch Med, Indianapolis, IN 46202 USA; Indiana Univ, Simon Canc Ctr, Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Lu, H (corresponding author), IN Univ, Dept Biochem & Mol Biol, Sch Med, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	hualu@iupui.edu			National Institutes of Health [CA095441, CA 079721, CA129828]; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA079721, R01CA129828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NCI Grants CA095441, CA 079721, and CA129828 (to H. L.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Chen-Kiang S, 2003, IMMUNOL REV, V194, P39, DOI 10.1034/j.1600-065X.2003.00065.x; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang MZ, 2010, CANCER PREV RES, V3, P640, DOI 10.1158/1940-6207.CAPR-09-0170; Gilkes DM, 2007, CELL CYCLE, V6, P151, DOI 10.4161/cc.6.2.3719; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Griniatsos J, 2006, WORLD J GASTROENTERO, V12, P2109, DOI 10.3748/wjg.v12.i13.2109; HARPER JW, 1993, CELL, V75, P805; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kasahara K, 2010, EMBO J, V29, P2802, DOI 10.1038/emboj.2010.157; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Lee H, 2006, J BIOL CHEM, V281, P26876, DOI 10.1074/jbc.M605366200; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Marine JC, 2004, CELL CYCLE, V3, P900; MICHIELI P, 1994, CANCER RES, V54, P3391; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Rossig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; VIDAL A, 2000, ONCOGENE, V247, P2756; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu HX, 2010, J BIOL CHEM, V285, P18407, DOI 10.1074/jbc.M109.059568; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	45	14	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5136	5142		10.1074/jbc.M110.190470	http://dx.doi.org/10.1074/jbc.M110.190470			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148311	hybrid, Green Published			2022-12-25	WOS:000287230600021
J	Thaler, R; Agsten, M; Spitzer, S; Paschalis, EP; Karlic, H; Klaushofer, K; Varga, F				Thaler, Roman; Agsten, Marlies; Spitzer, Silvia; Paschalis, Eleftherios P.; Karlic, Heidrun; Klaushofer, Klaus; Varga, Franz			Homocysteine Suppresses the Expression of the Collagen Cross-linker Lysyl Oxidase Involving IL-6, Fli1, and Epigenetic DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA HOMOCYSTEINE; HIP FRACTURE; GENE; INTERLEUKIN-6; RISK; METHYLTRANSFERASES; TRANSCRIPTION; CYTOKINES; ARTHRITIS; DISEASE	Elevated homocysteine (Hcys) serum levels represent a risk factor for several chronic pathologies, including cardiovascular disease, atherosclerosis, and chronic renal failure, and affect bone development, quality, and homeostasis. Hcys influences the formation of a stable bone matrix directly through the inhibition of the collagen cross-linking enzyme lysyl oxidase (Lox) and, as we have shown recently, by repressing its mRNA expression. The aim of this study was to investigate the mechanisms involved in this process. Through evaluation of gene arrays, quantitative RT-PCR, immunoblots, and ELISA, we identified a Hcys-dependent stimulation of interleukin 6 (IL-6) and genes involved in IL-6/Janus kinase 2 (JAK2)-dependent signal transduction pathways in pre-osteoblastic MC3T3-E1 cells. Moreover, up-regulation of genes essential for epigenetic DNA methylation (DNA (cytosine-5)-methyltransferases and helicase lymphoid-specific (Hells) was observed. Further investigations demonstrated that Hcys increased via IL-6/JAK2 the expression of Fli1 (Friend leukemia virus integration 1), a transcription factor, which we found essential for IL-6-dependent Dnmt1 stimulation. CpG methylation analysis of CpG-rich Lox proximal promoter revealed an increased CpG methylation status after treatment of the cells with Hcys indicating an epigenetic origin for Hcys-dependent Lox repression. Inhibition of the IL-6/JAK2 pathway or of CpG methylation reversed the repressive effect of Hcys on Lox expression. In conclusion, we demonstrate that Hcys stimulates IL-6 synthesis in osteoblasts, which is known to affect bone metabolism via osteoclasts. Furthermore, IL-6 stimulation results via JAK2, Fli1, and Dnmt1 in down-regulation of Lox expression by epigenetic CpG methylation revealing a new mechanism negatively affecting bone matrix formation.	[Thaler, Roman; Agsten, Marlies; Spitzer, Silvia; Paschalis, Eleftherios P.; Klaushofer, Klaus; Varga, Franz] Hanusch Hosp, Ludwig Boltzmann Inst Osteol, Dept Med 1, Wiener Gebietskrankenkasse & AUVA Trauma Ctr Meid, A-1140 Vienna, Austria; [Karlic, Heidrun] Hanusch Hosp, Ludwig Boltzmann Inst Leukemia Res & Hematol, A-1140 Vienna, Austria	Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital	Varga, F (corresponding author), Hanusch Hosp, Ludwig Boltzmann Inst Osteol, Dept Med 1, Wiener Gebietskrankenkasse & AUVA Trauma Ctr Meid, Heinrich Collin Str 30, A-1140 Vienna, Austria.	franz.varga@osteologie.at	/AAC-1939-2021		Fonds zur Foerderung der Wissenschaftlichen Forschung from the Austrian Science Fund [P20646-B11]; Social Health Insurance Vienna; Austrian Social Insurance for Occupational Risk	Fonds zur Foerderung der Wissenschaftlichen Forschung from the Austrian Science Fund(Austrian Science Fund (FWF)); Social Health Insurance Vienna; Austrian Social Insurance for Occupational Risk	This work was supported by the Fonds zur Foerderung der Wissenschaftlichen Forschung from the Austrian Science Fund Project P20646-B11, the Social Health Insurance Vienna, and the Austrian Social Insurance for Occupational Risk.	[Anonymous], 2009, J CLIN ENDOCR METAB, V94, P1207, DOI 10.1210/jc.2008-1777; Audelin MC, 2001, ATHEROSCLEROSIS, V159, P497, DOI 10.1016/S0021-9150(01)00531-7; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004; Blouin S, 2009, BONE, V44, P959, DOI 10.1016/j.bone.2008.12.023; Claes L, 2009, CALCIFIED TISSUE INT, V85, P17, DOI 10.1007/s00223-009-9262-6; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Duplomb L, 2008, ENDOCRINOLOGY, V149, P3688, DOI 10.1210/en.2007-1719; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gerdhem P, 2007, J BONE MINER RES, V22, P127, DOI 10.1359/JBMR.061003; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Gjesdal CG, 2007, J BONE MINER RES, V22, P747, DOI 10.1359/JBMR.070210; Hodge DR, 2002, BIOCHEM BIOPH RES CO, V292, P287, DOI 10.1006/bbrc.2002.6652; Hodge DR, 2001, J BIOL CHEM, V276, P39508, DOI 10.1074/jbc.C100343200; Iannucci CV, 2007, CURR PHARM DESIGN, V13, P2148; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kishikawa S, 2002, EUR J BIOCHEM, V269, P2961, DOI 10.1046/j.1432-1033.2002.02972.x; Liu GM, 1997, J BIOL CHEM, V272, P32370, DOI 10.1074/jbc.272.51.32370; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Raisz LG, 2004, NEW ENGL J MED, V350, P2089, DOI 10.1056/NEJMe048030; Raposo B, 2004, ATHEROSCLEROSIS, V177, P1, DOI 10.1016/j.atherosclerosis.2004.06.015; Schiller C, 1997, ENDOCRINOLOGY, V138, P4567, DOI 10.1210/en.138.11.4567; So KJ, 2006, CANCER SCI, V97, P1155, DOI 10.1111/j.1349-7006.2006.00302.x; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Tamura G, 2009, PATHOL INT, V59, P895, DOI 10.1111/j.1440-1827.2009.02458.x; Thaler R, 2010, APOPTOSIS, V15, P728, DOI 10.1007/s10495-010-0462-3; Thaler R, 2010, BONE, V46, P703, DOI 10.1016/j.bone.2009.10.038; Turecek C, 2008, CALCIFIED TISSUE INT, V82, pS121; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Wong PKK, 2003, ARTHRITIS RHEUM-US, V48, P1177, DOI 10.1002/art.10943; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Zhang Q, 2006, BLOOD, V108, P1058, DOI 10.1182/blood-2005-08-007377; Zhu K, 2009, OSTEOPOROSIS INT, V20, P1183, DOI 10.1007/s00198-008-0804-y	43	80	84	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5578	5588		10.1074/jbc.M110.166181	http://dx.doi.org/10.1074/jbc.M110.166181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148317	Green Published, hybrid			2022-12-25	WOS:000287230600067
J	Patel, A; Vought, VE; Dharmarajan, V; Cosgrove, MS				Patel, Anamika; Vought, Valarie E.; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.			A Novel Non-SET Domain Multi-subunit Methyltransferase Required for Sequential Nucleosomal Histone H3 Methylation by the Mixed Lineage Leukemia Protein-1 (MLL1) Core Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEGANS DOSAGE COMPENSATION; SACCHAROMYCES-CEREVISIAE; LYSINE METHYLTRANSFERASES; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; PRODUCT SPECIFICITY; ANGSTROM RESOLUTION; TRITHORAX FAMILY; CATALYTIC DOMAIN; STRUCTURAL BASIS	Gene expression within the context of eukaryotic chromatin is regulated by enzymes that catalyze histone lysine methylation. Histone lysine methyltransferases that have been identified to date possess the evolutionarily conserved SET or Dot1-like domains. We previously reported the identification of a new multi-subunit histone H3 lysine 4 methyltransferase lacking homology to the SET or Dot1 family of histone lysine methyltransferases. This enzymatic activity requires a complex that includes WRAD (WDR5, RbBP5, Ash2L, and DPY-30), a complex that is part of the MLL1 (mixed lineage leukemia protein-1) core complex but that also exists independently of MLL1 in the cell. Here, we report that the minimal complex required for WRAD enzymatic activity includes WDR5, RbBP5, and Ash2L and that DPY-30, although not required for enzymatic activity, increases the histone substrate specificity of the WRAD complex. We also show that WRAD requires zinc for catalytic activity, displays Michaelis-Menten kinetics, and is inhibited by S-adenosylhomocysteine. In addition, we demonstrate that WRAD preferentially methylates lysine 4 of histone H3 within the context of the H3/H4 tetramer but does not methylate nucleosomal histone H3 on its own. In contrast, we find that MLL1 and WRAD are required for nucleosomal histone H3 methylation, and we provide evidence suggesting that each plays distinct structural and catalytic roles in the recognition and methylation of a nucleosome substrate. Our results indicate that WRAD is a new H3K4 methyltransferase with functions that include regulating the substrate and product specificities of the MLL1 core complex.	[Patel, Anamika; Vought, Valarie E.; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Cosgrove, MS (corresponding author), 107 Coll Pl, Syracuse, NY 13244 USA.	mscosgro@syr.edu			National Institutes of Health [R01CA140522]; American Cancer Society [RSG-09-245-01-DMC]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA140522 (to M. S. C.). This work was also supported by Research Scholar Grant RSG-09-245-01-DMC from the American Cancer Society (to M. S. C.).	Adamson AL, 1996, GENETICS, V144, P621; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; CHANDRASEKHARAN MB, MOL CELL BIOL, V30, P3216; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Flaus A, 2004, EMBO J, V23, P343, DOI 10.1038/sj.emboj.7600047; Garapaty S, 2009, J BIOL CHEM, V284, P7542, DOI 10.1074/jbc.M805872200; Gori F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P338; Gori F, 2006, DEV BIOL, V295, P498, DOI 10.1016/j.ydbio.2006.02.031; HSU DR, 1995, DEVELOPMENT, V121, P3323; HSU DR, 1994, GENETICS, V137, P999; Krajewski WA, 2010, BIOCHEM BIOPH RES CO, V397, P112, DOI 10.1016/j.bbrc.2010.05.080; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Laue T. M., 1992, ANAL ULTRACENTRIFUGA, P19; LAWRENCE F, 1990, PROTEIN METHYLATION, P305; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Tan CC, 2008, P NATL ACAD SCI USA, V105, P7472, DOI 10.1073/pnas.0711896105; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang JH, 2001, J MOL MED, V79, P399, DOI 10.1007/s001090100222; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yates JA, 2010, FEBS LETT, V584, P689, DOI 10.1016/j.febslet.2010.01.022; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	82	56	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3359	3369		10.1074/jbc.M110.174524	http://dx.doi.org/10.1074/jbc.M110.174524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106533	Green Published, hybrid			2022-12-25	WOS:000286653200022
J	Liu, TA; Zhang, HT; Liu, FY; Wu, QY; Shen, X; Yang, Q				Liu, Tian; Zhang, Haitao; Liu, Fengyi; Wu, Qingyue; Shen, Xu; Yang, Qing			Structural Determinants of an Insect beta-N-Acetyl-D-hexosaminidase Specialized as a Chitinolytic Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; LOBES GENE ENCODES; TAY-SACHS-DISEASE; MOLECULAR-CLONING; OSTRINIA-FURNACALIS; TMG-CHITOTRIOMYCIN; CRYSTAL-STRUCTURE; SANDHOFF-DISEASE; PLASMA-MEMBRANE; SF9 CELLS	beta-N-Acetyl-D-hexosaminidase has been postulated to have a specialized function. However, the structural basis of this specialization is not yet established. OfHex1, the enzyme from the Asian corn borer Ostrinia furnacalis (one of the most destructive pests) has previously been reported to function merely in chitin degradation. Here the vital role of OfHex1 during the pupation of O. furnacalis was revealed by RNA interference, and the crystal structures of OfHex1 and OfHex1 complexed with TMG-chitotriomycin were determined at 2.1 angstrom. The mechanism of selective inhibition by TMG-chitotriomycin was related to the existence of the +1 subsite at the active pocket of OfHex1 and a key residue, Trp(490), at this site. Mutation of Trp(490) to Ala led to a 2,277-fold decrease in sensitivity toward TMG-chitotriomycin as well as an 18-fold decrease in binding affinity for the substrate (GlcNAc)(2). Although the overall topology of the catalytic domain of OfHex1 shows a high similarity with the human and bacterial enzymes, OfHex1 is distinguished from these enzymes by large conformational changes linked to an "open-close" mechanism at the entrance of the active site, which is characterized by the "lid" residue, Trp(448). Mutation of Trp(448) to Ala or Phe resulted in a more than 1,000-fold loss in enzyme activity, due mainly to the effect on k(cat). The current work has increased our understanding of the structure-function relationship of OfHex1, shedding light on the structural basis that accounts for the specialized function of beta-N-acetyl-D-hexosaminidase as well as making the development of species-specific pesticides a likely reality.	[Liu, Tian; Liu, Fengyi; Wu, Qingyue; Yang, Qing] Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian 116024, Peoples R China; [Yang, Qing] E China Univ Sci & Technol, Shanghai Key Lab Chem Biol, Shanghai 200237, Peoples R China; [Zhang, Haitao; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Shen, Xu] Shanghai Jiao Tong Univ, E Inst, Shanghai Municipal Educ Commiss, Sch Med, Shanghai 200025, Peoples R China	Dalian University of Technology; East China University of Science & Technology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University; Shanghai Municipal Education Commission (SHMEC)	Shen, X (corresponding author), 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	xshen@mail.shcnc.ac.cn; qingyang@dlut.edu.cn	Yang, Qing/GZK-2526-2022; Zhang, Haitao/L-7612-2015; Liu, Tian/E-2481-2012	Yang, Qing/0000-0001-8623-7532; Zhang, Haitao/0000-0003-4879-2951; Liu, Tian/0000-0001-9768-5496	National Key Project for Basic Research [2010CB126100, 2009CB918502, 2010CB912501]; Program for New Century Excellent Talents in University; East China University of Science and Technology, Shanghai, China; National Natural Science Foundation of China [10979072]; Key New Drug Creation and Manufacturing Program [2009ZX09301-001]; E-Institutes of Shanghai Municipal Education Commission [E09013]	National Key Project for Basic Research(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); East China University of Science and Technology, Shanghai, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key New Drug Creation and Manufacturing Program; E-Institutes of Shanghai Municipal Education Commission	This work is supported by National Key Project for Basic Research Grants 2010CB126100, 2009CB918502, and 2010CB912501; the Program for New Century Excellent Talents in University; the National Special Fund for State Key Laboratory of Bioreactor Engineering (East China University of Science and Technology, Shanghai, China); National Natural Science Foundation of China Grant 10979072; Key New Drug Creation and Manufacturing Program Grant 2009ZX09301-001; and E-Institutes of Shanghai Municipal Education Commission Grant E09013.	Aumiller JJ, 2006, PROTEIN EXPRES PURIF, V47, P571, DOI 10.1016/j.pep.2005.11.026; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cattaneo F, 2006, GLYCOBIOLOGY, V16, P786, DOI 10.1093/glycob/cwl007; Cattaneo F, 2002, INSECT BIOCHEM MOLEC, V32, P929, DOI 10.1016/S0965-1748(02)00031-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; He Y, 2009, CARBOHYD RES, V344, P627, DOI 10.1016/j.carres.2008.12.007; Hogenkamp DG, 2008, INSECT BIOCHEM MOLEC, V38, P478, DOI 10.1016/j.ibmb.2007.08.002; Intra J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-214; Langley DB, 2008, J MOL BIOL, V377, P104, DOI 10.1016/j.jmb.2007.09.028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Liu T, 2009, PROTEIN EXPRES PURIF, V68, P99, DOI 10.1016/j.pep.2009.06.004; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Miranda PV, 2000, MOL HUM REPROD, V6, P699, DOI 10.1093/molehr/6.8.699; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada T, 2007, BIOSCI BIOTECH BIOCH, V71, P1626, DOI 10.1271/bbb.60705; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Usuki H, 2008, J AM CHEM SOC, V130, P4146, DOI 10.1021/ja077641f; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Yang Q, 2008, FEBS J, V275, P5690, DOI 10.1111/j.1742-4658.2008.06695.x; Yang Y, 2009, J AM CHEM SOC, V131, P12076, DOI 10.1021/ja9055245	35	75	89	3	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4049	4058		10.1074/jbc.M110.184796	http://dx.doi.org/10.1074/jbc.M110.184796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21106526	Green Published, hybrid			2022-12-25	WOS:000286975700003
J	Bento, CF; Fernandes, R; Ramalho, J; Marques, C; Shang, F; Taylor, A; Pereira, P				Bento, Carla Figueira; Fernandes, Rosa; Ramalho, Jose; Marques, Carla; Shang, Fu; Taylor, Allen; Pereira, Paulo			The Chaperone-Dependent Ubiquitin Ligase CHIP Targets HIF-1 alpha for Degradation in the Presence of Methylglyoxal	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; GLYCATION END-PRODUCTS; COILED-COIL DOMAIN; E3 LIGASE; DIABETES-MELLITUS; HIF-ALPHA; HYPOXIA; PROTEIN; ANGIOGENESIS	Hypoxia-inducible factor-1 (HIF-1) plays a key role in cell adaptation to low oxygen and stabilization of HIF-1 is vital to ensure cell survival under hypoxia. Diabetes has been associated with impairment of the cell response to hypoxia and downregulation of HIF-1 is most likely the event that transduces hyperglycemia into increased cell death in diabetes-associated hypoxia. In this study, we aimed at identifying the molecular mechanism implicated in destabilization of HIF-1 by high glucose. In this work, we identified a new molecular mechanism whereby methylglyoxal (MGO), which accumulates in high-glucose conditions, led to a rapid proteasome-dependent degradation of HIF-1 alpha under hypoxia. Significantly, MGO-induced degradation of HIF-1 alpha did not require the recruitment of the ubiquitin ligase pVHL nor did it require hydroxylation of the proline residues P402/P564 of HIF-1 alpha. Moreover, we identified CHIP (Carboxy terminus of Hsp70-Interacting Protein) as the E3 ligase that ubiquitinated HIF-1 alpha in the presence of MGO. Consistently, silencing of endogenous CHIP and overexpression of glyoxalase I both stabilized HIF-1 alpha under hypoxia in the presence of MGO. Data shows that increased association of Hsp40/70 with HIF-1 alpha led to recruitment of CHIP, which promoted polyubiquitination and degradation of HIF-1 alpha. Moreover, MGO-induced destabilization of HIF-1 alpha led to a dramatic decrease in HIF-1 transcriptional activity. Altogether, data is consistent with a new pathway for degradation of HIF-1 alpha in response to intracellular accumulation of MGO. Moreover, we suggest that accumulation of MGO is likely to be the link between high glucose and the loss of cell response to hypoxia in diabetes.	[Bento, Carla Figueira; Fernandes, Rosa; Ramalho, Jose; Marques, Carla; Pereira, Paulo] Univ Coimbra, Fac Med, Ctr Ophthalmol & Vis Sci COCV, Inst Biomed Res Light & Image IBILI, Coimbra, Portugal; [Bento, Carla Figueira] Univ Coimbra, PhD Programme, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal; [Shang, Fu; Taylor, Allen] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Universidade de Coimbra; Universidade de Coimbra; Tufts University; United States Department of Agriculture (USDA)	Bento, CF (corresponding author), Univ Coimbra, Fac Med, Ctr Ophthalmol & Vis Sci COCV, Inst Biomed Res Light & Image IBILI, Coimbra, Portugal.	ppereira@ibili.uc.pt	Pereira, Paulo/AAD-8375-2022; Fernandes, Rosa/P-1102-2014; Ramalho, Jose/M-6415-2015; Marques, Carla/AAC-9838-2019	Pereira, Paulo/0000-0002-9908-2290; Fernandes, Rosa/0000-0001-7828-2296; Ramalho, Jose/0000-0002-1927-164X; Marques, Carla/0000-0002-1817-4813; Bento, Carla F./0000-0001-8377-4543	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal [POCTI/SAU-OBS/57772/2004, PDTC/SAU-OSM/67498/2006];  [SFRH/BD/15229/2004]	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); 	This work was supported by the PhD fellowship SFRH/BD/15229/2004 (Carla F. Bento) and by the grants POCTI/SAU-OBS/57772/2004 and PDTC/SAU-OSM/67498/2006 (FCT - Fundacao para a Ciencia e a Tecnologia, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Bento CF, 2010, EXP PHYSIOL, V95, P955, DOI 10.1113/expphysiol.2010.053561; Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200; Catrina SB, 2004, DIABETES, V53, P3226, DOI 10.2337/diabetes.53.12.3226; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; Coffe V, 2006, NEUROCHEM RES, V31, P103, DOI 10.1007/s11064-005-9236-7; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dobler D, 2006, DIABETES, V55, P1961, DOI 10.2337/db05-1634; Du J, 2006, INT J BIOCHEM CELL B, V38, P1084, DOI 10.1016/j.biocel.2005.10.019; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Laga M, 2007, BIOCHEM PHARMACOL, V74, P579, DOI 10.1016/j.bcp.2007.05.026; Larger E, 2004, DIABETES, V53, P752, DOI 10.2337/diabetes.53.3.752; Lee HK, 2009, J NEUROCHEM, V108, P273, DOI 10.1111/j.1471-4159.2008.05764.x; Liu LX, 2008, J CELL PHYSIOL, V217, P319, DOI 10.1002/jcp.21503; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Malmberg K, 1999, CIRCULATION, V99, P2626, DOI 10.1161/01.CIR.99.20.2626; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Miller AG, 2006, J BIOL CHEM, V281, P11864, DOI 10.1074/jbc.M513813200; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Portero-Otin M, 2002, DIABETES, V51, P1535, DOI 10.2337/diabetes.51.5.1535; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; Ravi R, 2000, GENE DEV, V14, P34; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Schalkwijk CG, 1999, PERITON DIALYSIS INT, V19, P325; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Slomiany MG, 2004, AM J PHYSIOL-CELL PH, V287, pC746, DOI 10.1152/ajpcell.00568.2003; Sohn SY, 2006, J GEN VIROL, V87, P1883, DOI 10.1099/vir.0.81684-0; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Takeshita T, 2009, CANCER CHEMOTH PHARM, V64, P1039, DOI 10.1007/s00280-009-0961-5; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; THANGARAJAH H, 2009, P NATL ACAD SCI US; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018	55	86	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15062	10.1371/journal.pone.0015062	http://dx.doi.org/10.1371/journal.pone.0015062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124777	gold, Green Published, Green Submitted			2022-12-25	WOS:000284686500029
J	Durand, N; Carot-Sans, G; Chertemps, T; Bozzolan, F; Party, V; Renou, M; Debernard, S; Rosell, G; Maibeche-Coisne, M				Durand, Nicolas; Carot-Sans, Gerard; Chertemps, Thomas; Bozzolan, Francoise; Party, Virginie; Renou, Michel; Debernard, Stephane; Rosell, Gloria; Maibeche-Coisne, Martine			Characterization of an Antennal Carboxylesterase from the Pest Moth Spodoptera littoralis Degrading a Host Plant Odorant	PLOS ONE			English	Article							PHEROMONE-BINDING PROTEIN; SEX-PHEROMONE; DETOXIFICATION ENZYMES; INSECTICIDE RESISTANCE; RECEPTOR NEURONS; ESTERASE CDNAS; CLONING; FEMALE; INACTIVATION; EXPRESSION	Background: Carboxyl/cholinesterases (CCEs) are highly diversified in insects. These enzymes have a broad range of proposed functions, in neuro/developmental processes, dietary detoxification, insecticide resistance or hormone/pheromone degradation. As few functional data are available on purified or recombinant CCEs, the physiological role of most of these enzymes is unknown. Concerning their role in olfaction, only two CCEs able to metabolize sex pheromones have been functionally characterized in insects. These enzymes are only expressed in the male antennae, and secreted into the lumen of the pheromone-sensitive sensilla. CCEs able to hydrolyze other odorants than sex pheromones, such as plant volatiles, have not been identified. Methodology: In Spodoptera littoralis, a major crop pest, a diversity of antennal CCEs has been previously identified. We have employed here a combination of molecular biology, biochemistry and electrophysiology approaches to functionally characterize an intracellular CCE, SlCXE10, whose predominant expression in the olfactory sensilla suggested a role in olfaction. A recombinant protein was produced using the baculovirus system and we tested its catabolic properties towards a plant volatile and the sex pheromone components. Conclusion: We showed that SlCXE10 could efficiently hydrolyze a green leaf volatile and to a lesser extent the sex pheromone components. The transcript level in male antennae was also strongly induced by exposure to this plant odorant. In antennae, SlCXE10 expression was associated with sensilla responding to the sex pheromones and to plant odours. These results suggest that a CCE-based intracellular metabolism of odorants could occur in insect antennae, in addition to the extracellular metabolism occurring within the sensillar lumen. This is the first functional characterization of an Odorant-Degrading Enzyme active towards a host plant volatile.	[Durand, Nicolas; Chertemps, Thomas; Bozzolan, Francoise; Party, Virginie; Renou, Michel; Debernard, Stephane; Maibeche-Coisne, Martine] Univ Paris 06, UMR 1272, UPMC INRA Physiol Insecte, Paris, France; [Durand, Nicolas; Chertemps, Thomas; Bozzolan, Francoise; Party, Virginie; Renou, Michel; Debernard, Stephane; Maibeche-Coisne, Martine] INRA, Paris, France; [Durand, Nicolas; Chertemps, Thomas; Bozzolan, Francoise; Party, Virginie; Renou, Michel; Debernard, Stephane; Maibeche-Coisne, Martine] Univ Paris 06, UMR 1272, UPMC INRA Physiol Insecte, Versailles, France; [Durand, Nicolas; Chertemps, Thomas; Bozzolan, Francoise; Party, Virginie; Renou, Michel; Debernard, Stephane; Maibeche-Coisne, Martine] INRA, F-78026 Versailles, France; [Carot-Sans, Gerard] Inst Adv Chem Catalonia IQAC CSIC, Dept Biol Chem & Mol Modelling, Barcelona, Spain; [Rosell, Gloria] Univ Barcelona, Unit Med Chem, CSIC, Fac Pharm, Barcelona, Spain	INRAE; UDICE-French Research Universities; Sorbonne Universite; INRAE; INRAE; UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	Durand, N (corresponding author), Univ Paris 06, UMR 1272, UPMC INRA Physiol Insecte, Paris, France.	martine.maibeche@snv.jussieu.fr	Durand, Nicolas F./D-3035-2011; RENOU, Michel/AAT-7340-2021	Durand, Nicolas F./0000-0002-3613-2609; RENOU, Michel/0000-0001-6172-0210	Universite Pierre et Marie Curie (UPMC), INRA [ANR-07-NEURO-037-01]; Research Ministry	Universite Pierre et Marie Curie (UPMC), INRA; Research Ministry	This work was supported by Universite Pierre et Marie Curie (UPMC), INRA, ANR-07-NEURO-037-01 funding and a fellowship from the Research Ministry to N. Durand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON P, 1995, PHYSIOL ENTOMOL, V20, P189, DOI 10.1111/j.1365-3032.1995.tb00001.x; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Biswas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009133; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Devonshire AL, 2007, INSECT BIOCHEM MOLEC, V37, P891, DOI 10.1016/j.ibmb.2007.04.011; Durand N, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00939.x; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; GYORGYI TK, 1988, P NATL ACAD SCI USA, V85, P9851, DOI 10.1073/pnas.85.24.9851; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Jonsson M, 1999, PHYSIOL ENTOMOL, V24, P377, DOI 10.1046/j.1365-3032.1999.00154.x; Kamita SG, 2003, INSECT BIOCHEM MOLEC, V33, P1261, DOI 10.1016/j.ibmb.2003.08.004; Laue M, 2000, ARTHROPOD STRUCT DEV, V29, P57, DOI 10.1016/S1467-8039(00)00013-X; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; Maibeche-Coisne M, 2004, CHEM SENSES, V29, P381, DOI 10.1093/chemse/bjh039; Marion-Poll F., 1995, J NEUROSCI METH, V63, P591, DOI [10.1016/0165-0270(95)00110-7, DOI 10.1016/0165-0270(95)00110-7]; Merlin C, 2007, INSECT MOL BIOL, V16, P73, DOI [10.1111/j.1365-2583.2006.00702.x, 10.1111/1365-2583.2006.00702.x]; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Oakeshott J.G, 2005, COMPREHENSIVE MOL IN, V5, P309, DOI [DOI 10.1016/B0-44-451924-6/00073-9, 10.1016/B0-44-451924-6/00073-9]; Oakeshott JG, 1999, BIOESSAYS, V21, P1031; Party V, 2009, CHEM SENSES, V34, P763, DOI 10.1093/chemse/bjp060; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; Quero C, 1996, J CHEM ECOL, V22, P1087, DOI 10.1007/BF02027947; Quero C, 2003, BIOORGAN MED CHEM, V11, P1047, DOI 10.1016/S0968-0896(02)00467-4; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Rogers ME, 1999, J EXP BIOL, V202, P1625; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Small GJ, 2000, INSECT MOL BIOL, V9, P647, DOI 10.1046/j.1365-2583.2000.00229.x; Steinbrecht R.A., 1987, P353; STEINBRECHT RA, 1992, CELL TISSUE RES, V270, P287, DOI 10.1007/BF00328015; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Teese MG, 2010, INSECT BIOCHEM MOLEC, V40, P1, DOI 10.1016/j.ibmb.2009.12.002; Tsubota T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-377; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1989, J NEUROSCI, V9, P3332; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; YU Q, 2009, BMC GENOMICS, V40, P100	46	68	75	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15026	10.1371/journal.pone.0015026	http://dx.doi.org/10.1371/journal.pone.0015026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124773	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500018
J	Del Bianco, C; Vedenko, A; Choi, SH; Berger, MF; Shokri, L; Bulyk, ML; Blacklow, SC				Del Bianco, Cristina; Vedenko, Anastasia; Choi, Sung Hee; Berger, Michael F.; Shokri, Leila; Bulyk, Martha L.; Blacklow, Stephen C.			Notch and MAML-1 Complexation Do Not Detectably Alter the DNA Binding Specificity of the Transcription Factor CSL	PLOS ONE			English	Article							C. ELEGANS; IN-VITRO; MICROARRAYS; MASTERMIND; SEQUENCE; COACTIVATOR; RECOGNITION; ACTIVATION; REPRESSOR; NETWORK	Background: Canonical Notch signaling is initiated when ligand binding induces proteolytic release of the intracellular part of Notch (ICN) from the cell membrane. ICN then travels into the nucleus where it drives the assembly of a transcriptional activation complex containing the DNA-binding transcription factor CSL, ICN, and a specialized co-activator of the Mastermind family. A consensus DNA binding site motif for the CSL protein was previously defined using selection-based methods, but whether subsequent association of Notch and Mastermind-like proteins affects the DNA binding preferences of CSL has not previously been examined. Principal Findings: Here, we utilized protein-binding microarrays (PBMs) to compare the binding site preferences of isolated CSL with the preferred binding sites of CSL when bound to the CSL-binding domains of all four different human Notch receptors. Measurements were taken both in the absence and in the presence of Mastermind-like-1 (MAML1). Our data show no detectable difference in the DNA binding site preferences of CSL before and after loading of Notch and MAML1 proteins. Conclusions/Significance: These findings support the conclusion that accrual of Notch and MAML1 promote transcriptional activation without dramatically altering the preferred sites of DNA binding, and illustrate the potential of PBMs to analyze the binding site preferences of multiprotein-DNA complexes.	[Del Bianco, Cristina; Choi, Sung Hee; Blacklow, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Del Bianco, Cristina; Choi, Sung Hee; Bulyk, Martha L.; Blacklow, Stephen C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Vedenko, Anastasia; Berger, Michael F.; Shokri, Leila; Bulyk, Martha L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Vedenko, Anastasia; Berger, Michael F.; Shokri, Leila; Bulyk, Martha L.; Blacklow, Stephen C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Berger, Michael F.; Bulyk, Martha L.; Blacklow, Stephen C.] Harvard Univ, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA; [Bulyk, Martha L.; Blacklow, Stephen C.] Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA USA; [Blacklow, Stephen C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Del Bianco, C (corresponding author), Univ Trent, Cibio Ctr Interdipartimentale Biol Integrata, Trento, Italy.	mlbulyk@receptor.med.harvard.edu; sblacklow@partners.org	Del Bianco, Cristina/J-4665-2012		National Institutes of Health/National Human Genome Research Institute [R01 HG003985, R01 CA092433]; NATIONAL CANCER INSTITUTE [R01CA092433] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003985] Funding Source: NIH RePORTER	National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by grant # R01 HG003985 from National Institutes of Health/National Human Genome Research Institute to M. L. B. and grant # R01 CA092433 to S. C. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIBES A, 2010, NUCL ACIDS IN PRESS; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger Michael F., 2006, V338, P245; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; DOU SB, 1994, MOL CELL BIOL, V14, P3310, DOI 10.1128/MCB.14.5.3310; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Friedmann DR, 2010, PROTEIN SCI, V19, P34, DOI 10.1002/pro.280; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Lesch BJ, 2009, GENE DEV, V23, P345, DOI 10.1101/gad.1763509; Liefke R, 2010, GENE DEV, V24, P590, DOI 10.1101/gad.563210; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	31	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15034	10.1371/journal.pone.0015034	http://dx.doi.org/10.1371/journal.pone.0015034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124806	Green Submitted, gold, Green Published			2022-12-25	WOS:000284572000021
J	Oida, T; Weiner, HL				Oida, Takatoku; Weiner, Howard L.			TGF-beta Induces Surface LAP Expression on Murine CD4 T Cells Independent of Foxp3 Induction	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LATENCY-ASSOCIATED PEPTIDE; RECEPTOR; GENE; BINDING; MICE; GARP	Background: It has been reported that human FOXP3(+) CD4 Tregs express GARP-anchored surface latency-associated peptide (LAP) after activation, based on the use of an anti-human LAP mAb. Murine CD4 Foxp3(+) Tregs have also been reported to express surface LAP, but these studies have been hampered by the lack of suitable anti-mouse LAP mAbs. Methodology/Principal Findings: We generated anti-mouse LAP mAbs by immunizing TGF-beta(-/-) animals with a mouse Tgfb1-transduced P3U1 cell line. Using these antibodies, we demonstrated that murine Foxp3(+) CD4 Tregs express LAP on their surface. In addition, retroviral transduction of Foxp3 into mouse CD4(+)CD25(-) T cells induced surface LAP expression. We then examined surface LAP expression after treating CD4(+)CD25(-) T cells with TGF-beta and found that TGF-beta induced surface LAP not only on T cells that became Foxp3(+) but also on T cells that remained Foxp3(-) after TGF-beta treatment. GARP expression correlated with the surface LAP expression, suggesting that surface LAP is GARP-anchored also in murine T cells. Conclusions/Significance: Unlike human CD4 T cells, surface LAP expression on mouse CD4 T cells is controlled by Foxp3 and TGF-beta. Our newly described anti-mouse LAP mAbs will provide a useful tool for the investigation and functional analysis of T cells that express LAP on their surface.	[Oida, Takatoku; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Oida, T (corresponding author), BioLegend Inc, San Diego, CA USA.	hweiner@rics.bwh.harvard.edu			National Institutes of Health [AI435801, NS38037]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Grants AI435801 and NS38037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; CHRIST M, 1994, J IMMUNOL, V153, P1936; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Docagne F, 2001, J BIOL CHEM, V276, P46243, DOI 10.1074/jbc.M010915200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; MIYAZONO K, 1993, GROWTH FACTORS, V8, P11, DOI 10.3109/08977199309029130; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Oida T, 2003, J IMMUNOL, V170, P2516, DOI 10.4049/jimmunol.170.5.2516; Oida T, 2010, J IMMUNOL, V185, P3529, DOI 10.4049/jimmunol.0904121; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Tran DQ, 2009, BLOOD, V113, P5125, DOI 10.1182/blood-2009-01-199950; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	20	50	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15523	10.1371/journal.pone.0015523	http://dx.doi.org/10.1371/journal.pone.0015523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124798	Green Submitted, Green Published, gold			2022-12-25	WOS:000284572000036
J	Hall, C; Welch, J; Kowbel, DJ; Glass, NL				Hall, Charles; Welch, Juliet; Kowbel, David J.; Glass, N. Louise			Evolution and Diversity of a Fungal Self/Nonself Recognition Locus	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; HETEROKARYON INCOMPATIBILITY LOCUS; HET-C LOCUS; VEGETATIVE INCOMPATIBILITY; NONSELF RECOGNITION; NEUROSPORA-CRASSA; BALANCING SELECTION; VIRUS TRANSMISSION; PODOSPORA-ANSERINA; ALLELIC DIVERSITY	Background: Self/nonself discrimination is an essential feature for pathogen recognition and graft rejection and is a ubiquitous phenomenon in many organisms. Filamentous fungi, such as Neurospora crassa, provide a model for analyses of population genetics/evolution of self/nonself recognition loci due to their haploid nature, small genomes and excellent genetic/genomic resources. In N. crassa, nonself discrimination during vegetative growth is determined by 11 heterokaryon incompatibility (het) loci. Cell fusion between strains that differ in allelic specificity at any of these het loci triggers a rapid programmed cell death response. Methodology/Principal Findings: In this study, we evaluated the evolution, population genetics and selective mechanisms operating at a nonself recognition complex consisting of two closely linked loci, het-c (NCU03493) and pin-c (NCU03494). The genomic position of pin-c next to het-c is unique to Neurospora/Sordaria species, and originated by gene duplication after divergence from other species within the Sordariaceae. The het-c pin-c alleles in N. crassa are in severe linkage disequilibrium and consist of three haplotypes, het-c1/pin-c1, het-c2/pin-c2 and het-c3/pin-c3, which are equally frequent in population samples and exhibit trans-species polymorphisms. The absence of recombinant haplotypes is correlated with divergence of the het-c/pin-c intergenic sequence. Tests for positive and balancing selection at het-c and pin-c support the conclusion that both of these loci are under non-neutral balancing selection; other regions of both genes appear to be under positive selection. Our data show that the het-c2/pin-c2 haplotype emerged by a recombination event between the het-c1/pin-c1 and het-c3/pin-c3 approximately 3-12 million years ago. Conclusions/Significance: These results support models by which loci that confer nonself discrimination form by the association of polymorphic genes with genes containing HET domains. Distinct allele classes can emerge by recombination and positive selection and are subsequently maintained by balancing selection and divergence of intergenic sequence resulting in recombination blocks between haplotypes.	[Hall, Charles; Welch, Juliet; Kowbel, David J.; Glass, N. Louise] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hall, C (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	Lglass@berkeley.edu	Glass, N. Louise/ABA-7303-2021		National Institutes of Health [GM60468, GM081597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM081597, R01GM060468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work is supported by an R01 grant from the National Institutes of Health to N.L.G. (GM60468) and a collaborative R24 grant from the National Institutes of Health to Drs. John W. Taylor, Rachel Brem (UCB) and N.L.G. (GM081597). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AKAIKE H, 1974, IEEE T AUTOMATIC CON, V19; ANWAR MM, 1993, J GEN MICROBIOL, V139, P1599, DOI 10.1099/00221287-139-7-1599; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Biella S, 2002, P ROY SOC B-BIOL SCI, V269, P2269, DOI 10.1098/rspb.2002.2148; Browne KA, 2002, J AM CHEM SOC, V124, P7950, DOI 10.1021/ja017746x; CAMBARERI EB, 1993, FUNGAL GENET NEWSL, V40, P22; CHARLESWORTH D, 1995, BIOESSAYS, V17, P31, DOI 10.1002/bies.950170108; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Chevanne D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-134; Chevanne D, 2009, CURR GENET, V55, P93, DOI 10.1007/s00294-008-0227-5; Cortesi P, 1998, APPL ENVIRON MICROB, V64, P2988; Cortesi P, 2001, GENETICS, V159, P107; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Debets AJM, 1998, MYCOL RES, V102, P1343, DOI 10.1017/S095375629800639X; DEBETS F, 1994, CURR GENET, V26, P113, DOI 10.1007/BF00313797; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dishaw LJ, 2009, CURR BIOL, V19, pR286, DOI 10.1016/j.cub.2009.02.035; DOBZHANSKY T, 1948, P NATL ACAD SCI USA, V34, P137, DOI 10.1073/pnas.34.4.137; Edh K, 2009, GENETICS, V181, P977, DOI 10.1534/genetics.108.090837; Espagne E, 2002, GENETICS, V161, P71; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fedorova ND, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-177; FIGUEROA F, 1988, NATURE, V335, P265, DOI 10.1038/335265a0; FISHER R, 1961, J THEOR BIOL, V4, P411; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; GAFF DF, 1971, J EXP BOT, V22, P756, DOI 10.1093/jxb/22.3.756; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Grosberg RK, 2000, SCIENCE, V289, P2111, DOI 10.1126/science.289.5487.2111; HASEGAWA M, 1991, J MOL EVOL, V32, P443, DOI 10.1007/BF02101285; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HOWLETT BJ, 1993, FUNGAL GENET NEWSL, V40, P40; Hutchison E, 2009, MICROBIOL-SGM, V155, P3957, DOI 10.1099/mic.0.032284-0; Jacobson DJ, 1998, FUNGAL GENET BIOL, V23, P45, DOI 10.1006/fgbi.1997.1020; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kamau E, 2005, CURR BIOL, V15, P1773, DOI 10.1016/j.cub.2005.08.062; Kaneko I, 2006, GENETICS, V172, P1545, DOI 10.1534/genetics.105.051490; Kerenyi Z, 2006, APPL ENVIRON MICROB, V72, P6527, DOI 10.1128/AEM.01543-06; Kusaba M, 1997, P NATL ACAD SCI USA, V94, P7673, DOI 10.1073/pnas.94.14.7673; LANGLEY CH, 1974, J MOL EVOL, V3, P161, DOI 10.1007/BF01797451; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marek SM, 2003, FUNGAL GENET BIOL, V40, P126, DOI 10.1016/S1087-1845(03)00086-0; Menkis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000030; Metzenberg RL., 2004, FUNGAL GENET REP, V51, P19, DOI [10.4148/1941-4765.1138, DOI 10.4148/1941-4765.1138]; Micali CO, 2006, GENETICS, V173, P1991, DOI 10.1534/genetics.106.057562; Mir-Rashed N, 2000, FUNGAL GENET BIOL, V30, P197, DOI 10.1006/fgbi.2000.1218; Muirhead CA, 2002, GENETICS, V161, P633; Nasrallah JB, 2002, SCIENCE, V296, P305, DOI 10.1126/science.296.5566.305; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEWHOUSE JR, 1991, CAN J BOT, V69, P602, DOI 10.1139/b91-082; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Pal K, 2007, STUD MYCOL, P19, DOI 10.3114/sim.2007.59.03; Paoletti M, 2007, EUKARYOT CELL, V6, P2001, DOI 10.1128/EC.00129-07; Paoletti M, 2009, BIOESSAYS, V31, P1201, DOI 10.1002/bies.200900085; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; PERKINS DD, 1976, EVOLUTION, V30, P281, DOI 10.1111/j.1558-5646.1976.tb00910.x; Perkins DD, 1988, FUNGAL GENET NEWSL, V35, P44, DOI DOI 10.4148/1941-4765.1546; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell AJ, 2001, J MOL EVOL, V52, P94, DOI 10.1007/s002390010138; Powell AJ, 2007, FUNGAL GENET BIOL, V44, P896, DOI 10.1016/j.fgb.2007.04.010; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sarkar S, 2002, EMBO J, V21, P4841, DOI 10.1093/emboj/cdf479; SAUPE S, 1995, CURR GENET, V27, P466, DOI 10.1007/BF00311217; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Saupe SJ, 1997, GENETICS, V146, P1299; Saupe SJ, 2000, CURR GENET, V38, P39, DOI 10.1007/s002940000130; Saupe SJ, 1996, GENETICS, V143, P1589; Shiu PKT, 1999, GENETICS, V151, P545; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Takuno S, 2007, GENETICS, V177, P949, DOI 10.1534/genetics.107.073825; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavare S., 1986, SOME PROBABILISTIC S; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Van Diepeningen AD, 2009, MYCOL RES, V113, P222, DOI 10.1016/j.mycres.2008.10.003; Vogel H.J., 1956, MICROBIAL GENET B, V13, P42; Wang X, 2001, PLANT PHYSIOL, V125, P1012, DOI 10.1104/pp.125.2.1012; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wu J, 1998, P NATL ACAD SCI USA, V95, P12398, DOI 10.1073/pnas.95.21.12398; Wu J, 2001, MOL CELL BIOL, V21, P1045, DOI 10.1128/MCB.21.4.1045-1057.2001	91	38	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14055	10.1371/journal.pone.0014055	http://dx.doi.org/10.1371/journal.pone.0014055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124910	Green Published, Green Submitted, gold			2022-12-25	WOS:000284400100007
J	Neumuller, KG; Elsayad, K; Reisecker, JM; Waxham, MN; Heinze, KG				Neumueller, Klaus G.; Elsayad, Kareem; Reisecker, Johannes M.; Waxham, M. Neal; Heinze, Katrin G.			Photounbinding of Calmodulin from a Family of CaM Binding Peptides	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; LIGHT; MECHANISM; PROTEINS; DYNAMICS; DYES	Background: Recent studies have shown that fluorescently labeled antibodies can be dissociated from their antigen by illumination with laser light. The mechanism responsible for the photounbinding effect, however, remains elusive. Here, we give important insights into the mechanism of photounbinding and show that the effect is not restricted to antibody/antigen binding. Methodology/Principal Findings: We present studies of the photounbinding of labeled calmodulin (CaM) from a set of CaM-binding peptides with different affinities to CaM after one- and two-photon excitation. We found that the photounbinding effect becomes stronger with increasing binding affinity. Our observation that photounbinding can be influenced by using free radical scavengers, that it does not occur with either unlabeled protein or non-fluorescent quencher dyes, and that it becomes evident shortly after or with photobleaching suggest that photounbinding and photobleaching are closely linked. Conclusions/Significance: The experimental results exclude surface effects, or heating by laser irradiation as potential causes of photounbinding. Our data suggest that free radicals formed through photobleaching may cause a conformational change of the CaM which lowers their binding affinity with the peptide or its respective binding partner.	[Neumueller, Klaus G.; Elsayad, Kareem; Reisecker, Johannes M.; Heinze, Katrin G.] Res Inst Mol Pathol, Dept Opt Engn, A-1030 Vienna, Austria; [Waxham, M. Neal] Univ Texas Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Texas System; University of Texas Health Science Center Houston	Neumuller, KG (corresponding author), DSM Biotechnol Ctr, Dept Appl Biochem, Delft, Netherlands.	katrin.heinze@imp.ac.at		Elsayad, Kareem/0000-0003-1642-2905; Waxham, M. Neal/0000-0003-4801-1190	Research Institute of Molecular Pathology, Vienna, Austria; Austrian Science Fund (FWF); NIH/NINDS [R01-NS026086]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026086] Funding Source: NIH RePORTER	Research Institute of Molecular Pathology, Vienna, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research was funded by the Research Institute of Molecular Pathology, Vienna, Austria and the Austrian Science Fund (FWF). MNW would like to acknowledge financial support from the NIH/NINDS, grant #R01-NS026086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; BARDEN JA, 1987, EUR J BIOCHEM, V162, P583, DOI 10.1111/j.1432-1033.1987.tb10679.x; Beutler M, 2008, EUR BIOPHYS J BIOPHY, V38, P69, DOI 10.1007/s00249-008-0361-5; Bingaman S, 2003, MICROCIRCULATION, V10, P221, DOI 10.1038/sj.mn.7800186; Bulina ME, 2006, NAT PROTOC, V1, P947, DOI 10.1038/nprot.2006.89; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Dittrich PS, 2001, APPL PHYS B-LASERS O, V73, P829, DOI 10.1007/sO03400100737; Dobrucki JW, 2007, BIOPHYS J, V93, P1778, DOI 10.1529/biophysj.106.096636; FAULSTICH H, 1997, HOPPESEYLERS Z PHYSL, V358, P181; Fureder-Kitzmuller E, 2005, CHEM PHYS LETT, V404, P13, DOI 10.1016/j.cplett.2005.01.053; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Hancock JT, 2001, BIOCHEM SOC T, V29, P345, DOI 10.1042/BST0290345; Heinze KG, 2009, J PHYS CHEM B, V113, P5225, DOI 10.1021/jp8060152; Hoebe RA, 2008, J MICROSC-OXFORD, V231, P9, DOI 10.1111/j.1365-2818.2008.02009.x; Hoogenboom JP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.097401; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; KASCHE V, 1964, J PHYS CHEM-US, V68, P817, DOI 10.1021/j100786a019; Kim SA, 2004, P NATL ACAD SCI USA, V101, P105, DOI 10.1073/pnas.2436461100; Koizumi M, 1972, MOL PHOTOCHEM, V4, P57; Kuno M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.125304; LINDQVIST L, 1961, ARK KEMI, V16, P79; Luschtinetz F, 2009, BIOCONJUGATE CHEM, V20, P576, DOI 10.1021/bc800497v; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; USUI Y, 1965, B CHEM SOC JPN, V38, P1015, DOI 10.1246/bcsj.38.1015; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; Yeow EKL, 2006, J PHYS CHEM A, V110, P1726, DOI 10.1021/jp055496r	32	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14050	10.1371/journal.pone.0014050	http://dx.doi.org/10.1371/journal.pone.0014050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124984	Green Submitted, Green Published, gold			2022-12-25	WOS:000284356900013
J	Yanaka, S; Sano, E; Naruse, N; Miura, K; Futatsumori-Sugai, M; Caaveiro, JMM; Tsumoto, K				Yanaka, Saeko; Sano, Emiko; Naruse, Norio; Miura, Kin-ichiro; Futatsumori-Sugai, Mutsumi; Caaveiro, Jose M. M.; Tsumoto, Kouhei			Non-core Region Modulates Interleukin-11 Signaling Activity GENERATION OF AGONIST AND ANTAGONIST VARIANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING SITES; CYTOKINE-RECEPTOR; CHEMICAL-MODIFICATION; CRYSTAL-STRUCTURE; FUSION-PROTEIN; GP130; GLYCOSYLATION; IDENTIFICATION; RECOGNITION; RECOMBINANT	Human interleukin-11 (hIL-11) is a pleiotropic cytokine administered to patients with low platelet counts. From a structural point of view hIL-11 belongs to the long-helix cytokine superfamily, which is characterized by a conserved core motif consisting of four alpha-helices. We have investigated the region of hIL-11 that does not belong to the alpha-helical bundle motif, and that for the purpose of brevity we have termed "non-core region." The primary sequence of the interleukin was altered at various locations within the non-core region by introducing glycosylation sites. Functional consequences of these modifications were examined in cell-based as well as biophysical assays. Overall, the data indicated that the non-core region modulates the function of hIL-11 in two ways. First, the majority of muteins displayed enhanced cell-stimulatory properties (superagonist behavior) in a glycosylation-dependent manner, suggesting that the non-core region is biologically designed to limit the full potential of hIL-11. Second, specific modification of a predicted mini alpha-helix led to cytokine inactivation, demonstrating that this putative structural element belongs to site III engaging a second copy of cell-receptor gp130. These findings have unveiled new and unexpected elements modulating the biological activity of hIL-11, which may be exploited to develop more versatile medications based on this important cytokine.	[Yanaka, Saeko; Sano, Emiko; Miura, Kin-ichiro; Futatsumori-Sugai, Mutsumi; Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; [Sano, Emiko; Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Kashiwa, Chiba 2778562, Japan; [Naruse, Norio] Proteios Inc, Kamakura, Kanagawa 2488555, Japan	University of Tokyo; University of Tokyo	Tsumoto, K (corresponding author), Univ Tokyo, Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan.	tsumoto@k.u-tokyo.ac.jp	Yanaka, Saeko/AAW-5301-2020; Caaveiro, Jose/J-2790-2013; Yanaka, Saeko/AAU-4487-2020	Yanaka, Saeko/0000-0002-3513-5701; Caaveiro, Jose/0000-0001-5568-2369; 	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for general research from the Japan Society for the Promotion of Science (to K. T.).	Aritomi M, 1999, NATURE, V401, P713, DOI 10.1038/44394; Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755; Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; Bhatia M, 2007, LEUKEMIA LYMPHOMA, V48, P9, DOI 10.1080/10428190600909115; Bhatia Prakash K., 1999, V64, P155; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Czupryn M, 1995, ANN NY ACAD SCI, V762, P152; CZUPRYN MJ, 1995, J BIOL CHEM, V270, P978, DOI 10.1074/jbc.270.2.978; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dela Cruz CS, 2004, J EXP MED, V199, P503, DOI 10.1084/jem.20031205; Du XX, 1997, AM J PHYSIOL-GASTR L, V272, pG545, DOI 10.1152/ajpgi.1997.272.3.G545; Du XX, 1997, BLOOD, V89, P3897, DOI 10.1182/blood.V89.11.3897; Feng YQ, 1999, BIOCHEMISTRY-US, V38, P4553, DOI 10.1021/bi982224o; Futatsumori-Sugai M., 2010, COMMUN, V391, P931; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Harmegnies D, 2003, BIOCHEM J, V375, P23, DOI 10.1042/BJ20030459; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; JENKINS N, 1994, ENZYME MICROB TECH, V16, P354, DOI 10.1016/0141-0229(94)90149-X; Karow J, 1996, BIOCHEM J, V318, P489, DOI 10.1042/bj3180489; Kaye J A, 1998, Stem Cells, V16 Suppl 2, P207; Lee CG, 2008, AM J RESP CELL MOL, V39, P739, DOI 10.1165/rcmb.2008-0053OC; Lewis VO, 2009, CANCER RES, V69, P1995, DOI 10.1158/0008-5472.CAN-08-4845; Matadeen R, 2007, STRUCTURE, V15, P441, DOI 10.1016/j.str.2007.02.006; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; Nicola NA, 1999, ADV PROTEIN CHEM, V52, P1; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; OHEDA M, 1990, J BIOL CHEM, V265, P11432; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; Peeters K, 2008, DRUG DISCOV TODAY, V13, P798, DOI 10.1016/j.drudis.2008.06.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflanz S, 1999, FEBS LETT, V450, P117, DOI 10.1016/S0014-5793(99)00477-9; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Sakamoto S, 2009, J MOL BIOL, V389, P880, DOI 10.1016/j.jmb.2009.04.050; Sands BE, 2002, ALIMENT PHARM THERAP, V16, P399, DOI 10.1046/j.1365-2036.2002.01179.x; SANO E, 1987, CELL STRUCT FUNCT, V12, P509, DOI 10.1247/csf.12.509; SCAHILL SJ, 1983, P NATL ACAD SCI-BIOL, V80, P4654, DOI 10.1073/pnas.80.15.4654; Schleinkofer K, 2001, J MOL BIOL, V306, P263, DOI 10.1006/jmbi.2000.4387; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Sola RJ, 2007, CELL MOL LIFE SCI, V64, P2133, DOI 10.1007/s00018-007-6551-y; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Tacken I, 1999, EUR J BIOCHEM, V265, P645, DOI 10.1046/j.1432-1327.1999.00755.x; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takagi A, 2007, J CONTROL RELEASE, V119, P271, DOI 10.1016/j.jconrel.2007.03.009; Tan HD, 2005, BIOTECHNOL LETT, V27, P905, DOI 10.1007/s10529-005-7179-3; Trepicchio WL, 1998, ANN NY ACAD SCI, V856, P12, DOI 10.1111/j.1749-6632.1998.tb08308.x; Underhill-Day N, 2003, ENDOCRINOLOGY, V144, P3406, DOI 10.1210/en.2002-0144; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616	55	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8085	8093		10.1074/jbc.M110.152561	http://dx.doi.org/10.1074/jbc.M110.152561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21138838	Green Published, hybrid			2022-12-25	WOS:000288013300039
J	Zander, U; Faust, A; Klink, BU; de Sanctis, D; Panjikar, S; Quentmeier, A; Bardischewsky, F; Friedrich, CG; Scheidig, AJ				Zander, Ulrich; Faust, Annette; Klink, Bjoern U.; de Sanctis, Daniele; Panjikar, Santosh; Quentmeier, Armin; Bardischewsky, Frank; Friedrich, Cornelius G.; Scheidig, Axel J.			Structural Basis for the Oxidation of Protein-bound Sulfur by the Sulfur Cycle Molybdohemo-Enzyme Sulfane Dehydrogenase SoxCD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; SULFITE-OXIDIZING ENZYMES; PARACOCCUS-PANTOTROPHUS; CRYSTAL-STRUCTURE; CYTOCHROME C(6); MOLYBDENUM COFACTOR; CROSS-VALIDATION; MOLECULAR-BASIS; GENE-CLUSTER; PULSED EPR	The sulfur cycle enzyme sulfane dehydrogenase SoxCD is an essential component of the sulfur oxidation (Sox) enzyme system of Paracoccus pantotrophus. SoxCD catalyzes a six-electron oxidation reaction within the Sox cycle. SoxCD is an alpha(2)beta(2) heterotetrameric complex of the molybdenum cofactor-containing SoxC protein and the diheme c-type cytochrome SoxD with the heme domains D-1 and D-2. SoxCD(1) misses the heme-2 domain D-2 and is catalytically as active as SoxCD. The crystal structure of SoxCD(1) was solved at 1.33 angstrom. The substrate of SoxCD is the outer (sulfane) sulfur of Cys-110-persulfide located at the C-terminal peptide swinging arm of SoxY of the SoxYZ carrier complex. The SoxCD(1) substrate funnel toward the molybdopterin is narrow and partially shielded by side-chain residues of SoxD(1). For access of the sulfane-sulfur of SoxY-Cys-110 persulfide we propose that (i) the blockage by SoxD-Arg-98 is opened via interaction with the C terminus of SoxY and (ii) the C-terminal peptide VTIGGCGG of SoxY provides interactions with the entrance path such that the cysteine-bound persulfide is optimally positioned near the molybdenum atom. The subsequent oxidation reactions of the sulfane-sulfur are initiated by the nucleophilic attack of the persulfide anion on the molybdenum atom that is, in turn, reduced. The close proximity of heme-1 to the molybdopterin allows easy acceptance of the electrons. Because SoxYZ, SoxXA, and SoxB are already structurally characterized, with SoxCD(1) the structures of all key enzymes of the Sox cycle are known with atomic resolution.	[Quentmeier, Armin; Bardischewsky, Frank; Friedrich, Cornelius G.] Tech Univ Dortmund, Fak Bio & Chem Ingn, D-44221 Dortmund, Germany; [Zander, Ulrich; Faust, Annette; Scheidig, Axel J.] Univ Kiel, Inst Zool, Dept Biol Struct, D-24118 Kiel, Germany; [Zander, Ulrich; Klink, Bjoern U.; Scheidig, Axel J.] Univ Saarland, Dept Biophys Struct Biol, D-66421 Homburg, Germany; [de Sanctis, Daniele] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble 9, France; [Panjikar, Santosh] DESY, EMBL Hamburg Outstn, D-22603 Hamburg, Germany	Dortmund University of Technology; University of Kiel; Saarland University; European Synchrotron Radiation Facility (ESRF); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Friedrich, CG (corresponding author), Tech Univ Dortmund, Fak Bio & Chem Ingn, Emil Figge Str 66, D-44221 Dortmund, Germany.	cornelius.friedrich@udo.edu; axel.scheidig@strubio.uni-kiel.de	Scheidig, Axel/C-9141-2011; Panjikar, Santosh/D-2709-2012	Panjikar, Santosh/0000-0001-7429-3879	Deutsche Forschungsgemeinschaft [Fr318/10-1, Sche545/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Fr318/10-1 and Sche545/9-1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akazaki H, 2008, ACTA CRYSTALLOGR F, V64, P674, DOI 10.1107/S1744309108017752; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey S, 2009, J BIOL CHEM, V284, P2053, DOI 10.1074/jbc.M807718200; Bamford VA, 2002, BIOCHEMISTRY-US, V41, P2921, DOI 10.1021/bi015765d; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Banci L, 1996, J BIOL INORG CHEM, V1, P330, DOI 10.1007/s007750050061; Bardischewsky F, 2005, BIOCHEMISTRY-US, V44, P7024, DOI 10.1021/bi047334b; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emesh S, 2009, BIOCHEMISTRY-US, V48, P2156, DOI 10.1021/bi801553q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer K, 2005, PLANT CELL, V17, P1167, DOI 10.1105/tpc.104.029694; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grimm F, 2010, MICROBIOL-SGM, V156, P764, DOI 10.1099/mic.0.034645-0; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; HILLE R, 1994, BBA-BIOENERGETICS, V1184, P143, DOI 10.1016/0005-2728(94)90220-8; HOBBS JD, 1995, J PROTEIN CHEM, V14, P19, DOI 10.1007/BF01902840; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jones S, 2000, PROTEIN ENG, V13, P77, DOI 10.1093/protein/13.2.77; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kappler U, 2005, J BIOL CHEM, V280, P24999, DOI 10.1074/jbc.M503237200; KELLY DP, 1982, PHILOS T R SOC B, V298, P499, DOI 10.1098/rstb.1982.0094; Kelly DP, 1997, ANTON LEEUW INT J G, V71, P95, DOI 10.1023/A:1000135707181; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Oliveira TF, 2008, J BIOL CHEM, V283, P34141, DOI 10.1074/jbc.M805643200; Ozawa K, 2003, BIOPHYS J, V85, P3367, DOI 10.1016/S0006-3495(03)74756-0; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Quentmeier A, 2000, ARCH MICROBIOL, V173, P117, DOI 10.1007/s002039900118; Rainey FA, 1999, INT J SYST BACTERIOL, V49, P645, DOI 10.1099/00207713-49-2-645; Raitsimring AM, 2005, INORG CHEM, V44, P7283, DOI 10.1021/ic0509534; Rapson TD, 2010, J BIOL INORG CHEM, V15, P505, DOI 10.1007/s00775-009-0619-0; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rother D, 2001, J BACTERIOL, V183, P4499, DOI 10.1128/JB.183.15.4499-4508.2001; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Sauve V, 2009, J BIOL CHEM, V284, P21707, DOI 10.1074/jbc.M109.002709; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Sezer D, 2009, PHYS CHEM CHEM PHYS, V11, P6626, DOI 10.1039/b905709a; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WOOTTON JC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P157, DOI 10.1016/S0005-2728(05)80100-8; Worrall JAR, 2007, J AM CHEM SOC, V129, P9468, DOI 10.1021/ja072346g	71	28	30	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8349	8360		10.1074/jbc.M110.193631	http://dx.doi.org/10.1074/jbc.M110.193631			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21147779	Green Published, hybrid			2022-12-25	WOS:000288013300063
J	Herskowitz, JH; Seyfried, NT; Gearing, M; Kahn, RA; Peng, JM; Levey, AI; Lah, JJ				Herskowitz, Jeremy H.; Seyfried, Nicholas T.; Gearing, Marla; Kahn, Richard A.; Peng, Junmin; Levey, Allan I.; Lah, James J.			Rho Kinase II Phosphorylation of the Lipoprotein Receptor LR11/SORLA Alters Amyloid-beta Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SORTILIN-RELATED RECEPTOR; APOLIPOPROTEIN-E RECEPTOR; PHOSPHOPROTEOMIC ANALYSIS; SERINE/THREONINE KINASE; CYTOPLASMIC DOMAIN; PROTEIN; BINDING; SORLA; LR11; ACTIVATION	LR11, also known as SorLA, is a mosaic low-density lipoprotein receptor that exerts multiple influences on Alzheimer disease susceptibility. LR11 interacts with the amyloid-beta precursor protein (APP) and regulates APP traffic and processing to amyloid-beta peptide (A beta). The functional domains of LR11 suggest that it can act as a cell surface receptor and as an intracellular sorting receptor for trans-Golgi network to endosome traffic. We show that LR11 over-expressed in HEK293 cells is radiolabeled following incubation of cells with [P-32(i)] orthophosphate. Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) was used to discover putative LR11 interacting kinases. Rho-associated coiled-coil containing protein kinase (ROCK) 2 was identified as a binding partner and a candidate kinase acting on LR11. LR11 and ROCK2 co-immunoprecipitate from post-mortem human brain tissue and drug inhibition of ROCK activity reduces LR11 phosphorylation in vivo. Targeted knockdown of ROCK2 with siRNA decreased LR11 ectodomain shedding while simultaneously increasing intracellular LR11 protein level. Site-directed mutagenesis of serine 2206 in the LR11 cytoplasmic tail reduced LR11 shedding, decreased LR11 phosphorylation in vitro, and abrogated LR11 mediated A beta reduction. These findings provide direct evidence that LR11 is phosphorylated in vivo and indicate that ROCK2 phosphorylation of LR11 may enhance LR11 mediated processing of APP and amyloid production.	[Lah, James J.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Neurol, Atlanta, GA 30322 USA; [Seyfried, Nicholas T.; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Gearing, Marla] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Peng, Junmin] Emory Univ, Sch Med, Prote Serv Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University	Lah, JJ (corresponding author), 615 Michael St,Suite 500, Atlanta, GA 30322 USA.	jlah@emory.edu	Kahn, Richard/ABD-2666-2020; Levey, Allan/F-2104-2011; Peng, Junmin/N-2614-2018	Kahn, Richard/0000-0002-0259-0601; Levey, Allan/0000-0002-3153-502X; Peng, Junmin/0000-0003-0472-7648	ADR, American Health Assistance Foundation; National Institutes of Health NINDS [T32 NS007480-07]; NIA [P01AG1449, R01GM067226]; Alzheimer Disease Research Center [AG025688, F32AG032848-02]; American Cancer Society [RSG-09-181-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, T32NS007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, F32AG032848] Funding Source: NIH RePORTER	ADR, American Health Assistance Foundation; National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer Disease Research Center; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Lah/Levey, Peng, and Mao Laboratories for constructive discussion regarding this manuscript, Marla Gearing, and the National Institutes of Health through the Emory NINDS Neuroscience Core Facilities (NS055077). Acknowledgment is made to the donors of ADR, a program of the American Health Assistance Foundation, for support of this research.; This work was supported, in whole or in part, by National Institutes of Health NINDS Training and Translational Research in Neurology Grant T32 NS007480-07, and Grants NIA P01AG1449 and R01GM067226. This work was also supported by Alzheimer Disease Research Center Grant AG025688, Training Grant (F32AG032848-02, to N. T. S.), and a Research Scholar Grant RSG-09-181-01 from the American Cancer Society.	Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Bohm C, 2006, J BIOL CHEM, V281, P14547, DOI 10.1074/jbc.M601660200; Cramer JF, 2010, TRAFFIC, V11, P259, DOI 10.1111/j.1600-0854.2009.01017.x; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Hampe W, 2000, J CELL SCI, V113, P4475; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hashimoto R, 1999, BIOCHEM BIOPH RES CO, V263, P575, DOI 10.1006/bbrc.1999.1409; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Herskowitz JH, 2010, J PROTEOME RES, V9, P6368, DOI 10.1021/pr100666c; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Kaneko T, 2000, BIOCHEM BIOPH RES CO, V273, P110, DOI 10.1006/bbrc.2000.2901; Kang JH, 2007, BIOCHIMIE, V89, P39, DOI 10.1016/j.biochi.2006.08.003; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kosako H, 1997, J BIOL CHEM, V272, P10333; Kubo Takekazu, 2008, Ther Clin Risk Manag, V4, P605; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Motoi Y, 1999, BRAIN RES, V833, P209, DOI 10.1016/S0006-8993(99)01542-5; Nagumo H, 2001, BIOCHEM BIOPH RES CO, V280, P605, DOI 10.1006/bbrc.2000.4179; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-3; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; Sager KL, 2007, ANN NEUROL, V62, P640, DOI 10.1002/ana.21190; Sasaki Y, 2003, J PHARMACOL SCI, V93, P35, DOI 10.1254/jphs.93.35; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schilling O, 2010, NAT METHODS, V7, P508, DOI [10.1038/NMETH.1467, 10.1038/nmeth.1467]; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Taira K, 2001, ARTERIOSCL THROM VAS, V21, P1501, DOI 10.1161/hq0901.094500; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	59	45	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6117	6127		10.1074/jbc.M110.167239	http://dx.doi.org/10.1074/jbc.M110.167239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21147781	hybrid, Green Published			2022-12-25	WOS:000287476400021
J	Lee, KH; Liu, YJ; Biswas, A; Ogawa, C; Kobayashi, KS				Lee, Kyoung-Hee; Liu, Yuen-Joyce; Biswas, Amlan; Ogawa, Chikako; Kobayashi, Koichi S.			A Novel Aminosaccharide Compound Blocks Immune Responses by Toll-like Receptors and Nucleotide-binding Domain, Leucine-rich Repeat Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; BLAU-SYNDROME; BACTERIAL PEPTIDOGLYCAN; REGULATORY ROLES; CARD15 MUTATIONS; CROHNS-DISEASE; CUTTING EDGE; MURINE MODEL; STRANDED-RNA	Toll-like receptors (TLRs) and nucleotide-binding domain, leucine-rich repeat (NLR) proteins are two major forms of innate immune receptors that trigger inflammatory responses by various biological mechanisms such as cytokine production, recruitment of inflammatory cells, or activation of adaptive immunity. Although the innate immune system is designed to fight against infectious pathogens, excessive activation of TLR or NLR signaling pathways may lead to unwarranted inflammation with hazardous outcomes, including septic shock or inflammatory diseases. As part of the search for effective therapeutics to regulate these responses, here we show that a novel aminosaccharide compound, named DFK1012, inhibits immune responses caused by TLR and NLR activation. Treatment with DFK1012, but not its derivatives DFK845 or DFK846, strongly inhibited pro-inflammatory cytokine production upon stimulation via either TLR or NLR proteins in macrophages. Importantly, we have not observed cytotoxicity in any range of its working concentration. Treatment with DFK1012 did not interfere with TLR- or NLR-induced activation of p38 and JNK, phosphorylation/degradation of I kappa B, and subsequent nuclear translocation of NF-kappa B subunit p65, suggesting that the inhibitory activity of DFK1012 is not due to the suppression of downstream signaling. Indeed, DFK1012 did not impair transcription of pro-inflammatory cytokine genes but rather promoted post-translational degradation of pro-inflammatory cytokines. Therefore, DFK1012 is a novel anti-inflammatory compound that drives proteolysis of proinflammatory cytokines induced by TLR and NLR stimulation. DFK1012 may represent a novel class of potential therapeutic agents aimed at the treatment of inflammatory disorders.	[Lee, Kyoung-Hee; Liu, Yuen-Joyce; Biswas, Amlan; Kobayashi, Koichi S.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Lee, Kyoung-Hee; Biswas, Amlan; Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ogawa, Chikako] Eisai Res Inst, Andover, MA 01810 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Eisai Co Ltd	Kobayashi, KS (corresponding author), 1420A,44 Binney St, Boston, MA 02115 USA.	Koichi_Kobayashi@dfci.harvard.edu		Liu, Yuen-Joyce/0000-0003-1772-0082; Kobayashi, Koichi/0000-0003-2930-0114	Eisai Research Institute under Dana-Farber Cancer Institute [2696, CRF 734]; Cancer Research Institute; Claudia Adams Barr Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	Eisai Research Institute under Dana-Farber Cancer Institute; Cancer Research Institute; Claudia Adams Barr Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Eisai Research Institute under the Sponsored Research Agreement (Dana-Farber Cancer Institute Agreement Number Reference 2696/Eisai Research Institute CRF 734).; A recipient of the Investigator Award from the Cancer Research Institute and the Claudia Adams Barr Award.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Berdeli A, 2005, J MOL MED, V83, P535, DOI 10.1007/s00109-005-0677-x; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Buckley GM, 2008, BIOORG MED CHEM LETT, V18, P3656, DOI 10.1016/j.bmcl.2008.04.042; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hill RJ, 2008, J PHARMACOL EXP THER, V327, P610, DOI 10.1124/jpet.108.139006; Hoshino K, 1999, J IMMUNOL, V162, P3749; JUE DM, 1990, BIOCHEMISTRY-US, V29, P8371, DOI 10.1021/bi00488a025; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MEDZHITOV R, 1997, INT IMMUNOL, V91, P317; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rose CD, 2005, J RHEUMATOL, V32, P373; Schmidt C, 2006, NAT BIOTECHNOL, V24, P230, DOI 10.1038/nbt0306-230; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Solomon KA, 1997, J IMMUNOL, V159, P4524; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tidswell M, 2010, CRIT CARE MED, V38, P72, DOI 10.1097/CCM.0b013e3181b07b78; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Wardowska A, 2009, VACCINE, V27, P369, DOI 10.1016/j.vaccine.2008.11.017; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952	59	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5727	5735		10.1074/jbc.M110.108001	http://dx.doi.org/10.1074/jbc.M110.108001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21138842	Green Published, hybrid			2022-12-25	WOS:000287230600081
J	Dong, JY; Sereno, A; Snyder, WB; Miller, BR; Tamraz, S; Doern, A; Favis, M; Wu, XF; Tran, H; Langley, E; Joseph, I; Boccia, A; Kelly, R; Wortham, K; Wang, Q; Berquist, L; Huang, F; Gao, SRX; Zhang, Y; Lugovskoy, A; Martin, S; Gouvis, H; Berkowitz, S; Chiang, G; Reff, M; Glaser, SM; Hariharan, K; Demarest, SJ				Dong, Jianying; Sereno, Arlene; Snyder, William B.; Miller, Brian R.; Tamraz, Susan; Doern, Adam; Favis, Michael; Wu, Xiufeng; Tran, Hon; Langley, Emma; Joseph, Ingrid; Boccia, Antonio; Kelly, Rebecca; Wortham, Kathleen; Wang, Qin; Berquist, Lisa; Huang, Flora; Gao, Sharon X.; Zhang, Ying; Lugovskoy, Alexey; Martin, Shelly; Gouvis, Heather; Berkowitz, Steven; Chiang, Gisela; Reff, Mitchell; Glaser, Scott M.; Hariharan, Kandasamy; Demarest, Stephen J.			Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN FV; MULTIPLE DISEASE MEDIATORS; HAMSTER OVARY CELLS; MONOCLONAL-ANTIBODIES; DOMAIN INTERACTIONS; ESCHERICHIA-COLI; CANCER-CELLS; STABILITY; FRAGMENTS; BINDING	Bispecific antibodies (BsAbs) target multiple epitopes on the same molecular target or different targets. Although interest in BsAbs has persisted for decades, production of stable and active BsAbs has hindered their clinical evaluation. Here, we describe the production and characterization of tetravalent IgG-like BsAbs that combine the activities of allosteric and competitive inhibitors of the type-I insulin-like growth factor receptor (IGF-1R). The BsAbs, which were engineered for thermal stability, express well, demonstrate favorable biophysical properties, and recognize both epitopes on IGF-1R. Only one BsAb with a unique geometry, denoted BIIB4-5scFv, was capable of engaging all four of its binding arms simultaneously. All the BsAbs (especially BIIB4-5scFv) demonstrated enhanced ligand blocking over the single monoclonal antibodies (mAbs), particularly at high ligand concentrations. The pharmacokinetic profiles of two IgG-like BsAbs were tested in nude mice and shown to be comparable with that of the parental mAbs. The BsAbs, especially BIIB4-5scFv, demonstrated an improved ability to reduce the growth of multiple tumor cell lines and to inhibit ligand-induced IGF-1R signaling in tumor cells over the parental mAbs. BIIB4-5scFv also led to superior tumor growth inhibition over its parental mAbs in vivo. In summary, BsAbs that bridge multiple inhibitory mechanisms against a single target may generally represent a more effective strategy for intervention in oncology or other indications compared with traditional mAb therapy.	[Dong, Jianying; Demarest, Stephen J.] Biogen Idec Inc, Dept Prot Chem, San Diego, CA 92122 USA	Biogen	Dong, JY (corresponding author), Biogen Idec Inc, Dept Prot Chem, San Diego, CA 92122 USA.	jianying_dong@yahoo.com; kdemarest7@gmail.com						ARTEAGA CL, 1989, J CLIN INVEST, V84, P1418, DOI 10.1172/JCI114315; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brezinsky SCG, 2003, J IMMUNOL METHODS, V277, P141, DOI 10.1016/S0022-1759(03)00108-X; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Coloma MJ, 1997, NAT BIOTECHNOL, V15, P159, DOI 10.1038/nbt0297-159; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Demarest SJ, 2006, PROTEIN ENG DES SEL, V19, P325, DOI 10.1093/protein/gzl016; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Doern A, 2009, J BIOL CHEM, V284, P10254, DOI 10.1074/jbc.M809709200; Dong JY, 2010, MOL CANCER THER, V9, P2593, DOI 10.1158/1535-7163.MCT-09-1018; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; Fedi P., 2000, HOLLAND FREI CANC ME, P33; Fischer N, 2007, PATHOBIOLOGY, V74, P3, DOI 10.1159/000101046; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; GLENNIE MJ, 1987, J IMMUNOL, V139, P2367; HEISS MM, 2010, INT J CANCER, DOI DOI 10.1002/IJC.25423; Hewish M, 2009, RECENT PAT ANTI-CANC, V4, P54, DOI 10.2174/157489209787002515; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; JACOBS S, 1986, ENDOCRINOLOGY, V118, P223, DOI 10.1210/endo-118-1-223; Jordan JL, 2009, PROTEINS, V77, P832, DOI 10.1002/prot.22502; Kontermann RE, 2010, CURR OPIN MOL THER, V12, P176; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Majors BS, 2008, BIOTECHNOL BIOENG, V101, P567, DOI 10.1002/bit.21917; Majors BS, 2008, J BIOTECHNOL, V138, P103, DOI 10.1016/j.jbiotec.2008.08.003; Michaelson JS, 2009, MABS-AUSTIN, V1, P128, DOI 10.4161/mabs.1.2.7631; Miller BR, 2010, PROTEIN ENG DES SEL, V23, P549, DOI 10.1093/protein/gzq028; Miller Brian R., 2009, V525, P279, DOI 10.1007/978-1-59745-554-1_14; Muller D, 2007, CURR OPIN MOL THER, V9, P319; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2008, CURR OPIN PHARMACOL, V8, P384, DOI 10.1016/j.coph.2008.07.004; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Qu ZX, 2008, BLOOD, V111, P2211, DOI 10.1182/blood-2007-08-110072; Robinson MK, 2008, BRIT J CANCER, V99, P1415, DOI 10.1038/sj.bjc.6604700; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; SOOS MA, 1992, J BIOL CHEM, V267, P12955; STAERZ UD, 1986, P NATL ACAD SCI USA, V83, P1453, DOI 10.1073/pnas.83.5.1453; Taylor FR, 2006, ANAL BIOCHEM, V353, P204, DOI 10.1016/j.ab.2006.02.022; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; Wang N, 2009, PROTEINS, V76, P99, DOI 10.1002/prot.22319; Willuda J, 1999, CANCER RES, V59, P5758; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345	52	30	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4703	4717		10.1074/jbc.M110.184317	http://dx.doi.org/10.1074/jbc.M110.184317			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123183	hybrid, Green Published			2022-12-25	WOS:000286975700069
J	Macdonald, J; Glover, JD; Taylor, L; Sang, HM; McGrew, MJ				Macdonald, Joni; Glover, James D.; Taylor, Lorna; Sang, Helen M.; McGrew, Michael J.			Characterisation and Germline Transmission of Cultured Avian Primordial Germ Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CHICK-EMBRYO; C-KIT; IN-VITRO; MOUSE; EXPRESSION; GENE; HOMOLOG; PATHWAY; ORIGIN	Background: Avian primordial germ cells (PGCs) have significant potential to be used as a cell-based system for the study and preservation of avian germplasm, and the genetic modification of the avian genome. It was previously reported that PGCs from chicken embryos can be propagated in culture and contribute to the germ cell lineage of host birds. Principal Findings: We confirm these results by demonstrating that PGCs from a different layer breed of chickens can be propagated for extended periods in vitro. We demonstrate that intracellular signalling through PI3K and MEK is necessary for PGC growth. We carried out an initial characterisation of these cells. We find that cultured PGCs contain large lipid vacuoles, are glycogen rich, and express the stem cell marker, SSEA-1. These cells also express the germ cell-specific proteins CVH and CDH. Unexpectedly, using RT-PCR we show that cultured PGCs express the pluripotency genes c-Myc, cKlf4, cPouV, cSox2, and cNanog. Finally, we demonstrate that the cultured PGCs will migrate to and colonise the forming gonad of host embryos. Male PGCs will colonise the female gonad and enter meiosis, but are lost from the gonad during sexual development. In male hosts, cultured PGCs form functional gametes as demonstrated by the generation of viable offspring. Conclusions: The establishment of in vitro cultures of germline competent avian PGCs offers a unique system for the study of early germ cell differentiation and also a comparative system for mammalian germ cell development. Primary PGC lines will form the basis of an alternative technique for the preservation of avian germplasm and will be a valuable tool for transgenic technology, with both research and industrial applications.	[Macdonald, Joni] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Macdonald, J (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	mike.mcgrew@roslin.ed.ac.uk		Glover, James/0000-0003-4678-5643	Biotechnology and Biological Sciences Research Council, U.K.; BBSRC [BB/H023593/1, BBS/E/R/00001607] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/R/00001607, BB/H023593/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, U.K.(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Biotechnology and Biological Sciences Research Council, U.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antin PB, 2010, DEV DYNAM, V239, P1879, DOI 10.1002/dvdy.22318; Aramaki S, 2009, J REPROD DEVELOP, V55, P214, DOI 10.1262/jrd.20154; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Bielanska-Osuchowska Zofia, 2006, Reprod Biol, V6, P161; Blesbois E, 2007, POULTRY SCI, V86, P555, DOI 10.1093/ps/86.3.555; Clinton M, 2001, BRIT POULTRY SCI, V42, P134, DOI 10.1080/713655025; De Felici M, 2004, HUM REPROD UPDATE, V10, P197, DOI 10.1093/humupd/dmh020; De Miguel MP, 2002, P NATL ACAD SCI USA, V99, P10458, DOI 10.1073/pnas.122249399; DOLCI S, 1991, NATURE, V352, P807; Donovan PJ, 1998, INT J DEV BIOL, V42, P1043; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; DURCOVAHILLS G, 2008, CURR PROTOC STEM CEL, V20, pCH1; Ehlermann JL, 2003, ANAT REC PART A, V273A, P677, DOI 10.1002/ar.a.10089; Farini D, 2005, DEV BIOL, V285, P49, DOI 10.1016/j.ydbio.2005.06.036; Feng HL, 1998, MOL REPROD DEV, V49, P317, DOI 10.1002/(SICI)1098-2795(199803)49:3&lt;317::AID-MRD12&gt;3.0.CO;2-T; FORD CE, 1975, PROC R SOC SER B-BIO, V190, P187, DOI 10.1098/rspb.1975.0086; FUJIMOTO T, 1977, ANAT REC, V188, P315, DOI 10.1002/ar.1091880305; FUJIMOTO T, 1976, DEV BIOL, V49, P278, DOI 10.1016/0012-1606(76)90273-6; Fulton JE, 2006, POULTRY SCI, V85, P227, DOI 10.1093/ps/85.2.227; GODIN I, 1991, NATURE, V352, P809; Goel S, 2009, REPROD FERT DEVELOP, V21, P696, DOI 10.1071/RD08176; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HILL DJ, 1985, ENDOCRINOLOGY, V117, P2061, DOI 10.1210/endo-117-5-2061; HIRNING U, 1991, MECH DEVELOP, V33, P119, DOI 10.1016/0925-4773(91)90078-K; Jung JS, 2005, STEM CELLS, V23, P689, DOI 10.1634/stemcells.2004-0208; Karagenc L, 1996, DEV GENET, V19, P290, DOI 10.1002/(SICI)1520-6408(1996)19:4<290::AID-DVG2>3.3.CO;2-S; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; MARANI E, 1986, ACTA MORPHOL NEER SC, V24, P103; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; MCGREW MJ, 2010, ENCY SUSTAI IN PRESS; Mozdziak PE, 2005, POULTRY SCI, V84, P594, DOI 10.1093/ps/84.4.594; Naito M, 1999, J REPROD FERTIL, V117, P291, DOI 10.1530/jrf.0.1170291; NIEUWKOOP P. D., 1979, PRIMORDAL GERM CELLS; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Pain B, 1996, DEVELOPMENT, V122, P2339; PALMER SJ, 1991, DEVELOPMENT, V112, P265; Park TS, 2000, MOL REPROD DEV, V56, P475, DOI 10.1002/1098-2795(200008)56:4&lt;475::AID-MRD5&gt;3.0.CO;2-M; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Petitte J.N., 2004, HDB STEM CELLS, P471; Petitte JN, 1997, POULTRY SCI, V76, P1084, DOI 10.1093/ps/76.8.1084; Petitte JN, 2004, MECH DEVELOP, V121, P1159, DOI 10.1016/j.mod.2004.05.003; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Sang H, 2006, NAT BIOTECHNOL, V24, P955, DOI 10.1038/nbt0806-955; Slanchev K, 2009, MECH DEVELOP, V126, P270, DOI 10.1016/j.mod.2008.10.006; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SPIEGELMAN M, 1973, J EMBRYOL EXP MORPH, V30, P97; Surani MA, 2008, COLD SH Q B, V73, P9, DOI 10.1101/sqb.2008.73.015; Takeuchi Y, 2005, DEVELOPMENT, V132, P5399, DOI 10.1242/dev.02080; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; van de Lavoir MC, 2006, MECH DEVELOP, V123, P31, DOI 10.1016/j.mod.2005.10.002; Wandzioch E, 2004, BLOOD, V104, P51, DOI 10.1182/blood-2003-07-2554; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4	67	94	110	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15518	10.1371/journal.pone.0015518	http://dx.doi.org/10.1371/journal.pone.0015518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124737	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500044
J	Pinton, G; Thomas, W; Bellini, P; Manente, AG; Favoni, RE; Harvey, BJ; Mutti, L; Moro, L				Pinton, Giulia; Thomas, Warren; Bellini, Paolo; Manente, Arcangela Gabriella; Favoni, Roberto E.; Harvey, Brian J.; Mutti, Luciano; Moro, Laura			Estrogen Receptor beta Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ENDOCRINE THERAPY RESISTANCE; FACTOR SIGNALING PATHWAYS; PROSTATE-CANCER CELLS; MOLECULAR-MECHANISM; LUNG-CANCER; PHASE-II; TYROSINE KINASE; BREAST-CANCER; CROSS-TALK	Background: The role of estrogen and estrogen receptors in oncogenesis has been investigated in various malignancies. Recently our group identified estrogen receptor beta (ER beta) expression as an independent prognostic factor in the progression of human Malignant Pleural Mesothelioma (MMe), but the underlying mechanism by which ER beta expression in tumors determines clinical outcome remains largely unknown. This study is aimed at investigating the molecular mechanisms of ER beta action in MMe cells and disclosing the potential translational implications of these results. Methods: We modulated ER beta expression in REN and MSTO-211H MMe cell lines and evaluated cell proliferation and EGF receptor (EGFR) activation. Results: Our data indicate that ER beta knockdown in ER positive cells confers a more invasive phenotype, increases anchorage independent proliferation and elevates the constitutive activation of EGFR-coupled signal transduction pathways. Conversely, re-expression of ER beta in ER negative cells confers a more epithelioid phenotype, decreases their capacity for anchorage independent growth and down-modulates proliferative signal transduction pathways. We identify a physical interaction between ER beta, EGFR and caveolin 1 that results in an altered internalization and in a selective reduced activation of EGFR-coupled signaling, when ER beta is over-expressed. We also demonstrate that differential expression of ER beta influences MMe tumor cell responsiveness to the therapeutic agent: Gefitinib. Conclusions: This study describes a role for ER beta in the modulation of cell proliferation and EGFR activation and provides a rationale to facilitate the targeting of a subgroup of MMe patients who would benefit most from therapy with Gefitinib alone or in combination with Akt inhibitors.	[Pinton, Giulia; Bellini, Paolo; Manente, Arcangela Gabriella; Moro, Laura] Univ Piemonte Orientale, Drug & Food Biotechnol Ctr, Dept Chem Food Pharmaceut & Pharmacol Sci, Novara, Italy; [Thomas, Warren; Harvey, Brian J.] Royal Coll Surgeons Ireland, Dept Mol Med, Dublin 2, Ireland; [Thomas, Warren; Harvey, Brian J.] Beaumont Hosp, Educ & Res Ctr, Dublin 9, Ireland; [Favoni, Roberto E.] Natl Canc Inst, Lab Expt Pharmacol, Genoa, Italy; [Mutti, Luciano] Dept Med, Local Hlth Unit 11, Vercelli, Italy	University of Eastern Piedmont Amedeo Avogadro; Royal College of Surgeons - Ireland	Pinton, G (corresponding author), Univ Piemonte Orientale, Drug & Food Biotechnol Ctr, Dept Chem Food Pharmaceut & Pharmacol Sci, Novara, Italy.	moro@pharm.unipmn.it	Harvey, Brian/AAJ-4085-2020; Moro, Laura/ABF-2175-2020; Pinton, Giulia/ABF-2199-2020; Thomas, Warren/A-5477-2010; Mutti, Luciano/A-3545-2011; Harvey, Brian J/A-5120-2010	Harvey, Brian/0000-0002-7388-8034; Harvey, Brian J/0000-0002-7388-8034; Pinton, Giulia/0000-0003-0496-0378; Thomas, Warren/0000-0003-2706-1770; Moro, Laura/0000-0003-3421-2522; Mutti, Luciano/0000-0002-1578-2637	MARF (Mesothelioma Applied Research Foundation); Fondazione Buzzi Unicem; Higher Education Authority of Ireland [PRTLI4]; Progetto Lagrange (Cassa di Risparmio di Torino)	MARF (Mesothelioma Applied Research Foundation); Fondazione Buzzi Unicem; Higher Education Authority of Ireland; Progetto Lagrange (Cassa di Risparmio di Torino)	This work was supported by MARF (Mesothelioma Applied Research Foundation), Fondazione Buzzi Unicem and Higher Education Authority of Ireland (PRTLI4) through the National Biophotonics and Imaging Platform. G. Pinton was supported by a PhD fellowship from Progetto Lagrange (Cassa di Risparmio di Torino). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; BEPLER G, 1988, DIFFERENTIATION, V37, P158, DOI 10.1111/j.1432-0436.1988.tb00806.x; Bonaccorsi L, 2004, INT J CANCER, V112, P78, DOI 10.1002/ijc.20362; Cortese JF, 2006, INT J CANCER, V118, P521, DOI 10.1002/ijc.21271; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; Edwards JG, 2006, LUNG CANCER, V54, P399, DOI 10.1016/j.lungcan.2006.08.012; Erlandsson MC, 2001, IMMUNOLOGY, V103, P17, DOI 10.1046/j.1365-2567.2001.01212.x; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Garland LL, 2007, J CLIN ONCOL, V25, P2406, DOI 10.1200/JCO.2006.09.7634; Govindan R, 2005, CLIN CANCER RES, V11, P2300, DOI 10.1158/1078-0432.CCR-04-1940; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Kato S, 1998, ONCOLOGY-BASEL, V55, P5, DOI 10.1159/000055253; Kato S, 2000, GENES CELLS, V5, P593, DOI 10.1046/j.1365-2443.2000.00354.x; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Lewis JD, 2007, MOL CANCER RES, V5, P133, DOI 10.1158/1541-7786.MCR-06-0245; Marino M, 2006, STEROIDS, V71, P298, DOI 10.1016/j.steroids.2005.09.011; Marino M, 2008, STEROIDS, V73, P853, DOI 10.1016/j.steroids.2007.12.003; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pass HI, 2009, SEMIN THORAC CARDIOV, V21, P97, DOI 10.1053/j.semtcvs.2009.06.007; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Pinton G, 2009, CANCER RES, V69, P4598, DOI 10.1158/0008-5472.CAN-08-4523; Richards WG, 2009, SEMIN THORAC CARDIOV, V21, P105, DOI 10.1053/j.semtcvs.2009.07.002; Sanchez M, 2010, TRENDS ENDOCRIN MET, V21, P104, DOI 10.1016/j.tem.2009.09.007; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Steele JPC, 2005, HEMATOL ONCOL CLIN N, V19, P1041, DOI 10.1016/j.hoc.2005.09.009; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P2959, DOI 10.1073/pnas.0511271103; Wang L, 2001, P NATL ACAD SCI USA, V98, P2792, DOI 10.1073/pnas.041617498; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898; Yang HC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-196; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003	40	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14110	10.1371/journal.pone.0014110	http://dx.doi.org/10.1371/journal.pone.0014110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124760	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500005
J	Touw, DS; Patel, DR; van den Berg, B				Touw, Debra S.; Patel, Dimki R.; van den Berg, Bert			The Crystal Structure of OprG from Pseudomonas aeruginosa, a Potential Channel for Transport of Hydrophobic Molecules across the Outer Membrane	PLOS ONE			English	Article							ESCHERICHIA-COLI; VIBRIO-CHOLERAE; DNA-SEQUENCE; BETA-BARREL; PROTEIN; OMPW; NAPHTHALENE; PLASMID; IDENTIFICATION; RESISTANCE	Background: The outer membrane (OM) of Gram-negative bacteria provides a barrier to the passage of hydrophobic and hydrophilic compounds into the cell. The OM has embedded proteins that serve important functions in signal transduction and in the transport of molecules into the periplasm. The OmpW family of OM proteins, of which P. aeruginosa OprG is a member, is widespread in Gram-negative bacteria. The biological functions of OprG and other OmpW family members are still unclear. Methodology/Principal Findings: In order to obtain more information about possible functions of OmpW family members we have solved the X-ray crystal structure of P. aeruginosa OprG at 2.4 angstrom resolution. OprG forms an eight-stranded beta-barrel with a hydrophobic channel that leads from the extracellular surface to a lateral opening in the barrel wall. The OprG barrel is closed off from the periplasm by interacting polar and charged residues on opposite sides of the barrel wall. Conclusions/Significance: The crystal structure, together with recent biochemical data, suggests that OprG and other OmpW family members form channels that mediate the diffusion of small hydrophobic molecules across the OM by a lateral diffusion mechanism similar to that of E. coli FadL.	[Touw, Debra S.; Patel, Dimki R.; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Touw, DS (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	bert.vandenberg@umassmed.edu		van den Berg, Bert/0000-0003-1966-8804	National Institutes of Health, (NIGMS) [5R01GM085785]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085785] Funding Source: NIH RePORTER	National Institutes of Health, (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by National Institutes of Health grant 5R01GM085785 (NIGMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold T, 2009, J BIOL CHEM, V284, P6403, DOI 10.1074/jbc.M808504200; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; BUEHLER LK, 1991, J BIOL CHEM, V266, P24446; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Das M, 1998, FEMS IMMUNOL MED MIC, V22, P303, DOI 10.1111/j.1574-695X.1998.tb01219.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DENOME SA, 1993, J BACTERIOL, V175, P6890, DOI 10.1128/jb.175.21.6890-6901.1993; EATON RW, 1994, J BACTERIOL, V176, P7757, DOI 10.1128/JB.176.24.7757-7762.1994; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gensberg K, 1999, J ANTIMICROB CHEMOTH, V43, P607, DOI 10.1093/jac/43.4.607; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hancock REW, 2002, ANNU REV MICROBIOL, V56, P17, DOI 10.1146/annurev.micro.56.012302.160310; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; JALAJAKUMARI MB, 1990, NUCLEIC ACIDS RES, V18, P2180, DOI 10.1093/nar/18.8.2180; McPhee JB, 2009, FEMS MICROBIOL LETT, V296, P241, DOI 10.1111/j.1574-6968.2009.01651.x; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Neher TM, 2009, CAN J MICROBIOL, V55, P553, DOI [10.1139/w09-002, 10.1139/W09-002]; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Peng XX, 2005, J PROTEOME RES, V4, P2257, DOI 10.1021/pr050159g; Soderblom T, 2005, CELL MICROBIOL, V7, P779, DOI 10.1111/j.1462-5822.2005.00510.x; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; VANBEILEN JB, 1992, MOL MICROBIOL, V6, P3121; Walzer G, 2009, J MICROBIOL METH, V76, P52, DOI 10.1016/j.mimet.2008.09.012; Wu LN, 2006, J PROTEOME RES, V5, P2250, DOI 10.1021/pr060046c; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	32	46	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15016	10.1371/journal.pone.0015016	http://dx.doi.org/10.1371/journal.pone.0015016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124774	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500015
J	Wright, AK; Wishart, TM; Ingham, CA; Gillingwater, TH				Wright, Ann K.; Wishart, Thomas M.; Ingham, Cali A.; Gillingwater, Thomas H.			Synaptic Protection in the Brain of Wld(S) Mice Occurs Independently of Age but Is Sensitive to Gene-Dose	PLOS ONE			English	Article							WALLERIAN DEGENERATION WLD(S); SPINAL MUSCULAR-ATROPHY; AXONAL DEGENERATION; TRANSGENIC MICE; IN-VIVO; NEUROMUSCULAR-JUNCTIONS; PARKINSON-DISEASE; MOUSE MODELS; MUTANT MICE; PROTEIN	Background: Disruption of synaptic connectivity is a significant early event in many neurodegenerative conditions affecting the aging CNS, including Alzheimer's disease and Parkinson's disease. Therapeutic approaches that protect synapses from degeneration in the aging brain offer the potential to slow or halt the progression of such conditions. A range of animal models expressing the slow Wallerian Degeneration (Wld(S)) gene show robust neuroprotection of synapses and axons from a wide variety of traumatic and genetic neurodegenerative stimuli in both the central and peripheral nervous systems, raising that possibility that Wld(S) may be useful as a neuroprotective agent in diseases with synaptic pathology. However, previous studies of neuromuscular junctions revealed significant negative effects of increasing age and positive effects of gene-dose on Wld(S)-mediated synaptic protection in the peripheral nervous system, raising doubts as to whether Wld(S) is capable of directly conferring synapse protection in the aging brain. Methodology/Principal Findings: We examined the influence of age and gene-dose on synaptic protection in the brain of mice expressing the Wld(S) gene using an established cortical lesion model to induce synaptic degeneration in the striatum. Synaptic protection was found to be sensitive to Wld(S) gene-dose, with heterozygous Wld(S) mice showing approximately half the level of protection observed in homozygous Wld(S) mice. Increasing age had no influence on levels of synaptic protection. In contrast to previous findings in the periphery, synapses in the brain of old Wld(S) mice were just as strongly protected as those in young mice. Conclusions/Significance: Our study demonstrates that Wld(S)-mediated synaptic protection in the CNS occurs independently of age, but is sensitive to gene dose. This suggests that the Wld(S) gene, and in particular its downstream endogenous effector pathways, may be potentially useful therapeutic agents for conferring synaptic protection in the aging brain.	[Wright, Ann K.; Wishart, Thomas M.; Gillingwater, Thomas H.] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; [Wright, Ann K.; Wishart, Thomas M.; Gillingwater, Thomas H.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Ingham, Cali A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Wright, AK (corresponding author), Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland.	T.Gillingwater@ed.ac.uk	Gillingwater, Thomas/G-2880-2011	wishart, thomas/0000-0002-1973-6654; Gillingwater, Thomas/0000-0002-0306-5577	Wellcome Trust [WT084151AIA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a grant from the Wellcome Trust (grant WT084151AIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalbert R, 2005, EUR J NEUROSCI, V21, P271, DOI 10.1111/j.1460-9568.2004.03833.x; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Beirowski B, 2010, NEUROSCIENCE, V166, P201, DOI 10.1016/j.neuroscience.2009.12.024; Beirowski B, 2008, EUR J NEUROSCI, V28, P1166, DOI 10.1111/j.1460-9568.2008.06426.x; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; CHEN S, 1990, BRAIN RES, V520, P103, DOI 10.1016/0006-8993(90)91695-D; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Conforti L, 2009, J CELL BIOL, V184, P491, DOI 10.1083/jcb.200807175; CRAWFORD TO, 1995, J NEUROCYTOL, V24, P333, DOI 10.1007/BF01189060; Ferri A, 2003, CURR BIOL, V13, P669, DOI 10.1016/S0960-9822(03)00206-9; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; FRANKLIN KBJ, 1997, MOUSE BRAIN STEREOTA, pR22; Gillingwater TH, 2004, J CEREBR BLOOD F MET, V24, P62, DOI 10.1097/01.WCB.0000095798.98378.34; Gillingwater TH, 2006, HUM MOL GENET, V15, P625, DOI 10.1093/hmg/ddi478; Gillingwater TH, 2003, J NEUROCYTOL, V32, P863, DOI 10.1023/B:NEUR.0000020629.51673.f5; Gillingwater TH, 2003, J ANAT, V203, P265, DOI 10.1046/j.1469-7580.2003.00214.x; Gillingwater TH, 2002, J PHYSIOL-LONDON, V543, P739, DOI 10.1113/jphysiol.2002.022343; Gillingwater TH, 2006, BRAIN, V129, P1546, DOI 10.1093/brain/awl101; Hasbani DM, 2006, EXP NEUROL, V202, P93, DOI 10.1016/j.expneurol.2006.05.017; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; KEMP JM, 1971, PHILOS T R SOC B, V262, P413, DOI 10.1098/rstb.1971.0104; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Kim SJ, 2008, J CLIN INVEST, V118, P3075, DOI 10.1172/JCI33482; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; LYON MF, 1993, P NATL ACAD SCI USA, V90, P9717, DOI 10.1073/pnas.90.20.9717; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; MI W, 2002, FENS FOR; Mi WQ, 2003, MUTAT RES-FUND MOL M, V526, P33, DOI 10.1016/S0027-5107(03)00011-3; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; Murray LM, 2008, J ANAT, V213, P633, DOI 10.1111/j.1469-7580.2008.01007.x; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Samsam M, 2003, J NEUROSCI, V23, P2833; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; SOMOGYI P, 1981, J COMP NEUROL, V195, P567, DOI 10.1002/cne.901950403; Wang MS, 2001, ANN NEUROL, V50, P773, DOI 10.1002/ana.10039; Wishart TM, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-21; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340; Wishart TM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-148; Wishart TM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r101; Wong F, 2009, MOL CELL NEUROSCI, V42, P296, DOI 10.1016/j.mcn.2009.08.002; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009	54	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15108	10.1371/journal.pone.0015108	http://dx.doi.org/10.1371/journal.pone.0015108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124744	Green Submitted, Green Published, gold			2022-12-25	WOS:000284686500039
J	Matsumoto, L; Takuma, H; Tamaoka, A; Kurisaki, H; Date, H; Tsuji, S; Iwata, A				Matsumoto, Lumine; Takuma, Hiroshi; Tamaoka, Akira; Kurisaki, Hiroshi; Date, Hidetoshi; Tsuji, Shoji; Iwata, Atsushi			CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson's Disease	PLOS ONE			English	Article							NEUROBLASTOMA SH-SY5Y CELLS; LEWY BODIES; DNA METHYLATION; TRANSCRIPTIONAL REGULATION; MESSENGER-RNA; UP-REGULATION; DEMENTIA; GENE; CANCER; BRAIN	Background: Alpha-synuclein (SNCA) gene expression is an important factor in the pathogenesis of Parkinson's disease (PD). Gene multiplication can cause inherited PD, and promoter polymorphisms that increase SNCA expression are associated with sporadic PD. CpG methylation in the promoter region may also influence SNCA expression. Methodology/Principal Findings: By using cultured cells, we identified a region of the SNCA CpG island in which the methylation status altered along with increased SNCA expression. Postmortem brain analysis revealed regional non-specific methylation differences in this CpG region in the anterior cingulate and putamen among controls and PD; however, in the substantia nigra of PD, methylation was significantly decreased. Conclusions/Significance: This CpG region may function as an intronic regulatory element for SNCA gene. Our findings suggest that a novel epigenetic regulatory mechanism controlling SNCA expression influences PD pathogenesis.	[Matsumoto, Lumine; Date, Hidetoshi; Tsuji, Shoji; Iwata, Atsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci,Bunkyo Ku, Tokyo, Japan; [Iwata, Atsushi] Univ Tokyo, Grad Sch Med, Dept Mol Neurosci Neurodegenerat, Bunkyo Ku, Tokyo, Japan; [Takuma, Hiroshi; Tamaoka, Akira] Univ Tsukuba, Dept Neurol, Tsukuba, Ibaraki, Japan; [Kurisaki, Hiroshi] Tokyo Hosp, Natl Hosp Org, Dept Neurol, Tokyo, Japan; [Iwata, Atsushi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; University of Tokyo; University of Tsukuba; Japan Science & Technology Agency (JST)	Matsumoto, L (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci,Bunkyo Ku, Tokyo, Japan.	iwata-tky@umin.ac.jp	Iwata, Atsushi/AAH-8924-2019; Iwata, Atsushi/A-9598-2013	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314	JSPS (Japan Society for the Promotion of Science); Japan Ministry of Education, Culture, Sports, Science and Technology; JST; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Brain Science Foundation; Cell Science Research Foundation; Janssen Pharmaceuticals	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Brain Science Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This study was supported by KAKENHI from JSPS (Japan Society for the Promotion of Science); Japan Ministry of Education, Culture, Sports, Science and Technology; PRESTO from JST; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Brain Science Foundation, the Cell Science Research Foundation and Janssen Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrachina M, 2009, J NEUROPATH EXP NEUR, V68, P880, DOI 10.1097/NEN.0b013e3181af2e46; Beyer K, 2004, NEUROPATH APPL NEURO, V30, P601, DOI 10.1111/j.1365-2990.2004.00572.x; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clough RL, 2007, FASEB J, V21, P596, DOI 10.1096/fj.06-7111com; Clough RL, 2009, J NEUROCHEM, V110, P1479, DOI 10.1111/j.1471-4159.2009.06250.x; Dachsel JC, 2007, MOVEMENT DISORD, V22, P293, DOI 10.1002/mds.21223; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; DRINKWATER RD, 1989, MUTAT RES, V219, P29, DOI 10.1016/0921-8734(89)90038-6; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Gomez-Santos C, 2003, J NEUROSCI RES, V73, P341, DOI 10.1002/jnr.10663; Gomez-Santos C, 2002, BRAIN RES, V935, P32, DOI 10.1016/S0006-8993(02)02422-8; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lu AP, 2001, ONCOGENE, V20, P5173, DOI 10.1038/sj.onc.1204668; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Mizuta I, 2006, HUM MOL GENET, V15, P1151, DOI 10.1093/hmg/ddl030; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Rauch T, 2005, LAB INVEST, V85, P1172, DOI 10.1038/labinvest.3700311; Rideout HJ, 2003, J NEUROCHEM, V84, P803, DOI 10.1046/j.1471-4159.2003.01574.x; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Takeda A, 2000, ACTA NEUROPATHOL, V99, P296, DOI 10.1007/PL00007441; Tanji K, 2002, PATHOL INT, V52, P572, DOI 10.1046/j.1440-1827.2002.01385.x; Tanji K, 2001, NEUROREPORT, V12, P1909, DOI 10.1097/00001756-200107030-00028; Terada S, 2000, ACTA NEUROPATHOL, V100, P464, DOI 10.1007/s004010000213; Terada S, 2003, ACTA NEUROPATHOL, V105, P163, DOI 10.1007/s00401-002-0622-9; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Yao L, 2008, MOL PHARMACOL, V73, P1105, DOI 10.1124/mol.107.042580	40	209	220	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15522	10.1371/journal.pone.0015522	http://dx.doi.org/10.1371/journal.pone.0015522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124796	Green Published, Green Submitted, gold			2022-12-25	WOS:000284572000035
J	Chun, JT; Puppo, A; Vasilev, F; Gragnaniello, G; Garante, E; Santella, L				Chun, Jong T.; Puppo, Agostina; Vasilev, Filip; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia			The Biphasic Increase of PIP2 in the Fertilized Eggs of Starfish: New Roles in Actin Polymerization and Ca2+ Signaling	PLOS ONE			English	Article							SEA-URCHIN EGGS; PLECKSTRIN HOMOLOGY DOMAIN; CORTICAL GRANULE TRANSLOCATION; PLASMA-MEMBRANE PTDINS(4,5)P-2; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE; EXTRACELLULAR-MATRIX; IN-VIVO; CALCIUM; CYTOSKELETON	Background: Fertilization of echinoderm eggs is accompanied by dynamic changes of the actin cytoskeleton and by a drastic increase of cytosolic Ca2+. Since the plasma membrane-enriched phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) serves as the precursor of inositol 1,4,5 trisphosphate (InsP(3)) and also regulates actin-binding proteins, PIP2 might be involved in these two processes. Methodology/Principal Findings: In this report, we have studied the roles of PIP2 at fertilization of starfish eggs by using fluorescently tagged pleckstrin homology (PH) domain of PLC-delta 1, which has specific binding affinity to PIP2, in combination with Ca2+ and F-actin imaging techniques and transmission electron microscopy. During fertilization, PIP2 increased at the plasma membrane in two phases rather than continually decreasing. The first increase was quickly followed by a decrease about 40 seconds after sperm-egg contact. However, these changes took place only after the Ca2+ wave had already initiated and propagated. The fertilized eggs then displayed a prolonged increase of PIP2 that was accompanied by the appearance of numerous spikes in the perivitelline space during the elevation of the fertilization envelope (FE). These spikes, protruding from the plasma membrane, were filled with microfilaments. Sequestration of PIP2 by RFP-PH at higher doses resulted in changes of subplasmalemmal actin networks which significantly delayed the intracellular Ca2+ signaling, impaired elevation of FE, and increased occurrences of polyspermic fertilization. Conclusions/Significance: Our results suggest that PIP2 plays comprehensive roles in shaping Ca2+ waves and guiding structural and functional changes required for successful fertilization. We propose that the PIP2 increase and the subsequent formation of actin spikes not only provide the mechanical supports for the elevating FE, but also accommodate increased membrane surfaces during cortical granule exocytosis.	[Chun, Jong T.; Puppo, Agostina; Vasilev, Filip; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia] Staz Zool Anton Dohrn, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Chun, JT (corresponding author), Staz Zool Anton Dohrn, Villa Comunale, Naples, Italy.	chun@szn.it	Chun, Jong Tai/AAM-3394-2020; Santella, Luigia/AAM-3524-2020	Chun, Jong Tai/0000-0002-6070-4953; Santella, Luigia/0000-0001-7159-0499	Regione Campania Research [2213/B6]	Regione Campania Research	This work was partly supported by Regione Campania Research Grant 2213/B6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BURGESS DR, 1977, J CELL BIOL, V74, P1032, DOI 10.1083/jcb.74.3.1032; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; CARRON CP, 1982, DEV BIOL, V89, P128, DOI 10.1016/0012-1606(82)90301-3; CHANDLER DE, 1980, J CELL BIOL, V84, P618, DOI 10.1083/jcb.84.3.618; Chun JT, 2009, ACTA PHYSIOL, V195, P61, DOI 10.1111/j.1748-1716.2008.01921.x; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; FORSCHER P, 1989, TRENDS NEUROSCI, V12, P468, DOI 10.1016/0166-2236(89)90098-2; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Halet G, 2002, J CELL SCI, V115, P2139; HARTWIG JH, 1989, J CELL BIOL, V109, P1571, DOI 10.1083/jcb.109.4.1571; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Kimata T, 2006, HEPATOLOGY, V44, P140, DOI 10.1002/hep.21215; Kuroda R, 2001, DEVELOPMENT, V128, P4405; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Kyozuka K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006296; Lange K, 2006, J CELL PHYSIOL, V209, P270, DOI 10.1002/jcp.20717; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Lim D, 2002, FASEB J, V16, P1050, DOI 10.1096/fj.02-0021com; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Lupu VD, 1998, J BIOL CHEM, V273, P14067, DOI 10.1074/jbc.273.23.14067; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Matese JC, 1997, DEV BIOL, V186, P16, DOI 10.1016/S0012-1606(97)98585-7; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Moccia F, 2003, FASEB J, V17, P1907, DOI 10.1096/fj.03-0178fje; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Puppo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003588; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Santella L, 2005, MOL INTERV, V5, P70, DOI 10.1124/mi.5.2.3; Santella L, 2004, TRENDS BIOCHEM SCI, V29, P400, DOI 10.1016/j.tibs.2004.06.009; Santella L, 1999, EXP CELL RES, V248, P567, DOI 10.1006/excr.1999.4425; Santella L, 2008, INT J DEV BIOL, V52, P571, DOI 10.1387/ijdb.072560ls; SCHROEDER TE, 1983, DEV BIOL, V98, P373, DOI 10.1016/0012-1606(83)90366-4; Sechi AS, 2000, J CELL SCI, V113, P3685; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Smith RM, 2000, J CELL BIOL, V148, P755, DOI 10.1083/jcb.148.4.755; Snow P, 1996, DEV BIOL, V180, P108, DOI 10.1006/dbio.1996.0288; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; SWANN K, 1986, J CELL BIOL, V103, P2333, DOI 10.1083/jcb.103.6.2333; Thaler CD, 2004, DEV GROWTH DIFFER, V46, P413, DOI 10.1111/j.1440-169x.2004.00758.x; TILNEY LG, 1973, J CELL BIOL, V59, P109, DOI 10.1083/jcb.59.1.109; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; TILNEY LG, 1980, J CELL BIOL, V87, pA217; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; TURNER PR, 1984, NATURE, V310, P414, DOI 10.1038/310414a0; VACQUIER VD, 1972, NATURE, V240, P352, DOI 10.1038/240352a0; VACQUIER VD, 1975, DEV BIOL, V43, P62, DOI 10.1016/0012-1606(75)90131-1; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; WEHLAND J, 1977, P NATL ACAD SCI USA, V74, P5613, DOI 10.1073/pnas.74.12.5613; Wessel GM, 2001, INT REV CYTOL, V209, P117; Wessel GM, 2002, DEVELOPMENT, V129, P4315; YAGISAWA H, 1994, J BIOL CHEM, V269, P20179; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549	67	35	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14100	10.1371/journal.pone.0014100	http://dx.doi.org/10.1371/journal.pone.0014100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124897	Green Submitted, Green Published, gold			2022-12-25	WOS:000284527900012
J	King, ONF; Li, XS; Sakurai, M; Kawamura, A; Rose, NR; Ng, SS; Quinn, AM; Rai, G; Mott, BT; Beswick, P; Klose, RJ; Oppermann, U; Jadhav, A; Heightman, TD; Maloney, DJ; Schofield, CJ; Simeonov, A				King, Oliver N. F.; Li, Xuan Shirley; Sakurai, Masaaki; Kawamura, Akane; Rose, Nathan R.; Ng, Stanley S.; Quinn, Amy M.; Rai, Ganesha; Mott, Bryan T.; Beswick, Paul; Klose, Robert J.; Oppermann, Udo; Jadhav, Ajit; Heightman, Tom D.; Maloney, David J.; Schofield, Christopher J.; Simeonov, Anton			Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE-FACTOR; PROLYL 4-HYDROXYLASES; LYSINE DEMETHYLASES; GENE-EXPRESSION; HIF FIH; HYDROXYLASE; METHYLATION; 2-OXOGLUTARATE; SPECIFICITY; LIBRARIES	Background: Small molecule modulators of epigenetic processes are currently sought as basic probes for biochemical mechanisms, and as starting points for development of therapeutic agents. N-e-Methylation of lysine residues on histone tails is one of a number of post-translational modifications that together enable transcriptional regulation. Histone lysine demethylases antagonize the action of histone methyltransferases in a site-and methylation state-specific manner. N-e-Methyllysine demethylases that use 2-oxoglutarate as co-factor are associated with diverse human diseases, including cancer, inflammation and X-linked mental retardation; they are proposed as targets for the therapeutic modulation of transcription. There are few reports on the identification of templates that are amenable to development as potent inhibitors in vivo and large diverse collections have yet to be exploited for the discovery of demethylase inhibitors. Principal Findings: High-throughput screening of a similar to 236,000-member collection of diverse molecules arrayed as dilution series was used to identify inhibitors of the JMJD2 (KDM4) family of 2-oxoglutarate-dependent histone demethylases. Initial screening hits were prioritized by a combination of cheminformatics, counterscreening using a coupled assay enzyme, and orthogonal confirmatory detection of inhibition by mass spectrometric assays. Follow-up studies were carried out on one of the series identified, 8-hydroxyquinolines, which were shown by crystallographic analyses to inhibit by binding to the active site Fe(II) and to modulate demethylation at the H3K9 locus in a cell-based assay. Conclusions: These studies demonstrate that diverse compound screening can yield novel inhibitors of 2OG dependent histone demethylases and provide starting points for the development of potent and selective agents to interrogate epigenetic regulation.	[King, Oliver N. F.; Ng, Stanley S.; Beswick, Paul; Oppermann, Udo; Heightman, Tom D.] Univ Oxford, Struct Genom Consortium, Headington, England; [Li, Xuan Shirley; Klose, Robert J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Sakurai, Masaaki; Quinn, Amy M.; Rai, Ganesha; Mott, Bryan T.; Jadhav, Ajit; Maloney, David J.; Simeonov, Anton] NHGRI, Chem Genom Ctr, NIH, Bethesda, MD 20892 USA; [Kawamura, Akane; Rose, Nathan R.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford OX1 3QU, England; [Kawamura, Akane; Rose, Nathan R.; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Oxford; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); University of Oxford; University of Oxford	King, ONF (corresponding author), Univ Oxford, Struct Genom Consortium, Headington, England.	asimeono@mail.nih.gov	Rose, Nathan R/A-9270-2013; Kawamura, Akane/I-4047-2018	Rose, Nathan R/0000-0002-1871-1156; Kawamura, Akane/0000-0003-1169-5082; Jadhav, Ajit/0000-0001-7955-1451; King, Oliver/0000-0002-6152-7207; Mott, Bryan/0000-0002-1912-6362; Schofield, Christopher/0000-0002-0290-6565	Molecular Libraries Initiative of the National Institutes of Health (NIH); NHGRI; NIH; Wellcome Trust; Commonwealth Scholarship Commission in the United Kingdom; Biotechnology and Biological Research Council (U.K.); Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; BBSRC [BB/D020190/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D020190/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Commonwealth Scholarship Commission in the United Kingdom; Biotechnology and Biological Research Council (U.K.)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by the Molecular Libraries Initiative of the National Institutes of Health (NIH) Roadmap for Medical Research and the Intramural Research Program of NHGRI, NIH, The Wellcome Trust, The Commonwealth Scholarship Commission in the United Kingdom, and the Biotechnology and Biological Research Council (U.K.). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2005, CCP4 NEWSL, V42; Archer TK, 2008, EXPERT OPIN THER TAR, V12, P1457, DOI [10.1517/14728222.12.10.1301 , 10.1517/14728220802384047, 10.1517/14728222.12.11.1457 , 10.1517/14728220802384013]; Bleijlevens B, 2008, EMBO REP, V9, P872, DOI 10.1038/embor.2008.120; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chowdhury R, 2008, CHEM SOC REV, V37, P1308, DOI 10.1039/b701676j; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flashman E, 2008, J BIOL CHEM, V283, P3808, DOI 10.1074/jbc.M707411200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hamada S, 2010, J MED CHEM, V53, P5629, DOI 10.1021/jm1003655; Hamada S, 2009, BIOORG MED CHEM LETT, V19, P2852, DOI 10.1016/j.bmcl.2009.03.098; Hewitson KS, 2008, J BIOL CHEM, V283, P25971, DOI 10.1074/jbc.M804999200; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lizcano JM, 2000, ANAL BIOCHEM, V286, P75, DOI 10.1006/abio.2000.4782; MAJAMAA K, 1985, BIOCHEM J, V229, P127, DOI 10.1042/bj2290127; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Moon H, 2010, MOL CELLS, V29, P471, DOI 10.1007/s10059-010-0058-3; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Ng SS, 2009, CELL MOL LIFE SCI, V66, P407, DOI 10.1007/s00018-008-8303-z; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; POWELL H, 2007, CCP4 NEWSLETTER PROT; Rose NR, 2008, J MED CHEM, V51, P7053, DOI 10.1021/jm800936s; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sakurai M, 2010, MOL BIOSYST, V6, P357, DOI 10.1039/b912993f; Sekirnik R, 2009, CHEM COMMUN, P6376, DOI 10.1039/b916357c; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Smirnova NA, 2010, CHEM BIOL, V17, P380, DOI 10.1016/j.chembiol.2010.03.008; Stubbs CJ, 2009, J MED CHEM, V52, P2799, DOI 10.1021/jm900285r; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; TSCHANK G, 1991, BIOCHEM J, V275, P469, DOI 10.1042/bj2750469; Warshakoon NC, 2006, BIOORG MED CHEM LETT, V16, P5517, DOI 10.1016/j.bmcl.2006.08.040; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004	48	167	175	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15535	10.1371/journal.pone.0015535	http://dx.doi.org/10.1371/journal.pone.0015535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124847	Green Submitted, Green Published, gold			2022-12-25	WOS:000284527900023
J	Usenik, A; Legisa, M				Usenik, Aleksandra; Legisa, Matic			Evolution of Allosteric Citrate Binding Sites on 6-phosphofructo-1-kinase	PLOS ONE			English	Article							MUSCLE PHOSPHOFRUCTOKINASE; REGULATORY PROPERTIES; ASPERGILLUS-NIGER; GROWTH; GLYCOLYSIS; FLUX; PHOSPHOFRUCTO-1-KINASE; PURIFICATION; QUANTITATION; INHIBITION	As an important part of metabolism, metabolic flux through the glycolytic pathway is tightly regulated. The most complex control is exerted on 6-phosphofructo-1-kinase (PFK1) level; this control overrules the regulatory role of other allosteric enzymes. Among other effectors, citrate has been reported to play a vital role in the suppression of this enzyme's activity. In eukaryotes, amino acid residues forming the allosteric binding site for citrate are found both on the N- and the C-terminal region of the enzyme. These site has evolved from the phosphoenolpyruvate/ADP binding site of bacterial PFK1 due to the processes of duplication and tandem fusion of prokaryotic ancestor gene followed by the divergence of the catalytic and effector binding sites. Stricter inhibition of the PFK1 enzyme was needed during the evolution of multi-cellular organisms, and the most stringent control of PFK1 by citrate occurs in vertebrates. By substituting a single amino acid (K557R or K617A) as a component of the allosteric binding site in the C-terminal region of human muscle type PFK-M with a residue found in the corresponding site of a fungal enzyme, the inhibitory effect of citrate was attenuated. Moreover, the proteins carrying these single mutations enabled growth of E. coli transformants encoding mutated human PFK-M in a glucose-containing medium that did not support the growth of E. coli transformed with native human PFK-M. Substitution of another residue at the citrate-binding site (D591V) of human PFK-M resulted in the complete loss of activity. Detailed analyses revealed that the mutated PFK-M subunits formed dimers but were unable to associate into the active tetrameric holoenzyme. These results suggest that stricter control over glycolytic flux developed in metazoans, whose somatic cells are largely characterized by slow proliferation.	[Usenik, Aleksandra; Legisa, Matic] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Usenik, A (corresponding author), Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia.	matic.legisa@ki.si		Usenik, Aleksandra/0000-0003-2366-2886	Slovenian Research Agency [1000-05-310165]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This research was funded by the Slovenian Research Agency (Contract No. 1000-05-310165; http://www.arrs.gov.si/sl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgstaller W, 2006, MICROBIOL-SGM, V152, P887, DOI 10.1099/mic.0.28454-0; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-59; DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Ferreras C, 2009, J BIOL CHEM, V284, P9124, DOI 10.1074/jbc.M807737200; HABISON A, 1983, BIOCHEM J, V209, P669, DOI 10.1042/bj2090669; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; KEMP RG, 1983, MOL CELL BIOCHEM, V57, P147, DOI 10.1007/BF00849191; Kemp RG, 2002, BIOCHEMISTRY-US, V41, P9426, DOI 10.1021/bi020110d; KEMP RG, 1987, BIOCHEMISTRY-US, V26, P3443, DOI 10.1021/bi00386a029; Li YL, 1999, BIOCHEMISTRY-US, V38, P16407, DOI 10.1021/bi991761l; Lovingshimer MR, 2006, PROTEIN EXPRES PURIF, V46, P475, DOI 10.1016/j.pep.2005.09.015; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Martinez-Oyanedel J, 2007, J MOL BIOL, V366, P1185, DOI 10.1016/j.jmb.2006.10.019; MERTENS E, 1991, FEBS LETT, V285, P1, DOI 10.1016/0014-5793(91)80711-B; Mlakar T, 2006, APPL ENVIRON MICROB, V72, P4515, DOI 10.1128/AEM.00539-06; NEWSHOLME EA, 1977, BIOCHEM J, V166, P123, DOI 10.1042/bj1660123; Paricharttanakul NM, 2005, BIOCHEMISTRY-US, V44, P15280, DOI 10.1021/bi051283g; PETERS SJ, 1995, J APPL PHYSIOL, V78, P1853, DOI 10.1152/jappl.1995.78.5.1853; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; Ruijter GJG, 1997, BBA-GEN SUBJECTS, V1334, P317, DOI 10.1016/S0304-4165(96)00110-9; SAMBROOK J, 2001, MOL CLONING LABOLATO; STAAL GEJ, 1987, CANCER RES, V47, P5047; Suarez RK, 1997, P NATL ACAD SCI USA, V94, P7065, DOI 10.1073/pnas.94.13.7065; Swiegers JH, 2006, CURR GENET, V50, P161, DOI 10.1007/s00294-006-0084-z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VORA S, 1985, BIOCHEM J, V229, P333, DOI 10.1042/bj2290333; YAMASAKI T, 1991, GENE, V104, P277, DOI 10.1016/0378-1119(91)90262-A	34	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15447	10.1371/journal.pone.0015447	http://dx.doi.org/10.1371/journal.pone.0015447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124851	gold, Green Published, Green Submitted			2022-12-25	WOS:000284527900019
J	Waseh, S; Hanifi-Moghaddam, P; Coleman, R; Masotti, M; Ryan, S; Foss, M; MacKenzie, R; Henry, M; Szymanski, CM; Tanha, J				Waseh, Shakeeba; Hanifi-Moghaddam, Pejman; Coleman, Russell; Masotti, Michael; Ryan, Shannon; Foss, Mary; MacKenzie, Roger; Henry, Matthew; Szymanski, Christine M.; Tanha, Jamshid			Orally Administered P22 Phage Tailspike Protein Reduces Salmonella Colonization in Chickens: Prospects of a Novel Therapy against Bacterial Infections	PLOS ONE			English	Article							HEAD-BINDING DOMAIN; O-ANTIGEN; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; IN-VITRO; GASTROINTESTINAL-TRACT; CLOSTRIDIUM-DIFFICILE; BACTERIOPHAGE THERAPY; PASSIVE-IMMUNIZATION; INTESTINAL-DISEASES	One of the major causes of morbidity and mortality in man and economically important animals is bacterial infections of the gastrointestinal (GI) tract. The emergence of difficult-to-treat infections, primarily caused by antibiotic resistant bacteria, demands for alternatives to antibiotic therapy. Currently, one of the emerging therapeutic alternatives is the use of lytic bacteriophages. In an effort to exploit the target specificity and therapeutic potential of bacteriophages, we examined the utility of bacteriophage tailspike proteins (Tsps). Among the best-characterized Tsps is that from the Podoviridae P22 bacteriophage, which recognizes the lipopolysaccharides of Salmonella enterica serovar Typhimurium. In this study, we utilized a truncated, functionally equivalent version of the P22 tailspike protein, P22sTsp, as a prototype to demonstrate the therapeutic potential of Tsps in the GI tract of chickens. Bacterial agglutination assays showed that P22sTsp was capable of agglutinating S. Typhimurium at levels similar to antibodies and incubating the Tsp with chicken GI fluids showed no proteolytic activity against the Tsp. Testing P22sTsp against the three major GI proteases showed that P22sTsp was resistant to trypsin and partially to chymotrypsin, but sensitive to pepsin. However, in formulated form for oral administration, P22sTsp was resistant to all three proteases. When administered orally to chickens, P22sTsp significantly reduced Salmonella colonization in the gut and its further penetration into internal organs. In in vitro assays, P22sTsp effectively retarded Salmonella motility, a factor implicated in bacterial colonization and invasion, suggesting that the in vivo decolonization ability of P22sTsp may, at least in part, be due to its ability to interfere with motility... Our findings show promise in terms of opening novel Tsp-based oral therapeutic approaches against bacterial infections in production animals and potentially in humans.	[Waseh, Shakeeba; Hanifi-Moghaddam, Pejman; Coleman, Russell; Masotti, Michael; Ryan, Shannon; Foss, Mary; MacKenzie, Roger; Szymanski, Christine M.; Tanha, Jamshid] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [MacKenzie, Roger; Tanha, Jamshid] Univ Guelph, Dept Environm Biol, Ontario Agr Coll, Guelph, ON N1G 2W1, Canada; [Henry, Matthew] Dow AgroSci, Dept Discovery Res, Indianapolis, IN USA; [Tanha, Jamshid] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	National Research Council Canada; University of Guelph; Dow Chemical Company; University of Ottawa	Waseh, S (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	cszymans@ualberta.ca; jamshid.tanha@nrc-cnrc.gc.ca			National Research Council of Canada; Dow AgroSciences Inc.	National Research Council of Canada; Dow AgroSciences Inc.	The financial support for this work was provided by National Research Council of Canada and Dow AgroSciences Inc. and resulted in a patent which is co-owned by both organizations. The funders played a role in study design and data collection and analysis.	Alisky J, 1998, J INFECTION, V36, P5, DOI 10.1016/S0163-4453(98)92874-2; Atterbury RJ, 2007, APPL ENVIRON MICROB, V73, P4543, DOI 10.1128/AEM.00049-07; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Barbirz S, 2009, MACROMOL BIOSCI, V9, P169, DOI 10.1002/mabi.200800278; Barrow P, 1998, CLIN DIAGN LAB IMMUN, V5, P294, DOI 10.1128/CDLI.5.3.294-298.1998; BARROW PA, 1994, INFECT IMMUN, V62, P4602, DOI 10.1128/IAI.62.10.4602-4610.1994; Barrow PA, 1997, TRENDS MICROBIOL, V5, P268, DOI 10.1016/S0966-842X(97)01054-8; Baxa U, 1996, BIOPHYS J, V71, P2040, DOI 10.1016/S0006-3495(96)79402-X; BERCHIERI A, 1991, RES MICROBIOL, V142, P541, DOI 10.1016/0923-2508(91)90187-F; Bjerrum L, 2005, AVIAN DIS, V49, P9, DOI 10.1637/7223-061504R; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; BRYAN FL, 1995, J FOOD PROTECT, V58, P326, DOI 10.4315/0362-028X-58.3.326; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carroll P, 2004, VET MICROBIOL, V102, P73, DOI 10.1016/j.vetmic.2004.05.003; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; CHEN BL, 1991, BIOCHEMISTRY-US, V30, P6260, DOI 10.1021/bi00239a026; Clark JR, 2006, TRENDS BIOTECHNOL, V24, P212, DOI 10.1016/j.tibtech.2006.03.003; CRAVEN SE, 1993, AVIAN DIS, V37, P339, DOI 10.2307/1591657; CRAVEN SE, 1994, AVIAN DIS, V38, P401, DOI 10.2307/1592059; DANNER M, 1993, EUR J BIOCHEM, V215, P653, DOI 10.1111/j.1432-1033.1993.tb18076.x; de Geus B, 1998, VET QUART, V20, pS87; DUCHETSUCHAUX M, 1992, INFECT IMMUN, V60, P2828, DOI 10.1128/IAI.60.7.2828-2834.1992; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Forbes SJ, 2008, INFECT IMMUN, V76, P4137, DOI 10.1128/IAI.00416-08; Freiberg A, 2003, J BIOL CHEM, V278, P1542, DOI 10.1074/jbc.M205294200; Harmsen MM, 2005, VET MICROBIOL, V111, P89, DOI 10.1016/j.vetmic.2005.09.005; Huff WE, 2006, POULTRY SCI, V85, P1373, DOI 10.1093/ps/85.8.1373; ISRAEL JV, 1967, P NATL ACAD SCI USA, V57, P284, DOI 10.1073/pnas.57.2.284; ISRAEL V, 1978, J GEN VIROL, V40, P669, DOI 10.1099/0022-1317-40-3-669; IWASHITA S, 1976, EUR J BIOCHEM, V65, P87, DOI 10.1111/j.1432-1033.1976.tb10392.x; Kaiser MG, 2001, POULTRY SCI, V80, P1105, DOI 10.1093/ps/80.8.1105; Khan MI, 2003, J APPL MICROBIOL, V95, P142, DOI 10.1046/j.1365-2672.2003.01953.x; Kramer J, 2001, VET IMMUNOL IMMUNOP, V79, P219, DOI 10.1016/S0165-2427(01)00261-6; Kreisberg JF, 2002, PROTEIN SCI, V11, P820, DOI 10.1110/ps.3440102; Kropinski Andrew M, 2006, Can J Infect Dis Med Microbiol, V17, P297; Kurtz CB, 2001, ANTIMICROB AGENTS CH, V45, P2340, DOI 10.1128/AAC.45.8.2340-2347.2001; LYERLY DM, 1991, INFECT IMMUN, V59, P2215, DOI 10.1128/IAI.59.6.2215-2218.1991; MA JKC, 1990, INFECT IMMUN, V58, P3407, DOI 10.1128/IAI.58.10.3407-3414.1990; Marco ML, 2006, CURR OPIN BIOTECH, V17, P204, DOI 10.1016/j.copbio.2006.02.005; Marcos LA, 2007, J INFECTION, V55, P385, DOI 10.1016/j.jinf.2007.07.016; Miller S, 1998, PROTEIN SCI, V7, P2223, DOI 10.1002/pro.5560071021; Morgavi DP, 2000, ENZYME MICROB TECH, V26, P171, DOI 10.1016/S0141-0229(99)00133-7; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; NEVOLA JJ, 1985, INFECT IMMUN, V50, P152, DOI 10.1128/IAI.50.1.152-159.1985; Northrop JH, 1920, J GEN PHYSIOL, V2, P465, DOI 10.1085/jgp.2.5.465; Oliveira A, 2009, BRIT POULTRY SCI, V50, P558, DOI 10.1080/00071660903141013; Parisien A, 2008, J APPL MICROBIOL, V104, P1, DOI 10.1111/j.1365-2672.2007.03498.x; Ryan S, 2009, BIOCONJUGATE CHEM, V20, P1966, DOI 10.1021/bc900332r; SCHMIDT P, 1989, J VET MED B, V36, P619, DOI 10.1111/j.1439-0450.1989.tb00653.x; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; SHIMIZU M, 1993, BIOSCI BIOTECH BIOCH, V57, P1445, DOI 10.1271/bbb.57.1445; SIGURSKJOLD BW, 1991, EUR J BIOCHEM, V197, P239, DOI 10.1111/j.1432-1033.1991.tb15904.x; SIITONEN A, 1992, INFECT IMMUN, V60, P3918, DOI 10.1128/IAI.60.9.3918-3920.1992; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; Steinbacher S, 1997, BIOL CHEM, V378, P337, DOI 10.1515/bchm.1997.378.3-4.337; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Walter M, 2008, J VIROL, V82, P2265, DOI 10.1128/JVI.01641-07; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; WIEDEMANN V, 1990, J VET MED B, V37, P163, DOI 10.1111/j.1439-0450.1990.tb01041.x; Worledge KL, 2000, DIGEST DIS SCI, V45, P2298, DOI 10.1023/A:1005554900286	65	72	77	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e13904	10.1371/journal.pone.0013904	http://dx.doi.org/10.1371/journal.pone.0013904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124920	Green Published, Green Submitted, gold			2022-12-25	WOS:000284467200001
J	Zhang, J; Yan, H; Wu, YP; Li, C; Zhang, GY				Zhang, Jia; Yan, Hui; Wu, Yong-Ping; Li, Chong; Zhang, Guang-Yi			Activation of GluR6-containing Kainate Receptors Induces Ubiquitin- dependent Bcl-2 Degradation via Denitrosylation in the Rat Hippocampus after Kainate Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN S-NITROSYLATION; NF-KAPPA-B; NITRIC-OXIDE; CEREBRAL-ISCHEMIA; SIGNALING PATHWAY; INDUCED APOPTOSIS; BAX; INHIBITION; PROTEASOME; DOMAIN	We previously showed that Bcl-2 (B-cell lymphoma 2) is down-regulated in a kainate (KA)-induced rat epileptic seizure model. The underlying mechanism had remained largely unknown, but we here report for the first time that denitrosylation and ubiquitination are involved. Our results show that the S-nitrosylation levels of Bcl-2 are down-regulated after KA injection and that the GluR6 (glutamate receptor 6) antagonist NS102 can inhibit the denitrosylation of Bcl-2. Moreover, the ubiquitin-dependent degradation of Bcl-2 was found to be promoted after KA treatment, which could be suppressed by the proteasome inhibitor MG132 and the NO donors, sodium nitroprusside and S-nitrosoglutathione. In addition, experiments based on siRNA transfections were performed in the human SH-SY5Y neuroblastoma cell line to verify that the stability of Bcl-2 is causal to neuronal survival. At the same time, it was found that the exogenous NO donor GSNO could protect neurons when Bcl-2 is targeted. Subsequently, these mechanisms were morphologically validated by immunohistochemistry, cresyl violet staining, and in situ TUNEL staining to analyze the expression of Bcl-2 as well as the survival of CA1 and CA3/DG pyramidal neurons. NS102, GSNO, sodium nitroprusside, and MG132 contribute to the survival of CA1 and CA3/DG pyramidal neurons by attenuating Bcl-2 denitrosylation. Taken together, our data reveal that Bcl-2 ubiquitin-dependent degradation is induced by Bcl-2 denitrosylation during neuronal apoptosis after KA treatment.	[Zhang, Jia; Yan, Hui; Li, Chong; Zhang, Guang-Yi] Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221002, Jiangsu, Peoples R China; [Wu, Yong-Ping] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221002, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Zhang, GY (corresponding author), Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221002, Jiangsu, Peoples R China.	gyzhang@xzmc.edu.cn		Yan, Hui/0000-0002-6990-2526	National Natural Science Foundation of China [30870543]; Education Departmental Nature Science Funds of Jiangsu Province of China [09KJB310015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Departmental Nature Science Funds of Jiangsu Province of China	This work was supported by Project Grant 30870543 from the National Natural Science Foundation of China and Education Departmental Nature Science Funds of Jiangsu Province of China (09KJB310015).	Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Baliga BC, 2002, HEMATOL ONCOL, V20, P63, DOI 10.1002/hon.685; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bentires-Alj M, 2001, ONCOGENE, V20, P2805, DOI 10.1038/sj.onc.1204343; Bloss EB, 2010, VITAM HORM, V82, P167, DOI 10.1016/S0083-6729(10)82009-6; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; CARDOZO C, 1993, ENZYME PROTEIN, V47, P296, DOI 10.1159/000468687; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chvanov M, 2006, EMBO J, V25, P3024, DOI 10.1038/sj.emboj.7601207; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Genovese T, 2007, SHOCK, V27, P258, DOI 10.1097/01.shk.0000239775.41022.54; Glasgow JN, 2001, NEUROCHEM RES, V26, P647, DOI 10.1023/A:1010987220034; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hirotani M, 1999, J BIOL CHEM, V274, P20415, DOI 10.1074/jbc.274.29.20415; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Li C, 2010, EPILEPSIA, V51, P391, DOI 10.1111/j.1528-1167.2009.02270.x; Li DC, 2004, CANCER SCI, V95, P644, DOI 10.1111/j.1349-7006.2004.tb03323.x; Li T, 2008, FEBS LETT, V582, P1894, DOI 10.1016/j.febslet.2008.05.009; Liu XM, 2006, J BIOL CHEM, V281, P17432, DOI 10.1074/jbc.M513490200; Lutz RJ, 2000, BIOCHEM SOC T, V28, P51, DOI 10.1042/bst0280051; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Mitchell KO, 2000, CANCER RES, V60, P6318; Pei DS, 2008, J NEUROCHEM, V106, P1952, DOI 10.1111/j.1471-4159.2008.05531.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tannenbaum SR, 2005, NAT CHEM BIOL, V1, P126, DOI 10.1038/nchembio0805-126; Tian H, 2005, BRAIN RES, V1061, P57, DOI 10.1016/j.brainres.2005.09.001; Wei L, 2004, BRAIN RES, V1022, P54, DOI 10.1016/j.brainres.2004.06.080; Yang YL, 2003, FASEB J, V17, P790, DOI 10.1096/fj.02-0654rev; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	37	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7669	7680		10.1074/jbc.M110.156299	http://dx.doi.org/10.1074/jbc.M110.156299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21148565	Green Published, hybrid			2022-12-25	WOS:000287737300080
J	Morris, MR; Ricketts, CJ; Gentle, D; McRonald, F; Carli, N; Khalili, H; Brown, M; Kishida, T; Yao, M; Banks, RE; Clarke, N; Latif, F; Maher, ER				Morris, M. R.; Ricketts, C. J.; Gentle, D.; McRonald, F.; Carli, N.; Khalili, H.; Brown, M.; Kishida, T.; Yao, M.; Banks, R. E.; Clarke, N.; Latif, F.; Maher, E. R.			Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma	ONCOGENE			English	Article						renal cell carcinoma; methylation; epigenetics	CLEAR-CELL; PROMOTER HYPERMETHYLATION; DNA METHYLATION; ABERRANT METHYLATION; GLUTAMINYL CYCLASE; TARGETED THERAPIES; KIDNEY CANCER; EXPRESSION; DISEASE; ESOPHAGEAL	The detection of promoter region hypermethylation and transcriptional silencing has facilitated the identification of candidate renal cell carcinoma (RCC) tumour suppressor genes (TSGs). We have used a genome-wide strategy (methylated DNA immunoprecipitation (MeDIP) and whole-genome array analysis in combination with high-density expression array analysis) to identify genes that are frequently methylated and silenced in RCC. MeDIP analysis on 9 RCC tumours and 3 non-malignant normal kidney tissue samples was performed, and an initial short-list of 56 candidate genes that were methylated by array analysis was further investigated; 9 genes were confirmed to show frequent promoter region methylation in primary RCC tumour samples (KLHL35 (39%), QPCT (19%), SCUBE3 (19%), ZSCAN18 (32%), CCDC8 (35%), FBN2 (34%), ATP5G2 (36%), PCDH8 (58%) and CORO6 (22%)). RNAi knockdown for KLHL35, QPCT, SCUBE3, ZSCAN18, CCDC8 and FBN2 resulted in an anchorage-independent growth advantage. Tumour methylation of SCUBE3 was associated with a significantly increased risk of cancer death or relapse (P = 0.0046). The identification of candidate epigenetically inactivated RCC TSGs provides new insights into renal tumourigenesis. Oncogene (2011) 30, 1390-1401; doi:10.1038/onc.2010.525; published online 6 December 2010	[Maher, E. R.] Univ Birmingham, Inst Biomed Res W, Dept Med & Mol Genet, Sch Clin & Expt Med,Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Morris, M. R.; Ricketts, C. J.; Gentle, D.; McRonald, F.; Latif, F.; Maher, E. R.] Univ Birmingham, Canc Res UK Renal Mol Oncol Grp, Birmingham B15 2TT, W Midlands, England; [Morris, M. R.; Ricketts, C. J.; Gentle, D.; Latif, F.; Maher, E. R.] Univ Birmingham, Ctr Rare Dis & Personalised Med, Birmingham B15 2TT, W Midlands, England; [Brown, M.; Clarke, N.] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England; [Kishida, T.; Yao, M.] Yokohama City Univ, Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan; [Banks, R. E.] St James Univ Hosp, Leeds Inst Mol Med, Canc Res UK Clin Ctr, Leeds, W Yorkshire, England; [Maher, E. R.] Birmingham Womens Hosp, W Midlands Region Genet Serv, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; Paterson Institute for Cancer Research; University of Manchester; Yokohama City University; Cancer Research UK; Saint James's University Hospital; University of Leeds; Birmingham Women's Hospital	Maher, ER (corresponding author), Univ Birmingham, Inst Biomed Res W, Dept Med & Mol Genet, Sch Clin & Expt Med,Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.	E.R.Maher@bham.ac.uk	Ricketts, Christopher/AAV-9580-2020; Brown, Mick D/N-6521-2015; Morris, Mark/C-6413-2008; MAHER, EAMONN R/A-9507-2008; Brown, Mick/A-1308-2012	Brown, Mick D/0000-0003-1322-4671; MAHER, EAMONN R/0000-0002-6226-6918; Clarke, Noel/0000-0001-7776-8059; McRonald, Fiona/0000-0001-7226-9461; Morris, Mark/0000-0002-0700-355X; Banks, Rosamonde/0000-0002-0042-8715	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank Cancer Research UK for financial support.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Battagli C, 2003, CANCER RES, V63, P8695; Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Breault JE, 2005, CLIN CANCER RES, V11, P557; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chen H, 2005, LUNG CANCER, V50, P43, DOI 10.1016/j.lungcan.2005.04.013; Chowdhury S, 2008, EUR J CANCER, V44, P2152, DOI 10.1016/j.ejca.2008.06.028; Christoph F, 2006, CLIN CANCER RES, V12, P5040, DOI 10.1158/1078-0432.CCR-06-0144; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; Costa LJ, 2007, ONCOLOGIST, V12, P1404, DOI 10.1634/theoncologist.12-12-1404; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; DYER MR, 1993, BIOCHEM J, V293, P51, DOI 10.1042/bj2930051; FISCHER WH, 1987, P NATL ACAD SCI USA, V84, P3628, DOI 10.1073/pnas.84.11.3628; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hogg RP, 2002, EUR J CANCER, V38, P1585, DOI 10.1016/S0959-8049(01)00422-1; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Imoto I, 2006, CANCER RES, V66, P4617, DOI 10.1158/0008-5472.CAN-05-4437; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Leshchenko VV, 2010, BLOOD, V116, P1025, DOI 10.1182/blood-2009-12-257485; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Morris MR, 2008, BRIT J CANCER, V98, P496, DOI 10.1038/sj.bjc.6604180; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Morris MR, 2005, CANCER RES, V65, P4598, DOI 10.1158/0008-5472.CAN-04-3371; Morris MR, 2004, J CLIN PATHOL, V57, P706, DOI 10.1136/jcp.2003.011767; Morris MR, 2003, ONCOGENE, V22, P6794, DOI 10.1038/sj.onc.1206914; Morrissey C, 2001, CANCER RES, V61, P7277; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063; Pflug BR, 2007, CANCER LETT, V246, P139, DOI 10.1016/j.canlet.2006.02.007; POHL T, 1991, P NATL ACAD SCI USA, V88, P10059, DOI 10.1073/pnas.88.22.10059; Ricketts C, 2008, J NATL CANCER I, V100, P1260, DOI 10.1093/jnci/djn254; Roadcap David W., 2008, V48, P124, DOI 10.1007/978-0-387-09595-0_12; Robinson PN, 2000, J MED GENET, V37, P9, DOI 10.1136/jmg.37.1.9; Sato N, 2003, CANCER RES, V63, P3735; Thouennon E, 2007, J CLIN ENDOCR METAB, V92, P4865, DOI 10.1210/jc.2007-1253; Tsunoda S, 2009, ONCOL REP, V21, P1067, DOI 10.3892/or_00000325; Urakami S, 2006, CLIN CANCER RES, V12, P6989, DOI 10.1158/1078-0432.CCR-06-1194; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yamada D, 2006, INT J CANCER, V118, P916, DOI 10.1002/ijc.21450; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	51	144	155	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	12					1390	1401		10.1038/onc.2010.525	http://dx.doi.org/10.1038/onc.2010.525			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	739UM	21132003	Green Published			2022-12-25	WOS:000288743800002
J	Benjamin, JJR; Poon, PP; Lewis, SM; Auger, A; Wong, TA; Singer, RA; Johnston, GC				Benjamin, Jeremy J. R.; Poon, Pak P.; Lewis, Stephen M.; Auger, Andreanne; Wong, Tania A.; Singer, Richard A.; Johnston, Gerald C.			The Yeast Arf GTPase-activating Protein Age1 Is Regulated by Phospholipase D for Post-Golgi Vesicular Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; SACCHAROMYCES-CEREVISIAE; SHUTTLE VECTORS; RETRIEVAL; BINDING; FAMILY; GCS1; COATOMER; VESICLES; SUBUNIT	Vesicular transport shuttles cargo among intracellular compartments. Several stages of vesicular transport are mediated by the small GTPase Arf, which is controlled in a cycle of GTP binding and hydrolysis by Arf guanine-nucleotide exchange factors and Arf GTPase-activating proteins (ArfGAPs), respectively. In budding yeast the Age2 + Gcs1 ArfGAP pair facilitates post-Golgi transport. We have found the AGE1 gene, encoding another ArfGAP, can in high gene-copy number alleviate the temperature sensitivity of cells carrying mutations affecting the Age2 + Gcs1 ArfGAP pair. Moreover, increased AGE1 gene dosage compensates for the complete absence of the otherwise essential Age2 + Gcs1 ArfGAP pair. Increased dosage of SFH2, encoding a phosphatidylinositol transfer protein, also allows cell growth in the absence of the Age2 + Gcs1 pair, but good growth in this situation requires Age1. The ability of Age1 to overcome the need for Age2 + Gcs1 depends on phospholipase D activity that regulates lipid composition. We show by direct assessment of Age1 ArfGAP activity that Age1 is regulated by lipid composition and can provide ArfGAP function for post-Golgi transport.	[Johnston, Gerald C.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; [Poon, Pak P.; Auger, Andreanne; Singer, Richard A.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	Dalhousie University; Dalhousie University	Johnston, GC (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada.	g.c.johnston@dal.ca	Lewis, Stephen/E-5533-2010	Lewis, Stephen/0000-0001-9537-5822	Canadian Institutes of Health Research [MOP-64293]; Beatrice Hunter Cancer Research Institute; The Terry Fox Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Beatrice Hunter Cancer Research Institute; The Terry Fox Foundation	This work was supported by Grant MOP-64293 from the Canadian Institutes of Health Research (to G.C.J. and R.A.S.).; Supported by a trainee award from The Beatrice Hunter Cancer Research Institute with funds provided by The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at Canadian Institutes of Health Research.	Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; ARCHAMBAULT J, 1992, MOL GEN GENET, V232, P408, DOI 10.1007/BF00266244; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Connolly JE, 2006, EUKARYOT CELL, V5, P112, DOI 10.1128/EC.5.1.112-124.2006; Corda D, 2002, CELL MOL LIFE SCI, V59, P1819, DOI 10.1007/PL00012508; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Fernandez-Ulibarri I, 2007, MOL BIOL CELL, V18, P3250, DOI 10.1091/mbc.E07-04-0334; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; HAUN RS, 1993, J BIOL CHEM, V268, P7064; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Huber I, 2001, METHOD ENZYMOL, V329, P307; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Li XM, 2000, MOL BIOL CELL, V11, P1989, DOI 10.1091/mbc.11.6.1989; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Routt SM, 2005, TRAFFIC, V6, P1157, DOI 10.1111/j.1600-0854.2005.00350.x; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SIKORSKI RS, 1989, GENETICS, V122, P19; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; STEARNS T, 1990, MOL CELL BIOL, V10, P6690, DOI 10.1128/MCB.10.12.6690; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Wong TA, 2005, P NATL ACAD SCI USA, V102, P12777, DOI 10.1073/pnas.0506156102; Yanagisawa LL, 2002, MOL BIOL CELL, V13, P2193, DOI 10.1091/mbc.01-11-0563; Zhang CJ, 2003, YEAST, V20, P315, DOI 10.1002/yea.966; Zhang CJ, 1998, J BIOL CHEM, V273, P19792, DOI 10.1074/jbc.273.31.19792	34	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5187	5196		10.1074/jbc.M110.185108	http://dx.doi.org/10.1074/jbc.M110.185108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135091	Green Published, hybrid			2022-12-25	WOS:000287230600027
J	Cabrera, R; Baez, M; Pereira, HM; Caniuguir, A; Garratt, RC; Babul, J				Cabrera, Ricardo; Baez, Mauricio; Pereira, Humberto M.; Caniuguir, Andres; Garratt, Richard C.; Babul, Jorge			The Crystal Complex of Phosphofructokinase-2 of Escherichia coli with Fructose-6-phosphate KINETIC AND STRUCTURAL ANALYSIS OF THE ALLOSTERIC ATP INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLOGRAPHIC STRUCTURE; REGULATORY PROPERTIES; DOMAIN MOTIONS; BINDING; MECHANISM; KINASE; AGGREGATION; TRANSITIONS; MUTAGENESIS; PHOSPHATE	Substrate inhibition by ATP is a regulatory feature of the phosphofructokinases isoenzymes from Escherichia coli (Pfk-1 and Pfk-2). Under gluconeogenic conditions, the loss of this regulation in Pfk-2 causes substrate cycling of fructose-6-phosphate (fructose-6-P) and futile consumption of ATP delaying growth. In the present work, we have broached the mechanism of ATP-induced inhibition of Pfk-2 from both structural and kinetic perspectives. The crystal structure of Pfk-2 in complex with fructose-6-P is reported to a resolution of 2 angstrom. The comparison of this structure with the previously reported inhibited form of the enzyme suggests a negative interplay between fructose-6-P binding and allosteric binding of MgATP. Initial velocity experiments show a linear increase of the apparent K-0.5 for fructose-6-P and a decrease in the apparent k(cat) as a function of MgATP concentration. These effects occur simultaneously with the induction of a sigmoidal kinetic behavior (n(H) of approximately 2). Differences and resemblances in the patterns of fructose-6-P binding and the mechanism of inhibition are discussed for Pfk-1 and Pfk-2, as an example of evolutionary convergence, because these enzymes do not share a common ancestor.	[Cabrera, Ricardo; Baez, Mauricio; Caniuguir, Andres; Babul, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Pereira, Humberto M.; Garratt, Richard C.] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Sao Paulo, Brazil	Universidad de Chile; Universidade de Sao Paulo	Cabrera, R (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Casilla 653, Santiago, Chile.	ricabrer@uchile.cl	Cabrera, Ricardo/H-8132-2014; garratt, richard c/F-6921-2011; Pereira, Humberto M/J-7824-2016; Inbeqmedi, Inct/I-1929-2013; 4, INCT/H-4499-2013; Baez, Mauricio/H-7517-2013	Pereira, Humberto M/0000-0002-8652-6729; garratt, richard/0000-0002-2016-3179; Cabrera, Ricardo/0000-0002-8896-3172	Comision Nacional de Investigacion Cientifica y Tecnologica, Chile [FONDECYT 1090336]; CEPID; FAPESP; CNPq	Comision Nacional de Investigacion Cientifica y Tecnologica, Chile; CEPID; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Comision Nacional de Investigacion Cientifica y Tecnologica Grant FONDECYT 1090336, Chile, and by funds from the following brazilian institutions: CEPID and INCT programs of FAPESP and CNPq (to R.C.G. and H.M.P.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ATKINSON DE, 1965, J BIOL CHEM, V240, P757; BABUL J, 1978, J BIOL CHEM, V253, P4350; Baez M, 2008, FEBS LETT, V582, P1907, DOI 10.1016/j.febslet.2008.05.011; Baez M, 2007, BIOCHEMISTRY-US, V46, P6141, DOI 10.1021/bi7002247; Baez M, 2009, FEBS LETT, V583, P2054, DOI 10.1016/j.febslet.2009.05.034; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERGER SA, 1992, BIOCHEMISTRY-US, V31, P9237, DOI 10.1021/bi00153a017; BERGER SA, 1991, BIOCHEMISTRY-US, V30, P8477, DOI 10.1021/bi00098a027; Cabrera R, 2003, J BIOL CHEM, V278, P12913, DOI 10.1074/jbc.M212137200; Cabrera R, 2008, J MOL BIOL, V383, P588, DOI 10.1016/j.jmb.2008.08.029; Cabrera R, 2010, ARCH BIOCHEM BIOPHYS, V502, P23, DOI 10.1016/j.abb.2010.06.024; CAMPOS G, 1984, J BIOL CHEM, V259, P6147; Cornish-Bowden A., 2004, FUNDAMENTAL ENZYME K, P88; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1979, NATURE, V279, P500, DOI 10.1038/279500a0; Fenton AW, 2003, BIOCHEMISTRY-US, V42, P12676, DOI 10.1021/bi0349221; Guixe V, 1998, BIOCHEMISTRY-US, V37, P13269, DOI 10.1021/bi980576p; GUIXE V, 1988, ARCH BIOCHEM BIOPHYS, V264, P519, DOI 10.1016/0003-9861(88)90317-7; JOHNSON JL, 1992, BIOCHEMISTRY-US, V31, P11510, DOI 10.1021/bi00161a032; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KOTLARZ D, 1981, EUR J BIOCHEM, V117, P569; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MacRae IJ, 1999, ARCH BIOCHEM BIOPHYS, V361, P277, DOI 10.1006/abbi.1998.0993; Maj MC, 2002, BIOCHEMISTRY-US, V41, P4059, DOI 10.1021/bi0119161; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miallau L, 2007, J BIOL CHEM, V282, P19948, DOI 10.1074/jbc.M701480200; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Parducci RE, 2006, BIOCHEMISTRY-US, V45, P9291, DOI 10.1021/bi060026o; Reinhart GD, 2004, METHOD ENZYMOL, V380, P187; Segel I. H., 1975, ENZYME KINETICS, pxxii; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; Torres JC, 1997, BIOCHEM J, V327, P675; Wang XJ, 2001, BIOCHEMISTRY-US, V40, P3938, DOI 10.1021/bi002709o; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Weber G., 1992, PROTEIN INTERACTIONS, P31; WYMAN J, 1965, J MOL BIOL, V11, P631, DOI 10.1016/S0022-2836(65)80017-1	40	21	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5774	5783		10.1074/jbc.M110.163162	http://dx.doi.org/10.1074/jbc.M110.163162			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21147773	Green Published, hybrid			2022-12-25	WOS:000287230600086
J	Chigaev, A; Wu, Y; Williams, DB; Smagley, Y; Sklar, LA				Chigaev, Alexandre; Wu, Yang; Williams, D. Bart; Smagley, Yelena; Sklar, Larry A.			Discovery of Very Late Antigen-4 (VLA-4, alpha(4)beta(1) Integrin) Allosteric Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; REAL-TIME ANALYSIS; MONOCLONAL-ANTIBODIES; CONFORMATIONAL REGULATION; CHEMOKINE RECEPTOR; ADHESION MOLECULES; CXCR4 ANTAGONIST; STROMAL CELLS; STEM-CELLS; MOBILIZATION	Integrins are cell adhesion receptors that mediate cell-to-cell, or cell-to-extracellular matrix adhesion. They represent an attractive target for treatment of multiple diseases. Two classes of small molecule integrin inhibitors have been developed. Competitive antagonists bind directly to the integrin ligand binding pocket and thus disrupt the ligand-receptor interaction. Allosteric antagonists have been developed primarily for alpha(L)beta(2)-integrin (LFA-1, lymphocyte function-associated antigen-1). Here we present the results of screening the Prestwick Chemical Library using a recently developed assay for the detection of alpha(4)beta(1)-integrin allosteric antagonists. Secondary assays confirmed that the compounds identified: 1) do not behave like competitive (direct) antagonists; 2) decrease ligand binding affinity for VLA-4 similar to 2 orders of magnitude; 3) exhibit antagonistic properties at low temperature. In a cell based adhesion assay in vitro, the compounds rapidly disrupted cellular aggregates. In accord with reports that VLA-4 antagonists in vivo induce mobilization of hematopoietic progenitors into the peripheral blood, we found that administration of one of the compounds significantly increased the number of colony-forming units in mice. This effect was comparable to AMD3100, a well known progenitor mobilizing agent. Because all the identified compounds are structurally related, previously used, or currently marketed drugs, this result opens a range of therapeutic possibilities for VLA-4-related pathologies.	Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Ctr Canc, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Chigaev, A (corresponding author), MSC08 4630,915 Camino Salud, Albuquerque, NM 87131 USA.	achigaev@salud.unm.edu; lsklar@salud.unm.edu	Chigaev, Alexandre/A-3103-2010	Chigaev, Alexandre/0000-0002-7726-638X	National Institutes of Health [U54 MH084690, HL081062]; Leukemia and Lymphoma Society [7388-06]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 MH084690 and HL081062 and the Leukemia and Lymphoma Society Grant 7388-06.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Berger JR, 2006, NEUROL RES, V28, P299, DOI 10.1179/016164106X98198; Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; Bonig H, 2009, STEM CELLS, V27, P836, DOI 10.1002/stem.9; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; CHEDID L, 1954, CR SOC BIOL, V148, P1039; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Chigaev A, 2003, J BIOL CHEM, V278, P38174, DOI 10.1074/jbc.M210472200; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Chigaev A, 2007, J IMMUNOL, V178, P6828, DOI 10.4049/jimmunol.178.11.6828; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; Chigaev A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-26; Coulombel L, 1997, ACTA HAEMATOL-BASEL, V97, P13, DOI 10.1159/000203655; Dijkgraaf I, 2009, FRONT BIOSCI-LANDMRK, V14, P887, DOI 10.2741/3284; Edwards BS, 2000, J IMMUNOL, V165, P404, DOI 10.4049/jimmunol.165.1.404; FIEVE RR, 1966, ARCH GEN PSYCHIAT, V15, P529; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Gazitt Y, 2004, LEUKEMIA, V18, P1, DOI 10.1038/sj.leu.2403173; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Humphries MJ, 2004, BIOCHEM SOC T, V32, P407, DOI 10.1042/BST0320407; Jackson DY, 2002, CURR PHARM DESIGN, V8, P1229, DOI 10.2174/1381612023394737; Johnson JP, 1999, CANCER METAST REV, V18, P345, DOI 10.1023/A:1006304806799; Kenakin T, 2004, MOL INTERV, V4, P222, DOI 10.1124/mi.4.4.6; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; MATTHEWS N, 1995, BIOCHEM PHARMACOL, V50, P1053, DOI 10.1016/0006-2952(95)00240-Z; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Njus BH, 2009, ASSAY DRUG DEV TECHN, V7, P507, DOI 10.1089/adt.2009.0203; Oostendorp RAJ, 1997, LEUKEMIA LYMPHOMA, V24, P423, DOI 10.3109/10428199709055581; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374; Pollmacher T, 2000, J PSYCHIATR RES, V34, P369, DOI 10.1016/S0022-3956(00)00032-7; Ramirez P, 2009, BLOOD, V114, P1340, DOI 10.1182/blood-2008-10-184721; Rigal E, 2009, M S-MED SCI, V25, P1135, DOI 10.1051/medsci/200925121135; ROUDEBUSH RE, 1991, INT J IMMUNOPHARMACO, V13, P961, DOI 10.1016/0192-0561(91)90049-D; Schmidmaier R, 2008, CURR MED CHEM, V15, P978, DOI 10.2174/092986708784049667; Shen WW, 1999, COMPR PSYCHIAT, V40, P407, DOI 10.1016/S0010-440X(99)90082-2; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Sklar LA, 2002, ANNU REV BIOPH BIOM, V31, P97, DOI 10.1146/annurev.biophys.31.082901.134406; Sudeshna G, 2010, EUR J PHARMACOL, V648, P6, DOI 10.1016/j.ejphar.2010.08.045; SURMAN OS, 1993, PSYCHOSOMATICS, V34, P139, DOI 10.1016/S0033-3182(93)71904-0; Thanacoody HKR, 2007, BRIT J CLIN PHARMACO, V64, P566, DOI 10.1111/j.1365-2125.2007.03021.x; Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006; Woodside DG, 2008, BIODRUGS, V22, P85, DOI 10.2165/00063030-200822020-00002; Yoneda T, 2000, J Orthop Sci, V5, P75, DOI 10.1007/s007760050012; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; Zohren F, 2008, BLOOD, V111, P3893, DOI 10.1182/blood-2007-10-120329; Zwartz G, 2004, BIOPHYS J, V86, P1243, DOI 10.1016/S0006-3495(04)74198-3	51	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5455	5463		10.1074/jbc.M110.162636	http://dx.doi.org/10.1074/jbc.M110.162636			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21131351	hybrid, Green Published			2022-12-25	WOS:000287230600054
J	Foster, JD; Vaughan, RA				Foster, James D.; Vaughan, Roxanne A.			Palmitoylation Controls Dopamine Transporter Kinetics, Degradation, and Protein Kinase C-dependent Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; PLASMA-MEMBRANE; MEDIATED PALMITOYLATION; INDUCED TRAFFICKING; TERMINAL RESIDUES; MOLECULAR-CLONING; GABA(A) RECEPTORS; CELL-LINES; ENDOCYTOSIS; SUBSTRATE	Palmitoylation is a lipid modification that confers diverse functions to target proteins and is a contributing factor for many neuronal diseases. In this study, we demonstrate using [H-3] palmitic acid labeling and acyl-biotinyl exchange that native and expressed dopamine transporters (DATs) are palmitoylated, and using the palmitoyl acyltransferase inhibitor 2-bromopalmitate (2BP), we identify several associated functions. Treatment of rat striatal synaptosomes with 2BP using lower doses or shorter times caused robust inhibition of transport V-max that occurred with no losses of DAT protein or changes in DAT surface levels, indicating that acute loss of palmitoylation leads to reduction of transport kinetics. Treatment of synaptosomes or cells with 2BP using higher doses or longer times resulted in DAT protein losses and production of transporter fragments, implicating palmitoylation in regulation of transporter degradation. Site-directed mutagenesis indicated that palmitoylation of rat DAT occurs at Cys-580 at the intracellular end of transmembrane domain 12 and at one or more additional unidentified site(s). Cys-580 mutation also led to production of transporter degradation fragments and to increased phorbol ester-induced down-regulation, further supporting palmitoylation in opposing DAT turnover and in opposing protein kinase C-mediated regulation. These results identify S-palmitoylation as a major regulator of DAT properties that could significantly impact acute and long term dopamine transport capacity.	[Foster, James D.; Vaughan, Roxanne A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA	University of North Dakota Grand Forks	Vaughan, RA (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, 501 N Columbia Rd,Stop 9037, Grand Forks, ND 58202 USA.	rvaughan@medicine.nodak.edu			NIDA, National Institutes of Health [R01 DA13147]; University of North Dakota faculty seed; National Center for Research Resources INBRE Program [P20 RR016741]; University of North Dakota;  [ND EPSCoR IIG]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013147] Funding Source: NIH RePORTER	NIDA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of North Dakota faculty seed; National Center for Research Resources INBRE Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of North Dakota; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA13147 (to R.A.V.) from the NIDA. This work was also supported by Grant ND EPSCoR IIG (to R.A.V. and J.D.F.), a University of North Dakota faculty seed grant (to J.D.F.), and National Center for Research Resources INBRE Program Grant P20 RR016741 (to the University of North Dakota).	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Bannon M. J., 1998, PSYCHOPHARMACOLOGY 4; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P589, DOI 10.1113/jphysiol.1975.sp010949; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Bruss M, 1999, J NEURAL TRANSM, V106, P657, DOI 10.1007/s007020050187; Carneiro AM, 2002, J NEUROSCI, V22, P7045; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gaffaney JD, 2004, MOL PHARMACOL, V65, P692, DOI 10.1124/mol.65.3.692; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1992, MOL PHARMACOL, V42, P383; GU H, 1994, J BIOL CHEM, V269, P7124; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Jackson C. S., 1996, CURRENT PROTOCOLS PR, P141211; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Kahlig KM, 2003, EUR J PHARMACOL, V479, P153, DOI 10.1016/j.ejphar.2003.08.065; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; KIMMICH GA, 1994, AM J PHYSIOL-CELL PH, V267, pC1119; Kobe F, 2008, BBA-MOL CELL RES, V1783, P1503, DOI 10.1016/j.bbamcr.2008.02.021; LEVER JR, 1993, J LABELLED COMPD RAD, V33, P1131, DOI 10.1002/jlcr.2580331207; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Lu JY, 2006, J LIPID RES, V47, P1352, DOI 10.1194/jlr.R600010-JLR200; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Parnas ML, 2008, MOL PHARMACOL, V73, P1141, DOI 10.1124/mol.107.043679; Plasek J, 1996, J PHOTOCH PHOTOBIO B, V33, P101, DOI 10.1016/1011-1344(96)07283-1; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Richards TL, 2009, J NEUROCHEM, V108, P1575, DOI 10.1111/j.1471-4159.2009.05910.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Sotnikova Tatyana D., 2006, CNS & Neurological Disorders-Drug Targets, V5, P45, DOI 10.2174/187152706784111579; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Vaughan RA, 1996, J BIOL CHEM, V271, P21672, DOI 10.1074/jbc.271.35.21672; Vaughan RA, 2005, J NEUROSCI METH, V143, P33, DOI 10.1016/j.jneumeth.2004.09.022; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Woehler A, 2009, GLYCOCONJUGATE J, V26, P749, DOI 10.1007/s10719-008-9187-8; Wu XH, 1999, GENE, V233, P163, DOI 10.1016/S0378-1119(99)00143-2; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zahniser NR, 2009, SEMIN CELL DEV BIOL, V20, P411, DOI 10.1016/j.semcdb.2009.01.004; Zahniser NR, 2004, NEUROPHARMACOLOGY, V47, P80, DOI 10.1016/j.neuropharm.2004.07.010	69	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5175	5186		10.1074/jbc.M110.187872	http://dx.doi.org/10.1074/jbc.M110.187872			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21118819	Green Published, hybrid			2022-12-25	WOS:000287230600026
J	Friis, S; Godiksen, S; Bornholdt, J; Selzer-Plon, J; Rasmussen, HB; Bugge, TH; Lin, CY; Vogel, LK				Friis, Stine; Godiksen, Sine; Bornholdt, Jette; Selzer-Plon, Joanna; Rasmussen, Hanne Borger; Bugge, Thomas H.; Lin, Chen-Yong; Vogel, Lotte K.			Transport via the Transcytotic Pathway Makes Prostasin Available as a Substrate for Matriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR ACTIVATOR INHIBITOR-1; EPIDERMAL BARRIER FUNCTION; PROTEOLYTIC CASCADE; PROTEASE; CHANNEL; PURIFICATION; EXPRESSION; PROTEINS; COMPLEX	The matriptase-prostasin proteolytic cascade is essential for epidermal tight junction formation and terminal epidermal differentiation. This proteolytic pathway may also be operative in a variety of other epithelia, as both matriptase and prostasin are involved in tight junction formation in epithelial monolayers. However, in polarized epithelial cells matriptase is mainly located on the basolateral plasma membrane whereas prostasin is mainly located on the apical plasma membrane. To determine how matriptase and prostasin interact, we mapped the subcellular itinerary of matriptase and prostasin in polarized colonic epithelial cells. We show that zymogen matriptase is activated on the basolateral plasma membrane where it is able to cleave relevant substrates. After activation, matriptase forms a complex with the cognate matriptase inhibitor, hepatocyte growth factor activator inhibitor (HAI)-1 and is efficiently endocytosed. The majority of prostasin is located on the apical plasma membrane albeit a minor fraction of prostasin is present on the basolateral plasma membrane. Basolateral prostasin is endocytosed and transcytosed to the apical plasma membrane where a long retention time causes an accumulation of prostasin. Furthermore, we show that prostasin on the basolateral membrane is activated before it is transcytosed. This study shows that matriptase and prostasin co-localize for a brief period of time at the basolateral plasma membrane after which prostasin is transported to the apical membrane as an active protease. This study suggests a possible explanation for how matriptase or other basolateral serine proteases activate prostasin on its way to its apical destination.	[Vogel, Lotte K.] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Godiksen, Sine] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Rasmussen, Hanne Borger] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Unit, NIH, Bethesda, MD 20892 USA; [Lin, Chen-Yong] Univ Maryland, Dept Biochem & Mol Biol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Maryland; University of Maryland Baltimore	Vogel, LK (corresponding author), Blegdamsvej 3,Bldg 6-4, DK-2200 Copenhagen N, Denmark.	vogel@sund.ku.dk	Rasmussen, Hanne B/N-9652-2016	Rasmussen, Hanne B/0000-0002-2218-5646; Vogel, Lotte K./0000-0001-9920-0982; johnson, Michael/0000-0001-6260-7586	NIDCR; National Institutes of Health [R01-CA-123223]; Harboe Foundation; Augustinus Foundation; Brothers Hartmanns Foundation; A.P. Mollers Foundation for the Advancement of Medical Science; University of Copenhagen; Lundbeck Foundation; NATIONAL CANCER INSTITUTE [R01CA123223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harboe Foundation; Augustinus Foundation; Brothers Hartmanns Foundation; A.P. Mollers Foundation for the Advancement of Medical Science; University of Copenhagen; Lundbeck Foundation(Lundbeckfonden); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the NIDCR Intramural Research Program and by National Institutes of Health Grant R01-CA-123223. This work was also supported by The Harboe Foundation, The Augustinus Foundation, The Brothers Hartmanns Foundation, The A.P. Mollers Foundation for the Advancement of Medical Science, The Cluster of Cell Biology at the University of Copenhagen, and the Lundbeck Foundation.	Alef T, 2009, J INVEST DERMATOL, V129, P862, DOI 10.1038/jid.2008.311; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; BACHER A, 1992, EXP CELL RES, V200, P97, DOI 10.1016/S0014-4827(05)80076-X; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Chen M., 2008, BIOCHIM BIOPHYS ACTA, V1785, P896; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Farkas K., 2010, INFLAMM BOW IN PRESS; Godiksen S, 2008, BIOCHEM J, V413, P251, DOI 10.1042/BJ20071496; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Mauro T, 2002, J INVEST DERMATOL, V118, P589, DOI 10.1046/j.1523-1747.2002.01721.x; Myerburg MM, 2010, AM J RESP CELL MOL, V43, P712, DOI 10.1165/rcmb.2009-0348OC; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Selzer-Plon J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-201; Steensgaard M, 2010, ACTA PHYSIOL, V200, P347, DOI 10.1111/j.1748-1716.2010.02170.x; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; Zeissig S, 2008, GASTROENTEROLOGY, V134, P1436, DOI 10.1053/j.gastro.2008.02.030	34	37	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5793	5802		10.1074/jbc.M110.186874	http://dx.doi.org/10.1074/jbc.M110.186874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148558	Green Published, hybrid			2022-12-25	WOS:000287230600088
J	Janganan, TK; Zhang, L; Bavro, VN; Matak-Vinkovic, D; Barrera, NP; Burton, MF; Steel, PG; Robinson, CV; Borges-Walmsley, MI; Walmsley, AR				Janganan, Thamarai K.; Zhang, Li; Bavro, Vassiliy N.; Matak-Vinkovic, Dijana; Barrera, Nelson P.; Burton, Matthew F.; Steel, Patrick G.; Robinson, Carol V.; Borges-Walmsley, Maria Ines; Walmsley, Adrian R.			Opening of the Outer Membrane Protein Channel in Tripartite Efflux Pumps Is Induced by Interaction with the Membrane Fusion Partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO FITNESS; MULTIDRUG EFFLUX; NEISSERIA-GONORRHOEAE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSPORTER ACRB; SYSTEM; RESISTANCE; TOLC; MECHANISM	The multiple transferable resistance (MTR) pump, from Neisseria gonorrhoeae, is typical of the specialized machinery used to translocate drugs across the inner and outer membranes of Gram-negative bacteria. It consists of a tripartite complex composed of an inner-membrane transporter, MtrD, a periplasmic membrane fusion protein, MtrC, and an outermembrane channel, MtrE. We have expressed the components of the pump in Escherichia coli and used the antibiotic vancomycin, which is too large to cross the outer-membrane by passive diffusion, to test for opening of the MtrE channel. Cells expressing MtrCDE are not susceptible to vancomycin, indicating that the channel is closed; but become susceptible to vancomycin in the presence of transported substrates, consistent with drug-induced opening of the MtrE channel. A mutational analysis identified residues Asn-198, Glu-434, and Gln-441, lining an intraprotomer groove on the surface of MtrE, to be important for pump function; mutation of these residues yielded cells that were sensitive to vancomycin. Pull-down assays and micro-calorimetry measurements indicated that this functional impairment is not due to the inability of MtrC to interact with the MtrE mutants; nor was it due to the MtrE mutants adopting an open conformation, because cells expressing these MtrE mutants alone are relatively insensitive to vancomycin. However, cells expressing the MtrE mutants with MtrC are sensitive to vancomycin, indicating that residues lining the intra-protomer groove control opening of the MtrE channel in response to binding of MtrC.	[Janganan, Thamarai K.; Zhang, Li; Borges-Walmsley, Maria Ines; Walmsley, Adrian R.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Bavro, Vassiliy N.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Matak-Vinkovic, Dijana; Barrera, Nelson P.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Burton, Matthew F.; Steel, Patrick G.] Univ Durham, Dept Chem, Sci Labs, Durham DH1 3LE, England; [Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 3QZ, England; [Robinson, Carol V.] Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	Durham University; University of Oxford; University of Cambridge; Durham University; University of Oxford; University of Oxford	Walmsley, AR (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	a.r.walmsley@durham.ac.uk	Bavro, Vassiliy/I-4846-2019; Janganan, Thamarai/AAQ-8705-2020; Steel, Patrick/G-3187-2012	Bavro, Vassiliy/0000-0003-2330-8924; Steel, Patrick/0000-0002-2493-5826; Barrera, Nelson/0000-0001-7825-1406; robinson, carol/0000-0001-7829-5505	BSAC (British Society for Antimicrobial Chemotherapy); Wellcome Trust; EU; BBSRC	BSAC (British Society for Antimicrobial Chemotherapy); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the BSAC (British Society for Antimicrobial Chemotherapy) and the Wellcome Trust (to M. I. B.-W. and A. R. W.). This work was also supported in part by a Marie Curie Fellowship from the EU (to V. N. B.), the Wellcome Trust (to C. V. R.), and the BBSRC (to N. P. B., D. M.-V., and C. V. R.).	Andersen C, 2002, P NATL ACAD SCI USA, V99, P11103, DOI 10.1073/pnas.162039399; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Augustus AM, 2004, J BACTERIOL, V186, P1851, DOI 10.1128/JB.186.6.1851-1860.2004; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bokma E, 2006, FEBS LETT, V580, P5339, DOI 10.1016/j.febslet.2006.09.005; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Elkins CA, 2003, J BACTERIOL, V185, P5349, DOI 10.1128/JB.185.18.5349-5356.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federici L, 2005, J BIOL CHEM, V280, P15307, DOI 10.1074/jbc.M500401200; HAGMAN KE, 1995, MICROBIOL-SGM, V141, P611, DOI 10.1099/13500872-141-3-611; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Jerse AE, 2003, INFECT IMMUN, V71, P5576, DOI 10.1128/IAI.71.10.5576-5582.2003; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUCAS CE, 1995, MOL MICROBIOL, V16, P1001, DOI 10.1111/j.1365-2958.1995.tb02325.x; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pietras Z, 2008, CURR DRUG TARGETS, V9, P719, DOI 10.2174/138945008785747743; Rouquette C, 1999, MOL MICROBIOL, V33, P651, DOI 10.1046/j.1365-2958.1999.01517.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCUDAMORE RA, 1979, ANTIMICROB AGENTS CH, V15, P820, DOI 10.1128/AAC.15.6.820; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Stegmeier JF, 2006, BIOCHEMISTRY-US, V45, P10303, DOI 10.1021/bi060320g; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Veal WL, 2002, J BACTERIOL, V184, P5619, DOI 10.1128/JB.184.20.5619-5624.2002; Vediyappan G, 2006, J BACTERIOL, V188, P3757, DOI 10.1128/JB.00038-06; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x; Warner DM, 2007, J INFECT DIS, V196, P1804, DOI 10.1086/522964; Weeks JW, 2010, MOL MICROBIOL, V75, P1468, DOI 10.1111/j.1365-2958.2010.07068.x; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457	48	25	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5484	5493		10.1074/jbc.M110.187658	http://dx.doi.org/10.1074/jbc.M110.187658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21115481	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000287230600058
J	Yamamoto, T; Lu, C; Ryan, RO				Yamamoto, Taichi; Lu, Christine; Ryan, Robert O.			A Two-step Binding Model of PCSK9 Interaction with the Low Density Lipoprotein Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; LDL-RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; LIGAND INTERACTIONS; APOLIPOPROTEIN-E; CHOLESTEROL; PH; ANTIBODY; DEGRADATION; DECREASES	PCSK9 (proprotein convertase subtilisin-like/ kexin type 9) is an emerging target for pharmaceutical intervention. This multidomain protein interacts with the LDL receptor (LDLR), promoting receptor degradation. Insofar as PCSK9 inhibition induces a decrease in plasma cholesterol levels, understanding the nature of the binding interaction between PCSK9 and the LDLR is of critical importance. In this study, the ability of PCSK9 to compete with apoE3 N-terminal domain-containing reconstituted HDL for receptor binding was examined. Whereas full-length PCSK9 was an effective competitor, the N-terminal domain (composed of the prodomain and catalytic domain) was not. Surprisingly, the C-terminal domain (CT domain) of PCSK9 was able to compete. Using a direct binding interaction assay, we show that the PCSK9 CT domain bound to the LDLR in a calcium-dependent manner and that co-incubation with the prodomain and catalytic domain had no effect on this binding. To further characterize this interaction, two LDLR fragments, the classical ligand-binding domain (LBD) and the EGF precursor homology domain, were expressed in stably transfected HEK 293 cells and isolated. Binding assays showed that the PCSK9 CT domain bound to the LBD at pH 5.4. Thus, CT domain interaction with the LBD of the LDLR at endosomal pH constitutes a second step in the PCSK9-mediated LDLR binding that leads to receptor degradation.	[Yamamoto, Taichi; Lu, Christine; Ryan, Robert O.] Childrens Hosp Oakland Res Inst, Ctr Prevent Obes Cardiovasc Dis & Diabet, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Ryan, RO (corresponding author), Childrens Hosp Oakland Res Inst, Ctr Prevent Obes Cardiovasc Dis & Diabet, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	rryan@chori.org			National Institutes of Health [HL 64159]; California Tobacco-Related Disease Research Program [17KT-0026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL064159, R01HL064159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Tobacco-Related Disease Research Program(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 64159. This work was also supported by California Tobacco-Related Disease Research Program New Investigator Award 17KT-0026 (to T. Y.).	Bajari TM, 2005, METHODS, V36, P109, DOI 10.1016/j.ymeth.2004.11.007; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Davignon J, 2010, CURR ATHEROSCLER REP, V12, P308, DOI 10.1007/s11883-010-0123-6; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Fisher CA, 1997, BIOCHEM CELL BIOL, V75, P45, DOI 10.1139/bcb-75-1-45; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Raussens V, 1998, J BIOL CHEM, V273, P25825, DOI 10.1074/jbc.273.40.25825; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Weers PMM, 2001, EUR J BIOCHEM, V268, P3728, DOI 10.1046/j.1432-1327.2001.02282.x; Yamamoto T, 2008, BIOCHEMISTRY-US, V47, P11647, DOI 10.1021/bi801117t; Yamamoto T, 2006, J LIPID RES, V47, P1091, DOI 10.1194/jlr.D600001-JLR200; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	27	81	88	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5464	5470		10.1074/jbc.M110.199042	http://dx.doi.org/10.1074/jbc.M110.199042			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149300	Green Published, hybrid			2022-12-25	WOS:000287230600055
J	Acharya, P; Liao, MX; Engel, JC; Correia, MA				Acharya, Poulomi; Liao, Mingxiang; Engel, Juan C.; Correia, Maria Almira			Liver Cytochrome P450 3A Endoplasmic Reticulum-associated Degradation A MAJOR ROLE FOR THE p97 AAA ATPase IN CYTOCHROME P450 3A EXTRACTION INTO THE CYTOSOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; VALOSIN-CONTAINING PROTEIN; MOTILITY FACTOR-RECEPTOR; HMG-COA REDUCTASE; AAA-ATPASE; RAT HEPATOCYTES; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; RETRO-TRANSLOCATION; UBIQUITIN LIGASES	The CYP3A subfamily of hepatic cytochromes P450, being engaged in the metabolism and clearance of > 50% of clinically relevant drugs, can significantly influence therapeutics and drug-drug interactions. Our characterization of CYP3A degradation has indicated that CYPs 3A incur ubiquitin-dependent proteasomal degradation (UPD) in an endoplasmic reticulum (ER)-associated degradation (ERAD) process. Cytochromes P450 are monotopic hemoproteins N-terminally anchored to the ER membrane with their protein bulk readily accessible to the cytosolic proteasome. Given this topology, it was unclear whether they would require the AAA-ATPase p97 chaperone complex that retrotranslocates/dislocates ubiquitinated ER-integral and luminal proteins into the cytosol for proteasomal delivery. To assess the in vivo relevance of this p97-CYP3A association, we used lentiviral shRNAs to silence p97 (80% mRNA and 90% protein knockdown relative to controls) in sandwich-cultured rat hepatocytes. This extensive hepatic p97 knockdown remarkably had no effect on cellular morphology, ER stress, and/or apoptosis, despite the well recognized strategic p97 roles in multiple important cellular processes. However, such hepatic p97 knockdown almost completely abrogated CYP3A extraction into the cytosol, resulting in a significant accumulation of parent and ubiquitinated CYP3A species that were firmly ER-tethered. Little detectable CYP3A accumulated in the cytosol, even after concomitant inhibition of proteasomal degradation, thereby documenting a major role of p97 in CYP3A extraction and delivery to the 26 S proteasome during its UPD/ERAD. Intriguingly, the accumulated parent CYP3A was functionally active, indicating that p97 can regulate physiological CYP3A content and thus influence its clinically relevant function.	[Acharya, Poulomi; Liao, Mingxiang; Correia, Maria Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Acharya, Poulomi; Liao, Mingxiang; Correia, Maria Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Acharya, Poulomi; Liao, Mingxiang; Correia, Maria Almira] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Acharya, Poulomi; Liao, Mingxiang; Correia, Maria Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA; [Engel, Juan C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Engel, Juan C.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Correia, MA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Box 2280,600 16th St, San Francisco, CA 94158 USA.	almira.correia@ucsf.edu			National Institutes of Health [DK26506, GM44037]; NIDDK, National Institutes of Health [P30DK26743]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026506, P30DK026743, R56DK026506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK26506 and GM44037.; We gratefully thank Chris Her (University of California San Francisco (UCSF) Liver Center Cell and Tissue Biology Core Facility) (Dr. J. J. Maher, Director) for hepatocyte isolation and Ahalya Sriskandarajan (UCSF) for able technical assistance in some of these studies. We also thank Dr. Alex Y. So (Keith Yamamoto laboratory, UCSF) for generous advice and training in the use of lentiviral shRNAi technology and Dr. Michelle Flanniken (Raul Andino laboratory, UCSF) for technical advice. We also acknowledge the UCSF Liver Center Core on Cell and Tissue Biology (supported by NIDDK, National Institutes of Health, Grant P30DK26743).	Acharya P, 2010, MOL PHARMACOL, V77, P575, DOI 10.1124/mol.109.061259; Acharya P, 2009, MOL PHARMACOL, V76, P503, DOI 10.1124/mol.109.056002; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Ballar P, 2008, BIOCHEM SOC T, V36, P818, DOI 10.1042/BST0360818; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; BROWN CA, 1989, J BIOL CHEM, V264, P4442; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Chefalo PJ, 1998, EUR J BIOCHEM, V258, P820, DOI 10.1046/j.1432-1327.1998.2580820.x; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Correia MA, 2007, EXPERT OPIN DRUG MET, V3, P33, DOI 10.1517/17425255.3.1.33; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Correia MA, 2003, DRUG METAB REV, V35, P107, DOI 10.1081/DMR-120023683; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; DELEMOSCHIARANDINI C, 1987, J CELL BIOL, V104, P209, DOI 10.1083/jcb.104.2.209; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; EDWARDS RJ, 1991, BIOCHEMISTRY-US, V30, P71, DOI 10.1021/bi00215a011; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Han XM, 2005, J PHARMACOL EXP THER, V314, P128, DOI 10.1124/jpet.105.084699; He K, 1998, BIOCHEMISTRY-US, V37, P17448, DOI 10.1021/bi9808464; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Ikeda Y, 2009, J BIOL CHEM, V284, P34889, DOI 10.1074/jbc.M109.044875; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; KEMPER B, 1989, DRUG METAB REV, V20, P811, DOI 10.3109/03602538909103580; Kim SM, 2010, J BIOL CHEM, V285, P35866, DOI 10.1074/jbc.M110.167189; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lecluyse E, 1999, DRUG METAB DISPOS, V27, P909; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McCormack T, 1997, J BIOL CHEM, V272, P26103, DOI 10.1074/jbc.272.42.26103; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; Murray BP, 2001, ARCH BIOCHEM BIOPHYS, V393, P106, DOI 10.1006/abbi.2001.2482; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; SAKAGUCHI M, 1984, P NATL ACAD SCI-BIOL, V81, P3361, DOI 10.1073/pnas.81.11.3361; SAKAGUCHI M, 1993, FRONTIERS BIOTRANSFO, V8, P59; SATO T, 1990, EMBO J, V9, P2391, DOI 10.1002/j.1460-2075.1990.tb07414.x; Szczena-Skorupa E, 2008, EXPERT OPIN DRUG MET, V4, P123, DOI 10.1517/17425255.4.2.123; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; VERGERES G, 1989, BIOCHEMISTRY-US, V28, P3650, DOI 10.1021/bi00435a005; Wang HF, 1999, ARCH BIOCHEM BIOPHYS, V365, P45, DOI 10.1006/abbi.1999.1139; Wang XY, 2001, BIOCHEMISTRY-US, V40, P11318, DOI 10.1021/bi010690z; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhao ML, 2010, J BIOL CHEM, V285, P4771, DOI 10.1074/jbc.M109.060095; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	90	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3815	3828		10.1074/jbc.M110.186981	http://dx.doi.org/10.1074/jbc.M110.186981			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21107009	hybrid, Green Published			2022-12-25	WOS:000286653200063
J	Ma, L; Dong, FM; Denis, M; Feng, Y; Wang, MD; Zha, XH				Ma, Loretta; Dong, Fumin; Denis, Maxime; Feng, Ying; Wang, Ming-Dong; Zha, Xiaohui			Ht31, a Protein Kinase A Anchoring Inhibitor, Induces Robust Cholesterol Efflux and Reverses Macrophage Foam Cell Formation through ATP-binding Cassette Transporter A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANGIER-DISEASE; ABCA1; ATHEROSCLEROSIS; MICE; MICROPARTICLES; TRAFFICKING; DEFICIENCY; MUTATIONS; MEMBRANE; HDL	Macrophage foam cell is the predominant cell type in atherosclerotic lesions. Removal of excess cholesterol from macrophages thus offers effective protection against atherosclerosis. Here we report that a protein kinase A (PKA)-anchoring inhibitor, st-Ht31, induces robust cholesterol/phospholipid efflux, and ATP-binding cassette transporter A1 (ABCA1) greatly facilitates this process. Remarkably, we found that st-Ht31 completely reverses foam cell formation, and this process is ABCA1-dependent. The reversal is also accompanied by the restoration of well modulated inflammatory response to LPS. There is no detectable toxicity associated with st-Ht31, even when cells export up to 20% cellular cholesterol per hour. Using FRET-based PKA biosensors in live cells, we provide evidence that st-Ht31 drives cholesterol efflux by elevating PKA activity specifically in the cytoplasm. Furthermore, ABCA1 facilitates st-Ht31 uptake. This allows st-Ht31 to effectively remove cholesterol from ABCA1-expressing cells. We speculate that de-anchoring of PKA offers a novel therapeutic strategy to remove excess cholesterol from lipid-laden lesion macrophages.	[Dong, Fumin; Denis, Maxime; Feng, Ying; Zha, Xiaohui] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Ma, Loretta; Zha, Xiaohui] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L6, Canada; [Wang, Ming-Dong] Univ Ottawa, Inst Heart, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Zha, XH (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada.	xzha@ohri.ca			Canadian Institutes of Health Research; Ontario Graduate Scholarship in Science and Technology; Canada Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship in Science and Technology; Canada Graduate Scholarship	This work is supported in part by a grant from Canadian Institutes of Health Research.; Supported by an Ontario Graduate Scholarship in Science and Technology and a Canada Graduate Scholarship.	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Buono C, 2009, J CLIN INVEST, V119, P1373, DOI 10.1172/JCI35548; CARR DW, 1992, J BIOL CHEM, V267, P13376; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Fitzgerald ML, 2002, J MOL MED, V80, P271, DOI 10.1007/s00109-001-0318-y; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Hayon T, 2003, LEUKEMIA LYMPHOMA, V44, P1957, DOI 10.1080/1042819031000116607; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Nandi S, 2009, J LIPID RES, V50, P456, DOI 10.1194/jlr.M800345-JLR200; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schillace RV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004807; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; Sethi AA, 2008, J BIOL CHEM, V283, P32273, DOI 10.1074/jbc.M804461200; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	27	24	26	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3370	3378		10.1074/jbc.M110.173666	http://dx.doi.org/10.1074/jbc.M110.173666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106522	hybrid, Green Published			2022-12-25	WOS:000286653200023
J	Marois, L; Pare, G; Vaillancourt, M; Rollet-Labelle, E; Naccache, PH				Marois, Louis; Pare, Guillaume; Vaillancourt, Myriam; Rollet-Labelle, Emmanuelle; Naccache, Paul H.			Fc gamma RIIIb Triggers Raft-dependent Calcium Influx in IgG-mediated Responses in Human Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TYROSINE PHOSPHORYLATION; LIPID RAFTS; LIGAND-BINDING; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; ANCHORED PROTEINS; RECEPTOR FUNCTION; IMMUNE-COMPLEXES	Human neutrophils constitutively express a unique combination of Fc gamma Rs, namely Fc gamma RIIa and Fc gamma RIIIb. Numerous lines of evidence support the concept that these Fc gamma Rs generate only partially characterized intracellular signals. However, despite the fact that both receptors are likely to be engaged simultaneously in a physiological setting, no recent publications have investigated the distinct, although partially convergent, results of their joint activation in IgG-dependent responses. To examine the significance of the co-expression of Fc gamma RIIa and Fc gamma RIIIb on human neutrophils, we analyzed the neutrophil responses to stimuli that engage these Fc gamma Rs, namely the phagocytosis of human IgG-opsonized zymosan and the responses to heat-aggregated IgGs. Blocking antibodies to either Fc gamma R significantly decreased the phagocytic index and the stimulated production of superoxide anions. Both receptors are required for optimal IgG-dependent responses by human neutrophils. On the other hand, only blocking antibodies to Fc gamma RIIIb, but not to Fc gamma RIIa, inhibited the mobilization of calcium in response to heat-aggregated IgGs. Furthermore, phagocytosis of IgG-opsonized zymosan by human neutrophils required an extracellular influx of calcium that was blocked only by antibodies against Fc gamma RIIIb. We also observed that this calcium influx as well as the IgG-dependent phagocytosis were dependent on the integrity of the plasma membrane detergent-resistant microdomains to which both isoforms were recruited following stimulation by heat-aggregated IgGs. These data clarify the mechanisms that regulate the Fc gamma Rs constitutively expressed on human neutrophils, describe a specific contribution of Fc gamma RIIIb at the level of the mobilization of calcium, and provide evidence for a crucial role of detergent-resistant microdomains in this process.	[Marois, Louis; Pare, Guillaume; Vaillancourt, Myriam; Rollet-Labelle, Emmanuelle; Naccache, Paul H.] Univ Laval, Dept Microbiol Infectiol & Immunol, Ctr Hosp Univ Quebec, Ctr Rech Rhumatol & Immunol,Ctr Rech,Fac Med, Quebec City, PQ G1V 4G2, Canada	Laval University	Rollet-Labelle, E (corresponding author), Univ Laval, Dept Microbiol Infectiol & Immunol, Ctr Hosp Univ Quebec, Ctr Rech Rhumatol & Immunol,Ctr Rech,Fac Med, 2705 Blvd Laurier,Rm T1-49, Quebec City, PQ G1V 4G2, Canada.	emmanuelle.rollet@crchul.ulaval.ca		Marois, Louis/0000-0002-1567-5583	Canadian Institutes of Health Research; Canadian Arthritis Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network	This work was supported in part by grants from the Canadian Institutes of Health Research.; Recipient of a Canadian Arthritis Network Graduate Award and a Canadian Institutes of Health Research Doctoral Research Award.	Alves CMOS, 2008, CLIN RHEUMATOL, V27, P701, DOI 10.1007/s10067-007-0768-x; Barabe F, 2002, J IMMUNOL, V168, P4042, DOI 10.4049/jimmunol.168.8.4042; Barabe F, 2002, J BIOL CHEM, V277, P13473, DOI 10.1074/jbc.M112149200; Belostocki K, 2005, CLIN IMMUNOL, V117, P78, DOI 10.1016/j.clim.2005.07.001; BIANCHINI L, 1993, J BIOL CHEM, V268, P3357; Bournazos S, 2009, J IMMUNOL, V182, P8026, DOI 10.4049/jimmunol.0900107; Chuang FYS, 2000, J IMMUNOL, V164, P350, DOI 10.4049/jimmunol.164.1.350; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; EDBERG JC, 1994, J IMMUNOL, V152, P5826; Edberg JC, 1998, J BIOL CHEM, V273, P8071, DOI 10.1074/jbc.273.14.8071; Fernandes MJG, 2006, BIOCHEM J, V393, P351, DOI 10.1042/BJ20050129; Fernandes MJG, 2005, J LEUKOCYTE BIOL, V78, P524, DOI 10.1189/jlb.0804479; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; Fossati G, 2002, ANN RHEUM DIS, V61, P13, DOI 10.1136/ard.61.1.13; Fossati G, 2002, ARTHRITIS RHEUM, V46, P1351, DOI 10.1002/art.10230; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; Gauthier LR, 2003, LIFE SCI, V74, P207, DOI 10.1016/j.lfs.2003.09.029; Hogarth PM, 2002, CURR OPIN IMMUNOL, V14, P798, DOI 10.1016/S0952-7915(02)00409-0; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; HUNTER S, 1994, P NATL ACAD SCI USA, V91, P10232, DOI 10.1073/pnas.91.21.10232; Ibarrola I, 1997, BBA-MOL CELL RES, V1357, P348, DOI 10.1016/S0167-4889(97)00034-7; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Katsumata O, 2001, J IMMUNOL, V167, P5814, DOI 10.4049/jimmunol.167.10.5814; KIMBERLY RP, 1995, ARTHRITIS RHEUM, V38, P306, DOI 10.1002/art.1780380303; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Kwiatkowska K, 2001, EUR J IMMUNOL, V31, P989, DOI 10.1002/1521-4141(200104)31:4<989::AID-IMMU989>3.0.CO;2-V; Lamberti Y, 2008, MICROB PATHOGENESIS, V44, P501, DOI 10.1016/j.micpath.2008.01.002; Li M, 1996, J EXP MED, V183, P1259, DOI 10.1084/jem.183.3.1259; Lowry MB, 1998, J EXP MED, V187, P161, DOI 10.1084/jem.187.2.161; Marois L, 2009, J IMMUNOL, V182, P2374, DOI 10.4049/jimmunol.0801420; Meknache N, 2009, J IMMUNOL, V182, P2542, DOI 10.4049/jimmunol.0801665; Nagarajan S, 2000, BLOOD, V95, P1069, DOI 10.1182/blood.V95.3.1069.003k14_1069_1077; Nagarajan S, 2005, J IMMUNOL, V174, P5423, DOI 10.4049/jimmunol.174.9.5423; NAGARAJAN S, 1995, J BIOL CHEM, V270, P25762, DOI 10.1074/jbc.270.43.25762; NAZIRUDDIN B, 1992, J IMMUNOL, V149, P3702; ODIN JA, 1991, SCIENCE, V254, P1785, DOI 10.1126/science.1837175; PETROSKI RJ, 1979, AM J PHYSIOL, V237, pC43, DOI 10.1152/ajpcell.1979.237.1.C43; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; PORGES AJ, 1994, J IMMUNOL, V153, P1271; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; Rivas-Fuentes S, 2010, CELL IMMUNOL, V263, P114, DOI 10.1016/j.cellimm.2010.03.006; ROLLET E, 1994, J IMMUNOL, V153, P353; Rollet-Labelle E, 2004, BIOCHEM J, V381, P919, DOI 10.1042/BJ20031808; SAGE SO, 1990, BIOCHEM J, V265, P915, DOI 10.1042/bj2650915; SALMON JE, 1991, J IMMUNOL, V146, P997; Sardjono CT, 2003, IMMUNOL CELL BIOL, V81, P374, DOI 10.1046/j.1440-1711.2003.01182.x; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Selvaraj P, 2004, IMMUNOL RES, V29, P219, DOI 10.1385/IR:29:1-3:219; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Shao DM, 2003, FEBS LETT, V550, P101, DOI 10.1016/S0014-5793(03)00845-7; Sharom FJ, 2002, BIOCHEM CELL BIOL, V80, P535, DOI 10.1139/O02-146; Slaughter N, 2003, CLIN IMMUNOL, V108, P138, DOI 10.1016/S1521-6616(03)00097-4; St-Onge M, 2010, FASEB J, V24, P2116, DOI 10.1096/fj.09-146167; Strzelecka-Kiliszek A, 2004, MOL MEMBR BIOL, V21, P101, DOI 10.1080/09687680310001639094; Van Laethem F., 2002, Current Molecular Medicine (Hilversum), V2, P557; VOSSEBELD PJM, 1995, J BIOL CHEM, V270, P10671, DOI 10.1074/jbc.270.18.10671; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wijngaarden S, 2005, RHEUMATOLOGY, V44, P729, DOI 10.1093/rheumatology/keh583; Willcocks LC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001161	61	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3509	3519		10.1074/jbc.M110.169516	http://dx.doi.org/10.1074/jbc.M110.169516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123174	Green Published, hybrid			2022-12-25	WOS:000286653200036
J	Nothmann, D; Leinenweber, A; Torres-Salazar, D; Kovermann, P; Hotzy, J; Gameiro, A; Grewer, C; Fahlke, C				Nothmann, Doreen; Leinenweber, Ariane; Torres-Salazar, Delany; Kovermann, Peter; Hotzy, Jasmin; Gameiro, Armanda; Grewer, Christof; Fahlke, Christoph			Hetero-oligomerization of Neuronal Glutamate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; INDIVIDUAL SUBUNITS; ANION CONDUCTANCE; CHLORIDE CHANNEL; EAAC1; STOICHIOMETRY; TRANSLOCATION; EXCHANGERS; BARTTIN; INJURY	Excitatory amino acid transporters (EAATs) mediate the uptake of glutamate into neuronal and glial cells of the mammalian central nervous system. Two transporters expressed primarily in glia, EAAT1 and EAAT2, are crucial for glutamate homeostasis in the adult mammalian brain. Three neuronal transporters (EAAT3, EAAT4, and EAAT5) appear to have additional functions in regulating and processing cellular excitability. EAATs are assembled as trimers, and the existence of multiple isoforms raises the question of whether certain isoforms can form hetero-oligomers. Co-expression and pull-down experiments of various glutamate transporters showed that EAAT3 and EAAT4, but neither EAAT1 and EAAT2, nor EAAT2 and EAAT3 are capable of co-assembling into heterotrimers. To study the functional consequences of hetero-oligomerization, we co-expressed EAAT3 and the serine-dependent mutant R501C EAAT4 in HEK293 cells and Xenopus laevis oocytes and studied glutamate/serine transport and anion conduction using electrophysiological methods. Individual subunits transport glutamate independently of each other. Apparent substrate affinities are not affected by hetero-oligomerization. However, polarized localization in Madin-Darby canine kidney cells was different for homo-and hetero-oligomers. EAAT3 inserts exclusively into apical membranes of Madin-Darby canine kidney cells when expressed alone. Co-expression with EAAT4 results in additional appearance of basolateral EAAT3. Our results demonstrate the existence of heterotrimeric glutamate transporters and provide novel information about the physiological impact of EAAT oligomerization.	[Nothmann, Doreen; Leinenweber, Ariane; Torres-Salazar, Delany; Kovermann, Peter; Hotzy, Jasmin; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Nothmann, Doreen; Leinenweber, Ariane; Torres-Salazar, Delany; Kovermann, Peter; Hotzy, Jasmin; Fahlke, Christoph] Zentrum Syst Neurowissensch, D-30559 Hannover, Germany; [Gameiro, Armanda; Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA	Hannover Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Fahlke, C (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	fahlke.christoph@mh-hannover.de	Albers, Thomas/A-9082-2012; Kovermann, Peter/AAF-4411-2020; Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Kovermann, Peter/0000-0001-5296-4918; Torres-Salazar, Delany/0000-0002-6789-9810	National Institutes of Health [R01-NS049335-05]; Deutsche Forschungsgemeinschaft [FA301/6, FA301/9]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-NS049335-05 (to C. G.). This work was also supported by Deutsche Forschungsgemeinschaft Grants FA301/6 and 9 (to Ch. F.).	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Cheng CL, 2002, J NEUROSCI, V22, P10643; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Furuta A, 1997, J NEUROSCI, V17, P8363; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Mim C, 2007, BIOCHEMISTRY-US, V46, P9007, DOI 10.1021/bi7005465; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Robertson JL, 2010, NATURE, V468, P844, DOI 10.1038/nature09556; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; Trotti D, 2001, BRAIN RES, V914, P196, DOI 10.1016/S0006-8993(01)02802-5; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	39	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3935	3943		10.1074/jbc.M110.187492	http://dx.doi.org/10.1074/jbc.M110.187492			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127051	Green Published, hybrid			2022-12-25	WOS:000286653200074
J	Dave, RH; Saengsawang, W; Lopus, M; Dave, S; Wilson, L; Rasenick, MM				Dave, Rahul H.; Saengsawang, Witchuda; Lopus, Manu; Dave, Sonya; Wilson, Leslie; Rasenick, Mark M.			A Molecular and Structural Mechanism for G Protein-mediated Microtubule Destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; TRANSDUCIN ALPHA-SUBUNIT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ADENYLYL-CYCLASE; GTPASE ACTIVITY; TUBULIN GTPASE; GAMMA-SUBUNIT; NMR ANALYSIS; LIPID RAFTS	The heterotrimeric, G protein-coupled receptor-associated G protein, G alpha(s), binds tubulin with nanomolar affinity and disrupts microtubules in cells and in vitro. Here we determine that the activated form of G alpha(s) binds tubulin with a K-D of 100 nM, stimulates tubulin GTPase, and promotes microtubule dynamic instability. Moreover, the data reveal that the alpha 3-beta 5 region of G alpha(s) is a functionally important motif in the G alpha(s)-mediated microtubule destabilization. Indeed, peptides corresponding to that region of G alpha(s) mimic G alpha(s) protein in activating tubulin GTPase and increase microtubule dynamic instability. We have identified specific mutations in peptides or proteins that interfere with this process. The data allow for a model of the G alpha(s)/tubulin interface in which G alpha(s) binds to the microtubule plus-end and activates the intrinsic tubulin GTPase. This model illuminates both the role of tubulin as an "effector" (e.g. adenylyl cyclase) for G alpha(s) and the role of G alpha(s) as a GTPase activator for tubulin. Given the ability of G alpha(s) to translocate intra-cellularly in response to agonist activation, G alpha(s) may play a role in hormone- or neurotransmitter-induced regulation of cellular morphology.	[Rasenick, Mark M.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Rasenick, Mark M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Dave, Rahul H.] Univ Illinois, Med Scientist Training Program, Chicago, IL 60612 USA; [Lopus, Manu; Wilson, Leslie] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Lopus, Manu; Wilson, Leslie] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Dave, Sonya] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Vanderbilt University	Rasenick, MM (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys, 835 S Wolcott,M-C 901, Chicago, IL 60612 USA.	raz@uic.edu	Lopus, Manu/C-8470-2012	Lopus, Manu/0000-0002-4829-3960	National Institutes of Health [NS 13560, T32-HL007692, MH 39595]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 13560 (to M. L. and L. W.), T32-HL007692 (to R. H. D.), and MH 39595 (to W. S. and M. M. R.). This work was also supported by AbdulRazzaq Al-Siddiqi.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bianchi M, 2009, SYNAPSE, V63, P359, DOI 10.1002/syn.20614; Chen NF, 2003, J BIOL CHEM, V278, P15285, DOI 10.1074/jbc.M300841200; Chen YB, 2001, J BIOL CHEM, V276, P45751, DOI 10.1074/jbc.M107191200; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Dave RH, 2009, NEUROSIGNALS, V17, P100, DOI 10.1159/000186693; DAVIDPFEUTY T, 1979, J BIOL CHEM, V254, P1696; Donati RJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1238, DOI 10.1038/sj.npp.1300697; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; Grishina G, 2000, MOL PHARMACOL, V57, P1081; Guo LW, 2007, PROTEIN EXPRES PURIF, V51, P187, DOI 10.1016/j.pep.2006.07.012; Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Layden BT, 2008, BBA-MOL CELL RES, V1783, P964, DOI 10.1016/j.bbamcr.2008.02.017; LIM SS, 1989, J CELL BIOL, V109, P253, DOI 10.1083/jcb.109.1.253; LINDER ME, 1990, J BIOL CHEM, V265, P8243; LOPUS M, 2009, WILEY ENCY CHEM BIOL, V3, P153; Lopus M, 2010, MOL CANCER THER, V9, P2689, DOI 10.1158/1535-7163.MCT-10-0644; MARGOLIS RL, 1977, P NATL ACAD SCI USA, V74, P3466, DOI 10.1073/pnas.74.8.3466; Mejillano MR, 1996, ARCH BIOCHEM BIOPHYS, V336, P130, DOI 10.1006/abbi.1996.0540; Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2; MURPHY DB, 1982, METHOD CELL BIOL, V24, P31; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Roychowdhury S, 1999, J BIOL CHEM, V274, P13485, DOI 10.1074/jbc.274.19.13485; Roychowdhury S, 2008, FEBS J, V275, P4654, DOI 10.1111/j.1742-4658.2008.06614.x; Skiba NP, 2000, METHOD ENZYMOL, V315, P502; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Smrcka AV, 2010, P NATL ACAD SCI USA, V107, P639, DOI 10.1073/pnas.0909503107; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; van Rossum D, 1999, J NEUROCHEM, V72, P962, DOI 10.1046/j.1471-4159.1999.0720962.x; WANG N, 1990, J BIOL CHEM, V265, P1239; Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312; Yan K, 1996, J NEUROCHEM, V66, P1489; Yenjerla M, 2010, METHOD CELL BIOL, V95, P189, DOI 10.1016/S0091-679X(10)95011-5; Yenjerla M, 2010, J ALZHEIMERS DIS, V19, P1377, DOI 10.3233/JAD-2010-1335; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200	43	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4319	4328		10.1074/jbc.M110.196436	http://dx.doi.org/10.1074/jbc.M110.196436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21112971	Green Published, hybrid			2022-12-25	WOS:000286975700031
J	Higashi, K; Tomigahara, Y; Shiraki, H; Miyata, K; Mikami, T; Kimura, T; Moro, T; Inagaki, Y; Kaneko, H				Higashi, Kiyoshi; Tomigahara, Yoshitaka; Shiraki, Hiroaki; Miyata, Kaori; Mikami, Toshiyuki; Kimura, Toru; Moro, Tadashi; Inagaki, Yutaka; Kaneko, Hideo			A Novel Small Compound That Promotes Nuclear Translocation of YB-1 Ameliorates Experimental Hepatic Fibrosis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; DEPENDENT TRANSCRIPTIONAL ACTIVATION; COLLAGEN GENE-EXPRESSION; BOX-BINDING-PROTEIN; RAT-LIVER FIBROSIS; FACTOR SUPPRESSES; STELLATE CELLS; MESSENGER-RNA; BETA; EXPORT	Transforming growth factor-beta (TGF-beta) is considered to be a major factor contributing to liver fibrosis. We have previously shown that nuclear translocation of YB-1 antagonizes the TGF-beta/Smad3 signaling in regulating collagen gene expression. More recently, we have demonstrated that the novel small compound HSc025 promotes nuclear translocation of YB-1, resulting in the improvement of skin and pulmonary fibrosis. Here, we presented evidence as to the mechanism by which HSc025 stimulates nuclear translocation of YB-1 and the pharmacological effects of HSc025 on a murine model of hepatic fibrosis. A proteomics approach and binding assays using HSc025-immobilized resin showed that HSc025 binds to the amino acid sequence within the C-tail region of YB-1. In addition, immunoprecipitation experiments and glutathione S-transferase pulldown assays identified poly(A)-binding protein (PABP) as one of the cytoplasmic anchor proteins of YB-1. HSc025 directly binds to YB-1 and interrupts its interaction with PABP, resulting in accelerated nuclear translocation of YB-1. Transfection of cells with PABP siRNA promoted nuclear translocation of YB-1 and subsequently inhibited basal and TGF-beta-stimulated collagen gene expression. Moreover, HSc025 significantly suppressed collagen gene expression in cultured activated hepatic stellate cells. Oral administration of HSc025 to mice with carbon tetrachloride-induced hepatic fibrosis improved liver injury as well as the degree of hepatic fibrosis. Altogether, the results provide a novel insight into therapy for organ fibrosis using YB-1 modulators.	[Higashi, Kiyoshi; Tomigahara, Yoshitaka; Shiraki, Hiroaki; Miyata, Kaori; Kaneko, Hideo] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka 5548558, Japan; [Mikami, Toshiyuki; Kimura, Toru] Dainippon Sumitomo Pharma Co Ltd, Genom Sci Labs, Osaka 5548558, Japan; [Moro, Tadashi; Inagaki, Yutaka] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa 2591193, Japan; [Moro, Tadashi] Minophagen Pharmaceut Co Ltd, Res Lab, Zama 2280002, Japan	Sumitomo Chem Co Ltd; Dainippon Sumitomo Pharmaceutical Company; Tokai University	Higashi, K (corresponding author), 1-98,Kasugadenaka 3 Chome,Konohana Ku, Osaka 5548558, Japan.	higashik2@sc.sumitomo-chem.co.jp		HIGASHI, KIYOSHI/0000-0003-3577-0526	Sumitomo Chemical Co. Ltd.	Sumitomo Chemical Co. Ltd.(Sumitomo Chem Co Ltd)	K. Higashi, Y. Tomigahara, H. Shiraki, K. Miyata, and H. Kaneko are employees of Sumitomo Chemical Co. Ltd., and T. Mikami and T. Kimura are employees of Dainippon Sumitomo Pharma Co. Ltd. Sumitomo Chemical Ltd. has applied for patents to use HSc025 and its analog as antifibrotic drugs. A part of the pharmacological studies of HSc025 was conducted by Y. Inagaki at Tokai University, which is supported by a research grant from Sumitomo Chemical Co. Ltd.	Albanis E, 2006, AM J TRANSPLANT, V6, P12, DOI 10.1111/j.1600-6143.2005.01143.x; Baroni GS, 1996, HEPATOLOGY, V23, P1189; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; CZAJA MJ, 1989, HEPATOLOGY, V10, P795, DOI 10.1002/hep.1840100508; Date M, 2000, GUT, V46, P719, DOI 10.1136/gut.46.5.719; Dooley S, 2006, J BIOL CHEM, V281, P1784, DOI 10.1074/jbc.M510215200; Duh JL, 1995, J BIOL CHEM, V270, P30499, DOI 10.1074/jbc.270.51.30499; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Ghiassi-Nejad Zahra, 2008, Expert Rev Gastroenterol Hepatol, V2, P803, DOI 10.1586/17474124.2.6.803; Hasegawa M, 2009, ARTHRITIS RHEUM-US, V60, P3465, DOI 10.1002/art.24934; Higashi K, 2003, J BIOL CHEM, V278, P43470, DOI 10.1074/jbc.M302339200; HIRAYAMA C, 1970, BIOCHEM J, V118, P229, DOI 10.1042/bj1180229; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Inagaki Y, 2005, GASTROENTEROLOGY, V129, P259, DOI 10.1053/j.gastro.2005.03.088; Inagaki Y, 2003, HEPATOLOGY, V38, P890, DOI 10.1053/jhep.2003.50408; Inagaki Y, 2008, GASTROENTEROLOGY, V134, P1180, DOI 10.1053/j.gastro.2008.01.014; KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866; Kawada N, 1996, DIGEST DIS SCI, V41, P1022, DOI 10.1007/BF02091547; KAWAGUCHI H, 1995, J MOL CELL CARDIOL, V27, P201, DOI 10.1016/S0022-2828(08)80019-3; Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MATSUDA Y, 1995, J BIOCHEM-TOKYO, V118, P643, DOI 10.1093/oxfordjournals.jbchem.a124958; Matsumoto K, 2005, MOL CELL BIOL, V25, P1779, DOI 10.1128/MCB.25.5.1779-1792.2005; Raj GV, 1996, J VIROL, V70, P5944, DOI 10.1128/JVI.70.9.5944-5953.1996; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Sakaida I, 1998, J HEPATOL, V28, P471, DOI 10.1016/S0168-8278(98)80322-X; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; Tamura T, 2003, BIOCONJUGATE CHEM, V14, P1222, DOI 10.1021/bc034099l; Yasuda H, 1996, HEPATOLOGY, V24, P636, DOI 10.1002/hep.510240328	31	45	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4485	4492		10.1074/jbc.M110.151936	http://dx.doi.org/10.1074/jbc.M110.151936			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115500	hybrid, Green Published			2022-12-25	WOS:000286975700048
J	Lalle, M; Camerini, S; Cecchetti, S; Fantauzzi, CB; Crescenzi, M; Pozio, E				Lalle, Marco; Camerini, Serena; Cecchetti, Serena; Fantauzzi, Claudia Blasetti; Crescenzi, Marco; Pozio, Edoardo			Giardia Duodenalis 14-3-3 Protein Is Polyglycylated by a Tubulin Tyrosine Ligase-like Member and Deglycylated by Two Metallocarboxypeptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; POSTTRANSLATIONAL POLYGLYCYLATION; CARBOXYPEPTIDASE YSCS; ALPHA-TUBULIN; BETA-TUBULIN; LAMBLIA; EXPRESSION; ENZYME; GENE; MICROTUBULES	The flagellated protozoan Giardia duodenalis is a parasite of the upper part of the small intestine of mammals, including humans, and an interesting biological model. Giardia harbors a single 14-3-3 isoform, a multifunctional protein family, that is modified at the C terminus by polyglycylation, an unusual post-translational modification consisting of the covalent addition of one or multiple glycines on the gamma-carboxyl groups of specific glutamic acids. Polyglycylation affects the intracellular localization of g14-3-3, as the shortening of the polyglycine chain is correlated with a partial relocalization of 14-3-3 inside the nuclei during encystation. In this work we demonstrate that the gTTLL3, a member of the tubulin tyrosine ligase-like family, is the enzyme responsible for the 14-3-3 polyglycylation. We also identify two metallopeptidases of the M20 family, here termed gDIP1 (giardial dipeptidase 1) and gDIP2, as enzymes able to shorten the g14-3-3 polyglycine tail both in vivo and in vitro. Finally, we show that the ectopic expression of gDIP2 alters the g14-3-3 localization and strongly hampers the cyst formation. In conclusion, we have identified a polyglycylase and two deglycylases that act in concert to modulate the stage-dependent glycylation status of the multifunctional regulatory g14-3-3 protein in G. duodenalis.	[Lalle, Marco; Fantauzzi, Claudia Blasetti; Pozio, Edoardo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [Camerini, Serena; Cecchetti, Serena; Crescenzi, Marco] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Lalle, M (corresponding author), Viale Regina Elena 299, I-00161 Rome, Italy.	marco.lalle@iss.it	Camerini, Serena/A-4637-2017; Lalle, Marco/O-2287-2015; Crescenzi, Marco/J-3603-2018; Cecchetti, Serena/N-1061-2015	Camerini, Serena/0000-0001-6131-4335; Lalle, Marco/0000-0001-5168-2150; Crescenzi, Marco/0000-0003-0156-1494; Cecchetti, Serena/0000-0002-3601-176X	European Commission [SANCO/2006/FOODSAFETY/032]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by European Commission Contract SANCO/2006/FOODSAFETY/032.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Alonso-del-Rivero M, 2009, FEBS J, V276, P4875, DOI 10.1111/j.1742-4658.2009.07187.x; Barrett AJ, 2003, BIOL CHEM, V384, P873, DOI 10.1515/BC.2003.098; BORDALLO J, 1991, FEBS LETT, V283, P27, DOI 10.1016/0014-5793(91)80546-F; Bre MH, 1996, J CELL SCI, V109, P727; Bre MH, 1998, MOL BIOL CELL, V9, P2655, DOI 10.1091/mbc.9.9.2655; Campanati L, 1999, BIOL CELL, V91, P499, DOI 10.1016/S0248-4900(00)88206-4; COLOMBO S, 1995, J BACTERIOL, V177, P5561, DOI 10.1128/jb.177.19.5561-5566.1995; Elmendorf HG, 2003, INT J PARASITOL, V33, P3, DOI 10.1016/S0020-7519(02)00228-X; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; FEELY DE, 1982, EXP PARASITOL, V53, P145, DOI 10.1016/0014-4894(82)90100-X; FELIX F, 1966, BIOCHIM BIOPHYS ACTA, V122, P127, DOI 10.1016/0926-6593(66)90096-8; FRIEND DS, 1966, J CELL BIOL, V29, P317, DOI 10.1083/jcb.29.2.317; Henrich B., 2004, HDB PROTEOLYTIC ENZY, P951; Ikegami K, 2008, FEBS LETT, V582, P1129, DOI 10.1016/j.febslet.2008.02.079; Ikegami K, 2009, FEBS LETT, V583, P1957, DOI 10.1016/j.febslet.2009.05.003; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Lalle M, 2010, INT J PARASITOL, V40, P201, DOI 10.1016/j.ijpara.2009.07.010; Midlej V, 2009, PARASITOL INT, V58, P72, DOI 10.1016/j.parint.2008.11.002; MINTON NP, 1983, J BACTERIOL, V156, P1222, DOI 10.1128/JB.156.3.1222-1227.1983; Mori S, 2005, BBA-PROTEINS PROTEOM, V1748, P26, DOI 10.1016/j.bbapap.2004.12.001; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOSER P, 1970, INT J PROT RES, V2, P191; NARCISI EM, 1994, J PARASITOL, V80, P468, DOI 10.2307/3283419; Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665; Palm D, 2005, MOL BIOCHEM PARASIT, V141, P199, DOI 10.1016/j.molbiopara.2005.03.005; Rawlings N. D., 2004, HDB PROTEOLYTIC ENZY, P231; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Redeker V, 2005, J BIOL CHEM, V280, P596, DOI 10.1074/jbc.M408324200; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sousa MC, 2001, CLIN DIAGN LAB IMMUN, V8, P258; SPORMANN DO, 1991, EUR J BIOCHEM, V197, P399, DOI 10.1111/j.1432-1033.1991.tb15924.x; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Suarez-Rendueles P., 2004, HDB PROTEOLYTIC ENZY, P950; Thompson RCA, 2000, INT J PARASITOL, V30, pV; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vanderheyden PML, 2006, FUND CLIN PHARMACOL, V20, P613, DOI 10.1111/j.1472-8206.2006.00444.x; Vinh J, 1999, BIOCHEMISTRY-US, V38, P3133, DOI 10.1021/bi982304s; Weber K, 1997, FEBS LETT, V419, P87, DOI 10.1016/S0014-5793(97)01436-1; WINIECKAKRUSNELL J, 1995, EUR J CLIN MICROBIOL, V14, P218, DOI 10.1007/BF02310359; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Wouters MA, 2001, J MOL BIOL, V314, P1191, DOI 10.1006/jmbi.2000.5161	47	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4471	4484		10.1074/jbc.M110.181511	http://dx.doi.org/10.1074/jbc.M110.181511			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21135098	Green Published, hybrid			2022-12-25	WOS:000286975700047
J	Sever-Chroneos, Z; Krupa, A; Davis, J; Hasan, M; Yang, CH; Szeliga, J; Herrmann, M; Hussain, M; Geisbrecht, BV; Kobzik, L; Chroneos, ZC				Sever-Chroneos, Zvjezdana; Krupa, Agnieszka; Davis, Jeremy; Hasan, Misbah; Yang, Ching-Hui; Szeliga, Jacek; Herrmann, Mathias; Hussain, Muzafar; Geisbrecht, Brian V.; Kobzik, Lester; Chroneos, Zissis C.			Surfactant Protein A (SP-A)-mediated Clearance of Staphylococcus aureus Involves Binding of SP-A to the Staphylococcal Adhesin Eap and the Macrophage Receptors SP-A Receptor 210 and Scavenger Receptor Class A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ADHERENCE PROTEIN; TUMOR-NECROSIS-FACTOR; HOST-CELL INVASION; PULMONARY SURFACTANT; MYCOBACTERIUM-TUBERCULOSIS; CHEMOKINE PRODUCTION; STREPTOCOCCUS-PNEUMONIAE; MYCOPLASMA-PNEUMONIAE; ALVEOLAR MACROPHAGES; POTENTIAL MECHANISM	Staphylococcus aureus causes life-threatening pneumonia in hospitals and deadly superinfection during viral influenza. The current study investigated the role of surfactant protein A (SP-A) in opsonization and clearance of S. aureus. Previous studies showed that SP-A mediates phagocytosis via the SP-A receptor 210 (SP-R210). Here, we show that SP-R210 mediates binding and control of SP-A-opsonized S. aureus by macrophages. We determined that SP-A binds S. aureus through the extracellular adhesin Eap. Consequently, SP-A enhanced macrophage uptake of Eap-expressing (Eap(+)) but not Eap-deficient (Eap(-)) S. aureus. In a reciprocal fashion, SP-A failed to enhance uptake of Eap(+) S. aureus in peritoneal Raw264.7 macrophages with a dominant negative mutation (SP-R210(DN)) blocking surface expression of SP-R210. Accordingly, WT mice cleared infection with Eap(+) but succumbed to sublethal infection with Eap-S. aureus. However, SP-R210(DN) cells compensated by increasing non-opsonic phagocytosis of Eap(+) S. aureus via the scavenger receptor scavenger receptor class A (SR-A), while non-opsonic uptake of Eap(+) S. aureus was impaired. Macrophages express two isoforms: SP-R210(L) and SP-R210(S). The results show that WT alveolar macrophages are distinguished by expression of SP-R210(L), whereas SR-A(-/-) alveolar macrophages are deficient in SP-R210(L) expressing only SP-R210(S). Accordingly, SR-A(-/-) mice were highly susceptible to both Eap(+) and Eap(-) S. aureus. The lungs of susceptible mice generated abnormal inflammatory responses that were associated with impaired killing and persistence of S. aureus infection in the lung. In conclusion, alveolar macrophage SP-R210(L) mediates recognition and killing of SP-A-opsonized S. aureus in vivo, coordinating inflammatory responses and resolution of S. aureus pneumonia through interaction with SR-A.	[Sever-Chroneos, Zvjezdana; Krupa, Agnieszka; Davis, Jeremy; Hasan, Misbah; Yang, Ching-Hui; Szeliga, Jacek; Chroneos, Zissis C.] Univ Texas Hlth Sci Ctr Tyler, Ctr Biomed Res, Tyler, TX 75708 USA; [Herrmann, Mathias] Univ Hosp Saarland, D-66421 Homburg, Germany; [Hussain, Muzafar] Univ Hosp Munster, Div Cell Biol & Biophys, D-48129 Munster, Germany; [Geisbrecht, Brian V.] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; [Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Universitatsklinikum des Saarlandes; University of Munster; University of Missouri System; University of Missouri Kansas City; Harvard University; Harvard T.H. Chan School of Public Health	Chroneos, ZC (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Ctr Biomed Res, 11937 US Hwy 271, Tyler, TX 75708 USA.	zissis.chroneos@uthct.edu	Herrmann, Mathias/B-6475-2013	Herrmann, Mathias/0000-0003-2638-2257; , Zissis/0000-0002-9841-7917; Krupa, Agnieszka/0000-0003-1303-4608	National Institutes of Health [HL068127, ES11008, AI071028]; Potts Memorial Foundation; Juvenile Diabetes Research Foundation; University of Texas Health Science Center at Tyler research council; Federal Ministry for Research and Technology [01KI07103]; Deutsche Forschungsgemeinschaft [1850/7-2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Potts Memorial Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); University of Texas Health Science Center at Tyler research council; Federal Ministry for Research and Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068127 (to Z.C.C.), ES11008 (to L.K.), and AI071028 (to B.V.G.). This work was also supported by the Potts Memorial Foundation (to Z.C.C.), the Juvenile Diabetes Research Foundation (to Z.C.C.), and University of Texas Health Science Center at Tyler research council grants (to Z.S.-C.).; Supported by Federal Ministry for Research and Technology Grant 01KI07103 and by Deutsche Forschungsgemeinschaft Grant 1850/7-2.	Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Athanasopoulos AN, 2006, BLOOD, V107, P2720, DOI 10.1182/blood-2005-08-3140; Banerjee S, 2010, J BIOL CHEM, V285, P2665, DOI 10.1074/jbc.M109.060822; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; Canadas O, 2008, BIOPHYS J, V95, P3287, DOI 10.1529/biophysj.108.137323; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Chimote G, 2008, J COLLOID INTERF SCI, V328, P288, DOI 10.1016/j.jcis.2008.08.022; Chroneos ZC, 1996, J BIOL CHEM, V271, P16375, DOI 10.1074/jbc.271.27.16375; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; COONROD JD, 1984, J CLIN INVEST, V74, P1269, DOI 10.1172/JCI111537; Cotena A, 2004, J IMMUNOL, V173, P6427, DOI 10.4049/jimmunol.173.10.6427; Crowther JE, 2004, J IMMUNOL, V172, P6866, DOI 10.4049/jimmunol.172.11.6866; Defres S, 2009, EUR RESPIR J, V34, P1470, DOI 10.1183/09031936.00122309; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; El Jamali A, 2010, FREE RADICAL BIO MED, V48, P798, DOI 10.1016/j.freeradbiomed.2009.12.018; Floros J, 2009, CRIT REV EUKAR GENE, V19, P125, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.30; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Garcia-Verdugo I, 2007, BIOPHYS J, V93, P3529, DOI 10.1529/biophysj.107.109793; Geisbrecht BV, 2005, J BIOL CHEM, V280, P17243, DOI 10.1074/jbc.M412311200; Gil M, 2009, J BIOL CHEM, V284, P7495, DOI 10.1074/jbc.M808643200; Gille C, 2007, J LIPID RES, V48, P307, DOI 10.1194/jlr.M600451-JLR200; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Gupta G, 2007, BIOESSAYS, V29, P452, DOI 10.1002/bies.20573; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Hammel M, 2007, PROTEIN SCI, V16, P2605, DOI 10.1110/ps.073170807; Harraghy N, 2005, MICROBIOL-SGM, V151, P1789, DOI 10.1099/mic.0.27902-0; Harraghy N, 2003, MICROBIOL-SGM, V149, P2701, DOI 10.1099/mic.0.26465-0; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Hodge-Dufour J, 1998, P NATL ACAD SCI USA, V95, P13806, DOI 10.1073/pnas.95.23.13806; Hussain M, 2001, CLIN DIAGN LAB IMMUN, V8, P1271, DOI 10.1128/CDLI.8.6.1271-1276.2001; Hussain M, 2002, INFECT IMMUN, V70, P2933, DOI 10.1128/IAI.70.6.2933-2940.2002; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; Hussain M, 2008, J CLIN MICROBIOL, V46, P470, DOI 10.1128/JCM.01425-07; Inden K, 2009, MICROBES INFECT, V11, P245, DOI 10.1016/j.micinf.2008.11.013; Joost I, 2009, J INFECT DIS, V199, P1471, DOI 10.1086/598484; Jozefowski S, 2004, J LEUKOCYTE BIOL, V76, P1066, DOI 10.1189/jlb.0504270; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; Kim MK, 2003, BLOOD, V101, P4479, DOI 10.1182/blood.V101.11.4479; Kobayashi SD, 2009, WIRES SYST BIOL MED, V1, P309, DOI 10.1002/wsbm.32; Kowanko IC, 1996, INFECT IMMUN, V64, P3435, DOI 10.1128/IAI.64.8.3435-3437.1996; Kudo K, 2004, J IMMUNOL, V172, P7592, DOI 10.4049/jimmunol.172.12.7592; Kuronuma K, 2004, J BIOL CHEM, V279, P21421, DOI 10.1074/jbc.M312490200; Ledford JG, 2009, J IMMUNOL, V182, P7818, DOI 10.4049/jimmunol.0900452; Lin YL, 2007, J BIOL CHEM, V282, P4653, DOI 10.1074/jbc.M608552200; MANZKEINKE H, 1992, EUR J CELL BIOL, V57, P95; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; McElroy MC, 2002, INFECT IMMUN, V70, P3865, DOI 10.1128/IAI.70.7.3865-3873.2002; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; MCNEELY TB, 1993, J INFECT DIS, V167, P91, DOI 10.1093/infdis/167.1.91; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007; Murray RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008705; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; NAKANE A, 1995, INFECT IMMUN, V63, P1165, DOI 10.1128/IAI.63.4.1165-1172.1995; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; NUGENT KM, 1982, INFECT IMMUN, V36, P1185, DOI 10.1128/IAI.36.3.1185-1191.1982; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Piboonpocanun S, 2005, J BIOL CHEM, V280, P9, DOI 10.1074/jbc.M411570200; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Pluddemann A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000297; Polotsky VY, 1996, INFECT IMMUN, V64, P380, DOI 10.1128/IAI.64.1.380-383.1996; Post SR, 2002, J LIPID RES, V43, P1829, DOI 10.1194/jlr.M200231-JLR200; Ragas A, 2007, J BIOL CHEM, V282, P5133, DOI 10.1074/jbc.M610183200; Rivera-Marrero CA, 2002, AM J PHYSIOL-LUNG C, V282, pL546, DOI 10.1152/ajplung.00175.2001; Sakamoto H, 2001, CIRCULATION, V104, P109, DOI 10.1161/hc2701.091070; Samten B, 2005, J IMMUNOL, V174, P6357, DOI 10.4049/jimmunol.174.10.6357; Samten B, 2008, J LEUKOCYTE BIOL, V84, P115, DOI 10.1189/jlb.1207835; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Szeliga J, 2005, ANAL BIOCHEM, V346, P179, DOI 10.1016/j.ab.2005.07.021; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; Todt JC, 2008, J LEUKOCYTE BIOL, V84, P510, DOI 10.1189/jlb.0307135; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; van de Wetering JK, 2001, J INFECT DIS, V184, P1143, DOI 10.1086/323746; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; Ventura CL, 2008, INFECT IMMUN, V76, P5862, DOI 10.1128/IAI.00865-08; Ventura CL, 2008, INFECT IMMUN, V76, P888, DOI 10.1128/IAI.01301-07; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; VIA DP, 1989, J LIPID RES, V30, P1515; von Garnier C, 2005, J IMMUNOL, V175, P1609, DOI 10.4049/jimmunol.175.3.1609; Wang ZD, 2008, TUBERCULOSIS, V88, P178, DOI 10.1016/j.tube.2007.11.003; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Watanabe I, 2007, J IMMUNOL, V178, P4917, DOI 10.4049/jimmunol.178.8.4917; Weikert LF, 2000, AM J PHYSIOL-LUNG C, V279, pL216, DOI 10.1152/ajplung.2000.279.2.L216; Weikert LF, 1997, AM J PHYSIOL-LUNG C, V272, pL989, DOI 10.1152/ajplung.1997.272.5.L989; WRIGHT SD, 1984, J CELL BIOL, V99, P336, DOI 10.1083/jcb.99.1.336; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Xie CP, 2006, J EXP MED, V203, P985, DOI 10.1084/jem.20051681; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Yang CH, 2005, J BIOL CHEM, V280, P34447, DOI 10.1074/jbc.M505229200; Zhou HW, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-7; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC	105	50	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4854	4870		10.1074/jbc.M110.125567	http://dx.doi.org/10.1074/jbc.M110.125567			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123169	Green Published, hybrid			2022-12-25	WOS:000286975700082
J	Cole, AM; Patton, DL; Rohan, LC; Cole, AL; Cosgrove-Sweeney, Y; Rogers, NA; Ratner, D; Sassi, AB; Lackman-Smith, C; Tarwater, P; Ramratnam, B; Ruchala, P; Lehrer, RI; Waring, AJ; Gupta, P				Cole, Alexander M.; Patton, Dorothy L.; Rohan, Lisa C.; Cole, Amy L.; Cosgrove-Sweeney, Yvonne; Rogers, Nicole A.; Ratner, Deena; Sassi, Alexandra B.; Lackman-Smith, Carol; Tarwater, Patrick; Ramratnam, Bharat; Ruchala, Piotr; Lehrer, Robert I.; Waring, Alan J.; Gupta, Phalguni			The Formulated Microbicide RC-101 Was Safe and Antivirally Active Following Intravaginal Application in Pigtailed Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FUSION INHIBITOR T-20; TOPICAL MICROBICIDE; MACACA-NEMESTRINA; EFFICACY EVALUATIONS; VAGINAL MICROFLORA; HIV-1 TRANSMISSION; THETA-DEFENSINS; COITAL ACT; MODEL	Background: RC-101 is a congener of the antiretroviral peptide retrocyclin, which we and others have reported is active against clinical HIV-1 isolates from all major clades, does not hemagglutinate, and is non-toxic and non-inflammatory in cervicovaginal cell culture. Herein, film-formulated RC-101 was assessed for its antiviral activity in vitro, safety in vivo, retention in the cervix and vagina, and ability to remain active against HIV-1 and SHIV after intravaginal application in macaques. Methodology/Principal Findings: RC-101 was formulated as a quick-dissolving film (2000 mu g/film), retained complete activity in vitro as compared to unformulated peptide, and was applied intravaginally in six pigtailed macaques daily for four days. At one and four days following the final application, the presence of RC-101 was assessed in peripheral blood, cervicovaginal lavage, cytobrushed cervicovaginal cells, and biopsied cervical and vaginal tissues by quantitative western blots. One day following the last film application, cervical biopsies from RC-101-exposed and placebo-controlled macaques were collected and were subjected to challenge with RT-SHIV in an ex vivo organ culture model. RC-101 peptide was detected primarily in the cytobrush and biopsied cervical and vaginal tissues, with little to no peptide detected in lavage samples, suggesting that the peptide was associated with the cervicovaginal epithelia. RC-101 remained in the tissues and cytobrush samples up to four days post-application, yet was not detected in any sera or plasma samples. RC-101, extracted from cytobrushes obtained one day post-application, remained active against HIV-1 BaL. Importantly, cervical biopsies from RC-101-treated animals reduced RT-SHIV replication in ex vivo organ culture as compared to placebo-treated animals. Conclusions/Significance: Formulated RC-101 was stable in vivo and was retained in the mucosa. The presence of antivirally active RC-101 after five days in vivo suggests that RC-101 would be an important molecule to develop further as a topical microbicide to prevent HIV-1 transmission.	[Cole, Alexander M.; Cole, Amy L.; Rogers, Nicole A.] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Patton, Dorothy L.; Cosgrove-Sweeney, Yvonne] Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Rohan, Lisa C.; Sassi, Alexandra B.] Univ Pittsburgh, Magee Womens Res Inst, Sch Pharm, Pittsburgh, PA USA; [Rohan, Lisa C.; Sassi, Alexandra B.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Ratner, Deena] Univ Pittsburgh, Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Lackman-Smith, Carol] So Res Inst, Dept Infect Dis Res, Frederick, MD USA; [Tarwater, Patrick] Texas Tech Univ, Hlth Sci Ctr, Dept Biostat, El Paso, TX USA; [Ramratnam, Bharat] Brown Univ, Div Biol & Med, Providence, RI 02912 USA; [Ruchala, Piotr; Lehrer, Robert I.; Waring, Alan J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	State University System of Florida; University of Central Florida; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas Tech University System; Texas Tech University; Brown University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cole, AM (corresponding author), Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	acole@mail.ucf.edu		RUCHALA, PIOTR/0000-0002-5574-2779	National Institutes of Health [U19 AI065430, R01 AI052017]; Washington National Primate Research Center [RR00166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI065430, R01AI052017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington National Primate Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant U19 AI065430 (to P. G., A. M. C., D. L. P., L. C. R., P. T., and B. R.) and R01 AI052017 (to A. M. C.) from the National Institutes of Health, as well as grant RR00166 from the Washington National Primate Research Center (to D. L. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AL, 2007, IMMUNOLOGY, V121, P140, DOI 10.1111/j.1365-2567.2006.02553.x; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Eckert Linda O, 2003, Infect Dis Obstet Gynecol, V11, P11, DOI 10.1155/S1064744903000024; FIELDS C G, 1991, Peptide Research, V4, P95; Fuhrman CA, 2007, FEBS J, V274, P6477, DOI 10.1111/j.1742-4658.2007.06165.x; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; Lichtenwalner AB, 2000, J MED PRIMATOL, V29, P36; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Nguyen TX, 2003, PEPTIDES, V24, P1647, DOI 10.1016/j.peptides.2003.07.023; Owen SM, 2004, AIDS RES HUM RETROV, V20, P1157, DOI 10.1089/aid.2004.20.1157; Owen SM, 2004, J PEPT RES, V63, P469, DOI 10.1111/j.1399-3011.2004.00155.x; Patton DL, 1996, SEX TRANSM DIS, V23, P461, DOI 10.1097/00007435-199611000-00004; Patton DL, 1999, AM J OBSTET GYNECOL, V180, P1080, DOI 10.1016/S0002-9378(99)70598-3; Patton DL, 2004, SEX TRANSM DIS, V31, P290, DOI 10.1097/01.OLQ.0000124614.91448.D4; Patton DL, 2004, J MED PRIMATOL, V33, P105, DOI 10.1111/j.1600-0684.2004.00059.x; Patton DL, 2003, SEX TRANSM DIS, V30, P568, DOI 10.1097/00007435-200307000-00007; Patton DL, 1998, SEX TRANSM DIS, V25, P421, DOI 10.1097/00007435-199809000-00007; Patton DL, 1996, SEX TRANSM DIS, V23, P489, DOI 10.1097/00007435-199611000-00009; Patton DL, 2008, SEX TRANSM DIS, V35, P889, DOI 10.1097/OLQ.0b013e31817dfdb8; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; SASSI AS, 2010, ANTIMICROB AGE UNPUB; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	32	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15111	10.1371/journal.pone.0015111	http://dx.doi.org/10.1371/journal.pone.0015111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124745	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500040
J	Sangare, LR; Stergachis, A; Brentlinger, PE; Richardson, BA; Staedke, SG; Kiwuwa, MS; Weiss, NS				Sangare, Laura R.; Stergachis, Andy; Brentlinger, Paula E.; Richardson, Barbra A.; Staedke, Sarah G.; Kiwuwa, Mpungu S.; Weiss, Noel S.			Determinants of Use of Intermittent Preventive Treatment of Malaria in Pregnancy: Jinja, Uganda	PLOS ONE			English	Article							PRESUMPTIVE TREATMENT; SULFADOXINE-PYRIMETHAMINE; WESTERN KENYA; WOMEN; TANZANIA; DISTRICT; BURDEN; FEVER; NETS	Background: Maternal malaria is associated with serious adverse pregnancy outcomes. One recommended means of preventing malaria during pregnancy is intermittent preventive therapy (IPTp) with sulfadoxine/pyrimethamine (SP). We sought to identify determinants of preventive use of SP during pregnancy among recently pregnant women in Uganda. Additionally, we characterized the timing of and indications for the administration of SP at antenatal care (ANC) visits and missed opportunities for SP administration. Methodology/Principal Findings: Utilizing a population-based random sample, we interviewed 500 women living in Jinja, Uganda who had been pregnant in the past year. Thirty-eight percent (192/500) of women received SP for the treatment of malaria and were excluded from the analysis of IPTp-SP. Of the remaining women, 275 (89.3%) reported at least two ANC visits after the first trimester and had an opportunity to receive IPTp-SP according to the Ugandan guidelines, but only 86 (31.3%) of these women received a full two-dose course of IPTp. The remaining 189 (68.7%) women missed one or more doses of IPTp-SP. Among the 168 women that were offered IPTp, 164 (97.6%) of them took the dose of SP. Conclusions/Significance: Use of IPTp in Uganda was found to be far below target levels. Our results suggest that women will take SP for IPTp if it is offered during an ANC visit. Missed opportunities to administer IPTp-SP during ANC were common in our study, suggesting provider-level improvements are needed.	[Sangare, Laura R.; Stergachis, Andy; Brentlinger, Paula E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Stergachis, Andy; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Staedke, Sarah G.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Staedke, Sarah G.] Infect Dis Res Collaborat, Kampala, Uganda; [Kiwuwa, Mpungu S.] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine; Makerere University	Sangare, LR (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	lsangare@u.washington.edu		Brentlinger, Paula/0000-0002-4865-8915	National Institutes of Health [TL1RR025016]; Department of Epidemiology; School of Public Health, University of Washington; Washington Global Health Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Epidemiology; School of Public Health, University of Washington(University of Washington); Washington Global Health Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health [TL1RR025016] and the Department of Epidemiology, small grants program at the School of Public Health, University of Washington, and the Washington Global Health Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkadi HO, 2007, CHEMOTHERAPY, V53, P385, DOI 10.1159/000109767; Anders K, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-79; [Anonymous], 2004, STRATEGIC FRAMEWORK; Bardaji A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-27; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Brentlinger PE, 2007, B WORLD HEALTH ORGAN, V85, P873, DOI 10.2471/BLT.06.033381; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; Gikandi PW, 2008, TROP MED INT HEALTH, V13, P208, DOI 10.1111/j.1365-3156.2007.01992.x; Guyatt HL, 2004, TROP MED INT HEALTH, V9, P255, DOI 10.1046/j.1365-3156.2003.01193.x; Holtz TH, 2004, TROP MED INT HEALTH, V9, P77, DOI 10.1046/j.1365-3156.2003.01170.x; Kachur SP, 2006, TROP MED INT HEALTH, V11, P441, DOI 10.1111/j.1365-3156.2006.01588.x; Kemble SK, 2006, AM J TROP MED HYG, V74, P999, DOI 10.4269/ajtmh.2006.74.999; Kiwuwa MS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-44; Lumley T, 2006, UW BIOSTATISTICS WOR, V293; Marchant T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-260; Mbonye AK, 2007, HEALTH POLICY, V81, P228, DOI 10.1016/j.healthpol.2006.05.018; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Mubyazi GM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-135; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; Ndyomugyenyi R, 2010, T ROY SOC TROP MED H, V104, P536, DOI 10.1016/j.trstmh.2010.02.003; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Olliaro PL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-234; Ouma PO, 2007, TROP MED INT HEALTH, V12, P953, DOI 10.1111/j.1365-3156.2007.01876.x; *PRES MAL I, 2007, UG MAL OP PLAN MOP; *PRES MAL I, 2009, UG MAL OP PLAN MOP; *PRES MAL I, 2008, UG MAL OP PLAN MOP; *REP UG, 2005, FLOW CHART MAL PREG; *REP UG, 2005, MAN UNC MAL PRACT GU; Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092; Rutstein S.O., 2004, DHS COMP REPORTS; Sirima SB, 2006, AM J TROP MED HYG, V75, P205, DOI 10.4269/ajtmh.2006.75.205; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Uganda Bureau of Statistics Macro International Inc, 2007, UG DEM HLTH SURV 200; Vallely A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-16; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P630, DOI 10.1111/j.1365-3156.2004.01242.x; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; World Health Organization, 2009, WHOHTMGMP20091	41	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15066	10.1371/journal.pone.0015066	http://dx.doi.org/10.1371/journal.pone.0015066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124732	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000284686500031
J	Zhang, MJ; He, LH; Li, Q; Sun, HH; Gu, YX; You, YH; Meng, FL; Zhang, JZ				Zhang, Maojun; He, Lihua; Li, Qun; Sun, Honghe; Gu, Yixin; You, Yuanhai; Meng, Fanliang; Zhang, Jianzhong			Genomic Characterization of the Guillain-Barre Syndrome-Associated Campylobacter jejuni ICDCCJ07001 Isolate	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; MOLECULAR MIMICRY; SEQUENCE; REVEALS; LIPOPOLYSACCHARIDES; OUTBREAK; STRAINS; BIOSYNTHESIS; MICROARRAY; DIVERSITY	Campylobacter jejuni ICDCCJ07001 (HS:41, ST2993) was isolated from a Guillain-Barre syndrome (GBS) patient during a 36-case GBS outbreak triggered by C. jejuni infections in north China in 2007. Sequence analysis revealed that the ICDCCJ07001 genome consisted of 1,664,840 base pairs (bp) and one tetracycline resistance plasmid of 44,084 bp. The GC content was 59.29% and 1,579 and 37 CDSs were identified on the chromosome and plasmid, respectively. The ICDCCJ07001 genome was compared to C. jejuni subsp. jejuni strains 81-176, 81116, NCTC11168, RM1221 and C. jejuni subsp. doylei 269.97. The length and organization of ICDCCJ07001 was similar to that of NCTC11168, 81-176 and 81-116 except that CMLP1 had a reverse orientation in strain ICDCCJ07001. Comparative genomic analyses were also carried out between GBS-associated C. jejuni strains. Thirteen common genes were present in four GBS-associated strains and 9 genes mapped to the LOS cluster and the ICDCCJ07001_pTet (44 kb) plasmid was mosaic in structure. Thirty-seven predicted CDS in ICDCCJ07001_pTet were homologous to genes present in three virulence-associated plasmids in Campylobacter: 81-176_pTet, pCC31 and 81-176_pVir. Comparative analysis of virulence loci and virulence-associated genes indicated that the LOS biosynthesis loci of ICDCCJ07001 belonged to type A, previously reported to be associated with cases of GBS. The polysaccharide capsular biosynthesis (CPS) loci and the flagella modification (FM) loci of ICDCCJ07001 were similar to corresponding sequences of strain 260.94 of similar serotype as strain ICDCCJ07001. Other virulence-associated genes including cadF, peb1, jlpA, cdt and ciaB were conserved between the C. jejuni strains examined.	[Zhang, Maojun; He, Lihua; Gu, Yixin; You, Yuanhai; Meng, Fanliang; Zhang, Jianzhong] Chinese Ctr Dis Control & Prevent, Natl Inst Commun Dis Control & Prevent, DCDD, Beijing, Peoples R China; [Li, Qun] Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Beijing, Peoples R China; [Sun, Honghe] BGI, Dept Appl sci Med, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Beijing Genomics Institute (BGI)	Zhang, MJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Commun Dis Control & Prevent, DCDD, Beijing, Peoples R China.	zhangjianzhong@icdc.cn	Zhang, Jianzhong/AAM-6179-2021	Zhang, Jianzhong/0000-0001-7056-8206	National Key Program for Infectious Disease of China [2008ZX10004-002, 2008ZX10004-008, 2008ZX10004-009]; Young Scholar Scientific Research Foundation of China CDC [2009A102]	National Key Program for Infectious Disease of China; Young Scholar Scientific Research Foundation of China CDC	This work was supported by grants from the National Key Program for Infectious Disease of China (2008ZX10004-002, 2008ZX10004-008 and 2008ZX10004-009) and the Young Scholar Scientific Research Foundation of China CDC (2009A102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Barton C, 2007, J CLIN MICROBIOL, V45, P386, DOI 10.1128/JCM.01513-06; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Clark CG, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-49; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Gilbert M, 2007, CHEMBIOCHEM, V8, P625, DOI 10.1002/cbic.200600508; Godschalk PCR, 2006, MICROBES INFECT, V8, P248, DOI 10.1016/j.micinf.2005.06.022; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Leonard EE, 2003, J INFECT DIS, V187, P691, DOI 10.1086/368268; May BJ, 2001, P NATL ACAD SCI USA, V98, P3460, DOI 10.1073/pnas.051634598; Moran AP, 1998, J INFECT DIS, V178, P1549, DOI 10.1086/314462; Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Parker CT, 2006, J CLIN MICROBIOL, V44, P4125, DOI 10.1128/JCM.01231-06; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Poly F, 2005, J CLIN MICROBIOL, V43, P2330, DOI 10.1128/JCM.43.5.2330-2338.2005; Poly F, 2007, INFECT IMMUN, V75, P3859, DOI 10.1128/IAI.00159-07; Poly F, 2007, INFECT IMMUN, V75, P3425, DOI 10.1128/IAI.00050-07; Prendergast MM, 1998, INFECT IMMUN, V66, P3649, DOI 10.1128/IAI.66.8.3649-3655.1998; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Sheikh KA, 1998, NEUROLOGY, V51, P371, DOI 10.1212/WNL.51.2.371; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Zhang MJ, 2010, FOODBORNE PATHOG DIS, V7, P913, DOI 10.1089/fpd.2009.0493	34	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15060	10.1371/journal.pone.0015060	http://dx.doi.org/10.1371/journal.pone.0015060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124772	Green Submitted, Green Published, gold			2022-12-25	WOS:000284686500028
J	Saito, M; Kumamoto, K; Robles, AI; Horikawa, I; Furusato, B; Okamura, S; Goto, A; Yamashita, T; Nagashima, M; Lee, TL; Baxendale, VJ; Rennert, OM; Takenoshita, S; Yokota, J; Sesterhenn, IA; Trivers, GE; Hussain, SP; Harris, CC				Saito, Motonobu; Kumamoto, Kensuke; Robles, Ana I.; Horikawa, Izumi; Furusato, Bungo; Okamura, Shu; Goto, Akiteru; Yamashita, Taro; Nagashima, Makoto; Lee, Tin-Lap; Baxendale, Vanessa J.; Rennert, Owen M.; Takenoshita, Seiichi; Yokota, Jun; Sesterhenn, Isabell A.; Trivers, Glenwood E.; Hussain, S. Perwez; Harris, Curtis C.			Targeted Disruption of Ing2 Results in Defective Spermatogenesis and Development of Soft-Tissue Sarcomas	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITOR; CHROMOSOME LONG ARM; TUMOR-SUPPRESSOR; GERM-CELL; CHROMATIN MODIFICATION; TESTICULAR CANCER; EPIGENETIC EVENTS; MEIOTIC PROPHASE; MALE-INFERTILITY; GENE-EXPRESSION	ING2 (inhibitor of growth family, member 2) is a member of the plant homeodomain (PHD)-containing ING family of putative tumor suppressors. As part of mSin3A HDAC corepressor complexes, ING2 binds to tri-methylated lysine 4 of histone H3 (H3K4me3) to regulate chromatin modification and gene expression. ING2 also functionally interacts with the tumor suppressor protein p53 to regulate cellular senescence, apoptosis and DNA damage response in vitro, and is thus expected to modulate carcinogenesis and aging. Here we investigate the developmental and physiological functions of Ing2 through targeted germline disruption. Consistent with its abundant expression in mouse and human testes, male mice deficient for Ing2 showed abnormal spermatogenesis and were infertile. Numbers of mature sperm and sperm motility were significantly reduced in Ing2(-/-) mice (similar to 2% of wild type, P<0.0001 and similar to 10% of wild type, P<0.0001, respectively). Their testes showed degeneration of seminiferous tubules, meiotic arrest before pachytene stage with incomplete meiotic recombination, induction of p53, and enhanced apoptosis. This phenotype was only partially abrogated by concomitant loss of p53 in the germline. The arrested spermatocytes in Ing2(-/-) testes were characterized by lack of specific HDAC1 accumulation and deregulated chromatin acetylation. The role of Ing2 in germ cell maturation may extend to human ING2 as well. Using publicly available gene expression datasets, low expression of ING2 was found in teratozoospermic sperm (>3-fold reduction) and in testes from patients with defective spermatogenesis (>7-fold reduction in Sertoli-cell only Syndrome). This study establishes ING2 as a novel regulator of spermatogenesis functioning through both p53- and chromatin-mediated mechanisms, suggests that an HDAC1/ING2/H3K4me3-regulated, stage-specific coordination of chromatin modifications is essential to normal spermatogenesis, and provides an animal model to study idiopathic and iatrogenic infertility in men. In addition, a bona fide tumor suppressive role of Ing2 is demonstrated by increased incidence of soft-tissue sarcomas in Ing2(-/-) mice.	[Saito, Motonobu; Kumamoto, Kensuke; Robles, Ana I.; Horikawa, Izumi; Okamura, Shu; Goto, Akiteru; Yamashita, Taro; Nagashima, Makoto; Trivers, Glenwood E.; Hussain, S. Perwez; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Furusato, Bungo; Sesterhenn, Isabell A.] Armed Forces Inst Pathol, Dept Genitourinary Pathol, Washington, DC 20306 USA; [Saito, Motonobu; Kumamoto, Kensuke; Takenoshita, Seiichi] Fukushima Med Univ, Sch Med, Dept Organ Regulatory Surg, Fukushima, Japan; [Lee, Tin-Lap; Baxendale, Vanessa J.; Rennert, Owen M.] NICHHD, Lab Clin & Dev Genom, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA; [Yokota, Jun] Natl Canc Ctr, Div Biol, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; Fukushima Medical University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Cancer Center - Japan	Saito, M (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	curtis_harris@nih.gov	Rennert, owen/AAI-7374-2020; Saito, Motonobu/AAQ-3633-2021; Lee, Tin-Lap/W-6595-2019; Lee, Tin-Lap/A-7853-2009; Goto, Akiteru/P-5775-2014	Saito, Motonobu/0000-0001-5072-3520; Lee, Tin-Lap/0000-0002-6654-0988; Lee, Tin-Lap/0000-0002-6654-0988; Robles, Ana/0000-0001-5019-4374; Furusato, Bungo/0000-0003-4614-9882; Hussain, S. Perwez/0000-0002-2294-522X; Goto, Akiteru/0000-0001-8776-9004	National Cancer Institute, National Institutes of Health; JA-Fukushima, Japan; NATIONAL CANCER INSTITUTE [ZIABC010875] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JA-Fukushima, Japan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. MS was supported by a scholarship from the JA-Fukushima, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2007, J BIOL CHEM, V282, P31060, DOI 10.1074/jbc.M701639200; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Binda O, 2008, ONCOGENE, V27, P3384, DOI 10.1038/sj.onc.1211014; Brydoy M, 2007, ACTA ONCOL, V46, P480, DOI 10.1080/02841860601166958; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Coussens M, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0001571, 10.1371/journal.pone.0002640]; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Faure AK, 2003, MOL HUM REPROD, V9, P757, DOI 10.1093/molehr/gag101; Feig C, 2007, MOL HUM REPROD, V13, P33, DOI 10.1093/molehr/gal097; Fenic I, 2004, J ANDROL, V25, P811; Fenic I, 2008, J ANDROL, V29, P172, DOI 10.2164/jandrol.107.003848; GALLI M, 2009, ANN HEMATOL; Gattiker A, 2007, NUCLEIC ACIDS RES, V35, pD457, DOI 10.1093/nar/gkl957; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Goto A, 2005, CANCER SCI, V96, P480, DOI 10.1111/j.1349-7006.2005.00075.x; Gromley A, 2009, P NATL ACAD SCI USA, V106, P6285, DOI 10.1073/pnas.0902310106; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Hussain SP, 2004, CANCER RES, V64, P6849, DOI 10.1158/0008-5472.CAN-04-2201; JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Khoo CM, 2007, P NATL ACAD SCI USA, V104, P3931, DOI 10.1073/pnas.0700093104; Kichina JV, 2006, ONCOGENE, V25, P857, DOI 10.1038/sj.onc.1209118; Kim SK, 2008, MOL CELLS, V25, P317; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Kumamoto K, 2009, INT J CANCER, V125, P1306, DOI 10.1002/ijc.24437; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Magelssen H, 2006, NAT CLIN PRACT UROL, V3, P312, DOI 10.1038/ncpuro0508; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; MEIROW D, 1995, HUM REPROD, V10, P2017, DOI 10.1093/oxfordjournals.humrep.a136228; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; Okada H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040026; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Raman JD, 2005, J UROLOGY, V174, P1819, DOI 10.1097/01.ju.0000177491.98461.aa; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Salazar G, 2005, DEV DYNAM, V234, P114, DOI 10.1002/dvdy.20533; Sargeant AM, 2008, CANCER RES, V68, P3999, DOI 10.1158/0008-5472.CAN-08-0203; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schwartz D, 1999, CELL GROWTH DIFFER, V10, P665; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shimada Y, 1998, CYTOGENET CELL GENET, V83, P232, DOI 10.1159/000015188; SIRONEN A, 2009, BIOL REPROD; Smith KT, 2010, CHEM BIOL, V17, P65, DOI 10.1016/j.chembiol.2009.12.010; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Spiess AN, 2003, BIOL REPROD, V68, P2044, DOI 10.1095/biolreprod.102.011593; Spiess AN, 2007, HUM REPROD, V22, P2936, DOI 10.1093/humrep/dem292; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Takano N, 2004, BIOL REPROD, V71, P1785, DOI 10.1095/biolreprod.104.030452; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; Toure A, 2004, GENETICS, V166, P901, DOI 10.1534/genetics.166.2.901; Unoki M, 2009, CURR DRUG TARGETS, V10, P442, DOI 10.2174/138945009788185059; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Yin YZ, 1998, DEV BIOL, V204, P165, DOI 10.1006/dbio.1998.9074	68	38	39	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e15541	10.1371/journal.pone.0015541	http://dx.doi.org/10.1371/journal.pone.0015541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124965	Green Published, gold, Green Submitted			2022-12-25	WOS:000284400100019
J	Eakin, CM; Morgan, JA; Heron, SF; Smith, TB; Liu, G; Alvarez-Filip, L; Baca, B; Bartels, E; Bastidas, C; Bouchon, C; Brandt, M; Bruckner, AW; Bunkley-Williams, L; Cameron, A; Causey, BD; Chiappone, M; Christensen, TRL; Crabbe, MJC; Day, O; de la Guardia, E; Diaz-Pulido, G; DiResta, D; Gil-Agudelo, DL; Gilliam, DS; Ginsburg, RN; Gore, S; Guzman, HM; Hendee, JC; Hernandez-Delgado, EA; Husain, E; Jeffrey, CFG; Jones, RJ; Jordan-Dahlgren, E; Kaufman, LS; Kline, DI; Kramer, PA; Lang, JC; Lirman, D; Mallela, J; Manfrino, C; Marechal, JP; Marks, K; Mihaly, J; Miller, WJ; Mueller, EM; Muller, EM; Toro, CAO; Oxenford, HA; Ponce-Taylor, D; Quinn, N; Ritchie, KB; Rodriguez, S; Ramirez, AR; Romano, S; Samhouri, JF; Sanchez, JA; Schmahl, GP; Shank, BV; Skirving, WJ; Steiner, SCC; Villamizar, E; Walsh, SM; Walter, C; Weil, E; Williams, EH; Roberson, KW; Yusuf, Y				Eakin, C. Mark; Morgan, Jessica A.; Heron, Scott F.; Smith, Tyler B.; Liu, Gang; Alvarez-Filip, Lorenzo; Baca, Bart; Bartels, Erich; Bastidas, Carolina; Bouchon, Claude; Brandt, Marilyn; Bruckner, Andrew W.; Bunkley-Williams, Lucy; Cameron, Andrew; Causey, Billy D.; Chiappone, Mark; Christensen, Tyler R. L.; Crabbe, M. James C.; Day, Owen; de la Guardia, Elena; Diaz-Pulido, Guillermo; DiResta, Daniel; Gil-Agudelo, Diego L.; Gilliam, David S.; Ginsburg, Robert N.; Gore, Shannon; Guzman, Hector M.; Hendee, James C.; Hernandez-Delgado, Edwin A.; Husain, Ellen; Jeffrey, Christopher F. G.; Jones, Ross J.; Jordan-Dahlgren, Eric; Kaufman, Les S.; Kline, David I.; Kramer, Philip A.; Lang, Judith C.; Lirman, Diego; Mallela, Jennie; Manfrino, Carrie; Marechal, Jean-Philippe; Marks, Ken; Mihaly, Jennifer; Miller, W. Jeff; Mueller, Erich M.; Muller, Erinn M.; Orozco Toro, Carlos A.; Oxenford, Hazel A.; Ponce-Taylor, Daniel; Quinn, Norman; Ritchie, Kim B.; Rodriguez, Sebastian; Rodriguez Ramirez, Alberto; Romano, Sandra; Samhouri, Jameal F.; Sanchez, Juan A.; Schmahl, George P.; Shank, Burton V.; Skirving, William J.; Steiner, Sascha C. C.; Villamizar, Estrella; Walsh, Sheila M.; Walter, Cory; Weil, Ernesto; Williams, Ernest H.; Roberson, Kimberly Woody; Yusuf, Yusri			Caribbean Corals in Crisis: Record Thermal Stress, Bleaching, and Mortality in 2005	PLOS ONE			English	Article							CLIMATE-CHANGE; REEF; EVENTS; TEMPERATURE; HURRICANES; SEVERITY; DISEASE; ISLAND	Background: The rising temperature of the world's oceans has become a major threat to coral reefs globally as the severity and frequency of mass coral bleaching and mortality events increase. In 2005, high ocean temperatures in the tropical Atlantic and Caribbean resulted in the most severe bleaching event ever recorded in the basin. Methodology/Principal Findings: Satellite-based tools provided warnings for coral reef managers and scientists, guiding both the timing and location of researchers' field observations as anomalously warm conditions developed and spread across the greater Caribbean region from June to October 2005. Field surveys of bleaching and mortality exceeded prior efforts in detail and extent, and provided a new standard for documenting the effects of bleaching and for testing nowcast and forecast products. Collaborators from 22 countries undertook the most comprehensive documentation of basin-scale bleaching to date and found that over 80% of corals bleached and over 40% died at many sites. The most severe bleaching coincided with waters nearest a western Atlantic warm pool that was centered off the northern end of the Lesser Antilles. Conclusions/Significance: Thermal stress during the 2005 event exceeded any observed from the Caribbean in the prior 20 years, and regionally-averaged temperatures were the warmest in over 150 years. Comparison of satellite data against field surveys demonstrated a significant predictive relationship between accumulated heat stress (measured using NOAA Coral Reef Watch's Degree Heating Weeks) and bleaching intensity. This severe, widespread bleaching and mortality will undoubtedly have long-term consequences for reef ecosystems and suggests a troubled future for tropical marine ecosystems under a warming climate.	[Eakin, C. Mark; Jeffrey, Christopher F. G.; Roberson, Kimberly Woody] Natl Ocean & Atmospher Adm, Ctr Coastal Monitoring & Assessment, Silver Spring, MD USA; [Morgan, Jessica A.; Liu, Gang; Christensen, Tyler R. L.] NOAA Coral Reef Watch, IM Syst Grp, Silver Spring, MD USA; [Heron, Scott F.; Skirving, William J.] ReefSense Pty Ltd, NOAA Coral Reef Watch, Townsville, Qld, Australia; [Heron, Scott F.] James Cook Univ, Sch Engn & Phys Sci, Townsville, Qld, Australia; [Smith, Tyler B.; Brandt, Marilyn; Romano, Sandra] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Alvarez-Filip, Lorenzo] Parque Nacl Arrecifes Cozumel, Cozumel, Mexico; [Alvarez-Filip, Lorenzo] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Baca, Bart] CSA S Inc, Dania, FL USA; [Bartels, Erich; Ritchie, Kim B.; Walter, Cory] Mote Marine Lab, Ctr Coral Reef Res, Summerland Key, FL USA; [Bastidas, Carolina; Rodriguez, Sebastian] Univ Simon Bolivar, Inst Tecnol & Ciencias Marinas, Caracas, Venezuela; [Bouchon, Claude] Univ Antilles Guyane, Biol Marine Lab, Pointe A Pitre, Guadeloupe, France; [Bruckner, Andrew W.] Khaled bin Sultan Living Oceans Fdn, Landover, MD USA; [Bunkley-Williams, Lucy; Weil, Ernesto; Williams, Ernest H.] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA; [Cameron, Andrew; Ponce-Taylor, Daniel] Global Vis Int & Amigos Sian Kaan Asociac Civil, Playa Del Carmen, Quintana Roo, Mexico; [Causey, Billy D.] Natl Ocean & Atmospher Adm, Off Natl Marine Sanctuaries, Key West, FL USA; [Chiappone, Mark] Univ N Carolina Wilmington, Ctr Marine Sci, Key Largo, FL USA; [Crabbe, M. James C.] Univ Bedfordshire, Luton Inst Res Appl Nat Sci, Luton, Beds, England; [Day, Owen] Buccoo Reef Trust, Carnbee, Trinidad Tobago; [de la Guardia, Elena] Univ La Habana, Ctr Invest Marinas, Havana, Cuba; [Diaz-Pulido, Guillermo] Univ Magdalena, Santa Marta, Colombia; [Diaz-Pulido, Guillermo] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Diaz-Pulido, Guillermo] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [DiResta, Daniel] Univ Miami, Marine & Atmospher Sci Program, Coral Gables, FL 33124 USA; [Gil-Agudelo, Diego L.; Rodriguez Ramirez, Alberto] Inst Invest Marinas & Costeras INVEMAR, Santa Marta, Colombia; [Gilliam, David S.] Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA; [Ginsburg, Robert N.; Lirman, Diego] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Virginia Key, FL USA; [Guzman, Hector M.; Kline, David I.] Smithsonian Trop Res Inst, Balboa, Panama; [Hendee, James C.] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Hernandez-Delgado, Edwin A.] Univ Puerto Rico, Ctr Appl Trop Ecol & Conservat, San Juan, PR 00936 USA; [Husain, Ellen] Univ Exeter, Marine Spatial Ecol Lab, Exeter, Devon, England; [Jones, Ross J.] Bermuda Inst Ocean Sci, St Georges, Bermuda; [Jordan-Dahlgren, Eric] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Cancun, Quintana Roo, Mexico; [Kaufman, Les S.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Kline, David I.] Univ Queensland, Global Change Inst, Brisbane, Qld, Australia; [Kramer, Philip A.] Nature Conservancy, Sugarloaf Key, FL USA; [Lang, Judith C.; Marks, Ken] Ocean Res & Educ Fdn Inc, Coral Gables, FL USA; [Mallela, Jennie] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Mallela, Jennie] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Manfrino, Carrie] Cent Caribbean Marine Inst, Union, NJ USA; [Manfrino, Carrie] Kean Univ, Union, NJ USA; [Marechal, Jean-Philippe] Observ Milieu Marin Martiniquais, Fort De France, Martinique, France; [Mihaly, Jennifer] Reef Check, Pacific Palisades, CA USA; [Miller, W. Jeff] S Florida Caribbean Network, St John, VI USA; [Mueller, Erich M.] Perry Inst Marine Sci, Jupiter, FL USA; [Muller, Erinn M.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Orozco Toro, Carlos A.] Corp Desarrollo Sostenible Archipielago San Andre, San Andres Isla, Colombia; [Oxenford, Hazel A.] Univ W Indies, Ctr Resource Management & Environm Studies, Cave Hill, Barbados; [Quinn, Norman] Dept Planning & Nat Resources, Christiansted, VI USA; [Samhouri, Jameal F.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Sanchez, Juan A.] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Schmahl, George P.] Natl Ocean & Atmospher Adm, Galveston, TX USA; [Shank, Burton V.] Natl Ocean & Atmospher Adm, NE Fisheries Sci Ctr, Woods Hole, MA USA; [Steiner, Sascha C. C.] Inst Trop Marine Ecol Inc, Roseau, Dominica; [Villamizar, Estrella] Cent Univ Venezuela, Inst Zool Trop, Caracas, Venezuela; [Walsh, Sheila M.] Brown Univ, Environm Change Initiat, Providence, RI 02912 USA; [Yusuf, Yusri] Univ Malaysia Terengganu, Inst Oceanog, Kuala Terengganu, Malaysia; [Yusuf, Yusri] Univ Malaysia Terengganu, ReefBase, Kuala Terengganu, Malaysia	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; University of the Virgin Islands; University of East Anglia; Mote Marine Laboratory & Aquarium; Simon Bolivar University; Universite des Antilles; University of Puerto Rico; University of Puerto Rico Mayaguez; National Oceanic Atmospheric Admin (NOAA) - USA; University of North Carolina; University of North Carolina Wilmington; University of Bedfordshire; Universidad de la Habana; Universidad del Magdalena; Griffith University; Griffith University; University of Miami; Nova Southeastern University; Smithsonian Institution; Smithsonian Tropical Research Institute; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Exeter; Bermuda Institute of Ocean Sciences; Universidad Nacional Autonoma de Mexico; Boston University; University of Queensland; University West Indies Mona Jamaica; University West Indies Saint Augustine; Australian National University; Florida Institute of Technology; University West Indies Mona Jamaica; University West Indies Cave Hill Campus; University of California System; University of California Los Angeles; Universidad de los Andes (Colombia); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Central Venezuela; Brown University; Universiti Malaysia Terengganu; Universiti Malaysia Terengganu	Eakin, CM (corresponding author), Natl Ocean & Atmospher Adm, Ctr Coastal Monitoring & Assessment, Silver Spring, MD USA.	coralreefwatch@noaa.gov	Alvarez-Filip, Lorenzo/C-9552-2011; Morgan, Jessica/E-7926-2011; Heron, Scott F/E-7928-2011; Christensen, Tyler/E-7922-2011; Hendee, James C/E-6358-2010; Weil, Ernesto/ABF-1290-2020; Yusuf, Yusri/A-5366-2019; Weil, Ernesto/AAI-3591-2020; Manfrino, Carrie/AAZ-9126-2021; Jones, Ross/N-4651-2013; Diaz-Pulido, Guillermo/B-3648-2013; Manfrino, Carrie/F-7588-2013; sanchez, juan/GSD-8167-2022; Rinaldi2, Carlos/D-4479-2011; Eakin, C. Mark/F-5585-2010; Liu, Gang/E-7921-2011; Skirving, William/E-7927-2011	Alvarez-Filip, Lorenzo/0000-0002-5726-7238; Hendee, James C/0000-0002-4799-5354; Weil, Ernesto/0000-0001-5275-1584; Yusuf, Yusri/0000-0003-2876-0987; Jones, Ross/0000-0003-1661-4149; Sanchez, Juan Armando/0000-0001-7149-8369; Mallela, Jennie/0000-0002-7811-6850; Heron, Scott/0000-0001-5262-6978; Eakin, C. Mark/0000-0002-5987-0858; Liu, Gang/0000-0001-8369-6805; Guzman, Hector M./0000-0001-9928-8523; Christensen, Tyler/0000-0002-9744-5270; Manfrino, Carrie/0000-0002-3129-9629; Rodriguez-Ramirez, Alberto/0000-0003-4855-7345; Kline, David/0000-0001-5128-9439; Skirving, William/0000-0003-0167-6427; Diaz-Pulido, Guillermo/0000-0002-0901-3727	NOAA	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was partially supported by salaries from the NOAA Coral Reef Conservation Program to the NOAA Coral Reef Conservation Program authors. NOAA provided funding to Caribbean ReefCheck investigators to undertake surveys of bleaching and mortality. Otherwise, no funding from outside authors' institutions was necessary for the undertaking of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Eakin C. M., 2009, V205, P41; Eakin CM, 2001, B MAR SCI, V69, P171; Glynn P.W., 1990, Elsevier Oceanography Series, V52, P55; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hill JJ, 2004, METHODS ECOLOGICAL M; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOEGHGULDBERG O, 2005, UNDERSTANDING STRESS, P107; Isaaks E.H., 1989, APPL GEOSTATISTICS; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Liu G., 2006, P 10 INT CORAL REEF, Vvol. 1793, P1783; Mallela J, 2009, MAR ENVIRON RES, V68, P158, DOI 10.1016/j.marenvres.2009.06.001; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; Marshall PA, 2006, REEF MANAGERS GUIDE; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; *NOAA NAT CLIM DAT, 2009, NOAA EXT REC SEA SUR; *NOAA NAT OC DAT C, 2009, NODC 4 KM PATHF VERS; Oxenford H. A., 2010, P 11 INT COR REEF S, P505; Oxenford HA, 2008, CLIMATIC CHANGE, V87, P435, DOI 10.1007/s10584-007-9311-y; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodriguez S, 2010, REV BIOL TROP, V58, P189; Shein KA, 2006, B AM METEOROL SOC, V87, pS6, DOI 10.1175/BAMS-87-6-shein; Smith TM, 2004, J CLIMATE, V17, P2466, DOI 10.1175/1520-0442(2004)017<2466:IEROS>2.0.CO;2; Trenberth KE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026894; Whelan KRT, 2007, CORAL REEFS, V26, P689, DOI 10.1007/s00338-007-0241-y; Wilkinson C, 2000, STATUS CORAL REEFS W; Wilkinson C, 2008, STATUS CARIBBEAN COR; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013	48	401	416	20	311	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13969	10.1371/journal.pone.0013969	http://dx.doi.org/10.1371/journal.pone.0013969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21125021	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000284231800007
J	Lisse, TS; Liu, T; Irmler, M; Beckers, J; Chen, H; Adams, JS; Hewison, M				Lisse, Thomas S.; Liu, Ting; Irmler, Martin; Beckers, Johannes; Chen, Hong; Adams, John S.; Hewison, Martin			Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling	FASEB JOURNAL			English	Article						resistance; bone; vitamin D receptor	MESSENGER-RNA TRANSLATION; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; MAMMALIAN TARGET; LIFE-SPAN; 24-HYDROXYLASE GENE; D RESISTANCE; CELL-GROWTH; DIFFERENTIATION; IDENTIFICATION	Transcriptional regulation by hormonal 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] involves occupancy of vitamin D response elements (VDREs) by the VDRE binding protein (VDRE-BP) or 1,25(OH)(2)D-3-bound vitamin D receptor (VDR). This relationship is disrupted by elevated VDRE-BP, causing a form of hereditary vitamin D-resistant rickets (HVDRR). DNA array analysis showed that of 114 genes regulated by 1,25(OH)(2)D-3 in control cells, almost all (113) were rendered insensitive to the hormone in VDRE-BP-overexpressing HVDRR cells. Among these was the gene for DNA-damage-inducible transcript 4 (DDIT4), an inhibitor of mammalian target of rapamycin (mTOR) signaling. Chromatin immunoprecipitation PCR using 1,25(OH)(2)D-3-treated osteoblasts confirmed that VDR and VDRE-BP compete for binding to the DDIT4 gene promoter. Expression of DDIT4 mRNA in these cells was induced (1.6-6 fold) by 1,25(OH)(2)D-3 (10-100 nM), and Western blot and flow cytometry analysis showed that this response involved suppression of phosphorylated S6K1(T389) (a downstream target of mTOR) similar to rapamycin treatment. siRNA knockdown of DDIT4 completely abrogated antiproliferative responses to 1,25(OH) 2D3, whereas overexpression of VDRE-BP exerted a dominant-negative effect on transcription of 1,25(OH)(2)D-3-target genes. DDIT4, an inhibitor of mTOR signaling, is a direct target for 1,25(OH)(2)D-3 and VDRE-BP, and functions to suppress cell proliferation in response to vitamin D.-Lisse, T. S., Liu, T., Irmler, M., Beckers, J., Chen, H., Adams, J. S., Hewison, M. Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling. FASEB J. 25, 937-947 (2011). www.fasebj.org	[Lisse, Thomas S.; Liu, Ting; Adams, John S.; Hewison, Martin] Univ Calif Los Angeles, Orthopaed Hosp Res Ctr, Los Angeles, CA USA; [Adams, John S.; Hewison, Martin] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Irmler, Martin; Beckers, Johannes] German Res Ctr Environm Hlth, Inst Expt Genet, Helmholtz Zentrum Munich, Neuherberg, Germany; [Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci, D-8050 Freising Weihenstephan, Germany; [Chen, Hong] Emory Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipids, Atlanta, GA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Emory University	Hewison, M (corresponding author), Univ Calif Los Angeles, Orthopaed Hosp Res Ctr, Rm 410D,615 Charles E Young Dr, S Los Angeles, CA 90095 USA.	mhewison@mednet.ucla.edu	Beckers, Johannes/K-7237-2012; Adams, John S/I-3365-2013; lisse, thomas/B-4847-2019; Irmler, Martin/B-3317-2013	Beckers, Johannes/0000-0001-7874-3822; Adams, John S/0000-0001-9607-5020; Irmler, Martin/0000-0003-3169-479X	U.S. National Institutes of Health [2R01AR037399-21]; German National Genome Research Network [01GS0850]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037399] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German National Genome Research Network; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Mark Meyer (University of Wisconsin, Madison, WI, USA) for help with analysis of VDREs, and Renata Pereira (UCLA) and Jeremy Laney (UCLA) for assistance with the human primary osteoblast cultures. This work is supported by U.S. National Institutes of Health grant 2R01AR037399-21 to J.S.A., and German National Genome Research Network NGFNplus grant 01GS0850 to J.B. The authors declare no conflicts of interest.	Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798; Adams JS, 2004, J STEROID BIOCHEM, V89-90, P461, DOI 10.1016/j.jsbmb.2004.03.016; ADAMS JS, J IMMUNOL, V182, P4289; Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Alvarez-Garcia O, 2010, KIDNEY INT, V78, P561, DOI 10.1038/ki.2010.173; Arbelle JE, 1996, ENDOCRINOLOGY, V137, P786, DOI 10.1210/en.137.2.786; Banwell CM, 2006, CLIN CANCER RES, V12, P2004, DOI 10.1158/1078-0432.CCR-05-1218; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Canaud G, 2010, AM J TRANSPLANT, V10, P1701, DOI 10.1111/j.1600-6143.2010.03152.x; Carlberg C, 2009, ANTICANCER RES, V29, P3485; Chen H, 2003, P NATL ACAD SCI USA, V100, P6109, DOI 10.1073/pnas.1031395100; Chen H, 2000, J BIOL CHEM, V275, P35557, DOI 10.1074/jbc.M007117200; Chen H, 2006, J BIOL CHEM, V281, P39114, DOI 10.1074/jbc.M608006200; Chung I, 2009, CANCER RES, V69, P967, DOI 10.1158/0008-5472.CAN-08-2307; DEMAY MB, 1992, P NATL ACAD SCI USA, V89, P8097, DOI 10.1073/pnas.89.17.8097; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fernandez-Garcia NI, 2005, ONCOGENE, V24, P6533, DOI 10.1038/sj.onc.1208801; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HEWISON M, 1993, CLIN ENDOCRINOL, V39, P663, DOI 10.1111/j.1365-2265.1993.tb02424.x; Iacobazzi V, 2004, HUM MUTAT, V24, P312, DOI 10.1002/humu.20085; Jurutka PW, 2007, J BONE MINER RES, V22, pV2, DOI 10.1359/JBMR.07S216; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kovalenko PL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-26; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Mahajan MC, 2005, P NATL ACAD SCI USA, V102, P15012, DOI 10.1073/pnas.0507596102; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Miller CW, 1997, MOL CARCINOGEN, V19, P254, DOI 10.1002/(SICI)1098-2744(199708)19:4<254::AID-MC6>3.0.CO;2-C; Muto A, 1999, BLOOD, V93, P2225, DOI 10.1182/blood.V93.7.2225.407a05_2225_2233; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; O'Kelly J, 2006, J STEROID BIOCHEM, V100, P107, DOI 10.1016/j.jsbmb.2006.04.003; Ohyama Y, 1996, J BIOL CHEM, V271, P30381, DOI 10.1074/jbc.271.48.30381; OMDAHL J, 2005, VITAMIN D, V1, P85; Penning TM, 2008, MOL CELL ENDOCRINOL, V281, P1, DOI 10.1016/j.mce.2007.10.008; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; TAY N, 1992, J VIROL, V66, P6841, DOI 10.1128/JVI.66.12.6841-6848.1992; Thakur MK, 2009, HORM RES, V71, P194, DOI 10.1159/000201107; Tiscornia G, 2000, MOL CELL, V5, P959, DOI 10.1016/S1097-2765(00)80261-0; Tolnay M, 1999, BIOCHEM J, V338, P417, DOI 10.1042/0264-6021:3380417; TOMONAGA T, 1995, J BIOL CHEM, V270, P4875, DOI 10.1074/jbc.270.9.4875; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wang QM, 1996, CANCER RES, V56, P264; Yang J, 2010, EXP HEMATOL, V38, P666, DOI 10.1016/j.exphem.2010.03.020; YEN A, 1994, EXP CELL RES, V214, P250, DOI 10.1006/excr.1994.1255; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; ZIEROLD C, 1994, P NATL ACAD SCI USA, V91, P900, DOI 10.1073/pnas.91.3.900	58	87	91	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					937	947		10.1096/fj.10-172577	http://dx.doi.org/10.1096/fj.10-172577			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21123297	Green Published			2022-12-25	WOS:000287806200014
J	Mason, FM; Heimsath, EG; Higgs, HN; Soderling, SH				Mason, Frank M.; Heimsath, Ernest G.; Higgs, Henry N.; Soderling, Scott H.			Bi-modal Regulation of a Formin by srGAP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; FC-GAMMA-R; RHO-GTPASES; MEDIATED PHAGOCYTOSIS; NEURONAL MIGRATION; ARP2/3 COMPLEX; FRL-ALPHA; ACTIN; DOMAIN; RAC	The maintenance of rapid and efficient actin dynamics in vivo requires coordination of filament assembly and disassembly. This regulation requires temporal and spatial integration of signaling pathways by protein complexes. However, it remains unclear how these complexes form and then regulate the actin cytoskeleton. Here, we identify a srGAP2 and formin-like 1 (FMNL1, also known as FRL1 or FRL alpha) complex whose assembly is regulated by Rac signaling. Our data suggest srGAP2 regulates FMNL1 in two ways; 1) Rac-mediated activation of FMNL1 leads to the recruitment of srGAP2, which contains a Rac-specific GAP domain; 2) the SH3 domain of srGAP2 binds the formin homology 1 domain of FMNL1 to inhibit FMNL1-mediated actin severing. Thus, srGAP2 can efficiently terminate the upstream activating Rac signal while also opposing an important functional output of FMNL1, namely actin severing. We also show that FMNL1 and srGAP2 localize to the actin-rich phagocytic cup of macrophage-derived cells, suggesting the complex may regulate this Rac- and actin-driven process in vivo. We propose that after Rac-dependent activation of FMNL1, srGAP2 mediates a potent mechanism to limit the duration of Rac action and inhibit formin activity during rapid actin dynamics.	[Mason, Frank M.; Soderling, Scott H.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Heimsath, Ernest G.; Higgs, Henry N.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Duke University; Dartmouth College	Soderling, SH (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27516 USA.	s.soderling@cellbio.duke.edu		Mason, Frank/0000-0003-1338-494X; Heimsath Jr, Ernest G/0000-0002-1839-6686; Higgs, Henry/0000-0002-2917-9644	National Institutes of Health [NS059957]; March of Dimes [5-FY07-671, GM069818]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059957, R56NS059957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS059957 (to S. H. S.). This work was also supported by March of Dimes Grant 5-FY07-671 (to S. H. S.) and GM069818 (to H. N. H.).	Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chesarone M, 2009, DEV CELL, V16, P292, DOI 10.1016/j.devcel.2008.12.001; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.255pe5; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000	40	33	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6577	6586		10.1074/jbc.M110.190397	http://dx.doi.org/10.1074/jbc.M110.190397			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148482	Green Published, hybrid			2022-12-25	WOS:000287476400067
J	Andersen, JT; Pehrson, R; Tolmachev, V; Daba, MB; Abrahmsen, L; Ekblad, C				Andersen, Jan Terje; Pehrson, Rikard; Tolmachev, Vladimir; Daba, Muluneh Bekele; Abrahmsen, Lars; Ekblad, Caroline			Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM-ALBUMIN; I-RELATED RECEPTOR; INTERSTITIAL EXCLUSION; ANTIBODY FRAGMENTS; FUSION PROTEIN; CONTINUOUS-INFUSION; AFFIBODY MOLECULE; IGG HOMEOSTASIS; THERAPEUTICS; EXPRESSION	The therapeutic and diagnostic efficiency of engineered small proteins, peptides, and chemical drug candidates is hampered by short in vivo serum half-life. Thus, strategies to tailor their biodistribution and serum persistence are highly needed. An attractive approach is to take advantage of the exceptionally long circulation half-life of serum albumin or IgG, which is attributed to a pH-dependent interaction with the neonatal Fc receptor (FcRn) rescuing these proteins from intracellular degradation. Here, we present molecular evidence that a minimal albumin binding domain (ABD) derived from streptococcal protein G can be used for efficient half-life extension by indirect targeting of FcRn. We show that ABD, and ABD recombinantly fused to an Affibody molecule, in complex with albumin does not interfere with the strictly pH-dependent FcRn-albumin binding kinetics. The same result was obtained in the presence of IgG. An in vivo study performed in rat confirmed that the clinically relevant human epidermal growth factor 2 (HER2)-targeting Affibody molecule fused to ABD has a similar half-life and biodistribution profile as serum albumin. The proof-of-concept described may be broadly applicable to extend the in vivo half-life of short lived biological or chemical drugs ultimately resulting in enhanced therapeutic or diagnostic efficiency, a more favorable dosing regimen, and improved patient compliance.	[Pehrson, Rikard; Tolmachev, Vladimir; Abrahmsen, Lars; Ekblad, Caroline] Affibody AB, SE-11251 Stockholm, Sweden; Univ Oslo, Ctr Immune Regulat, N-0316 Oslo, Norway; Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; [Tolmachev, Vladimir] Uppsala Univ, Rudbeck Lab, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden	University of Oslo; University of Oslo; Uppsala University	Ekblad, C (corresponding author), Affibody AB, Lindhagensgatan 133, SE-11251 Stockholm, Sweden.	caroline.ekblad@affibody.com	Tolmachev, Vladimir/I-3076-2012; Tolmachev, Vladimir/T-3722-2017; Tolmachev, Vladimir/U-3107-2019; Andersen, Jan Terje/AAB-6209-2020	Tolmachev, Vladimir/0000-0002-6122-1734; Tolmachev, Vladimir/0000-0002-6122-1734; Andersen, Jan Terje/0000-0003-1710-1628	Steering Board for Research in Molecular Biology, Biotechnology, and Bioinformatics at the University of Oslo; The Norwegian Research Council	Steering Board for Research in Molecular Biology, Biotechnology, and Bioinformatics at the University of Oslo; The Norwegian Research Council(Research Council of Norway)	This work was supported by grants from the Steering Board for Research in Molecular Biology, Biotechnology, and Bioinformatics at the University of Oslo (to J.T.A.) and The Norwegian Research Council (to J.T.A.).	Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2009, RECOMBINANT ANTIBODIES FOR IMMUNOTHERAPY, P293, DOI 10.1017/CBO9780511596773.023; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2010, CLIN BIOCHEM, V43, P367, DOI 10.1016/j.clinbiochem.2009.12.001; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Anderson CL, 2006, TRENDS IMMUNOL, V27, P343, DOI 10.1016/j.it.2006.05.004; Aunoble B, 2000, INT J ONCOL, V16, P567; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Chuang VTG, 2002, PHARMACEUT RES, V19, P569; Dennis MS, 2007, CANCER RES, V67, P254, DOI 10.1158/0008-5472.CAN-06-2531; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Halpern W, 2002, PHARMACEUT RES, V19, P1720, DOI 10.1023/A:1020917732218; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Jazayeri JA, 2008, BIODRUGS, V22, P11, DOI 10.2165/00063030-200822010-00002; Jonsson A, 2008, PROTEIN ENG DES SEL, V21, P515, DOI 10.1093/protein/gzn028; Konig T, 1998, J IMMUNOL METHODS, V218, P73, DOI 10.1016/S0022-1759(98)00112-4; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kwon Y., 2001, HDB ESSENTIAL PHARMA; Lejon S, 2004, J BIOL CHEM, V279, P42924, DOI 10.1074/jbc.M406957200; Makrides SC, 1996, J PHARMACOL EXP THER, V277, P534; McGregor DP, 2008, CURR OPIN PHARMACOL, V8, P616, DOI 10.1016/j.coph.2008.06.002; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; NYGREN PA, 1991, VACCINES, V91, P363; Ober RJ, 2004, J IMMUNOL, V172, P2021, DOI 10.4049/jimmunol.172.4.2021; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Orlova A, 2006, J NUCL MED, V47, P512; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Smith BJ, 2001, BIOCONJUGATE CHEM, V12, P750, DOI 10.1021/bc010003g; Stork R, 2007, PROTEIN ENG DES SEL, V20, P569, DOI 10.1093/protein/gzm061; Stork R, 2009, J BIOL CHEM, V284, P25612, DOI 10.1074/jbc.M109.027078; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Tolmachev V, 2007, CANCER RES, V67, P2773, DOI 10.1158/0008-5472.CAN-06-1630; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; Walker A, 2010, PROTEIN ENG DES SEL, V23, P271, DOI 10.1093/protein/gzp091; Ward ES, 2003, INT IMMUNOL, V15, P187, DOI 10.1093/intimm/dxg018; WIIG H, 1994, AM J PHYSIOL, V266, pH212, DOI 10.1152/ajpheart.1994.266.1.H212; WIIG H, 1992, AM J PHYSIOL, V263, pH1222, DOI 10.1152/ajpheart.1992.263.4.H1222; Wiig H, 2000, AM J PHYSIOL-HEART C, V278, pH1627, DOI 10.1152/ajpheart.2000.278.5.H1627; Wikman M, 2004, PROTEIN ENG DES SEL, V17, P455, DOI 10.1093/protein/gzh053; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812	52	122	144	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5234	5241		10.1074/jbc.M110.164848	http://dx.doi.org/10.1074/jbc.M110.164848			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21138843	hybrid, Green Published			2022-12-25	WOS:000287230600032
J	Chiu, J; Tactacan, CM; Tan, SX; Lin, RCY; Wouters, MA; Dawes, IW				Chiu, Joyce; Tactacan, Carole M.; Tan, Shi-Xiong; Lin, Ruby C. Y.; Wouters, Merridee A.; Dawes, Ian W.			Cell Cycle Sensing of Oxidative Stress in Saccharomyces cerevisiae by Oxidation of a Specific Cysteine Residue in the Transcription Factor Swi6p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT-MUTAGENESIS SLIM; START-SPECIFIC TRANSCRIPTION; LINOLEIC-ACID HYDROPEROXIDE; MAP KINASE PATHWAY; REGULATORY ASSOCIATIONS; S-GLUTATHIONYLATION; HYDROGEN-PEROXIDE; BUDDING YEAST; IDENTIFICATION; MECHANISMS	Yeast cells begin to bud and enter the S phase when growth conditions are favorable during the G(1) phase. When subjected to some oxidative stresses, cells delay entry at G(1), allowing repair of cellular damage. Hence, oxidative stress sensing is coordinated with the regulation of cell cycle. We identified a novel function of the cell cycle regulator of Saccharomyces cerevisiae, Swi6p, as a redox sensor through its cysteine residue at position 404. When alanine was substituted at this position, the resultant mutant, C404A, was sensitive to several reactive oxygen species and oxidants including linoleic acid hydroperoxide, the superoxide anion, and diamide. This mutant lost the ability to arrest in G(1) phase upon treatment with lipid hydroperoxide. The Cys-404 residue of Swi6p in wild-type cells was oxidized to a sulfenic acid when cells were subjected to linoleic acid hydroperoxide. Mutation of Cys-404 to Ala abolished the down-regulation of expression of the G(1) cyclin genes CLN1, CLN2, PCL1, and PCL2 that occurred when cells of the wild type were exposed to the lipid hydroperoxide. In conclusion, oxidative stress signaling for cell cycle regulation occurs through oxidation of the G(1)/S-speicific transcription factor Swi6p and consequently leads to suppression of the expression of G(1) cyclins and a delay in cells entering the cell cycle.	[Dawes, Ian W.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Wouters, Merridee A.] Victor Chang Cardiac Res Inst, Struct & Computat Biol Program, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Victor Chang Cardiac Research Institute	Dawes, IW (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia.	i.dawes@unsw.edu.au	Chiu, Joyce/H-7772-2017; Tan, Shi-Xiong/Y-3728-2019; Lin, Ruby CY/A-1636-2009; Wouters, Merridee/D-2046-2012; Wouters, Merridee A/G-2481-2015	Chiu, Joyce/0000-0001-8910-8664; Lin, Ruby CY/0000-0003-4163-511X; Wouters, Merridee A/0000-0002-2121-912X; Tan, Shi-Xiong/0000-0002-0020-2572	Australian Research Council; National Health and Medical Research Council Peter Doherty; University of New South Wales	Australian Research Council(Australian Research Council); National Health and Medical Research Council Peter Doherty; University of New South Wales	This work was supported by discovery grants from Australian Research Council (to I.W.D.) and National Health and Medical Research Council Peter Doherty and University of New South Wales vice-chancellor's post-doctoral fellowships (to R.C.Y.L.).	Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alic N, 2004, FREE RADICAL BIO MED, V37, P23, DOI 10.1016/j.freeradbiomed.2004.04.014; Alic N, 2003, J BIOL CHEM, V278, P41849, DOI 10.1074/jbc.M307760200; Alic N, 2001, MOL BIOL CELL, V12, P1801, DOI 10.1091/mbc.12.6.1801; Barrera G, 2005, BIOFACTORS, V24, P151, DOI 10.1002/biof.5520240118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; DIRICK L, 1992, NATURE, V357, P508, DOI 10.1038/357508a0; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Evans MV, 1998, J BACTERIOL, V180, P483, DOI 10.1128/JB.180.3.483-490.1998; Flattery-O'Brien JA, 1998, J BIOL CHEM, V273, P8564, DOI 10.1074/jbc.273.15.8564; FLATTERYOBRIEN J, 1993, J GEN MICROBIOL, V139, P501, DOI 10.1099/00221287-139-3-501; Fong CS, 2008, FEMS YEAST RES, V8, P386, DOI 10.1111/j.1567-1364.2007.00349.x; Foord R, 1999, NAT STRUCT BIOL, V6, P157; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; Gutteridge J. M., 1999, FREE RADICAL BIO MED, P36; Haase SB, 1997, METHOD ENZYMOL, V283, P322; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Neely MD, 2005, BRAIN RES, V1037, P90, DOI 10.1016/j.brainres.2004.12.027; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sedgwick SG, 1998, J MOL BIOL, V281, P763, DOI 10.1006/jmbi.1998.1996; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Shackelford RE, 1999, ENVIRON HEALTH PERSP, V107, P5, DOI 10.2307/3434468; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Siegmund RF, 1996, MOL CELL BIOL, V16, P2647; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, p371A; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102	57	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5204	5214		10.1074/jbc.M110.172973	http://dx.doi.org/10.1074/jbc.M110.172973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21147769	Green Published, hybrid			2022-12-25	WOS:000287230600029
J	Ranji, A; Shkriabai, N; Kvaratskhelia, M; Musier-Forsyth, K; Boris-Lawrie, K				Ranji, Arnaz; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka; Musier-Forsyth, Karin; Boris-Lawrie, Kathleen			Features of Double-stranded RNA-binding Domains of RNA Helicase A Are Necessary for Selective Recognition and Translation of Complex mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAD-BOX PROTEINS; VIRUS TYPE-1; REPORTER RNA; FAMILY; INTERACTS; RETROVIRUSES; EXPRESSION; NUCLEOLIN; SEQUENCE; DSRNA	The DExH protein RNA helicase A (RHA) plays numerous roles in cell physiology, and post-transcriptional activation of gene expression is a major role among them. RHA selectively activates translation of complex cellular and retroviral mRNAs. Although RHA requires interaction with structural features of the 5'-UTR of these target mRNAs, the molecular basis of their translation activation by RHA is poorly understood. RHA contains a conserved ATPase-dependent helicase core that is flanked by two alpha-beta-beta-beta-alpha double-stranded RNA-binding domains at the N terminus and repeated arginine-glycine residues at the C terminus. The individual recombinant N-erminal, centralhelicase, and C-terminal domains were evaluated for their ability to specifically interact with cognate RNAs by in vitro biochemical measurements and mRNA translation assays in cells. The results demonstrate that N-terminal residues confer selective interaction with retroviral and junD target RNAs. Conserved lysine residues in the distal alpha-helix of the double-stranded RNA-binding domains are necessary to engage structural features of retroviral and junD 5'-UTRs. Exogenous expression of the N terminus coprecipitates junD mRNA and inhibits the translation activity of endogenous RHA. The results indicate that the molecular basis for the activation of translation by RHA is recognition of target mRNA by the N-terminal domain that tethers the ATP-dependent helicase for rearrangement of the complex 5'-UTR.	[Ranji, Arnaz; Boris-Lawrie, Kathleen] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Musier-Forsyth, Karin] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Musier-Forsyth, Karin] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Ranji, Arnaz; Boris-Lawrie, Kathleen] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Ranji, Arnaz; Musier-Forsyth, Karin; Boris-Lawrie, Kathleen] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Ranji, Arnaz; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka; Musier-Forsyth, Karin; Boris-Lawrie, Kathleen] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Boris-Lawrie, K (corresponding author), Ohio State Univ, Dept Vet Biosci, 1925 Coffey Rd, Columbus, OH 43210 USA.	boris-lawrie.1@osu.edu	Boris-Lawrie, Kathleen/AAB-8953-2020	Boris-Lawrie, Kathleen/0000-0001-6366-6270	National Institutes of Health Grants [RO1CA108882, P30CA100730, RO1GM065056]; Ohio State University Comprehensive Cancer Center [P01CA16058]; Ohio State University College of Veterinary Medicine; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA108882, P01CA100730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065056] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Comprehensive Cancer Center; Ohio State University College of Veterinary Medicine(Ohio State University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA108882 (to K.B.- L.), P30CA100730 (to K.B.- L. and M.K.), RO1GM065056 (to K.M.- F.), and P01CA16058 (to the Ohio State University Comprehensive Cancer Center). This work was also supported by a Glenn Barber predoctoral fellowship from the Ohio State University College of Veterinary Medicine (to A.R.).	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Bolinger C, 2007, NUCLEIC ACIDS RES, V35, P2629, DOI 10.1093/nar/gkm124; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Butsch M, 1999, J VIROL, V73, P4847, DOI 10.1128/JVI.73.6.4847-4855.1999; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; Guenard F, 2009, J HUM GENET, V54, P152, DOI 10.1038/jhg.2009.6; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; Hull S, 2002, J VIROL, V76, P10211, DOI 10.1128/JVI.76.20.10211-10218.2002; Lebars I, 2001, EMBO J, V20, P7250, DOI 10.1093/emboj/20.24.7250; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Nagel R, 2000, RNA, V6, P1142, DOI 10.1017/S1355838200000431; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Roberts TM, 2003, J VIROL, V77, P11973, DOI 10.1128/JVI.77.22.11973-11984.2003; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Smith WA, 2004, J BIOL CHEM, V279, P22795, DOI 10.1074/jbc.C300512200; Stello T, 1999, NUCLEIC ACIDS RES, V27, P4823, DOI 10.1093/nar/27.24.4823; Stewart-Maynard KM, 2008, J VIROL, V82, P10129, DOI 10.1128/JVI.01169-08; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Zanotti KJ, 2006, BIOCHEMISTRY-US, V45, P8319, DOI 10.1021/bi060209a	37	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5328	5337		10.1074/jbc.M110.176339	http://dx.doi.org/10.1074/jbc.M110.176339			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21123178	Green Published, hybrid			2022-12-25	WOS:000287230600041
J	Hayashida, A; Amano, S; Park, PW				Hayashida, Atsuko; Amano, Shiro; Park, Pyong Woo			Syndecan-1 Promotes Staphylococcus aureus Corneal Infection by Counteracting Neutrophil-mediated Host Defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PSEUDOMONAS-AERUGINOSA; EPITHELIAL-CELLS; VIRULENCE FACTOR; ALPHA-TOXIN; BETA-TOXIN; BACTERIAL KERATITIS; LUNG INJURY; BINDING; INFILTRATION	Many microbial pathogens subvert cell surface heparan sulfate proteoglycans (HSPGs) to infect host cells in vitro. The significance of HSPG-pathogen interactions in vivo, however, remains to be determined. In this study, we examined the role of syndecan-1, a major cell surface HSPG of epithelial cells, in Staphylococcus aureus corneal infection. We found that syndecan-1 null (Sdc1(-/-)) mice significantly resist S. aureus corneal infection compared with wild type (WT) mice that express abundant syndecan-1 in their corneal epithelium. However, syndecan-1 did not bind to S. aureus, and syndecan-1 was not required for the colonization of cultured corneal epithelial cells by S. aureus, suggesting that syndecan-1 does not mediate S. aureus attachment to corneal tissues in vivo. Instead, S. aureus induced the shedding of syndecan-1 ectodomains from the surface of corneal epithelial cells. Topical administration of purified syndecan-1 ectodomains or heparan sulfate (HS) significantly increased, whereas inhibition of syndecan-1 shedding significantly decreased the bacterial burden in corneal tissues. Furthermore, depletion of neutrophils in the resistant Sdc1(-/-) mice increased the corneal bacterial burden to that of the susceptible WT mice, suggesting that syndecan-1 moderates neutrophils to promote infection. We found that syndecan-1 does not affect the infiltration of neutrophils into the infected cornea but that purified syndecan-1 ectodomain and HS significantly inhibit neutrophil-mediated killing of S. aureus. These data suggest a previously unknown bacterial subversion mechanism where S. aureus exploits the capacity of syndecan-1 ectodomains to inhibit neutrophil-mediated bacterial killing mechanisms in an HS-dependent manner to promote its pathogenesis in the cornea.	[Hayashida, Atsuko; Park, Pyong Woo] Harvard Univ, Childrens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Amano, Shiro] Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 1138655, Japan	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Tokyo	Park, PW (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Med, 320 Longwood Ave,Enders 461, Boston, MA 02115 USA.	pyong.park@childrens.harvard.edu		Park, Pyong Woo/0000-0002-7979-4979	National Institutes of Health [R01 HL94613]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL94613.	Bartlett AH, 2007, MOL CELLS, V24, P153; Bartlett AH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001367; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P834, DOI 10.1136/bjo.87.7.834; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carlson EC, 2006, INVEST OPHTH VIS SCI, V47, P241, DOI 10.1167/iovs.04-0741; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Chen HB, 1997, INVEST OPHTH VIS SCI, V38, P381; Chen Y, 2007, J BIOL CHEM, V282, P159, DOI 10.1074/jbc.M608542200; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Freissler E, 2000, CELL MICROBIOL, V2, P69, DOI 10.1046/j.1462-5822.2000.00036.x; Gao C, 2002, MOL CANCER RES, V1, P12; Girgis DO, 2005, INVEST OPHTH VIS SCI, V46, P2064, DOI 10.1167/iovs.04-0897; Gotte M, 2002, INVEST OPHTH VIS SCI, V43, P1135; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HAYASHI K, 1987, J HISTOCHEM CYTOCHEM, V35, P1079, DOI 10.1177/35.10.2957423; Hayashida A, 2009, AM J PATHOL, V174, P509, DOI 10.2353/ajpath.2009.080394; Hayashida K, 2008, J BIOL CHEM, V283, P19895, DOI 10.1074/jbc.M801614200; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Hayashida K, 2008, J BIOL CHEM, V283, P35435, DOI 10.1074/jbc.M804172200; Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005; Henry-Stanley MJ, 2003, MED MICROBIOL IMMUN, V192, P107, DOI 10.1007/s00430-002-0165-7; Hume EBH, 2000, INFECT IMMUN, V68, P6052, DOI 10.1128/IAI.68.10.6052-6055.2000; Jett BD, 2002, DNA CELL BIOL, V21, P397, DOI 10.1089/10445490260099683; Jett BD, 2002, INFECT IMMUN, V70, P4697, DOI 10.1128/IAI.70.8.4697-4700.2002; Khan S, 2007, J LEUKOCYTE BIOL, V81, P315, DOI 10.1189/jlb.0506344; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; LIANG OD, 1992, INFECT IMMUN, V60, P899, DOI 10.1128/IAI.60.3.899-906.1992; LIMBERG M B, 1991, American Journal of Ophthalmology, V112, p2S; Lin M, 2007, J LEUKOCYTE BIOL, V81, P786, DOI 10.1189/jlb.0806502; Ly CN, 2006, CLIN EXP OPHTHALMOL, V34, P44, DOI 10.1111/j.1442-9071.2006.01143.x; McCormick CC, 2009, INVEST OPHTH VIS SCI, V50, P2848, DOI 10.1167/iovs.08-3157; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; PARK PW, 1991, J BIOL CHEM, V266, P23399; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; PEREIRA HA, 1993, P NATL ACAD SCI USA, V90, P4733, DOI 10.1073/pnas.90.10.4733; Popova TG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-8; Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sack RA, 2001, BIOSCIENCE REP, V21, P463, DOI 10.1023/A:1017943826684; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Schaefer F, 2001, BRIT J OPHTHALMOL, V85, P842, DOI 10.1136/bjo.85.7.842; SHERERTZ RJ, 1993, J INFECT DIS, V167, P98, DOI 10.1093/infdis/167.1.98; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; Yost CC, 2009, BLOOD, V113, P6419, DOI 10.1182/blood-2008-07-171629; Zaidi TS, 2010, INVEST OPHTH VIS SCI, V51, P2085, DOI 10.1167/iovs.09-4139; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200	58	30	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3288	3297		10.1074/jbc.M110.185165	http://dx.doi.org/10.1074/jbc.M110.185165			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127056	Green Published, hybrid			2022-12-25	WOS:000286653200014
J	Della Bella, S; Taddeo, A; Colombo, E; Brambilla, L; Bellinvia, M; Pregliasco, F; Cappelletti, M; Calabro, ML; Villa, ML				Della Bella, Silvia; Taddeo, Adriano; Colombo, Elena; Brambilla, Lucia; Bellinvia, Monica; Pregliasco, Fabrizio; Cappelletti, Monica; Calabro, Maria Luisa; Villa, Maria Luisa			Human Herpesvirus-8 Infection Leads to Expansion of the Preimmune/Natural Effector B Cell Compartment	PLOS ONE			English	Article							CLASSIC KAPOSIS-SARCOMA; EFFUSION LYMPHOMA; PERIPHERAL-BLOOD; DENDRITIC CELLS; DC-SIGN; MEMORY; LYMPHOCYTES; NAIVE; VIRUS; EXPRESSION	Background: Human herpesvirus-8 (HHV-8) is the etiological agent of Kaposi's sarcoma (KS) and of some lymphoproliferative disorders of B cells. Most malignancies develop after long-lasting viral dormancy, and a preventing role for both humoral and cellular immune control is suggested by the high frequency of these pathologies in immunosuppressed patients. B cells, macrophages and dendritic cells of peripheral lymphoid organs and blood represent the major reservoir of HHV-8. Due to the dual role of B cells in HHV-8 infection, both as virus reservoir and as agents of humoral immune control, we analyzed the subset distribution and the functional state of peripheral blood B cells in HHV-8-infected individuals with and without cKS. Methodology/Principal Findings: Circulating B cells and their subsets were analyzed by 6-color flow cytometry in the following groups: 1- patients HHV-8 positive with classic KS (cKS) (n = 47); 2- subjects HHV-8 positive and cKS negative (HSP) (n = 10); 3- healthy controls, HHV-8 negative and cKS negative (HC) (n = 43). The number of B cells belonging to the preimmune/natural effector compartment, including transitional, pre-naive, naive and MZ-like subsets, was significantly higher among HHV-8 positive subjects, with or without cKS, while was comparable to healthy controls in the antigen-experienced T-cell dependent compartment. The increased number of preimmune/natural effector B cells was associated with increased resistance to spontaneous apoptosis, while it did not correlate with HHV-8 viral load. Conclusions/Significance: Our results indicate that long-lasting HHV-8 infection promotes an imbalance in peripheral B cell subsets, perturbing the equilibrium between earlier and later steps of maturation and activation processes. This observation may broaden our understanding of the complex interplay between viral and immune factors leading HHV-8-infected individuals to develop HHV-8-associated malignancies.	[Della Bella, Silvia; Taddeo, Adriano; Colombo, Elena; Cappelletti, Monica; Villa, Maria Luisa] Univ Milan, Dept Biomed Sci & Technol, I-20133 Milan, Italy; [Brambilla, Lucia; Bellinvia, Monica] Fdn IRCCS Osped Maggiore Policlin, Inst Dermatol Sci, Milan, Italy; [Pregliasco, Fabrizio] Univ Milan, Dept Publ Hlth Microbiol & Virol, Milan, Italy; [Calabro, Maria Luisa] IRCCS, IOV, Padua, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Istituto Oncologico Veneto (IOV)	Della Bella, S (corresponding author), Univ Milan, Dept Biomed Sci & Technol, I-20133 Milan, Italy.	silvia.dellabella@unimi.it	Pregliasco, Fabrizio Ernesto/D-1642-2012; pregliasco, fabrizio/AAD-7499-2022; Calabrò, Maria Luisa/H-6015-2016; Bella, Silvia Della/AAB-7904-2019; Taddeo, Adriano/AAW-3861-2021	Pregliasco, Fabrizio Ernesto/0000-0002-3919-0679; Calabrò, Maria Luisa/0000-0001-9401-6182; Taddeo, Adriano/0000-0003-3281-1548; Della Bella, Silvia/0000-0003-0818-5049	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2006065944-002, 2008A3E9WM]; Doctorate School of Molecular Medicine, University of Milan	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Doctorate School of Molecular Medicine, University of Milan	This work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) 2006065944-002 (to SDB) and 2008A3E9WM (to MLV and SDB). AT, EC and MC were supported by a fellowship of the Doctorate School of Molecular Medicine, University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JB, 2002, BLOOD, V99, P649, DOI 10.1182/blood.V99.2.649; Anolik J, 2003, EUR J IMMUNOL, V33, P2398, DOI 10.1002/eji.200323515; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Barozzi P, 2007, AUTOIMMUN REV, V7, P132, DOI 10.1016/j.autrev.2007.02.018; Boulanger E, 2004, AM J HEMATOL, V76, P88, DOI 10.1002/ajh.20048; Brambilla L, 2003, EUR J DERMATOL, V13, P83; Cagigi A, 2010, LANCET INFECT DIS, V10, P499, DOI 10.1016/S1473-3099(10)70117-1; Calabro M L, 1998, J Hum Virol, V1, P207; Carroll PA, 2004, VIROLOGY, V328, P7, DOI 10.1016/j.virol.2004.07.008; Chaganti S, 2008, BLOOD, V112, P672, DOI 10.1182/blood-2007-10-116269; Chaganti S, 2009, BLOOD, V113, P6372, DOI 10.1182/blood-2008-08-175828; Chandriani S, 2010, J VIROL, V84, P5565, DOI 10.1128/JVI.02723-09; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; Chong Y, 2005, INT IMMUNOL, V17, P383, DOI 10.1093/intimm/dxh218; Colonna-Romano G, 2009, MECH AGEING DEV, V130, P681, DOI 10.1016/j.mad.2009.08.003; Crowley JE, 2005, SEMIN IMMUNOL, V17, P193, DOI 10.1016/j.smim.2005.02.001; Dagklis A, 2009, BLOOD, V114, P26, DOI 10.1182/blood-2008-09-176933; Dagna L, 2005, NEW ENGL J MED, V353, P156, DOI 10.1056/NEJMoa042850; Della Bella S, 2006, CLIN IMMUNOL, V119, P317, DOI 10.1016/j.clim.2006.01.011; Della Bella S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001520; Della Bella S, 2008, J IMMUNOL METHODS, V339, P153, DOI 10.1016/j.jim.2008.09.009; Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Gasperini P, 2005, J CLIN MICROBIOL, V43, P2866, DOI 10.1128/JCM.43.6.2866-2875.2005; Ghia P, 2004, BLOOD, V103, P2337, DOI 10.1182/blood-2003-09-3277; Ginaldi L, 2001, AM J HEMATOL, V67, P63, DOI 10.1002/ajh.1082; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Hengge UR, 2002, LANCET INFECT DIS, V2, P344, DOI 10.1016/S1473-3099(02)00288-8; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Lanzavecchia A, 2009, CURR OPIN IMMUNOL, V21, P298, DOI 10.1016/j.coi.2009.05.019; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lee J, 2009, J IMMUNOL, V182, P4116, DOI 10.4049/jimmunol.0803391; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Monini P, 1999, BLOOD, V93, P4044; Ni JH, 2003, J IMMUNOL, V170, P3429, DOI 10.4049/jimmunol.170.6.3429; Palestro G, 1999, Adv Clin Path, V3, P11; Pensierosoa S, 2009, P NATL ACAD SCI USA, V106, P7939, DOI 10.1073/pnas.0901702106; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Racanelli V, 2006, J VIROL, V80, P3923, DOI 10.1128/JVI.80.8.3923-3934.2006; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Rappocciolo G, 2008, J VIROL, V82, P4793, DOI 10.1128/JVI.01587-07; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Sato S, 2004, ARTHRITIS RHEUM-US, V50, P1918, DOI 10.1002/art.20274; Schulz TF, 1998, J GEN VIROL, V79, P1573, DOI 10.1099/0022-1317-79-7-1573; Taddeo A, 2008, J INVEST DERMATOL, V128, P2125, DOI 10.1038/jid.2008.23; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Toubi E, 2004, J VIROL, V78, P11379, DOI 10.1128/JVI.78.20.11379-11384.2004; VALENTINE MA, 1987, P NATL ACAD SCI USA, V84, P8085, DOI 10.1073/pnas.84.22.8085; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wirths S, 2005, EUR J IMMUNOL, V35, P3433, DOI 10.1002/eji.200535364; Xu GW, 2007, BIOCHEM BIOPH RES CO, V361, P745, DOI 10.1016/j.bbrc.2007.07.052	57	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15029	10.1371/journal.pone.0015029	http://dx.doi.org/10.1371/journal.pone.0015029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124778	Green Published, gold			2022-12-25	WOS:000284686500019
J	Kersulyte, D; Kalia, A; Gilman, RH; Mendez, M; Herrera, P; Cabrera, L; Velapatino, B; Balqui, J; de la Vega, FPP; Ulloa, CAR; Cok, J; Hooper, CC; Dailide, G; Tamma, S; Berg, DE				Kersulyte, Dangeruta; Kalia, Awdhesh; Gilman, Robert H.; Mendez, Melissa; Herrera, Phabiola; Cabrera, Lilia; Velapatino, Billie; Balqui, Jacqueline; Puente de la Vega, Freddy Paredes; Rodriguez Ulloa, Carlos A.; Cok, Jaime; Hooper, Catherine C.; Dailide, Giedrius; Tamma, Sravya; Berg, Douglas E.			Helicobacter pylori from Peruvian Amerindians: Traces of Human Migrations in Strains from Remote Amazon, and Genome Sequence of an Amerind Strain	PLOS ONE			English	Article							INSERTION SPECIFICITY; FUNCTIONAL-ORGANIZATION; TRANSPOSABLE ELEMENT; INFECTION; CAGA; INFLAMMATION; DISEASES; TRANSMISSION; ASSOCIATION; POPULATIONS	Background: The gastric pathogen Helicobacter pylori is extraordinary in its genetic diversity, the differences between strains from well-separated human populations, and the range of diseases that infection promotes. Principal Findings: Housekeeping gene sequences from H. pylori from residents of an Amerindian village in the Peruvian Amazon, Shimaa, were related to, but not intermingled with, those from Asia. This suggests descent of Shimaa strains from H. pylori that had infected the people who migrated from Asia into The Americas some 15,000+ years ago. In contrast, European type sequences predominated in strains from Amerindian Lima shantytown residents, but with some 12% Amerindian or East Asian-like admixture, which indicates displacement of ancestral purely Amerindian strains by those of hybrid or European ancestry. The genome of one Shimaa village strain, Shi470, was sequenced completely. Its SNP pattern was more Asian-than European-like genome-wide, indicating a purely Amerind ancestry. Among its unusual features were two cagA virulence genes, each distinct from those known from elsewhere; and a novel allele of gene hp0519, whose encoded protein is postulated to interact with host tissue. More generally, however, the Shi470 genome is similar in gene content and organization to those of strains from industrialized countries. Conclusions: Our data indicate that Shimaa village H. pylori descend from Asian strains brought to The Americas many millennia ago; and that Amerind strains are less fit than, and were substantially displaced by, hybrid or European strains in less isolated communities. Genome comparisons of H. pylori from Amerindian and other communities should help elucidate evolutionary forces that have shaped pathogen populations in The Americas and worldwide.	[Kersulyte, Dangeruta; Mendez, Melissa; Velapatino, Billie; Dailide, Giedrius; Tamma, Sravya; Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Kalia, Awdhesh] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Gilman, Robert H.; Mendez, Melissa; Herrera, Phabiola; Velapatino, Billie; Balqui, Jacqueline; Hooper, Catherine C.] Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru; [Gilman, Robert H.; Cabrera, Lilia] Asociac Benef PRISMA, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Puente de la Vega, Freddy Paredes] Ctr Salud, Kepashiato, Cusco, Peru; [Rodriguez Ulloa, Carlos A.; Cok, Jaime] Policlin Peruano Japones, Lima, Peru; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); University of Louisville; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Washington University (WUSTL); Washington University (WUSTL)	Kersulyte, D (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	berg@borcim.wustl.edu	Herrera, Phabiola/AAL-7992-2021; Méndez, Melissa M/E-2833-2017	Méndez, Melissa M/0000-0001-8061-5002; Kalia, Awdhesh/0000-0001-5365-1702; Velapatino, Billie/0000-0003-3791-8395	US National Institutes of Health (NIH) [RO1 DK63041, R21 AI078237, R21 AI088337, 5R24 TW007988]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088337, R21AI078237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063041] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the US National Institutes of Health (NIH) RO1 DK63041, R21 AI078237, R21 AI088337 and 5R24 TW007988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Barbujani G, 2010, TRENDS GENET, V26, P285, DOI 10.1016/j.tig.2010.04.002; BIANCHINE PJ, 2002, ALLERGY PROC, V13, P225; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; D'Elios MM, 2009, HELICOBACTER, V14, P21, DOI 10.1111/j.1523-5378.2009.00698.x; Devi SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-191; Diamond J., 2010, RUZHYA MIKROBY STALI; Dominguez-Bello MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003307; Dorer MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000544; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; FISCHER W, 2010, NUCL ACIDS RES; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Graham DY, 2007, HELICOBACTER, V12, P64, DOI 10.1111/j.1523-5378.2007.00566.x; Herrera PM, 2008, J CLIN MICROBIOL, V46, P3912, DOI 10.1128/JCM.01453-08; Hunefeldt Christine, 2004, BRIEF HIST PERU; Hussein NR, 2010, EUR J CLIN MICROBIOL, V29, P817, DOI 10.1007/s10096-010-0933-z; Jeong JY, 2001, J BACTERIOL, V183, P5155, DOI 10.1128/JB.183.17.5155-5162.2001; Karnholz A, 2006, J BACTERIOL, V188, P882, DOI 10.1128/JB.188.3.882-893.2006; Kersulyte D, 1998, GENE, V223, P175, DOI 10.1016/S0378-1119(98)00164-4; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kersulyte D, 2004, J BACTERIOL, V186, P7521, DOI 10.1128/JB.186.22.7521-7528.2004; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Makola D, 2007, J CLIN GASTROENTEROL, V41, P548, DOI 10.1097/MCG.0b013e318030e3c3; Malaty HM, 2007, BEST PRACT RES CL GA, V21, P205, DOI 10.1016/j.bpg.2006.10.005; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Masterson D. M., 2003, JAPANESE LATIN AM; Matic I, 2000, J BACTERIOL, V182, P5922, DOI 10.1128/JB.182.20.5922-5924.2000; Meagher Arnold J., 2008, COOLIE TRADE TRAFFIC; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Nei M., 2000, MOL EVOLUTION PHYLOG; O'Rourke DH, 2009, CURR BIOL, V19, pR203, DOI 10.1016/j.cub.2009.01.021; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Oleastro M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-248; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Peck B, 1999, NUCLEIC ACIDS RES, V27, P3325, DOI 10.1093/nar/27.16.3325; Perry S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008804; RecavarrenArce S, 1997, CLIN INFECT DIS, V25, P1006, DOI 10.1086/516080; Robinson K, 2007, BEST PRACT RES CL GA, V21, P237, DOI 10.1016/j.bpg.2007.01.001; Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180; Soto G, 2003, J INFECT DIS, V188, P1263, DOI 10.1086/379046; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tegtmeyer N, 2009, CELL MICROBIOL, V11, P488, DOI 10.1111/j.1462-5822.2008.01269.x; Templeton AR, 2005, YEARB PHYS ANTHROPOL, V48, P33, DOI 10.1002/ajpa.20351; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang G, 1999, TRENDS MICROBIOL, V7, P488, DOI 10.1016/S0966-842X(99)01632-7; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Yamaoka Y, 2008, J MED MICROBIOL, V57, P545, DOI 10.1099/jmm.0.2008/000570-0	66	62	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15076	10.1371/journal.pone.0015076	http://dx.doi.org/10.1371/journal.pone.0015076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124785	Green Published, gold			2022-12-25	WOS:000284686500034
J	de Vries, HS; Morsche, RHMT; van Oijen, MGH; Nagtegaal, ID; Peters, WHM; de Jong, DJ				de Vries, Hilbert S.; Morsche, Rene H. M. Te; van Oijen, Martijn G. H.; Nagtegaal, Iris D.; Peters, Wilbert H. M.; de Jong, Dirk J.			The Functional-765G -> C Polymorphism of the COX-2 Gene May Reduce the Risk of Developing Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CYCLOOXYGENASE 2; MESSENGER-RNA; EXPRESSION; ASSOCIATION; COLITIS; CANCER; PREVALENCE; INHIBITORS; RELAPSE	Background: Cyclooxygenase-2 (COX-2) is a key enzyme involved in the conversion of arachidonic acid into prostaglandins. COX-2 is mainly induced at sites of inflammation in response to proinflammatory cytokines such as interleukin-1 alpha/beta, interferon-gamma and tumor necrosis factor-alpha produced by inflammatory cells. Aim: The aim of this study was to investigate the possible modulating effect of the functional COX-2 polymorphisms -1195 A -> G and -765G -> C on the risk for development of inflammatory bowel disease (IBD) in a Dutch population. Methods: Genomic DNA of 525 patients with Crohn's disease (CD), 211 patients with ulcerative colitis (UC) and 973 healthy controls was genotyped for the -1195 A -> G (rs689466) and -765G -> C (rs20417) polymorphisms. Distribution of genotypes in patients and controls were compared and genotype-phenotype interactions were investigated. Results: The genotype distribution of the -1195A -> G polymorphism was not different between the patients with CD or UC and the control group. The -765GC genotype was more prevalent in CD patients compared to controls with an OR of 1.33 (95% CI 1.04-1.69, p < 0.05). The -765GC and -765CC genotype carriers showed a tendency to be less frequent in patients with CD compared to controls, with ORs of 0.78 (95% CI: 0.61-1.00) and 0.49 (95% CI 0.22-1.08), respectively. Combining homozygous and heterozygous patients with the -765C allele showed a reduced risk for developing CD, with an OR of 0.75 (95% CI: 0.59-0.96). In the context of this, the G(-1195)G(-765)/A(-1195)C(-765) diplotype was significantly less common in patients with CD compared to controls, with an OR of 0.62 (95% CI: 0.39-0.98). For UC however, such an effect was not observed. No correlation was found between COX-2 diplotypes and clinical characteristics of IBD. Conclusions: The -765G -> C polymorphism was associated with a reduced risk for developing Crohn's disease in a Dutch population.	[de Vries, Hilbert S.; Morsche, Rene H. M. Te; van Oijen, Martijn G. H.; Peters, Wilbert H. M.; de Jong, Dirk J.] Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Nagtegaal, Iris D.] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Oijen, Martijn G. H.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	de Vries, HS (corresponding author), Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	h.devries@mdl.umcn.nl	Nagtegaal, Iris D/A-2448-2014; de Jong, D.J./L-4417-2015; te Morsche, R/P-9143-2015; Peters, W.H.M./L-4572-2015	Nagtegaal, Iris D/0000-0003-0887-4127; de Vries, Hilbert/0000-0003-4058-6459				Agoff SN, 2000, AM J PATHOL, V157, P737, DOI 10.1016/S0002-9440(10)64587-7; ANDERSEN V, INFLAMM BOW IN PRESS; Biancone L, 2004, ALIMENT PHARM THER, V19, P755, DOI 10.1111/j.1365-2036.2004.01907.x; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Carty E, 2000, GUT, V46, P487, DOI 10.1136/gut.46.4.487; Casparie M, 2007, CELL ONCOL, V29, P19; Courivaud C, 2009, AM J TRANSPLANT, V9, P2752, DOI 10.1111/j.1600-6143.2009.02830.x; Cox DG, 2005, WORLD J GASTROENTERO, V11, P6003, DOI 10.3748/wjg.v11.i38.6003; Fornai M, 2010, PHARMACOL THERAPEUT, V125, P62, DOI 10.1016/j.pharmthera.2009.09.007; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; Hasegawa K, 2001, EUR J CANCER, V37, P1469, DOI 10.1016/S0959-8049(01)00137-X; Hendel J, 1997, AM J GASTROENTEROL, V92, P1170; Hoff JH, 2009, WORLD J GASTROENTERO, V15, P4561, DOI 10.3748/wjg.15.4561; Hugot JP, 2007, AM J GASTROENTEROL, V102, P1259, DOI 10.1111/j.1572-0241.2007.01149.x; Jiang GL, 2007, J PHARMACOL EXP THER, V320, P22, DOI 10.1124/jpet.106.111146; Mariani F, 2009, CANCER LETT, V279, P221, DOI 10.1016/j.canlet.2009.02.001; Martin GR, 2006, EXP BIOL MED, V231, P130; Matuk R, 2004, INFLAMM BOWEL DIS, V10, P352, DOI 10.1097/00054725-200407000-00005; Ostergaard M, 2009, SCAND J GASTROENTERO, V44, P65, DOI 10.1080/00365520802400826; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; Peters WHM, 2009, HEAD NECK-J SCI SPEC, V31, P938, DOI 10.1002/hed.21058; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Roberts PJ, 2001, GUT, V48, P468, DOI 10.1136/gut.48.4.468; Rudock ME, 2009, ATHEROSCLEROSIS, V203, P459, DOI 10.1016/j.atherosclerosis.2008.07.018; Sanak M, 2005, J ALLERGY CLIN IMMUN, V116, P221, DOI 10.1016/j.jaci.2005.03.010; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Szczeklik W, 2004, J ALLERGY CLIN IMMUN, V114, P248, DOI 10.1016/j.jaci.2004.05.030; Tabernero A, 2003, CIRCULATION, V107, P1407, DOI 10.1161/01.CIR.0000055321.13957.17; Takeuchi K, 2006, CLIN GASTROENTEROL H, V4, P196, DOI 10.1016/S1542-3565(05)00980-8; Tan W, 2007, CARCINOGENESIS, V28, P1197, DOI 10.1093/carcin/bgl242; Trifan OC, 2003, J CELL MOL MED, V7, P207, DOI 10.1111/j.1582-4934.2003.tb00222.x; Wallace JL, 2006, THESCIENTIFICWORLDJO, V6, P577, DOI 10.1100/tsw.2006.122; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Westbrook AM, 2010, MUTAT RES-REV MUTAT, V705, P40, DOI 10.1016/j.mrrev.2010.03.001; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003; Zhao D, 2009, GASTROENTEROLOGY, V136, P1659, DOI 10.1053/j.gastro.2009.01.071	40	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15011	10.1371/journal.pone.0015011	http://dx.doi.org/10.1371/journal.pone.0015011			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124790	Green Published, Green Submitted, gold			2022-12-25	WOS:000284572000016
J	Knirr, S; Gomos-Klein, J; Andino, BE; Harrow, F; Erhard, KF; Kovalovsky, D; Sant'Angelo, DB; Ortiz, BD				Knirr, Stefan; Gomos-Klein, Janette; Andino, Blanca E.; Harrow, Faith; Erhard, Karl F.; Kovalovsky, Damian; Sant'Angelo, Derek B.; Ortiz, Benjamin D.			Ectopic T Cell Receptor-alpha Locus Control Region Activity in B Cells Is Suppressed by Direct Linkage to Two Flanking Genes at Once	PLOS ONE			English	Article							CHAIN CONSTANT-REGION; TCR-ALPHA; ALPHA/DELTA LOCUS; IN-VIVO; TRANSGENIC MICE; TRANSCRIPTION FACTORS; DAD1 GENES; EXPRESSION; ELEMENT; DEATH	The molecular mechanisms regulating the activity of the TCR alpha gene are required for the production of the circulating T cell repertoire. Elements of the mouse TCR alpha locus control region (LCR) play a role in these processes. We previously reported that TCR alpha LCR DNA supports a gene expression pattern that mimics proper thymus-stage, TCR alpha gene-like developmental regulation. It also produces transcription of linked reporter genes in peripheral T cells. However, TCR alpha LCR-driven transgenes display ectopic transcription in B cells in multiple reporter gene systems. The reasons for this important deviation from the normal TCR alpha gene regulation pattern are unclear. In its natural locus, two genes flank the TCR alpha LCR, TCR alpha (upstream) and Dad1 (downstream). We investigated the significance of this gene arrangement to TCR alpha LCR activity by examining transgenic mice bearing a construct where the LCR was flanked by two separate reporter genes. Surprisingly, the presence of a second, distinct, reporter gene downstream of the LCR virtually eliminated the ectopic B cell expression of the upstream reporter observed in earlier studies. Downstream reporter gene activity was unaffected by the presence of a second gene upstream of the LCR. Our findings indicate that a gene arrangement in which the TCR alpha LCR is flanked by two distinct transcription units helps to restrict its activity, selectively, on its 5'-flanking gene, the natural TCR alpha gene position with respect to the LCR. Consistent with these findings, a TCR alpha/Dad1 locus bacterial artificial chromosome dual-reporter construct did not display the ectopic upstream (TCR alpha) reporter expression in B cells previously reported for single TCR alpha transgenes.	[Knirr, Stefan; Gomos-Klein, Janette; Andino, Blanca E.; Harrow, Faith; Erhard, Karl F.; Ortiz, Benjamin D.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Kovalovsky, Damian; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Div Immunol, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); Memorial Sloan Kettering Cancer Center	Knirr, S (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	Ortiz@genectr.hunter.cuny.edu			National Institutes of Health (NIH) [AI-053050, GM-007823, GM-060665]; National Science Foundation [MCB-0236964]; Weill-Cornell Clinical Translational Science Center (NIH) [UL1-RR024996]; Hunter College Gene Center (NIH) [RR03037]; Ford Foundation; National Research Council; Hunter College Gene Center; Howard Hughes Medical Institute; National Cancer Institute [P30-CA 08748];  [T32-CA-09149-32]; NATIONAL CANCER INSTITUTE [P30CA008748, T32CA009149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996, G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053050, R21AI053050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007823, R25GM060665] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Weill-Cornell Clinical Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hunter College Gene Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation; National Research Council; Hunter College Gene Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant AI-053050 and National Science Foundation grant MCB-0236964 (to B.D.O.) and completed with the support of the collaborative pilot project program (to B.D.O. and D.B.S.) of the Weill-Cornell Clinical Translational Science Center (NIH grant UL1-RR024996) and the Hunter College Gene Center (NIH grant RR03037). The Hunter College Gene Center is also acknowledged for its support of J.G.K. through its Gene Center Fellows program, and S.K. and B.E.A. through its bridge funding program. B.E. A. was also supported by the Minority Access to Research Careers (MARC) program at Hunter College funded by NIH grant GM-007823. F.H. was supported by the Minority Biomedical Research Support (MBRS) program at Hunter College funded by NIH grant GM-060665 and a Ford Foundation Dissertation Fellowship from the National Research Council. K.F.E. was supported by the Howard Hughes Medical Institute Undergraduate Education Program at Hunter College. National Cancer Institute grant P30-CA 08748 provides partial support for MSKCC's Monoclonal Antibody, Flow Cytometry, Glassware Washing core facilities and the Research Animal Resource Center. D.K. is supported by grant T32-CA-09149-32. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abarrategui I, 2009, ADV EXP MED BIOL, V650, P93; Adlam M, 2003, IMMUNITY, V18, P173, DOI 10.1016/S1074-7613(03)00021-9; Bassing CH, 2003, P NATL ACAD SCI USA, V100, P2598, DOI 10.1073/pnas.0437943100; Brewster JL, 2000, GENESIS, V26, P271, DOI 10.1002/(SICI)1526-968X(200004)26:4<271::AID-GENE90>3.0.CO;2-E; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Gomos-Klein J, 2007, J IMMUNOL, V179, P1088, DOI 10.4049/jimmunol.179.2.1088; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Harrow F, 2005, J IMMUNOL, V175, P6659, DOI 10.4049/jimmunol.175.10.6659; Harrow F, 2004, J BIOL CHEM, V279, P17842, DOI 10.1074/jbc.M401258200; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hernandez-Munain C, 1998, MOL CELL BIOL, V18, P3223, DOI 10.1128/MCB.18.6.3223; Hong NA, 2000, DEV BIOL, V220, P76, DOI 10.1006/dbio.2000.9615; Hong NA, 1997, MOL CELL BIOL, V17, P2151, DOI 10.1128/MCB.17.4.2151; Hozumi K, 2000, IMMUNOL LETT, V71, P61, DOI 10.1016/S0165-2478(99)00167-4; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kabra NH, 1999, J IMMUNOL, V162, P2766; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; Kushida MM, 1997, J IMMUNOL, V159, P4913; LANG G, 1991, NUCLEIC ACIDS RES, V19, P5851, DOI 10.1093/nar/19.21.5851; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; LEIDEN JM, 1993, ANNU REV IMMUNOL, V11, P539, DOI 10.1146/annurev.iy.11.040193.002543; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Lin O, 2003, DEVELOPMENT, V130, P519, DOI 10.1242/dev.00227; Lobito AA, 2004, EUR J IMMUNOL, V34, P890, DOI 10.1002/eji.200324675; Magdinier F, 2004, J BIOL CHEM, V279, P25381, DOI 10.1074/jbc.M403121200; Melton E, 1996, EUR J IMMUNOL, V26, P2952, DOI 10.1002/eji.1830261222; NAKASHIMA T, 1993, MOL CELL BIOL, V13, P6367, DOI 10.1128/MCB.13.10.6367; Nishii K, 1999, GENES CELLS, V4, P243, DOI 10.1046/j.1365-2443.1999.00256.x; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Ortiz BD, 1999, MOL CELL BIOL, V19, P1901; Ortiz BD, 1997, EMBO J, V16, P5037, DOI 10.1093/emboj/16.16.5037; Ortiz BD, 2001, J IMMUNOL, V167, P3836, DOI 10.4049/jimmunol.167.7.3836; Papapetrou EP, 2009, J CLIN INVEST, V119, P157, DOI 10.1172/JCI37216; Ramirez J, 2010, CURR OPIN IMMUNOL, V22, P177, DOI 10.1016/j.coi.2010.02.003; Sabbattini P, 1999, MOL CELL BIOL, V19, P671; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000; SMITH VM, 1995, J BIOL CHEM, V270, P1515, DOI 10.1074/jbc.270.4.1515; Stolzer AL, 2005, EUR J IMMUNOL, V35, P1822, DOI 10.1002/eji.200526123; Wang K, 1997, IMMUNOGENETICS, V46, P376, DOI 10.1007/s002510050291; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Yang L, 2005, P NATL ACAD SCI USA, V102, P4518, DOI 10.1073/pnas.0500600102; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhong XP, 1999, J IMMUNOL, V163, P295; Zhou JM, 1999, CELL, V99, P567, DOI 10.1016/S0092-8674(00)81546-9	51	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e15527	10.1371/journal.pone.0015527	http://dx.doi.org/10.1371/journal.pone.0015527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124935	gold, Green Published			2022-12-25	WOS:000284467200020
J	Kelly, NE; Shea, EK; Metaxas, A; Haedrich, RL; Auster, PJ				Kelly, Noreen E.; Shea, Elizabeth K.; Metaxas, Anna; Haedrich, Richard L.; Auster, Peter J.			Biodiversity of the Deep-Sea Continental Margin Bordering the Gulf of Maine (NW Atlantic): Relationships among Sub-Regions and to Shelf Systems	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; WATER GORGONIAN CORALS; NEAR-BOTTOM CURRENTS; NEW-ENGLAND; SPECIES RICHNESS; TAXONOMIC DISTINCTNESS; SUBMARINE-CANYON; UNITED-STATES; NOVA-SCOTIA; SLOPE	Background: In contrast to the well-studied continental shelf region of the Gulf of Maine, fundamental questions regarding the diversity, distribution, and abundance of species living in deep-sea habitats along the adjacent continental margin remain unanswered. Lack of such knowledge precludes a greater understanding of the Gulf of Maine ecosystem and limits development of alternatives for conservation and management. Methodology/Principal Findings: We use data from the published literature, unpublished studies, museum records and online sources, to: (1) assess the current state of knowledge of species diversity in the deep-sea habitats adjacent to the Gulf of Maine (39-43 degrees N, 63-71 degrees W, 150-3000 m depth); (2) compare patterns of taxonomic diversity and distribution of megafaunal and macrofaunal species among six distinct sub-regions and to the continental shelf; and (3) estimate the amount of unknown diversity in the region. Known diversity for the deep-sea region is 1,671 species; most are narrowly distributed and known to occur within only one sub-region. The number of species varies by sub-region and is directly related to sampling effort occurring within each. Fishes, corals, decapod crustaceans, molluscs, and echinoderms are relatively well known, while most other taxonomic groups are poorly known. Taxonomic diversity decreases with increasing distance from the continental shelf and with changes in benthic topography. Low similarity in faunal composition suggests the deep-sea region harbours faunal communities distinct from those of the continental shelf. Non-parametric estimators of species richness suggest a minimum of 50% of the deep-sea species inventory remains to be discovered. Conclusions/Significance: The current state of knowledge of biodiversity in this deep-sea region is rudimentary. Our ability to answer questions is hampered by a lack of sufficient data for many taxonomic groups, which is constrained by sampling biases, life-history characteristics of target species, and the lack of trained taxonomists.	[Kelly, Noreen E.] Bedford Inst Oceanog, Ctr Marine Biodivers, Dartmouth, NS, Canada; [Shea, Elizabeth K.] Delaware Museum Nat Hist, Dept Mollusks, Wilmington, DE USA; [Metaxas, Anna] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Haedrich, Richard L.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Auster, Peter J.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Auster, Peter J.] Univ Connecticut, NE Underwater Res Technol & Educ Ctr, Groton, CT USA	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University; Memorial University Newfoundland; University of Connecticut; University of Connecticut	Kelly, NE (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	kellyne@yorku.ca	KELLY, NOREEN E/H-7628-2019; Auster, Peter/ABI-3568-2020	KELLY, NOREEN E/0000-0002-5432-5658; Shea, Elizabeth/0000-0002-5379-8410	Alfred P. Sloan Foundation; University of Southern Maine, Portland, Maine; Centre for Marine Biodiversity Centre for Marine Biodiversity, Bedford Institute of Oceanography, Dartmouth, Nova Scotia	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); University of Southern Maine, Portland, Maine; Centre for Marine Biodiversity Centre for Marine Biodiversity, Bedford Institute of Oceanography, Dartmouth, Nova Scotia	This synthesis was funded by a grant from the Alfred P. Sloan Foundation to the Gulf of Maine Area program of the Census of Marine Life, which is run jointly by scientists at the University of Southern Maine, Portland, Maine (L. S. Incze and S. L. Ellis) and the Centre for Marine Biodiversity, Bedford Institute of Oceanography, Dartmouth, Nova Scotia (P. Lawton). N. Kelly was supported by a post-doctoral fellowship at the Centre for Marine Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auster Peter J., 1996, Reviews in Fisheries Science, V4, P185; Auster PJ, 2005, ERLANGEN EARTH C SER, P761, DOI 10.1007/3-540-27673-4_40; BISCAYE PE, 1988, CONT SHELF RES, V8, P855, DOI 10.1016/0278-4343(88)90080-5; BOUCHET P, 2006, EXPLORATION MARINE B, P33; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Bryan TL, 2006, DEEP-SEA RES PT I, V53, P1865, DOI 10.1016/j.dsr.2006.09.006; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Buhl-Mortensen L, 2004, J NAT HIST, V38, P1233, DOI 10.1080/0022293031000155205; Cairns SD, 2007, P BIOL SOC WASH, V120, P243, DOI 10.2988/0006-324X(2007)120[243:SOWAOG]2.0.CO;2; CHO WW, 2008, THESIS MIT WHOI; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Cogswell A. T., 2009, 2855 FISH AQ SCI; Colwell R. K., 2006, ESTIMATES VERSION 8; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cooper R. A., 1987, NOAA S SER UNDERSEA, V2, P17; CSANADY GT, 1988, CONT SHELF RES, V8, P653, DOI 10.1016/0278-4343(88)90070-2; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; DeVaney SC, 2009, NORTHEAST NAT, V16, P409, DOI 10.1656/045.016.n308; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; DUNCAN RA, 1984, J GEOPHYS RES, V89, P9980, DOI 10.1029/JB089iB12p09980; ESSIM Planning Office, 2006, 200601 ESSIM PLANN O; FADER GBJ, 1988, 1692 GEOL SURV CAN; Gage JD, 1992, DEEP SEA BIOL NATURA; Giere, 2009, MEIOBENTHOLOGY THE M; Gordon J. D. M., 2003, Journal of Northwest Atlantic Fishery Science, V31, P57; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; GREENE CH, 1988, SCIENCE, V241, P359, DOI 10.1126/science.241.4863.359; HAEDRICH RL, 1975, J MAR RES, V33, P191; HAEDRICH RL, 1980, MAR BIOL, V57, P165, DOI 10.1007/BF00390735; Hamilton P., 1996, J MAR ENV ENG, V2, P203; Hartel KE, 2008, NORTHEAST NAT, V15, P317, DOI 10.1656/1092-6194-15.3.317; HECKER B, 1990, DEEP-SEA RES, V37, P37, DOI 10.1016/0198-0149(90)90028-T; Hecker B., 1980, EPIFAUNAL ZONATION C; Hecker B, 1983, CANYON SLOPE PROCESS; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; International Council for the Exploration of the Sea (ICES), 2008, ICES NAFO JOINT WORK; Kendall VJ, 2006, DEEP-SEA RES PT I, V53, P506, DOI 10.1016/j.dsr.2005.12.005; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; LAMBSHEAD PJD, 1993, OCEANIS S D, V19, P5; Loder JW, 2001, DEEP-SEA RES PT II, V48, P3, DOI 10.1016/S0967-0645(00)00080-1; MACIOLEK N, 1987, STUDY BIOL PROCESSES; Maciolek NJ, 2009, DEEP-SEA RES PT II, V56, P1763, DOI 10.1016/j.dsr2.2009.05.031; MACIOLEKBLAKE NJ, 1985, GEORGES BANK INFAUNA; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Merrett N. R., 1997, FISH FISHERIES SERIE; Metaxas A, 2005, J MAR BIOL ASSOC UK, V85, P1381, DOI 10.1017/S0025315405012567; Metaxas A, 2004, DEEP-SEA RES PT I, V51, P1307, DOI 10.1016/j.dsr.2004.06.001; Moore J. A., 2003, Journal of Northwest Atlantic Fishery Science, V31, P363; Moore JA, 2004, ARCH FISH MAR RES, V51, P241; Moore JA, 2003, NORTHEAST NAT, V10, P159, DOI 10.1656/1092-6194(2003)010[0159:AALODF]2.0.CO;2; Moore JA, 2009, B PEABODY MUS NAT HI, V50, P381, DOI 10.3374/014.050.0205; Moore Jon A., 2008, Bulletin of the Peabody Museum of Natural History, V49, P31, DOI 10.3374/0079-032X(2008)49[31:FBNHIT]2.0.CO;2; Mortensen PB, 2004, MAR BIOL, V144, P1223, DOI 10.1007/s00227-003-1280-8; Mosher CV, 2009, MAR ECOL PROG SER, V397, P81, DOI 10.3354/meps08113; POORE GCB, 1993, NATURE, V361, P597, DOI 10.1038/361597a0; RAMP SR, 1985, J PHYS OCEANOGR, V15, P1790, DOI 10.1175/1520-0485(1985)015<1790:TDFTTN>2.0.CO;2; Rex M. A, 2010, DEEP SEA BIODIVERSIT; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; ROWE GT, 1982, DEEP-SEA RES, V29, P257, DOI 10.1016/0198-0149(82)90113-3; ROWE GT, 1979, CONTINENTAL SLOPES, P49; Scanlon KM., 1984, GEOMARINE LETT, V4, P1; SCHMITZ WJ, 1987, MARINE ENV US ATLANT, P27; Smith CR, 2003, ECOSY WORLD, V28, P179; Smith Craig R., 2008, P334, DOI 10.1017/CBO9780511751790.030; Sutton TT, 2004, COPEIA, P116; Theroux R. B., 1998, 140 NOAA NMFS US DEP; THISTLE D, 1985, DEEP-SEA RES, V32, P1077, DOI 10.1016/0198-0149(85)90063-9; THISTLE D, 1991, MAR GEOL, V99, P413, DOI 10.1016/0025-3227(91)90053-7; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; UIBLEIN F, 2005, DEEP SEA 2003 C GO 1, P98; UZMANN JR, 1977, MAR FISH REV, V39, P12; VALENTINE P, 1987, US GEOLOGICAL SURVEY, V1782, P1; VALENTINE PC, 1984, J SEDIMENT PETROL, V54, P704; VALENTINE PC, 1980, MAR GEOL, V38, P283, DOI 10.1016/0025-3227(80)90004-3; Vetter EW, 1998, DEEP-SEA RES PT II, V45, P25, DOI 10.1016/S0967-0645(97)00048-9; Wahle RA, 2008, ICES J MAR SCI, V65, P862, DOI 10.1093/icesjms/fsn058; Watanabe S, 2009, DEEP-SEA RES PT I, V56, P2235, DOI 10.1016/j.dsr.2009.09.003; Watling L, 2005, ERLANGEN EARTH C SER, P279, DOI 10.1007/3-540-27673-4_13; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Watling L, 2007, J MAR BIOL ASSOC UK, V87, P393, DOI 10.1017/S002531540705535X; WILSON RR, 1987, SEAMOUNTS ISLANDS AT, V43, P319; WOLFF N, 2010, HYPSOMETRIC CHARACTE	84	15	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e13832	10.1371/journal.pone.0013832	http://dx.doi.org/10.1371/journal.pone.0013832			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124960	Green Accepted, gold, Green Published			2022-12-25	WOS:000284400100001
J	Dormoy, V; Beraud, C; Lindner, V; Thomas, L; Coquard, C; Barthelmebs, M; Jacqmin, D; Lang, H; Massfelder, T				Dormoy, V.; Beraud, C.; Lindner, V.; Thomas, L.; Coquard, C.; Barthelmebs, M.; Jacqmin, D.; Lang, H.; Massfelder, T.			LIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma	ONCOGENE			English	Article						renal cell carcinoma; developmental LIM class homeobox gene Lim1; growth; migration; VHL tumor suppressor	HORMONE-RELATED PROTEIN; FACTOR-KAPPA-B; IN-VIVO; PROGNOSTIC-SIGNIFICANCE; MICROVESSEL DENSITY; SIGNALING PATHWAYS; KIDNEY DEVELOPMENT; PANCREATIC-CANCER; GROWTH-FACTOR; TENASCIN-C	Human clear cell renal cell carcinoma (CCC) remains resistant to therapies. The transcription factor LIM-class homeobox gene Lim1 is required for normal organogenesis, including nephrogenesis, by regulating cell movements, differentiation and growth. Its expression is controlled partly by the sonic hedgehog-Gli signaling pathway, which we have recently shown to be reactivated in human CCC. So far, no study has assessed whether Lim1 may be associated with tumorigenesis. Using a panel of human CCC cell lines expressing or not the von Hippel-Lindau tumor suppressor gene and 44 tumor/normal tissues pairs, we found that Lim1 is constitutively and exclusively reexpressed in tumors. Through Lim1 silencing or overexpressing, we show that Lim1 is a growth and survival factor in human CCC, at least through the activation of oncogenic pathways including the phosphoinositide kinase-3/Akt and nuclear factor-kappaB pathways. More importantly, in nude mice bearing human CCC tumors, Lim1 silencing abolished tumor growth through the same mechanism as in vitro. In Lim1-depleted cells and tumors, cell movements were substantially impaired because of the inhibition of expression of various proteins involved in metastatic spread, such as paxillin or tenascin-C. These findings establish that the developmental marker Lim1 acts as an oncogene in cancer cells and targeting Lim1 may constitute an innovative therapeutic intervention in human CCC. Oncogene (2011) 30, 1753-1763; doi:10.1038/onc.2010.557; published online 6 December 2010	[Dormoy, V.; Beraud, C.; Thomas, L.; Coquard, C.; Barthelmebs, M.; Massfelder, T.] Univ Strasbourg, INSERM, U682, Sect Kidney Canc & Renal Physiopathol,Sch Med, F-67085 Strasbourg, France; [Lindner, V.] Hop Mulhouse, Dept Pathol, Mulhouse, France; [Jacqmin, D.; Lang, H.] Nouvel Hop Civil Strasbourg, Dept Urol, Strasbourg, France	CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Franche-Comte; CHU Strasbourg	Massfelder, T (corresponding author), Univ Strasbourg, INSERM, U682, Sect Kidney Canc & Renal Physiopathol,Sch Med, F-67085 Strasbourg, France.	thierry.massfelder@medecine.u-strasbg.fr	Dormoy, Valerian/P-5109-2016; Massfelder, Thierry/I-1260-2016	Dormoy, Valerian/0000-0003-1725-371X; 	INSERM (Institut National de la Sante Et de la Recherche Medicale); University of Strasbourg; French Ligue Contre le Cancer (Comite's du Bas-Rhin et du Haut-Rhin et Comite National)	INSERM (Institut National de la Sante Et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Strasbourg; French Ligue Contre le Cancer (Comite's du Bas-Rhin et du Haut-Rhin et Comite National)	This study was sponsored by INSERM (Institut National de la Sante Et de la Recherche Medicale), by University of Strasbourg and by the French Ligue Contre le Cancer (Comite's du Bas-Rhin et du Haut-Rhin et Comite National, recipient TM). We thank Dr A Donai for helpful suggestions, Dr J Barths for allowing us to perform FACS analysis and RA Hanna for text correction.	Agouni A, 2007, CARCINOGENESIS, V28, P1893, DOI 10.1093/carcin/bgm106; Arsanious A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-20; Baldewijns MM, 2010, J PATHOL, V221, P125, DOI 10.1002/path.2689; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chen J, 2009, INT J ONCOL, V34, P1029, DOI 10.3892/ijo_00000228; Clark PE, 2007, CURR OPIN UROL, V17, P331, DOI 10.1097/MOU.0b013e3282c508e0; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Escudier B, 2008, BIOL-TARGETS THER, V2, P517; Friedrich CA, 1999, CANCER-AM CANCER SOC, V86, P2478, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; Hueber PA, 2006, KIDNEY INT, V69, P1139, DOI 10.1038/sj.ki.5000136; Hueber PA, 2008, CANCER LETT, V265, P148, DOI 10.1016/j.canlet.2008.02.016; Imao T, 2004, INT J UROL, V11, P948, DOI 10.1111/j.1442-2042.2004.00931.x; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kawakami K, 2009, CANCER RES, V69, P8603, DOI 10.1158/0008-5472.CAN-09-2534; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; MACLENNAN GT, 1995, UROLOGY, V46, P27, DOI 10.1016/S0090-4295(99)80153-8; Massfelder T, 2004, CANCER RES, V64, P180, DOI 10.1158/0008-5472.CAN-03-1968; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Nativ O, 1998, UROLOGY, V51, P693, DOI 10.1016/S0090-4295(98)00019-3; Noguelra M, 2008, UROL ONCOL-SEMIN ORI, V26, P113, DOI 10.1016/j.urolonc.2007.03.028; Ohno Y, 2008, ONCOL REP, V20, P511, DOI 10.3892/or_00000035; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; Ryschich E, 2009, PANCREAS, V38, P804, DOI 10.1097/MPA.0b013e3181b9dfda; Sagalowsky Arthur I, 2002, Curr Opin Urol, V12, P371, DOI 10.1097/00042307-200209000-00001; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Sourbier C, 2007, CANCER RES, V67, P11668, DOI 10.1158/0008-5472.CAN-07-0632; Sourbier C, 2006, CANCER RES, V66, P5130, DOI 10.1158/0008-5472.CAN-05-1469; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Venegas-Ferrin M, 2010, INT J DEV BIOL, V54, P195, DOI 10.1387/ijdb.092870mv; Yao YZ, 2007, ANN CLIN LAB SCI, V37, P39	38	27	31	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	15					1753	1763		10.1038/onc.2010.557	http://dx.doi.org/10.1038/onc.2010.557			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	749ZM	21132009				2022-12-25	WOS:000289512200003
J	Zhang, H; Guttikonda, S; Roberts, L; Uziel, T; Semizarov, D; Elmore, SW; Leverson, JD; Lam, LT				Zhang, H.; Guttikonda, S.; Roberts, L.; Uziel, T.; Semizarov, D.; Elmore, S. W.; Leverson, J. D.; Lam, L. T.			Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines	ONCOGENE			English	Article						Mcl-1; NSCLC; Bcl-x(L)	BCL-2 FAMILY PROTEINS; APOPTOSIS; BAK; INHIBITOR; ABT-737; ACTIVATION; EXPRESSION; RESISTANCE; P53	Non-small-cell lung cancer (NSCLC) is the most deadly type of cancer in the United States and worldwide. Although new therapy is available, the survival rate of NSCLC patients remains low. One hallmark of cancer cells is defects in the apoptotic cell death program. In this study, we investigate the role of B-cell lymphoma 2 (Bcl-2) family members Bcl-2, Bcl-xL and Mcl-1, known to regulate cell survival and death, in a panel of fourteen NSCLC cell lines. NSCLC cell lines express high levels of Mcl-1 and Bcl-xL, but not Bcl-2. Silencing the expression of Mcl-1 with small interfering RNA ( siRNA) oligonucleotides potently killed a subgroup of NSCLC cell lines. In contrast, Bcl-xL siRNA had no effect in these lines unless Mcl-1 siRNA was also introduced. Interestingly, high MCL1 to BCL-xl messenger RNA determines whether the cells depend on Mcl-1 for survival. We further investigated the role of Mcl-1 in NSCLC cells using a Mcl-1-dependent cell line, H23. The expression of a complementary DNA containing only the coding region of MCL1 rescued H23 cells from the toxicity of a 30 untranslated region (UTR) targeting Mcl-1 siRNA but not a siRNA targeting the coding region of MCL1. Furthermore, we show that Mcl-1 sequesters the BH3-only protein Noxa and Bim and the apoptotic effector Bak. Not surprisingly, Noxa, Bim, or Bak knockdown partially rescued H23 cells from toxicity mediated by Mcl-1 siRNA to different degrees. Collectively, our results indicate that targeting Mcl-1 may improve therapy for a subset of NSCLC patients. Oncogene (2011) 30, 1963-1968; doi: 10.1038/onc.2010.559; published online 6 December 2010	[Lam, L. T.] Abbott Labs, Canc Res, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA	Abbott Laboratories	Lam, LT (corresponding author), Abbott Labs, Canc Res, Global Pharmaceut Res & Dev, AP10,100 Abbott Pk Rd, Abbott Pk, IL 60064 USA.	Lloyd.Lam@abbott.com						Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Berrieman HK, 2005, CANCER-AM CANCER SOC, V103, P1415, DOI 10.1002/cncr.20907; Borner MM, 1999, BRIT J CANCER, V79, P952, DOI 10.1038/sj.bjc.6690152; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Keuling AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006651; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li J, 2008, CANCER CHEMOTH PHARM, V61, P525, DOI 10.1007/s00280-007-0499-3; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Linardou H, 2009, NAT REV CLIN ONCOL, V6, P352, DOI 10.1038/nrclinonc.2009.62; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; RODENHUIS S, 1992, CANCER RES, V52, pS2665; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Tagscherer KE, 2008, ONCOGENE, V27, P6646, DOI 10.1038/onc.2008.259; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Wesarg E, 2007, INT J CANCER, V121, P2387, DOI 10.1002/ijc.22977; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885	26	127	132	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	16					1963	1968		10.1038/onc.2010.559	http://dx.doi.org/10.1038/onc.2010.559			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21132008				2022-12-25	WOS:000289777700012
J	Chavali, PL; Saini, RKR; Matsumoto, Y; Agren, H; Funa, K				Chavali, Pavithra Lakshminarasimhan; Saini, Ravi Kanth Rao; Matsumoto, Yoshiki; Agren, Hans; Funa, Keiko			Nuclear Orphan Receptor TLX Induces Oct-3/4 for the Survival and Maintenance of Adult Hippocampal Progenitors upon Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; INDUCED DEDIFFERENTIATION; EXPRESSION; GENE; DIFFERENTIATION; TRANSCRIPTION; NEUROGENESIS; PLURIPOTENCY; ACTIVATION; MECHANISM	Hypoxia promotes neural stem cell proliferation, the mechanism of which is poorly understood. Here, we have identified the nuclear orphan receptor TLX as a mediator for proliferation and pluripotency of neural progenitors upon hypoxia. We found an enhanced early protein expression of TLX under hypoxia potentiating sustained proliferation of neural progenitors. Moreover, TLX induction upon hypoxia in differentiating conditions leads to proliferation and a stem cell-like phenotype, along with coexpression of neural stem cell markers. Following hypoxia, TLX is recruited to the Oct-3/4 proximal promoter, augmenting the gene transcription and promoting progenitor proliferation and pluripotency. Knockdown of Oct-3/4 significantly reduced TLX-mediated proliferation, highlighting their interdependence in regulating the progenitor pool. Additionally, TLX synergizes with basic FGF to sustain cell viability upon hypoxia, since the knockdown of TLX along with the withdrawal of growth factor results in cell death. This can be attributed to the activation of Akt signaling pathway by TLX, the depletion of which results in reduced proliferation of progenitor cells. Cumulatively, the data presented here demonstrate a new role for TLX in neural stem cell proliferation and pluripotency upon hypoxia.	[Chavali, Pavithra Lakshminarasimhan; Saini, Ravi Kanth Rao; Matsumoto, Yoshiki; Funa, Keiko] Univ Gothenburg, Inst Biomed, Dept Med Chem & Cell Biol, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; [Agren, Hans] Univ Gothenburg, Dept Neurosci & Physiol, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Funa, K (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Chem & Cell Biol, Sahlgrenska Acad, Box 440,Medicinaregatan 9A, SE-40530 Gothenburg, Sweden.	keiko.funa@gu.se	MATSUMOTO, Yoshiki/AAW-8516-2020; Agren, Hans/H-7715-2016	MATSUMOTO, Yoshiki/0000-0002-8620-2863; Lakshminarasimhan Chavali, Pavithra/0000-0002-7525-5230	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Research Foundation; Hjalmar Svensson Foundation; ALF Funds at the Vastra Gotaland Region; Assar Gabrielson Foundation, Sweden; Swedish Institute, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Research Foundation; Hjalmar Svensson Foundation; ALF Funds at the Vastra Gotaland Region; Assar Gabrielson Foundation, Sweden; Swedish Institute, Sweden	This work was supported in part by grants from the Swedish Research Council, Swedish Cancer Society, Swedish Childhood Cancer Research Foundation, Hjalmar Svensson Foundation, ALF Funds at the Vastra Gotaland Region, and in part by Assar Gabrielson Foundation, Sweden.; Recipient of visiting researchers grant from the Swedish Institute, Sweden. To whom correspondence may be addressed: Institute of Biomedicine, Dept. of Medical Chemistry and Cell Biology, Sahlgrenska Academy, University of Gothenburg, Box 440, Medicinaregatan 9A, SE 405 30 Gothenburg, Sweden. Tel.: 46-31-786-3151; E-mail: pavithrachavali@anatcell.gu.se.	Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Blaud M, 2004, J MOL BIOL, V339, P1049, DOI 10.1016/j.jmb.2004.04.035; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chin JH, 2009, BIOCHEM BIOPH RES CO, V388, P247, DOI 10.1016/j.bbrc.2009.07.165; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Elmi M, 2007, MOL CELL NEUROSCI, V36, P248, DOI 10.1016/j.mcn.2007.07.001; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gritti A, 1999, J NEUROSCI, V19, P3287; Helczynska K, 2003, CANCER RES, V63, P1441; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; Iwahara N, 2009, BIOCHEM BIOPH RES CO, V386, P671, DOI 10.1016/j.bbrc.2009.06.103; Jogi A, 2003, CANCER LETT, V197, P145, DOI 10.1016/S0304-3835(03)00095-8; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kobayashi M, 2000, MOL CELL BIOL, V20, P8731, DOI 10.1128/MCB.20.23.8731-8739.2000; Li WW, 2008, MOL ENDOCRINOL, V22, P56, DOI 10.1210/me.2007-0290; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Minucci S, 1996, EMBO J, V15, P888, DOI 10.1002/j.1460-2075.1996.tb00423.x; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Okuda T, 2004, MOL BRAIN RES, V132, P18, DOI 10.1016/j.molbrainres.2004.08.021; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; PIKARSKY E, 1994, MOL CELL BIOL, V14, P1026, DOI 10.1128/MCB.14.2.1026; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Qu QH, 2009, J CELL PHYSIOL, V221, P5, DOI 10.1002/jcp.21862; Rodrigues CAV, 2010, BIOTECHNOL BIOENG, V106, P260, DOI 10.1002/bit.22648; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Stenman JM, 2003, J NEUROSCI, V23, P10568; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Uemura A, 2006, J CLIN INVEST, V116, P369, DOI 10.1172/JCI25964; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Zangrossi S, 2007, STEM CELLS, V25, P1675, DOI 10.1634/stemcells.2006-0611; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562	44	42	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9393	9404		10.1074/jbc.M110.167445	http://dx.doi.org/10.1074/jbc.M110.167445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21135096	Green Published, hybrid			2022-12-25	WOS:000288247700068
J	Chaix, A; Lopez, S; Voisset, E; Gros, L; Dubreuil, P; De Sepulveda, P				Chaix, Amandine; Lopez, Sophie; Voisset, Edwige; Gros, Laurent; Dubreuil, Patrice; De Sepulveda, Paulo			Mechanisms of STAT Protein Activation by Oncogenic KIT Mutants in Neoplastic Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; FACTOR RECEPTOR/C-KIT; C-KIT; SIGNAL TRANSDUCER; WILD-TYPE; SERINE PHOSPHORYLATION; JUXTAMEMBRANE DOMAIN; MITOCHONDRIAL STAT3; PKC-DELTA	Mutations in the c-kit gene occur in the vast majority of mastocytosis. In adult patients as well as in the cell line derived from mast cell neoplasms, the mutations occur almost exclusively at amino acid 816 within the kinase domain of KIT. Among the downstream effectors of KIT signaling, STAT3 and STAT5 have been shown to be critical for cell proliferation elicited by the KIT-Asp(816) mutant protein. However, little is known about the mechanisms of activation of STAT proteins. In this study, we identify and clarify the contribution of various STAT kinases in two widely used neoplastic mast cell lines, P815 and HMC-1. We show that STAT1, -3, and -5 proteins are activated downstream of the KIT-Asp(816) mutant. All three STAT proteins are located in the nucleus and are phosphorylated on serine residues. KIT-Asp(816) mutant can directly phosphorylate STATs on the activation-specific tyrosine residues in vitro. However, within cells, SRC family kinases and JAKs diversely contribute to tyrosine phosphorylation of STAT proteins downstream of the KIT mutant. Using a panel of inhibitors, we provide evidence for the implication or exclusion of serine/threonine kinases as responsible for serine phosphorylation of STAT1, -3, and -5 in the two cell lines. Finally, we show that only STAT5 is transcriptionally active in these cells. This suggests that the contribution of STAT1 and STAT3 downstream of KIT mutant is independent of their transcription factor function.	[De Sepulveda, Paulo] Ctr Rech Cancerol Marseille, U891, INSERM, F-13273 Marseille 9, France; [Chaix, Amandine; Lopez, Sophie; Voisset, Edwige; Dubreuil, Patrice; De Sepulveda, Paulo] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Chaix, Amandine; Lopez, Sophie; Voisset, Edwige; Dubreuil, Patrice; De Sepulveda, Paulo] Univ Aix Marseille 2, F-13009 Marseille, France; [Gros, Laurent] AB Sci, F-75008 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite	De Sepulveda, P (corresponding author), Ctr Rech Cancerol Marseille, U891, INSERM, 27 Blvd Lei Roure,BP30059, F-13273 Marseille 9, France.	paulo.de-sepulveda@inserm.fr	dubreuil, patrice/F-5346-2011; Voisset, Edwige/GSE-5113-2022; Dubreuil, Patrice/V-4816-2019; Voisset, Edwige/AAM-3503-2021; LOPEZ, SOPHIE/R-1917-2016; De sepulveda, paulo/K-6043-2015	dubreuil, patrice/0000-0003-1155-1150; Voisset, Edwige/0000-0002-0943-4847; Dubreuil, Patrice/0000-0003-1155-1150; Voisset, Edwige/0000-0002-0943-4847; LOPEZ, SOPHIE/0000-0002-5009-5533; De sepulveda, paulo/0000-0001-8295-5414	La Ligue Contre le Cancer; l'Institut National du Cancer; l'Agence Nationale de la Recherche ANR-M-RAR; Ministere de la Recherche/Ecole Normale Superieure; Association pour la Recherche sur le Cancer; Societe Francaise d'Hematologie; Agence Nationale de la Recherche; INSERM-Region Provence Alpes Cote d'Azur	La Ligue Contre le Cancer(Ligue nationale contre le cancer); l'Institut National du Cancer(Institut National du Cancer (INCA) France); l'Agence Nationale de la Recherche ANR-M-RAR(French National Research Agency (ANR)); Ministere de la Recherche/Ecole Normale Superieure(Ministry of Research, France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Societe Francaise d'Hematologie; Agence Nationale de la Recherche(French National Research Agency (ANR)); INSERM-Region Provence Alpes Cote d'Azur(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Provence-Alpes-Cote d'Azur)	This work was supported in part by La Ligue Contre le Cancer (label Ligue 2008), l'Institut National du Cancer, and l'Agence Nationale de la Recherche ANR-M-RAR.; Recipient of Ph.D. fellowships from Ministere de la Recherche/Ecole Normale Superieure and Association pour la Recherche sur le Cancer and financial support from Societe Francaise d'Hematologie.; Supported by Agence Nationale de la Recherche.; Supported by INSERM-Region Provence Alpes Cote d'Azur, Association pour la Recherche sur le Cancer, and Societe Francaise d'Hematologie.	Ali MS, 2000, J BIOL CHEM, V275, P15586, DOI 10.1074/jbc.M908931199; Aman MJ, 1999, J BIOL CHEM, V274, P30266, DOI 10.1074/jbc.274.42.30266; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baumgartner C, 2009, AM J PATHOL, V175, P2416, DOI 10.2353/ajpath.2009.080953; Beghini A, 2004, HAEMATOLOGICA, V89, P920; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Cairoli R, 2006, BLOOD, V107, P3463, DOI 10.1182/blood-2005-09-3640; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Chaturvedi P, 1998, ONCOGENE, V16, P1749, DOI 10.1038/sj.onc.1201972; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; DeBerry C, 1997, BIOCHEM J, V327, P73, DOI 10.1042/bj3270073; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Gartsbein M, 2006, J CELL SCI, V119, P470, DOI 10.1242/jcs.02744; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Harir N, 2008, BLOOD, V112, P2463, DOI 10.1182/blood-2007-09-115477; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; HOCKE GM, 1995, CYTOKINE, V7, P491, DOI 10.1006/cyto.1995.0067; Jelacic T, 2005, BLOOD, V105, P1923, DOI 10.1182/blood-2004-04-1450; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Krejci P, 2008, J CELL SCI, V121, P272, DOI 10.1242/jcs.017160; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Looijenga LHJ, 2003, CANCER RES, V63, P7674; Maki K, 2008, J IMMUNOL, V181, P494, DOI 10.4049/jimmunol.181.1.494; Ning ZQ, 2001, BLOOD, V97, P3559, DOI 10.1182/blood.V97.11.3559; Pan J, 2007, BLOOD, V109, P315, DOI 10.1182/blood-2006-04-013805; Paukku K, 2000, BIOCHEM J, V345, P759, DOI 10.1042/0264-6021:3450759; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Storz P, 1999, FEBS LETT, V464, P159, DOI 10.1016/S0014-5793(99)01689-0; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Tomasson MH, 2000, J CLIN INVEST, V105, P423, DOI 10.1172/JCI8902; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Tyner JW, 2008, BLOOD, V111, P2238, DOI 10.1182/blood-2007-06-097253; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Valent P, 2005, LEUKEMIA LYMPHOMA, V46, P35, DOI 10.1080/10428190400010775; Vignais ML, 1999, MOL CELL BIOL, V19, P3727; Voisset E, 2007, BLOOD, V110, P2593, DOI 10.1182/blood-2007-02-076471; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zappulla JP, 2005, J EXP MED, V202, P1635, DOI 10.1084/jem.20050807; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120	58	50	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5956	5966		10.1074/jbc.M110.182642	http://dx.doi.org/10.1074/jbc.M110.182642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135090	Green Published, hybrid			2022-12-25	WOS:000287476400003
J	Jaremko, L; Jaremko, M; Elfaki, I; Mueller, JW; Ejchart, A; Bayer, P; Zhukov, I				Jaremko, Lukasz; Jaremko, Mariusz; Elfaki, Imadeldin; Mueller, Jonathan W.; Ejchart, Andrzej; Bayer, Peter; Zhukov, Igor			Structure and Dynamics of the First Archaeal Parvulin Reveal a New Functionally Important Loop in Parvulin-type Prolyl Isomerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR RELAXATION MEASUREMENTS; MITOTIC REGULATOR HPIN1; TORSION ANGLE DYNAMICS; BACKBONE DYNAMICS; BACILLUS-SUBTILIS; SUBSTRATE-BINDING; ESCHERICHIA-COLI; N-15 RELAXATION; CHEMICAL-SHIFTS; PROTEIN	Parvulins are a group of peptidyl-prolyl isomerases (PPIases) responsible for important biological processes in all kingdoms of life. The PinA protein from the psychrophilic archaeon Cenarchaeum symbiosum is a parvulin-like PPIase. Due to its striking similarity to the human parvulins Pin1 and Par14, PinA constitutes an interesting subject for structural and functional studies. Here, we present the first high resolution NMR structure of an archaeal parvulin, PinA, based on 1798 conformational restraints. Structure calculation yields an ensemble of 20 convergent low energy structures with a backbone r.m.s.d. value of 0.6 angstrom within the secondary structure elements. The overall fold of PinA comprises the beta-alpha(3)-beta-alpha-beta(2) fold typical for all parvulin structures known so far, but with helix III being a short 3(10)-helix. A detailed comparison of this high resolution structure of the first archaeal PinA protein with bacterial and eukaryotic parvulin PPIase structures reveals an atypically large catalytic binding site. This feature provides an explanation for cold-adapted protein function. Moreover, the residues in and around 3(10)-helix III exhibit strong intramolecular dynamics on a microsecond to millisecond timescale and display structural heterogeneity within the NMR ensemble. A putative peptide ligand was found for PinA by phage display and was used for H-1-N-15-HSQC titrations. Again, the flexible region around 3(10)-helix III as well as residues of the peptide binding pocket showed the strongest chemical shift perturbations upon peptide binding. The local flexibility of this region also was modulated by ligand binding. A glycine and two positively charged residues are conserved in most parvulin proteins in this flexible loop region, which may be of general functional importance for parvulin-type PPIases.	[Elfaki, Imadeldin; Mueller, Jonathan W.; Bayer, Peter] Univ Duisburg Essen, Inst Struct & Med Biochem, Ctr Med Biotechnol, ZMB, D-45117 Essen, Germany; [Jaremko, Lukasz; Jaremko, Mariusz; Ejchart, Andrzej; Zhukov, Igor] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Zhukov, Igor] Natl Inst Chem, Slovenian NMR Ctr, SI-1000 Ljubljana, Slovenia; [Jaremko, Lukasz] Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland; [Zhukov, Igor] EN FIST Ctr Excellence, SI-1000 Ljubljana, Slovenia	University of Duisburg Essen; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; National Institute of Chemistry - Slovenia; University of Warsaw	Bayer, P (corresponding author), Univ Duisburg Essen, Inst Struct & Med Biochem, Ctr Med Biotechnol, ZMB, Univ Str 2, D-45117 Essen, Germany.	peter.bayer@uni-due.de; igor.zhukov@ki.si	Jaremko, Lukasz/A-3101-2009; Elfaki, Imadeldin/AER-0062-2022; Jaremko, Lukasz/GQB-5017-2022; Bayer, Peter/B-8803-2009; Mueller, Jonathan Wolf/D-1632-2010; Zhukov, Igor/J-4069-2015	Jaremko, Lukasz/0000-0001-7684-9359; Bayer, Peter/0000-0003-0435-7202; Mueller, Jonathan Wolf/0000-0003-1212-189X; Zhukov, Igor/0000-0002-9912-1018; Jaremko, Mariusz/0000-0002-0787-702X	Polish Ministry of Science and Higher Education [N301 07131/2159, IP2010014570]; Slovenian Research Agency [P1-0242-0104]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported in part by Polish Ministry of Science and Higher Education Grant N301 07131/2159, Slovenian Research Agency Grant P1-0242-0104 (to I. Z.), Polish Ministry of Science and Higher Education luventus Plus program (project nr IP2010014570, to L. J.).	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bayer E, 2003, J BIOL CHEM, V278, P26183, DOI 10.1074/jbc.M300721200; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; BUCK M, 1995, BIOCHEMISTRY-US, V34, P4041, DOI 10.1021/bi00012a023; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding KY, 2004, J AM CHEM SOC, V126, P6232, DOI 10.1021/ja049049l; Fushman D., 2003, BIONMR DRUG RES; Ghalebani L, 2008, J MAGN RESON, V195, P1, DOI 10.1016/j.jmr.2008.07.025; Grum D, 2010, BIOCHEM BIOPH RES CO, V395, P420, DOI 10.1016/j.bbrc.2010.04.039; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P531, DOI 10.1016/0022-2836(91)90755-U; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Heikkinen O, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-17; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Kazimierczuk K, 2008, J AM CHEM SOC, V130, P5404, DOI 10.1021/ja800622p; Kessler D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-37; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozminski W, 2005, J BIOMOL NMR, V31, P87, DOI 10.1007/s10858-004-7563-7; Kuhlewein A, 2004, PROTEIN SCI, V13, P2378, DOI 10.1110/ps.04756704; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Maruyama T, 2004, FRONT BIOSCI-LANDMRK, V9, P1680, DOI 10.2741/1361; Mueller JW, 2008, PERSPECT MED CHEM, V2, P11; Mueller JW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Rak A, 2002, BIOCHEM BIOPH RES CO, V299, P710, DOI 10.1016/S0006-291X(02)02721-3; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rudrabhatla P, 2008, J BIOL CHEM, V283, P26737, DOI 10.1074/jbc.M801633200; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Sekerina E, 2000, J MOL BIOL, V301, P1003, DOI 10.1006/jmbi.2000.4013; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Suzuki Y, 2004, EUR J BIOCHEM, V271, P1372, DOI 10.1111/j.1432-1033.2004.04049.x; Tossavainen H, 2006, FEBS LETT, V580, P1822, DOI 10.1016/j.febslet.2006.02.042; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wong KB, 1997, J MOL BIOL, V268, P494, DOI 10.1006/jmbi.1997.0989; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Ye KQ, 2002, EUR J BIOCHEM, V269, P5182, DOI 10.1046/j.1432-1033.2002.03222.x; Yongye AB, 2010, J COMPUT AID MOL DES, V24, P675, DOI 10.1007/s10822-010-9365-1	51	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6554	6565		10.1074/jbc.M110.160713	http://dx.doi.org/10.1074/jbc.M110.160713			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21138844	Green Published, hybrid			2022-12-25	WOS:000287476400065
J	Kasai, K; Takano, J; Miwa, K; Toyoda, A; Fujiwara, T				Kasai, Koji; Takano, Junpei; Miwa, Kyoko; Toyoda, Atsushi; Fujiwara, Toru			High Boron-induced Ubiquitination Regulates Vacuolar Sorting of the BOR1 Borate Transporter in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; PREVACUOLAR COMPARTMENTS; RHAMNOGALACTURONAN-II; PLANT DEVELOPMENT; CROSS-LINKING; ENDOCYTOSIS; TOXICITY; CELLS; EXPRESSION; TOLERANCE	Boron homeostasis is important for plants, as boron is essential but is toxic in excess. Under high boron conditions, the Arabidopsis thaliana borate transporter BOR1 is trafficked from the plasma membrane (PM) to the vacuole via the endocytic pathway for degradation to avoid excess boron transport. Here, we show that boron-induced ubiquitination is required for vacuolar sorting of BOR1. We found that a substitution of lysine 590 with alanine (K590A) in BOR1 blocked degradation. BOR1 was mono-or diubiquitinated within several minutes after applying a high concentration of boron, whereas the K590A mutant was not. The K590A mutation abolished vacuolar transport of BOR1 but did not apparently affect polar localization to the inner PM domains. Furthermore, brefeldin A and wortmannin treatment suggested that Lys-590 is required for BOR1 translocation from an early endosomal compartment to multivesicular bodies. Our results show that boron-induced ubiquitination of BOR1 is not required for endocytosis from the PM but is crucial for the sorting of internalized BOR1 to multivesicular bodies for subsequent degradation in vacuoles.	[Fujiwara, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Kasai, Koji; Miwa, Kyoko; Toyoda, Atsushi; Fujiwara, Toru] Univ Tokyo, Biotechnol Res Ctr, Tokyo 1138657, Japan; [Takano, Junpei] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Fujiwara, Toru] Japan Sci & Technol Agcy, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; Hokkaido University; Japan Science & Technology Agency (JST)	Fujiwara, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atorufu@mail.ecc.u-tokyo.ac.jp	MIWA, Kyoko/D-4220-2009; Takano, Junpei/A-5255-2012	Takano, Junpei/0000-0002-7474-3101; Miwa, Kyoko/0000-0001-7328-3628	Japan Society for the Promotion of Science [19-7094]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [21228002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid 19-7094 for JSPS Fellows from the Japan Society for the Promotion of Science (to K. K.), a grant-in-aid for scientific research (to T. F.), and a grant-in-aid for scientific research priority areas (to T. F.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Frommer WB, 2002, NATURE, V420, P282, DOI 10.1038/420282a; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; ITO K, 1981, CELL, V24, P707, DOI 10.1016/0092-8674(81)90097-0; Iwai H, 2006, P NATL ACAD SCI USA, V103, P16592, DOI 10.1073/pnas.0605141103; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kato Y, 2009, PLANT CELL PHYSIOL, V50, P58, DOI 10.1093/pcp/pcn168; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kerkeb L, 2008, PLANT PHYSIOL, V146, P1964, DOI 10.1104/pp.107.113282; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Lee HK, 2009, PLANT CELL, V21, P622, DOI 10.1105/tpc.108.061994; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Miwa K, 2007, SCIENCE, V318, P1417, DOI 10.1126/science.1146634; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; Nozawa A, 2006, FEMS MICROBIOL LETT, V262, P216, DOI 10.1111/j.1574-6968.2006.00395.x; Nozawa A, 2006, BIOSCI BIOTECH BIOCH, V70, P1724, DOI 10.1271/bbb.60065; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Ochiai K, 2008, THEOR APPL GENET, V117, P125, DOI 10.1007/s00122-008-0758-7; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Reid RJ, 2004, PLANT CELL ENVIRON, V27, P1405, DOI 10.1111/j.1365-3040.2004.01243.x; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Ruiz JM, 2003, PLANT SCI, V165, P811, DOI 10.1016/S0168-9452(03)00276-0; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069; Spitzer C, 2009, PLANT CELL, V21, P749, DOI 10.1105/tpc.108.064865; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2008, TRENDS PLANT SCI, V13, P451, DOI 10.1016/j.tplants.2008.05.007; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Takano Junpei, 2010, Proc Natl Acad Sci U S A, V107, P5220, DOI 10.1073/pnas.0910744107; Tamura K, 2003, PLANT J, V35, P545, DOI 10.1046/j.1365-313X.2003.01822.x; Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703; Viotti C, 2010, PLANT CELL, V22, P1344, DOI 10.1105/tpc.109.072637; Wang JQ, 2009, J EXP BOT, V60, P3075, DOI 10.1093/jxb/erp136	47	144	147	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6175	6183		10.1074/jbc.M110.184929	http://dx.doi.org/10.1074/jbc.M110.184929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148314	Green Published, hybrid			2022-12-25	WOS:000287476400026
J	Usuki, F; Yamashita, A; Fujimura, M				Usuki, Fusako; Yamashita, Akio; Fujimura, Masatake			Post-transcriptional Defects of Antioxidant Selenoenzymes Cause Oxidative Stress under Methylmercury Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; THIOREDOXIN REDUCTASE; GLUTATHIONE-PEROXIDASE; SIGNALING PATHWAYS; MERCURY TOXICITY; CELL-LINES; SELENIUM; EBSELEN; SUBSTRATE; MECHANISM	Methylmercury (MeHg) toxicity is a continuous environmental problem to human health. The critical role of oxidative stress in the pathogenesis of MeHg cytotoxicity has been clarified, but the molecular mechanisms underlying MeHg-mediated oxidative stress remain to be elucidated. Here we demonstrate a post-transcriptional effect of MeHg on antioxidant selenoenzymes by using a MeHg-susceptible cell line. MeHg-induced selenium deficiency leads to failure of the recoding of a UGA codon for selenocysteine and results in degradation of the major antioxidant selenoenzyme glutathione peroxidase 1 (GPx1) mRNA by nonsense-mediated mRNA decay (NMD), a cellular mechanism that detects the premature termination codon (PTC) located 5'-upstream of the last exon-exon junction and degrades PTC-containing mRNAs. In contrast, thioredoxin reductase 1 (TrxR1), another antioxidant selenoenzyme of the thioredoxin system, was likely skipped by NMD because of a UGA codon in the last exon. However, TrxR1 activity was decreased despite mRNA up-regulation, which was probably due to the synthesis of aberrant TrxR1 protein without selenocysteine. Changes in selenoenzyme GPx1 and TrxR1 mRNAs were observed earlier than was the incidence of oxidative stress and up-regulation of other antioxidant enzyme mRNAs. Results indicated that the MeHg-induced relative selenium-deficient condition affects the major antioxidant selenoenzymes GPx1 and TrxR1 through a post-transcriptional effect, resulting in the disturbance of cellular redox systems and the incidence of oxidative stress. Treatment with ebselen, a seleno-organic compound, effectively suppressed oxidative stress and protected cells against MeHg-induced relative selenium deficiency and cytotoxicity.	Natl Inst Minamata Dis, Dept Clin Med, Minamata 8670008, Japan; [Fujimura, Masatake] Natl Inst Minamata Dis, Dept Basic Med Sci, Minamata 8670008, Japan; [Yamashita, Akio] Yokohama City Univ, Dept Microbiol & Mol Biodef Res, Sch Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Yamashita, Akio] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Yokohama City University; Japan Science & Technology Agency (JST)	Usuki, F (corresponding author), 4058-18 Hama, Minamata 8670008, Japan.	usuki@nimd.go.jp			KAKENHI [20591015]; Japan Society for the Promotion of Science; Japan Science and Technology Corporation; Yokohama Foundation for Advancement of Medical Science	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Yokohama Foundation for Advancement of Medical Science	This study was supported in part by KAKENHI (20591015) (to F. U.). This work was also supported in part by grants from the Japan Society for the Promotion of Science (to A. Y.), from the Japan Science and Technology Corporation (to A. Y.), and from the Yokohama Foundation for Advancement of Medical Science (to A. Y.).	BAKIR F, 1973, SCIENCE, V181, P230, DOI 10.1126/science.181.4096.230; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; Carvalho CML, 2008, J BIOL CHEM, V283, P11913, DOI 10.1074/jbc.M710133200; DAVIS LE, 1994, ANN NEUROL, V35, P680, DOI 10.1002/ana.410350608; Farina M, 2004, TOXICOL LETT, V146, P227, DOI 10.1016/j.toxlet.2003.10.001; GANTHER HE, 1972, SCIENCE, V175, P1122, DOI 10.1126/science.175.4026.1122; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; HIROTA Y, 1980, TOXICOL APPL PHARM, V53, P174, DOI 10.1016/0041-008X(80)90394-4; Imura N, 1986, Dev Toxicol Environ Sci, V12, P115; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; Lu J, 2009, FASEB J, V23, P2394, DOI 10.1096/fj.08-127662; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; NISHIKIDO N, 1987, TOXICOL APPL PHARM, V88, P322, DOI 10.1016/0041-008X(87)90207-9; NOBUNAGA T, 1979, TOXICOL APPL PHARM, V47, P79, DOI 10.1016/0041-008X(79)90074-7; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Park ST, 1996, NEUROTOXICOLOGY, V17, P37; SATOH H, 1985, TOXICOL LETT, V25, P199; Shanker G, 2003, MOL BRAIN RES, V110, P85, DOI 10.1016/S0169-328X(02)00642-3; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; SUGIURA Y, 1978, BIOINORG CHEM, V9, P167, DOI 10.1016/S0006-3061(00)80288-4; Usuki F, 1998, NEUROREPORT, V9, P2291, DOI 10.1097/00001756-199807130-00027; Usuki F, 2004, ACTA NEUROPATHOL, V108, P1, DOI 10.1007/s00401-004-0844-0; Usuki F, 2001, NEUROSCI LETT, V304, P199, DOI 10.1016/S0304-3940(01)01764-5; Usuki F, 2001, J HEALTH SCI, V47, P162, DOI 10.1248/jhs.47.162; Usuki F, 2000, BIOCHEM BIOPH RES CO, V267, P739, DOI 10.1006/bbrc.1999.2026; Usuki F, 2008, NEUROTOXICOLOGY, V29, P22, DOI 10.1016/j.neuro.2007.08.011; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; Watanabe C, 1999, NEUROTOXICOL TERATOL, V21, P83, DOI 10.1016/S0892-0362(98)00036-1; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002; Yamashita A, 2009, GENE DEV, V23, P1091, DOI 10.1101/gad.1767209; Yee S, 1996, NEUROTOXICOLOGY, V17, P17; YEE S, 1994, EXP MOL PATHOL, V60, P188, DOI 10.1006/exmp.1994.1017; Zhao R, 2002, J BIOL CHEM, V277, P39456, DOI 10.1074/jbc.M206452200; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399; [No title captured]	39	60	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6641	6649		10.1074/jbc.M110.168872	http://dx.doi.org/10.1074/jbc.M110.168872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21106535	hybrid, Green Published			2022-12-25	WOS:000287476400072
J	Salem, T; Mazzella, A; Barberini, ML; Wengier, D; Motillo, V; Parisi, G; Muschietti, J				Salem, Tamara; Mazzella, Agustina; Laura Barberini, Maria; Wengier, Diego; Motillo, Viviana; Parisi, Gustavo; Muschietti, Jorge			Mutations in Two Putative Phosphorylation Motifs in the Tomato Pollen Receptor Kinase LePRK2 Show Antagonistic Effects on Pollen Tube Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLAR CELL-GROWTH; TIP GROWTH; IN-VIVO; ARABIDOPSIS; GERMINATION; COMPLEX; DOMAIN; SITES; ROP; ACTIVATION	The tip-growing pollen tube is a useful model for studying polarized cell growth in plants. We previously characterized LePRK2, a pollen-specific receptor-like kinase from tomato (1). Here, we showed that LePRK2 is present as multiple phosphorylated isoforms in mature pollen membranes. Using comparative sequence analysis and phosphorylation site prediction programs, we identified two putative phosphorylation motifs in the cytoplasmic juxtamembrane (JM) domain. Site-directed mutagenesis in these motifs, followed by transient overexpression in tobacco pollen, showed that both motifs have opposite effects in regulating pollen tube length. Relative to LePRK2-eGFP pollen tubes, alanine substitutions in residues of motif I, Ser(277)/Ser(279)/Ser(282), resulted in longer pollen tubes, but alanine substitutions in motif II, Ser(304)/Ser(307)/Thr(308), resulted in shorter tubes. In contrast, phosphomimicking aspartic substitutions at these residues gave reciprocal results, that is, shorter tubes with mutations in motif I and longer tubes with mutations in motif II. We conclude that the length of pollen tubes can be negatively and positively regulated by phosphorylation of residues in motif I and II respectively. We also showed that LePRK2-eGFP significantly decreased pollen tube length and increased pollen tube tip width, relative to eGFP tubes. The kinase activity of LePRK2 was relevant for this phenotype because tubes that expressed a mutation in a lysine essential for kinase activity showed the same length and width as the eGFP control. Taken together, these results suggest that LePRK2 may have a central role in pollen tube growth through regulation of its own phosphorylation status.	[Salem, Tamara; Mazzella, Agustina; Laura Barberini, Maria; Wengier, Diego; Muschietti, Jorge] Consejo Nacl Invest Cient & Tecn, Inst Ingn Genet & Biol Mol INGEBI, RA-1428 Buenos Aires, DF, Argentina; [Muschietti, Jorge] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, RA-1428 Buenos Aires, DF, Argentina; [Motillo, Viviana; Parisi, Gustavo] Univ Nacl Quilmes, Ctr Estudios & Invest, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Muschietti, J (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Ingn Genet & Biol Mol INGEBI, RA-1428 Buenos Aires, DF, Argentina.	prometeo@dna.uba.ar		parisi, gustavo/0000-0001-7444-1624; Muschietti, Jorge/0000-0002-5719-4833; , Maria Agustina/0000-0001-6205-3085	Universidad de Buenos Aires [UBACYT-X109]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2005-31656, PICT2007-01976]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-CONICET-5545]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Grants Universidad de Buenos Aires UBACYT-X109, Agencia Nacional de Promocion Cientifica y Tecnologica PICT2005-31656, PICT2007-01976, and Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP-CONICET-5545 (to J.M.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cai G, 2009, J EXP BOT, V60, P495, DOI 10.1093/jxb/ern321; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Chen CYH, 2003, PLANT CELL, V15, P237, DOI 10.1105/tpc.007153; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; Cheung AY, 2003, J EXP BOT, V54, P73, DOI 10.1093/jxb/54.380.73; Dowd PE, 2006, PLANT CELL, V18, P1438, DOI 10.1105/tpc.106.041582; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Hematy K, 2008, CURR OPIN PLANT BIOL, V11, P321, DOI 10.1016/j.pbi.2008.02.008; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Hwang JU, 2005, MOL BIOL CELL, V16, P5385, DOI 10.1091/mbc.E05-05-0409; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Kim HU, 2002, PLANT MOL BIOL, V50, P1, DOI 10.1023/A:1016077014583; Klahre U, 2006, PLANT J, V46, P1018, DOI 10.1111/j.1365-313X.2006.02757.x; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Miyahara A, 2008, J BIOL CHEM, V283, P25381, DOI 10.1074/jbc.M800400200; Muschietti J, 1998, PLANT CELL, V10, P319, DOI 10.1105/tpc.10.3.319; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Shichrur K, 2006, TRENDS PLANT SCI, V11, P57, DOI 10.1016/j.tplants.2005.12.001; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wengier D, 2003, P NATL ACAD SCI USA, V100, P6860, DOI 10.1073/pnas.0631728100; Wengier DL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-33; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Xu WH, 2006, PLANT J, V45, P740, DOI 10.1111/j.1365-313X.2005.02638.x; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Yoon GM, 2006, PLANT CELL, V18, P867, DOI 10.1105/tpc.105.037135; Yun HS, 2009, MOL CELLS, V27, P183, DOI 10.1007/s10059-009-0023-1; Zhang D, 2008, PLANT PHYSIOL, V148, P1368, DOI 10.1104/pp.108.124420; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104	37	14	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4882	4891		10.1074/jbc.M110.147512	http://dx.doi.org/10.1074/jbc.M110.147512			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131355	Green Published, hybrid			2022-12-25	WOS:000286975700084
J	Moore, MD; Cookson, J; Coventry, VK; Sproat, B; Rabe, L; Cranston, RD; McGowan, I; James, W				Moore, Michael D.; Cookson, Jonathan; Coventry, Veronica K.; Sproat, Brian; Rabe, Lorna; Cranston, Ross D.; McGowan, Ian; James, William			Protection of HIV Neutralizing Aptamers against Rectal and Vaginal Nucleases IMPLICATIONS FOR RNA-BASED THERAPEUTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FUSION INHIBITOR T-20; R5 STRAINS; STRUCTURAL-CHARACTERIZATION; MICROBICIDES; BINDS	RNA-based drugs are an emerging class of therapeutics. They have the potential to regulate proteins, chromatin, as well as bind to specific proteins of interest in the form of aptamers. These aptamers are protected from nuclease attack by chemical modifications that enhance their stability for in vivo usage. However, nucleases are ubiquitous, and as we have yet to characterize the entire human microbiome it is likely that many nucleases are yet to be identified. Any novel, unusual enzymes present in vivo might reduce the efficacy of RNA-based therapeutics, even when they are chemically modified. We have previously identified an RNA-based aptamer capable of neutralizing a broad spectrum of clinical HIV-1 isolates and are developing it as a vaginal and rectal microbicide candidate. As a first step we addressed aptamer stability in the milieu of proteins present in these environments. Here we uncover a number of different nucleases that are able to rapidly degrade 2'-F-modified RNA. We demonstrate that the aptamer can be protected from the nuclease(s) present in the vaginal setting, without affecting its antiviral activity, by replacement of key positions with 2'-O-Me-modified nucleotides. Finally, we show that the aptamer can be protected from all nucleases present in both vaginal and rectal compartments using Zn2+ cations. In conclusion we have derived a stable, antiviral RNA-based aptamer that could form the basis of a pre-exposure microbicide or be a valuable addition to the current tenofovir-based microbicide candidate undergoing clinical trials.	[Moore, Michael D.; Cookson, Jonathan; Coventry, Veronica K.; James, William] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Rabe, Lorna; Cranston, Ross D.; McGowan, Ian] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Sproat, Brian] Chemconsilium GCV, B-2221 Booischot, Belgium	University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Moore, MD (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	kenny.moore@path.ox.ac.uk	M, Ian/AAP-1032-2021; M, i/HCI-9242-2022; james, william/H-4289-2013	M, Ian/0000-0002-6470-8476; james, william/0000-0002-2506-1198; Cranston, Ross/0000-0002-2687-6217	National Institutes of Health from the NIAID [DMID U01 AI066734]; National Center for Research Resources [1 UL1 RR024153]; MRC [G0401610] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066734] Funding Source: NIH RePORTER; Medical Research Council [G0401610] Funding Source: researchfish	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DMID U01 AI066734 from the NIAID and National Center for Research Resources, Clinical and Translational Science Award 1 UL1 RR024153.	Ashihara E, 2010, CURR DRUG TARGETS, V11, P345, DOI 10.2174/138945010790711897; Cohen C, 2008, VIROLOGY, V381, P46, DOI 10.1016/j.virol.2008.08.025; de Campos WRL, 2009, ANTIMICROB AGENTS CH, V53, P3056, DOI 10.1128/AAC.01502-08; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dey AK, 2005, J VIROL, V79, P13806, DOI 10.1128/JVI.79.21.13806-13810.2005; Dey AK, 2005, RNA, V11, P873, DOI 10.1261/rna.7205405; Dupureur CM, 2008, CURR OPIN CHEM BIOL, V12, P250, DOI 10.1016/j.cbpa.2008.01.012; Ge Q, 2010, RNA, V16, P118, DOI 10.1261/rna.1901810; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; James W, 2007, J GEN VIROL, V88, P351, DOI 10.1099/vir.0.82442-0; Joubert MK, 2010, BIOCHEMISTRY-US, V49, P5880, DOI 10.1021/bi100301k; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; KASS EH, 1989, REV INFECT DIS, V11, pS167; Katakowski JA, 2010, CURR OPIN MOL THER, V12, P192; Khati M, 2003, J VIROL, V77, P12692, DOI 10.1128/JVI.77.23.12692-12698.2003; Khati M, 2010, J CLIN PATHOL, V63, P480, DOI 10.1136/jcp.2008.062786; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; OOSTERLINCK W, 1991, UROL RES, V19, P265, DOI 10.1007/BF00305309; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; Sayer N, 2002, BIOCHEM BIOPH RES CO, V293, P924, DOI 10.1016/S0006-291X(02)00308-X; Scherer L, 2007, GENE THER, V14, P1057, DOI 10.1038/sj.gt.3302977; SHIMAYAMA T, 1993, NUCLEIC ACIDS RES, V21, P2605, DOI 10.1093/nar/21.11.2605; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Zhou JH, 2008, MOL THER, V16, P1481, DOI 10.1038/mt.2008.92	27	27	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2526	2535		10.1074/jbc.M110.178426	http://dx.doi.org/10.1074/jbc.M110.178426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21106536	hybrid, Green Published			2022-12-25	WOS:000286464300017
J	Li, MM; Li, P; Song, RT; Xu, ZK				Li, Mangmang; Li, Ping; Song, Rentao; Xu, Zhengkai			An Induced Hypersensitive-Like Response Limits Expression of Foreign Peptides via a Recombinant TMV-Based Vector in a Susceptible Tobacco	PLOS ONE			English	Article							DEFENSE-RELATED GENES; MEMBRANE PROTEIN F; VIRUS COAT PROTEIN; MOSAIC-VIRUS; PSEUDOMONAS-AERUGINOSA; NICOTIANA-SYLVESTRIS; MESSENGER-RNAS; VIRAL VECTORS; RESISTANCE; INFECTION	Background: By using tobacco mosaic virus (TMV)-based vectors, foreign epitopes of the VP1 protein from food-and-month disease virus (FMDV) could be fused near to the C-terminus of the TMV coat protein (CP) and expressed at high levels in susceptible tobacco plants. Previously, we have shown that the recombinant TMV vaccines displaying FMDV VP1 epitopes could generate protection in guinea pigs and swine against the FMDV challenge. Recently, some recombinant TMV, such as TMVFN20 that contains an epitope FN20 from the FMDV VP1, were found to induce local necrotic lesions (LNL) on the inoculated leaves of a susceptible tobacco, Nicotiana tabacum Samsun nn. This hypersensitive-like response (HLR) blocked amplification of recombinant TMVFN20 in tobacco and limited the utility of recombinant TMV vaccines against FMDV. Methodology/ Principal Findings: Here we investigate the molecular mechanism of the HLR in the susceptible Samsun nn. Histochemical staining analyses show that these LNL are similar to those induced in a resistant tobacco Samsun NN inoculated with wild type (wt) TMV. The recombinant CP subunits are specifically related to the HLR. Interestingly, this HLR in Samsun nn (lacking the N/N'-gene) was able to be induced by the recombinant TMV at both 25 degrees C and 33 degrees C, whereas the hypersensitive response (HR) in the resistant tobacco plants induced by wt TMV through the N/N'-gene pathways only at a permissive temperature (below 30 degrees C). Furthermore, we reported for the first time that some of defense response (DR)-related genes in tobacco were transcriptionally upregulated during HLR. Conclusions: Unlike HR, HLR is induced in the susceptible tobacco through N/N'-gene independent pathways. Induction of the HLR is associated with the expression of the recombinant CP subunits and upregulation of the DR-related genes.	[Li, Mangmang; Xu, Zhengkai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Li, Ping; Song, Rentao; Xu, Zhengkai] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University	Xu, ZK (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	zkxu@staff.shu.edu.cn	Song, Rentao/AAG-9107-2021; Song, Rentao/A-6544-2012; LI, MANGMANG/J-1683-2015	Song, Rentao/0000-0003-1810-9875; Song, Rentao/0000-0003-1810-9875; 	National Natural Science Foundation of China [30700525]; Science and Technology Commission of Shanghai [08QA14033]; Shanghai Committee of Science and Technology [06JC14030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This project was supported by the National Natural Science Foundation of China (No. 30700525), the Science and Technology Commission of Shanghai (No. 08QA14033), and Shanghai Committee of Science and Technology (No. 06JC14030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CJ, 1994, PLANT CELL TISS ORG, V39, P7, DOI 10.1007/BF00037585; BALANDIN T, 1995, PLANT MOL BIOL, V27, P1197, DOI 10.1007/BF00020893; Bendahmane M, 1999, J MOL BIOL, V290, P9, DOI 10.1006/jmbi.1999.2860; BOL JF, 1990, ANNU REV PHYTOPATHOL, V28, P113, DOI 10.1146/annurev.py.28.090190.000553; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; CORNELISSEN BJC, 1986, EMBO J, V5, P37, DOI 10.1002/j.1460-2075.1986.tb04174.x; CULVER JN, 1994, J MOL BIOL, V242, P130, DOI 10.1006/jmbi.1994.1564; CULVER JN, 1989, VIROLOGY, V173, P755, DOI 10.1016/0042-6822(89)90592-8; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Erickson FL, 1999, PHILOS T ROY SOC B, V354, P653, DOI 10.1098/rstb.1999.0417; FITCHEN J, 1995, VACCINE, V13, P1051, DOI 10.1016/0264-410X(95)00075-C; Gilleland HE, 2000, FEMS IMMUNOL MED MIC, V27, P291, DOI 10.1111/j.1574-695X.2000.tb01442.x; GONDET L, 1992, BIOCHEM BIOPH RES CO, V186, P888, DOI 10.1016/0006-291X(92)90829-A; Grdzelishvili VZ, 2000, VIROLOGY, V275, P177, DOI 10.1006/viro.2000.0511; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jiang LB, 2006, VACCINE, V24, P109, DOI 10.1016/j.vaccine.2005.09.060; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang MK, 1998, MOL CELLS, V8, P388; Koo M, 1999, P NATL ACAD SCI USA, V96, P7774, DOI 10.1073/pnas.96.14.7774; Lacorte C, 2007, VIRUS RES, V129, P80, DOI 10.1016/j.virusres.2007.06.020; LAWTON K, 1992, PLANT MOL BIOL, V19, P735, DOI 10.1007/BF00027070; Li QL, 2007, J VIROL METHODS, V140, P212, DOI 10.1016/j.jviromet.2006.10.011; Li QL, 2006, VIROLOGY, V348, P253, DOI 10.1016/j.virol.2005.11.013; MATTHEWS REF, 1981, PLANT VIROLOGY; McCormick AA, 2008, EXPERT REV VACCINES, V7, P33, DOI 10.1586/14760584.7.1.33; Murphy AM, 2004, J GEN VIROL, V85, P3777, DOI 10.1099/vir.0.80385-0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; Oh SK, 2006, PLANTA, V223, P1101, DOI 10.1007/s00425-006-0232-1; Palmer KE, 2006, VACCINE, V24, P5516, DOI 10.1016/j.vaccine.2006.04.058; Pontier D, 1999, PLANT MOL BIOL, V39, P1243, DOI 10.1023/A:1006133311402; SINGH NK, 1987, PLANT PHYSIOL, V85, P529, DOI 10.1104/pp.85.2.529; Smith ML, 2007, VIROLOGY, V358, P321, DOI 10.1016/j.virol.2006.08.040; Staczek J, 2000, VACCINE, V18, P2266, DOI 10.1016/S0264-410X(99)00571-X; TAKAMATSU N, 1990, FEBS LETT, V269, P73, DOI 10.1016/0014-5793(90)81121-4; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Ueda H, 2006, PLANT MOL BIOL, V61, P31, DOI 10.1007/s11103-005-5817-8; VANDENBULCKE M, 1989, P NATL ACAD SCI USA, V86, P2673, DOI 10.1073/pnas.86.8.2673; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Wu LG, 2003, VACCINE, V21, P4390, DOI 10.1016/S0264-410X(03)00428-6	42	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15087	10.1371/journal.pone.0015087	http://dx.doi.org/10.1371/journal.pone.0015087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124743	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500036
J	Romih, V; Lepej, SZ; Gedike, K; Lukas, D; Begovac, J				Romih, Vanja; Lepej, Snjezana Zidovec; Gedike, Kornelija; Lukas, Davorka; Begovac, Josip			Frequency of HIV-1 Viral Load Monitoring of Patients Initially Successfully Treated with Combination Antiretroviral Therapy	PLOS ONE			English	Article							CROATIA; PREVALENCE; INFECTION; HIV/AIDS; ROUTINE; ZAGREB; STILL	Background: Although considered an essential tool for monitoring the effect of combination antiretroviral treatment (CART), HIV-1 RNA (viral load, VL) testing is greatly influenced by cost and availability of resources. Objectives: To examine whether HIV infected patients who were initially successfully treated with CART have less frequent monitoring of VL over time and whether CART failure and other HIV-disease and sociodemographic characteristics are associated with less frequent VL testing. Methods: The study included patients who started CART in the period 1999-2004, were older than 18 years, CART naive, had two consecutive viral load measurements of <400 copies/ml after 5 months of treatment and had continuous CART during the first 15 months. The time between two consecutive visits (days) was the outcome and associated factors were assessed using linear mixed models. Results: We analyzed a total of 128 patients with 1683 visits through December 2009. CART failure was observed in 31 (24%) patients. When adjusted for the follow-up time, the mean interval between two consecutive VL tests taken in patients before CART failure (155.2 days) was almost identical to the interval taken in patients who did not fail CART (155.3 days). On multivariable analysis, we found that the adjusted estimated time between visits was 150.9 days before 2003 and 177.6 in 2008/2009. A longer time between visits was observed in seafarers compared to non-seafarers; the mean difference was 30.7 days (95% CI, 14.0 to 47.4; p<0.001); and in individuals who lived more than 160 kilometers from the HIV treatment center (mean difference, 16 days, p = 0.010). Conclusions: Less frequent monitoring of VL became common in recent years and was not associated with failure. We identified seafarers as a population with special needs for CART monitoring and delivery.	[Romih, Vanja; Lepej, Snjezana Zidovec; Gedike, Kornelija; Lukas, Davorka; Begovac, Josip] Univ Hosp Infect Dis, Zagreb, Croatia; [Begovac, Josip] Univ Zagreb, Sch Med, Dept Infect Dis, Zagreb 41001, Croatia	University of Zagreb	Romih, V (corresponding author), Univ Hosp Infect Dis, Zagreb, Croatia.	jbegovac@bfm.hr	Begovac, Josip/AAI-5672-2021	Begovac, Josip/0000-0003-2641-4327	Croatian Ministry of Science, Education and Sports [108-1080116-0098, 143-1080116-0097]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This study was supported in part by grants from the Croatian Ministry of Science, Education and Sports to Josip Begovac and Snjezana Zidovec Lepej (Grants 108-1080116-0098 and 143-1080116-0097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Begovac J, 2006, COLLEGIUM ANTROPOL, V30, P17; Bernays S, 2009, AIDS CARE, V21, P315, DOI 10.1080/09540120802183495; Bozicevic I, 2009, AIDS BEHAV, V13, P303, DOI 10.1007/s10461-008-9436-7; Haubrich RH, 2001, CLIN INFECT DIS, V33, P1060, DOI 10.1086/322636; Kendall MA, 2006, CONTEMP CLIN TRIALS, V27, P287, DOI 10.1016/j.cct.2006.02.001; Laine C, 2002, J ACQ IMMUN DEF SYND, V29, P270, DOI 10.1097/00126334-200203010-00007; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Raboud JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-40; Raboud JM, 2005, JAIDS-J ACQ IMM DEF, V39, P327, DOI 10.1097/01.qai.0000143603.94728.b2; Ramirez-Piedad MK, 2009, J MED VIROL, V81, P573, DOI 10.1002/jmv.21433; Reekie J, 2008, AIDS, V22, P2381, DOI 10.1097/QAD.0b013e328317a6eb; Tesic V, 2006, COLLEGIUM ANTROPOL, V30, P89; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004	14	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15051	10.1371/journal.pone.0015051	http://dx.doi.org/10.1371/journal.pone.0015051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124844	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000284572000023
J	Chinappi, M; Via, A; Marcatili, P; Tramontano, A				Chinappi, Mauro; Via, Allegra; Marcatili, Paolo; Tramontano, Anna			On the Mechanism of Chloroquine Resistance in Plasmodium falciparum	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN PFCRT; DIGESTIVE VACUOLE; STRUCTURE PREDICTION; HOMOLOGY DETECTION; DRUG-RESISTANCE; EFFLUX SYSTEM; H+ LEAK; TRANSPORTER; MUTATIONS; PH	Resistance to chloroquine of malaria strains is known to be associated with a parasite protein named PfCRT, the mutated form of which is able to reduce chloroquine accumulation in the digestive vacuole of the pathogen. Whether the protein mediates extrusion of the drug acting as a channel or as a carrier and which is the protonation state of its chloroquine substrate is the subject of a scientific debate. We present here an analytical approach that explores which combination of hypotheses on the mechanism of transport and the protonation state of chloroquine are consistent with available equilibrium experimental data. We show that the available experimental data are not, by themselves, sufficient to conclude whether the protein acts as a channel or as a transporter, which explains the origin of their different interpretation by different authors. Interestingly, though, each of the two models is only consistent with a subset of hypotheses on the protonation state of the transported molecule. The combination of these results with a sequence and structure analysis of PfCRT, which strongly suggests that the molecule is a carrier, indicates that the transported species is either or both the mono and di-protonated forms of chloroquine. We believe that our results, besides shedding light on the mechanism of chloroquine resistance in P. falciparum, have implications for the development of novel therapies against resistant malaria strains and demonstrate the usefulness of an approach combining systems biology strategies with structural bioinformatics and experimental data.	[Chinappi, Mauro; Via, Allegra; Marcatili, Paolo; Tramontano, Anna] Univ Roma La Sapienza, Dept Biochem Sci, Rome, Italy; [Tramontano, Anna] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Chinappi, M (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci, Rome, Italy.	Anna.Tramontano@uniroma1.it	Via, Allegra/AAY-7435-2020; Tramontano, anna/D-5378-2009; Marcatili, Paolo/G-9673-2016	Tramontano, anna/0000-0002-5610-3338; Chinappi, Mauro/0000-0002-4509-1247; Marcatili, Paolo/0000-0003-2615-5695	King Abdullah University of Science and Technology (KAUST) [KUK-I1-012-43]; Human Frontier Science Program (HFSP) [RGP0054/2006-C]; Fondazione Roma	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Fondazione Roma(Fondazione RomaEuropean Commission)	This work was supported by King Abdullah University of Science and Technology (KAUST) - Award No. KUK-I1-012-43 (http://www.kaust.edu.sa/), Human Frontier Science Program (HFSP) -RGP0054/2006-C grant (http://www.hfsp.org/), and Fondazione Roma (http://www.fondazioneroma.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernsel A, 2008, PROTEINS, V71, P1387, DOI 10.1002/prot.21825; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; BRAY PG, 1992, BIOCHEM PHARMACOL, V44, P1317, DOI 10.1016/0006-2952(92)90532-N; Bray PG, 1998, MOL PHARMACOL, V54, P170, DOI 10.1124/mol.54.1.170; Bray PG, 1999, J CELL BIOL, V145, P363, DOI 10.1083/jcb.145.2.363; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Cooper RA, 2005, ACTA TROP, V94, P170, DOI 10.1016/j.actatropica.2005.04.004; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FERRARI V, 1991, BIOCHEM PHARMACOL, V41, P23, DOI 10.1016/0006-2952(91)90006-Q; FERRARI V, 1991, BIOCHEM PHARMACOL, V42, pS167, DOI 10.1016/0006-2952(91)90407-V; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1970, SCIENCE, V169, P289, DOI 10.1126/science.169.3942.289; Hayward R, 2006, J CELL SCI, V119, P1016, DOI 10.1242/jcs.02795; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Huaman MC, 2004, AM J TROP MED HYG, V71, P40, DOI 10.4269/ajtmh.2004.71.40; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Lehane AM, 2008, ANTIMICROB AGENTS CH, V52, P4374, DOI 10.1128/AAC.00666-08; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Perrin DD, 1965, INT UNION PURE APPL; Saliba KJ, 1998, BIOCHEM PHARMACOL, V56, P313, DOI 10.1016/S0006-2952(98)00140-3; Sanchez CP, 2007, TRENDS PARASITOL, V23, P332, DOI 10.1016/j.pt.2007.04.013; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Sanchez CP, 2005, BIOCHEMISTRY-US, V44, P9862, DOI 10.1021/bi050061f; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stein W., 2012, TRANSPORT DIFFUSION; SUGIOKA K, 1987, FEBS LETT, V210, P37, DOI 10.1016/0014-5793(87)81293-0; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Sullivan DJ, 1998, J BIOL CHEM, V273, P31103, DOI 10.1074/jbc.273.47.31103; Wang Y, 2009, BIOINFORMATICS, V25, P2076, DOI 10.1093/bioinformatics/btp346; Warhurst DC, 2002, LANCET, V360, P1527, DOI 10.1016/S0140-6736(02)11577-7; Wellems TE, 2004, NAT MED, V10, P1169, DOI 10.1038/nm1104-1169; Wellems TE, 2003, NEW ENGL J MED, V349, P1496, DOI 10.1056/NEJMp038127; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x	55	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14064	10.1371/journal.pone.0014064	http://dx.doi.org/10.1371/journal.pone.0014064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124966	Green Published, Green Submitted, gold			2022-12-25	WOS:000284400100013
J	Cronshaw, DG; Nie, YC; Waite, J; Zou, YR				Cronshaw, Darran G.; Nie, Yuchun; Waite, Janelle; Zou, Yong-Rui			An Essential Role of the Cytoplasmic Tail of CXCR4 in G-Protein Signaling and Organogenesis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; COUPLED RECEPTORS; BETA-ARRESTIN; WHIM-SYNDROME; CELL-ADHESION; BONE-MARROW; 7-TRANSMEMBRANE RECEPTORS; INTRACELLULAR DOMAINS; CRYSTAL-STRUCTURE; TYROSINE KINASE	CXCR4 regulates cell proliferation, enhances cell survival and induces chemotaxis, yet molecular mechanisms underlying its signaling remain elusive. Like all other G-protein coupled receptors (GPCRs), CXCR4 delivers signals through G-protein-dependent and -independent pathways, the latter involving its serine-rich cytoplasmic tail. To evaluate the signaling and biological contribution of this G-protein-independent pathway, we generated mutant mice that express cytoplasmic tail-truncated CXCR4 (Delta T) by a gene knock-in approach. We found that Delta T mice exhibited multiple developmental defects, with not only G-protein-independent but also G-protein-dependent signaling events completely abolished, despite Delta's ability to still associate with G-proteins. These results reveal an essential positive regulatory role of the cytoplasmic tail in CXCR4 signaling and suggest the tail is crucial for mediating G-protein activation and initiating crosstalk between G-protein-dependent and G-protein-independent pathways for correct GPCR signaling.	[Cronshaw, Darran G.; Nie, Yuchun; Waite, Janelle; Zou, Yong-Rui] Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA	Northwell Health	Cronshaw, DG (corresponding author), Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA.	yzou@nshs.edu			DANA Foundation [CU-51912001]; Sandler Program for Asthma Research [SPAR 04-0179]; Irene Diamond Fund [SHRI 1703]	DANA Foundation; Sandler Program for Asthma Research; Irene Diamond Fund	This work was supported in part by the DANA Foundation (CU-51912001), the Sandler Program for Asthma Research (SPAR 04-0179), and the Irene Diamond Fund (SHRI 1703) to Y.-R. Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagri A, 2002, DEVELOPMENT, V129, P4249; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; Diaz GA, 2005, IMMUNOL REV, V203, P235, DOI 10.1111/j.0105-2896.2005.00226.x; Ding Y, 2008, EXP CELL RES, V314, P590, DOI 10.1016/j.yexcr.2007.10.032; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Gosling J, 1997, P NATL ACAD SCI USA, V94, P5061, DOI 10.1073/pnas.94.10.5061; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Kawai T, 2005, EXP HEMATOL, V33, P460, DOI 10.1016/j.exphem.2005.01.001; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; McCormick PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008102; Meng EC, 2001, TRENDS PHARMACOL SCI, V22, P587, DOI 10.1016/S0165-6147(00)01825-3; Moepps B, 1997, EUR J IMMUNOL, V27, P2102, DOI 10.1002/eji.1830270839; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Roland J, 2003, BLOOD, V101, P399, DOI 10.1182/blood-2002-03-0978; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SAVARESE TM, 1992, BIOCHEM J, V283, P1; Signoret N, 1998, J CELL SCI, V111, P2819; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Ueda Y, 2006, CANCER RES, V66, P5665, DOI 10.1158/0008-5472.CAN-05-3579; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e15397	10.1371/journal.pone.0015397	http://dx.doi.org/10.1371/journal.pone.0015397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124917	gold, Green Published, Green Submitted			2022-12-25	WOS:000284400100018
J	Li, SL; Quarto, N; Longaker, MT				Li, Shuli; Quarto, Natalina; Longaker, Michael T.			Activation of FGF Signaling Mediates Proliferative and Osteogenic Differences between Neural Crest Derived Frontal and Mesoderm Parietal Derived Bone	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; TRANSCRIPTIONAL CONTROL; MOLECULAR-MECHANISMS; STROMAL CELLS; SELF-RENEWAL; STEM-CELLS; PDGF-BB; DIFFERENTIATION; SURVIVAL; EXPRESSION	Background: As a culmination of efforts over the last years, our knowledge of the embryonic origins of the mammalian frontal and parietal cranial bones is unambiguous. Progenitor cells that subsequently give rise to frontal bone are of neural crest origin, while parietal bone progenitors arise from paraxial mesoderm. Given the unique qualities of neural crest cells and the clear delineation of the embryonic origins of the calvarial bones, we sought to determine whether mouse neural crest derived frontal bone differs in biology from mesoderm derived parietal bone. Methods: BrdU incorporation, immunoblotting and osteogenic differentiation assays were performed to investigate the proliferative rate and osteogenic potential of embryonic and postnatal osteoblasts derived from mouse frontal and parietal bones. Co-culture experiments and treatment with conditioned medium harvested from both types of osteoblasts were performed to investigate potential interactions between the two different tissue origin osteoblasts. Immunoblotting techniques were used to investigate the endogenous level of FGF-2 and the activation of three major FGF signaling pathways. Knockdown of FGF Receptor 1 (FgfR1) was employed to inactivate the FGF signaling. Results: Our results demonstrated that striking differences in cell proliferation and osteogenic differentiation between the frontal and parietal bone can be detected already at embryonic stages. The greater proliferation rate, as well as osteogenic capacity of frontal bone derived osteoblasts, were paralleled by an elevated level of FGF-2 protein synthesis. Moreover, an enhanced activation of FGF-signaling pathways was observed in frontal bone derived osteoblasts. Finally, the greater osteogenic potential of frontal derived osteoblasts was dramatically impaired by knocking down FgfR1. Conclusions: Osteoblasts from mouse neural crest derived frontal bone displayed a greater proliferative and osteogenic potential and endogenous enhanced activation of FGF signaling compared to osteoblasts from mesoderm derived parietal bone. FGF signaling plays a key role in determining biological differences between the two types of osteoblasts.	[Li, Shuli; Quarto, Natalina; Longaker, Michael T.] Stanford Univ, Sch Med, Childrens Surg Res Program, Dept Surg, Stanford, CA 94305 USA; [Quarto, Natalina] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy	Stanford University; University of Naples Federico II	Li, SL (corresponding author), Stanford Univ, Sch Med, Childrens Surg Res Program, Dept Surg, Stanford, CA 94305 USA.	Longaker@stanford.edu			Oak Foundation; National Institutes of Health (NIH) [R01 DE014526, R01 DE13194, 1R01DE019434]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013194] Funding Source: NIH RePORTER	Oak Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This investigation was supported by the Oak Foundation and National Institutes of Health (NIH) grants R01 DE014526, R01 DE13194 and 1R01DE019434 to M. T. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2000, PHILOS T R SOC B, V355, P953, DOI 10.1098/rstb.2000.0631; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Chaudhary LR, 2001, J CELL BIOCHEM, V81, P304, DOI 10.1002/1097-4644(20010501)81:2<304::AID-JCB1045>3.3.CO;2-L; Chaudhary LR, 1997, BIOCHEM BIOPH RES CO, V238, P134, DOI 10.1006/bbrc.1997.7256; Couly G, 1996, DEVELOPMENT, V122, P3393; Cowan CM, 2003, J BIOL CHEM, V278, P32005, DOI 10.1074/jbc.M304698200; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Fakhry A, 2005, BONE, V36, P254, DOI 10.1016/j.bone.2004.10.003; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kontges G, 1996, DEVELOPMENT, V122, P3229; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Li S, 2007, AM J PHYSIOL-CELL PH, V293, pC1834, DOI 10.1152/ajpcell.00135.2007; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Morriss-Kay GM, 2001, J ANAT, V199, P143; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; Naski M C, 1998, Front Biosci, V3, pd781; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Quarto N, 2006, TISSUE ENG, V12, P1405, DOI 10.1089/ten.2006.12.1405; Quarto N, 2010, J BONE MINER RES, V25, P1680, DOI 10.1359/jbmr.091116; Quarto N, 2009, CELLS TISSUES ORGANS, V190, P158, DOI 10.1159/000202789; Trainor P, 2002, SCIENCE, V297, P781, DOI 10.1126/science.1075454; Trentin A, 2004, P NATL ACAD SCI USA, V101, P4495, DOI 10.1073/pnas.0400629101; Yang DH, 2006, BONE, V38, P485, DOI 10.1016/j.bone.2005.10.009	37	39	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14033	10.1371/journal.pone.0014033	http://dx.doi.org/10.1371/journal.pone.0014033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124973	Green Published, gold, Green Submitted			2022-12-25	WOS:000284356900002
J	Goodman, CA; Mabrey, DM; Frey, JW; Miu, MH; Schmidt, EK; Pierre, P; Hornberger, TA				Goodman, Craig A.; Mabrey, Danielle M.; Frey, John W.; Miu, Man Hing; Schmidt, Enrico K.; Pierre, Philippe; Hornberger, Troy A.			Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive in vivo technique	FASEB JOURNAL			English	Article						hypertrophy; atrophy; growth	PHOSPHOINOSITIDE 3-KINASE; HYPERTROPHY; ATROPHY; TISSUES; PATHWAY; KINASE; RATS; RHEB	In this study, the principles of surface sensing of translation (SUnSET) were used to develop a nonradioactive method for ex vivo and in vivo measurements of protein synthesis (PS). Compared with controls, we first demonstrate excellent agreement between SUnSET and a [H-3] phenylalanine method when detecting synergist ablation-induced increases in skeletal muscle PS ex vivo. We then show that SUnSET can detect the same synergist ablation-induced increase in PS when used in vivo (IV-SUnSET). In addition, IV-SUnSET detected food deprivation-induced decreases in PS in the heart, kidney, and skeletal muscles, with similar changes being visualized with an immunohistochemical version of IV-SUnSET (IV-IHC-SUnSET). By combining IV-IHC-SUnSET with in vivo transfection, we demonstrate that constitutively active PKB induces a robust increase in skeletal muscle PS. Furthermore, transfection with Ras homolog enriched in brain (Rheb) revealed that a PKB-independent activation of mammalian target of rapamycin is also sufficient to induce an increase in skeletal muscle PS. Finally, IV-IHC-SUnSET exposed the existence of fiber type-dependent differences in skeletal muscle PS, with PS in type 2B and 2X fibers being significantly lower than that in type 2A fibers within the same muscle. Thus, our nonradioactive method allowed us to accurately visualize and quantify PS under various ex vivo and in vivo conditions and revealed novel insights into the regulation of PS in skeletal muscle.-Goodman, C. A., Mabrey, D. M., Frey, J. W., Miu, M. H., Schmidt, E. K., Pierre, P., Hornberger, T. A. Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive in vivo technique. FASEB J. 25, 1028-1039 (2011). www.fasebj.org	[Goodman, Craig A.; Mabrey, Danielle M.; Frey, John W.; Miu, Man Hing; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA; [Schmidt, Enrico K.; Pierre, Philippe] Univ Mediterranee, Ctr Immunol Marseille Luminy, Marseille, France; [Schmidt, Enrico K.; Pierre, Philippe] INSERM, U631, F-13258 Marseille, France; [Schmidt, Enrico K.; Pierre, Philippe] CNRS, UMR6102, Marseille, France	University of Wisconsin System; University of Wisconsin Madison; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Hornberger, TA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, 2015 Linden Dr, Madison, WI 53706 USA.	thornb1@svm.vetmed.wisc.edu	Goodman, Craig/H-8085-2019	Goodman, Craig/0000-0002-5874-7743; Hornberger, Troy/0000-0002-2349-1899; pierre, philippe/0000-0003-0863-8255	U.S. National Institutes of Health [AR057347]; Agence Nationale de la Recherche DC-trans; Human Frontier Science Program Organization [RGP0045/2005]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche DC-trans(French National Research Agency (ANR)); Human Frontier Science Program Organization(Human Frontier Science Program); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The type 1, 2a, and 2b MHC monoclonal antibodies developed by S. Schiaffino and the type 2x MHC monoclonal antibody developed by C. Lucas were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and maintained by the University of Iowa Department of Biology (Ames, IA, USA). This work was supported by U.S. National Institutes of Health grant AR057347 to T.A.H. and Agence Nationale de la Recherche DC-trans and Human Frontier Science Program Organization grant RGP0045/2005 to P.P.	Adams GR, 2002, AM J PHYSIOL-CELL PH, V283, pC1182, DOI 10.1152/ajpcell.00173.2002; ARMSTRONG RB, 1985, J EXP BIOL, V115, P201; AUGERT G, 1986, DIABETOLOGIA, V29, P248, DOI 10.1007/BF00454885; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; GARLICK PJ, 1975, BIOCHIM BIOPHYS ACTA, V414, P71, DOI 10.1016/0005-2787(75)90126-4; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; GOLDBERG AL, 1967, NATURE, V216, P1219, DOI 10.1038/2161219a0; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Habets PEMH, 1999, J HISTOCHEM CYTOCHEM, V47, P995, DOI 10.1177/002215549904700803; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Jefferson LS, 1999, INT J BIOCHEM CELL B, V31, P191, DOI 10.1016/S1357-2725(98)00141-1; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; MCALLISTER RM, 1993, J RECONSTR MICROSURG, V9, P313, DOI 10.1055/s-2007-1006673; Nader GA, 2005, INT J BIOCHEM CELL B, V37, P1985, DOI 10.1016/j.biocel.2005.02.026; NAKANO K, 1979, BIOCHEM J, V184, P663, DOI 10.1042/bj1840663; NATHANS D, 1964, P NATL ACAD SCI USA, V51, P585, DOI 10.1073/pnas.51.4.585; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Wolfe RR., 2005, ISOTOPE TRACERS META, V2	25	315	321	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1028	1039		10.1096/fj.10-168799	http://dx.doi.org/10.1096/fj.10-168799			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21148113	Green Published			2022-12-25	WOS:000287806200022
J	Tinnes, S; Schafer, MKE; Flubacher, A; Munzner, G; Frotscher, M; Haas, CA				Tinnes, Stefanie; Schaefer, Michael K. E.; Flubacher, Armin; Muenzner, Gert; Frotscher, Michael; Haas, Carola A.			Epileptiform activity interferes with proteolytic processing of Reelin required for dentate granule cell positioning	FASEB JOURNAL			English	Article						hippocampus; dispersion; kainate; lamination; organotypic slice cultures	TEMPORAL-LOBE EPILEPSY; METALLOPROTEINASES-1 TIMP-1; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; KNOCKOUT MICE; MUTANT MICE; NEURONS; HIPPOCAMPUS; DISPERSION; PROTEIN	The extracellular matrix protein Reelin is an essential regulator of neuronal migration and lamination in the developing and mature brain. Lack of Reelin causes severe disturbances in cerebral layering, such as the reeler phenotype and granule cell dispersion in temporal lobe epilepsy. Reelin is synthesized and secreted by Cajal-Retzius cells and GABAergic interneurons, and its function depends on proteolytic cleavage after secretion. The mechanisms regulating these processes are largely unknown. Here, we used rat hippocampal slice cultures to investigate the effect of neuronal activation and hyperexcitation on Reelin synthesis, secretion, and proteolytic processing. We show that enhanced neuronal activity does not modulate Reelin synthesis or secretion. Moreover, we found that intracellular Reelin resides predominantly in the endoplasmic reticulum before it is constitutively secreted via the early secretory pathway. Epileptiform activity, however, impairs the proteolytic processing of Reelin and leads to accumulation of Reelin in the extracellular matrix. We found that both conditions, epileptiform activity and impaired proteolytic cleavage of Reelin, cause granule cell dispersion via inhibition of metalloproteinases. Taken together, our results strongly suggest that secretion of Reelin is activity-independent and that proteolytic processing of Reelin is required for the maintenance of granule cell lamination in the dentate gyrus.-Tinnes, S., Schafer, M. K. E., Flubacher, A., Munzner, G., Frotscher, M., Haas, C. A. Epileptiform activity interferes with proteolytic processing of Reelin required for dentate granule cell positioning. FASEB J. 25, 1002-1013 (2011). www.fasebj.org	[Tinnes, Stefanie; Flubacher, Armin; Muenzner, Gert; Haas, Carola A.] Univ Clin Freiburg, Neuroctr, Expt Epilepsy Grp, Freiburg, Germany; [Schaefer, Michael K. E.; Frotscher, Michael] Univ Clin Freiburg, Inst Anat & Cell Biol, Freiburg, Germany	University of Freiburg; University of Freiburg	Haas, CA (corresponding author), Univ Clin Freiburg, Neuroctr, Expt Epilepsy Grp, Freiburg, Germany.	carola.haas@uniklinik-freiburg.de	Schaefer, Michael K.E./S-1715-2019	Schaefer, Michael K.E./0000-0001-6055-6244	Deutsche Forschungsgemeinschaft (DFG) [SFB TR3, SFB 780]; German Federal Ministery of Education and Research [01GQ0420]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministery of Education and Research	The authors thank Dr. Hans Bock (Institute of Anatomy and Cell Biology, University of Freiburg, Freiburg, Germany) for the gift of recombinant Reelin and S. Huber and F. Moos for excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (DFG; Transregio SFB TR3; SFB 780) and the German Federal Ministery of Education and Research (grant 01GQ0420).	Alcantara S, 1998, J NEUROSCI, V18, P7779; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; Derer P, 2001, J COMP NEUROL, V440, P136, DOI 10.1002/cne.1375; Drakew A, 2002, EXP NEUROL, V176, P12, DOI 10.1006/exnr.2002.7918; Duveau V, 2011, HIPPOCAMPUS, V21, P935, DOI 10.1002/hipo.20793; Dzwonek J, 2004, FEBS LETT, V567, P129, DOI 10.1016/j.febslet.2004.03.070; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; Haas CA, 2002, J NEUROSCI, V22, P5797; Haas CA, 2010, EXP BRAIN RES, V200, P141, DOI 10.1007/s00221-009-1948-5; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Jourquin J, 2005, EUR J NEUROSCI, V22, P2569, DOI 10.1111/j.1460-9568.2005.04426.x; Lacor PN, 2000, P NATL ACAD SCI USA, V97, P3556, DOI 10.1073/pnas.050589597; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lugli Giovanni, 2003, BMC Biochem, V4, P9, DOI 10.1186/1471-2091-4-9; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Mimura N, 2008, MOL CELL BIOL, V28, P293, DOI 10.1128/MCB.00473-07; Muller MC, 2009, EXP NEUROL, V216, P390, DOI 10.1016/j.expneurol.2008.12.029; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Ramos-Moreno T, 2006, EUR J NEUROSCI, V23, P401, DOI 10.1111/j.1460-9568.2005.04567.x; Rivera S, 1997, J NEUROSCI, V17, P4223; Routbort MJ, 1999, NEUROSCIENCE, V94, P755, DOI 10.1016/S0306-4522(99)00358-9; SONNENBERG JL, 1989, J NEUROSCI RES, V24, P72, DOI 10.1002/jnr.490240111; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; STANFIELD BB, 1979, J COMP NEUROL, V185, P393, DOI 10.1002/cne.901850302; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104	43	46	48	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1002	1013		10.1096/fj.10-168294	http://dx.doi.org/10.1096/fj.10-168294			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21148112				2022-12-25	WOS:000287806200020
J	Zigrino, P; Nischt, R; Mauch, C				Zigrino, Paola; Nischt, Roswitha; Mauch, Cornelia			The Disintegrin-like and Cysteine-rich domains of ADAM-9 Mediate Interactions between Melanoma Cells and Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG INTEGRIN ALPHA-6-BETA-1; GROWTH-FACTOR; COLLAGEN-I; ADHESION; METALLOPROTEINASES; EXPRESSION; PROTEIN; CANCER; INVASION; BINDING	A characteristic of malignant cells is their capacity to invade their surrounding and to metastasize to distant organs. During these processes, proteolytic activities of tumor and stromal cells modify the extracellular matrix to produce a microenvironment suitable for their growth and migration. In recent years the family of ADAM proteases has been ascribed important roles in these processes. ADAM-9 is expressed in human melanoma at the tumor-stroma border where direct or indirect interactions between tumor cells and fibroblasts occur. To analyze the role of ADAM-9 for the interaction between melanoma cells and stromal fibroblasts, we produced the recombinant disintegrin-like and cysteine-rich domain of ADAM-9 (DC-9). Melanoma cells and human fibroblasts adhered to immobilized DC-9 in a Mn2+-dependent fashion suggesting an integrin-mediated process. Inhibition studies showed that adhesion of fibroblasts was mediated by several beta 1 integrin receptors independent of the RGD and ECD recognition motif. Furthermore, interaction of fibroblasts and high invasive melanoma cells with soluble recombinant DC-9 resulted in enhanced expression of MMP-1 and MMP-2. Silencing of ADAM-9 in melanoma cells significantly reduced cell adhesion to fibroblasts. Ablation of ADAM-9 in fibroblasts almost completely abolished these cellular interactions and melanoma cell invasion in vitro. In summary, these results suggest that ADAM-9 expression plays an important role in mediating cell-cell contacts between fibroblasts and melanoma cells and that these interactions contribute to proteolytic activities required during invasion of melanoma cells.	Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50937 Cologne, Germany	University of Cologne; University of Cologne	Zigrino, P (corresponding author), Univ Hosp Cologne, Dept Dermatol, Kerpener Str 62, D-50937 Cologne, Germany.	Paola.Zigrino@uni-koeln.de		Zigrino, Paola/0000-0002-7470-0064	Melanoma Research Network of the Deutsche Krebshilfe (Melanoma Verbund)	Melanoma Research Network of the Deutsche Krebshilfe (Melanoma Verbund)	This work was supported by the Melanoma Research Network of the Deutsche Krebshilfe (Melanoma Verbund, to P. Z. and C. M.).	ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Bergers G, 2000, CURR OPIN GENET DEV, V10, P120, DOI 10.1016/S0959-437X(99)00043-X; Blobel Carl P., 1992, Current Opinion in Cell Biology, V4, P760; Charrier L, 2007, J BIOL CHEM, V282, P16948, DOI 10.1074/jbc.M700158200; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Heino J, 1996, INT J CANCER, V65, P717, DOI 10.1002/(SICI)1097-0215(19960315)65:6<717::AID-IJC1>3.3.CO;2-P; Hofmann UB, 1999, BRIT J CANCER, V81, P774, DOI 10.1038/sj.bjc.6690763; Jia LG, 2000, ARCH BIOCHEM BIOPHYS, V373, P281, DOI 10.1006/abbi.1999.1517; Kamiguti AS, 2003, FEBS LETT, V549, P129, DOI 10.1016/S0014-5793(03)00799-3; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Kurschat P, 1999, J BIOL CHEM, V274, P21056, DOI 10.1074/jbc.274.30.21056; Kurschat P, 2002, J PATHOL, V197, P179, DOI 10.1002/path.1080; Loffek S, 2006, EUR J CELL BIOL, V85, P1167, DOI 10.1016/j.ejcb.2006.07.003; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Mauch C, 2010, J INVEST DERMATOL, V130, P2120, DOI 10.1038/jid.2010.60; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; Namba K, 2001, CELL IMMUNOL, V213, P104, DOI 10.1006/cimm.2001.1873; Nath D, 2000, J CELL SCI, V113, P2319; Nath D, 1999, J CELL SCI, V112, P579; O'Shea C, 2003, INT J CANCER, V105, P754, DOI 10.1002/ijc.11161; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Peduto L, 2009, CURR PHARM DESIGN, V15, P2282, DOI 10.2174/138161209788682415; Puissegur MP, 2007, J IMMUNOL, V178, P3161, DOI 10.4049/jimmunol.178.5.3161; Schlondorff J, 1999, J CELL SCI, V112, P3603; Serrano SMT, 2005, BIOCHEM J, V391, P69, DOI 10.1042/BJ20050483; Stuelten CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009832; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; Wandel E, 2000, EXP DERMATOL, V9, P34, DOI 10.1034/j.1600-0625.2000.009001034.x; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345; Zhou M, 2001, BIOCHEM BIOPH RES CO, V280, P574, DOI 10.1006/bbrc.2000.4155; Zigrino P, 2005, INT J CANCER, V116, P853, DOI 10.1002/ijc.21087; Zigrino P, 2001, EUR J CELL BIOL, V80, P68, DOI 10.1078/0171-9335-00134; Zigrino P, 2007, J BIOL CHEM, V282, P30785, DOI 10.1074/jbc.M701658200; Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130	41	42	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6801	6807		10.1074/jbc.M110.168617	http://dx.doi.org/10.1074/jbc.M110.168617			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135106	Green Published, hybrid			2022-12-25	WOS:000287476400087
J	Behnke-Parks, WM; Vendome, J; Honig, B; Maliga, Z; Moores, C; Rosenfeld, SS				Behnke-Parks, William M.; Vendome, Jeremie; Honig, Barry; Maliga, Zoltan; Moores, Carolyn; Rosenfeld, Steven S.			Loop L5 Acts as a Conformational Latch in the Mitotic Kinesin Eg5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC INHIBITOR; DIMERIC KINESIN; ATP HYDROLYSIS; NECK-LINKER; HUMAN KSP; SWITCH-I; MOTOR; MECHANISM; MONASTROL; PROTEIN	All members of the kinesin superfamily of molecular motors contain an unusual structural motif consisting of an alpha-helix that is interrupted by a flexible loop, referred to as L5. We have examined the function of L5 in the mitotic kinesin Eg5 by combining site-directed mutagenesis of L5 with transient state kinetics, molecular dynamics simulations, and docking using cryo electron microscopy density. We find that mutation of a proline residue located at a turn within this loop profoundly slows nucleotide-induced structural changes both at the catalytic site as well as at the microtubule binding domain and the neck linker. Molecular dynamics simulations reveal that this mutation affects the dynamics not only of L5 itself but also of the switch I structural elements that sense ATP binding to the catalytic site. Our results lead us to propose that L5 regulates the rate of conformational change in key elements of the nucleotide binding site through its interactions with alpha 3 and in so doing controls the speed of movement and force generation in kinesin motors.	[Rosenfeld, Steven S.] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Dept Biol, New York, NY 10032 USA; [Vendome, Jeremie; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Maliga, Zoltan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Moores, Carolyn] Univ London, Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England	Columbia University; Columbia University; Columbia University; Max Planck Society; University of London; Birkbeck University London	Rosenfeld, SS (corresponding author), Columbia Univ, Dept Neurol, Coll Phys & Surg, 710 W 168th St, New York, NY 10032 USA.	sr2327@columbia.edu	Moores, Carolyn/A-4942-2010		National Institutes of Health [AR048565]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/H005137/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H005137/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR048565 (NIAMS; to S.S.R.). This work was also supported by the Biotechnology and Biological Sciences Research Council.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Brier S, 2006, J MOL BIOL, V360, P360, DOI 10.1016/j.jmb.2006.04.062; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Creighton TE, 1983, PROTEINS STRUCTURES; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; Klumpp LM, 2003, J BIOL CHEM, V278, P39059, DOI 10.1074/jbc.M304250200; Kull FJ, 2002, J CELL SCI, V115, P15; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luo LS, 2004, BIOCHEMISTRY-US, V43, P15258, DOI 10.1021/bi048282t; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Maliga Z, 2006, J BIOL CHEM, V281, P7977, DOI 10.1074/jbc.M511955200; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Marx A, 2005, ADV PROTEIN CHEM, V71, P299, DOI 10.1016/S0065-3233(04)71008-6; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107	30	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5242	5253		10.1074/jbc.M110.192930	http://dx.doi.org/10.1074/jbc.M110.192930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148480	Green Published, hybrid			2022-12-25	WOS:000287230600033
J	Dhennin-Duthille, I; Nyga, R; Yahiaoui, S; Gouilleux-Gruart, V; Regnier, A; Lassoued, K; Gouilleux, F				Dhennin-Duthille, Isabelle; Nyga, Remy; Yahiaoui, Saliha; Gouilleux-Gruart, Valerie; Regnier, Aline; Lassoued, Kaiss; Gouilleux, Fabrice			The Tumor Suppressor hTid1 Inhibits STAT5b Activity via Functional Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE SIGNAL-TRANSDUCTION; EPIDERMAL-GROWTH-FACTOR; ALPHA-HELICAL REGION; HUMAN DNAJ PROTEIN; TRANSACTIVATION DOMAIN; HUMAN HOMOLOG; LYMPHOID DEVELOPMENT; NEGATIVE REGULATORS; HEMATOPOIETIC-CELLS; ACTIVATED STAT5A	STAT5a and -5b (signal transducers and activators of transcription 5a and 5b) proteins play an essential role in hematopoietic cell proliferation and survival and are frequently constitutively active in hematologic neoplasms and solid tumors. Because STAT5a and STAT5b differ mainly in the carboxylterminal transactivation domain, we sought to identify new proteins that bind specifically to this domain by using a bacterial two-hybrid screening. We isolated hTid1, a human DnaJ protein that acts as a tumor suppressor in various solid tumors. hTid1 interacts specifically with STAT5b but not with STAT5a in hematopoietic cell lines. This interaction involves the cysteine-rich region of the hTid1 DnaJ domain. We also demonstrated that hTid1 negatively regulates the expression and transcriptional activity of STAT5b and suppresses the growth of hematopoietic cells transformed by an oncogenic form of STAT5b. Our findings define hTid1 as a novel partner and negative regulator of STAT5b.	[Dhennin-Duthille, Isabelle; Nyga, Remy; Yahiaoui, Saliha; Gouilleux-Gruart, Valerie; Regnier, Aline; Lassoued, Kaiss; Gouilleux, Fabrice] Univ Picardie Jules Verne, INSERM, UFR Med, U925, F-80036 Amiens, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Lassoued, K (corresponding author), Univ Picardie Jules Verne, INSERM, UFR Med, U925, 3 Rue Louvels, F-80036 Amiens, France.	kaiss.lassoued@sa.u-picardie.fr; fabrice.gouilleux@univ-tours.fr		Gouilleux, Fabrice/0000-0001-6047-1718	INSERM; Association de la Recherche contre le Cancer, Ligue contre le Cancer, Conseil Regional de Picardie; Ministere de la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association de la Recherche contre le Cancer, Ligue contre le Cancer, Conseil Regional de Picardie(Fondation ARC pour la Recherche sur le CancerRegion Hauts-de-France); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by INSERM, Association de la Recherche contre le Cancer, Ligue contre le Cancer, Conseil Regional de Picardie.; Supported by the "Ministere de la Recherche."	Ahn BY, 2010, ONCOGENE, V29, P1155, DOI 10.1038/onc.2009.413; Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Bae MK, 2005, CANCER RES, V65, P2520, DOI 10.1158/0008-5472.CAN-03-2735; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Beuvink I, 2000, J BIOL CHEM, V275, P10247, DOI 10.1074/jbc.275.14.10247; Buitenhuis M, 2004, INT J BIOCHEM CELL B, V36, P2120, DOI 10.1016/j.biocel.2003.11.008; Chen CY, 2009, J PATHOL, V219, P347, DOI 10.1002/path.2604; Chen YH, 2006, BLOOD, V108, P566, DOI 10.1182/blood-2005-12-4777; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2001, CURR BIOL, V11, P1771, DOI 10.1016/S0960-9822(01)00540-1; Constantino S, 2001, ONCOGENE, V20, P2080, DOI 10.1038/sj.onc.1204308; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Dumon S, 1999, ONCOGENE, V18, P4191, DOI 10.1038/sj.onc.1202796; Edwards KM, 2004, ONCOGENE, V23, P8419, DOI 10.1038/sj.onc.1207732; Gu L, 2010, AM J PATHOL, V176, P1959, DOI 10.2353/ajpath.2010.090653; Guo F, 2005, BLOOD, V105, P1246, DOI 10.1182/blood-2004-05-2041; Harir N, 2008, BLOOD, V112, P2463, DOI 10.1182/blood-2007-09-115477; Hilton DJ, 1999, CELL MOL LIFE SCI, V55, P1568, DOI 10.1007/s000180050396; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Kaymer M, 1997, GENE, V204, P91, DOI 10.1016/S0378-1119(97)00528-3; Kazansky AV, 2001, CELL GROWTH DIFFER, V12, P1; Kieslinger M, 2000, GENE DEV, V14, P232; Kile BT, 2001, INT J HEMATOL, V73, P292, DOI 10.1007/BF02981953; Kim SW, 2004, CANCER RES, V64, P7732, DOI 10.1158/0008-5472.CAN-04-1323; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; Kloth MT, 2002, J BIOL CHEM, V277, P8693, DOI 10.1074/jbc.M111884200; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Lanvin O, 2004, ONCOGENE, V23, P3040, DOI 10.1038/sj.onc.1207450; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liang QC, 2009, CANCER LETT, V273, P164, DOI 10.1016/j.canlet.2008.08.011; Litterst CM, 2003, J BIOL CHEM, V278, P45340, DOI 10.1074/jbc.M303644200; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Mizuki M, 2000, BLOOD, V96, p680A; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Qian J, 2010, GASTROENTEROLOGY, V138, P1418, DOI 10.1053/j.gastro.2009.10.044; Rigacci S, 2003, BIOCHEM BIOPH RES CO, V312, P360, DOI 10.1016/j.bbrc.2003.10.126; Santos SCR, 2000, ONCOGENE, V19, P1164, DOI 10.1038/sj.onc.1203418; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shelburne CP, 2003, BLOOD, V102, P1290, DOI 10.1182/blood-2002-11-3490; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Syken J, 2003, ONCOGENE, V22, P4636, DOI 10.1038/sj.onc.1206569; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Tan SH, 2008, ENDOCR-RELAT CANCER, V15, P367, DOI 10.1677/ERC-08-0013; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Torregroza I, 2006, BIOCHEM J, V393, P311, DOI 10.1042/BJ20050785; Trentin GA, 2004, FEBS LETT, V578, P323, DOI 10.1016/j.febslet.2004.11.034; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Wang DM, 2000, EMBO J, V19, P392, DOI 10.1093/emboj/19.3.392; Xi SC, 2003, CANCER RES, V63, P6763; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yin X, 2001, GENE, V278, P201, DOI 10.1016/S0378-1119(01)00720-X; Yu CL, 2000, J BIOL CHEM, V275, P599, DOI 10.1074/jbc.275.1.599; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659	65	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5034	5042		10.1074/jbc.M110.155903	http://dx.doi.org/10.1074/jbc.M110.155903			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21106534	Green Published, hybrid			2022-12-25	WOS:000287230600011
J	Terao, M; Fratelli, M; Kurosaki, M; Zanetti, A; Guarnaccia, V; Paroni, G; Tsykin, A; Lupi, M; Gianni, M; Goodall, GJ; Garattini, E				Terao, Mineko; Fratelli, Maddalena; Kurosaki, Mami; Zanetti, Adriana; Guarnaccia, Valeria; Paroni, Gabriela; Tsykin, Anna; Lupi, Monica; Gianni, Maurizio; Goodall, Gregory J.; Garattini, Enrico			Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells BIOLOGICAL CORRELATES AND MOLECULAR TARGETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; TUMOR-SUPPRESSOR GENE; CANCER-CELLS; MICRORNA-21 TARGETS; MESENCHYMAL TRANSITION; NEGATIVE FEEDBACK; PROSTATE-CANCER; EXPRESSION; ALPHA; APOPTOSIS	Retinoids are promising agents for the treatment/prevention of breast carcinoma. We examined the role of microRNAs in mediating the effects of all-trans-retinoic acid (ATRA), which suppresses the proliferation of estrogen receptor-positive (ER alpha(+)) breast carcinoma cells, such as MCF-7, but not estrogen receptor-negative cells, such as MDA-MB-231. We found that pro-oncogenic miR-21 is selectively induced by ATRA in ER alpha(+) cells. Induction of miR-21 counteracts the anti-proliferative action of ATRA but has the potentially beneficial effect of reducing cell motility. In ER alpha(+) cells, retinoid-dependent induction of miR-21 is due to increased transcription of the MIR21 gene via ligand-dependent activation of the nuclear retinoid receptor, RAR alpha. RAR alpha is part of the transcription complex present in the 5'-flanking region of the MIR21 gene. The receptor binds to two functional retinoic acid-responsive elements mapping upstream of the transcription initiation site. Silencing of miR-21 enhances ATRA-dependent growth inhibition and senescence while reverting suppression of cell motility afforded by the retinoid. Up-regulation of miR-21 results in retinoid-dependent inhibition of the established target, maspin. Knockdown and overexpression of maspin in MCF-7 cells indicates that the protein is involved in ATRA-induced growth inhibition and contributes to the ATRA-dependent anti-motility responses. Integration between whole genome analysis of genes differentially regulated by ATRA in MCF-7 and MDA-MB-231 cells, prediction of miR-21 regulated genes, and functional studies led to the identification of three novel direct miR-21 targets: the pro-inflammatory cytokine IL1B, the adhesion molecule ICAM-1 and PLAT, the tissue-type plasminogen activator. Evidence for ICAM-1 involvement in retinoid-dependent inhibition of MCF-7 cell motility is provided.	[Terao, Mineko; Fratelli, Maddalena; Kurosaki, Mami; Zanetti, Adriana; Guarnaccia, Valeria; Paroni, Gabriela; Lupi, Monica; Gianni, Maurizio; Garattini, Enrico] Ist Ric Farmacol Mario Negri, Mol Biol Lab, I-20156 Milan, Italy; [Goodall, Gregory J.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Tsykin, Anna; Goodall, Gregory J.] Univ Adelaide, Dept Med, Adelaide, SA 5005, Australia	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Centre for Cancer Biology; SA Pathology; University of Adelaide	Garattini, E (corresponding author), Ist Ric Farmacol Mario Negri, Mol Biol Lab, Via La Masa 19, I-20156 Milan, Italy.	egarattini@marionegri.it	Garattini, Enrico/AAI-1998-2019; KUROSAKI, Mami/ABG-2224-2020; adriana, zanetti/ABA-1189-2020; Fratelli, Maddalena/AAA-6446-2020; Terao, Mineko/AAA-6415-2020; Paroni, Gabriela/J-4848-2018; Gianni, Maurizio/ABG-6322-2020; terao, mineko/AAU-8089-2020; Lupi, Monica/AAH-5704-2019	KUROSAKI, Mami/0000-0001-8231-713X; adriana, zanetti/0000-0002-5825-9707; Fratelli, Maddalena/0000-0002-1769-3427; Terao, Mineko/0000-0002-9976-9869; Paroni, Gabriela/0000-0003-0132-0869; Gianni, Maurizio/0000-0002-6945-708X; Tsykin, Anna/0000-0001-5965-6803; Goodall, Gregory/0000-0003-1294-0692; Lupi, Monica/0000-0002-9835-7870; Garattini, Enrico/0000-0001-8983-886X	Associazione Italiana Ricerca contro il Cancro; Ministero della Universita e della Ricerca; Fondazione "Italo Monzino"; Fondazione "Negri-Weizmann"	Associazione Italiana Ricerca contro il Cancro; Ministero della Universita e della Ricerca; Fondazione "Italo Monzino"; Fondazione "Negri-Weizmann"	This work was supported by the Associazione Italiana Ricerca contro il Cancro, Ministero della Universita e della Ricerca, Fondazione "Italo Monzino," and Fondazione "Negri-Weizmann."	Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chen YH, 2006, CANCER RES, V66, P8749, DOI 10.1158/0008-5472.CAN-06-0581; Ciana P, 2001, MOL ENDOCRINOL, V15, P1104, DOI 10.1210/me.15.7.1104; DeClerck YA, 1997, ADV EXP MED BIOL, V425, P89; del Rincon SV, 2004, ONCOGENE, V23, P9269, DOI 10.1038/sj.onc.1208104; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Elgort MG, 1996, MOL ENDOCRINOL, V10, P477, DOI 10.1210/me.10.5.477; ERICKSON CA, 1989, J EXP ZOOL, V251, P123, DOI 10.1002/jez.1402510203; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fu HY, 2006, BIOCHEM BIOPH RES CO, V343, P1009, DOI 10.1016/j.bbrc.2006.02.176; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Garattini E, 2004, CURR PHARM DESIGN, V10, P433, DOI 10.2174/1381612043453351; Garattini E, 2007, CURR PHARM DESIGN, V13, P1375, DOI 10.2174/138161207780618786; Gianni M, 1996, BLOOD, V87, P1520, DOI 10.1182/blood.V87.4.1520.bloodjournal8741520; Gianni M, 2009, CANCER RES, V69, P1016, DOI 10.1158/0008-5472.CAN-08-2603; Gozgit JM, 2006, MOL CANCER RES, V4, P905, DOI 10.1158/1541-7786.MCR-06-0147; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Joensuu KM, 2009, HUM PATHOL, V40, P1143, DOI 10.1016/j.humpath.2009.02.006; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Latha K, 2005, MOL CELL BIOL, V25, P1737, DOI 10.1128/MCB.25.5.1737-1748.2005; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; Mandal S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-181; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marchetti M, 2003, HAEMATOLOGICA, V88, P895; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mologni L, 1999, BLOOD, V93, P1045, DOI 10.1182/blood.V93.3.1045.403k22_1045_1061; Nwankwo JO, 2002, ANTICANCER RES, V22, P4129; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oliveira Andre M, 2005, Am J Clin Pathol, V124 Suppl, pS16; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Parrella E, 2006, MOL PHARMACOL, V70, P909, DOI 10.1124/mol.106.023614; Patel JB, 2007, BRIT J CANCER, V96, P1204, DOI 10.1038/sj.bjc.6603705; Plumb LA, 2004, METH MOLEC MED, V88, P165; Powell JA, 2009, BLOOD, V114, P4859, DOI 10.1182/blood-2009-02-204818; Qin LX, 2004, J CANCER RES CLIN, V130, P497, DOI 10.1007/s00432-004-0572-9; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; Rickles FR, 2009, THROMB RES, V123, pS16, DOI 10.1016/S0049-3848(09)70004-0; RISHI AK, 1995, CANCER RES, V55, P4999; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Strell C, 2010, EXP CELL RES, V316, P138, DOI 10.1016/j.yexcr.2009.09.003; Terao M, 2009, MOL CELL BIOL, V29, P357, DOI 10.1128/MCB.01385-08; Uray IP, 2006, EXPERT OPIN INV DRUG, V15, P1583, DOI 10.1517/13543784.15.12.1583; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang Y, 2009, PROTEOMICS, V9, P1374, DOI 10.1002/pmic.200800551; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; Zhu WY, 1999, CANCER RES, V59, P85; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	67	74	81	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					4027	4042		10.1074/jbc.M110.184994	http://dx.doi.org/10.1074/jbc.M110.184994			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21131358	Green Published, hybrid			2022-12-25	WOS:000286653200083
J	Wang, E; Mueller, WF; Hertel, KJ; Cambi, F				Wang, Erming; Mueller, William F.; Hertel, Klemens J.; Cambi, Franca			G Run-mediated Recognition of Proteolipid Protein and DM20 5 ' Splice Sites by U1 Small Nuclear RNA Is Regulated by Context and Proximity to the Splice Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; COMPLEX-FORMATION; 5'-SPLICE SITES; SR PROTEINS; ENHANCER; INTRON; OLIGODENDROCYTES; BINDS; EXON; ATP	Highly conserved G runs, G1M2 and ISE, regulate the proteolipid protein (PLP)/DM20 ratio. We have investigated recruitment of U1 small nuclear ribonuclear protein (snRNP) by G1M2 and ISE and examined the effect of splice site strength, distance, and context on G run function. G1M2 is necessary for initial recruitment of U1snRNP to the DM20 5' splice site independent of the strength of the splice site. G1M2 regulates E complex formation and supports DM20 splicing when functional U1snRNP is reduced. By contrast, the ISE is not required for the initial recruitment of U1snRNP to the PLP 5' splice site. However, in close proximity to either the DM20 or the PLP 5' splice site, the ISE recruits U1snRNP to both splice sites. The ISE enhances DM20 splicing, whereas close to the PLP 5' splice site, it inhibits PLP splicing. Splicing enhancement and inhibition are mediated by heterogeneous nuclear ribonuclear protein (hnRNP)H/F. The data show that recognition of the DM20 5' splice site depends on G run-mediated recruitment of U1snRNA, whereas a complex interaction between the ISE G runs, context and position determines the functional outcome on splicing. The data suggest that different mechanisms underlie G run-mediated recognition of 5' splice sites and that context and position play a critical role.	[Cambi, Franca] Univ Kentucky, Dept Neurol, KY Clin L445, Lexington, KY 40536 USA; [Mueller, William F.; Hertel, Klemens J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of Kentucky; University of California System; University of California Irvine	Cambi, F (corresponding author), Univ Kentucky, Dept Neurol, KY Clin L445, Lexington, KY 40536 USA.	franca.cambi@uky.edu		Hertel, Klemens/0000-0002-7560-9529	National Institutes of Health [RO1NS053905, RO1GM62287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS053905 (to F.C.) and RO1GM62287 (to K.J.H.).	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Buratti E, 2004, NUCLEIC ACIDS RES, V32, P4224, DOI 10.1093/nar/gkh752; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; Caputi M, 2002, EMBO J, V21, P845, DOI 10.1093/emboj/21.4.845; Carlo T, 2000, MOL CELL BIOL, V20, P3988, DOI 10.1128/MCB.20.11.3988-3995.2000; Carlo T, 1996, RNA, V2, P342; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; Dhir A, 2010, EMBO J, V29, P749, DOI 10.1038/emboj.2009.397; Du H, 2001, RNA, V7, P133, DOI 10.1017/S1355838201001844; Du HS, 2002, NATURE, V419, P86, DOI 10.1038/nature00947; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Hastings ML, 2001, RNA, V7, P859, DOI 10.1017/S1355838201002084; Hobson GM, 2006, HUM MUTAT, V27, P69, DOI 10.1002/humu.20276; Hobson GM, 2002, ANN NEUROL, V52, P477, DOI 10.1002/ana.10320; Hwang DY, 1996, GENE DEV, V10, P338, DOI 10.1101/gad.10.3.338; Kostadinov R, 2006, NUCLEIC ACIDS RES, V34, pD119, DOI 10.1093/nar/gkj073; Ladd AN, 2002, GENOME BIOL, V3; Lim SR, 2004, MOL CELL, V15, P477, DOI 10.1016/j.molcel.2004.06.025; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; MADHANI HD, 1994, ANNU REV GENET, V28, P1; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; Nagai K, 2001, BIOCHEM SOC T, V29, P15; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; NUSSINOV R, 1987, BIOCHIM BIOPHYS ACTA, V910, P261, DOI 10.1016/0167-4781(87)90119-9; NUSSINOV R, 1988, J THEOR BIOL, V133, P73, DOI 10.1016/S0022-5193(88)80025-0; NUSSINOV R, 1989, J BIOMOL STRUCT DYN, V6, P985, DOI 10.1080/07391102.1989.10506526; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Vouyiouklis DA, 2000, J NEUROCHEM, V74, P940, DOI 10.1046/j.1471-4159.2000.0740940.x; Wang EM, 2006, J CELL BIOCHEM, V97, P999, DOI 10.1002/jcb.20692; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wang EM, 2009, J BIOL CHEM, V284, P11194, DOI 10.1074/jbc.M809373200; Wang E, 2008, EXP NEUROL, V214, P322, DOI 10.1016/j.expneurol.2008.09.001; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101	44	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4059	4071		10.1074/jbc.M110.199927	http://dx.doi.org/10.1074/jbc.M110.199927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127064	Green Published, hybrid			2022-12-25	WOS:000286975700004
J	Aisiku, OR; Runnels, LW; Scarlata, S				Aisiku, Omozuanvbo R.; Runnels, Loren W.; Scarlata, Suzanne			Identification of a Novel Binding Partner of Phospholipase C beta 1: Translin-Associated Factor X	PLOS ONE			English	Article							BETA-GAMMA-SUBUNITS; G-ALPHA-Q; G-PROTEINS; LIVING CELLS; ACTIVATION; G-ALPHA(Q); INOSITIDES; RECEPTORS; EFFECTORS; MEMBRANE	Mammalian phospholipase C beta 1 (PLC beta 1) is activated by the ubiquitous G alpha(q) family of G proteins on the surface of the inner leaflet of plasma membrane where it catalyzes the hydrolysis of phosphatidylinositol 4,5 bisphosphate. In general, PLC beta 1 is mainly localized on the cytosolic plasma membrane surface, although a substantial fraction is also found in the cytosol and, under some conditions, in the nucleus. The factors that localize PLC beta 1 in these other compartments are unknown. Here, we identified a novel binding partner, translin-associated factor X (TRAX). TRAX is a cytosolic protein that can transit into the nucleus. In purified form, PLC beta 1 binds strongly to TRAX with an affinity that is only ten-fold weaker than its affinity for its functional partner, G alpha(q). In solution, TRAX has little effect on the membrane association or the catalytic activity of PLC beta 1. However, TRAX directly competes with G alpha(q) for PLC beta 1 binding, and excess TRAX reverses G alpha(q) activation of PLC beta 1. In C6 glia cells, endogenous PLC beta 1 and TRAX colocalize in the cytosol and the nucleus, but not on the plasma membrane where TRAX is absent. In Neuro2A cells expressing enhanced yellow and cyano fluorescent proteins (i.e., eYFP-PLC beta 1 and eCFP-TRAX), Forster resonance energy transfer (FRET) is observed mostly in the cytosol and a small amount is seen in the nucleus. FRET does not occur at the plasma membrane where TRAX is not found. Our studies show that TRAX, localized in the cytosol and nucleus, competes with plasma-membrane bound G alpha(q) for PLC beta 1 binding thus stabilizing PLC beta 1 in other cellular compartments.	[Aisiku, Omozuanvbo R.; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Runnels, Loren W.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rutgers State University New Brunswick; Rutgers State University Medical Center	Aisiku, OR (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	suzanne.scarlata@sunysb.edu		Runnels, Loren/0000-0002-2537-7360	National Institutes of Health [NIH053132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, NIH053132. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Cho YS, 2004, J BIOL CHEM, V279, P31514, DOI 10.1074/jbc.M401442200; Cocco L, 2002, ADV ENZYME REGUL, V42, P181, DOI 10.1016/S0065-2571(01)00030-9; Cocco L, 2000, ADV ENZYME REGUL, V40, P83, DOI 10.1016/S0065-2571(99)00028-X; Cocco L, 2006, BBA-MOL CELL BIOL L, V1761, P509, DOI 10.1016/j.bbalip.2006.03.001; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Garcia-Hoz C, 2010, J BIOL CHEM, V285, P13480, DOI 10.1074/jbc.M109.098699; Golebiewska U, 2008, BIOPHYS J, V95, P2575, DOI 10.1529/biophysj.108.129353; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Manzoli L, 1997, CANCER RES, V57, P2137; Manzoli L, 1999, ANTICANCER RES, V19, P3753; PARK DG, 1993, J BIOL CHEM, V268, P3710; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Phillips F, 2006, SOCIAL CULTURE AND HIGH-TECH ECONOMIC DEVELOPMENT, P15; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Runnels LW, 1998, BIOCHEMISTRY-US, V37, P15563, DOI 10.1021/bi9811258; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; Sugiura I, 2004, ACTA CRYSTALLOGR D, V60, P674, DOI 10.1107/S0907444904002549; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Sun CN, 2006, MOL PHARMACOL, V70, P454, DOI 10.1124/mol.105.021261; Wang J, 2004, BIOCHEMISTRY-US, V43, P13424, DOI 10.1021/bi048847l; Wang T, 1999, P NATL ACAD SCI USA, V96, P7843, DOI 10.1073/pnas.96.14.7843; Yang SC, 2004, J BIOL CHEM, V279, P12605, DOI 10.1074/jbc.M313133200	32	31	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15001	10.1371/journal.pone.0015001	http://dx.doi.org/10.1371/journal.pone.0015001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124736	Green Submitted, Green Published, gold			2022-12-25	WOS:000284686500013
J	Wohlrab, S; Iversen, MH; John, U				Wohlrab, Sylke; Iversen, Morten H.; John, Uwe			A Molecular and Co-Evolutionary Context for Grazer Induced Toxin Production in Alexandrium tamarense	PLOS ONE			English	Article							ATLANTIC RIGHT WHALES; POISONING PSP TOXINS; PLANKTONIC COPEPODS; EUBALAENA-GLACIALIS; MARINE; PHYTOPLANKTON; DIVERSITY; PREY; COMMUNICATION; METABOLITES	Marine dinoflagellates of the genus Alexandrium are the proximal source of neurotoxins associated with Paralytic Shellfish Poisoning. The production of these toxins, the toxin biosynthesis and, thus, the cellular toxicity can be influenced by abiotic and biotic factors. There is, however, a lack of substantial evidence concerning the toxins' ecological function such as grazing defense. Waterborne cues from copepods have been previously found to induce a species-specific increase in toxin content in Alexandrium minutum. However, it remains speculative in which context these species-specific responses evolved and if it occurs in other Alexandrium species as well. In this study we exposed Alexandrium tamarense to three copepod species (Calanus helgolandicus, Acartia clausii, and Oithona similis) and their corresponding cues. We show that the species-specific response towards copepod-cues is not restricted to one Alexandrium species and that co-evolutionary processes might be involved in these responses, thus giving additional evidence for the defensive role of phycotoxins. Through a functional genomic approach we gained insights into the underlying molecular processes which could trigger the different outcomes of these species-specific responses and consequently lead to increased toxin content in Alexandrium tamarense. We propose that the regulation of serine/threonine kinase signaling pathways has a major influence in directing the external stimuli i.e. copepod-cues, into different intracellular cascades and networks in A. tamarense. Our results show that A. tamarense can sense potential predating copepods and respond to the received information by increasing its toxin production. Furthermore, we demonstrate how a functional genomic approach can be used to investigate species interactions within the plankton community.	[Wohlrab, Sylke; John, Uwe] Alfred Wegener Inst Polar & Marine Res, Dept Ecol Chem, Bremerhaven, Germany; [Iversen, Morten H.] Univ Bremen, Dept Geosci Marum, Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Wohlrab, S (corresponding author), Alfred Wegener Inst Polar & Marine Res, Dept Ecol Chem, Bremerhaven, Germany.	Sylke.Wohlrab@awi.de	john, uwe/S-3009-2016; Wohlrab, Sylke/R-7435-2016; Iversen, Morten/C-7741-2013; Iversen, Morten Hvitfeldt/Q-3774-2016	john, uwe/0000-0002-1297-4086; Wohlrab, Sylke/0000-0003-3190-0880; Iversen, Morten Hvitfeldt/0000-0002-5287-1110	Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment; EU [GOCE-CT-2004-511154]; Marine Genomics [GOCE-CT-2004-505403]	Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment; EU(European Commission); Marine Genomics	Financial support was provided by the PACES (Polar regions and Coasts in a changing Earth System) research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment, and by the EU-Project ESTTAL (Expressed Sequence Tags of Toxic Algae, GOCE-CT-2004-511154) and Marine Genomics (GOCE-CT-2004-505403). The Poseidon cruise (P352) was endorsed by the SCOR-IOC (Scientific Committee on Oceanographic Research - Intergovernmental Oceanographic Commission) program GEOHAB (Global Ecology and Oceanography of Harmful Algal Blooms) as a contribution to the Core Research Project on Harmful Algal Blooms in Fjords and Coastal Embayments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpermann TJ, 2010, J PHYCOL, V46, P18, DOI 10.1111/j.1529-8817.2009.00767.x; Avery DE, 2007, LIMNOL OCEANOGR, V52, P2099, DOI 10.4319/lo.2007.52.5.2099; Bagoien E, 1996, MAR BIOL, V126, P361, DOI 10.1007/BF00354618; Bagoien E, 2005, MAR ECOL PROG SER, V300, P129, DOI 10.3354/meps300129; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Bergkvist J, 2008, OECOLOGIA, V156, P147, DOI 10.1007/s00442-008-0981-6; BOYD CM, 1976, LIMNOL OCEANOGR, V21, P175, DOI 10.4319/lo.1976.21.1.0175; CASTOR G, 2002, MARINE ECOLOGY PROGR, V240, P105; Cembella A, 1998, PHYSL ECOLOGY HARMFU, P381; Cembella AD, 2003, PHYCOLOGIA, V42, P420, DOI 10.2216/i0031-8884-42-4-420.1; Colin SP, 2004, EVOL ECOL, V18, P355, DOI 10.1007/s10682-004-2369-3; Doucette GJ, 2006, MAR ECOL PROG SER, V306, P303, DOI 10.3354/meps306303; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Durbin E, 2002, HARMFUL ALGAE, V1, P243, DOI 10.1016/S1568-9883(02)00046-X; Ferrari MCO, 2008, BEHAV ECOL SOCIOBIOL, V62, P1079, DOI 10.1007/s00265-007-0535-7; Fink P, 2007, MAR FRESHW BEHAV PHY, V40, P155, DOI 10.1080/10236240701602218; Fistarol GO, 2005, AQUAT MICROB ECOL, V41, P153, DOI 10.3354/ame041153; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hansson LA, 2000, ECOLOGY, V81, P842, DOI 10.2307/177381; HARRIS RP, 1994, MAR BIOL, V119, P431, DOI 10.1007/BF00347540; Iversen MH, 2007, MAR ECOL PROG SER, V350, P79, DOI 10.3354/meps07095; Jasti S, 2005, APPL ENVIRON MICROB, V71, P3483, DOI 10.1128/AEM.71.7.3483-3494.2005; Jenster G, 2004, MOL CELL ENDOCRINOL, V218, P1, DOI 10.1016/j.mce.2004.01.012; KELLER MD, 1987, J PHYCOL, V23, P633; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; Kiorboe T, 2005, MAR ECOL PROG SER, V300, P117, DOI 10.3354/meps300117; Korth KL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-221; Kozlowsky-Suzuki B, 2009, HARMFUL ALGAE, V8, P395, DOI 10.1016/j.hal.2008.08.025; Krock B, 2007, HARMFUL ALGAE, V6, P734, DOI 10.1016/j.hal.2007.02.005; Laforsch C, 2006, LIMNOL OCEANOGR, V51, P1466, DOI 10.4319/lo.2006.51.3.1466; Liu JW, 2006, PROG NAT SCI-MATER, V16, P671; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Medhekar B, 2007, CURR OPIN MICROBIOL, V10, P388, DOI 10.1016/j.mib.2007.06.004; Mortensen A. M., 1985, TOXIC DINOFLAGELLATE, P163; PAFFENHOFER GA, 1993, J PLANKTON RES, V15, P37, DOI 10.1093/plankt/15.1.37; Pflugmacher S, 1998, BBA-GEN SUBJECTS, V1425, P527, DOI 10.1016/S0304-4165(98)00107-X; Pohnert G, 2007, TRENDS ECOL EVOL, V22, P198, DOI 10.1016/j.tree.2007.01.005; Pohnert G, 2010, J PLANKTON RES, V32, P141, DOI 10.1093/plankt/fbp118; PRAKASH A, 1971, FISH RES BD CAN B, V177, P87; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Saiz E, 2009, ENVIRON POLLUT, V157, P1219, DOI 10.1016/j.envpol.2008.12.011; SCHANTZ EJ, 1975, J AM CHEM SOC, V97, P1238, DOI 10.1021/ja00838a045; Schwachtje J, 2008, PLANT PHYSIOL, V146, P845, DOI 10.1104/pp.107.112490; Selander E, 2006, P ROY SOC B-BIOL SCI, V273, P1673, DOI 10.1098/rspb.2006.3502; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; Svensen C, 2000, J PLANKTON RES, V22, P1155, DOI 10.1093/plankt/22.6.1155; Teegarden GJ, 1999, MAR ECOL PROG SER, V181, P163, DOI 10.3354/meps181163; Teegarden GJ, 1996, J EXP MAR BIOL ECOL, V196, P145, DOI 10.1016/0022-0981(95)00128-X; Teegarden GJ, 2003, J PLANKTON RES, V25, P429, DOI 10.1093/plankt/25.4.429; Teegarden GJ, 2008, HARMFUL ALGAE, V7, P33, DOI 10.1016/j.hal.2007.05.010; Tillmann U, 2007, J PLANKTON RES, V29, P527, DOI 10.1093/plankt/fbm034; Tillmann U, 2009, HARMFUL ALGAE, V8, P759, DOI 10.1016/j.hal.2009.03.005; TILLMANNS AR, 2008, METAANALYSIS CYANOBA; Turner Jefferson T., 1998, NATO ASI Series Series G Ecological Sciences, V41, P453; Turner JT, 2000, MAR ECOL PROG SER, V203, P95, DOI 10.3354/meps203095; Turner JT, 1997, LIMNOL OCEANOGR, V42, P1203, DOI 10.4319/lo.1997.42.5_part_2.1203; UYE S-I, 1982, Journal of the Oceanographical Society of Japan, V38, P149, DOI 10.1007/BF02110286; Vardi A, 2002, CURR BIOL, V12, P1767, DOI 10.1016/S0960-9822(02)01217-4; Verret F, 2010, NEW PHYTOL, V187, P23, DOI 10.1111/j.1469-8137.2010.03271.x; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Wootton EC, 2007, ENVIRON MICROBIOL, V9, P216, DOI 10.1111/j.1462-2920.2006.01130.x; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x; Wyatt T, 1997, J PLANKTON RES, V19, P551, DOI 10.1093/plankt/19.5.551; Yang I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-248	67	47	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15039	10.1371/journal.pone.0015039	http://dx.doi.org/10.1371/journal.pone.0015039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124775	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500020
J	Monnet, C; Loux, V; Gibrat, JF; Spinnler, E; Barbe, V; Vacherie, B; Gavory, F; Gourbeyre, E; Siguier, P; Chandler, M; Elleuch, R; Irlinger, F; Vallaeys, T				Monnet, Christophe; Loux, Valentin; Gibrat, Jean-Francois; Spinnler, Eric; Barbe, Valerie; Vacherie, Benoit; Gavory, Frederick; Gourbeyre, Edith; Siguier, Patricia; Chandler, Michael; Elleuch, Rayda; Irlinger, Francoise; Vallaeys, Tatiana			The Arthrobacter arilaitensis Re117 Genome Sequence Reveals Its Genetic Adaptation to the Surface of Cheese	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; BREVIBACTERIUM-LINENS; CORYNEBACTERIUM-GLUTAMICUM; AMINO-ACIDS; LISTERIA-MONOCYTOGENES; RIPENED CHEESES; L-TYROSINE; SP NOV.; SMEAR; PURIFICATION	Arthrobacter arilaitensis is one of the major bacterial species found at the surface of cheeses, especially in smear-ripened cheeses, where it contributes to the typical colour, flavour and texture properties of the final product. The A. arilaitensis Re117 genome is composed of a 3,859,257 bp chromosome and two plasmids of 50,407 and 8,528 bp. The chromosome shares large regions of synteny with the chromosomes of three environmental Arthrobacter strains for which genome sequences are available: A. aurescens TC1, A. chlorophenolicus A6 and Arthrobacter sp. FB24. In contrast however, 4.92% of the A. arilaitensis chromosome is composed of ISs elements, a portion that is at least 15 fold higher than for the other Arthrobacter strains. Comparative genomic analyses reveal an extensive loss of genes associated with catabolic activities, presumably as a result of adaptation to the properties of the cheese surface habitat. Like the environmental Arthrobacter strains, A. arilaitensis Re117 is well-equipped with enzymes required for the catabolism of major carbon substrates present at cheese surfaces such as fatty acids, amino acids and lactic acid. However, A. arilaitensis has several specificities which seem to be linked to its adaptation to its particular niche. These include the ability to catabolize D-galactonate, a high number of glycine betaine and related osmolyte transporters, two siderophore biosynthesis gene clusters and a high number of Fe3+/siderophore transport systems. In model cheese experiments, addition of small amounts of iron strongly stimulated the growth of A. arilaitensis, indicating that cheese is a highly iron-restricted medium. We suggest that there is a strong selective pressure at the surface of cheese for strains with efficient iron acquisition and salt-tolerance systems together with abilities to catabolize substrates such as lactic acid, lipids and amino acids.	[Monnet, Christophe; Spinnler, Eric; Irlinger, Francoise] INRA, Genie & Microbiol Procedes Alimentaires UMR782, F-78850 Thiverval Grignon, France; [Monnet, Christophe; Spinnler, Eric; Irlinger, Francoise] AgroParisTech, Genie & Microbiol Procedes Alimentaires UMR782, Thiverval Grignon, France; [Elleuch, Rayda] Univ Sci Sfax, Lab Genie Enzymat & Microbiol, Sfax, Tunisia; [Vallaeys, Tatiana] Univ Montpellier 2, CNRS CC093, Ecosyst Lagunaires UMR5119, Montpellier, France; [Gourbeyre, Edith; Siguier, Patricia; Chandler, Michael] Univ Toulouse 3, Lab Microbiol & Genet Mol, CNRS, UMR5100, F-31062 Toulouse, France; [Barbe, Valerie; Vacherie, Benoit; Gavory, Frederick] CEA DSV IG Genoscope, Evry, France; [Loux, Valentin; Gibrat, Jean-Francois] INRA, Math Informat & Genome UR1077, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Universite de Sfax; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CEA; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Monnet, C (corresponding author), INRA, Genie & Microbiol Procedes Alimentaires UMR782, F-78850 Thiverval Grignon, France.	monnet@grignon.inra.fr	Spinnler, Henry-Eric/H-1956-2011; Vallaeys, Tatiana/AAE-5508-2019; PONNERASSERY, Sudheesh/C-4589-2014	Spinnler, Henry-Eric/0000-0002-6778-6736; IRLINGER, Francoise/0000-0001-7883-7589; Siguier, Patricia/0000-0003-1620-6495; Vacherie, Benoit/0000-0002-1564-0575; Gavory, Frederick/0000-0003-1534-5725; Loux, Valentin/0000-0002-8268-915X; Chandler, Michael/0000-0002-0292-6662	AgroParistech;  [UMR782]	AgroParistech; 	The work was partially supported by AgroParistech and internal funds of UMR782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarita F, 2004, APPL ENVIRON MICROB, V70, P7348, DOI 10.1128/AEM.70.12.7348-7354.2004; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P1013, DOI 10.1128/AEM.69.2.1013-1022.2003; ARCHIBALD F, 1983, FEMS MICROBIOL LETT, V19, P29, DOI 10.1111/j.1574-6968.1983.tb00504.x; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bentley SD, 2003, LANCET, V361, P637, DOI 10.1016/S0140-6736(03)12597-4; Beresford T., 2004, CHEESE CHEM PHYS MIC, V1, P287, DOI DOI 10.1016/S1874-558X(04)80071-X; BLAKLEY ER, 1977, CAN J MICROBIOL, V23, P1128, DOI 10.1139/m77-169; Bockelmann W, 2001, INT DAIRY J, V11, P307, DOI 10.1016/S0958-6946(01)00060-7; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Braun V, 2005, FEMS MICROBIOL REV, V29, P673, DOI 10.1016/j.femsre.2004.10.001; Brennan NM, 2002, APPL ENVIRON MICROB, V68, P820, DOI 10.1128/AEM.68.2.820-830.2002; Brocker M, 2009, J BACTERIOL, V191, P3869, DOI 10.1128/JB.00113-09; BRUYNEEL B, 1989, BIOTECHNOL LETT, V11, P401, DOI 10.1007/BF01089472; Bryson K, 2006, NUCLEIC ACIDS RES, V34, P3533, DOI 10.1093/nar/gkl471; Callanan M, 2008, J BACTERIOL, V190, P727, DOI 10.1128/JB.01295-07; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; CHANG SF, 1985, J DAIRY SCI, V68, P2840, DOI 10.3168/jds.S0022-0302(85)81176-0; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; DEACON J, 1977, FEBS LETT, V77, P201, DOI 10.1016/0014-5793(77)80234-2; Deetae P, 2007, APPL MICROBIOL BIOT, V76, P1161, DOI 10.1007/s00253-007-1095-5; Dias B, 1998, APPL ENVIRON MICROB, V64, P3320; Elshafei AM, 2001, ENZYME MICROB TECH, V29, P76, DOI 10.1016/S0141-0229(01)00346-5; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fan F, 2004, ARCH BIOCHEM BIOPHYS, V421, P149, DOI 10.1016/j.abb.2003.10.003; FERCHICHI M, 1985, J GEN MICROBIOL, V131, P715; Fetherston JD, 1999, MOL MICROBIOL, V32, P289, DOI 10.1046/j.1365-2958.1999.01348.x; Feurer C, 2004, J DAIRY SCI, V87, P3189, DOI 10.3168/jds.S0022-0302(04)73454-2; Feurer C, 2004, J APPL MICROBIOL, V97, P546, DOI 10.1111/j.1365-2672.2004.02333.x; Fox P. E, 2000, FUNDAMENTALS CHEESE; Galaup P, 2007, INNOV FOOD SCI EMERG, V8, P373, DOI 10.1016/j.ifset.2007.03.017; Gaucheron F, 1997, INT DAIRY J, V7, P141, DOI 10.1016/S0958-6946(96)00054-4; Goerges S, 2008, APPL ENVIRON MICROB, V74, P2210, DOI 10.1128/AEM.01663-07; Gomez JE, 2000, P NATL ACAD SCI USA, V97, P8554, DOI 10.1073/pnas.140225297; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Irlinger F, 2005, INT J SYST EVOL MICR, V55, P457, DOI 10.1099/ijs.0.63125-0; ISHIZUKA H, 1993, J GEN MICROBIOL, V139, P425, DOI 10.1099/00221287-139-3-425; JACOBSEN T, 1989, APPL MICROBIOL BIOT, V32, P256; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Jerke K, 2008, PLASMID, V59, P73, DOI 10.1016/j.plasmid.2007.12.003; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; KORMANEC J, 1993, NUCLEIC ACIDS RES, V21, P2512, DOI 10.1093/nar/21.10.2512; Krause I, 1997, LAIT, V77, P101, DOI 10.1051/lait:199716; KRINSKY NI, 1989, FREE RADICAL BIO MED, V7, P617, DOI 10.1016/0891-5849(89)90143-3; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Leclercq-Perlat MN, 2004, J DAIRY SCI, V87, P1536, DOI 10.3168/jds.S0022-0302(04)73305-6; Leuschner RGK, 1998, J FOOD PROTECT, V61, P874, DOI 10.4315/0362-028X-61.7.874; LING MF, 1994, J MOL BIOL, V243, P950, DOI 10.1006/jmbi.1994.1696; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynch D, 2001, J BACTERIOL, V183, P2576, DOI 10.1128/JB.183.8.2576-2585.2001; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Molenaar D, 2000, J BACTERIOL, V182, P6884, DOI 10.1128/JB.182.24.6884-6891.2000; Molimard P, 1996, J DAIRY SCI, V79, P169, DOI 10.3168/jds.S0022-0302(96)76348-8; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; Monnet C, 2006, APPL ENVIRON MICROB, V72, P6972, DOI 10.1128/AEM.01303-06; Monnet C, 2010, FOOD MICROBIOL, V27, P302, DOI 10.1016/j.fm.2009.11.009; Mounier J, 2006, J APPL MICROBIOL, V101, P668, DOI 10.1111/j.1365-2672.2006.02922.x; Mounier J, 2005, APPL ENVIRON MICROB, V71, P6489, DOI 10.1128/AEM.71.11.6489-6500.2005; Nomura M, 1998, J DAIRY SCI, V81, P1486, DOI 10.3168/jds.S0022-0302(98)75714-5; Noordman WH, 2006, J APPL MICROBIOL, V101, P637, DOI 10.1111/j.1365-2672.2006.02928.x; ONG SA, 1979, J AGR FOOD CHEM, V27, P990, DOI 10.1021/jf60225a033; Pocsi I, 2008, MOL NUTR FOOD RES, V52, P1434, DOI 10.1002/mnfr.200700467; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; POLYCHRONIADOU A, 1979, LAIT, V59, P234, DOI 10.1051/lait:1979585-58612; Prakash P, 2005, BIOINFORMATICS, V21, P2161, DOI 10.1093/bioinformatics/bti375; Preston A, 2004, NAT REV MICROBIOL, V2, P379, DOI 10.1038/nrmicro886; Rattray FP, 1997, INT DAIRY J, V7, P273, DOI 10.1016/S0958-6946(97)00013-7; Rea MC, 2007, J DAIRY SCI, V90, P2200, DOI 10.3168/jds.2006-377; REINSCHEID DJ, 1994, J BACTERIOL, V176, P3474, DOI 10.1128/JB.176.12.3474-3483.1994; Rudolf M, 2001, INT J FOOD MICROBIOL, V63, P91, DOI 10.1016/S0168-1605(00)00413-X; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Schadewaldt P, 2004, J CHROMATOGR B, V801, P249, DOI 10.1016/j.jchromb.2003.11.020; Shimizu E, 1997, BIOSCI BIOTECH BIOCH, V61, P501, DOI 10.1271/bbb.61.501; Siguier P, 2009, RES MICROBIOL, V160, P232, DOI 10.1016/j.resmic.2009.02.003; SIMON N, 1995, APPL ENVIRON MICROB, V61, P1643, DOI 10.1128/AEM.61.4.1643-1645.1995; Smacchi E, 1999, FEMS MICROBIOL LETT, V178, P191, DOI 10.1111/j.1574-6968.1999.tb13777.x; Smacchi E, 2000, LAIT, V80, P255, DOI 10.1051/lait:2000124; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; SPARNINS VL, 1976, J BACTERIOL, V127, P362, DOI 10.1128/JB.127.1.362-366.1976; STRATTON JE, 1991, J FOOD PROT, V54; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tauch A, 2000, PLASMID, V44, P285, DOI 10.1006/plas.2000.1489; Van Gijsegem F, 2008, MOL PLANT MICROBE IN, V21, P1471, DOI 10.1094/MPMI-21-11-1471; VISCA P, 1994, J BACTERIOL, V176, P1128, DOI 10.1128/JB.176.4.1128-1140.1994; Wang F, 2007, BIOTECHNOL ADV, V25, P211, DOI 10.1016/j.biotechadv.2006.12.001; WAYNE AW, 2010, FEMS MICROB IN PRESS; Weinberg ED, 1997, PERSPECT BIOL MED, V40, P578; Westerberg K, 2000, INT J SYST EVOL MICR, V50, P2083, DOI 10.1099/00207713-50-6-2083; Wiens GD, 2008, J BACTERIOL, V190, P6970, DOI 10.1128/JB.00721-08	94	55	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15489	10.1371/journal.pone.0015489	http://dx.doi.org/10.1371/journal.pone.0015489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124797	Green Submitted, Green Published, gold			2022-12-25	WOS:000284572000029
J	Major, JM; Doubeni, CA; Freedman, ND; Park, Y; Lian, M; Hollenbeck, AR; Schatzkin, A; Graubard, BI; Sinha, R				Major, Jacqueline M.; Doubeni, Chyke A.; Freedman, Neal D.; Park, Yikyung; Lian, Min; Hollenbeck, Albert R.; Schatzkin, Arthur; Graubard, Barry I.; Sinha, Rashmi			Neighborhood Socioeconomic Deprivation and Mortality: NIH-AARP Diet and Health Study	PLOS ONE			English	Article							RISK-FACTORS; FOLLOW-UP; WOMEN; AREA; MEN; INEQUALITIES; GENDER; DIFFERENTIALS; RETIREMENT; AMERICAN	Purpose: Residing in deprived areas may increase risk of mortality beyond that explained by a person's own SES-related factors and lifestyle. The aim of this study was to examine the relation between neighborhood socioeconomic deprivation and all-cause, cancer-and cardiovascular disease (CVD)-specific mortality for men and women after accounting for education and other important person-level risk factors. Methods: In the longitudinal NIH-AARP Study, we analyzed data from healthy participants, ages 50-71 years at study baseline (1995-1996). Deaths (n = 33831) were identified through December 2005. Information on census tracts was obtained from the 2000 US Census. Cox models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for quintiles of neighborhood deprivation. Results: Participants in the highest quintile of deprivation had elevated risks for overall mortality (HRmen = 1.17, 95% CI: 1.10, 1.24; HRwomen = 1.13, 95% CI: 1.05, 1.22) and marginally increased risk for cancer deaths (HRmen = 1.09, 95% CI: 1.00, 1.20; HRwomen = 1.09, 95% CI: 0.99, 1.22). CVD mortality associations appeared stronger in men (HR = 1.33, 95% CI: 1.19, 1.49) than women (HR = 1.18, 95% CI: 1.01, 1.38). There was no evidence of an effect modification by education. Conclusion: Higher neighborhood deprivation was associated with modest increases in all-cause, cancer-and CVD-mortality after accounting for many established risk factors.	[Major, Jacqueline M.; Freedman, Neal D.; Park, Yikyung; Schatzkin, Arthur; Graubard, Barry I.; Sinha, Rashmi] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Doubeni, Chyke A.] Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA USA; [Lian, Min] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hollenbeck, Albert R.] Amer Assoc Retired Persons, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Worcester; Washington University (WUSTL); American Association of Retired Persons (AARP)	Major, JM (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	Jacqueline.major@nih.gov	Freedman, Neal David/B-9741-2015; Doubeni, Chyke A/W-6749-2019; Hollenbeck, Albert/AAG-9461-2020; Sinha, Rashmi/G-7446-2015	Freedman, Neal David/0000-0003-0074-1098; Doubeni, Chyke A/0000-0001-7495-0285; Sinha, Rashmi/0000-0002-2466-7462; Park, Yikyung/0000-0002-6281-489X	National Cancer Institute, National Institute of Health; NATIONAL CANCER INSTITUTE [U01CA151736, R01CA137750, ZIACP010196, K01CA127118] Funding Source: NIH RePORTER	National Cancer Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Intramural Research Program of the National Cancer Institute, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PK, 1997, BIOMETRICS, V53, P1475, DOI 10.2307/2533513; Borrell LN, 2004, INT J EPIDEMIOL, V33, P398, DOI 10.1093/ije/dyh063; Bosma H, 2001, AM J EPIDEMIOL, V153, P363, DOI 10.1093/aje/153.4.363; CARSTAIRS V, 1989, COMMUNITY MED, V11, P210, DOI 10.1093/oxfordjournals.pubmed.a042469; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chung RY, 2010, AM J EPIDEMIOL, V171, P345, DOI 10.1093/aje/kwp378; Feinglass J, 2007, J GERONTOL B-PSYCHOL, V62, pS209, DOI 10.1093/geronb/62.4.S209; GOLDBLATT P, 1991, AM J IND MED, V20, P285, DOI 10.1002/ajim.4700200303; KLEIN JP, 1992, BIOMETRICS, V48, P795, DOI 10.2307/2532345; KOSKINEN S, 1994, SOC SCI MED, V38, P1385, DOI 10.1016/0277-9536(94)90276-3; Krieger N, 2007, EPIDEMIOLOGY, V18, P658, DOI 10.1097/EDE.0b013e318156bfcd; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; LeClere FB, 1998, J HEALTH SOC BEHAV, V39, P91, DOI 10.2307/2676393; MacIntire S, 1993, J SOC POLICY, V22, P21; Mackenbach JP, 1999, AM J PUBLIC HEALTH, V89, P1800, DOI 10.2105/AJPH.89.12.1800; MARKIDES KS, 1989, INT J AGING HUM DEV, V29, P95, DOI 10.2190/4LHT-Y4DM-73F6-N75L; Marmot MG, 1996, BRIT MED J, V313, P1177, DOI 10.1136/bmj.313.7066.1177; Martikainen P, 2003, J EPIDEMIOL COMMUN H, V57, P210, DOI 10.1136/jech.57.3.210; McDonough P, 1999, J HEALTH SOC BEHAV, V40, P17, DOI 10.2307/2676376; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; MILLAR WJ, 1983, CAN J PUBLIC HEALTH, V74, P329; Mustard CA, 2003, J EPIDEMIOL COMMUN H, V57, P974, DOI 10.1136/jech.57.12.974; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Sloggett A, 1998, J EPIDEMIOL COMMUN H, V52, P228, DOI 10.1136/jech.52.4.228; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Therneau TM, 2000, MODELING SURVIVAL DA; Vagero D, 2000, BRIT MED J, V320, P1286, DOI 10.1136/bmj.320.7245.1286; Waitzman NJ, 1998, AM J PUBLIC HEALTH, V88, P973, DOI 10.2105/AJPH.88.6.973; WEI LJ, 1989, J AM STAT ASSOC, V84, P8; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Winkleby MA, 2003, J EPIDEMIOL COMMUN H, V57, P444, DOI 10.1136/jech.57.6.444; Yen IH, 1999, AM J EPIDEMIOL, V149, P898	37	82	82	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15538	10.1371/journal.pone.0015538	http://dx.doi.org/10.1371/journal.pone.0015538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684DM	21124858	Green Published, gold, Green Submitted			2022-12-25	WOS:000284527900025
J	He, M; Zhao, M; Shen, B; Prise, KM; Shao, C				He, M.; Zhao, M.; Shen, B.; Prise, K. M.; Shao, C.			Radiation-induced intercellular signaling mediated by cytochrome-c via a p53-dependent pathway in hepatoma cells	ONCOGENE			English	Article						irradiation; hepatoma cells; bystander effect; p53; cytochrome-c	ALPHA-PARTICLES; NITRIC-OXIDE; BYSTANDER RESPONSES; IONIZING-RADIATION; ADAPTIVE RESPONSE; HUMAN FIBROBLASTS; PIFITHRIN-ALPHA; GLIOMA-CELLS; P53; GROWTH	The tumor suppressor p53 has a crucial role in cellular response to DNA damage caused by ionizing radiation, but it is still unclear whether p53 can modulate radiation-induced bystander effects (RIBE). In the present work, three different hepatoma cell lines, namely HepG2 (wild p53), PLC/PRF/5 (mutation p53) and Hep3B (p53 null), were irradiated with c-rays and then co-cultured with normal Chang liver cell (wild p53) in order to elucidate the mechanisms of RIBE. Results showed that the radiosensitivity of HepG2 cells was higher than that of PLC/PRF/5 and Hep3B cells. Only irradiated HepG2 cells, rather than irradiated PLC/PRF/5 or Hep3B cells, could induce bystander effect of micronuclei (MN) formation in the neighboring Chang liver cells. When HepG2 cells were treated with 20 mu M pifithrin-alpha, an inhibitor of p53 function, or 5 lM cyclosporin A (CsA), an inhibitor of cytochrome- c release from mitochondria, the MN induction in bystander Chang liver cells was diminished. In fact, it was found that after irradiation, cytochrome- c was released from mitochondria into the cytoplasm only in HepG2 cells in a p53- dependent manner, but not in PLC/PRF/5 and Hep3B cells. Interestingly, when 50 lg/ml exogenous cytochrome- c was added into cell co- culture medium, RIBE was significantly triggered by irradiated PLC/PRF/5 and Hep3B cells, which previously failed to provoke a bystander effect. In addition, this exogenous cytochrome- c also partly recovered the RIBE induced by irradiated HepG2 cells even with CsA treatment. Our results provide new evidence that the RIBE can be modulated by the p53 status of irradiated hepatoma cells and that a p53- dependent release of cytochrome- c may be involved in the RIBE. Oncogene (2011) 30, 1947- 1955; doi: 10.1038/onc. 2010.567; published online 6 December 2010	[He, M.; Zhao, M.; Shen, B.; Shao, C.] Fudan Univ, Inst Radiat Med, Shanghai 200032, Peoples R China; [Prise, K. M.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Fudan University; Queens University Belfast	Shao, C (corresponding author), Fudan Univ, Inst Radiat Med, 2094 Xie Tu Rd, Shanghai 200032, Peoples R China.	clshao@shmu.edu.cn	Prise, Kevin/N-7872-2015	Prise, Kevin/0000-0001-6134-7946; Shao, Chunlin/0000-0001-9336-9912	National Nature Science Foundation of China [30770644, 31070758]; Shanghai Health Bureau [08GWD09, 08GWZX0602]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Health Bureau	We thank the National Nature Science Foundation of China Grant numbers 30770644 and 31070758, the Shanghai Health Bureau (08GWD09, 08GWZX0602) for funding this work.	AIN JF, 1994, J SURG RES, V57, P366, DOI 10.1006/jsre.1994.1156; Atlante A, 2000, J BIOL CHEM, V275, P37159, DOI 10.1074/jbc.M002361200; Azzam EI, 2003, CANCER RES, V63, P7128; Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; BARTEK J, 1991, ONCOGENE, V6, P1699; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Chen HH, 2008, INT J RADIAT ONCOL, V72, P1560, DOI 10.1016/j.ijrobp.2008.07.038; Chen S, 2008, BRIT J CANCER, V98, P1839, DOI 10.1038/sj.bjc.6604358; Chhipa RR, 2007, J CELL BIOCHEM, V101, P68, DOI 10.1002/jcb.21153; Coates P, 2008, J PATHOL, V214, P610, DOI 10.1002/path.2321; Concin N, 2000, CANCER LETT, V150, P191, DOI 10.1016/S0304-3835(99)00393-6; Emerit I, 1996, P NATL ACAD SCI USA, V93, P12799, DOI 10.1073/pnas.93.23.12799; Han W, 2010, CARCINOGENESIS, V31, P275, DOI 10.1093/carcin/bgp301; Harada K, 2009, CANCER SCI, V100, P684, DOI 10.1111/j.1349-7006.2009.01093.x; Iyer R, 2000, CANCER RES, V60, P1290; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 1998, ONCOGENE, V17, P1089, DOI 10.1038/sj.onc.1202303; Komarova EA, 2003, J BIOL CHEM, V278, P15465, DOI 10.1074/jbc.C300011200; Lehnert BE, 1997, ENVIRON HEALTH PERSP, V105, P1095, DOI 10.2307/3433515; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; Ma SM, 2010, CANCER TREAT REV, V36, P157, DOI 10.1016/j.ctrv.2009.11.008; Mancuso M, 2008, P NATL ACAD SCI USA, V105, P12445, DOI 10.1073/pnas.0804186105; Matsumoto H, 2001, RADIAT RES, V155, P387, DOI 10.1667/0033-7587(2001)155[0387:IORBAN]2.0.CO;2; Mitchell SA, 2004, INT J RADIAT BIOL, V80, P465, DOI 10.1080/09553000410001725116; Morgan WF, 2002, MUTAT RES-FUND MOL M, V504, P91, DOI 10.1016/S0027-5107(02)00083-0; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; MOSES AC, 1983, J CLIN ENDOCR METAB, V56, P1003, DOI 10.1210/jcem-56-5-1003; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Murphy JEJ, 2005, MUTAT RES-GEN TOX EN, V585, P127, DOI 10.1016/j.mrgentox.2005.04.011; Nagasawa H, 1999, RADIAT RES, V152, P552, DOI 10.2307/3580153; NAGASAWA H, 1992, CANCER RES, V52, P6394; Narayanan PK, 1997, CANCER RES, V57, P3963; Narayanan PK, 1999, RADIAT RES, V152, P57, DOI 10.2307/3580049; Ng LT, 2006, AM J CHINESE MED, V34, P125, DOI 10.1142/S0192415X06003692; Peixoto PM, 2009, BIOCHEM BIOPH RES CO, V390, P38, DOI 10.1016/j.bbrc.2009.09.054; Preta G, 2009, BIOCHEM BIOPH RES CO, V389, P575, DOI 10.1016/j.bbrc.2009.09.021; PUISIEUX A, 1993, FASEB J, V7, P1407, DOI 10.1096/fasebj.7.14.8224613; Ryan LA, 2008, RADIAT RES, V169, P188, DOI 10.1667/RR1141.1; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Seymour C B, 1997, Radiat Oncol Investig, V5, P106, DOI 10.1002/(SICI)1520-6823(1997)5:3<106::AID-ROI4>3.0.CO;2-1; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shao C, 2005, INT J CANCER, V116, P45, DOI 10.1002/ijc.21003; Shao C, 2008, MUTAT RES-FUND MOL M, V638, P139, DOI 10.1016/j.mrfmmm.2007.09.007; Shao CL, 2010, NUCL INSTRUM METH B, V268, P627, DOI 10.1016/j.nimb.2009.12.024; Shao CL, 2004, P NATL ACAD SCI USA, V101, P13495, DOI 10.1073/pnas.0404930101; Shao CL, 2003, FASEB J, V17, P1422, DOI 10.1096/fj.02-1115com; Shao CL, 2003, RADIAT ENVIRON BIOPH, V42, P183, DOI 10.1007/s00411-003-0202-y; Shao CL, 2003, RADIAT RES, V160, P318, DOI 10.1667/RR3044; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Tartier L, 2007, CANCER RES, V67, P5872, DOI 10.1158/0008-5472.CAN-07-0188; Tsai KKC, 2009, RADIAT RES, V172, P306, DOI 10.1667/RR1764.1; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang B, 2000, RADIAT RES, V154, P277, DOI 10.1667/0033-7587(2000)154[0277:ARIEIR]2.0.CO;2; Yang G, 2009, BRIT J CANCER, V100, P1912, DOI 10.1038/sj.bjc.6605087; You KR, 2002, J BIOL CHEM, V277, P3870, DOI 10.1074/jbc.M109284200; Yuan DX, 2010, MUTAT RES-FUND MOL M, V688, P66, DOI 10.1016/j.mrfmmm.2010.03.010; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zhang Y, 2008, RADIAT RES, V169, P197, DOI 10.1667/RR1189.1; Zhou HN, 2005, P NATL ACAD SCI USA, V102, P14641, DOI 10.1073/pnas.0505473102; Zhou HN, 2008, CANCER RES, V68, P2233, DOI 10.1158/0008-5472.CAN-07-5278	61	58	65	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	16					1947	1955		10.1038/onc.2010.567	http://dx.doi.org/10.1038/onc.2010.567			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	753MA	21132005	Green Accepted			2022-12-25	WOS:000289777700010
J	Moore, B; Miles, AJ; Guerra-Giraldez, C; Simpson, P; Iwata, M; Wallace, BA; Matthews, SJ; Smith, DF; Brown, KA				Moore, Benjamin; Miles, Andrew J.; Guerra-Giraldez, Cristina; Simpson, Peter; Iwata, Momi; Wallace, B. A.; Matthews, Stephen J.; Smith, Deborah F.; Brown, Katherine A.			Structural Basis of Molecular Recognition of the Leishmania Small Hydrophilic Endoplasmic Reticulum-associated Protein (SHERP) at Membrane Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; PROTOZOAN PARASITE LEISHMANIA; BOUND ALPHA-SYNUCLEIN; REGULATED GENE FAMILY; VACUOLAR H+-ATPASE; SECONDARY STRUCTURE; DONOVANI PROMASTIGOTES; UNILAMELLAR VESICLES; THERMUS-THERMOPHILUS; SUBUNIT ARRANGEMENT	The 57-residue small hydrophilic endoplasmic reticulum-associated protein (SHERP) shows highly specific, stage-regulated expression in the non-replicative vector-transmitted stages of the kinetoplastid parasite, Leishmania major, the causative agent of human cutaneous leishmaniasis. Previous studies have demonstrated that SHERP localizes as a peripheral membrane protein on the cytosolic face of the endoplasmic reticulum and on outer mitochondrial membranes, whereas its high copy number suggests a critical function in vivo. However, the absence of defined domains or identifiable orthologues, together with lack of a clear phenotype in transgenic parasites lacking SHERP, has limited functional understanding of this protein. Here, we use a combination of biophysical and biochemical methods to demonstrate that SHERP can be induced to adopt a globular fold in the presence of anionic lipids or SDS. Cross-linking and binding studies suggest that SHERP has the potential to form a complex with the vacuolar type H+-ATPase. Taken together, these results suggest that SHERP may function in modulating cellular processes related to membrane organization and/or acidification during vector transmission of infective Leishmania.	[Simpson, Peter; Iwata, Momi; Matthews, Stephen J.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, London SW7 2AZ, England; [Moore, Benjamin; Brown, Katherine A.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Miles, Andrew J.; Wallace, B. A.] Univ London Birkbeck Coll, Dept Crystallog, Inst Struct & Mol Biol, London WC1E 7HX, England; [Guerra-Giraldez, Cristina; Smith, Deborah F.] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5YW, N Yorkshire, England; [Iwata, Momi] Diamond Light Source Ltd, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Brown, Katherine A.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Imperial College London; Imperial College London; University of London; Birkbeck University London; University of York - UK; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Texas System; University of Texas Austin	Matthews, SJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, Exhibit Rd, London SW7 2AZ, England.	s.j.matthews@imperial.ac.uk; deborah.smith@york.ac.uk; k.brown@imperial.ac.uk	Guerra-Giraldez, Cristina/AAK-8596-2020; Wallace, B A/C-3753-2008	Guerra-Giraldez, Cristina/0000-0002-9287-9838; Simpson, Pete/0000-0002-2679-9303; Wallace, B A/0000-0001-9649-5092; Matthews, Steve/0000-0003-0676-0927	United Kingdom Biotechnology and Biological Science Research Council; Wellcome Trust [077503, 079819, 085464, 068779]; SRCD; European Union [RII3-CT-2004-506008]; BBSRC [BB/G530417/1] Funding Source: UKRI; MRC [G0800038] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G530417/1] Funding Source: researchfish; Medical Research Council [G0800038] Funding Source: researchfish	United Kingdom Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); SRCD; European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the United Kingdom Biotechnology and Biological Science Research Council (to K.A.B., D.F.S., and B.A.W.); Wellcome Trust Program Grant 077503 (to D.F.S.) and Program Grant 079819 and Equipment Grant 085464 (to S.J.M.); and SRCD beamtime grants (to B.A.W. and K.A.B.).; Supported by Wellcome Trust Traveling Fellowship 068779. Present address: Dept. de Microbiologia, Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, Lima 31, Peru.; Access to the CD1 beamline at the Institute for Synchrotron Studies is acknowledged under the European Union Integrated Infrastructure Initiative (I3), Integrated Activity on Synchrotron and Free Electron Laser Science (IA-SFS), contract RII3-CT-2004-506008. NMR spectra were recorded at the Medical Research Council Biomedical NMR Centre (Mill Hill, UK). We thank Dr. G. Kelly and Dr. T. A. Frankiel for assistance in data recording.	ALEXANDER J, 1992, ADV PARASIT, V31, P175, DOI 10.1016/S0065-308X(08)60022-6; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; BEACH DH, 1979, J PARASITOL, V65, P203, DOI 10.2307/3280147; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Beverley SM, 1998, TRENDS MICROBIOL, V6, P35, DOI 10.1016/S0966-842X(97)01180-3; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Boucher J, 2004, J LIPID RES, V45, P849, DOI 10.1194/jlr.M300431-JLR200; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cunningham ML, 2001, SCIENCE, V292, P285, DOI 10.1126/science.1057740; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Descoteaux A, 2002, MICROBES INFECT, V4, P975, DOI 10.1016/S1286-4579(02)01624-6; Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Ferreon ACM, 2007, BIOCHEMISTRY-US, V46, P4499, DOI 10.1021/bi602461y; FLINN HM, 1994, MOL BIOCHEM PARASIT, V65, P259, DOI 10.1016/0166-6851(94)90077-9; FLINN HM, 1992, NUCLEIC ACIDS RES, V20, P755, DOI 10.1093/nar/20.4.755; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fossi M, 2005, J MAGN RESON, V175, P92, DOI 10.1016/j.jmr.2005.03.020; Gangabadage CS, 2008, J BIOL CHEM, V283, P17416, DOI 10.1074/jbc.M800756200; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Knuepfer E, 2001, BIOCHEM J, V356, P335, DOI 10.1042/0264-6021:3560335; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lees JG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-507; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; MacRaild CA, 2004, BIOCHEMISTRY-US, V43, P8084, DOI 10.1021/bi049817l; MAO D, 1984, BIOCHEMISTRY-US, V23, P2667, DOI 10.1021/bi00307a020; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; McKean PG, 1997, MOL BIOCHEM PARASIT, V85, P221, DOI 10.1016/S0166-6851(97)02829-6; McKean PG, 2001, CELL MICROBIOL, V3, P511, DOI 10.1046/j.1462-5822.2001.00135.x; Meier S, 2002, J BIOMOL NMR, V24, P351, DOI 10.1023/A:1021609207024; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; Miles AJ, 2003, SPECTROSC-INT J, V17, P653, DOI 10.1155/2003/379137; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Pandey AP, 2009, BIOPHYS J, V96, P540, DOI 10.1016/j.bpj.2008.10.011; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Qi J, 2007, J BIOENERG BIOMEMBR, V39, P423, DOI 10.1007/s10863-007-9116-8; Rakotomanga M, 2007, ANTIMICROB AGENTS CH, V51, P1425, DOI 10.1128/AAC.01123-06; Ramakrishnan M, 2003, BIOCHEMISTRY-US, V42, P12919, DOI 10.1021/bi035048e; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; SACKS DL, 1985, J IMMUNOL, V135, P564; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Sadlova J, 2010, CELL MICROBIOL, V12, P1765, DOI 10.1111/j.1462-5822.2010.01507.x; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; Sreerama N, 1999, PROTEIN SCI, V8, P370; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Urwin PE, 1998, PLANTA, V204, P472, DOI 10.1007/s004250050281; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wallace BA, 2003, PROTEIN SCI, V12, P875, DOI 10.1110/ps.0229603; Wang GS, 1997, BIOCHEMISTRY-US, V36, P13657, DOI 10.1021/bi971151q; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WASSEF MK, 1985, LIPIDS, V20, P108, DOI 10.1007/BF02534216; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wien F, 2005, APPL SPECTROSC, V59, P1109, DOI 10.1366/0003702055012546; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200	78	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9246	9256		10.1074/jbc.M110.130427	http://dx.doi.org/10.1074/jbc.M110.130427			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21106528	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000288247700055
J	Arun, SN; Kaddour-Djebbar, I; Shapiro, BA; Bollag, WB				Arun, S. N.; Kaddour-Djebbar, I.; Shapiro, B. A.; Bollag, W. B.			Ultraviolet B irradiation and activation of protein kinase D in primary mouse epidermal keratinocytes	ONCOGENE			English	Article						apoptosis; epidermis; protein kinase C; protein kinase D; skin; Src	NF-KAPPA-B; RADIATION-INDUCED APOPTOSIS; POTENTIATES DNA-SYNTHESIS; D-DEPENDENT ACTIVATION; G(Q)-COUPLED RECEPTORS; LOOP PHOSPHORYLATION; SKIN-CANCER; C-MU; PROLIFERATION; EXPRESSION	Our previous studies demonstrated that protein kinase D (PKD), a serine/threonine kinase implicated in various cell processes, is upregulated in basal cell carcinoma (BCC), supporting a possible tumorigenic role for PKD in skin. As the greatest risk factor for BCC is sun exposure, the ability of ultraviolet B (UVB) irradiation to activate PKD in primary mouse keratinocytes was investigated. Using western analysis with two autophosphorylation-specific antibodies, we show for the first time that UVB activated PKD in a time-and dose-dependent manner. UVB-induced PKD activation was verified using an in vitro kinase assay. Furthermore, activation was reduced by antioxidant pretreatment, suggesting a link with oxidative stress. UVB-induced PKD activation was mediated primarily by Src family tyrosine kinases rather than protein kinase C (PKC), and in fact, UVB did not alter PKC-mediated transphosphorylation. UVB induced apoptosis dose dependently, and this death could be prevented by overexpression of wild-type PKD, but not mutant PKD or the empty adenovirus. Indeed, a mutant that cannot be phosphorylated by Src kinases exacerbated UVB-elicited apoptosis. Thus, our data indicate that UVB irradiation of keratinocytes induces Src-mediated activation of PKD, which protects cells from UVB-stimulated apoptosis, providing a possible explanation for the observed upregulation of PKD in BCC. Oncogene (2011) 30, 1586-1596; doi: 10.1038/onc.2010.540; published online 6 December 2010	[Bollag, W. B.] Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA; [Arun, S. N.; Shapiro, B. A.; Bollag, W. B.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Kaddour-Djebbar, I.; Bollag, W. B.] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Bollag, W. B.] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Bollag, W. B.] Med Coll Georgia, Dept Dermatol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University	Bollag, WB (corresponding author), Med Coll Georgia, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA.	wbollag@mcg.edu		Bollag, Wendy/0000-0003-3146-162X	Veterans' Administration; National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases [AR45212, AR57321]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057321, R01AR045212, R29AR045212] Funding Source: NIH RePORTER	Veterans' Administration(US Department of Veterans Affairs); National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was supported by a Merit Award from the Veterans' Administration and grants from the National Institutes of Health/National Institute of Arthritis, Musculoskeletal and Skin Diseases #AR45212 and AR57321 (WBB). We thank Dr Alex Toker for generously providing the various PKD constructs as well as for his useful discussions, and Dr Bert Vogelstein for his kind gift of the AdEasy adenovirus system. We appreciate the expert technical assistance of Mr Peter Parker and Ms Mariya Wilson. This work was submitted in partial fulfilment of the requirements for a doctoral degree from the Medical College of Georgia (SNA).	Assefa Z, 2005, BBA-REV CANCER, V1755, P90, DOI 10.1016/j.bbcan.2005.04.001; Assefa Z, 2003, FEBS LETT, V540, P125, DOI 10.1016/S0014-5793(03)00238-2; Bollag WB, 2004, DRUG NEWS PERSPECT, V17, P117, DOI 10.1358/dnp.2004.17.2.829045; Brash DE, 1996, NAT MED, V2, P525, DOI 10.1038/nm0596-525; Chen WX, 2001, ONCOGENE, V20, P3921, DOI 10.1038/sj.onc.1204530; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Dodd ME, 2005, J INVEST DERMATOL, V125, P294, DOI 10.1111/j.0022-202X.2005.23780.x; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jadali A, 2010, J BIOL CHEM, V285, P23385, DOI 10.1074/jbc.M110.105619; Jung EM, 1999, CARCINOGENESIS, V20, P569, DOI 10.1093/carcin/20.4.569; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Marathe GK, 2005, J BIOL CHEM, V280, P35448, DOI 10.1074/jbc.M503811200; Matsumura M, 2003, BIOCHEM BIOPH RES CO, V303, P350, DOI 10.1016/S0006-291X(03)00345-0; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Przybyszewski J, 1998, CARCINOGENESIS, V19, P1467, DOI 10.1093/carcin/19.8.1467; Reelfs O, 2004, J INVEST DERMATOL, V122, P1440, DOI 10.1111/j.0022-202X.2004.22620.x; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Ristich VL, 2006, BRIT J DERMATOL, V154, P586, DOI 10.1111/j.1365-2133.2005.07073.x; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Sitailo LA, 2002, J BIOL CHEM, V277, P19346, DOI 10.1074/jbc.M200401200; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200	41	20	25	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	13					1586	1596		10.1038/onc.2010.540	http://dx.doi.org/10.1038/onc.2010.540			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	743DU	21132013	Green Accepted			2022-12-25	WOS:000288998300009
J	Godshalk, SE; Paranjape, T; Nallur, S; Speed, W; Chan, E; Molinaro, AM; Bacchiocchi, A; Hoyt, K; Tworkoski, K; Stern, DF; Sznol, M; Ariyan, S; Lazova, R; Halaban, R; Kidd, KK; Weidhaas, JB; Slack, FJ				Godshalk, S. E.; Paranjape, T.; Nallur, S.; Speed, W.; Chan, E.; Molinaro, A. M.; Bacchiocchi, A.; Hoyt, K.; Tworkoski, K.; Stern, D. F.; Sznol, M.; Ariyan, S.; Lazova, R.; Halaban, R.; Kidd, K. K.; Weidhaas, J. B.; Slack, F. J.			A Variant in a MicroRNA complementary site in the 3 ' UTR of the KIT oncogene increases risk of acral melanoma	ONCOGENE			English	Article						melanoma; acral; microRNA; cancer risk; miR-221; KIT	CELL GROWTH-FACTOR; C-KIT; IMATINIB MESYLATE; EXPRESSION; DATABASE; CANCER; PROGRESSION; ACTIVATION; KINASE; CKIT	MicroRNAs (miRNAs) are small similar to 22nt single stranded RNAs that negatively regulate protein expression by binding to partially complementary sequences in the 3' untranslated region (3' UTRs) of target gene messenger RNAs (mRNA). Recently, mutations have been identified in both miRNAs and target genes that disrupt regulatory relationships, contribute to oncogenesis and serve as biomarkers for cancer risk. KIT, an established oncogene with a multifaceted role in melanogenesis and melanoma pathogenesis, has recently been shown to be upregulated in some melanomas, and is also a target of the miRNA miR-221. Here, we describe a genetic variant in the 3' UTR of the KIT oncogene that correlates with a greater than fourfold increased risk of acral melanoma. This KIT variant results in a mismatch in the seed region of a miR-221 complementary site and reporter data suggests that this mismatch can result in increased expression of the KIT oncogene. Consistent with the hypothesis that this is a functional variant, KIT mRNA and protein levels are both increased in the majority of samples harboring the KIT variant. This work identifies a novel genetic marker for increased heritable risk of melanoma. Oncogene (2011) 30, 1542-1550; doi: 10.1038/onc.2010.536; published online 29 November 2010	[Paranjape, T.; Nallur, S.; Chan, E.; Weidhaas, J. B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Godshalk, S. E.; Slack, F. J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Speed, W.; Kidd, K. K.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Molinaro, A. M.] Yale Univ, Sch Publ Hlth, Div Biostat, New Haven, CT 06520 USA; [Bacchiocchi, A.; Hoyt, K.; Lazova, R.; Halaban, R.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Tworkoski, K.; Stern, D. F.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Sznol, M.] Yale Univ, Sch Med, Sect Med Oncol, New Haven, CT 06520 USA; [Ariyan, S.] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Weidhaas, JB (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	joanne.weidhaas@yale.edu; frank.slack@yale.edu	Paranjape, Trupti/E-4338-2012; ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Slack, Frank/0000-0001-8263-0409; Sznol, Mario/0000-0002-4359-8749; Weidhaas, Joanne/0000-0002-5096-3281	National Cancer Institute [1 P50 CA121974]; National Center for Research Resources (NCRR), National Institutes of Health (NIH) [UL1 RR024139]; NIH roadmap for Medical Research;  [K08 CA124484]; NATIONAL CANCER INSTITUTE [P50CA121974, K08CA124484] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Yale SPORE in Skin Cancer funded by the National Cancer Institute grant number 1 P50 CA121974 (R Halaban, PI) and by a generous gift from Milstein-Meyer Center for Melanoma Research. JW is supported by K08 CA124484. AMM is supported by the CTSA Grant number UL1 RR024139 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH roadmap for Medical Research. The testing of the samples from the several world populations was supported by 1 P01 GM057672 (KK Kidd, PI).	Alexeev V, 2006, J INVEST DERMATOL, V126, P1102, DOI 10.1038/sj.jid.5700125; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Ashida A, 2009, INT J CANCER, V124, P862, DOI 10.1002/ijc.24048; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; FUNASAKA Y, 1992, MOL BIOL CELL, V3, P197, DOI 10.1091/mbc.3.2.197; Gershenwald JE, 2010, ANN SURG ONCOL, V17, P1475, DOI 10.1245/s10434-010-0986-3; Godshalk SE, 2008, CELL CYCLE, V7, P3595, DOI 10.4161/cc.7.22.7120; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Huang S, 1998, EMBO J, V17, P4358, DOI 10.1093/emboj/17.15.4358; Huang SY, 1996, ONCOGENE, V13, P2339; Igoucheva O, 2009, BIOCHEM BIOPH RES CO, V379, P790, DOI 10.1016/j.bbrc.2008.12.152; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Jiang XF, 2008, CLIN CANCER RES, V14, P7726, DOI 10.1158/1078-0432.CCR-08-1144; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; LASSAM N, 1992, ONCOGENE, V7, P51; Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Meyle KD, 2009, HUM GENET, V126, P499, DOI 10.1007/s00439-009-0715-9; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Monsel G, 2010, ONCOGENE, V29, P227, DOI 10.1038/onc.2009.320; NATALI PG, 1992, INT J CANCER, V52, P197, DOI 10.1002/ijc.2910520207; Rajeevan H, 2005, EVOL BIOINFORM, V1, P1; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Rigel DS, 2010, ARCH DERMATOL, V146, P318, DOI 10.1001/archdermatol.2009.379; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smalley KSM, 2008, CANCER RES, V68, P5743, DOI 10.1158/0008-5472.CAN-08-0235; Smalley KSM, 2009, CANCER RES, V69, P3241, DOI 10.1158/0008-5472.CAN-08-4305; Smalley KSM, 2009, HISTOL HISTOPATHOL, V24, P643, DOI 10.14670/HH-24.643; Speed WC, 2009, PHARMACOGENOMICS J, V9, P283, DOI 10.1038/tpj.2009.10; Stefani G, 2007, EXPERT OPIN BIOL TH, V7, P1833, DOI 10.1517/14712598.7.12.1833; Went PT, 2004, J CLIN ONCOL, V22, P4514, DOI 10.1200/JCO.2004.10.125; ZAKUT R, 1993, ONCOGENE, V8, P2221	40	28	29	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	13					1542	1550		10.1038/onc.2010.536	http://dx.doi.org/10.1038/onc.2010.536			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	743DU	21119596	Green Accepted, Green Submitted			2022-12-25	WOS:000288998300005
J	Poland, PA; Rondanino, C; Kinlough, CL; Heimburg-Molinaro, J; Arthur, CM; Stowell, SR; Smith, DF; Hughey, RP				Poland, Paul A.; Rondanino, Christine; Kinlough, Carol L.; Heimburg-Molinaro, Jamie; Arthur, Connie M.; Stowell, Sean R.; Smith, Dave F.; Hughey, Rebecca P.			Identification and Characterization of Endogenous Galectins Expressed in Madin Darby Canine Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED MDCK CELLS; BLOOD-GROUP ANTIGENS; BIOSYNTHETIC-PATHWAY; APICAL TRAFFICKING; N-GLYCAN; MUC1; PROTEINS; LECTINS; BINDING; SURFACE	Madin Darby canine kidney (MDCK) cells are a well characterized epithelial cell line used to study mechanisms of polarized delivery. As glycans on apically expressed proteins have been identified as targeting signals, and crosslinking by the abundant galectin-3 has been implicated in the mechanism of glycan-dependent sorting, we wanted to identify other members of the galectin (Gal) family expressed in MDCK cells. By analyzing intron-exon boundaries, we identified canine genes that were highly homologous to mammalian Gal-1, 2, 3, 4, 7, 8, 9, and 12, and galectin-related HSPC159 and GRIFIN. Transcripts for Gal-2 and -12 were not detected in MDCK cells, but we found transcript levels for Gal-3 > Gal-9 > Gal-8 > Gal-1 Gal-4 > Gal-7. Canine Gal-1, -2, -3, -4, -7, -8, -9, and -12 were cloned and expressed in Escherichia coli as GST fusion proteins to characterize binding specificities on arrays of synthetic glycans on glass slides from Core H of the NIH Consortium for Functional Glycomics. Individual expression of the N-terminal (GST-Gal-9N) and C-terminal (GST-Gal-9C) carbohydrate recognition domains greatly improved protein yield and the ability to characterize Gal-9 binding on the array. Canine galectins differentially bound sulfated disaccharides as well as human blood groups A, B, and H on both N-glycans and linear glycan structures on the array. Analysis of GST-Gal-1, -3, -4, -7, -8, -9N, and -9C binding to immunopurified human MUC1 expressed in MDCK cells revealed a preference for binding GST-Gal-3 and -9, which interestingly reflects the two most abundant galectins expressed in MDCK cells.	[Hughey, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Heimburg-Molinaro, Jamie; Arthur, Connie M.; Stowell, Sean R.; Smith, Dave F.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University	Hughey, RP (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, S-933 Scaife Hall, Pittsburgh, PA 15261 USA.	hugheyr@pitt.edu	Rondanino, Christine/S-6880-2018	Rondanino, Christine/0000-0002-1100-9401	National Institutes of Health [DK054787, GM85448, GM62116]; Genzyme Renal Innovations Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, R01GM085448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Renal Innovations Program(Sanofi-AventisGenzyme Corporation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK054787 (to R. P. H.), GM85448 (to D. F. S.), and Genzyme Renal Innovations Program (to R. P. H.).; We thank Sandra Gendler for the CT-2 antibody, and Ora Weisz and Rick Cummings for helpful discussions. Glycan microarray data were obtained through the Protein-Glycan Interaction Core (Core H) of the Consortium for Functional Glycomics supported by National Institutes of Health Grant GM62116.	Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Brewer CF, 2002, GLYCOCONJUGATE J, V19, P459, DOI 10.1023/B:GLYC.0000014075.62724.d0; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; Cummings RD, 2009, GALECTINS; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Guerriero CJ, 2008, J BIOL CHEM, V283, P18040, DOI 10.1074/jbc.M802048200; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Markova V, 2006, INT J MOL MED, V18, P65; Mattila PE, 2009, BIOL CHEM, V390, P551, DOI 10.1515/BC.2009.088; Morelle W, 2009, BIOL CHEM, V390, P529, DOI 10.1515/BC.2009.075; Neil SJD, 2005, BLOOD, V105, P4693, DOI 10.1182/blood-2004-11-4267; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pemberton LF, 1996, J BIOL CHEM, V271, P2332, DOI 10.1074/jbc.271.4.2332; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; SPRINGER GF, 1969, J CLIN INVEST, V48, P1280, DOI 10.1172/JCI106094; SPRINGER GF, 1961, J EXP MED, V113, P1077, DOI 10.1084/jem.113.6.1077; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Varki A., 2009, ESSENTIALS GLYCOBIOL; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200	42	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6780	6790		10.1074/jbc.M110.179002	http://dx.doi.org/10.1074/jbc.M110.179002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21127048	hybrid, Green Published			2022-12-25	WOS:000287476400085
J	Ramani, VC; Yang, Y; Ren, YS; Nan, L; Sanderson, RD				Ramani, Vishnu C.; Yang, Yang; Ren, Yongsheng; Nan, Li; Sanderson, Ralph D.			Heparanase Plays a Dual Role in Driving Hepatocyte Growth Factor (HGF) Signaling by Enhancing HGF Expression and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; RECEPTOR C-MET; MULTIPLE-MYELOMA; TUMOR-GROWTH; BONE-MARROW; 4-KRINGLE ANTAGONIST; OSTEOCLAST FORMATION; IN-VITRO; INTERLEUKIN-11; SYNDECAN-1	Hepatocyte growth factor (HGF) is a heparin-binding cytokine that enhances growth, motility, and angiogenesis of many tumor types, including multiple myeloma where it is often highly expressed. However, little is known regarding what controls HGF level and activity in these tumors. Evaluation of bone marrow biopsies from myeloma patients revealed a strong positive correlation between the levels of HGF and heparanase, an endoglucuronidase known to promote aggressive tumor behavior. In vitro, addition of recombinant heparanase to myeloma cells or transfection of myeloma cell lines with the cDNA for heparanase significantly increased tumor cell expression and secretion of biologically active HGF. Shed syndecan-1, whose levels in myeloma are also enhanced by heparanase expression, binds to secreted HGF. This syndecan-1-HGF complex is active as shown by its ability to stimulate paracrine signaling via c-Met, the cell surface receptor for HGF. Surprisingly, heparanase enzyme activity was not required for up-regulation of HGF expression by the tumor cells. This is in contrast to the heparanase-mediated enhanced syndecan-1 shedding, which does require activity of the enzyme. This suggests that two different functional domains within the heparanase enzyme (the enzyme active site and a separate site) contribute to events leading to enhanced HGF signaling. These findings demonstrate a novel mechanism driving the HGF pathway whereby heparanase stimulates an increase in both HGF expression and syndecan-1 shedding to enhance HGF signaling. This work also provides further mechanistic insight into the dynamic role of heparanase in driving aggressive tumor progression.	[Ramani, Vishnu C.; Yang, Yang; Ren, Yongsheng; Nan, Li; Sanderson, Ralph D.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Yang, Yang; Sanderson, Ralph D.] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Yang, Yang; Sanderson, Ralph D.] Univ Alabama, Ctr Metab Bone Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanderson, RD (corresponding author), Univ Alabama, Dept Pathol, 814 SHEL,1530 3rd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu	nan, li li/HHM-7022-2022		National Institutes of Health [CA135075, CA138340]; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA138340, R01CA135075, R01CA151538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135075 and CA138340 (to R. D. S.). This work was also supported by Multiple Myeloma Research Foundation research fellow award (to V. C. R.) and Multiple Myeloma Research Foundation senior research award (to Y. Y.).	Abdallah BM, 2005, CALCIFIED TISSUE INT, V76, P90, DOI 10.1007/s00223-004-0074-4; Ahlen J, 2002, BONE, V31, P242, DOI 10.1016/S8756-3282(02)00784-6; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Bayer-Garner IB, 2001, MODERN PATHOL, V14, P1052, DOI 10.1038/modpathol.3880435; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Borset M, 2000, BLOOD, V96, P2528; Borset M, 1999, LEUKEMIA LYMPHOMA, V32, P249, DOI 10.3109/10428199909167385; Borset M, 1996, BLOOD, V88, P3998, DOI 10.1182/blood.V88.10.3998.bloodjournal88103998; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; COOPER CS, 1992, ONCOGENE, V7, P3; Date K, 1998, ONCOGENE, V17, P3045, DOI 10.1038/sj.onc.1202231; Derksen PWB, 2003, LEUKEMIA, V17, P764, DOI 10.1038/sj.leu.2402875; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Hill PA, 1998, ENDOCRINOLOGY, V139, P1564, DOI 10.1210/en.139.4.1564; Hjertner O, 1999, BLOOD, V94, P3883; HUGHES FJ, 1993, CALCIFIED TISSUE INT, V53, P362, DOI 10.1007/BF01351844; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Kelly T, 2003, CANCER RES, V63, P8749; Khotskaya YB, 2009, J BIOL CHEM, V284, P26085, DOI 10.1074/jbc.M109.018473; Kuba K, 2000, CANCER RES, V60, P6737; Kudo O, 2003, BONE, V32, P1, DOI 10.1016/S8756-3282(02)00915-8; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Matsumoto K, 2003, CANCER SCI, V94, P321, DOI 10.1111/j.1349-7006.2003.tb01440.x; Morrissey C, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-148; NAKA D, 1992, J BIOL CHEM, V267, P20114; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Rajgopal R, 2006, J BIOL CHEM, V281, P20780, DOI 10.1074/jbc.M600169200; Reiland J, 2004, J BIOL CHEM, V279, P8047, DOI 10.1074/jbc.M304872200; Romas E, 1996, J EXP MED, V183, P2581, DOI 10.1084/jem.183.6.2581; Sanderson RD, 2008, CLIN EXP METASTAS, V25, P149, DOI 10.1007/s10585-007-9125-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seidel C, 2000, BLOOD, V96, P3139, DOI 10.1182/blood.V96.9.3139.h8003139_3139_3146; Seidel C, 1998, BLOOD, V91, P806, DOI 10.1182/blood.V91.3.806.806_806_812; Shaughnessy SG, 2002, CYTOKINE, V20, P78, DOI 10.1006/cyto.2002.1981; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Yap TA, 2010, MOL CANCER THER, V9, P1077, DOI 10.1158/1535-7163.MCT-10-0122; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhang AB, 2010, J CELL BIOCHEM, V111, P469, DOI 10.1002/jcb.22729	52	94	98	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6490	6499		10.1074/jbc.M110.183277	http://dx.doi.org/10.1074/jbc.M110.183277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21131364	Green Published, hybrid			2022-12-25	WOS:000287476400059
J	Pesce, A; Nardini, M; Dewilde, S; Capece, L; Marti, MA; Congia, S; Salter, MD; Blouin, GC; Estrin, DA; Ascenzi, P; Moens, L; Bolognesi, M; Olson, JS				Pesce, Alessandra; Nardini, Marco; Dewilde, Sylvia; Capece, Luciana; Marti, Marcelo A.; Congia, Sonia; Salter, Mallory D.; Blouin, George C.; Estrin, Dario A.; Ascenzi, Paolo; Moens, Luc; Bolognesi, Martino; Olson, John S.			Ligand Migration in the Apolar Tunnel of Cerebratulus lacteus Mini-Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM-WHALE MYOGLOBIN; DISTAL HISTIDINE; NEMERTEAN WORM; NERVE GLOBINS; HEME-PROTEINS; RESP MODEL; O-2 ENTRY; BINDING; CAVITIES; AFFINITY	The large apolar tunnel traversing the mini-hemoglobin from Cerebratulus lacteus (CerHb) has been examined by x-ray crystallography, ligand binding kinetics, and molecular dynamic simulations. The addition of 10 atm of xenon causes loss of diffraction in wild-type (wt) CerHbO(2) crystals, but Leu-86(G12)Ala CerHbO(2), which has an increased tunnel volume, stably accommodates two discrete xenon atoms: one adjacent to Leu-86(G12) and another near Ala-55(E18). Molecular dynamics simulations of ligand migration in wt CerHb show a low energy pathway through the apolar tunnel when Leu or Ala, but not Phe or Trp, is present at the 86(G12) position. The addition of 10-15 atm of xenon to solutions of wt CerHbCO and L86A CerHbCO causes 2-3-fold increases in the fraction of geminate ligand recombination, indicating that the bound xenon blocks CO escape. This idea was confirmed by L86F and L86W mutations, which cause even larger increases in the fraction of geminate CO rebinding, 2-5-fold decreases in the bimolecular rate constants for ligand entry, and large increases in the computed energy barriers for ligand movement through the apolar tunnel. Both the addition of xenon to the L86A mutant and oxidation of wt CerHb heme iron cause the appearance of an out Gln-44(E7) conformer, in which the amide side chain points out toward the solvent and appears to lower the barrier for ligand escape through the E7 gate. However, the observed kinetics suggest little entry and escape (<= 25%) through the E7 pathway, presumably because the in Gln-44(E7) conformer is thermodynamically favored.	[Salter, Mallory D.; Blouin, George C.; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; [Dewilde, Sylvia; Moens, Luc] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Capece, Luciana; Marti, Marcelo A.; Estrin, Dario A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE CONICET, Dept Quim Inorgan Analit & Quim Fis, Buenos Aires, DF, Argentina; [Ascenzi, Paolo] Univ Roma Tre, Dept Biol, I-00146 Rome, Italy; [Ascenzi, Paolo] Univ Roma Tre, Interdept Lab Elect Microscopy, I-00146 Rome, Italy	Rice University; University of Genoa; University of Milan; University of Antwerp; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Roma Tre University; Roma Tre University	Olson, JS (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main St, Houston, TX 77005 USA.	olson@rice.edu	Estrin, Dario/AAY-7549-2020; Pesce, Alessandra/A-3660-2015; Bolognesi, Martino/B-7924-2017; Nardini, Marco/B-7842-2017	Bolognesi, Martino/0000-0002-9253-5170; Nardini, Marco/0000-0002-3718-2165; Estrin, Dario/0000-0002-5006-7225; Marti, Marcelo/0000-0002-7911-9340; Olson, John/0000-0002-0760-5403	National Institutes of Health [GM035649, HL047020]; Italian Ministry of University and Scientific Research; University of Milano [RBLA03B3KC]; Universidad de Buenos Aires [08-X625, X076]; Agencia de Promocion Cientifica y Tecnologica [07-1650, 06-25667]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 5218]; Guggenheim Foundation fellowship; Welch Foundation [C-0612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Milano; Universidad de Buenos Aires(University of Buenos Aires); Agencia de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Guggenheim Foundation fellowship; Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM035649 and HL047020 (to J.S.O.). This work was also supported by grants from the Italian Ministry of University and Scientific Research (FIRB Project "Biologia Strutturale, "RBLA03B3KC) and from the University of Milano (to M. B.), Universidad de Buenos Aires Grants 08-X625 (to M.A.M.) and X076 (to D.A.E.), Agencia de Promocion Cientifica y Tecnologica Grants 07-1650 (to M.A.M.) and 06-25667 (to D.A.E.), Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP 5218 and a Guggenheim Foundation fellowship (to D.A.E.), and Robert A. Welch Foundation Grant C-0612 (to J.S.O.).	BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; Deng PC, 2007, GENE, V398, P208, DOI 10.1016/j.gene.2007.01.037; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Elber R, 2010, CURR OPIN STRUC BIOL, V20, P162, DOI 10.1016/j.sbi.2010.01.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Geuens E, 2004, IUBMB LIFE, V56, P653, DOI 10.1080/15216540500037471; Hundahl C, 2006, FEBS J, V273, P1323, DOI 10.1111/j.1742-4658.2006.05158.x; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Knapp JE, 2009, STRUCTURE, V17, P1494, DOI 10.1016/j.str.2009.09.004; LAI HH, 1995, PROTEINS, V22, P322, DOI 10.1002/prot.340220404; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leach A. R., 2001, MOL MODELLING PRINCI, P581; Leslie AGM, 2003, MOSFLM USER GUIDE MO; Marti MA, 2006, PROTEINS, V62, P641, DOI 10.1002/prot.20822; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; MIMS MP, 1983, J BIOL CHEM, V258, P4219; Moschetti T, 2009, BIOPHYS J, V97, P1700, DOI 10.1016/j.bpj.2009.05.059; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pesce A, 2004, J BIOL CHEM, V279, P33662, DOI 10.1074/jbc.M403597200; Pesce A, 2002, STRUCTURE, V10, P725, DOI 10.1016/S0969-2126(02)00763-3; Pesce A, 2001, ACTA CRYSTALLOGR D, V57, P1897, DOI 10.1107/S0907444901015815; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Salter MD, 2008, J BIOL CHEM, V283, P35689, DOI 10.1074/jbc.M805727200; Savino C, 2009, BIOPOLYMERS, V91, P1097, DOI 10.1002/bip.21201; SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0; SCHOENBORN BP, 1965, NATURE, V208, P760, DOI 10.1038/208760a0; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vandergon TL, 1998, J BIOL CHEM, V273, P16998, DOI 10.1074/jbc.273.27.16998; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123	42	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5347	5358		10.1074/jbc.M110.169045	http://dx.doi.org/10.1074/jbc.M110.169045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21147768	hybrid, Green Published			2022-12-25	WOS:000287230600043
J	ter Beek, J; Duurkens, RH; Erkens, GB; Slotboom, DJ				ter Beek, Josy; Duurkens, Ria H.; Erkens, Guus B.; Slotboom, Dirk Jan			Quaternary Structure and Functional Unit of Energy Coupling Factor (ECF)-type Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLED GENE-EXPRESSION; ABC TRANSPORTERS; LACTOCOCCUS-LACTIS; MEMBRANE-PROTEINS; LIGHT-SCATTERING; BINDING; BACTERIA; PROKARYOTES; AFFINITY; SYSTEMS	ATP-binding cassette (ABC) transporters mediate transport of diverse substrates across membranes. We have determined the quaternary structure and functional unit of the recently discovered ECF-type (energy coupling factor) of ABC transporters, which is widespread among prokaryotes. ECF transporters are protein complexes consisting of a conserved energizing module (two peripheral ATPases and the integral membrane protein EcfT) and a non-conserved integral membrane protein responsible for substrate specificity (S-component). S-components for different substrates are often unrelated in amino acid sequence but may associate with the same energizing module. Here, the energizing module from Lactococcus lactis was shown to form stable complexes with each of the eight predicted S-components found in the organism. The quaternary structures of three of these complexes were determined by light scattering. EcfT, the two ATPases (EcfA and EcfA`), and the S-components were found to be present in a 1:1:1:1 ratio. The complexes were reconstituted in proteoliposomes and shown to mediate ATP-dependent transport. ECF-type transporters are the smallest known ABC transporters.	[ter Beek, Josy; Duurkens, Ria H.; Erkens, Guus B.; Slotboom, Dirk Jan] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands	University of Groningen	Slotboom, DJ (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	d.j.slotboom@rug.nl	Beek, Josy ter/AAG-8291-2021	Beek, Josy ter/0000-0003-4165-9277	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a toptalent grant from the Netherlands Organisation for Scientific Research (NWO) (to J. t. B.) and a vidi grant from the NWO (to D. J. S.).	Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Erkens GB, 2010, BIOCHEMISTRY-US, V49, P3203, DOI 10.1021/bi100154r; Finkenwirth F, 2010, BIOCHEM J, V431, P373, DOI 10.1042/BJ20100813; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; WERTMAN KF, 1986, GENE, V49, P253, DOI 10.1016/0378-1119(86)90286-6; Zhang P, 2010, NATURE, V468, P717, DOI 10.1038/nature09488	20	42	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5471	5475		10.1074/jbc.M110.199224	http://dx.doi.org/10.1074/jbc.M110.199224			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135102	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000287230600056
J	Bosch, DE; Kimple, AJ; Sammond, DW; Muller, RE; Miley, MJ; Machius, M; Kuhlman, B; Willard, FS; Siderovski, DP				Bosch, Dustin E.; Kimple, Adam J.; Sammond, Deanne W.; Muller, Robin E.; Miley, Michael J.; Machius, Mischa; Kuhlman, Brian; Willard, Francis S.; Siderovski, David P.			Structural Determinants of Affinity Enhancement between GoLoco Motifs and G-Protein alpha Subunit Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESIGN; PINS; FLUORESCENCE; ACTIVATION; MUTATIONS; HOMOLOG; DISPLAY	GoLoco motif proteins bind to the inhibitory G(i) subclass of G-protein alpha subunits and slow the release of bound GDP; this interaction is considered critical to asymmetric cell division and neuro-epithelium and epithelial progenitor differentiation. To provide protein tools for interrogating the precise cellular role(s) of GoLoco motif/G alpha(i) complexes, we have employed structure-based protein design strategies to predict gain-of-function mutations that increase GoLoco motif binding affinity. Here, we describe fluorescence polarization and isothermal titration calorimetry measurements showing three predicted G alpha(i1) point mutations, E116L, Q147L, and E245L; each increases affinity for multiple GoLoco motifs. A component of this affinity enhancement results from a decreased rate of dissociation between the G alpha mutants and GoLoco motifs. For G alpha(Q147L)(i1), affinity enhancement was seen to be driven by favorable changes in binding enthalpy, despite reduced contributions from binding entropy. The crystal structure of G(alpha i1)(Q147L) bound to the RGS14 GoLoco motif revealed disorder among three peptide residues surrounding a well defined Leu-147 side chain. Monte Carlo simulations of the peptide in this region showed a sampling of multiple backbone conformations in contrast to the wild-type complex. We conclude that mutation of Glu-147 to leucine creates a hydrophobic surface favorably buried upon GoLoco peptide binding, yet the hydrophobic Leu-147 also promotes flexibility among residues 511-513 of the RGS14 GoLoco peptide.	[Willard, Francis S.; Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Sammond, Deanne W.; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Willard, FS (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	francis.willard@gmail.com; dsiderov@med.unc.edu	, PEP-MX Core/AGV-4051-2022; Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Kimple, Adam/0000-0003-1670-8401; Bosch, Dustin/0000-0002-7430-2939	National Institutes of Health [R01 CA127152, F30 MH074266, T32 GM008719]; NATIONAL CANCER INSTITUTE [R01CA127152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073960, T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH074266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA127152 (to D. P. S.), F30 MH074266 (to A. J. K.), and T32 GM008719 (to D. E. B. and A. J. K.).	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Brady GP, 1997, CURR OPIN STRUC BIOL, V7, P215, DOI 10.1016/S0959-440X(97)80028-0; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hahn KM, 2010, NAT METHODS, V7, P595, DOI 10.1038/nmeth0810-595; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; Hutsell SQ, 2010, METHODS MOL BIOL, V627, P75, DOI 10.1007/978-1-60761-670-2_4; Iscru E, 2009, MOL CELL NEUROSCI, V40, P62, DOI 10.1016/j.mcn.2008.09.002; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rao BM, 2005, NAT BIOTECHNOL, V23, P191, DOI 10.1038/nbt1064; Reynolds KA, 2008, J MOL BIOL, V382, P1265, DOI 10.1016/j.jmb.2008.05.051; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sammond DW, 2010, PROTEINS, V78, P1055, DOI 10.1002/prot.22631; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Woodnutt G, 2008, CURR OPIN DRUG DISC, V11, P754; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	42	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3351	3358		10.1074/jbc.M110.190496	http://dx.doi.org/10.1074/jbc.M110.190496			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115486	Green Published, hybrid			2022-12-25	WOS:000286653200021
J	Dominguez, V; Raimondi, C; Somanath, S; Bugliani, M; Loder, MK; Edling, CE; Divecha, N; da Silva-Xavier, G; Marselli, L; Persaud, SJ; Turner, MD; Rutter, GA; Marchetti, P; Falasca, M; Maffucci, T				Dominguez, Veronica; Raimondi, Claudio; Somanath, Sangeeta; Bugliani, Marco; Loder, Merewyn K.; Edling, Charlotte E.; Divecha, Nullin; da Silva-Xavier, Gabriela; Marselli, Lorella; Persaud, Shanta J.; Turner, Mark D.; Rutter, Guy A.; Marchetti, Piero; Falasca, Marco; Maffucci, Tania			Class II Phosphoinositide 3-Kinase Regulates Exocytosis of Insulin Granules in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUCOSE-UPTAKE; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; MUSCLE-CELLS; SECRETION; ISLETS; PATHWAY; MICE; P110-GAMMA; MODULATION	Phosphoinositide 3-kinases (PI3Ks) are critical regulators of pancreatic beta cell mass and survival, whereas their involvement in insulin secretion is more controversial. Furthermore, of the different PI3Ks, the class II isoforms were detected in beta cells, although their role is still not well understood. Here we show that down-regulation of the class II PI3K isoform PI3K-C2 alpha specifically impairs insulin granule exocytosis in rat insulinoma cells without affecting insulin content, the number of insulin granules at the plasma membrane, or the expression levels of key proteins involved in insulin secretion. Proteolysis of synaptosomal-associated protein of 25 kDa, a process involved in insulin granule exocytosis, is impaired in cells lacking PI3K-C2 alpha. Finally, our data suggest that the mRNA for PI3K-C2 alpha may be down-regulated in islets of Langerhans from type 2 diabetic compared with non-diabetic individuals. Our results reveal a critical role for PI3K-C2 alpha in beta cells and suggest that down-regulation of PI3K-C2 alpha may be a feature of type 2 diabetes.	[Maffucci, Tania] Queen Mary Univ London, Inositide Signalling Grp, Barts & London Sch Med & Dent, Ctr Diabet,Blizard Inst Cell & Mol Sci, London E1 2AT, England; [Bugliani, Marco; Marselli, Lorella; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, I-56100 Pisa, Italy; [Loder, Merewyn K.; da Silva-Xavier, Gabriela; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Sect Cell Biol, Div Diabet Endocrinol & Metab, Dept Med, London SW7 2AZ, England; [Divecha, Nullin] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Persaud, Shanta J.] Kings Coll London, Diabet Res Grp, London SE1 1UL, England	University of London; Queen Mary University London; University of Pisa; Imperial College London; Paterson Institute for Cancer Research; University of Manchester; University of London; King's College London	Maffucci, T (corresponding author), Queen Mary Univ London, Inositide Signalling Grp, Barts & London Sch Med & Dent, Ctr Diabet,Blizard Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.	t.maffucci@qmul.ac.uk	Raimondi, Claudio/AAJ-4335-2020; Bugliani, Marco/I-3168-2019; Persaud, Shanta/AAH-3200-2021; Marchetti, Piero/J-7439-2013; Falasca, Marco/S-4020-2016	Raimondi, Claudio/0000-0002-1419-6855; Bugliani, Marco/0000-0002-1744-1561; Marchetti, Piero/0000-0003-4907-0635; Turner, Mark/0000-0001-7175-1053; Falasca, Marco/0000-0002-9801-7235; Marselli, Lorella/0000-0002-6698-2962; divecha, nullin/0000-0001-9695-6039; Rutter, Guy/0000-0001-6360-0343; da Silva Xavier, Gabriela/0000-0002-0678-012X; Persaud, Shanta/0000-0002-4933-5958	Barts and The London Charity [430/647, RAB/06/PHD/12]; Diabetes Research & Wellness Foundation; Diabetes UK [BDA: 09/0003971]; Pancreatic Cancer Research Fund; Wellcome Trust; Medical Research Council; European Union; Juvenile Diabetes Research Foundation; Diabetes UK [09/0003971] Funding Source: researchfish; Medical Research Council [G0401641] Funding Source: researchfish; MRC [G0401641] Funding Source: UKRI	Barts and The London Charity; Diabetes Research & Wellness Foundation; Diabetes UK(Diabetes UK); Pancreatic Cancer Research Fund; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Barts and The London Charity Grant 430/647, Diabetes Research & Wellness Foundation, and Diabetes UK Grant BDA: 09/0003971 (all to T. M.).; Supported by Barts and The London Charity Grants 430/647 (to T. M.) and RAB/06/PHD/12 (to M. D. T.).; Supported by the Pancreatic Cancer Research Fund (to M. F.).; Supported by grants from The Wellcome Trust, Medical Research Council, European Union (FP6 "Savebeta"), Juvenile Diabetes Research Foundation, and Diabetes UK.; Supported by grants from the European Union (FP6 "EURODIA").	[Anonymous], 1995, Diabetes, V44, P1249; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Brown AE, 2007, MOL GENET METAB, V91, P318, DOI 10.1016/j.ymgme.2007.05.001; Bugliani M, 2009, ISLETS, V1, P106, DOI 10.4161/isl.1.2.9142; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Daimon M, 2008, BIOCHEM BIOPH RES CO, V365, P466, DOI 10.1016/j.bbrc.2007.10.180; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Del Prato S, 2007, DIABETES-METAB RES, V23, P518, DOI 10.1002/dmrr.770; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Elis W, 2008, MOL CANCER RES, V6, P614, DOI 10.1158/1541-7786.MCR-07-0262; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2009, BBA-MOL CELL RES, V1793, P1795, DOI 10.1016/j.bbamcr.2009.10.003; Gauthier BR, 2008, FASEB J, V22, P194, DOI 10.1096/fj.07-8333com; HAGIWARA S, 1995, BIOCHEM BIOPH RES CO, V214, P51, DOI 10.1006/bbrc.1995.2255; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Iezzi M, 2004, J CELL SCI, V117, P3119, DOI 10.1242/jcs.01179; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Logie LJ, 2005, MOL GENET METAB, V85, P54, DOI 10.1016/j.ymgme.2005.01.003; MacDonald PE, 2004, ENDOCRINOLOGY, V145, P4078, DOI 10.1210/en.2004-0028; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marchetti P, 2008, REGUL PEPTIDES, V146, P4, DOI 10.1016/j.regpep.2007.08.017; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Muller D, 2007, DIABETOLOGIA, V50, P1239, DOI 10.1007/s00125-007-0671-7; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; Ng SKL, 2009, BIOCHEM BIOPH RES CO, V387, P310, DOI 10.1016/j.bbrc.2009.07.013; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Paul DS, 2003, BIOCHEM J, V376, P625, DOI 10.1042/BJ20030681; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rutter GA, 2004, DIABETOLOGIA, V47, P1861, DOI 10.1007/s00125-004-1541-1; Rutter GA, 2008, FRONT HORM RES, V36, P118, DOI 10.1159/000115360; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Turner MD, 2000, J BIOL CHEM, V275, P14025, DOI 10.1074/jbc.275.19.14025; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Weyer C, 2001, DIABETES CARE, V24, P89, DOI 10.2337/diacare.24.1.89; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; Yu J, 2007, MOL ENDOCRINOL, V21, P2775, DOI 10.1210/me.2006-0473; Zawalich WS, 2000, J ENDOCRINOL, V166, P111, DOI 10.1677/joe.0.1660111; Zawalich WS, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740247	54	96	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4216	4225		10.1074/jbc.M110.200295	http://dx.doi.org/10.1074/jbc.M110.200295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21127054	hybrid, Green Published			2022-12-25	WOS:000286975700020
J	Ma, DD; Zhang, R; Sun, Y; Rios, HF; Haruyama, N; Han, XL; Kulkarni, AB; Qin, CL; Feng, JQ				Ma, Dedong; Zhang, Rong; Sun, Yao; Rios, Hector F.; Haruyama, Naoto; Han, Xianglong; Kulkarni, Ashok B.; Qin, Chunlin; Feng, Jian Q.			A Novel Role of Periostin in Postnatal Tooth Formation and Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTIN MATRIX PROTEIN-1; TRANSFORMING GROWTH-FACTOR-BETA-1; SIBLING PROTEINS; PERIODONTAL-LIGAMENT; ENAMEL DEFECTS; NULL MUTATION; MOUSE TEETH; BONE; MICE; SIALOPHOSPHOPROTEIN	Periostin plays multiple functions during development. Our previous work showed a critical role of this disulfide-linked cell adhesion protein in maintenance of periodontium integrity in response to occlusal load. In this study, we attempted to address whether this mechanical response molecule played a direct role in postnatal tooth development. Our key findings are 1) periostin is expressed in preodontoblasts, and odontoblasts; and the periostin-null incisor displayed a massive increase in dentin formation after mastication; 2) periostin is also expressed in the ameloblast cells, and an enamel defect is identified in both the adult-null incisor and molar; 3) deletion of periostin leads to changes in expression profiles of many non-collagenous protein such as DSPP, DMP1, BSP, and OPN in incisor dentin; 4) the removal of a biting force leads to reduction of mineralization, which is partially prevented in periostin-null mice; and 6) both in vitro and in vivo data revealed a direct regulation of periostin by TGF-beta 1 in dentin formation. In conclusion, periostin plays a novel direct role in controlling postnatal tooth formation, which is required for the integrity of both enamel and dentin.	[Ma, Dedong] Shandong Univ, Dept Resp Med, Qilu Hosp, Jinan 250012, Peoples R China; [Ma, Dedong; Zhang, Rong; Sun, Yao; Han, Xianglong; Qin, Chunlin; Feng, Jian Q.] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dallas, TX 75246 USA; [Zhang, Rong] Fourth Mil Med Univ, Dept Operat Dent & Endodont, Sch Stomatol, Xian 710032, Peoples R China; [Rios, Hector F.] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Haruyama, Naoto; Kulkarni, Ashok B.] NIDCR, Funct Genom Sect, NIH, Bethesda, MD 20892 USA	Shandong University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Air Force Military Medical University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Feng, JQ (corresponding author), Dept Biomed Sci, 3302 Gaston Ave, Dallas, TX 75246 USA.	jfeng@bcd.tamhsc.edu	Haruyama, Naoto/D-1993-2011	Haruyama, Naoto/0000-0001-6225-5816	National Institutes of adhesive molecule [NIH/NIDCR DE015209, DE005092]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE005092, R01DE018486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	National Institutes of adhesive molecule; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of adhesive molecule highly expressed in the PDL, is essential for Health (NIH/NIDCR DE015209 (to J. Q. F.), and DE005092 (to C. Q.)).	Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; BENES AJ, 1985, J CELL SCI, V75, P35; BOWERS GN, 1975, CLIN CHEM, V21, P1988; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; DSouza RN, 1995, CONNECT TISSUE RES, V32, P41, DOI 10.3109/03008209509013704; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Frost HM, 2004, ANGLE ORTHOD, V74, P3; Haruyama N, 2006, EUR J ORAL SCI, V114, P30, DOI 10.1111/j.1600-0722.2006.00276.x; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Kruzynska-Frejtag A, 2004, DEV DYNAM, V229, P857, DOI 10.1002/dvdy.10453; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Maciejewska I, 2009, CELLS TISSUES ORGANS, V189, P186, DOI 10.1159/000151372; Melsen B, 2001, EUR J ORTHODONT, V23, P671, DOI 10.1093/ejo/23.6.671; MICHAELI Y, 1968, J DENT RES, V47, P633, DOI 10.1177/00220345680470042101; MILLER SC, 1985, J DENT RES, V64, P1062, DOI 10.1177/00220345850640080701; NILSSON BE, 1971, CLIN ORTHOP RELAT R, P179; Priam F, 2005, ARCH ORAL BIOL, V50, P271, DOI 10.1016/j.archoralbio.2004.10.007; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, EUR J ORAL SCI, V111, P235, DOI 10.1034/j.1600-0722.2003.00043.x; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Risnes S, 1996, Adv Dent Res, V10, P261; Risnes S, 1995, CONNECT TISSUE RES, V32, P183, DOI 10.3109/03008209509013722; SKOBE Z, 1993, J DENT RES, V72, P46, DOI 10.1177/00220345930720010601; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sreenath TL, 2003, GENESIS, V35, P94, DOI 10.1002/gene.10170; Sreenath TL, 1999, INT J DEV BIOL, V43, P509; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Thyagarajan T, 2001, J BIOL CHEM, V276, P11016, DOI 10.1074/jbc.M010502200; Tsuchiya M, 2009, EUR J ORAL SCI, V117, P105, DOI 10.1111/j.1600-0722.2009.00612.x; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509	36	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4302	4309		10.1074/jbc.M110.140202	http://dx.doi.org/10.1074/jbc.M110.140202			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131362	Green Published, hybrid			2022-12-25	WOS:000286975700029
J	Mukherjee, PK; Wiest, A; Ruiz, N; Keightley, A; Moran-Diez, ME; McCluskey, K; Pouchus, YF; Kenerley, CM				Mukherjee, Prasun K.; Wiest, Aric; Ruiz, Nicolas; Keightley, Andrew; Moran-Diez, Maria E.; McCluskey, Kevin; Pouchus, Yves Francois; Kenerley, Charles M.			Two Classes of New Peptaibols Are Synthesized by a Single Non-ribosomal Peptide Synthetase of Trichoderma virens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL-FORMING PEPTAIBOLS; SECONDARY METABOLISM; ADENYLATION DOMAINS; FUNGAL METABOLITES; MASS-SPECTROMETRY; FUTURE-PROSPECTS; PEPTAIBIOTICS; BIOSYNTHESIS; ANTIBIOTICS; HYPOCREA	Peptaibols are a group of small peptides having a high alpha-aminoisobutyric acid (Aib) content and produced by filamentous fungi, especially by the members of the genus Trichoderma (anamorph Hypocrea). These antibiotics are economically important for their anti-microbial and anti-cancer properties as well as ability to induce systemic resistance in plants against microbial invasion. In this study we present sequences of two classes (11-residue and 14-residue) of peptaibols produced by the biocontrol fungus Trichoderma virens. Of the 35 11-residue peptaibols sequenced, 18 are hitherto not described, and all the 53 14-residue sequences described by us here are new. We have also identified a peptaibol synthetase (non-ribosomal peptide synthetase, NRPS) with 14 complete modules in the genome of this fungus and disruption of this single gene (designated as tex2) resulted in the loss of both the classes of peptaibols. We, thus present here an unprecedented case where a single NRPS encodes for two classes of peptaibols. The new peptaibols identified here could have applications as therapeutic agents for the management of human and plant health.	[Mukherjee, Prasun K.; Moran-Diez, Maria E.; Kenerley, Charles M.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Mukherjee, Prasun K.] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Mumbai 400085, Maharashtra, India; [Wiest, Aric; McCluskey, Kevin] Univ Missouri, Fungal Genet Stock Ctr, Kansas City, MO 64110 USA; [Ruiz, Nicolas; Pouchus, Yves Francois] Univ Nantes, Fac Pharm, MMS EA 2160, F-44000 Nantes, France; [Keightley, Andrew] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA	Texas A&M University System; Texas A&M University College Station; Bhabha Atomic Research Center (BARC); University of Missouri System; University of Missouri Kansas City; Nantes Universite; University of Missouri System; University of Missouri Kansas City	Kenerley, CM (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	c-kenerley@tamu.edu	Moran-Diez, Maria E/A-9461-2017	Moran-Diez, Maria E/0000-0003-0253-5669	National Research Initiative [2008-35319-04470]	National Research Initiative(United States Department of Agriculture (USDA))	This project was supported by the National Research Initiative Competitive Grants Program Grant 2008-35319-04470 (to C. M. K.).	Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Becker D, 1997, LIEBIGS ANN-RECL, P767; Berg A, 2003, J PEPT SCI, V9, P810, DOI 10.1002/psc.498; Bode HB, 2006, J IND MICROBIOL BIOT, V33, P577, DOI 10.1007/s10295-006-0082-7; Brotman Y, 2010, CURR BIOL, V20, pR390, DOI 10.1016/j.cub.2010.02.042; Chutrakul C, 2008, CHEM BIODIVERS, V5, P1694, DOI 10.1002/cbdv.200890158; Daniel JFD, 2007, NAT PROD REP, V24, P1128, DOI 10.1039/b618086h; Degenkolb T, 2003, J PEPT SCI, V9, P666, DOI 10.1002/psc.497; Degenkolb T, 2008, CHEM BIODIVERS, V5, P1817, DOI 10.1002/cbdv.200890171; Degenkolb T, 2008, CHEM BIODIVERS, V5, P693, DOI 10.1002/cbdv.200890066; Degenkolb T, 2008, CHEM BIODIVERS, V5, P671, DOI 10.1002/cbdv.200890064; Degenkolb T, 2006, J AGR FOOD CHEM, V54, P7047, DOI 10.1021/jf060788q; Duclohier H, 2007, CHEM BIODIVERS, V4, P1023, DOI 10.1002/cbdv.200790094; Engelberth J, 2000, ANGEW CHEM INT EDIT, V39, P1860, DOI 10.1002/(SICI)1521-3773(20000515)39:10<1860::AID-ANIE1860>3.0.CO;2-F; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; IIDA A, 1995, CHEM PHARM BULL, V43, P392, DOI 10.1248/cpb.43.392; Komon-Zelazowska M, 2007, EUKARYOT CELL, V6, P2332, DOI 10.1128/EC.00143-07; Krause C, 2007, CHEM BIODIVERS, V4, P1083, DOI 10.1002/cbdv.200790098; Kubicek CP, 2007, CHEM BIODIVERS, V4, P1068, DOI 10.1002/cbdv.200790097; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Maddau L, 2009, MICROBIOL-SGM, V155, P3371, DOI 10.1099/mic.0.030916-0; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Marahiel MA, 2009, J PEPT SCI, V15, P799, DOI 10.1002/psc.1183; Mohamed-Benkada M, 2006, RAPID COMMUN MASS SP, V20, P1176, DOI 10.1002/rcm.2430; Mukherjee PK, 2003, EUKARYOT CELL, V2, P446, DOI 10.1128/EC.2.3.446-455.2003; MUKHERJEE PK, 2008, SOIL BIOL SERIES; Neuhof T, 2007, MICROBIOL-SGM, V153, P3417, DOI 10.1099/mic.0.2007/006692-0; Peltola J, 2004, APPL ENVIRON MICROB, V70, P4996, DOI 10.1128/AEM.70.8.4996-5004.2004; Pruksakorn P, 2010, BIOORG MED CHEM LETT, V20, P3658, DOI 10.1016/j.bmcl.2010.04.100; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; REBUFFAT S, 1995, J CHEM SOC P1, V14, P1849; Ren JW, 2009, J NAT PROD, V72, P1036, DOI 10.1021/np900190w; Ruiz N, 2007, PEPTIDES, V28, P1351, DOI 10.1016/j.peptides.2007.05.012; Sang Yongming, 2008, Animal Health Research Reviews, V9, P227, DOI 10.1017/S1466252308001497; SANSOM MSP, 1993, Q REV BIOPHYS, V26, P365, DOI 10.1017/S0033583500002833; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-26; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; Szekeres A., 2005, Acta Microbiologica et Immunologica Hungarica, V52, P137, DOI 10.1556/AMicr.52.2005.2.2; THOMAS MD, 1989, CURR GENET, V15, P415, DOI 10.1007/BF00376798; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; Viterbo A, 2007, MOL PLANT PATHOL, V8, P737, DOI 10.1111/J.1364-3703.2007.00430.X; Vizcaino JA, 2006, FOLIA MICROBIOL, V51, P114, DOI 10.1007/BF02932165; WADA S, 1995, CHEM PHARM BULL, V43, P910; Weckwerth W, 2000, J BIOL CHEM, V275, P17909, DOI 10.1074/jbc.M001084200; Wei MC, 2010, CURR ORG CHEM, V14, P1433, DOI 10.2174/138527210791616759; Wei XY, 2005, CAN J MICROBIOL, V51, P423, DOI 10.1139/W05-006; Wenzel SC, 2006, ANGEW CHEM INT EDIT, V45, P2296, DOI 10.1002/anie.200503737; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Wenzel SC, 2005, CHEMBIOCHEM, V6, P375, DOI 10.1002/cbic.200400282; Wiest A, 2002, J BIOL CHEM, V277, P20862, DOI 10.1074/jbc.M201654200; Yun BS, 2000, TETRAHEDRON LETT, V41, P1429, DOI 10.1016/S0040-4039(99)02308-4; Zocher R, 1997, ADV MICROB PHYSIOL, V38, P85	54	65	68	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4544	4554		10.1074/jbc.M110.159723	http://dx.doi.org/10.1074/jbc.M110.159723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123172	Green Published, hybrid			2022-12-25	WOS:000286975700055
J	Pirie, CM; Hackel, BJ; Rosenblum, MG; Wittrup, KD				Pirie, Christopher M.; Hackel, Benjamin J.; Rosenblum, Michael G.; Wittrup, K. Dane			Convergent Potency of Internalized Gelonin Immunotoxins across Varied Cell Lines, Antigens, and Targeting Moieties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; SINGLE-CHAIN IMMUNOTOXIN; CARCINOEMBRYONIC ANTIGEN; PSEUDOMONAS EXOTOXIN; MONOCLONAL-ANTIBODIES; QUANTITATIVE-ANALYSIS; SYNTHESIS INHIBITION; CYTOTOXIC ACTIVITY; COLORECTAL-CANCER; DIPHTHERIA-TOXIN	Gelonin-based immunotoxins vary widely in their cytotoxic potency as a function of antigen density, target cell internalization and trafficking kinetics, and conjugate properties. We have synthesized novel gelonin immunotoxins using two different binding scaffold types (single-chain antibody variable fragments and fibronectin domains) targeting two different tumor antigens (carcinoembryonic antigen and EGF receptor). Constructs were characterized using an antigen-negative cell line (HT-1080), cell lines positive for each antigen (HT-1080(CEA) for carcinoembryonic antigen and A431 for EGF receptor), and a cell line positive for both antigens (HT-29). Immunotoxins exhibited K-d values between 8 and 15 nM and showed 20-2000-fold enhanced cytotoxicity compared with gelonin (IC50 similar to 0.25-30 nM versus 500 nM). Using quantitative fluorescence flow cytometry, we measured internalization of gelonin (via pinocytosis) and gelonin-based immunotoxins (via antigen-dependent, receptor-mediated endocytosis). Results were matched with cytotoxicity measurements made at equivalent concentration and exposures. Unexpectedly, when matched internalization and cytotoxicity data were combined, a conserved internalized cytotoxicity curve was generated that was common across experimental conditions. Considerable variations in antigen expression, trafficking kinetics, extracellular immunotoxin concentration, and exposure time were all found to collapse to a single potency curve on the basis of internalized immunotoxin. Fifty percent cytotoxicity occurred when similar to 5 x 10(6) toxin molecules were internalized regardless of the mechanism of uptake. Cytotoxicity observed at a threshold internalization was consistent with the hypothesis that endosomal escape is a common, highly inefficient, rate-limiting step following internalization by any means tested. Methods designed to enhance endosomal escape might be utilized to improve the potency of gelonin-based immunotoxins.	[Pirie, Christopher M.; Wittrup, K. Dane] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Hackel, Benjamin J.; Wittrup, K. Dane] MIT, Dept Chem Engn, Cambridge, MA 02142 USA; [Wittrup, K. Dane] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Rosenblum, Michael G.] Univ Texas Houston, MD Anderson Canc Ctr, Immunopharmacol & Targeted Therapy Lab, Dept Expt Therapeut, Houston, TX 77030 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Wittrup, KD (corresponding author), 400 Main St,E19-551, Cambridge, MA 02142 USA.	wittrup@mit.edu			National Institutes of Health [CA96504, CA101830]; Massachusetts Institute of Technology Center for Cancer Nanotechnology Excellence; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA101830, R01CA096504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Institute of Technology Center for Cancer Nanotechnology Excellence; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA96504 and CA101830. This work was also supported by a pilot project grant from the Massachusetts Institute of Technology Center for Cancer Nanotechnology Excellence and by National Science Foundation graduate research fellowships (to C. M. P. and B. J. H.).	Ackerman ME, 2008, MOL CANCER THER, V7, P2233, DOI 10.1158/1535-7163.MCT-08-0067; Akamatsu Y, 1998, CLIN CANCER RES, V4, P2825; AVILA AD, 1989, INT J CANCER, V43, P926, DOI 10.1002/ijc.2910430533; Beers R, 2000, CLIN CANCER RES, V6, P2835; Boehm MK, 2000, BIOCHEM J, V346, P519, DOI 10.1042/0264-6021:3460519; Chan MC, 1999, CANCER IMMUNOL IMMUN, V47, P321, DOI 10.1007/s002620050537; CHESTER KA, 1994, LANCET, V343, P455, DOI 10.1016/S0140-6736(94)92695-6; Chiron MF, 1997, J BIOL CHEM, V272, P31707, DOI 10.1074/jbc.272.50.31707; Convertine AJ, 2009, J CONTROL RELEASE, V133, P221, DOI 10.1016/j.jconrel.2008.10.004; Deen WM, 2001, AM J PHYSIOL-RENAL, V281, pF579; DiMassimo AM, 1997, BRIT J CANCER, V75, P822, DOI 10.1038/bjc.1997.147; Du X, 2008, CANCER RES, V68, P6300, DOI 10.1158/0008-5472.CAN-08-0461; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; GOLDMACHER VS, 1989, J CELL PHYSIOL, V141, P222, DOI 10.1002/jcp.1041410129; Graff CP, 2004, PROTEIN ENG DES SEL, V17, P293, DOI 10.1093/protein/gzh038; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Keller J, 2001, J CONTROL RELEASE, V74, P259, DOI 10.1016/S0168-3659(01)00329-7; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2007, METH MOL B, V352, P95; KONDO T, 1988, J BIOL CHEM, V263, P9470; Kraeber-Bodere F, 2006, J NUCL MED, V47, P247; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Kreitman RJ, 2009, J CLIN ONCOL, V27, P2983, DOI 10.1200/JCO.2008.20.2630; LAMBERT JM, 1985, J BIOL CHEM, V260, P2035; LEVIN LV, 1987, CANCER IMMUNOL IMMUN, V24, P202; Liu Z., 2010, ASCR 101 ANN M WASH; MAY RD, 1991, CELL IMMUNOL, V135, P490, DOI 10.1016/0008-8749(91)90292-J; NEVILLE DM, 1989, J BIOL CHEM, V264, P14653; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; PREIJERS FWMB, 1988, BRIT J HAEMATOL, V70, P289, DOI 10.1111/j.1365-2141.1988.tb02484.x; Rathore D, 1996, BIOCHEM BIOPH RES CO, V222, P58, DOI 10.1006/bbrc.1996.0697; REITER Y, 1994, J BIOL CHEM, V269, P18327; Roberts LM, 2004, MINI-REV MED CHEM, V4, P505, DOI 10.2174/1389557043403846; Rosenblum MG, 2003, CANCER RES, V63, P3995; ROSENBLUM MG, 1995, J INTERF CYTOK RES, V15, P547, DOI 10.1089/jir.1995.15.547; Schmidt MM, 2008, CANCER IMMUNOL IMMUN, V57, P1879, DOI 10.1007/s00262-008-0518-1; SCOTT CF, 1987, INT J IMMUNOPHARMACO, V9, P211, DOI 10.1016/0192-0561(87)90096-8; SEETHARAM S, 1991, J BIOL CHEM, V266, P17376; Sharma SK, 2005, CLIN CANCER RES, V11, P814; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; STIRPE F, 1980, J BIOL CHEM, V255, P6947; Thompson J, 2001, PROTEIN ENG, V14, P1035, DOI 10.1093/protein/14.12.1035; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Wegener WA, 2000, J NUCL MED, V41, P1016; Wenning LA, 1999, BIOTECHNOL BIOENG, V62, P562; Wenning LA, 1998, BIOTECHNOL BIOENG, V57, P484, DOI 10.1002/(SICI)1097-0290(19980220)57:4<484::AID-BIT13>3.0.CO;2-C; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; YAZDI PT, 1994, CANCER RES, V54, P6387; Zhang M, 2007, ANTICANCER RES, V27, P35	50	60	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4165	4172		10.1074/jbc.M110.186973	http://dx.doi.org/10.1074/jbc.M110.186973			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21138845	hybrid, Green Published			2022-12-25	WOS:000286975700015
J	Pallares-Ruiz, N; Philibert, L; Dumont, B; Fabre, A; Cuisset, L; Cointin, E; Rittore, C; Soler, S; Touitou, I				Pallares-Ruiz, Nathalie; Philibert, Laurent; Dumont, Bruno; Fabre, Aurelie; Cuisset, Laurence; Cointin, Elodie; Rittore, Cecile; Soler, Stephan; Touitou, Isabelle			Combined Mutation And Rearrangement Screening by Quantitative PCR High-Resolution Melting: Is It Relevant for Hereditary Recurrent Fever Genes?	PLOS ONE			English	Article							AUTOINFLAMMATORY SYNDROME; GERMLINE MUTATIONS; DELETIONS	The recent identification of genes implicated in hereditary recurrent fevers has allowed their specific diagnosis. So far however, only punctual mutations have been identified and a significant number of patients remain with no genetic confirmation of their disease after routine molecular approaches such as sequencing. The possible involvement of sequence rearrangements in these patients has only been examined in familial Mediterranean fever and was found to be unlikely. To assess the existence of larger genetic alterations in 3 other concerned genes, MVK (Mevalonate kinase), NLRP3 (Nod like receptor family, pyrin domain containing 3) and TNFRSF1A (TNF receptor superfamily 1A), we adapted the qPCR-HRM method to study possible intragenic deletions and duplications. This single-tube approach, combining both qualitative (mutations) and quantitative (rearrangement) screening, has proven effective in Lynch syndrome diagnosis. Using this approach, we studied 113 unselected (prospective group) and 88 selected (retrospective group) patients and identified no intragenic rearrangements in the 3 genes. Only qualitative alterations were found with a sensitivity similar to that obtained using classical molecular techniques for screening punctual mutations. Our results support that deleterious copy number alterations in MVK, NLRP3 and TNFRSF1A are rare or absent from the mutational spectrum of hereditary recurrent fevers, and demonstrate that a routine combined method such as qPCR-HRM provides no further help in genetic diagnosis. However, quantitative approaches such as qPCR or SQF-PCR did prove to be quick and effective and could still be useful after non contributory punctual mutation screening in the presence of clinically evocative signs.	[Pallares-Ruiz, Nathalie; Philibert, Laurent; Dumont, Bruno; Fabre, Aurelie; Cointin, Elodie; Rittore, Cecile; Soler, Stephan; Touitou, Isabelle] Hop A de Villeneuve, Genet Lab, Unite Med Malad Auto Inflammatories, Montpellier, France; [Cuisset, Laurence] Univ Paris 05, Hop Cochin, Assistance Publ Hop Paris, Paris, France; [Cuisset, Laurence] Univ Paris 05, Inst Cochin, INSERM, Paris, France; [Touitou, Isabelle] Univ Montpellier I, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier	Pallares-Ruiz, N (corresponding author), Hop A de Villeneuve, Genet Lab, Unite Med Malad Auto Inflammatories, Montpellier, France.	i-touitou@chu-montpellier.fr			French Ministry of Health; University Hospital of Montpellier; European Community [HEALTH-F2-2008-200923]	French Ministry of Health; University Hospital of Montpellier; European Community(European Commission)	This work was supported by the French Ministry of Health, the University Hospital of Montpellier, and the Coordination Theme 1 (Health) of the European Community's FP7, Grant Agreement Number HEALTH-F2-2008-200923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chou LS, 2005, AM J CLIN PATHOL, V124, P330, DOI 10.1309/BF3MLJN8J527MWQY; Cuisset L, 2001, EUR J HUM GENET, V9, P260, DOI 10.1038/sj.ejhg.5200614; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Giansily-Blaizot M, 2007, BRIT J HAEMATOL, V138, P359, DOI 10.1111/j.1365-2141.2007.06660.x; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Jeru I, 2006, ARTHRITIS RHEUM-US, V54, P508, DOI 10.1002/art.21618; Kalari KR, 2008, BIOINFORMATICS, V24, P1975, DOI 10.1093/bioinformatics/btn370; Laccone F, 2004, HUM MUTAT, V23, P234, DOI 10.1002/humu.20004; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Rouleau E, 2009, HUM MUTAT, V30, P867, DOI 10.1002/humu.20947; Sellner LN, 2004, HUM MUTAT, V23, P413, DOI 10.1002/humu.20035; Simon A, 2007, AM J PHYSIOL-REG I, V292, pR86, DOI 10.1152/ajpregu.00504.2006; STEGER G, 1994, NUCLEIC ACIDS RES, V22, P2760, DOI 10.1093/nar/22.14.2760; van Gijn ME, 2008, EUR J HUM GENET, V16, P1404, DOI 10.1038/ejhg.2008.135; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	17	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14096	10.1371/journal.pone.0014096	http://dx.doi.org/10.1371/journal.pone.0014096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124859	Green Published, gold, Green Submitted			2022-12-25	WOS:000284527900009
J	Wang, X; Bjorklund, S; Wasik, AM; Grandien, A; Andersson, P; Kimby, E; Dahlman-Wright, K; Zhao, CY; Christensson, B; Sander, B				Wang, Xiao; Bjoerklund, Stefan; Wasik, Agata M.; Grandien, Alf; Andersson, Patrik; Kimby, Eva; Dahlman-Wright, Karin; Zhao, Chunyan; Christensson, Birger; Sander, Birgitta			Gene Expression Profiling and Chromatin Immunoprecipitation Identify DBN1, SETMAR and HIG2 as Direct Targets of SOX11 in Mantle Cell Lymphoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX11; ACTIN-BINDING-PROTEIN; THYMOSIN BETA 15; DIFFERENTIAL EXPRESSION; NEURAL DIFFERENTIATION; NUCLEAR EXPRESSION; ALZHEIMER-DISEASE; TISSUE; MOUSE; BOX	The SRY (sex determining region Y)-box 11 (SOX11) gene, located on chromosome 2p25, encodes for a transcription factor that is involved in tissue remodeling during embryogenesis and is crucial for neurogenesis. The role for SOX11 in hematopoiesis has not yet been defined. Two genes under direct control of SOX11 are the class-III beta-tubulin gene (TUBB3) in neural cells and the transcription factor TEA domain family member 2 (TEAD2) in neural and mesenchymal progenitor cells. Normal, mature lymphocytes lack SOX11 but express SOX4, another member of the same group of SOX transcription factors. We and others recently identified SOX11 as aberrantly expressed in mantle cell lymphoma (MCL). Since SOX11 is variably expressed in MCL it may not be essential for tumorigenesis, but may carry prognostic information. Currently, no specific functional effects have been linked to SOX11 expression in MCL and it is not known which genes are under influence of SOX11 in lymphoma. In this study we found variable expression of SOX11, SOX4 and SOX12 mRNA in mantle cell lymphoma cell lines. Downregulation of SOX11 expression by siRNA verified that SOX11 controlled the expression of the gene TUBB3 in the MCL cell line Granta 519. Furthermore we identified, by global gene expression analysis, 26 new target genes influenced by siRNA SOX11 downmodulation. Among these genes, DBN1, SETMAR and HIG2 were found to be significantly correlated to SOX11 expression in two cohorts of primary mantle cell lymphomas. Chromatin immunoprecipitation (ChIP) analysis showed that these genes are direct targets of the SOX11 protein. In spite of almost complete downregulation of the SOX11 protein no significant effects on Granta 519 cell proliferation or survival in short term in vitro experiments was found. In summary we have identified a number of genes influenced by SOX11 expression in MCL cell lines and primary MCL. Among these genes, DBN1, SETMAR and HIG2 are direct transcriptional targets of the SOX11 protein.	[Wang, Xiao; Bjoerklund, Stefan; Wasik, Agata M.; Christensson, Birger; Sander, Birgitta] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Wang, Xiao; Bjoerklund, Stefan; Wasik, Agata M.; Christensson, Birger; Sander, Birgitta] Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Grandien, Alf] Karolinska Inst, Ctr Infect Med, Stockholm, Sweden; [Grandien, Alf] Karolinska Inst, Ctr Expt Hematol, Stockholm, Sweden; [Grandien, Alf; Kimby, Eva] Karolinska Inst, Dept Med, Div Hematol, Stockholm, Sweden; [Grandien, Alf; Kimby, Eva] Karolinska Univ Hosp, Stockholm, Sweden; [Andersson, Patrik] Stockholm S Hosp, Dept Hematol, Stockholm, Sweden; [Zhao, Chunyan] Karolinska Inst, Dept Biosci & Nutr, Novum, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Wang, X (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	birgitta.sander@ki.se		Kimby, Eva/0000-0003-3078-6131	Swedish Cancer Society; Swedish Research Council; Cancer Society in Stockholm; Karolinska Institutet; Stockholm Country Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Society in Stockholm; Karolinska Institutet(Karolinska Institutet); Stockholm Country Council	This work was funded by a grant from the Swedish Cancer Society, the Swedish Research Council, the Cancer Society in Stockholm, the Karolinska Institutet Funds, and the Stockholm Country Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bao L, 1998, CLIN EXP METASTAS, V16, P227, DOI 10.1023/A:1006540824969; Bao L, 2000, GENE, V260, P37, DOI 10.1016/S0378-1119(00)00452-2; Bao LR, 1996, NAT MED, V2, P1322, DOI 10.1038/nm1296-1322; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; BHATTARAM P, NAT COMMUN, V1, P9; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; Brennana DJ, 2009, EUR J CANCER, V45, P1510, DOI 10.1016/j.ejca.2009.01.028; Chen YH, 2010, MODERN PATHOL, V23, P105, DOI 10.1038/modpathol.2009.140; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Dictor M, 2009, HAEMATOL-HEMATOL J, V94, P1563, DOI 10.3324/haematol.2009.008474; Dun XP, 2010, HISTOL HISTOPATHOL, V25, P533, DOI 10.14670/HH-25.533; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Ek S, 2008, BLOOD, V111, P800, DOI 10.1182/blood-2007-06-093401; Fernandez V, 2010, CANCER RES, V70, P1408, DOI 10.1158/0008-5472.CAN-09-3419; Gold JS, 1997, MODERN PATHOL, V10, P1106; Gustafsson K, 2008, INT J CANCER, V123, P1025, DOI 10.1002/ijc.23584; Hargrave M, 1997, DEV DYNAM, V210, P79, DOI 10.1002/(SICI)1097-0177(199710)210:2<79::AID-AJA1>3.0.CO;2-6; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Haslinger A, 2009, EUR J NEUROSCI, V29, P2103, DOI 10.1111/j.1460-9568.2009.06768.x; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; JAY P, 1995, GENOMICS, V29, P541, DOI 10.1006/geno.1995.9970; Keon BH, 2000, J CELL SCI, V113, P325; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Kojima N, 1988, Brain Res, V464, P207; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Lee CJ, 2002, J NEURO-ONCOL, V57, P201, DOI 10.1023/A:1015773818302; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li C, 2006, GLIA, V53, P392, DOI 10.1002/glia.20291; LOVEC H, 1994, EMBO J, V13, P3487, DOI 10.1002/j.1460-2075.1994.tb06655.x; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; McDonough WS, 2005, NEOPLASIA, V7, P862, DOI 10.1593/neo.05190; Mozos A, 2009, HAEMATOL-HEMATOL J, V94, P1555, DOI 10.3324/haematol.2009.010264; Nemeth MJ, 2006, P NATL ACAD SCI USA, V103, P13783, DOI 10.1073/pnas.0604006103; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; Sander B, 2005, INT J CANCER, V117, P418, DOI 10.1002/ijc.21166; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; SHIRAO T, 1988, MOL BRAIN RES, V4, P71, DOI 10.1016/0169-328X(88)90020-4; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Wang X, 2008, BRIT J HAEMATOL, V143, P248, DOI 10.1111/j.1365-2141.2008.07329.x; Weigle B, 2005, ONCOL REP, V13, P139; Wray J, 2009, BLOOD, V114, P1852, DOI 10.1182/blood-2008-08-175760; Wray J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005323; Yan B, 2009, DEV DYNAM, V238, P1358, DOI 10.1002/dvdy.21885; Yan B, 2009, DEV BIOL, V329, P80, DOI 10.1016/j.ydbio.2009.02.019; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x	50	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14085	10.1371/journal.pone.0014085	http://dx.doi.org/10.1371/journal.pone.0014085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124928	Green Submitted, gold, Green Published			2022-12-25	WOS:000284467200016
J	Miller, AK; Print, CG; Nielsen, PMF; Crampin, EJ				Miller, Andrew K.; Print, Cristin G.; Nielsen, Poul M. F.; Crampin, Edmund J.			A Bayesian Search for Transcriptional Motifs	PLOS ONE			English	Article							FACTOR-BINDING SITES; DNA	Identifying transcription factor (TF) binding sites (TFBSs) is an important step towards understanding transcriptional regulation. A common approach is to use gaplessly aligned, experimentally supported TFBSs for a particular TF, and algorithmically search for more occurrences of the same TFBSs. The largest publicly available databases of TF binding specificities contain models which are represented as position weight matrices (PWM). There are other methods using more sophisticated representations, but these have more limited databases, or aren't publicly available. Therefore, this paper focuses on methods that search using one PWM per TF. An algorithm, MATCHTM, for identifying TFBSs corresponding to a particular PWM is available, but is not based on a rigorous statistical model of TF binding, making it difficult to interpret or adjust the parameters and output of the algorithm. Furthermore, there is no public description of the algorithm sufficient to exactly reproduce it. Another algorithm, MAST, computes a p-value for the presence of a TFBS using true probabilities of finding each base at each offset from that position. We developed a statistical model, BaSeTraM, for the binding of TFs to TFBSs, taking into account random variation in the base present at each position within a TFBS. Treating the counts in the matrices and the sequences of sites as random variables, we combine this TFBS composition model with a background model to obtain a Bayesian classifier. We implemented our classifier in a package (SBaSeTraM). We tested SBaSeTraM against a MATCHTM implementation by searching all probes used in an experimental Saccharomyces cerevisiae TF binding dataset, and comparing our predictions to the data. We found no statistically significant differences in sensitivity between the algorithms (at fixed selectivity), indicating that SBaSeTraM's performance is at least comparable to the leading currently available algorithm. Our software is freely available at: http://wiki.github.com/A1kmm/sbasetram/building-the-tools.	[Miller, Andrew K.; Nielsen, Poul M. F.; Crampin, Edmund J.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, Dept Mol Med, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, NZ Bioinformat Inst, Auckland 1, New Zealand; [Nielsen, Poul M. F.; Crampin, Edmund J.] Univ Auckland, Fac Engn, Dept Engn Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Miller, AK (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand.	ak.miller@auckland.ac.nz; e.crampin@auckland.ac.nz	Nielsen, Poul M F/A-5814-2009	Nielsen, Poul M F/0000-0002-4704-0179; Print, Cristin/0000-0001-8345-7812	New Zealand Tertiary Education Commission; New Zealand Health Research Council; Breast Cancer Research Trust; New Zealand Foundation for Research, Science and Technology; King Abdullah University of Science and Technology [KUK-C1-013-04]	New Zealand Tertiary Education Commission; New Zealand Health Research Council(Health Research Council of New Zealand); Breast Cancer Research Trust; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This work was supported by the New Zealand Tertiary Education Commission [Top Achiever's Doctoral Scholarship] to AKM (http://www.tec.govt.nz); the New Zealand Health Research Council International Investment Opportunities Fund (http://www.hrc.govt.nz/) to CGP and EJC; the Breast Cancer Research Trust (http://www.breastcancercure.org.nz/) to CGP and EJC; and the New Zealand Foundation for Research, Science and Technology to CGP and EJC (http://www.frst.govt.nz/). This publication is based on work (by EJC) that was supported in part by award No. KUK-C1-013-04, made by King Abdullah University of Science and Technology (http://www.kaust.edu.sa/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Gropp W., 1999, USING MPI 2 ADV FEAT; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HOLM S, 1979, SCAND J STAT, V6, P65; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lahdesmaki H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001820; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Olver F. W., 2010, NIST HDB MATH FUNCTI; R Development Core Team, 2009, R FDN STAT COMP; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Weidendorfer J, 2008, TOOLS FOR HIGH PERFORMANCE COMPUTING, P93, DOI 10.1007/978-3-540-68564-7_7; [No title captured]	17	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e13897	10.1371/journal.pone.0013897	http://dx.doi.org/10.1371/journal.pone.0013897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124986	Green Published, gold			2022-12-25	WOS:000284356900001
J	Gosai, SJ; Kwak, JH; Luke, CJ; Long, OS; King, DE; Kovatch, KJ; Johnston, PA; Shun, TY; Lazo, JS; Perlmutter, DH; Silverman, GA; Pak, SC				Gosai, Sager J.; Kwak, Joon Hyeok; Luke, Cliff J.; Long, Olivia S.; King, Dale E.; Kovatch, Kevin J.; Johnston, Paul A.; Shun, Tong Ying; Lazo, John S.; Perlmutter, David H.; Silverman, Gary A.; Pak, Stephen C.			Automated High-Content Live Animal Drug Screening Using C-elegans Expressing the Aggregation Prone Serpin alpha 1-antitrypsin Z	PLOS ONE			English	Article							HIGH-THROUGHPUT SCREEN; CAENORHABDITIS-ELEGANS; PROTEIN AGGREGATION; MK2-EGFP TRANSLOCATION; KINASE INHIBITORS; CELLULAR ASPECTS; ADMET RULES; LIFE-SPAN; AUTOPHAGY; ASSAY	The development of preclinical models amenable to live animal bioactive compound screening is an attractive approach to discovering effective pharmacological therapies for disorders caused by misfolded and aggregation-prone proteins. In general, however, live animal drug screening is labor and resource intensive, and has been hampered by the lack of robust assay designs and high throughput work-flows. Based on their small size, tissue transparency and ease of cultivation, the use of C. elegans should obviate many of the technical impediments associated with live animal drug screening. Moreover, their genetic tractability and accomplished record for providing insights into the molecular and cellular basis of human disease, should make C. elegans an ideal model system for in vivo drug discovery campaigns. The goal of this study was to determine whether C. elegans could be adapted to high-throughput and high-content drug screening strategies analogous to those developed for cell-based systems. Using transgenic animals expressing fluorescently-tagged proteins, we first developed a high-quality, high-throughput work-flow utilizing an automated fluorescence microscopy platform with integrated image acquisition and data analysis modules to qualitatively assess different biological processes including, growth, tissue development, cell viability and autophagy. We next adapted this technology to conduct a small molecule screen and identified compounds that altered the intracellular accumulation of the human aggregation prone mutant that causes liver disease in alpha 1-antitrypsin deficiency. This study provides powerful validation for advancement in preclinical drug discovery campaigns by screening live C. elegans modeling alpha 1-antitrypsin deficiency and other complex disease phenotypes on high-content imaging platforms.	[Gosai, Sager J.; Kwak, Joon Hyeok; Luke, Cliff J.; Long, Olivia S.; King, Dale E.; Kovatch, Kevin J.; Perlmutter, David H.; Silverman, Gary A.; Pak, Stephen C.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat Cell Biol & Physiol,UPMC, Pittsburgh, PA 15260 USA; [Gosai, Sager J.; Kwak, Joon Hyeok; Luke, Cliff J.; Long, Olivia S.; King, Dale E.; Kovatch, Kevin J.; Perlmutter, David H.; Silverman, Gary A.; Pak, Stephen C.] Magee Womens Hosp, Res Inst, Pittsburgh, PA USA; [Johnston, Paul A.; Shun, Tong Ying; Lazo, John S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Drug Discovery Inst, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gosai, SJ (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat Cell Biol & Physiol,UPMC, Pittsburgh, PA 15260 USA.	gsilverman@upmc.edu; paksc@upmc.edu	Silverman, Gary/AAJ-1269-2020	Pak, Stephen/0000-0002-8089-3237; Johnston, Paul/0000-0001-5815-3091	Hartwell Foundation; Fiske Drug Discovery Fund; National Institutes of Health [DK079806, DK081422, MH07441]; NIH National Center for Research Resources (NCRR); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079806, R01DK084512, R01DK076918, R01DK081422] Funding Source: NIH RePORTER	Hartwell Foundation; Fiske Drug Discovery Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from The Hartwell Foundation (GAS), the Fiske Drug Discovery Fund (JSL) and the National Institutes of Health (DK079806 and DK081422 to GAS and MH07441 to JSL). Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bartolini M, 2010, CHEMBIOCHEM, V11, P1018, DOI 10.1002/cbic.200900666; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; de Voer G, 2008, BBA-MOL BASIS DIS, V1782, P433, DOI 10.1016/j.bbadis.2008.04.003; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Ellerbrock BR, 2004, J BIOMOL SCREEN, V9, P147, DOI 10.1177/1087057103261038; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Frearson JA, 2009, DRUG DISCOV TODAY, V14, P1150, DOI 10.1016/j.drudis.2009.09.004; Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; Giuliano KA, 2006, METHOD ENZYMOL, V414, P601, DOI 10.1016/S0076-6879(06)14031-8; Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q; Gleeson P, 2009, BIOORGAN MED CHEM, V17, P5906, DOI 10.1016/j.bmc.2009.07.002; Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.drudis.2006.08.015; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hodgson J, 2001, NAT BIOTECHNOL, V19, P722, DOI 10.1038/90761; Johnston PA, 2002, DRUG DISCOV TODAY, V7, P353, DOI 10.1016/S1359-6446(01)02140-7; Johnston PA, 2008, ASSAY DRUG DEV TECHN, V6, P505, DOI 10.1089/adt.2008.151; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P319, DOI 10.1089/adt.2007.066; Johnston PA, 2009, ASSAY DRUG DEV TECHN, V7, P250, DOI 10.1089/adt.2008.186; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Krainc D, 2010, ARCH NEUROL-CHICAGO, V67, P388, DOI 10.1001/archneurol.2010.40; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; Lee S, 2006, METHOD ENZYMOL, V414, P468, DOI 10.1016/S0076-6879(06)14025-2; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Lomas DA, 2005, BIOCHEM SOC T, V33, P321, DOI 10.1042/BST0330321; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; Nickischer D, 2006, METHOD ENZYMOL, V414, P389, DOI 10.1016/S0076-6879(06)14022-7; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Oeda T, 2001, HUM MOL GENET, V10, P2013, DOI 10.1093/hmg/10.19.2013; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Perlmutter DH, 2002, J CLIN INVEST, V110, P1579, DOI 10.1172/JCI200216787; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Picken MM, 2010, ARCH PATHOL LAB MED, V134, P545, DOI 10.1043/1543-2165-134.4.545; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Royal DC, 2005, J BIOL CHEM, V280, P41976, DOI 10.1074/jbc.M510732200; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Szewczyk NJ, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-19; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Trask OJ, 2006, METHOD ENZYMOL, V414, P419, DOI 10.1016/S0076-6879(06)14023-9; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Williams RG, 2006, METHOD ENZYMOL, V414, P364, DOI 10.1016/S0076-6879(06)14021-5; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	69	128	132	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15460	10.1371/journal.pone.0015460	http://dx.doi.org/10.1371/journal.pone.0015460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103396	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000284147700030
J	Laaberki, MH; Pfeffer, J; Clarke, AJ; Dworkin, J				Laaberki, Maria-Halima; Pfeffer, John; Clarke, Anthony J.; Dworkin, Jonathan			O-Acetylation of Peptidoglycan Is Required for Proper Cell Separation and S-layer Anchoring in Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALL POLYSACCHARIDE; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL PEPTIDOGLYCAN; PSEUDOMONAS-AERUGINOSA; NEISSERIA-GONORRHOEAE; ENTEROCOCCUS-FAECALIS; LYSOZYME RESISTANCE; MUREIN HYDROLASES; ESCHERICHIA-COLI; LYTIC ACTIVITY	O-Acetylation of the MurNAc moiety of peptidoglycan is typically associated with bacterial resistance to lysozyme, a muramidase that serves as a central component of innate immunity. Here, we report that the peptidoglycan of Bacillus anthracis, the etiological agent of anthrax, is O-acetylated and that, unusually, this modification is produced by two unrelated families of O-acetyltransferases. Also, in contrast to other bacteria, O-acetylation of B. anthracis peptidoglycan is combined with N-deacetylation to confer resistance of cells to lysozyme. Activity of the Pat O-acetyltransferases is required for the separation of the daughter cells following bacterial division and for anchoring of one of the major S-layer proteins. Our results indicate that peptidoglycan O-acetylation modulates endogenous muramidase activity affecting the cell-surface properties and morphology of this important pathogen.	Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Pfeffer, John; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Columbia University; University of Guelph	Dworkin, J (corresponding author), 701 W 168th St,Rm 1218, New York, NY 10032 USA.	jonathan.dworkin@columbia.edu	Laaberki, Maria-Halima/M-6369-2014	Laaberki, Maria-Halima/0000-0001-5796-5995	National Institutes of Health [AI76841]; Irma; Canadian Institutes of Health Research [MOP 81223]; Natural Sciences and Research Council of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI76841 and an Irma T. Hirschl Scholar award (to J.D.), by operating Grant MOP 81223 (to A. J. C.) from the Canadian Institutes of Health Research, and by a postgraduate scholarship (PGS D) (to J. P.) from the Natural Sciences and Research Council of Canada.	Ahn JS, 2006, MOL MICROBIOL, V62, P1158, DOI 10.1111/j.1365-2958.2006.05433.x; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; Bahl H, 1997, FEMS MICROBIOL REV, V20, P47, DOI 10.1016/S0168-6445(97)00050-8; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; Clarke A. J., 2000, GLYCOMICROBIOLOGY; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; Dommett R, 2005, MOL IMMUNOL, V42, P903, DOI 10.1016/j.molimm.2004.12.004; Dowd MM, 2008, J BACTERIOL, V190, P4541, DOI 10.1128/JB.00249-08; DOYLE RJ, 1988, MICROBIOL REV, V52, P554, DOI 10.1128/MMBR.52.4.554-567.1988; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Dunn AK, 2003, APPL ENVIRON MICROB, V69, P1197, DOI 10.1128/AEM.69.2.1197-1205.2003; Franklin MJ, 2004, J BACTERIOL, V186, P4759, DOI 10.1128/JB.186.14.4759-4773.2004; Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; KEMPER MA, 1993, J BACTERIOL, V175, P5690, DOI 10.1128/JB.175.17.5690-5696.1993; Laaberki MH, 2008, J BACTERIOL, V190, P6197, DOI 10.1128/JB.00623-08; Langer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003706; Leoff C, 2008, J BIOL CHEM, V283, P29812, DOI 10.1074/jbc.M803234200; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Rollins SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001824; ROSENTHAL RS, 1983, INFECT IMMUN, V40, P903, DOI 10.1128/IAI.40.3.903-911.1983; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Shatalin KY, 2005, FEMS MICROBIOL LETT, V245, P315, DOI 10.1016/j.femsle.2005.03.029; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; Strating H, 2001, ANAL BIOCHEM, V291, P149, DOI 10.1006/abio.2001.5007; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	52	57	58	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5278	5288		10.1074/jbc.M110.183236	http://dx.doi.org/10.1074/jbc.M110.183236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135105	Green Published, hybrid			2022-12-25	WOS:000287230600036
J	Muhlen, S; Ruchaud-Sparagano, MH; Kenny, B				Muehlen, Sabrina; Ruchaud-Sparagano, Marie-Helene; Kenny, Brendan			Proteasome-independent Degradation of Canonical NF kappa B Complex Components by the NleC Protein of Pathogenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; ACTIVATION; PATHWAY; PHOSPHORYLATION; MANIPULATION; PROTEOLYSIS; SUBUNIT; SYSTEM; FAMILY; VIRUS	The NF kappa B transcription factor is a key component of immune and inflammatory signaling as its activation induces the expression of antimicrobial reagents, chemokines, cytokines, and anti-apoptotic factors. Many pathogens encode effector proteins that target factors regulating NF kappa B activity and can provide novel insights on regulatory mechanisms. Given the link of NF kappa B dysfunction with inflammatory diseases and some cancers, these effectors have therapeutic potential. Here, screening enteropathogenic Escherichia coli proteins for those implicated in suppressing NF kappa B function revealed that eGFP-NleC, unlike eGFP, strongly inhibited basal and TNF alpha-induced NF kappa B reporter activity to prevent secretion of the chemokine, IL-8. Work involving NleC variants, chemical inhibitors, and immunoprecipitation studies support NleC being a zinc metalloprotease that degrades NF kappa B-I kappa B alpha complexes. The findings are consistent with features between residues 33-65 recruiting NF kappa B for proteasomal-independent degradation by a mechanism inhibited by metalloprotease inhibitors or disruption of a consensus zinc metalloprotease motif spanning NleC residues 183-187. This raises the prospect that mammalian cells, or other pathogens, employ a similar mechanism to modulate NF kappa B activity. Moreover, NleC represents a novel tool for validating NF kappa B as a therapeutic target and, indeed, as a possible therapeutic reagent.	[Muehlen, Sabrina; Ruchaud-Sparagano, Marie-Helene; Kenny, Brendan] Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Kenny, B (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	brendan.kenny@ncl.ac.uk		Muehlen, Sabrina/0000-0001-7474-705X; , Brendan/0000-0001-7455-360X	Wellcome Trust [083313]; Deutsche Forschungsgemeinschaft [MU3050/2-1]	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Wellcome Trust Grant 083313 (to B. K.).; Supported by Deutsche Forschungsgemeinschaft Research Fellowship MU3050/2-1.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Dean P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000961; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; FRANZOSO G, 1994, J EXP MED, V180, P1445, DOI 10.1084/jem.180.4.1445; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; Kelly M, 2006, INFECT IMMUN, V74, P2328, DOI 10.1128/IAI.74.4.2328-2337.2006; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; KUNSCH C, 1994, J IMMUNOL, V153, P153; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Marches O, 2005, INFECT IMMUN, V73, P8411, DOI 10.1128/IAI.73.12.8411-8417.2005; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; O'Dea E, 2009, WIRES SYST BIOL MED, V1, P107, DOI 10.1002/wsbm.30; Orange JS, 2008, CELL MOL LIFE SCI, V65, P3564, DOI 10.1007/s00018-008-8222-z; Radons J, 2002, J BIOL CHEM, V277, P16456, DOI 10.1074/jbc.M201000200; Ravi R, 1998, CANCER RES, V58, P882; Roe AJ, 2007, MICROBIOL-SGM, V153, P1350, DOI 10.1099/mic.0.2006/003707-0; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Ruchaud-Sparagano MH, 2007, CELL MICROBIOL, V9, P1909, DOI 10.1111/j.1462-5822.2007.00923.x; Ruckdeschel K, 2001, J IMMUNOL, V166, P1823, DOI 10.4049/jimmunol.166.3.1823; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schroder M, 2007, BIOCHEM SOC T, V35, P1512, DOI 10.1042/BST0351512; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641	37	69	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5100	5107		10.1074/jbc.M110.172254	http://dx.doi.org/10.1074/jbc.M110.172254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148319	Green Published, hybrid			2022-12-25	WOS:000287230600017
J	Papadopoulos, C; Arato, K; Lilienthal, E; Zerweck, J; Schutkowski, M; Chatain, N; Muller-Newen, G; Becker, W; de la Luna, S				Papadopoulos, Chrisovalantis; Arato, Krisztina; Lilienthal, Eva; Zerweck, Johannes; Schutkowski, Mike; Chatain, Nicolas; Mueller-Newen, Gerhard; Becker, Walter; de la Luna, Susana			Splice Variants of the Dual Specificity Tyrosine Phosphorylation-regulated Kinase 4 (DYRK4) Differ in Their Subcellular Localization and Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; GENE-EXPRESSION; APOPTOTIC RESPONSE; GLYCOGEN-SYNTHASE; SERINE RESIDUE; CELL-SURVIVAL; DNA-DAMAGE; FAMILY; ACTIVATION; SUBSTRATE	Dual specificity tyrosine phosphorylation-regulated kinases, DYRKs, are a family of conserved protein kinases that play key roles in the regulation of cell differentiation, proliferation, and survival. Of the five mammalian DYRKs, DYRK4 is the least studied family member. Here, we show that several splice variants of DYRK4 are expressed in tissue-specific patterns and that these variants have distinct functional capacities. One of these variants contains a nuclear localization signal in its extended N terminus that mediates its interaction with importin alpha 3 and alpha 5 and that is capable of targeting a heterologous protein to the nucleus. Consequently, the nucleocytoplasmic mobility of this variant differs from that of a shorter isoform in live cell imaging experiments. Other splicing events affect the catalytic domain, including a three-amino acid deletion within subdomain XI that markedly reduces the enzymatic activity of DYRK4. We also show that autophosphorylation of a tyrosine residue within the activation loop is necessary for full DYRK4 kinase activity, a defining feature of the DYRK family. Finally, by comparing the phosphorylation of an array of 720 peptides, we show that DYRK1A, DYRK2, and DYRK4 differ in their target recognition sequence and that preference for an arginine residue at position P - 3 is a feature of DYRK1A but not of DYRK2 and DYRK4. Therefore, we highlight the use of subcellular localization as an important regulatory mechanism for DYRK proteins, and we propose that substrate specificity could be a source of functional diversity among DYRKs.	[Papadopoulos, Chrisovalantis; Arato, Krisztina; de la Luna, Susana] Univ Pompeu Fabra, Genes & Dis Program, Ctr Genom Regulat, Barcelona 08003, Spain; [Papadopoulos, Chrisovalantis; Lilienthal, Eva; Becker, Walter] Rheinisch Westfael Tech Hsch Aachen Univ, Inst Pharmacol & Toxicol, D-52074 Aachen, Germany; [Arato, Krisztina; de la Luna, Susana] Ctr Invest Biomed Red Enfermedades Raras, Barcelona 08003, Spain; [Chatain, Nicolas; Mueller-Newen, Gerhard] Rheinisch Westfael Tech Hsch Aachen Univ, Dept Biochem, D-52074 Aachen, Germany; [Zerweck, Johannes; Schutkowski, Mike] JPT Peptide Technol GmbH, D-12489 Berlin, Germany; [Schutkowski, Mike] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Saale, Germany; [de la Luna, Susana] Inst Catalana Recerca & Estudis Avancats, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); RWTH Aachen University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; RWTH Aachen University; Martin Luther University Halle Wittenberg; ICREA	de la Luna, S (corresponding author), Ctr Regulacio Genom CRG, Dr Aiguader 88, Barcelona 08003, Spain.	susana.luna@crg.es	Becker, Walter/B-8889-2008; Arató, Krisztina/AAB-6057-2019; Arató, Krisztina/M-7505-2015; de la Luna, Susana/E-9553-2015	Becker, Walter/0000-0002-0347-4768; Arató, Krisztina/0000-0003-0366-0998; Arató, Krisztina/0000-0003-0366-0998; de la Luna, Susana/0000-0001-7765-916X; Schutkowski, MIke/0000-0003-0919-7076	Spanish Ministry of Science and Innovation [BFU2007-61043, BFU2010-15347]; Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya [2009SGR1464]; Deutsche Forschungsgemeinschaft [SFB 542, B12, Z1, BE-1967/2-1]; German Academic Exchange Service DAAD; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya(Generalitat de Catalunya); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); ICREA(ICREA)	This work was supported by Spanish Ministry of Science and Innovation Grant BFU2007-61043 and BFU2010-15347 (to S. L.), Departament d'Innovacio, Universitats i Empresa de la Generalitat de Catalunya Grant 2009SGR1464 (to S. L.), Deutsche Forschungsgemeinschaft SFB 542, Projects B12 and Z1 (to G. M.-N.) and BE-1967/2-1 (to W. B.), and the German Academic Exchange Service DAAD doctoral fellowship (to C. P.).	Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Alvarez M, 2007, MOL BIOL CELL, V18, P1167, DOI 10.1091/mbc.E06-08-0668; Aranda S., 2011, FASEB J IN PRESS; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; de Graaf K, 2004, J BIOL CHEM, V279, P4612, DOI 10.1074/jbc.M310794200; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Geiger JN, 2001, BLOOD, V97, P901, DOI 10.1182/blood.V97.4.901; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hiller M, 2008, TRENDS GENET, V24, P246, DOI 10.1016/j.tig.2008.03.003; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Kassis S, 2000, BIOCHEM J, V348, P263, DOI 10.1042/0264-6021:3480263; Kelly PA, 2005, MOL BIOL CELL, V16, P3562, DOI 10.1091/mbc.E04-12-1085; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kinstrie R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000579; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leder S, 2003, BIOCHEM J, V372, P881, DOI 10.1042/BJ20030182; Lee K, 2000, CANCER RES, V60, P3631; Leypoldt F, 2001, J NEUROCHEM, V76, P806, DOI 10.1046/j.1471-4159.2001.00079.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Lord KA, 2000, BLOOD, V95, P2838, DOI 10.1182/blood.V95.9.2838.009k29_2838_2846; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Mercer SE, 2006, CANCER RES, V66, P5143, DOI 10.1158/0008-5472.CAN-05-1539; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Nakai Kenta, 2007, V390, P429; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Raich WB, 2003, GENETICS, V163, P571; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Sacher F, 2007, MOL CELL ENDOCRINOL, V267, P80, DOI 10.1016/j.mce.2006.12.041; Schutkowski M, 2004, ANGEW CHEM INT EDIT, V43, P2671, DOI 10.1002/anie.200453900; Sitz JH, 2004, MOL CELL BIOL, V24, P5821, DOI 10.1128/MCB.24.13.5821-5834.2004; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taira N, 2010, J BIOL CHEM, V285, P4909, DOI 10.1074/jbc.M109.042341; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Varjosalo M, 2008, CELL, V133, P537, DOI 10.1016/j.cell.2008.02.047; von Groote-Bidlingmaier F, 2003, BIOCHEM BIOPH RES CO, V300, P764, DOI 10.1016/S0006-291X(02)02914-5; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Zhang DY, 2005, GENOMICS, V85, P117, DOI 10.1016/j.ygeno.2004.08.021	48	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5494	5505		10.1074/jbc.M110.157909	http://dx.doi.org/10.1074/jbc.M110.157909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21127067	Green Published, hybrid			2022-12-25	WOS:000287230600059
J	Shirakawa, T; Kawazoe, Y; Tsujikawa, T; Jung, DJ; Sato, S; Uesugi, M				Shirakawa, Takashi; Kawazoe, Yoshinori; Tsujikawa, Tomoko; Jung, Dongju; Sato, Shin-ichi; Uesugi, Motonari			Deactivation of STAT6 through Serine 707 Phosphorylation by JNK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASE; C-JUN; DNA-BINDING; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; INTERLEUKIN-4-INDUCED TRANSCRIPTION; MAMMALIAN-CELLS; KAPPA-B; IL-4	Signal transducer and activator of transcription 6 (STAT6), which plays a critical role in immune responses, is activated by interleukin-4 (IL-4). Activity of STAT family members is regulated primarily by tyrosine phosphorylations and possibly also by serine phosphorylations. Here, we report a previously undescribed serine phosphorylation of STAT6, which is activated by cell stress or by the pro-inflammatory cytokine, interleukin-1 beta (IL-1 beta). Our analyses suggest that Ser-707 is phosphorylated by c-Jun N-terminal kinase (JNK). Phosphorylation decreases the DNA binding ability of IL-4-stimulated STAT6, thereby inhibiting the transcription of STAT6-responsive genes. Inactivation of STAT6 by JNK-dependent Ser-707 phosphorylation may be one mechanism of controlling the balance between IL-1 beta and IL-4 signals.	[Kawazoe, Yoshinori; Tsujikawa, Tomoko; Uesugi, Motonari] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Shirakawa, Takashi; Jung, Dongju; Sato, Shin-ichi; Uesugi, Motonari] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Uesugi, M (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	uesugi@scl.kyoto-u.ac.jp	Uesugi, Motonari/AAM-9777-2020		JSPS [21310140, 20611007]; Uehara Memorial Foundation; Naito Foundation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation)	This work was supported in part by grants from JSPS (21310140, to M. U., and 20611007, to Y. K.), the Uehara Memorial Foundation (to M. U.), and the Naito Foundation (to S. S.).	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ahn HJ, 2009, KOREAN J PARASITOL, V47, P117, DOI 10.3347/kjp.2009.47.2.117; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; CAELLES C, 1995, MOL CELL BIOL, V15, P6694; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; Cowley DO, 2000, GENE DEV, V14, P366; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dickensheets HL, 1999, P NATL ACAD SCI USA, V96, P10800, DOI 10.1073/pnas.96.19.10800; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; Golks A, 2008, EMBO REP, V9, P748, DOI 10.1038/embor.2008.129; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; GUPTA RK, 1995, J PEDIATR-US, V126, P389, DOI 10.1016/S0022-3476(95)70454-X; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Litterst CM, 2001, J BIOL CHEM, V276, P45713, DOI 10.1074/jbc.M108132200; Losman JA, 1999, J IMMUNOL, V162, P3770; Maiti NR, 2005, J INTERF CYTOK RES, V25, P553, DOI 10.1089/jir.2005.25.553; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL SW, 1994, NEW ZEAL MED J, V107, P434; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; SCHINDLER U, 1995, IMMUNITY, V2, P689, DOI 10.1016/1074-7613(95)90013-6; Shen CH, 1998, MOL CELL BIOL, V18, P3395, DOI 10.1128/MCB.18.6.3395; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Uciechowski P, 1996, FEBS LETT, V394, P273, DOI 10.1016/0014-5793(96)00967-2; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Wang YL, 2004, J BIOL CHEM, V279, P25196, DOI 10.1074/jbc.M313668200; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Woetmann A, 2003, J BIOL CHEM, V278, P2787, DOI 10.1074/jbc.M210196200; Yamagishi S, 2001, J BIOL CHEM, V276, P5129, DOI 10.1074/jbc.M007258200; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	58	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					4003	4010		10.1074/jbc.M110.168435	http://dx.doi.org/10.1074/jbc.M110.168435			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123173	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000286653200080
J	Adams, EDM; Goss, GG; Leys, SP				Adams, Emily D. M.; Goss, Greg G.; Leys, Sally P.			Freshwater Sponges Have Functional, Sealing Epithelia with High Transepithelial Resistance and Negative Transepithelial Potential	PLOS ONE			English	Article							SEPTATE JUNCTIONS; CELL-ADHESION; EVOLUTION; DEMOSPONGIAE; INSIGHTS; ORGANIZATION; PROTEINS; COLLAGEN; RECEPTOR; POLARITY	Epithelial tissue - the sealed and polarized layer of cells that regulates transport of ions and solutes between the environment and the internal milieu - is a defining characteristic of the Eumetazoa. Sponges, the most ancient metazoan phylum [1,2], are generally believed to lack true epithelia [3,4,5], but their ability to occlude passage of ions has never been tested. Here we show that freshwater sponges (Demospongiae, Haplosclerida) have functional epithelia with high transepithelial electrical resistance (TER), a transepithelial potential (TEP), and low permeability to small-molecule diffusion. Curiously, the Amphimedon queenslandica sponge genome lacks the classical occluding genes [5] considered necessary to regulate sealing and control of ion transport. The fact that freshwater sponge epithelia can seal suggests that either occluding molecules have been lost in some sponge lineages, or demosponges use novel molecular complexes for epithelial occlusion; if the latter, it raises the possibility that mechanisms for occlusion used by sponges may exist in other metazoa. Importantly, our results imply that functional epithelia evolved either several times, or once, in the ancestor of the Metazoa.	[Adams, Emily D. M.; Goss, Greg G.; Leys, Sally P.] Univ Alberta, Dept Biol Sci, Physiol Cell & Dev Biol Grp, Edmonton, AB, Canada	University of Alberta	Adams, EDM (corresponding author), Univ Alberta, Dept Biol Sci, Physiol Cell & Dev Biol Grp, Edmonton, AB, Canada.	sleys@ualberta.ca	Leys, Sally/A-2660-2014; Goss, Greg/D-2723-2015	Leys, Sally/0000-0001-9268-2181; Goss, Greg/0000-0003-0786-8868	National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by Discovery Grants from the National Science and Engineering Research Council of Canada (G. G. and S. P. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2004, J MOL EVOL, V59, P41, DOI 10.1007/s00239-004-2602-2; Adell T, 2003, FEBS LETT, V554, P363, DOI 10.1016/S0014-5793(03)01190-6; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Aouacheria A, 2006, MOL BIOL EVOL, V23, P2288, DOI 10.1093/molbev/msl100; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; Brower DL, 1997, P NATL ACAD SCI USA, V94, P9182, DOI 10.1073/pnas.94.17.9182; Cereijido M, 2004, PHYSIOL REV, V84, P1229, DOI 10.1152/physrev.00001.2004; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eerkes-Medrano DI, 2006, INVERTEBR BIOL, V125, P177, DOI 10.1111/j.1744-7410.2006.00051.x; Elliott GRD, 2007, J EXP BIOL, V210, P3736, DOI 10.1242/jeb.003392; Elliott GRD, 2010, J EXP BIOL, V213, P2310, DOI 10.1242/jeb.039859; Fahey B, 2010, EVOL DEV, V12, P601, DOI 10.1111/j.1525-142X.2010.00445.x; Franke WW, 2009, CELL TISSUE RES, V338, P1, DOI 10.1007/s00441-009-0849-z; GREEN CR, 1982, J CELL SCI, V53, P279; Green CR, 1979, C INT CENT NATL RECH, V291, P153; GRELL K G, 1971, Cytobiologie, V4, P216; HAND AR, 1972, J CELL BIOL, V52, P397, DOI 10.1083/jcb.52.2.397; Hyman LH., 1940, INVERTEBRATES; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; LABATROBERT J, 1981, P NATL ACAD SCI-BIOL, V78, P6261, DOI 10.1073/pnas.78.10.6261; LEDGER PW, 1975, TISSUE CELL, V7, P13, DOI 10.1016/S0040-8166(75)80004-8; Leik J, 1970, Tissue cell, V2, P435, DOI 10.1016/S0040-8166(70)80043-X; Leys SP, 2009, INTEGR COMP BIOL, V49, P167, DOI 10.1093/icb/icp038; Leys SP, 1997, NATURE, V387, P29, DOI 10.1038/387029b0; Leys SP, 2006, INTEGR COMP BIOL, V46, P104, DOI 10.1093/icb/icj016; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Mackie GO., 1984, BIOL INTEGUMENT, P43; Magie CR, 2008, BIOL BULL-US, V214, P218, DOI 10.2307/25470665; Meixner MJ, 2007, MOL PHYLOGENET EVOL, V45, P875, DOI 10.1016/j.ympev.2007.09.007; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nickel M, 2010, INVERTEBR BIOL, V129, P1, DOI 10.1111/j.1744-7410.2010.00193.x; PARKER GH, 1910, J EXP ZOOL, V8, P765, DOI DOI 10.1002/JEZ.1400080102; PEASE DC, 1955, J HISTOCHEM CYTOCHEM, V3, P295, DOI 10.1177/3.4.295; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; RASMONT R, 1966, ANN SOC R ZOOL BELG, V91, P147; Revel J. P., 1966, Biological Bulletin Marine Biological Laboratory Woods Hole, V131, P402; SKAER HL, 1987, J CELL SCI, V88, P139; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Tyler S, 2003, INTEGR COMP BIOL, V43, P55, DOI 10.1093/icb/43.1.55; Wilson HV, 1910, J EXP ZOOL, V9, P537, DOI 10.1002/jez.1400090305; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204	47	49	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15040	10.1371/journal.pone.0015040	http://dx.doi.org/10.1371/journal.pone.0015040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124779	gold, Green Published, Green Submitted			2022-12-25	WOS:000284686500021
J	Christensen, D; Lindenstrom, T; van de Wijdeven, G; Andersen, P; Agger, EM				Christensen, Dennis; Lindenstrom, Thomas; van de Wijdeven, Gijsbert; Andersen, Peter; Agger, Else Marie			Syringe Free Vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles Provides Strong and Prolonged Protection Against Tuberculosis	PLOS ONE			English	Article							CATIONIC LIPOSOMES; GLOBAL BURDEN; CORD FACTOR; INJECTIONS; MEMORY	Bioneedles are small hollow sugar based needles administered with a simple compressed air device. In the present study we investigate how incorporation of a subunit vaccine based on TB vaccine hybrid Ag85B-ESAT-6 adjuvated with CAF01 into Bioneedles affects its immunogenicity as well as its ability to protect against TB in a mouse model. The CMI response measured by IFN-gamma and antigen specific CD4+ T-cells was, two weeks after the last vaccination, significantly lower in the group immunized with Bioneedle-incorporated vaccine compared to the conventional vaccine, using syringe and needle. However, at four, nine and 52 weeks after vaccination we observed similar high IFN-gamma levels in the Bioneedle group and the group vaccinated using syringe and needle and comparable levels of antigen specific T-cells. Furthermore, the protective efficacy for the two vaccination methods was comparable and similar to BCG vaccination both six and 52 weeks after vaccination. These results therefore advocate the further development of the Bioneedle devises and applicators for the delivery of human vaccines.	[Christensen, Dennis; Lindenstrom, Thomas; Andersen, Peter; Agger, Else Marie] Statens Serum Inst, Dept Infect Dis Immunol Vaccine Delivery & Formul, DK-2300 Copenhagen, Denmark; [van de Wijdeven, Gijsbert] Bioneedle Technol Grp BV, Eindhoven, Netherlands	Statens Serum Institut	Christensen, D (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol Vaccine Delivery & Formul, DK-2300 Copenhagen, Denmark.	den@ssi.dk	Christensen, Dennis/C-6378-2008; Lindenstrøm, Thomas/ABE-4203-2020	Christensen, Dennis/0000-0003-2382-8639; Lindenstrøm, Thomas/0000-0002-7162-8124; Andersen, Peter/0000-0002-5869-2551	European Commission [LSHP-CT-2003-503367]; Statens Serum Institut	European Commission(European CommissionEuropean Commission Joint Research Centre); Statens Serum Institut	This work was partly funded by the European Commission contract No. LSHP-CT-2003-503367 and partly by core funding from Statens Serum Institut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Agger EM, 2001, VACCINE, V19, P2298, DOI 10.1016/S0264-410X(00)00519-3; ANDERSEN P, 1991, INFECT IMMUN, V59, P1558, DOI 10.1128/IAI.59.4.1558-1563.1991; CANTER J, 1990, ARCH INTERN MED, V150, P1923, DOI 10.1001/archinte.150.9.1923; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; duChatelet IP, 1997, VACCINE, V15, P449, DOI 10.1016/S0264-410X(96)00173-9; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V142, P180, DOI 10.1016/j.jconrel.2009.10.022; Hirschberg HJHB, 2008, VACCINE, V26, P2389, DOI 10.1016/j.vaccine.2008.02.067; Holten-Andersen L, 2004, INFECT IMMUN, V72, P1608, DOI 10.1128/IAI.72.3.1608-1617.2004; Ishii Y, 2008, J CONTROL RELEASE, V131, P113, DOI 10.1016/j.jconrel.2008.07.025; Kelly K, 2008, VACCINE, V26, P1344, DOI 10.1016/j.vaccine.2007.12.041; Kim YC, 2010, J INFECT DIS, V201, P190, DOI 10.1086/649228; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Rosenkrands I, 2005, INFECT IMMUN, V73, P5817, DOI 10.1128/IAI.73.9.5817-5826.2005; Salehi AS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-19; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; van de Wijdeven GGP, 2002, J CONTROL RELEASE, V85, P145, DOI 10.1016/S0168-3659(02)00283-3; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001	21	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15043	10.1371/journal.pone.0015043	http://dx.doi.org/10.1371/journal.pone.0015043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124731	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500023
J	Dai, C; Liang, D; Li, HW; Sasaki, M; Dawson, TM; Dawson, VL				Dai, Cheng; Liang, Dong; Li, Huiwu; Sasaki, Masayuki; Dawson, Ted M.; Dawson, Valina L.			Functional Identification of Neuroprotective Molecules	PLOS ONE			English	Article							GENE-EXPRESSION; CELL-SURVIVAL; GROWTH; NEURONS; KINASE; PARTHANATOS; MUTATIONS; REGULATOR; MESSENGER; PROTEINS	The central nervous system has the capacity to activate profound neuroprotection following sub-lethal stress in a process termed preconditioning. To gain insight into this potent survival response we developed a functional cloning strategy that identified 31 putative neuroprotective genes of which 28 were confirmed to provide protection against oxygen-glucose deprivation (OGD) or excitotoxic exposure to N-methyl-D-aspartate (NMDA) in primary rat cortical neurons. These results reveal that the brain possesses a wide and diverse repertoire of neuroprotective genes. Further characterization of these and other protective signals could provide new treatment opportunities for neurological injury from ischemia or neurodegenerative disease.	[Dai, Cheng; Sasaki, Masayuki; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Neuroregenerat Program, Baltimore, MD 21218 USA; [Dai, Cheng; Sasaki, Masayuki; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD USA; [Dai, Cheng; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Liang, Dong; Li, Huiwu; Sasaki, Masayuki; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dai, C (corresponding author), Johns Hopkins Univ, Sch Med, Neuroregenerat Program, Baltimore, MD 21218 USA.	tdawson@jhmi.edu; vdawson@jhmi.edu	Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970	American Heart Association; McKnight Foundation; USPHS [NS40809, DA000266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040809] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); McKnight Foundation; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an American Heart Association Predoctoral Award to CD, a McKnight Foundation Neuroscience of Brain Disorders Award to VLD, and USPHS NS40809 DA000266. TMD is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CM, 2009, BIOCHEM SOC T, V37, P1293, DOI 10.1042/BST0371293; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Huang YF, 2007, P NATL ACAD SCI USA, V104, P4194, DOI 10.1073/pnas.0611609104; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jiang HP, 2000, P NATL ACAD SCI USA, V97, P12684, DOI 10.1073/pnas.220431297; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; KURNELLAS MP, 2010, CELL DEATH DIFFER; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Michiels F, 2000, METHOD ENZYMOL, V325, P295; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wahab N, 2007, BIOCHEM J, V406, P131, DOI 10.1042/BJ20061817; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	32	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15008	10.1371/journal.pone.0015008	http://dx.doi.org/10.1371/journal.pone.0015008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124846	Green Published, Green Submitted, gold			2022-12-25	WOS:000284572000015
J	Zhong, J; Chuang, SC; Bianchi, R; Zhao, WF; Paul, G; Thakkar, P; Liu, D; Fenton, AA; Wong, RKS; Tiedge, H				Zhong, Jun; Chuang, Shih-Chieh; Bianchi, Riccardo; Zhao, Wangfa; Paul, Geet; Thakkar, Punam; Liu, David; Fenton, Andre A.; Wong, Robert K. S.; Tiedge, Henri			Regulatory BC1 RNA and the Fragile X Mental Retardation Protein: Convergent Functionality in Brain	PLOS ONE			English	Article							FMR1 KNOCKOUT MICE; MESSENGER-RNA; EPILEPTIFORM DISCHARGES; TRANSLATIONAL CONTROL; BEHAVIORAL EVIDENCE; HIPPOCAMPAL SLICES; MOUSE MODEL; BC200 RNA; POLYRIBOSOMES; INITIATION	Background: BC RNAs and the fragile X mental retardation protein (FMRP) are translational repressors that have been implicated in the control of local protein synthesis at the synapse. Work with BC1 and Fmr1 animal models has revealed that phenotypical consequences resulting from the absence of either BC1 RNA or FMRP are remarkably similar. To establish functional interactions between BC1 RNA and FMRP is important for our understanding of how local protein synthesis regulates neuronal excitability. Methodology/Principal Findings: We generated BC1(-/-) Fmr1(-/-) double knockout (dKO) mice. We examined such animals, lacking both BC1 RNA and FMRP, in comparison with single knockout (sKO) animals lacking either one repressor. Analysis of neural phenotypical output revealed that at least three attributes of brain functionality are subject to control by both BC1 RNA and FMRP: neuronal network excitability, epileptogenesis, and place learning. The severity of CA3 pyramidal cell hyperexcitability was significantly higher in BC1(-/-) Fmr1(-/-) dKO preparations than in the respective sKO preparations, as was seizure susceptibility of BC1(-/-) Fmr1(-/-) dKO animals in response to auditory stimulation. In place learning, BC1(-/-) Fmr1(-/-) dKO animals were severely impaired, in contrast to BC1(-/-) or Fmr1(-/-) sKO animals which exhibited only mild deficits. Conclusions/Significance: Our data indicate that BC1 RNA and FMRP operate in sequential-independent fashion. They suggest that the molecular interplay between two translational repressors directly impacts brain functionality.	[Zhong, Jun; Chuang, Shih-Chieh; Bianchi, Riccardo; Zhao, Wangfa; Paul, Geet; Thakkar, Punam; Liu, David; Fenton, Andre A.; Wong, Robert K. S.; Tiedge, Henri] SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Chuang, Shih-Chieh; Bianchi, Riccardo; Zhao, Wangfa; Fenton, Andre A.; Wong, Robert K. S.; Tiedge, Henri] SUNY Hlth Sci Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Wong, Robert K. S.; Tiedge, Henri] SUNY Hlth Sci Ctr, Dept Neurol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Zhong, J (corresponding author), SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA.	jun.zhong@downstate.edu; henri.tiedge@downstate.edu	Bianchi, Riccardo/GLT-3136-2022; Cabrera, Mariel/GMX-2706-2022	Bianchi, Riccardo/0000-0002-1656-4455; Fenton, Andre/0000-0002-5063-1156	National Institutes of Health [HD43428, NS057839, NS035481, NS046769]; National Science Foundation [IOS-0725001]; FRAXA Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035481, R01NS046769, R43NS057839, R56NS035481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); FRAXA Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health HD43428, NS057839, NS035481, NS046769; National Science Foundation IOS-0725001; and the FRAXA Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Centonze D, 2008, BIOL PSYCHIAT, V63, P963, DOI 10.1016/j.biopsych.2007.09.008; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Chuang SC, 2005, J NEUROSCI, V25, P8048, DOI 10.1523/JNEUROSCI.1777-05.2005; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DHooge R, 1997, NEUROSCIENCE, V76, P367, DOI 10.1016/S0306-4522(96)00224-2; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Iacoangeli A, 2010, BRAIN RES, V1338, P36, DOI 10.1016/j.brainres.2010.03.042; Jacquemont S, 2007, LANCET NEUROL, V6, P45, DOI 10.1016/S1474-4422(06)70676-7; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lee AC, 2002, J NEUROPHYSIOL, V88, P1625, DOI 10.1152/jn.2002.88.4.1625; Lewejohann L, 2004, BEHAV BRAIN RES, V154, P273, DOI 10.1016/j.bbr.2004.02.015; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; Maccarrone M, 2010, NEUROPSYCHOPHARMACOL, V35, P1500, DOI 10.1038/npp.2010.19; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P9698, DOI 10.1073/pnas.90.20.9698; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Miyashiro KY, 2009, TRENDS PHARMACOL SCI, V30, P203, DOI 10.1016/j.tips.2009.01.005; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; NELSON DL, 1995, SEMIN CELL BIOL, V6, P5, DOI 10.1016/1043-4682(95)90009-8; Olypher AV, 2006, J NEUROSCI, V26, P158, DOI 10.1523/JNEUROSCI.2064-05.2006; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Sung YJ, 2003, J BIOL CHEM, V278, P15669, DOI 10.1074/jbc.M211117200; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WANG H, 2009, NEUROSCIENCE, V3, P431; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; Wang HD, 2002, J NEUROSCI, V22, P10232; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Yan QJ, 2004, GENES BRAIN BEHAV, V3, P337, DOI 10.1111/j.1601-183X.2004.00087.x; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhong J, 2009, J NEUROSCI, V29, P9977, DOI 10.1523/JNEUROSCI.3893-08.2009	53	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15509	10.1371/journal.pone.0015509	http://dx.doi.org/10.1371/journal.pone.0015509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124905	Green Published, gold, Green Submitted			2022-12-25	WOS:000284527900022
J	Chong, P; Chattoraj, P; Biswas, I				Chong, Patrick; Chattoraj, Partho; Biswas, Indranil			Activation of the SMU.1882 Transcription by CovR in Streptococcus mutans	PLOS ONE			English	Article							HYALURONIC-ACID CAPSULE; GROUP-A STREPTOCOCCUS; RESPONSE REGULATOR; VIRULENCE FACTORS; STRESS TOLERANCE; GENOME SEQUENCE; STREPTOLYSIN-S; SIGMA-SUBUNIT; IN-VIVO; EXPRESSION	In Streptococcus mutans, the global response regulator CovR plays an important role in biofilm formation, stress-tolerance response, and caries production. We have previously shown that CovR acts as a transcriptional repressor by binding to the upstream promoter regions of its target genes. Here, we report that in vivo, CovR activates the transcription of SMU. 1882, which encodes a small peptide containing a double-glycine motif. We also show that SMU. 1882 is transcriptionally linked to comA that encodes a putative ABC transporter protein. Several genes from man gene clusters that encode mannose phosphotranferase system flank SMU. 1882 -comA genes. Genomic comparison with other streptococci indicates that SMU. 1882 is uniquely present in S. mutans, while the man operon is conserved among all streptococci, suggesting that a genetic rearrangement might have taken place at this locus. With the use of a transcriptional reporter system and semi-quantitative RT-PCR, we demonstrated the transcriptional regulation of SMU. 1882 by CovR. In vitro gel shift and DNase I foot-printing analyses with purified CovR suggest that CovR binds to a large region surrounding the -10 region of the P-1882. Using this information and comparing with other CovR regulated promoters, we have developed a putative consensus binding sequence for CovR. Although CovR binds to P-1882, in vitro experiments using purified S. mutans RpoD, E. coli RNA polymerase, and CovR did not activate transcription from this promoter. Thus, we speculate that in vivo, CovR may interfere with the binding of a repressor or requires a cofactor.	[Chong, Patrick; Chattoraj, Partho; Biswas, Indranil] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Chong, P (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA.	ibiswas@kumc.edu			National Institute of Dental and Craniofacial Research (NIDCR) [DE016686]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016686] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was made possible by a National Institute of Dental and Craniofacial Research (NIDCR) grant (DE016686) to IB. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abranches J, 2003, APPL ENVIRON MICROB, V69, P4760, DOI 10.1128/AEM.69.8.4760-4769.2003; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Banerjee A, 2008, APPL ENVIRON MICROB, V74, P2037, DOI 10.1128/AEM.02346-07; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Biswas I, 2007, J BACTERIOL, V189, P6521, DOI 10.1128/JB.00825-07; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dalton TL, 2006, MICROB PATHOGENESIS, V40, P221, DOI 10.1016/j.micpath.2006.01.005; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Dirix G, 2004, MICROBIOL-SGM, V150, P1121, DOI 10.1099/mic.0.27040-0; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Federle MJ, 2002, MOL MICROBIOL, V43, P1161, DOI 10.1046/j.1365-2958.2002.02810.x; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gusa AA, 2005, MOL MICROBIOL, V56, P1195, DOI 10.1111/j.1365-2958.2005.04623.x; Gusa AA, 2007, J BACTERIOL, V189, P1407, DOI 10.1128/JB.01036-06; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; HORAUD T, 1984, EUR HEART J, V5, P39, DOI 10.1093/eurheartj/5.suppl_C.39; Idone V, 2003, INFECT IMMUN, V71, P4351, DOI 10.1128/IAI.71.8.4351-4360.2003; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Kaste LM, 1996, J DENT RES, V75, P631, DOI 10.1177/002203459607502S03; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MALAKOOTI J, 1995, J BACTERIOL, V177, P6854, DOI 10.1128/jb.177.23.6854-6860.1995; Mouslim C, 2003, J BIOL CHEM, V278, P50588, DOI 10.1074/jbc.M309433200; NICOLAS GG, 2007, MOL GENET GENOMICS, P193; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; PETERSON P, 2003, WORLD ORAL HLTH REPO; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitts NB, 2006, BRIT DENT J, V200, P313, DOI 10.1038/sj.bdj.4813377; Sato Y, 2000, FEMS MICROBIOL LETT, V186, P187, DOI 10.1111/j.1574-6968.2000.tb09102.x; Steffen P, 1997, MOL MICROBIOL, V23, P945, DOI 10.1046/j.1365-2958.1997.2741639.x; Steiner K, 2002, INFECT IMMUN, V70, P3627, DOI 10.1128/IAI.70.7.3627-3636.2002; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; SURZYCKI SJ, 1976, P NATL ACAD SCI USA, V73, P3961, DOI 10.1073/pnas.73.11.3961; Tanzer J M, 2001, J Dent Educ, V65, P1028; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	49	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e15528	10.1371/journal.pone.0015528	http://dx.doi.org/10.1371/journal.pone.0015528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124877	Green Published, Green Submitted, gold			2022-12-25	WOS:000284467200021
J	Myhre, S; Mohammed, H; Tramm, T; Alsner, J; Finak, G; Park, M; Overgaard, J; Borresen-Dale, AL; Frigessi, A; Sorlie, T				Myhre, Simen; Mohammed, Hayat; Tramm, Trine; Alsner, Jan; Finak, Greg; Park, Morag; Overgaard, Jens; Borresen-Dale, Anne-Lise; Frigessi, Arnoldo; Sorlie, Therese			In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome	PLOS ONE			English	Article							POSTMASTECTOMY RADIOTHERAPY; ESTROGEN; PATTERNS; CHEMOTHERAPY; RECURRENCE; SIGNATURE; SURVIVAL; ISOFORM; ASSAY; RISK	Breast tumors consist of several different tissue components. Despite the heterogeneity, most gene expression analyses have traditionally been performed without prior microdissection of the tissue sample. Thus, the gene expression profiles obtained reflect the mRNA contribution from the various tissue components. We utilized histopathological estimations of area fractions of tumor and stromal tissue components in 198 fresh-frozen breast tumor tissue samples for a cell type-associated gene expression analysis associated with distant metastasis. Sets of differentially expressed gene-probes were identified in tumors from patients who developed distant metastasis compared with those who did not, by weighing the contribution from each tumor with the relative content of stromal and tumor epithelial cells in their individual tumor specimen. The analyses were performed under various assumptions of mRNA transcription level from tumor epithelial cells compared with stromal cells. A set of 30 differentially expressed gene-probes was ascribed solely to carcinoma cells. Furthermore, two sets of 38 and five differentially expressed gene-probes were mostly associated to tumor epithelial and stromal cells, respectively. Finally, a set of 26 differentially expressed gene-probes was identified independently of cell type focus. The differentially expressed genes were validated in independent gene expression data from a set of laser capture microdissected invasive ductal carcinomas. We present a method for identifying and ascribing differentially expressed genes to tumor epithelial and/or stromal cells, by utilizing pathologic information and weighted t-statistics. Although a transcriptional contribution from the stromal cell fraction is detectable in microarray experiments performed on bulk tumor, the gene expression differences between the distant metastasis and no distant metastasis group were mostly ascribed to the tumor epithelial cells of the primary breast tumors. However, the gene PIP5K2A was found significantly elevated in stroma cells in distant metastasis group, compared to stroma in no distant metastasis group. These findings were confirmed in gene expression data from the representative compartments from microdissected breast tissue. The method described was also found to be robust to different histopathological procedures.	[Myhre, Simen; Mohammed, Hayat; Borresen-Dale, Anne-Lise; Sorlie, Therese] Oslo Univ Hosp Radiumhosp, Div Surg & Canc, Inst Canc Res, Dept Genet, Oslo, Norway; [Myhre, Simen; Borresen-Dale, Anne-Lise; Sorlie, Therese] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Mohammed, Hayat; Frigessi, Arnoldo] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Tramm, Trine; Alsner, Jan; Overgaard, Jens] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; [Finak, Greg; Park, Morag] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada	University of Oslo; University of Oslo; University of Oslo; Aarhus University; McGill University	Myhre, S (corresponding author), Oslo Univ Hosp Radiumhosp, Div Surg & Canc, Inst Canc Res, Dept Genet, Oslo, Norway.	simenmy@rr-research.no	Alsner, Jan/A-3056-2009; Sørlie, Therese/B-1413-2015	Alsner, Jan/0000-0002-5395-3193; Sørlie, Therese/0000-0002-5995-2319; Frigessi, Arnoldo/0000-0001-7103-7589; Finak, Greg/0000-0003-4341-9090; Tramm, Trine/0000-0003-3894-4552	Norwegian Research Council [163027/V40, 175240/S10]; Norwegian Cancer Society [PR-2006-0332, 80108003]; "Foreningen for brystkreftopererte" (FFB); Centre Statistics for Innovation; Danish Cancer Society; Danish Medical Research Council; CIRRO - the Lundbeck Foundation Center for Interventional Research in Radiation Oncology; Reseau de Recherche en Cancer du FRSQ; Canadian Institutes of Health Research Team	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); "Foreningen for brystkreftopererte" (FFB); Centre Statistics for Innovation; Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CIRRO - the Lundbeck Foundation Center for Interventional Research in Radiation Oncology; Reseau de Recherche en Cancer du FRSQ; Canadian Institutes of Health Research Team(Canadian Institutes of Health Research (CIHR))	This study was supported by the Norwegian Research Council (163027/V40 to TS and FUGE II, 175240/S10 to ALB), The Norwegian Cancer Society (PR-2006-0332 to TS and 80108003 to ALB), "Foreningen for brystkreftopererte" (FFB), and the Centre Statistics for Innovation, The Danish Cancer Society, The Danish Medical Research Council and CIRRO - the Lundbeck Foundation Center for Interventional Research in Radiation Oncology, Reseau de Recherche en Cancer du FRSQ, and a Canadian Institutes of Health Research Team Grant to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Blake CA, 2005, EXP BIOL MED, V230, P800, DOI 10.1177/153537020523001104; Cardoso F, 2008, J CLIN ONCOL, V26, P2058, DOI 10.1200/JCO.2007.15.6638; Carter CJ, 2007, NEUROCHEM INT, V50, P461, DOI 10.1016/j.neuint.2006.11.009; Cleator SJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1506; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; De Souza SE, 2008, INT J ONCOL, V33, P25; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franzen LE, 2005, MODERN PATHOL, V18, P912, DOI 10.1038/modpathol.3800370; Gonda TJ, 2008, EXPERT OPIN BIOL TH, V8, P713, DOI [10.1517/14712598.8.6.713, 10.1517/14712598.8.6.713 ]; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kyndi M, 2009, RADIOTHER ONCOL, V90, P74, DOI 10.1016/j.radonc.2008.04.014; Miller MM, 1997, J CLIN ENDOCR METAB, V82, P2956, DOI 10.1210/jc.82.9.2956; Nielsen HM, 2006, J CLIN ONCOL, V24, P2268, DOI 10.1200/JCO.2005.02.8738; Noth S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-307; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Radisky D, 2001, SEMIN CANCER BIOL, V11, P87, DOI 10.1006/scbi.2000.0360; Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI 10.1200/JCO.2008.16.7528; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Su LK, 2001, GENOMICS, V71, P142, DOI 10.1006/geno.2000.6428; Sugiyama Y, 2005, GASTROENTEROLOGY, V128, P480, DOI 10.1053/j.gastro.2004.11.010; Tessitore L, 2004, INT J ONCOL, V24, P1529; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wakefield L, 2008, GENE CHROMOSOME CANC, V47, P118, DOI 10.1002/gcc.20512; Wincewicz A, 2007, FOLIA HISTOCHEM CYTO, V45, P81; Yau WL, 2006, INT J CANCER, V119, P2821, DOI 10.1002/ijc.22232	37	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14002	10.1371/journal.pone.0014002	http://dx.doi.org/10.1371/journal.pone.0014002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124964	Green Submitted, gold, Green Published			2022-12-25	WOS:000284400100002
J	Wang, QY; Shinkre, BA; Lee, JG; Weniger, MA; Liu, YF; Chen, WP; Wiestner, A; Trenkle, WC; Ye, YH				Wang, Qiuyan; Shinkre, Bidhan A.; Lee, Jin-gu; Weniger, Marc A.; Liu, Yanfen; Chen, Weiping; Wiestner, Adrian; Trenkle, William C.; Ye, Yihong			The ERAD Inhibitor Eeyarestatin I Is a Bifunctional Compound with a Membrane-Binding Domain and a p97/VCP Inhibitory Group	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; CELL CARCINOMA-CELLS; AAA-ATPASE; PROTEASOME INHIBITORS; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; QUALITY-CONTROL; HEAVY-CHAINS; CANCER-CELLS	Background: Protein homeostasis in the endoplasmic reticulum (ER) has recently emerged as a therapeutic target for cancer treatment. Disruption of ER homeostasis results in ER stress, which is a major cause of cell death in cells exposed to the proteasome inhibitor Bortezomib, an anti-cancer drug approved for treatment of multiple myeloma and Mantle cell lymphoma. We recently reported that the ERAD inhibitor Eeyarestatin I (EerI) also disturbs ER homeostasis and has anticancer activities resembling that of Bortezomib. Methodology and Principal Findings: Here we developed in vitro binding and cell-based functional assays to demonstrate that a nitrofuran-containing (NFC) group in EerI is the functional domain responsible for the cytotoxicity. Using both SPR and pull down assays, we show that EerI directly binds the p97 ATPase, an essential component of the ERAD machinery, via the NFC domain. An aromatic domain in EerI, although not required for p97 interaction, can localize EerI to the ER membrane, which improves its target specificity. Substitution of the aromatic module with another benzene-containing domain that maintains membrane localization generates a structurally distinct compound that nonetheless has similar biologic activities as EerI. Conclusions and Significance: Our findings reveal a class of bifunctional chemical agents that can preferentially inhibit membrane-bound p97 to disrupt ER homeostasis and to induce tumor cell death. These results also suggest that the AAA ATPase p97 may be a potential drug target for cancer therapeutics.	[Wang, Qiuyan; Lee, Jin-gu; Liu, Yanfen; Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Weniger, Marc A.; Wiestner, Adrian] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Shinkre, Bidhan A.; Trenkle, William C.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD USA; [Chen, Weiping] NIDDK, Genom Core Lab, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wang, QY (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov	Chen, Weiping/C-9550-2011	Lee, Jin-Gu/0000-0001-9477-6990	NIH; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute, National Institutes of Health; Korean Government [KRF-2008-357-C00103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK071004] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Korean Government(Korean Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research is supported by the NIH intramural AIDS Targeted Antiviral Program (IATAP), and by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and of the National Heart, Lung, and Blood Institute, National Institutes of Health, and by the Korea Research Foundation Grant funded by the Korean Government [KRF-2008-357-C00103] to J.-G. Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; ARMSTRONG JL, 2009, J BIOL CHEM; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Borroto JIG, 2002, MUTAT RES-GEN TOX EN, V519, P179, DOI 10.1016/S1383-5718(02)00133-X; Cross BCS, 2009, J CELL SCI, V122, P4393, DOI 10.1242/jcs.054494; EDER E, 1991, MUTAGENESIS, V6, P261, DOI 10.1093/mutage/6.4.261; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nilsson IM, 2001, J BIOL CHEM, V276, P41748, DOI 10.1074/jbc.M105823200; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rizzatti EG, 2008, LEUKEMIA LYMPHOMA, V49, P798, DOI 10.1080/10428190801910912; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Szokalska A, 2009, CANCER RES, V69, P4235, DOI 10.1158/0008-5472.CAN-08-3439; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang Q., 2008, J BIOL CHEM; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, ESSAYS BIOCHEM, V41, P99, DOI 10.1042/EB0410099; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	50	146	148	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15479	10.1371/journal.pone.0015479	http://dx.doi.org/10.1371/journal.pone.0015479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21124757	gold, Green Published, Green Submitted			2022-12-25	WOS:000284147700032
J	Edwards, LM; Murray, AJ; Holloway, CJ; Carter, EE; Kemp, GJ; Codreanu, I; Brooker, H; Tyler, DJ; Robbins, PA; Clarke, K				Edwards, Lindsay M.; Murray, Andrew J.; Holloway, Cameron J.; Carter, Emma E.; Kemp, Graham J.; Codreanu, Ion; Brooker, Helen; Tyler, Damian J.; Robbins, Peter A.; Clarke, Kieran			Short-term consumption of a high-fat diet impairs whole-body efficiency and cognitive function in sedentary men	FASEB JOURNAL			English	Article						exercise; magnetic resonance; nutrition; mitochondria	ACTIVATED RECEPTOR-ALPHA; SKELETAL-MUSCLE; DECREASED EFFICIENCY; UNCOUPLING PROTEINS; CYCLING EFFICIENCY; MITOCHONDRIAL; PERFORMANCE; METABOLISM; ACIDS; EXERCISE	We recently showed that a short-term high-fat diet blunted exercise performance in rats, accompanied by increased uncoupling protein levels and greater respiratory uncoupling. In this study, we investigated the effects of a similar diet on physical and cognitive performance in humans. Twenty sedentary men were assessed when consuming a standardized, nutritionally balanced diet (control) and after 7 d of consuming a diet comprising 74% kcal from fat. Efficiency was measured during a standardized exercise task, and cognition was assessed using a computerized assessment battery. Skeletal muscle mitochondrial function was measured using P-31 magnetic resonance spectroscopy. The diet increased mean +/- SE plasma free fatty acids by 44% (0.32 +/- 0.03 vs. 0.46 +/- 0.05 mM; P < 0.05) and decreased whole-body efficiency by 3% (21 +/- 1 vs. 18 +/- 1%; P < 0.05), although muscle uncoupling protein (UCP3) content and maximal mitochondrial function were unchanged. High-fat diet consumption also increased subjects' simple reaction times (P < 0.01) and decreased power of attention (P < 0.01). Thus, we have shown that a high-fat diet blunts whole-body efficiency and cognition in sedentary men. We suggest that this effect may be due to increased respiratory uncoupling.-Edwards, L. M., Murray, A. J., Holloway, C. J., Carter, E. E., Kemp, G. J., Codreanu, I., Brooker, H., Tyler, D. J. Tyler, Robbins, P. A., Clarke, K. Short-term consumption of a high-fat diet impairs whole-body efficiency and cognitive function in sedentary men. FASEB J. 25, 1088-1096 (2011). www.fasebj.org	[Edwards, Lindsay M.; Carter, Emma E.; Tyler, Damian J.; Robbins, Peter A.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Edwards, Lindsay M.; Holloway, Cameron J.; Codreanu, Ion] John Radcliffe Hosp, Oxford Ctr Clin Magnet Resonance Res, Oxford OX3 9DU, England; [Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Kemp, Graham J.] Univ Liverpool, Inst Ageing & Chron Dis, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England; [Brooker, Helen] Cognit Drug Res Ltd, Goring On Thames, England	University of Oxford; University of Oxford; University of Cambridge; University of Liverpool	Edwards, LM (corresponding author), Univ Tasmania, Sch Med, Private Bag 34,Med Sci 1, Hobart, Tas 7001, Australia.	l.m.edwards@utas.edu.au	Kemp, Graham J/A-7540-2008; Murray, Andrew/B-3130-2010; Codreanu, Ion/AAS-4378-2020; Tyler, Damian/E-6296-2011; Robbins, Peter/C-7846-2016	Kemp, Graham J/0000-0002-8324-9666; Murray, Andrew/0000-0002-0929-9315; Codreanu, Ion/0000-0002-2644-5572; Tyler, Damian/0000-0002-0780-8905; Robbins, Peter/0000-0002-4975-0609	British Heart Foundation [FS/10/002/28078, PS/02/002/14893, RG/07/004/22659] Funding Source: Medline; Medical Research Council [G0601490] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AHMAD ER, 2010, P JOINT ANN M INT SO; AMIEL SA, 1995, P NUTR SOC, V54, P151, DOI 10.1079/PNS19950044; ATKINS RC, 2003, ATKINS NEW DIET REVO; Azzu V, 2010, BIOCHEM J, V426, P13, DOI 10.1042/BJ20091321; Benedict FG, 1913, MUSCULAR WORK METABO; Bigrigg JK, 2009, AM J PHYSIOL-REG I, V297, pR885, DOI 10.1152/ajpregu.90604.2008; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Burke LM, 2006, J APPL PHYSIOL, V100, P7, DOI 10.1152/japplphysiol.01238.2005; Coyle E F, 1999, J Sci Med Sport, V2, P181; COYLE EF, 1992, MED SCI SPORT EXER, V24, P782; Edwards LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010681; Edwards LM, 2009, J SPORT SCI, V27, P319, DOI 10.1080/02640410802526916; Erlenbusch M, 2005, INT J SPORT NUTR EXE, V15, P1, DOI 10.1123/ijsnem.15.1.1; FEINSTEIN AR, 2001, MED STAT; Gardner AS, 2004, MED SCI SPORT EXER, V36, P1252, DOI 10.1249/01.MSS.0000132380.21785.03; Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; Helge JW, 1996, J PHYSIOL-LONDON, V492, P293, DOI 10.1113/jphysiol.1996.sp021309; Helge JW, 2001, J PHYSIOL-LONDON, V537, P1009, DOI 10.1113/jphysiol.2001.012933; HERMANSE.L, 1967, ACTA PHYSIOL SCAND, V71, P129, DOI 10.1111/j.1748-1716.1967.tb03719.x; Hesselink MKC, 2003, J CLIN INVEST, V111, P479, DOI 10.1172/JCI16653; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Hirabara SM, 2006, BBA-BIOENERGETICS, V1757, P57, DOI 10.1016/j.bbabio.2005.11.007; HULTMAN E, 1967, ACTA MED SCAND, V182, P109; HULTMAN E, 1967, SCAND J CLIN LAB INV, VS 19, P11; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB, P1; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Kemp G, 2008, AM J PHYSIOL-CELL PH, V295, pC844, DOI 10.1152/ajpcell.00264.2008; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; MARKS MR, 1951, PSYCHOL REV, V58, P179, DOI 10.1037/h0055614; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Moseley L, 2001, MED SCI SPORT EXER, V33, P621; Murray AJ, 2005, DIABETES, V54, P3496, DOI 10.2337/diabetes.54.12.3496; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Murray AJ, 2007, CURR OPIN CLIN NUTR, V10, P704, DOI 10.1097/MCO.0b013e3282f0ecbe; Murray AJ, 2009, FASEB J, V23, P4353, DOI 10.1096/fj.09-139691; Nabben M, 2008, FEBS LETT, V582, P4147, DOI 10.1016/j.febslet.2008.11.016; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Parrott AC, 1996, HUM PSYCHOPHARM CLIN, V11, P391; Paton CD, 2006, INT J SPORTS MED, V27, P444, DOI 10.1055/s-2005-865781; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Priego T, 2008, OBESITY, V16, P819, DOI 10.1038/oby.2007.117; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; SIMPSON PM, 1991, INT J GERIATR PSYCH, V6, P95, DOI 10.1002/gps.930060208; Stavinoha MA, 2004, AM J PHYSIOL-ENDOC M, V287, pE888, DOI 10.1152/ajpendo.00190.2004; Tran TK, 1999, AM J PHYSIOL-REG I, V276, pR1682, DOI 10.1152/ajpregu.1999.276.6.R1682; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; WAHREN J, 1984, J CLIN INVEST, V73, P1367, DOI 10.1172/JCI111340; Walker MP, 1999, HUM PSYCHOPHARM CLIN, V14, P483, DOI 10.1002/(SICI)1099-1077(199910)14:7<483::AID-HUP133>3.0.CO;2-T; Wesnes KA, 2000, PSYCHOPHARMACOLOGY, V152, P353, DOI 10.1007/s002130000533; Wesnes KA, 1997, BRIT J SURG, V84, P493; WING RR, 1995, INT J OBESITY, V19, P811; Winocur G, 2005, NEUROBIOL AGING, V26, pS46, DOI 10.1016/j.neurobiolaging.2005.09.003; WOITCZAK L, 1993, BIOCHIM BIOPHYS ACTA, V1183, P41, DOI 10.1016/0005-2728(93)90004-Y; Young ME, 2001, FASEB J, V15, P833, DOI 10.1096/fj.00-0351com; Zhang J, 2006, NUTR NEUROSCI, V9, P179, DOI 10.1080/10284150600955172	60	84	85	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					1088	1096		10.1096/fj.10-171983	http://dx.doi.org/10.1096/fj.10-171983			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21106937				2022-12-25	WOS:000287806200028
J	Freeman, KW; Bowman, BR; Zetter, BR				Freeman, Kevin W.; Bowman, Brian R.; Zetter, Bruce R.			Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling	FASEB JOURNAL			English	Article						ATP synthase; ATPase inhibitory factor 1; angiogenesis; wound healing; migration	ENDOTHELIAL-CELL SURFACE; ATP SYNTHASE; SUBUNIT; NEOVASCULARIZATION; MITOCHONDRIA; ANGIOSTATIN; F-1-ATPASE; RECEPTORS; MIGRATION; SURVIVAL	By an unknown mechanism, beta-thymosins are extracellular modulators of angiogenesis, inflammation, wound healing, and development. We were interested in identifying beta-thymosin interactors and determining their importance in beta-thymosins signaling in human vein endothelial cells (HUVECs). We performed pulldown experiments with biotinylated thymosin beta-4 (T beta 4) in comparison to neutravidin beads alone and used mass spectrometric analysis to identify differentially interacting proteins. By this method, we identified F1-F0 ATP synthase, a known target of antiangiogenic angiostatin. By surface plasmon resonance, we determined for T beta 4 binding to the beta subunit of ATP synthase a K-D of 12 nM. Blocking antibodies and antagonists (oligomycin, IC50 similar to 1.8 mu M; piceatannol, IC50 similar to 1.05 mu M; and angiostatin, IC50 similar to 2.9 mu g/ml) of ATP synthase inhibited the T beta 4-induced increase in cell surface ATP levels, as measured by luciferase assay, and the T beta 4-induced increase in HUVEC migration, as measured by transwell migration assay. Silencing of the ATP-responsive purinergic receptor P2X4 with siRNA also blocked T beta 4-induced HUVEC migration in a transwell assay. Furthermore, in silico we identified common amphiphilic alpha-helical structural similarities between beta-thymosins and the inhibitory factor 1 (IF1), an inhibitor of ATP synthase hydrolysis. In summary, we have identified an extracellular signaling pathway where T beta 4 increases cell surface ATP levels via ATP synthase and have shown further that ATP-responsive P2X4 receptor is required for T beta 4-induced HUVEC migration.-Freeman, K. W., Bowman, B. R., Zetter, B. R. Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling. FASEB J. 25, 907-915 (2011). www.fasebj.org	[Freeman, Kevin W.; Zetter, Bruce R.] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Freeman, Kevin W.; Zetter, Bruce R.] Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Freeman, Kevin W.; Zetter, Bruce R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bowman, Brian R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Zetter, BR (corresponding author), Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA.	bruce.zetter@childrens.harvard.edu						Ausiello G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S24; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Burwick NR, 2005, J BIOL CHEM, V280, P1740, DOI 10.1074/jbc.M405947200; Campanella M, 2009, TRENDS BIOCHEM SCI, V34, P343, DOI 10.1016/j.tibs.2009.03.006; Chang SY, 2002, J BIOL CHEM, V277, P8388, DOI 10.1074/jbc.M108792200; Chi SL, 2007, CANCER RES, V67, P4716, DOI 10.1158/0008-5472.CAN-06-1094; Chi SL, 2006, ANN MED, V38, P429, DOI 10.1080/07853890600928698; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan Y, 2009, DEV CELL, V16, P661, DOI 10.1016/j.devcel.2009.03.009; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Freeman KW, 2009, FUTURE ONCOL, V5, P755, DOI [10.2217/fon.09.71, 10.2217/FON.09.71]; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Gledhill JR, 2005, BIOCHEM J, V386, P591, DOI 10.1042/BJ20041513; GOLDSTEIN AL, 2005, ANN NY ACAD SCI, V11, P171; Huang CM, 2006, PROTEOMICS, V6, P5805, DOI 10.1002/pmic.200600163; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Kim SH, 2004, MICROBIOL-SGM, V150, P2493, DOI 10.1099/mic.0.27312-0; Mangiullo R, 2008, BBA-BIOENERGETICS, V1777, P1326, DOI 10.1016/j.bbabio.2008.08.003; Mannherz HG, 2009, CELL MOTIL CYTOSKEL, V66, P839, DOI 10.1002/cm.20371; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Marx J, 2007, SCIENCE, V316, P682, DOI 10.1126/science.316.5825.682; Mollinari C, 2009, J CELL SCI, V122, P4195, DOI 10.1242/jcs.056895; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Philp D, 2003, WOUND REPAIR REGEN, V11, P19, DOI 10.1046/j.1524-475X.2003.11105.x; Roth LWA, 1999, DEVELOPMENT, V126, P1365; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Sonin D, 2008, AM J PHYSIOL-HEART C, V295, pH1191, DOI 10.1152/ajpheart.00577.2008; Sosne G, 2007, CLIN OPHTHALMOL, V1, P201; Stoll R, 1997, BIOPOLYMERS, V41, P623, DOI 10.1002/(SICI)1097-0282(199705)41:6<623::AID-BIP3>3.0.CO;2-S; Veitonmaki N, 2004, CANCER RES, V64, P3679, DOI 10.1158/0008-5472.CAN-03-1754; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Yamamoto K, 2007, AM J PHYSIOL-HEART C, V293, pH1646, DOI 10.1152/ajpheart.01385.2006; Yang H, 2008, NEUROCHEM RES, V33, P2269, DOI 10.1007/s11064-008-9712-y	35	52	55	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					907	915		10.1096/fj.10-169417	http://dx.doi.org/10.1096/fj.10-169417			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21106936				2022-12-25	WOS:000287806200011
J	Dani, N; Mayo, E; Stilla, A; Marchegiani, A; Di Paola, S; Corda, D; Di Girolamo, M				Dani, Nadia; Mayo, Emilia; Stilla, Annalisa; Marchegiani, Adriano; Di Paola, Simone; Corda, Daniela; Di Girolamo, Maria			Mono-ADP-ribosylation of the G Protein beta gamma Dimer Is Modulated by Hormones and Inhibited by Arf6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							39-KDA POLY(ADP-RIBOSE) GLYCOHYDROLASE; COUPLED RECEPTOR ENDOCYTOSIS; BINDING-PROTEINS; EXCHANGE FACTOR; CHOLERA-TOXIN; BOVINE BRAIN; ACTIVATION; MEMBRANE; ORGANIZATION; FAMILY	Mono-ADP-ribosylation is a reversible post-translational modification that can modulate the functions of target proteins. We have previously demonstrated that the beta subunit of heterotrimeric G proteins is endogenously mono-ADP-ribosylated, and once modified, the beta gamma dimer is inactive toward its effector enzymes. To better understand the physiological relevance of this post-translational modification, we have studied its hormonal regulation. Here, we report that G beta subunit mono-ADP-ribosylation is differentially modulated by G protein-coupled receptors. In intact cells, hormone stimulation of the thrombin receptor induces G beta subunit mono-ADP-ribosylation, which can affect G protein signaling. Conversely, hormone stimulation of the gonadotropin-releasing hormone receptor (GnRHR) inhibits G beta subunit mono-ADP-ribosylation. We also provide the first demonstration that activation of the GnRHR can activate the ADP-ribosylation factor Arf6, which in turn inhibits G beta subunit mono-ADP-ribosylation. Indeed, removal of Arf6 from purified plasma membranes results in loss of GnRHR-mediated inhibition of G beta subunit mono-ADP-ribosylation, which is fully restored by re-addition of purified, myristoylated Arf6. We show that Arf6 acts as a competitive inhibitor of the endogenous ADP-ribosyltransferase and is itself modified by this enzyme. These data provide further understanding of the mechanisms that regulate endogenous ADP-ribosylation of the G beta subunit, and they demonstrate a novel role for Arf6 in hormone regulation of G beta subunit mono-ADP-ribosylation.	[Dani, Nadia; Mayo, Emilia; Stilla, Annalisa; Marchegiani, Adriano; Di Paola, Simone; Corda, Daniela; Di Girolamo, Maria] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Prot Mediated Signalling Lab G, I-66030 Santa Maria Imbaro, Chieti, Italy	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Di Girolamo, M (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Prot Mediated Signalling Lab G, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Chieti, Italy.	d.corda@ibp.cnr.it; mdigirolamo@negrisud.it	Corda, Daniela/K-6385-2016; Di Paola, Simone/GYU-0514-2022	Corda, Daniela/0000-0002-3614-751X; Di Paola, Simone/0000-0003-3753-5722	Ministero dell'Istruzione, Universita e Ricerca [RBIP06LSS2_005, DM26545]; Italian Association for Cancer Research	Ministero dell'Istruzione, Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by Ministero dell'Istruzione, Universita e Ricerca, Grants RBIP06LSS2_005 and DM26545.; Supported by Italian Association for Cancer Research fellowship. Present address: Institute for Cancer Research and Treatment and Dept. of Oncological Sciences, University of Torino, Candiolo 10060, Italy. To whom correspondence may be addressed. E-mail: nadia.dani@ircc.it.	Bourne H. R., 2006, E SCHERING FDN S P, V2, P1; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Claing A, 2004, BIOCHEM CELL BIOL, V82, P610, DOI 10.1139/O04-113; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dania N, 2009, P NATL ACAD SCI USA, V106, P4243, DOI 10.1073/pnas.0900066106; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Dessauer CW, 1996, CLIN SCI, V91, P527, DOI 10.1042/cs0910527; Di Girolamo M, 2005, FEBS J, V272, P4565, DOI 10.1111/j.1742-4658.2005.04876.x; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Hunzicker-Dunn M, 2002, FEBS LETT, V521, P3, DOI 10.1016/S0014-5793(02)02822-3; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Koch-Nolte F, 2008, FRONT BIOSCI-LANDMRK, V13, P6716, DOI 10.2741/3184; LEE CM, 1991, J CLIN INVEST, V87, P1780, DOI 10.1172/JCI115197; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lupi R, 2000, J BIOL CHEM, V275, P9418, DOI 10.1074/jbc.275.13.9418; Lupi R, 2002, BIOCHEM J, V367, P825, DOI 10.1042/BJ20020660; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; Mariggio S, 2006, CELL SIGNAL, V18, P2200, DOI 10.1016/j.cellsig.2006.05.003; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Offermanns S, 1996, CANCER SURV, V27, P177; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; Randazzo Paul A, 2002, Methods Mol Biol, V189, P169; Riese MJ, 2002, J BIOL CHEM, V277, P12082, DOI 10.1074/jbc.M109039200; Robertson DN, 2003, MOL PHARMACOL, V64, P1239, DOI 10.1124/mol.64.5.1239; Salvador LM, 2001, J BIOL CHEM, V276, P33773, DOI 10.1074/jbc.M101498200; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Seman M, 2004, CURR MED CHEM, V11, P857, DOI 10.2174/0929867043455611; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; TSAI SC, 1988, J BIOL CHEM, V263, P1768; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005	48	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5995	6005		10.1074/jbc.M110.112466	http://dx.doi.org/10.1074/jbc.M110.112466			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148312	hybrid, Green Published			2022-12-25	WOS:000287476400007
J	Rodrigues, JF; Mathias-Santos, C; Sbrogio-Almeida, ME; Amorim, JH; Cabrera-Crespo, J; Balan, A; Ferreira, LCS				Rodrigues, Juliana F.; Mathias-Santos, Camila; Sbrogio-Almeida, Maria Elisabete; Amorim, Jaime H.; Cabrera-Crespo, Joaquim; Balan, Andrea; Ferreira, Luis C. S.			Functional Diversity of Heat-labile Toxins (LT) Produced by Enterotoxigenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLTRANSFERASE ACTIVITY; CHOLERA-TOXIN; MUCOSAL ADJUVANTS; B-SUBUNIT; A-SUBUNIT; IMMUNOGENICITY; RESPONSES; BINDING; MUTANT; SITE	Heat-labile toxins (LTs) have ADP-ribosylation activity and induce the secretory diarrhea caused by enterotoxigenic Escherichia coli (ETEC) strains in different mammalian hosts. LTs also act as adjuvants following delivery via mucosal, parenteral, or transcutaneous routes. Previously we have shown that LT produced by human-derived ETEC strains encompass a group of 16 polymorphic variants, including the reference toxin (LT1 or hLT) produced by the H10407 strain and one variant that is found mainly among bacterial strains isolated from pigs (LT4 or pLT). Herein, we show that LT4 ( with six polymorphic sites in the A (K4R, K213E, and N238D) and B (S4T, A46E, and E102K) subunits) displays differential in vitro toxicity and in vivo adjuvant activities compared with LT1. One in vitro generated LT mutant (LTK4R), in which the lysine at position 4 of the A subunit was replaced by arginine, showed most of the LT4 features with an similar to 10-fold reduction of the cytotonic effects, ADP-ribosylation activity, and accumulation of intracellular cAMP in Y1 cells. Molecular dynamic studies of the A subunit showed that the K4R replacement reduces the N-terminal region flexibility and decreases the catalytic site crevice. Noticeably, LT4 showed a stronger Th1-biased adjuvant activity with regard to LT1, particularly concerning activation of cytotoxic CD8(+) T lymphocytes when delivered via the intranasal route. Our results further emphasize the relevance of LT polymorphism among human-derived ETEC strains that may impact both the pathogenicity of the bacterial strain and the use of these toxins as potential vaccine adjuvants.	[Ferreira, Luis C. S.] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Vaccine Dev Lab, BR-05508000 Sao Paulo, Brazil; [Sbrogio-Almeida, Maria Elisabete; Cabrera-Crespo, Joaquim] Butantan Inst, Technol Dev Div, BR-05503900 Sao Paulo, Brazil; [Balan, Andrea] Res Ctr Energy & Mat, Natl Lab Biosci, BR-13084971 Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan	Ferreira, LCS (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Vaccine Dev Lab, BR-05508000 Sao Paulo, Brazil.	lcsf@usp.br	Rodrigues, Juliana/AAC-3512-2019; Ferreira, Luis Carlos S/M-3954-2014; Balan, Andrea/D-1891-2014; Amorim, Jaime Henrique/O-9222-2017; Cabrera-Crespo, Joaquin/D-3183-2015	Ferreira, Luis Carlos S/0000-0002-4883-1693; Balan, Andrea/0000-0001-6199-3198; Amorim, Jaime Henrique/0000-0002-0623-2879; Cabrera-Crespo, Joaquin/0000-0002-1457-6786	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grants.	[Anonymous], 1998, PYM; Arce S, 2005, INFECT IMMUN, V73, P2718, DOI 10.1128/IAI.73.5.2718-2727.2005; BACK E, 1979, J CLIN MICROBIOL, V10, P791; Braga CJM, 2008, BRAZ J MICROBIOL, V39, P44, DOI 10.1590/S1517-838220080001000011; CHUNG DW, 1977, INFECT IMMUN, V16, P832, DOI 10.1128/IAI.16.3.832-841.1977; de Haan L, 1998, IMMUNOL CELL BIOL, V76, P270, DOI 10.1046/j.1440-1711.1998.00745.x; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; De Haan L, 1998, IMMUNOLOGY, V94, P424, DOI 10.1046/j.1365-2567.1998.00535.x; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; DOMENIGHINI M, 1994, MOL MICROBIOL, V14, P41, DOI 10.1111/j.1365-2958.1994.tb01265.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser SA, 2003, INFECT IMMUN, V71, P1527, DOI 10.1128/IAI.71.3.1527-1537.2003; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Giuliani MM, 1998, J EXP MED, V187, P1123, DOI 10.1084/jem.187.7.1123; Hagiwara Y, 2001, VACCINE, V19, P1652, DOI 10.1016/S0264-410X(00)00412-6; Hajishengallis G, 2005, J DENT RES, V84, P1104, DOI 10.1177/154405910508401205; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HIRST TR, 1999, COMPREHENSIVE SOURCE, P104; Holmgren J, 2003, VACCINE, V21, pS89, DOI 10.1016/S0264-410X(03)00206-8; HONDA T, 1981, INFECT IMMUN, V34, P337, DOI 10.1128/IAI.34.2.337-340.1981; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KARMALI MA, 1985, J CLIN MICROBIOL, V22, P614, DOI 10.1128/JCM.22.4.614-619.1985; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lasaro MA, 2008, J BACTERIOL, V190, P2400, DOI 10.1128/JB.00988-07; Lasaro MA, 2009, FEMS IMMUNOL MED MIC, V55, P93, DOI 10.1111/j.1574-695X.2008.00506.x; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEONG J, 1985, INFECT IMMUN, V48, P73, DOI 10.1128/IAI.48.1.73-77.1985; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; MACKLER B, 1967, METHOD ENZYMOL, V10, P261; MEKALANOS JJ, 1978, INFECT IMMUN, V20, P552, DOI 10.1128/IAI.20.2.552-558.1978; Nashar TO, 1996, P NATL ACAD SCI USA, V93, P226, DOI 10.1073/pnas.93.1.226; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Partidos CD, 1999, IMMUNOL LETT, V67, P209, DOI 10.1016/S0165-2478(99)00013-9; PIZZA M, 1994, J EXP MED, V180, P2147, DOI 10.1084/jem.180.6.2147; PIZZA M, 1994, MOL MICROBIOL, V14, P51, DOI 10.1111/j.1365-2958.1994.tb01266.x; Ryan EJ, 2000, J IMMUNOL, V165, P5750, DOI 10.4049/jimmunol.165.10.5750; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schweizer HP, 2001, CURR OPIN BIOTECH, V12, P439, DOI 10.1016/S0958-1669(00)00242-1; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; Simmons CP, 1999, J IMMUNOL, V163, P6502; Simmons CP, 2001, SCAND J IMMUNOL, V53, P218, DOI 10.1046/j.1365-3083.2001.00884.x; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; SIXMA TK, 1993, J MOL BIOL, V230, P890, DOI 10.1006/jmbi.1993.1209; Stabb EV, 2001, J BACTERIOL, V183, P309, DOI 10.1128/JB.183.1.309-317.2001; TSUJI T, 1982, INFECT IMMUN, V38, P444, DOI 10.1128/IAI.38.2.444-448.1982; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Ginkel FW, 2005, INFECT IMMUN, V73, P6892, DOI 10.1128/IAI.73.10.6892-6902.2005; VANDENAKKER F, 1995, BIOCHEMISTRY-US, V34, P10996, DOI 10.1021/bi00035a005; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97; YAMAMOTO T, 1984, J BIOL CHEM, V259, P5037; YOST DA, 1981, J BIOL CHEM, V256, P3647; Zhang WP, 2008, APPL ENVIRON MICROB, V74, P5832, DOI 10.1128/AEM.00893-08; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05	54	20	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5222	5233		10.1074/jbc.M110.173682	http://dx.doi.org/10.1074/jbc.M110.173682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21135101	hybrid, Green Published			2022-12-25	WOS:000287230600031
J	Saijo, M; Takedachi, A; Tanaka, K				Saijo, Masafumi; Takedachi, Arato; Tanaka, Kiyoji			Nucleotide Excision Repair by Mutant Xeroderma Pigmentosum Group A (XPA) Proteins with Deficiency in Interaction with RPA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENTATION GROUP-A; HUMAN CELL-EXTRACTS; DNA-BINDING DOMAIN; DAMAGE-RECOGNITION; GROUP-C; TRANSCRIPTION FACTOR; MUTATIONAL ANALYSIS; COMPLEX; ERCC1; STRAND	The xeroderma pigmentosum group A protein (XPA) is a core component of nucleotide excision repair (NER). To coordinate early stage NER, XPA interacts with various proteins, including replication protein A (RPA), ERCC1, DDB2, and TFIIH, in addition to UV-damaged or chemical carcinogen-damaged DNA. In this study, we investigated the effects of mutations in the RPA binding regions of XPA on XPA function in NER. XPA binds through an N-terminal region to the middle subunit (RPA32) of the RPA heterotrimer and through a central region that overlaps with its damaged DNA binding region to the RPA70 subunit. In cell-free NER assays, an N-terminal deletion mutant of XPA showed loss of binding to RPA32 and reduced DNA repair activity, but it could still bind to UV-damaged DNA and RPA. In contrast, amino acid substitutions in the central region reduced incisions at the damaged site in the cell-free NER assay, and four of these mutants (K141A, T142A, K167A, and K179A) showed reduced binding to RPA70 but normal binding to damaged DNA. Furthermore, mutants that had one of the four aforementioned substitutions and an N-terminal deletion exhibited lower DNA incision activity and binding to RPA than XPA with only one of these substitutions or the deletion. Taken together, these results indicate that XPA interaction with both RPA32 and RPA70 is indispensable for NER reactions.	[Saijo, Masafumi; Takedachi, Arato; Tanaka, Kiyoji] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University	Saijo, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.	saijom@fbs.osaka-u.ac.jp; ktanaka@fbs.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Solution-oriented Research for Science and Technology program of the Japan Science and Technology Agency.	Araujo SJ, 1999, MUTAT RES-DNA REPAIR, V435, P23, DOI 10.1016/S0921-8777(99)00042-7; ASAHINA H, 1994, MUTAT RES-DNA REPAIR, V315, P229, DOI 10.1016/0921-8777(94)90034-5; Bootsma D., 1998, GENETIC BASIS HUMAN, P245; Buchko GW, 1999, BIOCHEMISTRY-US, V38, P15116, DOI 10.1021/bi991755p; Buchko GW, 1998, NUCLEIC ACIDS RES, V26, P2779, DOI 10.1093/nar/26.11.2779; Camenisch U, 2007, DNA REPAIR, V6, P1819, DOI 10.1016/j.dnarep.2007.07.011; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; EVANS MK, 1993, J BIOL CHEM, V268, P4839; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Hanawalt PC, 1999, NATO ADV SCI I A-LIF, V302, P169; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hermanson-Miller IL, 2002, BIOCHEMISTRY-US, V41, P2402, DOI 10.1021/bi0112863; Ikegami T, 1998, NAT STRUCT BIOL, V5, P701, DOI 10.1038/1400; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12096, DOI 10.1021/bi00096a021; KENNY M K, 1990, Journal of Biological Chemistry, V265, P7693; Kobayashi T, 1998, NUCLEIC ACIDS RES, V26, P4662, DOI 10.1093/nar/26.20.4662; Kuraoka I, 1996, MUTAT RES-DNA REPAIR, V362, P87, DOI 10.1016/0921-8777(95)00038-0; LI L, 1995, MOL CELL BIOL, V15, P1993; LI L, 1994, P NATL ACAD SCI USA, V91, P5012, DOI 10.1073/pnas.91.11.5012; LI L, 1995, MOL CELL BIOL, V15, P5396; MASUTANI C, 1993, J BIOL CHEM, V268, P9105; MATSUDA T, 1995, J BIOL CHEM, V270, P4152, DOI 10.1074/jbc.270.8.4152; MIYAMOTO I, 1992, J BIOL CHEM, V267, P12182; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; NAGAI A, 1995, BIOCHEM BIOPH RES CO, V211, P960, DOI 10.1006/bbrc.1995.1905; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; Nocentini S, 1997, J BIOL CHEM, V272, P22991, DOI 10.1074/jbc.272.37.22991; PARK CH, 1995, J BIOL CHEM, V270, P4896, DOI 10.1074/jbc.270.9.4896; Patrick SM, 2002, J BIOL CHEM, V277, P16096, DOI 10.1074/jbc.M200816200; Rademakers S, 2003, MOL CELL BIOL, V23, P5755, DOI 10.1128/MCB.23.16.5755-5767.2003; Reardon JT, 2002, MOL CELL BIOL, V22, P5938, DOI 10.1128/MCB.22.16.5938-5945.2002; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Saijo M, 2004, BIOCHEM BIOPH RES CO, V321, P815, DOI 10.1016/j.bbrc.2004.07.030; Saijo M, 1996, NUCLEIC ACIDS RES, V24, P4719, DOI 10.1093/nar/24.23.4719; Stapleton AE, 1999, METH MOL B, V113, P157; VENEMA J, 1990, NUCLEIC ACIDS RES, V18, P443, DOI 10.1093/nar/18.3.443; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 2009, NUCLEIC ACIDS RES, V37, P516, DOI 10.1093/nar/gkn964; Yang ZG, 2002, BIOCHEMISTRY-US, V41, P13012, DOI 10.1021/bi026064z; You JS, 2003, J BIOL CHEM, V278, P7476, DOI 10.1074/jbc.M210603200	45	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5476	5483		10.1074/jbc.M110.172916	http://dx.doi.org/10.1074/jbc.M110.172916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148310	Green Published, hybrid			2022-12-25	WOS:000287230600057
J	Dong, LJ; Zhang, XY; Fu, XA; Zhang, XZ; Gao, XJ; Zhu, MY; Wang, XT; Yang, ZX; Jensen, ON; Saarikettu, J; Yao, Z; Silvennoinen, O; Yang, J				Dong, Lijie; Zhang, Xinyu; Fu, Xiao; Zhang, Xianzhi; Gao, Xingjie; Zhu, Mengyu; Wang, Xinting; Yang, ZhenXia; Jensen, Ole Norregaard; Saarikettu, Juha; Yao, Zhi; Silvennoinen, Olli; Yang, Jie			PTB-associated Splicing Factor (PSF) Functions as a Repressor of STAT6-mediated Ig epsilon Gene Transcription by Recruitment of HDAC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVELY ACTIVE STAT6; JAK-3 JANUS KINASE; RNA-POLYMERASE-II; HISTONE ACETYLATION; SIGNAL TRANSDUCER; RECEPTOR; ACTIVATION; EXPRESSION; IL-4; COACTIVATOR	Regulation of transcription requires cooperation between sequence-specific transcription factors and numerous coregulatory proteins. In IL-4/IL-13 signaling several coactivators for STAT6 have been identified, but the molecular mechanisms of STAT6-mediated gene transcription are still not fully understood. Here we identified by proteomic approach that the PTB-associated splicing factor (PSF) interacts with STAT6. In intact cells the interaction was observed only after IL-4 stimulation. The IL-4-induced tyrosine phosphorylation of both STAT6 and PSF is a prerequisite for the efficient association of the two proteins. Functional analysis demonstrated that ectopic expression of PSF resulted in inhibition of STAT6-mediated transcriptional activation and mRNA expression of the Ig epsilon germline heavy chain gene, whereas knockdown of PSF increased the STAT6-mediated responses. PSF recruited histone deacetylase 1 (HDAC1) to the STAT6 transcription complex, which resulted in reduction of H3 acetylation at the promoter regions of Ig heavy chain germline Ig epsilon and inhibition of STAT6-mediated transcription. In addition, the HDACs inhibitor trichostatin A (TSA) enhanced H3 acetylation, and reverted the PSF-mediated transcriptional repression of Ig epsilon gene transcription. In summary, these results identify PSF as a repressor of STAT6-mediated transcription that functions through recruitment of HDAC to the STAT6 transcription complex, and delineates a novel regulatory mechanism of IL-4 signaling that may have implications in the pathogenesis of allergic diseases and pharmacological HDAC inhibition in lymphomas.	[Zhang, Xianzhi; Saarikettu, Juha; Silvennoinen, Olli] Univ Tampere, Tampere Univ Hosp, Inst Med Technol, FI-33014 Tampere, Finland; [Jensen, Ole Norregaard] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Dong, Lijie; Zhang, Xinyu; Fu, Xiao; Gao, Xingjie; Zhu, Mengyu; Wang, Xinting; Yang, ZhenXia; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Basic Med Coll, Dept Immunol, Tianjin 300070, Peoples R China; [Dong, Lijie; Zhang, Xinyu; Fu, Xiao; Gao, Xingjie; Zhu, Mengyu; Wang, Xinting; Yang, ZhenXia; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Tianjin Key Lab Cellular & Mol Immunol, Tianjin 300070, Peoples R China; [Dong, Lijie; Zhang, Xinyu; Fu, Xiao; Gao, Xingjie; Zhu, Mengyu; Wang, Xinting; Yang, ZhenXia; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Minist China, Key Lab Educ, Tianjin 300070, Peoples R China; [Fu, Xiao; Gao, Xingjie; Wang, Xinting; Yang, ZhenXia; Yang, Jie] Tianjin Med Univ, Lab Mol Immunol, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China	Tampere University; Tampere University Hospital; University of Southern Denmark; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Silvennoinen, O (corresponding author), Univ Tampere, Tampere Univ Hosp, Inst Med Technol, Biokatu 8, FI-33014 Tampere, Finland.	olli.silvennoinen@uta.fi; yangj@tijmu.edu.cn	Jensen, Ole N/J-1763-2012	Jensen, Ole N/0000-0003-1862-8528	Ministry of Science and Technology of China [2007AA02Z115]; NSFC [90919032, 30970562, 30670441]; 973 program [2009CB918903]; Specialized Fund for the Doctoral Program of Higher Education [20091202110001]; Tianjin Educational Committee Foundation [2008ZD01]; Tianjin Municipal Science and Technology Commission [08ZCGHHZ01900, 08JCYBJC07700]; Medical Research Council of Academy of Finland; Finnish Foundation for Cancer Research; Pirkanmaa Hospital District Research Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); NSFC(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Specialized Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tianjin Educational Committee Foundation; Tianjin Municipal Science and Technology Commission; Medical Research Council of Academy of Finland(Academy of Finland); Finnish Foundation for Cancer Research; Pirkanmaa Hospital District Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation	This work was supported by the 863 project of the Ministry of Science and Technology of China Grants 2007AA02Z115, NSFC Grants 90919032, 30970562, and 30670441, 973 program Grant 2009CB918903, Specialized Fund for the Doctoral Program of Higher Education Grant 20091202110001, Tianjin Educational Committee Foundation Grant 2008ZD01, Tianjin Municipal Science and Technology Commission Grants 08ZCGHHZ01900 and 08JCYBJC07700, Medical Research Council of Academy of Finland, Finnish Foundation for Cancer Research, Pirkanmaa Hospital District Research Foundation, Sigrid Juselius Foundation, and the Tampere Tuberculosis Foundation.	An Woojin, 2007, Subcell Biochem, V41, P351; Barnes Peter J, 2009, Proc Am Thorac Soc, V6, P693, DOI 10.1513/pats.200907-071DP; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Bhavsar P, 2008, J ALLERGY CLIN IMMUN, V121, P580, DOI 10.1016/j.jaci.2007.12.1156; Bruns HA, 2006, CRIT REV ONCOL HEMAT, V57, P245, DOI 10.1016/j.critrevonc.2005.08.005; Buglio D, 2008, BLOOD, V112, P1424, DOI 10.1182/blood-2008-01-133769; Dong XS, 2005, J BIOL CHEM, V280, P13329, DOI 10.1074/jbc.M409187200; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Goenka S, 2003, J BIOL CHEM, V278, P50362, DOI 10.1074/jbc.M305854200; Goenka S, 2007, J BIOL CHEM, V282, P18732, DOI 10.1074/jbc.M611283200; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Kaplan MH, 2007, BLOOD, V110, P4367, DOI 10.1182/blood-2007-06-098244; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Lu XQ, 2007, MOL CELL BIOL, V27, P2166, DOI 10.1128/MCB.01234-06; Lutz M, 2000, BIOCHEM SOC T, V28, P386, DOI 10.1042/0300-5127:0280386; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Ritz O, 2008, LEUKEMIA, V22, P2106, DOI 10.1038/leu.2008.85; Sehra S, 2008, J IMMUNOL, V180, P3551, DOI 10.4049/jimmunol.180.5.3551; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; Shen CH, 2001, J IMMUNOL, V166, P411, DOI 10.4049/jimmunol.166.1.411; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Valineva T, 2006, NUCLEIC ACIDS RES, V34, P3938, DOI 10.1093/nar/gkl539; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; WARREN WD, 1995, J IMMUNOL, V155, P5637; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	37	19	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3451	3459		10.1074/jbc.M110.168377	http://dx.doi.org/10.1074/jbc.M110.168377			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21106524	Green Published, hybrid			2022-12-25	WOS:000286653200031
J	Gieseking, S; Bergen, K; Di Pasquale, F; Diederichs, K; Welte, W; Marx, A				Gieseking, Sonja; Bergen, Konrad; Di Pasquale, Francesca; Diederichs, Kay; Welte, Wolfram; Marx, Andreas			Human DNA Polymerase beta Mutations Allowing Efficient Abasic Site Bypass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; APURINIC APYRIMIDINIC SITES; ACTIVE-SITE; CELLULAR-TRANSFORMATION; TRANSLESION SYNTHESIS; MISMATCH-EXTENSION; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; MUTATOR MUTANT; AMINO-ACID	The DNA of every cell in the human body gets damaged more than 50,000 times a day. The most frequent damages are abasic sites. This kind of damage blocks proceeding DNA synthesis by several DNA polymerases that are involved in DNA replication and repair. The mechanistic basis for the incapability of these DNA polymerases to bypass abasic sites is not clarified. To gain insights into the mechanistic basis, we intended to identify amino acid residues that govern for the pausing of DNA polymerase beta when incorporating a nucleotide opposite to abasic sites. Human DNA polymerase beta was chosen because it is a well characterized DNA polymerase and serves as model enzyme for studies of DNA polymerase mechanisms. Moreover, it acts as the main gap-filling enzyme in base excision repair, and human tumor studies suggest a link between DNA polymerase beta and cancer. In this study we employed high throughput screening of a library of more than 11,000 human DNA polymerase beta variants. We identified two mutants that have increased ability to incorporate a nucleotide opposite to an abasic site. We found that the substitutions E232K and T233I promote incorporation opposite the lesion. In addition to this feature, the variants have an increased activity and a lower fidelity when processing nondamaged DNA. The mutations described in this work are located in well characterized regions but have not been reported before. A crystallographic structure of one of the mutants was obtained, providing structural insights.	[Marx, Andreas] Univ Konstanz, Konstanz Res Sch Chem Biol, Dept Chem, D-78464 Constance, Germany; Univ Konstanz, Konstanz Res Sch Chem Biol, Dept Biol, D-78464 Constance, Germany	University of Konstanz; University of Konstanz	Marx, A (corresponding author), Univ Konstanz, Konstanz Res Sch Chem Biol, Dept Chem, Univ Str 10, D-78464 Constance, Germany.	andreas.marx@uni-konstanz.de			Deutsche Forschungsgemeinschaft [SPP1170]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft within SPP1170.	ABBOTTS J, 1988, BIOCHEMISTRY-US, V27, P901, DOI 10.1021/bi00403a010; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; CASASFINET JR, 1992, BIOCHEMISTRY-US, V31, P10272, DOI 10.1021/bi00157a014; Clairmont CA, 1999, P NATL ACAD SCI USA, V96, P9580, DOI 10.1073/pnas.96.17.9580; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Dalal S, 2005, BIOCHEMISTRY-US, V44, P15664, DOI 10.1021/bi051179z; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Efrati E, 1999, J BIOL CHEM, V274, P15920, DOI 10.1074/jbc.274.22.15920; Efrati E, 1997, J BIOL CHEM, V272, P2559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; Gloeckner C, 2007, ANGEW CHEM INT EDIT, V46, P3115, DOI 10.1002/anie.200603987; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Idriss HT, 2002, INT J BIOCHEM CELL B, V34, P321, DOI 10.1016/S1357-2725(01)00131-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kosa JL, 1999, J BIOL CHEM, V274, P3851, DOI 10.1074/jbc.274.6.3851; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; KUMAR A, 1990, J BIOL CHEM, V265, P2124; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; Lang TM, 2004, P NATL ACAD SCI USA, V101, P6074, DOI 10.1073/pnas.0308571101; Li SX, 1999, BIOCHEMISTRY-US, V38, P4800, DOI 10.1021/bi9827058; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; Minnick DT, 1996, J BIOL CHEM, V271, P24954, DOI 10.1074/jbc.271.40.24954; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Opresko PL, 1998, BIOCHEMISTRY-US, V37, P2111, DOI 10.1021/bi9722711; Patel PH, 2000, P NATL ACAD SCI USA, V97, P5095, DOI 10.1073/pnas.97.10.5095; Patel PH, 2001, J BIOL CHEM, V276, P5044, DOI 10.1074/jbc.M008701200; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; Saul R L, 1986, Basic Life Sci, V38, P529; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SCHAAPER RM, 1983, P NATL ACAD SCI-BIOL, V80, P487, DOI 10.1073/pnas.80.2.487; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Shah AM, 2001, J BIOL CHEM, V276, P10824, DOI 10.1074/jbc.M008680200; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Starcevic D, 2005, BIOCHEMISTRY-US, V44, P3775, DOI 10.1021/bi047956x; Starcevic D, 2004, CELL CYCLE, V3, P998; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Strerath M, 2007, CHEMBIOCHEM, V8, P395, DOI 10.1002/cbic.200600337; Summerer D, 2005, ANGEW CHEM INT EDIT, V44, P4712, DOI 10.1002/anie.200500047; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Sweasy JB, 2006, RADIAT RES, V166, P693, DOI 10.1667/RR0706.1	59	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					4011	4020		10.1074/jbc.M110.176826	http://dx.doi.org/10.1074/jbc.M110.176826			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21107011	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000286653200081
J	Mabilleau, G; Chappard, D; Sabokbar, A				Mabilleau, Guillaume; Chappard, Daniel; Sabokbar, Afsie			Role of the A20-TRAF6 Axis in Lipopolysaccharide-mediated Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TOLL-LIKE RECEPTOR; BONE-RESORPTION; RHEUMATOID-ARTHRITIS; IN-VITRO; DEFECTIVE INTERLEUKIN-1; OSTEOPROTEGERIN LIGAND; DIFFERENTIATION FACTOR; ACTIVATION	Bacterial lipopolysaccharide (LPS) has long been suggested as a potent inducer of bone loss in vivo despite controversial effects on osteoclast precursors. Recently, the role of the deubiquitinating protease A20 in regulating the LPS response in various organs was reported. In the present study, we investigated whether A20 is expressed in osteoclast cultures in response to RANKL or LPS and whether this protein plays a role in osteoclast formation and activation. Human peripheral blood mononuclear cells were cultured in the presence of M-CSF +/- RANKL +/- LPS. Although LPS induced the formation of multinucleated TRAP-positive cells expressing OSCAR, cathepsin K, and the calcitonin receptor, these cells were not capable of lacunar resorption. Release of TNF-alpha was noted in LPS-treated cultures, and the addition of a neutralizing anti-TNF-alpha antibody abrogated osteoclast formation in these cultures. A20 appeared to be a late-expressed gene in LPS-treated cultures and was associated with TRAF6 degradation and NF-kappa B inhibition. Silencing of A20 restored TRAF6 expression and NF-kappa B activation and resulted in increased bone resorption in LPS-treated cultures. A20 appeared important in the control of bone resorption and could represent a therapeutic target to treat patients with bone resorption associated with inflammatory diseases.	[Mabilleau, Guillaume] Univ Angers, INSERM, Fac Med, Inst Biol Sante,LHEA,U922, F-49933 Angers 09, France; Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Oxford	Mabilleau, G (corresponding author), Univ Angers, INSERM, Fac Med, Inst Biol Sante,LHEA,U922, 4 Rue Larrey, F-49933 Angers 09, France.	guillaume.mabilleau@univ-angers.fr	Daniel, chappard/AFK-4857-2022; Daniel, chappard/AAG-3528-2022; Mabilleau, Guillaume/M-8261-2018	Mabilleau, Guillaume/0000-0003-1445-329X	National Institute for Health and Research, Oxford University Musculoskeletal Biomedical Research Unit; Diabetes UK-R.D. Lawrence	National Institute for Health and Research, Oxford University Musculoskeletal Biomedical Research Unit; Diabetes UK-R.D. Lawrence(Diabetes UK)	This work was supported by the National Institute for Health and Research, Oxford University Musculoskeletal Biomedical Research Unit.; Recipient of a Diabetes UK-R.D. Lawrence research fellowship. To whom correspondence should be addressed: INSERM, U922, LHEA, Institut de Biologie en Sante, 4 Rue Larrey, 49933 Angers Cedex 09, France. Tel.: 33-0-244688349; Fax: 33-0-241735886; E-mail: guillaume.mabilleau@univangers.fr.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Edwards JR, 2006, ARTHRITIS RHEUM-US, V54, P1451, DOI 10.1002/art.21821; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Husheem M, 2005, CALCIFIED TISSUE INT, V76, P222, DOI 10.1007/s00223-004-0123-z; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Kudo O, 2002, J PATHOL, V198, P220, DOI 10.1002/path.1190; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mabilleau G, 2008, DIABETOLOGIA, V51, P1035, DOI 10.1007/s00125-008-0992-1; Mabilleau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004173; Massey HM, 1999, BRIT J HAEMATOL, V106, P167; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; O'Reilly SM, 2003, BIOCHEM BIOPH RES CO, V303, P586, DOI 10.1016/S0006-291X(03)00389-9; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Sakuma Y, 2000, INFECT IMMUN, V68, P6819, DOI 10.1128/IAI.68.12.6819-6825.2000; Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	47	47	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3242	3249		10.1074/jbc.M110.150300	http://dx.doi.org/10.1074/jbc.M110.150300			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21127049	Green Published, hybrid			2022-12-25	WOS:000286653200009
J	Brams, M; Gay, EA; Saez, JC; Guskov, A; van Elk, R; van der Schors, RC; Peigneur, S; Tytgat, J; Strelkov, SV; Smit, AB; Yakel, JL; Ulens, C				Brams, Marijke; Gay, Elaine A.; Saez, Jose Colon; Guskov, Albert; van Elk, Rene; van der Schors, Roel C.; Peigneur, Steve; Tytgat, Jan; Strelkov, Sergei V.; Smit, August B.; Yakel, Jerrel L.; Ulens, Chris			Crystal Structures of a Cysteine-modified Mutant in Loop D of Acetylcholine-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; AGONIST BINDING; AMINO-ACIDS; CONFORMATIONAL-CHANGES; EXTRACELLULAR DOMAIN; STRUCTURE VALIDATION; NICOTINIC RECEPTORS; GABA(A) RECEPTOR; VOLTAGE-SENSOR	Covalent modification of alpha 7 W55C nicotinic acetylcholine receptors (nAChR) with the cysteine-modifying reagent [2-(trimethylammonium) ethyl] methanethiosulfonate (MTSET+) produces receptors that are unresponsive to acetylcholine, whereas methyl methanethiolsulfonate (MMTS) produces enhanced acetylcholine-gated currents. Here, we investigate structural changes that underlie the opposite effects of MTSET+ and MMTS using acetylcholine-binding protein (AChBP), a homolog of the extracellular domain of the nAChR. Crystal structures of Y53C AChBP show that MT-SET+-modification stabilizes loop C in an extended conformation that resembles the antagonist-bound state, which parallels our observation that MTSET+ produces unresponsive W55C nAChRs. The MMTS-modified mutant in complex with acetylcholine is characterized by a contracted C-loop, similar to other agonist-bound complexes. Surprisingly, we find two acetylcholine molecules bound in the ligand-binding site, which might explain the potentiating effect of MMTS modification in W55C nAChRs. Unexpectedly, we observed in the MMTS-Y53C structure that ten phosphate ions arranged in two rings at adjacent sites are bound in the vestibule of AChBP. We mutated homologous residues in the vestibule of alpha 1 GlyR and observed a reduction in the single channel conductance, suggesting a role of this site in ion permeation. Taken together, our results demonstrate that targeted modification of a conserved aromatic residue in loop D is sufficient for a conformational switch of AChBP and that a defined region in the vestibule of the extracellular domain contributes to ion conduction in an-ion-selective Cys-loop receptors.	[Ulens, Chris] KULeuven, Lab Struct Neurobiol, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Peigneur, Steve; Tytgat, Jan] KULeuven, Toxicol Lab, B-3000 Louvain, Belgium; [Strelkov, Sergei V.] KULeuven, Lab Biocrystallog, B-3000 Louvain, Belgium; [Gay, Elaine A.; Saez, Jose Colon; Yakel, Jerrel L.] NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [van Elk, Rene; van der Schors, Roel C.; Smit, August B.] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [Guskov, Albert] Nanyang Technol Univ, Div Struct & Computat Biol, Singapore 138673, Singapore	KU Leuven; KU Leuven; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Vrije Universiteit Amsterdam; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ulens, C (corresponding author), KULeuven, Lab Struct Neurobiol, Dept Mol Cell Biol, Herestr 49,PB 601, B-3000 Louvain, Belgium.	chris.ulens@med.kuleuven.be	Guskov, Albert/G-1286-2016; Strelkov, Sergei V/G-7425-2014; Smit, August B/E-8410-2011	Guskov, Albert/0000-0003-2340-2216; Strelkov, Sergei V/0000-0001-7189-4652; Peigneur, Steve/0000-0003-0504-5702; Colon-Saez, Jose/0000-0003-4913-0300; Tytgat, Jan/0000-0003-1778-6022; Yakel, Jerrel/0000-0001-5463-674X	National Institutes of Health, NIEHS; FWO-Vlaanderen [G.0330.06, G.0257.08]; Belgian Federal Science Policy Office [P6/31]; EU [2020288]; KULeuven Onderzoekstoelage [OT/08/048]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090089] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); FWO-Vlaanderen(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); EU(European Commission); KULeuven Onderzoekstoelage(KU Leuven); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIEHS (to E. A. G., J. C. S., and J. L. Y.), by Grants FWO-Vlaanderen (G.0330.06, G.0257.08), and the Belgian Federal Science Policy Office, Interuniversity Attraction Poles program (P6/31) (to J. T.), EU FP7 2020288 NeuroCypres (to C. U., A. B. S., and R. C. vd. S.), and KULeuven Onderzoekstoelage OT/08/048 (to S. V. S. and C. U.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Akk G, 2002, J PHYSIOL-LONDON, V544, P695, DOI 10.1113/jphysiol.2002.029413; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bricogne G, 2009, BUSTER VERSION 2 8 0; Broomand A, 2008, NEURON, V59, P770, DOI 10.1016/j.neuron.2008.07.008; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dutertre S, 2006, BIOCHEM PHARMACOL, V72, P661, DOI 10.1016/j.bcp.2006.03.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hanson SM, 2008, J MED CHEM, V51, P7243, DOI 10.1021/jm800889m; Hibbs RE, 2006, J MOL NEUROSCI, V30, P73, DOI 10.1385/JMN:30:1:73; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein NA, 2007, J BIOL CHEM, V282, P5899, DOI 10.1074/jbc.M609202200; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Parker MJ, 2001, J PHARMACOL EXP THER, V299, P385; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Suryanarayanan A, 2005, BIOCHEMISTRY-US, V44, P9140, DOI 10.1021/bi050661e; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Toshima K, 2009, NEUROPHARMACOLOGY, V56, P264, DOI 10.1016/j.neuropharm.2008.08.022; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Ulens C, 2009, J MED CHEM, V52, P2372, DOI 10.1021/jm801400g; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Yi MG, 2008, P NATL ACAD SCI USA, V105, P8280, DOI 10.1073/pnas.0710530105; Young GT, 2007, MOL PHARMACOL, V71, P389, DOI 10.1124/ml.106.030809; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	52	41	41	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4420	4428		10.1074/jbc.M110.188730	http://dx.doi.org/10.1074/jbc.M110.188730			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115477	Green Published, hybrid			2022-12-25	WOS:000286975700042
J	Essalmani, R; Susan-Resiga, D; Chamberland, A; Abifadel, M; Creemers, JW; Boileau, C; Seidah, NG; Prat, A				Essalmani, Rachid; Susan-Resiga, Delia; Chamberland, Ann; Abifadel, Marianne; Creemers, John W.; Boileau, Catherine; Seidah, Nabil G.; Prat, Annik			In Vivo Evidence That Furin from Hepatocytes Inactivates PCSK9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTASE SUBTILISIN/KEXIN TYPE-9; PROPROTEIN CONVERTASES; FAMILIAL HYPERCHOLESTEROLEMIA; RECEPTOR DEGRADATION; LIVER-REGENERATION; SECRETED PCSK9; MOUSE-LIVER; MUTATIONS; CHOLESTEROL; GENE	The proprotein convertase PCSK9 plays a key role in cholesterol homeostasis by binding the LDL receptor and targeting it toward degradation. PCSK9 is strongly expressed in the liver and is found in human and mouse plasma as mature (similar to 62 kDa) and inactivated (similar to 55 kDa) forms. Ex vivo data showed that human PCSK9 is inactivated by cleavage at Arg218 down arrow by the overexpressed convertases furin and PC5/6A. Analysis of the plasma of human heterozygotes for R218S and F216L mutations revealed a similar to 50% reduction in the levels of the similar to 55-kDa form. To identify the convertase(s) responsible for cleavage at Arg(218) in vivo, we inactivated the genes of furin and/or PC5/6 specifically in hepatocytes. The PCSK9-inactivated form was strongly reduced in mice lacking furin in hepatocytes (Fur-hKO) and only slightly reduced in PC5/6-hKO plasma. In agreement with a key role of furin in regulating PCSK9 activity in vivo, we observed an overall 26% drop in the LDL receptor protein levels of Fur-hKO livers, likely due to the compound effects of a 35% increase in PCSK9 mRNA levels and the loss of PCSK9 cleavage, suggesting a higher activity of PCSK9 in these mice. Overexpression of PCSK9 in primary hepatocytes obtained from these mice revealed that only full-length, membrane-bound, but not soluble, furin is the cognate convertase. We conclude that in hepatocytes furin regulates PCSK9 mRNA levels and is the key in vivo-inactivating protease of circulating PCSK9.	[Seidah, Nabil G.; Prat, Annik] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Creemers, John W.] Katholieke Univ Leuven, Biochem Neuroendocrinol Lab, Ctr Human Genet, B-3000 Louvain, Belgium; [Abifadel, Marianne; Boileau, Catherine] Hop Bichat Claude Bernard, INSERM, UMR698, F-75877 Paris 18, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; KU Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Prat, A (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	prata@ircm.qc.ca	boileau, catherine/M-4482-2017; Seidah, Nabil/I-3596-2013; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017; Abifadel, Marianne/ABH-5370-2020; Prat, Annik/S-6757-2018	boileau, catherine/0000-0002-0371-7539; Seidah, Nabil/0000-0001-6503-9342; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Prat, Annik/0000-0002-8007-5277; ABIFADEL, Marianne/0000-0001-7645-8323	Canadian Institutes of Health Research [MOP-102741, CTP-82946]; Strauss Foundation; Canada Chair [201652]; Fonds voor Wentenschappelijk Vlaanderen; Geconcerteerde Onderzoeks Actie [2008/16]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair; Fonds voor Wentenschappelijk Vlaanderen; Geconcerteerde Onderzoeks Actie	This work was supported by Canadian Institutes of Health Research Grants MOP-102741 and CTP-82946 (to N. G. S.), a Strauss Foundation grant (to N. G. S.), Canada Chair 201652 (to N. G. S.), Fonds voor Wentenschappelijk Vlaanderen (to J. W. C.), and Geconcerteerde Onderzoeks Actie 2008/16 Grant (to J. W. C.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Constam DB, 2000, GENE DEV, V14, P1146; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Kourimate S, 2008, J BIOL CHEM, V283, P9666, DOI 10.1074/jbc.M705831200; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Mayne J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-22; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Persson L, 2010, ARTERIOSCL THROM VAS, V30, P2666, DOI 10.1161/ATVBAHA.110.214130; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1999, BRAIN RES, V848, pA14; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	35	118	125	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4257	4263		10.1074/jbc.M110.192104	http://dx.doi.org/10.1074/jbc.M110.192104			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21147780	Green Published, hybrid			2022-12-25	WOS:000286975700024
J	Li, JM; Wang, JJ; Zhang, SX				Li, Jingming; Wang, Joshua J.; Zhang, Sarah X.			Preconditioning with Endoplasmic Reticulum Stress Mitigates Retinal Endothelial Inflammation via Activation of X-box Binding Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; OXYGEN-INDUCED RETINOPATHY; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; BARRIER BREAKDOWN; MACULAR EDEMA; ER STRESS; GROWTH-FACTOR; P-SELECTIN; TNF-ALPHA	Endoplasmic reticulum (ER) stress is widely implicated in various pathological conditions such as diabetes. Previously, we reported that enhanced ER stress contributes to inflammation and vascular damage in diabetic and ischemia-induced retinopathy. However, the exact role of the signaling pathways activated by ER stress in vascular inflammation remains poorly understood. In the present study, we investigated the role of X-box binding protein 1 (XBP1) in retinal adhesion molecule expression, leukostasis, and vascular leakage. Exposure of human retinal endothelial cells to low dose ER stress inducers resulted in a robust activation of XBP1 but did not affect inflammatory gene expression. However, ER stress preconditioning almost completely abolished TNF-alpha-elicited NF-kappa B activation and adhesion molecule ICAM-1 and VCAM-1 expression. Pharmaceutical inhibition of XBP1 activation or knockdown of XBP1 by siRNA markedly attenuated the effects of preconditioning on inflammation. Moreover, loss of XBP1 led to an increase in ICAM-1 and VCAM-1 expression. Conversely, overexpression of spliced XBP1 attenuated TNF-alpha-induced phosphorylation of IKK, I kappa B alpha, and NF-kappa B p65, accompanied by decreased NF-kappa B activity and reduced adhesion molecule expression. Finally, in vivo studies show that activation of XBP1 by ER stress preconditioning prevents TNF-alpha-induced ICAM-1 and VCAM-1 expression, leukostasis, and vascular leakage in mouse retinas. These results collectively indicate a protective effect of ER stress preconditioning against retinal endothelial inflammation, which is likely through activation of XBP1-mediated unfolded protein response (UPR) and inhibition of NF-kappa B activation.	[Li, Jingming; Wang, Joshua J.; Zhang, Sarah X.] Univ Oklahoma, Hlth Sci Ctr, Dept Med Endocrinol & Diabet, Oklahoma City, OK 73104 USA; [Li, Jingming; Wang, Joshua J.; Zhang, Sarah X.] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK 73104 USA; [Zhang, Sarah X.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhang, SX (corresponding author), 941 Stanton L Young Blvd,BSEB331A, Oklahoma City, OK 73104 USA.	xin-zhang@ouhsc.edu	li, jingming/J-5760-2012	li, jingming/0000-0003-2300-8614	National Institutes of Health [EY019949, P20RR024215]; Juvenile Diabetes Research Foundation [5-2009-475]; Oklahoma Center for the Advancement of Science and Technology [HR07-167, HR10-060]; American Health Assistance Foundation [M2010088]; Harold Hamm Oklahoma Diabetes Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Oklahoma Center for the Advancement of Science and Technology; American Health Assistance Foundation(BrightFocus Foundation); Harold Hamm Oklahoma Diabetes Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019949 and P20RR024215. This work was also supported by Research Award 5-2009-475 from the Juvenile Diabetes Research Foundation, Research Grants HR07-167 and HR10-060 from the Oklahoma Center for the Advancement of Science and Technology, Research Grant M2010088 from the American Health Assistance Foundation, and the Dr. William Talley Research Award from the Harold Hamm Oklahoma Diabetes Center.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Aiello LP, 2000, KIDNEY INT, V58, pS113, DOI 10.1046/j.1523-1755.2000.07718.x; Bayat H, 2008, ARTERIOSCL THROM VAS, V28, P127, DOI 10.1161/ATVBAHA.107.150250; Behl Y, 2008, AM J PATHOL, V172, P1411, DOI 10.2353/ajpath.2008.071070; De La Cruz MDJP, 2004, DIABETES-METAB RES, V20, P91; Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037; Gardner TW, 2008, CURR DIABETES REP, V8, P263, DOI 10.1007/s11892-008-0047-5; Hayakawa K, 2008, BIOCHEM BIOPH RES CO, V365, P47, DOI 10.1016/j.bbrc.2007.10.115; Hayakawa K, 2009, J IMMUNOL, V182, P1182, DOI 10.4049/jimmunol.182.2.1182; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Inagi R, 2008, J AM SOC NEPHROL, V19, P915, DOI 10.1681/ASN.2007070745; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Joussen AM, 2009, MOL VIS, V15, P1418; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kawamura T, 2008, J ANTIBIOT, V61, P312, DOI 10.1038/ja.2008.44; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; KLEIN R, 1992, DIABETES CARE, V15, P1875, DOI 10.2337/diacare.15.12.1875; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Li JM, 2009, EXP EYE RES, V89, P71, DOI 10.1016/j.exer.2009.02.013; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miller JW, 1997, DIABETES METAB REV, V13, P37, DOI 10.1002/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K; Mori K, 2002, INVEST OPHTH VIS SCI, V43, pU956; Mullins RF, 2006, MOL VIS, V12, P224; Norman MU, 2008, J LEUKOCYTE BIOL, V84, P68, DOI 10.1189/jlb.1107796; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Peyrou M, 2007, TOXICOL IN VITRO, V21, P878, DOI 10.1016/j.tiv.2007.03.001; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Shestakova MV, 2002, TERAPEVT ARKH, V74, P24; TANG SB, 1995, GRAEF ARCH CLIN EXP, V233, P21, DOI 10.1007/BF00177781; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Zhang SX, 2005, CURR EYE RES, V30, P681, DOI 10.1080/02713680590934102; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9	42	88	91	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4912	4921		10.1074/jbc.M110.199729	http://dx.doi.org/10.1074/jbc.M110.199729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21138840	Green Published, hybrid			2022-12-25	WOS:000286975700087
J	Sever, D; Eldor, R; Sadoun, G; Amior, L; Dubois, D; Boitard, C; Aflalo, C; Melloul, D				Sever, Dror; Eldor, Roy; Sadoun, Gadi; Amior, Livnat; Dubois, Daniele; Boitard, Christian; Aflalo, Claude; Melloul, Danielle			Evaluation of impaired beta-cell function in nonobese-diabetic (NOD) mouse model using bioluminescence imaging	FASEB JOURNAL			English	Article						diabetes mellitus; beta-cell mass; firefly luciferase; cytokines	LOCALIZED FIREFLY LUCIFERASE; IN-VIVO; INSULIN-SECRETION; PANCREATIC-ISLETS; INFLAMMATION; MASS; ONSET; TRANSPLANTATION; AUTOIMMUNITY; PROGRESSION	Insulin-producing pancreatic beta cells are functionally impaired or destroyed in diabetes mellitus. The onset of type 1 diabetes (T1D) represents the culmination of a prolonged prediabetic phase of immune-mediated beta-cell destruction. To assess the in vivo metabolic status of these cells, we used the ATP-sensitive firefly luciferase bioluminescence imaging approach, as a noninvasive probe to monitor pathological alterations in beta-cell function in the nonobese-diabetic (NOD) mouse model of T1D. Hence, we generated the ToI beta-NOD transgenic mice in which doxycycline-inducible luciferase gene is selectively expressed in beta cells. A sharp reduction in bioluminescence emitted in vivo from beta cells at the early stages, preceded by several weeks of a limited reduction in beta-cell mass. Since this decline could be due to the ongoing inflammatory process occurring in vivo, we exposed control islets to inflammatory cytokines and observed a dramatic decrease in luciferase luminescence, which appears to be due in part to a decrease in protein levels and a drop in intracellular ATP levels. This is the first evidence that selective expression of the luciferase gene represents a sensitive method for noninvasive in vivo monitoring of early beta-cell dysfunction, subtle metabolic changes, such as endogenous ATP levels, indicative of a pathological condition in a tissue at the cellular level.-Sever, D., Eldor, R., Sadoun, G., Amior, L., Dubois, D., Boitard, C., Aflalo, C., Melloul, D. Evaluation of impaired beta-cell function in nonobese-diabetic (NOD) mouse model using bioluminescence imaging. FASEB J. 25, 676-684 (2011). www.fasebj.org	[Sever, Dror; Eldor, Roy; Sadoun, Gadi; Amior, Livnat; Melloul, Danielle] Hadassah Univ Hosp, Dept Endocrinol, IL-91120 Jerusalem, Israel; [Dubois, Daniele; Boitard, Christian] Cochin St Vincent de Paul, INSERM, U561, Paris, France; [Aflalo, Claude] Ben Gurion Univ Negev, Inst Agr & Biotechnol Drylands, Blaustein Inst Desert Res, Sede Boqer, Israel	Hebrew University of Jerusalem; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Ben Gurion University	Melloul, D (corresponding author), Hadassah Univ Hosp, Dept Endocrinol, POB 12000, IL-91120 Jerusalem, Israel.	daniellem@ekmd.huji.ac.il	Eldor, Roy/AAD-4397-2022; Aflalo, Claude/H-4638-2011	Aflalo, Claude/0000-0002-3864-0666; Dubois-Laforgue, Daniele/0000-0003-3287-6309; BOITARD, Christian/0000-0003-3985-9405	Juvenile Diabetes Research Foundation [1-2007-60]; European Union [036903]; Israel Ministry of Health	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); Israel Ministry of Health	The authors thank Decio Eizirik, Chantal Mathieu, and Guy Rutter for helpful discussions. The authors thank Dr. Ronit Sionov for critical reading of the manuscript; Eli Reich, Roy Abel, Adi Tamari, and Nilly Lador-Carp for excellent assistance; and Evelyne Zeira and Hagit Yotfat for assistance with the bioluminescence imaging; as well as Hadas Zohar for helping with graphic design. The authors also thank Yael Morgenstern for the maintenance of the ToI beta-NOD colony. This work was supported by grants from the Juvenile Diabetes Research Foundation (1-2007-60), the European Union (STREP Savebeta, contract 036903) in Framework Programme 6, and the Israel Ministry of Health.	Achenbach P, 2005, DIABETES, V54, pA312; Aflalo C, 1997, J BIOENERG BIOMEMBR, V29, P549, DOI 10.1023/A:1022478917573; AFLALO C, 1991, INT REV CYTOL, V130, P269, DOI 10.1016/S0074-7696(08)61506-5; Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Antkowiak PF, 2009, AM J PHYSIOL-ENDOC M, V296, pE573, DOI 10.1152/ajpendo.90336.2008; Chen XJ, 2006, TRANSPLANTATION, V81, P1421, DOI 10.1097/01.tp.0000206109.71181.bf; Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.0404307101; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Faideau B, 2005, DIABETES, V54, pS87, DOI 10.2337/diabetes.54.suppl_2.S87; Fowler M, 2005, TRANSPLANTATION, V79, P768, DOI 10.1097/01.TP.0000152798.03204.5C; Gimi B, 2006, CELL TRANSPLANT, V15, P195, DOI 10.3727/000000006783982151; Honigman A, 2001, MOL THER, V4, P239, DOI 10.1006/mthe.2001.0437; Kawasaki E, 2004, DIABETES RES CLIN PR, V66, pS27, DOI 10.1016/j.diabres.2003.09.015; Kay TWH, 2000, TRENDS ENDOCRIN MET, V11, P11, DOI 10.1016/S1043-2760(99)00210-6; Klinke DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001374; Lin M, 2008, FRONT BIOSCI-LANDMRK, V13, P4558, DOI 10.2741/3023; Lundin A, 2000, METHOD ENZYMOL, V305, P346; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mauricio D, 1998, DIABETES, V47, P1537, DOI 10.2337/diabetes.47.10.1537; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Meredith M, 1996, DIABETES, V45, P1783, DOI 10.2337/diabetes.45.12.1783; Park SY, 2009, HORM METAB RES, V41, P1, DOI 10.1055/s-0028-1087209; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; Paty BW, 2004, TRANSPLANTATION, V77, P1133, DOI 10.1097/01.TP.0000113231.90613.0E; Pipeleers D, 2008, DIABETES OBES METAB, V10, P54, DOI 10.1111/j.1463-1326.2008.00941.x; Reddy S, 2008, J MOL HISTOL, V39, P25, DOI 10.1007/s10735-007-9122-5; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Shimada A, 1996, DIABETES, V45, P1063, DOI 10.2337/diabetes.45.8.1063; Smith SJ, 2006, MOL IMAGING, V5, P65, DOI 10.2310/7290.2006.00007; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Steele C, 2004, DIABETES, V53, P426, DOI 10.2337/diabetes.53.2.426; STRANDELL E, 1990, J CLIN INVEST, V85, P1944, DOI 10.1172/JCI114657; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; Turvey SE, 2005, J CLIN INVEST, V115, P2454, DOI 10.1172/JCI25048; Virostko J, 2004, MOL IMAGING, V3, P333, DOI 10.1162/1535350042973508; Virostko J, 2009, MOL IMAGING BIOL, V11, P204, DOI 10.1007/s11307-008-0193-9; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x	42	20	21	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2011	25	2					676	684		10.1096/fj.10-158121	http://dx.doi.org/10.1096/fj.10-158121			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	713GZ	21118902				2022-12-25	WOS:000286724800025
J	Sultan, A; Nesslany, F; Violet, M; Begard, S; Loyens, A; Talahari, S; Mansuroglu, Z; Marzin, D; Sergeant, N; Humez, S; Colin, M; Bonnefoy, E; Buee, L; Galas, MC				Sultan, Audrey; Nesslany, Fabrice; Violet, Marie; Begard, Severine; Loyens, Anne; Talahari, Smail; Mansuroglu, Zeyni; Marzin, Daniel; Sergeant, Nicolas; Humez, Sandrine; Colin, Morvane; Bonnefoy, Eliette; Buee, Luc; Galas, Marie-Christine			Nuclear Tau, a Key Player in Neuronal DNA Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GEL-ELECTROPHORESIS ASSAY; HUMAN NEUROBLASTOMA-CELLS; ALZHEIMERS-DISEASE; COMET ASSAY; HEAT-SHOCK; IN-VITRO; PROTEIN; PHOSPHORYLATION; DAMAGE; BRAIN	Tau, a neuronal protein involved in neurodegenerative disorders such as Alzheimer disease, which is primarily described as a microtubule-associated protein, has also been observed in the nuclei of neuronal and non-neuronal cells. However, the function of the nuclear form of Tau in neurons has not yet been elucidated. In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus. These results highlight a novel role for nuclear Tau as a key player in early stress response.	[Sultan, Audrey; Violet, Marie; Begard, Severine; Loyens, Anne; Sergeant, Nicolas; Humez, Sandrine; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] INSERM, UMR837, F-59045 Lille, France; [Sultan, Audrey; Violet, Marie; Begard, Severine; Loyens, Anne; Sergeant, Nicolas; Humez, Sandrine; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] Univ Lille 2, Jean Pierre Aubert Res Ctr, Inst Med Predict & Rech Therapeut, Fac Med Pole Rech, Lille, France; [Sultan, Audrey; Violet, Marie; Begard, Severine; Loyens, Anne; Sergeant, Nicolas; Humez, Sandrine; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] CHU Lille, F-59037 Lille, France; [Nesslany, Fabrice; Talahari, Smail; Marzin, Daniel] Inst Pasteur, Lab Toxicol Genet, F-59019 Lille, France; [Mansuroglu, Zeyni; Bonnefoy, Eliette] Univ Paris 05, CNRS, FRE 3235, F-75270 Paris 06, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Galas, MC (corresponding author), INSERM, U837, 1 Rue Michel Polonovski, F-59045 Lille, France.	marie-christine.galas@inserm.fr	Sergeant, Nicolas/O-5467-2017; BUEE, Luc/B-3126-2010; Galas, Marie-Christine/AAL-9812-2020; LICEND, CEMND/F-1296-2015	Sergeant, Nicolas/0000-0003-1448-124X; BUEE, Luc/0000-0002-6261-4230; Galas, Marie-Christine/0000-0002-3766-7103; Colin, Morvane/0000-0003-0611-4167	Inserm; CNRS; IMPRT; University Lille 2; Region Nord/Pas-de-Calais; Fonds Europeen de Development Regional; DN2M; ANR [ANR-08-MNPS002/AMYTOXTAU]; European Community MEMOSAD [200611]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); IMPRT; University Lille 2; Region Nord/Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Fonds Europeen de Development Regional; DN2M; ANR(French National Research Agency (ANR)); European Community MEMOSAD	This work was supported by Inserm, CNRS, IMPRT, University Lille 2, Region Nord/Pas-de-Calais, Fonds Europeen de Development Regional, DN2M, as well as grants from ANR-08-MNPS002/AMYTOXTAU and from the European Community MEMOSAD (FP7 Contract 200611).	ASHBY J, 1995, MUTAGENESIS, V10, P85, DOI 10.1093/mutage/10.2.85; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRADY RM, 1995, NEUROBIOL AGING, V16, P479; Bruskov VI, 2002, NUCLEIC ACIDS RES, V30, P1354, DOI 10.1093/nar/30.6.1354; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Coppede F, 2009, CURR ALZHEIMER RES, V6, P36, DOI 10.2174/156720509787313970; Crampton N, 2009, MOL BIOL CELL, V20, P5106, DOI 10.1091/mbc.E09-05-0397; Cross DC, 2000, J CELL BIOCHEM, V78, P305, DOI 10.1002/(SICI)1097-4644(20000801)78:2<305::AID-JCB12>3.3.CO;2-N; Daniel S, 2008, BBA-MOL CELL RES, V1783, P1003, DOI 10.1016/j.bbamcr.2008.01.014; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Giavara S, 2005, CURR BIOL, V15, P68, DOI 10.1016/j.cub.2004.12.065; Goldbaum O, 2002, GLIA, V40, P271, DOI 10.1002/glia.10119; GREENWOOD JA, 1995, EXP CELL RES, V220, P332, DOI 10.1006/excr.1995.1323; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; HELLMAN B, 1995, MUTAT RES-DNA REPAIR, V336, P123, DOI 10.1016/0921-8777(94)00047-A; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Hua Q, 2002, PROTEIN PEPTIDE LETT, V9, P349, DOI 10.2174/0929866023408652; Iijima-Ando K, 2010, HUM MOL GENET, V19, P1930, DOI 10.1093/hmg/ddq068; Karuppagounder SS, 2008, NEUROCHEM RES, V33, P1365, DOI 10.1007/s11064-008-9594-z; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kodiha M, 2005, AM J PHYSIOL-CELL PH, V289, pC1034, DOI 10.1152/ajpcell.00590.2004; Lee KS, 2008, P NATL ACAD SCI USA, V105, P2806, DOI 10.1073/pnas.0708244105; Lemay J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-47; LINDWALL G, 1984, J BIOL CHEM, V259, P2241; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Merk O, 1999, ENVIRON MOL MUTAGEN, V33, P167, DOI 10.1002/(SICI)1098-2280(1999)33:2<167::AID-EM9>3.0.CO;2-D; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Padmaraju V, 2010, NEUROCHEM INT, V57, P51, DOI 10.1016/j.neuint.2010.04.013; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Rogee S, 2007, MOL THER, V15, P1963, DOI 10.1038/sj.mt.6300283; Roque A, 2004, NUCLEIC ACIDS RES, V32, P6111, DOI 10.1093/nar/gkh945; Rossi G, 2008, CELL CYCLE, V7, P1788, DOI 10.4161/cc.7.12.6012; Rutten BPF, 2007, NEUROBIOL AGING, V28, P91, DOI 10.1016/j.neurobiolaging.2005.10.019; Sestili P, 2006, MUTAT RES-GEN TOX EN, V607, P205, DOI 10.1016/j.mrgentox.2006.04.018; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Shanavas A, 2000, P NATL ACAD SCI USA, V97, P14139, DOI 10.1073/pnas.97.26.14139; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Thurston VC, 1996, CHROMOSOMA, V105, P20, DOI 10.1007/BF02510035; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; WANG Y, 1993, J CELL BIOL, V121, P257, DOI 10.1083/jcb.121.2.257; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Xu SL, 2006, BIOCHEM BIOPH RES CO, V342, P330, DOI 10.1016/j.bbrc.2006.01.148; Yoshimura Y, 2003, NEUROSCI LETT, V353, P185, DOI 10.1016/j.neulet.2003.09.037; Zhao QL, 2006, FREE RADICAL BIO MED, V40, P1131, DOI 10.1016/j.freeradbiomed.2005.10.064	51	261	271	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4566	4575		10.1074/jbc.M110.199976	http://dx.doi.org/10.1074/jbc.M110.199976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131359	hybrid, Green Published			2022-12-25	WOS:000286975700057
J	Chan, P; Gabay, M; Wright, FA; Kan, W; Oner, SS; Lanier, SM; Smrcka, AV; Blumer, JB; Tall, GG				Chan, PuiYee; Gabay, Meital; Wright, Forrest A.; Kan, Wei; Oner, Sukru S.; Lanier, Stephen M.; Smrcka, Alan V.; Blumer, Joe B.; Tall, Gregory G.			Purification of Heterotrimeric G Protein alpha Subunits by GST-Ric-8 Association PRIMARY CHARACTERIZATION OF PURIFIED G alpha(olf)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING REGULATORY PROTEINS; NUCLEOTIDE EXCHANGE FACTOR; ASYMMETRIC CELL-DIVISION; PHOSPHOLIPASE-C-BETA; CONFORMATIONAL-CHANGES; ADENYLYL-CYCLASE; PLASMA-MEMBRANE; CORTICAL LOCALIZATION; GUANINE-NUCLEOTIDES; LIMITED PROTEOLYSIS	Ric-8A and Ric-8B are nonreceptor G protein guanine nucleotide exchange factors that collectively bind the four subfamilies of G protein alpha subunits. Co-expression of G alpha subunits with Ric-8A or Ric-8B in HEK293 cells or insect cells greatly promoted G alpha protein expression. We exploited these characteristics of Ric-8 proteins to develop a simplified method for recombinant G protein alpha subunit purification that was applicable to all G alpha subunit classes. The method allowed production of the olfactory adenylyl cyclase stimulatory protein G alpha(olf) for the first time and unprecedented yield of G alpha(q) and G alpha(13). G alpha subunits were co-expressed with GST-tagged Ric-8A or Ric-8B in insect cells. GST-Ric-8-G alpha complexes were isolated from whole cell detergent lysates with glutathione-Sepharose. G alpha subunits were dissociated from GST-Ric-8 with GDP-AlF4- (GTP mimicry) and found to be > 80% pure, bind guanosine 5 '-[gamma -thio]triphosphate (GTP gamma S), and stimulate appropriate G protein effector enzymes. A primary characterization of G alpha(olf) showed that it binds GTP gamma S at a rate marginally slower than G alpha(s short) and directly activates adenylyl cyclase isoforms 3, 5, and 6 with less efficacy than G alpha(s short).	[Chan, PuiYee; Gabay, Meital; Wright, Forrest A.; Kan, Wei; Smrcka, Alan V.; Tall, Gregory G.] Univ Rochester, Dept Physiol & Pharmacol, Med Ctr, Rochester, NY 14642 USA; [Oner, Sukru S.; Lanier, Stephen M.; Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA	University of Rochester; Medical University of South Carolina	Tall, GG (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	gregory_tall@urmc.rochester.edu	Oner, Sukru/K-8032-2012	Oner, Sukru/0000-0002-8864-7356; Kan, Wei/0000-0002-6830-6714; Blumer, Joe/0000-0002-0020-3815; Lanier, Stephen/0000-0002-2740-7607; Chan, PuiYee/0000-0002-9133-9506	National Institutes of Health [GM088242, GM053536, GM086510, NS24821, DA025896]; New York State Stem Cell Science [C024307]; National Institute on Drug Abuse [T32 DA07232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081772, R01GM053536, R01GM088242, R01GM086510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896, T32DA007232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM088242 (to G. G. T.), GM053536 (to A. V. S.), GM086510 (to J. B. B.), and NS24821 and DA025896 (to S. M. L.). This work was also supported by New York State Stem Cell Science Grant C024307 (to G. G. T.) and National Institute on Drug Abuse Grant T32 DA07232 (to P. C.).	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Biddlecome GH, 1996, J BIOL CHEM, V271, P33705; Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; FUNG BKK, 1983, J BIOL CHEM, V258, P503; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HALLIDAY KR, 1984, J BIOL CHEM, V259, P516; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; HEPLER JR, 1994, METHOD ENZYMOL, V237, P191; HUDSON TH, 1981, J BIOL CHEM, V256, P1459; JONES DT, 1990, J BIOL CHEM, V265, P2671; Kerr DS, 2008, MOL CELL NEUROSCI, V38, P341, DOI 10.1016/j.mcn.2008.03.006; Klattenhoff C, 2003, J CELL PHYSIOL, V195, P151, DOI 10.1002/jcp.10300; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; KOZASA T, 1999, PROTEINS TECHNIQUES, P23; LEE E, 1994, METHOD ENZYMOL, V237, P146; Lehmann DM, 2007, METHOD ENZYMOL, V434, P29, DOI 10.1016/S0076-6879(07)34003-2; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LINDER ME, 1990, J BIOL CHEM, V265, P8243; Liu HY, 2001, J NEUROCHEM, V78, P325, DOI 10.1046/j.1471-4159.2001.00422.x; Malik S, 2005, MOL PHARMACOL, V68, P129, DOI 10.1124/mol.104.010116; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; MUMBY SM, 1991, METHOD ENZYMOL, V195, P215; Nagai Y, 2010, J BIOL CHEM, V285, P11114, DOI 10.1074/jbc.M109.063313; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; SINGER WD, 1994, J BIOL CHEM, V269, P19796; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; SVOBODA P, 1994, EUR J BIOCHEM, V224, P455, DOI 10.1111/j.1432-1033.1994.00455.x; SVOBODA P, 1992, EUR J BIOCHEM, V208, P693, DOI 10.1111/j.1432-1033.1992.tb17236.x; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tall GG, 2004, METHOD ENZYMOL, V390, P377; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; WINSLOW JW, 1986, J BIOL CHEM, V261, P7571; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X	47	48	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2625	2635		10.1074/jbc.M110.178897	http://dx.doi.org/10.1074/jbc.M110.178897			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21115479	Green Published, hybrid			2022-12-25	WOS:000286464300028
J	Bousema, T; Roeffen, W; Meijerink, H; Mwerinde, H; Mwakalinga, S; van Gemert, GJ; van de Vegte-Bolmer, M; Mosha, F; Targett, G; Riley, EM; Sauerwein, R; Drakeley, C				Bousema, Teun; Roeffen, Will; Meijerink, Hinta; Mwerinde, Harry; Mwakalinga, Steve; van Gemert, Geert-Jan; van de Vegte-Bolmer, Marga; Mosha, Frank; Targett, Geoffrey; Riley, Eleanor M.; Sauerwein, Robert; Drakeley, Chris			The Dynamics of Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs230 & Pfs48/45 in a Low Endemic Area in Tanzania	PLOS ONE			English	Article							TRANSMISSION-BLOCKING IMMUNITY; HUMAN-ANTIBODY RESPONSES; MALARIA TRANSMISSION; SURFACE-ANTIGEN; GAMETOCYTES; AGE; REACTIVITY; REDUCTION; PAPUA; SERA	Background: Naturally acquired immune responses against sexual stages of P. falciparum can reduce the transmission of malaria from humans to mosquitoes. These antigens are candidate transmission-blocking vaccines but little is known about the acquisition of sexual stage immunity after exposure to gametocytes, or their longevity and functionality. We conducted a longitudinal study on functional sexual stage immune responses. Methodology/Principal Findings: Parasitaemic individuals (n = 116) were recruited at a health centre in Lower Moshi, Tanzania. Patients presented with gametocytes (n = 16), developed circulating gametocytes by day 7 (n = 69) or between day 7 and 14 (n = 10) after treatment or did not develop gametocytes (n = 21). Serum samples were collected on the first day of gametocytaemia and 28 and 84 days post-enrolment (or d7, 28, 84 after enrolment from gametocyte-negative individuals). Antibody responses to sexual stage antigens Pfs230 and Pfs48/45 were detected in 20.7% (72/348) and 15.2% (53/348) of the samples, respectively, and were less prevalent than antibodies against asexual stage antigens MSP-1(19) (48.1%; 137/285) and AMA-1 (52.4%; 129/246)(p<0.001). The prevalence of anti-Pfs230 (p = 0.026) and anti-Pfs48/45 antibodies (p = 0.017) increased with longer duration of gametocyte exposure and had an estimated half-life of approximately 3 months. Membrane feeding experiments demonstrated a strong association between the prevalence and concentration of Pfs230 and Pfs48/45 antibodies and transmission reducing activity (TRA, p<0.01). Conclusions/Significance: In a longitudinal study, anti-Pfs230 and Pf48/45 antibodies developed rapidly after exposure to gametocytes and were strongly associated with transmission-reducing activity. Our data indicate that the extent of antigen exposure is important in eliciting functional transmission-reducing immune responses.	[Bousema, Teun; Targett, Geoffrey; Riley, Eleanor M.; Drakeley, Chris] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1E 7HT, England; [Bousema, Teun; Mwakalinga, Steve; Mosha, Frank; Drakeley, Chris] Joint Malaria Programme, Moshi, Tanzania; [Roeffen, Will; Meijerink, Hinta; van Gemert, Geert-Jan; van de Vegte-Bolmer, Marga; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Mwerinde, Harry] Tanzania Plantat Co, TPC Dist Designated Hosp, Lower Moshi, Tanzania; [Mwakalinga, Steve] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Mosha, Frank] Kilimanjaro Clin Res Inst, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; Radboud University Nijmegen; University of Copenhagen	Bousema, T (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England.	chris.drakeley@lshtm.ac.uk	Roeffen, W.F.G./L-4607-2015; Sauerwein, Robert/C-8519-2013; Bousema, Teun/N-3574-2014; Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013	Bousema, Teun/0000-0003-2666-094X; Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570; Drakeley, Chris/0000-0003-4863-075X	Wellcome Trust [063516] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; Babiker HA, 2008, TRENDS PARASITOL, V24, P525, DOI 10.1016/j.pt.2008.08.001; Baird JK, 1998, J INFECT DIS, V178, P592, DOI 10.1086/517482; BAIRD JK, 1995, PARASITOL TODAY, V11, P105, DOI 10.1016/0169-4758(95)80167-7; Baton LA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-15; Bousema JT, 2007, PARASITE IMMUNOL, V29, P309, DOI 10.1111/j.1365-3024.2007.00948.x; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Bousema JT, 2006, AM J TROP MED HYG, V74, P425; Bousema JT, 2006, CURR MOL MED, V6, P223, DOI 10.2174/156652406776055140; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Buckling A, 2001, P ROY SOC B-BIOL SCI, V268, P2325, DOI 10.1098/rspb.2001.1808; CARTER R, 1990, PARASITE IMMUNOL, V12, P587, DOI 10.1111/j.1365-3024.1990.tb00990.x; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; DELGIUDICE G, 1990, B WORLD HEALTH ORGAN, V68, P191; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; Drakeley CJ, 2006, PARASITE IMMUNOL, V28, P185, DOI 10.1111/j.1365-3024.2005.00818.x; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Drakeley CJ, 2004, PARASITE IMMUNOL, V26, P159, DOI 10.1111/j.0141-9838.2004.00696.x; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; Fonjungo PN, 1999, INFECT IMMUN, V67, P2975, DOI 10.1128/IAI.67.6.2975-2985.1999; Giha HA, 2010, VACCINE, V28, P1732, DOI 10.1016/j.vaccine.2009.12.018; Girard MP, 2007, VACCINE, V25, P1567, DOI 10.1016/j.vaccine.2006.09.074; GRAVES PM, 1988, PARASITE IMMUNOL, V10, P209, DOI 10.1111/j.1365-3024.1988.tb00215.x; GRAVES PM, 1990, AM J TROP MED HYG, V42, P515, DOI 10.4269/ajtmh.1990.42.515; GRAVES PM, 1980, T ROY SOC TROP MED H, V74, P738, DOI 10.1016/0035-9203(80)90189-3; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; Healer J, 1999, PARASITOLOGY, V119, P425, DOI 10.1017/S0031182099005041; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Lensen A, 1996, T ROY SOC TROP MED H, V90, P20, DOI 10.1016/S0035-9203(96)90464-2; Miura K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-107; Mulder B, 1999, EXP PARASITOL, V92, P81, DOI 10.1006/expr.1999.4398; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; ONG CSL, 1990, PARASITE IMMUNOL, V12, P447, DOI 10.1111/j.1365-3024.1990.tb00980.x; Ouedraogo AL, 2007, AM J TROP MED HYG, V76, P626, DOI 10.4269/ajtmh.2007.76.626; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; PREMAWANSA S, 1994, PARASITE IMMUNOL, V16, P35, DOI 10.1111/j.1365-3024.1994.tb00302.x; RILEY EM, 1994, PARASITE IMMUNOL, V16, P55, DOI 10.1111/j.1365-3024.1994.tb00323.x; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; ROEFFEN W, 1995, AM J TROP MED HYG, V52, P60, DOI 10.4269/ajtmh.1995.52.60; ROEFFEN W, 1994, MEM I OSWALDO CRUZ, V89, P13, DOI 10.1590/S0074-02761994000600004; Sauerwein RW, 2007, MICROBES INFECT, V9, P792, DOI 10.1016/j.micinf.2007.02.011; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Shekalaghe S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-69; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; Targett GA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S10; Taylor RR, 1996, INT IMMUNOL, V8, P905, DOI 10.1093/intimm/8.6.905; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; van der Kolk M, 2006, INT J PARASITOL, V36, P1091, DOI 10.1016/j.ijpara.2006.05.004; Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636; Yazdanbakhsh M, 2010, NAT REV IMMUNOL, V10, P80, DOI 10.1038/nri2673	60	66	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14114	10.1371/journal.pone.0014114	http://dx.doi.org/10.1371/journal.pone.0014114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124765	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000284686500006
J	Gilbert, JA; Field, D; Swift, P; Thomas, S; Cummings, D; Temperton, B; Weynberg, K; Huse, S; Hughes, M; Joint, I; Somerfield, PJ; Muhling, M				Gilbert, Jack A.; Field, Dawn; Swift, Paul; Thomas, Simon; Cummings, Denise; Temperton, Ben; Weynberg, Karen; Huse, Susan; Hughes, Margaret; Joint, Ian; Somerfield, Paul J.; Muehling, Martin			The Taxonomic and Functional Diversity of Microbes at a Temperate Coastal Site: A 'Multi-Omic' Study of Seasonal and Diel Temporal Variation	PLOS ONE			English	Article							WESTERN ENGLISH-CHANNEL; COMMUNITY STRUCTURE; RARE BIOSPHERE; OCEAN; GENOMICS; BACTERIAL; DYNAMICS; WATERS; SEA; METAGENOMICS	How microbial communities change over time in response to the environment is poorly understood. Previously a six-year time series of 16S rRNA V6 data from the Western English Channel demonstrated robust seasonal structure within the bacterial community, with diversity negatively correlated with day-length. Here we determine whether metagenomes and metatranscriptomes follow similar patterns. We generated 16S rRNA datasets, metagenomes (1.2 GB) and metatranscriptomes (157 MB) for eight additional time points sampled in 2008, representing three seasons (Winter, Spring, Summer) and including day and night samples. This is the first microbial 'multi-omic' study to combine 16S rRNA amplicon sequencing with metagenomic and metatranscriptomic profiling. Five main conclusions can be drawn from analysis of these data: 1) Archaea follow the same seasonal patterns as Bacteria, but show lower relative diversity; 2) Higher 16S rRNA diversity also reflects a higher diversity of transcripts; 3) Diversity is highest in winter and at night; 4) Community-level changes in 16S-based diversity and metagenomic profiles are better explained by seasonal patterns (with samples closest in time being most similar), while metatranscriptomic profiles are better explained by diel patterns and shifts in particular categories (i.e., functional groups) of genes; 5) Changes in key genes occur among seasons and between day and night (i.e., photosynthesis); but these samples contain large numbers of orphan genes without known homologues and it is these unknown gene sets that appear to contribute most towards defining the differences observed between times. Despite the huge diversity of these microbial communities, there are clear signs of predictable patterns and detectable stability over time. Renewed and intensified efforts are required to reveal fundamental deterministic patterns in the most complex microbial communities. Further, the presence of a substantial proportion of orphan sequences underscores the need to determine the gene products of sequences with currently unknown function.	[Gilbert, Jack A.; Swift, Paul; Thomas, Simon; Cummings, Denise; Temperton, Ben; Weynberg, Karen; Joint, Ian; Somerfield, Paul J.] Plymouth Marine Lab, Plymouth, Devon, England; [Gilbert, Jack A.] Argonne Natl Lab, Argonne, IL 60439 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Field, Dawn; Swift, Paul] Natl Environm Res Council NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Huse, Susan] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Hughes, Margaret] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Muehling, Martin] TU Bergakad Freiberg, IOZ Interdisciplinary Ctr Ecol, Freiberg, Germany	Plymouth Marine Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; UK Centre for Ecology & Hydrology (UKCEH); Marine Biological Laboratory - Woods Hole; University of Liverpool; Technical University Freiberg	Gilbert, JA (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.	gilbertjack@gmail.com	Gilbert, Jack/AAF-3270-2019; Weynberg, Karen/AAW-1657-2020; Weynberg, Karen/P-2526-2017; Temperton, Ben/AAE-2785-2021; Somerfield, Paul J/J-9189-2014; Field, Dawn/C-1653-2010	Weynberg, Karen/0000-0002-9856-2137; Somerfield, Paul J/0000-0002-7581-5621; Thomas, Simon/0000-0002-8474-1230; Temperton, Ben/0000-0002-3667-8302	Natural Environmental Research Council [NE/F00138X/1]; NERC [pml010004, NE/F00138X/1, pml010009] Funding Source: UKRI; Natural Environment Research Council [NE/F00138X/1, pml010004, CEH010021, pml010009] Funding Source: researchfish	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this work was provided by a Natural Environmental Research Council (www.nerc.ac.uk) grant, NE/F00138X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2008, ENVIRON MICROBIOL, V10, P2444, DOI 10.1111/j.1462-2920.2008.01674.x; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; BINDER BJ, 1995, APPL ENVIRON MICROB, V61, P708, DOI 10.1128/AEM.61.2.708-717.1995; Booth T, 2007, BIOTECHNIQUES, V42, P300, DOI 10.2144/000112385; CAPORASO JG, 2010, P NATL ACAD SCI US; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DELONG EF, 2001, ENV DIVERSITY BACTER, V50, P1; Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gilbert J., 2010, NAT PRECED; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P111, DOI 10.1111/j.1462-2920.2008.01745.x; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; GOOD IJ, 1956, BIOMETRIKA, V43, P45; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mary I, 2006, AQUAT MICROB ECOL, V42, P119, DOI 10.3354/ame042119; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Oremland RS, 2005, NAT REV MICROBIOL, V3, P572, DOI 10.1038/nrmicro1182; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Rees AP, 1999, DEEP-SEA RES PT I, V46, P483, DOI 10.1016/S0967-0637(98)00073-9; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; SWEENEY BM, 1989, J PHYCOL, V25, P183, DOI 10.1111/j.0022-3646.1989.00183.x; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Wellington EMH, 2003, CURR OPIN MICROBIOL, V6, P295, DOI 10.1016/S1369-5274(03)00066-3; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759	49	156	160	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15545	10.1371/journal.pone.0015545	http://dx.doi.org/10.1371/journal.pone.0015545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124740	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000284686500047
J	Hansen, KF; Sakamoto, K; Wayman, GA; Impey, S; Obrietan, K				Hansen, Katelin F.; Sakamoto, Kensuke; Wayman, Gary A.; Impey, Soren; Obrietan, Karl			Transgenic miR132 Alters Neuronal Spine Density and Impairs Novel Object Recognition Memory	PLOS ONE			English	Article							INDUCED MICRORNA; NERVOUS-SYSTEM; C-ELEGANS; IN-VIVO; MECP2; CREB; EXPRESSION; IDENTIFICATION; TRANSCRIPTION; HIPPOCAMPUS	Inducible gene expression plays a central role in neuronal plasticity, learning, and memory, and dysfunction of the underlying molecular events can lead to severe neuronal disorders. In addition to coding transcripts (mRNAs), non-coding microRNAs (miRNAs) appear to play a role in these processes. For instance, the CREB-regulated miRNA miR132 has been shown to affect neuronal structure in an activity-dependent manner, yet the details of its physiological effects and the behavioral consequences in vivo remain unclear. To examine these questions, we employed a transgenic mouse strain that expresses miR132 in forebrain neurons. Morphometric analysis of hippocampal neurons revealed that transgenic miR132 triggers a marked increase in dendritic spine density. Additionally, miR132 transgenic mice exhibited a decrease in the expression of MeCP2, a protein implicated in Rett Syndrome and other disorders of mental retardation. Consistent with these findings, miR132 transgenic mice displayed significant deficits in novel object recognition. Together, these data support a role for miR132 as a regulator of neuronal structure and function, and raise the possibility that dysregulation of miR132 could contribute to an array of cognitive disorders.	[Hansen, Katelin F.; Sakamoto, Kensuke; Obrietan, Karl] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Wayman, Gary A.] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; [Impey, Soren] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97201 USA	University System of Ohio; Ohio State University; Washington State University; Oregon Health & Science University	Hansen, KF (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.	obrietan.1@osu.edu	Hansen, Katelin/H-3447-2013	Hansen, Katelin/0000-0001-7065-0154	National Institutes of Health [MH62335, MH086032, NS066345, NS067409]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086032, R01MH062335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067409, R01NS066345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health Grant numbers: MH62335, MH086032, NS066345 and NS067409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Khudayberdiev Sharof, 2009, Commun Integr Biol, V2, P411; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MORRIS R, 1985, DEV NEUROSCI-BASEL, V7, P133, DOI 10.1159/000112283; Nakazawa T, 2008, J NEUROCHEM, V105, P1384, DOI 10.1111/j.1471-4159.2008.05335.x; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Schule B, 2008, CLIN GENET, V74, P116, DOI 10.1111/j.1399-0004.2008.01005.x; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Viosca J, 2009, LEARN MEMORY, V16, P198, DOI 10.1101/lm.1220309; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vuksic M, 2008, HIPPOCAMPUS, V18, P364, DOI 10.1002/hipo.20398; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102	31	172	178	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15497	10.1371/journal.pone.0015497	http://dx.doi.org/10.1371/journal.pone.0015497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124738	Green Published, gold, Green Submitted			2022-12-25	WOS:000284686500042
J	Leck, KJ; Zhang, SG; Hauser, CAE				Leck, Kwong-Joo; Zhang, Shuguang; Hauser, Charlotte A. E.			Study of Bioengineered Zebra Fish Olfactory Receptor 131-2: Receptor Purification and Secondary Structure Analysis	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; INTEGRAL MEMBRANE-PROTEINS; HIGH-LEVEL EXPRESSION; CRYSTAL-STRUCTURE; GENES; RHODOPSIN; EVOLUTION; SEQUENCE; SYSTEM	How fishes are able to detect trace molecules in large bodies of water is not understood. It is plausible that they use olfactory receptors to detect water-soluble compounds. How the zebra fish Danio Rerio, an organism with only 98 functional olfactory receptors, is able to selectively detect and recognize numerous compounds in water remains a puzzling phenomenon. We are interested in studying the biochemical and molecular mechanisms of olfaction in fish. Here, we report on the study of a bioengineered zebra fish olfactory receptor OR131-2, affinity-purified from a HEK293S tetracycline-inducible system. This receptor was expressed and translocated to the cell plasma membrane as revealed by confocal microscopy. Circular dichroism spectroscopy showed that the purified zebra fish receptor folded into an a-helical structure, as observed for other G-protein coupled receptors (GPCRs). Our study shows that it is possible to produce viable quantities of the zebra fish olfactory receptor. This will not only enable detailed structural and functional analyses, but also aid in the design of biosensor devices in order to detect water-soluble metabolites or its intermediates, which are associated with human health.	[Leck, Kwong-Joo; Zhang, Shuguang; Hauser, Charlotte A. E.] Inst Bioengn & Nanotechnol, Membrane Prot Nanobiotechnol Lab, Singapore, Singapore; [Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); Massachusetts Institute of Technology (MIT)	Leck, KJ (corresponding author), Inst Bioengn & Nanotechnol, Membrane Prot Nanobiotechnol Lab, Singapore, Singapore.	chauser@ibn.a-star.edu.sg	Hauser, Charlotte A. E./C-1321-2014; Leck, Kwong Joo/B-2336-2012; Hauser, Charlotte/B-6850-2015	Hauser, Charlotte A. E./0000-0001-8251-7246; Zhang, Shuguang/0000-0002-3856-3752	Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)	Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)(Agency for Science Technology & Research (A*STAR))	This work is supported by an internal grant provided by the Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Fleischer J, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.009.2009; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Quignon P, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r80; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Wallace BA, 2003, PROTEIN SCI, V12, P875, DOI 10.1110/ps.0229603; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Young JM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r71	34	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2010	5	11							e15027	10.1371/journal.pone.0015027	http://dx.doi.org/10.1371/journal.pone.0015027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686GM	21124770	Green Submitted, Green Published, gold			2022-12-25	WOS:000284684800001
J	Marshall, J; Ashe, KM; Bangari, D; McEachern, K; Chuang, WL; Pacheco, J; Copeland, DP; Desnick, RJ; Shayman, JA; Scheule, RK; Cheng, SH				Marshall, John; Ashe, Karen M.; Bangari, Dinesh; McEachern, KerryAnne; Chuang, Wei-Lien; Pacheco, Joshua; Copeland, Diane P.; Desnick, Robert J.; Shayman, James A.; Scheule, Ronald K.; Cheng, Seng H.			Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease	PLOS ONE			English	Article							AGALSIDASE-BETA THERAPY; GAUCHER-DISEASE; REPLACEMENT THERAPY; ALPHA-GALACTOSIDASE; RENAL-FUNCTION; MICE; GLOBOTRIAOSYLCERAMIDE; INVOLVEMENT; MIGLUSTAT; SAFETY	Fabry disease is an X-linked glycosphingolipid storage disorder caused by a deficiency in the activity of the lysosomal hydrolase a-galactosidase A (a-gal). This deficiency results in accumulation of the glycosphingolipid globotriaosylceramide (GL-3) in lysosomes. Endothelial cell storage of GL-3 frequently leads to kidney dysfunction, cardiac and cerebrovascular disease. The current treatment for Fabry disease is through infusions of recombinant a-gal (enzyme-replacement therapy; ERT). Although ERT can markedly reduce the lysosomal burden of GL-3 in endothelial cells, variability is seen in the clearance from several other cell types. This suggests that alternative and adjuvant therapies may be desirable. Use of glucosylceramide synthase inhibitors to abate the biosynthesis of glycosphingolipids (substrate reduction therapy, SRT) has been shown to be effective at reducing substrate levels in the related glycosphingolipidosis, Gaucher disease. Here, we show that such an inhibitor (eliglustat tartrate, Genz-112638) was effective at lowering GL-3 accumulation in a mouse model of Fabry disease. Relative efficacy of SRT and ERT at reducing GL-3 levels in Fabry mouse tissues differed with SRT being more effective in the kidney, and ERT more efficacious in the heart and liver. Combination therapy with ERT and SRT provided the most complete clearance of GL-3 from all the tissues. Furthermore, treatment normalized urine volume and uromodulin levels and significantly delayed the loss of a nociceptive response. The differential efficacies of SRT and ERT in the different tissues indicate that the combination approach is both additive and complementary suggesting the possibility of an improved therapeutic paradigm in the management of Fabry disease.	[Marshall, John; Ashe, Karen M.; Bangari, Dinesh; McEachern, KerryAnne; Chuang, Wei-Lien; Pacheco, Joshua; Copeland, Diane P.; Scheule, Ronald K.; Cheng, Seng H.] Genzyme Corp, Appl Discovery Res, Framingham, MA 01701 USA; [Desnick, Robert J.] Mt Sinai Sch Med, New York, NY USA; [Shayman, James A.] Univ Michigan, Genzyme Corp, Ann Arbor, MI 48109 USA	Sanofi-Aventis; Genzyme Corporation; Icahn School of Medicine at Mount Sinai; Sanofi-Aventis; Genzyme Corporation; University of Michigan System; University of Michigan	Marshall, J (corresponding author), Genzyme Corp, Appl Discovery Res, Framingham, MA 01701 USA.	john.marshall@genzyme.com	Cheng, Seng H/AAC-6564-2022	Marshall, John/0000-0003-1361-2869	NIDDK NIH HHS [R01 DK055823] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055823] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe A, 2000, J CLIN INVEST, V105, P1563, DOI 10.1172/JCI9711; [Anonymous], 2014, METABOLIC MOL BASES; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Cox TM, 2003, J INHERIT METAB DIS, V26, P513, DOI 10.1023/A:1025902113005; Crosbie TW, 2009, J INHERIT METAB DIS, V32, P745, DOI 10.1007/s10545-009-1254-1; Dutsch M, 2002, J CLIN NEUROPHYSIOL, V19, P575; GADOTH N, 1983, J MED GENET, V20, P309, DOI 10.1136/jmg.20.4.309; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Heare T, 2007, J INHERIT METAB DIS, V30, P79, DOI 10.1007/s10545-006-0473-y; Hoffmann B, 2007, CLIN GASTROENTEROL H, V5, P1447, DOI 10.1016/j.cgh.2007.08.012; Hollak CEM, 2009, PHARMACOEPIDEM DR S, V18, P770, DOI 10.1002/pds.1779; Kobayashi M, 2008, J Inherit Metab Dis, V31 Suppl 3, P483, DOI 10.1007/s10545-007-0740-6; Lidove O, 2007, INT J CLIN PRACT, V61, P293, DOI 10.1111/j.1742-1241.2006.01237.x; Luciano CA, 2002, MUSCLE NERVE, V26, P622, DOI 10.1002/mus.10236; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Moller AT, 2009, PAIN, V145, P237, DOI 10.1016/j.pain.2009.06.032; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moore DF, 2006, ACTA PAEDIATR, V95, P69, DOI 10.1080/08035320600618932; Ohshima T, 1999, P NATL ACAD SCI USA, V96, P6423, DOI 10.1073/pnas.96.11.6423; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Pastores GM, 2005, CLIN THER, V27, P1215, DOI 10.1016/j.clinthera.2005.08.004; Platt FM, 2009, BBA-MOL CELL RES, V1793, P737, DOI 10.1016/j.bbamcr.2008.08.009; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Schiffmann R, 2002, ACTA PAEDIATR, V91, P48, DOI 10.1080/080352502762457923; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Schiffmann R, 2007, J AM SOC NEPHROL, V18, P1576, DOI 10.1681/ASN.2006111263; Sessa A, 2003, J NEPHROL, V16, P310; Shu L, 2007, J BIOL CHEM, V282, P20960, DOI 10.1074/jbc.M702436200; Shu LM, 2005, J AM SOC NEPHROL, V16, P2636, DOI 10.1681/ASN.2005040383; Thurberg BL, 2009, CIRCULATION, V119, P2561, DOI 10.1161/CIRCULATIONAHA.108.841494; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Vylet'al P, 2008, J INHERIT METAB DIS, V31, P508, DOI 10.1007/s10545-008-0900-3; Waldek S, 2009, GENET MED, V11, P790, DOI 10.1097/GIM.0b013e3181bb05bb; Wang A. M., 1996, American Journal of Human Genetics, V59, pA208; Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366; Ziegler RJ, 2007, MOL THER, V15, P492, DOI 10.1038/sj.mt.6300066	40	54	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15033	10.1371/journal.pone.0015033	http://dx.doi.org/10.1371/journal.pone.0015033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124789	Green Published, gold, Green Submitted			2022-12-25	WOS:000284572000020
J	Res, PCM; Piskin, G; de Boer, OJ; van der Loos, CM; Teeling, P; Bos, JD; Teunissen, MBM				Res, Pieter C. M.; Piskin, Gamze; de Boer, Onno J.; van der Loos, Chris M.; Teeling, Peter; Bos, Jan D.; Teunissen, Marcel B. M.			Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis	PLOS ONE			English	Article							INTERFERON-GAMMA; EPIDERMAL HYPERPLASIA; MONOCLONAL-ANTIBODY; FAMILY CYTOKINES; VULGARIS LESIONS; TYPE-1 CYTOKINES; INTERLEUKIN 22; EXPRESSION; IDENTIFICATION; INFLAMMATION	Background: Although recent studies indicate a crucial role for IL-17A and IL-22 producing T cells in the pathogenesis of psoriasis, limited information is available on their frequency and heterogeneity and their distribution in skin in situ. Methodology/Principal Findings: By spectral imaging analysis of double-stained skin sections we demonstrated that IL-17 was mainly expressed by mast cells and neutrophils and IL-22 by macrophages and dendritic cells. Only an occasional IL-17(pos), but no IL-22(pos) T cell could be detected in psoriatic skin, whereas neither of these cytokines was expressed by T cells in normal skin. However, examination of in vitro-activated T cells by flow cytometry revealed that substantial percentages of skin-derived CD4 and CD8 T cells were able to produce IL-17A alone or together with IL-22 (i.e. Th17 and Tc17, respectively) or to produce IL-22 in absence of IL-17A and IFN-gamma (i.e. Th22 and Tc22, respectively). Remarkably, a significant proportional rise in Tc17 and Tc22 cells, but not in Th17 and Th22 cells, was found in T cells isolated from psoriatic versus normal skin. Interestingly, we found IL-22 single-producers in many skin-derived IL-17A(pos) CD4 and CD8 T cell clones, suggesting that in vivo IL-22 single-producers may arise from IL-17A(pos) T cells as well. Conclusions/Significance: The increased presence of Tc17 and Tc22 cells in lesional psoriatic skin suggests that these types of CD8 T cells play a significant role in the pathogenesis of psoriasis. As part of the skin-derived IL-17A(pos) CD4 and CD8 T clones developed into IL-22 single-producers, this demonstrates plasticity in their cytokine production profile and suggests a developmental relationship between Th17 and Th22 cells and between Tc17 and Tc22 cells.	[Res, Pieter C. M.; Piskin, Gamze; Bos, Jan D.; Teunissen, Marcel B. M.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [de Boer, Onno J.; van der Loos, Chris M.; Teeling, Peter] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Res, PCM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands.	p.c.res@amc.uva.nl; m.b.teunissen@amc.uva.nl	Teunissen, Marcel BM/D-6512-2012	de Boer, Onno/0000-0001-8844-1326				Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Bos JD, 2007, J AM ACAD DERMATOL, V56, P468, DOI 10.1016/j.jaad.2006.12.006; Bos JD, 2005, BRIT J DERMATOL, V152, P1098, DOI 10.1111/j.1365-2133.2005.06645.x; BOS JD, 1989, ARCH DERMATOL RES, V281, P24, DOI 10.1007/BF00424268; BOS JD, 1983, ARCH DERMATOL RES, V275, P181, DOI 10.1007/BF00510050; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Fan X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000038; Friese MA, 2009, ANN NEUROL, V66, P132, DOI 10.1002/ana.21744; Fuschiotti P, 2009, ARTHRITIS RHEUM-US, V60, P1119, DOI 10.1002/art.24432; Gottlieb AB, 2007, CURR MED RES OPIN, V23, P1081, DOI 10.1185/030079907X182112; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Ikeda K, 2003, BLOOD, V101, P3594, DOI 10.1182/blood-2002-09-2817; Johnston A, 2004, CLIN EXP IMMUNOL, V138, P83, DOI 10.1111/j.1365-2249.2004.00600.x; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Streeck H, 2008, J IMMUNOL METHODS, V333, P115, DOI 10.1016/j.jim.2008.01.018; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Szabo SK, 1998, J INVEST DERMATOL, V111, P1072, DOI 10.1046/j.1523-1747.1998.00419.x; TEUNISSEN MB, 2007, GIORN ITAL DERMAT V, V142, P229; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Toichi E, 2006, J IMMUNOL, V177, P4917, DOI 10.4049/jimmunol.177.7.4917; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Vissers WHPM, 2004, BRIT J DERMATOL, V150, P852, DOI 10.1111/j.1365-2133.2004.05863.x; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	53	227	245	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14108	10.1371/journal.pone.0014108	http://dx.doi.org/10.1371/journal.pone.0014108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124836	Green Published, gold, Green Submitted			2022-12-25	WOS:000284572000010
J	Buttstedt, A; Winter, R; Sackewitz, M; Hause, G; Schmid, FX; Schwarz, E				Buttstedt, Anja; Winter, Reno; Sackewitz, Mirko; Hause, Gerd; Schmid, Franz-Xaver; Schwarz, Elisabeth			Influence of the Stability of a Fused Protein and Its Distance to the Amyloidogenic Segment on Fibril Formation	PLOS ONE			English	Article							COLD SHOCK PROTEIN; SINGLE-STRANDED-DNA; OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; N-TERMINAL DOMAIN; BACILLUS-SUBTILIS CSPB; IN-VITRO; NUCLEAR INCLUSIONS; MESSENGER-RNA; MUSCLE-FIBERS; EXPANSIONS	Conversion of native proteins into amyloid fibrils is irreversible and therefore it is difficult to study the interdependence of conformational stability and fibrillation by thermodynamic analyses. Here we approached this problem by fusing amyloidogenic poly-alanine segments derived from the N-terminal domain of the nuclear poly (A) binding protein PABPN1 with a well studied, reversibly unfolding protein, CspB from Bacillus subtilis. Earlier studies had indicated that CspB could maintain its folded structure in fibrils, when it was separated from the amyloidogenic segment by a long linker. When CspB is directly fused with the amyloidogenic segment, it unfolds because its N-terminal chain region becomes integrated into the fibrillar core, as shown by protease mapping experiments. Spacers of either 3 or 16 residues between CspB and the amyloidogenic segment were not sufficient to prevent this loss of CspB structure. Since the low thermodynamic stability of CspB (Delta G(D) = 12.4 kJ/mol) might be responsible for unfolding and integration of CspB into fibrils, fusions with a CspB mutant with enhanced thermodynamic stability (Delta G(D) = 26.9 kJ/mol) were studied. This strongly stabilized CspB remained folded and prevented fibril formation in all fusions. Our data show that the conformational stability of a linked, independently structured protein domain can control fibril formation.	[Buttstedt, Anja; Winter, Reno; Sackewitz, Mirko; Schwarz, Elisabeth] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany; [Hause, Gerd] Univ Halle Wittenberg, Bioctr, Halle, Germany; [Schmid, Franz-Xaver] Univ Bayreuth, Biochem Lab, D-8580 Bayreuth, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; University of Bayreuth	Buttstedt, A (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany.	elisabeth.schwarz@biochemtech.uni-halle.de	Buttstedt, Anja/B-5281-2012	Buttstedt, Anja/0000-0003-2299-7000	Deutsche Forschungsgemeinschaft (DFG) [1026, GRK 1026, SFB 610]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) through Graduiertenkolleg 1026 (Conformational transitions in macromolecular interactions) (GRK 1026 and SFB 610) (http://www.biochemtech.uni-halle.de/grk1026/ and http://www.sfb610.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Espargaro A, 2008, J MOL BIOL, V378, P1116, DOI 10.1016/j.jmb.2008.03.020; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAUMANN P, 1994, FEBS LETT, V338, P157, DOI 10.1016/0014-5793(94)80355-2; Lodderstedt G, 2008, BIOCHEMISTRY-US, V47, P2181, DOI 10.1021/bi701322g; Lodderstedt G, 2007, FEBS J, V274, P346, DOI 10.1111/j.1742-4658.2006.05595.x; Lopez MM, 2000, BBA-PROTEIN STRUCT M, V1479, P196, DOI 10.1016/S0167-4838(00)00048-0; Lopez MM, 2001, J BIOL CHEM, V276, P15511, DOI 10.1074/jbc.M010474200; Lopez MM, 1999, J BIOL CHEM, V274, P33601, DOI 10.1074/jbc.274.47.33601; Max KEA, 2007, J MOL BIOL, V369, P1087, DOI 10.1016/j.jmb.2007.04.016; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; MAYR LM, 1993, J MOL BIOL, V231, P897, DOI 10.1006/jmbi.1993.1336; Messaed C, 2009, NEUROBIOL DIS, V34, P397, DOI 10.1016/j.nbd.2009.02.013; Ohnishi S, 2004, CELL MOL LIFE SCI, V61, P511, DOI 10.1007/s00018-003-3264-8; Pace C N, 1986, Methods Enzymol, V131, P266; PAJOT P, 1976, EUR J BIOCHEM, V63, P263, DOI 10.1111/j.1432-1033.1976.tb10228.x; Rohrberg J, 2008, FEBS LETT, V582, P1587, DOI 10.1016/j.febslet.2008.04.002; Sackewitz M, 2008, J AM CHEM SOC, V130, P7172, DOI 10.1021/ja800120s; Sackewitz M, 2008, PROTEIN SCI, V17, P1044, DOI 10.1110/ps.073276308; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scheuermann T, 2003, PROTEIN SCI, V12, P2685, DOI 10.1110/ps.03214703; Schindler T, 1999, J BIOL CHEM, V274, P3407, DOI 10.1074/jbc.274.6.3407; SCHINDLER T, 1995, NAT STRUCT BIOL, V2, P663, DOI 10.1038/nsb0895-663; Shinchuk LM, 2005, PROTEINS, V61, P579, DOI 10.1002/prot.20536; Tome FMS, 1997, NEUROMUSCULAR DISORD, V7, pS63, DOI 10.1016/S0960-8966(97)00085-0; TOME FMS, 1989, NEUROLOGY, V39, P926, DOI 10.1212/WNL.39.7.926; Uyama E, 1997, NEUROMUSCULAR DISORD, V7, pS41, DOI 10.1016/S0960-8966(97)00081-3; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; WALLACE RB, 1987, METHOD ENZYMOL, V152, P432; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Wunderlich M, 2005, J MOL BIOL, V347, P1063, DOI 10.1016/j.jmb.2005.02.014; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Zeeb M, 2006, NUCLEIC ACIDS RES, V34, P4561, DOI 10.1093/nar/gkl376	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15436	10.1371/journal.pone.0015436	http://dx.doi.org/10.1371/journal.pone.0015436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124848	gold, Green Published, Green Submitted			2022-12-25	WOS:000284527900018
J	Kudryavtseva, NN; Bondar, NP; Boyarskikh, UA; Filipenko, ML				Kudryavtseva, Natalia N.; Bondar, Natalia P.; Boyarskikh, Ul'yana A.; Filipenko, Maxim L.			Snca and Bdnf Gene Expression in the VTA and Raphe Nuclei of Midbrain in Chronically Victorious and Defeated Male Mice	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; VENTRAL TEGMENTAL AREA; ALPHA-SYNUCLEIN; REPEATED EXPERIENCE; NOREPINEPHRINE TRANSPORTER; SEROTONIN TRANSPORTER; BRAIN; DOPAMINE; COCAINE; BEHAVIOR	Background: Alpha-synuclein (alpha-Syn) is a small neuronal protein that has been found to be expressed throughout the brain. It has been shown that alpha-Syn regulates the homeostasis of monoamine neurotransmitters and is involved in various degenerative and affective disorders. There is indication that alpha-Syn may regulate expression of the brain-derived neurotropic factor (BDNF) which plays an important role in the mood disorders. Methodology/Principal Findings: The study aimed to analyze the mRNA levels of Snca and Bdnf genes in the ventral tegmental area (VTA) and raphe nuclei of the midbrain in male mice that had each won or defeated 20 encounters (20-time winners and 20-time losers, respectively) in daily agonistic interactions. Groups of animals that had the same winning and losing track record followed by a no-fight period for 14 days (no-fighting winners and no-fighting losers) were also studied. Snca mRNA levels were increased in the raphe nuclei in the 20-time losers and in the VTA of the 20-time winners. After no-fight period Snca mRNA levels decreased in both groups. Snca mRNA levels were similar to the control level in the VTA of the 20-time losers and in the raphe nuclei of the 20-time winners. However Snca gene expression increased in these areas in the no-fighting winners and no-fighting losers in comparison with respective mRNA levels in animals before no-fight period. Bdnf mRNA levels increased in VTA of 20-time winners. Significant positive correlations were found between the mRNA levels of Snca and Bdnf genes in the raphe nuclei. Conclusions/Significance: Social experience affects Snca gene expression depending on brain areas and functional activity of monoaminergic systems in chronically victorious or defeated mice. These findings may be useful for understanding the mechanisms of forming different alpha-synucleinopathies.	[Kudryavtseva, Natalia N.; Bondar, Natalia P.] Inst Cytol & Genet SD RAS, Novosibirsk, Russia; [Boyarskikh, Ul'yana A.; Filipenko, Maxim L.] Inst Chem Biol & Basic Med SD RAS, Novosibirsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Kudryavtseva, NN (corresponding author), Inst Cytol & Genet SD RAS, Novosibirsk, Russia.	natnik@bionet.nsc.ru	Kudryavtseva, Natalia/AAI-1127-2019; Boyarskikh, Ulyana/AAU-9540-2020; Bondar, Natalya/Q-7908-2016	Bondar, Natalya/0000-0002-5602-5149	Russian Academy of Sciences [22.16]	Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by research grant (22.16) from the Russian Academy of Sciences (Molecular and Cellular Biology Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstislavskaya TG, 1997, FEBS LETT, V406, P106, DOI 10.1016/S0014-5793(97)00252-4; Avgustinovich D F, 2005, Ross Fiziol Zh Im I M Sechenova, V91, P1454; Avgustinovich D. F., 2004, Uspekhi Fiziologicheskikh Nauk, V35, P19; Azaryan AV, 1998, CAN J PHYSIOL PHARM, V76, P278, DOI 10.1139/cjpp-76-3-278; Bondar NP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004190; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCCARO EF, 1992, INT CLIN PSYCHOPHARM, V7, P3, DOI 10.1097/00004850-199200710-00001; COOPER SJ, 1991, MESOLIMBIC DOPAMINE SYSTEM : FROM MOTIVATION TO ACTION, P331; Crespo JA, 2001, NEUROPSYCHOPHARMACOL, V25, P185, DOI 10.1016/S0893-133X(01)00221-4; de Boer SF, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.052.2009; Devoino L V, 1998, Vestn Ross Akad Med Nauk, P19; Filipenko ML, 2001, MOL BRAIN RES, V96, P77, DOI 10.1016/S0169-328X(01)00270-4; Filipenko ML, 2002, BIOCHEMISTRY-MOSCOW+, V67, P451, DOI 10.1023/A:1015238124000; Fish EW, 2002, PSYCHOPHARMACOLOGY, V163, P459, DOI 10.1007/s00213-002-1211-2; Frieling H, 2008, NEUROPSYCHOBIOLOGY, V58, P48, DOI 10.1159/000155991; George JM, 2002, GENOME BIOL, V3; Goloshchapov AV, 2005, MOL BRAIN RES, V135, P290, DOI 10.1016/j.molbrainres.2004.11.009; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; HAHN MK, 2002, PHARMACOGENOMICS J, V25, P487; Heinz A, 2001, ALCOHOL CLIN EXP RES, V25, P487; Jeannotte AM, 2009, NEUROPSYCHOPHARMACOL, V34, P987, DOI 10.1038/npp.2008.146; Kao AW, 2009, ALZ DIS ASSOC DIS, V23, P365, DOI 10.1097/WAD.0b013e3181b5065d; Kreek MJ, 1996, J ADDICT DIS, V15, P73, DOI 10.1300/J069v15n04_05; Kudryavtseva N.N., 2006, PERSPECTIVES PSYCHOL, P35; Kudryavtseva NN, 1998, AGGRESSIVE BEHAV, V24, P271, DOI 10.1002/(SICI)1098-2337(1998)24:4<271::AID-AB3>3.0.CO;2-M; KUDRYAVTSEVA NN, 1991, ZH VYSSH NERV DEYAT+, V41, P459; Kudryavtseva NN, 2004, RUSS J GENET+, V40, P590, DOI 10.1023/B:RUGE.0000033307.59669.d6; KUDRYAVTSEVA NN, 1991, AGGRESSIVE BEHAV, V17, P285, DOI 10.1002/1098-2337(1991)17:5<285::AID-AB2480170505>3.0.CO;2-P; KULIKOV AV, 1995, PHARMACOL BIOCHEM BE, V50, P431, DOI 10.1016/0091-3057(94)00293-R; Mash DC, 2003, J NEUROSCI, V23, P2564; Mauceli G, 2006, ANN NY ACAD SCI, V1074, P191, DOI 10.1196/annals.1369.019; Miczek K.A., 2007, HDB NEUROCHEMISTRY M, P285, DOI DOI 10.1007/978-0-387-30405-2_7; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Nichols CD, 2003, MOL BRAIN RES, V111, P182, DOI 10.1016/S0169-328X(03)00029-9; Nikulina EM, 1999, NEUROREPORT, V10, P3015, DOI 10.1097/00001756-199909290-00026; Parain K, 1999, NEUROREPORT, V10, P557, DOI 10.1097/00001756-199902250-00021; Rosen GD, 2000, INT MOUSE GENOME C, V14, P166; Scott J.P., 1971, PHYSL AGGRESSION DEF, P11; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Spangler R, 1996, MOL BRAIN RES, V38, P71, DOI 10.1016/0169-328X(95)00319-N; Totterdell S, 2004, BRAIN RES, V1004, P61, DOI 10.1016/j.brainres.2003.10.072; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wersinger C, 2006, EUR J NEUROSCI, V24, P3141, DOI 10.1111/j.1460-9568.2006.05181.x; Wersinger C, 2006, EUR J NEUROSCI, V24, P55, DOI 10.1111/j.1460-9568.2006.04900.x; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; YUAN Y, 2010, CELL M IN PRESS 0420	47	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14089	10.1371/journal.pone.0014089	http://dx.doi.org/10.1371/journal.pone.0014089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124898	Green Submitted, gold, Green Published			2022-12-25	WOS:000284527900007
J	Sahaboglu, A; Tanimoto, N; Kaur, J; Sancho-Pelluz, J; Huber, G; Fahl, E; Arango-Gonzalez, B; Zrenner, E; Ekstrom, P; Lowenheim, H; Seeliger, M; Paquet-Durand, F				Sahaboglu, Ayse; Tanimoto, Naoyuki; Kaur, Jasvir; Sancho-Pelluz, Javier; Huber, Gesine; Fahl, Edda; Arango-Gonzalez, Blanca; Zrenner, Eberhart; Ekstrom, Per; Loewenheim, Hubert; Seeliger, Mathias; Paquet-Durand, Francois			PARP1 Gene Knock-Out Increases Resistance to Retinal Degeneration without Affecting Retinal Function	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE GENE; PHOTORECEPTOR CELL-DEATH; CROSS-TALK; GUANOSINE-MONOPHOSPHATE; EXCESSIVE ACTIVATION; MICE LACKING; BETA-SUBUNIT; MOUSE; MITOCHONDRIAL; CONTRIBUTES	Retinitis pigmentosa (RP) is a group of inherited neurodegenerative diseases affecting photoreceptors and causing blindness in humans. Previously, excessive activation of enzymes belonging to the poly-ADP-ribose polymerase (PARP) group was shown to be involved in photoreceptor degeneration in the human homologous rd1 mouse model for RP. Since there are at least 16 different PARP isoforms, we investigated the exact relevance of the predominant isoform - PARP1 - for photoreceptor cell death using PARP1 knock-out (KO) mice. In vivo and ex vivo morphological analysis using optic coherence tomography (OCT) and conventional histology revealed no major alterations of retinal phenotype when compared to wild-type (wt). Likewise, retinal function as assessed by electroretinography (ERG) was normal in PARP1 KO animals. We then used retinal explant cultures derived from wt, rd1, and PARP1 KO animals to test their susceptibility to chemically induced photoreceptor degeneration. Since photoreceptor degeneration in the rd1 retina is triggered by a loss-of-function in phosphodiesterase-6 (PDE6), we used selective PDE6 inhibition to emulate the rd1 situation on non-rd1 genotypes. While wt retina subjected to PDE6 inhibition showed massive photoreceptor degeneration comparable to rd1 retina, in the PARP1 KO situation, cell death was robustly reduced. Together, these findings demonstrate that PARP1 activity is in principle dispensable for normal retinal function, but is of major importance for photoreceptor degeneration under pathological conditions. Moreover, our results suggest that PARP dependent cell death or PARthanatos may play a major role in retinal degeneration and highlight the possibility to use specific PARP inhibitors for the treatment of RP.	[Sahaboglu, Ayse; Kaur, Jasvir; Sancho-Pelluz, Javier; Arango-Gonzalez, Blanca; Zrenner, Eberhart; Paquet-Durand, Francois] Univ Tubingen, Div Expt Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Tanimoto, Naoyuki; Huber, Gesine; Fahl, Edda; Seeliger, Mathias] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Ocular Neurodegenerat Res Grp, Tubingen, Germany; [Ekstrom, Per] Lund Univ, Dept Ophthalmol, Lund, Sweden; [Loewenheim, Hubert] Univ Tubingen, Dept Otolaryngol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Lund University; Eberhard Karls University of Tubingen	Sahaboglu, A (corresponding author), Univ Tubingen, Div Expt Ophthalmol, Inst Ophthalm Res, Tubingen, Germany.	francois.paquet-durand@klinikum.uni-tuebingen.de	Arango-Gonzalez, Blanca/AAR-7427-2021; Paquet-Durand, Francois/G-6709-2015; Sancho-Pelluz, Javier/AAB-2786-2019; Paquet-Durand, Francois/C-6094-2008; Löwenheim, Hubert/GPS-7207-2022	Arango-Gonzalez, Blanca/0000-0002-9045-182X; Paquet-Durand, Francois/0000-0001-7355-5742; Sancho-Pelluz, Javier/0000-0001-5409-5760; Löwenheim, Hubert/0000-0001-8200-8804; Sahaboglu, Ayse/0000-0003-3241-0672	Charlotte and Tistou Kerstan Foundation; European Union [EVI-GENORET: LSHG-CT-2005-512036, NEUROTRAIN: MEST-CT-2005-020235, HEALTH-F2-2008-200234]; Fundacion Oftalmologica del Mediterraneo (FOM); Deutsche Forschungsgemeinschaft (DFG) [PA1751/1-1, Se837/5-2, Se837/6-1, Se837/7-1]; Werner Reichhardt Centre for Integrative Neuroscience (CIN) [PP2009-20]	Charlotte and Tistou Kerstan Foundation; European Union(European Commission); Fundacion Oftalmologica del Mediterraneo (FOM)(FOM (The Netherlands)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Werner Reichhardt Centre for Integrative Neuroscience (CIN)	This work has been supported by grants from the Charlotte and Tistou Kerstan Foundation, the European Union (EVI-GENORET: LSHG-CT-2005-512036, NEUROTRAIN: MEST-CT-2005-020235, HEALTH-F2-2008-200234), Fundacion Oftalmologica del Mediterraneo (FOM), Deutsche Forschungsgemeinschaft (DFG; PA1751/1-1, Se837/5-2, Se837/6-1, Se837/7-1), and the Werner Reichhardt Centre for Integrative Neuroscience (CIN, No. PP2009-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Beneke S, 2004, INT J CANCER, V111, P813, DOI 10.1002/ijc.20342; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Caffe AR, 2001, J CHEM NEUROANAT, V22, P263; Contin MA, 2006, FASEB J, V20, P2648, DOI 10.1096/fj.06-6133fje; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; DEVENTE J, 1987, NEUROSCIENCE, V22, P361, DOI 10.1016/0306-4522(87)90226-0; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Hauck SM, 2006, MOL CELL PROTEOMICS, V5, P324, DOI 10.1074/mcp.M500217-MCP200; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Herse Peter, 2005, Clin Exp Optom, V88, P335; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Morin F, 2001, J NEUROCHEM, V78, P88, DOI 10.1046/j.1471-4159.2001.00407.x; Murashita H, 2006, HEARING RES, V214, P1, DOI 10.1016/j.heares.2005.12.008; Nucci C, 2000, BIOCHEM BIOPH RES CO, V278, P360, DOI 10.1006/bbrc.2000.3811; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Sanges D, 2006, APOPTOSIS, V11, P1629, DOI 10.1007/s10495-006-9006-2; SANYAL S, 1973, Z ANAT ENTWICKLUNGS, V142, P219, DOI 10.1007/BF00519723; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; SIMS JL, 1983, BIOCHEMISTRY-US, V22, P5188, DOI 10.1021/bi00291a019; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tabuchi K, 2001, ANN OTO RHINOL LARYN, V110, P118; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Vallazza-Deschamps G, 2005, EUR J NEUROSCI, V22, P1013, DOI 10.1111/j.1460-9568.2005.04306.x; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509	47	62	65	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15495	10.1371/journal.pone.0015495	http://dx.doi.org/10.1371/journal.pone.0015495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124852	Green Published, gold, Green Submitted			2022-12-25	WOS:000284527900021
J	Manjoo, P; Joseph, L; Pilote, L; Dasgupta, K				Manjoo, Priya; Joseph, Lawrence; Pilote, Louise; Dasgupta, Kaberi			Sex Differences in Step Count-Blood Pressure Association: A Preliminary Study in Type 2 Diabetes	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EXERCISE; WALKING; MORTALITY; RISK; STEPS/DAY; ACCURACY; PROGRAM; ADULTS	Background: Walking and cardiovascular mortality are inversely associated in type 2 diabetes, but few studies have objectively measured associations of walking with individual cardiovascular risk factors. Such information would be useful for "dosing" daily steps in clinical practice. This study aimed to quantify decrements in blood pressure and glycated hemoglobin (A1C) per 1,000 daily step increments. Methodology/Principal Findings: Two hundred and one subjects with type 2 diabetes underwent assessments of step counts (pedometer-measured), blood pressure, A1C and anthropometric parameters. Due to missing data, the final analysis was conducted on 83 women and 102 men, with a mean age of 60 years. Associations of daily steps with blood pressure and A1C were evaluated using sex-specific multivariate linear regression models (adjusted for age, ethnicity, and BMI). Potential sex differences were confirmed in a combined model (women and men) with interaction terms. Mean values for daily steps, blood pressure, A1C and BMI were 5,357 steps/day; 137/80 mm Hg; 7.7% and 30.4 kg/m(2) respectively. A 1,000 daily step increment among women was associated with a -2.6 (95% CI: -4.1 to -1.1) mm Hg change in systolic and a -1.4 (95% CI: -2.2 to -0.6) mm Hg change in diastolic blood pressure. Among men, corresponding changes were -0.7 (95% CI: -2.1 to 0.7) and -0.6 (95% CI: -1.4 to 0.3) mm Hg, respectively. Sex differences were confirmed in combined models. Step counts and A1C did not demonstrate clinically important associations. Conclusions/Significance: A 1,000 steps/day increment is associated with important blood pressure decrements among women with type 2 diabetes but the data were inconclusive among men. Targeted "dose increments" of 1,000 steps/day in women may lead to measurable blood pressure reductions. This information may be of potential use in the titration or "dosing" of daily steps. No associations were found between step count increments and A1C.	[Manjoo, Priya; Joseph, Lawrence; Pilote, Louise; Dasgupta, Kaberi] McGill Univ, Dept Med, Div Clin Epidemiol, Ctr Hlth, Montreal, PQ, Canada; [Manjoo, Priya] Vancouver Isl Hlth Author, Dept Med, Victoria, BC, Canada	McGill University; Vancouver Island Health Authority	Manjoo, P (corresponding author), McGill Univ, Dept Med, Div Clin Epidemiol, Ctr Hlth, Montreal, PQ, Canada.	kaberi.dasgupta@mcgill.ca		Pilote, Louise/0000-0002-6159-0628	Canadian Institutes of Health Research (CIHR) [MOP-79275]; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was funded by an operating grant from the Canadian Institutes of Health Research (CIHR, MOP-79275). KD holds a career award from the CIHR (New Investigator Award). LP holds a career award from the Fonds de la Recherche en Sante du Quebec (National Researcher Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Carroll S, 2004, SPORTS MED, V34, P371, DOI 10.2165/00007256-200434060-00004; Chan CB, 2003, OBES RES, V11, P1563, DOI 10.1038/oby.2003.208; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cyarto EV, 2004, MED SCI SPORT EXER, V36, P205, DOI 10.1249/01.MSS.0000113476.62469.98; DASGUPTA K, 2009, PRELIMINARY ANAL DEM; Dasgupta K, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-1; Dunn AL, 1998, MED SCI SPORT EXER, V30, P1076, DOI 10.1097/00005768-199807000-00009; Eriksson J, 1997, DIABETOLOGIA, V40, P125; Feinstein A.R., 1996, MULTIVARIABLE ANAL I; Fritz T, 2006, DIABETES RES CLIN PR, V71, P21, DOI 10.1016/j.diabres.2005.06.002; Gregg EW, 2003, ARCH INTERN MED, V163, P1440, DOI 10.1001/archinte.163.12.1440; Hagberg JM, 2000, SPORTS MED, V30, P193, DOI 10.2165/00007256-200030030-00004; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hu FB, 2001, ANN INTERN MED, V134, P96, DOI 10.7326/0003-4819-134-2-200101160-00009; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Marshall SJ, 2009, AM J PREV MED, V36, P410, DOI 10.1016/j.amepre.2009.01.021; Praet SFE, 2008, DIABETOLOGIA, V51, P736, DOI 10.1007/s00125-008-0950-y; Schmidt MD, 2009, AM J PREV MED, V37, P278, DOI 10.1016/j.amepre.2009.05.020; Schneider PL, 2004, MED SCI SPORT EXER, V36, P331, DOI 10.1249/01.MSS.0000113486.60548.E9; Shatenstein B, 2005, CAN J DIET PRACT RES, V66, P67, DOI 10.3148/66.2.2005.67; Shepherd EF, 1999, J ORTHOP RES, V17, P703, DOI 10.1002/jor.1100170512; Sisson SB, 2010, AM J PREV MED, V38, P575, DOI 10.1016/j.amepre.2010.02.015; Svacinova H, 2003, Vnitr Lek, V49, P205; Swartz AM, 2007, GERONTOLOGY, V53, P454, DOI 10.1159/000118600; Tanasescu M, 2003, CIRCULATION, V107, P2435, DOI 10.1161/01.CIR.0000066906.11109.1F; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2004, INT J OBESITY, V28, P113, DOI 10.1038/sj.ijo.0802485; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c	33	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14086	10.1371/journal.pone.0014086	http://dx.doi.org/10.1371/journal.pone.0014086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124929	gold, Green Published			2022-12-25	WOS:000284467200017
J	Waller-Evans, H; Promel, S; Langenhan, T; Dixon, J; Zahn, D; Colledge, WH; Doran, J; Carlton, MBL; Davies, B; Aparicio, SAJR; Grosse, J; Russ, AP				Waller-Evans, Helen; Proemel, Simone; Langenhan, Tobias; Dixon, John; Zahn, Dirk; Colledge, William H.; Doran, Joanne; Carlton, Mark B. L.; Davies, Ben; Aparicio, Samuel A. J. R.; Grosse, Johannes; Russ, Andreas P.			The Orphan Adhesion-GPCR GPR126 Is Required for Embryonic Development in the Mouse	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CARDIAC NEURAL CREST; NEUREGULIN RECEPTOR; SCHWANN-CELLS; POLARITY; ERBB2; MYELINATION; CLEAVAGE; FATE	Adhesion-GPCRs provide essential cell-cell and cell-matrix interactions in development, and have been implicated in inherited human diseases like Usher Syndrome and bilateral frontoparietal polymicrogyria. They are the second largest subfamily of seven-transmembrane spanning proteins in vertebrates, but the function of most of these receptors is still not understood. The orphan Adhesion-GPCR GPR126 has recently been shown to play an essential role in the myelination of peripheral nerves in zebrafish. In parallel, whole-genome association studies have implicated variation at the GPR126 locus as a determinant of body height in the human population. The physiological function of GPR126 in mammals is still unknown. We describe a targeted mutation of GPR126 in the mouse, and show that GPR126 is required for embryonic viability and cardiovascular development.	[Waller-Evans, Helen; Proemel, Simone; Langenhan, Tobias; Russ, Andreas P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Waller-Evans, Helen; Proemel, Simone; Langenhan, Tobias; Russ, Andreas P.] Univ Oxford, Magdalen Coll, Oxford OX1 3QU, England; [Dixon, John; Zahn, Dirk; Doran, Joanne; Carlton, Mark B. L.; Grosse, Johannes] Takeda Cambridge Ltd, Cambridge, England; [Colledge, William H.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Davies, Ben] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Aparicio, Samuel A. J. R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Aparicio, Samuel A. J. R.] Univ British Columbia, BC Canc Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of Oxford; University of Oxford; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Waller-Evans, H (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	andreas.russ@bioch.ox.ac.uk	Davies, Ben/GYD-9163-2022; Colledge, William/X-4976-2019; Langenhan, Tobias/AAY-3773-2020	Davies, Ben/0000-0003-3405-507X; Colledge, William/0000-0002-9603-4429; Langenhan, Tobias/0000-0002-9061-3809; Aparicio, Samuel/0000-0002-0487-9599; Davies, Benjamin/0000-0003-3623-600X; Promel, Simone/0000-0001-7800-7323; Waller-Evans, Helen/0000-0003-4133-6064	Environmental Protection Agency Cephalosporin Trust [CF077]; Royal Society; Wellcome Trust [WT075336AIA]; Biotechnology and Biological Sciences Research Council [BB/C504200/1]; Daimler-Benz Foundation	Environmental Protection Agency Cephalosporin Trust; Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Daimler-Benz Foundation	This work was supported by grants from the Environmental Protection Agency Cephalosporin Trust (CF077), the Royal Society, the Wellcome Trust (WT075336AIA), the Biotechnology and Biological Sciences Research Council (BB/C504200/1) to APR, and by DPhil studentships from the BBSRC to HW-E, the Daimler-Benz Foundation to SP, and the Wellcome Trust to TL. The GPR126 mutant mouse strain was generated by Takeda Cambridge Ltd. and made available to the APR lab for analysis under a material transfer agreement for academic research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUAYO AJ, 1977, NATURE, V268, P753, DOI 10.1038/268753a0; BJARNADOTTIR T, 2007, CELL MOL LIFE SCI; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Chai Y, 2000, DEVELOPMENT, V127, P1671; Conway SJ, 1997, DEVELOPMENT, V124, P505; Creazzo TL, 1998, ANNU REV PHYSIOL, V60, P267, DOI 10.1146/annurev.physiol.60.1.267; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; HANCOCK DB, 2009, NAT GENET; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Laisney JAGC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-27; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Stehlik C, 2004, FEBS LETT, V569, P149, DOI 10.1016/j.febslet.2004.05.038; Strutt D, 2008, CURR BIOL, V18, pR898, DOI 10.1016/j.cub.2008.07.055; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zhao JH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-96	32	58	60	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14047	10.1371/journal.pone.0014047	http://dx.doi.org/10.1371/journal.pone.0014047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124978	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000284356900010
J	Kraemer, S; Lue, HQ; Zernecke, A; Kapurniotu, A; Andreetto, E; Frank, R; Lennartz, B; Weber, C; Bernhagen, J				Kraemer, Sandra; Lue, Hongqi; Zernecke, Alma; Kapurniotu, Aphrodite; Andreetto, Erika; Frank, Ronald; Lennartz, Birgitt; Weber, Christian; Bernhagen, Juergen			MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism	FASEB JOURNAL			English	Article						CLF chemokine; G-protein-coupled receptor; cytokine; domain analysis; structure-activity analysis	MIGRATION INHIBITORY FACTOR; PROTEIN-COUPLED RECEPTOR; IMMATURE DENDRITIC CELLS; TRANSFER-RNA SYNTHETASE; CRYSTAL-STRUCTURE; AMINO-TERMINUS; HIV-1 ENTRY; INTERLEUKIN-8 RECEPTOR; MOLECULAR-DYNAMICS; LIGAND SELECTIVITY	Macrophage migration inhibitory factor (MIF) is a cytokine that mediates inflammatory diseases. MIF promotes atherogenic leukocyte recruitment through a promiscuous, yet highly affine, interaction with CXCR2 and CXCR4. Binding to CXCR2 is dependent on a pseudo-(E)LR motif in MIF, but a second interaction site has been elusive. Here we identified an N-like loop in MIF, suggesting that MIF binding to CXCR2 follows the 2-site binding mode of bona fide chemokines. For MIF, the model predicts interactions between the N-like loop and the CXCR2 N domain (site 1) and pseudo-(E) LR and extracellular loops (ELs) of CXCR2 (site 2). Applying biophysical and peptide array analysis, we demonstrated an interaction between MIF and the CXCR2 N domain, which was pseudo-(E) LR independent. Peptide array analysis also indicated that the pseudo-(E) LR motif is responsible for MIF binding to EL2 and 3. Notably, peptides MIF-(40-49) and MIF-(47-56), representing N-like-loop-derived peptides, but not a scrambled control peptide, significantly blocked MIF/CXCR2 binding, MIF-mediated monocyte arrest under flow on aortic endothelial cells in vitro (IC50: 1.24x10(-6) M), and MIF-dependent monocyte adhesion to atherosclerotic mouse carotid arteries in vivo. Thus, the N-like loop in MIF is critical for MIF's noncognate interaction with CXCR2 and proatherogenic functions. The 2-site binding model that explains chemokine receptor activation also applies to MIF.-Kraemer, S., Lue, H., Zernecke, A., Kapurniotu, A., Andreetto, E., Frank, R., Lennartz, B., Weber, C., Bernhagen, J. MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism. FASEB J. 25, 894-906 (2011). www.fasebj.org	[Kraemer, Sandra; Lue, Hongqi; Lennartz, Birgitt; Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, D-52074 Aachen, Germany; [Zernecke, Alma] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, Wurzburg, Germany; [Kapurniotu, Aphrodite; Andreetto, Erika] Tech Univ Munich, Div Peptide Biochem, Munich, Germany; [Frank, Ronald] Helmholtz Ctr Infect Res, Dept Biol Chem, Braunschweig, Germany; [Weber, Christian] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany	RWTH Aachen University; University of Wurzburg; Technical University of Munich; Helmholtz Association; Helmholtz-Center for Infection Research; University of Munich	Bernhagen, J (corresponding author), Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Pauwelsstr 30, D-52074 Aachen, Germany.	jbernhagen@ukaachen.de	Weber, Christian/AAW-2153-2020	Weber, Christian/0000-0003-4610-8714	Deutsche Forschungsgemeinschaft (DFG) [DFG-FOR809, Be1977/4-2, TP1, Ze 827/1-1, TP3, We 1913/11-1, TP4]; Carolus Therapeutics (San Diego, CA, USA)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Carolus Therapeutics (San Diego, CA, USA)	The authors thank M. Dewor, Sabine Winkler, Susan Daenicke, and M. Drechsler for technical assistance and helpful advice with the cell culture, peptide handling, and mice. The authors also thank Javier Navarro (University of Texas Medical Branch, Galveston, TX, USA) for kindly providing the CXCR1/CXCR2 chimera constructs and M. Fioroni and U. Schwaneberg for help with the VMD structural analysis software. The authors are grateful to J. Schultz for invaluable discussions on the MIF peptides and ligand/receptor interface. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to J.B., C.W., and A.Z. (DFG-FOR809 projects: Be1977/4-2, TP1; Ze 827/1-1, TP3; We 1913/11-1, TP4) and in part by Carolus Therapeutics (San Diego, CA, USA; peptide supply and spot arrays).	Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Degryse B, 2003, FEBS LETT, V553, P11, DOI 10.1016/S0014-5793(03)01027-5; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Frank R, 1996, Methods Mol Biol, V66, P149; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GAYLE RB, 1993, J BIOL CHEM, V268, P7283; Gong JH, 1996, J BIOL CHEM, V271, P10521, DOI 10.1074/jbc.271.18.10521; Hammond MEW, 1996, J BIOL CHEM, V271, P8228, DOI 10.1074/jbc.271.14.8228; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; Heveker N, 2001, MOL PHARMACOL, V59, P1418, DOI 10.1124/mol.59.6.1418; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Huang XQ, 2003, BIOPHYS J, V84, P171, DOI 10.1016/S0006-3495(03)74840-1; Huynh N, 2008, BIOPOLYMERS, V89, P52, DOI 10.1002/bip.20851; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Katancik JA, 2000, CYTOKINE, V12, P1480, DOI 10.1006/cyto.2000.0742; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murphy PM, 2000, PHARMACOL REV, V52, P145; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perez-Canadillas JM, 2001, J BIOL CHEM, V276, P28372, DOI 10.1074/jbc.M103121200; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Qian YQ, 1999, J MOL BIOL, V294, P1065, DOI 10.1006/jmbi.1999.3333; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Taylor K, 2008, J BIOL CHEM, V283, P6631, DOI 10.1074/jbc.M709238200; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; WEBER C, 1993, EUR J IMMUNOL, V23, P852, DOI 10.1002/eji.1830230413; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	74	43	43	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2011	25	3					894	906		10.1096/fj.10-168559	http://dx.doi.org/10.1096/fj.10-168559			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21106938				2022-12-25	WOS:000287806200010
J	Carrillo, LD; Froemming, JA; Mahal, LK				Carrillo, Luz D.; Froemming, Joshua A.; Mahal, Lara K.			Targeted in Vivo O-GlcNAc Sensors Reveal Discrete Compartment-specific Dynamics during Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; PROTEIN-KINASE; NUCLEAR-LOCALIZATION; ACTIVATION DOMAIN; PHOSPHORYLATION; MEMBRANE; EXPORT; TRANSFERASE; REPORTER	beta-O-N-acetyl-D-glucosamine (O-GlcNAc) is a post-translational modification involved in a plethora of biological systems ranging from cellular stress to insulin signaling. This modification shares many hallmarks with phosphorylation, including its dynamic cycling onto a host of proteins such as transcription factors, kinases, and phosphatases, and regulation of cellular functions, including cell signaling. Herein, we report the development of an improved genetically based O-GlcNAc FRET sensor and compartmentalized targeted variants for the characterization of the spatiotemporal dynamics of O-GlcNAc. During serum-stimulated signal transduction, rapid increases in O-GlcNAc activity were observed at both the plasma membrane and the nucleus, with a concomitant decrease detected in the cytoplasm. These findings suggest the existence of compartment specific dynamics for O-GlcNAc in response to signal-inducing stimuli, pointing to complex regulation of this modification. In addition, inhibition of the PI3K pathway by wortmannin abolished the O-GlcNAc response, suggesting that the activity observed is modulated downstream of the PI3K pathway. Taken together, our data argues that O-GlcNAc is a rapidly induced component of signaling and that the interplay between O-GlcNAc and kinase signaling may be more akin to the complex relationship between kinase pathways.	[Carrillo, Luz D.; Froemming, Joshua A.; Mahal, Lara K.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Mahal, Lara K.] NYU, Dept Chem, New York, NY 10003 USA	University of Texas System; University of Texas Austin; New York University	Mahal, LK (corresponding author), 100 Washington Sq E,Rm 1001, New York, NY 10003 USA.	lkmahal@nyu.edu	Mahal, Lara/GRY-7287-2022	Mahal, Lara/0000-0003-4791-8524	American Heart Association [0755146Y]; Alfred P. Sloan Foundation	American Heart Association(American Heart Association); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Financial Support for this work came from the American Heart Association (Grant-in-aid, 0755146Y) and the Alfred P. Sloan Foundation.	Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Carrillo LD, 2006, J AM CHEM SOC, V128, P14768, DOI 10.1021/JA065835+; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gao XX, 2008, MOL BIOL CELL, V19, P4366, DOI 10.1091/mbc.E08-05-0449; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kneass ZT, 2005, J BIOL CHEM, V280, P14579, DOI 10.1074/jbc.M414066200; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Nanashima N, 2005, J BIOL CHEM, V280, P43010, DOI 10.1074/jbc.M509481200; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; SAARELA S, 1995, J BACTERIOL, V177, P1477, DOI 10.1128/jb.177.6.1477-1484.1995; Saxena A, 2002, J BIOL CHEM, V277, P49935, DOI 10.1074/jbc.M206497200; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tanskanen J, 2001, J BACTERIOL, V183, P512, DOI 10.1128/JB.183.2.512-519.2001; TIGYI G, 1990, P NATL ACAD SCI USA, V87, P1521, DOI 10.1073/pnas.87.4.1521; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	44	25	25	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6650	6658		10.1074/jbc.M110.191627	http://dx.doi.org/10.1074/jbc.M110.191627			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21138847	Green Published, hybrid			2022-12-25	WOS:000287476400073
J	Florek, P; Levdikov, VM; Blagova, E; Lebedev, AA; Skrabana, R; Resetarova, S; Pavelcikova, P; Barak, I; Wilkinson, AJ				Florek, Patrik; Levdikov, Vladimir M.; Blagova, Elena; Lebedev, Andrey A.; Skrabana, Rostislav; Resetarova, Stanislava; Pavelcikova, Pamela; Barak, Imrich; Wilkinson, Anthony J.			The Structure and Interactions of SpoIISA and SpoIISB, a Toxin-Antitoxin System in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MOLECULAR-GRAPHICS; STATIONARY-PHASE; DIFFRACTION DATA; GAF DOMAIN; EXPRESSION; COMPLEX; PROTEIN	Spore formation in Bacillus subtilis begins with an asymmetric cell division, following which differential gene expression is established by alternative compartment-specific RNA polymerase sigma factors. The spoIISAB operon of B. subtilis was identified as a locus whose mutation leads to increased activity of the first sporulation-specific sigma factor, sigma(F). Inappropriate spoIISA expression causes lysis of vegetatively growing B. subtilis cells and Escherichia coli cells when expressed heterologously, effects that are countered by co-expression of spoIISB, identifying SpoIISA-SpoIISB as a toxin-antitoxin system. SpoIISA has three putative membrane-spanning segments and a cytoplasmic domain. Here, the crystal structure of a cytoplasmic fragment of SpoIISA (CSpoIISA) in complex with SpoIISB has been determined by selenomethionine-multiwavelength anomalous dispersion phasing to 2.5 angstrom spacing, revealing a CSpoIISA(2) . SpoIISB(2) heterotetramer. CSpoIISA has a single domain alpha/beta structure resembling a GAF domain with an extended alpha-helix at its N terminus. The two CSpoIISA protomers form extensive interactions through an intermolecular four-helix bundle. Each SpoIISB chain is highly extended and lacking tertiary structure. The SpoIISB chains wrap around the CSpoIISA dimer, forming extensive interactions with both CSpoIISA protomers. CD spectroscopy experiments indicate that SpoIISB is a natively disordered protein that adopts structure only in the presence of CSpoIISA, whereas surface plasmon resonance experiments revealed that the CSpoIISA . SpoIISB complex is stable with a dissociation constant in the nanomolar range. The results are interpreted in relation to sequence conservation and mutational data, and possible mechanisms of cell killing by SpoIISA are discussed.	[Resetarova, Stanislava; Pavelcikova, Pamela; Barak, Imrich] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551 45, Slovakia; [Levdikov, Vladimir M.; Blagova, Elena; Lebedev, Andrey A.; Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Skrabana, Rostislav] Slovak Acad Sci, Inst Neuroimmunol, Bratislava 84510 45, Slovakia	Slovak Academy of Sciences; University of York - UK; Slovak Academy of Sciences	Barak, I (corresponding author), Slovak Acad Sci, Inst Mol Biol, Bratislava 84551 45, Slovakia.	Imrich.Barak@savba.sk; ajw@ysbl.york.ac.uk	Rešetárová, Stanislava/ABA-8823-2020; Barak, Imrich/H-7285-2019; Levdikov, Vladimir/AAA-6139-2022; Skrabana, Rostislav/T-7382-2019	Barak, Imrich/0000-0002-3690-404X; Skrabana, Rostislav/0000-0001-8200-5275; Wilkinson, Anthony/0000-0003-4577-9479; Levdikov, Vladimir/0000-0003-3041-1049	Slovak Academy of Sciences [2/0016/10]; Slovak Research and Development Agency [APVT-51-0278, LPP-0218-06]; European Science Foundation [ESF-EC-0106]; Wellcome Trust [082829/Z/07/Z]	Slovak Academy of Sciences(Slovak Academy of Sciences); Slovak Research and Development Agency(Slovak Research and Development Agency); European Science Foundation(European Science Foundation (ESF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Grant 2/0016/10 from the Slovak Academy of Sciences, by grants from the Slovak Research and Development Agency under Contracts APVT-51-0278 and LPP-0218-06, by a European Science Foundation Grant ESF-EC-0106, and by Grant 082829/Z/07/Z from the Wellcome Trust.	Adler E, 2001, J BACTERIOL, V183, P3574, DOI 10.1128/JB.183.12.3574-3581.2001; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BENSON AK, 1993, J BACTERIOL, V175, P2347, DOI 10.1128/JB.175.8.2347-2356.1993; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Dewey JS, 2010, P NATL ACAD SCI USA, V107, P2219, DOI 10.1073/pnas.0914030107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florek P, 2008, FEMS MICROBIOL LETT, V278, P177, DOI 10.1111/j.1574-6968.2007.00984.x; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hanna RA, 2007, FEBS LETT, V581, P2894, DOI 10.1016/j.febslet.2007.05.035; Harwood C.R., 1990, MOL BIOL METHODS BAC; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Ju JL, 1998, J BACTERIOL, V180, P1673, DOI 10.1128/JB.180.7.1673-1681.1998; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Levdikov VM, 2009, J MOL BIOL, V390, P1007, DOI 10.1016/j.jmb.2009.05.077; Levdikov VM, 2006, J BIOL CHEM, V281, P11366, DOI 10.1074/jbc.M513015200; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; MAUGUEN Y, 1982, NATURE, V297, P162, DOI 10.1038/297162a0; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ramakrishnan V, 1997, METHOD ENZYMOL, V276, P538, DOI 10.1016/S0076-6879(97)76077-4; Resetarova S, 2010, RES MICROBIOL, V161, P750, DOI 10.1016/j.resmic.2010.09.005; Savva CG, 2008, MOL MICROBIOL, V69, P784, DOI 10.1111/j.1365-2958.2008.06298.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; SEVCIK J, 1991, ACTA CRYSTALLOGR B, V47, P240, DOI 10.1107/S0108768190009569; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Steil L, 2005, MICROBIOL-SGM, V151, P399, DOI 10.1099/mic.0.27493-0; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1	53	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6808	6819		10.1074/jbc.M110.172429	http://dx.doi.org/10.1074/jbc.M110.172429			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21147767	Green Published, hybrid			2022-12-25	WOS:000287476400088
J	Riese, MJ; Grewal, J; Das, J; Zou, T; Patil, V; Chakraborty, AK; Koretzky, GA				Riese, Matthew J.; Grewal, Jashanpreet; Das, Jayajit; Zou, Tao; Patil, Vineet; Chakraborty, Arup K.; Koretzky, Gary A.			Decreased Diacylglycerol Metabolism Enhances ERK Activation and Augments CD8(+) T Cell Functional Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBL-B; KINASE-ZETA; HOMEOSTATIC PROLIFERATION; RAS ACTIVATION; IN-VIVO; POSITIVE SELECTION; ANTIGEN; PROTEIN; ALPHA; NAIVE	Modulation of T cell receptor signal transduction in CD8(+) T cells represents a novel strategy toward enhancing the immune response to tumor. Recently, levels of guanine exchange factors, RasGRP and SOS, within T cells have been shown to represent a key determinant in the regulation of the analog to the digital activation threshold of Ras. One important for regulating activation levels of RasGRP is diacylglycerol (DAG), and its levels are influenced by diacylglycerol kinase-zeta (DGK zeta), which metabolizes DAG into phosphatidic acid, terminating DAG-mediated Ras signaling. We sought to determine whether DGK zeta-deficient CD8(+) T cells demonstrated enhanced in vitro responses in a manner predicted by the current model of Ras activation and to evaluate whether targeting this threshold confers enhanced CD8(+) T cell responsiveness to tumor. We observed that DGK zeta-deficient CD8(+) T cells conform to most predictions of the current model of how RasGRP levels influence Ras activation. But our results differ in that the EC50 value of stimulation is not altered for any T cell receptor stimulus, a finding that suggests a further degree of complexity to how DGK zeta deficiency affects signals important for Ras and ERK activation. Additionally, we found that DGK zeta-deficient CD8(+) T cells demonstrate enhanced responsiveness in a subcutaneous lymphoma model, implicating the analog to a digital conversion threshold as a novel target for potential therapeutic manipulation.	[Koretzky, Gary A.] Univ Penn, Dept Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Riese, Matthew J.] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Koretzky, Gary A.] Univ Penn, Dept Med, Div Rheumatol, Philadelphia, PA 19104 USA; [Das, Jayajit] Nationwide Childrens Hosp, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Das, Jayajit] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Koretzky, Gary A.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] Massachusetts Gen Hosp, Ragon Inst, MIT, Charlestown, MA 02129 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Koretzky, GA (corresponding author), 413 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	koretzky@mail.med.upenn.edu	Das, Jayajit/E-2951-2011; Das, Jayajit/AAD-8502-2022; Koretzky, Gary/AAU-5381-2021	Das, Jayajit/0000-0001-9649-4698; Riese, Matthew/0000-0002-2423-0017	National Institutes of Health; NATIONAL CANCER INSTITUTE [K08CA151893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant.	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Chakraborty AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.266pt2; Chiang JY, 2007, J CLIN INVEST, V117, P1029, DOI 10.1172/JCI29472; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; DiSpirito JR, 2010, CELL RES, V20, P13, DOI 10.1038/cr.2009.140; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FRANKLIN RA, 1994, J CLIN INVEST, V93, P2134, DOI 10.1172/JCI117209; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldberg J, 2003, J IMMUNOL, V170, P228, DOI 10.4049/jimmunol.170.1.228; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Guo R, 2008, P NATL ACAD SCI USA, V105, P11909, DOI 10.1073/pnas.0711856105; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Johnson KG, 1999, J IMMUNOL, V162, P3802; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Norment AM, 2003, J IMMUNOL, V170, P1141, DOI 10.4049/jimmunol.170.3.1141; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Posevitz V, 2008, J IMMUNOL, V180, P1634, DOI 10.4049/jimmunol.180.3.1634; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Shamim M, 2007, J IMMUNOL, V179, P7233, DOI 10.4049/jimmunol.179.11.7233; Simma O, 2009, CANCER RES, V69, P203, DOI 10.1158/0008-5472.CAN-08-1705; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Van Kampen NG, 1992, STOCHASTIC PROCESSES; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Yi TL, 2008, CURR ONCOL REP, V10, P114, DOI 10.1007/s11912-008-0019-6; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zhang H, 2005, J LEUKOCYTE BIOL, V78, P1070, DOI 10.1189/jlb0605-317; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	46	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5254	5265		10.1074/jbc.M110.171884	http://dx.doi.org/10.1074/jbc.M110.171884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21138839	hybrid, Green Published			2022-12-25	WOS:000287230600034
J	Yano, M; Watanabe, K; Yamamoto, T; Ikeda, K; Senokuchi, T; Lu, MH; Kadomatsu, T; Tsukano, H; Ikawa, M; Okabe, M; Yamaoka, S; Okazaki, T; Umehara, H; Gotoh, T; Song, WJ; Node, K; Taguchi, R; Yamagata, K; Oike, Y				Yano, Masato; Watanabe, Ken; Yamamoto, Tadashi; Ikeda, Kazutaka; Senokuchi, Takafumi; Lu, Meihong; Kadomatsu, Tsuyoshi; Tsukano, Hiroto; Ikawa, Masahito; Okabe, Masaru; Yamaoka, Shohei; Okazaki, Toshiro; Umehara, Hisanori; Gotoh, Tomomi; Song, Wen-Jie; Node, Koichi; Taguchi, Ryo; Yamagata, Kazuya; Oike, Yuichi			Mitochondrial Dysfunction and Increased Reactive Oxygen Species Impair Insulin Secretion in Sphingomyelin Synthase 1-null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; PANCREATIC BETA-CELLS; SPHINGOLIPID METABOLISM; CERAMIDE; APOPTOSIS; PROTEINS; DETERMINANTS; TRAFFICKING; INHIBITION; SENESCENCE	Sphingomyelin synthase 1 (SMS1) catalyzes the conversion of ceramide to sphingomyelin. Here, we generated and analyzed SMS1-null mice. SMS1-null mice exhibited moderate neonatal lethality, reduced body weight, and loss of fat tissues mass, suggesting that they might have metabolic abnormality. Indeed, analysis on glucose metabolism revealed that they showed severe deficiencies in insulin secretion. Isolated mutant islets exhibited severely impaired ability to release insulin, dependent on glucose stimuli. Further analysis indicated that mitochondria in mutant islet cells cannot up-regulate ATP production in response to glucose. We also observed additional mitochondrial abnormalities, such as hyperpolarized membrane potential and increased levels of reactive oxygen species (ROS) in mutant islets. Finally, when SMS1-null mice were treated with the anti-oxidant N-acetyl cysteine, we observed partial recovery of insulin secretion, indicating that ROS overproduction underlies pancreatic beta-cell dysfunction in SMS1-null mice. Altogether, our data suggest that SMS1 is important for controlling ROS generation, and that SMS1 is required for normal mitochondrial function and insulin secretion in pancreatic beta-cells.	[Yano, Masato; Yamamoto, Tadashi; Kadomatsu, Tsuyoshi; Tsukano, Hiroto; Gotoh, Tomomi; Oike, Yuichi] Kumamoto Univ, Fac Life Sci, Dept Mol Genet, Kumamoto 8608556, Japan; [Senokuchi, Takafumi; Yamagata, Kazuya] Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto 8608556, Japan; [Lu, Meihong; Song, Wen-Jie] Kumamoto Univ, Fac Life Sci, Dept Sensory & Cognit Physiol, Kumamoto 8608556, Japan; [Watanabe, Ken] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Aichi 4748511, Japan; [Yamamoto, Tadashi; Node, Koichi] Saga Univ, Dept Cardiovasc & Renal Med, Saga 8498501, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Tokyo 1130033, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Res Inst Microbial Dis & Pharmaceut Sci, Osaka 5650871, Japan; [Yamaoka, Shohei; Okazaki, Toshiro] Tottori Univ, Div Clin Lab Med & Hematol Oncol, Fac Med, Tottori 6838503, Japan; [Umehara, Hisanori] Kanazawa Med Univ, Dept Hematol & Immunol, Ishikawa 9200293, Japan	Kumamoto University; Kumamoto University; Kumamoto University; National Center for Geriatrics & Gerontology; Saga University; University of Tokyo; Osaka University; Tottori University; Kanazawa Medical University	Yano, M (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Mol Genet, Kumamoto 8608556, Japan.	myano@gpo.kumamoto-u.ac.jp; oike@gpo.kumamoto-u.ac.jp	Watanabe, Ken/I-3960-2013; ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	Watanabe, Ken/0000-0003-0664-3915; ikawa, masahito/0000-0001-9859-6217; Okabe, Masaru/0000-0002-0803-9044; Song, Wen-Jie/0000-0003-2909-3098	Ministry of Education, Science, Technology, Sports, and Culture of Japan [19790215, 22116009]; Japan Society for the Promotion of Science [22659156]; Takeda Science Foundation; Inamori Foundation	Ministry of Education, Science, Technology, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation	This work was supported by Grants-in-Aid 19790215 (to M. Y.), and 22116009 (to Y. O.) from the Ministry of Education, Science, Technology, Sports, and Culture of Japan, by Grant-in-Aid 22659156 (to Y. O.) from the Japan Society for the Promotion of Science, and by grants-in-aid from the Takeda Science Foundation and Inamori Foundation (to M. Y.).	Affourtit C, 2008, BBA-BIOENERGETICS, V1777, P973, DOI 10.1016/j.bbabio.2008.03.022; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Ikeda K, 2009, J CHROMATOGR B, V877, P2639, DOI 10.1016/j.jchromb.2009.03.047; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Menaldino DS, 2003, PHARMACOL RES, V47, P373, DOI 10.1016/S1043-6618(03)00054-9; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Separovic D, 2008, EXP CELL RES, V314, P1860, DOI 10.1016/j.yexcr.2008.02.008; Shimomura K, 2009, METHOD ENZYMOL, V457, P451, DOI 10.1016/S0076-6879(09)05025-3; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; WOLLHEIM CB, 1990, METHOD ENZYMOL, V192, P188; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamagata K, 2002, DIABETES, V51, P114, DOI 10.2337/diabetes.51.1.114; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yano M, 2000, MOL CELL BIOL, V20, P7205, DOI 10.1128/MCB.20.19.7205-7213.2000; Yano M, 2007, EXP CELL RES, V313, P3767, DOI 10.1016/j.yexcr.2007.07.031; Zeidan YH, 2008, CURR DRUG TARGETS, V9, P653, DOI 10.2174/138945008785132358; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	48	106	109	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3992	4002		10.1074/jbc.M110.179176	http://dx.doi.org/10.1074/jbc.M110.179176			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115496	Green Published, hybrid			2022-12-25	WOS:000286653200079
J	Chen, X; Tomkinson, AE				Chen, Xi; Tomkinson, Alan E.			Yeast Nej1 Is a Key Participant in the Initial End Binding and Final Ligation Steps of Nonhomologous End Joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; DNA-LIGASE-IV; DEPENDENT PROTEIN-KINASE; HUMAN XLF; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; COMPLEX; REPAIR; XRCC4; DNL4-LIF1	In Saccharomyces cerevisiae, the key components of the nonhomologous end joining (NHEJ) pathway that repairs DNA double-strand breaks (DSBs) are yeast Ku (yKu), Mre11-Rad50-Xrs2, Dnl4-Lif1, and Nej1. Here, we examined the role of Nej1 in NHEJ by a combination of molecular genetic and biochemical approaches. As expected, the recruitment of Nej1 to in vivo DSBs is dependent upon yKu. Surprisingly, Nej1 is required for the stable binding of yKu to in vivo DSBs, in addition to Dnl4-Lif1. Thus, Nej1 and Dnl4-Lif1 are independently recruited by yKu to in vivo DSBs, forming a stable ternary complex that channels DSBs into the NHEJ pathway. In accord with these results, purified Nej1 interacts with yKu and preferentially binds to DNA ends bound by yKu. Furthermore, the binding of a mixture of Nej1 and Dnl4-Lif1 to DNA ends bound by yKu is greater than the sum of the binding of the individual proteins, indicating that pairwise interactions among yKu, Nej1, and Dnl4-Lif1 contribute to complex assembly at DNA ends. Nej1 stimulates intermolecular ligation by Dnl4-Lif1, but, more interestingly, the addition of Nej1 results in more than one intermolecular ligation per Dnl4 molecule. Thus, Nej1 not only plays an important role in determining repair pathway choice by participating in the initial NHEJ complex formed at DSBs but also contributes to the reactivation of Dnl4-Lif1 after repair is complete, thereby increasing the capacity of the NHEJ repair pathway.	[Tomkinson, Alan E.] Univ Maryland, Sch Med, Dept Radiat Oncol, Radiat Oncol Res Lab, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Tomkinson, AE (corresponding author), Univ Maryland, Sch Med, Dept Radiat Oncol, Radiat Oncol Res Lab, 655 W Baltimore St,BRB 7-025, Baltimore, MD 21201 USA.	atomkinson@som.umaryland.edu			National Institutes of Health Grant [GM47251]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047251, R01GM047251] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM47251 (to A. E. T.).	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Carter SD, 2009, P NATL ACAD SCI USA, V106, P12037, DOI 10.1073/pnas.0903869106; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; Chen X, 2009, DNA REPAIR, V8, P961, DOI 10.1016/j.dnarep.2009.06.002; Clikeman JA, 2001, GENETICS, V157, P579; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; Deshpande RA, 2007, DNA REPAIR, V6, P1507, DOI 10.1016/j.dnarep.2007.04.014; Dore AS, 2006, DNA REPAIR, V5, P362, DOI 10.1016/j.dnarep.2005.11.004; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Hentges P, 2006, J BIOL CHEM, V281, P37517, DOI 10.1074/jbc.M608727200; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Huang Y, 2009, J EXP MED, V206, P893, DOI 10.1084/jem.20082396; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Lee K, 2007, GENETICS, V176, P2003, DOI 10.1534/genetics.107.076539; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Li Y, 2008, EMBO J, V27, P290, DOI 10.1038/sj.emboj.7601942; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Modesti M, 2003, J MOL BIOL, V334, P215, DOI 10.1016/j.jmb.2003.09.031; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Palmbos PL, 2005, MOL CELL BIOL, V25, P10782, DOI 10.1128/MCB.25.24.10782-10790.2005; Riballo E, 2001, J BIOL CHEM, V276, P31124, DOI 10.1074/jbc.M103866200; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Robins P, 1996, J BIOL CHEM, V271, P24257, DOI 10.1074/jbc.271.39.24257; Schar P, 1997, GENE DEV, V11, P1912, DOI 10.1101/gad.11.15.1912; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Teo SH, 2000, CURR BIOL, V10, P165, DOI 10.1016/S0960-9822(00)00317-1; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Tseng HM, 2002, J BIOL CHEM, V277, P45630, DOI 10.1074/jbc.M206861200; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Wang Y, 2007, BIOCHEMISTRY-US, V46, P4962, DOI 10.1021/bi0621516; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261	50	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4931	4940		10.1074/jbc.M110.195024	http://dx.doi.org/10.1074/jbc.M110.195024			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21149442	hybrid, Green Published			2022-12-25	WOS:000286975700089
J	Koerdt, A; Godeke, J; Berger, J; Thormann, KM; Albers, SV				Koerdt, Andrea; Goedeke, Julia; Berger, Juergen; Thormann, Kai M.; Albers, Sonja-Verena			Crenarchaeal Biofilm Formation under Extreme Conditions	PLOS ONE			English	Article							ARCHAEON SULFOLOBUS-SOLFATARICUS; PSEUDOMONAS-AERUGINOSA; BACTERIAL BIOFILMS; PYROCOCCUS-FURIOSUS; GENUS SULFOLOBUS; HOT-SPRINGS; EXOPOLYSACCHARIDE; ENVIRONMENT; MULTIPLE; MATRIX	Background: Biofilm formation has been studied in much detail for a variety of bacterial species, as it plays a major role in the pathogenicity of bacteria. However, only limited information is available for the development of archaeal communities that are frequently found in many natural environments. Methodology: We have analyzed biofilm formation in three closely related hyperthermophilic crenarchaeotes: Sulfolobus acidocaldarius, S. solfataricus and S. tokodaii. We established a microtitre plate assay adapted to high temperatures to determine how pH and temperature influence biofilm formation in these organisms. Biofilm analysis by confocal laser scanning microscopy demonstrated that the three strains form very different communities ranging from simple carpet-like structures in S. solfataricus to high density tower-like structures in S. acidocaldarius in static systems. Lectin staining indicated that all three strains produced extracellular polysaccharides containing glucose, galactose, mannose and N-acetylglucosamine once biofilm formation was initiated. While flagella mutants had no phenotype in two days old static biofilms of S. solfataricus, a UV-induced pili deletion mutant showed decreased attachment of cells. Conclusion: The study gives first insights into formation and development of crenarchaeal biofilms in extreme environments.	[Koerdt, Andrea; Goedeke, Julia; Thormann, Kai M.] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Berger, Juergen] Max Planck Inst Dev Biol, Tubingen, Germany	Max Planck Society; Max Planck Society	Koerdt, A (corresponding author), Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany.	albers@mpi-marburg.mpg.de	Albers, Sonja-Verena/H-8689-2019; Albers, Sonja-Verena/H-1213-2012	Albers, Sonja-Verena/0000-0003-2459-2226; Koerdt, Andrea/0000-0002-9214-6183	Max Planck Society	Max Planck Society(Max Planck Society)	The work was supported by intramural funds of the Max Planck Society to SVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 2009, EXTREMOPHILES, V13, P403, DOI 10.1007/s00792-009-0241-7; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; BAKERAUSTIN C, 2010, EXTREMOPHILES; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Ellen AF, 2009, EXTREMOPHILES, V13, P67, DOI 10.1007/s00792-008-0199-x; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Froels S, 2008, MOL MICROBIOL, V70, P938, DOI 10.1111/j.1365-2958.2008.06459.x; Grogan DW, 1996, J MICROBIOL METH, V26, P35, DOI 10.1016/0167-7012(96)00840-8; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Inskeep WP, 2004, GEOCHIM COSMOCHIM AC, V68, P3141, DOI 10.1016/j.gca.2003.09.020; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kruger M, 2008, ENVIRON MICROBIOL, V10, P1934, DOI 10.1111/j.1462-2920.2008.01607.x; LaPaglia C, 1997, APPL ENVIRON MICROB, V63, P3158, DOI 10.1128/AEM.63.8.3158-3163.1997; Macur RE, 2004, GEOBIOLOGY, V2, P163, DOI 10.1111/j.1472-4677.2004.00032.x; Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431; Nather DJ, 2006, J BACTERIOL, V188, P6915, DOI 10.1128/JB.00527-06; NICOLAUS B, 1993, FEMS MICROBIOL LETT, V109, P203, DOI 10.1111/j.1574-6968.1993.tb06168.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Rinker KD, 1996, APPL ENVIRON MICROB, V62, P4478, DOI 10.1128/AEM.62.12.4478-4485.1996; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; Schopf S, 2008, ARCH MICROBIOL, V190, P371, DOI 10.1007/s00203-008-0371-9; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Suzuki T, 2002, EXTREMOPHILES, V6, P39, DOI 10.1007/s007920100221; Szabo Z, 2007, J BACTERIOL, V189, P4305, DOI 10.1128/JB.00042-07; Thoma C, 2008, ENVIRON MICROBIOL, V10, P2785, DOI 10.1111/j.1462-2920.2008.01698.x; Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004; Veith A, 2009, MOL MICROBIOL, V73, P58, DOI 10.1111/j.1365-2958.2009.06746.x; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609; ZILLIG W, 1980, ARCH MICROBIOL, V125, P259, DOI 10.1007/BF00446886; Zolghadr B, 2010, J BACTERIOL, V192, P104, DOI 10.1128/JB.01061-09	37	85	85	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14104	10.1371/journal.pone.0014104	http://dx.doi.org/10.1371/journal.pone.0014104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124788	Green Submitted, Green Published, gold			2022-12-25	WOS:000284572000006
J	Caillaud, D; Crofoot, MC; Scarpino, SV; Jansen, PA; Garzon-Lopez, CX; Winkelhagen, AJS; Bohlman, SA; Walsh, PD				Caillaud, Damien; Crofoot, Margaret C.; Scarpino, Samuel V.; Jansen, Patrick A.; Garzon-Lopez, Carol X.; Winkelhagen, Annemarie J. S.; Bohlman, Stephanie A.; Walsh, Peter D.			Modeling the Spatial Distribution and Fruiting Pattern of a Key Tree Species in a Neotropical Forest: Methodology and Potential Applications	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; DIPTERYX-PANAMENSIS; HABITAT SELECTION; SEED DISPERSAL; EL-NINO; MOVEMENT; RECRUITMENT; PREDATION; FRAMEWORK; BEHAVIOR	Background: The movement patterns of wild animals depend crucially on the spatial and temporal availability of resources in their habitat. To date, most attempts to model this relationship were forced to rely on simplified assumptions about the spatiotemporal distribution of food resources. Here we demonstrate how advances in statistics permit the combination of sparse ground sampling with remote sensing imagery to generate biological relevant, spatially and temporally explicit distributions of food resources. We illustrate our procedure by creating a detailed simulation model of fruit production patterns for Dipteryx oleifera, a keystone tree species, on Barro Colorado Island (BCI), Panama. Methodology and Principal Findings: Aerial photographs providing GPS positions for large, canopy trees, the complete census of a 50-ha and 25-ha area, diameter at breast height data from haphazardly sampled trees and long-term phenology data from six trees were used to fit 1) a point process model of tree spatial distribution and 2) a generalized linear mixed-effect model of temporal variation of fruit production. The fitted parameters from these models are then used to create a stochastic simulation model which incorporates spatio-temporal variations of D. oleifera fruit availability on BCI. Conclusions and Significance: We present a framework that can provide a statistical characterization of the habitat that can be included in agent-based models of animal movements. When environmental heterogeneity cannot be exhaustively mapped, this approach can be a powerful alternative. The results of our model on the spatio-temporal variation in D. oleifera fruit availability will be used to understand behavioral and movement patterns of several species on BCI.	[Caillaud, Damien; Scarpino, Samuel V.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Caillaud, Damien] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Crofoot, Margaret C.; Jansen, Patrick A.] Smithsonian Trop Res Inst, Panama City, Panama; [Crofoot, Margaret C.] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Crofoot, Margaret C.; Bohlman, Stephanie A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Jansen, Patrick A.; Winkelhagen, Annemarie J. S.] Wageningen Univ, Forest Ecol & Forest Management Grp, Wageningen, Netherlands; [Jansen, Patrick A.; Garzon-Lopez, Carol X.] Univ Groningen, Community & Conservat Ecol Grp, Haren, Netherlands; [Walsh, Peter D.] VaccinApe, Bethesda, MD USA	University of Texas System; University of Texas Austin; Max Planck Society; Smithsonian Institution; Smithsonian Tropical Research Institute; Max Planck Society; Princeton University; Wageningen University & Research; University of Groningen	Caillaud, D (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	dcaillaud@austin.utexas.edu	Caillaud, Damien/AAH-5850-2019; Jansen, Patrick/G-2545-2015; Garzon-Lopez, Carol/G-6251-2014	Caillaud, Damien/0000-0002-8347-6869; Jansen, Patrick/0000-0002-4660-0314; Garzon-Lopez, Carol/0000-0002-4099-2740	NSF [DEB-0553768, DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197, DEB-0749097]; University of California Santa Barbara and the State of California; Center for Tropical Forest Science; Smithsonian Tropical Forest Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Celera Foundation; Division Of Environmental Biology [0749097] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of California Santa Barbara and the State of California(University of California System); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Forest Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Celera Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Center For Ecological Analysis is supported by NSF Grant DEB-0553768, the University of California Santa Barbara and the State of California. The Forest Dynamics Plots were funded by NSF Grants to Stephen Hubbell DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197, and by the Center for Tropical Forest Science, the Smithsonian Tropical Forest Research Institute, The John D. and Catherine T. MacArthur Foundation, the Mellon Foundation and the Celera Foundation. DC is supported by NSF grant DEB-0749097 to L. A. Meyers. SS is supported by an NSF Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; BARTUMEUS F, 2010, CURR BIOL, P215; Beaumont MA, 2002, GENETICS, V162, P2025; BERMAN M, 1992, J R STAT SOC C-APPL, V41, P31; BONACCORSO FJ, 1980, REV BIOL TROP, V28, P61; BOYER D, P R SOC B IN PRESS; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cartar RV, 1997, OECOLOGIA, V112, P430, DOI 10.1007/s004420050329; Ciarniello LM, 2007, ECOL APPL, V17, P1424, DOI 10.1890/06-1100.1; Condit R, 1998, TROPICAL FOREST CENS; Craft ME, 2009, P ROY SOC B-BIOL SCI, V276, P1777, DOI 10.1098/rspb.2008.1636; Crofoot MC, 2008, P NATL ACAD SCI USA, V105, P577, DOI 10.1073/pnas.0707749105; DESTEVEN D, 1984, OIKOS, V43, P207, DOI 10.2307/3544770; Dietrich W.E., 1982, ECOLOGY TROPICAL FOR, P21; Diggle P., 2003, STAT ANAL SPATIAL PO; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; FORGET PM, 1993, OECOLOGIA, V94, P255, DOI 10.1007/BF00341325; Foster R. B., 1982, ECOLOGY TROPICAL FOR, P151; Goverde M, 2002, BIOL CONSERV, V104, P293, DOI 10.1016/S0006-3207(01)00194-X; Hadley AS, 2009, BIOL LETTERS, V5, P207, DOI 10.1098/rsbl.2008.0691; Hanson T, 2007, J TROP ECOL, V23, P635, DOI 10.1017/S0266467407004488; Holland RA, 2009, J MAMMAL, V90, P1324, DOI 10.1644/09-MAMM-S-086R2.1; Howe H.F., 1986, P123; Hubbell S.P., 2005, BARRO COLORADO FORES; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jansen PA, 2008, ECOGRAPHY, V31, P33, DOI 10.1111/j.2007.0906-7590.05151.x; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; LEIGH EG, 1999, TROPICAL FOREST ECOL; LEUENBERGER C, 2010, BAYESIAN COMPUTATION, P243; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Musiega DE, 2006, ECOL RES, V21, P530, DOI 10.1007/s11284-006-0175-9; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newton I, 1687, PHILOS NATURALIS PRI; Ovaskainen O, 2004, ECOLOGY, V85, P242, DOI 10.1890/02-0706; Remais J, 2010, J R SOC INTERFACE, V7, P1181, DOI 10.1098/rsif.2009.0523; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Ripley B.D., 1988, STAT INFERENCE SPATI; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; SCHICK RS, 2008, ECOL LETT, P1338; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Smythe N., 1970, AM NAT, V104, P25, DOI DOI 10.1086/282638; Stoyan D., 1994, FRACTALS RANDOM SHAP; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552	50	16	18	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e15002	10.1371/journal.pone.0015002	http://dx.doi.org/10.1371/journal.pone.0015002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124927	Green Published, gold			2022-12-25	WOS:000284467200018
J	Dorum, S; Arntzen, MO; Qiao, SW; Holm, A; Koehler, CJ; Thiede, B; Sollid, LM; Fleckenstein, B				Dorum, Siri; Arntzen, Magnus O.; Qiao, Shuo-Wang; Holm, Anders; Koehler, Christian J.; Thiede, Bernd; Sollid, Ludvig M.; Fleckenstein, Burkhard			The Preferred Substrates for Transglutaminase 2 in a Complex Wheat Gluten Digest Are Peptide Fragments Harboring Celiac Disease T-Cell Epitopes	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE; GLIADIN PEPTIDES; BINDING CHARACTERISTICS; ALPHA-GLIADIN; DEAMIDATION; IDENTIFICATION; SPECIFICITY; MOLECULE; SPRUE; RECOGNIZE	Background: Celiac disease is a T-cell mediated chronic inflammatory disorder of the gut that is induced by dietary exposure to gluten proteins. CD4+ T cells of the intestinal lesion recognize gluten peptides in the context of HLA-DQ2.5 or HLA-DQ8 and the gluten derived peptides become better T-cell antigens after deamidation catalyzed by the enzyme transglutaminase 2 (TG2). In this study we aimed to identify the preferred peptide substrates of TG2 in a heterogeneous proteolytic digest of whole wheat gluten. Methods: A method was established to enrich for preferred TG2 substrates in a complex gluten peptide mixture by tagging with 5-biotinamido-pentylamine. Tagged peptides were isolated and then identified by nano-liquid chromatography online-coupled to tandem mass spectrometry, database searching and final manual data validation. Results: We identified 31 different peptides as preferred substrates of TG2. Strikingly, the majority of these peptides were harboring known gluten T-cell epitopes. Five TG2 peptide substrates that were predicted to bind to HLA-DQ2.5 did not contain previously characterized sequences of T-cell epitopes. Two of these peptides elicited T-cell responses when tested for recognition by intestinal T-cell lines of celiac disease patients, and thus they contain novel candidate T-cell epitopes. We also found that the intact 9mer core sequences of the respective epitopes were not present in all peptide substrates. Interestingly, those epitopes that were represented by intact forms were frequently recognized by T cells in celiac disease patients, whereas those that were present in truncated versions were infrequently recognized. Conclusion: TG2 as well as gastrointestinal proteolysis play important roles in the selection of gluten T-cell epitopes in celiac disease.	[Dorum, Siri; Qiao, Shuo-Wang; Sollid, Ludvig M.; Fleckenstein, Burkhard] Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway; [Arntzen, Magnus O.; Koehler, Christian J.; Thiede, Bernd] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Arntzen, Magnus O.; Fleckenstein, Burkhard] Oslo Univ Hosp, Rikshosp, Prote Core Facil, Oslo, Norway; [Arntzen, Magnus O.] Norwegian Univ Life Sci, Prote Core Facil, As, Norway; [Holm, Anders; Sollid, Ludvig M.] Oslo Univ Hosp, Rikshosp, Inst Immunol, Ctr Immune Regulat, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; Norwegian University of Life Sciences; University of Oslo; National Hospital Norway	Dorum, S (corresponding author), Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway.	siri.dorum@rr-research.no	Sollid, Ludvig/N-9691-2015; Arntzen, Magnus Ø/N-6983-2016; Koehler, Christian/A-5950-2013; Qiao, Shuo-Wang/ABE-8148-2020	Sollid, Ludvig/0000-0001-8860-704X; Arntzen, Magnus Ø/0000-0002-1803-727X; Qiao, Shuo-Wang/0000-0002-0935-8397	Research Council of Norway	Research Council of Norway(Research Council of Norway)	This research was supported by the National Program for Research in Functional Genomics (FUGE and FUGE-Ost) of the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Camarca A, 2009, J IMMUNOL, V182, P4158, DOI 10.4049/jimmunol.0803181; DERITIS G, 1988, GASTROENTEROLOGY, V94, P41, DOI 10.1016/0016-5085(88)90607-5; Dorum S, 2009, J PROTEOME RES, V8, P1748, DOI 10.1021/pr800960n; Fleckenstein B, 2004, J BIOL CHEM, V279, P17607, DOI 10.1074/jbc.M310198200; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; Godkin A, 1997, INT IMMUNOL, V9, P905, DOI 10.1093/intimm/9.6.905; Johansen BH, 1996, INT IMMUNOL, V8, P177, DOI 10.1093/intimm/8.2.177; Kwok WW, 1996, J IMMUNOL, V156, P2171; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Marti T, 2005, J PHARMACOL EXP THER, V312, P19, DOI 10.1124/jpet.104.073312; Mazzeo MF, 2003, PROTEIN SCI, V12, P2434, DOI 10.1110/ps.03185903; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; Molberg O, 1997, SCAND J IMMUNOL, V46, P103, DOI 10.1046/j.1365-3083.1997.d01-93.x; Piper JL, 2002, BIOCHEMISTRY-US, V41, P386, DOI 10.1021/bi011715x; Qiao SW, 2005, J IMMUNOL, V175, P254, DOI 10.4049/jimmunol.175.1.254; Salentijn EMJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-48; Shan L, 2005, J PROTEOME RES, V4, P1732, DOI 10.1021/pr050173t; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Sollid LM, 1997, GUT, V41, P851, DOI 10.1136/gut.41.6.851; STAMNAES J, 2008, BIOCH BIOPHYS ACTA; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; van de Wal Y, 1999, EUR J IMMUNOL, V29, P3133, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3133::AID-IMMU3133&gt;3.0.CO;2-G; vandeWal Y, 1996, IMMUNOGENETICS, V44, P246, DOI 10.1007/s002510050120; Vartdal F, 1996, EUR J IMMUNOL, V26, P2764, DOI 10.1002/eji.1830261132	34	52	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14056	10.1371/journal.pone.0014056	http://dx.doi.org/10.1371/journal.pone.0014056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124911	Green Submitted, Green Published, gold			2022-12-25	WOS:000284400100008
J	Chen, HK; Ji, ZS; Dodson, SE; Miranda, RD; Rosenblum, CI; Reynolds, IJ; Freedman, SB; Weisgraber, KH; Huang, YD; Mahley, RW				Chen, Hung-Kai; Ji, Zhong-Sheng; Dodson, Sara E.; Miranda, Rene D.; Rosenblum, Charles I.; Reynolds, Ian J.; Freedman, Stephen B.; Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.			Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTERIOR CINGULATE CORTEX; CYTOCHROME-C-OXIDASE; E TYPE-4 ALLELE; AMYLOID-BETA; OXIDATIVE STRESS; NEURONAL CELLS; EXPRESSION; BRAIN; DYSFUNCTION; ENERGY	Apolipoprotein (apo) E4 is the major genetic risk factor for late-onset Alzheimer disease (AD). ApoE4 assumes a pathological conformation through an intramolecular interaction mediated by Arg-61 in the amino-terminal domain and Glu-255 in the carboxyl-terminal domain, referred to as apoE4 domain interaction. Because AD is associated with mitochondrial dysfunction, we examined the effect of apoE4 domain interaction on mitochondrial respiratory function. Steady-state amounts of mitochondrial respiratory complexes were examined in neurons cultured from brain cortices of neuron-specific enolase promoter-driven apoE3 (NSE-apoE3) or apoE4 (NSEapoE4) transgenic mice. All subunits of mitochondrial respiratory complexes assessed were significantly lower in NSEapoE4 neurons compared with NSE-apoE3 neurons. However, no significant differences in levels of mitochondrial complexes were detected between astrocytes expressing different apoE isoforms driven by the glial fibrillary acidic protein promoter, leading to our conclusion that the effect of apoE4 is neuron specific. In neuroblastoma Neuro-2A (N2A) cells, apoE4 expression reduced the levels of mitochondrial respiratory complexes I, IV, and V. Complex IV enzymatic activity was also decreased, lowering mitochondrial respiratory capacity. Mutant apoE4 ( apoE4-Thr-61) lacking domain interaction did not induce mitochondrial dysfunction in N2A cells, indicating that the effect is specific to apoE4-expressing cells and dependent on domain interaction. Consistent with this finding, treatment of apoE4-expressing N2A cells with a small molecule that disrupts apoE4 domain interaction restored mitochondrial respiratory complex IV levels. These results suggest that pharmacological intervention with small molecules that disrupt apoE4 domain interaction is a potential therapeutic approach for apoE4-carrying AD subjects.	[Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Chen, Hung-Kai; Ji, Zhong-Sheng; Dodson, Sara E.; Miranda, Rene D.; Freedman, Stephen B.; Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Gladstone Ctr Translat Res, San Francisco, CA 95158 USA; [Weisgraber, Karl H.; Huang, Yadong; Mahley, Robert W.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Mahley, Robert W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weisgraber, Karl H.; Mahley, Robert W.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Rosenblum, Charles I.] Merck Res Labs, Rahway, NJ 07065 USA; [Reynolds, Ian J.] Merck Res Labs, West Point, PA 19486 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck & Company; Merck & Company	Mahley, RW (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	rmahley@gladstone.ucsf.edu	Reynolds, Ian/C-4358-2008; Reynolds, Ian Jeffery/ABH-3197-2020	Reynolds, Ian/0000-0003-3028-5070; Chen, Hung-Kai/0000-0002-2169-4924	Merck Research Laboratories	Merck Research Laboratories(Merck & Company)	This work was supported in part by Merck Research Laboratories.	Atamna H, 2007, MITOCHONDRION, V7, P297, DOI 10.1016/j.mito.2007.06.001; Bonilla E, 1999, BBA-BIOENERGETICS, V1410, P171, DOI 10.1016/S0005-2728(98)00165-0; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Buttini M, 1999, J NEUROSCI, V19, P4867; Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hauptmann S, 2006, EXP GERONTOL, V41, P668, DOI 10.1016/j.exger.2006.03.012; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mahley RW, 2009, ANN NEUROL, V65, P623, DOI 10.1002/ana.21736; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; MAHLEY RW, 1989, ARTERIOSCLEROSIS, V9, pI14; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Mozo J, 2006, BIOCHEM J, V393, P431, DOI 10.1042/BJ20050494; Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35; Parihar MS, 2007, AM J PHYSIOL-CELL PH, V292, pC8, DOI 10.1152/ajpcell.00232.2006; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Richter OMH, 2003, REV PHYSIOL BIOCH P, V147, P47, DOI 10.1007/s10254-003-0006-0; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Valla J, 2001, J NEUROSCI, V21, P4923, DOI 10.1523/JNEUROSCI.21-13-04923.2001; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu PT, 2006, NEUROBIOL DIS, V21, P256, DOI 10.1016/j.nbd.2005.07.004; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200	49	128	132	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5215	5221		10.1074/jbc.M110.151084	http://dx.doi.org/10.1074/jbc.M110.151084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21118811	Green Published, hybrid			2022-12-25	WOS:000287230600030
J	Wyatt, D; Malik, R; Vesecky, AC; Marchese, A				Wyatt, Debra; Malik, Rohit; Vesecky, Alissa C.; Marchese, Adriano			Small Ubiquitin-like Modifier Modification of Arrestin-3 Regulates Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; SUMO MODIFICATION; CLATHRIN ADAPTER; STRUCTURAL BASIS; PROTEIN; SUMOYLATION; COMPLEX; ACTIVATION; INTERACTS	Nonvisual arrestins are regulated by direct post-translational modifications, such as phosphorylation, ubiquitination, and nitrosylation. However, whether arrestins are regulated by other post-translational modifications remains unknown. Here we show that nonvisual arrestins are modified by small ubiquitin-like modifier 1 (SUMO-1) upon activation of beta(2)-adrenergic receptor (beta(2)AR). Lysine residues 295 and 400 in arrestin-3 fall within canonical SUMO consensus sites, and mutagenic analysis reveals that Lys-400 represents the main SUMOylation site. Depletion of the SUMO E2 modifying enzyme Ubc9 blocks arrestin-3 SUMOylation and attenuates beta(2)AR internalization, suggesting that arrestin SUMOylation mediates G protein-coupled receptor endocytosis. Consistent with this, expression of a SUMO-deficient arrestin mutant failed to promote beta(2)AR internalization as compared with wild-type arrestin-3. Our data reveal an unprecedented role for SUMOylation in mediating GPCR endocytosis and provide novel mechanistic insight into arrestin function and regulation.	[Marchese, Adriano] Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol, Maywood, IL 60153 USA; [Malik, Rohit; Marchese, Adriano] Loyola Univ Chicago, Stritch Sch Med, Program Mol Biol, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago	Marchese, A (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol, 2160 S 1st Ave,Bldg 101,Rm 2721, Maywood, IL 60153 USA.	amarchese@lumc.edu		Malik, Rohit/0000-0003-4537-3452	National Institutes of Health [GM75159, DA026040]; American Heart Association [0910098G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM75159 and DA026040 (to A. M.). This work was also supported by Predoctoral Fellowship 0910098G from the American Heart Association (to R. M.).	Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mishra RK, 2004, J BIOL CHEM, V279, P31445, DOI 10.1074/jbc.M402911200; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rodriguez-Munoz M, 2007, NEUROPSYCHOPHARMACOL, V32, P842, DOI 10.1038/sj.npp.1301184; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Tang ZS, 2005, J BIOL CHEM, V280, P38153, DOI 10.1074/jbc.M508168200; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	36	34	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3884	3893		10.1074/jbc.M110.152116	http://dx.doi.org/10.1074/jbc.M110.152116			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21118812	hybrid, Green Published			2022-12-25	WOS:000286653200069
J	Busam, RD; Thorsell, AG; Flores, A; Hammarstrom, M; Persson, C; Obrink, B; Hallberg, BM				Busam, Robert D.; Thorsell, Ann-Gerd; Flores, Alex; Hammarstrom, Martin; Persson, Camilla; Obrink, Bjorn; Hallberg, B. Martin			Structural Basis of Tumor Suppressor in Lung Cancer 1 (TSLC1) Binding to Differentially Expressed in Adenocarcinoma of the Lung (DAL-1/4.1B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION-MOLECULE; CRYSTAL-STRUCTURE; PROTEIN 4.1R; FERM DOMAIN; CELL-ADHESION; RECOGNITION; INTERACTS; GENE; TAIL	Perturbed cell adhesion mechanisms are crucial for tumor invasion and metastasis. A cell adhesion protein, TSLC1 (tumor suppressor in lung cancer 1), is inactivated in a majority of metastatic cancers. DAL-1 (differentially expressed in adenocarcinoma of the lung protein), another tumor suppressor, binds through its FERM domain to the TSLC1 C-terminal, 4.1 glycophorin C-like, cytoplasmic domain. However, the molecular basis for this interaction is unknown. Here, we describe the crystal structure of a complex between the DAL-1 FERM domain and a portion of the TSLC1 cytoplasmic domain. DAL-1 binds to TSLC1 through conserved residues in a well defined hydrophobic pocket in the structural C-lobe of the DAL-1 FERM domain. From the crystal structure, it is apparent that Tyr(406) and Thr(408) in the TSLC1 cytoplasmic domain form the most important interactions with DAL-1, and this was also confirmed by surface plasmon resonance studies. Our results refute earlier exon deletion experiments that indicated that glycophorin C interacts with the alpha-lobe of 4.1 FERM domains.	[Busam, Robert D.; Thorsell, Ann-Gerd; Flores, Alex; Hammarstrom, Martin; Persson, Camilla] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, SE-17177 Stockholm, Sweden; [Obrink, Bjorn; Hallberg, B. Martin] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet		Martin.Hallberg@ki.se	Hallberg, B. Martin/C-5361-2009	Hallberg, B. Martin/0000-0002-6781-0345	Canadian Institutes for Health Research [1097737]; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck and Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Wenner Foundation; Gren Foundation; Swedish Research Council [20073772, 20064211]; Swedish Cancer Foundation [07 0629]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck and Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Wenner Foundation; Gren Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck and Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; Supported by the Wenner-Gren Foundations.; Supported by grants from the Swedish Research Council (Grant 20073772) and the Swedish Cancer Foundation (Grant 07 0629). Junior Research Fellow of The Swedish Research Council (Grant 20064211).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Bernkopf DB, 2008, EXPERT OPIN THER TAR, V12, P845, DOI 10.1517/14728222.12.7.845 ; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Han BG, 2000, NAT STRUCT BIOL, V7, P871; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Kusunoki H, 2009, PROTEINS, V76, P255, DOI 10.1002/prot.22405; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lung HL, 2006, CANCER RES, V66, P9385, DOI 10.1158/0008-5472.CAN-06-0590; Mao XL, 2003, CANCER RES, V63, P7979; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nunomura W, 2000, J BIOL CHEM, V275, P24540, DOI 10.1074/jbc.M002492200; Nunomura W, 2000, J BIOL CHEM, V275, P6360, DOI 10.1074/jbc.275.9.6360; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Surace EI, 2006, J ANDROL, V27, P816, DOI 10.2164/jandrol.106.000398; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; Tran YK, 1999, CANCER RES, V59, P35; Watabe K, 2003, HISTOL HISTOPATHOL, V18, P1321, DOI 10.14670/HH-18.1321; Yageta M, 2002, CANCER RES, V62, P5129; Yu TX, 2002, BIOCHEM J, V365, P783, DOI 10.1042/BJ20020060	45	20	25	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4511	4516		10.1074/jbc.M110.174011	http://dx.doi.org/10.1074/jbc.M110.174011			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131357	hybrid, Green Published			2022-12-25	WOS:000286975700051
J	LaLonde, DP; Bretscher, A				LaLonde, David P.; Bretscher, Anthony			The UBX Protein SAKS1 Negatively Regulates Endoplasmic Reticulum-associated Degradation and p97-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; PEPTIDE-N-GLYCANASE; AAA ATPASE P97/VCP; DEUBIQUITINATING ENZYME; UBIQUITIN; P97; ER; COMPLEX; DOMAIN; POLYUBIQUITIN	Endoplasmic reticulum-associated degradation (ERAD) is an essential quality control process whereby misfolded proteins are exported from the endoplasmic reticulum and degraded by the proteasome in the cytosol. The ATPase p97 acts as an essential component of this process by providing the force needed for retrotranslocation and by serving as a processing station for the substrate once in the cytosol. Proteins containing the ubiquitin regulatory X (UBX) ubiquitin-like domain function as adaptors for p97 through their direct binding with the amino terminus of the ATPase. We demonstrate that the UBX protein SAKS1 is able to act as an adaptor for p97 that negatively modulates ERAD. This requires the ability of SAKS1 to bind both polyubiquitin and p97. Moreover, the association between SAKS1 and p97 is positively regulated by polyubiquitin binding of the UBX protein. SAKS1 also negatively impacts the p97-dependent processing required for degradation of a cytosolic, non-ERAD, substrate. We find SAKS1 is able to protect polyubiquitin from the activity of deubiquitinases, such as ataxin-3, that are necessary for efficient ERAD. Thus, SAKS1 inhibits protein degradation mediated by p97 complexes in the cytosol with a component of the mechanism being the ability to shield polyubiquitin chains from ubiquitin-processing factors.	[LaLonde, David P.; Bretscher, Anthony] Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University	LaLonde, DP (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Weill Inst Cell & Mol Biol, 434 Weill Hall, Ithaca, NY 14853 USA.	DPL36@cornell.edu			National Institutes of Health [GM036652]; NRSA [GM080847]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036652, F32GM080847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM036652 (to A. B.) and NRSA Postdoctoral Fellowship GM080847 (to D. P. L.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Hartmann-Petersen R, 2003, FEBS LETT, V535, P77, DOI 10.1016/S0014-5793(02)03874-7; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Ishibashi T, 2005, J BIOCHEM, V137, P617, DOI 10.1093/jb/mvi074; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; McNeill H, 2004, BIOCHEM J, V384, P391, DOI 10.1042/BJ20041498; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wu-Baer F, 2010, MOL CELL BIOL, V30, P2787, DOI 10.1128/MCB.01056-09; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864	40	25	27	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4892	4901		10.1074/jbc.M110.158030	http://dx.doi.org/10.1074/jbc.M110.158030			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21135095	Green Published, hybrid			2022-12-25	WOS:000286975700085
J	Mengeling, BJ; Phan, TQ; Goodson, ML; Privalsky, ML				Mengeling, Brenda J.; Phan, Theresa Q.; Goodson, Michael L.; Privalsky, Martin L.			Aberrant Corepressor Interactions Implicated in PML-RAR alpha and PLZF-RAR alpha Leukemogenesis Reflect an Altered Recruitment and Release of Specific NCoR and SMRT Splice Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; NUCLEAR HORMONE-RECEPTORS; RETINOIC ACID RECEPTORS; TRANSCRIPTION FACTOR; DNA RECOGNITION; X-RECEPTOR; HELIX 12; BINDING; RXR; REPRESSION	Human acute promyelocytic leukemia is causally linked to chromosomal translocations that generate chimeric retinoic acid receptor-alpha proteins (x-RAR alpha fusions). Wild-type RAR alpha is a transcription factor that binds to the SMRT/NCoR family of corepressors in the absence of hormone but releases from corepressor and binds coactivators in response to retinoic acid. In contrast, the x-RAR alpha fusions are impaired for corepressor release and operate in acute promyelocytic leukemia as dominant-negative inhibitors of wild-type RAR alpha. We report that the two most common x-RAR alpha fusions, PML-RAR alpha and PLZF-RAR alpha, have gained the ability to recognize specific splice variants of SMRT and NCoR that are poorly recognized by RAR alpha. These differences in corepressor specificity between the normal and oncogenic receptors are further magnified in the presence of a retinoid X receptor heteromeric partner. The ability of retinoids to fully release corepressor from PML-RAR alpha differs for the different splice variants, a phenomenon relevant to the requirement for supraphysiological levels of this hormone in differentiation therapy of leukemic cells. We propose that this shift in the specificity of the x-RAR alpha fusions to a novel repertoire of corepressors contributes to the dominant-negative and oncogenic properties of these oncoproteins and helps explain previously paradoxical aspects of their behavior.	[Mengeling, Brenda J.; Phan, Theresa Q.; Goodson, Michael L.; Privalsky, Martin L.] Univ Calif Davis, Dept Microbiol, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Privalsky, ML (corresponding author), Univ Calif Davis, Dept Microbiol, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	mlprivalsky@ucdavis.edu	Goodson, Michael L/G-4175-2010	Goodson, Michael/0000-0002-3464-490X	National Institutes of Health [RO1DK53528]; National Institute of General Medical Sciences [T32-GM007377]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK53528.; Supported in part by Public Health Service Predoctoral Training Award T32-GM007377 from the National Institute of General Medical Sciences.	ALLENBY G, 1994, J BIOL CHEM, V269, P16689; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; Cohen RN, 2000, MOL ENDOCRINOL, V14, P900, DOI 10.1210/me.14.6.900; Collins SJ, 2008, CURR OPIN HEMATOL, V15, P346, DOI 10.1097/MOH.0b013e3283007edf; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Farboud B, 2003, MOL CELL BIOL, V23, P2844, DOI 10.1128/MCB.23.8.2844-2858.2003; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Goodson ML, 2005, J BIOL CHEM, V280, P7493, DOI 10.1074/jbc.M411514200; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Guidez F, 1998, BLOOD, V91, P2634, DOI 10.1182/blood.V91.8.2634.2634_2634_2642; Hauksdottir H, 2001, CELL GROWTH DIFFER, V12, P85; Hong SH, 2001, MOL CELL BIOL, V21, P7172, DOI 10.1128/MCB.21.21.7172-7182.2001; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Jonas BA, 2007, MOL ENDOCRINOL, V21, P1924, DOI 10.1210/me.2007-0035; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kamashev D, 2004, J EXP MED, V199, P1163, DOI 10.1084/jem.20032226; Kogan SC, 2000, BLOOD, V95, P1541, DOI 10.1182/blood.V95.5.1541.005k28_1541_1550; Kwok C, 2006, CANCER CELL, V9, P95, DOI 10.1016/j.ccr.2006.01.005; LANOTTE M, 1991, BLOOD, V77, P1080; Lazar Mitchell A, 2003, Nucl Recept Signal, V1, pe001; Lin BC, 1997, J BIOL CHEM, V272, P9860; Lin RJ, 2000, MOL CELL, V5, P821, DOI 10.1016/S1097-2765(00)80322-6; Malartre M, 2004, NUCLEIC ACIDS RES, V32, P4676, DOI 10.1093/nar/gkh786; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Mengeling BJ, 2008, MOL CELL ENDOCRINOL, V280, P47, DOI 10.1016/j.mce.2007.09.011; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Nasr R, 2009, CLIN CANCER RES, V15, P6321, DOI 10.1158/1078-0432.CCR-09-0209; Ordentlich P, 2001, CURR TOP MICROBIOL, V254, P101; PEREZ A, 1993, EMBO J, V12, P3171, DOI 10.1002/j.1460-2075.1993.tb05986.x; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Phan TQ, 2010, MOL CELL ENDOCRINOL, V319, P88, DOI 10.1016/j.mce.2009.11.010; Privalsky M. L, 2008, NR COREGULATORS HUMA, P243; Redner RL, 2002, LEUKEMIA, V16, P1927, DOI 10.1038/sj.leu.2402720; Rosen MD, 2009, MOL ENDOCRINOL, V23, P1183, DOI 10.1210/me.2009-0126; Short S, 2005, BIOCHEM BIOPH RES CO, V334, P845, DOI 10.1016/j.bbrc.2005.06.175; Sternsdorf T, 2006, CANCER CELL, V9, P81, DOI 10.1016/j.ccr.2005.12.030; Sutanto MM, 2006, MOL CELL ENDOCRINOL, V259, P43, DOI 10.1016/j.mce.2006.08.004; Wang KK, 2010, CANCER CELL, V17, P186, DOI 10.1016/j.ccr.2009.12.045; Wong CW, 1998, MOL CELL BIOL, V18, P5724, DOI 10.1128/MCB.18.10.5724; XIAO JH, 1995, J BIOL CHEM, V270, P3001, DOI 10.1074/jbc.270.7.3001; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zhang JS, 1999, MOL CELL BIOL, V19, P6448; Zhou J, 2006, P NATL ACAD SCI USA, V103, P9238, DOI 10.1073/pnas.0603324103; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	48	21	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4236	4247		10.1074/jbc.M110.200964	http://dx.doi.org/10.1074/jbc.M110.200964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131350	Green Published, hybrid			2022-12-25	WOS:000286975700022
J	Shpilman, M; Niv-Spector, L; Katz, M; Varol, C; Solomon, G; Ayalon-Soffer, M; Boder, E; Halpern, Z; Elinav, E; Gertler, A				Shpilman, Michal; Niv-Spector, Leonora; Katz, Meirav; Varol, Chen; Solomon, Gili; Ayalon-Soffer, Michal; Boder, Eric; Halpern, Zamir; Elinav, Eran; Gertler, Arieh			Development and Characterization of High Affinity Leptins and Leptin Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE RECEPTOR ANTAGONISTS; LARGE-SCALE PREPARATION; YEAST SURFACE DISPLAY; BINDING-SITE-III; GROWTH-HORMONE; BREAST-CANCER; RECOMBINANT HUMAN; OVINE; EXPRESSION; CELLS	Leptin is a pleiotropic hormone acting both centrally and peripherally. It participates in a variety of biological processes, including energy metabolism, reproduction, and modulation of the immune response. So far, structural elements affecting leptin binding to its receptor remain unknown. We employed random mutagenesis of leptin, followed by selection of high affinity mutants by yeast surface display and discovered that replacing residue Asp-23 with a non-negatively charged amino acid leads to dramatically enhanced affinity of leptin for its soluble receptor. Rational mutagenesis of Asp-23 revealed the D23L substitution to be most effective. Coupling the Asp-23 mutation with alanine mutagenesis of three amino acids (L39A/D40A/F41A) previously reported to convert leptin into antagonist resulted in potent antagonistic activity. These novel superactive mouse and human leptin antagonists (D23L/L39A/D40A/F41A), termed SMLA and SHLA, respectively, exhibited over 60-fold increased binding to leptin receptor and 14-fold higher antagonistic activity in vitro relative to the L39A/D40A/F41A mutants. To prolong and enhance in vivo activity, SMLA and SHLA were monopegylated mainly at the N terminus. Administration of the pegylated SMLA to mice resulted in a remarkably rapid, significant, and reversible 27-fold more potent increase in body weight (as compared with pegylated mouse leptin antagonist), because of increased food consumption. Thus, recognition and mutagenesis of Asp-23 enabled construction of novel compounds that induce potent and reversible central and peripheral leptin deficiency. In addition to enhancing our understanding of leptin interactions with its receptor, these antagonists enable in vivo study of the role of leptin in metabolic and immune processes and hold potential for future therapeutic use in disease pathologies involving leptin.	[Gertler, Arieh] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel; [Katz, Meirav; Varol, Chen; Halpern, Zamir; Elinav, Eran] Tel Aviv Univ, Res Ctr Digest Tract & Liver Dis, Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel; [Katz, Meirav; Varol, Chen; Halpern, Zamir; Elinav, Eran] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel; [Ayalon-Soffer, Michal] Bioline Innovat, IL-91450 Jerusalem, Israel; [Boder, Eric] Univ Tennessee, Dept Chem & Biomol Engn, Knoxville, TN 37996 USA	Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Tennessee System; University of Tennessee Knoxville	Gertler, A (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food Sci & Nutr, POB 12, IL-76100 Rehovot, Israel.	gertler@agri.huji.ac.il	Elinav, Eran/ABE-8881-2020; Varol, Chen/ABH-6487-2020; Boder, Eric T./E-9635-2015; Elinav, Eran/C-8077-2011; Varol, Chen/AAW-4202-2021	Elinav, Eran/0000-0002-5775-2110; Boder, Eric T./0000-0003-4095-5680; 	Israel Science Foundation [521/07]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation Grant 521/07 (to A. G. and E. E.).	Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Choi JH, 2004, J CLIN ENDOCR METAB, V89, P5508, DOI 10.1210/jc.2004-0044; Elinav E., 2009, LEPTIN LEPTIN ANTAGO, P133; Elinav E, 2009, HEPATOLOGY, V49, P278, DOI 10.1002/hep.22584; Elinav E, 2009, ENDOCRINOLOGY, V150, P3083, DOI 10.1210/en.2008-1706; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Frankenberry KA, 2006, INT J ONCOL, V28, P985; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gertler A, 1998, FEBS LETT, V422, P137, DOI 10.1016/S0014-5793(97)01613-X; Gertler A, 1996, J BIOL CHEM, V271, P24482, DOI 10.1074/jbc.271.40.24482; Gertler A, 2007, NAT MED, V13, P18, DOI 10.1038/nm0107-18; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Holness MJ, 1999, MOL CELL ENDOCRINOL, V157, P11, DOI 10.1016/S0303-7207(99)00126-4; Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386; Karmiris K, 2008, MOL NUTR FOOD RES, V52, P855, DOI 10.1002/mnfr.200700050; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; MEILHOC E, 1990, BIO-TECHNOL, V8, P223, DOI 10.1038/nbt0390-223; Muller AF, 2004, J CLIN ENDOCR METAB, V89, P1503, DOI 10.1210/jc.2002-022049; Niv-Spector L, 2005, BIOCHEM J, V391, P221, DOI 10.1042/BJ20050457; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Raver N, 2002, GEN COMP ENDOCR, V126, P52, DOI 10.1006/gcen.2001.7766; Raver N, 2000, PROTEIN EXPRES PURIF, V19, P30, DOI 10.1006/prep.2000.1202; Ray A, 2010, EXPERT OPIN THER TAR, V14, P443, DOI 10.1517/14728221003716466; Raymond CK, 1999, BIOTECHNIQUES, V26, P134, DOI 10.2144/99261rr02; Salomon G, 2006, PROTEIN EXPRES PURIF, V47, P128, DOI 10.1016/j.pep.2005.09.016; Sandowski Y, 2002, J BIOL CHEM, V277, P46304, DOI 10.1074/jbc.M207556200; Siegmund B, 2002, GASTROENTEROLOGY, V122, pA86; Somasundar P, 2004, J SURG RES, V118, P71, DOI 10.1016/j.jss.2004.01.017; Udagawa J, 2006, ENDOCRINOLOGY, V147, P647, DOI 10.1210/en.2005-0791; van der Lely AJ, 2006, NEUROENDOCRINOLOGY, V83, P264, DOI 10.1159/000095537; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0	40	108	111	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4429	4442		10.1074/jbc.M110.196402	http://dx.doi.org/10.1074/jbc.M110.196402			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21119198	Green Published, hybrid			2022-12-25	WOS:000286975700043
J	Zanotti, S; Smerdel-Ramoya, A; Canalis, E				Zanotti, Stefano; Smerdel-Ramoya, Anna; Canalis, Ernesto			Reciprocal Regulation of Notch and Nuclear Factor of Activated T-cells (NFAT) c1 Transactivation in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; BONE-FORMATION; TRANSCRIPTIONAL REPRESSION; SIGNALING PATHWAYS; CAUSES OSTEOPENIA; RNA INTERFERENCE; QUANTITATIVE PCR; MAMMALIAN-CELLS; PRIMARY TARGET; DIFFERENTIATION	Notch are transmembrane receptors involved in the determination of cell fate. Nuclear factor of activated T-cells (NFAT) c are transcription factors that control cell differentiation and function. We tested whether Notch and NFAT signaling pathways interacted in osteoblastic cells. Notch signaling was induced in ST-2 cells using vectors expressing Notch1 intracellular domain (NICD), and in Rosa(Notch) osteoblastic cells by Cre recombinase-mediated excision of a loxP-flanked STOP cassette cloned between the Rosa26 promoter and NICD. NFATc1 was induced in Rosa(Notch) osteoblastic cells by transducing an adenoviral vector expressing constitutively active NFATc1. Notch inhibited NFAT transactivation and NFATc1 transcription. In ST-2 cells, suppression of NFAT transactivation by Notch was reversed by constitutively active cGMP-dependent protein kinase type II. NFATc1 inhibited the transactivation of Notch target genes, and competed for binding to DNA with the Notch interacting protein Epstein-Barr virus latency C promoter binding factor-1, suppressor of hairless, Lag-1 (CSL). Co-immunoprecipitation and confocal microscopy demonstrated that NFATc1 and CSL interacted. Studies on the effects of NICD and NFATc1 on the differentiation and function of osteoblastic cells demonstrated that NICD and NFATc1 inhibited expression of osteoblast gene markers in Rosa(Notch) osteoblasts, but only NICD suppressed the commitment of bone marrow stromal cells to the osteoblastic lineage. In conclusion, NICD and NFATc1 reciprocally inhibit their signaling pathways, and form a regulatory network to control their activity in osteoblasts.	[Zanotti, Stefano; Smerdel-Ramoya, Anna; Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Zanotti, Stefano; Canalis, Ernesto] Univ Connecticut, Sch Med, Farmington, CT 06030 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Zanotti, S (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	szanotti@stfranciscare.org			NIDDK [DK045227]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK045227 from the NIDDK.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Canalis E, 2005, J Endocrinol Invest, V28, P3; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Chow W, 2008, EXP CELL RES, V314, P2919, DOI 10.1016/j.yexcr.2008.07.010; Cohen TV, 2004, J NEUROCHEM, V90, P1059, DOI 10.1111/j.1471-4159.2004.02564.x; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MCCARTHY TL, 1990, J BIOL CHEM, V265, P15353; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; NELSON JA, 1987, MOL CELL BIOL, V7, P4125, DOI 10.1128/MCB.7.11.4125; NYE JS, 1994, DEVELOPMENT, V120, P2421; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Otsuka E, 1999, AM J PHYSIOL-CELL PH, V277, pC132, DOI 10.1152/ajpcell.1999.277.1.C132; Pan L, 2005, J BIOL CHEM, V280, P20860, DOI 10.1074/jbc.M414618200; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Shen TS, 2007, J PHYSIOL-LONDON, V579, P535, DOI 10.1113/jphysiol.2006.120048; Sokal R. R, 1981, BIOMETRY; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Tang L, 2002, CELL BIOL INT, V26, P75, DOI 10.1006/cbir.2001.0812; Vaandrager AB, 2003, J BIOL CHEM, V278, P28651, DOI 10.1074/jbc.M303699200; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yeo HJ, 2007, J BIOL CHEM, V282, P35318, DOI 10.1074/jbc.M702435200; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09	71	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4576	4588		10.1074/jbc.M110.161893	http://dx.doi.org/10.1074/jbc.M110.161893			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21131365	hybrid, Green Published			2022-12-25	WOS:000286975700058
J	Hao, PL; Ren, Y; Xie, YM				Hao, Piliang; Ren, Yan; Xie, Yongming			An Improved Protocol for N-Glycosylation Analysis of Gel-Separated Sialylated Glycoproteins by MALDI-TOF/TOF	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; SAMPLE PURIFICATION; OLIGOSACCHARIDES; PROTEOMICS; DEGLYCOSYLATION; PROTEINS; GLYCANS; CANCER; TIME; ELECTROPHORESIS	Different glycoforms of some proteins have been identified as differential spots for certain diseases in 2-DE, indicating disease-related glycosylation changes. It is routine to determine the site-specific glycosylation of nonsialylated N-glycoproteins from a single gel spot, but some obstacles still exist in analyzing sialylated glycoproteins due to the lability and higher detection limit of acid glycans in MALDI-TOF/TOF analysis. Thus, we present an improved protocol here. Tryptic glycopeptides were separated and subjected to MALDI-TOF/TOF analysis, resulting in the identification of site-specific glycosylation of high-intensity glycopeptides. Sequential deglycosylation and desialylation were used to improve the identification of glycosylation sites and desialylated glycans. The site-specific glycosylation of large glycopeptides and low-intensity glycopeptides was deduced based on the masses of glycopeptides, deglycosylated peptides and desialylated glycans. By applying it to 2-DE separated human serum, the difference of N-glycosylation was successfully determined for alpha 1-antitrypsin between different gel spots.	[Hao, Piliang; Ren, Yan] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Xie, Yongming] Appl Biosyst Inc China, Shanghai, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Thermo Fisher Scientific; Applied Biosystems	Hao, PL (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China.	hpiliang@163.com			Beijing Institute of Genomics, Chinese Academy of Sciences	Beijing Institute of Genomics, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Research Grant from Beijing Institute of Genomics, Chinese Academy of Sciences. It also received instrumental support from Applied Biosystems Inc. (China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman PS, 2007, ELECTROPHORESIS, V28, P1989, DOI 10.1002/elps.200600629; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Chen CB, 2008, CLIN CHIM ACTA, V398, P48, DOI 10.1016/j.cca.2008.08.001; Chen Y, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-37; Chen Y, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-20; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ghafouri B, 2006, J PROTEOME RES, V5, P330, DOI 10.1021/pr050341h; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Graham DRM, 2008, PROTEOMICS, V8, P4919, DOI 10.1002/pmic.200800608; Hagglund P, 2004, J PROTEOME RES, V3, P556, DOI 10.1021/pr034112b; HARVEY DJ, 1993, RAPID COMMUN MASS SP, V7, P614, DOI 10.1002/rcm.1290070712; Herve F, 1998, J CHROMATOGR B, V715, P111, DOI 10.1016/S0378-4347(98)00085-1; Iijima S, 2000, ELECTROPHORESIS, V21, P753, DOI 10.1002/(SICI)1522-2683(20000301)21:4<753::AID-ELPS753>3.0.CO;2-Y; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P107, DOI 10.1074/mcp.M400068-MCP200; Lee CW, 2007, CLIN CHIM ACTA, V375, P104, DOI 10.1016/j.cca.2006.06.019; Llop E, 2007, PROTEOMICS, V7, P4278, DOI 10.1002/pmic.200700572; Mills PB, 2001, PROTEOMICS, V1, P778, DOI 10.1002/1615-9861(200106)1:6<778::AID-PROT778>3.3.CO;2-8; Morelle W, 2006, PROTEOMICS, V6, P3993, DOI 10.1002/pmic.200600129; MORTEN TA, 2006, AM BIOTECHNOL LAB, P24; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Papac DI, 1996, ANAL CHEM, V68, P3215, DOI 10.1021/ac960324z; Ren Y, 2007, J PROTEOME RES, V6, P2812, DOI 10.1021/pr070047k; Rohrer JS, 1998, GLYCOBIOLOGY, V8, P35, DOI 10.1093/glycob/8.1.35; Sagil D, 2005, PROTEOMICS, V5, P2689, DOI 10.1002/pmic.200401312; Sparbier Katrin, 2005, J Biomol Tech, V16, P407; Stubiger G, 2005, J SEP SCI, V28, P1764, DOI 10.1002/jssc.200500148; Sung HJ, 2008, BMB REP, V41, P615, DOI 10.5483/BMBRep.2008.41.9.615; Uematsu R, 2005, MOL CELL PROTEOMICS, V4, P1977, DOI 10.1074/mcp.M500203-MCP200; Vanderver A, 2005, CLIN CHEM, V51, P2031, DOI 10.1373/clinchem.2005.055053; von Witzendorff D, 2005, GLYCOBIOLOGY, V15, P475, DOI 10.1093/glycob/cwi022; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wuhrer M, 2007, J CHROMATOGR B, V849, P115, DOI 10.1016/j.jchromb.2006.09.041; Zhang XM, 2007, PROTEOMICS, V7, P2340, DOI 10.1002/pmic.200600184	35	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15096	10.1371/journal.pone.0015096	http://dx.doi.org/10.1371/journal.pone.0015096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124746	Green Published, Green Submitted, gold			2022-12-25	WOS:000284686500038
J	Songhet, P; Barthel, M; Rohn, TA; Van Maele, L; Cayet, D; Sirard, JC; Bachmann, M; Kopf, M; Hardt, WD				Songhet, Pascal; Barthel, Manja; Roehn, Till A.; Van Maele, Laurye; Cayet, Delphine; Sirard, Jean-Claude; Bachmann, Martin; Kopf, Manfred; Hardt, Wolf-Dietrich			IL-17A/F-Signaling Does Not Contribute to the Initial Phase of Mucosal Inflammation Triggered by S. Typhimurium	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; COLONY-STIMULATING FACTOR; SEROVAR TYPHIMURIUM; IL-17 RECEPTOR; NEUTROPHIL RECRUITMENT; KLEBSIELLA-PNEUMONIAE; AIRWAY INFLAMMATION; CUTTING EDGE; HOST-DEFENSE; MOUSE MODEL	Salmonella enterica subspecies 1 serovar Typhimurium ( S. Typhimurium) causes diarrhea and acute inflammation of the intestinal mucosa. The pro-inflammatory cytokines IL-17A and IL-17F are strongly induced in the infected mucosa but their contribution in driving the tissue inflammation is not understood. We have used the streptomycin mouse model to analyze the role of IL-17A and IL-17F and their cognate receptor IL-17RA in S. Typhimurium enterocolitis. Neutralization of IL-17A and IL-17F did not affect mucosal inflammation triggered by infection or spread of S. Typhimurium to systemic sites by 48 h p.i. Similarly, Il17ra(-/-) mice did not display any reduction in infection or inflammation by 12 h p.i. The same results were obtained using S. Typhimurium variants infecting via the TTSS1 type III secretion system, the TTSS1 effector SipA or the TTSS1 effector SopE. Moreover, the expression pattern of 45 genes encoding chemokines/cytokines (including CXCL1, CXCL2, IL-17A, IL-17F, IL-1 alpha, IL-1 beta, IFN gamma, CXCL-10, CXCL-9, IL-6, CCL3, CCL4) and antibacterial molecules was not affected by Il17ra deficiency by 12 h p.i. Thus, in spite of the strong increase in Il17a/Il17f mRNA in the infected mucosa, IL-17RA signaling seems to be dispensable for eliciting the acute disease. Future work will have to address whether this is attributable to redundancy in the cytokine signaling network.	[Songhet, Pascal; Barthel, Manja; Hardt, Wolf-Dietrich] Swiss Fed Inst Technol, Inst Microbiol, D BIOL, Zurich, Switzerland; [Roehn, Till A.; Bachmann, Martin] Cytos Biotechnol AG, Schlieren, Switzerland; [Van Maele, Laurye; Cayet, Delphine; Sirard, Jean-Claude] Univ Lille Nord France, CNRS, Inst Pasteur Lille,Ctr Infect & Immun Lille,U1019, Inst Natl St & Rech Med,UMR 8204, Lille, France; [Kopf, Manfred] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Swiss Federal Institutes of Technology Domain; ETH Zurich	Songhet, P (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, D BIOL, Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Van Maele, Laurye/ABD-3375-2020; Sirard, Jean-Claude/B-5932-2011; Van Maele, Laurye/P-2882-2017; Kopf, Manfred/B-6907-2009	Van Maele, Laurye/0000-0001-9495-5403; Sirard, Jean-Claude/0000-0001-9854-4652; Van Maele, Laurye/0000-0001-9495-5403; Kopf, Manfred/0000-0002-0628-7140; Hardt, Wolf-Dietrich/0000-0002-9892-6420; CAYET, Delphine/0000-0003-1720-0845	Swiss National Science Foundation [310000-113623/1, 310030-132997/1]; KTI; European Union [INCO-CT-2006-032296]; Cytos Biotechnology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); KTI; European Union(European Commission); Cytos Biotechnology	This work was supported by grants to WDH from the Swiss National Science Foundation (310000-113623/1 and 310030-132997/1), the KTI (to MB and WDH) and a grant to JCS and WDH from the European Union (SavinMucoPath INCO-CT-2006-032296). Funding for the research was also provided by Cytos Biotechnology to MB and TR who are employees of Cytos Biotechnology. However, company policy allows MB and TR to choose and perform their research independently. Thus, the authors would simply like to acknowledge the fact that MB and TR were employed by Cytos Biotechnology and that this funder therefore had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Altmeyer M, 2010, INFECT IMMUN, V78, P3420, DOI 10.1128/IAI.00211-10; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BUONOCORE S, 1923, NATURE, V464, P1371; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; NUNES JS, 2010, VET PATHOL; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Suar M, 2009, INFECT IMMUN, V77, P3569, DOI 10.1128/IAI.00511-09; Uzzau S, 2000, FEMS MICROBIOL LETT, V188, P15, DOI 10.1111/j.1574-6968.2000.tb09161.x; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e13804	10.1371/journal.pone.0013804	http://dx.doi.org/10.1371/journal.pone.0013804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124903	Green Published, Green Submitted, gold			2022-12-25	WOS:000284527900001
J	Flahou, B; Haesebrouck, F; Pasmans, F; D'Herde, K; Driessen, A; Van Deun, K; Smet, A; Duchateau, L; Chiers, K; Ducatelle, R				Flahou, Bram; Haesebrouck, Freddy; Pasmans, Frank; D'Herde, Katharina; Driessen, Ann; Van Deun, Kim; Smet, Annemieke; Duchateau, Luc; Chiers, Koen; Ducatelle, Richard			Helicobacter suis Causes Severe Gastric Pathology in Mouse and Mongolian Gerbil Models of Human Gastric Disease	PLOS ONE			English	Article							LONG-TERM INFECTION; PYLORI INFECTION; LYMPHOID-TISSUE; MALT LYMPHOMA; INFLAMMATORY RESPONSE; HEILMANNII INFECTION; FELIS INFECTION; IMMUNE-RESPONSE; C57BL/6 MICE; MUCOSA	Background: "Helicobacter (H.) heilmannii type 1 is the most prevalent gastric non-H. pylori Helicobacter species in humans suffering from gastric disease. It has been shown to be identical to H. suis, a bacterium which is mainly associated with pigs. To obtain better insights into the long-term pathogenesis of infections with this micro-organism, experimental infections were carried out in different rodent models. Methodology/Principal Findings: Mongolian gerbils and mice of two strains (BALB/c and C57BL/6) were infected with H. suis and sacrificed at 3 weeks, 9 weeks and 8 months after infection. Gastric tissue samples were collected for PCR analysis, histological and ultrastructural examination. In gerbils, bacteria mainly colonized the antrum and a narrow zone in the fundus near the forestomach/stomach transition zone. In both mice strains, bacteria colonized the entire glandular stomach. Colonization with H. suis was associated with necrosis of parietal cells in all three animal strains. From 9 weeks after infection onwards, an increased proliferation rate of mucosal epithelial cells was detected in the stomach regions colonized with H. suis. Most gerbils showed a marked lymphocytic infiltration in the antrum and in the forestomach/stomach transition zone, becoming more pronounced in the course of time. At 8 months post infection, severe destruction of the normal antral architecture at the inflamed sites and development of mucosa-associated lymphoid tissue (MALT) lymphoma-like lesions were observed in some gerbils. In mice, the inflammatory response was less pronounced than in gerbils, consisting mainly of mononuclear cell infiltration and being most severe in the fundus. Conclusions/Significance: H. suis causes death of parietal cells, epithelial cell hyperproliferation and severe inflammation in mice and Mongolian gerbil models of human gastric disease. Moreover, MALT lymphoma-like lesions were induced in H. suis-infected Mongolian gerbils. Therefore, the possible involvement of this micro-organism in human gastric disease should not be neglected.	[Flahou, Bram; Haesebrouck, Freddy; Pasmans, Frank; Van Deun, Kim; Smet, Annemieke; Chiers, Koen; Ducatelle, Richard] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [D'Herde, Katharina] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, B-9000 Ghent, Belgium; [Driessen, Ann] Maastricht Univ, Dept Pathol, Med Ctr, Maastricht, Netherlands; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, Merelbeke, Belgium	Ghent University; Ghent University; Maastricht University; Ghent University	Flahou, B (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	bram.flahou@ugent.be	Driessen, Ann/D-3768-2017; D'Herde, Katharina/AAM-4570-2020; Smet, Annemieke/M-9295-2017; Pasmans, Frank/D-3667-2014; Haesebrouck, Freddy/M-3857-2014	Driessen, Ann/0000-0003-4148-610X; D'Herde, Katharina/0000-0001-6591-0476; Smet, Annemieke/0000-0002-1271-6191; Haesebrouck, Freddy/0000-0002-1709-933X	Ghent University, Ghent, Belgium [GOA01G00408]	Ghent University, Ghent, Belgium(Ghent University)	This study was funded by a grant from the Research Fund of Ghent University, Ghent, Belgium (Grant no. GOA01G00408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Baele M, 2008, INT J SYST EVOL MICR, V58, P1350, DOI 10.1099/ijs.0.65133-0; Baele M, 2009, FEMS IMMUNOL MED MIC, V55, P306, DOI 10.1111/j.1574-695X.2009.00535.x; Cinque SMS, 2006, BRAZ J MED BIOL RES, V39, P253, DOI 10.1590/S0100-879X2006000200012; De Bock M, 2005, J COMP PATHOL, V133, P83, DOI 10.1016/j.jcpa.2005.01.007; De Bock M, 2006, J COMP PATHOL, V135, P226, DOI 10.1016/j.jcpa.2006.08.003; De Groote D, 2005, HELICOBACTER, V10, P398, DOI 10.1111/j.1523-5378.2005.00347.x; De Groote D, 2000, J CLIN MICROBIOL, V38, P1131, DOI 10.1128/JCM.38.3.1131-1135.2000; DEBONGNIE JC, 1995, AM J GASTROENTEROL, V90, P411; Debongnie JC, 1998, EUR J GASTROEN HEPAT, V10, P251, DOI 10.1097/00042737-199803000-00011; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; ENNO A, 1995, AM J PATHOL, V147, P217; Ferrero RL, 2000, J PATHOL, V191, P333; Ferrero RL, 2005, MOL IMMUNOL, V42, P879, DOI 10.1016/j.molimm.2004.12.001; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Flahou B, 2010, HELICOBACTER, V15, P67, DOI 10.1111/j.1523-5378.2009.00736.x; Haesebrouck F, 2009, CLIN MICROBIOL REV, V22, P202, DOI 10.1128/CMR.00041-08; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; MARSHALL BJ, 1984, LANCET, V1, P1311; Meyer F, 2000, INFECT IMMUN, V68, P6265, DOI 10.1128/IAI.68.11.6265-6272.2000; Mobley HL, 2001, HELICOBACTER PYLORI; Mohammadi M, 1996, INFECT IMMUN, V64, P238, DOI 10.1128/IAI.64.1.238-245.1996; MORGNER A, 1995, LANCET, V346, P511, DOI 10.1016/S0140-6736(95)91364-5; Morgner A, 2000, GASTROENTEROLOGY, V118, P821, DOI 10.1016/S0016-5085(00)70167-3; MOURA SB, 1993, J MED MICROBIOL, V39, P64, DOI 10.1099/00222615-39-1-64; Mueller R, 1997, LAB INVEST, V76, P117; Nakamura M, 2007, INFECT IMMUN, V75, P1214, DOI 10.1128/IAI.01459-06; Nishikawa K, 2007, FEMS IMMUNOL MED MIC, V50, P268, DOI 10.1111/j.1574-695X.2007.00252.x; O'Rourke JL, 2004, J PATHOL, V203, P896, DOI 10.1002/path.1593; O'Rourke JL, 2003, MICROBES INFECT, V5, P741, DOI 10.1016/S1286-4579(03)00123-0; O'Rourke JL, 2004, INT J SYST EVOL MICR, V54, P2203, DOI 10.1099/ijs.0.63117-0; Park JH, 2003, J COMP PATHOL, V129, P154, DOI 10.1016/S0021-9975(03)00024-0; Park JH, 2008, J COMP PATHOL, V139, P208, DOI 10.1016/j.jcpa.2008.04.005; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peterson RA, 2001, VET PATHOL, V38, P173, DOI 10.1354/vp.38-2-173; Rogers AB, 2004, AM J PHYSIOL-GASTR L, V286, pG361, DOI 10.1152/ajpgi.00499.2003; Sakagami T, 1996, GUT, V39, P639, DOI 10.1136/gut.39.5.639; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Shirin H, 1998, GUT, V43, P592, DOI 10.1136/gut.43.5.592; Stolte M, 1997, SCAND J GASTROENTERO, V32, P28, DOI 10.3109/00365529709025059; Stolte M, 2002, GUT, V50, P19, DOI 10.1136/gut.50.suppl_3.iii19; Van den Bulck K, 2005, J CLIN MICROBIOL, V43, P2256, DOI 10.1128/JCM.43.5.2256-2260.2005; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008	45	44	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14083	10.1371/journal.pone.0014083	http://dx.doi.org/10.1371/journal.pone.0014083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124878	Green Published, gold, Green Submitted			2022-12-25	WOS:000284467200014
J	Kim, JH; Yoon, S; Park, M; Park, HO; Ko, JJ; Lee, K; Bae, J				Kim, J-H; Yoon, S.; Park, M.; Park, H-O; Ko, J-J; Lee, K.; Bae, J.			Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W)	ONCOGENE			English	Article						FOXL2; granulosa cell tumor; apoptosis; caspase; BAK; death receptors	OUTER-MEMBRANE PERMEABILIZATION; DEATH RECEPTORS; CYTOCHROME-C; MYELOID-LEUKEMIA; OVARY; COMPLEX; BAX; TRANSCRIPTION; ACTIVATION; REPRESSES	Some mutations in FOXL2 result in premature ovarian failure accompanied by blepharophimosis, ptosis, epicanthus inversus syndrome type I disease, and FOXL2-null mice exhibit developmental defects in granulosa cells. Recently, FOXL2 c.402C>G, a new somatic mutation that leads to a p. C134W change, was found in the majority of adult-type ovarian granulosa cell tumors (GCTs). In this study, we investigated the possible mechanisms by which the C134W mutation contributes to the development of GCTs. Wild-type (WT) and mutant FOXL2 displayed differential apoptotic activities. Specifically, WT FOXL2 induced significant granulosa cell death, but the mutant exhibited minimal cell death. The FOXL2-induced apoptotic response was greatly dependent on caspase 8, BID and BAK because the depletion of any of these three proteins inhibited FOXL2 from eliciting the full apoptotic response. Activation of caspase 8 and subsequent increased production of truncated BID, and oligomerization of BAK, and release of cytochrome c were all associated with the apoptosis induced by WT FOXL2 expression. In contrast, the mutant FOXL2 was unable to elicit the full array of apoptotic signaling responses. In addition, we found differential TNF-R1 (tumor necrosis factor-receptor 1) and Fas (CD95/APO-1) upregulation between the WT and the mutant, and the silencing of TNF-R1 or Fas and the blockage of the death signaling mediated by TNF-R1 or Fas using TNF-Fc or Fas-Fc, respectively, resulted in significant attenuations of FOXL2-induced apoptosis. Moreover, granulosa cells that expressed either WT FOXL2 or mutant exhibited distinct cell death sensitivities on activation of death receptors and deprivation of serum. Thus, the differential activities of FOXL2 and its mutant may partially account for the pathophysiology of GCT development. Oncogene (2011) 30, 1653-1663; doi:10.1038/onc.2010.541; published online 29 November 2010	[Kim, J-H; Yoon, S.; Park, M.; Park, H-O; Ko, J-J; Bae, J.] CHA Univ, Coll Life Sci, Dept Biomed Sci, Songnam 463836, South Korea; [Lee, K.] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea	Pochon Cha University; Chung Ang University	Bae, J (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, 222 Yatap Dong, Songnam 463836, South Korea.	jeehyeon@cha.ac.kr			National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology [2009-0066320, 2009-0093821]; Ministry of Health, Welfare and Family Affairs [A084923]	National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology(National Research Foundation of Korea); Ministry of Health, Welfare and Family Affairs(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Basic Science Research Program (2009-0066320) and the Priority Research Centers Program (2009-0093821) through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology and by a grant (A084923) from the Korea Healthcare Technology R&D Project from the Ministry of Health, Welfare and Family Affairs.	Arnoult D, 2008, METHODS, V44, P229, DOI 10.1016/j.ymeth.2007.11.003; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Ganju N, 2003, CELL DEATH DIFFER, V10, P652, DOI 10.1038/sj.cdd.4401234; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hail N, 2005, APOPTOSIS, V10, P687, DOI 10.1007/s10495-005-0792-8; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Kang BPS, 2003, AM J PHYSIOL-RENAL, V284, pF455, DOI 10.1152/ajprenal.00137.2002; Kim MS, 2010, J PATHOL, V221, P147, DOI 10.1002/path.2688; Kornblau SM, 2010, CLIN CANCER RES, V16, P1865, DOI 10.1158/1078-0432.CCR-09-2551; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LI P, 2004, CELL, V116, P57; Mahmood Z, 2010, EXP CELL RES, V316, P887, DOI 10.1016/j.yexcr.2009.12.011; Muzio M, 1998, INT J CLIN LAB RES, V28, P141, DOI 10.1007/s005990050035; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park M, 2010, MOL ENDOCRINOL, V24, P1024, DOI 10.1210/me.2009-0375; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Wei MC, 2000, GENE DEV, V14, P2060; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	35	78	81	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2011	30	14					1653	1663		10.1038/onc.2010.541	http://dx.doi.org/10.1038/onc.2010.541			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	746IS	21119601				2022-12-25	WOS:000289239400004
J	Lin, CT; Datta, V; Okwan-Duodu, D; Chen, X; Fuchs, S; Alsabeh, R; Billet, S; Bernstein, KE; Shen, XZ				Lin, Chentao; Datta, Vivekanand; Okwan-Duodu, Derick; Chen, Xu; Fuchs, Sebastien; Alsabeh, Randa; Billet, Sandrine; Bernstein, Kenneth E.; Shen, Xiao Z.			Angiotensin-converting enzyme is required for normal myelopoiesis	FASEB JOURNAL			English	Article						myeloid proliferation; myelodifferentiation; substance P	HEMATOPOIETIC STEM-CELLS; SUBSTANCE-P; BONE-MARROW; DEFICIENT MICE; UP-REGULATION; II RECEPTOR; 1A RECEPTOR; EXPRESSION; SYSTEM; PROLIFERATION	Inhibition of angiotensin-converting enzyme (ACE) induces anemia in humans and mice, but it is unclear whether ACE is involved in other aspects of hematopoiesis. Here, we systemically evaluated ACE-knockout (KO) mice and found myelopoietic abnormalities characterized by increased bone marrow myeloblasts and myelocytes, as well as extramedullary myelopoiesis. Peritoneal macrophages from ACE-KO mice were deficient in the production of effector molecules, such as tumor necrosis factor-alpha, interleukin-12p40, and CD86 when stimulated with lipopolysaccharide and interferon-gamma. ACE-KO mice were more susceptible to Staphylococcus aureus infection. Further studies using total or fractionated bone marrows revealed that ACE regulates myeloid proliferation, differentiation, and functional maturation via angiotensin II and substance P and through the angiotensin II receptor type 1 and substance P neurokinin 1 receptors. Angiotensin II was correlated with CCAAT-enhancer-binding protein-alpha up-regulation during myelopoiesis. Angiotensin II supplementation of ACE-KO mice rescued macrophage functional maturation. These results demonstrate a previous unrecognized significant role for ACE in myelopoiesis and imply new perspectives for manipulating myeloid cell expansion and maturation.-Lin, C., Datta, V., Okwan-Duodu, D., Chen, X., Fuchs, S., Alsabeh, R., Billet, S., Bernstein, K. E., Shen, X. Z. Angiotensin-converting enzyme is required for normal myelopoiesis. FASEB J. 25, 1145-1155 (2011). www.fasebj.org	[Lin, Chentao; Okwan-Duodu, Derick; Chen, Xu; Fuchs, Sebastien; Billet, Sandrine; Bernstein, Kenneth E.; Shen, Xiao Z.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Datta, Vivekanand; Fuchs, Sebastien; Alsabeh, Randa; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Okwan-Duodu, Derick] Emory Univ, Sch Med, Atlanta, GA USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Emory University	Shen, XZ (corresponding author), 8700 Beverly Blvd,Davis Bldg 2019, Los Angeles, CA 90048 USA.	xiao.shen@cshs.org		Bernstein, Kenneth/0000-0001-8097-3272	U.S. National Institutes of Health [R01 DK-039777, R01 DK-051445]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051445, R01DK039777] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Kenneth Dorshkind (University of California, Los Angeles, CA, USA) for the S17 cell line, Ellan Bernstein for animal husbandry, and Patricia Lin for cell sorting. This work was supported by U.S. National Institutes of Health grants R01 DK-039777 and R01 DK-051445 (to K. E. Bernstein). The authors have no financial conflicts of interest.	Aksu S, 2006, LEUKEMIA LYMPHOMA, V47, P891, DOI 10.1080/10428190500399250; Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; Billet S, 2007, J CLIN INVEST, V117, P1914, DOI 10.1172/JCI28764; BONNET D, 1992, EXP HEMATOL, V20, P1165; Bramucci M, 1999, BIOCHEM MOL BIOL INT, V47, P107; Charrier S, 2004, BLOOD, V104, P978, DOI 10.1182/blood-2003-11-3828; Cole J, 2000, J CLIN INVEST, V106, P1391, DOI 10.1172/JCI10557; CORVOL P, 1995, METHOD ENZYMOL, V248, P283; Davies John Q, 2005, Methods Mol Biol, V290, P91; De Giorgio R, 1998, J NEUROIMMUNOL, V82, P175, DOI 10.1016/S0165-5728(97)00201-4; Esther CR, 1996, LAB INVEST, V74, P953; Garcia GE, 2010, AM J PHYSIOL-RENAL, V298, pF868, DOI 10.1152/ajprenal.00041.2010; GREENO EW, 1993, J EXP MED, V177, P1269, DOI 10.1084/jem.177.5.1269; GRIFFING GT, 1982, LANCET, V1, P1361; Haznedaroglu IC, 2003, INT J BIOCHEM CELL B, V35, P867, DOI 10.1016/S1357-2725(02)00278-9; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jokubaitis VJ, 2008, BLOOD, V111, P4055, DOI 10.1182/blood-2007-05-091710; Kato H, 2005, FASEB J, V19, P2023, DOI 10.1096/fj.05-3820fje; Mrug M, 1997, J CLIN INVEST, V100, P2310, DOI 10.1172/JCI119769; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nowicki M, 2007, J CLIN PATHOL, V60, P749, DOI 10.1136/jcp.2006.041475; Park TS, 2009, HAEMATOL-HEMATOL J, V94, P745, DOI 10.3324/haematol.2009.006965; PASCUAL DW, 1990, IMMUNOLOGY, V71, P52; PRATT MC, 1992, BRIT J CLIN PHARMACO, V34, P363, DOI 10.1111/j.1365-2125.1992.tb05644.x; RAMESHWAR P, 1993, BLOOD, V81, P391; RAMESHWAR P, 1995, BLOOD, V86, P482, DOI 10.1182/blood.V86.2.482.bloodjournal862482; Re RN, 2001, CURR OPIN CARDIOL, V16, P317, DOI 10.1097/00001573-200111000-00002; Riviere G, 2007, GENE, V399, P81, DOI 10.1016/j.gene.2007.05.010; Rodgers K, 2003, CANCER CHEMOTH PHARM, V51, P97, DOI 10.1007/s00280-002-0509-4; Rodgers KE, 2000, STEM CELLS, V18, P287, DOI 10.1634/stemcells.18-4-287; Rousseau-Plasse A, 1998, EXP HEMATOL, V26, P1074; Scholzen TE, 2004, EXP DERMATOL, V13, P22, DOI 10.1111/j.1600-0625.2004.00260.x; Shen XZ, 2008, J BIOL CHEM, V283, P9957, DOI 10.1074/jbc.M709574200; Strawn WB, 2004, BRIT J HAEMATOL, V126, P120, DOI 10.1111/j.1365-2141.2004.04998.x; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Tsubakimoto Y, 2009, ARTERIOSCL THROM VAS, V29, P1529, DOI 10.1161/ATVBAHA.109.187732; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Zambidis ET, 2008, BLOOD, V112, P3601, DOI 10.1182/blood-2008-03-144766; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 1998, J EXP MED, V188, P1173, DOI 10.1084/jem.188.6.1173	41	45	47	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1145	1155		10.1096/fj.10-169433	http://dx.doi.org/10.1096/fj.10-169433			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21148418	Green Published			2022-12-25	WOS:000288982800004
J	Amengual, J; Lobo, GP; Golczak, M; Li, HNM; Klimova, T; Hoppel, CL; Wyss, A; Palczewski, K; von Lintig, J				Amengual, Jaume; Lobo, Glenn P.; Golczak, Marcin; Li, Hua Nan M.; Klimova, Tatyana; Hoppel, Charles L.; Wyss, Adrian; Palczewski, Krzysztof; von Lintig, Johannes			A mitochondrial enzyme degrades carotenoids and protects against oxidative stress	FASEB JOURNAL			English	Article						carotenoid-oxygenases; apocarotenoids; respiration; reactive oxygen species	VITAMIN-A PRODUCTION; BETA-CAROTENE; RETINOID ISOMERASE; GENE-EXPRESSION; PLASMA KINETICS; VISUAL CYCLE; IDENTIFICATION; ZEAXANTHIN; OXYGENASE; 15,15-MONOOXYGENASE	Carotenoids are the precursors for vitamin A and are proposed to prevent oxidative damage to cells. Mammalian genomes encode a family of structurally related nonheme iron oxygenases that modify double bonds of these compounds by oxidative cleavage and cis-to-trans isomerization. The roles of the family members BCMO1 and RPE65 for vitamin A production and vision have been well established. Surprisingly, we found that the third family member, beta,beta-carotene-9',10'-oxygenase (BCDO2), is a mitochondrial carotenoid-oxygenase with broad substrate specificity. In BCDO2-deficient mice, carotenoid homeostasis was abrogated, and carotenoids accumulated in several tissues. In hepatic mitochondria, accumulated carotenoids induced key markers of mitochondrial dysfunction, such as manganese superoxide dismutase (9-fold), and reduced rates of ADP-dependent respiration by 30%. This impairment was associated with an 8- to 9-fold induction of phosphor-MAP kinase and phosphor-AKT, markers of cell signaling pathways related to oxidative stress and disease. Administration of carotenoids to human HepG2 cells depolarized mitochondrial membranes and resulted in the production of reactive oxygen species. Thus, our studies in BCDO2-deficient mice and human cell cultures indicate that carotenoids can impair respiration and induce oxidative stress. Mammalian cells thus express a mitochondrial carotenoid-oxygenase that degrades carotenoids to protect these vital organelles.-Amengual, J., Lobo, G. P., Golczak, M., Li, H. N. M., Klimova, T., Hoppel, C. L., Wyss, A., Palczewski, K., von Lintig, J. A mitochondrial enzyme degrades carotenoids and protects against oxidative stress. FASEB J. 25, 948-959 (2011). www.fasebj.org	[Amengual, Jaume; Lobo, Glenn P.; Golczak, Marcin; Li, Hua Nan M.; Klimova, Tatyana; Hoppel, Charles L.; Palczewski, Krzysztof; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol W333, Cleveland, OH 44160 USA; [Wyss, Adrian] DSM Nutr Prod Ltd, Res & Dev, Human Nutr & Hlth, Basel, Switzerland	Case Western Reserve University; DSM NV	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol W333, 10900 Euclid Ave, Cleveland, OH 44160 USA.	johannes.vonlintig@case.edu	Lobo, Glenn P./AAI-9736-2020	von Lintig, Johannes/0000-0002-2079-2143	U.S. National Institute of Health [EY019641, EY009339, P30 EY11373]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373, R01EY019641] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Drs. L. T. Webster and M. Maguire for helpful manuscript comments. The authors also thank Catherine Doller (Case Western Reserve University) for performing histological analyses. This work was supported by U.S. National Institute of Health grants EY019641 (to J.V.L.), EY009339, and P30 EY11373, and by a Research to Prevent Blindness grant (to K.P.).	Bernstein PS, 1998, INVEST OPHTH VIS SCI, V39, P2003; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; Bhosale P, 2007, ARCH BIOCHEM BIOPHYS, V458, P121, DOI 10.1016/j.abb.2006.10.005; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; Greenwald Peter, 2003, J Natl Cancer Inst, V95, pE1; Hantz HL, 2005, EXP BIOL MED, V230, P171; Hartmann D, 2004, AM J CLIN NUTR, V79, P410; He MA, 2010, ARTERIOSCL THROM VAS, V30, P885, DOI 10.1161/ATVBAHA.109.199422; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Leung WC, 2009, FASEB J, V23, P1041, DOI 10.1096/fj.08-121962; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lindqvist A, 2005, J HISTOCHEM CYTOCHEM, V53, P1403, DOI 10.1369/jhc.5A6705.2005; Lindqvist A, 2007, J NUTR, V137, P2346, DOI 10.1093/jn/137.11.2346; Liu C, 2000, CARCINOGENESIS, V21, P2245, DOI 10.1093/carcin/21.12.2245; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; Ma Q, 2010, PHARMACOL THERAPEUT, V125, P376, DOI 10.1016/j.pharmthera.2009.11.004; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; Paolini M, 2001, CARCINOGENESIS, V22, P1483, DOI 10.1093/carcin/22.9.1483; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; SNODDERLY DM, 1991, INVEST OPHTH VIS SCI, V32, P268; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Thurmann PA, 2005, AM J CLIN NUTR, V82, P88; Tian R, 2010, ANIM GENET, V41, P253, DOI 10.1111/j.1365-2052.2009.01990.x; VAGE DI, BMC GENET, V11, P10; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975	42	215	220	0	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2011	25	3					948	959		10.1096/fj.10-173906	http://dx.doi.org/10.1096/fj.10-173906			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21106934	Green Published			2022-12-25	WOS:000287806200015
J	Lui, VWY; Yau, DMS; Cheung, CSF; Wong, SCC; Chan, AKC; Zhou, Q; Wong, EL; Lau, CPY; Lam, EKY; Hui, EP; Hong, B; Hui, CWC; Chan, ASK; Ng, PKS; Ng, YK; Lo, KW; Tsang, CM; Tsui, SKW; Tsao, SW; Chan, ATC				Lui, V. W. Y.; Yau, D. M-S; Cheung, C. S-F; Wong, S. C. C.; Chan, A. K-C; Zhou, Q.; Wong, EY-L; Lau, C. P. Y.; Lam, E. K. Y.; Hui, E. P.; Hong, B.; Hui, C. W. C.; Chan, A. S-K; Ng, P. K. S.; Ng, Y-K; Lo, K-W; Tsang, C. M.; Tsui, S. K. W.; Tsao, S-W; Chan, A. T. C.			FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation	ONCOGENE			English	Article						FGF8b; NPC; LMP1; NF-kappa B	INDUCED GROWTH-FACTOR; ANDROGEN RECEPTORS; FGF-8 ISOFORMS; FIBROBLAST-GROWTH-FACTOR-8 EXPRESSION; ESOPHAGEAL ADENOCARCINOMA; OVER-EXPRESSION; PROSTATE-CANCER; PROGRESSION; ACTIVATION; SURVIVAL	The fibroblast growth factor 8b (FGF8b) oncogene is known to be primarily involved in the tumorigenesis and progression of hormone-related cancers. Its role in other epithelial cancers has not been investigated, except for esophageal cancer, in which FGF8b overexpression was mainly found in tumor biopsies of male patients. These observations were consistent with previous findings in these cancer types that the male sex-hormone androgen is responsible for FGF8b expression. Nasopharyngeal carcinoma (NPC) is a highly metastatic cancer of head and neck commonly found in Asia. It is etiologically associated with Epstein-Barr Virus (EBV) infection, inflammatory tumor microenvironment and relatively higher male predominance. Here, we reported for the first time that FGF8b is overexpressed in this EBV-associated non-hormone-related cancer of the head and neck, NPC. More importantly, overexpression of FGF8b mRNA and protein was detected in a large majority of NPC tumors from both male and female genders, in addition to multiple NPC cell lines. We hypothesized that FGF8b overexpression may contribute to NPC tumorigenesis. Using EBV-associated NPC cell lines, we demonstrated that specific knockdown of FGF8b by small interfering RNA inhibited cell proliferation, migration and invasion, whereas exogenous FGF8b stimulated these multiple phenotypes. Further mechanistic investigation revealed that in addition to NF-kappa B signaling (a major inflammatory signaling pathway known to be activated in NPC), an important EBV oncoprotein, the latent membrane protein 1 (LMP1), was found to be a direct inducer of FGF8b overexpression in NPC cells, whereas androgen (testosterone) has minimal effect on FGF8b expression in EBV-associated NPC cells. In summary, our study has identified LMP1 as the first viral oncogene capable of directly inducing FGF8b (an important cellular oncogene) expression in human cancer cells. This novel mechanism of viral-mediated FGF8 upregulation may implicate a new role of oncoviruses in human carcinogenesis. Oncogene (2011) 30, 1518-1530; doi: 10.1038/onc.2010.529; published online 29 November 2010	[Lui, V. W. Y.; Yau, D. M-S; Cheung, C. S-F; Wong, S. C. C.; Zhou, Q.; Wong, EY-L; Lau, C. P. Y.; Lam, E. K. Y.; Hui, E. P.; Hong, B.; Hui, C. W. C.; Chan, A. S-K; Chan, A. T. C.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, State Key Lab Oncol S China,Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China; [Chan, A. K-C] Queen Elizabeth Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Ng, P. K. S.; Tsui, S. K. W.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Ng, Y-K] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Lo, K-W] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Tsang, C. M.; Tsao, S-W] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Chan, ATC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, State Key Lab Oncol S China,Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China.	vivian@clo.cuhk.edu.hk; anthony@clo.cuhk.edu.hk	Hui, Edwin/ABC-1818-2021; Tsui, Stephen Kwok-Wing/E-4385-2015; Hong, Bo/ABA-3687-2021; Ng, Yuen-Keng/ABC-3906-2020; Lui, Vivian W. Y./I-5458-2016; Chan, Anthony Tak Cheung/R-3940-2018	Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Hong, Bo/0000-0001-8117-5029; Ng, Yuen-Keng/0000-0003-4491-5221; Lui, Vivian W. Y./0000-0001-6918-1573; Chan, Anthony Tak Cheung/0000-0002-6912-8091; Lo, Kwok Wai/0000-0002-3488-6124; WONG, Sze Chuen Cesar/0000-0003-0058-140X	Clinical Oncology, CUHK	Clinical Oncology, CUHK(Chinese University of Hong Kong)	Financial support by research fund, Clinical Oncology, CUHK (VWYL). We thank Drs Q Tao and GT Chung for experimental assistance.	Anderson KE, 2006, CANC EPIDEMIOLOGY PR, P721; Armstrong K, 2006, PROSTATE, V66, P1223, DOI 10.1002/pros.20376; Awan AK, 2007, EJSO-EUR J SURG ONC, V33, P561, DOI 10.1016/j.ejso.2006.12.001; Bhattacharyya N, 2004, AM J OTOLARYNG, V25, P94, DOI 10.1016/j.amjoto.2003.11.005; BLOT WJ, 1993, JAMA-J AM MED ASSOC, V270, P1320, DOI 10.1001/jama.270.11.1320; Blunt AG, 1997, J BIOL CHEM, V272, P3733, DOI 10.1074/jbc.272.6.3733; Castellano I, 2010, BREAST CANCER RES TR, V124, P607, DOI 10.1007/s10549-010-0761-y; Chan ATC, 2002, ANN ONCOL, V13, P1007, DOI 10.1093/annonc/mdf179; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Cui D, 2001, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V15, P202; Daphna-Iken D, 1998, ONCOGENE, V17, P2711, DOI 10.1038/sj.onc.1202212; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Dorkin TJ, 1999, ONCOGENE, V18, P2755, DOI 10.1038/sj.onc.1202624; Gemel J, 1996, GENOMICS, V35, P253, DOI 10.1006/geno.1996.0349; Gnanapragasam V, 2003, BRIT J CANCER, V88, P1432, DOI 10.1038/sj.bjc.6600875; Gnanapragasam VJ, 2002, ONCOGENE, V21, P5069, DOI 10.1038/sj.onc.1205663; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; Hong B, 2009, INVEST NEW DRUGS; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Kuo Wen-Rei, 1994, Journal of the Formosan Medical Association, V93, P569; Leung HY, 1996, ONCOGENE, V12, P1833; Liao Wei, 2001, Zhonghua Zhongliu Zazhi, V23, P199; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; MACARTHUR CA, 1995, CELL GROWTH DIFFER, V6, P817; MACARTHUR CA, 1995, J VIROL, V69, P2501, DOI 10.1128/JVI.69.4.2501-2507.1995; Marsh SK, 1999, ONCOGENE, V18, P1053, DOI 10.1038/sj.onc.1202392; Mattila MA, 2007, CYTOKINE GROWTH F R, V18, P257, DOI 10.1016/j.cytogfr.2007.04.010; Ohshima K, 1998, CANCER LETT, V122, P43, DOI 10.1016/S0304-3835(97)00368-6; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Park S, 2010, ANN ONCOL, V21, P488, DOI 10.1093/annonc/mdp510; Rudra-Ganguly N, 1998, ONCOGENE, V16, P1487, DOI 10.1038/sj.onc.1201652; Ruohola JK, 2001, CANCER RES, V61, P4229; Shi W, 2006, INT J CANCER, V119, P2467, DOI 10.1002/ijc.22107; SKINNER DW, 1991, ANN OTO RHINOL LARYN, V100, P544, DOI 10.1177/000348949110000705; Song ZG, 2000, CANCER RES, V60, P6730; Song ZG, 2002, CANCER RES, V62, P5096; Spano JP, 2003, EUR J CANCER, V39, P2121, DOI 10.1016/S0959-8049(03)00367-8; Tanaka A, 1998, CANCER RES, V58, P2053; TANAKA A, 1995, FEBS LETT, V363, P226, DOI 10.1016/0014-5793(95)00324-3; Tanaka A, 2002, VIRCHOWS ARCH, V441, P380, DOI 10.1007/s00428-002-0687-9; TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928; Tanaka S, 2001, DIGEST DIS SCI, V46, P1016, DOI 10.1023/A:1010753826788; Thaver V, 2009, CELL BIOCHEM FUNCT, V27, P205, DOI 10.1002/cbf.1557; Thornburg NJ, 2003, CANCER RES, V63, P8293; Tsao SW, 2002, SEMIN CANCER BIOL, V12, P473, DOI 10.1016/S1044579X02000901; Tucker AS, 1999, DEVELOPMENT, V126, P51; Valta MP, 2008, INT J CANCER, V123, P22, DOI 10.1002/ijc.23422; Valve EM, 2001, LAB INVEST, V81, P815, DOI 10.1038/labinvest.3780291; Wong JHT, 2010, CANCER LETT, V287, P23, DOI 10.1016/j.canlet.2009.05.022; Wong SCC, 2002, J PATHOL, V196, P145, DOI 10.1002/path.1035; Wong SCC, 2001, J PATHOL, V194, P35, DOI 10.1002/path.838; YAMASHITA Y, 1989, JPN J SURG, V19, P195, DOI 10.1007/BF02471585; Zhong C, 2006, CANCER RES, V66, P2188, DOI 10.1158/0008-5472.CAN-05-3440	60	11	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2011	30	13					1518	1530		10.1038/onc.2010.529	http://dx.doi.org/10.1038/onc.2010.529			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	743DU	21119603				2022-12-25	WOS:000288998300003
J	Schupp, N; Kolkhof, P; Queisser, N; Gartner, S; Schmid, U; Kretschmer, A; Hartmann, E; Oli, RG; Schafer, S; Stopper, H				Schupp, Nicole; Kolkhof, Peter; Queisser, Nina; Gaertner, Sabine; Schmid, Ursula; Kretschmer, Axel; Hartmann, Elke; Oli, Rajaraman G.; Schaefer, Stefan; Stopper, Helga			Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats	FASEB JOURNAL			English	Article						8-oxodG; double-strand breaks; hypertension; oxidative DNA damage; oxidative stress	OXIDATIVE STRESS; IN-VITRO; ARTIFACTUAL OXIDATION; ALDOSTERONE BLOCKADE; CHROMOSOMAL DAMAGE; DOCA/SALT RATS; STRAND BREAKS; RENAL DAMAGE; INJURY; CANCER	Epidemiological studies exploring the connection between hypertension and cancer demonstrate a higher cancer incidence, especially of kidney cancer, and a higher cancer mortality in hypertensive patients. Hormones elevated in hypertension, i.e., aldosterone and angiotensin II, which exert genotoxic effects in vitro, could contribute to carcinogenesis in hypertension. The present study was conducted to investigate the possible DNA-damaging effect of aldosterone receptor activation in vivo. Crl:CD (Sprague-Dawley) rats were treated for 6 wk with desoxycorticosterone acetate (DOCA) and salt to induce a mineralocorticoid-dependent hypertension. DOCA-salt treatment caused increased blood pressure (+26 mmHg) compared to untreated rats, elevated markers of kidney failure (up to 62-fold for Kim-1), and the induction of several proinflammatory genes and proteins (up to 2.6-fold for tissue MCP-1). The mineralocorticoid receptor (MR) antagonist spironolactone (MR IC(50) 24 nM) and the novel nonsteroidal antagonist BR-4628 (MR IC(50) 28 nM) decreased these damage markers. DOCA-salt treatment also caused 8.8-fold increased structural DNA damage, determined with the comet assay, double-strand breaks (3.5-fold), detected immunohistochemically, and oxidative stress. Furthermore, the oxidatively modified mutagenic DNA base 7,8-dihydro-8-oxo-guanine (8-oxodG), quantified by LC-MS/MS, was almost 2-fold higher in DOCA-salt-treated kidneys. Our results suggest a mutagenic potential of high mineralocorticoid levels, frequent in hypertensive individuals.-Schupp, N., Kolkhof, P., Queisser, N., Gartner, S., Schmid, U., Kretschmer, A., Hartmann, E., Oli, R G., Schafer, S., Stopper, H. Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats. FASEB J. 25, 968-978 (2011). www.fasebj.org	[Schupp, Nicole; Queisser, Nina; Gaertner, Sabine; Schmid, Ursula; Oli, Rajaraman G.; Stopper, Helga] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Kolkhof, Peter; Schaefer, Stefan] Bayer Schering Pharma AG, Cardiol Res, Wuppertal, Germany; [Kretschmer, Axel] Bayer Schering Pharma AG, Target Discovery, Wuppertal, Germany; [Hartmann, Elke] Bayer Schering Pharma AG, Inst Toxicol, Global Drug Discovery, Wuppertal, Germany	University of Wurzburg; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Schupp, N (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	nicole.schupp@toxi.uni-wuerzburg.de		Schupp, Nicole/0000-0002-1836-6348	Bayer Schering Pharma AG; Deutsche Forschungsgemeinschaft [SCHU 2367/1-1]	Bayer Schering Pharma AG(Bayer AG); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge the excellent technical assistance of Michaela Wolf, Thomas Budel, Elisabeth Stein, and Maria Scheurich at the Institute of Toxicology, University of Wurzburg, Germany and of Petra Ammelung, Dorota Chodor, Andreas Gotte, and Isabella Hutmacher at Bayer Schering Pharma AG. This work was supported by Bayer Schering Pharma AG and by the Deutsche Forschungsgemeinschaft (grant SCHU 2367/1-1). P.K., A.K., and E.H. are employees of Bayer Schering Pharma AG, and P.K. and E.H. hold stock options of Bayer Schering Pharma AG. S.S. is a former employee of Bayer Schering Pharma AG and holds stock options of Bayer Schering Pharma AG. P.K. is coinventor of patent WO2007/025604. The other authors report no conflicts of interest. Parts of this work were presented at Eurotox2009 (54) and at the 51st Meeting of the German Society of Pharmacology and Toxicology 2010 (55).	Almeida MR, 2008, MUTAT RES-GEN TOX EN, V657, P155, DOI 10.1016/j.mrgentox.2008.09.005; BATLLE DC, 1990, KIDNEY INT, V37, P21, DOI 10.1038/ki.1990.3; Beswick RA, 2001, HYPERTENSION, V38, P1107, DOI 10.1161/hy1101.093423; Bianchi S, 2005, AM J KIDNEY DIS, V46, P45, DOI 10.1053/j.ajkd.2005.03.007; Brink A, 2006, J CHROMATOGR B, V830, P255, DOI 10.1016/j.jchromb.2005.10.046; Burniston JG, 2005, J MOL CELL CARDIOL, V39, P395, DOI 10.1016/j.yjmcc.2005.04.001; Calhoun DA, 2006, CLIN J AM SOC NEPHRO, V1, P1039, DOI 10.2215/CJN.01060306; Chao MR, 2008, FREE RADICAL BIO MED, V44, P464, DOI 10.1016/j.freeradbiomed.2007.10.003; Corrao G, 2007, CURR DRUG SAF, V2, P125, DOI 10.2174/157488607780598296; Devarajan Prasad, 2007, Cancer Ther, V5, P463; Devarajan P, 2007, CONTRIB NEPHROL, V156, P203; Eddy AA, 1996, KIDNEY INT, V50, P1139, DOI 10.1038/ki.1996.421; Epstein M, 2006, AM J MED, V119, P912, DOI 10.1016/j.amjmed.2006.03.038; Espinosa O, 2007, FREE RADICAL RES, V41, P546, DOI 10.1080/10715760601164050; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Feldt S, 2008, J AM SOC NEPHROL, V19, P743, DOI 10.1681/ASN.2007091030; Friis S, 2001, CANCER-AM CANCER SOC, V92, P2462, DOI 10.1002/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L; Grossman E, 2002, AM J MED, V112, P479, DOI 10.1016/S0002-9343(02)01049-5; Gur M, 2007, CLIN BIOCHEM, V40, P454, DOI 10.1016/j.clinbiochem.2006.10.024; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Hofstra JM, 2008, NEPHROL DIAL TRANSPL, V23, P3160, DOI 10.1093/ndt/gfn190; Huang X, 2005, CELL PROLIFERAT, V38, P223, DOI 10.1111/j.1365-2184.2005.00344.x; Ichino M, 2009, J UROLOGY, V181, P2326, DOI 10.1016/j.juro.2009.01.010; Ishikawa Y, 2006, HYPERTENSION, V47, P1075, DOI 10.1161/01.HYP.0000221605.94532.71; Ismail IH, 2008, ENVIRON MOL MUTAGEN, V49, P73, DOI 10.1002/em.20358; Jin L, 2006, J PHYSIOL PHARMACOL, V57, P343; Johnston NIF, 2008, FRONT BIOSCI-LANDMRK, V13, P4361, DOI 10.2741/3009; Manning RD, 2005, AM J NEPHROL, V25, P311, DOI 10.1159/000086411; Marney AM, 2007, CLIN SCI, V113, P267, DOI 10.1042/CS20070123; Mathew JT, 2008, AM J PHYSIOL-RENAL, V295, pF73, DOI 10.1152/ajprenal.00435.2007; Moore LE, 2005, CANCER INVEST, V23, P240, DOI 10.1081/CNV-200055962; Nakabeppu Y, 2006, BIOL CHEM, V387, P373, DOI 10.1515/BC.2006.050; Ndisang JF, 2008, J HYPERTENS, V26, P1188, DOI 10.1097/HJH.0b013e3282fad93d; Nishiyama A, 2006, J PHARMACOL SCI, V100, P9, DOI 10.1254/jphs.FMJ05003X3; Oli RG, 2010, J NEURAL TRANSM, V117, P737, DOI 10.1007/s00702-010-0401-z; Orend G, 2005, INT J BIOCHEM CELL B, V37, P1066, DOI 10.1016/j.biocel.2004.12.002; Park E, 2005, J NUTR SCI VITAMINOL, V51, P254, DOI 10.3177/jnsv.51.254; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rasband W., 2006, IMAGEJ; Ravanat JL, 2002, CARCINOGENESIS, V23, P1911, DOI 10.1093/carcin/23.11.1911; Remuzzi G, 2008, J AM SOC NEPHROL, V19, P1459, DOI 10.1681/ASN.2007101079; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Schmid U, 2008, CANCER RES, V68, P9239, DOI 10.1158/0008-5472.CAN-08-1310; Schupp N, 2010, N-S ARCH PHARMACOL, V381, P66; Schupp N, 2010, HORM METAB RES, V42, P458, DOI 10.1055/s-0029-1243253; Schupp N, 2007, AM J PHYSIOL-RENAL, V292, pF1427, DOI 10.1152/ajprenal.00458.2006; Schupp N, 2009, TOXICOL LETT, V189, pS98, DOI 10.1016/j.toxlet.2009.06.319; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; STANTON HC, 1971, EXPT HYPERTENSION, V1; Terada Y, 2005, J AM SOC NEPHROL, V16, P2296, DOI 10.1681/ASN.2005020129; Trapp C, 2007, CANCER RES, V67, P5156, DOI 10.1158/0008-5472.CAN-07-0335; Tylicki L, 2008, AM J KIDNEY DIS, V52, P486, DOI 10.1053/j.ajkd.2008.02.297; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050	55	56	58	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2011	25	3					968	978		10.1096/fj.10-173286	http://dx.doi.org/10.1096/fj.10-173286			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	727MZ	21135038				2022-12-25	WOS:000287806200017
J	Nakamichi, Y; Maruyama, Y; Mikami, B; Hashimoto, W; Murata, K				Nakamichi, Yusuke; Maruyama, Yukie; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Structural Determinants in Streptococcal Unsaturated Glucuronyl Hydrolase for Recognition of Glycosaminoglycan Sulfate Groups	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SP GL1; CRYSTAL-STRUCTURE; FLAVOBACTERIUM-HEPARINUM; SUBSTRATE-SPECIFICITY; HYALURONIDASE GENE; ESCHERICHIA-COLI; DEGRADATION; PURIFICATION; PNEUMONIAE; PROTEIN	Pathogenic Streptococcus agalactiae produces polysaccharide lyases and unsaturated glucuronyl hydrolase (UGL), which are prerequisite for complete degradation of mammalian extracellular matrices, including glycosaminoglycans such as chondroitin and hyaluronan. Unlike the Bacillus enzyme, streptococcal UGLs prefer sulfated glycosaminoglycans. Here, we show the loop flexibility for substrate binding and structural determinants for recognition of glycosaminoglycan sulfate groups in S. agalactiae UGL (SagUGL). UGL also degraded unsaturated heparin disaccharides; this indicates that the enzyme released unsaturated iduronic and glucuronic acids from substrates. We determined the crystal structures of SagUGL wild-type enzyme and both substrate-free and substrate-bound D175N mutants by x-ray crystallography and noted that the loop over the active cleft exhibits flexible motion for substrate binding. Several residues in the active cleft bind to the substrate, unsaturated chondroitin disaccharide with a sulfate group at the C-6 position of GalNAc residue. The sulfate group is hydrogen-bonded to Ser-365 and Ser-368 and close to Lys-370. As compared with wild-type enzyme, S365H, S368G, and K370I mutants exhibited higher Michaelis constants toward the substrate. The conversion of SagUGL to Bacillus sp. GL1 UGL-like enzyme via site-directed mutagenesis demonstrated that Ser-365 and Lys-370 are essential for direct binding and for electrostatic interaction, respectively, for recognition of the sulfate group by SagUGL. Molecular conversion was also achieved in SagUGL Arg-236 with an affinity for the sulfate group at the C-4 position of the GalNAc residue. These residues binding to sulfate groups are frequently conserved in pathogenic bacterial UGLs, suggesting that the motif "R-//-SXX(S)XK" (where the hyphen and slash marks in the motif indicate the presence of over 100 residues in the enzyme and parentheses indicate that Ser-368 makes little contribution to enzyme activity) is crucial for degradation of sulfated glycosaminoglycans.	[Nakamichi, Yusuke; Maruyama, Yukie; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Grad Sch Agr, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp	Nakamichi, Yusuke/Y-2830-2019; Nakamichi, Yusuke/H-1221-2018	Nakamichi, Yusuke/0000-0001-7089-663X; Nakamichi, Yusuke/0000-0001-7089-663X	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (to K. M. and W. H.) and by the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. Part of this work was supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists (to Y. M.).	Auperin TC, 2005, J BIOL CHEM, V280, P18245, DOI 10.1074/jbc.M412391200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERRY AM, 1994, INFECT IMMUN, V62, P1101, DOI 10.1128/IAI.62.3.1101-1108.1994; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHENG QO, 1995, J BACTERIOL, V177, P3721, DOI 10.1128/jb.177.13.3721-3727.1995; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gase K, 1998, BBA-GENE STRUCT EXPR, V1398, P86, DOI 10.1016/S0167-4781(98)00045-1; GU KN, 1995, BIOCHEM J, V312, P569, DOI 10.1042/bj3120569; Hascall V., 2009, ESSENTIALS GLYCOBIOL, V15, P219; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Hynes WL, 2000, FEMS MICROBIOL LETT, V184, P109, DOI 10.1016/S0378-1097(00)00029-X; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Itoh T, 2006, J BIOL CHEM, V281, P29807, DOI 10.1074/jbc.M604975200; Jedrzejas MJ, 2007, CELL MOL LIFE SCI, V64, P2799, DOI 10.1007/s00018-007-7125-8; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauder RM, 2009, COMPLEMENT THER MED, V17, P56, DOI 10.1016/j.ctim.2008.08.004; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Mello LV, 2002, J BIOL CHEM, V277, P36678, DOI 10.1074/jbc.M205140200; Mori S, 2003, PROTEIN EXPRES PURIF, V29, P77, DOI 10.1016/S1046-5928(03)00019-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myette JR, 2009, J BIOL CHEM, V284, P35189, DOI 10.1074/jbc.M109.053835; Myette JR, 2009, J BIOL CHEM, V284, P35177, DOI 10.1074/jbc.M109.053801; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; NADER HB, 1990, J BIOL CHEM, V265, P16807; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATON JC, 1993, ANNU REV MICROBIOL, V47, P89, DOI 10.1146/annurev.mi.47.100193.000513; PRITCHARD DG, 1994, ARCH BIOCHEM BIOPHYS, V315, P431, DOI 10.1006/abbi.1994.1521; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sava IG, 2009, J BIOL CHEM, V284, P18194, DOI 10.1074/jbc.M901460200; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tkalec AL, 2000, APPL ENVIRON MICROB, V66, P29, DOI 10.1128/AEM.66.1.29-35.2000; Tonnaer ELGM, 2006, MICROBES INFECT, V8, P316, DOI 10.1016/j.micinf.2005.06.028; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	50	11	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6262	6271		10.1074/jbc.M110.182618	http://dx.doi.org/10.1074/jbc.M110.182618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21147778	hybrid, Green Published			2022-12-25	WOS:000287476400036
J	Jurgensen, S; Antonio, LL; Mussi, GEA; Brito-Moreira, J; Bomfim, TR; De Felice, FG; Garrido-Sanabria, ER; Cavalheiro, EA; Ferreira, ST				Juergensen, Sofia; Antonio, Leandro L.; Mussi, Gabriela E. A.; Brito-Moreira, Jordano; Bomfim, Theresa R.; De Felice, Fernanda G.; Garrido-Sanabria, Emilio R.; Cavalheiro, Esper A.; Ferreira, Sergio T.			Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-beta Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; AMPA-RECEPTORS; DEPENDENT MECHANISM; PERISYNAPTIC SITES; SURFACE EXPRESSION; ALZHEIMERS-DISEASE; SECRETED OLIGOMERS; PLASTICITY; TRAFFICKING; GLUR1	Soluble oligomers of the amyloid-beta peptide (A beta Os) accumulate in the brains of Alzheimer disease (AD) patients and are implicated in synapse failure and early memory loss in AD. A beta Os have been shown to impact synapse function by inhibiting long term potentiation, facilitating the induction of long term depression and inducing internalization of both AMPA and NMDA glutamate receptors, critical players in plasticity mechanisms. Because activation of dopamine D1/D5 receptors plays important roles in memory circuits by increasing the insertion of AMPA and NMDA receptors at synapses, we hypothesized that selective activation of D1/D5 receptors could protect synapses from the deleterious action of A beta Os. We show that SKF81297, a selective D1/D5 receptor agonist, prevented the reduction in surface levels of AMPA and NMDA receptors induced by A beta Os in hippocampal neurons in culture. Protection by SKF81297 was abrogated by the specific D1/D5 antagonist, SCH23390. Levels of AMPA receptor subunit GluR1 phosphorylated at Ser(845), which regulates AMPA receptor association with the plasma membrane, were reduced in a calcineurin-dependent manner in the presence of A beta Os, and treatment with SKF81297 prevented this reduction. Establishing the functional relevance of these findings, SKF81297 blocked the impairment of long term potentiation induced by A beta Os in hippocampal slices. Results suggest that D1/D5 receptors may be relevant targets for development of novel pharmacological approaches to prevent synapse failure in AD.	[Juergensen, Sofia; Mussi, Gabriela E. A.; Brito-Moreira, Jordano; Bomfim, Theresa R.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-1944590 Rio De Janeiro, Brazil; [Antonio, Leandro L.; Cavalheiro, Esper A.] Univ Fed Sao Paulo, Dept Expt Neurol, BR-04023900 Sao Paulo, Brazil; [Garrido-Sanabria, Emilio R.] Univ Texas Brownsville, Ctr Biomed Studies, Dept Biol Sci, Brownsville, TX 78520 USA	Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; University of Texas Rio Grande Valley	Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, CCS IBqM, BR-21941590 Rio De Janeiro, Brazil.	ferreira@bioqmed.ufrj.br	Cavalheiro, Esper A/I-3084-2016; Cavalheiro, Esper A/F-4325-2014; Neurociencia, Inct/I-1011-2013; Cavalheiro, Esper/N-3985-2019; De Felice, Fernanda G/M-1074-2017; Ferreira, Sergio/AAZ-1576-2020	Cavalheiro, Esper A/0000-0002-0854-3582; Cavalheiro, Esper A/0000-0002-0854-3582; Cavalheiro, Esper/0000-0002-0854-3582; Ferreira, Sergio/0000-0001-7160-9866	National Institutes of Health [5SC1NS063950-04, 3SC1NS063950-03S1]; Conselho Nacional de Desenvolvimento Cientifico Tecnologico; Instituto Nacional de Neurociencia Translacional; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Human Frontier Science Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC1NS063950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Neurociencia Translacional; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5SC1NS063950-04 and 3SC1NS063950-03S1 (to E. R. G.-S.). This work was also supported by grants from Conselho Nacional de Desenvolvimento Cientifico Tecnologico, Instituto Nacional de Neurociencia Translacional, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to S. T. F.); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to E. A. C.); and Human Frontier Science Program (to F. G. D. F.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Castner SA, 2007, BRAIN COGNITION, V63, P94, DOI 10.1016/j.bandc.2006.11.002; Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Chen QS, 2002, NEUROBIOL LEARN MEM, V77, P354, DOI 10.1006/nlme.2001.4034; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Dalley JW, 2009, SEMIN CELL DEV BIOL, V20, P403, DOI 10.1016/j.semcdb.2009.01.002; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; DEKEYSER J, 1990, BRAIN RES, V528, P308, DOI 10.1016/0006-8993(90)91672-4; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Gao C, 2006, J NEUROCHEM, V98, P1664, DOI 10.1111/j.1471-4159.2006.03999.x; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Ikonemevic MD, 1999, EXP NEUROL, V160, P194, DOI 10.1006/exnr.1999.7196; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Knobloch M, 2007, J NEUROSCI, V27, P7648, DOI 10.1523/JNEUROSCI.0395-07.2007; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Missale C, 2006, CURR TOP MED CHEM, V6, P801, DOI 10.2174/156802606777057562; Mockett BG, 2007, J NEUROSCI, V27, P2918, DOI 10.1523/JNEUROSCI.0838-06.2007; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Rui YF, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-10; Sanabria ERG, 2002, BRAIN RES BULL, V59, P47, DOI 10.1016/S0361-9230(02)00837-7; Schaeffer EL, 2009, PROG NEURO-PSYCHOPH, V33, P1087, DOI 10.1016/j.pnpbp.2009.06.024; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder GL, 1998, J NEUROSCI, V18, P10297; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; WALS P, 1998, P NATL ACAD SCI USA, V95, P6448; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wolf ME, 2003, ANN NY ACAD SCI, V1003, P241, DOI 10.1196/annals.1300.015; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; YASUDA RP, 1995, BRAIN RES, V678, P161, DOI 10.1016/0006-8993(95)00178-S; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	63	71	75	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3270	3276		10.1074/jbc.M110.177790	http://dx.doi.org/10.1074/jbc.M110.177790			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21115476	Green Published, hybrid			2022-12-25	WOS:000286653200012
J	Shlyakhtenko, LS; Lushnikov, AY; Li, M; Lackey, L; Harris, RS; Lyubchenko, YL				Shlyakhtenko, Luda S.; Lushnikov, Alexander Y.; Li, Ming; Lackey, Lela; Harris, Reuben S.; Lyubchenko, Yuri L.			Atomic Force Microscopy Studies Provide Direct Evidence for Dimerization of the HIV Restriction Factor APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; DNA; DEAMINASE; PROTEINS; GAG; HYPERMUTATION; DYNAMICS; VIRIONS; COMPLEX	APOBEC3G (A3G) is an antiviral protein that binds RNA and single-stranded DNA (ssDNA). The oligomerization state of A3G is likely to be influenced by these nucleic acid interactions. We applied the power of nanoimaging atomic force microscopy technology to characterize the role of ssDNA in A3G oligomerization. We used recombinant human A3G prepared from HEK-293 cells and specially designed DNA substrates that enable free A3G to be distinguished unambiguously from DNA-bound protein complexes. This DNA substrate can be likened to a molecular ruler because it consists of a 235-bp double-stranded DNA visual tag spliced to a 69-nucleotide ssDNA substrate. This hybrid substrate enabled us to use volume measurements to determine A3G stoichiometry in both free and ssDNA-bound states. We observed that free A3G is primarily monomeric, whereas ssDNA-complexed A3G is mostly dimeric. A3G stoichiometry increased slightly with the addition of Mg2+, but dimers still predominated when Mg2+ was depleted. A His-248/His-250 Zn2+-mediated intermolecular bridge was observed in a catalytic domain crystal structure (Protein Data Bank code 3IR2); however, atomic force microscopy analyses showed that the stoichiometry of the A3G-ssDNA complexes changed insignificantly when these residues were mutated to Ala. We conclude that A3G exchanges between oligomeric forms in solution with monomers predominating and that this equilibrium shifts toward dimerization upon binding ssDNA.	[Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Li, Ming; Lackey, Lela; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Ctr Genome Engn,Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of Nebraska System; University of Nebraska Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Lyubchenko, YL (corresponding author), 986025 Nebraska Med Ctr, Omaha, NE 68198 USA.	ylyubchenko@unmc.edu		Lackey, Lela/0000-0003-2163-4005	National Institutes of Health [AI064046, P01 GM091743, SIG 1S10 SS023400]; National Science Foundation [PHY-0615590]; NATO [SFP-983204]; Nebraska Research Initiative Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI064046, T32AI083196, R56AI064046, R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM091743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATO(NATO (North Atlantic Treaty Organisation)); Nebraska Research Initiative Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064046 (to R. S. H.) and P01 GM091743 (to R. S. H. and Y. L. L.). This work was also supported by National Science Foundation Grant PHY-0615590 (to Y. L. L.), NATO Grant SFP-983204 (to Y. L. L.), a Nebraska Research Initiative Grant (to Y. L. L.), and a National Science Foundation doctoral scholarship (to L. L.). The AFM experiments were performed in the University of Nebraska Nanoimaging Core Facility with the use of AFM instruments purchased with National Institutes of Health Support Grant SIG 1S10 SS023400.	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Brar SS, 2008, DNA REPAIR, V7, P77, DOI 10.1016/j.dnarep.2007.08.002; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; HANSMA HG, 1995, BIOPHYS J, V68, P1672, DOI 10.1016/S0006-3495(95)80343-7; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Hultquist JF, 2009, FUTURE VIROL, V4, P605, DOI 10.2217/FVL.09.59; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Kataoka Naoyuki, 2008, V488, P357, DOI 10.1007/978-1-60327-475-3_23; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Lushnikov AY, 2006, BIOCHEMISTRY-US, V45, P152, DOI 10.1021/bi051767c; Lushnikov AY, 2004, NUCLEIC ACIDS RES, V32, P4704, DOI 10.1093/nar/gkh810; Lyubchenko YL, 2004, CELL BIOCHEM BIOPHYS, V41, P75, DOI 10.1385/CBB:41:1:075; Lyubchenko YL, 2009, METHODS, V47, P206, DOI 10.1016/j.ymeth.2008.09.002; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Salter JD, 2009, BIOCHEMISTRY-US, V48, P10685, DOI 10.1021/bi901642c; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6; Shlyakhtenko LS, 2007, BIOCHEMISTRY-US, V46, P11128, DOI 10.1021/bi701123u; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wang XJ, 2007, J BIOL CHEM, V282, P1585, DOI 10.1074/jbc.M610150200; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wichroski Michael J., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020041; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	48	67	67	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3387	3395		10.1074/jbc.M110.195685	http://dx.doi.org/10.1074/jbc.M110.195685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21123176	hybrid, Green Published			2022-12-25	WOS:000286653200025
J	Agbor, TA; Cheong, A; Comerford, KM; Scholz, CC; Bruning, U; Clarke, A; Cummins, EP; Cagney, G; Taylor, CT				Agbor, Terence A.; Cheong, Alex; Comerford, Katrina M.; Scholz, Carsten C.; Bruning, Ulrike; Clarke, Ambrose; Cummins, Eoin P.; Cagney, Gerard; Taylor, Cormac T.			Small Ubiquitin-related Modifier (SUMO)-1 Promotes Glycolysis in Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; PROTEIN SUMOYLATION; INDUCIBLE FACTOR-1; SUMO; EXPRESSION; CELLS; HIF-1; RESPONSES; CYTOPROTECTION; RESPIRATION	Under conditions of hypoxia, most eukaryotic cells undergo a shift in metabolic strategy, which involves increased flux through the glycolytic pathway. Although this is critical for bioenergetic homeostasis, the underlying mechanisms have remained incompletely understood. Here, we report that the induction of hypoxia-induced glycolysis is retained in cells when gene transcription or protein synthesis are inhibited suggesting the involvement of additional post-translational mechanisms. Post-translational protein modification by the small ubiquitin related modifier-1 (SUMO-1) is induced in hypoxia and mass spectrometric analysis using yeast cells expressing tap-tagged Smt3 (the yeast homolog of mammalian SUMO) revealed hypoxia-dependent modification of a number of key glycolytic enzymes. Overexpression of SUMO-1 in mammalian cancer cells resulted in increased hypoxia-induced glycolysis and resistance to hypoxia-dependent ATP depletion. Supporting this, non-transformed cells also demonstrated increased glucose uptake upon SUMO-1 overexpression. Conversely, cells overexpressing the de-SUMOylating enzyme SENP-2 failed to demonstrate hypoxia-induced glycolysis. SUMO-1 overexpressing cells demonstrated focal clustering of glycolytic enzymes in response to hypoxia leading us to hypothesize a role for SUMOylation in promoting spatial re-organization of the glycolytic pathway. In summary, we hypothesize that SUMO modification of key metabolic enzymes plays an important role in shifting cellular metabolic strategies toward increased flux through the glycolytic pathway during periods of hypoxic stress.	[Taylor, Cormac T.] Univ Coll Dublin, Coll Life Sci, Sch Med & Med Sci, UCD Conway Inst, Dublin 4, Ireland; [Agbor, Terence A.] Univ Massachusetts, Sch Med, Dept Mol Genet, Worcester, MA 01655 USA; [Agbor, Terence A.] Univ Massachusetts, Sch Med, Dept Microbiol, Worcester, MA 01655 USA	University College Dublin; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Taylor, CT (corresponding author), Univ Coll Dublin, Coll Life Sci, Sch Med & Med Sci, UCD Conway Inst, Dublin 4, Ireland.	cormac.taylor@ucd.ie	Scholz, Carsten C./P-3185-2019; Cheong, Alex/E-5049-2011; Cummins, Eoin/S-7554-2019	Scholz, Carsten C./0000-0001-6579-8015; Cheong, Alex/0000-0003-2482-9078; Cummins, Eoin/0000-0002-9346-8299; Cagney, Gerard/0000-0001-7189-9496; Taylor, Cormac/0000-0002-0946-1247	Science Foundation Ireland; European Union	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union(European Commission)	This work was supported by grants from the Science Foundation Ireland and European Union Marie Curie Action.	Agbor TA, 2008, BIOCHEM SOC T, V36, P445, DOI 10.1042/BST0360445; Anderson DB, 2009, DRUG NEWS PERSPECT, V22, P255, DOI 10.1358/dnp.2009.22.5.1378636; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jacques C, 2005, J CLIN ENDOCR METAB, V90, P2314, DOI 10.1210/jc.2004-1337; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim KI, 2009, INT REV CEL MOL BIO, V273, P265, DOI 10.1016/S1937-6448(08)01807-8; Lee YJ, 2006, BIOCHEM SOC T, V34, P1295, DOI 10.1042/BST0341295; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Nguyen HV, 2006, AM J PATHOL, V168, P1452, DOI 10.2353/ajpath.2006.050782; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; RACKER E, 1972, AM SCI, V60, P56; Sagar GDV, 2007, MOL CELL BIOL, V27, P4774, DOI 10.1128/MCB.00283-07; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Spoden GA, 2009, J CELL BIOCHEM, V107, P293, DOI 10.1002/jcb.22125; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Ulrich HD, 2007, CELL, V131, P446, DOI 10.1016/j.cell.2007.10.026; Vigodner M, 2009, CELL TISSUE RES, V336, P277, DOI 10.1007/s00441-009-0775-0; Wilson V. G., 2005, SCI STKE, V290, P32; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601	39	46	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4718	4726		10.1074/jbc.M110.115931	http://dx.doi.org/10.1074/jbc.M110.115931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21123177	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000286975700070
J	Wang, BZ; Xu, R; Quan, FS; Kang, SM; Wang, L; Compans, RW				Wang, Bao-Zhong; Xu, Rui; Quan, Fu-Shi; Kang, Sang-Moo; Wang, Li; Compans, Richard W.			Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; SIMIAN IMMUNODEFICIENCY VIRUS; GRAM-NEGATIVE FLAGELLIN; MUCOSAL IMMUNIZATION; IMMUNE-RESPONSES; EFFECTIVE ADJUVANT; CROSS-PROTECTION; VACCINE; DELIVERY; CHALLENGE	We demonstrated previously that the incorporation of a membrane-anchored form of flagellin into influenza virus-like particles (VLPs) improved the immunogenicity of VLPs significantly, inducing partially protective heterosubtypic immunity by intramuscular immunization. Because the efficacy of mucosal vaccination is highly dependent on an adjuvant, and is particularly effective for preventing mucosal infections such as influenza, we determined whether the membrane-anchored flagellin is an efficient adjuvant for VLP vaccines by a mucosal immunization route. We compared the adjuvant effect of membrane-anchored and soluble flagellins for immunization with influenza A/PR8 (H1N1) VLPs by the intranasal route in a mouse model. The results demonstrate that membrane-anchored flagellin is an effective adjuvant for intranasal (IN) immunization, inducing enhanced systemic and mucosal antibody responses. High cellular responses were also observed as shown by cytokine production in splenocyte cultures when stimulated with viral antigens. All mice immunized with flagellin-containing VLPs survived challenge with a high lethal dose of homologous virus as well as a high dose heterosubtypic virus challenge (40 LD(50) of A/Philippines/82, H3N2). In contrast, no protection was observed with a standard HA/M1 VLP group upon heterosubtypic challenge. Soluble flagellin exhibited a moderate adjuvant effect when co-administered with VLPs by the mucosal route, as indicated by enhanced systemic and mucosal responses and partial heterosubtypic protection. The membrane-anchored form of flagellin incorporated together with antigen into influenza VLPs is effective as an adjuvant by the mucosal route and unlike standard VLPs, immunization with such chimeric VLPs elicits protective immunity to challenge with a distantly related influenza A virus.	[Wang, Bao-Zhong] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	Emory University; Emory University	Wang, BZ (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rcompan@emory.edu	Quan, Fu-Shi/V-1826-2019; Compans, Richard W/I-4087-2013	Compans, Richard W/0000-0003-2360-335X; Wang, Bao-Zhong/0000-0002-1561-4318	National Institutes of Health [AI068003, AI074579]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579, R01AI068003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institutes of Health (AI068003 & AI074579). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2008, VACCINE, V26, P1525, DOI 10.1016/j.vaccine.2008.01.019; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Eriksson K, 2002, CURR OPIN IMMUNOL, V14, P666, DOI 10.1016/S0952-7915(02)00384-9; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; GREGORIADIS G, 1990, IMMUNOL TODAY, V11, P89, DOI 10.1016/0167-5699(90)90034-7; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Kang SM, 2003, J VIROL, V77, P9823, DOI 10.1128/JVI.77.18.9823-9830.2003; Kang SM, 2003, J VIROL, V77, P3615, DOI 10.1128/JVI.77.6.3615-3623.2003; Kreijtz JHCM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007790; KUNOSAKAI H, 1994, VACCINE, V12, P1303, DOI 10.1016/S0264-410X(94)80056-6; Levi R, 1996, VACCINE, V14, P85, DOI 10.1016/0264-410X(95)00088-I; McCluskie MJ, 2001, VACCINE, V19, P3759, DOI 10.1016/S0264-410X(01)00088-3; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P153, DOI 10.1016/B978-012491543-5/50013-9; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Moors MA, 2001, INFECT IMMUN, V69, P4424, DOI 10.1128/IAI.69.7.4424-4429.2001; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; NOVAK M, 1993, VACCINE, V11, P55, DOI 10.1016/0264-410X(93)90339-Y; Nugent J, 1998, J CLIN PHARM THER, V23, P257; OKADA H, 1995, CRIT REV THER DRUG, V12, P1; Palese P, 2002, J CLIN INVEST, V110, P9, DOI 10.1172/JCI200215999; PARHAM P, 2000, IMMUNE SYSTEM, P31; Poland GA, 2007, VACCINE, V25, P3057, DOI 10.1016/j.vaccine.2007.01.050; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Reed L. J., 1938, AM J HYG, V27, P5; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058; Skountzou I, 2010, VACCINE, V28, P4103, DOI 10.1016/j.vaccine.2009.07.058; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Takahashi I, 2009, CURR OPIN IMMUNOL, V21, P352, DOI 10.1016/j.coi.2009.04.002; Takahashi T, 2007, NEW ENGL J MED, V356, P1172; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Vyas SP, 2007, EXPERT REV VACCINES, V6, P401, DOI 10.1586/14760584.6.3.401; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08	45	71	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e13972	10.1371/journal.pone.0013972	http://dx.doi.org/10.1371/journal.pone.0013972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124769	Green Submitted, Green Published, gold			2022-12-25	WOS:000284686500002
J	Wakakuwa, M; Terakita, A; Koyanagi, M; Stavenga, DG; Shichida, Y; Arikawa, K				Wakakuwa, Motohiro; Terakita, Akihisa; Koyanagi, Mitsumasa; Stavenga, Doekele G.; Shichida, Yoshinori; Arikawa, Kentaro			Evolution and Mechanism of Spectral Tuning of Blue-Absorbing Visual Pigments in Butterflies	PLOS ONE			English	Article							COLOR-VISION; MESSENGER-RNAS; RED RECEPTORS; RHODOPSIN; EYE; EXPRESSION; RETINA; PHOTORECEPTORS; HETEROGENEITY; LOCALIZATION	The eyes of flower-visiting butterflies are often spectrally highly complex with multiple opsin genes generated by gene duplication, providing an interesting system for a comparative study of color vision. The Small White butterfly, Pieris rapae, has duplicated blue opsins, PrB and PrV, which are expressed in the blue (lambda(max) = 453 nm) and violet receptors (lambda(max) = 425 nm), respectively. To reveal accurate absorption profiles and the molecular basis of the spectral tuning of these visual pigments, we successfully modified our honeybee opsin expression system based on HEK293s cells, and expressed PrB and PrV, the first lepidopteran opsins ever expressed in cultured cells. We reconstituted the expressed visual pigments in vitro, and analysed them spectroscopically. Both reconstituted visual pigments had two photointerconvertible states, rhodopsin and metarhodopsin, with absorption peak wavelengths 450 nm and 485 nm for PrB and 420 nm and 482 nm for PrV. We furthermore introduced site-directed mutations to the opsins and found that two amino acid substitutions, at positions 116 and 177, were crucial for the spectral tuning. This tuning mechanism appears to be specific for invertebrates and is partially shared by other pierid and lycaenid butterfly species.	[Wakakuwa, Motohiro; Arikawa, Kentaro] Sokendai, Lab Neuroethol, Hayama, Kanagawa, Japan; [Wakakuwa, Motohiro; Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto, Japan; [Terakita, Akihisa; Koyanagi, Mitsumasa] Osaka City Univ, Dept Biol & Geosci, Grad Sch Sci, Osaka 558, Japan; [Stavenga, Doekele G.] Univ Groningen, Dept Neurobiophys, Groningen, Netherlands	Graduate University for Advanced Studies - Japan; Kyoto University; Osaka Metropolitan University; University of Groningen	Wakakuwa, M (corresponding author), Sokendai, Lab Neuroethol, Hayama, Kanagawa, Japan.	arikawa@soken.ac.jp		Koyanagi, Mitsumasa/0000-0002-7741-918X; Terakita, Akihisa/0000-0002-8379-8913	JSPS (Japan Society for the Promotion of Science) [21247009, 19207006]; MAFF (Ministry of Agriculture, Forestry and Fisheries of Japan) [INSECT-1101]; Air Force Office of Scientific Research/The European Office of Aerospace Research and Development (AFOSR/EOARD) [FA8655-08-1-3012]; Grants-in-Aid for Scientific Research [22687005] Funding Source: KAKEN	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MAFF (Ministry of Agriculture, Forestry and Fisheries of Japan)(Ministry of Agriculture Forestry & Fisheries - Japan); Air Force Office of Scientific Research/The European Office of Aerospace Research and Development (AFOSR/EOARD)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the Promotion of Science) grants No. 21247009 to KA and No. 19207006 to AT, MAFF (Ministry of Agriculture, Forestry and Fisheries of Japan) grant No. INSECT-1101 to KA. DGS is supported by Air Force Office of Scientific Research/The European Office of Aerospace Research and Development (AFOSR/EOARD) grant No. FA8655-08-1-3012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa K, 2005, J NEUROSCI, V25, P5935, DOI 10.1523/JNEUROSCI.1364-05.2005; Arikawa K, 2003, J COMP PHYSIOL A, V189, P791, DOI 10.1007/s00359-003-0454-7; Awata H, 2009, J COMP PHYSIOL A, V195, P401, DOI 10.1007/s00359-009-0418-7; BERNARD GD, 1991, P NATL ACAD SCI USA, V88, P2783, DOI 10.1073/pnas.88.7.2783; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2003, J COMP NEUROL, V458, P334, DOI 10.1002/cne.10582; Briscoe AD, 2008, J EXP BIOL, V211, P1805, DOI 10.1242/jeb.013045; Briscoe AD, 2010, P NATL ACAD SCI USA, V107, P3628, DOI 10.1073/pnas.0910085107; Frentiu FD, 2007, P NATL ACAD SCI USA, V104, P8634, DOI 10.1073/pnas.0701447104; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; KAYADA S, 1995, COMP BIOCHEM PHYS B, V110, P599, DOI 10.1016/0305-0491(94)00179-X; Kitamoto J, 1998, J EXP BIOL, V201, P1255; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nagata T, 2002, J PHYS CHEM A, V106, P1969, DOI 10.1021/jp0124488; OBARA Y, 1968, P JPN ACAD, V44, P829, DOI 10.2183/pjab1945.44.829; Pirih P, 2010, J COMP PHYSIOL A, V196, P501, DOI 10.1007/s00359-010-0538-0; Qiu X, 2003, J COMP PHYSIOL A, V189, P81, DOI 10.1007/s00359-002-0380-0; Qiu XD, 2003, J EXP BIOL, V206, P2787, DOI 10.1242/jeb.00493; Salcedo E, 2003, J NEUROSCI, V23, P10873; Salcedo E, 2009, J BIOL CHEM, V284, P5717, DOI 10.1074/jbc.M807368200; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; SEKI T, 1987, EXP BIOL, V47, P95; Sison-Mangus MP, 2006, J EXP BIOL, V209, P3079, DOI 10.1242/jeb.02360; Spaethe J, 2005, J EXP BIOL, V208, P2347, DOI 10.1242/jeb.01634; STAVENGA DG, J COMP PH A IN PRESS; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Wakakuwa M, 2004, J EXP BIOL, V207, P2803, DOI 10.1242/jeb.01078; White RH, 2003, J EXP BIOL, V206, P3337, DOI 10.1242/jeb.00571	31	26	26	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15015	10.1371/journal.pone.0015015	http://dx.doi.org/10.1371/journal.pone.0015015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124838	Green Published, gold, Green Submitted			2022-12-25	WOS:000284572000018
J	Weiss, SM; Saint, DA				Weiss, Steven M.; Saint, David A.			The Persistent Sodium Current Blocker Riluzole Is Antiarrhythmic and Anti-Ischaemic in a Pig Model of Acute Myocardial Infarction	PLOS ONE			English	Article							RAT VENTRICULAR MYOCYTES; SPINAL-CORD; ISCHEMIA; ARRHYTHMIAS; REPERFUSION; FIBRILLATION; HEART; TACHYCARDIA; TARGET	Background: The potential of the cardiac persistent sodium current as a target for protection of the myocardium from ischaemia and reperfusion injury is gaining increasing interest. We have investigated the anti-ischaemic and antiarrhythmic effects of riluzole, a selective INaP blocker, in an open chest pig model of infarction. Methods and Principal Findings: The left anterior descending coronary artery (LAD) was ligated in 27 anesthetised pigs (landrace or large white, either sex, 20-35 kg) which had received riluzole (8 mg/kg IP; n = 6), lidocaine (2.5-12 mg/kg bolus plus 0.05-0.24 mg/kg/min; n = 11) or vehicle (n = 10) 50 min prior. Arrhythmias could be delineated into phase 1a (0 to 20 min), phase 1b (20 to 50 min) and phase 2 (from 50 min to termination at 180 min) and were classified as premature ventricular contractions (PVCs), non-sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) (spontaneously reverting within 15 s) or sustained VT or VF (ie. requiring cardioversion at 15 s). Riluzole reduced the average number of all arrhythmias in Phase 2 (PVCs from 484+/-119 to 32+/-13; non sustained arrhythmias from 8.9+/-4.4 to 0.7+/-0.5; sustained arrhythmias from 3.9+/-2.2 to 0.5+/-0.4); lidocaine reduced the average number of non-sustained and sustained arrhythmias (to 0.4+/-0.3 and 0.4+/-0.3 respectively) but not PVCs (to 390+/-234). Riluzole and lidocaine reduced the average number of sustained arrhythmias in phase 1b (from 1.8+/-0.4 to 0.17+/-0.13 (p < 0.02) and to 0.55+/-0.26 (p = ns) respectively). Neither lidocaine or riluzole changed the ECG intervals: there was no statistical significance between groups at time zero (just before ligation) for any ECG measure. During the course of the 3 hour period of the ischaemia R-R, and P-R intervals shortened slightly in control and riluzole groups (not significantly different from each other) but not in the lidocaine group (significantly different from control). QRS and QTc did not change appreciably in any group Riluzole reduced the degree of histopathological tissue damage across the infarct zone considerably more than did lidocaine. Conclusions: At the doses used, riluzole was at least as effective as lidocaine at reducing the number of episodes of ischaemic VT or VF in pigs, and much more effective at reducing the number of PVCs. We propose that this is related to the ability of riluzole to block cardiac persistent sodium current.	[Weiss, Steven M.] Australian Natl Univ, Canberra, ACT, Australia; [Saint, David A.] Univ Adelaide, Adelaide, SA, Australia	Australian National University; University of Adelaide	Weiss, SM (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.	david.saint@adelaide.edu.au			Australian National University	Australian National University(Australian National University)	This work was supported by general funds from the Australian National University (for S. Weiss' PhD work). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Bae HJ, 2000, NEUROSCI LETT, V294, P29, DOI 10.1016/S0304-3940(00)01536-6; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Barrett TD, 1997, J PHARMACOL TOX MET, V37, P27, DOI 10.1016/S1056-8719(96)00145-1; Bernus O, 2005, EUROPACE, V7, pS93, DOI 10.1016/j.eupc.2005.03.018; Bryson HM, 1996, DRUGS, V52, P549, DOI 10.2165/00003495-199652040-00010; Cascio WE, 2005, J ELECTROCARDIOL, V38, P55, DOI 10.1016/j.jelectrocard.2005.06.019; Cheema AN, 1998, CIRCULATION, V98, P2030, DOI 10.1161/01.CIR.98.19.2030; Clements-Jewery H, 2002, BRIT J PHARMACOL, V135, P807, DOI 10.1038/sj.bjp.0704509; Clements-Jewery H, 2005, BRIT J PHARMACOL, V145, P551, DOI 10.1038/sj.bjp.0706231; Clements-Jewery H, 2007, CARDIOVASC RES, V73, P761, DOI 10.1016/j.cardiores.2006.12.017; Curtis MJ, 1998, CARDIOVASC RES, V39, P194, DOI 10.1016/S0008-6363(98)00083-2; Dekker LRC, 1998, CIRCULATION, V97, P1724, DOI 10.1161/01.CIR.97.17.1724; DILLY SG, 1988, J PHYSIOL-LONDON, V402, P315, DOI 10.1113/jphysiol.1988.sp017206; Gumina RJ, 2000, EUR J PHARMACOL, V396, P119, DOI 10.1016/S0014-2999(00)00200-4; HARRIS AS, 1950, CIRCULATION, V1, P1318, DOI 10.1161/01.CIR.1.6.1318; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Ju YK, 1996, J PHYSIOL-LONDON, V497, P337, DOI 10.1113/jphysiol.1996.sp021772; JU YK, 1992, BRIT J PHARMACOL, V107, P311, DOI 10.1111/j.1476-5381.1992.tb12743.x; Lamanauskas N, 2008, EUR J NEUROSCI, V27, P2501, DOI 10.1111/j.1460-9568.2008.06211.x; Meesman W., 1982, EARLY ARRHYTHMIAS RE, P93; Parker KK, 2004, J APPL PHYSIOL, V97, P377, DOI 10.1152/japplphysiol.01235.2001; Pratt CM, 1998, AM J CARDIOL, V81, p1C, DOI 10.1016/S0002-9149(98)00180-5; PUGSLEY MK, 1995, LIFE SCI, V57, P1219, DOI 10.1016/0024-3205(95)02070-Y; Remme CA, 2000, CARDIOVASC DRUG THER, V14, P17, DOI 10.1023/A:1007882819423; Riley MP, 2008, J CARDIOVASC ELECTR, V19, P224, DOI 10.1111/j.1540-8167.2007.01007.x; RUSSELL DC, 1984, AM J CARDIOL, V53, P307, DOI 10.1016/0002-9149(84)90444-2; Saint DA, 2008, BRIT J PHARMACOL, V153, P1133, DOI 10.1038/sj.bjp.0707492; SAINT DA, 1992, J PHYSIOL-LONDON, V453, P219, DOI 10.1113/jphysiol.1992.sp019225; Satoh H, 2003, MOL CELL BIOCHEM, V242, P11, DOI 10.1023/A:1021192318882; Sedlis S P, 1992, Cardiovasc Clin, V22, P3; Swerdlow CD, 2007, PACE, V30, P258, DOI 10.1111/j.1540-8159.2007.00659.x; Vacher B, 2009, BRIT J PHARMACOL, V156, P214, DOI 10.1111/j.1476-5381.2008.00062.x; WAINWRIGHT CL, 1988, EUR J PHARMACOL, V145, P183, DOI 10.1016/0014-2999(88)90229-4; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Weiss S, 2010, BRIT J PHARMACOL, V160, P1072, DOI 10.1111/j.1476-5381.2010.00766.x; Weiss Steven M., 1993, Journal of Clinical Engineering, V18, P347; Yan GX, 2004, CIRCULATION, V110, P1036, DOI 10.1161/01.CIR.0000140258.09964.19	38	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14103	10.1371/journal.pone.0014103	http://dx.doi.org/10.1371/journal.pone.0014103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124787	Green Published, Green Submitted, gold			2022-12-25	WOS:000284572000005
J	Petheo, GL; Orient, A; Barath, M; Kovacs, I; Rethi, B; Lanyi, A; Rajki, A; Rajnavolgyi, E; Geiszt, M				Petheo, Gabor L.; Orient, Anna; Barath, Monika; Kovacs, Istvan; Rethi, Bence; Lanyi, Arpad; Rajki, Aniko; Rajnavoelgyi, Eva; Geiszt, Miklos			Molecular and Functional Characterization of H(v)1 Proton Channel in Human Granulocytes	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SUPEROXIDE-PRODUCTION; HUMAN-NEUTROPHILS; REACTIVE OXYGEN; 2 PORES; VOLTAGE; HV1; CONDUCTANCE; SUBUNIT; DIFFERENTIATION	Voltage-gated proton current (I-Hv) has been characterized in several cell types, but the majority of the data was collected in phagocytes, especially in human granulocytes. The prevailing view about the role of I-Hv in phagocytes is that it is an essential supporter of the intense and sustained activity of Nox2 (the core enzyme of the phagocyte NADPH oxidase complex) during respiratory burst. Recently H(v)1, a voltage-gated proton channel, was cloned, and leukocytes from H(v)1 knockout mice display impaired respiratory burst. On the other hand, hardly anything is known about H(v)1 in human granulocytes. Using qPCR and a self made antibody, we detected a significant amount of H(v)1 in human eosinophil and neutrophil granulocytes and in PLB-985 leukemia cells. Using different crosslinking agents and detergents in reducing and non-reducing PAGE, significant expression of H(v)1 homodimers, but not that of higher-order multimers, could be detected in granulocytes. Results of subcellular fractionation and confocal imaging indicate that H(v)1 is resident in both plasmalemmal and granular membrane compartments of resting neutrophils. Furthermore, it is also demonstrated that H(v)1 accumulates in phagosome wall during zymosan engulfment together with, but independently of Nox2. During granulocytic differentiation early and parallel upregulation of H(v)1 and Nox2 expression was observed in PLB-985 cells. The upregulation of H(v)1 or Nox2 expression did not require the normal expression of the other molecule. Using RNA interference, we obtained strong correlation between H(v)1 expression and I-Hv density in PLB-985 cells. It is also demonstrated that a massive reduction in H(v)1 expression can limit the Nox2 mediated superoxide production of PLB-985 granulocytes. In summary, beside monomers native H(v)1 forms stable proton channel dimer in resting and activated human granulocytes. The expression pattern of H(v)1 in granulocytes is optimized to support intense NADPH oxidase activity.	[Petheo, Gabor L.; Orient, Anna; Kovacs, Istvan; Rajki, Aniko; Geiszt, Miklos] Semmelweis Univ, Fac Med, Dept Physiol, H-1085 Budapest, Hungary; [Petheo, Gabor L.; Rajki, Aniko] Hungarian Acad Sci, Lab Neurobiochem & Mol Physiol, Budapest, Hungary; [Barath, Monika; Rethi, Bence; Lanyi, Arpad; Rajnavoelgyi, Eva] Univ Debrecen, Inst Immunol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary	Semmelweis University; Hungarian Academy of Sciences; University of Debrecen	Petheo, GL (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, H-1085 Budapest, Hungary.	gabor.petheo@eok.sote.hu	Petheő, Gábor/O-1149-2017; Rethi, Bence/C-5770-2013; Rajnavölgyi, Éva/D-4384-2013	Petheő, Gábor/0000-0002-1773-4129; Rethi, Bence/0000-0001-8220-5015; 	Hungarian National Science Foundation [OTKA F-68023, NF-72669, 042573, K-63700]; Council for Medical Research [ETT 615/2006]; Cystic Fibrosis Foundation (USA); Hungarian Academy of Sciences	Hungarian National Science Foundation; Council for Medical Research; Cystic Fibrosis Foundation (USA); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian National Science Foundation (OTKA F-68023, NF-72669, 042573, K-63700), the Council for Medical Research (ETT 615/2006) and the Cystic Fibrosis Foundation (USA). A.L. and G.L.P. are recipients of Bolyai Research Fellowships from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato L, 2002, NEUROBIOL AGING, V23, P819, DOI 10.1016/S0197-4580(02)00069-6; Banfi B, 1999, J EXP MED, V190, P183, DOI 10.1084/jem.190.2.183; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Burritt JB, 2000, EUR J HAEMATOL, V65, P407, DOI 10.1034/j.1600-0609.2000.065006407.x; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2008, J PHYSIOL-LONDON, V586, P5305, DOI 10.1113/jphysiol.2008.161703; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Fisher AB, 2009, ANTIOXID REDOX SIGN, V11, P1349, DOI [10.1089/ars.2008.2378, 10.1089/ARS.2008.2378]; GINSEL LA, 1990, BLOOD, V76, P2105; Henderson LM, 2002, J GEN PHYSIOL, V120, P759, DOI 10.1085/jgp.20028708; HLADKY SB, 1972, BIOCHIM BIOPHYS ACTA, V274, P294, DOI 10.1016/0005-2736(72)90178-2; KJELDSEN L, 1992, BIOCHEM J, V287, P603, DOI 10.1042/bj2870603; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; LI SJ, 2010, J BIOL CHEM; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Maturana A, 2002, J GEN PHYSIOL, V120, P781, DOI 10.1085/jgp.20028713; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Murphy R, 2006, BBA-BIOENERGETICS, V1757, P996, DOI 10.1016/j.bbabio.2006.01.005; Musset B, 2008, J PHYSIOL-LONDON, V586, P2477, DOI 10.1113/jphysiol.2007.149427; MUSSET B, 2010, J PHYSL; NAKAMURA M, 1987, BLOOD, V69, P1404; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; Petheo GL, 2003, J GEN PHYSIOL, V122, P713, DOI 10.1085/jgp.200308891; QU AY, 1994, AM J PHYSIOL, V266, pC1263, DOI 10.1152/ajpcell.1994.266.5.C1263; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shepherd V L, 1986, Semin Respir Infect, V1, P99; Suenaga T, 2007, EUR J IMMUNOL, V37, P3197, DOI 10.1002/eji.200737052; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tombola F, 2010, NAT STRUCT MOL BIOL, V17, P44, DOI 10.1038/nsmb.1738; Tsang JLY, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-32; van Bruggen R, 2004, J BIOL CHEM, V279, P9097, DOI 10.1074/jbc.M309284200; van Manen HJ, 2003, J AM CHEM SOC, V125, P12112, DOI 10.1021/ja036973r; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	43	47	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14081	10.1371/journal.pone.0014081	http://dx.doi.org/10.1371/journal.pone.0014081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124855	gold, Green Submitted, Green Published			2022-12-25	WOS:000284527900004
J	Sun, YP; Bi, YH; Pu, JA; Hu, YX; Wang, JJ; Gao, HJ; Liu, LQ; Xu, Q; Tan, YY; Liu, MD; Guo, X; Yang, HC; Liu, JH				Sun, Yipeng; Bi, Yuhai; Pu, Juan; Hu, Yanxin; Wang, Jingjing; Gao, Huijie; Liu, Linqing; Xu, Qi; Tan, Yuanyuan; Liu, Mengda; Guo, Xin; Yang, Hanchun; Liu, Jinhua			Guinea Pig Model for Evaluating the Potential Public Health Risk of Swine and Avian Influenza Viruses	PLOS ONE			English	Article							RECEPTOR SPECIFICITY; HUMAN TISSUES; HUMAN AIRWAY; H1N1 VIRUS; A VIRUS; HUMANS; ORIGIN; TRANSMISSION; EMERGENCE; INFECTION	Background: The influenza viruses circulating in animals sporadically transmit to humans and pose pandemic threats. Animal models to evaluate the potential public health risk potential of these viruses are needed. Methodology/Principal Findings: We investigated the guinea pig as a mammalian model for the study of the replication and transmission characteristics of selected swine H1N1, H1N2, H3N2 and avian H9N2 influenza viruses, compared to those of pandemic (H1N1) 2009 and seasonal human H1N1, H3N2 influenza viruses. The swine and avian influenza viruses investigated were restricted to the respiratory system of guinea pigs and shed at high titers in nasal tracts without prior adaptation, similar to human strains. None of the swine and avian influenza viruses showed transmissibility among guinea pigs; in contrast, pandemic (H1N1) 2009 virus transmitted from infected guinea pigs to all animals and seasonal human influenza viruses could also horizontally transmit in guinea pigs. The analysis of the receptor distribution in the guinea pig respiratory tissues by lectin histochemistry indicated that both SA alpha 2,3-Gal and SA alpha 2,6-Gal receptors widely presented in the nasal tract and the trachea, while SA alpha 2,3-Gal receptor was the main receptor in the lung. Conclusions/Significance: We propose that the guinea pig could serve as a useful mammalian model to evaluate the potential public health threat of swine and avian influenza viruses.	[Sun, Yipeng; Bi, Yuhai; Pu, Juan; Hu, Yanxin; Wang, Jingjing; Gao, Huijie; Liu, Linqing; Xu, Qi; Tan, Yuanyuan; Liu, Mengda; Guo, Xin; Yang, Hanchun; Liu, Jinhua] China Agr Univ, Coll Vet Med, Key Lab Zoonosis Minist Agr, Beijing 100094, Peoples R China; [Liu, Jinhua] Shandong Anim Dis Control Ctr, Jinan, Shandong, Peoples R China; [Bi, Yuhai] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Sun, YP (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Zoonosis Minist Agr, Beijing 100094, Peoples R China.	ljh@cau.edu.cn		Bi, Yuhai/0000-0002-5595-363X; Liu, Mengda/0000-0003-4039-9143	National Science Fund for Distinguished Young Scholars [31025029]; National Basic Research Program (973 Program) [2011CB504702]; National Natural Science Foundation of China [30901072]; Fundamental Research Funds for the Central Universities [2009JC02]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20090008120007]; Program for Cheung Kong Scholars; Innovative Research Teams in Chinese Universities [IRT0866]; Taishan Scholar Foundation	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Cheung Kong Scholars; Innovative Research Teams in Chinese Universities; Taishan Scholar Foundation	This work was supported by the National Science Fund for Distinguished Young Scholars (31025029; http://www.nsfc.gov.cn/Portal0/InfoModule_537/30599.htm), the National Basic Research Program (973 Program) (2011CB504702; http://www.973.gov.cn/AreaAppl.aspx), the National Natural Science Foundation of China (30901072; http://www.nsfc.gov.cn/nsfc2009/index.htm), the Fundamental Research Funds for the Central Universities (2009JC02; http://kyy.cau.edu.cn/ArticleRead.aspx?uid = 527&cid = 114), the Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) (20090008120007; http://www.cutech.edu.cn/cn/zxgz/2009/02/1229478100938120.htm) and the Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities (No. IRT0866; http://www.cksp.edu.cn). Jinhua Liu was funded by Taishan Scholar Foundation (http://rsxx.sdau.edu.cn/tsxzdzgg.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastien N, 2010, J INFECT DIS, V201, P1178, DOI 10.1086/651507; BI Y, EMERG INFECT DIS, V16, P1162; Bouvier NM, 2008, J VIROL, V82, P10052, DOI 10.1128/JVI.01226-08; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Kwon YK, 2009, VET PATHOL, V46, P138, DOI 10.1354/vp.46-1-138; Lamb FH, 1919, J AMER MED ASSOC, V72, P1056, DOI 10.1001/jama.1919.02610150014005; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Shaoqing Y, 2009, ALLERGOL IMMUNOPATH, V37, P180, DOI 10.1016/j.aller.2009.03.002; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Sun Y, 2010, VET MICROBIOL; Tang XH, 2009, J GEN VIROL, V90, P386, DOI 10.1099/vir.0.007054-0; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Wang L, 2005, AM J PHYSIOL-LUNG C, V289, pL902, DOI 10.1152/ajplung.00005.2005; Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com; Yu SQ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-23	31	41	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15537	10.1371/journal.pone.0015537	http://dx.doi.org/10.1371/journal.pone.0015537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124850	Green Published, Green Submitted, gold			2022-12-25	WOS:000284527900024
J	Bonifaci, N; Gorski, B; Masojc, B; Wokolorczyk, D; Jakubowska, A; Debniak, T; Berenguer, A; Musach, JS; Brunet, J; Dopazo, J; Narod, SA; Lubinski, J; Lazaro, C; Cybulski, C; Pujana, MA				Bonifaci, Nuria; Gorski, Bohdan; Masojc, Bartlomiej; Wokolorczyk, Dominika; Jakubowska, Anna; Debniak, Tadeusz; Berenguer, Antoni; Serra Musach, Jordi; Brunet, Joan; Dopazo, Joaquin; Narod, Steven A.; Lubinski, Jan; Lazaro, Conxi; Cybulski, Cezary; Angel Pujana, Miguel			Exploring the Link between Germline and Somatic Genetic Alterations in Breast Carcinogenesis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANCER SUSCEPTIBILITY LOCI; BRCA2 MUTATION CARRIERS; FAMILIAL GASTRIC-CANCER; COLORECTAL-CANCER; EXPRESSION SIGNATURE; COMMON VARIANTS; RISK; PATHWAYS; ALLELES	Recent genome-wide association studies (GWASs) have identified candidate genes contributing to cancer risk through low-penetrance mutations. Many of these genes were unexpected and, intriguingly, included well-known players in carcinogenesis at the somatic level. To assess the hypothesis of a germline-somatic link in carcinogenesis, we evaluated the distribution of somatic gene labels within the ordered results of a breast cancer risk GWAS. This analysis suggested frequent influence on risk of genetic variation in loci encoding for "driver kinases" (i.e., kinases encoded by genes that showed higher somatic mutation rates than expected by chance and, therefore, whose deregulation may contribute to cancer development and/or progression). Assessment of these predictions using a population-based case-control study in Poland replicated the association for rs3732568 in EPHB1 (odds ratio (OR) = 0.79; 95% confidence interval (CI): 0.63-0.98; P-trend = 0.031). Analyses by early age at diagnosis and by estrogen receptor alpha (ER alpha) tumor status indicated potential associations for rs6852678 in CDKL2 (OR = 0.32, 95% CI: 0.10-1.00; P-recessive = 0.044) and rs10878640 in DYRK2 (OR = 2.39, 95% CI: 1.32-4.30; P-dominant = 0.003), and for rs12765929, rs9836340, rs4707795 in BMPR1A, EPHA3 and EPHA7, respectively (ER alpha tumor status P-interaction<0.05). The identification of three novel candidates as EPH receptor genes might indicate a link between perturbed compartmentalization of early neoplastic lesions and breast cancer risk and progression. Together, these data may lay the foundations for replication in additional populations and could potentially increase our knowledge of the underlying molecular mechanisms of breast carcinogenesis.	[Bonifaci, Nuria; Berenguer, Antoni; Serra Musach, Jordi; Angel Pujana, Miguel] Inst Invest Biomed Bellvitge IDIBELL, Biomarkers & Susceptibil Unit, Catalan Inst Oncol, Spanish Biomed Res Ctr Network Epidemiol & Publ H, Barcelona, Spain; [Gorski, Bohdan; Masojc, Bartlomiej; Wokolorczyk, Dominika; Jakubowska, Anna; Debniak, Tadeusz; Lubinski, Jan; Cybulski, Cezary] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Brunet, Joan] IdIBGi, Catalan Inst Oncol, Hereditary Canc Programme, Girona, Spain; [Dopazo, Joaquin] Funct Genom Node & Spanish Biomed Res Ctr Network, Ctr Invest Principe Felipe, Dept Bioinformat & Genom, Valencia, Spain; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Narod, Steven A.] Womens Coll Hosp, Toronto, ON M5S 1B2, Canada; [Lazaro, Conxi] IDIBELL, Catalan Inst Oncol, Hereditary Canc Programme, Barcelona, Spain; [Angel Pujana, Miguel] IDIBELL, Catalan Inst Oncol, Translat Res Lab, Barcelona, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Pomeranian Medical University; Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Prince Felipe Research Center; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Bonifaci, N (corresponding author), Inst Invest Biomed Bellvitge IDIBELL, Biomarkers & Susceptibil Unit, Catalan Inst Oncol, Spanish Biomed Res Ctr Network Epidemiol & Publ H, Barcelona, Spain.	cezarycy@sci.pam.szczecin.pl; mapujana@iconcologia.net	bonifaci, nuria/B-8104-2019; Jakubowska, Anna/O-8050-2014; Dopazo, Joaquin/A-9270-2014; GARCIA, CONXI LAZARO/Q-2410-2016; Pujana, Miquel Angel/N-3127-2014; Narod, Steven A/AAA-6112-2022; Brunet, Joan/C-5292-2018	bonifaci, nuria/0000-0002-8193-6825; Jakubowska, Anna/0000-0002-5650-0501; Dopazo, Joaquin/0000-0003-3318-120X; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Pujana, Miquel Angel/0000-0003-3222-4044; Berenguer-LLergo, Antoni/0000-0002-3742-8161; Brunet, Joan/0000-0003-1945-3512; Lubinski, Jan/0000-0003-2931-3003	Spanish Society of Medical Oncology; Ramon Areces Foundation XV and FIS [09/02483]; Biomedical Research Centre Network for Epidemiology and Public Health group; "Roses contra el Cancer" Foundation; Spanish Ministry of Science and Innovation; IDIBELL; RTICCC [RD06/0020/0028]	Spanish Society of Medical Oncology; Ramon Areces Foundation XV and FIS; Biomedical Research Centre Network for Epidemiology and Public Health group; "Roses contra el Cancer" Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); IDIBELL; RTICCC	The work was supported by the Spanish Society of Medical Oncology 2009 grant to JB and MAP, the Ramon Areces Foundation XV and FIS (09/02483) grants, and the Biomedical Research Centre Network for Epidemiology and Public Health group 55 to MAP, and the "Roses contra el Cancer" Foundation and RTICCC RD06/0020/0028 grants to JB. MAP was supported by the "Ramon y Cajal" Young Investigator program of the Spanish Ministry of Science and Innovation and NB by an IDIBELL fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Antoniou AC, 2009, HUM MOL GENET, V18, P4442, DOI 10.1093/hmg/ddp372; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonifaci N, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-62; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang JC, 2005, J CLIN ONCOL, V23, P1169, DOI 10.1200/JCO.2005.03.156; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; CLAUS EB, 1990, ANN HUM GENET, V54, P169, DOI 10.1111/j.1469-1809.1990.tb00373.x; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Emery LA, 2009, AM J PATHOL, V175, P1292, DOI 10.2353/ajpath.2009.090115; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Furney SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-3; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia-Closas M, 2008, CLIN CANCER RES, V14, P8000, DOI 10.1158/1078-0432.CCR-08-0975; Gorski B, 2000, AM J HUM GENET, V66, P1963, DOI 10.1086/302922; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hansen RM, 2005, J PATHOL, V207, P27, DOI 10.1002/path.1816; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kraft P, 2009, EPIDEMIOLOGY, V20, P508, DOI 10.1097/EDE.0b013e3181a93b98; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Medina I, 2009, NUCLEIC ACIDS RES, V37, pW340, DOI 10.1093/nar/gkp481; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schnitt SJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2228; Sole X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-12; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stanley SM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-94; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taglienti CA, 1996, ONCOGENE, V13, P2563; Taira N, 2010, J BIOL CHEM, V285, P4909, DOI 10.1074/jbc.M109.042341; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaught D, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2207; Wang XD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r255; Wheeler JMD, 2001, GUT, V48, P367, DOI 10.1136/gut.48.3.367; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	68	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14078	10.1371/journal.pone.0014078	http://dx.doi.org/10.1371/journal.pone.0014078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124932	Green Published, gold, Green Submitted			2022-12-25	WOS:000284467200011
J	Mittelman, K; Ziv, K; Maoz, T; Kleinberger, T				Mittelman, Karin; Ziv, Keren; Maoz, Tsofnat; Kleinberger, Tamar			The Cytosolic Tail of the Golgi Apyrase Ynd1 Mediates E4orf4-Induced Toxicity in Saccharomyces cerevisiae	PLOS ONE			English	Article							ADENOVIRUS E4ORF4 PROTEIN; PHOSPHATASE 2A; CELL-DEATH; P53-INDEPENDENT APOPTOSIS; TRANSFORMED-CELLS; B-ALPHA; SUBUNIT; YEAST; ACTIVATION; INTERACTS	The adenovirus E4 open reading frame 4 (E4orf4) protein contributes to regulation of the progression of virus infection. When expressed individually, E4orf4 was shown to induce non-classical transformed cell-specific apoptosis in mammalian cells. At least some of the mechanisms underlying E4orf4-induced toxicity are conserved from yeast to mammals, including the requirement for an interaction of E4orf4 with protein phosphatase 2A (PP2A). A genetic screen in yeast revealed that the Golgi apyrase Ynd1 associates with E4orf4 and contributes to E4orf4-induced toxicity, independently of Ynd1 apyrase activity. Ynd1 and PP2A were shown to contribute additively to E4orf4-induced toxicity in yeast, and to interact genetically and physically. A mammalian orthologue of Ynd1 was shown to bind E4orf4 in mammalian cells, confirming the evolutionary conservation of this interaction. Here, we use mutation analysis to identify the cytosolic tail of Ynd1 as the protein domain required for mediation of the E4orf4 toxic signal and for the interaction with E4orf4. We also show that E4orf4 associates with cellular membranes in yeast and is localized at their cytoplasmic face. However, E4orf4 is membrane-associated even in the absence of Ynd1, suggesting that additional membrane proteins may mediate E4orf4 localization. Based on our results and on a previous report describing a collection of Ynd1 protein partners, we propose that the Ynd1 cytoplasmic tail acts as a scaffold, interacting with a multi-protein complex, whose targeting by E4orf4 leads to cell death.	[Mittelman, Karin; Ziv, Keren; Maoz, Tsofnat; Kleinberger, Tamar] Technion Israel Inst Technol, Fac Med, Dept Mol Microbiol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Mittelman, K (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	tamark@tx.technion.ac.il			Israel Science Foundation [769/07]; Deutsche Forschungsgemeinschaft (DFG)	Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Israel Science Foundation (Grant 769/07) and by the Deutsche Forschungsgemeinschaft (DFG) within the framework of the German-Israeli Project Cooperation (DIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi R, 2001, J VIROL, V75, P4444, DOI 10.1128/JVI.75.9.4444-4447.2001; Ben-Israel H, 2008, J VIROL, V82, P9381, DOI 10.1128/JVI.00791-08; Biederbick A, 1999, J CELL SCI, V112, P2473; Bondesson M, 1996, J VIROL, V70, P3844, DOI 10.1128/JVI.70.6.3844-3851.1996; Champagne C, 2004, J BIOL CHEM, V279, P25905, DOI 10.1074/jbc.M400933200; Gingras MC, 2002, MOL CELL BIOL, V22, P41, DOI 10.1128/MCB.22.1.41-56.2002; Hobdy-Henderson KC, 2003, TRAFFIC, V4, P681, DOI 10.1034/j.1600-0854.2003.00124.x; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; KLEINBERGER T, 1993, J VIROL, V67, P7556, DOI 10.1128/JVI.67.12.7556-7560.1993; Kornitzer D, 2001, J CELL BIOL, V154, P331, DOI 10.1083/jcb.200104104; Landry MC, 2009, MOL BIOL CELL, V20, P4091, DOI 10.1091/mbc.E09-01-0057; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Lavoie JN, 2000, J CELL BIOL, V150, P1037, DOI 10.1083/jcb.150.5.1037; Livne A, 2001, J VIROL, V75, P789, DOI 10.1128/JVI.75.2.789-798.2001; Mannervik M, 1999, VIROLOGY, V256, P313, DOI 10.1006/viro.1999.9663; Maoz T, 2005, J BIOL CHEM, V280, P41270, DOI 10.1074/jbc.M507281200; Marcellus RC, 1998, J VIROL, V72, P7144, DOI 10.1128/JVI.72.9.7144-7153.1998; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Matsuyama S, 1999, CURR OPIN MICROBIOL, V2, P618, DOI 10.1016/S1369-5274(99)00031-4; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Miron MJ, 2004, ONCOGENE, V23, P7458, DOI 10.1038/sj.onc.1207919; Mui MZ, 2010, J VIROL, V84, P4798, DOI 10.1128/JVI.02434-09; MULLER U, 1992, J VIROL, V66, P5867; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; O'Shea C, 2005, EMBO J, V24, P1211, DOI 10.1038/sj.emboj.7600597; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Robert A, 2002, J CELL BIOL, V158, P519, DOI 10.1083/jcb.200201106; Roopchand DE, 2001, ONCOGENE, V20, P5279, DOI 10.1038/sj.onc.1204693; Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06; Sherman F., 1982, METHODS YEAST GENETI; Shtrichman R, 2000, ONCOGENE, V19, P3757, DOI 10.1038/sj.onc.1203705; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; TORRES JZ, MOL BIOL CELL, V21, P897; Zhong XT, 1999, J BIOL CHEM, V274, P32704, DOI 10.1074/jbc.274.46.32704; Zhong XT, 2005, FEBS LETT, V579, P5643, DOI 10.1016/j.febslet.2005.09.036; Zhong XT, 2000, J BIOL CHEM, V275, P35592, DOI 10.1074/jbc.M006932200; Zimmermann H, 2001, DRUG DEVELOP RES, V52, P44, DOI 10.1002/ddr.1097	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e15539	10.1371/journal.pone.0015539	http://dx.doi.org/10.1371/journal.pone.0015539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124936	gold, Green Published, Green Submitted			2022-12-25	WOS:000284467200022
J	Barsony, J; Sugimura, Y; Verbalis, JG				Barsony, Julia; Sugimura, Yoshihisa; Verbalis, Joseph G.			Osteoclast Response to Low Extracellular Sodium and the Mechanism of Hyponatremia-induced Bone Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; OXIDATIVE STRESS; RECEPTOR ACTIVATOR; ASCORBIC-ACID; REDOX REGULATION; IN-VIVO; TRANSPORT; RANKL; DIFFERENTIATION; CALCIUM	Our recent animal and human studies revealed that chronic hyponatremia is a previously unrecognized cause of osteoporosis that is associated with increased osteoclast numbers in a rat model of the human disease of the syndrome of inappropriate antidiuretic hormone secretion (SIADH). We used cellular and molecular approaches to demonstrate that sustained low extracellular sodium ion concentrations ([Na+]) directly stimulate osteoclastogenesis and resorptive activity and to explore the mechanisms underlying this effect. Assays on murine preosteoclastic RAW 264.7 cells and on primary bone marrow monocytes both indicated that lowering the medium [Na+] dose-dependently increased osteoclast formation and resorptive activity. Low [Na+], rather than low osmolality, triggered these effects. Chronic reduction of [Na+] dose-dependently decreased intracellular calcium without depleting endoplasmic reticulum calcium stores. Moreover, we found that reduction of [Na+] dose-dependently decreased cellular uptake of radiolabeled ascorbic acid, and reduction of ascorbic acid in the culture medium mimicked the osteoclastogenic effect of low [Na+]. We also detected downstream effects of reduced ascorbic acid uptake, namely evidence of hyponatremia-induced oxidative stress. This was manifested by increased intracellular free oxygen radical accumulation and proportional changes in protein expression and phosphorylation, as indicated by Western blot analysis from cellular extracts and by increased serum 8-hydroxy-2'-deoxyguanosine levels in vivo in rats. Our results therefore reveal novel sodium signaling mechanisms in osteoclasts that may serve to mobilize sodium from bone stores during prolonged hyponatremia, thereby leading to a resorptive osteoporosis in patients with SIADH.	[Barsony, Julia; Sugimura, Yoshihisa; Verbalis, Joseph G.] Georgetown Univ, Div Endocrinol & Metab, Washington, DC 20007 USA	Georgetown University	Barsony, J (corresponding author), Georgetown Univ, Div Endocrinol & Metab, 4000 Reservoir Rd NW,D-233, Washington, DC 20007 USA.	jb394@georgetown.edu	Sugimura, Yoshihisa/Q-8716-2019		National Institutes of Health [Z01-DK060050, R01-AG029477]; Yamanouchi Pharma America (Paramus, NJ); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK060050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yamanouchi Pharma America (Paramus, NJ); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01-DK060050 and Extramural Grant R01-AG029477. This work was also supported by a research grant from Yamanouchi Pharma America (Paramus, NJ).	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Baek KH, 2010, CALCIFIED TISSUE INT, V87, P226, DOI 10.1007/s00223-010-9393-9; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; BERGSTROM WH, 1954, J CLIN INVEST, V33, P867, DOI 10.1172/JCI102959; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Blair HC, 2006, REV ENDOCR METAB DIS, V7, P23, DOI 10.1007/s11154-006-9010-4; CHRISTENSEN O, 1987, NATURE, V330, P66, DOI 10.1038/330066a0; DATTA HK, 1990, BIOCHEM BIOPH RES CO, V167, P183, DOI 10.1016/0006-291X(90)91748-H; Davey RA, 2008, J BONE MINER RES, V23, P1182, DOI 10.1359/JBMR.080310; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; FRANCESCHI RT, 1995, AM J PHYSIOL-CELL PH, V268, pC1430, DOI 10.1152/ajpcell.1995.268.6.C1430; Gupta A, 1997, J CLIN INVEST, V100, P538, DOI 10.1172/JCI119563; Huber DM, 2001, ENDOCRINOLOGY, V142, P3800, DOI 10.1210/en.142.9.3800; KELLY MEM, 1994, J PHYSIOL-LONDON, V475, P377, DOI 10.1113/jphysiol.1994.sp020079; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Kim HJ, 2006, FREE RADICAL BIO MED, V40, P1483, DOI 10.1016/j.freeradbiomed.2005.10.066; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Komarova SV, 2001, CURR PHARM DESIGN, V7, P637, DOI 10.2174/1381612013397799; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Li JP, 2007, ENDOCRINOLOGY, V148, P2116, DOI 10.1210/en.2006-1321; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Niwa K, 2003, ANTIOXID REDOX SIGN, V5, P713, DOI 10.1089/152308603770380016; PERKINS SL, 1994, BONE, V15, P65, DOI 10.1016/8756-3282(94)90893-1; Perry SF, 2006, J EXP BIOL, V209, P4591, DOI 10.1242/jeb.02558; Riihonen R, 2010, MATRIX BIOL, V29, P287, DOI 10.1016/j.matbio.2010.01.003; Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sakuta Koichi, 2002, Osaka City Medical Journal, V48, P29; Sandhu HS, 2009, INT UROL NEPHROL, V41, P733, DOI 10.1007/s11255-009-9585-2; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Seeliger E, 2006, AM J PHYSIOL-REG I, V290, pR1429, DOI 10.1152/ajpregu.00676.2005; Sharif-Naeini R, 2008, KIDNEY INT, V73, P811, DOI 10.1038/sj.ki.5002788; SHIOI A, 1994, CALCIFIED TISSUE INT, V55, P387, DOI 10.1007/BF00299320; Shui C, 2002, CALCIFIED TISSUE INT, V71, P437, DOI 10.1007/s00223-001-1138-3; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Skerry T. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P166; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Tsuzuki T, 2000, JPN J PHYSIOL, V50, P67, DOI 10.2170/jjphysiol.50.67; Verbalis JG, 2007, J AM SOC NEPHROL, V18, P3056, DOI 10.1681/ASN.2007070825; Verbalis JG, 2010, J BONE MINER RES, V25, P554, DOI 10.1359/jbmr.090827; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; WILSON JX, 1989, J MEMBRANE BIOL, V111, P83, DOI 10.1007/BF01869211; Xu Y, 2010, ANTIOXID REDOX SIGN, V13, P27, DOI 10.1089/ars.2009.2886; Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324; Zhang Y, 2005, APOPTOSIS, V10, P545, DOI 10.1007/s10495-005-1885-0	51	123	133	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10864	10875		10.1074/jbc.M110.155002	http://dx.doi.org/10.1074/jbc.M110.155002			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21135109	Green Published, hybrid			2022-12-25	WOS:000288547000100
J	Qiu, Y; Stavreva, DA; Luo, Y; Indrawan, A; Chang, MR; Hager, GL				Qiu, Yi; Stavreva, Diana A.; Luo, Yi; Indrawan, Anindya; Chang, Myron; Hager, Gordon L.			Dynamic Interaction of HDAC1 with a Glucocorticoid Receptor-regulated Gene Is Modulated by the Activity State of the Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELLS; CHROMATIN DYNAMICS; TRANSCRIPTION; TRAFFICKING; INHIBITION; EXCHANGE; ALPHA	Although histone deacetylases (HDACs) are normally considered as co-repressors, HDAC1 has been identified as a coactivator for the glucocorticoid receptor (GR) (Qiu, Y., Zhao, Y., Becker, M., John, S., Parekh, B. S., Huang, S., Hendarwanto, A., Martinez, E. D., Chen, Y., Lu, H., Adkins, N. L., Stavreva, D. A., Wiench, M., Georgel, P. T., Schiltz, R. L., and Hager, G. L. (2006) Mol. Cell 22, 669-679). Furthermore, HDAC1 is acetylated, and its acetylation level is linked to the transcription state of a GR-induced promoter (mouse mammary tumor virus). GR is also known to interact dynamically with regulatory elements in living cells (McNally, J. G., Muller, W. G., Walker, D., Wolford, R., and Hager, G. L. (2000) Science 287, 1262-1265). However, HDAC1 dynamics have never been studied. We demonstrate here that HDAC1 also exchanges rapidly with promoter chromatin, and its exchange rate is significantly modulated during the development of promoter activity. Prior to induction, HDAC1 mobility was retarded compared with the exchange rate for GR. HDAC1 mobility then increased substantially, coordinately with the peak of promoter activity. At later time points, promoter activity was severely repressed, and HDAC1 mobility returned to the rate of exchange observed for the uninduced promoter. Thus, alterations of the exchange rates of HDAC1 at the promoter are correlated with the activity state of the promoter. These findings provide direct evidence for the functional role of highly mobile transcription factor complexes in transcription regulation.	[Qiu, Yi; Luo, Yi] Univ Florida, Shands Canc Ctr, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Chang, Myron] Univ Florida, Dept Epidemiol & Hlth Policy Res, Div Biostat, Gainesville, FL 32610 USA; [Stavreva, Diana A.; Indrawan, Anindya; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hager, GL (corresponding author), Univ Florida, Shands Canc Ctr, Dept Anat & Cell Biol, Rm 356,2033 Mowry Rd, Gainesville, FL 32610 USA.	qiuy@ufl.edu; hagerg@exchange.nih.gov	Stavreva, Diana/AAW-8964-2020	, Yi/0000-0002-3282-6072	National Institutes of Health [R01 HL095674-01]; Bankhead-Coley Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC005450, ZIABC010027] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program and Grant R01 HL095674-01 (to Y. Q.). This work was also supported by the Bankhead-Coley Research Foundation (to Y. Q.).	Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Hager GL, 2006, CHROMOSOME RES, V14, P107, DOI 10.1007/s10577-006-1030-0; Hager GL, 2004, BBA-GENE STRUCT EXPR, V1677, P46, DOI 10.1016/j.bbaexp.2003.09.016; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Nagaich AK, 2004, ANN NY ACAD SCI, V1024, P213, DOI 10.1196/annals.1321.002; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874	27	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7641	7647		10.1074/jbc.M110.185488	http://dx.doi.org/10.1074/jbc.M110.185488			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21127047	Green Published, hybrid			2022-12-25	WOS:000287737300077
J	Guerrero, F; Sedoud, A; Kirilovsky, D; Rutherford, AW; Ortega, JM; Roncel, M				Guerrero, Fernando; Sedoud, Arezki; Kirilovsky, Diana; Rutherford, A. William; Ortega, Jose M.; Roncel, Mercedes			A High Redox Potential Form of Cytochrome c(550) in Photosystem II from Thermosynechococcus elongatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; OXYGEN EVOLUTION; C-TYPE; GENE; MANGANESE; COMPLEX; BINDING; PHOTOACTIVATION; CYANOBACTERIA; RESOLUTION	Cytochrome c(550) (cyt c(550)) is a component of photosystem II (PSII) from cyanobacteria, red algae, and some other eukaryotic algae. Its physiological role remains unclear. In the present work, measurements of the midpoint redox potential (E-m) were performed using intact PSII core complexes preparations from a histidine-tagged PSII mutant strain of the thermophilic cyanobacterium Thermosynechococcus (T.) elongatus. When redox titrations were done in the absence of redox mediators, an E-m value of +200 mV was obtained for cyt c(550). This value is similar to 300 mV more positive than that previously measured in the presence of mediators (E-m = -80 mV). The shift from the high potential form (E-m = +200 mV) to the low potential form (E-m = -80 mV) of cyt c(550) is attributed to conformational changes, triggered by the reduction of a component of PSII that is sequestered and out of equilibrium with the medium, most likely the Mn4Ca cluster. This reduction can occur when reduced low potential redox mediators are present or under highly reducing conditions even in the absence of mediators. Based on these observations, it is suggested that the E-m of +200 mV obtained without mediators could be the physiological redox potential of the cyt c(550) in PSII. This value opens the possibility of a redox function for cyt c(550) in PSII.	[Roncel, Mercedes] Univ Seville, Inst Bioquim Vegetal & Fotosintesis, CSIC, Seville 41092, Spain; [Guerrero, Fernando; Sedoud, Arezki; Kirilovsky, Diana; Rutherford, A. William] Commissariat Energie Atom, Inst Biol & Technol Saclay iBiTec S, F-91191 Gif Sur Yvette, France; [Sedoud, Arezki; Kirilovsky, Diana; Rutherford, A. William] Ctr Natl Rech Sci, URA 2096, F-91191 Gif Sur Yvette, France	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Roncel, M (corresponding author), Univ Seville, Inst Bioquim Vegetal & Fotosintesis, CSIC, Americo Vespucio 49, Seville 41092, Spain.	mroncel@us.es	RONCEL, MERCEDES/G-3035-2015; Rutherford, Alfred W/A-7831-2019; Ortega, José María/O-7697-2014; Kirilovsky, Diana/I-2359-2014	RONCEL, MERCEDES/0000-0001-8749-7432; Rutherford, Alfred W/0000-0002-3124-154X; Ortega, José María/0000-0002-7841-3687; Kirilovsky, Diana/0000-0003-2146-3103; Guerrero, Fernando/0000-0003-2215-3115	Ministry of Education and Culture of Spain [BFU2007-68107-C02-01/BMC]; Andalusia Government [PAI CVI-261]; EU/Energy Network [212508]	Ministry of Education and Culture of Spain(Spanish Government); Andalusia Government; EU/Energy Network(European Commission)	This work was supported by grants from the Ministry of Education and Culture of Spain (BFU2007-68107-C02-01/BMC, cofinanced by FEDER), and Andalusia Government (PAI CVI-261) and the EU/Energy Network project SOLAR-H2 (FP7 Contract 212508).	ALAM J, 1984, BIOCHIM BIOPHYS ACTA, V766, P317, DOI 10.1016/0005-2728(84)90247-0; Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n; Biesiadka J, 2004, PHYS CHEM CHEM PHYS, V6, P4733, DOI 10.1039/b406989g; Burnap RL, 2004, PHYS CHEM CHEM PHYS, V6, P4803, DOI 10.1039/b407094a; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; CHENIAE GM, 1972, PLANT PHYSIOL, V50, P87, DOI 10.1104/pp.50.1.87; Clark W. M., 1960, OXIDATION REDUCTION; Dasgupta J, 2008, COORDIN CHEM REV, V252, P347, DOI 10.1016/j.ccr.2007.08.022; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; Dutton P L, 1978, Methods Enzymol, V54, P411; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frazao C, 2001, J BIOL INORG CHEM, V6, P324, DOI 10.1007/s007750100208; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HOGANSON CW, 1990, BIOCHIM BIOPHYS ACTA, V1016, P203, DOI 10.1016/0005-2728(90)90059-D; HOGANSON CW, 1991, BIOCHIM BIOPHYS ACTA, V1057, P399, DOI 10.1016/S0005-2728(05)80154-9; HOLTON RW, 1963, SCIENCE, V142, P234, DOI 10.1126/science.142.3589.234; Ishikita H, 2005, FEBS LETT, V579, P3190, DOI 10.1016/j.febslet.2005.05.004; JOHNSON GN, 1995, BBA-BIOENERGETICS, V1229, P202, DOI 10.1016/0005-2728(95)00003-2; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; KANG C, 1994, FEBS LETT, V344, P5, DOI 10.1016/0014-5793(94)00341-6; KASSNER RJ, 1972, P NATL ACAD SCI USA, V69, P2263, DOI 10.1073/pnas.69.8.2263; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P599, DOI 10.1093/pcp/pce074; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kerfeld CA, 2003, PLANT CELL PHYSIOL, V44, P697, DOI 10.1093/pcp/pcg084; KIENZL PF, 1983, FEBS LETT, V162, P76, DOI 10.1016/0014-5793(83)81052-7; Kirilovsky D, 2004, J BIOL CHEM, V279, P52869, DOI 10.1074/jbc.M408206200; KRIEGER A, 1995, BBA-BIOENERGETICS, V1229, P193, DOI 10.1016/0005-2728(95)00002-Z; KROGMANN DW, 1991, BIOCHIM BIOPHYS ACTA, V1058, P35, DOI 10.1016/S0005-2728(05)80264-6; Mao JJ, 2003, BIOCHEMISTRY-US, V42, P9829, DOI 10.1021/bi027288k; MEI R, 1991, BIOCHEMISTRY-US, V30, P7836, DOI 10.1021/bi00245a025; MIYAO M, 1991, BIOCHEMISTRY-US, V30, P5379, DOI 10.1021/bi00236a008; Morand L.Z., 1994, MOL BIOL CYANOBACTER, P381; Moser CC, 2005, PHOTOCH PHOTOBIO SCI, V4, P933, DOI 10.1039/b507352a; Muhlenhoff U, 1996, MOL GEN GENET, V252, P93, DOI 10.1007/s004389670011; NAVARRO JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P46, DOI 10.1006/abbi.1995.1202; NISHIYAMA Y, 1994, PLANT PHYSIOL, V105, P1313, DOI 10.1104/pp.105.4.1313; Roncel M, 2003, J BIOL INORG CHEM, V8, P206, DOI 10.1007/s00775-002-0406-7; Sawaya MR, 2001, BIOCHEMISTRY-US, V40, P9215, DOI 10.1021/bi002679p; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; TAMURA N, 1985, BIOCHIM BIOPHYS ACTA, V809, P245, DOI 10.1016/0005-2728(85)90068-4; Vrettos JS, 2001, J BIOL INORG CHEM, V6, P708, DOI 10.1007/s007750100249; Wilson G S, 1978, Methods Enzymol, V54, P396; Wirtz M, 2000, FARADAY DISCUSS, V116, P221, DOI 10.1039/b001520m; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	45	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5985	5994		10.1074/jbc.M110.170126	http://dx.doi.org/10.1074/jbc.M110.170126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21135104	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000287476400006
J	Zhao, W; Wang, LJ; Zhang, M; Wang, P; Zhang, L; Yuan, C; Qi, JN; Qiao, Y; Kuo, PC; Gao, CJ				Zhao, Wei; Wang, Lijuan; Zhang, Meng; Wang, Peng; Zhang, Lei; Yuan, Chao; Qi, Jianni; Qiao, Yu; Kuo, Paul C.; Gao, Chengjiang			Peroxisome Proliferator-activated Receptor gamma Negatively Regulates IFN-beta Production in Toll-like Receptor (TLR) 3-and TLR4-stimulated Macrophages by Preventing Interferon Regulatory Factor 3 Binding to the IFN-beta Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PPAR-GAMMA; I INTERFERON; ADAPTER PROTEIN; MEDIATED DEGRADATION; MURINE LUPUS; EXPRESSION; INFLAMMATION; AGONISTS	Toll-like receptors 3 and 4 utilize adaptor TRIF to activate interferon regulatory factor 3 (IRF3), resulting in IFN-beta production to mediate anti-viral and bacterial infection. Peroxisome proliferator-activated receptor (PPAR)-gamma is a ligand-activated transcription factor expressed in various immune cells and acts as a transcriptional repressor to inhibit the transcription of many proinflammatory cytokines. But, the function of PPAR-gamma in TLR3- and -4-mediated IFN-beta production is not well elucidated. Here, we have analyzed the effect of the PPAR-gamma agonists on IFN-beta production in peritoneal primary macrophages in response to LPS and poly(I:C). PPAR-gamma agonists inhibited LPS and poly(I:C)-induced IFN-beta transcription and secretion. siRNA knockdown of PPAR-gamma expression and transfection of PPAR-gamma expression plasmid demonstrated that PPAR-gamma agonist inhibits IFN-beta production in a PPAR-gamma-dependent manner. The ability of the PPAR-gamma agonist to inhibit IFN-beta production was confirmed in vivo as mice treated with troglitazone exhibited decreased levels of IFN-beta upon LPS and poly(I:C) challenge. Chromatin immunoprecipitation (CHIP) assay and electrophoretic mobility shift assay (EMSA) demonstrated that troglitazone treatment impaired IRF3 binding to the IFN-beta promoter. Furthermore, troglitazone could inhibit LPS and poly(I:C)-induced STAT1 phosphorylation and subsequent ISRE activation. These results demonstrate that PPAR-gamma negatively regulates IFN-beta production in TLR3- and 4-stimulated macrophages by preventing IRF3 binding to the IFN-beta promoter.	[Zhao, Wei; Wang, Lijuan; Zhang, Meng; Wang, Peng; Zhang, Lei; Yuan, Chao; Qi, Jianni; Qiao, Yu; Gao, Chengjiang] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China; [Zhao, Wei; Wang, Lijuan; Zhang, Meng; Wang, Peng; Zhang, Lei; Yuan, Chao; Qi, Jianni; Qiao, Yu; Gao, Chengjiang] Shandong Univ, Sch Med, Dept Immunol, Jinan 250012, Shandong, Peoples R China; [Kuo, Paul C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Shandong University; Shandong University; Duke University	Gao, CJ (corresponding author), 44 Wenhua Western Rd, Jinan 250012, Shandong, Peoples R China.	cgao@sdu.edu.cn	WANG, Peng/GSN-5263-2022; ZHAO, WEI/C-9163-2011	Zhao, Wei/0000-0001-8440-2274; Gao, Chengjiang/0000-0002-9365-4497	Taishan Scholar Program of Shandong Province; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090131110045]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry	Taishan Scholar Program of Shandong Province; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported in part by the Taishan Scholar Program of Shandong Province, Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20090131110045, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry (to G. C.).	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Appel S, 2005, BLOOD, V106, P3888, DOI 10.1182/blood-2004-12-4709; Aprahamian T, 2009, J IMMUNOL, V182, P340, DOI 10.4049/jimmunol.182.1.340; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Bonfield TL, 2008, J IMMUNOL, V181, P235, DOI 10.4049/jimmunol.181.1.235; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Cunard R, 2004, J IMMUNOL, V172, P7530, DOI 10.4049/jimmunol.172.12.7530; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lefort S, 2007, J VIROL, V81, P10950, DOI 10.1128/JVI.00183-07; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mangini AJ, 2007, ANN NY ACAD SCI, V1108, P11, DOI 10.1196/annals.1422.002; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Park SJ, 2009, J IMMUNOL, V183, P3259, DOI 10.4049/jimmunol.0900231; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhao W, 2007, IMMUNOL LETT, V108, P137, DOI 10.1016/j.imlet.2006.11.008; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312; Zhao WP, 2009, J IMMUNOL, V183, P2729, DOI 10.4049/jimmunol.0804341	37	48	50	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5519	5528		10.1074/jbc.M110.149823	http://dx.doi.org/10.1074/jbc.M110.149823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148557	Green Published, hybrid			2022-12-25	WOS:000287230600061
J	Bertoni, A; Giuliano, P; Galgani, M; Rotoli, D; Ulianich, L; Adornetto, A; Santillo, MR; Porcellini, A; Avvedimento, VE				Bertoni, Alessandra; Giuliano, Paola; Galgani, Mario; Rotoli, Deborah; Ulianich, Luca; Adornetto, Annagrazia; Santillo, Maria Rosaria; Porcellini, Antonio; Avvedimento, Vittorio Enrico			Early and Late Events Induced by PolyQ-expanded Proteins IDENTIFICATION OF A COMMON PATHOGENIC PROPERTY OF POLYQ-EXPANDED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; LIPID RAFTS; NEUROBLASTOMA-CELLS; NADPH OXIDASES; NOX FAMILY; HUNTINGTIN; TRANSCRIPTION; PROTEASOME; SYSTEM; ROS	To find a common pathogenetic trait induced by polyQ-expanded proteins, we have used a conditional expression system in PC12 cells to tune the expression of these proteins and analyze the early and late consequences of their expression. We find that expression for 3 h of a polyQ-expanded protein stimulates cellular reactive oxygen species (ROS) levels and significantly reduces the mitochondrial electrochemical gradient. 24-36 h later, ROS induce DNA damage and activation of the checkpoint kinase, ATM. DNA damage signatures are reversible and persist as long as polyQ-expanded proteins are expressed. Transcription of neural and stress response genes is down-regulated in these cells. Selective inhibition of ATM or histone deacetylase rescues transcription and restores the expression of silenced genes. Eventually, after 1 week, the expression of polyQ-expanded protein also induces endoplasmic reticulum stress. As to the primary mechanism responsible for ROS generation, we find that polyQ-expanded proteins, including native Ataxin-2 and Huntingtin, are selectively sequestered in the lipid raft membrane compartment and interact with gp91, the membrane NADPH-oxidase subunit. Selective inhibition of NADPH oxidase or silencing of H-Ras signaling dissolves the aggregates and eliminates DNA damage. We suggest that targeting of the polyQ-expanded proteins to the lipid rafts activates the resident NADPH oxidase. This triggers a signal linking H-Ras, ROS, and ERK1/2 that maintains and propagates the ROS wave to the nucleus. This mechanism may represent the common pathogenetic signature of all polyQ-expanded proteins independently of the specific context or the function of the native wild type protein.	[Avvedimento, Vittorio Enrico] Univ Naples Federico II, Sch Med, Dept Mol & Cellular Biol & Pathol, I-80131 Naples, Italy; [Rotoli, Deborah; Ulianich, Luca] CNR, Inst Endocrinol & Expt Oncol, I-80125 Naples, Italy; [Adornetto, Annagrazia; Santillo, Maria Rosaria] Univ Naples Federico II, Sch Med, Physiol Unit, Dept Neurosci, I-80131 Naples, Italy; [Porcellini, Antonio] Univ Molise, Dept Hlth Sci, I-86100 Campobasso, Italy; [Porcellini, Antonio] Univ Naples Federico II, Dept Struct & Funct Biol, I-80126 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Molise; University of Naples Federico II	Porcellini, A (corresponding author), Univ Campobasso, Dept Hlth Sci, Via De Sanctis, I-86100 Campobasso, Italy.	Antonio.Porcellini@unimol.it; avvedim@unina.it	Rotoli, Deborah/AAB-3237-2022; Ulianich, Luca/ABD-2530-2020; Porcellini, Antonio/E-1900-2011; Porcellini, Antonio/AAC-6097-2019; Galgani, Mario/AAC-3298-2022; Adornetto, Annagrazia/AAG-5467-2020	Rotoli, Deborah/0000-0001-9760-4211; Porcellini, Antonio/0000-0001-6882-9518; Adornetto, Annagrazia/0000-0003-1869-2642; Galgani, Mario/0000-0001-8414-1676	Associazione Italiana per la Ricerca sul Cancro and CariVerona	Associazione Italiana per la Ricerca sul Cancro and CariVerona(Fondazione AIRC per la ricerca sul cancro)	This work supported in part by Associazione Italiana per la Ricerca sul Cancro and CariVerona.	Abramov AY, 2004, BBA-MOL CELL RES, V1742, P81, DOI 10.1016/j.bbamcr.2004.09.006; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Calabresi P, 1998, ANN NEUROL, V43, P586, DOI 10.1002/ana.410430506; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Das R, 2007, FREE RADICAL BIO MED, V42, P541, DOI 10.1016/j.freeradbiomed.2006.11.020; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; Fuhler GM, 2007, J LEUKOCYTE BIOL, V81, P449, DOI 10.1189/jlb.0506311; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Guo C, 2007, CELL SIGNAL, V19, P504, DOI 10.1016/j.cellsig.2006.08.001; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hsiao HY, 2010, MOL NEUROBIOL, V41, P248, DOI 10.1007/s12035-009-8097-5; Hu H, 2004, EUR J NEUROSCI, V20, P3351, DOI 10.1111/j.1460-9568.2004.03796.x; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Illuzzi J, 2009, J NEUROSCI RES, V87, P733, DOI 10.1002/jnr.21881; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Iwahori S, 2008, CELL SIGNAL, V20, P1795, DOI 10.1016/j.cellsig.2008.06.007; Jin S, 2008, ARTERIOSCL THROM VAS, V28, P485, DOI 10.1161/ATVBAHA.107.159772; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Lefrancois-Martinez AM, 2004, J CLIN ENDOCR METAB, V89, P3010, DOI 10.1210/jc.2003-031830; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Noh JY, 2009, J BIOL CHEM, V284, P11318, DOI 10.1074/jbc.M807620200; Olofsson BA, 2007, MOL CANCER RES, V5, P1319, DOI 10.1158/1541-7786.MCR-07-0374; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Quintanilla RA, 2009, BRAIN RES BULL, V80, P242, DOI 10.1016/j.brainresbull.2009.07.010; Reiner A, 2003, MOL NEUROBIOL, V28, P259, DOI 10.1385/MN:28:3:259; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Seru R, 2004, J NEUROCHEM, V91, P613, DOI 10.1111/j.1471-4159.2004.02754.x; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Sim S, 2005, J IMMUNOL, V174, P4279, DOI 10.4049/jimmunol.174.7.4279; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200; Vacca F, 2004, J NEUROSCI RES, V76, P653, DOI 10.1002/jnr.20069; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829	53	52	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4727	4741		10.1074/jbc.M110.156521	http://dx.doi.org/10.1074/jbc.M110.156521			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21115499	Green Published, hybrid			2022-12-25	WOS:000286975700071
J	Liu, B; Moloney, A; Meehan, S; Morris, K; Thomas, SE; Serpell, LC; Hider, R; Marciniak, SJ; Lomas, DA; Crowther, DC				Liu, Beinan; Moloney, Aileen; Meehan, Sarah; Morris, Kyle; Thomas, Sally E.; Serpell, Louise C.; Hider, Robert; Marciniak, Stefan J.; Lomas, David A.; Crowther, Damian C.			Iron Promotes the Toxicity of Amyloid beta Peptide by Impeding Its Ordered Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; DROSOPHILA MODEL; BINDING; CHEMISTRY; METALS; COPPER; DAMAGE; IONS	We have previously shown that overexpressing subunits of the iron-binding protein ferritin can rescue the toxicity of the amyloid beta (A beta) peptide in our Drosophila model system. These data point to an important pathogenic role for iron in Alzheimer disease. In this study, we have used an iron-selective chelating compound and RNAi-mediated knockdown of endogenous ferritin to further manipulate iron in the brain. We confirm that chelation of iron protects the fly from the harmful effects of A beta. To understand the pathogenic mechanisms, we have used biophysical techniques to see how iron affects A beta aggregation. We find that iron slows the progression of the A beta peptide from an unstructured conformation to the ordered cross-beta fibrils that are characteristic of amyloid. Finally, using mammalian cell culture systems, we have shown that iron specifically enhances A beta toxicity but only if the metal is present throughout the aggregation process. These data support the hypothesis that iron delays the formation of well ordered aggregates of A beta and so promotes its toxicity in Alzheimer disease.	[Liu, Beinan; Moloney, Aileen; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Marciniak, Stefan J.; Lomas, David A.; Crowther, Damian C.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Meehan, Sarah] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Morris, Kyle; Serpell, Louise C.] Univ Sussex, Dept Biochem, Sch Life Sci, Falmer BN1 6PD, Sussex, England; [Hider, Robert] Kings Coll London, Dept Biol Chem, Pharmaceut Sci Res Div, London WC2R 2LS, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Sussex; University of London; King's College London	Crowther, DC (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	dcc26@cam.ac.uk	Marciniak, Stefan J/F-1855-2010	Hider, Robert/0000-0003-1330-5797; Serpell, Louise/0000-0001-9335-7751; Morris, Kyle L/0000-0002-1717-8134; Marciniak, Stefan/0000-0001-8472-7183	MRC (UK); Engineering and Physical Sciences Research Council (EPSRC) (UK); Diabetes UK; Alzheimers Research UK [ART-ESG2010-3, ART-SRF2010-2, ART-PhD2006-5] Funding Source: researchfish; Medical Research Council [G0601840, G0901786, MC_G1000734, G0700990] Funding Source: researchfish; MRC [G0601840, G0700990, MC_G1000734, G0901786] Funding Source: UKRI	MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (EPSRC) (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Diabetes UK(Diabetes UK); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the MRC (UK), Engineering and Physical Sciences Research Council (EPSRC) (UK), and Diabetes UK.	Brorsson AC, 2010, BIOPHYS J, V98, P1677, DOI 10.1016/j.bpj.2009.12.4320; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Garzon-Rodriguez W, 1999, BIOORG MED CHEM LETT, V9, P2243, DOI 10.1016/S0960-894X(99)00357-1; Grossi C, 2009, J ALZHEIMERS DIS, V17, P423, DOI 10.3233/JAD-2009-1063; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Huang JJ, 2006, BRAIN RES, V1097, P52, DOI 10.1016/j.brainres.2006.04.047; Huang XD, 2004, ANN NY ACAD SCI, V1012, P153, DOI 10.1196/annals.1306.012; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li YP, 1996, BRAIN RES, V738, P196, DOI 10.1016/S0006-8993(96)00733-0; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Makin O. Sumner, 2004, V299, P67; Molina-Holgado F, 2007, BIOMETALS, V20, P639, DOI 10.1007/s10534-006-9033-z; Nair NG, 2010, J ALZHEIMERS DIS, V20, P57, DOI 10.3233/JAD-2010-1346; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Rival T, 2009, EUR J NEUROSCI, V29, P1335, DOI 10.1111/j.1460-9568.2009.06701.x; ROGERS DR, 1965, AM J CLIN PATHOL, V44, P59; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wan L., 2010, FREE RADIC IN PRESS; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Zecca L, 2004, P NATL ACAD SCI USA, V101, P9843, DOI 10.1073/pnas.0403495101	33	148	156	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4248	4256		10.1074/jbc.M110.158980	http://dx.doi.org/10.1074/jbc.M110.158980			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21147772	Green Published, hybrid			2022-12-25	WOS:000286975700023
J	Mellert, HS; Stanek, TJ; Sykes, SM; Rauscher, FJ; Schultz, DC; McMahon, SB				Mellert, Hestia S.; Stanek, Timothy J.; Sykes, Stephen M.; Rauscher, Frank J., III; Schultz, David C.; McMahon, Steven B.			Deacetylation of the DNA-binding Domain Regulates p53-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; HISTONE DEACETYLASE-1; MDM2 INTERACTION; P53; ACETYLATION; INHIBITORS; REPRESSION; FAMILY; COREPRESSOR; ACTIVATION	In unstressed cells, the p53 tumor suppressor is highly unstable. DNA damage and other forms of cellular stress rapidly stabilize and activate p53. This process is regulated by a complex array of post-translational modifications that are dynamically deposited onto p53. Recent studies show that these modifications orchestrate p53-mediated processes such as cell cycle arrest and apoptosis. Cancer cells carry inherent genetic damage, but avoid arrest and apoptosis by inactivating p53. Defining the enzymatic machinery that regulates the stress-induced modification of p53 at single-residue resolution is critical to our understanding of the biochemical mechanisms that control this critical tumor suppressor. Specifically, acetylation of p53 at lysine 120, a DNA-binding domain residue mutated in human cancer, is essential for triggering apoptosis. Given the oncogenic properties of deacetylases and the success of deacetylase inhibitors as anticancer agents, we investigated the regulation of Lys(120) deacetylation using pharmacologic and genetic approaches. This analysis revealed that histone deacetylase 1 is predominantly responsible for the deacetylation of Lys(120). Furthermore, treatment with the clinical-grade histone deacetylase inhibitor entinostat enhances Lys(120) acetylation, an event that is mechanistically linked to its apoptotic effect. These data expand our understanding of the mechanisms controlling p53 function and suggest that regulation of p53 modification status at single-residue resolution by targeted therapeutics can selectively alter p53 pathway function. This knowledge may impact the rational application of deacetylase inhibitors in the treatment of human cancer.	[Stanek, Timothy J.; McMahon, Steven B.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Mellert, Hestia S.] Univ Penn, Philadelphia, PA 19104 USA; [Sykes, Stephen M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Rauscher, Frank J., III; Schultz, David C.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Jefferson University; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; The Wistar Institute	McMahon, SB (corresponding author), 609 BLSB,233 S 10th St, Philadelphia, PA 19107 USA.	Steven.McMahon@jci.tju.edu	qiao, zhixin/I-3408-2012	Stanek, Timothy/0000-0001-9192-4978; McMahon, Steven/0000-0002-3405-1768	National Institutes of Health [CA090465, CA152786, CA098172]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R21CA152786, R01CA090465, R01CA098172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA090465, CA152786, and CA098172 (to S. B. M.). This work was also supported by the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health.	Bandyopadhyay D, 2004, CANCER RES, V64, P7706, DOI 10.1158/0008-5472.CAN-03-3897; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cerna D, 2006, CURR TOP DEV BIOL, V73, P173, DOI 10.1016/S0070-2153(05)73006-4; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Habold C, 2008, J CELL MOL MED, V12, P607, DOI 10.1111/j.1582-4934.2007.00136.x; Hess-Stumpp H, 2007, INT J BIOCHEM CELL B, V39, P1388, DOI 10.1016/j.biocel.2007.02.009; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfister S, 2008, INT J CANCER, V122, P1207, DOI 10.1002/ijc.23283; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	42	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4264	4270		10.1074/jbc.M110.184663	http://dx.doi.org/10.1074/jbc.M110.184663			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148320	Green Published, hybrid			2022-12-25	WOS:000286975700025
J	Pu, SY; Turinsky, AL; Vlasblom, J; On, T; Xiong, XJ; Emili, A; Zhang, ZL; Greenblatt, J; Parkinson, J; Wodak, SJ				Pu, Shuye; Turinsky, Andrei L.; Vlasblom, James; On, Tuan; Xiong, Xuejian; Emili, Andrew; Zhang, Zhaolei; Greenblatt, Jack; Parkinson, John; Wodak, Shoshana J.			Expanding the Landscape of Chromatin Modification (CM)-Related Functional Domains and Genes in Human	PLOS ONE			English	Article							DNA-BINDING; LYSINE METHYLATION; PROTEIN COMPLEXES; SWIRM DOMAIN; FAMILY; EVOLUTION; RECOGNITION; ACETYLATION; DEMETHYLASE; PREDICTION	Chromatin modification (CM) plays a key role in regulating transcription, DNA replication, repair and recombination. However, our knowledge of these processes in humans remains very limited. Here we use computational approaches to study proteins and functional domains involved in CM in humans. We analyze the abundance and the pair-wise domain-domain co-occurrences of 25 well-documented CM domains in 5 model organisms: yeast, worm, fly, mouse and human. Results show that domains involved in histone methylation, DNA methylation, and histone variants are remarkably expanded in metazoan, reflecting the increased demand for cell type-specific gene regulation. We find that CM domains tend to co-occur with a limited number of partner domains and are hence not promiscuous. This property is exploited to identify 47 potentially novel CM domains, including 24 DNA-binding domains, whose role in CM has received little attention so far. Lastly, we use a consensus Machine Learning approach to predict 379 novel CM genes (coding for 329 proteins) in humans based on domain compositions. Several of these predictions are supported by very recent experimental studies and others are slated for experimental verification. Identification of novel CM genes and domains in humans will aid our understanding of fundamental epigenetic processes that are important for stem cell differentiation and cancer biology. Information on all the candidate CM domains and genes reported here is publicly available.	[Pu, Shuye; Turinsky, Andrei L.; Vlasblom, James; On, Tuan; Xiong, Xuejian; Parkinson, John; Wodak, Shoshana J.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Vlasblom, James; Parkinson, John; Wodak, Shoshana J.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [On, Tuan; Emili, Andrew; Zhang, Zhaolei; Greenblatt, Jack; Parkinson, John; Wodak, Shoshana J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Emili, Andrew; Zhang, Zhaolei; Greenblatt, Jack] Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Emili, Andrew; Zhang, Zhaolei; Greenblatt, Jack] Banting & Best Dept Med Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto	Pu, SY (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	shoshana@sickkids.ca	Parkinson, John/A-4424-2008	Parkinson, John/0000-0001-9815-1189; wodak, shoshana/0000-0002-0701-6545	Canadian Institutes of Health Research (CIHR TEAM) [82940]; Hospital for Sick Children; Ontario Genomics Institute; Ontario Ministry of Research and Innovation; Genome Canada; Canadian Institutes for Health Research; Sickkids Foundation, Toronto, Canada	Canadian Institutes of Health Research (CIHR TEAM)(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children(University of Toronto); Ontario Genomics Institute; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Genome Canada(Genome Canada); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Sickkids Foundation, Toronto, Canada	This work was funded by a grant from the Canadian Institutes of Health Research (CIHR TEAM Grant #82940). S.J.W. is a Tier 1 Canada Research Chair in Computational Biology and Bioinformatics and acknowledges support from the Canadian Institutes for Health Research, the Hospital for Sick Children and the Sickkids Foundation, Toronto, Canada. J.G. acknowledges support from Ontario Genomics Institute and Genome Canada. J.P. is supported by a CIHR New Investigators award and an Early Researcher award from the Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Bao Yunhe, 2007, Cell, V129, P632, DOI 10.1016/j.cell.2007.04.018; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Goodson HV, 2002, J CELL SCI, V115, P2619; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hayete B, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P127; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Joachims T., 1999, ADV KERNEL METHODS S; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; Lall S, 2007, NAT STRUCT MOL BIOL, V14, P1110, DOI 10.1038/nsmb1107-1110; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Lobley AE, 2008, NUCLEIC ACIDS RES, V36, pW297, DOI 10.1093/nar/gkn193; MAK AB, 2010, MOL CELL PROTEOMICS; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Martin DMA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-178; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; ON T, 2010, PROTEINS IN PRESS; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pillus L, 2008, CURR OPIN CELL BIOL, V20, P326, DOI 10.1016/j.ceb.2008.04.009; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Qiu J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000054; Rodriguez MC, 2008, FRONT BIOSCI-LANDMRK, V13, P5905, DOI 10.2741/3125; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sampath V, 2009, MOL CELL BIOL, V29, P2532, DOI 10.1128/MCB.01682-08; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Singhal M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-199; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; van Rijsbergen C. J., 1979, INFORM RETIREVAL; Vogel C, 2005, J MOL BIOL, V346, P355, DOI 10.1016/j.jmb.2004.11.050; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Weiner J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-285; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhou XF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-294	81	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14122	10.1371/journal.pone.0014122	http://dx.doi.org/10.1371/journal.pone.0014122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124763	Green Submitted, gold, Green Published			2022-12-25	WOS:000284686500010
J	Gomes, NCM; Cleary, DFR; Pinto, FN; Egas, C; Almeida, A; Cunha, A; Mendonca-Hagler, LCS; Smalla, K				Gomes, Newton C. M.; Cleary, Daniel F. R.; Pinto, Fernando N.; Egas, Conceicao; Almeida, Adelaide; Cunha, Angela; Mendonca-Hagler, Leda C. S.; Smalla, Kornelia			Taking Root: Enduring Effect of Rhizosphere Bacterial Colonization in Mangroves	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; SEDIMENTS; RESTORATION; PATTERNS; WORLD	Background: Mangrove forests are of global ecological and economic importance, but are also one of the world's most threatened ecosystems. Here we present a case study examining the influence of the rhizosphere on the structural composition and diversity of mangrove bacterial communities and the implications for mangrove reforestation approaches using nursery-raised plants. Methodology/Principal Findings: A barcoded pyrosequencing approach was used to assess bacterial diversity in the rhizosphere of plants in a nursery setting, nursery-raised transplants and native (non-transplanted) plants in the same mangrove habitat. In addition to this, we also assessed bacterial composition in the bulk sediment in order to ascertain if the roots of mangrove plants affect sediment bacterial composition. We found that mangrove roots appear to influence bacterial abundance and composition in the rhizosphere. Due to the sheer abundance of roots in mangrove habitat, such an effect can have an important impact on the maintenance of bacterial guilds involved in nutrient cycling and other key ecosystem functions. Surprisingly, we also noted a marked impact of initial nursery conditions on the rhizosphere bacterial composition of replanted mangrove trees. This result is intriguing because mangroves are periodically inundated with seawater and represent a highly dynamic environment compared to the more controlled nursery environment. Conclusions/Significance: In as far as microbial diversity and composition influences plant growth and health, this study indicates that nursery conditions and early microbial colonization patterns of the replants are key factors that should be considered during reforestation projects. In addition to this, our results provide information on the role of the mangrove rhizosphere as a habitat for bacteria from estuarine sediments.	[Gomes, Newton C. M.; Cleary, Daniel F. R.; Almeida, Adelaide; Cunha, Angela] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Gomes, Newton C. M.; Cleary, Daniel F. R.; Almeida, Adelaide; Cunha, Angela] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Pinto, Fernando N.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Egas, Conceicao] Biocant Biotechnol Innovat Ctr, Cantanhede, Portugal; [Egas, Conceicao] Univ Coimbra, Ctr Neurosci & Cellular Biol, Coimbra, Portugal; [Mendonca-Hagler, Leda C. S.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil; [Smalla, Kornelia] Julius Kuhn Inst Cultivated Crops, Braunschweig, Germany	Universidade de Aveiro; Universidade de Aveiro; Universidade Federal do Rio de Janeiro; Universidade de Coimbra; Universidade Federal do Rio de Janeiro; Julius Kuhn-Institut	Gomes, NCM (corresponding author), Univ Aveiro, CESAM, P-3800 Aveiro, Portugal.	gomesncm@ua.pt	Gomes, Newton Carlos Marcial/K-3211-2015; Almeida, Adelaide/D-9899-2011; Cleary, Daniel/D-2582-2012; Cunha, Angela/AAC-3830-2019; Gomes, Newton Carlos Marcial/AAV-4603-2021; Cleary, Daniel/ABA-9393-2021; Smalla, Kornelia/H-4002-2011; Gomes, Newton CM/F-7430-2012; Cunha, Angela/E-9537-2011; Egas, Conceição/K-4866-2014	Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Almeida, Adelaide/0000-0002-8422-8664; Cleary, Daniel/0000-0002-6143-3390; Cunha, Angela/0000-0002-9118-3521; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Cleary, Daniel/0000-0002-6143-3390; Gomes, Newton CM/0000-0003-1934-0091; Cunha, Angela/0000-0002-9118-3521; Egas, Conceição/0000-0002-2307-5414	Deutsche Forschungsgemeinschaft [SM59/4-1, 4-2]; FAPERJ-Brazil; Centre for Environmental and Marine Studies (CESAM, Portugal)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FAPERJ-Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Centre for Environmental and Marine Studies (CESAM, Portugal)	This study was funded by the Deutsche Forschungsgemeinschaft SM59/4-1 and 4-2 (http://www.dfg.de/en/index.jsp), FAPERJ-Brazil (http://www.faperj.br/) and Centre for Environmental and Marine Studies (CESAM, Portugal) (http://www.cesam.ua.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Elster C, 2000, FOREST ECOL MANAG, V131, P201, DOI 10.1016/S0378-1127(99)00214-5; Flores-Mireles AL, 2007, APPL ENVIRON MICROB, V73, P7308, DOI 10.1128/AEM.01892-06; GATTENLOHNER U, MANGROVE REHABILITAT; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gomes NCM, 2008, FEMS MICROBIOL ECOL, V66, P96, DOI 10.1111/j.1574-6941.2008.00519.x; Gomes NCM, 2007, APPL ENVIRON MICROB, V73, P7392, DOI 10.1128/AEM.01099-07; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; HOFLICH G, 1994, EXPERIENTIA, V50, P897, DOI 10.1007/BF01923476; Imhoff JF, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P846, DOI 10.1007/0-387-30746-x_31; Kathiresan K, 2005, ESTUAR COAST SHELF S, V65, P601, DOI 10.1016/j.ecss.2005.06.022; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; Kirui BYK, 2008, HYDROBIOLOGIA, V603, P171, DOI 10.1007/s10750-007-9270-3; Lyimo TJ, 2009, FEMS MICROBIOL ECOL, V70, P483, DOI 10.1111/j.1574-6941.2009.00765.x; MCKEE KL, 1993, J ECOL, V81, P477, DOI 10.2307/2261526; MCKEE KL, 1995, OECOLOGIA, V101, P448, DOI 10.1007/BF00329423; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Philippot L, 2009, PLANT SOIL, V321, P61, DOI 10.1007/s11104-008-9796-9; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Primavera J. H., 2008, Wetlands Ecology and Management, V16, P345, DOI 10.1007/s11273-008-9101-y; ROBERTSON AI, 1995, HYDROBIOLOGIA, V295, P311, DOI 10.1007/BF00029138; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Sorensen J., 1997, Modern soil microbiology., P21; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Toledo G, 2001, HYDROBIOLOGIA, V444, P101, DOI 10.1023/A:1017552305401; VOGT KA, 1986, ADV ECOL RES, V15, P303, DOI 10.1016/S0065-2504(08)60122-1; WILSON JB, 1991, J VEG SCI, V2, P35, DOI 10.2307/3235896; Yuan SY, 2007, J ENVIRON SCI HEAL B, V42, P63, DOI 10.1080/03601230601020860; ZABLOTOWICZ RM, 1995, APPL ENVIRON MICROB, V61, P1054, DOI 10.1128/AEM.61.3.1054-1060.1995; Zhang M, 2009, CHEMOSPHERE, V76, P677, DOI 10.1016/j.chemosphere.2009.03.066	37	86	88	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14065	10.1371/journal.pone.0014065	http://dx.doi.org/10.1371/journal.pone.0014065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124923	gold, Green Published, Green Submitted			2022-12-25	WOS:000284467200005
J	Stofanko, M; Kwon, SY; Badenhorst, P				Stofanko, Martin; Kwon, So Yeon; Badenhorst, Paul			Lineage Tracing of Lamellocytes Demonstrates Drosophila Macrophage Plasticity	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSE; LYMPH GLAND; HEMOCYTES; REVEALS; PROTEIN; SCREEN; SYSTEM; GENES; EYE; DIFFERENTIATION	Leukocyte-like cells called hemocytes have key functions in Drosophila innate immunity. Three hemocyte types occur: plasmatocytes, crystal cells, and lamellocytes. In the absence of qimmune challenge, plasmatocytes are the predominant hemocyte type detected, while crystal cells and lamellocytes are rare. However, upon infestation by parasitic wasps, or in melanotic mutant strains, large numbers of lamellocytes differentiate and encapsulate material recognized as "non-self". Current models speculate that lamellocytes, plasmatocytes and crystal cells are distinct lineages that arise from a common prohemocyte progenitor. We show here that over-expression of the CoREST-interacting transcription factor Chn in plasmatocytes induces lamellocyte differentiation, both in circulation and in lymph glands. Lamellocyte increases are accompanied by the extinction of plasmatocyte markers suggesting that plasmatocytes are transformed into lamellocytes. Consistent with this, timed induction of Chn over-expression induces rapid lamellocyte differentiation within 18 hours. We detect double-positive intermediates between plasmatocytes and lamellocytes, and show that isolated plasmatocytes can be triggered to differentiate into lamellocytes in vitro, either in response to Chn over-expression, or following activation of the JAK/STAT pathway. Finally, we have marked plasmatocytes and show by lineage tracing that these differentiate into lamellocytes in response to the Drosophila parasite model Leptopilina boulardi. Taken together, our data suggest that lamellocytes arise from plasmatocytes and that plasmatocytes may be inherently plastic, possessing the ability to differentiate further into lamellocytes upon appropriate challenge.	[Stofanko, Martin; Kwon, So Yeon; Badenhorst, Paul] Univ Birmingham, Inst Biomed Res, Edgbaston, England	University of Birmingham	Stofanko, M (corresponding author), Univ Birmingham, Inst Biomed Res, Edgbaston, England.	p.w.badenhorst@bham.ac.uk	Kwon, So Yeon/M-5625-2014	Kwon, So Yeon/0000-0002-8490-9101; /0000-0002-2542-0250	Medical Research Council; Cancer Research UK	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	This work was supported by funding from the Medical Research Council and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Avet-Rochex A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-65; Bataille L, 2005, DEVELOPMENT, V132, P4635, DOI 10.1242/dev.02034; Carrera P, 1998, P NATL ACAD SCI USA, V95, P10779, DOI 10.1073/pnas.95.18.10779; Crew JR, 1997, DEV GENES EVOL, V206, P481, DOI 10.1007/s004270050079; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Dallman JE, 2004, J NEUROSCI, V24, P7186, DOI 10.1523/JNEUROSCI.0238-04.2004; Escudero LM, 2005, DEVELOPMENT, V132, P1211, DOI 10.1242/dev.01691; Frandsen Joel L., 2008, Proceedings of the National Academy of Sciences of the United States of America, V105, P14952, DOI 10.1073/pnas.0808208105; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Hartenstein V, 2006, ANNU REV CELL DEV BI, V22, P677, DOI 10.1146/annurev.cellbio.22.010605.093317; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Honti V, 2010, MOL IMMUNOL, V47, P1997, DOI 10.1016/j.molimm.2010.04.017; JONES SL, 1999, PHAGOCYTOSIS; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; KANIA A, 1995, GENETICS, V139, P1663; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; O'Shea John J, 2008, Nat Immunol, V9, P450, DOI 10.1038/ni0508-450; Qiu P, 1998, DEVELOPMENT, V125, P1909; RIZKI MOHAMMED TAHIR MIRZA, 1957, J MORPH, V100, P437, DOI 10.1002/jmor.1051000303; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; Rizki TM, 1957, J MORPHOL, V100, P459; Rus F, 2006, GENE EXPR PATTERNS, V6, P928, DOI 10.1016/j.modgep.2006.03.005; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Stofanko M, 2008, GENETICS, V180, P253, DOI 10.1534/genetics.108.089094; Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tsuda L, 2006, EMBO J, V25, P3191, DOI 10.1038/sj.emboj.7601179; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90; Waltzer L, 2002, EMBO J, V21, P5477, DOI 10.1093/emboj/cdf545; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	48	76	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14051	10.1371/journal.pone.0014051	http://dx.doi.org/10.1371/journal.pone.0014051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124962	Green Submitted, Green Published, gold			2022-12-25	WOS:000284400100005
J	Chen, CH; Gau, V; Zhang, DD; Liao, JC; Wang, FY; Wong, PK				Chen, Chia Hsiang; Gau, Vincent; Zhang, Donna D.; Liao, Joseph C.; Wang, Fei-Yue; Wong, Pak Kin			Statistical Metamodeling for Revealing Synergistic Antimicrobial Interactions	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; COMBINATORY DRUGS; ESCHERICHIA-COLI; ESSENTIAL OILS; OPTIMIZATION; GENTAMICIN; DISCOVERY; TRIMETHOPRIM; CONSTITUENTS; ANTIBIOTICS	Many bacterial pathogens are becoming drug resistant faster than we can develop new antimicrobials. To address this threat in public health, a metamodel antimicrobial cocktail optimization (MACO) scheme is demonstrated for rapid screening of potent antibiotic cocktails using uropathogenic clinical isolates as model systems. With the MACO scheme, only 18 parallel trials were required to determine a potent antimicrobial cocktail out of hundreds of possible combinations. In particular, trimethoprim and gentamicin were identified to work synergistically for inhibiting the bacterial growth. Sensitivity analysis indicated gentamicin functions as a synergist for trimethoprim, and reduces its minimum inhibitory concentration for 40-fold. Validation study also confirmed that the trimethoprim-gentamicin synergistic cocktail effectively inhibited the growths of multiple strains of uropathogenic clinical isolates. With its effectiveness and simplicity, the MACO scheme possesses the potential to serve as a generic platform for identifying synergistic antimicrobial cocktails toward management of bacterial infection in the future.	[Chen, Chia Hsiang; Wong, Pak Kin] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA; [Gau, Vincent] GeneFluidics Inc, Monterey Pk, CA USA; [Zhang, Donna D.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Liao, Joseph C.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Wang, Fei-Yue] Chinese Acad Sci, Inst Automat, Key Lab Complex Syst & Intelligence Sci, Beijing, Peoples R China; [Wong, Pak Kin] Univ Arizona, Biomed Engn & Bio5 Inst, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; Stanford University; Chinese Academy of Sciences; Institute of Automation, CAS; University of Arizona	Chen, CH (corresponding author), Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA.	pak@email.arizona.edu	Zhang, Donna/B-1015-2012; Liao, Joseph C/J-5874-2015; Wong, Pak Kin/A-7974-2012	Wong, Pak Kin/0000-0001-7388-2110; Liao, Joseph/0000-0003-2448-5463	National Institutes of Health [1DP2OD007161-01]; National Institutes of Health National Institute of Allergy and Infectious Diseases [1U01AI082457-01, R43AI088756-01]; National Institutes of Health National Institute of Child Health and Human Development [R43HD065303-01]; National Science Foundation [0900899]; GeneFluidics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R43HD065303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082457, R44AI088756, R43AI088756] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF)); GeneFluidics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Institutes of Health Director's New Innovator Award (1DP2OD007161-01), National Institutes of Health National Institute of Allergy and Infectious Diseases (1U01AI082457-01; R43AI088756-01), National Institutes of Health National Institute of Child Health and Human Development (R43HD065303-01) and National Science Foundation (0900899). VG, who is the director of GeneFluidics Inc., designed the experiments and analyzed the result. NIH and NSF had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; VG is the director of GeneFluidics Inc. JCL and PKW are co-investigators in research grants of GeneFluidics. These affiliations do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Antony J, 2003, DESIGN EXPT ENG SCI; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; BUSHBY SRM, 1968, BRIT J PHARMACOL, V33, P72, DOI 10.1111/j.1476-5381.1968.tb00475.x; Chang ST, 2001, J ETHNOPHARMACOL, V77, P123, DOI 10.1016/S0378-8741(01)00273-2; Chen CH, 2010, ANAL CHEM, V82, P1012, DOI 10.1021/ac9022764; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; CLSI, 2006, PERF STAND ANT SUSC; Feala JD, 2010, WIRES SYST BIOL MED, V2, P181, DOI 10.1002/wsbm.51; FORREST RD, 1982, J ROY SOC MED, V75, P198; FORREST S, 1993, SCIENCE, V261, P872, DOI 10.1126/science.8346439; Friedman M, 2004, J FOOD PROTECT, V67, P1774, DOI 10.4315/0362-028X-67.8.1774; Hartmann A.K., 2002, OPTIMIZATION ALGORIT; HEWITT WL, 1974, POSTGRAD MED J, V50, P55; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kollef MH, 2001, ANN INTERN MED, V134, P298, DOI 10.7326/0003-4819-134-4-200102200-00014; Kolusheva S, 2000, NAT BIOTECHNOL, V18, P225, DOI 10.1038/72697; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Mach K. E., 2009, J UROL; MACH KE, J UROLOGY IN PRESS; PAISLEY JW, 1978, ANTIMICROB AGENTS CH, V14, P656, DOI 10.1128/AAC.14.5.656; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Queipo NV, 2005, PROG AEROSP SCI, V41, P1, DOI 10.1016/j.paerosci.2005.02.001; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Sun CP, 2009, INTEGR BIOL-UK, V1, P123, DOI 10.1039/b815225j; Sundin DP, 2001, J AM SOC NEPHROL, V12, P114, DOI 10.1681/ASN.V121114; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105; Wu J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1035; Zinner RG, 2009, MOL CANCER THER, V8, P521, DOI 10.1158/1535-7163.MCT-08-0937; Zinner S H, 1982, Eur J Clin Microbiol, V1, P144, DOI 10.1007/BF02019614	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15472	10.1371/journal.pone.0015472	http://dx.doi.org/10.1371/journal.pone.0015472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21124958	Green Published, gold, Green Submitted			2022-12-25	WOS:000284087800026
J	Hunt, ME; Scherrer, MP; Ferrari, FD; Matz, MV				Hunt, Marguerite E.; Scherrer, Michael P.; Ferrari, Frank D.; Matz, Mikhail V.			Very Bright Green Fluorescent Proteins from the Pontellid Copepod Pontella mimocerami	PLOS ONE			English	Article							CORAL; REPORTER; RED; GFP; AMPHIOXUS; DIVERSITY; EVOLUTION; MUTANTS; EMBRYOS; MARKER	Background: Fluorescent proteins (FP) homologous to the green fluorescent protein (GFP) from the jellyfish Aequorea victoria have revolutionized biomedical research due to their usefulness as genetically encoded fluorescent labels. Fluorescent proteins from copepods are particularly promising due to their high brightness and rapid fluorescence development. Results: Here we report two novel FPs from Pontella mimocerami (Copepoda, Calanoida, Pontellidae), which were identified via fluorescence screening of a bacterial cDNA expression library prepared from the whole-body total RNA of the animal. The proteins are very similar in sequence and spectroscopic properties. They possess high molar extinction coefficients (79,000 M(-1) cm(-)) and quantum yields (0.92), which make them more than two-fold brighter than the most common FP marker, EGFP. Both proteins form oligomers, which we were able to counteract to some extent by mutagenesis of the N-terminal region; however, this particular modification resulted in substantial drop in brightness. Conclusions: The spectroscopic characteristics of the two P. mimocerami proteins place them among the brightest green FPs ever described. These proteins may therefore become valuable additions to the in vivo imaging toolkit.	[Hunt, Marguerite E.; Scherrer, Michael P.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ferrari, Frank D.] Smithsonian Inst, Dept Invertebrate Zool, Natl Museum Nat Hist, Suitland, MD USA; [Matz, Mikhail V.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Texas System; University of Texas Austin	Hunt, ME (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	matz@mail.utexas.edu	Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819; Janga, Sarath Chandra/0000-0001-7351-6268	National Institutes of Health [R01 GM078247]; Ocean Exploration program of the National Oceanic and Atmospheric Administration; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ocean Exploration program of the National Oceanic and Atmospheric Administration; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Ocean Exploration program of the National Oceanic and Atmospheric Administration ("Operation Deep Scope 2007''), and the National Institutes of Health grant R01 GM078247 to M. V. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMSTERDAM A, 1995, DEV BIOL, V171, P123, DOI 10.1006/dbio.1995.1265; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bomati EK, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-77; Bryan B., 2001, United States Patent, Patent No. 6232107; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHUDAKOV DM, FLUORESCENT IN PRESS; Cormack B, 1998, CURR OPIN MICROBIOL, V1, P406, DOI 10.1016/S1369-5274(98)80057-X; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; DRUMMOND AJ, 2009, GENEIOUS V4 8; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Fleminger A., 1957, Tulane Studies in Zoology, V5, P19; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2003, BIOCHEM J, V373, P403, DOI 10.1042/BJ20021966; Harvey E.N., 1952, BIOLUMINESCENCE; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HERRING PJ, 1988, HYDROBIOLOGIA, V167, P183, DOI 10.1007/BF00026304; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; LAND MF, 1988, J EXP BIOL, V140, P381; Masuda H, 2006, GENE, V372, P18, DOI 10.1016/j.gene.2005.11.031; Matz MV, 2006, METHOD BIOCHEM ANAL, V47, P139; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Matz MV, 1999, NAT BIOTECHNOL, V17, P1227; Ohtsuka S, 2001, HYDROBIOLOGIA, V453, P441, DOI 10.1023/A:1013162605809; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shagin DA, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e23; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHEEN J, 1995, PLANT J, V8, P777, DOI 10.1046/j.1365-313X.1995.08050777.x; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X	35	87	90	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11517	10.1371/journal.pone.0011517	http://dx.doi.org/10.1371/journal.pone.0011517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644720	gold, Green Published			2022-12-25	WOS:000279884900005
J	Suhr, ST; Chang, EA; Rodriguez, RM; Wang, K; Ross, PJ; Beyhan, Z; Murthy, S; Cibelli, JB				Suhr, Steven T.; Chang, Eun Ah; Rodriguez, Ramon M.; Wang, Kai; Ross, Pablo J.; Beyhan, Zeki; Murthy, Shashanka; Cibelli, Jose B.			Telomere Dynamics in Human Cells Reprogrammed to Pluripotency	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CLONING; CANCER; LENGTH	Background: Human induced pluripotent stem cells (IPSCs) have enormous potential in the development of cellular models of human disease and represent a potential source of autologous cells and tissues for therapeutic use. A question remains as to the biological age of IPSCs, in particular when isolated from older subjects. Studies of cloned animals indicate that somatic cells reprogrammed to pluripotency variably display telomere elongation, a common indicator of cell "rejuvenation.'' Methodology/Principal Findings: We examined telomere lengths in human skin fibroblasts isolated from younger and older subjects, fibroblasts converted to IPSCs, and IPSCs redifferentiated through teratoma formation and explant culture. In IPSCs analyzed at passage five (P5), telomeres were significantly elongated in 6/7 lines by >40% and approximated telomere lengths in human embryonic stem cells (hESCs). In cell lines derived from three IPSC-teratoma explants cultured to P5, two displayed telomeres shortened to lengths similar to input fibroblasts while the third line retained elongated telomeres. Conclusions/Significance: While these results reveal some heterogeneity in the reprogramming process with respect to telomere length, human somatic cells reprogrammed to pluripotency generally displayed elongated telomeres that suggest that they will not age prematurely when isolated from subjects of essentially any age.	[Suhr, Steven T.; Chang, Eun Ah; Rodriguez, Ramon M.; Wang, Kai; Ross, Pablo J.; Beyhan, Zeki; Murthy, Shashanka; Cibelli, Jose B.] Michigan State Univ, Cellular Reprogramming Lab, Dept Anim Sci, E Lansing, MI 48824 USA; [Ross, Pablo J.; Cibelli, Jose B.] Programa Andaluz Terapia Celular & Med Regenerat, Andalucia, Spain	Michigan State University	Suhr, ST (corresponding author), Michigan State Univ, Cellular Reprogramming Lab, Dept Anim Sci, E Lansing, MI 48824 USA.	cibelli@anr.msu.edu	Rodriguez, Ramon Maria/AAF-9376-2019; wang, kai/G-4932-2011	Rodriguez, Ramon Maria/0000-0002-6770-5123; Goissis, Marcelo/0000-0002-7382-7477; Cibelli, Jose/0000-0002-2176-3854; Perkins, Guy/0000-0002-1834-6646	Naylor Family Foundation	Naylor Family Foundation	Funding was obtained from the Naylor Family Foundation, Michigan State University Vice President for Research and Graduate Studies and The Michigan Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Cheung ALM, 2008, FRONT BIOSCI-LANDMRK, V13, P2075, DOI 10.2741/2825; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrington L, 2004, ONCOGENE, V23, P7283, DOI 10.1038/sj.onc.1207948; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kubota C, 2004, NAT BIOTECHNOL, V22, P693, DOI 10.1038/nbt975; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Riethman H, 2008, ANNU REV GENOM HUM G, V9, P1, DOI 10.1146/annurev.genom.8.021506.172017; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	216	221	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8124	10.1371/journal.pone.0008124	http://dx.doi.org/10.1371/journal.pone.0008124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956585	Green Published, gold, Green Submitted			2022-12-25	WOS:000272828800018
